PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bian, T; Gibbs, JD; Orvell, C; Imani, F				Bian, Tao; Gibbs, John D.; Orvell, Claes; Imani, Farhad			Respiratory Syncytial Virus Matrix Protein Induces Lung Epithelial Cell Cycle Arrest through a p53 Dependent Pathway	PLOS ONE			English	Article							INFECTION; REPLICATION; EXPRESSION; ASSOCIATION; INCREASES; APOPTOSIS; CHILDREN; INFANTS; IMPACT; RISK	Respiratory syncytial virus (RSV) is the major cause of viral respiratory infections in children. Our previous study showed that the RSV infection induced lung epithelial cell cycle arrest, which enhanced virus replication. To address the mechanism of RSV-induced cell cycle arrest, we examined the contribution of RSV-matrix (RSV-M) protein. In this report, we show that in both the A549 cell line and primary human bronchial epithelial (PHBE) cells, transfection with RSV-M protein caused the cells to proliferate at a slower rate than in control cells. The cell cycle analysis showed that RSV-M protein induced G1 phase arrest in A549 cells, and G1 and G2/M phase arrest in PHBE cells. Interestingly, RSV-M expression induced p53 and p21 accumulation and decreased phosphorylation of retinoblastoma protein (Rb). Further, induction of cell cycle arrest by RSV-M was not observed in a p53-deficient epithelial cell line (H1299). However, cell cycle arrest was restored after transfection of p53 cDNA into H1299 cells. Taken together, these results indicate that RSV-M protein regulates lung epithelial cell cycle through a p53-dependent pathway, which enhances RSV replication.	[Bian, Tao] Natl Inst Environm Human Sci, Lab Resp Biol, Durham, NC USA; [Gibbs, John D.] Global Vaccines Inc, Durham, NC USA; [Orvell, Claes] Karolinska Inst, Huddinge Univ Hosp, Dept Clin Virol, Stockholm, Sweden; [Imani, Farhad] ViraSource Labs, Durham, NC USA	Karolinska Institutet	Bian, T (corresponding author), Natl Inst Environm Human Sci, Lab Resp Biol, Durham, NC USA.	fimani@virasource.com	Bian, Tao/I-7604-2013		National Institute of Health (NIH)	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was fully funded by Intramural National Institute of Health (NIH) funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Casavant NC, 2006, J VIROL, V80, P8390, DOI 10.1128/JVI.00505-06; Centers for Disease Control and Prevention, 2008, RESP SYNC VIR INF, P18; Chulu JL, 2010, J VIROL; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; De Beeck AO, 2001, J VIROL, V75, P11071, DOI 10.1128/JVI.75.22.11071-11078.2001; Eckardt-Michel J, 2008, J VIROL, V82, P3236, DOI 10.1128/JVI.01887-07; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emmett Stevan R., 2004, V296, P197; Genini D, 2001, FASEB J, V15, P5; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2003, ARCH VIROL, V148, P1419, DOI 10.1007/s00705-003-0112-y; Ghildyal R, 2002, J GEN VIROL, V83, P753, DOI 10.1099/0022-1317-83-4-753; Ghildyal R, 2006, FEMS MICROBIOL REV, V30, P692, DOI 10.1111/j.1574-6976.2006.00025.x; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hayon IL, 2002, CELL CYCLE, V1, P111, DOI 10.4161/cc.1.2.109; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Hwang ES, 2009, J VIROL, V83, P12388, DOI 10.1128/JVI.00304-09; Kash JC, 2011, MBIO, V2, DOI 10.1128/mBio.00172-11; Klein MI, 2006, J INFECT DIS, V193, P1544, DOI 10.1086/503806; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Lu MS, 1999, J VIROL, V73, P676, DOI 10.1128/JVI.73.1.676-683.1999; Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005; Orba Y, 2010, J BIOL CHEM, V285, P1544, DOI 10.1074/jbc.M109.064311; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2008, J GEN VIROL, V89, P1106, DOI 10.1099/vir.0.83262-0; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Park GB, 2009, IMMUNOLOGY, V128, P360, DOI 10.1111/j.1365-2567.2009.03111.x; Pavelic SK, 2009, J CANCER RES CLIN, V135, P1747, DOI 10.1007/s00432-009-0621-5; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Restle A, 2005, ONCOGENE, V24, P4380, DOI 10.1038/sj.onc.1208639; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Royds JA, 2006, ONCOGENE, V25, P1509, DOI 10.1038/sj.onc.1209185; Sarfraz S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-133; Sato Y, 2010, CELL CYCLE, V9, P807, DOI 10.4161/cc.9.4.10675; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Subbramanian RA, 1998, J MOL BIOL, V278, P13, DOI 10.1006/jmbi.1998.1685; Vilcek J, 2003, NAT IMMUNOL, V4, P825, DOI 10.1038/ni0903-825; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027	46	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38052	10.1371/journal.pone.0038052	http://dx.doi.org/10.1371/journal.pone.0038052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662266	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300158
J	Hu, SS; Wang, BB; Qi, YH; Lin, H				Hu, Shanshan; Wang, Binbin; Qi, Yanhua; Lin, Hui			The Arg233Lys AQP0 Mutation Disturbs Aquaporin0-Calmodulin Interaction Causing Polymorphic Congenital Cataract	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; NUCLEAR CATARACT; MIP; GENE	Calmodulin (CaM) directly interacts with the aquaporin 0 (AQP0) C-terminus in a calcium dependent manner to regulate the water permeability of AQP0. We previously identified a missense mutation (p.R233K) in the putative CaM binding domain of AQP0 C-terminus in a congenital cataract family. This study was aimed at exploring the potential pathogenesis of this mutation causative of cataract and mainly identifying how it influenced the binding of AQP0 to CaM. Wild type and R233K mutant AQP0 with EGFP-tag were transfected separately into Hela cells to determine the expression and subcellular localizations. The co-immunoprecipitation (CoIP) assay was used to detect the interaction between AQP0 and CaM. AQP0 C-terminus peptides were synthesized with and without R233K, and the binding abilities of these peptides to CaM were assessed using a fluorescence binding assay. Localizations of wild type and R233K mutant AQP0 were determined from EGFP fluorescence, and the chimeric proteins were both localized abundantly in the plasma membrane. Protein expression levels of the culture cells showed no significant difference between them. The results from CoIP assay implied that R233K mutant presented more weakly in association with CaM than wild type AQP0. The AQP0 C-terminal mutant peptide was found to have 2.5-fold lower binding affinity to CaM than wild type peptide. These results suggested that R233K mutation did not affect the expression, location and trafficking of the protein but did influence the interaction between AQP0 and CaM. The binding affinity of AQP0 C-terminus to CaM was significantly reduced. Due to lack of the modulation of the Ca2+-calmodulin complex, the water permeability of AQP0 was subsequently augmented, which might lead to the development of this cataract.	[Hu, Shanshan; Qi, Yanhua; Lin, Hui] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China; [Wang, Binbin] Natl Res Inst Family Planning, Ctr Genet, Beijing, Peoples R China	Harbin Medical University; National Research Institute for Family Planning - China	Qi, YH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China.	qyh64@hotmail.com; LL266@yahoo.com		Wang, Binbin/0000-0002-1597-5930	National Natural Science Foundation of China [30801274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 30801274] (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2005, BIOL CELL, V97, P355, DOI 10.1042/BC20050027; ALCALA J, 1975, EXP EYE RES, V21, P581, DOI 10.1016/0014-4835(75)90040-8; ARNESON ML, 1995, EUR J BIOCHEM, V234, P670, DOI 10.1111/j.1432-1033.1995.670_b.x; Babu YS, 1998, J MOL BIOL, V1, P191; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Chepelinsky AB, 2003, J EXP ZOOL PART A, V300A, P41, DOI 10.1002/jez.a.10307; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; Golestaneh N, 2008, MOL VIS, V14, P1006; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gu F, 2007, MOL VIS, V13, P1651; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; Jiang J, 2009, MOL VIS, V15, P38; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; KUSHMERICK C, 1995, EXP EYE RES, V61, P351, DOI 10.1016/S0014-4835(05)80129-0; Lin H, 2007, MOL VIS, V13, P1822; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; MAUCH L, 1990, J BIOL CHEM, V265, P12761; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Nemeth-Cahalan KL, 2007, J GEN PHYSIOL, V5, P4574; OH BH, 1993, J BIOL CHEM, V268, P11348; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; Varadaraj K, 2008, EXP EYE RES, V87, P9, DOI 10.1016/j.exer.2008.04.001; Varadaraj K, 1999, J MEMBRANE BIOL, V170, P191, DOI 10.1007/s002329900549; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Wang KJ, 2011, MOL VIS, V17, P70; Wang W, 2010, MOL VIS, V16, P534; Xiao Xueshan, 2011, Mol Vis, V17, P2049; Yang GX, 2011, MOL VIS, V17, P1320; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313	35	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37637	10.1371/journal.pone.0037637	http://dx.doi.org/10.1371/journal.pone.0037637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662182	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300072
J	Johansson, M; Roberts, A; Chen, D; Li, YY; Delahaye-Sourdeix, M; Aswani, N; Greenwood, MA; Benhamou, S; Lagiou, P; Holcatova, I; Richiardi, L; Kjaerheim, K; Agudo, A; Castellsague, X; Macfarlane, TV; Barzan, L; Canova, C; Thakker, NS; Conway, DI; Znaor, A; Healy, CM; Ahrens, W; Zaridze, D; Szeszenia-Dabrowska, N; Lissowska, J; Fabianova, E; Mates, IN; Bencko, V; Foretova, L; Janout, V; Curado, MP; Koifman, S; Menezes, A; Wunsch, V; Eluf-Neto, J; Boffetta, P; Franceschi, S; Herrero, R; Garrote, LF; Talamini, R; Boccia, S; Galan, P; Vatten, L; Thomson, P; Zelenika, D; Lathrop, M; Byrnes, G; Cunningham, H; Brennan, P; Wakefield, J; Mckay, JD				Johansson, Mattias; Roberts, Angus; Chen, Dan; Li, Yaoyong; Delahaye-Sourdeix, Manon; Aswani, Niraj; Greenwood, Mark A.; Benhamou, Simone; Lagiou, Pagona; Holcatova, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsague, Xavier; Macfarlane, Tatiana V.; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S.; Conway, David I.; Znaor, Ariana; Healy, Claire M.; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Boffetta, Paolo; Franceschi, Silvia; Herrero, Rolando; Fernandez Garrote, Leticia; Talamini, Renato; Boccia, Stefania; Galan, Pilar; Vatten, Lars; Thomson, Peter; Zelenika, Diana; Lathrop, Mark; Byrnes, Graham; Cunningham, Hamish; Brennan, Paul; Wakefield, Jon; Mckay, James D.			Using Prior Information from the Medical Literature in GWAS of Oral Cancer Identifies Novel Susceptibility Variant on Chromosome 4-the AdAPT Method	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; POOLED ANALYSIS; 15Q25; LOCUS; DISEASES; EUROPE; GENES; RISK	Background: Genome-wide association studies (GWAS) require large sample sizes to obtain adequate statistical power, but it may be possible to increase the power by incorporating complementary data. In this study we investigated the feasibility of automatically retrieving information from the medical literature and leveraging this information in GWAS. Methods: We developed a method that searches through PubMed abstracts for pre-assigned keywords and key concepts, and uses this information to assign prior probabilities of association for each single nucleotide polymorphism (SNP) with the phenotype of interest - the Adjusting Association Priors with Text (AdAPT) method. Association results from a GWAS can subsequently be ranked in the context of these priors using the Bayes False Discovery Probability (BFDP) framework. We initially tested AdAPT by comparing rankings of known susceptibility alleles in a previous lung cancer GWAS, and subsequently applied it in a two-phase GWAS of oral cancer. Results: Known lung cancer susceptibility SNPs were consistently ranked higher by AdAPT BFDPs than by p-values. In the oral cancer GWAS, we sought to replicate the top five SNPs as ranked by AdAPT BFDPs, of which rs991316, located in the ADH gene region of 4q23, displayed a statistically significant association with oral cancer risk in the replication phase (per-rare-allele log additive p-value [p(trend)] = 2.5 x 10(-3)). The combined OR for having one additional rare allele was 0.83 (95% CI: 0.76-0.90), and this association was independent of previously identified susceptibility SNPs that are associated with overall UADT cancer in this gene region. We also investigated if rs991316 was associated with other cancers of the upper aerodigestive tract (UADT), but no additional association signal was found. Conclusion: This study highlights the potential utility of systematically incorporating prior knowledge from the medical literature in genome-wide analyses using the AdAPT methodology. AdAPT is available online (url: http://services.gate.ac.uk/lld/gwas/service/config).	[Johansson, Mattias; Chen, Dan; Delahaye-Sourdeix, Manon; Franceschi, Silvia; Byrnes, Graham; Brennan, Paul; Mckay, James D.] Int Agcy Res Canc IARC, Sect Infect, Lyon, France; [Roberts, Angus; Aswani, Niraj; Greenwood, Mark A.; Cunningham, Hamish] Univ Sheffield, Dept Comp Sci, GATE Team, Sheffield S10 2TN, S Yorkshire, England; [Li, Yaoyong] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England; [Benhamou, Simone] INSERM, U946, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, CNRS, UMR8200, Villejuif, France; [Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Holcatova, Ivana; Bencko, Vladimir] Charles Univ Prague, Inst Hyg & Epidemiol, Fac Med 1, Prague, Czech Republic; [Richiardi, Lorenzo] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Agudo, Antonio; Castellsague, Xavier] IDIBELL, Inst Catala Oncol ICO, Lhospitalet De Llobregat, Catalonia, Spain; [Castellsague, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Barzan, Luigi] Gen Hosp Pordenone, Pordenone, Italy; [Canova, Cristina] Univ Padua, Dept Mol Med, Padua, Italy; [Canova, Cristina] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth Resp Epidemiol & Publ, Natl Heart & Lung Inst, London, England; [Thakker, Nalin S.] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Znaor, Ariana] Croatian Natl Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Healy, Claire M.] Trinity Coll Dublin, Sch Dent Sci, Dublin, Ireland; [Ahrens, Wolfgang] Inst Epidemiol & Prevent Res BIPS, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Inst Stat, D-28359 Bremen, Germany; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Fabianova, Eleonora] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Mates, Ioan Nicolae] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Curado, Maria Paula; Boffetta, Paolo] Int Prevent Res Inst IPRI, Ecully, France; [Curado, Maria Paula] Hosp Araujo Jorge ACCG, Goiania, Go, Brazil; [Koifman, Sergio] Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil; [Menezes, Ana] Univ Fed Pelotas, Pelotas, Brazil; [Wuensch-Filho, Victor; Eluf-Neto, Jose] Univ Sao Paulo, Sao Paulo, Brazil; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Herrero, Rolando] Inst Invest Epidemiol, San Jose, Costa Rica; [Fernandez Garrote, Leticia] Inst Oncol & Radiobiol, Havana, Cuba; [Talamini, Renato] IRCSS, Natl Canc Inst, Aviano, Italy; [Boccia, Stefania] Univ Cattolica Sacro Cuore, Inst Hyg, Rome, Italy; [Boccia, Stefania] IRCCS San Raffaele Pisana, Rome, Italy; [Galan, Pilar] Univ Paris 13, INSERM, U557, UMR Inserm,INRA,CNAM, Paris, France; [Galan, Pilar] CRNH IdF, Bobigny, France; [Vatten, Lars] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Thomson, Peter] Newcastle Univ, Sch Dent, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Zelenika, Diana; Lathrop, Mark] Commissariat Energie Atom, Ctr Natl Genotypage, Inst Genom, Evry, France; [Lathrop, Mark] Fondat Jean Dausset CEPH, Paris, France; [Wakefield, Jon] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wakefield, Jon] Univ Washington, Dept Stat, Seattle, WA 98195 USA	World Health Organization; International Agency for Research on Cancer (IARC); University of Sheffield; Paterson Institute for Cancer Research; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; Athens Medical School; National & Kapodistrian University of Athens; Charles University Prague; University of Turin; University of Oslo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Aberdeen; University of Padua; Imperial College London; University of Manchester; University of Glasgow; Trinity College Dublin; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Regional Authority of Public Health Banska Bystrica; Carol Davila University of Medicine & Pharmacy; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Fundacao Oswaldo Cruz; Universidade Federal de Pelotas; Universidade de Sao Paulo; Icahn School of Medicine at Mount Sinai; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS San Raffaele Pisana; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite Paris 13; Norwegian University of Science & Technology (NTNU); Newcastle University - UK; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Johansson, M (corresponding author), Int Agcy Res Canc IARC, Sect Infect, Lyon, France.	johanssonm@iarc.fr; mckay@iarc.fr	Menezes, Ana MB/G-7266-2012; franceschi, silvia/M-2452-2014; Johansson, Mattias/ABF-3365-2020; Boccia, Stefania/AAB-9533-2022; Curado, Maria Paula/M-6200-2013; Boffetta, Paolo/AAI-7767-2021; Vatten, Lars/AAF-9380-2022; Holcatova, Ivana/C-8327-2017; Healy, Claire M/AGL-9755-2022; Boccia, Stefania/AFN-1666-2022; Agudo, Antonio/J-1805-2016; Filho, Victor Wunsch/C-4475-2012; Bencko, Vladimir/H-8598-2017; Pique, Xavier Castellsagué/N-5795-2014; Mates, Ioan Nicolae/E-9255-2017; Benhamou, Simone/K-6554-2015; Benhamou, Simone/ABD-2590-2020; Znaor, A/H-6718-2019; Janout, Vladimir/M-5133-2014; Szeszenia-Dabrowska, Neonila/F-7190-2010; Vatten, Lars/AFK-2073-2022; Zaridze, David/K-5605-2013; Eluf-Neto, Jose/B-2522-2009; Lissowska, Jolanta/AAH-3252-2020; richiardi, lorenzo/J-3480-2018; Thomson, Peter/L-7719-2016; Ahrens, Wolfgang/A-2740-2012	Menezes, Ana MB/0000-0002-2996-9427; franceschi, silvia/0000-0003-4181-8071; Boccia, Stefania/0000-0002-1864-749X; Curado, Maria Paula/0000-0001-8172-2483; Boffetta, Paolo/0000-0002-3811-2791; Holcatova, Ivana/0000-0002-1366-0337; Healy, Claire M/0000-0003-0583-6360; Boccia, Stefania/0000-0002-1864-749X; Agudo, Antonio/0000-0001-9900-5677; Bencko, Vladimir/0000-0003-1935-2228; Pique, Xavier Castellsagué/0000-0002-0802-3595; Eluf-Neto, Jose/0000-0001-7504-2115; Lissowska, Jolanta/0000-0003-2695-5799; Healy, Claire M/0000-0001-7940-4611; richiardi, lorenzo/0000-0003-0316-9402; CANOVA, CRISTINA/0000-0001-7027-7935; Roberts, Angus/0000-0002-4570-9801; Johansson, Mattias/0000-0002-3116-5081; Thomson, Peter/0000-0002-2007-7975; Cunningham, Hamish/0000-0001-5901-5483; Conway, David/0000-0001-7762-4063; Kjaerheim, Kristina/0000-0003-0691-3735; Ahrens, Wolfgang/0000-0003-3777-570X; Macfarlane, Tatiana/0000-0002-9392-0812; Foretova, Lenka/0000-0003-0494-2620; Ioan Nicoale, Mates/0000-0001-7210-0615; BENHAMOU, Simone/0000-0001-5853-8047; Byrnes, Graham/0000-0003-3893-7539	EU; United States National Cancer Institute [R01 CA092039 05]; National Institute of Dental and Craniofacial Research [1R03DE020116]; INCa (Institut National du Cancer, France);  [FP7-215535]; NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020116] Funding Source: NIH RePORTER	EU(European Commission); United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); INCa (Institut National du Cancer, France); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by EU-FP7 grant [LarKC, url: http://www.larkc.eu][FP7-215535]. Funding for study coordination, genotyping of replication studies and statistical analysis was provided by the United States National Cancer Institute (R01 CA092039 05) and the National Institute of Dental and Craniofacial Research (1R03DE020116). Support for the central Europe and ARCAGE genome-wide studies was provided by INCa (Institut National du Cancer, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], 2009, UMLS REF MAN; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen D, 2011, CANCER EPIDEM BIOMAR, V20, P658, DOI 10.1158/1055-9965.EPI-10-1008; Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007; Cunningham H, 2011, INFORM EXTRACTION SE, P307; Cunningham H., 2011, TEXT PROCESSING GATE; Falush D, 2003, GENETICS, V164, P1567; Garavello W, 2008, INT J CANCER, V122, P1827, DOI 10.1002/ijc.23199; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Scelo G, 2004, CANCER CAUSE CONTROL, V15, P445, DOI 10.1023/B:CACO.0000036444.11655.be; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	31	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36888	10.1371/journal.pone.0036888	http://dx.doi.org/10.1371/journal.pone.0036888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662130	Green Published, gold, Green Accepted			2022-12-27	WOS:000305342300021
J	Khodadad, CLM; Foster, JS				Khodadad, Christina L. M.; Foster, Jamie S.			Metagenomic and Metabolic Profiling of Nonlithifying and Lithifying Stromatolitic Mats of Highborne Cay, The Bahamas	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; MODERN MARINE STROMATOLITES; LITHIFIED MICRITIC LAMINAE; MICROBIAL MATS; BIOCHEMICAL-CHARACTERIZATION; RAST SERVER; DIVERSITY; COMMUNITY; LITHIFICATION; CYANOBACTERIA	Background: Stromatolites are laminated carbonate build-ups formed by the metabolic activity of microbial mats and represent one of the oldest known ecosystems on Earth. In this study, we examined a living stromatolite located within the Exuma Sound, The Bahamas and profiled the metagenome and metabolic potential underlying these complex microbial communities. Methodology/Principal Findings: The metagenomes of the two dominant stromatolitic mat types, a nonlithifying (Type 1) and lithifying (Type 3) microbial mat, were partially sequenced and compared. This deep-sequencing approach was complemented by profiling the substrate utilization patterns of the mats using metabolic microarrays. Taxonomic assessment of the protein-encoding genes confirmed previous SSU rRNA analyses that bacteria dominate the metagenome of both mat types. Eukaryotes comprised less than 13% of the metagenomes and were rich in sequences associated with nematodes and heterotrophic protists. Comparative genomic analyses of the functional genes revealed extensive similarities in most of the subsystems between the nonlithifying and lithifying mat types. The one exception was an increase in the relative abundance of certain genes associated with carbohydrate metabolism in the lithifying Type 3 mats. Specifically, genes associated with the degradation of carbohydrates commonly found in exopolymeric substances, such as hexoses, deoxy-and acidic sugars were found. The genetic differences in carbohydrate metabolisms between the two mat types were confirmed using metabolic microarrays. Lithifying mats had a significant increase in diversity and utilization of carbon, nitrogen, phosphorus and sulfur substrates. Conclusion/Significance: The two stromatolitic mat types retained similar microbial communities, functional diversity and many genetic components within their metagenomes. However, there were major differences detected in the activity and genetic pathways of organic carbon utilization. These differences provide a strong link between the metagenome and the physiology of the mats, as well as new insights into the biological processes associated with carbonate precipitation in modern marine stromatolites.	[Khodadad, Christina L. M.; Foster, Jamie S.] Univ Florida, Dept Microbiol & Cell Sci, Space Life Sci Lab, Kennedy Space Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Khodadad, CLM (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Space Life Sci Lab, Kennedy Space Ctr, Gainesville, FL 32611 USA.	jfoster@ufl.edu		Foster, Jamie/0000-0001-8603-4006	National Aeronautics Space Administration (NASA): Exobiology and Evolutionary Biology Program Element [NNX09AO57G]; NASA Florida Space Grant Consortium	National Aeronautics Space Administration (NASA): Exobiology and Evolutionary Biology Program Element(National Aeronautics & Space Administration (NASA)); NASA Florida Space Grant Consortium	This work was supported by the National Aeronautics Space Administration (NASA): Exobiology and Evolutionary Biology Program Element (NNX09AO57G) (http://astrobiology.nasa.gov/) and the NASA Florida Space Grant Consortium (http://www.floridaspacegrant.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, EARLY LIFE EARTH; Apple JK, 2011, APPL ENVIRON MICROB, V77, P3074, DOI 10.1128/AEM.02241-10; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Bianchi TS, 2007, BIOCH ESTUARIES; Bowlin EM, 2011, SEDIMENT GEOL, DOI [10.1016/j.sedgeo.2011.1008.1002, DOI 10.1016/J.SEDGEO.2011.1008.1002]; Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Burns BP, 2004, ENVIRON MICROBIOL, V6, P1096, DOI 10.1111/j.1462-2920.2004.00651.x; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; De Philippis R, 1998, APPL ENVIRON MICROB, V64, P1130; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Foster JS, 2011, CELL ORIG LIFE EXTRE, V18, P385; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Frias-Lopez J, 2009, ENVIRON MICROBIOL, V11, P512, DOI 10.1111/j.1462-2920.2008.01793.x; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Green SJ, 2008, ISME J, V2, P457, DOI 10.1038/ismej.2008.6; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; GUDE H, 1985, MICROBIAL ECOL, V11, P193, DOI 10.1007/BF02010599; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hewson I, 2010, ENVIRON MICROBIOL, V12, P1940, DOI 10.1111/j.1462-2920.2010.02198.x; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawaguchi T, 2000, PREP BIOCHEM BIOTECH, V30, P321, DOI 10.1080/10826060008544971; Kawaguchi T, 2002, PREP BIOCHEM BIOTECH, V32, P51, DOI 10.1081/PB-120013161; Macintyre IG, 2000, SEDIMENTOLOGY, V47, P915, DOI 10.1046/j.1365-3091.2000.00327.x; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; Moreno AM, 2010, APPL ENVIRON MICROB, V76, P2203, DOI 10.1128/AEM.02777-09; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Paerl HW, 2001, ENVIRON MICROBIOL, V3, P123, DOI 10.1046/j.1462-2920.2001.00168.x; Perkins RG, 2007, MAR ECOL PROG SER, V349, P23, DOI 10.3354/meps07087; Pinckney JL, 1997, FACIES, V36, P204; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Steppe TF, 2001, MICROB ECOL, V41, P36; Stolz John F., 2009, Atoll Research Bulletin, P1; Varin T, 2010, LIMNOL OCEANOGR, V55, P1901, DOI 10.4319/lo.2010.55.5.1901; Visscher PT, 2000, GEOLOGY, V28, P919, DOI 10.1130/0091-7613(2000)028<0919:MOOSRC>2.3.CO;2; Visscher PT, 1999, APPL ENVIRON MICROB, V65, P3272; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Visscher PT, 2002, ACS SYM SER, V220, P265	59	40	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38229	10.1371/journal.pone.0038229	http://dx.doi.org/10.1371/journal.pone.0038229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662280	gold, Green Published			2022-12-27	WOS:000305342300172
J	Qi, RF; Zhang, LJ; Xu, Q; Zhong, JH; Wu, SY; Zhang, ZQ; Liao, W; Ni, L; Zhang, ZJ; Chen, HF; Zhong, Y; Jiao, Q; Wu, XJ; Fan, XX; Liu, YJ; Lu, GM				Qi, Rongfeng; Zhang, Long Jiang; Xu, Qiang; Zhong, Jianhui; Wu, Shengyong; Zhang, Zhiqiang; Liao, Wei; Ni, Ling; Zhang, Zongjun; Chen, Huafu; Zhong, Yuan; Jiao, Qing; Wu, Xingjiang; Fan, Xinxin; Liu, Yijun; Lu, Guangming			Selective Impairments of Resting-State Networks in Minimal Hepatic Encephalopathy	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; BRAIN METABOLISM; NEURAL MECHANISM; WORKING PARTY; DEFAULT-MODE; CIRRHOSIS; ABNORMALITIES; DIAGNOSIS	Background: Minimal hepatic encephalopathy (MHE) is a neuro-cognitive dysfunction characterized by impairment in attention, vigilance and integrative functions, while the sensorimotor function was often unaffected. Little is known, so far, about the exact neuro-pathophysiological mechanisms of aberrant cognition function in this disease. Methodology/Principal Findings: To investigate how the brain function is changed in MHE, we applied a resting-state fMRI approach with independent component analysis (ICA) to assess the differences of resting-state networks (RSNs) between MHE patients and healthy controls. Fourteen MHE patients and 14 age-and sex-matched healthy subjects underwent resting-state fMRI scans. ICA was used to identify six RSNs [dorsal attention network (DAN), default mode network (DMN), visual network (VN), auditory network (AN), sensorimotor network (SMN), self-referential network (SRN)] in each subject. Group maps of each RSN were compared between the MHE and healthy control groups. Pearson correlation analysis was performed between the RSNs functional connectivity (FC) and venous blood ammonia levels, and neuropsychological tests scores for all patients. Compared with the healthy controls, MHE patients showed significantly decreased FC in DAN, both decreased and increased FC in DMN, AN and VN. No significant differences were found in SRN and SMN between two groups. A relationship between FC and blood ammonia levels/neuropsychological tests scores were found in specific regions of RSNs, including middle and medial frontal gyrus, inferior parietal lobule, as well as anterior and posterior cingulate cortex/precuneus. Conclusions/Significance: MHE patients have selective impairments of RSNs intrinsic functional connectivity, with aberrant functional connectivity in DAN, DMN, VN, AN, and spared SMN and SRN. Our fMRI study might supply a novel way to understand the neuropathophysiological mechanism of cognition function changes in MHE.	[Qi, Rongfeng; Zhang, Long Jiang; Zhang, Zhiqiang; Ni, Ling; Zhang, Zongjun; Zhong, Yuan; Jiao, Qing; Lu, Guangming] Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Xu, Qiang; Liao, Wei; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Dalian, Sichuan Provinc, Peoples R China; [Zhong, Jianhui] Univ Rochester, Sch Med & Dent, Dept Imaging Sci, Rochester, NY USA; [Wu, Shengyong] Med Imaging Inst Tianjin, Tianjin, Peoples R China; [Wu, Xingjiang; Fan, Xinxin] Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA	Nanjing University; University of Electronic Science & Technology of China; University of Rochester; Nanjing University; State University System of Florida; University of Florida	Qi, RF (corresponding author), Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020; Wu, Shawn/J-8611-2014	Wu, Shawn/0000-0003-3432-9819; Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 61125304, 30971019]; Natural Scientific Foundation of Jiangsu Province [BK2007572]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Jiangsu Province	This work was supported by the grants from the Natural Scientific Foundation of China [grant no. 30700194 for LJZ grant no. 61125304 for HC, grant no. 30971019 for QJ] and the Natural Scientific Foundation of Jiangsu Province [grant no. BK2007572 for LJZ]. The funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen HJ, 2011, EUR J RADIOL; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordoba J, 2008, SEMIN LIVER DIS, V28, P70, DOI 10.1055/s-2008-1040322; Dhiman RK, 2010, J GASTROEN HEPATOL, V25, P1029, DOI 10.1111/j.1440-1746.2010.06318.x; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Keiding S, 2006, HEPATOLOGY, V43, P42, DOI 10.1002/hep.21001; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MOORE JW, 1989, J HEPATOL, V9, P319, DOI 10.1016/0168-8278(89)90140-2; Munoz SJ, 2008, MED CLIN N AM, V92, P795, DOI 10.1016/j.mcna.2008.03.009; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; SCHOMERUS H, 1993, Z GASTROENTEROL, V31, P231; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang L, 2011, HUM BRAIN MAPP; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	37	54	56	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37400	10.1371/journal.pone.0037400	http://dx.doi.org/10.1371/journal.pone.0037400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662152	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300041
J	Reiner, I; Beutel, M; Skaletz, C; Brahler, E; Stobel-Richter, Y				Reiner, Iris; Beutel, Manfred; Skaletz, Christian; Braehler, Elmar; Stoebel-Richter, Yve			Validating the German Version of the Quality of Relationship Inventory: Confirming the Three-Factor Structure and Report of Psychometric Properties	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL SATISFACTION; CLOSE RELATIONSHIPS; GENDER; STRESS; PERCEPTIONS; RELIABILITY; PARENTHOOD; SYMPTOMS; MARRIAGE	Research on psychosocial influences such as relationship characteristics has received increased attention in the clinical as well as social-psychological field. Several studies demonstrated that the quality of relationships, in particular with respect to the perceived support within intimate relationships, profoundly affects individuals' mental and physical health. There is, however, a limited choice of valid and internationally known assessments of relationship quality in Germany. We report the validation of the German version of the Quality of Relationships Inventory (QRI). First, we evaluated its factor structure in a representative German sample of 1.494 participants by means of confirmatory factor analysis. Our findings support the previously proposed three-factor structure. Second, importance and satisfaction with different relationship domains (family/children and relationship/sexuality) were linked with the QRI scales, demonstrating high construct validity. Finally, we report sex and age differences regarding the perceived relationship support, conflict and depth in our German sample. In conclusion, the QRI is a reliable and valid measurement to assess social support in romantic relationships in the German population.	[Reiner, Iris; Beutel, Manfred; Skaletz, Christian] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Braehler, Elmar; Stoebel-Richter, Yve] Univ Hosp Leipzig, Dept Mental Hlth, Leipzig, Germany	Johannes Gutenberg University of Mainz; Leipzig University	Reiner, I (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	iris.reiner@unimedizin-mainz.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728				Berry JW, 2001, J COUNS PSYCHOL, V48, P447, DOI 10.1037//0022-0167.48.4.447; Birditt K, 2008, SOC SCI MED, V67, P1291, DOI 10.1016/j.socscimed.2008.06.029; Brackett MA, 2005, PERS RELATIONSHIP, V12, P197, DOI 10.1111/j.1350-4126.2005.00111.x; Burleson BR, 2003, PERS RELATIONSHIP, V10, P1, DOI 10.1111/1475-6811.00033; Byers ES, 2005, J SEX RES, V42, P113, DOI 10.1080/00224490509552264; Campo RA, 2009, J COMMUNITY PSYCHOL, V37, P471, DOI 10.1002/jcop.20308; Chandola T, 2007, J PSYCHOSOM RES, V63, P403, DOI 10.1016/j.jpsychores.2007.07.012; Choi NG, 2011, AGING MENT HEALTH, V15, P307, DOI 10.1080/13607863.2010.513042; Cunningham CJL, 2008, J OCCUP HEALTH PSYCH, V13, P271, DOI 10.1037/1076-8998.13.3.271; Doss BD, 2009, J PERS SOC PSYCHOL, V96, P601, DOI 10.1037/a0013969; Fekete E.M., 2007, FAMILIES SYSTEMS HLT, V25, P204, DOI [10.1037/1091-7527.25.2.204, DOI 10.1037/1091-7527.25.2.204, https://doi.org/10.1037/1091-7527.25.2.204]; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Gerson CD, 2008, EUR J GASTROEN HEPAT, V20, P659, DOI 10.1097/MEG.0b013e3282f53a24; Hauser W, 2011, DTSCH ARZTEBL INT, V108, P287, DOI 10.3238/arztebl.2011.0287; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holt-Lunstad J, 2009, INT J PSYCHOPHYSIOL, V71, P211, DOI 10.1016/j.ijpsycho.2008.09.008; Joreskog K.G., 1993, LISREL 8 STRUCTURAL; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kurdek LA, 2005, J MARRIAGE FAM, V67, P68, DOI 10.1111/j.0022-2445.2005.00006.x; LEVENSON RW, 1993, PSYCHOL AGING, V8, P301, DOI 10.1037/0882-7974.8.2.301; Madia BP, 2004, J APPL SOC PSYCHOL, V34, P598, DOI 10.1111/j.1559-1816.2004.tb02562.x; Muthen L, 2007, MUTH N MUTH N; Nakano Y, 2002, PSYCHIAT CLIN NEUROS, V56, P527, DOI 10.1046/j.1440-1819.2002.01049.x; Page M, 2007, CONTEMP FAM THER, V29, P237, DOI 10.1007/s10591-007-9043-1; Pierce GR, 1997, J SOC PERS RELAT, V14, P339, DOI 10.1177/0265407597143004; PIERCE GR, 1991, J PERS SOC PSYCHOL, V61, P1028, DOI 10.1037/0022-3514.61.6.1028; Purnine DM, 1997, J CONSULT CLIN PSYCH, V65, P1017, DOI 10.1037/0022-006X.65.6.1017; Reis H. T., 2001, EMOTION SOCIAL RELAT, P57; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Schwarzer R, 2007, INT J PSYCHOL, V42, P243, DOI 10.1080/00207590701396641; Sharpe L, 2005, PSYCHO-ONCOLOGY, V14, P102, DOI 10.1002/pon.825; Twenge JM, 2003, J MARRIAGE FAM, V65, P574, DOI 10.1111/j.1741-3737.2003.00574.x; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Vandervoort D, 1999, CURR PSYCHOL, V18, P205, DOI 10.1007/s12144-999-1029-8; Verhofstadt LL, 2006, PSYCHOL ASSESSMENT, V18, P15, DOI 10.1037/1040-3590.18.1.15; Vilchinsky N, 2011, HEALTH PSYCHOL, V30, P411, DOI 10.1037/a0023453; Weiss T, 2004, PSYCHO-ONCOLOGY, V13, P260, DOI 10.1002/pon.735	37	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37380	10.1371/journal.pone.0037380	http://dx.doi.org/10.1371/journal.pone.0037380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662151	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300040
J	Slater, H; Davies, SJ; Parsons, R; Quintner, JL; Schug, SA				Slater, Helen; Davies, Stephanie Joy; Parsons, Richard; Quintner, John Louis; Schug, Stephan Alexander			A Policy-into-Practice Intervention to Increase the Uptake of Evidence-Based Management of Low Back Pain in Primary Care: A Prospective Cohort Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE; EUROPEAN GUIDELINES; START BACK; MUSCULOSKELETAL PAIN; PROVIDERS ATTITUDES; REPORTED BEHAVIOR; AMERICAN-COLLEGE; SELF-MANAGEMENT	Background: Persistent non-specific low back pain (nsLBP) is poorly understood by the general community, by educators, researchers and health professionals, making effective care problematic. This study evaluated the effectiveness of a policy-into-practice intervention developed for primary care physicians (PCPs). Methods: To encourage PCPs to adopt practical evidence-based approaches and facilitate time-efficient, integrated management of patients with nsLBP, we developed an interdisciplinary evidence-based, practical pain education program (gPEP) based on a contemporary biopsychosocial framework. One hundred and twenty six PCPs from primary care settings in Western Australia were recruited. PCPs participated in a 6.5-hour gPEP. Self-report measures recorded at baseline and at 2 months post-intervention included PCPs' attitudes, beliefs (modified Health Care Providers Pain and Impairment Relationship Scale (HC-PAIRS), evidence-based clinical practices (knowledge and skills regarding nsLBP management: 5-point Likert scale with 1 = nil and 5 = excellent) and practice behaviours (recommendations based on a patient vignette; 5-point Likert scale). Results: Ninety one PCPs participated (attendance rate of 72%; post-intervention response rate 88%). PCP-responders adopted more positive, guideline-consistent beliefs, evidenced by clinically significant HC-PAIRS score differences (mean change = -5.6 +/- 8.2, p<0.0001; 95% confidence interval: -7.6 to -3.6) and significant positive shifts on all measures of clinical knowledge and skills (p<0.0001 for all questions). Self management strategies were recommended more frequently post-intervention. The majority of responders who were guideline-inconsistent for work and bed rest recommendations (82% and 62% respectively) at pre-intervention, gave guideline-consistent responses at post-intervention. Conclusion: An interprofessional pain education program set within a framework that aligns health policy and practice, encourages PCPs to adopt more self-reported evidence-based attitudes, beliefs and clinical behaviours in their management of patients with nsLBP. However, further research is required to determine cost effectiveness of this approach when compared with other modes of educational delivery and to examine PCP behaviours in actual clinical practice.	[Slater, Helen; Davies, Stephanie Joy] Curtin Univ Technol, Sch Physiotherapy, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Slater, Helen; Davies, Stephanie Joy; Quintner, John Louis] Fremantle Hosp & Hlth Serv, Pain Med Unit, Perth, WA, Australia; [Parsons, Richard] Curtin Univ Technol, Sch Occupat Therapy, Perth, WA, Australia; [Parsons, Richard] Curtin Univ Technol, Sch Pharm, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Schug, Stephan Alexander] Univ Western Australia, Pharmacol & Anaesthesiol Unit, Perth, WA 6009, Australia; [Slater, Helen; Schug, Stephan Alexander] Royal Perth Hosp, Dept Anaesthesia & Pain Med, Perth, WA, Australia	Curtin University; Curtin University; Curtin University; University of Western Australia; Royal Perth Hospital; University of Western Australia	Slater, H (corresponding author), Curtin Univ Technol, Sch Physiotherapy, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.	h.slater@curtin.edu.au	Slater, Helen/B-7416-2013; Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315; Slater, Helen/0000-0002-4868-4988	State Health Research Advisory Council Research Translation Project Grant (Department of Health, Western Australia, Australia); Pfizer Australia	State Health Research Advisory Council Research Translation Project Grant (Department of Health, Western Australia, Australia); Pfizer Australia(PfizerPfizer Australia)	This project was funded by a State Health Research Advisory Council Research Translation Project Grant (Department of Health, Western Australia, Australia: http://www.shrac.health.wa.gov.au/home/), titled 'Increasing the uptake of evidence-based clinical guidelines in the management of acute non-specific low back pain in primary care: a targeted education program for General Practitioners' 2008-2009. The following authors received an honorarium for developing and delivering the gPEP programs: SD, SS and JQ. The support of Pfizer Australia in funding the food and non-alcoholic beverages for the workshops is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AD, 2010, SPINE, V35, P848, DOI 10.1097/BRS.0b013e3181d1049f; Accident Compensation Corporation New Zealand Guidelines Group, 2004, NZ AC LOW BACK PAIN; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Australian Acute Musculoskeletal Pain Guidelines Group, 2003, EV BAS MAN AC MUSC P; Balague F, 2007, LANCET, V369, P726, DOI 10.1016/S0140-6736(07)60340-7; Bishop A, 2007, PAIN, V132, P91, DOI 10.1016/j.pain.2007.01.028; Blyth FM, 2005, PAIN, V113, P285, DOI 10.1016/j.pain.2004.12.004; Boersma K, 2005, BEHAV RES THER, V43, P1495, DOI 10.1016/j.brat.2004.11.006; Buchbinder R, 2007, SPINE, V32, pE156, DOI 10.1097/01.brs.0000256885.00681.00; Bunzli S, 2011, PHYSIOTHER RES INT, V16, P4, DOI 10.1002/pri.465; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2010, DRUGS, V70, P387, DOI 10.2165/11318690-000000000-00000; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Corbett M, 2009, FAM PRACT, V26, P359, DOI 10.1093/fampra/cmp042; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Damush TM, 2003, ARCH INTERN MED, V163, P2632, DOI 10.1001/archinte.163.21.2632; Davies S, 2011, PAIN MED, V12, P59, DOI 10.1111/j.1526-4637.2010.01001.x; Davies SJ, 2011, PAIN MED, V12, P4, DOI 10.1111/j.1526-4637.2010.01016.x; Department of Health Western Australia, 2009, SPIN PAIN MOD CAR; Dobkin PL, 2008, PAIN MED, V9, P881, DOI 10.1111/j.1526-4637.2007.00326.x; Domenech J, 2011, PAIN, V152, P2557, DOI 10.1016/j.pain.2011.07.023; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Evans DW, 2010, SPINE, V35, P858, DOI 10.1097/BRS.0b013e3181d4e04b; Evans DW, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-41; Feuerstein M, 2006, PAIN, V124, P140, DOI 10.1016/j.pain.2006.04.007; Flynn TW, 2011, J ORTHOP SPORT PHYS, V41, P838, DOI 10.2519/jospt.2011.3618; Foster NE, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-108; Foster NE, 2011, MANUAL THER, V16, P3, DOI 10.1016/j.math.2010.05.013; Foster NE, 2010, PAIN, V148, P398, DOI 10.1016/j.pain.2009.11.002; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Fullen BM, 2007, EUR J PAIN, V11, P614, DOI 10.1016/j.ejpain.2006.09.007; Gandjour A, 2005, SPINE, V30, P969, DOI 10.1097/01.brs.0000158944.54033.60; Hay EM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-58; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hill JC, 2011, PHYS THER, V91, P712, DOI 10.2522/ptj.20100280; Hill JC, 2010, CLIN J PAIN, V26, P783, DOI 10.1097/AJP.0b013e3181f18aac; Houben RMA, 2004, CLIN J PAIN, V20, P37, DOI 10.1097/00002508-200401000-00008; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Kendall NAS, 2004, GUIDE ASSESSING PSYC; Kent PM, 2009, MANUAL THER, V14, P387, DOI 10.1016/j.math.2008.07.003; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Lamb SE, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14410; Lamb SE, 2010, HEALTH TECHNOL ASSES, V14, piii; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Lim KL, 2006, SPINE, V31, P212, DOI 10.1097/01.brs.0000194773.10461.9f; Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luck J, 2000, AM J MED, V108, P642, DOI 10.1016/S0002-9343(00)00363-6; MacDermid JC, 2009, HAND CLIN, V25, P125, DOI 10.1016/j.hcl.2008.10.003; MacDonald D, 2009, PAIN, V142, P183, DOI 10.1016/j.pain.2008.12.002; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; MATHERS N, 1995, BRIT J GEN PRACT, V45, P293; MBF Foundation, 2007, HIGH PRIC PAIN EC IM; McCracken LM, 2007, PAIN, V130, P119, DOI 10.1016/j.pain.2006.11.016; McGuirk B, 2007, OCCUP MED-OXFORD, V57, P36, DOI 10.1093/occmed/kql102; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; Moseley GL, 2004, CLIN J PAIN, V20, P324, DOI 10.1097/00002508-200409000-00007; Moseley GL, 2004, EUR J PAIN, V8, P39, DOI 10.1016/S1090-3801(03)00063-6; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Nimgade A, 2010, SPINE, V35, P769, DOI 10.1097/BRS.0b013e3181c06a89; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Pransky G, 2010, BEST PRACT RES CL RH, V24, P291, DOI 10.1016/j.berh.2010.01.001; Rainville J, 1995, CLIN J PAIN, V11, P287, DOI 10.1097/00002508-199512000-00006; Rainville J, 2000, SPINE, V25, P2210, DOI 10.1097/00007632-200009010-00012; RILEY JF, 1988, ARCH PHYS MED REHAB, V69, P579; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Sng BL, 2009, ANN ACAD MED SINGAP, V38, P960; Szabo RM, 2009, HAND CLIN, V25, pXI, DOI 10.1016/j.hcl.2008.12.001; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Weiner SS, 2011, SPINE, V36, P1987, DOI 10.1097/BRS.0b013e3181fee8ef	75	35	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38037	10.1371/journal.pone.0038037	http://dx.doi.org/10.1371/journal.pone.0038037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662264	Green Published, gold			2022-12-27	WOS:000305342300156
J	Eppinger, B; Nystrom, LE; Cohen, JD				Eppinger, Ben; Nystrom, Leigh E.; Cohen, Jonathan D.			Reduced Sensitivity to Immediate Reward during Decision-Making in Older than Younger Adults	PLOS ONE			English	Article							DELAYED REWARDS; NEURAL MECHANISMS; AGE-DIFFERENCES; LIFE-SPAN; MAGNITUDE; CHOICE	We examined whether older adults differ from younger adults in the degree to which they favor immediate over delayed rewards during decision-making. To examine the neural correlates of age-related differences in delay discounting we acquired functional MR images while participants made decisions between smaller but sooner and larger but later monetary rewards. The behavioral results show age-related reductions in delay discounting. Less impulsive decision-making in older adults was associated with lower ventral striatal activations to immediate reward. Furthermore, older adults showed an overall higher percentage of delayed choices and reduced activity in the dorsal striatum than younger adults. This points to a reduced reward sensitivity of the dorsal striatum in older adults. Taken together, our findings indicate that less impulsive decision-making in older adults is due to a reduced sensitivity of striatal areas to reward. These age-related changes in reward sensitivity may result from transformations in dopaminergic neuromodulation with age.	[Eppinger, Ben; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Eppinger, Ben; Cohen, Jonathan D.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Ctr Demog Aging, Princeton, NJ 08544 USA; [Eppinger, Ben] Max Planck Inst Human Dev & Educ, Berlin, Germany	Princeton University; Princeton University; Max Planck Society	Eppinger, B (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	eppinger@mpib-berlin.mpg	Eppinger, Ben/N-1865-2016	Eppinger, Ben/0000-0003-3639-2459	National Institute on Aging [AG02436, P30AG024361]; Center for Health and Wellbeing at Princeton University; NATIONAL INSTITUTE ON AGING [P30AG024361] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Health and Wellbeing at Princeton University(Princeton University); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging grants AG02436 and P30AG024361 (http://www.nia.nih.gov/GrantsAndTraining/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jessica Hughes, Paul Kruger, Peter Foster and Laura deSouza for assistance with data acquisition. We are also grateful for the support of the Center for Health and Wellbeing at Princeton University through which the grant was administered.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baddeley AD, 1992, SPEED CAPACITY LANGU; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Brown SBRE, 2009, COGN AFFECT BEHAV NE, V9, P365, DOI 10.3758/CABN.9.4.365; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Christakou A, 2011, NEUROIMAGE, V54, P1344, DOI 10.1016/j.neuroimage.2010.08.067; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Harris KC, 2009, J NEUROSCI, V29, P6078, DOI 10.1523/JNEUROSCI.0412-09.2009; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Manton KG, 2007, P NATL ACAD SCI USA, V104, P10802, DOI 10.1073/pnas.0704185104; Marco-Pallares J, 2010, BRAIN RES, V1320, P123, DOI 10.1016/j.brainres.2010.01.025; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mell T, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.034.2009; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Raven J. C., 1998, RAVEN MANUAL; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Vaupel JW, 2006, SCIENCE, V312, P1911, DOI 10.1126/science.1127487; Wechsler W, 1982, HANDANWEISUNG ZUM HA	47	79	82	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36953	10.1371/journal.pone.0036953	http://dx.doi.org/10.1371/journal.pone.0036953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UB	22655032	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900007
J	Kobayashi, M; Teramoto, W; Hidaka, S; Sugita, Y				Kobayashi, Maori; Teramoto, Wataru; Hidaka, Souta; Sugita, Yoichi			Sound Frequency and Aural Selectivity in Sound-Contingent Visual Motion Aftereffect	PLOS ONE			English	Article							TEMPORAL-ORDER; VENTRILOQUISM; ADAPTATION; PERCEPTION; RECALIBRATION; SIMULTANEITY; ATTENTION	Background: One possible strategy to evaluate whether signals in different modalities originate from a common external event or object is to form associations between inputs from different senses. This strategy would be quite effective because signals in different modalities from a common external event would then be aligned spatially and temporally. Indeed, it has been demonstrated that after adaptation to visual apparent motion paired with alternating auditory tones, the tones begin to trigger illusory motion perception to a static visual stimulus, where the perceived direction of visual lateral motion depends on the order in which the tones are replayed. The mechanisms underlying this phenomenon remain unclear. One important approach to understanding the mechanisms is to examine whether the effect has some selectivity in auditory processing. However, it has not yet been determined whether this aftereffect can be transferred across sound frequencies and between ears. Methodology/Principal Findings: Two circles placed side by side were presented in alternation, producing apparent motion perception, and each onset was accompanied by a tone burst of a specific and unique frequency. After exposure to this visual apparent motion with tones for a few minutes, the tones became drivers for illusory motion perception. However, the aftereffect was observed only when the adapter and test tones were presented at the same frequency and to the same ear. Conclusions/Significance: These findings suggest that the auditory processing underlying the establishment of novel audiovisual associations is selective, potentially but not necessarily indicating that this processing occurs at an early stage.	[Kobayashi, Maori; Teramoto, Wataru] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Teramoto, Wataru] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Hidaka, Souta] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan	Tohoku University; Tohoku University; Rikkyo University; National Institute of Advanced Industrial Science & Technology (AIST)	Kobayashi, M (corresponding author), Meiji Univ, Dept Sci & Technol, Kawasaki, Kanagawa, Japan.	te11001@meiji.ac.jp; y.sugita@waseda.jp	Hidaka, Souta/L-6393-2019	Hidaka, Souta/0000-0001-6727-5322	Ministry of Education, Science, and Culture, Japan [19001004]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman AC, 2006, VISION RES, V46, P2968, DOI 10.1016/j.visres.2006.03.003; Canon KL, 1970, J EXP PSYCHOL, V84, P141; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frissen I, 2005, ACTA PSYCHOL, V118, P93, DOI 10.1016/j.actpsy.2004.10.004; Frissen I, 2003, ACTA PSYCHOL, V113, P315, DOI 10.1016/S0001-6918(03)00043-X; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; HALL JW, 1983, J ACOUST SOC AM, V73, P894, DOI 10.1121/1.389013; Hidaka S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-44; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; Lewald J, 2002, LEARN MEMORY, V9, P268, DOI 10.1101/lm.51402; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; MACLEOD A, 1990, British Journal of Audiology, V24, P29, DOI 10.3109/03005369009077840; RADEAU M, 1974, Q J EXP PSYCHOL, V26, P63, DOI 10.1080/14640747408400388; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Stein BE., 1993, MERGING SENSES; Teramoto W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012255; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Welch R.B, 1986, HDB PERCEPTION HUMAN, V1; Xial LQ, 2008, CURR BIOL, V18, P1922; Yeh SL, 1996, J EXP PSYCHOL HUMAN, V22, P446, DOI 10.1037/0096-1523.22.2.446	23	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36803	10.1371/journal.pone.0036803	http://dx.doi.org/10.1371/journal.pone.0036803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649500	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800017
J	Kyrylkova, K; Kyryachenko, S; Biehs, B; Klein, O; Kioussi, C; Leid, M				Kyrylkova, Kateryna; Kyryachenko, Sergiy; Biehs, Brian; Klein, Ophir; Kioussi, Chrissa; Leid, Mark			BCL11B Regulates Epithelial Proliferation and Asymmetric Development of the Mouse Mandibular Incisor	PLOS ONE			English	Article							STEM-CELL COMPARTMENT; AMELOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; TOOTH DEVELOPMENT; SIGNALING CENTER; DUAL ROLE; HEDGEHOG; FGF10; MORPHOGENESIS; EXPRESSION	Mouse incisors grow continuously throughout life with enamel deposition uniquely on the outer, or labial, side of the tooth. Asymmetric enamel deposition is due to the presence of enamel-secreting ameloblasts exclusively within the labial epithelium of the incisor. We have previously shown that mice lacking the transcription factor BCL11B/CTIP2 (BCL11B hereafter) exhibit severely disrupted ameloblast formation in the developing incisor. We now report that BCL11B is a key factor controlling epithelial proliferation and overall developmental asymmetry of the mouse incisor: BCL11B is necessary for proliferation of the labial epithelium and development of the epithelial stem cell niche, which gives rise to ameloblasts; conversely, BCL11B suppresses epithelial proliferation, and development of stem cells and ameloblasts on the inner, or lingual, side of the incisor. This bidirectional action of BCL11B in the incisor epithelia appears responsible for the asymmetry of ameloblast localization in developing incisor. Underlying these spatio-specific functions of BCL11B in incisor development is the regulation of a large gene network comprised of genes encoding several members of the FGF and TGF beta superfamilies, Sprouty proteins, and Sonic hedgehog. Our data integrate BCL11B into these pathways during incisor development and reveal the molecular mechanisms that underlie phenotypes of both Bcl11b(-/-) and Sprouty mutant mice.	[Kyrylkova, Kateryna; Kyryachenko, Sergiy; Kioussi, Chrissa; Leid, Mark] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Biehs, Brian; Klein, Ophir] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Biehs, Brian; Klein, Ophir] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Biehs, Brian; Klein, Ophir] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA USA	Oregon State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kyrylkova, K (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	chrissa.kioussi@oregonstate.edu; mark.leid@oregonstate.edu		Klein, Ophir/0000-0002-6254-7082; Kioussi, Chrissa/0000-0001-8226-9908	NIH/NIDCR [DE021879]; NIH/NIAMS [AR054406]; CIRM New Faculty Award II; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R15DE021879] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CIRM New Faculty Award II; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR (grant DE021879 to ML), NIH/NIAMS (grant AR054406 to CK), and by a CIRM New Faculty Award II to ODK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Bellusci S, 1996, DEVELOPMENT, V122, P1693; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Caton J, 2009, DEV BIOL, V328, P493, DOI 10.1016/j.ydbio.2009.02.014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, DEVELOPMENT, V129, P1533; KERLEY M A, 1975, Proceedings of the Oklahoma Academy of Science, V55, P6; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; O'Hagan RC, 1998, ONCOGENE, V16, P301, DOI 10.1038/sj.onc.1201547; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Porntaveetus T, 2011, J ANAT; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Takahashi S, 2007, BIOCHEM BIOPH RES CO, V353, P405, DOI 10.1016/j.bbrc.2006.12.053; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zhang YD, 2000, DEVELOPMENT, V127, P1431	42	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37670	10.1371/journal.pone.0037670	http://dx.doi.org/10.1371/journal.pone.0037670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629441	gold, Green Published			2022-12-27	WOS:000305345300068
J	Wali, JA; de Boo, HA; Derraik, JGB; Phua, HH; Oliver, MH; Bloomfield, FH; Harding, JE				Wali, Jibran A.; de Boo, Hendrina A.; Derraik, Jose G. B.; Phua, Hui Hui; Oliver, Mark H.; Bloomfield, Frank H.; Harding, Jane E.			Weekly Intra-Amniotic IGF-1 Treatment Increases Growth of Growth-Restricted Ovine Fetuses and Up-Regulates Placental Amino Acid Transporters	PLOS ONE			English	Article							LATE-GESTATION; FACTOR-I; AMNIOTIC-FLUID; GLUCOSE TRANSPORTERS; MAMMALIAN TARGET; PLASMA-MEMBRANE; FETAL; EXPRESSION; PROTEIN; SYNCYTIOTROPHOBLAST	Frequent treatment of the growth-restricted (IUGR) ovine fetus with intra-amniotic IGF-1 increases fetal growth. We aimed to determine whether increased growth was maintained with an extended dosing interval and to examine possible mechanisms. Pregnant ewes were allocated to three groups: Control, and two IUGR groups (induced by placental embolization) treated with weekly intra-amniotic injections of either saline (IUGR) or 360 mg IGF-1 (IGF1). IUGR fetuses were hypoxic, hyperuremic, hypoglycemic, and grew more slowly than controls. Placental glucose uptake and SLC2A1 (GLUT2) mRNA levels decreased in IUGR fetuses, but SLC2A3 (GLUT3) and SLC2A4 (GLUT4) levels were unaffected. IGF-1 treatment increased fetal growth rate, did not alter uterine blood flow or placental glucose uptake, and increased placental SLC2A1 and SLC2A4 (but not SLC2A3) mRNA levels compared with saline-treated IUGR animals. Following IGF-1 treatment, placental mRNA levels of isoforms of the system A, y(+), and L amino acid transporters increased 1.3 to 5.0 fold, while the ratio of phosphorylated-mTOR to total mTOR also tended to increase. Weekly intra-amniotic IGF-1 treatment provides a promising avenue for intra-uterine treatment of IUGR babies, and may act via increased fetal substrate supply, up-regulating placental transporters for neutral, cationic, and branched-chain amino acids, possibly via increased activation of the mTOR pathway.	[Wali, Jibran A.; de Boo, Hendrina A.; Derraik, Jose G. B.; Phua, Hui Hui; Oliver, Mark H.; Bloomfield, Frank H.; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland	Wali, JA (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.harding@auckland.ac.nz	Wali, Jibran/K-9843-2019; Derraik, José Guilherme Behrensdorf/A-1925-2008; Harding, Jane E/J-5853-2015	Wali, Jibran/0000-0002-8524-5773; Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Harding, Jane E/0000-0003-2697-1422; Bloomfield, Frank/0000-0001-6424-6577; Oliver, Mark/0000-0002-0359-2297	Health Research Council of New Zealand [HRC 05-193]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded by the Health Research Council of New Zealand (grant HRC 05-193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; Arroyo JA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.031; BATTAGLIA C, 1992, AM J OBSTET GYNECOL, V167, P430, DOI 10.1016/S0002-9378(11)91424-0; Bloomfield FH, 2002, REPROD FERT DEVELOP, V14, P393, DOI 10.1071/RD02022; Bloomfield FH, 2002, AM J PHYSIOL-ENDOC M, V282, pE259, DOI 10.1152/ajpendo.00200.2001; Bloomfield FH, 2002, J PEDIATR GASTR NUTR, V35, P287, DOI 10.1097/00005176-200209000-00010; Bloomfield FH, 2002, PEDIATR RES, V51, P361, DOI 10.1203/00006450-200203000-00016; Bloomfield FH, 1998, FETAL MAT MED REV, V10, P91, DOI DOI 10.1017/S0965539597000235; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Cariappa R, 2003, PLACENTA, V24, P713, DOI 10.1016/S0143-4004(03)00085-7; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Eremia SC, 2007, ENDOCRINOLOGY, V148, P2963, DOI 10.1210/en.2006-1701; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Fang J, 2006, GROWTH HORM IGF RES, V16, P318, DOI 10.1016/j.ghir.2006.08.002; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; GITLIN D, 1972, AM J OBSTET GYNECOL, V113, P632, DOI 10.1016/0002-9378(72)90632-1; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Grillo MA, 2008, AMINO ACIDS, V34, P517, DOI 10.1007/s00726-007-0006-5; GULL I, 1993, AM J OBSTET GYNECOL, V168, P706, DOI 10.1016/0002-9378(93)90520-S; HARDING JE, 1994, ENDOCRINOLOGY, V134, P1509, DOI 10.1210/en.134.3.1509; Harding JE, 2001, LUNG BIOL HEALTH DIS, V151, P181; Harding JE, 1997, PRENAT NEONAT MED, V2, P300; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jensen EC, 1999, J ENDOCRINOL, V161, P485, DOI 10.1677/joe.0.1610485; Kainulainen H, 1997, GYNECOL OBSTET INVES, V44, P89, DOI 10.1159/000291493; KARL PI, 1995, J CELL PHYSIOL, V165, P83, DOI 10.1002/jcp.1041650111; Kevorkova O, 2007, BIOL REPROD, V76, P487, DOI 10.1095/biolreprod.106.055285; KNISS DA, 1994, J REPROD MED, V39, P249; Korgun ET, 2001, BIOL REPROD, V65, P1364, DOI 10.1095/biolreprod65.5.1364; Koupil I, 2005, J EPIDEMIOL COMMUN H, V59, P473, DOI 10.1136/jech.2004.026518; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Miller SL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.029; Owens J.A., 1989, ADV FETAL PHYSL, P263; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIMENTEL G, 1986, AM J OBSTET GYNECOL, V155, P1181, DOI 10.1016/0002-9378(86)90141-9; PRITCHAR.JA, 1965, OBSTET GYNECOL, V25, P289; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Roos S, 2009, AM J PHYSIOL-CELL PH, V296, pC142, DOI 10.1152/ajpcell.00330.2008; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Ross MG, 2008, SEMIN PERINATOL, V32, P213, DOI 10.1053/j.semperi.2007.11.005; Rumball CWH, 2008, ENDOCRINOLOGY, V149, P1163, DOI 10.1210/en.2007-1306; Schini-Kerth V. B., 1999, Journal of Endocrinological Investigation, V22, P82; Shaikh S, 2005, J ENDOCRINOL, V186, P145, DOI 10.1677/joe.1.06113; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; Winer N, 2009, CLIN NUTR, V28, P243, DOI 10.1016/j.clnu.2009.03.007; Wooding FBP, 2005, PLACENTA, V26, P626, DOI 10.1016/j.placenta.2004.09.013; YOUNG WP, 1974, J APPL PHYSIOL, V37, P620, DOI 10.1152/jappl.1974.37.4.620; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zaitoun I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-49; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	61	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37899	10.1371/journal.pone.0037899	http://dx.doi.org/10.1371/journal.pone.0037899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629469	gold, Green Published			2022-12-27	WOS:000305345300083
J	Standl, M; Lattka, E; Stach, B; Koletzko, S; Bauer, CP; von Berg, A; Berdel, D; Kramer, U; Schaaf, B; Roder, S; Herbarth, O; Buyken, A; Drogies, T; Thiery, J; Koletzko, B; Heinrich, J				Standl, Marie; Lattka, Eva; Stach, Barbara; Koletzko, Sibylle; Bauer, Carl-Peter; von Berg, Andrea; Berdel, Dietrich; Kraemer, Ursula; Schaaf, Beate; Roeder, Stefan; Herbarth, Olf; Buyken, Anette; Drogies, Tim; Thiery, Joachim; Koletzko, Berthold; Heinrich, Joachim		GINIplus Study Grp; LISAplus Study Grp	FADS1 FADS2 Gene Cluster, PUFA Intake and Blood Lipids in Children: Results from the GINIplus and LISAplus Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; PROLIFERATOR-ACTIVATED RECEPTOR; CARDIOVASCULAR RISK-FACTORS; FATTY-ACID-COMPOSITION; NUTRITIONAL INTERVENTION; VARIANTS; ASSOCIATION; ATHEROSCLEROSIS	Background: Elevated cholesterol levels in children can be a risk factor for cardiovascular diseases in later life. In adults, it has been shown that blood lipid levels are strongly influenced by polymorphisms in the fatty acid desaturase (FADS) gene cluster in addition to nutritional and other exogenous and endogenous determinants. Our aim was to investigate whether lipid levels are determined by the FADS genotype already in children and whether this association interacts with dietary intake of n-3 fatty acids. Methods: The analysis was based on data of 2006 children from two German prospective birth cohort studies. Total cholesterol, HDL, LDL and triglycerides were measured at 10 years of age. Six single nucleotide polymorphisms (SNPs) of the FADS gene cluster were genotyped. Dietary n-3 fatty acid intake was assessed by food frequency questionnaire. Linear regression modeling was used to assess the association between lipid levels, n-3 fatty acid intake and FADS genotype. Results: Individuals carrying the homozygous minor allele had lower levels of total cholesterol [means ratio (MR) ranging from 0.96 (p = 0.0093) to 0.98 (p = 0.2949), depending on SNPs] and LDL [MR between 0.94 (p = 0.0179) and 0.97 (p = 0.2963)] compared to homozygous major allele carriers. Carriers of the heterozygous allele showed lower HDL levels [beta between -0.04 (p = 0.0074) to -0.01 (p = 0.3318)] and higher triglyceride levels [MR ranging from 1.06 (p = 0.0065) to 1.07 (p = 0.0028)] compared to homozygous major allele carriers. A higher n-3 PUFA intake was associated with higher concentrations of total cholesterol, LDL, HDL and lower triglyceride levels, but these associations did not interact with the FADS1 FADS2 genotype. Conclusion: Total cholesterol, HDL, LDL and triglyceride concentrations may be influenced by the FADS1 FADS2 genotype already in 10 year old children. Genetically determined blood lipid levels during childhood might differentially predispose individuals to the development of cardiovascular diseases later in life.	[Standl, Marie; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Lattka, Eva] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Stach, Barbara; Drogies, Tim; Thiery, Joachim] Univ Hosp Leipzig, Fac Med, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Koletzko, Sibylle; Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Med Ctr, Munich, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Pediat, Munich, Germany; [von Berg, Andrea; Berdel, Dietrich] Marien Hosp Wesel, Dept Pediat, Wesel, Germany; [Kraemer, Ursula] Univ Dusseldorf, IUF, Leibniz Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; [Schaaf, Beate] Med Practice Pediat, Bad Honnef, Germany; [Roeder, Stefan] UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany; [Herbarth, Olf] Univ Leipzig, Fac Med Environm Med & Hyg, Leipzig, Germany; [Buyken, Anette] Univ Bonn, Res Inst Child Nutr, Dortmund, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; University of Munich; Technical University of Munich; St. Marien Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; University of Bonn	Standl, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	heinrich@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Reischl, Eva/B-9311-2013	Heinrich, Joachim/0000-0002-9620-1629; Reischl, Eva/0000-0003-4055-8060; Standl, Marie/0000-0002-5345-2049	"Kompetenznetz Adipositas" ("Competence Network Obesity"); German Federal Ministry of Education and Research [FKZ: 01GI0826]; Munich Center of Health Sciences (MCHEALTH); Federal Ministry for Education, Science, Research and Technology [01 EG 9705/2, 01EG9732]; Federal Ministry of Environment (IUF) [FKS 20462296]; Bristol-Myers Squibb Foundation, New York, NY, USA	"Kompetenznetz Adipositas" ("Competence Network Obesity"); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MCHEALTH); Federal Ministry for Education, Science, Research and Technology; Federal Ministry of Environment (IUF); Bristol-Myers Squibb Foundation, New York, NY, USA(Bristol-Myers Squibb)	This work was supported financially in part by the "Kompetenznetz Adipositas" ("Competence Network Obesity") funded by the German Federal Ministry of Education and Research (FKZ: 01GI0826) and by the Munich Center of Health Sciences (MCHEALTH). The LISAplus study was funded by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EG 9705/2 and 01EG9732) and the 6 years follow-up of the LISAplus study was partly funded by the Federal Ministry of Environment (IUF, FKS 20462296). BK is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA. The authors gratefully acknowledge partial financial support from the Commission of the European Communities, specific RTD Programme "Quality of Life and Management of Living Resources", within the 7th Framework Programme NUTRIMENTHE, FP7-212652. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baylin A, 2007, AM J CLIN NUTR, V85, P554, DOI 10.1093/ajcn/85.2.554; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Calabresi L, 2004, METABOLISM, V53, P153, DOI 10.1016/j.metabol.2003.09.007; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hartmann B., 2005, BUNDESLEBENSMITTELSC; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kareinen A, 2001, ARTERIOSCL THROM VAS, V21, P1346, DOI 10.1161/hq0801.093655; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Stiegler P, 2010, PUBLIC HEALTH NUTR, V13, P38, DOI 10.1017/S1368980009005813; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; VUDAC N, 1994, J BIOL CHEM, V269, P31012; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	42	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37780	10.1371/journal.pone.0037780	http://dx.doi.org/10.1371/journal.pone.0037780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629455	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100050
J	Bishop, DVM; Hardiman, MJ; Barry, JG				Bishop, D. V. M.; Hardiman, Mervyn J.; Barry, Johanna G.			Auditory Deficit as a Consequence Rather than Endophenotype of Specific Language Impairment: Electrophysiological Evidence	PLOS ONE			English	Article							MISMATCH NEGATIVITY; T-COMPLEX; EVOKED-POTENTIALS; LEARNING-PROBLEMS; SYSTEM ACTIVITY; CHILDREN; MATURATION; RESPONSES; BRAIN; SPEECH	Background: Are developmental language disorders caused by poor auditory discrimination? This is a popular theory, but behavioural evidence has been inconclusive. Here we studied children with specific language impairment, measuring the brain's electrophysiological response to sounds in a passive paradigm. We focused on the T-complex, an event-related peak that has different origins and developmental course from the well-known vertex response. Methods: We analysed auditory event-related potentials to tones and syllables from 16 children and 16 adolescents with specific language impairment who were compared with 32 typically-developing controls, matched for gender, IQ and age. Results: We replicated prior findings of significant reduction in Ta amplitude for both children and adolescents with specific language impairment, which was particularly marked for syllables. The topography of the T-complex to syllables indicated a less focal response in those with language impairments. To distinguish causal models, we considered correlations between size of the Ta response and measures of language and literacy in parents as well as children. The best-fitting model was one in which auditory deficit was a consequence rather than a cause of difficulties in phonological processing. Conclusions: The T-complex to syllables has abnormal size and topography in children with specific language impairment, but this is more likely to be a consequence rather than a cause of difficulties in phonological processing.	[Bishop, D. V. M.; Hardiman, Mervyn J.; Barry, Johanna G.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	dorothy.bishop@psy.ox.ac.uk		Barry, Johanna/0000-0002-3733-8721; Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust [053335]; MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_U135097130] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Wellcome Trust Programme Grant 053335 (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Barry JG, 2007, GENES BRAIN BEHAV, V6, P66, DOI 10.1111/j.1601-183X.2006.00232.x; Bishop D., 2003, CHILDRENS COMMUNICAT; Bishop D.V., 2004, EXPRESSION RECEPTION; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; Bishop D.V.M., 2005, TEST RECEPTION GRAMM; Bishop D. V. M, 1989, TEST RECEPTION GRAMM, V2; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P565, DOI 10.1111/j.1467-7687.2007.00619.x; Bishop DVM, 2006, Q J EXP PSYCHOL, V59, P1153, DOI 10.1080/17470210500489372; Bishop DVM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018993; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bishop DVM, 2010, J NEUROSCI, V30, P15578, DOI 10.1523/JNEUROSCI.2217-10.2010; Bishop DVM, 2009, CHILD DEV, V80, P593, DOI 10.1111/j.1467-8624.2009.01281.x; Bishop DVM, 2004, DEVELOPMENTAL SCI, V7, pF11, DOI 10.1111/j.1467-7687.2004.00356.x; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; CACACE AT, 1988, HEARING RES, V34, P225, DOI 10.1016/0378-5955(88)90002-0; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 2002, NEUROSCI LETT, V325, P187, DOI 10.1016/S0304-3940(02)00269-0; de Guibert C, 2011, BRAIN, V134, P3044, DOI 10.1093/brain/awr141; Diaz B, 2008, P NATL ACAD SCI USA, V105, P16083, DOI 10.1073/pnas.0805022105; Fox AM, 2011, DEV SCI; Gomes H, 2001, DEV BRAIN RES, V129, P147, DOI 10.1016/S0165-3806(01)00196-1; Korkman M., 2007, NEPSY 2, V2nd; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; MASON SM, 1984, ELECTROEN CLIN NEURO, V59, P297, DOI 10.1016/0168-5597(84)90047-9; McArthur G, 2009, DEVELOPMENTAL SCI, V12, P768, DOI 10.1111/j.1467-7687.2008.00804.x; Miller CA, 2011, LANG SPEECH HEAR SER, V42, P309, DOI 10.1044/0161-1461(2011/10-0040); Norbury C. E, 2008, RUTTERS CHILD ADOLES, P782, DOI DOI 10.1002/9781444300895.CH47; Pang EW, 2000, CLIN NEUROPHYSIOL, V111, P388, DOI 10.1016/S1388-2457(99)00259-X; Parviainen T, 2011, HUM BRAIN MAPP, V32, P2193, DOI 10.1002/hbm.21181; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; ROBINSON RJ, 1991, DEV MED CHILD NEUROL, V33, P943; Shafer VL, 2011, CLIN NEUROPHYSIOL, V122, P1137, DOI 10.1016/j.clinph.2010.10.046; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; TonnquistUhlen I, 1996, ACTA OTO-LARYNGOL, V116, P680, DOI 10.3109/00016489609137907; Torgesen J.K., 1999, TOWRE TEST WORD READ; Weber-Fox C, 2010, BRAIN LANG, V115, P162, DOI 10.1016/j.bandl.2010.09.001; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Whitehouse AJO, 2008, BRAIN, V131, P3193, DOI 10.1093/brain/awn266; WOLPAW JR, 1977, ELECTROEN CLIN NEURO, V43, P99, DOI 10.1016/0013-4694(77)90200-0; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Wright BA, 2004, P NATL ACAD SCI USA, V101, P9942, DOI 10.1073/pnas.0401825101; Wright S, 1978, APPL PATH ANAL ECOLO; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008	46	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35851	10.1371/journal.pone.0035851	http://dx.doi.org/10.1371/journal.pone.0035851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22662112	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100012
J	Burgio, G; Baylac, M; Heyer, E; Montagutelli, X				Burgio, Gaetan; Baylac, Michel; Heyer, Evelyne; Montagutelli, Xavier			Nasal Bone Shape Is under Complex Epistatic Genetic Control in Mouse Interspecific Recombinant Congenic Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ELLIPTIC FOURIER-ANALYSIS; MICE; INTEGRATION; TOOL; ARCHITECTURE; EVOLUTION	Background: Genetic determinism of cranial morphology in the mouse is still largely unknown, despite the localization of putative QTLs and the identification of genes associated with Mendelian skull malformations. To approach the dissection of this multigenic control, we have used a set of interspecific recombinant congenic strains (IRCS) produced between C57BL/6 and mice of the distant species Mus spretus (SEG/Pas). Each strain has inherited 1.3% of its genome from SEG/Pas under the form of few, small-sized, chromosomal segments. Results: The shape of the nasal bone was studied using outline analysis combined with Fourier descriptors, and differential features were identified between IRCS BcG-66H and C57BL/6. An F2 cross between BcG-66H and C57BL/6 revealed that, out of the three SEG/Pas-derived chromosomal regions present in BcG-66H, two were involved. Segments on chromosomes 1 (similar to 32 Mb) and 18 (similar to 13 Mb) showed additive effect on nasal bone shape. The three chromosomal regions present in BcG-66H were isolated in congenic strains to study their individual effect. Epistatic interactions were assessed in bicongenic strains. Conclusions: Our results show that, besides a strong individual effect, the QTL on chromosome 1 interacts with genes on chromosomes 13 and 18. This study demonstrates that nasal bone shape is under complex genetic control but can be efficiently dissected in the mouse using appropriate genetic tools and shape descriptors.	[Burgio, Gaetan; Montagutelli, Xavier] Inst Pasteur, CNRS, Unite Genet Fonct Souris, URA 2578, Paris, France; [Burgio, Gaetan; Heyer, Evelyne] Univ Paris 07, CNRS, Museum Natl Hist Nat, Unite Ecoanthropol,UMR 7206, Paris, France; [Burgio, Gaetan] Univ Tasmania, Dept Genet, Menzies Res Inst, Hobart, Tas, Australia; [Baylac, Michel] Museum Natl Hist Nat, UMR 5202, F-75231 Paris, France; [Baylac, Michel] Museum Natl Hist Nat, CNRS, IFR 101, F-75231 Paris, France; [Baylac, Michel] Museum Natl Hist Nat, Entomol Lab, UMR 5202, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; University of Tasmania; Menzies Institute for Medical Research; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	Burgio, G (corresponding author), Inst Pasteur, CNRS, Unite Genet Fonct Souris, URA 2578, Paris, France.	grburgio@utas.edu.au	Burgio, Gaetan/B-6722-2015; Heyer, Evelyne/K-9184-2013	Burgio, Gaetan/0000-0002-7434-926X; Heyer, Evelyne/0000-0002-0266-3196				Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burgio G, 2007, GENETICS, V177, P2321, DOI 10.1534/genetics.107.078006; Burgio G, 2009, EVOLUTION, V63, P2668, DOI 10.1111/j.1558-5646.2009.00737.x; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Dohmoto A, 2002, J DENT RES, V81, P501, DOI 10.1177/154405910208100714; Dryden IL, 1998, STAT SHAPE ANAL, Vxvii; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Kawakami M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-73; Kelsey JL., 1996, METHODS OBSERVATIONA; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2001, GENETICS, V157, P785; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; LACHENBR.PA, 1968, TECHNOMETRICS, V10, P1, DOI 10.2307/1266219; Laissue P, 2009, INT J DEV BIOL, V53, P623, DOI 10.1387/ijdb.082613pl; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Leamy LJ, 1999, AM NAT, V153, P201, DOI 10.1086/303165; MOEN CJA, 1991, MAMM GENOME, V1, P217, DOI 10.1007/BF00352328; Monti L, 2001, BIOL J LINN SOC, V72, P391, DOI [10.1006/bijl.2000.0506, 10.1111/j.1095-8312.2001.tb01325.x]; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 1997, J IMMUNOL, V158, P6019; Rao CR, 1998, P NATL ACAD SCI USA, V95, P4121, DOI 10.1073/pnas.95.8.4121; Rogner UC, 2001, GENOMICS, V74, P163, DOI 10.1006/geno.2001.6508; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Sherwood RJ, 2008, GENETICS, V180, P619, DOI 10.1534/genetics.108.090407; Willmore KE, 2006, J ANAT, V208, P361, DOI 10.1111/j.1469-7580.2006.00527.x; Wolf JB, 2005, GENETICS, V171, P683, DOI 10.1534/genetics.104.038885	31	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37721	10.1371/journal.pone.0037721	http://dx.doi.org/10.1371/journal.pone.0037721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662199	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300089
J	de Borst, MH; Nauta, FL; Vogt, L; Laverman, GD; Gansevoort, RT; Navis, G				de Borst, Martin H.; Nauta, Ferdau L.; Vogt, Liffert; Laverman, Gozewijn D.; Gansevoort, Ron T.; Navis, Gerjan			Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIETARY-SODIUM RESTRICTION; CONVERTING ENZYME-INHIBITION; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM PROGNOSIS; NEPHROTIC SYNDROME; INJURY MOLECULE-1; PROTEINURIA; GLOMERULONEPHRITIS; NEPHROPATHY	Under specific conditions non-steroidal anti-inflammatory drugs (NSAIDs) may be used to lower therapy-resistant proteinuria. The potentially beneficial anti-proteinuric, tubulo-protective, and anti-inflammatory effects of NSAIDs may be offset by an increased risk of (renal) side effects. We investigated the effect of indomethacin on urinary markers of glomerular and tubular damage and renal inflammation. We performed a post-hoc analysis of a prospective open-label crossover study in chronic kidney disease patients (n = 12) with mild renal function impairment and stable residual proteinuria of 4.7 +/- 4.1 g/d. After a wash-out period of six wks without any RAAS blocking agents or other therapy to lower proteinuria (untreated proteinuria (UP)), patients subsequently received indomethacin 75 mg BID for 4 wks (NSAID). Healthy subjects (n = 10) screened for kidney donation served as controls. Urine and plasma levels of total IgG, IgG4, KIM-1, beta-2-microglobulin, H-FABP, MCP-1 and NGAL were determined using ELISA. Following NSAID treatment, 24 h -urinary excretion of glomerular and proximal tubular damage markers was reduced in comparison with the period without anti-proteinuric treatment (total IgG: UP 131[38-513] vs NSAID 38[17-218] mg/24 h, p<0.01; IgG4: 50[16-68] vs 10[1-38] mg/24 h, p<0.001; beta-2-microglobulin: 200[55-404] vs 50[28-110] ug/24 h, p = 0.03; KIM-1: 9[5-14] vs 5[2-9] ug/24 h, p = 0.01). Fractional excretions of these damage markers were also reduced by NSAID. The distal tubular marker H-FABP showed a trend to reduction following NSAID treatment. Surprisingly, NSAID treatment did not reduce urinary excretion of the inflammation markers MCP-1 and NGAL, but did reduce plasma MCP-1 levels, resulting in an increased fractional MCP-1 excretion. In conclusion, the anti-proteinuric effect of indomethacin is associated with reduced urinary excretion of glomerular and tubular damage markers, but not with reduced excretion of renal inflammation markers. Future studies should address whether the short term glomerulo- and tubulo-protective effects as observed outweigh the possible side-effects of NSAID treatment on the long term.	[de Borst, Martin H.; Nauta, Ferdau L.; Laverman, Gozewijn D.; Gansevoort, Ron T.; Navis, Gerjan] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands; [de Borst, Martin H.; Nauta, Ferdau L.; Laverman, Gozewijn D.; Gansevoort, Ron T.; Navis, Gerjan] Univ Groningen, Groningen, Netherlands; [Vogt, Liffert] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	de Borst, MH (corresponding author), Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands.	m.h.de.borst@umcg.nl	Vogt, Liffert/C-3168-2018	Vogt, Liffert/0000-0002-4585-7505; De Borst, Martin/0000-0002-4127-8733	Merck Company [MSGP 9661]; personal development grants from the Dutch Kidney foundation [KJPB.08.07]; University Medical Center Groningen (Mandema stipend)	Merck Company(Merck & Company); personal development grants from the Dutch Kidney foundation; University Medical Center Groningen (Mandema stipend)	The original study that served as the source of the current post-hoc analysis was supported by Merck & Company (grant MSGP 9661). Dr. De Borst is supported by personal development grants from the Dutch Kidney foundation (KJPB.08.07; http://www.nierstichting.nl) and the University Medical Center Groningen (Mandema stipend). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berden AE, 2012, J AM SOC NEPHROL, V23, P313, DOI 10.1681/ASN.2011040330; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Cheng HF, 2002, KIDNEY INT, V62, P929, DOI 10.1046/j.1523-1755.2002.00520.x; Cheng HF, 2011, J AM SOC NEPHROL, V22, P1240, DOI 10.1681/ASN.2010111149; de Borst MH, 2007, AM J PHYSIOL-RENAL, V292, pF313, DOI 10.1152/ajprenal.00180.2006; DONKER AJM, 1978, NEPHRON, V22, P374, DOI 10.1159/000181478; GANSEVOORT RT, 1992, NEPHROL DIAL TRANSPL, V7, P91; GUASCH A, 1993, J CLIN INVEST, V92, P2274, DOI 10.1172/JCI116831; HEEG JE, 1991, CLIN SCI, V81, P367, DOI 10.1042/cs0810367; HEEG JE, 1990, AM J NEPHROL, V10, P94, DOI 10.1159/000168201; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; John R, 2009, J CLIN PATHOL, V62, P505, DOI 10.1136/jcp.2008.058271; Kramer AB, 2003, J PATHOL, V201, P160, DOI 10.1002/path.1405; Kramer AB, 2009, AM J PHYSIOL-RENAL, V296, pF1136, DOI 10.1152/ajprenal.00541.2007; Krikken JA, 2009, CURR OPIN NEPHROL HY, V18, P531, DOI 10.1097/MNH.0b013e3283312fc8; LAGRUE G, 1988, International Urology and Nephrology, V20, P669, DOI 10.1007/BF02549501; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Pisoni R, 2002, KIDNEY INT, V62, P1010, DOI 10.1046/j.1523-1755.2002.00535.x; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Sauvant C, 2010, AM J NEPHROL, V32, P57, DOI 10.1159/000313452; Schneider R, 2009, AM J PHYSIOL-RENAL, V297, pF1614, DOI 10.1152/ajprenal.00268.2009; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Vogt L, 2010, NETH J MED, V68, P400; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; Vogt L, 2009, NEPHROL DIAL TRANSPL, V24, P1182, DOI 10.1093/ndt/gfn644; VRIESENDORP R, 1986, AM J MED, V81, P84, DOI 10.1016/0002-9343(86)90910-1; VRIESENDORP R, 1985, AM J NEPHROL, V5, P236, DOI 10.1159/000166941; VRIESENDORP R, 1986, CLIN NEPHROL, V25, P105; Waanders F, 2009, AM J KIDNEY DIS, V53, P16, DOI 10.1053/j.ajkd.2008.07.021; WEHRMANN M, 1989, CLIN NEPHROL, V31, P67; WEHRMANN M, 1990, CLIN NEPHROL, V33, P115; Whelton A, 2006, KIDNEY INT, V70, P1495, DOI 10.1038/sj.ki.5001766; WHELTON A, 1991, J CLIN PHARMACOL, V31, P588, DOI 10.1002/j.1552-4604.1991.tb03743.x	34	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37957	10.1371/journal.pone.0037957	http://dx.doi.org/10.1371/journal.pone.0037957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662255	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300146
J	Luby, MD; Hsu, CT; Shuster, SA; Gallardo, CM; Mistlberger, RE; King, OD; Steele, AD				Luby, Matthew D.; Hsu, Cynthia T.; Shuster, Scott A.; Gallardo, Christian M.; Mistlberger, Ralph E.; King, Oliver D.; Steele, Andrew D.			Food Anticipatory Activity Behavior of Mice across a Wide Range of Circadian and Non-Circadian Intervals	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; SUPRACHIASMATIC LESIONS; FEEDING SCHEDULES; DAILY MEAL; RATS; RHYTHMS; TIME; CLOCK; ENTRAINMENT; EXPRESSION	When rodents are fed in a limited amount during the daytime, they rapidly redistribute some of their nocturnal activity to the time preceding the delivery of food. In rats, anticipation of a daily meal has been interpreted as a circadian rhythm controlled by a food-entrained oscillator (FEO) with circadian limits to entrainment. Lesion experiments place this FEO outside of the light-entrainable circadian pacemaker in the suprachiasmatic nucleus. Mice also anticipate a fixed daily meal, but circadian limits to entrainment and anticipation of more than 2 daily meals, have not been assessed. We used a video-based behavior recognition system to quantify food anticipatory activity in mice receiving 2, 3, or 6 daily meals at intervals of 12, 8, or 4-hours (h). Individual mice were able to anticipate as many as 4 of 6 daily meals, and anticipation persisted during meal omission tests. On the 6 meal schedule, pre-prandial activity and body temperature were poorly correlated, suggesting independent regulation. Mice showed a limited ability to anticipate an 18 h feeding schedule. Finally, mice showed concurrent circadian and sub-hourly anticipation when provided with 6 small meals, at 30 minute intervals, at a fixed time of day. These results indicate that mice can anticipate feeding opportunities at a fixed time of day across a wide range of intervals not previously associated with anticipatory behavior in studies of rats. The methods described here can be exploited to determine the extent to which timing of different intervals in mice relies on common or distinct neural and molecular mechanisms.	[Luby, Matthew D.; Hsu, Cynthia T.; Shuster, Scott A.; Gallardo, Christian M.; Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [King, Oliver D.] Boston Biomed Res Inst, Watertown, MA USA	California Institute of Technology; Simon Fraser University; Boston Biomedical Research Institute	Luby, MD (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	steelea@caltech.edu		Gallardo, Christian/0000-0001-5702-0852	Ellison Medical Foundation; Klarman Family Foundation; Broad Fellows in Brain Circuitry Program at Caltech	Ellison Medical Foundation(Lawrence Ellison Foundation); Klarman Family Foundation; Broad Fellows in Brain Circuitry Program at Caltech	These studies were funded by grants to ADS from the Ellison Medical Foundation, the Klarman Family Foundation Program in Eating Disorders, and the Broad Fellows in Brain Circuitry Program at Caltech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2002, J BIOL RHYTHM, V17, P330, DOI 10.1177/074873002129002636; ASCHOFF J, 1986, MONIT ZOOL ITAL, V20, P195; BIEBACH H, 1991, J BIOL RHYTHM, V6, P353, DOI 10.1177/074873049100600406; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOLLES RC, 1962, J COMP PHYSIOL PSYCH, V55, P760, DOI 10.1037/h0046716; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; BOULOS Z, 1990, PHYSIOL BEHAV, V48, P523, DOI 10.1016/0031-9384(90)90294-E; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cordes S, 2008, BRAIN RES, V1227, P120, DOI 10.1016/j.brainres.2008.06.043; Crystal JD, 2006, BEHAV PROCESS, V72, P149, DOI 10.1016/j.beproc.2006.01.010; Crystal JD, 2001, J EXP PSYCHOL ANIM B, V27, P68, DOI 10.1037/0097-7403.27.1.68; Crystal JD, 2009, EUR J NEUROSCI, V30, P1756, DOI 10.1111/j.1460-9568.2009.06968.x; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gitler AD, 2007, J NEUROSCI, V27, P2433, DOI 10.1523/JNEUROSCI.0094-07.2007; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Gunapala KM, 2010, PRION, V4, P302, DOI 10.4161/pri.4.4.13721; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; Hsu CL, 2010, PLOS ONE, V5; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Mendoza J, 2008, J NEUROENDOCRINOL, V20, P251, DOI 10.1111/j.1365-2826.2007.01636.x; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Sanabria F, 2007, BEHAV PROCESS, V74, P126, DOI 10.1016/j.beproc.2006.10.012; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; STEPHAN FK, 1981, NEUROSCIENCE, V6, P2625, DOI 10.1016/0306-4522(81)90108-1; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2011, J MOL NEUROSCI; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37992	10.1371/journal.pone.0037992	http://dx.doi.org/10.1371/journal.pone.0037992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662260	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305342300152
J	Versluis, B; Dremmen, MHG; Nelemans, PJ; Wildberger, JE; Schurink, GW; Leiner, T; Backes, WH				Versluis, Bas; Dremmen, Marjolein H. G.; Nelemans, Patty J.; Wildberger, Joachim E.; Schurink, Geert-Willem; Leiner, Tim; Backes, Walter H.			Dynamic Contrast-Enhanced MRI Assessment of Hyperemic Fractional Microvascular Blood Plasma Volume in Peripheral Arterial Disease: Initial Findings	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; MUSCLE PERFUSION; ENDOTHELIAL DYSFUNCTION; LOWER-EXTREMITY; VASCULAR-MEDICINE; SKELETAL-MUSCLE; REPRODUCIBILITY; PERMEABILITY; INFLAMMATION; METAANALYSIS	Objectives: The aim of the current study was to describe a method that assesses the hyperemic microvascular blood plasma volume of the calf musculature. The reversibly albumin binding contrast agent gadofosveset was used in dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) to assess the microvascular status in patients with peripheral arterial disease (PAD) and healthy controls. In addition, the reproducibility of this method in healthy controls was determined. Materials and Methods: Ten PAD patients with intermittent claudication and 10 healthy control subjects were included. Patients underwent contrast-enhanced MR angiography of the peripheral arteries, followed by one DCE MRI examination of the musculature of the calf. Healthy control subjects were examined twice on different days to determine normative values and the interreader and interscan reproducibility of the technique. The MRI protocol comprised dynamic imaging of contrast agent wash-in under reactive hyperemia conditions of the calf musculature. Using pharmacokinetic modeling the hyperemic fractional microvascular blood plasma volume (V-p, unit: %) of the anterior tibial, gastrocnemius and soleus muscles was calculated. Results: V-p was significantly lower for all muscle groups in PAD patients (4.3 +/- 1.6%, 5.0 +/- 3.3% and 6.1 +/- 3.6% for anterior tibial, gastrocnemius and soleus muscles, respectively) compared to healthy control subjects (9.1 +/- 2.0%, 8.9 +/- 1.9% and 9.3 +/- 2.1%). Differences in V-p between muscle groups were not significant. The coefficient of variation of V-p varied from 10-14% and 11-16% at interscan and interreader level, respectively. Conclusions: Using DCE MRI after contrast-enhanced MR angiography with gadofosveset enables reproducible assessment of hyperemic fractional microvascular blood plasma volume of the calf musculature. V-p was lower in PAD patients than in healthy controls, which reflects a promising functional (hemodynamic) biomarker for the microvascular impairment of macrovascular lesions.	[Versluis, Bas; Dremmen, Marjolein H. G.; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands; [Schurink, Geert-Willem] Maastricht Univ Med Ctr, Dept Surg, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [Versluis, Bas; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Versluis, B (corresponding author), Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands.	w.backes@maastrichtuniversity.nl		Backes, Walter H/0000-0001-7905-0681; Wildberger, Joachim/0000-0002-4810-6854				Aslam F, 2009, SOUTH MED J, V102, P1141, DOI 10.1097/SMJ.0b013e3181bb9ab8; Begelman Susan M, 2006, Cleve Clin J Med, V73 Suppl 4, pS22; Bland JM, 1996, BRIT MED J, V313, P744; Caravan P, 2002, J AM CHEM SOC, V124, P3152, DOI 10.1021/ja017168k; Caravan P, 2007, INORG CHEM, V46, P6632, DOI 10.1021/ic700686k; Chao CYL, 2009, DIABETES-METAB RES, V25, P604, DOI 10.1002/dmrr.1004; Creager M A, 1997, Vasc Med, V2, P231; de Lussanet QG, 2007, NMR BIOMED, V20, P717, DOI 10.1002/nbm.1133; de Vries M, 2005, INVEST RADIOL, V40, P495, DOI 10.1097/01.rli.0000163004.65460.8b; de Vries M, 2005, J MAGN RESON IMAGING, V21, P37, DOI 10.1002/jmri.20240; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; Gerhard-Herman M, 2006, VASC MED, V11, P183, DOI 10.1177/1358863x06070516; Grover-Paez F, 2009, DIABETES RES CLIN PR, V84, P1, DOI 10.1016/j.diabres.2008.12.013; Haacke EM, 2007, MAGN RESON MED, V58, P463, DOI 10.1002/mrm.21358; Haacke M, 1999, MAGNETIC RESONANCE I, P654; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Isbell DC, 2007, J MAGN RESON IMAGING, V25, P1013, DOI 10.1002/jmri.20899; Jansen JFA, 2007, INVEST RADIOL, V42, P327, DOI 10.1097/01.rli.0000262757.10271.e5; Kershaw LE, 2006, MAGN RESON MED, V56, P986, DOI 10.1002/mrm.21040; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Ledermann HP, 2006, CIRCULATION, V113, P2929, DOI 10.1161/CIRCULATIONAHA.105.605717; Leiner T, 2005, RADIOLOGY, V235, P699, DOI 10.1148/radiol.2352040089; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; McDermott MM, 2004, J VASC SURG, V39, P523, DOI 10.1016/j.jvs.2003.08.038; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Nelemans PJ, 2000, RADIOLOGY, V217, P105, DOI 10.1148/radiology.217.1.r00oc11105; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Press WH, 1992, NUMERICAL RECIPES C, Vxxvi, P994; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Ribeiro Fernando, 2009, Rev Port Cardiol, V28, P1121; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Thompson RB, 2005, MAGNET RESON MED, V54, P289, DOI 10.1002/mrm.20535; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1994, MAGN RESON IMAGING, V12, P81, DOI 10.1016/0730-725X(94)92355-8; Versluis B, 2011, INVEST RADIOL, V46, P11, DOI 10.1097/RLI.0b013e3181f2bfb8; Vita JA, 2010, CAN J CARDIOL, V26, p45A, DOI 10.1016/S0828-282X(10)71062-X; Weber MA, 2007, EUR RADIOL, V17, P2663, DOI 10.1007/s00330-007-0641-y; Wong WT, 2010, J CARDIOVASC PHARM, V55, P300, DOI 10.1097/FJC.0b013e3181d7671c; Ziegler MA, 2010, MICROCIRCULATION, V17, P3, DOI 10.1111/j.1549-8719.2010.00008.x	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37756	10.1371/journal.pone.0037756	http://dx.doi.org/10.1371/journal.pone.0037756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662212	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300102
J	Zaki, R; Bulgiba, A; Ismail, R; Ismail, NA				Zaki, Rafdzah; Bulgiba, Awang; Ismail, Roshidi; Ismail, Noor Azina			Statistical Methods Used to Test for Agreement of Medical Instruments Measuring Continuous Variables in Method Comparison Studies: A Systematic Review	PLOS ONE			English	Review							FOOD FREQUENCY QUESTIONNAIRE; VALIDATION	Background: Accurate values are a must in medicine. An important parameter in determining the quality of a medical instrument is agreement with a gold standard. Various statistical methods have been used to test for agreement. Some of these methods have been shown to be inappropriate. This can result in misleading conclusions about the validity of an instrument. The Bland-Altman method is the most popular method judging by the many citations of the article proposing this method. However, the number of citations does not necessarily mean that this method has been applied in agreement research. No previous study has been conducted to look into this. This is the first systematic review to identify statistical methods used to test for agreement of medical instruments. The proportion of various statistical methods found in this review will also reflect the proportion of medical instruments that have been validated using those particular methods in current clinical practice. Methodology/Findings: Five electronic databases were searched between 2007 and 2009 to look for agreement studies. A total of 3,260 titles were initially identified. Only 412 titles were potentially related, and finally 210 fitted the inclusion criteria. The Bland-Altman method is the most popular method with 178 (85%) studies having used this method, followed by the correlation coefficient (27%) and means comparison (18%). Some of the inappropriate methods highlighted by Altman and Bland since the 1980s are still in use. Conclusions: This study finds that the Bland-Altman method is the most popular method used in agreement research. There are still inappropriate applications of statistical methods in some studies. It is important for a clinician or medical researcher to be aware of this issue because misleading conclusions from inappropriate analyses will jeopardize the quality of the evidence, which in turn will influence quality of care given to patients in the future.	[Zaki, Rafdzah; Bulgiba, Awang; Ismail, Roshidi] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Ismail, Noor Azina] Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Zaki, R (corresponding author), Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	rafdzah@hotmail.com	Bulgiba, Awang/B-8271-2010; ZAKI, RAFDZAH AHMAD/B-9520-2010; Javed, Nasir/C-2501-2012; ISMAIL, NOOR AZINA/B-5341-2010	Bulgiba, Awang/0000-0002-5313-0445; ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; Javed, Nasir/0000-0002-6390-431X; ISMAIL, NOOR AZINA/0000-0001-8032-2162; Ismail, Roshidi/0000-0002-0698-7964	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]; University of Malaya student research grant [PS162/2009B]	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant; University of Malaya student research grant	This work is part of the Meta-Analysis project (STeMM Programme) supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant number E000010-20001), and the University of Malaya student research grant (PS162/2009B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Ahn Y, 2008, ACTA PAEDIATR, V97, P366, DOI 10.1111/j.1651-2227.2008.00666.x; Allen R, 2007, J EXPO SCI ENV EPID, V17, P468, DOI 10.1038/sj.jes.7500539; Altman DG, 1983, J R STAT SOC D-STAT, V32, P307, DOI DOI 10.2307/2987937; Anderst W, 2009, MED ENG PHYS, V31, P10, DOI 10.1016/j.medengphy.2008.03.003; Andrieux P, 2008, J AOAC INT, V91, P777; Barthelemy J, 2009, ORAL SURG ORAL MED O, V107, P437, DOI 10.1016/j.tripleo.2008.11.010; BLAND JM, 1990, COMPUT BIOL MED, V20, P337, DOI 10.1016/0010-4825(90)90013-F; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Camara O, 2008, NEUROIMAGE, V42, P696, DOI 10.1016/j.neuroimage.2008.04.259; Cuervo MLC, 2008, BIOLOGICALS, V36, P375, DOI 10.1016/j.biologicals.2008.06.005; Cuker A, 2009, J THROMB HAEMOST, V7, P80, DOI 10.1111/j.1538-7836.2008.03224.x; Daly LE., 2000, INTERPRETATION USES, V5, P568, DOI [10.1002/9780470696750, DOI 10.1002/9780470696750]; Davis JA, 2007, CLIN PHYSIOL FUNCT I, V27, P381, DOI 10.1111/j.1475-097X.2007.00762.x; Di Noia J, 2009, J AM DIET ASSOC, V109, P1785, DOI 10.1016/j.jada.2009.07.002; Essack Y, 2009, JEMDSA, V14, P102, DOI 10.1080/22201009.2009.10872202; Fay MP, 2005, BIOSTATISTICS, V6, P171, DOI 10.1093/biostatistics/kxh027; Hacihaliloglu I, 2009, ULTRASOUND MED BIOL, V35, P1475, DOI 10.1016/j.ultrasmedbio.2009.04.015; Hanbazaza SM, 2012, SAUDI MED J, V33, P91; Hof I, 2008, AM J CARDIOL, V102, P1567, DOI 10.1016/j.amjcard.2008.07.048; HOPKINS WG, 2004, SPORTSCIENCE, V8, P42; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; LEE J, 1989, COMPUT BIOL MED, V19, P61, DOI 10.1016/0010-4825(89)90036-X; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; Luiz RR, 2005, J CLIN EPIDEMIOL, V58, P215, DOI 10.1016/j.jclinepi.2004.07.007; Mundermann A, 2008, KNEE, V15, P480, DOI 10.1016/j.knee.2008.07.002; Naidu SH, 2009, J HAND THER, V22, P250, DOI 10.1016/j.jht.2008.11.003; Reis M, 2007, INT J HYG ENVIR HEAL, V3-4, P419; Satia JA, 2007, J AM DIET ASSOC, V107, P782, DOI 10.1016/j.jada.2007.02.004; Satia JA, 2009, J AM DIET ASSOC, V109, P502, DOI 10.1016/j.jada.2008.11.033; Shuaibi AM, 2008, J AM DIET ASSOC, V108, P2041, DOI 10.1016/j.jada.2008.09.002; ten Boekel E, 2007, THROMB RES, V121, P361, DOI 10.1016/j.thromres.2007.05.006; Vet de HC, 1998, ENCY BIOSTATISTICS, V4, P3123; Wikipedia, WIK FREE ENC BLAND A	36	174	182	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37908	10.1371/journal.pone.0037908	http://dx.doi.org/10.1371/journal.pone.0037908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662248	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305342300139
J	Fang, YJ; Wu, H; Zhang, TW; Yang, M; Yin, YX; Pan, LL; Yu, XG; Zhang, XW; Hu, SNA; Al-Mssallem, IS; Yu, J				Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun			A Complete Sequence and Transcriptomic Analyses of Date Palm (Phoenix dactylifera L.) Mitochondrial Genome	PLOS ONE			English	Article							TRANSFER-RNA GENES; PLANT MITOCHONDRIAL; PHYLOGENETIC ANALYSIS; DYNAMIC EVOLUTION; LAND PLANTS; CHLOROPLAST; PROTEIN; MAIZE; DNA; ARABIDOPSIS	Based on next-generation sequencing data, we assembled the mitochondrial (mt) genome of date palm (Phoenix dactylifera L.) into a circular molecule of 715,001 bp in length. The mt genome of P. dactylifera encodes 38 proteins, 30 tRNAs, and 3 ribosomal RNAs, which constitute a gene content of 6.5% (46,770 bp) over the full length. The rest, 93.5% of the genome sequence, is comprised of cp (chloroplast)-derived (10.3% with respect to the whole genome length) and non-coding sequences. In the non-coding regions, there are 0.33% tandem and 2.3% long repeats. Our transcriptomic data from eight tissues (root, seed, bud, fruit, green leaf, yellow leaf, female flower, and male flower) showed higher gene expression levels in male flower, root, bud, and female flower, as compared to four other tissues. We identified 120 potential SNPs among three date palm cultivars (Khalas, Fahal, and Sukry), and successfully found seven SNPs in the coding sequences. A phylogenetic analysis, based on 22 conserved genes of 15 representative plant mitochondria, showed that P. dactylifera positions at the root of all sequenced monocot mt genomes. In addition, consistent with previous discoveries, there are three co-transcribed gene clusters-18S-5S rRNA, rps3-rpl16 and nad3-rps12-in P. dactylifera, which are highly conserved among all known mitochondrial genomes of angiosperms.	[Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun] KACST, JCGR, Riyadh, Saudi Arabia; [Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun] Chinese Acad Sci, Riyadh, Saudi Arabia; [Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Hu, Songnian; Yu, Jun] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Yongjun; Wu, Hao; Zhang, Tongwu; Yang, Meng; Yin, Yuxin; Pan, Linlin; Yu, Xiaoguang; Zhang, Xiaowei; Hu, Songnian; Al-Mssallem, Ibrahim S.; Yu, Jun] Chinese Acad Sci, BIG, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Al-Mssallem, Ibrahim S.] King Faisal Univ, Dept Biotechnol, Coll Agr & Food Sci, Al Hufuf, Saudi Arabia	King Abdulaziz City for Science & Technology; Zhejiang University; Chinese Academy of Sciences; King Faisal University	Fang, YJ (corresponding author), KACST, JCGR, Riyadh, Saudi Arabia.	zhangxw@big.ac.cn; husn@big.ac.cn; imssallem@kacst.edu.sa; junyu@big.ac.cn	; Hu, Songnian/C-6509-2013	, Meng/0000-0002-2672-3069; Hu, Songnian/0000-0003-3966-3111	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [428-29]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia	The project is supported by a project grant from King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [428-29]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Binder S, 1996, PLANT MOL BIOL, V32, P303, DOI 10.1007/BF00039387; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Carlsson J, 2008, MITOCHONDRION, V8, P74, DOI 10.1016/j.mito.2007.09.006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Cummings MP, 2003, CURR GENET, V43, P131, DOI 10.1007/s00294-003-0378-3; FINNEGAN PM, 1990, PLANT CELL, V2, P71, DOI 10.1105/tpc.2.1.71; Fujii S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-279; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grosskopf D, 1996, CURR GENET, V29, P556, DOI 10.1007/BF02426960; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He SC, 1996, P NATL ACAD SCI USA, V93, P11763, DOI 10.1073/pnas.93.21.11763; Hedtke B, 2002, PLANT J, V30, P625, DOI 10.1046/j.1365-313X.2002.01318.x; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; HUANG J, 1994, PLANT CELL, V6, P439, DOI 10.1105/tpc.6.3.439; HUH T Y, 1982, Plant Molecular Biology, V1, P245, DOI 10.1007/BF00021035; IS A-M, 1996, ARABIAN GLOBAL ENCY, V7, P182; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kadowaki KI, 1996, EMBO J, V15, P6652, DOI 10.1002/j.1460-2075.1996.tb01055.x; Kalantidis K, 2002, SEX PLANT REPROD, V14, P299, DOI 10.1007/s00497-001-0114-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Lilly JW, 2001, GENETICS, V159, P317; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marienfeld J, 1999, TRENDS PLANT SCI, V4, P495, DOI 10.1016/S1360-1385(99)01502-2; McCauley DE, 2008, EVOLUTION, V62, P1013, DOI 10.1111/j.1558-5646.2008.00363.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Mower JP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-96; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; PRING D, 1993, PLANT MOL BIOL, V21, P1163, DOI 10.1007/BF00023611; Sghaier-Hammami B, 2009, PROTEOMICS, V9, P2543, DOI 10.1002/pmic.200800523; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; STERN DB, 1984, P NATL ACAD SCI-BIOL, V81, P1946, DOI 10.1073/pnas.81.7.1946; THOMSON MC, 1994, NUCLEIC ACIDS RES, V22, P5745, DOI 10.1093/nar/22.25.5745; Tian XJ, 2007, J MOL EVOL, V64, P299, DOI 10.1007/s00239-005-0200-6; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WINKLER M, 1991, CURR GENET, V20, P495, DOI 10.1007/BF00334778; WINTZ H, 1991, CURR GENET, V19, P61, DOI 10.1007/BF00362089; WISSINGER B, 1992, TRENDS GENET, V8, P322, DOI 10.1016/0168-9525(92)90265-6; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762	69	70	74	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37164	10.1371/journal.pone.0037164	http://dx.doi.org/10.1371/journal.pone.0037164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655034	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900009
J	Molenda, O; Reid, A; Lortie, CJ				Molenda, Olivia; Reid, Anya; Lortie, Christopher J.			The Alpine Cushion Plant Silene acaulis as Foundation Species: A Bug's-Eye View to Facilitation and Microclimate	PLOS ONE			English	Article							POSITIVE INTERACTIONS; COMMUNITIES; PATTERNS; VEGETATION; SOIL; CONSEQUENCES; ECOSYSTEMS; RESPONSES; RICHNESS; INCREASE	Alpine ecosystems are important globally with high levels of endemic and rare species. Given that they will be highly impacted by climate change, understanding biotic factors that maintain diversity is critical. Silene acaulis is a common alpine nurse plant shown to positively influence the diversity and abundance of organisms-predominantly other plant species. The hypothesis that cushion or nurse plants in general are important to multiple trophic levels has been proposed but rarely tested. Alpine arthropod diversity is also largely understudied worldwide, and the plant-arthropod interactions reported are mostly negative, that is, herbivory. Plant and arthropod diversity and abundance were sampled on S. acaulis and at paired adjacent microsites with other non-cushion forming vegetation present on Whistler Mountain, B. C., Canada to examine the relative trophic effects of cushion plants. Plant species richness and abundance but not Simpson's diversity index was higher on cushion microsites relative to other vegetation. Arthropod richness, abundance, and diversity were all higher on cushion microsites relative to other vegetated sites. On a microclimatic scale, S. acaulis ameliorated stressful conditions for plants and invertebrates living inside it, but the highest levels of arthropod diversity were observed on cushions with tall plant growth. Hence, alpine cushion plants can be foundation species not only for other plant species but other trophic levels, and these impacts are expressed through both direct and indirect effects associated with altered environmental conditions and localized productivity. Whilst this case study tests a limited subset of the membership of alpine animal communities, it clearly demonstrates that cushion-forming plant species are an important consideration in understanding resilience to global changes for many organisms in addition to other plants.	[Molenda, Olivia] Univ Toronto, Toronto, ON, Canada; [Reid, Anya; Lortie, Christopher J.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; York University - Canada	Molenda, O (corresponding author), Univ Toronto, Toronto, ON, Canada.	lortie@yorku.ca	lortie, christopher j/F-6241-2014	lortie, christopher j/0000-0002-4291-7023; Molenda, Olivia/0000-0002-9487-0861	Natural Sciences and Engineering Research Council of Canada Discovery Grant; Natural Sciences and Engineering Research Council of Canada Pollination Initiative grant; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada Pollination Initiative grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to CJL and a Natural Sciences and Engineering Research Council of Canada Pollination Initiative grant to CJL. AR was funded by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VM, 2007, J APPL ENTOMOL, V131, P493, DOI 10.1111/j.1439-0418.2007.01197.x; [Anonymous], 1996, BOUNDARY LAYER CLIMA; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Antonsson H, 2009, PLANT ECOL DIVERS, V2, P17, DOI 10.1080/17550870902926504; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Badano EI, 2006, J BIOGEOGR, V33, P304, DOI 10.1111/j.1365-2699.2005.01384.x; Badano EI, 2009, PERSPECT PLANT ECOL, V11, P191, DOI 10.1016/j.ppees.2009.03.002; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bonhomme V, 2011, J TROP ECOL, V27, P15, DOI 10.1017/S0266467410000532; Brooker R.W., 2008, J ECOL, V96, P8; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brooker RW, 2009, J ECOL, V97, P1117, DOI 10.1111/j.1365-2745.2009.01580.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaghan TV, 2004, AMBIO, V33, P436, DOI 10.1639/0044-7447(2004)033[0436:EOTSOA]2.0.CO;2; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Colwell R.K., 2010, ESTIMATES STAT ESTIM; Coulson SI, 2003, ECOGRAPHY, V26, P801, DOI 10.1111/j.0906-7590.2003.03646.x; Crain CM, 2006, BIOSCIENCE, V56, P211; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DAYTON PK, 1972, P C CONS PROBL ANT L; DETHIER M, 1984, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V57, P317; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Finch OD, 2010, BIODIVERS CONSERV, V19, P1341, DOI 10.1007/s10531-009-9765-5; Gobbi M, 2006, GLOBAL CHANGE BIOL, V12, P1985, DOI 10.1111/j.1365-2486.2006.01236.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hughes BB, 2010, J EXP MAR BIOL ECOL, V393, P90, DOI 10.1016/j.jembe.2010.07.003; Badano EI, 2010, ACTA OECOL, V36, P46, DOI 10.1016/j.actao.2009.09.008; Kaplan JO, 2006, CLIMATIC CHANGE, V79, P213, DOI 10.1007/s10584-006-9113-7; Kleier C, 2009, PLANT BIOLOGY, V11, P351, DOI 10.1111/j.1438-8677.2008.00115.x; KORNER C, 1979, OECOLOG PLANTAR, V14, P109; Krebs C.J., 1999, ECOLOGICAL METHODOLO, P410; Larcher W, 2010, FLORA, V205, P3, DOI 10.1016/j.flora.2008.12.005; Manly B.F.J., 1994, MULTIVARIATE STAT ME; MATTHEY W, 1981, B ECOL, V12, P339; Molina-Montenegro MA, 2006, ARCT ANTARCT ALP RES, V38, P224, DOI 10.1657/1523-0430(2006)38[224:CPAMSF]2.0.CO;2; Molina-Montenegro MA, 2009, ECOL RES, V24, P31, DOI 10.1007/s11284-008-0477-1; Mysterud A, 2010, BASIC APPL ECOL, V11, P320, DOI 10.1016/j.baae.2010.02.009; Offenberg J, 2006, FUNCT ECOL, V20, P52, DOI 10.1111/j.1365-2435.2005.01059.x; Oke T. R., 2005, BOUNDARY LAYER CLIMA; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; PAN HL, 1987, BOUND-LAY METEOROL, V38, P185, DOI 10.1007/BF00121563; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Prevey JS, 2010, ECOL APPL, V20, P1890, DOI 10.1890/09-0750.1; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Quiroz CL, 2009, REV CHIL HIST NAT, V82, P171; Ren H, 2008, PROG NAT SCI-MATER, V18, P137, DOI 10.1016/j.pnsc.2007.07.008; Sapir Y, 2009, ARTHROPOD-PLANT INTE, V3, P115, DOI 10.1007/s11829-009-9062-y; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Sokal RR, 2003, BIOMETRY; Streinzer M, 2010, ARTHROPOD-PLANT INTE, V4, P141, DOI 10.1007/s11829-010-9093-4; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Xu J, 2010, PLANT BIOLOGY, V12, P780, DOI 10.1111/j.1438-8677.2009.00271.x; Yang Y, 2010, J VEG SCI, V21, P1048, DOI 10.1111/j.1654-1103.2010.01215.x; Zuur Alain F., 2009, P1	62	47	49	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37223	10.1371/journal.pone.0037223	http://dx.doi.org/10.1371/journal.pone.0037223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655035	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900010
J	Faria, LCB; Rocha, ASL; Kleinschmidt, JH; Silva-Filho, MC; Bim, E; Herai, RH; Yamagishi, MEB; Palazzo, R				Faria, Luzinete C. B.; Rocha, Andrea S. L.; Kleinschmidt, Joao H.; Silva-Filho, Marcio C.; Bim, Edson; Herai, Roberto H.; Yamagishi, Michel E. B.; Palazzo, Reginaldo, Jr.			Is a Genome a Codeword of an Error-Correcting Code?	PLOS ONE			English	Article							BCH CODES	Since a genome is a discrete sequence, the elements of which belong to a set of four letters, the question as to whether or not there is an error-correcting code underlying DNA sequences is unavoidable. The most common approach to answering this question is to propose a methodology to verify the existence of such a code. However, none of the methodologies proposed so far, although quite clever, has achieved that goal. In a recent work, we showed that DNA sequences can be identified as codewords in a class of cyclic error-correcting codes known as Hamming codes. In this paper, we show that a complete intron-exon gene, and even a plasmid genome, can be identified as a Hamming code codeword as well. Although this does not constitute a definitive proof that there is an error-correcting code underlying DNA sequences, it is the first evidence in this direction.	[Faria, Luzinete C. B.; Rocha, Andrea S. L.; Palazzo, Reginaldo, Jr.] Univ Estadual Campinas, Dept Telemat, Sao Paulo, Brazil; [Kleinschmidt, Joao H.] Univ Fed ABC, Ctr Engn Modelagem & Ciencias Sociais Aplicadas, Sao Paulo, Brazil; [Silva-Filho, Marcio C.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz Queiroz, Sao Paulo, Brazil; [Bim, Edson] Univ Estadual Campinas, Dept Sistema Controle Energia, Sao Paulo, Brazil; [Herai, Roberto H.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yamagishi, Michel E. B.] Embrapa Informat Agropecuaria, Lab Bioinforma Aplicada, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Estadual de Campinas; University of California System; University of California San Diego; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Faria, LCB (corresponding author), Univ Estadual Campinas, Dept Telemat, Sao Paulo, Brazil.	luzinete@dt.fee.unicamp.br; andrea@dt.fee.unicamp.br	Herai, Roberto/HII-2648-2022; Kleinschmidt, João Henrique/E-9372-2012; Bim, Edson/AAQ-8069-2020; Yamagishi, Michel Eduardo Beleza/B-7902-2012; Silva-Filho, Marcio/F-2639-2012	Herai, Roberto/0000-0001-9885-2735; Kleinschmidt, João Henrique/0000-0001-6706-455X; Yamagishi, Michel Eduardo Beleza/0000-0001-7109-3038; Silva-Filho, Marcio/0000-0003-2129-0388	Brazilian agencies FAPESP; CNPq; CAPES	Brazilian agencies FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the Brazilian agencies FAPESP, CNPq and CAPES for the financial support during the period of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AA, 2003, COMPUT APPL MATH, V22, P233, DOI 10.1590/S1807-03022003000200005; Bose R.C., 1960, INFORM CONTR, V3, P68, DOI DOI 10.1016/S0019-9958(60)90287-4; de Andrade AA, 1999, LINEAR ALGEBRA APPL, V286, P69, DOI 10.1016/S0024-3795(98)10163-5; Elia M., 2000, J DISCRETE MATH SCI, V3, P41; Faria LCB, 2010, ELECTRON LETT, V46, P202, DOI 10.1049/el.2010.3397; FORSDYKE DR, 1981, J THEOR BIOL, V93, P861, DOI 10.1016/0022-5193(81)90344-1; Hocquenghem A., 1959, CHIFFRES, P147; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huffman W., 2003, FUNDAMENTALS ERROR C; Interlando JC, 1997, IEEE T INFORM THEORY, V43, P1013, DOI 10.1109/18.568713; Kumar RP, 2010, BIOESSAYS, V32, P165, DOI 10.1002/bies.200900111; Rocha ASL, 2010, IEEE INT SYMP INFO, P1320, DOI 10.1109/ISIT.2010.5513747; Liebovitch LS, 1996, BIOPHYS J, V71, P1539, DOI 10.1016/S0006-3495(96)79356-6; McWilliams FJ., 1977, THEORY ERROR CORRECT; Ozturk S, 2011, HISTOL HISTOPATHOL, V26, P505, DOI 10.14670/HH-26.505; Peterson WW., 1972, ERROR CORRECTING COD; Pless VS, 1996, IEEE T INFORM THEORY, V42, P1594, DOI 10.1109/18.532906; Rosen GL, 2006, IEEE ENG MED BIOL, V25, P62, DOI 10.1109/MEMB.2006.1578665; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SHANKAR P, 1979, IEEE T INFORM THEORY, V25, P480, DOI 10.1109/TIT.1979.1056063	20	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36644	10.1371/journal.pone.0036644	http://dx.doi.org/10.1371/journal.pone.0036644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649495	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800012
J	Fontaine, B; van Achterberg, K; Alonso-Zarazaga, MA; Araujo, R; Asche, M; Aspock, H; Aspock, U; Audisio, P; Aukema, B; Bailly, N; Balsamo, M; Bank, RA; Belfiore, C; Bogdanowicz, W; Boxshall, G; Burckhardt, D; Chylarecki, P; Deharveng, L; Dubois, A; Enghoff, H; Fochetti, R; Fontaine, C; Gargominy, O; Lopez, MSG; Goujet, D; Harvey, MS; Heller, KG; van Helsdingen, P; Hoch, H; De Jong, Y; Karsholt, O; Los, W; Magowski, W; Massard, JA; McInnes, SJ; Mendes, LF; Mey, E; Michelsen, V; Minelli, A; Nafria, JMN; van Nieukerken, EJ; Pape, T; De Prins, W; Ramos, M; Ricci, C; Roselaar, C; Rota, E; Segers, H; Timm, T; van Tol, J; Bouchet, P				Fontaine, Benoit; van Achterberg, Kees; Angel Alonso-Zarazaga, Miguel; Araujo, Rafael; Asche, Manfred; Aspoeck, Horst; Aspoeck, Ulrike; Audisio, Paolo; Aukema, Berend; Bailly, Nicolas; Balsamo, Maria; Bank, Ruud A.; Belfiore, Carlo; Bogdanowicz, Wieslaw; Boxshall, Geoffrey; Burckhardt, Daniel; Chylarecki, Przemyslaw; Deharveng, Louis; Dubois, Alain; Enghoff, Henrik; Fochetti, Romolo; Fontaine, Colin; Gargominy, Olivier; Gomez Lopez, Maria Soledad; Goujet, Daniel; Harvey, Mark S.; Heller, Klaus-Gerhard; van Helsdingen, Peter; Hoch, Hannelore; De Jong, Yde; Karsholt, Ole; Los, Wouter; Magowski, Wojciech; Massard, Jos A.; McInnes, Sandra J.; Mendes, Luis F.; Mey, Eberhard; Michelsen, Verner; Minelli, Alessandro; Nieto Nafria, Juan M.; van Nieukerken, Erik J.; Pape, Thomas; De Prins, Willy; Ramos, Marian; Ricci, Claudia; Roselaar, Cees; Rota, Emilia; Segers, Hendrik; Timm, Tarmo; van Tol, Jan; Bouchet, Philippe			New Species in the Old World: Europe as a Frontier in Biodiversity Exploration, a Test Bed for 21st Century Taxonomy	PLOS ONE			English	Article							ASTRONOMY; AMATEURS	The number of described species on the planet is about 1.9 million, with ca. 17,000 new species described annually, mostly from the tropics. However, taxonomy is usually described as a science in crisis, lacking manpower and funding, a politically acknowledged problem known as the Taxonomic Impediment. Using data from the Fauna Europaea database and the Zoological Record, we show that contrary to general belief, developed and heavily-studied parts of the world are important reservoirs of unknown species. In Europe, new species of multicellular terrestrial and freshwater animals are being discovered and named at an unprecedented rate: since the 1950s, more than 770 new species are on average described each year from Europe, which add to the 125,000 terrestrial and freshwater multicellular species already known in this region. There is no sign of having reached a plateau that would allow for the assessment of the magnitude of European biodiversity. More remarkably, over 60% of these new species are described by non-professional taxonomists. Amateurs are recognized as an essential part of the workforce in ecology and astronomy, but the magnitude of non-professional taxonomist contributions to alpha-taxonomy has not been fully realized until now. Our results stress the importance of developing a system that better supports and guides this formidable workforce, as we seek to overcome the Taxonomic Impediment and speed up the process of describing the planetary biodiversity before it is too late.	[Fontaine, Benoit; Fontaine, Colin] Museum Natl Hist Nat, UMR 7204, F-75231 Paris, France; [van Achterberg, Kees; van Nieukerken, Erik J.; van Tol, Jan] NCB Nat, Leiden, Netherlands; [Angel Alonso-Zarazaga, Miguel; Araujo, Rafael; Ramos, Marian] CSIC, Museo Nacl Ciencias Nat, Depto Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Asche, Manfred; Hoch, Hannelore] Humboldt Univ, Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10099 Berlin, Germany; [Aspoeck, Horst] Med Univ Vienna, Dept Med Parasitol, Vienna, Austria; [Aspoeck, Ulrike] Univ Vienna, Nat Hist Museum Wien, Vienna, Austria; [Audisio, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Rome, Italy; [Bailly, Nicolas] WorldFish Ctr, Laguna, Philippines; [Balsamo, Maria] Univ Urbino Carlo Bo, Dipartimento Sci Uomo Ambiente & Nat, Urbino, Italy; [Belfiore, Carlo] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy; [Bogdanowicz, Wieslaw; Chylarecki, Przemyslaw] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Boxshall, Geoffrey] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Burckhardt, Daniel] Nat Hist Museum, Basel, Switzerland; [Deharveng, Louis; Dubois, Alain; Bouchet, Philippe] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Enghoff, Henrik; Karsholt, Ole; Michelsen, Verner; Pape, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Fochetti, Romolo] Univ Tuscia, Dipartimento Sci Ambientali, Viterbo, Italy; [Gargominy, Olivier] Museum Natl Hist Nat, Serv Patrimoine Nat, F-75231 Paris, France; [Gomez Lopez, Maria Soledad] Univ Barcelona, Parasitol Lab, Barcelona, Spain; [Goujet, Daniel] Museum Natl Hist Nat, Dept Hist Terre, F-75231 Paris, France; [Harvey, Mark S.] Western Australian Museum, Dept Terr Zool, Welshpool, WA, Australia; [Heller, Klaus-Gerhard] Univ Erlangen Nurnberg, Inst Zool, D-91054 Erlangen, Germany; [van Helsdingen, Peter] European Invertebrate Survey, Natl Nat Hist Museum Nat, Leiden, Netherlands; [De Jong, Yde; Los, Wouter] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [Magowski, Wojciech] Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland; [McInnes, Sandra J.] British Antarctic Survey, Cambridge, England; [Mendes, Luis F.] Ctr Zool, Inst Invest Cient Trop, Lisbon, Portugal; [Mey, Eberhard] Nat Hist Museum Thuringer Landesmuseum, Rudolstadt, Germany; [Minelli, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Nieto Nafria, Juan M.] Univ Leon, Dept Biodiversidad & Gest Ambiental, E-24071 Leon, Spain; [De Prins, Willy] Flemish Entomol Soc, Leefdaal, Belgium; [Ricci, Claudia] Univ Milan, Dipartimento Protez Sistemi Agroalimentare & Urba, Milan, Italy; [Roselaar, Cees] NCB Nat, Amsterdam, Netherlands; [Rota, Emilia] Univ Siena, Dipartimento Sci Ambientali, Sez Sistemat Ecol Anim & Vegetale, I-53100 Siena, Italy; [Segers, Hendrik] Royal Belgian Inst Nat Sci, Freshwater Lab, Brussels, Belgium; [Timm, Tarmo] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartumaa, Estonia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Medical University of Vienna; University of Vienna; Sapienza University Rome; CGIAR; Worldfish; University of Urbino; Tuscia University; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); University of Copenhagen; Tuscia University; Museum National d'Histoire Naturelle (MNHN); University of Barcelona; Museum National d'Histoire Naturelle (MNHN); Western Australian Museum; University of Erlangen Nuremberg; University of Amsterdam; Adam Mickiewicz University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Padua; Universidad de Leon; University of Milan; University of Siena; Royal Belgian Institute of Natural Sciences; Estonian University of Life Sciences	Fontaine, B (corresponding author), Museum Natl Hist Nat, UMR 7204, F-75231 Paris, France.	fontaine@mnhn.fr	van Achterberg, Kees/AFV-5150-2022; van Nieukerken, Erik/B-4512-2012; Fontaine, Colin/N-6469-2015; McInnes, Sandra/AAN-4773-2020; Dubois, Arnaud/C-1791-2014; Bailly, Nicolas/AID-4444-2022; Pape, Thomas/E-7520-2011; Balsamo, Maria/AAW-3205-2020; Ramos, Maria Angeles/E-5536-2013; Harvey, Mark/P-4265-2019; Mendes, Luis/N-3140-2013; Aspöck, Horst/O-1990-2017; Chylarecki, Przemysław/B-7696-2013; Segers, Hendrik/C-4101-2009; Harvey, Mark S/L-1177-2013; Enghoff, Henrik/A-5796-2013	van Nieukerken, Erik/0000-0002-5721-1840; Fontaine, Colin/0000-0001-5367-5675; Pape, Thomas/0000-0001-6609-0609; Balsamo, Maria/0000-0002-7947-0632; Ramos, Maria Angeles/0000-0001-5224-5665; Harvey, Mark/0000-0003-1482-0109; Mendes, Luis/0000-0002-2873-6066; Aspöck, Horst/0000-0001-9407-3566; Chylarecki, Przemysław/0000-0001-6863-4294; Segers, Hendrik/0000-0001-5399-3657; Harvey, Mark S/0000-0003-1482-0109; AUDISIO, Paolo Aldo/0000-0002-7990-6934; Gargominy, Olivier/0000-0001-7807-944X; BELFIORE, Carlo/0000-0002-0061-8658; Burckhardt, Daniel/0000-0001-8368-5268; Bogdanowicz, Wieslaw/0000-0003-1196-2494; Magowski, Wojciech/0000-0003-2521-9458; Boxshall, Geoffrey/0000-0001-8170-7734; Rota, Emilia/0000-0002-8235-6419; Minelli, Alessandro/0000-0003-3387-1489; Los, Wouter/0000-0001-7433-4431	European Commission [EVR1-CT-1999-20001]; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Fauna Europaea project was supported by the European Commission under contract no. EVR1-CT-1999-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; [Anonymous], 2010, SOS STATE OBSERVED S; Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; Boero F., 2010, BIODIVERSITY, V2, P115; Bohannon J, 2007, SCIENCE, V318, P192, DOI 10.1126/science.318.5848.192; Bouchet P, 1997, VELIGER, V40, P1; Bouchet Philippe, 1999, Bulletin of Zoological Nomenclature, V56, P6; Bouchet Philippe, 2009, Vita Malacologica, V8, P1; Chapman A, 2009, NUMBERS LIVING SPECI; Cotterill FPD, 2010, BIODIVERS CONSERV, V19, P291, DOI 10.1007/s10531-009-9721-4; DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.1093/biomet/74.1.33; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; EDIT, 2010, EDIT EP7 APPL TAX CO; Fauna_Europaea, 2004, FAUN EUR DAT; Foissner W, 2004, ACTA PROTOZOOL, V43, P3; Fontaine B, 2007, BIOL CONSERV, V139, P167, DOI 10.1016/j.biocon.2007.06.012; Fontaine B, 2010, NATURE, V468, P377, DOI 10.1038/468377a; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Green SV, 1998, J INSECT CONSERV, V2, P151, DOI 10.1023/A:1009633811789; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; IBOL, 2009, LEP BARC LIF SPHING; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Martinez SI, 2010, CURR OPIN ENV SUST, V2, P27, DOI 10.1016/j.cosust.2010.03.004; May RM, 2004, PHILOS T ROY SOC B, V359, P733, DOI 10.1098/rstb.2003.1455; MAY RM, 1995, NATURE, V378, P447, DOI 10.1038/378447a0; Minelli A, 2003, TRENDS ECOL EVOL, V18, P75, DOI 10.1016/S0169-5347(02)00051-4; Morchio R, 2000, RIV BIOL-BIOL FORUM, V93, P373; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; NEW TR, 1995, INTRO INVERTEBRATE C; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Pearson DL, 2011, BIOSCIENCE, V61, P58, DOI 10.1525/bio.2011.61.1.11; Reaka-Kudla Marjorie L., 1997, P83; SCBD (Secretariat of the Convention on Biological Diversity), 2010, WHAT IS PROBL TAX IM; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452	38	77	88	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36881	10.1371/journal.pone.0036881	http://dx.doi.org/10.1371/journal.pone.0036881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649502	gold, Green Published, Green Accepted			2022-12-27	WOS:000305335800020
J	Gosoniu, L; Msengwa, A; Lengeler, C; Vounatsou, P				Gosoniu, Laura; Msengwa, Amina; Lengeler, Christian; Vounatsou, Penelope			Spatially Explicit Burden Estimates of Malaria in Tanzania: Bayesian Geostatistical Modeling of the Malaria Indicator Survey Data	PLOS ONE			English	Article							TRANSMISSION	A national HIV/AIDS and malaria parasitological survey was carried out in Tanzania in 2007-2008. In this study the parasitological data were analyzed: i) to identify climatic/environmental, socio-economic and interventions factors associated with child malaria risk and ii) to produce a contemporary, high spatial resolution parasitaemia risk map of the country. Bayesian geostatistical models were fitted to assess the association between parasitaemia risk and its determinants. Bayesian kriging was employed to predict malaria risk at unsampled locations across Tanzania and to obtain the uncertainty associated with the predictions. Markov chain Monte Carlo (MCMC) simulation methods were employed for model fit and prediction. Parasitaemia risk estimates were linked to population data and the number of infected children at province level was calculated. Model validation indicated a high predictive ability of the geostatistical model, with 60.00% of the test locations within the 95% credible interval. The results indicate that older children are significantly more likely to test positive for malaria compared with younger children and living in urban areas and better-off households reduces the risk of infection. However, none of the environmental and climatic proxies or the intervention measures were significantly associated with the risk of parasitaemia. Low levels of malaria prevalence were estimated for Zanzibar island. The population-adjusted prevalence ranges from 0.29% in Kaskazini province (Zanzibar island) to 18.65% in Mtwara region. The pattern of predicted malaria risk is similar with the previous maps based on historical data, although the estimates are lower. The predicted maps could be used by decision-makers to allocate resources and target interventions in the regions with highest burden of malaria in order to reduce the disease transmission in the country.	[Gosoniu, Laura; Lengeler, Christian; Vounatsou, Penelope] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Publ Hlth & Epidemiol, CH-4003 Basel, Switzerland; [Msengwa, Amina] Univ Dar Es Salaam, Dept Stat, Dar Es Salaam, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; University of Dar es Salaam	Gosoniu, L (corresponding author), Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Publ Hlth & Epidemiol, CH-4003 Basel, Switzerland.	penelope.vounatsou@unibas.ch		Vounatsou, Penelope/0000-0002-4904-5352	Swiss National Science Foundation [IZLSZ3 122926]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This investigation received financial support from the Swiss National Science Foundation Project No. IZLSZ3 122926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT MAL MED TERM STR; [Anonymous], TANZ HIV AIDS MAL IN; [Anonymous], 2004, COCHRANE DB SYST REV; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gosoniu L, 2007, THESIS U BASEL; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Le Sueur D, 1998, ATLAS MALARIA AFRICA, V19, p[1998, 23]; MARA/ARMA, 1998, 1 MARA ARMA COLL; Ministry of Health and Social Welfare, 2006, ZANZ MAL CONTR PROGR; Msengwa A, 2010, THESIS U DAR ES SALA; Smithson P, 2009, BUT NOT OUT IMPACT M; World Health Organization, GLOB MAL CONTR EL RE	16	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e23966	10.1371/journal.pone.0023966	http://dx.doi.org/10.1371/journal.pone.0023966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649486	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305335800002
J	Liu, YG; Bridges, R; Wortham, A; Kulesz-Martin, M				Liu, Yuangang; Bridges, Rebecca; Wortham, Aaron; Kulesz-Martin, Molly			NF-kappa B Repression by PIAS3 Mediated RelA SUMOylation	PLOS ONE			English	Article							GENE-ACTIVATION; SUMO-1 MODIFICATION; TEMPORAL CONTROL; DNA-BINDING; ALPHA; TRANSCRIPTION; PROTEINS; MOTIF; COMPLEXES; RECEPTOR	Negative regulation of the NF-kappa B transcription factor is essential for tissue homeostasis in response to stress and inflammation. NF-kappa B activity is regulated by a variety of biochemical mechanisms including phosphorylation, acetylation, and ubiquitination. In this study, we provide the first experimental evidence that NF-kappa B is regulated by SUMOylation, where the RelA subunit of NF-kappa B is SUMOylated by PIAS3, a member of the PIAS (protein inhibitor of activated STAT) protein family with E3 SUMO ligase activity. PIAS3-mediated NF-kappa B repression was compromised by either RelA mutant resistant to SUMOylation or PIAS3 mutant defective in SUMOylation. PIAS3-mediated SUMOylation of endogenous RelA was induced by NF-kappa B activation thus forming a negative regulatory loop. The SUMOylation of endogenous RelA was enhanced in IkB alpha null as compared with wild type fibroblasts. The RelA SUMOylation was induced by TNF alpha but not leptomycin B mediated RelA nuclear translocation. Furthermore, RelA mutants defective in DNA binding were not SUMOylated by PIAS3, suggesting that RelA DNA binding is a signal for PIAS3-mediated SUMOylation. These results support a novel negative feedback mechanism for NF-kappa B regulation by PIAS3-mediated RelA SUMOylation.	[Liu, Yuangang; Bridges, Rebecca; Wortham, Aaron; Kulesz-Martin, Molly] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	Oregon Health & Science University	Liu, YG (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	liuy@ohsu.edu; kuleszma@ohsu.edu			National Institutes of Health (NIH) [CA098577, NIH AR55651]; OHSU Knight Cancer Institute [CA69533]; National Psoriasis Foundation; NATIONAL CANCER INSTITUTE [R01CA098577, P30CA069533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Knight Cancer Institute; National Psoriasis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health (NIH) CA098577 and NIH AR55651 (http://www.nih.gov/), OHSU Knight Cancer Institute CA69533 (www.ohsu.edu), and the National Psoriasis Foundation (http://www.psoriasis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Liu YG, 2001, CANCER RES, V61, P5402; Liu YG, 2007, CANCER RES, V67, P10711, DOI 10.1158/0008-5472.CAN-07-1968; Liu YG, 2010, J INVEST DERMATOL, V130, P1384, DOI 10.1038/jid.2009.416; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; SCHNEIDER BL, 1993, J INVEST DERMATOL, V101, P595, DOI 10.1111/1523-1747.ep12366051; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wissink S, 1997, J BIOL CHEM, V272, P22278, DOI 10.1074/jbc.272.35.22278; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	38	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37636	10.1371/journal.pone.0037636	http://dx.doi.org/10.1371/journal.pone.0037636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649547	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800066
J	Lesscher, HMB; Houthuijzen, JM; Koerkamp, MJG; Holstege, FCP; Vanderschuren, LJMJ				Lesscher, Heidi M. B.; Houthuijzen, Julia M.; Koerkamp, Marian J. Groot; Holstege, Frank C. P.; Vanderschuren, Louk J. M. J.			Amygdala 14-3-3 zeta as a Novel Modulator of Escalating Alcohol Intake in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; GAMMA-AMINOBUTYRIC-ACID; VENTRAL TEGMENTAL AREA; PARKINSONS-DISEASE; DRUG-ADDICTION; C57BL/6J MICE; NUCLEUS-ACCUMBENS; EXTENDED AMYGDALA; ETHANOL DRINKING; GENE-EXPRESSION	Alcoholism is a devastating brain disorder that affects millions of people worldwide. The development of alcoholism is caused by alcohol-induced maladaptive changes in neural circuits involved in emotions, motivation, and decision-making. Because of its involvement in these processes, the amygdala is thought to be a key neural structure involved in alcohol addiction. However, the molecular mechanisms that govern the development of alcoholism are incompletely understood. We have previously shown that in a limited access choice paradigm, C57BL/6J mice progressively escalate their alcohol intake and display important behavioral characteristic of alcohol addiction, in that they become insensitive to quinine-induced adulteration of alcohol. This study used the limited access choice paradigm to study gene expression changes in the amygdala during the escalation to high alcohol consumption in C57BL/6J mice. Microarray analysis revealed that changes in gene expression occurred predominantly after one week, i.e. during the initial escalation of alcohol intake. One gene that stood out from our analysis was the adapter protein 14-3-3 zeta, which was up-regulated during the transition from low to high alcohol intake. Independent qPCR analysis confirmed the up-regulation of amygdala 14-3-3 zeta during the escalation of alcohol intake. Subsequently, we found that local knockdown of 14-3-3 zeta in the amygdala, using RNA interference, dramatically augmented alcohol intake. In addition, knockdown of amygdala 14-3-3 zeta promoted the development of inflexible alcohol drinking, as apparent from insensitivity to quinine adulteration of alcohol. This study identifies amygdala 14-3-3 zeta as a novel key modulator that is engaged during escalation of alcohol use.	[Lesscher, Heidi M. B.; Houthuijzen, Julia M.; Vanderschuren, Louk J. M. J.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Lesscher, Heidi M. B.; Vanderschuren, Louk J. M. J.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Lesscher, HMB (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	h.m.b.lesscher@uu.nl	Holstege, Frank/AAM-9944-2021; Vanderschuren, Louk/AAS-4391-2020	Vanderschuren, Louk/0000-0002-5379-0363; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Houthuijzen, Julia/0000-0003-0404-1961	Brain Foundation of the Netherlands [H06.08]; Netherlands organization for health research and development (ZonMw) [91679134]	Brain Foundation of the Netherlands; Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by a Fellowship from the Brain Foundation of the Netherlands, grant H06.08, and a VENI grant from the Netherlands organization for health research and development (ZonMw), grant 91679134, to H.M.B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2012, NEUROSCIENCE, V211, P107, DOI 10.1016/j.neuroscience.2011.08.014; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson NJ, 2007, ALCOHOL CLIN EXP RES, V31, P1061, DOI 10.1111/j.1530-0277.2007.00394.x; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; BREESE CR, 1995, BRAIN RES, V674, P82, DOI 10.1016/0006-8993(94)01384-T; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Contet C, 2011, ADDICT BIOL, V16, P615, DOI 10.1111/j.1369-1600.2010.00304.x; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; Dai JG, 2003, J NEUROCHEM, V84, P23, DOI 10.1046/j.1471-4159.2003.01254.x; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; Dick DM, 2006, ALCOHOL CLIN EXP RES, V30, P1101, DOI 10.1111/j.1530-0277.2006.00136.x; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Ford MM, 2008, ALCOHOL CLIN EXP RES, V32, P1408, DOI 10.1111/j.1530-0277.2008.00718.x; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Haugbol SR, 2005, ALCOHOL ALCOHOLISM, V40, P89, DOI 10.1093/alcalc/agh117; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; HYYTIA P, 1995, EUR J PHARMACOL, V283, P151, DOI 10.1016/0014-2999(95)00314-B; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Koob GF, 2009, NAT REV DRUG DISCOV, V8, P500, DOI 10.1038/nrd2828; Koob GF, 2003, EUR NEUROPSYCHOPHARM, V13, P442, DOI 10.1016/j.euroneuro.2003.08.005; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Lancien M, 2006, PLANT CELL ENVIRON, V29, P1430, DOI 10.1111/j.1365-3040.2006.01526.x; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lesscher HMB, 2009, GENES BRAIN BEHAV, V8, P493, DOI 10.1111/j.1601-183X.2009.00485.x; Lesscher HMB, 2010, ALCOHOL CLIN EXP RES, V34, P1219, DOI 10.1111/j.1530-0277.2010.01199.x; Lesscher HMB, 2009, PHARMACOGENET GENOM, V19, P719, DOI 10.1097/FPC.0b013e3283311320; Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655; MacKay RK, 2011, ALCOHOL CLIN EXP RES, V35, P1041, DOI 10.1111/j.1530-0277.2011.01436.x; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Noble EP, 1998, PSYCHIAT RES, V81, P133, DOI 10.1016/S0165-1781(98)00084-5; O'Brien CP, 2008, PHILOS T R SOC B, V363, P3277, DOI 10.1098/rstb.2008.0105; Olive MF, 2000, EUR J NEUROSCI, V12, P4131, DOI 10.1046/j.1460-9568.2000.00297.x; Park CS, 2006, J KOREAN MED SCI, V21, P533, DOI 10.3346/jkms.2006.21.3.533; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips AG, 2003, NEUROSCI BIOBEHAV R, V27, P543, DOI 10.1016/j.neubiorev.2003.09.002; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Qian Z, 2012, NEUROSCIENCE, V201, P34, DOI 10.1016/j.neuroscience.2011.11.021; Radel M, 2005, ARCH GEN PSYCHIAT, V62, P47, DOI 10.1001/archpsyc.62.1.47; Ravindran CRM, 2006, NEUROCHEM RES, V31, P1111, DOI 10.1007/s11064-006-9124-9; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Roberto M, 2004, J NEUROSCI, V24, P10159, DOI 10.1523/JNEUROSCI.3004-04.2004; Roberto M, 2003, P NATL ACAD SCI USA, V100, P2053, DOI 10.1073/pnas.0437926100; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rodaros D, 2007, NEUROSCIENCE, V150, P8, DOI 10.1016/j.neuroscience.2007.09.043; Rodd ZA, 2008, PHARMACOL BIOCHEM BE, V89, P481, DOI 10.1016/j.pbb.2008.01.023; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Rose R, 2010, ANGEW CHEM INT EDIT, V49, P4129, DOI 10.1002/anie.200907203; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sanchis-Segura C, 2006, J NEUROSCI, V26, P1231, DOI 10.1523/JNEUROSCI.4237-05.2006; Sander T, 1999, ALCOHOL CLIN EXP RES, V23, P427, DOI 10.1097/00000374-199903000-00007; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Soo Hoo Guy W, 2003, J Intensive Care Med, V18, P150; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; Ubl A, 2002, MOL BRAIN RES, V108, P33, DOI 10.1016/S0169-328X(02)00510-7; van den Brink W, 2012, CURR DRUG ABUSE REV, DOI [10.2174/1874212221267084737, DOI 10.2174/1874212221267084737]; Vanderschuren LJMJ, 2005, EUR J PHARMACOL, V526, P77, DOI 10.1016/j.ejphar.2005.09.037; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; WHO, 2004, GLOB STAT REP ALC; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	83	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37999	10.1371/journal.pone.0037999	http://dx.doi.org/10.1371/journal.pone.0037999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629472	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300086
J	Phillips, HM; Papoutsi, T; Soenen, H; Ybot-Gonzalez, P; Henderson, DJ; Chaudhry, B				Phillips, Helen M.; Papoutsi, Tania; Soenen, Helena; Ybot-Gonzalez, Patricia; Henderson, Deborah J.; Chaudhry, Bill			Neural Crest Cell Survival Is Dependent on Rho Kinase and Is Required for Development of the Mid Face in Mouse Embryos	PLOS ONE			English	Article							VENTRAL BODY-WALL; FRONTONASAL DYSPLASIA; ROCK-I; MIGRATION; ACTIVATION; GTPASES; CLOSURE; ROLES; ACTIN	Neural crest cells (NCC) give rise to much of the tissue that forms the vertebrate head and face, including cartilage and bone, cranial ganglia and teeth. In this study we show that conditional expression of a dominant-negative (DN) form of Rho kinase (Rock) in mouse NCC results in severe hypoplasia of the frontonasal processes and first pharyngeal arch, ultimately resulting in reduction of the maxilla and nasal bones and severe craniofacial clefting affecting the nose, palate and lip. These defects resemble frontonasal dysplasia in humans. Disruption of the actin cytoskeleton, which leads to abnormalities in cell-matrix attachment, is seen in the RockDN;Wnt1-cre mutant embryos. This leads to elevated cell death, resulting in NCC deficiency and hypoplastic NCC-derived craniofacial structures. Rock is thus essential for survival of NCC that form the craniofacial region. We propose that reduced NCC numbers in the frontonasal processes and first pharyngeal arch, resulting from exacerbated cell death, may be the common mechanism underlying frontonasal dysplasia.	[Phillips, Helen M.; Papoutsi, Tania; Soenen, Helena; Henderson, Deborah J.; Chaudhry, Bill] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ybot-Gonzalez, Patricia] Hosp Infantil Virgen del Rocio, Dept Pediat, Seville, Spain	Newcastle University - UK; Virgen del Rocio University Hospital	Phillips, HM (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	deborah.henderson@ncl.ac.uk	IBIS, INMUNODEFICIEN/C-1245-2016; Papoutsi, Tania/F-2324-2016; Ybot-González, Patricia/D-6947-2014; IBIS, NEUROCIENCIA APLICAD/C-2516-2016; ybot-gonzalez, patricia/C-9625-2016	Papoutsi, Tania/0000-0001-6393-7253; Ybot-González, Patricia/0000-0001-7836-2659; Phillips, Helen Margaret/0000-0003-4513-9148; Henderson, Deborah/0000-0002-2705-5998	British Heart Foundation [BS/05/003, RG/07/007]; British Heart Foundation [RG/07/007/23635, FS/11/20/28857] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Funding provided by British Heart Foundation (grants BS/05/003 and RG/07/007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fogelgren B, 2008, DEV DYNAM, V237, P1767, DOI 10.1002/dvdy.21587; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Groysman M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-27; Hildreth V, 2009, J ANAT, V214, P894, DOI 10.1111/j.1469-7580.2009.01087.x; Iwao K, 2008, GRAEF ARCH CLIN EXP, V246, P1117, DOI 10.1007/s00417-008-0845-0; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Ma WB, 1999, CLIN ANAT, V12, P315, DOI 10.1002/(SICI)1098-2353(1999)12:5<315::AID-CA2>3.0.CO;2-2; McBratney BM, 2003, ANAT REC PART A, V271A, P291, DOI 10.1002/ar.a.10034; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qu SM, 1999, DEVELOPMENT, V126, P359; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thomas PS, 2010, DEV BIOL, V340, P613, DOI 10.1016/j.ydbio.2010.02.021; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Wei L, 2001, DEVELOPMENT, V128, P2953; Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172	36	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37685	10.1371/journal.pone.0037685	http://dx.doi.org/10.1371/journal.pone.0037685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629443	Green Published, gold			2022-12-27	WOS:000305343100046
J	Zimmer, SL; McEvoy, SM; Menon, S; Read, LK				Zimmer, Sara L.; McEvoy, Sarah M.; Menon, Sarita; Read, Laurie K.			Additive and Transcript-Specific Effects of KPAP1 and TbRND Activities on 3 ' Non-Encoded Tail Characteristics and mRNA Stability in Trypanosoma brucei	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; DEVELOPMENTAL REGULATION; MITOCHONDRIAL RNAS; NADH DEHYDROGENASE; APOCYTOCHROME-B; POLYADENYLATION; COMPLEX; ENDONUCLEASE; INFORMATION; METABOLISM	Short, non-encoded oligo(A), oligo(U), or A/U tails can impact mRNA stability in kinetoplastid mitochondria. However, a comprehensive picture of the relative effects of these modifications in RNA stability is lacking. Furthermore, while the U-preferring exoribonuclease TbRND acts on U-tailed gRNAs, its role in decay of uridylated mRNAs has only been cursorily investigated. Here, we analyzed the roles of mRNA 3' tail composition and TbRND in RNA decay using cells harbouring single or double knockdown of TbRND and the KPAP1 poly(A) polymerase. Analysis of mRNA abundance and tail composition reveals dramatic and transcript-specific effects of adenylation and uridylation on mitochondrial RNAs. Oligo(A) and A-rich tails can stabilize a proportion of edited and never-edited RNAs. However, non-tailed RNAs are not inherently unstable, implicating additional stability determinants and/or spatial segregation of sub-populations of a given RNA in regulation of RNA decay. Oligo(U) tails, which have been shown to contribute to decay of some never-edited RNAs, are not universally destabilizing. We also show that RNAs display very different susceptibility to uridylation in the absence of KPAP1, a factor that may contribute to regulation of decay. Finally, 3' tail composition apparently impacts the ability of an RNA to be edited.	[Zimmer, Sara L.; McEvoy, Sarah M.; Menon, Sarita; Read, Laurie K.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zimmer, SL (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	lread@buffalo.edu		Menon, Sarita/0000-0001-9548-149X; Zimmer, Sara/0000-0002-1707-1839	National Institutes of Health [R01 AI077520, F32 AI092902]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077520, F32AI092902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health (R01 AI077520 to LKR; F32 AI092902 to SLZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Aphasizheva I, 2009, RNA, V15, P1322, DOI 10.1261/rna.1538809; BHAT GJ, 1992, MOL BIOCHEM PARASIT, V52, P231, DOI 10.1016/0166-6851(92)90055-O; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1985, NUCLEIC ACIDS RES, V13, P4577, DOI 10.1093/nar/13.12.4577; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Kao CY, 2007, MOL BIOCHEM PARASIT, V154, P158, DOI 10.1016/j.molbiopara.2007.04.014; Kao CY, 2005, MOL CELL BIOL, V25, P1634, DOI 10.1128/MCB.25.5.1634-1644.2005; Koslowsky DJ, 1997, MOL BIOCHEM PARASIT, V90, P81, DOI 10.1016/S0166-6851(97)00133-3; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Mattiacio JL, 2008, NUCLEIC ACIDS RES, V36, P319, DOI 10.1093/nar/gkm690; MICHELOTTI EF, 1992, MOL BIOCHEM PARASIT, V54, P31, DOI 10.1016/0166-6851(92)90092-X; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Penschow JL, 2004, EUKARYOT CELL, V3, P1206, DOI 10.1128/EC.3.5.1206-1216.2004; READ LK, 1992, J BIOL CHEM, V267, P1123; RILEY GR, 1995, NUCLEIC ACIDS RES, V23, P708, DOI 10.1093/nar/23.4.708; Ryan CM, 2003, J BIOL CHEM, V278, P32753, DOI 10.1074/jbc.M303552200; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SOUZA AE, 1992, MOL CELL BIOL, V12, P2100, DOI 10.1128/MCB.12.5.2100; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zimmer SL, 2011, J BIOL CHEM, V286, P10329, DOI 10.1074/jbc.M110.152439	40	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37639	10.1371/journal.pone.0037639	http://dx.doi.org/10.1371/journal.pone.0037639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629436	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100043
J	Tripathi, S; Emmert-Streib, F				Tripathi, Shailesh; Emmert-Streib, Frank			Assessment Method for a Power Analysis to Identify Differentially Expressed Pathways	PLOS ONE			English	Article							GENE SET ENRICHMENT; REGULATORY NETWORKS; COVARIANCE-MATRIX; MICROARRAY DATA; RNA-SEQ; INFERENCE; STABILITY; SELECTION; TESTS; TOOL	Gene expression data can provide a very rich source of information for elucidating the biological function on the pathway level if the experimental design considers the needs of the statistical analysis methods. The purpose of this paper is to provide a comparative analysis of statistical methods for detecting the differentially expression of pathways (DEP). In contrast to many other studies conducted so far, we use three novel simulation types, producing a more realistic correlation structure than previous simulation methods. This includes also the generation of surrogate data from two large-scale microarray experiments from prostate cancer and ALL. As a result from our comprehensive analysis of 41,004 parameter configurations, we find that each method should only be applied if certain conditions of the data from a pathway are met. Further, we provide method-specific estimates for the optimal sample size for microarray experiments aiming to identify DEP in order to avoid an underpowered design. Our study highlights the sensitivity of the studied methods on the parameters of the system.	[Tripathi, Shailesh; Emmert-Streib, Frank] Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Tripathi, S (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020; Trpathi, Shailesh/T-2123-2017	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641; 	Center for Cancer Research and Cell Biology (QUB); Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; National Institute of Immunology	Center for Cancer Research and Cell Biology (QUB); Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; National Institute of Immunology	This project is supported by the Center for Cancer Research and Cell Biology (QUB) and the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ST is supported by a studentship from the National Institute of Immunology.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Alon U., 2006, INTRO SYSTEMS BIOL D; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Callow MJ, 2000, GENOME RES, V10, P2022, DOI 10.1101/gr.10.12.2022; Castelo R, 2006, J MACH LEARN RES, V7, P2621; Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chiaretti S, 2005, CLIN CANCER RES, V11, P7209, DOI 10.1158/1078-0432.CCR-04-2165; Choi Y, 2009, BIOINFORMATICS, V25, P2780, DOI 10.1093/bioinformatics/btp502; Davison AC, 1997, BOOTSTRAP METHODS TH; Dudoit S, 2008, SPRINGER SER STAT, P1; Efron B., 1994, INTRO BOOTSTRAP; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emmert-Streib F, MED BIOSTATISTICS CO; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Emmert-Streib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002053; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Garge NR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S10; Glazko GV, 2009, BIOINFORMATICS, V25, P2348, DOI 10.1093/bioinformatics/btp406; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Jung K, 2011, BIOINFORMATICS, V27, P1377, DOI 10.1093/bioinformatics/btr152; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klebanov Lev, 2007, J Bioinform Comput Biol, V5, P1139, DOI 10.1142/S0219720007003041; Ledoit O, 2004, J PORTFOLIO MANAGE, V30, P110, DOI 10.3905/jpm.2004.110; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Ledoit O., 2003, J EMPIR FINANCE, V10, P603, DOI [10.1016/S0927-5398(03)00007-0, DOI 10.1016/S0927-5398(03)00007-0]; Lehman E. L., 2005, TESTING STAT HYPOTHE, V3rd; Li HZ, 2006, BIOSTATISTICS, V7, P302, DOI 10.1093/biostatistics/kxj008; Liu Q, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-431; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nettleton D, 2008, BIOINFORMATICS, V24, P192, DOI 10.1093/bioinformatics/btm583; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Niiranen S, INFORM PROCESSING BI; Qiu X, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-50; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; R Core Team, 2018, R LANG ENV STAT COMP; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Whittaker J., 1990, GRAPHICAL MODELS APP; Wille A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r92; Xiong H, 2006, BIOINFORMATICS, V22, P919, DOI 10.1093/bioinformatics/btl034	73	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37510	10.1371/journal.pone.0037510	http://dx.doi.org/10.1371/journal.pone.0037510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629411	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500127
J	Cai, YM; Zhou, Q; Yu, CX; Wang, XM; Hu, SN; Yu, J; Yu, XM				Cai, Yimei; Zhou, Qing; Yu, Caixia; Wang, Xumin; Hu, Songnian; Yu, Jun; Yu, Xiaomin			Transposable-Element Associated Small RNAs in Bombyx mori Genome	PLOS ONE			English	Article							ENDOGENOUS SIRNAS; MOBILE ELEMENTS; HUMAN MICRORNAS; SILKWORM; DEFENSE; PATHWAY; PIWI; TRANSCRIPTS; EVOLUTION; SEQUENCE	Small RNAs are a group of regulatory RNA molecules that control gene expression at transcriptional or post-transcriptional levels among eukaryotes. The silkworm, Bombyx mori L., genome harbors abundant repetitive sequences derived from families of retrotransposons and transposons, which together constitute almost half of the genome space and provide ample resource for biogenesis of the three major small RNA families. We systematically discovered transposable-element (TE)-associated small RNAs in B. mori genome based on a deep RNA-sequencing strategy and the effort yielded 182, 788 and 4,990 TE-associated small RNAs in the miRNA, siRNA and piRNA species, respectively. Our analysis suggested that the three small RNA species preferentially associate with different TEs to create sequence and functional diversity, and we also show evidence that a Bombyx non-LTR retrotransposon, bm1645, alone contributes to the generation of TE-associated small RNAs in a very significant way. The fact that bm1645-associated small RNAs partially overlap with each other implies a possibility that this element may be modulated by different mechanisms to generate different products with diverse functions. Taken together, these discoveries expand the small RNA pool in B. mori genome and lead to new knowledge on the diversity and functional significance of TE-associated small RNAs.	[Cai, Yimei; Zhou, Qing; Yu, Caixia; Wang, Xumin; Hu, Songnian; Yu, Jun; Yu, Xiaomin] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yu, Xiaomin] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cai, YM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn; yuxm@big.ac.cn	wang, xumin/HII-8627-2022; Yu, Xiaomin/I-6407-2016; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [31000578]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences and the National Natural Science Foundation of China (31000578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai YM, 2010, FUNCT INTEGR GENOMIC, V10, P405, DOI 10.1007/s10142-010-0162-7; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fujii Yoichi R, 2010, Open Virol J, V4, P63, DOI 10.2174/1874357901004010063; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Hedges DJ, 2005, BIOESSAYS, V27, P785, DOI 10.1002/bies.20268; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nilsen TW, 2008, NAT STRUCT MOL BIOL, V15, P546, DOI 10.1038/nsmb0608-546; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Osanai-Futahashi M, 2008, INSECT BIOCHEM MOLEC, V38, P1046, DOI 10.1016/j.ibmb.2008.05.012; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wang X, 1992, J S CHINA AGR U, V2, P95; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36599	10.1371/journal.pone.0036599	http://dx.doi.org/10.1371/journal.pone.0036599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22662121	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500019
J	Thulborn, T				Thulborn, Tony			Impact of Sauropod Dinosaurs on Lagoonal Substrates in the Broome Sandstone (Lower Cretaceous), Western Australia	PLOS ONE			English	Article							FOSSIL VERTEBRATE TRACKS; PRESERVATION; UNDERTRACKS; MECHANICS	Existing knowledge of the tracks left by sauropod dinosaurs (loosely 'brontosaurs') is essentially two-dimensional, derived mainly from footprints exposed on bedding planes, but examples in the Broome Sandstone (Early Cretaceous) of Western Australia provide a complementary three-dimensional picture showing the extent to which walking sauropods could deform the ground beneath their feet. The patterns of deformation created by sauropods traversing thinly-stratified lagoonal deposits of the Broome Sandstone are unprecedented in their extent and structural complexity. The stacks of transmitted reliefs (underprints or ghost prints) beneath individual footfalls are nested into a hierarchy of deeper and more inclusive basins and troughs which eventually attain the size of minor tectonic features. Ultimately the sauropod track-makers deformed the substrate to such an extent that they remodelled the topography of the landscape they inhabited. Such patterns of substrate deformation are revealed by investigating fragmentary and eroded footprints, not by the conventional search for pristine footprints on intact bedding planes. For that reason it is not known whether similar patterns of substrate deformation might occur at sauropod track-sites elsewhere in the world.				paswamp@mailbox.uq.edu.au						Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; ALLEN JRL, 1989, J GEOL SOC LONDON, V146, P600, DOI 10.1144/gsjgs.146.4.0600; [Anonymous], 2009, GEOLOGY JAMES PRICE; Avanzini Marco, 1998, Ichnos, V6, P129; Brunnschweiler RO, 1957, REP AUST BUREAU MINE, V13, P1; COLBERT E H, 1967, Journal of the Royal Society of Western Australia, V50, P21; DETTMANN ME, 1992, CRETACEOUS RES, V13, P207, DOI 10.1016/0195-6671(92)90001-7; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Farlow J.O., 1989, P371; Farlow James O., 1992, Zubia, V10, P89; Fornos JJ, 2002, PALAEOGEOGR PALAEOCL, V180, P277, DOI 10.1016/S0031-0182(01)00431-X; Gatesy Stephen M., 2003, Ichnos, V10, P91, DOI 10.1080/10420940390255484; GILL ED, 1972, SEARCH, V3, P444; Glauert L., 1952, West Australian Naturalist, V3, P82; Gorter JD, 1981, B AUST BUREAU MINERA, V210, P37; Henderson R.A., 2000, Memoir of the Association of Australasian Palaeontologists, V23, P355; Hill D, 1966, JURASSIC FOSSILS QUE; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Hunt A, 1995, REV GEOCIENC MUS NAC, V10, P261; Jackson S, 2002, PALAEONTOLOGICAL ASS, V51, P81; Karajas J, 1984, CANNING BASIN W AUST, P169; Klein N., 2011, BIOL SAUROPOD DINOSA; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley Martin G., 2004, Ichnos, V11, P261, DOI 10.1080/10420940490428805; Long JA, 1992, REC N TERRITORY MUS, V9, P262; Long John A., 1998, Records of the Western Australian Museum, V19, P121; Long John A., 1992, Beagle, V9, P21; MARTY D., 2008, GEOFOCUS, V21, P1; McLoughlin S, 2001, ANCIENT FLORAS W AUS; McLoughlin Stephen, 1996, P61; MCWHAE JRH, 1958, J GEOLOGICAL SOC AUS, V4, P1; Middleton MF, 1990, MEMOIR GEOL SURV W A, V3, P425; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Milan J, 2004, LETHAIA, V37, P285, DOI 10.1080/00241160410002036; Milan J, 2003, 1 M EUR ASS VERT PAL, P15; Molnar R., 1982, P169; MOLNAR R E, 1982, Memoirs of the Queensland Museum, V20, P613; Molnar Ralph E., 1991, P605; Pittman J.G., 1989, P313; Playford PE, 1975, MEM GEOL SURV W AUST, V2, P221; Ride W. D. L., 1999, INT CODE ZOOLOGICAL; Rogers KAC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P1; Rose PJ, 2007, PALAEONTOL ELECTRON, V10; Siversson M, 2010, 60103995 AECOM AUSTR; Siversson M, 2010, REPORT MACROFO UNPUB; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Thulborn R.A., 1989, DINOSAUR TRACKS TRAC, P39; THULBORN RA, 1982, PALAEOGEOGR PALAEOCL, V38, P227, DOI 10.1016/0031-0182(82)90005-0; Thulborn RA, 1995, REV GEOCIENC MUS NAC, V10, P85; Thulborn T., 1990, DINOSAUR TRACKS; Thulborn T, 2009, MEGALOSAUROPUS BROOM; Towner R. R., 1983, BUREAU MINERAL RESOU, V215, P1; Veevers J. J., 1961, BUREAU MINERAL RESOU, V60, P1; Weishampel D.B., 1990, P63; White M. E., 1961, BUREAU MINERAL RESOU, V60, P291; YEATES AN, 1984, CANNING BASIN, P23; Zammit M, 2012, AUSTR AGE DINOSAURS, V9, P22	58	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36208	10.1371/journal.pone.0036208	http://dx.doi.org/10.1371/journal.pone.0036208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662116	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300010
J	Xu, F; Xie, L; Li, X; Li, Q; Wang, T; Ji, YJ; Kong, F; Zhan, QL; Cheng, K; Fang, L; Xie, P				Xu, Fan; Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Zhan, Qunlin; Cheng, Ke; Fang, Liang; Xie, Peng			Construction and Validation of a Systematic Ethogram of Macaca fascicularis in a Free Enclosure	PLOS ONE			English	Article							ANIMAL-WELFARE; BEHAVIOR; MONKEYS; ISSUES; FILES	Behavioral studies in non-human primates have become ideal models for further investigations into advanced cognitive function in humans. To date, there is no systematic ethogram of the cynomolgus monkey (Macaca fascicularis) in a free enclosure. In a field observation of 6012 subjects, 107 distinct behaviors of M. fascicularis were preliminarily described. 83 of these behaviors were then independently validated through a randomized cohort and classified into 12 behavioral categories. 53 of these behaviors were then selected to accurately reflect the daily mundane activity of the species in a free enclosure. These findings systematically document the behavior of M. fascicularis in a free enclosure for use in further investigations.	[Xu, Fan; Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Cheng, Ke; Fang, Liang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Cheng, Ke; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Xu, Fan; Xie, Liang; Li, Xin; Li, Qi; Wang, Tao; Ji, Yongjia; Kong, Fei; Cheng, Ke; Fang, Liang; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhan, Qunlin] Fifth Peoples Hosp Chongqing, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xu, F (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Cheng, Ke/HCH-8846-2022; Li, Qi/ABE-4182-2021	Li, Qi/0000-0002-9144-148X	National Basic Research Program of China (the 973 Program) [2009CB918300]; National Natural Science Foundation of China [30900456]; Natural Science Foundation Project of Chongqing (CSTC) [2010BB5185, 2011BA5012]	National Basic Research Program of China (the 973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This work was supported by the National Basic Research Program of China (the 973 Program; Grant No. 2009CB918300), the National Natural Science Foundation of China (Grant No. 30900456) and the Natural Science Foundation Project of Chongqing (CSTC, 2010BB5185 and 2011BA5012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MR, 1984, J UROLOGY, V131, P571, DOI 10.1016/S0022-5347(17)50506-6; Allen C., 1995, PERSP ETHOL, P1; ALMOND R, 1969, J NERV MENT DIS, V149, P398, DOI 10.1097/00005053-196911000-00003; Bakeman R, 2000, BEHAV RES METH INS C, V32, P207, DOI 10.3758/BF03200803; Beauchamp TL, 1994, PRINCIPLES BIOMEDICA, p[12, 327]; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Cappenter S, 2000, MONITOR PSYCHOL, V31, P22; Dawkins MS, 1990, BEHAV BRAIN SCI, V13, P54; Duncan I. J. H., 1997, Animal welfare., P19; Duncan Ian J. H., 1993, Journal of Agricultural and Environmental Ethics, V6, P8; HUNTINGFORD FA, 1984, ANIM BEHAV, V32, P210, DOI 10.1016/S0003-3472(84)80339-5; Jiang Zhigang, 2000, Acta Theriologica Sinica, V20, P1; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Lehner PN, HANDBBOK ETHOLOGICAL, P1; Martin PBP, MEASURE BEHAV INTRO, P1; MEARS CE, 1975, P NATL ACAD SCI USA, V72, P1878, DOI 10.1073/pnas.72.5.1878; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; Regan T, 1983, CASE ANIMAL RIGHTS, P20; Rollin BE, 1992, ANIMAL RIGHTS HUMAN, P21; SKINNER SW, 1979, APPL ANIM ETHOL, V5, P241, DOI 10.1016/0304-3762(79)90059-2; Stafleu FR, 1996, ANIM WELFARE, V5, P225; TANNENBAUM J, 1991, J AM VET MED ASSOC, V198, P1360; THORPE WH, 1969, NATURE, V224, P18, DOI 10.1038/224018a0; William T, 1971, ARCH GEN PSYCHIAT, V26, P1313; WOODGUSH DG, 1973, BRIT VET J, V129, P167, DOI 10.1016/S0007-1935(17)36541-7; Yamada Kazunori, 2010, Japanese Journal of Animal Psychology, V59, P199, DOI 10.2502/janip.59.2.2; Zhang J, 2010, CURR ZOOL, V56, P222, DOI 10.1093/czoolo/56.2.222	27	16	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37486	10.1371/journal.pone.0037486	http://dx.doi.org/10.1371/journal.pone.0037486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662158	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300048
J	Cheuk, BLY; Chan, YC; Cheng, SWK				Cheuk, Bernice L. Y.; Chan, Y. C.; Cheng, Stephen W. K.			Changes in Inflammatory Response after Endovascular Treatment for Type B Aortic Dissection	PLOS ONE			English	Article							STENT-GRAFT PLACEMENT; NECROSIS-FACTOR-ALPHA; ANEURYSM REPAIR; RENAL-FUNCTION; IMPACT; STRATEGIES; SURGERY; INJURY; TRIAL	This present study aims to investigate the changes in the inflammatory markers after elective endovascular treatment of Type B aortic dissection with aneurysm, as related to different anatomical features of the dissection flap in the paravisceral perfusion. Consecutive patients with type B aortic dissections with elective endovascular stent graft repair were recruited and categorized into different groups. Serial plasma levels of cytokines (Interleukin-1 beta, -6, -8, -10, TNF-alpha), chemokines (MCP-1), and serum creatinine were monitored at pre-, peri-and post-operative stages. The length of stent graft employed in each surgery was retrieved and correlated with the change of all studied biochemical parameters. A control group of aortic dissected patients with conventional medication management was recruited for comparing the baseline biochemical parameters. In total, 22 endovascular treated and 16 aortic dissected patients with surveillance were recruited. The endovascular treated patients had comparable baseline levels as the non-surgical patients. There was no immediate or thirty day-mortality, and none of the surgical patients developed post-operative mesenteric ischaemia or clinically significant renal impairment. All surgical patients had detectable pro-inflammatory mediators, but none of the them showed any statistical significant surge in the peri-operative period except IL-1 beta and IL-6. Similar results were obtained when categorized into different groups. IL-1 beta and IL-6 showed maximal levels within hours of the endovascular procedure (range, 3.93 to 27.3 higher than baseline; p = 0.001), but returned to baseline 1 day post-operatively. The change of IL-1 beta and IL-6 at the stent graft deployment was statistically greater in longer stent graft (p>0.05). No significant changes were observed in the serum creatinine levels. In conclusion, elective endovascular repair of type B aortic dissection associated with insignificant changes in inflammatory mediators and creatinine. All levels fell toward basal levels post-operatively suggesting that thoracic endovascular aortic repair is rather less aggressive with insignificant inflammatory modulation.	[Cheuk, Bernice L. Y.; Chan, Y. C.; Cheng, Stephen W. K.] Univ Hong Kong, Med Ctr, Dept Surg, Div Vasc Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheuk, BLY (corresponding author), Univ Hong Kong, Med Ctr, Dept Surg, Div Vasc Surg, Hong Kong, Hong Kong, Peoples R China.	bernice@hku.hk			University of Hong Kong [201007176013, 10401294.41462.21700.323.01]	University of Hong Kong(University of Hong Kong)	This work was supported by Small Project Funding, The University of Hong Kong (Fund Code: 201007176013; Account code: 10401294.41462.21700.323.01) to BLYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho PS, 2007, SCAND J SURG, V96, P229, DOI 10.1177/145749690709600308; Akowuah Enoch, 2007, Interact Cardiovasc Thorac Surg, V6, P741; Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Alric P, 2003, J ENDOVASC THER, V10, P397, DOI 10.1583/1545-1550(2003)010<0397:LRFFEA>2.0.CO;2; Alsac JM, 2005, J VASC SURG, V41, P926, DOI 10.1016/j.jvs.2005.02.024; Arnaoutoglou E, 2011, INTERACT CARDIOV TH, V12, P609, DOI 10.1510/icvts.2010.256784; Benvenuti Luiz Alberto, 2005, Clinics, V60, P355, DOI 10.1590/S1807-59322005000500002; Birch PC, 1999, EUR J VASC ENDOVASC, V17, P185, DOI 10.1053/ejvs.1998.0672; Carpenter JP, 2001, CARDIOVASC SURG, V9, P559, DOI 10.1016/S0967-2109(01)00085-0; Chan YC, 2011, EUR J VASC ENDOVASC, V42, P464, DOI 10.1016/j.ejvs.2011.05.022; Chan Yiu Che, 2008, Asian Cardiovasc Thorac Ann, V16, P272; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; Dake MD, 2006, SEMIN VASC SURG, V19, P40, DOI 10.1053/j.semvascsurg.2005.11.007; De La Motte L, 2011, J CARDIOVASC SURG, V52, P73; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Eggebrecht H, 2008, J ENDOVASC THER, V15, P135, DOI 10.1583/07-2284.1; Gerasimidis T, 2005, ANGIOLOGY, V56, P743, DOI 10.1177/000331970505600612; GOLDBLUM SE, 1987, J APPL PHYSIOL, V62, P122, DOI 10.1152/jappl.1987.62.1.122; Gomes WJ, 2006, ANN THORAC SURG, V81, P1918, DOI 10.1016/j.athoracsur.2005.10.014; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Karthikesalingam A, 2011, VASC ENDOVASC SURG, V44, P165; Lin Yan-jun, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P108; Melissano G, 2008, J THORAC CARDIOV SUR, V136, P1012, DOI 10.1016/j.jtcvs.2008.06.021; Nienaber CA, 2010, J THORAC CARDIOV SUR, V140, pS101, DOI 10.1016/j.jtcvs.2010.07.026; Oberhuber A, 2011, J VASC SURG, V54, P1303, DOI 10.1016/j.jvs.2011.05.020; Shu C, 2011, EUR J VASC ENDOVASC, V42, P448, DOI 10.1016/j.ejvs.2011.05.013; Swartbol P, 1996, EUR J VASC ENDOVASC, V12, P18, DOI 10.1016/S1078-5884(96)80270-X; Sweeney KJ, 2002, EUR J VASC ENDOVASC, V23, P303, DOI 10.1053/ejvs.2001.1585; Ting ACW, 2009, ASIAN J SURG, V32, P39, DOI 10.1016/S1015-9584(09)60007-5; Tsai TT, 2007, NEW ENGL J MED, V357, P349, DOI 10.1056/NEJMoa063232; van Keulen JW, 2009, EUR J VASC ENDOVASC, V38, P586, DOI 10.1016/j.ejvs.2009.06.018; Veenhof AAFA, 2012, ANN SURG, V255, P216, DOI 10.1097/SLA.0b013e31824336e2; Welorn MB, 2000, CRIT CARE MED, V28, P3356; Wen D, 2012, CLIN CHIM ACTA, V413, P198, DOI 10.1016/j.cca.2011.09.029; Xenos ES, 2009, EUR J CARDIO-THORAC, V35, P282, DOI 10.1016/j.ejcts.2008.10.042; Zipfel B, 2011, J ENDOVASC THER, V18, P131, DOI 10.1583/10-3233MR.1	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37389	10.1371/journal.pone.0037389	http://dx.doi.org/10.1371/journal.pone.0037389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655044	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900019
J	Haj, FG; Sabet, O; Kinkhabwala, A; Wimmer-Kleikamp, S; Roukos, V; Han, HM; Grabenbauer, M; Bierbaum, M; Antony, C; Neel, BG; Bastiaens, PI				Haj, Fawaz G.; Sabet, Ola; Kinkhabwala, Ali; Wimmer-Kleikamp, Sabine; Roukos, Vassilis; Han, Hong-Mei; Grabenbauer, Markus; Bierbaum, Martin; Antony, Claude; Neel, Benjamin G.; Bastiaens, Philippe I.			Regulation of Signaling at Regions of Cell-Cell Contact by Endoplasmic Reticulum-Bound Protein-Tyrosine Phosphatase 1B	PLOS ONE			English	Article							PLASMA-MEMBRANE; FLUORESCENCE RECOVERY; INSULIN-RECEPTOR; PHOTOBLEACHING RECOVERY; SPATIAL REGULATION; H-RAS; K-RAS; BINDING; PTP1B; DYNAMICS	Protein-tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed PTP that is anchored to the endoplasmic reticulum (ER). PTP1B dephosphorylates activated receptor tyrosine kinases after endocytosis, as they transit past the ER. However, PTP1B also can access some plasma membrane (PM)-bound substrates at points of cell-cell contact. To explore how PTP1B interacts with such substrates, we utilized quantitative cellular imaging approaches and mathematical modeling of protein mobility. We find that the ER network comes in close proximity to the PM at apparently specialized regions of cell-cell contact, enabling PTP1B to engage substrate(s) at these sites. Studies using PTP1B mutants show that the ER anchor plays an important role in restricting its interactions with PM substrates mainly to regions of cell-cell contact. In addition, treatment with PTP1B inhibitor leads to increased tyrosine phosphorylation of EphA2, a PTP1B substrate, specifically at regions of cell-cell contact. Collectively, our results identify PM-proximal sub-regions of the ER as important sites of cellular signaling regulation by PTP1B.	[Haj, Fawaz G.; Neel, Benjamin G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Sabet, Ola; Kinkhabwala, Ali; Wimmer-Kleikamp, Sabine; Roukos, Vassilis; Han, Hong-Mei; Grabenbauer, Markus; Bierbaum, Martin; Bastiaens, Philippe I.] Max Planck Inst Mol Physiol, Dept System Cell Biol, D-44139 Dortmund, Germany; [Antony, Claude] European Mol Biol Labs, Heidelberg, Germany; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst,Campbel Family Canc Res Inst, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Davis; Max Planck Society; European Molecular Biology Laboratory (EMBL); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Haj, FG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	fghaj@ucdavis.edu; bneel@uhnresreach.ca; philippe.bastiaens@mpi-dortmund.mpg.de	Roukos, Vassilis/AAC-4827-2020; Han, Hong-Mei/I-6916-2015; antony, claude/K-5342-2013; Roukos, Vassilis/K-6248-2012	Roukos, Vassilis/0000-0002-5065-3937	EMBO; Juvenile Diabetes Research Foundation [1-2009-337]; American Diabetes Association [7-06-JF-28, R37 CA49152]; Ontario Ministry of Health; Princess Margaret Hospital Foundation; National Health and Medical Research Council of Australia [384352]; Sydney Medical School; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by an EMBO short-term fellowship, a Research Grant from the Juvenile Diabetes Research Foundation (1-2009-337) and a Junior Faculty Award from the American Diabetes Association (7-06-JF-28) to F. G. H., and R37 CA49152 to B.G.N. B.G.N. is a Canada Research Chair, Tier 1, and work in his laboratory is partially supported by funds from the Ontario Ministry of Health and The Princess Margaret Hospital Foundation. S. W. K was supported by a CJ Martin Fellowship (384352) of the National Health and Medical Research Council of Australia, and an Early Career Award of the Sydney Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bouchet-Marquis C, 2008, J MICROSC-OXFORD, V230, P308, DOI 10.1111/j.1365-2818.2008.01988.x; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cromlish WA, 2006, BIOCHEM PHARMACOL, V72, P1279, DOI 10.1016/j.bcp.2006.07.038; Dadke S, 2000, J BIOL CHEM, V275, P23642, DOI 10.1074/jbc.M001063200; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095; Lavieu G, 2010, P NATL ACAD SCI USA, V107, P6876, DOI 10.1073/pnas.1002536107; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mertins P, 2008, MOL CELL PROTEOMICS; Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ramachandran C, 2003, CURR TOP MED CHEM, V3, P749, DOI 10.2174/1568026033452276; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sprague BL, 2006, BIOPHYS J, V91, P1169, DOI 10.1529/biophysj.105.073676; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stuible M, 2010, J BIOL CHEM, V285, P23899, DOI 10.1074/jbc.M110.115295; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; TERASAKI M, 1994, CELL MOTIL CYTOSKEL, V29, P291, DOI 10.1002/cm.970290402; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	61	43	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36633	10.1371/journal.pone.0036633	http://dx.doi.org/10.1371/journal.pone.0036633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655028	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900002
J	Andersson, G; Carlbring, P; Furmark, T				Andersson, Gerhard; Carlbring, Per; Furmark, Tomas		SOFIE Res Grp	Therapist Experience and Knowledge Acquisition in Internet-Delivered CBT for Social Anxiety Disorder: A Randomized Controlled Trial	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SELF-HELP; PSYCHOLOGICAL TREATMENTS; GENERAL-POPULATION; PUBLIC SPEAKING; PANIC DISORDER; GROUP EXPOSURE; RATING-SCALE; PHOBIA; DEPRESSION	Background: Guided internet-delivered cognitive behavior therapy (ICBT) has been tested in several trials on social anxiety disorder (SAD) with moderate to large effects. The aims of this study were threefold. First, to compare the effects of ICBT including online discussion forum with a moderated online discussion forum only. Second, to investigate if knowledge about SAD increased following treatment and third to compare the effects of inexperienced versus experienced therapists on patient outcomes. Methods: A total of 204 participants with a primary diagnosis of SAD were included and randomized to either guided ICBT or the control condition. ICBT consisted of a 9-week treatment program which was guided by either psychology students at MSc level (n=6) or by licensed psychologists with previous experience of ICBT (n=7). A knowledge test dealing with social anxiety was administered before and after treatment. Measures of social anxiety and secondary outcomes dealing with general anxiety, depression, and quality of life were administered before and after treatment. In addition, a 1-year follow-up was conducted on the treated individuals. Results: Immediately following treatment, the ICBT group showed superior outcome on the Liebowitz Social Anxiety Scale self-report version with a between group posttreatment Hedges g effect size of g=0.75. In addition, significant differences on all the secondary outcomes were observed. Gains were well maintained one year later. Knowledge, as assessed by the knowledge test, increased following treatment with little gain in the control group. Therapist experience did not result in different outcomes, but experienced therapists logged in less frequently compared to the inexperienced therapists, suggesting that they needed less time to support patients. Discussion: We conclude that guided ICBT reduce symptoms of SAD, increase knowledge about SAD and that therapist experience does not make a difference apart from the finding that experienced therapist may require less time to guide patients.	[Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Swedish Inst Disabil Res, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, Stockholm, Sweden; [Carlbring, Per] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Furmark, Tomas] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Linkoping University; Karolinska Institutet; Umea University; Uppsala University	Andersson, G (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Swedish Inst Disabil Res, Linkoping, Sweden.	gerhard.andersson@liu.se	Andersson, Gerhard/J-8529-2012; Carlbring, Per/R-1220-2019; Carlbring, Per/D-3628-2009	Andersson, Gerhard/0000-0003-4753-6745; Carlbring, Per/0000-0002-2172-8813; Carlbring, Per/0000-0002-2172-8813; Furmark, Tomas/0000-0001-6821-9058	Swedish Research Council; Linko ping University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linko ping University	This study was sponsored in part by a grant from the Swedish Research Council to Dr Furmark, and a grant from Linko ping University to Dr Andersson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2009, J BEHAV THER EXP PSY, V40, P98, DOI 10.1016/j.jbtep.2008.04.004; Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590; Almlov J, 2011, BEHAV COGN PSYCHOTH, V39, P311, DOI 10.1017/S135246581000069X; Almlov Jonas, 2009, Cognitive Behaviour Therapy, V38, P247, DOI 10.1080/16506070903116935; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson Gerhard, 2011, Cognitive Behaviour Therapy, V40, P57, DOI 10.1080/16506073.2010.529457; Andersson G, 2011, STEPPED CARE AND E-HEALTH: PRACTICAL APPLICATIONS TO BEHAVIORAL DISORDERS, P99, DOI 10.1007/978-1-4419-6510-3_6; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Aydos L, 2009, AUSTRALAS PSYCHIATRY, V17, P488, DOI 10.1080/10398560903284943; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Barak A, 2009, ANN BEHAV MED, V38, P4, DOI 10.1007/s12160-009-9130-7; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berger T, 2011, BEHAV RES THER, V49, P158, DOI 10.1016/j.brat.2010.12.007; Berger T, 2009, J CLIN PSYCHOL, V65, P1021, DOI 10.1002/jclp.20603; Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54; Botella C, 2010, CYBERPSYCH BEH SOC N, V13, P407, DOI 10.1089/cyber.2009.0224; Brown H., 1999, APPL MIXED MODELS ME; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring P, 2009, BEHAV RES THER, V47, P848, DOI 10.1016/j.brat.2009.06.012; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Erwin BA, 2004, J ANXIETY DISORD, V18, P629, DOI 10.1016/j.janxdis.2003.08.002; First M. B., 1997, STRUCTURED CLIN INTE; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Furmark T, 2000, PSYCHOL MED, V30, P1335, DOI 10.1017/S0033291799002615; FURMARK T, 2006, SOCIAL FOBI EFFEKTIV; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Griffiths KM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1270; Griffiths KM, 2004, BRIT J PSYCHIAT, V185, P342, DOI 10.1192/bjp.185.4.342; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Hedman E, 2011, JMIR, V13; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Hofmann SG, 2004, J CONSULT CLIN PSYCH, V72, P392, DOI 10.1037/0022-006X.72.3.392; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Houston TK, 2002, AM J PSYCHIAT, V159, P2062, DOI 10.1176/appi.ajp.159.12.2062; Hunsley J, 2007, PROF PSYCHOL-RES PR, V38, P21, DOI 10.1037/0735-7028.38.1.21; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kiropoulos LA, 2008, J ANXIETY DISORD, V22, P1273, DOI 10.1016/j.janxdis.2008.01.008; Kronmuller KT, 2007, J AFFECT DISORDERS, V104, P155, DOI 10.1016/j.jad.2007.02.010; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McKenna KYA, 1998, J PERS SOC PSYCHOL, V75, P681, DOI 10.1037/0022-3514.75.3.681; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Palmqvist Bjorn, 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P291, DOI 10.1586/14737167.7.3.291; Ponniah K, 2008, PSYCHOL MED, V38, P3, DOI 10.1017/S0033291707000918; Rapee RM, 2007, BRIT J PSYCHIAT, V191, P246, DOI 10.1192/bjp.bp.106.028167; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Scogin F, 1998, COGNITIVE THER RES, V22, P475, DOI 10.1023/A:1018773632550; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Stangier U, 2011, ARCH GEN PSYCHIAT, V68, P692, DOI 10.1001/archgenpsychiatry.2011.67; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1; Tillfors M, 2008, DEPRESS ANXIETY, V25, P708, DOI 10.1002/da.20416; Tillfors Maria, 2011, Cognitive Behaviour Therapy, V40, P147, DOI 10.1080/16506073.2011.555486; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2010, AUST NZ J PSYCHIAT, V44, P938, DOI 10.3109/00048674.2010.493859; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P920, DOI 10.1080/00048670903179228; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; Waller G, 2009, BEHAV RES THER, V47, P119, DOI 10.1016/j.brat.2008.10.018	69	99	99	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37411	10.1371/journal.pone.0037411	http://dx.doi.org/10.1371/journal.pone.0037411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649526	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800044
J	Lisciandro, JG; Prescott, SL; Nadal-Sims, MG; Devitt, CJ; Pomat, W; Siba, PM; Tulic, MC; Holt, PG; Strickland, D; van den Biggelaar, AHJ				Lisciandro, Joanne G.; Prescott, Susan L.; Nadal-Sims, Marie G.; Devitt, Catherine J.; Pomat, William; Siba, Peter M.; Tulic, Meri C.; Holt, Patrick G.; Strickland, Deborah; van den Biggelaar, Anita H. J.			Ontogeny of Toll-Like and NOD-Like Receptor-Mediated Innate Immune Responses in Papua New Guinean Infants	PLOS ONE			English	Article							CYTOKINE RESPONSES; VACCINATION; INFLAMMASOME; POPULATION; MECHANISMS; INDUCTION; PROFILES; NEWBORN; NLRP3; ALUM	Studies addressing the ontogeny of the innate immune system in early life have reported mainly on Toll-like receptor (TLR) responses in infants living in high-income countries, with little or even no information on other pattern recognition receptors or on early life innate immune responses in children living under very different environmental conditions in less-developed parts of the world. In this study, we describe whole blood innate immune responses to both Toll-like and nucleotide-binding oligomerization domain (NOD)-like receptor agonists including the widely used vaccine adjuvant 'alum' in a group of Papua New Guinean infants aged 1-3 (n = 18), 4-6 (n = 18), 7-12 (n = 21) and 13-18 (n = 10) months old. Depending on the ligands and cytokines studied, different age-related patterns were found: alum-induced IL-1 beta and CXCL8 responses were found to significantly decline with increasing age; inflammatory (IL-6, IL-1 beta, IFN-gamma) responses to TLR2 and TLR3 agonists increased; and IL-10 responses remained constant or increased during infancy, while TNF-alpha responses either declined or remained the same. We report for the first time that whole blood innate immune responses to the vaccine adjuvant alum decrease with age in infancy; a finding that may imply that the adjuvant effect of alum in pediatric vaccines could be age-related. Our findings further suggest that patterns of innate immune development may vary between geographically diverse populations, which in line with the 'hygiene hypothesis' particularly involves persistence of innate IL-10 responses in populations experiencing higher infectious pressure.	[Lisciandro, Joanne G.; Nadal-Sims, Marie G.; Devitt, Catherine J.; Holt, Patrick G.; Strickland, Deborah; van den Biggelaar, Anita H. J.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Lisciandro, Joanne G.; Prescott, Susan L.; Tulic, Meri C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Pomat, William; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea	Telethon Kids Institute; University of Western Australia; University of Western Australia; PNG Institute Of Medical Research	Lisciandro, JG (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	joannel@ichr.uwa.edu.au	strickland, deborah/K-4597-2019; Prescott, Susan/H-5665-2014; Strickland, Deborah/AGV-6937-2022; Tulic, Meri/P-6613-2016; Tulic, Meri K/ABB-5138-2020; Holt, Patrick/H-1548-2011	Strickland, Deborah/0000-0003-0114-4201; Tulic, Meri/0000-0002-2661-2369; Tulic, Meri K/0000-0002-2661-2369; Holt, Patrick/0000-0003-1193-0935	Australian National Health and Medical Research Council (NHMRC) [513836]; University of Western Australia Research Grants Scheme; Australian Postgraduate Award; Stan and Jean Perron Award; NHMRC R Douglas Wright Biomedical Career Development [458780]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia Research Grants Scheme; Australian Postgraduate Award(Australian Government); Stan and Jean Perron Award; NHMRC R Douglas Wright Biomedical Career Development(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NHMRC) Project Grant (513836) and a University of Western Australia Research Grants Scheme. JL received an Australian Postgraduate Award and a Stan and Jean Perron Award, and AB received a NHMRC R Douglas Wright Biomedical Career Development Grant (458780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Becky, 2003, Clin Dev Immunol, V10, P43, DOI 10.1080/10446670310001598474; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1367; Atkinson W, 2011, EP PREV VACC PREV DI; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fleer A, 2007, NEONATOLOGY, V92, P145, DOI 10.1159/000102054; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Herbert OC, 2009, WORLD ALLERGY ORGAN, V2, P130, DOI 10.1097/WOX.0b013e3181accf27; Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lisciandro JG, 2010, CLIN EXP ALLERGY, V40, P1719, DOI 10.1111/j.1365-2222.2010.03629.x; Mutapi F, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-139; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Prescott SL, 2003, CLIN EXP ALLERGY, V33, P566, DOI 10.1046/j.1365-2222.2003.01659.x; Prescott SL, 2008, J ALLERGY CLIN IMMUN, V122, P391, DOI 10.1016/j.jaci.2008.04.042; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; van den Biggelaar AHJ, 2010, CLIN EXP IMMUNOL, V160, P42, DOI 10.1111/j.1365-2249.2010.04137.x; van den Biggelaar AHJ, 2011, VACCINE, V29, P5414, DOI 10.1016/j.vaccine.2011.05.065; van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124, P544, DOI 10.1016/j.jaci.2009.03.040; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	43	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36793	10.1371/journal.pone.0036793	http://dx.doi.org/10.1371/journal.pone.0036793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649499	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335800016
J	Yuan, YH; Gao, MY; Wu, DD; Liu, PM; Wu, Y				Yuan, Yihui; Gao, Meiying; Wu, Dandan; Liu, Pengming; Wu, Yan			Genome Characteristics of a Novel Phage from Bacillus thuringiensis Showing High Similarity with Phage from Bacillus cereus	PLOS ONE			English	Article							ANTHRACIS; SEQUENCE; DNA; PBCLIN15; SPOIIIE; BAM35; LIFE	Bacillus thuringiensis is an important entomopathogenic bacterium belongs to the Bacillus cereus group, which also includes B. anthracis and B. cereus. Several genomes of phages originating from this group had been sequenced, but no genome of Siphoviridae phage from B. thuringiensis has been reported. We recently sequenced and analyzed the genome of a novel phage, BtCS33, from a B. thuringiensis strain, subsp. kurstaki CS33, and compared the gneome of this phage to other phages of the B. cereus group. BtCS33 was the first Siphoviridae phage among the sequenced B. thuringiensis phages. It produced small, turbid plaques on bacterial plates and had a narrow host range. BtCS33 possessed a linear, double-stranded DNA genome of 41,992 bp with 57 putative open reading frames (ORFs). It had a typical genome structure consisting of three modules: the "late'' region, the "lysogeny-lysis'' region and the "early'' region. BtCS33 exhibited high similarity with several phages, B. cereus phage W beta and some variants of W beta, in genome organization and the amino acid sequences of structural proteins. There were two ORFs, ORF22 and ORF35, in the genome of BtCS33 that were also found in the genomes of B. cereus phage Wb and may be involved in regulating sporulation of the host cell. Based on these observations and analysis of phylogenetic trees, we deduced that B. thuringiensis phage BtCS33 and B. cereus phage W beta may have a common distant ancestor.	[Yuan, Yihui; Gao, Meiying; Wu, Dandan; Liu, Pengming; Wu, Yan] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Yuan, YH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China.	mygao@wh.iov.cn			National Project [2009ZX08009-056B]; National Natural Science Foundation of China [31170123]; Chinese Academy of Sciences [KSCX2-EW-G-16]	National Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Project (2009ZX08009-056B), the National Natural Science Foundation of China (No. 31170123) and the projects of the Chinese Academy of Sciences (KSCX2-EW-G-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN HW, 1994, ARCH VIROL, V135, P333, DOI 10.1007/BF01310018; AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Chang KC, 2011, GENOMICS, V97, P249, DOI 10.1016/j.ygeno.2011.01.002; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fogg PCM, 2011, NUCLEIC ACIDS RES, V39, P2116, DOI 10.1093/nar/gkq923; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; Hardies SC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-97; HARRELL LJ, 1995, J CLIN MICROBIOL, V33, P1847, DOI 10.1128/JCM.33.7.1847-1850.1995; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hirano N, 2011, APPL MICROBIOL BIOT, V89, P1877, DOI 10.1007/s00253-010-3003-7; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kochkina ZM, 2000, MICROBIOLOGY+, V69, P217, DOI 10.1007/BF02756202; Kochkina ZM, 2001, MICROBIOLOGY+, V70, P706, DOI 10.1023/A:1013144000718; Liao W, 2008, ARCH VIROL, V153, P1855, DOI 10.1007/s00705-008-0201-z; Lynch KH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-599; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Minakhin L, 2005, J MOL BIOL, V354, P1, DOI 10.1016/j.jmb.2005.09.052; Morita K, 2009, FEMS MICROBIOL LETT, V297, P234, DOI 10.1111/j.1574-6968.2009.01683.x; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Ravantti JJ, 2003, VIROLOGY, V313, P401, DOI 10.1016/S0042-6822(03)00295-2; SANTOS MA, 1991, NUCLEIC ACIDS RES, V19, P5442, DOI 10.1093/nar/19.19.5442; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; Sozhamannan S, 2008, APPL ENVIRON MICROB, V74, P6792, DOI 10.1128/AEM.01124-08; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Stromsten NJ, 2003, J BACTERIOL, V185, P6985, DOI 10.1128/JB.185.23.6985-6989.2003; SUSSKIND MM, 1975, J MOL BIOL, V98, P413, DOI 10.1016/S0022-2836(75)80127-6; Thomas JA, 2007, VIROLOGY, V368, P405, DOI 10.1016/j.virol.2007.06.043; Verheust C, 2005, J BACTERIOL, V187, P1966, DOI 10.1128/JB.187.6.1966-1973.2005; Verheust C, 2003, MICROBIOL-SGM, V149, P2083, DOI 10.1099/mic.0.26307-0; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029	41	71	71	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37557	10.1371/journal.pone.0037557	http://dx.doi.org/10.1371/journal.pone.0037557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649540	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335800059
J	Menendez, R; Torres, A; Reyes, S; Zalacain, R; Capelastegui, A; Rajas, O; Borderias, L; Martin-Villasclaras, JJ; Bello, S; Alfageme, I; de Castro, FR; Rello, J; Molinos, L; Ruiz-Manzano, J				Menendez, Rosario; Torres, Antoni; Reyes, Soledad; Zalacain, Rafael; Capelastegui, Alberto; Rajas, Olga; Borderias, Luis; Martin-Villasclaras, Juan J.; Bello, Salvador; Alfageme, Inmaculada; Rodriguez de Castro, Felipe; Rello, Jordi; Molinos, Luis; Ruiz-Manzano, Juan			Compliance with Guidelines-Recommended Processes in Pneumonia: Impact of Health Status and Initial Signs	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; QUALITY-OF-CARE; ANTIMICROBIAL THERAPY; ANTIBIOTIC DELIVERY; MEDICARE PATIENTS; ELDERLY-PATIENTS; OUTCOMES; MORTALITY; ADHERENCE; PATIENT	Initial care has been associated with improved survival of community-acquired pneumonia (CAP). We aimed to investigate patient comorbidities and health status measured by the Charlson index and clinical signs at diagnosis associated with adherence to recommended processes of care in CAP. We studied 3844 patients hospitalized with CAP. The evaluated recommendations were antibiotic adherence to Spanish guidelines, first antibiotic dose,6 hours and oxygen assessment. Antibiotic adherence was 72.6%, first dose <6 h was 73.4% and oxygen assessment was 90.2%. Antibiotic adherence was negatively associated with a high Charlson score (Odds ratio [OR], 0.91), confusion (OR, 0.66) and tachycardia >= 100 bpm (OR, 0.77). Delayed first dose was significantly lower in those with tachycardia (OR, 0.75). Initial oxygen assessment was negatively associated with fever (OR, 0.61), whereas tachypnea >= 30 (OR, 1.58), tachycardia (OR, 1.39), age >65 (OR, 1.51) and COPD (OR, 1.80) were protective factors. The combination of antibiotic adherence and timing <6 hours was negatively associated with confusion (OR, 0.69) and a high Charlson score (OR, 0.92) adjusting for severity and hospital effect, whereas age was not an independent factor. Deficient health status and confusion, rather than age, are associated with lower compliance with antibiotic therapy recommendations and timing, thus identifying a subpopulation more prone to receiving lower quality care.	[Menendez, Rosario; Reyes, Soledad] Univ Hosp, Serv Neumol, Valencia, Spain; [Torres, Antoni] Univ Barcelona, CIBERES, IDIBAPS, Inst Clin Torax,Serv Pneumol, Barcelona, Spain; [Zalacain, Rafael] Hosp Cruces, Serv Neumol, Bilbao, Spain; [Capelastegui, Alberto] Hosp Galdakao, Serv Neumol, Galdakao, Spain; [Rajas, Olga] Hosp Princesa, Serv Neumol, Madrid, Spain; [Borderias, Luis] Hosp San Jorge, Serv Neumol, Huesca, Spain; [Martin-Villasclaras, Juan J.] Hosp Carlos Haya, Serv Neumol, Malaga, Spain; [Bello, Salvador] Hosp Miguel Servet, Serv Neumol, Zaragoza, Spain; [Alfageme, Inmaculada] Hosp Valme, Serv Neumol, Seville, Spain; [Rodriguez de Castro, Felipe] Hosp Dr Negrin, Serv Neumol, Las Palmas Gran Canaria, Spain; [Rello, Jordi] Hosp Valle De Hebron, Inst Recerca Vall Hebron UAB, CIBERES, Barcelona, Spain; [Molinos, Luis] Univ Oviedo, Hosp Cent Asturias, Serv Neumol, E-33080 Oviedo, Spain; [Ruiz-Manzano, Juan] Hosp Badalona Germans Trias & Pujol, Serv Neumol, Badalona, Spain; [Menendez, Rosario; Reyes, Soledad] Politecn La Fe, CIBERES, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario Cruces; Galdakao Hospital; Hospital de La Princesa; Hospital Universidad San Jorge; Hospital Carlos Haya; Miguel Servet University Hospital; Hospital Valme; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Central University Hospital Asturias; University of Oviedo; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Menendez, R (corresponding author), Univ Hosp, Serv Neumol, Valencia, Spain.	rosmenend@gmail.com	Alfageme, Inmaculada/K-2092-2014; Menéndez, Rosario/G-9723-2016; de Castro, Felipe Rodriguez/R-8416-2019; Zalacain, Rafael/E-2972-2012; Rello, Jordi/P-2402-2019; Torres, Antoni/H-6128-2017; , Ivan/D-6804-2012	Alfageme, Inmaculada/0000-0002-5106-1669; Menéndez, Rosario/0000-0002-3592-3839; Rello, Jordi/0000-0003-0676-6210; Torres, Antoni/0000-0002-8643-2167; Rodriguez de Castro, Felipe/0000-0002-6812-2739; , Ivan/0000-0002-3108-058X; Borderias, Luis/0000-0003-3296-9644	CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis [PI 041150]; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) [2006/0237]; Beca de la Conselleria Sanitat Comunidad Valenciana [2007/0059]; PII (Programme of research of SEPAR) in respiratory infections	CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica); Beca de la Conselleria Sanitat Comunidad Valenciana; PII (Programme of research of SEPAR) in respiratory infections	This work was supported by CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis (PI 041150); Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) (2006/0237); Beca de la Conselleria Sanitat Comunidad Valenciana (2007/0059) and PII (Programme of research of SEPAR) in respiratory infections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfageme I, 2005, ARCH BRONCONEUMOL, V41, P272; Battleman DS, 2002, ARCH INTERN MED, V162, P682, DOI 10.1001/archinte.162.6.682; Blasi F, 2008, EUR RESPIR J, V32, P902, DOI 10.1183/09031936.00092607; Blot SI, 2007, CRIT CARE MED, V35, P2509, DOI 10.1097/01.CCM.0000287587.43801.9C; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Capelastegui A, 2004, CLIN INFECT DIS, V39, P955, DOI 10.1086/423960; Caterino JM, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dambrava PG, 2008, EUR RESPIR J, V32, P892, DOI 10.1183/09031936.00163407; Dean NC, 2006, CHEST, V130, P794, DOI 10.1378/chest.130.3.794; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Feagan BG, 2000, CAN MED ASSOC J, V162, P1415; Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC; Fine JM, 2002, ARCH INTERN MED, V162, P827, DOI 10.1001/archinte.162.7.827; Frei CR, 2010, CLIN THER, V32, P293, DOI 10.1016/j.clinthera.2010.02.006; Halm EA, 2000, ARCH INTERN MED, V160, P98, DOI 10.1001/archinte.160.1.98; HOSMER DW, 1989, APPL LOGISTIC REGRES; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Marras Theodore K, 2004, Can Respir J, V11, P131; McCabe C, 2009, ARCH INTERN MED, V169, P1525, DOI 10.1001/archinternmed.2009.259; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Menendez R, 2005, AM J RESP CRIT CARE, V172, P757, DOI 10.1164/rccm.200411-1444OC; Menendez R, 2012, EUR RESPIR J, V39, P156, DOI 10.1183/09031936.00188710; Metersky ML, 2006, CHEST, V130, P16, DOI 10.1378/chest.130.1.16; Mortensen EM, 2004, AM J MED, V117, P726, DOI 10.1016/j.amjmed.2004.06.028; Mortensen EM, 2006, AM J MED, V119, P859, DOI 10.1016/j.amjmed.2006.04.017; Pines JM, 2009, J EMERG MED, V37, P335, DOI 10.1016/j.jemermed.2009.06.127; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37570	10.1371/journal.pone.0037570	http://dx.doi.org/10.1371/journal.pone.0037570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629420	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300052
J	Lockwood, WW; Wilson, IM; Coe, BP; Chari, R; Pikor, LA; Thu, KL; Solis, LM; Nunez, MI; Behrens, C; Yee, J; English, J; Murray, N; Tsao, MS; Minna, JD; Gazdar, AF; Wistuba, II; MacAulay, CE; Lam, S; Lam, WL				Lockwood, William W.; Wilson, Ian M.; Coe, Bradley P.; Chari, Raj; Pikor, Larissa A.; Thu, Kelsie L.; Solis, Luisa M.; Nunez, Maria I.; Behrens, Carmen; Yee, John; English, John; Murray, Nevin; Tsao, Ming-Sound; Minna, John D.; Gazdar, Adi F.; Wistuba, Ignacio I.; MacAulay, Calum E.; Lam, Stephen; Lam, Wan L.			Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA METHYLATION PROFILES; GENE-EXPRESSION; MOLECULAR-ORIGINS; TRANSCRIPTION FACTORS; DOWN-REGULATION; STEM-CELLS; FHIT GENE; SURVIVAL; ASSOCIATION	For therapeutic purposes, non-small cell lung cancer (NSCLC) has traditionally been regarded as a single disease. However, recent evidence suggest that the two major subtypes of NSCLC, adenocarcinoma (AC) and squamous cell carcinoma (SqCC) respond differently to both molecular targeted and new generation chemotherapies. Therefore, identifying the molecular differences between these tumor types may impact novel treatment strategy. We performed the first large-scale analysis of 261 primary NSCLC tumors (169 AC and 92 SqCC), integrating genome-wide DNA copy number, methylation and gene expression profiles to identify subtype-specific molecular alterations relevant to new agent design and choice of therapy. Comparison of AC and SqCC genomic and epigenomic landscapes revealed 778 altered genes with corresponding expression changes that are selected during tumor development in a subtype-specific manner. Analysis of >200 additional NSCLCs confirmed that these genes are responsible for driving the differential development and resulting phenotypes of AC and SqCC. Importantly, we identified key oncogenic pathways disrupted in each subtype that likely serve as the basis for their differential tumor biology and clinical outcomes. Downregulation of HNF4 alpha target genes was the most common pathway specific to AC, while SqCC demonstrated disruption of numerous histone modifying enzymes as well as the transcription factor E2F1. In silico screening of candidate therapeutic compounds using subtype-specific pathway components identified HDAC and PI3K inhibitors as potential treatments tailored to lung SqCC. Together, our findings suggest that AC and SqCC develop through distinct pathogenetic pathways that have significant implication in our approach to the clinical management of NSCLC.	[Lockwood, William W.; Wilson, Ian M.; Coe, Bradley P.; Chari, Raj; Pikor, Larissa A.; Thu, Kelsie L.; MacAulay, Calum E.; Lam, Stephen; Lam, Wan L.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Solis, Luisa M.; Behrens, Carmen; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Nunez, Maria I.; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Yee, John] Vancouver Gen Hosp, Dept Surg, Vancouver, BC, Canada; [English, John] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Murray, Nevin] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Tsao, Ming-Sound] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Tsao, Ming-Sound] Univ Toronto, Dept Pathol, Univ Hlth Network Princess Margaret Hosp, Toronto, ON, Canada; [Minna, John D.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	British Columbia Cancer Agency; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lockwood, WW (corresponding author), NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	william.lockwood@nih.gov	Chari, Raj/G-3285-2019; Coe, Bradley/A-2878-2009; Tsao, Ming-Sound/M-3503-2017; Lockwood, William W/A-2879-2009; MacAulay, Calum/K-1795-2016; Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405; Coe, Bradley/0000-0001-8471-4016; MacAulay, Calum/0000-0003-4440-2792; Thu, Kelsie/0000-0001-9262-7238	Canadian Institutes for Health Research (CIHR) [MOP-86731, MOP-77903, MOP-110949]; Canadian Cancer Society [CCS20485]; NCI Early Detection Research Network; Department of Defence [CDMRP W81XWH-10-1-0634]; CIHR; NSERC (Natural Sciences and Engineering Research Council); CIHR Jean-Francois Saint Denis Fellowship in Cancer Research; Banting Postdoctoral Fellowship; Vanier Canada Graduate Scholarships; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defence; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Sciences and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Jean-Francois Saint Denis Fellowship in Cancer Research(Canadian Institutes of Health Research (CIHR)); Banting Postdoctoral Fellowship; Vanier Canada Graduate Scholarships; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) (MOP-86731, MOP-77903, MOP-110949), Canadian Cancer Society (CCS20485), NCI Early Detection Research Network, and Department of Defence (CDMRP W81XWH-10-1-0634). W. W. L., I. M. W., B. P. C., R. C., K. L. T. and L. A. P. were supported by scholarships from CIHR and NSERC (Natural Sciences and Engineering Research Council), and W. W. L. by a CIHR Jean-Francois Saint Denis Fellowship in Cancer Research, R. C. by a Banting Postdoctoral Fellowship, K. L. T. and L. A. P. by Vanier Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bardelli A, 2001, P NATL ACAD SCI USA, V98, P5770, DOI 10.1073/pnas.081082898; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Broet P, 2009, CANCER RES, V69, P1055, DOI 10.1158/0008-5472.CAN-08-1116; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Cheng L, 2000, CARCINOGENESIS, V21, P1527, DOI 10.1093/carcin/21.8.1527; Chi B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-13; Chi B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-243; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Coe BP, 2008, J CELL PHYSIOL, V217, P590, DOI 10.1002/jcp.21554; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; de Fraipont F, 2005, LUNG CANCER, V50, P199, DOI 10.1016/j.lungcan.2005.05.019; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Felip E, 2007, EXPERT REV MOL DIAGN, V7, P261, DOI 10.1586/14737159.7.3.261; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Garraway LA, 2006, CANCER RES, V66, P2506, DOI 10.1158/0008-5472.CAN-05-4604; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Geradts J, 2000, BRIT J CANCER, V82, P1191, DOI 10.1054/bjoc.1999.1062; Giangreco A, 2007, AM J RESP CRIT CARE, V175, P547, DOI 10.1164/rccm.200607-984PP; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HIGASHIYAMA M, 1995, CANCER RES, V55, P6040; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Hyman E, 2002, CANCER RES, V62, P6240; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Kim H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077; Kim JS, 2004, CARCINOGENESIS, V25, P2165, DOI 10.1093/carcin/bgh217; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich NL, 2008, BIOCHEMISTRY-MOSCOW+, V73, P573, DOI 10.1134/S0006297908050106; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; ORZAN F, 2010, NEUROPATHOL APPL NEU; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen I, 1997, CANCER RES, V57, P2331; Petersen I, 2009, LUNG CANCER, V65, P312, DOI 10.1016/j.lungcan.2008.12.013; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Sel S, 1996, CANCER LETT, V101, P205, DOI 10.1016/0304-3835(96)04136-5; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sozzi G, 1997, CANCER RES, V57, P2121; Sozzi G, 1998, CANCER RES, V58, P5032; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sy SMH, 2004, EUR J CANCER, V40, P1082, DOI 10.1016/j.ejca.2004.01.012; Thomas RK, 2006, CLIN CANCER RES, V12, p4384S, DOI 10.1158/1078-0432.CCR-06-0098; Tomizawa Y, 1998, CANCER RES, V58, P5478; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Toyooka S, 2001, MOL CANCER THER, V1, P61; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Travis W, 2004, WHO CLASSIFICATION T; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vilmar A, 2009, LUNG CANCER, V64, P131, DOI 10.1016/j.lungcan.2008.08.006; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Watson SK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-6; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wu ZL, 2009, CELL DEATH DIFFER; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009355; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	96	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37775	10.1371/journal.pone.0037775	http://dx.doi.org/10.1371/journal.pone.0037775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629454	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100049
J	Maron, JL; Johnson, KL; Dietz, JA; Chen, MHL; Bianchi, DW				Maron, Jill L.; Johnson, Kirby L.; Dietz, Jessica A.; Chen, Minghua L.; Bianchi, Diana W.			Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate	PLOS ONE			English	Article							BODY-WEIGHT; BEHAVIOR; NPYY2; GENE	Background: The current practice in newborn medicine is to subjectively assess when a premature infant is ready to feed by mouth. When the assessment is inaccurate, the resulting feeding morbidities may be significant, resulting in long-term health consequences and millions of health care dollars annually. We hypothesized that the developmental maturation of hypothalamic regulation of feeding behavior is a predictor of successful oral feeding in the premature infant. To test this hypothesis, we analyzed the gene expression of neuropeptide Y2 receptor (NPY2R), a known hypothalamic regulator of feeding behavior, in neonatal saliva to determine its role as a biomarker in predicting oral feeding success in the neonate. Methodology/Principal Findings: Salivary samples (n = 116), were prospectively collected from 63 preterm and 13 term neonates (post-conceptual age (PCA) 26 4/7 to 41 4/7 weeks) from five predefined feeding stages. Expression of NPY2R in neonatal saliva was determined by multiplex RT-qPCR amplification. Expression results were retrospectively correlated with feeding status at time of sample collection. Statistical analysis revealed that expression of NPY2R had a 95% positive predictive value for feeding immaturity. NPY2R expression statistically significantly decreased with advancing PCA (Wilcoxon test p value<0.01), and was associated with feeding status (chi square p value = 0.013). Conclusions/Significance: Developmental maturation of hypothalamic regulation of feeding behavior is an essential component of oral feeding success in the newborn. NPY2R expression in neonatal saliva is predictive of an immature feeding pattern. It is a clinically relevant biomarker that may be monitored in saliva to improve clinical care and reduce significant feeding-associated morbidities that affect the premature neonate.	[Maron, Jill L.; Dietz, Jessica A.; Chen, Minghua L.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Div Newborn Med, Boston, MA 02111 USA; [Johnson, Kirby L.; Bianchi, Diana W.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Div Genet, Boston, MA USA; [Maron, Jill L.; Johnson, Kirby L.; Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA	Floating Hospital For Children; Tufts Medical Center; Floating Hospital For Children; Tufts Medical Center; Tufts Medical Center	Maron, JL (corresponding author), Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Div Newborn Med, Boston, MA 02111 USA.	jmaron@tuftsmedicalcenter.org		Daley, Jessica/0000-0001-5133-448X	NICHD [K08 HD 059819-03]; Charles H. Hood Foundation; Richard Saltonstall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD059819] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles H. Hood Foundation; Richard Saltonstall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NICHD K08 HD 059819-03, the Charles H. Hood Foundation (www.hria.org/tmfservices/tmfgrants/hood.html), and the Richard Saltonstall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaizu N, 2008, ACTA PAEDIATR, V97, P61, DOI 10.1111/j.1651-2227.2007.00548.x; Barlow SM, 2009, CURR OPIN OTOLARYNGO, V17, P187, DOI 10.1097/MOO.0b013e32832b312a; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7; Campbell CD, 2007, DIABETES, V56, P1460, DOI 10.2337/db06-1051; Delaney AL, 2008, DEV DISABIL RES REV, V14, P105, DOI 10.1002/ddrr.16; Dietz JA, 2012, NEONATOLOGY, V101, P55, DOI 10.1159/000328026; Huang XF, 2008, NEUROCHEM RES, V33, P1881, DOI 10.1007/s11064-008-9661-5; Kamiji MM, 2007, CURR TOP MED CHEM, V7, P1734, DOI 10.2174/156802607782340957; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Lau C., 2006, NEOREVIEWS, V7, P19, DOI [10.1542/neo.7-1-e19, DOI 10.1542/neo.7-1-e19, DOI 10.1542/NEO.7-1-E19]; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Maron JL, 2010, CLIN CHEM, V56, P409, DOI 10.1373/clinchem.2009.136234; Mizuno K, 2005, DEV MED CHILD NEUROL, V47, P299, DOI 10.1017/S0012162205000587; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; PANKSEPP J, 1974, FED PROC, V33, P1150; Samara M, 2010, DEV MED CHILD NEUROL, V52, pe16, DOI 10.1111/j.1469-8749.2009.03512.x; Sato N, 2009, EXPERT OPIN THER PAT, V19, P1401, DOI 10.1517/13543770903251722; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Takiguchi E, 2010, METABOLISM, V59, P1591, DOI 10.1016/j.metabol.2010.02.014; Uddman R, 2002, PEPTIDES, V23, P927, DOI 10.1016/S0196-9781(02)00003-7; Wang LX, 2010, AM J PHYSIOL-GASTR L, V298, pG45, DOI 10.1152/ajpgi.00349.2009; Yoo SB, 2011, NEUROPEPTIDES, V45, P343, DOI 10.1016/j.npep.2011.07.005; Zimmermann BG, 2007, ANN NY ACAD SCI, V1098, P184, DOI 10.1196/annals.1384.002	24	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37870	10.1371/journal.pone.0037870	http://dx.doi.org/10.1371/journal.pone.0037870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629465	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100056
J	Su, CH; Wang, JT; Hsiung, CA; Chien, LJ; Chi, CL; Yu, HT; Chang, FY; Chang, SC				Su, Chiu-Hsia; Wang, Jann-Tay; Hsiung, Chao A.; Chien, Li-Jung; Chi, Cheng-Liang; Yu, Hui-Tzu; Chang, Feng-Yee; Chang, Shan-Chwen			Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage	PLOS ONE			English	Article							RISK-FACTORS; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC USAGE; OUTBREAK; COLONIZATION; EMERGENCE; SPREAD; ACQUISITION; BACTEREMIA; PROGNOSIS	Objective: Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as an important pathogen causing healthcare-associated infections (HAIs) in Taiwan. The present study is aimed to investigate the epidemiology of HAIs caused by CRAB and the association of CRAB infection and hospital usage of different antimicrobials. Methods: Two nationwide databases in the period 2003 to 2008, the Taiwan Nosocomial Infection Surveillance System and National Health Insurance claim data, were used for analysis. A total of 13,811 healthcare-associated A. baumannii infections and antimicrobial usage data from 121 hospitals were analyzed. Results: There was a significant increase in the proportion of number of HAIs caused by CRAB over that by all A. baumannii (CRABpAB), from 14% in 2003 to 46% in 2008 (P<0.0001). The greatest increase was in central Taiwan, from 4% in 2003 to 62% in 2008 (P<0.0001). Use of anti-pseudomonal carbapenems, but not other classes of antibiotics, was significantly correlated with the increase of CRABpAB (r = 0.86, P<0.0001). Conclusions: We suggested that dedicated use of anti-pseudomonal carbapenems would be an important intervention to control the increase of CRABpAB.	[Su, Chiu-Hsia; Chien, Li-Jung; Chang, Feng-Yee] Ctr Dis Control Taiwan, Taipei, Taiwan; [Su, Chiu-Hsia] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wang, Jann-Tay; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hsiung, Chao A.; Chi, Cheng-Liang; Yu, Hui-Tzu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Pharm, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Su, CH (corresponding author), Ctr Dis Control Taiwan, Taipei, Taiwan.	changsc@ntu.edu.tw	Hsiung, Chao Agnes/E-3994-2010	CHANG, SHAN-CHWEN/0000-0001-6505-4139; WANG, JANN-TAY/0000-0002-0924-3469				Akinci E, 2005, J HOSP INFECT, V59, P317, DOI 10.1016/j.jhin.2004.09.030; Baran G, 2008, INT J INFECT DIS, V12, P16, DOI 10.1016/j.ijid.2007.03.005; Bureau of National Health Insurance, 2009, INTR NAT HLTH INS TA; *CDC TAIW, 2009, STAT COMM DIS SURV R; Centers for Disease Control of Taiwan, 2004, STAT COMM DIS SURV R; Chen CM, 2009, DIAGN MICR INFEC DIS, V63, P394, DOI 10.1016/j.diagmicrobio.2008.12.011; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P4575, DOI 10.1128/AAC.00764-10; Cisneros JM, 2002, CLIN MICROBIOL INFEC, V8, P687, DOI 10.1046/j.1469-0691.2002.00487.x; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Corbella X, 2000, J CLIN MICROBIOL, V38, P4086, DOI 10.1128/JCM.38.11.4086-4095.2000; Romanelli RMD, 2009, BRAZ J INFECT DIS, V13, P341, DOI 10.1590/S1413-86702009000500005; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HICPAC, 2006, MAN MULT RES ORG HEA; Karageorgopoulos DE, 2008, J ANTIMICROB CHEMOTH, V62, P45, DOI 10.1093/jac/dkn165; Katragkou A, 2006, INTENS CARE MED, V32, P1384, DOI 10.1007/s00134-006-0239-x; Kim YA, 2008, SCAND J INFECT DIS, V40, P234, DOI 10.1080/00365540701633004; Kuo HY, 2010, DIAGN MICR INFEC DIS, V66, P195, DOI 10.1016/j.diagmicrobio.2009.09.013; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; Lee TM, 2010, INFECT CONTROL J, V20, P107; Lee YT, 2012, J MICROBIOL IMMUNOL, V45, P43, DOI 10.1016/j.jmii.2011.09.020; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lu PL, 2009, J ANTIMICROB CHEMOTH, V63, P641, DOI 10.1093/jac/dkn553; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Schreckenberg PC, 2003, MANUAL CLIN MICROBIO, P749; Smolyakova R, 2003, J HOSP INFECT, V54, P32, DOI 10.1016/S0195-6701(03)00046-X; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x; Tsai HT, 2008, DIAGN MICR INFEC DIS, V62, P298, DOI 10.1016/j.diagmicrobio.2008.06.017; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Unal S, 2005, DIAGN MICR INFEC DIS, V53, P265, DOI 10.1016/j.diagmicrobio.2005.10.002; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Williams VR, 2009, AM J INFECT CONTROL, V37, P106, DOI 10.1016/j.ajic.2008.05.007; World Health Organization: Geneva (WHO), 2007, COLL CTR DRUG STAT M	36	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37788	10.1371/journal.pone.0037788	http://dx.doi.org/10.1371/journal.pone.0037788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629456	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100051
J	Lu, L; Yan, WH; Xue, WY; Shao, D; Xing, YZ				Lu, Li; Yan, Wenhao; Xue, Weiya; Shao, Di; Xing, Yongzhong			Evolution and Association Analysis of Ghd7 in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FLOWERING-TIME; GENE-EXPRESSION; ARABIDOPSIS; SOFTWARE; DOMESTICATION; DIVERSITY; HD1; POPULATION	Plant height, heading date, and yield are the main targets for rice genetic improvement. Ghd7 is a pleiotropic gene that controls the aforementioned traits simultaneously. In this study, a rice germplasm collection of 104 accessions (Oryza sativa) and 3 wild rice varieties (O. rufipogon) was used to analyze the evolution and association of Ghd7 with plant height, heading date, and yield. Among the 104 accessions, 76 single nucleotide polymorphisms (SNPs) and six insertions and deletions were found within a 3932-bp DNA fragment of Ghd7. A higher pairwise pi and theta in the promoter indicated a highly diversified promoter of Ghd7. Sixteen haplotypes and 8 types of Ghd7 protein were detected. SNP changes between haplotypes indicated that Ghd7 evolved from two distinct ancestral gene pools, and independent domestication processes were detected in indica and japonica varietals respectively. In addition to the previously reported premature stop mutation in the first exon of Ghd7, which caused phenotypic changes of multiple traits, we found another functional C/T mutation (SNP S_555) by structure-based association analysis. SNP S_555 is located in the promoter and was related to plant height probably by altering gene expression. Moreover, another seven SNP mutations in complete linkage were found to be associated with the number of spikelets per panicle, regardless of the photoperiod. These associations provide the potential for flexibility of Ghd7 application in rice breeding programs.	[Lu, Li] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lu, L (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yzxing@mail.hzau.edu.cn		Xing, Yongzhong/0000-0003-1376-1514; Lu, Li/0000-0003-0490-7163	National Science Foundation of China [30830064]; 863 program on platform establishment for rice resources, genomics and bioinformatics [2012AA10A304]; National Special Program for Research of Transgenic Plant of China [2008ZX08009-103B]; National Key Program on the Development of Basic Research of China [2007CB109001]; Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation [2009YB006]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program on platform establishment for rice resources, genomics and bioinformatics; National Special Program for Research of Transgenic Plant of China; National Key Program on the Development of Basic Research of China; Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation	The work was supported by National Science Foundation of China (30830064); 863 program on platform establishment for rice resources, genomics and bioinformatics (2012AA10A304); National Special Program for Research of Transgenic Plant of China (2008ZX08009-103B); National Key Program on the Development of Basic Research of China (2007CB109001); and Huazhong Agricultural University Scientific & Technological Self-Innovation Foundation (2009YB006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chen YS, 2010, TRENDS PLANT SCI, V15, P454, DOI 10.1016/j.tplants.2010.05.004; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pritchard JK, 2000, GENETICS, V155, P945; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu L, 2010, PLANT CELL REP, V29, P1061, DOI 10.1007/s00299-010-0892-y; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	41	68	74	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e34021	10.1371/journal.pone.0034021	http://dx.doi.org/10.1371/journal.pone.0034021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666315	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400004
J	Rogers, SW; Gahring, LC				Rogers, Scott W.; Gahring, Lorise C.			Nicotinic Receptor Alpha7 Expression during Tooth Morphogenesis Reveals Functional Pleiotropy	PLOS ONE			English	Article							DEVELOPING RAT MOLARS; 1ST MOLAR; ACETYLCHOLINE-RECEPTORS; DENTAL DEVELOPMENT; GENETIC-BASIS; NGF RECEPTOR; NERVE-FIBERS; ENAMEL KNOT; CELLS; MOUSE	The expression of nicotinic acetylcholine receptor (nAChR) subtype, alpha7, was investigated in the developing teeth of mice that were modified through homologous recombination to express a bi-cistronic IRES-driven tau-enhanced green fluorescent protein (GFP); alpha7GFP) or IRES-Cre (alpha7Cre). The expression of alpha7GFP was detected first in cells of the condensing mesenchyme at embryonic (E) day E13.5 where it intensifies through E14.5. This expression ends abruptly at E15.5, but was again observed in ameloblasts of incisors at E16.5 or molar ameloblasts by E17.5-E18.5. This expression remains detectable until molar enamel deposition is completed or throughout life as in the constantly erupting mouse incisors. The expression of alpha7GFP also identifies all stages of innervation of the tooth organ. Ablation of the alpha7-cell lineage using a conditional alpha7Cre x ROSA26-LoxP(diphtheria toxin A) strategy substantially reduced the mesenchyme and this corresponded with excessive epithelium overgrowth consistent with an instructive role by these cells during ectoderm patterning. However, alpha7knock-out (KO) mice exhibited normal tooth size and shape indicating that under normal conditions alpha7 expression is dispensable to this process. The function of ameloblasts in alpha7KO mice is altered relative to controls. High resolution micro-computed tomography analysis of adult mandibular incisors revealed enamel volume of the alpha7KO was significantly reduced and the organization of enamel rods was altered relative to controls. These results demonstrate distinct and varied spatiotemporal expression of alpha7 during tooth development, and they suggest that dysfunction of this receptor would have diverse impacts upon the adult organ.	[Rogers, Scott W.; Gahring, Lorise C.] Vet Adm, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Gahring, Lorise C.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Vet Adm, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.	Scott.Rogers@hsc.utah.edu			National Institutes of Health [DA025057, AG017517, AG029838]; NATIONAL INSTITUTE ON AGING [R01AG017517, R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA025057, AG017517 and AG029838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arredondo J, 2003, LIFE SCI, V72, P2063, DOI 10.1016/S0024-3205(03)00084-5; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Atluri P, 2001, DEV BIOL, V240, P143, DOI 10.1006/dbio.2001.0453; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; BYERS MR, 1990, DEVELOPMENT, V109, P461; Chowdhury IG, 2000, ANAT RECORD, V258, P397; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; FRIED K, 1982, J NEUROL SCI, V53, P169, DOI 10.1016/0022-510X(82)90003-X; Fried K, 2000, CRIT REV ORAL BIOL M, V11, P318, DOI 10.1177/10454411000110030301; FRISTAD I, 1994, ARCH ORAL BIOL, V39, P633, DOI 10.1016/0003-9969(94)90089-2; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2003, J NEUROCHEM, V87, P1125, DOI 10.1046/j.1471-4159.2003.02074.x; Gubbins EJ, 2010, BRAIN RES, V1328, P1, DOI 10.1016/j.brainres.2010.02.083; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Jussila M, 2012, COLD SPRING HARB PER; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; KHAN MA, 1981, J BIOL BUCCALE, V9, P335; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Leamy LJ, 2005, HEREDITY, V94, P316, DOI 10.1038/sj.hdy.6800637; Li Q, 2011, CELL PHYSIOL BIOCHEM, V27, P605, DOI 10.1159/000329982; Li Y, 2008, J BIOL CHEM, V283, P15056, DOI 10.1074/jbc.M707992200; Loes S, 2002, ANAT EMBRYOL, V205, P187, DOI 10.1007/s00429-002-0247-8; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; Luukko K, 2005, DEV DYNAM, V234, P482, DOI 10.1002/dvdy.20586; Luukko K, 2008, ANN ANAT, V190, P178, DOI 10.1016/j.aanat.2007.10.003; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; MITSIADIS TA, 1992, DIFFERENTIATION, V49, P47, DOI 10.1111/j.1432-0436.1992.tb00768.x; Moe K, 2008, ARCH ORAL BIOL, V53, P865, DOI 10.1016/j.archoralbio.2008.03.004; MOHAMED SS, 1983, J ANAT, V136, P735; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; Picciotto MR, 2001, PHARMACOL THERAPEUT, V92, P89, DOI 10.1016/S0163-7258(01)00161-9; Rajchgot H, 2009, SCHIZOPHR RES, V110, P194, DOI 10.1016/j.schres.2009.02.014; ROBINSON RM, 1984, CALCIFIED TISSUE INT, V36, P31, DOI 10.1007/BF02405291; Rogers SW, 2012, AM J MED GE IN PRESS; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; SAAD AY, 1991, ACTA ANAT, V140, P269; Shore R C, 1995, Connect Tissue Res, V33, P151, DOI 10.3109/03008209509016995; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Thesleff I, 2003, QUINTESSENCE INT, V34, P613; Thesleff I, 2001, Adv Dent Res, V15, P14; Thesleff I, 1997, COLD SPRING HARB SYM, V62, P257; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; TSUZUKI H, 1991, ARCH ORAL BIOL, V36, P139, DOI 10.1016/0003-9969(91)90076-7; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tucker AS, 1999, J DENT RES, V78, P826, DOI 10.1177/00220345990780040201; Tulin S, 2010, BIRTH DEFECTS RES C, V90, P214, DOI 10.1002/bdrc.20182; Workman MS, 2002, GENETICS, V160, P1573; Xu MQ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-19; Xu W, 1999, J NEUROSCI, V19, P9298; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	59	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36467	10.1371/journal.pone.0036467	http://dx.doi.org/10.1371/journal.pone.0036467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666322	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400009
J	Bauze, AE; Tran, LN; Nguyen, KH; Firth, S; Jimenez-Soto, E; Dwyer-Lindgren, L; Hodge, A; Lopez, AD				Bauze, Anna E.; Tran, Linda N.; Nguyen, Kim-Huong; Firth, Sonja; Jimenez-Soto, Eliana; Dwyer-Lindgren, Laura; Hodge, Andrew; Lopez, Alan D.			Equity and Geography: The Case of Child Mortality in Papua New Guinea	PLOS ONE			English	Article							UNDER-5 MORTALITY; COUNTRIES; COUNTDOWN; COVERAGE; PROGRESS; NEWBORN; TRENDS	Background: Recent assessments show continued decline in child mortality in Papua New Guinea (PNG), yet complete subnational analyses remain rare. This study aims to estimate under-five mortality in PNG at national and subnational levels to examine the importance of geographical inequities in health outcomes and track progress towards Millennium Development Goal (MDG) 4. Methodology: We performed retrospective data validation of the Demographic and Health Survey (DHS) 2006 using 2000 Census data, then applied advanced indirect methods to estimate under-five mortality rates between 1976 and 2000. Findings: The DHS 2006 was found to be unreliable. Hence we used the 2000 Census to estimate under-five mortality rates at national and subnational levels. During the period under study, PNG experienced a slow reduction in national under-five mortality from approximately 103 to 78 deaths per 1,000 live births. Subnational analyses revealed significant disparities between rural and urban populations as well as inter-and intra-regional variations. Some of the provinces that performed the best (worst) in terms of under-five mortality included the districts that performed worst (best), with district-level under-five mortality rates correlating strongly with poverty levels and access to services. Conclusions: The evidence from PNG demonstrates substantial within-province heterogeneity, suggesting that under-five mortality needs to be addressed at subnational levels. This is especially relevant in countries, like PNG, where responsibility for health services is devolved to provinces and districts. This study presents the first comprehensive estimates of under-five mortality at the district level for PNG. The results demonstrate that for countries that rely on few data sources even greater importance must be given to the quality of future population surveys and to the exploration of alternative options of birth and death surveillance.	[Bauze, Anna E.] Burnet Inst, Melbourne, Vic, Australia; [Tran, Linda N.; Nguyen, Kim-Huong; Firth, Sonja; Jimenez-Soto, Eliana; Hodge, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Dwyer-Lindgren, Laura] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Burnet Institute; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Bauze, AE (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	a.hodge@uq.edu.au	Nguyen, Kim-Huong/C-7260-2017; Hodge, Andrew/C-4779-2014; Nguyen, Kim-Huong/ABA-5902-2020; Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Nguyen, Kim-Huong/0000-0002-2592-9372; Hodge, Andrew/0000-0002-7203-9233; Nguyen, Kim-Huong/0000-0002-2592-9372; Lopez, Alan D/0000-0001-5818-6512; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Bill and Melinda Gates Foundation [20098011047721006588]; AusAID [20098011060821604142]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); AusAID(Australian Aid (AusAID))	This work was funded by The Bill and Melinda Gates Foundation, Fund code: 20098011047721006588, URL: www.gatesfoundation.org) and AusAID, Fund code: 20098011060821604142, URL: www.ausaid.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2011, B WORLD HEALTH ORGAN, V89, P12, DOI 10.2471/BLT.10.076851; Bakker ML, 1986, MORTALITY SITUATION; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Gibson J, 2003, ECON DEV CULT CHANGE, V52, P159, DOI 10.1086/380424; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Jahn A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011320; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; National Statistical Office of Papua New Guinea, 2003, REC FERT MORT IND TR; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026856; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; World Bank, 2004, PAP NEW GUIN POV ASS	21	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37861	10.1371/journal.pone.0037861	http://dx.doi.org/10.1371/journal.pone.0037861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662238	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300128
J	Alsio, A; Rembeck, K; Askarieh, G; Christensen, PB; Farkkila, M; Langeland, N; Buhl, MR; Pedersen, C; Morch, K; Haagmans, BL; Nasic, S; Westin, J; Hellstrand, K; Norkrans, G; Lagging, M				Alsio, Asa; Rembeck, Karolina; Askarieh, Galia; Christensen, Peer Brehm; Farkkila, Martti; Langeland, Nina; Buhl, Mads Rauning; Pedersen, Court; Morch, Kristine; Haagmans, Bart L.; Nasic, Salmir; Westin, Johan; Hellstrand, Kristoffer; Norkrans, Gunnar; Lagging, Martin			Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; BODY-MASS INDEX; VIRUS-INFECTION; ANTIVIRAL TREATMENT; INSULIN-RESISTANCE; RANDOMIZED-TRIAL; PLUS RIBAVIRIN; DOSE RIBAVIRIN; VIRAL KINETICS; NON-A	Background and Aims: Having a body mass index above or equal to 30 kg/m(2) in conjunction with chronic hepatitis C virus infection is associated with non-responsiveness to treatment with interferon and ribavirin, but details regarding the mechanisms whereby obesity reduces the efficacy of therapy remain unclear. Methods: This study evaluated impact of obesity on outcome as well as interferon and ribavirin concentrations following standard-of-care fixed dosing with peginterferon-alpha 2a 180 mu g once weekly and ribavirin 800 mg daily among 303 HCV genotype 2/3-infected patients enrolled in the per-protocol analysis of a recently completed phase III trial (NORDynamIC). Results: Patients with BMI >= 30 kg/m(2) showed poorer outcome following 24 weeks of therapy (SVR 62% vs. 89% for BMI >= 30 vs. <30; P = 0.006) along with significantly higher steatosis grade (P = 0.002), HOMA-IR (P<0.0001), triglyceride levels (P = 0.0002), and baseline viral load (P = 0.028). Obesity was also significantly associated with lower plasma interferon concentrations on days 3, 7, and 29 (P = 0.02, P = 0.0017, and P<0.0001, respectively) and lower plasma ribavirin concentrations day 29 (P = 0.025), and lower concentration of interferon in turn was associated with a poorer first phase reduction in HCV RNA (P<0.0001). In multivariate analysis, ribavirin concentrations week 12, interferon concentrations day 29, and baseline HCV RNA levels were independent predictors of achieving SVR among patients treated for 24 weeks (n = 140). Conclusions: Reduced bioavailability of interferon and ribavirin along with higher baseline viral load are dominant risk factors for treatment failure in obese patients with chronic hepatitis C.	[Alsio, Asa; Rembeck, Karolina; Askarieh, Galia; Westin, Johan; Hellstrand, Kristoffer; Norkrans, Gunnar; Lagging, Martin] Univ Gothenburg, Inst Biomed, Dept Infect Dis Virol, Gothenburg, Sweden; [Christensen, Peer Brehm; Pedersen, Court] Univ So Denmark, Dept Infect Dis, Odense, Denmark; [Farkkila, Martti] Univ Helsinki, Dept Gastroenterol, Helsinki, Finland; [Langeland, Nina; Morch, Kristine] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Langeland, Nina; Morch, Kristine] Univ Bergen, Inst Med, Bergen, Norway; [Buhl, Mads Rauning] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark; [Haagmans, Bart L.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Nasic, Salmir] Skaraborg Hosp, Dept Res & Dev Stat, Skovde, Sweden	University of Gothenburg; University of Southern Denmark; University of Helsinki; University of Bergen; Haukeland University Hospital; University of Bergen; Aarhus University; Erasmus University Rotterdam; Erasmus MC	Alsio, A (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Dis Virol, Gothenburg, Sweden.	martin.lagging@medfak.gu.se	Färkkilä, Martti/AAG-6970-2021; Haagmans, Bart/E-9791-2015; Lagging, Martin/D-7734-2015	Färkkilä, Martti/0000-0002-0250-8559; Haagmans, Bart/0000-0001-6221-2015; Lagging, Martin/0000-0002-7995-3626; Christensen, Peer Brehm/0000-0003-1394-058X; Nasic, Salmir/0000-0003-0437-3958; Hellstrand, Kristoffer/0000-0002-6617-5976	Swedish Society of Medicine; Swedish Medical Research Council; Cancerfonden; Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; Sahlgrenska University Hospital; Roche	Swedish Society of Medicine; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Cancerfonden(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; Sahlgrenska University Hospital; Roche(Roche Holding)	This work was supported by the Swedish Society of Medicine, The Swedish Medical Research Council, Cancerfonden, The Torsten and Ragnar Soderberg Foundation, The Swedish Society of Microbiology, and ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital. Unrestricted grants from Roche affiliates in the Nordic region also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; Charlton MR, 2006, HEPATOLOGY, V43, P1177, DOI 10.1002/hep.21239; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Fried MW, 2008, HEPATOLOGY, V48, P1033, DOI 10.1002/hep.22448; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Harrison SA, 2006, HEPATOLOGY, V43, P1168, DOI 10.1002/hep.21125; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hickman IJ, 2002, GUT, V51, P89, DOI 10.1136/gut.51.1.89; Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Lagging LM, 2002, LIVER, V22, P136, DOI 10.1034/j.1600-0676.2002.01623.x; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lam NP, 1997, DIGEST DIS SCI, V42, P178, DOI 10.1023/A:1018865928308; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Ortiz V, 2002, AM J GASTROENTEROL, V97, P2408, DOI 10.1111/j.1572-0241.2002.05995.x; Pattullo V, 2010, J VIRAL HEPATITIS, V17, P834, DOI 10.1111/j.1365-2893.2010.01248.x; Pedersen C, 2011, J VIRAL HEPATITIS, V18, P245, DOI 10.1111/j.1365-2893.2010.01303.x; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Reddy KR, 2010, GASTROENTEROLOGY, V139, P1972, DOI 10.1053/j.gastro.2010.08.051; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x	29	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37521	10.1371/journal.pone.0037521	http://dx.doi.org/10.1371/journal.pone.0037521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655053	Green Published, gold			2022-12-27	WOS:000305338900029
J	Kidd, C; Piantadosi, ST; Aslin, RN				Kidd, Celeste; Piantadosi, Steven T.; Aslin, Richard N.			The Goldilocks Effect: Human Infants Allocate Attention to Visual Sequences That Are Neither Too Simple Nor Too Complex	PLOS ONE			English	Article							PREFERENCES; INFORMATION; NOVELTY; FAMILIARITY; REDUNDANCY	Human infants, like immature members of any species, must be highly selective in sampling information from their environment to learn efficiently. Failure to be selective would waste precious computational resources on material that is already known (too simple) or unknowable (too complex). In two experiments with 7- and 8-month-olds, we measure infants' visual attention to sequences of events varying in complexity, as determined by an ideal learner model. Infants' probability of looking away was greatest on stimulus items whose complexity (negative log probability) according to the model was either very low or very high. These results suggest a principle of infant attention that may have broad applicability: infants implicitly seek to maintain intermediate rates of information absorption and avoid wasting cognitive resources on overly simple or overly complex events.	[Kidd, Celeste; Aslin, Richard N.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Rochester	Kidd, C (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	ckidd@bcs.rochester.edu			National Science Foundation; National Institutes of Health [HD-37082]; J.S. McDonnell Foundation [220020096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037082] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	CK and STP were supported by Graduate Research Fellowships from the National Science Foundation (www.nsf.gov). The research was supported by grants from the National Institutes of Health (HD-37082, www.nih.gov) and the J.S. McDonnell Foundation (220020096, www.jsmf.org) to RNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Berlyne DE, 1960, CONFLICT AROUSAL CUR, V331; Civan A, 2005, INFANCY, V7, P111, DOI 10.1207/s15327078in0702_1; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; DEMBER WN, 1957, PSYCHOL REV, V64, P91, DOI 10.1037/h0046861; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Fiser J, 2002, P NATL ACAD SCI USA, V99, P15822, DOI 10.1073/pnas.232472899; Genzel D, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P199; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kaldy Z, 2006, DEVELOPMENTAL SCI, V9, P482, DOI 10.1111/j.1467-7687.2006.00515.x; KINNEY DK, 1976, CHILD DEV, V47, P155; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Levy R., 2007, ADV NEURAL INFORM PR, V19, P849; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Piaget J., 1970, STRUCTURALISM; Piantadosi ST, R RICH METH IN PRESS; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Roder BJ, 2000, INFANCY, V1, P491, DOI 10.1207/S15327078IN0104_9; ROSE SA, 1982, DEV PSYCHOL, V18, P704, DOI 10.1037/0012-1649.18.5.704; ROVEECOLLIER CK, 1980, SCIENCE, V208, P1159, DOI 10.1126/science.7375924; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saylor MM, 2007, J COGN DEV, V8, P113, DOI 10.1207/s15327647jcd0801_6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIQUELAND ER, 1969, SCIENCE, V165, P1144, DOI 10.1126/science.165.3898.1144; Sokolov E.N., 1963, PERCEPTION CONDITION; Stevenson H. W., 1972, CHILDRENS LEARNING; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tribus M., 1961, THERMOSTATICS THERMO; Turk-Browne NB, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.016.2008; Wagner S.H., 1986, ADV INFANCY RES, V4, P240; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	40	279	280	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36399	10.1371/journal.pone.0036399	http://dx.doi.org/10.1371/journal.pone.0036399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649492	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800009
J	Lima, JC; Rodrigues-da-Silva, RN; Banic, DM; Jiang, JL; Singh, B; Fabricio-Silva, GM; Porto, LCS; Meyer, EVS; Moreno, A; Rodrigues, MM; Barnwell, JW; Galinski, MR; de Oliveira-Ferreira, J				Lima-Junior, Josue C.; Rodrigues-da-Silva, Rodrigo N.; Banic, Dalma M.; Jiang, Jianlin; Singh, Balwan; Fabricio-Silva, Gustavo M.; Porto, Luis C. S.; Meyer, Esmeralda V. S.; Moreno, Alberto; Rodrigues, Mauricio M.; Barnwell, John W.; Galinski, Mary R.; de Oliveira-Ferreira, Joseli			Influence of HLA-DRB1 and HLA-DQB1 Alleles on IgG Antibody Response to the P. vivax MSP-1, MSP-3 alpha and MSP-9 in Individuals from Brazilian Endemic Area	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; HLA CLASS-II; C-TERMINAL REGIONS; PLASMODIUM-VIVAX; IMMUNE-RESPONSES; CIRCUMSPOROZOITE PROTEIN; IMMUNOGENIC PROPERTIES; MALARIA PARASITES; FALCIPARUM; VACCINE	Background: The antibody response generated during malaria infections is of particular interest, since the production of specific IgG antibodies is required for acquisition of clinical immunity. However, variations in antibody responses could result from genetic polymorphism of the HLA class II genes. Given the increasing focus on the development of subunit vaccines, studies of the influence of class II alleles on the immune response in ethnically diverse populations is important, prior to the implementation of vaccine trials. Methods and Findings: In this study, we evaluated the influence of HLA-DRB1* and -DQB1* allelic groups on the naturally acquired humoral response from Brazilian Amazon individuals (n = 276) against P. vivax Merozoite Surface Protein-1 (MSP-1), MSP-3 alpha and MSP-9 recombinant proteins. Our results provide information concerning these three P. vivax antigens, relevant for their role as immunogenic surface proteins and vaccine candidates. Firstly, the studied population was heterogeneous presenting 13 HLA-DRB1* and 5 DQB1* allelic groups with a higher frequency of HLA-DRB1*04 and HLA-DQB1*03. The proteins studied were broadly immunogenic in a naturally exposed population with high frequency of IgG antibodies against PvMSP1-19 (86.7%), PvMSP-3 (77%) and PvMSP-9 (76%). Moreover, HLA-DRB1*04 and HLA-DQB1*03 alleles were associated with a higher frequency of IgG immune responses against five out of nine antigens tested, while HLA-DRB1* 01 was associated with a high frequency of non-responders to repetitive regions of PvMSP-9, and the DRB1*16 allelic group with the low frequency of responders to PvMSP3 full length recombinant protein. Conclusions: HLA-DRB1*04 alleles were associated with high frequency of antibody responses to five out of nine recombinant proteins tested in Rondonia State, Brazil. These features could increase the success rate of future clinical trials based on these vaccine candidates.	[Lima-Junior, Josue C.; de Oliveira-Ferreira, Joseli] Inst Oswaldo Cruz, Lab Immunoparasitol, BR-20001 Rio De Janeiro, Brazil; [Lima-Junior, Josue C.; Rodrigues-da-Silva, Rodrigo N.] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil; [Banic, Dalma M.; Meyer, Esmeralda V. S.] Inst Oswaldo Cruz, Lab Simulideos & Oncocercose, BR-20001 Rio De Janeiro, Brazil; [Jiang, Jianlin; Singh, Balwan; Meyer, Esmeralda V. S.; Moreno, Alberto; Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Fabricio-Silva, Gustavo M.; Porto, Luis C. S.] Univ Estado Rio De Janeiro, Histocompatibil & Cryopreservat Lab, Rio De Janeiro, Brazil; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Ctr Terapia Celular & Mol CTCMol, Escola Paulista Med, Sao Paulo, Brazil; [Moreno, Alberto; Galinski, Mary R.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Barnwell, John W.] CDC Natl Ctr Infect Dis, Div Parasit Dis, Atlanta, GA USA	Fundacao Oswaldo Cruz; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Emory University; Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Emory University; Centers for Disease Control & Prevention - USA	Lima, JC (corresponding author), Inst Oswaldo Cruz, Lab Immunoparasitol, BR-20001 Rio De Janeiro, Brazil.	lila@ioc.fiocruz.br	da Costa Lima-Junior, Josue/AAI-4746-2021; Lima-Junior, Josué C/B-1361-2014; Oliveira-Ferreira, Joseli/E-7942-2014; Rodrigues, Mauricio M./B-8512-2012; Porto, Luis Cristovao/U-6499-2019; Porto, Luis Cristovao M S/I-2984-2013	da Costa Lima-Junior, Josue/0000-0002-5848-404X; Lima-Junior, Josué C/0000-0002-5848-404X; Oliveira-Ferreira, Joseli/0000-0002-6063-465X; Porto, Luis Cristovao/0000-0003-1499-1821; Porto, Luis Cristovao M S/0000-0003-1499-1821; Banic, Dalma Maria/0000-0003-1619-3794; Rodrigues-da-Silva, Rodrigo Nunes/0000-0002-9772-849X; Moreno, Alberto/0000-0002-3031-7194	Brazilian National Research Council - CNPq/ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) Fiocruz; FAPESP (Foundation for Research Support of the State of Sao Paulo) [2009/15132-4]; INCTV-CNPq, (The National Institute for Vaccine Technology) National Institute of Health; Yerkes National Primate Research Center Base [RR00165]; National Center for Research Resources of the National Institutes of Health; NIH [RO1 AI0555994]; CAPES/Fiocruz; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Brazilian National Research Council - CNPq/ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) Fiocruz; FAPESP (Foundation for Research Support of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCTV-CNPq, (The National Institute for Vaccine Technology) National Institute of Health; Yerkes National Primate Research Center Base; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES/Fiocruz(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Sade) Fiocruz, FAPESP (Foundation for Research Support of the State of Sao Paulo) 2009/15132-4 and INCTV-CNPq, (The National Institute for Vaccine Technology) National Institute of Health, the Yerkes National Primate Research Center Base Grant # RR00165 awarded by the National Center for Research Resources of the National Institutes of Health, and NIH Grants # RO1 AI0555994. Josue da Costa Lima Junior was the recipient of a CAPES/Fiocruz Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banic DM, 2002, AM J TROP MED HYG, V66, P509, DOI 10.4269/ajtmh.2002.66.509; Barnwell JW, 1999, EXP PARASITOL, V91, P238, DOI 10.1006/expr.1998.4372; Bastos MS, 2007, CLIN VACCINE IMMUNOL, V14, P1249, DOI 10.1128/CVI.00243-07; BECK HP, 1995, AM J TROP MED HYG, V53, P284; Buhler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014643; Chauhan VS, 2010, HUM VACCIN, V6; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; Davenport MP, 1996, MOL MED TODAY, V2, P38, DOI 10.1016/1357-4310(96)88757-0; de Oliveira CI, 1999, VACCINE, V17, P2959, DOI 10.1016/S0264-410X(99)00176-0; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Dias S, 2011, VACCINE, V29, P7491, DOI 10.1016/j.vaccine.2011.07.029; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Higgs ES, 2005, AM J TROP MED HYG, V73, P1; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Johnson A, 2000, INFECT IMMUN, V68, P2231, DOI 10.1128/IAI.68.4.2231-2236.2000; Johnson AH, 2004, INFECT IMMUN, V72, P2762, DOI 10.1128/IAI.72.5.2762-2771.2004; Lima JC, 2010, VACCINE, V28, P3185, DOI 10.1016/j.vaccine.2010.02.046; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lima-Junior JC, 2011, VACCINE; MCCUTCHAN TF, 1985, SCIENCE, V230, P1381, DOI 10.1126/science.2416057; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Modiano D, 1999, AM J TROP MED HYG, V61, P663, DOI 10.4269/ajtmh.1999.61.663; Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; OEUVRAY C, 1994, BLOOD, V84, P1594; Oliveira-Ferreira J, 2004, ACTA TROP, V92, P63, DOI 10.1016/j.actatropica.2004.02.011; Oliveira-Ferreira J, 2004, VACCINE, V22, P2023, DOI 10.1016/j.vaccine.2003.07.021; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; PATARROYO ME, 1991, PARASITE IMMUNOL, V13, P509, DOI 10.1111/j.1365-3024.1991.tb00547.x; Pratt-Riccio LR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-144; Pratt-Riccio LR, 2005, AM J TROP MED HYG, V73, P1096, DOI 10.4269/ajtmh.2005.73.1096; Ribeiro RS, 2011, MEM I OSWALDO CRUZ, V106, P27, DOI 10.1590/S0074-02762011000900004; RILEY E, 1992, IMMUNOL TODAY, V13, P333, DOI 10.1016/0167-5699(92)90165-4; RILEY EM, 1992, INT IMMUNOL, V4, P1055, DOI 10.1093/intimm/4.9.1055; SINIGAGLIA F, 1990, IMMUNOL LETT, V25, P265, DOI 10.1016/0165-2478(90)90125-A; Soares IS, 2002, PARASITOLOGY, V124, P237, DOI 10.1017/S003118200100110X; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; STEPHENS HAF, 1995, EUR J IMMUNOL, V25, P3142, DOI 10.1002/eji.1830251123; Stern LJ, 2009, CURR PHARM DESIGN, V15, P3249, DOI 10.2174/138161209789105171; Suh KN, 2004, CAN MED ASSOC J, V170, P1693, DOI 10.1503/cmaj.1030418; SVS SdVeS-, 2011, SIST INF GER DIV SIG; van Lith M, 2010, J BIOL CHEM, V285, P40800, DOI 10.1074/jbc.M110.148155; Vargas-Serrato E, 2002, MOL BIOCHEM PARASIT, V120, P41, DOI 10.1016/S0166-6851(01)00433-9; Volpini WMG, 2001, HUM IMMUNOL, V62, P1226, DOI 10.1016/S0198-8859(01)00323-8; *WHO, 2005, WORLD MAL REP; Yang CF, 1999, INFECT IMMUN, V67, P342, DOI 10.1128/IAI.67.1.342-349.1999; Zhang QF, 2009, J CLIN IMMUNOL, V29, P454, DOI 10.1007/s10875-009-9281-0	59	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36419	10.1371/journal.pone.0036419	http://dx.doi.org/10.1371/journal.pone.0036419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649493	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800010
J	Lou, YF; Wang, MY; Mao, WL				Lou, YuFeng; Wang, ManYi; Mao, WeiLin			Clinical Usefulness of Measuring Red Blood Cell Distribution Width in Patients with Hepatitis B	PLOS ONE			English	Article							STAGE LIVER-DISEASE; HEART-FAILURE; ACUTE EXACERBATION; PROGNOSTIC MARKER; SCORING SYSTEM; ENDEMIC AREA; C VIRUS; ANEMIA; VOLUME; RISK	Background: Red blood cell distribution width (RDW), an automated measure of red blood cell size heterogeneity (e. g., anisocytosis) that is largely overlooked, is a newly recognized risk marker in patients with cardiovascular diseases, but its role in persistent viral infection has not been well-defined. The present study was designed to investigate the association between RDW values and different disease states in hepatitis B virus (HBV)-infected patients. In addition, we analyzed whether RDW is associated with mortality in the HBV-infected patients. Methodology/Principal Findings: One hundred and twenty-three patients, including 16 with acute hepatitis B (AHB), 61 with chronic hepatitis B (CHB), and 46 with chronic severe hepatitis B (CSHB), and 48 healthy controls were enrolled. In all subjects, a blood sample was collected at admission to examine liver function, renal function, international normalized ratio and routine hematological testing. All patients were followed up for at least 4 months. A total of 10 clinical chemistry, hematology, and biochemical variables were analyzed for possible association with outcomes by using Cox proportional hazards and multiple regression models. RDW values at admission in patients with CSHB (18.30 +/- 3.11%, P<0.001), CHB (16.37 +/- 2.43%, P<0.001) and AHB (14.38 +/- 1.72%, P<0.05) were significantly higher than those in healthy controls (13.03 +/- 1.33%). Increased RDW values were clinically associated with severe liver disease and increased 3-month mortality rate. Multivariate analysis demonstrated that RDW values and the model for end-stage liver disease score were independent predictors for mortality (both P<0.001). Conclusion: RDW values are significantly increased in patients with hepatitis B and associated with its severity. Moreover, RDW values are an independent predicting factor for the 3-month mortality rate in patients with hepatitis B.	[Lou, YuFeng; Wang, ManYi; Mao, WeiLin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Mao, WL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	mao_wei_lin@163.com			Health Department of Zhejiang Province [2011KYA058]	Health Department of Zhejiang Province	The work was supported by grants from Health Department of Zhejiang Province (2011KYA058). URL http://www.zjwst.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Asahina Y, 1996, J HEPATOL, V25, P787, DOI 10.1016/S0168-8278(96)80280-7; Aslan D, 2002, AM J HEMATOL, V69, P31, DOI 10.1002/ajh.10011; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; BESSMAN JD, 1983, CYTOMETRY, V3, P292, DOI 10.1002/cyto.990030411; BINGHAM J, 1960, BLOOD, V15, P244, DOI 10.1182/blood.V15.2.244.244; Bramhall SR, 2001, WORLD J GASTROENTERO, V7, P602; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chu CM, 1999, J MED VIROL, V58, P154, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;154::AID-JMV9&gt;3.0.CO;2-E; Coursaget P, 1998, AM J TROP MED HYG, V58, P330, DOI 10.4269/ajtmh.1998.58.330; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Demir A, 2002, PEDIATR INT, V44, P612, DOI 10.1046/j.1442-200X.2002.01636.x; DOUGLAS SW, 1975, BLOOD, V45, P55; ENGLAND JM, 1974, LANCET, V1, P701; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; HORNEY JT, 1977, GASTROENTEROLOGY, V73, P639; Huo TI, 2006, LIVER TRANSPLANT, V12, P65, DOI 10.1002/lt.20560; Huo TI, 2005, J HEPATOL, V42, P826, DOI 10.1016/j.jhep.2005.01.019; Imperial JC, 1999, J GASTROEN HEPATOL, V14, pS1, DOI 10.1046/j.1440-1746.1999.01903.x; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; KARNAD A, 1985, ARCH INTERN MED, V145, P1270, DOI 10.1001/archinte.145.7.1270; KATZ R, 1964, GASTROENTEROLOGY, V46, P399; Lai YC, 2002, WORLD J GASTROENTERO, V8, P567, DOI 10.3748/wjg.v8.i3.567; LIEBERMAN FL, 1967, J CLIN INVEST, V46, P1297, DOI 10.1172/JCI105622; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Mao WL, 2011, J CLIN GASTROENTEROL, V45, P551, DOI 10.1097/MCG.0b013e3181faefa3; Mao WL, 2010, ASAIO J, V56, P475, DOI 10.1097/MAT.0b013e3181e6bf13; Maruyama S, 2001, J LAB CLIN MED, V138, P332, DOI 10.1067/mlc.2001.119106; NUNNALLY RM, 1961, AM J MED, V30, P972, DOI 10.1016/0002-9343(61)90185-1; Okumura A, 2001, J GASTROENTEROL, V36, P103, DOI 10.1007/s005350170138; Pascual-Figal DA, 2009, EUR J HEART FAIL, V11, P840, DOI 10.1093/eurjhf/hfp109; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perkins SL., 2003, WINTROBES CLIN HEMAT, P5; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Shiota G, 2000, LIVER, V20, P415, DOI 10.1034/j.1600-0676.2000.020005415.x; Summerfield JA, 2000, J ROY COLL PHYS LOND, V34, P381; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; THOMPSON WG, 1988, ARCH INTERN MED, V148, P2128, DOI 10.1001/archinte.148.10.2128; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Xess A, 2001, Indian J Pathol Microbiol, V44, P253; Xue YL, 2001, WORLD J GASTROENTERO, V7, P826, DOI 10.3748/wjg.v7.i6.826	49	90	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37644	10.1371/journal.pone.0037644	http://dx.doi.org/10.1371/journal.pone.0037644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649548	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800067
J	Xu, WH; Liu, ZB; Yang, C; Qin, W; Shao, ZM				Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Qin, Wenxin; Shao, Zhi-Ming			Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; HEPATOCELLULAR CARCINOMAS; TUMORS; PROTEIN; PATTERNS; CELLS; GENE; ACCUMULATION; METASTASIS; INHIBITOR	Background and Aim: We investigated the prognostic importance of dickkopf-1(DKK1) and beta-catenin expression in triple negative breast cancers. Methods: The expression of DKK1 and beta-catenin was evaluated in breast cell lines using RT-PCR and western blot. Immunohistochemistry was used to characterize the expression pattern of DKK1 and beta-catenin in 85 triple negative breast cancers and prognostic significance was assessed by Kaplan-Meier analysis and Cox proportional hazards regression modeling. Results: The expression of DKK1 was confirmed in hormone-resistant breast cell lines MDA-MB-231, MDA-MB-231-HM and MDA-MB-435. Expression of DKK1 in triple negative breast cancers correlated with cytoplasmic/ nuclear beta-catenin (p=0.000). Elevated expression of DKK1 and cytoplasmic/nuclear beta-catenin in triple negative cancers indicate poor outcome of patients. DKK1 was also a prognostic factor for patients with earlier stage or no lymph node metastasis. Conclusion: DKK1 together with beta-catenin might be important prognostic factors in triple negative breast carcinoma. DKK1 might be a valuable biomarker in predicting the prognosis of patients with earlier stage or no lymph node metastasis. It is possible that through further understanding of the role of Wnt/beta-catenin pathway activation, beta-catenin would be a potential therapeutic target for the triple negative breast cancer.	[Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Shao, Zhi-Ming] Fudan Univ, Canc Hosp, Breast Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China; [Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Qin, Wenxin] Shanghai Jiao Tong Univ, WHO Collaborating Ctr Res Canc, Shanghai Canc Inst, Natl Lab Oncogenes & Related Genes,Sch Med, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University	Xu, WH (corresponding author), Fudan Univ, Canc Hosp, Breast Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81072165, 81001169]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Ministry of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Ministry of Health	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, 81072165, 81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), and the Key Clinical Program of the Ministry of Health (2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Karayiannakis AJ, 2001, EUR J SURG ONCOL, V27, P31, DOI 10.1053/ejso.1999.1017; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020	26	52	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37624	10.1371/journal.pone.0037624	http://dx.doi.org/10.1371/journal.pone.0037624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649545	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800064
J	Pawelczyk, S; Scott, KA; Hamer, R; Blades, G; Deane, CM; Wadhams, GH				Pawelczyk, Sonja; Scott, Kathryn A.; Hamer, Rebecca; Blades, Gareth; Deane, Charlotte M.; Wadhams, George H.			Predicting Inter-Species Cross-Talk in Two-Component Signalling Systems	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES; PHOSPHORYLATION SITE; RESPONSE REGULATOR; PROTEIN; TRANSDUCTION; KINASE; SPECIFICITY; CHEMOTAXIS; OMPR; PHOSPHOTRANSFER	Phosphosignalling pathways are an attractive option for the synthetic biologist looking for a wide repertoire of modular components from which to build. We demonstrate that two-component systems can be used in synthetic biology. However, their potential is limited by the fact that host cells contain many of their own phosphosignalling pathways and these may interact with, and cross-talk to, the introduced synthetic components. In this paper we also demonstrate a simple bioinformatic tool that can help predict whether interspecies cross-talk between introduced and native two-component signalling pathways will occur and show both in vitro and in vivo that the predicted interactions do take place. The ability to predict potential cross-talk prior to designing and constructing novel pathways or choosing a host organism is essential for the promise that phosphosignalling components hold for synthetic biology to be realised.	[Pawelczyk, Sonja; Scott, Kathryn A.; Hamer, Rebecca; Blades, Gareth; Deane, Charlotte M.; Wadhams, George H.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Hamer, Rebecca; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; University of Oxford	Pawelczyk, S (corresponding author), Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England.	george.wadhams@bioch.ox.ac.uk		Scott, Kathryn/0000-0003-3395-9210; Deane, Charlotte/0000-0003-1388-2252	BBSRC (Biotechnology and Biological Sciences Research Council); EPSRC (Engineering and Physical Sciences Research Council) [BB/D020190/I]	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the BBSRC (Biotechnology and Biological Sciences Research Council) and EPSRC (Engineering and Physical Sciences Research Council) grant (BB/D020190/I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; DELGADO J, 1993, MOL MICROBIOL, V10, P1037, DOI 10.1111/j.1365-2958.1993.tb00974.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FISHER SL, 1995, J BIOL CHEM, V270, P23143, DOI 10.1074/jbc.270.39.23143; FORST SA, 1994, RES MICROBIOL, V145, P363, DOI 10.1016/0923-2508(94)90083-3; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; Ind AC, 2009, APPL ENVIRON MICROB, V75, P6613, DOI 10.1128/AEM.01587-09; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; JIN T, 1993, J MOL BIOL, V232, P484, DOI 10.1006/jmbi.1993.1404; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Martin AC, 2001, MOL MICROBIOL, V40, P1261, DOI 10.1046/j.1365-2958.2001.02468.x; Mattison K, 2002, J MOL BIOL, V315, P497, DOI 10.1006/jmbi.2001.5222; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Ninfa AJ, 2007, METHOD ENZYMOL, V422, P488, DOI 10.1016/S0076-6879(06)22025-1; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; Porter SL, 2002, J MOL BIOL, V324, P35, DOI 10.1016/S0022-2836(02)01031-8; Porter SL, 2011, J BACTERIOL; Porter SL, 2008, TRENDS MICROBIOL, V16, P251, DOI 10.1016/j.tim.2008.02.006; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Scott KA, 2010, MOL MICROBIOL, V76, P318, DOI 10.1111/j.1365-2958.2010.07095.x; Shah DSH, 2000, MOL MICROBIOL, V35, P101, DOI 10.1046/j.1365-2958.2000.01680.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Verhamme DT, 2002, MICROBIOL-SGM, V148, P69, DOI 10.1099/00221287-148-1-69; Wadhams GH, 2002, MOL MICROBIOL, V46, P1211, DOI 10.1046/j.1365-2958.2002.03252.x; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Yoshida T, 2002, MOL MICROBIOL, V46, P1273, DOI 10.1046/j.1365-2958.2002.03239.x; Yoshida T, 2007, METHOD ENZYMOL, V423, P166, DOI 10.1016/S0076-6879(07)23007-1	48	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37737	10.1371/journal.pone.0037737	http://dx.doi.org/10.1371/journal.pone.0037737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629451	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300074
J	Wei, W; Gai, ZC; Ai, H; Wu, WX; Yang, YB; Peng, JX; Hong, HZ; Li, Y; Liu, KY				Wei, Wei; Gai, Zhongchao; Ai, Hui; Wu, Wenxian; Yang, Yongbo; Peng, Jianxin; Hong, Huazhu; Li, Yi; Liu, Kaiyu			Baculovirus Infection Triggers a Shift from Amino Acid Starvation-Induced Autophagy to Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VIRUS; EXPRESSION; REPLICATION; SUBVERSION; SILKWORM; PREVENTS; PROTECTS; CLEAVAGE	Autophagy plays a central role in regulating important cellular functions such as cell survival during starvation and control of infectious pathogens. On the other hand, many pathogens have evolved mechanisms of inhibition of autophagy such as blockage of the formation of autophagosomes or the fusion of autophagosomes with lysosomes. Baculoviruses are important insect pathogens for pest control, and autophagy activity increases significantly during insect metamorphosis. However, it is not clear whether baculovirus infection has effects on the increased autophagy. In the present study, we investigated the effects of the Autographa californica nucleopolyhedrovirus (AcMNPV) infection on autophagy in SL-HP cell line from Spodoptera litura induced under amino acid deprivation. The results revealed that AcMNPV infection did not inhibit autophagy but triggered apoptosis under starvation pressure. In the early stage of infection under starvation, mitochondrial dysfunction was detected, suggesting the organelles might be involved in cell apoptosis. The semi-quantitative PCR assay revealed that the expression of both p35 and ie-1 genes of AcMNPV had no significant difference between the starved and unstarved SL-HP cells. The western blot analysis showed that no cleavage of endogenous Atg6 occurred during the process of apoptosis in SL-HP cells. These data demonstrated that some permissive insect cells may defend baculovirus infection via apoptosis under starvation and apoptosis is independent of the cleavage of Atg6 in SL-HP cells.	[Wei, Wei; Gai, Zhongchao; Ai, Hui; Wu, Wenxian; Yang, Yongbo; Peng, Jianxin; Hong, Huazhu; Li, Yi; Liu, Kaiyu] Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China	Central China Normal University	Wei, W (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China.	liyi@mail.ccnu.edu.cn; liukaiyu@mail.ccnu.edu.cn	Gai, Zhongchao/GON-5469-2022; Wu, Wenxian/AAG-9752-2019	Gai, Zhongchao/0000-0003-3367-3378; Wu, Wenxian/0000-0003-4059-5945	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [230594]; Hubei Province Natural Science Foundation [2007ABA160]; National Natural Science Foundation of China [30470073, 30970136]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project-sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (230594), Hubei Province Natural Science Foundation (2007ABA160) and the National Natural Science Foundation of China (30470073; 30970136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2008, AUTOPHAGY, V4, P101, DOI 10.4161/auto.5222; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Gannage M, 2010, AUTOPHAGY, V6, P166, DOI 10.4161/auto.6.1.10624; Ghadimi D, 2010, INT IMMUNOPHARMACOL, V10, P694, DOI 10.1016/j.intimp.2010.03.014; Goncu E, 2008, AUTOPHAGY, V4, P1069, DOI 10.4161/auto.6953; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Kang KD, 2011, J INVERTEBR PATHOL, V106, P205, DOI 10.1016/j.jip.2010.09.005; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Liu KY, 2012, INSECT SCI, V19, P30, DOI 10.1111/j.1744-7917.2011.01431.x; Liu KY, 2011, J VIROL, V85, P10069, DOI 10.1128/JVI.00625-11; Liu LJ, 2007, CELL BIOL INT, V31, P996, DOI 10.1016/j.cellbi.2007.03.011; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mpakou VE, 2008, AUTOPHAGY, V4, P97, DOI 10.4161/auto.5205; Munafo DB, 2001, J CELL SCI, V114, P3619; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Schultz KLW, 2009, J VIROL, V83, P262, DOI 10.1128/JVI.01827-08; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wu WX, 2011, J INSECT PHYSIOL, V57, P723, DOI 10.1016/j.jinsphys.2011.02.008; Wu YL, 2008, VIRUS RES, V135, P247, DOI 10.1016/j.virusres.2008.04.001; XIE W, 1988, ACTA SCI NATURALISM, V4, P113; Zeng XD, 2009, SCI CHINA SER C, V52, P761, DOI 10.1007/s11427-009-0105-5; Zhang X, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-50; Zhang XP, 2008, CYTOTECHNOLOGY, V57, P233, DOI 10.1007/s10616-008-9158-8	35	15	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37457	10.1371/journal.pone.0037457	http://dx.doi.org/10.1371/journal.pone.0037457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629397	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100029
J	Ortega, FJ; Moreno-Navarrete, JM; Mayas, D; Garcia-Santos, E; Gomez-Serrano, M; Rodriguez-Hermosa, JI; Ruiz, B; Ricart, W; Tinahones, FJ; Fruhbeck, G; Peral, B; Fernandez-Real, JM				Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Mayas, Dolores; Garcia-Santos, Eva; Gomez-Serrano, Maria; Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu; Ricart, Wifredo; Tinahones, Francisco J.; Fruehbeck, Gema; Peral, Belen; Fernandez-Real, Jose M.			Breast Cancer 1 (BrCa1) May Be behind Decreased Lipogenesis in Adipose Tissue from Obese Subjects	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; INSULIN-RESISTANCE; EXPRESSION PATTERNS; GENE-EXPRESSION; CELLS; DIFFERENTIATION; ADIPOGENESIS; MICE; PROLIFERATION; MORPHOGENESIS	Context: Expression and activity of the main lipogenic enzymes is paradoxically decreased in obesity, but the mechanisms behind these findings are poorly known. Breast Cancer 1 (BrCa1) interacts with acetyl-CoA carboxylase (ACC) reducing the rate of fatty acid biosynthesis. In this study, we aimed to evaluate BrCa1 in human adipose tissue according to obesity and insulin resistance, and in vitro cultured adipocytes. Research Design and Methods: BrCa1 gene expression, total and phosphorylated (P-) BrCa1, and ACC were analyzed in adipose tissue samples obtained from a total sample of 133 subjects. BrCa1 expression was also evaluated during in vitro differentiation of human adipocytes and 3T3-L1 cells. Results: BrCa1 gene expression was significantly up-regulated in both omental (OM; 1.36-fold, p = 0.002) and subcutaneous (SC; 1.49-fold, p = 0.001) adipose tissue from obese subjects. In parallel with increased BrCa1 mRNA, P-ACC was also up-regulated in SC (p = 0.007) as well as in OM (p = 0.010) fat from obese subjects. Consistent with its role limiting fatty acid biosynthesis, both BrCa1 mRNA (3.5-fold, p<0.0001) and protein (1.2-fold, p = 0.001) were increased in pre-adipocytes, and decreased during in vitro adipogenesis, while P-ACC decreased during differentiation of human adipocytes (p = 0.005) allowing lipid biosynthesis. Interestingly, BrCa1 gene expression in mature adipocytes was restored by inflammatory stimuli (macrophage conditioned medium), whereas lipogenic genes significantly decreased. Conclusions: The specular findings of BrCa1 and lipogenic enzymes in adipose tissue and adipocytes reported here suggest that BrCa1 might help to control fatty acid biosynthesis in adipocytes and adipose tissue from obese subjects.	[Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Ricart, Wifredo; Fernandez-Real, Jose M.] CIBER Fisiopatol Obesidad & Nutr, Inst Invest Biomed Girona, Serv Diabet Endocrinol & Nutr, Girona, Spain; [Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Salud Carlos III, Girona, Spain; [Mayas, Dolores; Tinahones, Francisco J.] Hosp Clin Univ Virgen de Victoria Malaga, CIBER Fisiopatol Obesidad & Nutr, Serv Endocrinol & Nutr, Malaga, Spain; [Mayas, Dolores; Tinahones, Francisco J.] Inst Salud Carlos III, Malaga, Spain; [Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] CSIC, Inst Invest Biomed Alberto Sols, Dept Endocrinol Physiopathol & Nervous Syst, Madrid, Spain; [Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu] Inst Invest Biomed Girona, Dept Surg, Girona, Spain; [Fruehbeck, Gema] Univ Navarra Clin, CIBER Fisiopatol Obesidad & Nutr, Inst Salud Carlos III, Dept Endocrinol, Navarra, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra	Ortega, FJ (corresponding author), CIBER Fisiopatol Obesidad & Nutr, Inst Invest Biomed Girona, Serv Diabet Endocrinol & Nutr, Girona, Spain.	jmfernandezreal.girona.ics@gencat.cat	Fernández-Real, Jose Manuel/AGH-3599-2022; Peral, Belén/F-4562-2015; Moreno-Navarrete, José María/H-9772-2015; Moreno-Navarrete, José María/ABG-5548-2021; Tinahones, Francisco José/AAB-2882-2020; Ortega, Francisco José J/F-3883-2016; Gómez-Serrano, María/AAZ-3953-2021	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Peral, Belén/0000-0003-4984-4020; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Gómez-Serrano, María/0000-0002-9669-091X; Ricart, Wifredo/0000-0002-3452-9098; Tinahones, Francisco J/0000-0001-6871-4403	Ministerio de Educacion y Ciencia [SAF2008-02073, SAF2009-10461]; Fundacion Mutua Madrilena; Instituto de Salud Carlos III [ISCIIIRETIC RD06, CIBERObN]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by research grants from the Ministerio de Educacion y Ciencia (SAF2008-02073 and SAF2009-10461), the Fundacion Mutua Madrilena, and the Instituto de Salud Carlos III (ISCIIIRETIC RD06, CIBERObN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bernard-Gallon DJ, 2001, INT J ONCOL, V18, P271; Blackshear PE, 1998, ONCOGENE, V16, P61, DOI 10.1038/sj.onc.1201506; BROOK CGD, 1972, BMJ-BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5804.25; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; Fernandez-Real JM, 1998, DIABETES, V47, P1757, DOI 10.2337/diabetes.47.11.1757; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; Mayas MD, 2009, AM J HYPERTENS, V22, P1258, DOI 10.1038/ajh.2009.178; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; MIETTINEN TA, 1981, INT J OBESITY, V5, P613; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Mobbs CV, 2002, NAT MED, V8, P335, DOI 10.1038/nm0402-335; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Moreno-Navarrete JM, 2009, INT J OBESITY, V33, P991, DOI 10.1038/ijo.2009.143; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ortega FJ, 2009, INT J OBES LOND; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Ray H, 2009, BIOCHEM BIOPH RES CO, V378, P615, DOI 10.1016/j.bbrc.2008.11.090; Ray H, 2006, J MOL BIOL, V359, P973, DOI 10.1016/j.jmb.2006.04.010; RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Shen Y, 2008, BIOCHEMISTRY-US, V47, P5767, DOI 10.1021/bi800314m; Smith J, 2006, CLIN SCI, V110, P1; Swierczynski J, 2003, MOL CELL BIOCHEM, V254, P55, DOI 10.1023/A:1027332523114; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e33233	10.1371/journal.pone.0033233	http://dx.doi.org/10.1371/journal.pone.0033233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666314	Green Published, gold			2022-12-27	WOS:000305353400003
J	Soland, MA; Bego, MG; Colletti, E; Porada, CD; Zanjani, ED; Jeor, SS; Almeida-Porada, G				Soland, Melisa A.; Bego, Mariana G.; Colletti, Evan; Porada, Christopher D.; Zanjani, Esmail D.; Jeor, Stephen St.; Almeida-Porada, Graca			Modulation of Human Mesenchymal Stem Cell Immunogenicity through Forced Expression of Human Cytomegalovirus US Proteins	PLOS ONE			English	Article							MARROW STROMAL CELLS; SUPPRESS T-LYMPHOCYTE; COMPLEX CLASS-I; DOWN-REGULATION; IMMUNE-RESPONSE; HLA EXPRESSION; IFN-GAMMA; NK CELLS; TRANSPLANTATION; PROLIFERATION	Background: Mesenchymal stem cells (MSC) are promising candidates for cell therapy, as they migrate to areas of injury, differentiate into a broad range of specialized cells, and have immunomodulatory properties. However, MSC are not invisible to the recipient's immune system, and upon in vivo administration, allogeneic MSC are able to trigger immune responses, resulting in rejection of the transplanted cells, precluding their full therapeutic potential. Human cytomegalovirus (HCMV) has developed several strategies to evade cytotoxic T lymphocyte (CTL) and Natural Killer (NK) cell recognition. Our goal is to exploit HCMV immunological evasion strategies to reduce MSC immunogenicity. Methodology/Principal Findings: We genetically engineered human MSC to express HCMV proteins known to downregulate HLA-I expression, and investigated whether modified MSC were protected from CTL and NK attack. Flow cytometric analysis showed that amongst the US proteins tested, US6 and US11 efficiently reduced MSC HLA-I expression, and mixed lymphocyte reaction demonstrated a corresponding decrease in human and sheep mononuclear cell proliferation. NK killing assays showed that the decrease in HLA-I expression did not result in increased NK cytotoxicity, and that at certain NK: MSC ratios, US11 conferred protection from NK cytotoxic effects. Transplantation of MSC-US6 or MSC-US11 into pre-immune fetal sheep resulted in increased liver engraftment when compared to control MSC, as demonstrated by qPCR and immunofluorescence analyses. Conclusions and Significance: These data demonstrate that engineering MSC to express US6 and US11 can be used as a means of decreasing recognition of MSC by the immune system, allowing higher levels of engraftment in an allogeneic transplantation setting. Since one of the major factors responsible for the failure of allogeneic-donor MSC to engraft is the mismatch of HLA-I molecules between the donor and the recipient, MSC-US6 and MSC-US11 could constitute an off-the-shelf product to overcome donor-recipient HLA-I mismatch.	[Soland, Melisa A.; Colletti, Evan; Porada, Christopher D.; Zanjani, Esmail D.; Almeida-Porada, Graca] Univ Nevada, Dept Anim Biotechnol, Reno, NV 89557 USA; [Bego, Mariana G.] IRCM, Lab Human Retrovirol, Montreal, PQ, Canada; [Jeor, Stephen St.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Nevada System of Higher Education (NSHE); University of Nevada Reno	Soland, MA (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.	galmeida@wakehealth.edu		soland, Melisa/0000-0001-8217-9734; Almeida-Porada, Maria da Graca/0000-0002-6715-865X	National Institutes of Health (Bethesda, MD, USA) [HL73737, HL97623]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097623, R01HL073737] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (Bethesda, MD, USA) grants HL73737 and HL97623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lin AF, 2007, CELL MOL IMMUNOL, V4, P91; Bacigalupo A, 2007, BRIT J HAEMATOL, V137, P87, DOI 10.1111/j.1365-2141.2007.06533.x; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Barel MT, 2003, J IMMUNOL, V171, P6757, DOI 10.4049/jimmunol.171.12.6757; BILGRAMI S, 1994, BRIT J HAEMATOL, V87, P357, DOI 10.1111/j.1365-2141.1994.tb04922.x; Bocelli-Tyndall C, 2010, ARTHRITIS RHEUM-US, V62, P3815, DOI 10.1002/art.27736; BRUTKIEWICZ RR, 1995, J VIROL, V69, P3967, DOI 10.1128/JVI.69.7.3967-3971.1995; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Colletti EJ, 2009, STEM CELL RES, V2, P125, DOI 10.1016/j.scr.2008.08.002; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; de Jong MD, 1998, ANTIVIR RES, V39, P141, DOI 10.1016/S0166-3542(98)00044-8; de la Garza-Rodea AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014493; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fletcher JM, 1998, J IMMUNOL, V161, P2365; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Gotherstrom C, 2010, CYTOTHERAPY, V0, P1; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Isakova IA, 2010, EXP HEMATOL, V38, P957, DOI 10.1016/j.exphem.2010.06.011; Jones DRE, 1999, MOL MED TODAY, V5, P288, DOI 10.1016/S1357-4310(99)01473-2; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kim JY, 2005, INT J BIOCHEM CELL B, V37, P69, DOI 10.1016/j.biocel.2004.04.024; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee EM, 2005, BIOCHEM BIOPH RES CO, V326, P825, DOI 10.1016/j.bbrc.2004.11.106; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Li A, 2006, GENE THER, V13, P1178, DOI 10.1038/sj.gt.3302741; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; Morandi F, 2008, STEM CELLS, V26, P1275, DOI 10.1634/stemcells.2007-0878; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Obara H, 2005, AM J TRANSPLANT, V5, P2094, DOI 10.1111/j.1600-6143.2005.00995.x; Petersdorf EW, 1997, BLOOD, V89, P1818, DOI 10.1182/blood.V89.5.1818.1818_1818_1823; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rehm A, 2002, J VIROL, V76, P5043, DOI 10.1128/JVI.76.10.5043-5050.2002; ROLSTAD B, 1984, EUR J IMMUNOL, V14, P793, DOI 10.1002/eji.1830140906; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Rouas-Freiss N, 2003, AM J TRANSPLANT, V3, P11, DOI 10.1034/j.1600-6143.2003.30103.x; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhang H, 2011, J IMMUNOTHER, V34, P187, DOI 10.1097/CJI.0b013e31820d2a21	63	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36163	10.1371/journal.pone.0036163	http://dx.doi.org/10.1371/journal.pone.0036163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666319	Green Submitted, Green Published, gold			2022-12-27	WOS:000305353400006
J	Aljubran, SA; Cox, R; Parthasarathy, PT; Ramanathan, GK; Rajanbabu, V; Bao, H; Mohapatra, SM; Lockey, R; Kolliputi, N				Aljubran, Salman A.; Cox, Ruan, Jr.; Parthasarathy, Prasanna Tamarapu; Ramanathan, Gurukumar Kollongod; Rajanbabu, Venugopal; Huynh Bao; Mohapatra, Shyam M.; Lockey, Richard; Kolliputi, Narasaiah			Enhancer of Zeste Homolog 2 Induces Pulmonary Artery Smooth Muscle Cell Proliferation	PLOS ONE			English	Article							OPERATION EVEREST-II; GROUP PROTEIN EZH2; POLYCOMB PROTEIN; HYPERTENSION; CANCER; CALPONIN; OVEREXPRESSION; APOPTOSIS; ALTITUDE; HYPOXIA	Introduction: Pulmonary Arterial Hypertension (PAH) is a progressively devastating disease characterized by excessive proliferation of the Pulmonary Arterial Smooth Muscle Cells (PASMCs). Studies suggest that PAH and cancers share an apoptosis-resistant state featuring excessive cell proliferation. The proliferation of cancer cells is mediated by increased expression of Enhancer of Zeste Homolog 2 (EZH2), a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes. However, the role of EZH2 in PAH has not been studied. In this study, it is hypothesized that EZH2 could play a role in the proliferation of PASMCs. Methods: In the present study, the expression patterns of EZH2 were investigated in normal and hypertensive mouse PASMCs. The effects of EZH2 overexpression on the proliferation of human PASMCs were tested. PASMCs were transfected with EZH2 or GFP using nucleofector system. After transfection, the cells were incubated for 48 hours at 37 degrees C. Proliferation and cell cycle analysis were performed using flow cytometry. Apoptosis of PASMCs was determined using annexin V staining and cell migration was tested by wound healing assay. Results: EZH2 protein expression in mouse PASMCs were correlated with an increase in right ventricular systolic pressure and Right Ventricular Hypertrophy (RVH). The overexpression of EZH2 in human PASMCs enhances proliferation, migration, and decrease in the rate of apoptosis when compared to GFP-transfected cells. In the G2/M phase of the EZH2 transfected cells, there was a 3.5 fold increase in proliferation, while there was a significant decrease in the rate of apoptosis of PASMCs, when compared to control. Conclusion: These findings suggest that EZH2 plays a role in the migration and proliferation of PASMCs, which is a major hallmark in PAH. It also suggests that EZH2 could play a role in the development of PAH and can serve as a potential target for new therapies for PAH.	[Aljubran, Salman A.; Cox, Ruan, Jr.; Parthasarathy, Prasanna Tamarapu; Ramanathan, Gurukumar Kollongod; Rajanbabu, Venugopal; Huynh Bao; Lockey, Richard; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Div Allergy & Immunol, Tampa, FL 33620 USA; [Mohapatra, Shyam M.] Univ S Florida, Morsani Coll Med, Nanomed Res Ctr, Tampa, FL USA; [Mohapatra, Shyam M.] Univ S Florida, Morsani Coll Med, Div Translat Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Aljubran, SA (corresponding author), Univ S Florida, Morsani Coll Med, Div Allergy & Immunol, Tampa, FL 33620 USA.	nkollipu@health.usf.edu	Kolliputi, Narasaiah/I-6050-2012; Rajanbabu, Venugopal/AAE-5576-2020	Kolliputi, Narasaiah/0000-0002-2654-1900; Rajanbabu, Venugopal/0000-0001-8761-3333	American Heart Association National Scientist Development Grant [09SDG2260957]; National Institutes of Health [R01 HL105932]; Joy McCann Culverhouse Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joy McCann Culverhouse Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the American Heart Association National Scientist Development Grant 09SDG2260957 and National Institutes of Health R01 HL105932 to NK and the Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Archer SL, 2006, CURR OPIN CARDIOL, V21, P385; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; ARIASSTELLA J, 1963, CIRCULATION, V28, P915, DOI 10.1161/01.CIR.28.5.915; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Dromparis P, 2010, J MOL MED, V88, P1003, DOI 10.1007/s00109-010-0670-x; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Durak H, 2010, BRATISL MED J, V111, P432; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Gladwin MT, 2010, AM J RESP CRIT CARE, V181, P1020, DOI 10.1164/rccm.201002-0235UP; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P5476, DOI 10.1002/cncr.26179; GROVES BM, 1987, J APPL PHYSIOL, V63, P521, DOI 10.1152/jappl.1987.63.2.521; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Jiang Z, 1997, FEBS LETT, V413, P441, DOI 10.1016/S0014-5793(97)00944-7; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Kolliputi N, 2009, AM J PHYSIOL-LUNG C, V297, pL6, DOI 10.1152/ajplung.90381.2008; Kolliputi N, 2009, AM J RESP CELL MOL, V40, P314, DOI 10.1165/rcmb.2007-0287OC; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Sakao S, 2011, INT J CARDIOL, V147, P4, DOI 10.1016/j.ijcard.2010.07.003; Sklepkiewicz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018883; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sutendra G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002194; Tonini T, 2008, J CELL PHYSIOL, V214, P295, DOI 10.1002/jcp.21241; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Xu XF, 2011, HYPERTENS RES, V34, P981, DOI 10.1038/hr.2011.79; Yu LY, 2011, AM J RESP CELL MOL, V45, P923, DOI 10.1165/rcmb.2011-0032OC; Zakrzewicz Dariusz, 2009, BMC Pulm Med, V9, P5, DOI 10.1186/1471-2466-9-5	38	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37712	10.1371/journal.pone.0037712	http://dx.doi.org/10.1371/journal.pone.0037712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662197	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300087
J	Furger, E; Fedosov, SN; Lildballe, DL; Waibel, R; Schibli, R; Nexo, E; Fischer, E				Furger, Evelyne; Fedosov, Sergey N.; Lildballe, Dorte Launholt; Waibel, Robert; Schibli, Roger; Nexo, Ebba; Fischer, Eliane			Comparison of Recombinant Human Haptocorrin Expressed in Human Embryonic Kidney Cells and Native Haptocorrin	PLOS ONE			English	Article							HUMAN INTRINSIC-FACTOR; VITAMIN-B12 BINDING-PROTEINS; COBALAMIN-BINDING; HEPATOCELLULAR-CARCINOMA; AFFINITY-CHROMATOGRAPHY; TRANSCOBALAMIN-I; HUMAN-PLASMA; ANALOGS; PURIFICATION; RECOGNITION	Haptocorrin (HC) is a circulating corrinoid binding protein with unclear function. In contrast to transcobalamin, the other transport protein in blood, HC is heavily glycosylated and binds a variety of cobalamin (Cbl) analogues. HC is present not only in blood but also in various secretions like milk, tears and saliva. No recombinant form of HC has been described so far. We report the expression of recombinant human HC (rhHC) in human embryonic kidney cells. We purified the protein with a yield of 6 mg (90 nmol) per litre of cell culture supernatant. The isolated rhHC behaved as native HC concerning its spectral properties and ability to recognize both Cbl and its baseless analogue cobinamide. Similar to native HC isolated from blood, rhHC bound to the asialoglycoprotein receptor only after removal of terminal sialic acid residues by treatment with neuraminidase. Interestingly, rhHC, that compared to native HC contains four excessive amino acids ( ... LVPR) at the C-terminus, showed subtle changes in the binding kinetics of Cbl, cobinamide and the fluorescent Cbl conjugate CBC. The recombinant protein has properties very similar to native HC and although showing slightly different ligand binding kinetics, rhHC is valuable for further biochemical and structural studies.	[Furger, Evelyne; Waibel, Robert; Schibli, Roger; Fischer, Eliane] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, Villigen, Switzerland; [Fedosov, Sergey N.] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Lildballe, Dorte Launholt; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Aarhus University; Aarhus University	Furger, E (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci, Villigen, Switzerland.	eliane.fischer@psi.ch	Fedosov, Sergey N./J-2340-2019; Fischer, Eliane/M-2590-2013	Fedosov, Sergey N./0000-0002-7016-2959; Fischer, Eliane/0000-0002-3399-3737; Schibli, Roger/0000-0002-1537-3833; Nexo, Ebba/0000-0001-9406-9081	PSI Forschungskommission; Danish Medical Research Council; Lundbeck Foundation	PSI Forschungskommission; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the PSI Forschungskommission, The Danish Medical Research Council, and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGER RL, 1975, J CLIN INVEST, V56, P1262, DOI 10.1172/JCI108202; BURGER RL, 1975, J BIOL CHEM, V250, P7707; BURGER RL, 1974, J BIOL CHEM, V249, P7220; Clardy SM, 2011, EXPERT OPIN DRUG DEL, V8, P127, DOI 10.1517/17425247.2011.539200; Fedosov SN, 2007, J ORGANOMET CHEM, V692, P1234, DOI 10.1016/j.jorganchem.2006.08.081; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2006, FEBS J, V273, P4742, DOI 10.1111/j.1742-4658.2006.05478.x; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Fedosov SN, 2005, BIOCHEMISTRY-US, V44, P3604, DOI 10.1021/bi047936v; Fedosov SN, 1999, J BIOL CHEM, V274, P26015, DOI 10.1074/jbc.274.37.26015; Fedosov SN, 2003, EUR J BIOCHEM, V270, P3362, DOI 10.1046/j.1432-1033.2003.03716.x; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; GORDON M, 1992, BIOCHIM BIOPHYS ACTA, V1132, P276, DOI 10.1016/0167-4781(92)90161-R; Grunberg J, 2003, BIOTECHNIQUES, V34, P968, DOI 10.2144/03345st02; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Henning Stefanie, 2009, V492, P181, DOI 10.1007/978-1-59745-493-3_10; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Lildballe DL, 2011, EJSO-EUR J SURG ONC, V37, P72, DOI 10.1016/j.ejso.2010.11.001; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Morkbak AL, 2005, CLIN CHIM ACTA, V356, P184, DOI 10.1016/j.cccn.2005.01.013; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1976, BIOCHIM BIOPHYS ACTA, V446, P143, DOI 10.1016/0005-2795(76)90106-9; NEXO E, 1975, SCAND J HAEMATOL, V14, P320; NEXO E, 1978, SCAND J HAEMATOL, V20, P221; NEXO E, 1975, SCAND J CLIN LAB INV, V35, P683, DOI 10.3109/00365517509095798; Nexo E., 1998, VITAMIN B12 B12 PROT; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park JH, 1998, BIOCHEM BIOPH RES CO, V244, P304, DOI 10.1006/bbrc.1998.8256; QUADROS EV, 1993, BLOOD, V81, P1239; Sandig V., 2005, PRODUCTION RECOMBINA, P233; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394; YANG SY, 1982, BLOOD, V59, P747	40	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37421	10.1371/journal.pone.0037421	http://dx.doi.org/10.1371/journal.pone.0037421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662153	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300042
J	Meeran, SM; Patel, SN; Li, YY; Shukla, S; Tollefsbol, TO				Meeran, Syed M.; Patel, Shweta N.; Li, Yuanyuan; Shukla, Samriddhi; Tollefsbol, Trygve O.			Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HISTONE DEACETYLASE INHIBITOR; TUMOR-SUPPRESSOR GENES; DNA METHYLTRANSFERASE; TEA POLYPHENOL; METHYLATION; APOPTOSIS; GROWTH; SULFORAPHANE; MECHANISMS	Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tamoxifen therapy is successful for some patients, it does not provide adequate benefit for those who have estrogen receptor (ER)-negative cancers. Therefore, we approached novel treatment strategies by combining two potential bioactive dietary supplements for the reactivation of ER alpha expression for effective treatment of ER alpha-negative breast cancer with tamoxifen. Bioactive dietary supplements such as green tea polyphenols (GTPs) and sulforaphane (SFN) inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), respectively, which are of central importance to cancer prevention. In the present study, we have observed that treatment of ER alpha-negative breast cancer cells with GTPs and SFN alone or in combination leads to the reactivation of ER alpha expression. The combination of 20 mu g/mL GTPs and 5 mu M SFN was found to be the optimal dose of ER alpha-reactivation at 3 days in MDA-MB-231 cells. The reactivation of ER alpha expression was consistently correlated with ER alpha promoter hypomethylation and hyperacetylation. Chromatin immunoprecipitation (ChIP) analysis of the ER alpha promoter revealed that GTPs and SFN altered the binding of ER alpha-transcriptional co-repressor complex thereby contributing to ER alpha-activation. In addition, treatment with tamoxifen in combination with GTPs and SFN significantly increased both cell death and inhibition of cellular proliferation in MDA-MB-231 cells in comparison to treatment with tamoxifen alone. Collectively, our findings suggest that a novel combination of bioactive-HDAC inhibitors with bioactive-demethylating agents is a promising strategy for the effective treatment of hormonal refractory breast cancer with available anti-estrogens.	[Meeran, Syed M.; Shukla, Samriddhi] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Meeran, Syed M.; Patel, Shweta N.; Li, Yuanyuan; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Meeran, SM (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	s.musthapa@cdri.res.in	Shukla, Samriddhi/AAF-1876-2021; Meeran, Syed Musthapa/AAG-2157-2020	Shukla, Samriddhi/0000-0002-3771-4184; Meeran, Syed Musthapa/0000-0003-3859-146X; Tollefsbol, Trygve/0000-0002-0284-1511	National Cancer Institute, National Institutes of Health [R01 CA129415]; American Institute for Cancer Research; Ministry of Health and Family Welfare, Government of India, India; CSIR, Government of India; NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research; Ministry of Health and Family Welfare, Government of India, India; CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants to TOT from the National Cancer Institute, National Institutes of Health (R01 CA129415) and the American Institute for Cancer Research. Part of the work was also supported by the Ministry of Health and Family Welfare, Government of India, India (SMM). Junior Research Fellowship grant from CSIR, Government of India, is also acknowledged (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Ciftci K, 2003, J PHARM PHARMACOL, V55, P1135, DOI 10.1211/002235703322277177; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Fang MZ, 2003, CANCER RES, V63, P7563; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Issa JPJ, 1996, CANCER RES, V56, P973; Jang ER, 2004, ONCOGENE, V23, P1724, DOI 10.1038/sj.onc.1207315; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Landis-Piwowar KR, 2008, J CELL BIOCHEM, V105, P514, DOI 10.1002/jcb.21853; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Li YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-274; Lin Jen-Kun, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P1; Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Meeran SM, 2006, MOL CANCER THER, V5, P825, DOI 10.1158/1535-7163.MCT-06-0003; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Meeran SM, 2011, CANCER PREV RES, V4, P1243, DOI 10.1158/1940-6207.CAPR-11-0009; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Nian H, 2009, ENVIRON MOL MUTAGEN, V50, P213, DOI 10.1002/em.20454; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Rossi C, 2008, EUR J CANCER, V44, P2696, DOI 10.1016/j.ejca.2008.08.021; Saxena Neeraj K, 2010, Mol Cell Pharmacol, V2, P191; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Yang XW, 2001, CANCER RES, V61, P7025; Zhou Q, 2007, CANCER BIOL THER, V6, P64, DOI 10.4161/cbt.6.1.3549	36	83	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37748	10.1371/journal.pone.0037748	http://dx.doi.org/10.1371/journal.pone.0037748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662208	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300098
J	Wiemann, P; Albermann, S; Niehaus, EM; Studt, L; von Bargen, KW; Brock, NL; Humpf, HU; Dickschat, JS; Tudzynski, B				Wiemann, Philipp; Albermann, Sabine; Niehaus, Eva-Maria; Studt, Lena; von Bargen, Katharina W.; Brock, Nelson L.; Humpf, Hans-Ulrich; Dickschat, Jeroen S.; Tudzynski, Bettina			The Sfp-Type 4 '-Phosphopantetheinyl Transferase Ppt1 of Fusarium fujikuroi Controls Development, Secondary Metabolism and Pathogenicity	PLOS ONE			English	Article							GIBBERELLA-FUJIKUROI; SIDEROPHORE BIOSYNTHESIS; TRANSCRIPTION FACTOR; OXIDATIVE-STRESS; SYNTHETASE GENE; USTILAGO-MAYDIS; IRON STORAGE; ACID; MONILIFORMIN; SYNTHASE	The heterothallic ascomycete Fusarium fujikuroi is a notorious rice pathogen causing super-elongation of plants due to the production of terpene-derived gibberellic acids (GAs) that function as natural plant hormones. Additionally, F. fujikuroi is able to produce a variety of polyketide- and non-ribosomal peptide-derived metabolites such as bikaverins, fusarubins and fusarins as well as metabolites from yet unidentified biosynthetic pathways, e. g. moniliformin. The key enzymes needed for their production belong to the family of polyketide synthases (PKSs) and non-ribosomal peptide synthases (NRPSs) that are generally known to be post-translationally modified by a Sfp-type 4'-phosphopantetheinyl transferase (PPTase). In this study we provide evidence that the F. fujikuroi Sfp-type PPTase FfPpt1 is essentially involved in lysine biosynthesis and production of bikaverins, fusarubins and fusarins, but not moniliformin as shown by analytical methods. Concomitantly, targeted Ffppt1 deletion mutants reveal an enhancement of terpene-derived metabolites like GAs and volatile substances such as alpha-acorenol. Pathogenicity assays on rice roots using fluorescent labeled wild-type and Ffppt1 mutant strains indicate that lysine biosynthesis and iron acquisition but not PKS and NRPS metabolism is essential for establishment of primary infections of F. fujikuroi. Additionally, FfPpt1 is involved in conidiation and sexual mating recognition possibly by activating PKS- and/or NRPS-derived metabolites that could act as diffusible signals. Furthermore, the effect on iron acquisition of Ffppt1 mutants led us to identify a previously uncharacterized putative third reductive iron uptake system (FfFtr3/FfFet3) that is closely related to the FtrA/FetC system of A. fumigatus. Functional characterization provides evidence that both proteins are involved in iron acquisition and are liable to transcriptional repression of the homolog of the Aspergillus GATA-type transcription factor SreA under iron-replete conditions. Targeted deletion of the first Fusarium homolog of this GATA-type transcription factor-encoding gene, Ffsre1, strongly indicates its involvement in regulation of iron homeostasis and oxidative stress resistance.	[Wiemann, Philipp; Albermann, Sabine; Niehaus, Eva-Maria; Studt, Lena; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Pflanzen, Munster, Germany; [Studt, Lena; von Bargen, Katharina W.; Humpf, Hans-Ulrich] Univ Munster, Inst Lebensmittelchem, D-4400 Munster, Germany; [Brock, Nelson L.; Dickschat, Jeroen S.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany	University of Munster; University of Munster; Braunschweig University of Technology	Wiemann, P (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, Hindenburgpl 55, Munster, Germany.	tudzynsb@uni-muenster.de	Humpf, Hans-Ulrich/AAV-4845-2020; Studt, Lena/AAE-3991-2021	Wiemann, Philipp/0000-0002-7983-2218; Humpf, Hans-Ulrich/0000-0003-3296-3058; Studt-Reinhold, Lena/0000-0002-8738-2106	Allianz Industrie Forschung [IGF16001N]; Deutsche Forschungsgemeinschaft [TU 101/16-1, HU 730/9-1, GRK1409, DI1536/1-2]; Fonds der Chemischen Industrie	Allianz Industrie Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	The project was supported by the "Allianz Industrie Forschung'' (IGF16001N); by the "Deutsche Forschungsgemeinschaft'' (TU 101/16-1; HU 730/9-1; GRK1409 and DI1536/1-2) as well as the "Fonds der Chemischen Industrie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE J, 1993, FUNGAL GENET NEWSL A, V40, P68; Allen G, 2011, FUNGAL GENET BIOL, V48, P456, DOI 10.1016/j.fgb.2010.12.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An ZQ, 1997, P NATL ACAD SCI USA, V94, P5882, DOI 10.1073/pnas.94.11.5882; Apsimon John W., 1994, P3; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AVALOS J, 1986, PHYTOCHEMISTRY, V25, P1837, DOI 10.1016/S0031-9422(00)81158-9; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; BARRERO AF, 1991, PHYTOCHEMISTRY, V30, P2259, DOI 10.1016/0031-9422(91)83625-U; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Brock NL, 2011, CHEMBIOCHEM, V12, P2667, DOI 10.1002/cbic.201100516; Carreto JI, 2011, MAR DRUGS, V9, P387, DOI 10.3390/md9030387; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Choquer M, 2007, FEBS LETT, V581, P489, DOI 10.1016/j.febslet.2007.01.011; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; Crawford JM, 2008, CHEMBIOCHEM, V9, P1559, DOI 10.1002/cbic.200700659; Dalmais B, 2011, MOL PLANT PATHOL, V12, P564, DOI [10.1111/j.1364-3703.2010.00692.x, 10.1111/J.1364-3703.2010.00692.X]; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dyer RB, 2005, J AGR FOOD CHEM, V53, P9281, DOI 10.1021/jf051441a; Ehmann DE, 1999, BIOCHEMISTRY-US, V38, P6171, DOI 10.1021/bi9829940; Eichhorn H, 2006, PLANT CELL, V18, P3332, DOI 10.1105/tpc.106.043588; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; FAVREBONVIN J, 1976, CAN J CHEM, V54, P1105, DOI 10.1139/v76-158; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fotso J, 2002, APPL ENVIRON MICROB, V68, P5195, DOI 10.1128/AEM.68.10.5195-5197.2002; GAUMANN E, 1957, PHYTOPATHOLOGY, V47, P342; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Glenn AE, 2008, MOL PLANT MICROBE IN, V21, P87, DOI 10.1094/MPMI-21-1-0087; Greenshields DL, 2007, MOL PLANT PATHOL, V8, P411, DOI [10.1111/j.1364-3703.2007.00401.x, 10.1111/J.1364-3703.2007.00401.X]; Haas H, 1997, GENE, V184, P33, DOI 10.1016/S0378-1119(96)00570-7; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Han Yoo Jeong, 1993, Korean Journal of Genetics, V15, P1; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Horbach R, 2009, PLANT CELL, V21, P3379, DOI 10.1105/tpc.108.064188; Hubner Florian, 2012, Mycotoxin Res, V28, P37, DOI 10.1007/s12550-011-0114-7; Hwang LH, 2012, EUKARYOT CELL, V11, P16, DOI 10.1128/EC.05274-11; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Keszenman-Pereyra D, 2003, CURR GENET, V43, P186, DOI 10.1007/s00294-003-0382-7; Keszthelyi A, 2007, ANTON LEEUW INT J G, V91, P373, DOI 10.1007/s10482-006-9123-5; Kim HK, 2008, FUNGAL GENET BIOL, V45, P1188, DOI 10.1016/j.fgb.2008.05.008; KJAER D, 1971, J CHEM SOC C, P2792, DOI 10.1039/j39710002792; Kleigrewe K, 2011, J AGR FOOD CHEM, V59, P10470, DOI 10.1021/jf2026814; KLITTICH CJR, 1988, GENETICS, V118, P417; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee JK, 2008, EUKARYOT CELL, V7, P1211, DOI 10.1128/EC.00272-07; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Leng YQ, 2012, MOL PLANT PATHOL, V13, P375, DOI 10.1111/j.1364-3703.2011.00756.x; Lev S, 2005, EUKARYOT CELL, V4, P443, DOI 10.1128/EC.4.2.443-454.2005; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Marquez-Fernandez O, 2007, EUKARYOT CELL, V6, P710, DOI 10.1128/EC.00362-06; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; Mikkelsen L, 2003, FEMS MICROBIOL LETT, V223, P135, DOI 10.1016/S0378-1097(03)00355-0; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Neville C, 2005, CHEMBIOCHEM, V6, P679, DOI 10.1002/cbic.200400147; Oberegger H, 2003, CURR GENET, V44, P211, DOI 10.1007/s00294-003-0434-z; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Park YS, 2007, BIOCHEM J, V408, P97, DOI 10.1042/BJ20070450; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Proctor RH, 2004, MYCOL RES, V108, P815, DOI 10.1017/S0953756204000577; Rademacher W., 1997, FUNGAL BIOTECHNOLOGY, P193; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2007, PLOS PATHOG, V6; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2011, CURR OPIN MICROBIOL, V14, P400, DOI 10.1016/j.mib.2011.06.002; Schwerdt G, 2009, J APPL TOXICOL, V29, P174, DOI 10.1002/jat.1398; Seefelder W, 2003, TOXICOL APPL PHARM, V192, P146, DOI 10.1016/S0041-008X(03)00262-X; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Sondergaard TE, 2011, TOXICOL LETT, V205, P116, DOI 10.1016/j.toxlet.2011.05.1029; Sorensen JL, 2007, J AGR FOOD CHEM, V55, P9764, DOI 10.1021/jf0715875; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Stuible HP, 1998, J BIOL CHEM, V273, P22334, DOI 10.1074/jbc.273.35.22334; Teichert S, 2004, MOL MICROBIOL, V53, P1661, DOI 10.1111/j.1365-2958.2004.04243.x; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; TRIONE EJ, 1966, NATURE, V212, P163, DOI 10.1038/212163a0; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Tudzynski B, 1998, CURR GENET, V34, P234, DOI 10.1007/s002940050392; Velazquez-Robledo R, 2011, MOL PLANT MICROBE IN, V24, P1459, DOI 10.1094/MPMI-02-11-0045; VOISARD C, 1993, MOL CELL BIOL, V13, P7091, DOI 10.1128/MCB.13.11.7091; von Bargen KW, 2012, J AGR FOOD CHEM, V60, P3586, DOI 10.1021/jf300323d; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Yabuta T., 1935, AGR HORTIC, V10, P17; Zhan JX, 2007, J NAT PROD, V70, P227, DOI 10.1021/np060394t; Zhao Deyu, 1993, Biomedical and Environmental Sciences, V6, P37	104	50	54	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37519	10.1371/journal.pone.0037519	http://dx.doi.org/10.1371/journal.pone.0037519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662164	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300054
J	Blinowska, KJ; Kwaskiewicz, K; Jedrzejczak, WW; Skarzynski, H				Blinowska, Katarzyna J.; Kwaskiewicz, Konrad; Jedrzejczak, W. Wiktor; Skarzynski, Henryk			Musical Ratios in Sounds from the Human Cochlea	PLOS ONE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; OUTER HAIR-CELLS; RESONANT MODES; BASILAR-MEMBRANE; HIGH-RESOLUTION; SYNCHRONIZATION; MICROSTRUCTURE; DISSONANCE; CONSONANCE; AMPLIFIER	The physiological roots of music perception are a matter of long-lasting debate. Recently light on this problem has been shed by the study of otoacoustic emissions (OAEs), which are weak sounds generated by the inner ear following acoustic stimulation and, sometimes, even spontaneously. In the present study, a high-resolution time-frequency method called matching pursuit was applied to the OAEs recorded from the ears of 45 normal volunteers so that the component frequencies, amplitudes, latencies, and time-spans could be accurately determined. The method allowed us to find that, for each ear, the OAEs consisted of characteristic frequency patterns that we call resonant modes. Here we demonstrate that, on average, the frequency ratios of the resonant modes from all the cochleas studied possessed small integer ratios. The ratios are the same as those found by Pythagoras as being most musically pleasant and which form the basis of the Just tuning system. The statistical significance of the results was verified against a random distribution of ratios. As an explanatory model, there are attractive features in a recent theory that represents the cochlea as a surface acoustic wave resonator; in this situation the spacing between the rows of hearing receptors can create resonant cavities of defined lengths. By adjusting the geometry and the lengths of the resonant cavities, it is possible to generate the preferred frequency ratios we have found here. We conclude that musical perception might be related to specific geometrical and physiological properties of the cochlea.	[Blinowska, Katarzyna J.; Kwaskiewicz, Konrad] Univ Warsaw, Dept Biomed Phys, Fac Phys, Warsaw, Poland; [Jedrzejczak, W. Wiktor; Skarzynski, Henryk] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Jedrzejczak, W. Wiktor; Skarzynski, Henryk] World Hearing Ctr, Kajetany, Poland	University of Warsaw; Institute of Physiology & Hearing Pathology; Institute of Physiology & Hearing Pathology	Blinowska, KJ (corresponding author), Univ Warsaw, Dept Biomed Phys, Fac Phys, Warsaw, Poland.	w.jedrzejczak@ifps.org.pl	Jedrzejczak, W. Wiktor/L-2529-2015	Jedrzejczak, W. Wiktor/0000-0001-8404-0672; Blinowska, Katarzyna/0000-0001-6429-4421; Skarzynski, Henryk/0000-0001-7141-9851	Ministry of Science and High Education	Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	The research was supported by statutory grant from Ministry of Science and High Education to Faculty of Physics Warsaw University and to Institute of Physiology and Pathology of Hearing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SCI MUSIC NATURE WEB; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Bell A, 2004, J ACOUST SOC AM, V116, P1016, DOI 10.1121/1.1766053; Bell A, 2002, P INT C MUS PERC COG; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Blinowska K. J., 1994, Intelligent Engineering Systems Through Artificial Neural Networks. Vol.4, P535; Blinowska KJ, 2007, PHYSIOL MEAS, V28, P1293, DOI 10.1088/0967-3334/28/10/013; Blinowska KJ, 2005, BIOL CYBERN, V93, P366, DOI 10.1007/s00422-005-0012-l; Blinowska KJ, 2001, ACTA NEUROBIOL EXP, V61, P157; Braun M, 1997, HEARING RES, V114, P197, DOI 10.1016/S0378-5955(97)00160-3; BROWNELL WE, 1990, EAR HEARING, V11, P82, DOI 10.1097/00003446-199004000-00003; Carterette EC, 1999, PSYCHOL MUSIC, P725; Chernick M. R., 2007, BOOTSTRAP METHODS GU, V2nd; Durka PJ, 2001, MED BIOL ENG COMPUT, V39, P315, DOI 10.1007/BF02345286; ELBERLING C, 1985, ACTA OTO-LARYNGOL, P77; Jedrzejczak WW, 2008, HEARING RES, V235, P80, DOI 10.1016/j.heares.2007.10.005; Jedrzejczak WW, 2007, HEARING RES, V231, P54, DOI 10.1016/j.heares.2007.05.009; Jedrzejczak WW, 2009, J ACOUST SOC AM, V126, P3137, DOI 10.1121/1.3243294; Jedrzejczak WW, 2008, J ACOUST SOC AM, V124, P3720, DOI 10.1121/1.2999556; Jedrzejczak WW, 2006, J ACOUST SOC AM, V119, P2226, DOI 10.1121/1.2178718; Jedrzejczak WW, 2004, J ACOUST SOC AM, V115, P2148, DOI 10.1121/1.1690077; Kemp David T., 2008, V30, P1; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; LONSBURYMARTIN BL, 1988, HEARING RES, V33, P69, DOI 10.1016/0378-5955(88)90021-4; Lots IS, 2008, J R SOC INTERFACE, V5, P1429, DOI 10.1098/rsif.2008.0143; Malinowska U, 2006, IEEE ENG MED BIOL, V25, P26, DOI 10.1109/MEMB.2006.1657784; Malinowska U, 2009, NEUROINFORMATICS, V7, P245, DOI 10.1007/s12021-009-9059-9; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; Nobili R, 2003, JARO-J ASSOC RES OTO, V4, P478, DOI 10.1007/s10162-002-3055-1; Notaro G, 2007, J ACOUST SOC AM, V122, P3576, DOI 10.1121/1.2799924; Pinsky MA, INTRO FOURIER ANAL W; PRIEVE BA, 1995, EAR HEARING, V16, P521, DOI 10.1097/00003446-199510000-00009; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Schwartz DA, 2003, J NEUROSCI, V23, P7160, DOI 10.1523/JNEUROSCI.23-18-07160.2003; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Sisto R, 1999, J ACOUST SOC AM, V106, P1893, DOI 10.1121/1.427938; Talmadge CL, 2000, J ACOUST SOC AM, V108, P2911, DOI 10.1121/1.1321012; WABLE J, 1994, HEARING RES, V80, P141, DOI 10.1016/0378-5955(94)90105-8; Zatorre RJ, 2001, ANN N Y ACAD SCI, V930; ZWEIG G, 1995, J ACOUST SOC AM, V98, P2018, DOI 10.1121/1.413320; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3	42	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37988	10.1371/journal.pone.0037988	http://dx.doi.org/10.1371/journal.pone.0037988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655092	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900069
J	Kiss, K; Brozik, A; Kucsma, N; Toth, A; Gera, M; Berry, L; Vallentin, A; Vial, H; Vidal, M; Szakacs, G				Kiss, Katalin; Brozik, Anna; Kucsma, Nora; Toth, Alexandra; Gera, Melinda; Berry, Laurence; Vallentin, Alice; Vial, Henri; Vidal, Michel; Szakacs, Gergely			Shifting the Paradigm: The Putative Mitochondrial Protein ABCB6 Resides in the Lysosomes of Cells and in the Plasma Membrane of Erythrocytes	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE; IRON HOMEOSTASIS; RETICULOCYTE MATURATION; INNER MEMBRANE; HEME-SYNTHESIS; BLOOD-CELLS; K562 CELLS; DIFFERENTIATION; SYSTEM	ABCB6, a member of the adenosine triphosphate-binding cassette (ABC) transporter family, has been proposed to be responsible for the mitochondrial uptake of porphyrins. Here we show that ABCB6 is a glycoprotein present in the membrane of mature erythrocytes and in exosomes released from reticulocytes during the final steps of erythroid maturation. Consistent with its presence in exosomes, endogenous ABCB6 is localized to the endo/lysosomal compartment, and is absent from the mitochondria of cells. Knock-down studies demonstrate that ABCB6 function is not required for de novo heme biosynthesis in differentiating K562 cells, excluding this ABC transporter as a key regulator of porphyrin synthesis. We confirm the mitochondrial localization of ABCB7, ABCB8 and ABCB10, suggesting that only three ABC transporters should be classified as mitochondrial proteins. Taken together, our results challenge the current paradigm linking the expression and function of ABCB6 to mitochondria.	[Kiss, Katalin; Brozik, Anna; Kucsma, Nora; Toth, Alexandra; Gera, Melinda; Szakacs, Gergely] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Berry, Laurence; Vallentin, Alice; Vial, Henri; Vidal, Michel] Univ Montpellier 2, CNRS, Unite Mixte Rech Dynam Interact Membranaires Norm, Montpellier, France	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Kiss, K (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	szakacs@biomembrane.hu	Szakacs, Gergely/A-2580-2009	Szakacs, Gergely/0000-0002-9311-7827; Vidal, Michel/0000-0002-5451-5603; Berry, laurence/0000-0002-8150-7860	National Institutes of Health [R01 AR055225]; ANR-NKTH ADD-MAL (Agence Nationale de la Recherche-Nemzeti Kutatasi es Fejlesztesi Hivatal, "Antimalarial drug discovery and development of new in vitro assays for the optimization of antimalarial therapy"); Lendulet Program of the Hungarian Academy of Sciences; CNRS; University Montpellier II; ANR (Agence Nationale de la Recherche) [ANR-09-BLAN-0292-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR-NKTH ADD-MAL (Agence Nationale de la Recherche-Nemzeti Kutatasi es Fejlesztesi Hivatal, "Antimalarial drug discovery and development of new in vitro assays for the optimization of antimalarial therapy")(French National Research Agency (ANR)); Lendulet Program of the Hungarian Academy of Sciences; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Montpellier II; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (R01 AR055225), ANR-NKTH ADD-MAL (Agence Nationale de la Recherche-Nemzeti Kutatasi es Fejlesztesi Hivatal, "Antimalarial drug discovery and development of new in vitro assays for the optimization of antimalarial therapy"), and the Lendulet Program of the Hungarian Academy of Sciences (GS). AV and MV were supported by the CNRS, the University Montpellier II and a grant from ANR (Agence Nationale de la Recherche) (ANR-09-BLAN-0292-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Annereau JP, 2004, MOL PHARMACOL, V66, P1397, DOI 10.1124/mol.104.005009; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Blanc L, 2005, BLOOD CELL MOL DIS, V35, P21, DOI 10.1016/j.bcmd.2005.04.008; Blanc L, CURR OPIN HEMATOL, V17, P177; Blanc L, 2009, BLOOD, V114, P3928, DOI 10.1182/blood-2009-06-230086; Brozik A, 2006, ANN NY ACAD SCI, V1090, P344, DOI 10.1196/annals.1378.038; Chandra NC, 1998, J BIOL CHEM, V273, P19715, DOI 10.1074/jbc.273.31.19715; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chloupkova M, 2003, J MOL BIOL, V331, P155, DOI 10.1016/S0022-2836(03)00666-1; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; D'Alessandro A, J PROTEOME RES, V9, P144; DEAN A, 1981, SCIENCE, V212, P459, DOI 10.1126/science.6163216; Demirel O, 2007, J BIOL CHEM, V282, P37836, DOI 10.1074/jbc.M708139200; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LUFTIG RB, 1977, J VIROL, V23, P799, DOI 10.1128/JVI.23.3.799-810.1977; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marzac C, 2011, HAEMATOL-HEMATOL J, V96, P1293, DOI 10.3324/haematol.2010.031823; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Polireddy K, 2011, MOL ONCOL; Ponka P, 1997, BLOOD, V89, P1; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schueck ND, 2001, MITOCHONDRION, V1, P51, DOI 10.1016/S1567-7249(01)00004-6; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Steck T L, 1974, Methods Enzymol, V31, P172; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Tang L, 2011, BRIT J HAEMATOLOGY; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Turk D, 2009, IDRUGS, V12, P246; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; VIDAL MJ, 1993, EUR J CELL BIOL, V60, P261; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639	64	66	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37378	10.1371/journal.pone.0037378	http://dx.doi.org/10.1371/journal.pone.0037378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655043	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900018
J	Tayabali, AF; Nguyen, KC; Shwed, PS; Crosthwait, J; Coleman, G; Seligy, VL				Tayabali, Azam F.; Nguyen, Kathy C.; Shwed, Philip S.; Crosthwait, Jennifer; Coleman, Gordon; Seligy, Verner L.			Comparison of the Virulence Potential of Acinetobacter Strains from Clinical and Environmental Sources	PLOS ONE			English	Article							EPITHELIAL-CELLS; HEMOLYTIC-ACTIVITY; LWOFFII INFECTION; IMMUNE-RESPONSE; BAUMANNII; CALCOACETICUS; BACTERIA; INTERLEUKIN-8; GENE; BIODEGRADATION	Several Acinetobacter strains have utility for biotechnology applications, yet some are opportunistic pathogens. We compared strains of seven Acinetobacter species (baumannii, Ab; calcoaceticus, Ac; guillouiae, Ag; haemolyticus, Ah; lwoffii, Al; junii, Aj; and venetianus, Av-RAG-1) for their potential virulence attributes, including proliferation in mammalian cell conditions, haemolytic/cytolytic activity, ability to elicit inflammatory signals, and antibiotic susceptibility. Only Ah grew at 10(2) and 10(4) bacteria/well in mammalian cell culture medium at 37 degrees C. However, co-culture with colonic epithelial cells (HT29) improved growth of all bacterial strains, except Av-RAG-1. Cytotoxicity of Ab and Ah toward HT29 was at least double that of other test bacteria. These effects included bacterial adherence, loss of metabolism, substrate detachment, and cytolysis. Only Ab and Ah exhibited resistance to killing by macrophage-like J774A.1 cells. Haemolytic activity of Ah and Av-RAG-1 was strong, but undetectable for other strains. When killed with an antibiotic, Ab, Ah, Aj and Av-RAG-1 induced 3 to 9-fold elevated HT29 interleukin (IL)-8 levels. However, none of the strains altered levels of J774A. 1 pro-inflammatory cytokines (IL-1 beta, IL-6 and tumor necrosis factor-alpha). Antibiotic susceptibility profiling showed that Ab, Ag and Aj were viable at low concentrations of some antibiotics. All strains were positive for virulence factor genes ompA and epsA, and negative for mutations in gyrA and parC genes that convey fluoroquinolone resistance. The data demonstrate that Av-RAG-1, Ag and Al lack some potentially harmful characteristics compared to other Acinetobacter strains tested, but the biotechnology candidate Av-RAG-1 should be scrutinized further prior to widespread use.	[Tayabali, Azam F.; Nguyen, Kathy C.; Shwed, Philip S.; Crosthwait, Jennifer; Coleman, Gordon; Seligy, Verner L.] Hlth Canada, Biotechnol Lab, Environm Hlth Sci & Res Bur, Ctr Environm Hlth, Ottawa, ON K1A 0L2, Canada	Health Canada	Tayabali, AF (corresponding author), Hlth Canada, Biotechnol Lab, Environm Hlth Sci & Res Bur, Ctr Environm Hlth, Ottawa, ON K1A 0L2, Canada.	azam.tayabali@hc-sc.gc.ca		Shwed, Philip/0000-0002-8009-2085	Canadian Regulatory System for Biotechnology (CRSB)	Canadian Regulatory System for Biotechnology (CRSB)	This research was supported by the Canadian Regulatory System for Biotechnology (CRSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-el-haleem D., 2003, AFR J BIOTECHNOL, V2, P71, DOI 10.5897/AJB2003.000-1014; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Apisarnthanarak A, 2007, INFECT CONT HOSP EP, V28, P637, DOI 10.1086/513620; Baldi F, 2003, RES MICROBIOL, V154, P417, DOI 10.1016/S0923-2508(03)00128-1; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BIFULCO JM, 1989, APPL ENVIRON MICROB, V55, P2214, DOI 10.1128/AEM.55.9.2214-2219.1989; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Cayo R, 2011, J MED MICROBIOL, V60, P375, DOI 10.1099/jmm.0.024596-0; Chen TL, 2008, J CLIN MICROBIOL, V46, P2938, DOI 10.1128/JCM.00232-08; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, FEMS MICROBIOL LETT, V288, P62, DOI 10.1111/j.1574-6968.2008.01323.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Dalpke A, 2002, CRIT REV IMMUNOL, V22, P217; Dams-Kozlowska H, 2008, APPL MICROBIOL BIOT, V81, P201, DOI 10.1007/s00253-008-1664-2; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; Dijkshoorn L., 2008, ACINETOBACTER MOL MI; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Garcia A, 1999, J MED MICROBIOL, V48, P479, DOI 10.1099/00222615-48-5-479; Garnacho-Montero J, 2010, CURR OPIN INFECT DIS, V23, P332, DOI 10.1097/QCO.0b013e32833ae38b; Giamarellou H, 2008, INT J ANTIMICROB AG, V32, P106, DOI 10.1016/j.ijantimicag.2008.02.013; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Gootz TD, 2008, EXPERT REV ANTI-INFE, V6, P309, DOI 10.1586/14787210.6.3.309; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Gospodarek Eugenia, 1993, Medycyna Doswiadczalna i Mikrobiologia, V45, P317; Ho J, 2010, CAN J INFECT DIS MED, V21, P83, DOI 10.1155/2010/690715; Hung YT, 2009, J MICROBIOL IMMUNOL, V42, P47; Huttunen K, 2003, ENVIRON HEALTH PERSP, V111, P85, DOI 10.1289/ehp.5478; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Jung J, 2011, J MICROBIOL, V49, P208, DOI 10.1007/s12275-011-0395-8; Keen EF, 2010, BURNS, V36, P819, DOI 10.1016/j.burns.2009.10.013; Kim SA, 2008, FEMS IMMUNOL MED MIC, V54, P45, DOI 10.1111/j.1574-695X.2008.00446.x; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee JC, 2001, APMIS, V109, P679, DOI 10.1034/j.1600-0463.2001.d01-132.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; LEHMANN V, 1971, ACTA PATHOLOG MICROB, VB 79, P61, DOI 10.1111/j.1699-0463.1971.tb00033.x; LEHMANN V, 1973, ACTA PATH MICRO IM B, VB 81, P427, DOI 10.1111/j.1699-0463.1973.tb02226.x; Livermore DM, 2003, ANN MED, V35, P226, DOI 10.1080/07853890310001609; Luckarift HR, 2011, BIOTECHNOLOGY PROGR; Luna CM, 2007, RESPIROLOGY, V12, P787, DOI 10.1111/j.1440-1843.2007.01147.x; Silva GM, 2012, REV PORT PNEUMOL, V18, P96, DOI 10.1016/j.rppneu.2011.07.006; Neonakis IK, 2011, INT J ANTIMICROB AG, V37, P102, DOI 10.1016/j.ijantimicag.2010.10.014; Ong CWM, 2009, RESPIROLOGY, V14, P1200, DOI 10.1111/j.1440-1843.2009.01630.x; Ozaki T, 2009, J INFECT CHEMOTHER, V15, P322, DOI 10.1007/s10156-009-0704-x; Palfreyman RW, 1997, INFECT IMMUN, V65, P617, DOI 10.1128/IAI.65.2.617-622.1997; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pellegrino FLPC, 2011, J CLIN MICROBIOL, V49, P2283, DOI 10.1128/JCM.00326-11; Rathinavelu S, 2003, MICROBES INFECT, V5, P651, DOI 10.1016/S1286-4579(03)00099-6; Reen DJ, 1994, BASIC PROTEIN PEPTID, V32; Regalado NG, 2009, TRAVEL MED INFECT DI, V7, P316, DOI 10.1016/j.tmaid.2009.06.001; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85; Sechi LA, 2004, MED SCI MONITOR, V10, pBR180; Seligy VL, 1999, J IND MICROBIOL BIOT, V22, P565, DOI 10.1038/sj.jim.2900625; Seligy VL, 1997, J IND MICROBIOL BIOT, V18, P370, DOI 10.1038/sj.jim.2900404; Sengstock DM, 2010, CLIN INFECT DIS, V50, P1611, DOI 10.1086/652759; Simoes LC, 2008, APPL ENVIRON MICROB, V74, P1259, DOI 10.1128/AEM.01747-07; Singh GB, 2011, B ENVIRON CONTAM TOX, V87, P522, DOI 10.1007/s00128-011-0382-0; SMITH AW, 1991, J MED MICROBIOL, V34, P83, DOI 10.1099/00222615-34-2-83; Snellman EA, 2002, EUR J BIOCHEM, V269, P5771, DOI 10.1046/j.1432-1033.2002.03235.x; Su WT, 2009, APPL MICROBIOL BIOT, V84, P271, DOI 10.1007/s00253-009-1957-0; Tayabali AF, 1997, ECOTOX ENVIRON SAFE, V37, P152, DOI 10.1006/eesa.1997.1525; Tayabali AF, 2000, ENVIRON HEALTH PERSP, V108, P919, DOI 10.2307/3435049; Tayabali AF, 2011, TOXICOL ENVIRON CHEM, V93, P314, DOI 10.1080/02772248.2010.526784; TAYLOR D, 1990, BRIT J DERMATOL, V122, P23, DOI 10.1111/j.1365-2133.1990.tb08235.x; Utaisincharoen P, 2003, CLIN EXP IMMUNOL, V132, P70, DOI 10.1046/j.1365-2249.2003.02107.x; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vaneechoutte M, 1999, RES MICROBIOL, V150, P69, DOI 10.1016/S0923-2508(99)80047-3; Vaneechoutte M, 2009, INT J SYST EVOL MICR, V59, P1376, DOI 10.1099/ijs.0.003541-0; VILA J, 1995, ANTIMICROB AGENTS CH, V39, P1201, DOI 10.1128/AAC.39.5.1201; Vila J, 1997, J ANTIMICROB CHEMOTH, V39, P757, DOI 10.1093/jac/39.6.757; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Zhao ZY, 2011, J HAZARD MATER, V190, P345, DOI 10.1016/j.jhazmat.2011.03.042	78	38	40	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37024	10.1371/journal.pone.0037024	http://dx.doi.org/10.1371/journal.pone.0037024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655033	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900008
J	Brown, J; Gedeon, T				Brown, Jacob; Gedeon, Tomas			Structure of the Afferent Terminals in Terminal Ganglion of a Cricket and Persistent Homology	PLOS ONE			English	Article							NEURAL MAP	We use topological data analysis to investigate the three dimensional spatial structure of the locus of afferent neuron terminals in crickets Acheta domesticus. Each afferent neuron innervates a filiform hair positioned on a cercus: a protruding appendage at the rear of the animal. The hairs transduce air motion to the neuron signal that is used by a cricket to respond to the environment. We stratify the hairs (and the corresponding afferent terminals) into classes depending on hair length, along with position. Our analysis uncovers significant structure in the relative position of these terminal classes and suggests the functional relevance of this structure. Our method is very robust to the presence of significant experimental and developmental noise. It can be used to analyze a wide range of other point cloud data sets.	[Brown, Jacob; Gedeon, Tomas] Montana State Univ, Dept Math Sci, Ctr Computat Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Brown, J (corresponding author), Montana State Univ, Dept Math Sci, Ctr Computat Biol, Bozeman, MT 59717 USA.	gedeon@math.montana.edu			NSF (National Science Foundation) [DMS-081878, CMMI-0849433]; Defense Advanced Research Project Agency (DARPA) [00001741/HR0011-09-1-0055]; Division Of Mathematical Sciences [0818785] Funding Source: National Science Foundation	NSF (National Science Foundation)(National Science Foundation (NSF)); Defense Advanced Research Project Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work has been partially supported by NSF (National Science Foundation) grants DMS-081878 and CMMI-0849433, and a Defense Advanced Research Project Agency (DARPA) grant 00001741/HR0011-09-1-0055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Edelsbrunner H, 2000, ANN IEEE SYMP FOUND, P454; Goodman JE, 2008, CONT MATH, V453, P257; Jacobs GA, 1996, J NEUROSCI, V16, P769; Jacobs GA, 2000, J NEUROSCI, V20, P2934; Kaczynski T., 2004, APPL MATH SCI; Lee AB, 2003, INT J COMPUT VISION, V54, P83, DOI 10.1023/A:1023705401078; Miller J., COMMUNICATION; Mrozek M, 2006, HOMOLOGY SOFTWARE WE; Mrozek M, 2010, COMPUTER MATH APPL, V60; Mrozek M, 2009, DISCRETE COMPUT GEOM, V41, P96, DOI 10.1007/s00454-008-9073-y; Mulder-Rosi J, 2010, J NEUROPHYSIOL, V103, P1823, DOI 10.1152/jn.00875.2009; Munkres J. R., 1984, ELEMENTS ALGEBRAIC T; Paydar S, 1999, J NEUROSCI, V19, P1771; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; Storjohann A., 1996, ISSAC 96. Proceedings of the 1996 International Symposium on Symbolic and Algebraic Computation, P267, DOI 10.1145/236869.237084	16	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37278	10.1371/journal.pone.0037278	http://dx.doi.org/10.1371/journal.pone.0037278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649516	Green Published, gold			2022-12-27	WOS:000305335800034
J	Spisak, BR				Spisak, Brian R.			The General Age of Leadership: Older-Looking Presidential Candidates Win Elections during War	PLOS ONE			English	Article							TESTOSTERONE; AGGRESSION; EVOLUTION	As nation-state leaders age they increasingly engage in inter-state militarized disputes yet in industrialized societies a steady decrease in testosterone associated with aging is observed - which suggests a decrease in dominance behavior. The current paper points out that from modern societies to Old World monkeys increasing both in age and social status encourages dominant strategies to maintain acquired rank. Moreover, it is argued this consistency has shaped an implicit prototype causing followers to associate older age with dominance leadership. It is shown that (i) faces of older leaders are preferred during intergroup conflict and (ii) morphing U.S. Presidential candidates to appear older or younger has an overriding effect on actual election outcomes. This indicates that democratic voting can be systematically adjusted by activating innate biases. These findings appear to create a new line of research regarding the biology of leadership and contextual cues of age.	Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Spisak, BR (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	b.r.spisak@vu.nl		Spisak, Brian/0000-0002-6628-2034				Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Bak D, 2010, FOREIGN POL ANAL-US, V6, P257, DOI 10.1111/j.1743-8594.2010.00111.x; Boesch C, 2000, CHIMPANZEES TAI FORE; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Campbell JE, 2008, FORUM-J APPL RES CON, V6; Dittrich R, 2002, COMPUT STAT DATA AN, V40, P39, DOI 10.1016/S0167-9473(01)00106-2; FLANAGAN JG, 1989, ANNU REV ANTHROPOL, V18, P245; Gibson SJ, 2009, INT J ELECTRON SECUR, V2, P156, DOI 10.1504/IJESDF.2009.024900; Goodall J., 1986, CHIMPANZEES GOMBE PA; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Horowitz M, 2005, J CONFLICT RESOLUT, V49, P661, DOI 10.1177/0022002705279469; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Montepare JM, 1998, ADV EXP SOC PSYCHOL, V30, P93, DOI 10.1016/S0065-2601(08)60383-4; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Potter PBK, 2007, J CONFLICT RESOLUT, V51, P351, DOI 10.1177/0022002707300179; Pusey Anne E., 1997, P254; Sharpanskykh A., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P848, DOI 10.1109/PASSAT/SocialCom.2011.145; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Spisak BR, 2011, EVOLUTIONARY PSYCHOLOGY IN THE BUSINESS SCIENCES, P165, DOI 10.1007/978-3-540-92784-6_7; Takahashi H, 2002, PRIMATES, V43, P133, DOI 10.1007/BF02629673; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Van Vugt M, 2008, PSYCHOL SCI, V19, P854, DOI 10.1111/j.1467-9280.2008.02168.x; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Zacher H, 2011, LEADERSHIP QUART, V22, P43, DOI 10.1016/j.leaqua.2010.12.006	26	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36945	10.1371/journal.pone.0036945	http://dx.doi.org/10.1371/journal.pone.0036945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649504	Green Published, gold			2022-12-27	WOS:000305335800022
J	Tomotani, BM; Flores, DEFL; Tachinardi, P; Paliza, JD; Oda, GA; Valentinuzzi, VS				Tomotani, Barbara M.; Flores, Danilo E. F. L.; Tachinardi, Patricia; Paliza, Jose D.; Oda, Gisele A.; Valentinuzzi, Veronica S.			Field and Laboratory Studies Provide Insights into the Meaning of Day-Time Activity in a Subterranean Rodent (Ctenomys aff. knighti), the Tuco-Tuco	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; MOLE-RATS; BEHAVIORAL ACTIVITY; ACTIVITY PATTERNS; TALARUM RODENTIA; MONTE DESERT; TEMPERATURE; ENTRAINMENT; MASKING	South American subterranean rodents (Ctenomys aff. knighti), commonly known as tuco-tucos, display nocturnal, wheel-running behavior under light-dark (LD) conditions, and free-running periods >24 h in constant darkness (DD). However, several reports in the field suggested that a substantial amount of activity occurs during daylight hours, leading us to question whether circadian entrainment in the laboratory accurately reflects behavior in natural conditions. We compared circadian patterns of locomotor activity in DD of animals previously entrained to full laboratory LD cycles (LD12:12) with those of animals that were trapped directly from the field. In both cases, activity onsets in DD immediately reflected the previous dark onset or sundown. Furthermore, freerunning periods upon release into DD were close to 24 h indicating aftereffects of prior entrainment, similarly in both conditions. No difference was detected in the phase of activity measured with and without access to a running wheel. However, when individuals were observed continuously during daylight hours in a semi-natural enclosure, they emerged above-ground on a daily basis. These day-time activities consisted of foraging and burrow maintenance, suggesting that the designation of this species as nocturnal might be inaccurate in the field. Our study of a solitary subterranean species suggests that the circadian clock is entrained similarly under field and laboratory conditions and that day-time activity expressed only in the field is required for foraging and may not be time-dictated by the circadian pacemaker.	[Tomotani, Barbara M.; Flores, Danilo E. F. L.; Tachinardi, Patricia; Oda, Gisele A.] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil; [Paliza, Jose D.; Valentinuzzi, Veronica S.] Ctr Reg Invest Cient & Transferencia Tecnol CRILA, Anillaco, La Rioja, Argentina	Universidade de Sao Paulo	Tomotani, BM (corresponding author), Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil.	gaoda@ib.usp.br; vvalentinuzzi@crilar-conicet.gob.ar	Mizumo Tomotani, Barbara/A-5600-2013; oda, gisele a/F-4283-2012	Mizumo Tomotani, Barbara/0000-0002-8855-4803; oda, gisele a/0000-0001-7776-5368; Eugenio de Franca Laurindo Flores, Danilo/0000-0003-1770-3581	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP-11420090100252]; CRILAR (Centro Regional de Investigaciones Cientificas y Transferencia Tecnologica); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/55035-5, 2010/502221]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [130021/2009-1]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CRILAR (Centro Regional de Investigaciones Cientificas y Transferencia Tecnologica); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, grant PIP-11420090100252), CRILAR (Centro Regional de Investigaciones Cientificas y Transferencia Tecnologica), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants 2008/55035-5, 2010/502221), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 130021/2009-1) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2009, J ARID ENVIRON, V73, P144, DOI 10.1016/j.jaridenv.2008.09.028; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Aton SJ, 2004, J BIOL RHYTHM, V19, P198, DOI 10.1177/0748730404264156; Beaule C, 2011, J BIOL RHYTHM, V26, P561, DOI 10.1177/0748730411416329; Bidau C, 2006, MAMIFEROS ARGENTINA, P219; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Buffenstein R, 2000, LIFE UNDERGROUND BIO, P183; Burda H, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P21, DOI 10.1007/978-3-540-69276-8_3; Busch C, 2000, LIFE UNDERGROUND, P183; Cohen R, 2010, J BIOL RHYTHM, V25, P47, DOI 10.1177/0748730409351672; Cook JA, 1998, EVOLUTION, V52, P1521, DOI 10.1111/j.1558-5646.1998.tb02035.x; Cutrera AP, 2006, J MAMMAL, V87, P1183, DOI 10.1644/05-MAMM-A-386R1.1; Daan S., 1981, HDB BEHAVIOURAL NEUR, P275, DOI DOI 10.1007/978-1-4615-6552-9_15; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; DECOURSEY PJ, 1986, J COMP PHYSIOL A, V159, P161, DOI 10.1007/BF00612299; Erkert HG, 2006, FOLIA PRIMATOL, V77, P87, DOI 10.1159/000089697; Fracchia S, 2011, J ARID ENVIRON, V75, P1016, DOI 10.1016/j.jaridenv.2011.04.034; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Gritton HJ, 2009, BEHAV NEUROSCI, V123, P937, DOI 10.1037/a0017128; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Hut RA, 1999, J BIOL RHYTHM, V14, P290, DOI 10.1177/074873099129000704; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P277, DOI 10.1177/0748730410376159; Kas MJH, 1999, J NEUROSCI, V19, P328, DOI 10.1523/JNEUROSCI.19-01-00328.1999; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Luna F, 2002, CAN J ZOOL, V80, P2144, DOI 10.1139/Z02-201; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; MARIMUTHU G, 1981, BEHAV ECOL SOCIOBIOL, V8, P147, DOI 10.1007/BF00300827; MARQUES MD, 1994, CHRONOBIOL INT, V11, P146, DOI 10.3109/07420529409057234; MOORE RY, 1983, FED PROC, V42, P2783; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; Page TL, 1997, J BIOL RHYTHM, V12, P218, DOI 10.1177/074873049701200303; Pittendrigh C.S., 1981, BIOL CLOCKS SEASONAL, P1; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Rezende EL, 2003, J ARID ENVIRON, V55, P63, DOI 10.1016/S0140-1963(02)00259-8; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Schleich CE, 2007, ETHOLOGY, V113, P573, DOI 10.1111/j.1439-0310.2007.01352.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; VASSALLO AI, 1994, J MAMMAL, V75, P725, DOI 10.2307/1382522; Vivanco P, 2010, CHRONOBIOL INT, V27, P517, DOI 10.3109/07420521003743660	47	44	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37918	10.1371/journal.pone.0037918	http://dx.doi.org/10.1371/journal.pone.0037918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649565	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800085
J	Niki, Y; Takeuchi, T; Nakayama, M; Nagasawa, H; Kurasawa, T; Yamada, H; Toyama, Y; Miyamoto, T				Niki, Yasuo; Takeuchi, Tsutomu; Nakayama, Masanori; Nagasawa, Hayato; Kurasawa, Takahiko; Yamada, Harumoto; Toyama, Yoshiaki; Miyamoto, Takeshi			Clinical Significance of Cartilage Biomarkers for Monitoring Structural Joint Damage in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy	PLOS ONE			English	Article							PREDICT RADIOGRAPHIC PROGRESSION; SERUM KERATAN SULFATE; MATRIX PROTEIN COMP; KNEE OSTEOARTHRITIS; DISEASE-ACTIVITY; BIOCHEMICAL MARKERS; DESTRUCTION; ETANERCEPT; METABOLISM; INFLIXIMAB	Purpose: With the current use of biologics in rheumatoid arthritis (RA), there is a need to monitor ongoing structural joint damage due to the dissociation of articular cartilage damage from disease activity of RA. This study longitudinally analyzed levels of serum cartilage biomarkers during 54 weeks of infliximab therapy, to evaluate the feasibility of biomarkers for monitoring structural joint damage. Methods: Subjects comprised 33 patients with early RA and 33 patients with established RA. All patients received 3 mg/kg of infliximab and methotrexate for 54 weeks. Levels of the following serum cartilage markers were measured at baseline and at weeks 14, 22, and 54: hyaluronan (HA); cartilage oligometric matrix protein (COMP); type II collagen (CII)-related neoepitope (C2C); type II procollagen carboxy-propeptide (CPII); and keratin sulfate (KS). Time courses for each biomarker were assessed, and relationships between these biomarkers and clinical or radiographic parameters generally used for RA were investigated. Results: Levels of CRP, MMP-3, DAS28-CRP, and annual progression of TSS were improved to similar degrees in both groups at week 54. HA and C2C/CPII were significantly decreased compared to baseline in the early RA group (p<0.001), whereas HA and COMP, but not C2C/CPII, were decreased in the established RA group. Strikingly, serum C2C/CPII levels were universally improved in early RA, regardless of EULAR response grade. Both Delta HA and Delta C2C/CPII from baseline to week 54 correlated significantly with not only Delta CRP, but also Delta DAS28 in early RA. Interestingly, when partial correlation coefficients were calculated by standardizing CRP levels, the significant correlation of Delta HA to Delta DAS28 disappeared, whereas correlations of Delta C2C/CPII to Delta DAS28, Delta JNS, and Delta HAQ remained significant. These results suggest a role of Delta C2C/CPII as a marker of ongoing structural joint damage with the least association with CRP, and that irreversible cartilage damage in established RA limits restoration of the C2C/CPII level, even with tight control of joint inflammation. Conclusion: The temporal course of C2C/CPII level during anti-TNF therapy indicates that CII turnover shifts toward CII synthesis in early RA, but not in established RA, potentially due to irreversible cartilage damage. Delta C2C/CPII appears to offer a useful marker reflecting ongoing structural joint damage, dissociated from inflammatory indices such as CRP and MMP-3.	[Niki, Yasuo; Nakayama, Masanori; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Takeuchi, Tsutomu; Nagasawa, Hayato; Kurasawa, Takahiko] Saitama Med Ctr, Div Rheumatol & Clin Immunol, Saitama, Japan; [Yamada, Harumoto] Fujita Hlth Univ, Dept Orthopaed Surg, Nagoya, Aichi, Japan	Keio University; Keio University; Fujita Health University	Niki, Y (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	y-niki@a8.keio.jp	Toyama, Yoshiaki/K-5743-2013; Kurasawa, Takahiko/L-2905-2013; Takeuchi, Tsutomu/L-2327-2013; Takeuchi, Tsutomu/AFM-8316-2022	Takeuchi, Tsutomu/0000-0003-1111-8218; 				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Cahue S, 2007, OSTEOARTHR CARTILAGE, V15, P819, DOI 10.1016/j.joca.2007.01.016; Crnkic M, 2003, ARTHRITIS RES THER, V5, pR181, DOI 10.1186/ar760; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Garnero P, 2001, ANN RHEUM DIS, V60, P619, DOI 10.1136/ard.60.6.619; Gordon CD, 2008, CLIN CHIM ACTA, V398, P21, DOI 10.1016/j.cca.2008.07.031; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Kim TH, 2005, ARTHRITIS RHEUM-US, V52, P885, DOI 10.1002/art.20870; Kong SY, 2006, ARTHRITIS RHEUM-US, V54, P2496, DOI 10.1002/art.21977; Lamers RJAN, 2005, OSTEOARTHR CARTILAGE, V13, P762, DOI 10.1016/j.joca.2005.04.005; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; MANSSON B, 1995, J CLIN INVEST, V95, P1071, DOI 10.1172/JCI117753; Morozzi G, 2007, CLIN RHEUMATOL, V26, P1335, DOI 10.1007/s10067-006-0520-y; Mullan RH, 2007, ARTHRITIS RHEUM, V56, P2919, DOI 10.1002/art.22843; Mundermann A, 2005, OSTEOARTHR CARTILAGE, V13, P34, DOI 10.1016/j.joca.2004.09.007; POOLE AR, 1995, MECH MODELS RHEUMATO, P163; POOLE AR, 1993, ARTHRITIS ALLIED CON, P279; RIZKALLA G, 1992, J CLIN INVEST, V90, P2268, DOI 10.1172/JCI116113; ROOS H, 1995, OSTEOARTHR CARTILAGE, V3, P7, DOI 10.1016/S1063-4584(05)80033-0; Takeuchi T, 2008, MOD RHEUMATOL, V18, P447, DOI 10.1007/s10165-008-0077-5; THONAR EJMA, 1992, CLIN BIOCHEM, V25, P175, DOI 10.1016/0009-9120(92)90263-R; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P187, DOI 10.1007/s10545-005-5673-3; van den Broek M, 2011, ANN RHEUM DIS, V70, P1389, DOI 10.1136/ard.2010.147751; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2; Vignon E, 2001, OSTEOARTHR CARTILAGE, V9, P289, DOI 10.1053/joca.2000.0387; Wakitani S, 2007, RHEUMATOLOGY, V46, P1652, DOI 10.1093/rheumatology/kem220; Young-Min S, 2007, ARTHRITIS RHEUM-US, V56, P3236, DOI 10.1002/art.22923	29	17	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37447	10.1371/journal.pone.0037447	http://dx.doi.org/10.1371/journal.pone.0037447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629396	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343100028
J	Cancedda, R; Liu, Y; Ruggiu, A; Tavella, S; Biticchi, R; Santucci, D; Schwartz, S; Ciparelli, P; Falcetti, G; Tenconi, C; Cotronei, V; Pignataro, S				Cancedda, Ranieri; Liu, Yi; Ruggiu, Alessandra; Tavella, Sara; Biticchi, Roberta; Santucci, Daniela; Schwartz, Silvia; Ciparelli, Paolo; Falcetti, Giancarlo; Tenconi, Chiara; Cotronei, Vittorio; Pignataro, Salvatore			The Mice Drawer System (MDS) Experiment and the Space Endurance Record-Breaking Mice	PLOS ONE			English	Article							SIMULATED MICROGRAVITY; SKELETAL-MUSCLE; BONE-FORMATION; HEART-RATE; EXPRESSION; COSMONAUTS; HUMANS; FLIGHT; DIFFERENTIATION; PROLIFERATION	The Italian Space Agency, in line with its scientific strategies and the National Utilization Plan for the International Space Station (ISS), contracted Thales Alenia Space Italia to design and build a spaceflight payload for rodent research on ISS: the Mice Drawer System (MDS). The payload, to be integrated inside the Space Shuttle middeck during transportation and inside the Express Rack in the ISS during experiment execution, was designed to function autonomously for more than 3 months and to involve crew only for maintenance activities. In its first mission, three wild type (Wt) and three transgenic male mice overexpressing pleiotrophin under the control of a bone-specific promoter (PTN-Tg) were housed in the MDS. At the time of launch, animals were 2-months old. MDS reached the ISS on board of Shuttle Discovery Flight 17A/STS-128 on August 28th, 2009. MDS returned to Earth on November 27th, 2009 with Shuttle Atlantis Flight ULF3/STS-129 after 91 days, performing the longest permanence of mice in space. Unfortunately, during the MDS mission, one PTN-Tg and two Wt mice died due to health status or payload-related reasons. The remaining mice showed a normal behavior throughout the experiment and appeared in excellent health conditions at landing. During the experiment, the mice health conditions and their water and food consumption were daily checked. Upon landing mice were sacrificed, blood parameters measured and tissues dissected for subsequent analysis. To obtain as much information as possible on microgravity-induced tissue modifications, we organized a Tissue Sharing Program: 20 research groups from 6 countries participated. In order to distinguish between possible effects of the MDS housing conditions and effects due to the near-zero gravity environment, a ground replica of the flight experiment was performed at the University of Genova. Control tissues were collected also from mice maintained on Earth in standard vivarium cages.	[Cancedda, Ranieri; Liu, Yi; Ruggiu, Alessandra; Tavella, Sara; Biticchi, Roberta] Univ Genoa, Genoa, Italy; [Cancedda, Ranieri; Liu, Yi; Ruggiu, Alessandra; Tavella, Sara; Biticchi, Roberta] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Santucci, Daniela; Schwartz, Silvia] Ist Super Sanita, Dept Cell Biol & Neurosci, Behav Neurosci Sect, I-00161 Rome, Italy; [Ciparelli, Paolo; Falcetti, Giancarlo; Tenconi, Chiara] Thales Alenia Space, Vimodrone, MI, Italy; [Cotronei, Vittorio; Pignataro, Salvatore] ASI, Rome, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Istituto Superiore di Sanita (ISS); Thales Group; Agenzia Spaziale Italiana (ASI)	Cancedda, R (corresponding author), Univ Genoa, Genoa, Italy.	ranieri.cancedda@unige.it	Tavella, Sara/D-3011-2017	Tavella, Sara/0000-0003-1478-4910; Schwartz, Silvia/0000-0003-1615-2378				Adami G, 2002, J Gravit Physiol, V9, pP341; Bao JX, 2007, AVIAT SPACE ENVIR MD, V78, P852; Blomqvist C G, 1994, J Gravit Physiol, V1, pP122; Bucaro MA, 2007, J CELL BIOCHEM, V102, P483, DOI 10.1002/jcb.21310; Caillot-Augusseau A, 1998, CLIN CHEM, V44, P578; Colleran PN, 2000, J APPL PHYSIOL, V89, P1046, DOI 10.1152/jappl.2000.89.3.1046; Davidson JM, 1999, FASEB J, V13, P325, DOI 10.1096/fasebj.13.2.325; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Diedrich A, 2007, AM J MED SCI, V334, P80, DOI 10.1097/MAJ.0b013e318065b89b; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; FritschYelle JM, 1996, J APPL PHYSIOL, V80, P910, DOI 10.1152/jappl.1996.80.3.910; Fuller C A, 1985, Physiologist, V28, pS199; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gundel A, 2002, AVIAT SPACE ENVIR MD, V73, P17; Hahn H, 2008, J NEUROSCI METH, V171, P60, DOI 10.1016/j.jneumeth.2008.02.004; Kalb R, 2007, ARCH NEUROL-CHICAGO, V64, P485, DOI 10.1001/archneur.64.4.485; Lackner JR, 2006, EXP BRAIN RES, V175, P377, DOI 10.1007/s00221-006-0697-y; Li G, 2005, CALCIFIED TISSUE INT, V76, P299, DOI 10.1007/s00223-004-0145-6; Liu Y, 2009, BASIC APPL MYOL, P87; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; Meshkov D, 1995, ACTA ASTRONAUT, V36, P719, DOI 10.1016/0094-5765(95)00162-X; Mikelis C, 2011, J CELL BIOCHEM, V112, P1532, DOI 10.1002/jcb.23066; Mulavara AP, 2010, EXP BRAIN RES, V202, P649, DOI 10.1007/s00221-010-2171-0; Norsk P, 2005, CURR PHARM BIOTECHNO, V6, P325, DOI 10.2174/1389201054553734; Pietrzyk RA, 2007, AVIAT SPACE ENVIR MD, V78, pA9; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Slentz DH, 2001, IN VITRO CELL DEV-AN, V37, P148; Sonnenfeld G, 2002, MED SCI SPORT EXER, V34, P2021, DOI 10.1097/00005768-200212000-00024; Tesch PA, 2008, J APPL PHYSIOL, V105, P902, DOI 10.1152/japplphysiol.90558.2008; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; WOODS KM, 1994, EXP CELL RES, V211, P171, DOI 10.1006/excr.1994.1074; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47	32	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e32243	10.1371/journal.pone.0032243	http://dx.doi.org/10.1371/journal.pone.0032243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666312	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349600002
J	Byun, K; Bayarsaikhan, E; Kim, D; Kim, CY; Mook-Jung, I; Paek, SH; Kim, SU; Yamamoto, T; Won, MH; Song, BJ; Park, YM; Lee, B				Byun, Kyunghee; Bayarsaikhan, Enkhjaigal; Kim, Daesik; Kim, Chae Young; Mook-Jung, Inhee; Paek, Sun Ha; Kim, Seung U.; Yamamoto, Tadashi; Won, Moo-Ho; Song, Byoung-Joon; Park, Young Mok; Lee, Bonghee			Induction of Neuronal Death by Microglial AGE-Albumin: Implications for Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; ADVANCED GLYCATION ENDPRODUCTS; CEREBROSPINAL-FLUID; PROGRESSION FACTOR; PROTEIN; ACTIVATION; APOPTOSIS; SYSTEM; IMMUNE; CELLS	Advanced glycation end products (AGEs) have long been considered as potent molecules promoting neuronal cell death and contributing to neurodegenerative disorders such as Alzheimer's disease (AD). In this study, we demonstrate that AGE-albumin, the most abundant AGE product in human AD brains, is synthesized in activated microglial cells and secreted into the extracellular space. The rate of AGE-albumin synthesis in human microglial cells is markedly increased by amyloid-beta exposure and oxidative stress. Exogenous AGE-albumin upregulates the receptor protein for AGE (RAGE) and augments calcium influx, leading to apoptosis of human primary neurons. In animal experiments, soluble RAGE (sRAGE), pyridoxamine or ALT-711 prevented A beta-induced neuronal death in rat brains. Collectively, these results provide evidence for a new mechanism by which microglial cells promote death of neuronal cells through synthesis and secretion of AGE-albumin, thereby likely contributing to neurodegenerative diseases such as AD.	[Byun, Kyunghee; Bayarsaikhan, Enkhjaigal; Kim, Daesik; Lee, Bonghee] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea; [Byun, Kyunghee; Lee, Bonghee] Gachon Univ Med & Sci, Dept Anat & Cell Biol, Inchon, South Korea; [Kim, Chae Young; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Yamamoto, Tadashi] Niigata Univ, Inst Nephrol, Grad Sch Med & Dent Sci, Niigata, Japan; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chunchon, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, South Korea; [Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA; [Park, Young Mok] Korea Basic Sci Inst, Mass Spectrometer Res Ctr, Chungcheong Bukdo, South Korea	Gachon University; Gachon University; Seoul National University (SNU); Seoul National University (SNU); University of British Columbia; Niigata University; Kangwon National University; Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Korea Basic Science Institute (KBSI)	Byun, K (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea.	ympark@kbsi.re.kr; bhlee@gachon.ac.kr	Paek, Sun Ha/J-2760-2012; Mook, Inhee/J-2754-2012; Kim, Chaeyoung/GPW-6531-2022		National Research Foundation grant; Korean Government [SC-2110, 20110003677, 2010-0002054]; KBSI (Korea Basic Science Institute) grant [G30124]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	National Research Foundation grant(National Research Foundation of Korea); Korean Government(Korean Government); KBSI (Korea Basic Science Institute) grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Research Foundation grant funded by the Korean Government (No. SC-2110, 20110003677 and 2010-0002054) and the KBSI (Korea Basic Science Institute) grant (G30124; Y.M.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; [Anonymous], 2002, CELL CALCIUM, V40, P553; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Eikelenboom P, 2000, ALZ DIS ASSOC DIS, V14, pS54, DOI 10.1097/00002093-200000001-00009; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Gsell W, 1996, J NEURAL TRANSM-SUPP, P73; Gsell W, 1997, J NEURAL TRANSM-SUPP, P145; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Ko HW, 1998, J NEUROCHEM, V71, P1390; Ko HW, 1998, KO HW PARK KY KIM H; Krautwald M, 2011, REJUV RES, V14, P383, DOI 10.1089/rej.2010.1143; LeBlanc A, 1995, J NEUROSCI, V15, P7837; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; LUBERNAROD J, 1988, NEUROSCI LETT, V94, P17, DOI 10.1016/0304-3940(88)90263-7; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Munch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y; Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1; Munch G, 1998, J NEURAL TRANSM, V105, P439, DOI 10.1007/s007020050069; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rahmadi A, 2011, CLIN CHEM LAB MED, V49, P385, DOI 10.1515/CCLM.2011.079; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHUMACHER U, 1994, ACTA NEUROPATHOL, V87, P422; Shuvaev VV, 2001, NEUROBIOL AGING, V22, P397, DOI 10.1016/S0197-4580(00)00253-0; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takeuchi M, 2007, MED HYPOTHESES, V69, P1358, DOI 10.1016/j.mehy.2006.12.017; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030	34	59	59	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37917	10.1371/journal.pone.0037917	http://dx.doi.org/10.1371/journal.pone.0037917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662249	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300140
J	Hauser, W; Jung, E; Erbsloh-Moller, B; Gesmann, M; Kuhn-Becker, H; Petermann, F; Langhorst, J; Weiss, T; Winkelmann, A; Wolfe, F				Haeuser, Winfried; Jung, Eva; Erbsloeh-Moeller, Brigitte; Gesmann, Mechthild; Kuehn-Becker, Hedi; Petermann, Franz; Langhorst, Jost; Weiss, Thomas; Winkelmann, Andreas; Wolfe, Frederick			Validation of the Fibromyalgia Survey Questionnaire within a Cross-Sectional Survey	PLOS ONE			English	Article							OF-RHEUMATOLOGY CRITERIA; GERMAN VERSION; TENDER POINTS; DIAGNOSIS; CLASSIFICATION; DISEASE; SCALE; PAIN	The Fibromyalgia Survey Questionnaire (FSQ) assesses the key symptoms of fibromyalgia syndrome. The FSQ can be administrated in survey research and settings where the use of interviews to evaluate the number of pain sites and extent of somatic symptom intensity and tender point examination would be difficult. We validated the FSQ in a cross-sectional survey with FMS patients. In a cross-sectional survey, participants with physician diagnosis of FMS were recruited by FMS-self help organisations and nine clinical institutions of different levels of care. Participants answered the FSQ (composed by the Widespread Pain Index [WPI] and the Somatic Severity Score [SSS]) assessing the Fibromyalgia Survey Diagnostic Criteria (FSDC) and the Patient Health Questionnaire PHQ 4. American College of Rheumatology 1990 classification criteria were assessed in a subgroup of participants. 1,651 persons diagnosed with FMS were included into analysis. The acceptance of the FSQ-items ranged between 78.9 to 98.1% completed items. The internal consistency of the items of the SSS ranged between 0.75-0.82. 85.5% of the study participants met the FSDC. The concordance rate of the FSDC and ACR 1990 criteria was 72.7% in a subsample of 128 patients. The Pearson correlation of the SSS with the PHQ 4 depression score was 0.52 (p<0.0001) and with the PHQ anxiety score was 0.51 (p<0.0001) (convergent validity). 64/202 (31.7%) of the participants not meeting the FSDC criteria and 152/1283 (11.8%) of the participants meeting the FSDC criteria reported an improvement (slightly too very much better) in their health status since FMS-diagnosis (Chi(2) = 55, p<0.0001) (discriminant validity). The study demonstrated the feasibility of the FSQ in a cross-sectional survey with FMS-patients. The reliability, convergent and discriminant validity of the FSQ were good. Further validation studies of the FSQ in clinical and general population settings are necessary.	[Haeuser, Winfried; Jung, Eva] Klinikum Saarbrucken, Dept Internal Med 1, Saarbrucken, Germany; [Haeuser, Winfried; Jung, Eva] Tech Univ Munich, Dept Psychosomat Med & Psychotherapy, Munich, Germany; [Petermann, Franz] Univ Bremen, Ctr Clin Psychol & Rehabil, D-28359 Bremen, Germany; [Langhorst, Jost] Kliniken Essen Mitte, Dept Internal Med Intergrat Med 5, Essen, Germany; [Weiss, Thomas] Outpatient Clin Mannheim, Mannheim, Germany; [Winkelmann, Andreas] Klinikum Univ Munchen, Dept Phys Med & Rehabil, Munich, Germany; [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS USA; [Wolfe, Frederick] Univ Kansas, Sch Med, Wichita, KS 67214 USA	Technical University of Munich; University of Bremen; Kliniken Essen-Mitte; University of Munich; National Data Bank for Rheumatic Diseases; University of Kansas; University of Kansas Medical Center	Hauser, W (corresponding author), Klinikum Saarbrucken, Dept Internal Med 1, Saarbrucken, Germany.	whaeuser@klinikum-saarbruecken.de	Häuser, Winfried/AAX-6231-2021; Häuser, Winfried/AAH-6633-2021	Hauser, Winfried/0000-0002-3742-729X; Wolfe, Frederick/0000-0002-2801-6413	German League for People with Arthritis and Rheumatism; Eli-Lilly; Pfizer	German League for People with Arthritis and Rheumatism; Eli-Lilly(Eli Lilly); Pfizer(Pfizer)	The study was financially supported by the German League for People with Arthritis and Rheumatism (www.rheuma-liga.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Hauser received honoraria for education lectures from Eli-Lilly, Pfizer and Janssen-Cilag and a congress travel grant by Eli-Lilly. Dr Weiss and Dr. Winkelmann were investigators in a study of pregabalin in FMS, sponsored by Pfizer. The other authors have no conflicts of interest to declare. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Croft P, 1996, ANN RHEUM DIS, V55, P482, DOI 10.1136/ard.55.7.482; ERICSSON KA, 1980, PSYCHOL REV, V87, P215, DOI 10.1037/0033-295X.87.3.215; Fletcher Astrid, 1992, British Medical Journal, V305, P1145; Goldenberg Don L, 2009, Am J Med, V122, pS14, DOI 10.1016/j.amjmed.2009.09.007; Hauser W, 2010, SCHMERZ, V24, P226, DOI 10.1007/s00482-010-0931-1; Hauser W, 2007, J CLIN GASTROENTEROL, V41, P157; Hauser W, 2010, CLIN J PAIN, V26, P505, DOI 10.1097/AJP.0b013e3181d92a6c; Hauser W, 2009, J RHEUMATOL, V36, P2806, DOI 10.3899/jrheum.090579; Hauser W, 2009, DTSCH ARZTEBL INT, V106, P383, DOI 10.3238/arztebl.2009.0383; Hauser W, 2004, EUR J GASTROEN HEPAT, V16, P599, DOI 10.1097/01.meg.000108324.52416.18; Katz RS, 2006, ARTHRITIS RHEUM-US, V54, P169, DOI 10.1002/art.21533; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Okifuji A, 1997, J RHEUMATOL, V24, P377; Walitt B, 2011, J RHEUMATOL, V38, P2238, DOI 10.3899/jrheum.110026; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1990, ARTHRITIS CARE RES H, V62, P600; Wolfe F, 2011, ARTHRIT CARE RES, V63, P1073, DOI 10.1002/acr.20468; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594	19	83	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37504	10.1371/journal.pone.0037504	http://dx.doi.org/10.1371/journal.pone.0037504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662163	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300053
J	Villar, VH; Vogler, O; Martinez-Serra, J; Ramos, R; Calabuig-Farinas, S; Gutierrez, A; Barcelo, F; Martin-Broto, J; Alemany, R				Hugo Villar, Victor; Voegler, Oliver; Martinez-Serra, Jordi; Ramos, Rafael; Calabuig-Farinas, Silvia; Gutierrez, Antonio; Barcelo, Francisca; Martin-Broto, Javier; Alemany, Regina			Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE INHIBITORS; DOSE DOXORUBICIN; CANCER-THERAPY; CELL-LINES; BCR-ABL; PHASE-I; IMATINIB; SUNITINIB	The therapeutic effect of doxorubicin (DXR) in the treatment of soft tissue sarcomas (STS) is limited by its toxicity and the development of multidrug resistance (MDR), the latter mainly induced by high expression of efflux pumps (e. g., P-glycoprotein [P-gp]). Therefore, the search for alternative therapies, which sensitize these tumors to chemotherapy while maintaining a low toxicity profile, is a rational approach. We assessed efficacy and molecular mechanisms involved in the antiproliferative effects of the tyrosine kinase inhibitors, nilotinib and imatinib, as single agents or in combination with DXR, in human synovial sarcoma SW982 and leiomyosarcoma SK-UT-1 cells. As single compound nilotinib (1-10 mu M) was more potent than imatinib inhibiting the growth of SK-UT-1 and SW982 cells by 33.5-59.6%, respectively. Importantly, only nilotinib synergized the antitumoral effect of DXR (0.05-0.5 mu M) by at least 2-fold, which clearly surpassed the mere sum of effects according to isobolographic analysis. Moreover, nilotinib in combination with DXR had a sustained effect on cell number (-70.3+/-5.8%) even 12 days after withdrawal of drugs compared to DXR alone. On the molecular level, only nilotinib fully blocked FBS-induced ERK1 and p38 MAPK activation, hence, reducing basal and DXR-induced up-regulation of P-gp levels. Moreover, efflux activity of the MDR-related proteins P-gp and MRP-1 was inhibited, altogether resulting in intracellular DXR retention. In high-risk STS tumors 53.8% and 15.4% were positive for P-gp and MRP-1 expression, respectively, with high incidence of P-gp in synovial sarcoma (72.7%). In summary, nilotinib exhibits antiproliferative effects on cellular models of STS and sensitizes them to DXR by reverting DXR-induced P-gp-mediated MDR and inhibiting MRP-1 activity, leading to a synergistic effect with potential for clinical treatment.	[Hugo Villar, Victor; Voegler, Oliver; Martinez-Serra, Jordi; Ramos, Rafael; Calabuig-Farinas, Silvia; Gutierrez, Antonio; Barcelo, Francisca; Martin-Broto, Javier; Alemany, Regina] Univ Balearic Isl, Clin & Translat Res Grp, Dept Biol, Inst Univ Invest Ciencies Salut IUNICS, Palma De Mallorca, Spain; [Martinez-Serra, Jordi; Gutierrez, Antonio] Univ Hosp Son Espases, Dept Hematol, Palma De Mallorca, Spain; [Ramos, Rafael] Univ Hosp Son Espases, Dept Pathol, Palma De Mallorca, Spain; [Calabuig-Farinas, Silvia; Martin-Broto, Javier] Univ Hosp Son Espases, Dept Oncol, Palma De Mallorca, Spain	Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases	Villar, VH (corresponding author), Univ Balearic Isl, Clin & Translat Res Grp, Dept Biol, Inst Univ Invest Ciencies Salut IUNICS, Palma De Mallorca, Spain.	regina.alemany@uib.es	VILLAR, VICTOR H./AAD-2404-2020; Fariñas, Silvia Calabuig/D-8196-2018; IBIS, BIOMARCADORES/P-3515-2015; Alemany, Regina/A-2314-2011; Martinez-Serra, Jordi/C-2535-2009; Martín-Broto, Javier/AAI-2313-2019; Villar, Victor H./GQA-6295-2022; Barceló, Francisca/K-5288-2014; Vögler, Oliver/D-7658-2011; Villar, Victor H./GQR-0553-2022; Gutiérrez, Antonio/AAL-9381-2021	Villar, Victor H./0000-0003-2837-5018; Barceló, Francisca/0000-0002-9158-099X; Villar, Victor H./0000-0003-2837-5018; Martin-Broto, Javier/0000-0001-7350-6916; Alemany, Regina/0000-0003-2180-1213; Calabuig, Silvia/0000-0001-7749-174X	"Jose Ma Buesa del grupo GEIS"; "Asociacion Espanola contra el Cancer (Junta de Baleares)"; Spanish Ministry of Health [EC10-150]; "Conselleria d'Economia, Hisenda i Innovacio (Govern de les Illes Balears)"	"Jose Ma Buesa del grupo GEIS"; "Asociacion Espanola contra el Cancer (Junta de Baleares)"; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); "Conselleria d'Economia, Hisenda i Innovacio (Govern de les Illes Balears)"	Research was supported by grants "Jose Ma Buesa del grupo GEIS" and the "Asociacion Espanola contra el Cancer (Junta de Baleares)" and by Grand EC10-150 awarded by the Spanish Ministry of Health in 2010 (Independent Clinical Research Call). V. H. V. is supported by a PhD fellowship from the "Conselleria d'Economia, Hisenda i Innovacio (Govern de les Illes Balears)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Breccia M, 2010, LEUKEMIA RES, V34, P129, DOI 10.1016/j.leukres.2009.08.031; Davies A, 2009, LEUKEMIA, V23, P1999, DOI 10.1038/leu.2009.166; DeAngelo DJ, 2010, LEUKEMIA LYMPHOMA, V51, P363, DOI 10.3109/10428190903518295; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Gonzalez I, 2004, CLIN CANCER RES, V10, P751, DOI 10.1158/1078-0432.CCR-0778-03; Gooskens SLM, 2010, PEDIATR BLOOD CANCER, V55, P369, DOI 10.1002/pbc.22494; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gramza AW, 2009, CLIN CANCER RES, V15, P7510, DOI 10.1158/1078-0432.CCR-09-0190; Gronchi A, 2010, J CLIN ONCOL, V28, p15s; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Hamada A, 2003, J PHARMACOL EXP THER, V307, P824, DOI 10.1124/jpet.103.055574; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Moreno BH, 2010, CLIN TRANSL ONCOL, V12, P468, DOI 10.1007/s12094-010-0539-z; Le Cesne A, 2000, J CLIN ONCOL, V18, P2676, DOI 10.1200/JCO.2000.18.14.2676; Lu MS, 2008, J HUAZHONG U SCI-MED, V28, P451, DOI 10.1007/s11596-008-0417-x; Lubieniecka JM, 2005, J SURG ONCOL, V92, P267, DOI 10.1002/jso.20409; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Maurel J, 2010, CANCER-AM CANCER SOC, V116, P3692, DOI 10.1002/cncr.25111; Mealey KL, 1998, CANCER LETT, V126, P187, DOI 10.1016/S0304-3835(98)00004-4; Milano A, 2006, CRIT REV ONCOL HEMAT, V59, P74, DOI 10.1016/j.critrevonc.2005.12.002; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Nichols GL, 2003, CANCER INVEST, V21, P758, DOI 10.1081/CNV-120023774; O'Connor R, 2007, ANTICANCER RES, V27, P1267; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Peng CL, 2009, CANCER BIOL THER, V8, P1729, DOI 10.4161/cbt.8.18.9208; Potti A, 2004, ANTICANCER RES, V24, P333; Prenen H, 2006, PHARMACOLOGY, V77, P11, DOI 10.1159/000091943; Quintas-Cardama A, 2008, FUTURE ONCOL, V4, P611, DOI 10.2217/14796694.4.5.611; Reichardt P, 2008, CURR ONCOL REP, V10, P344, DOI 10.1007/s11912-008-0053-4; SCHOENFELD DA, 1982, CANCER, V50, P2757, DOI 10.1002/1097-0142(19821215)50:12<2757::AID-CNCR2820501211>3.0.CO;2-J; Serra JM, 2008, MOL PHARMACOL, V73, P1679, DOI 10.1124/mol.107.043372; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Swords R, 2009, DRUG DES DEV THER, V3, P89; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687	44	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37735	10.1371/journal.pone.0037735	http://dx.doi.org/10.1371/journal.pone.0037735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662203	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300093
J	Lohmann, M; Walenda, G; Hemeda, H; Joussen, S; Drescher, W; Jockenhoevel, S; Hutschenreuter, G; Zenke, M; Wagner, W				Lohmann, Michael; Walenda, Gudrun; Hemeda, Hatim; Joussen, Sylvia; Drescher, Wolf; Jockenhoevel, Stefan; Hutschenreuter, Gabriele; Zenke, Martin; Wagner, Wolfgang			Donor Age of Human Platelet Lysate Affects Proliferation and Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							FETAL BOVINE SERUM; FIBROBLAST-GROWTH-FACTOR; STROMAL CELLS; RICH PLASMA; DNA-METHYLATION; OSTEOGENIC DIFFERENTIATION; INTERNATIONAL-SOCIETY; ANIMAL SERUM; CALF SERUM; LIFE-SPAN	The regenerative potential declines upon aging. This might be due to cell-intrinsic changes in stem and progenitor cells or to influences by the microenvironment. Mesenchymal stem cells (MSC) raise high hopes in regenerative medicine. They are usually culture expanded in media with fetal calf serum (FCS) or other serum supplements such as human platelet lysate (HPL). In this study, we have analyzed the impact of HPL-donor age on culture expansion. 31 single donor derived HPLs (25 to 57 years old) were simultaneously compared for culture of MSC. Proliferation of MSC did not reveal a clear association with platelet counts of HPL donors or growth factors concentrations (PDGF-AB, TGF-beta 1, bFGF, or IGF-1), but it was significantly higher with HPLs from younger donors (<35 years) as compared to older donors (>45 years). Furthermore, HPLs from older donors increased activity of senescence-associated beta-galactosidase (SA-beta gal). HPL-donor age did not affect the fibroblastoid colony-forming unit (CFU-f) frequency, immunophenotype or induction of adipogenic differentiation, whereas osteogenic differentiation was significantly lower with HPLs from older donors. Concentrations of various growth factors (PDGF-AB, TGF-beta 1, bFGF, IGF-1) or hormones (estradiol, parathormone, leptin, 1,25 vitamin D3) were not associated with HPL-donor age or MSC growth. Taken together, our data support the notion that aging is associated with systemic feedback mechanisms acting on stem and progenitor cells, and this is also relevant for serum supplements in cell culture: HPLs derived from younger donors facilitate enhanced expansion and more pronounced osteogenic differentiation.	[Lohmann, Michael; Walenda, Gudrun; Hemeda, Hatim; Joussen, Sylvia; Zenke, Martin; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Dept Stem Cell Biol & Cellular Engn, Helmholtz Inst Biomed Engn, Aachen, Germany; [Drescher, Wolf] Rhein Westfal TH Aachen, Dept Orthoped, Sch Med, D-52062 Aachen, Germany; [Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Dept Appl Med Engn, Helmholtz Inst Biomed Engn, D-52062 Aachen, Germany; [Hutschenreuter, Gabriele] Rhein Westfal TH Aachen, Sch Med, Inst Transfus Med, D-52062 Aachen, Germany; [Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Inst Biomed Engn Cell Biol, D-52062 Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Lohmann, M (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Stem Cell Biol & Cellular Engn, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de		Jockenhoevel, Stefan/0000-0003-0584-9444; Wagner, Wolfgang/0000-0002-1971-3217	German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES); Else-Kroner Fresenius Stiftung; state North Rhine Westphalia within BioNRW2 (StemCellFactory); state North Rhine Westphalia within Stem Cell Network NRW	German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES)(Federal Ministry of Education & Research (BMBF)); Else-Kroner Fresenius Stiftung; state North Rhine Westphalia within BioNRW2 (StemCellFactory); state North Rhine Westphalia within Stem Cell Network NRW	This work was supported by the German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES), by the Else-Kroner Fresenius Stiftung, and by the state North Rhine Westphalia within BioNRW2 (StemCellFactory) and the Stem Cell Network NRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; Auer D, 2008, ANTICANCER RES, V28, P2213; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carrel A, 1921, J EXP MED, V34, P599, DOI 10.1084/jem.34.6.599; Chieregato K, 2011, CYTOTHERAPY, V13, P933, DOI 10.3109/14653249.2011.583232; Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; DOUMIT ME, 1993, J CELL PHYSIOL, V157, P326, DOI 10.1002/jcp.1041570216; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; George T, 2010, EXP GERONTOL, V45, P875, DOI 10.1016/j.exger.2010.07.006; Goedecke A, 2011, J TISSUE ENG REGEN M, V5, P648, DOI 10.1002/term.359; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Huang Q, 2009, CHINESE MED J-PEKING, V122, P83, DOI 10.3760/cma.j.issn.0366-6999.2009.01.015; HWANG DL, 1992, EXP CELL RES, V200, P358, DOI 10.1016/0014-4827(92)90183-9; Koch CM, 2012, AGING CELL, V11, P366, DOI 10.1111/j.1474-9726.2011.00784.x; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; KONDO H, 1988, EXP CELL RES, V178, P287, DOI 10.1016/0014-4827(88)90399-0; Kumar A, 2010, TISSUE ENG PT A, V16, P983, DOI [10.1089/ten.tea.2009.0230, 10.1089/ten.TEA.2009.0230]; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Lucchini G, 2010, BIOL BLOOD MARROW TR, V16, P1293, DOI 10.1016/j.bbmt.2010.03.017; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller I, 2006, CYTOTHERAPY, V8, P437, DOI 10.1080/14653240600920782; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ogino Y, 2006, ORAL SURG ORAL MED O, V101, P724, DOI 10.1016/j.tripleo.2005.08.016; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Parker RC, 1931, SCIENCE, V74, P181, DOI 10.1126/science.74.1911.181; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Schallmoser Katharina, 2009, J Vis Exp, DOI 10.3791/1523; Schallmoser K, 2009, BIO-MED MATER ENG, V19, P271, DOI 10.3233/BME-2009-0591; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; von Bonin M, 2009, BONE MARROW TRANSPL, V43, P245, DOI 10.1038/bmt.2008.316; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Walsh S, 2003, BONE, V33, P80, DOI 10.1016/S8756-3282(03)00165-0; Wirz S, 2011, TISSUE ENG PT A, V17, P1891, DOI [10.1089/ten.tea.2010.0610, 10.1089/ten.TEA.2010.0610]; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	61	106	113	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37839	10.1371/journal.pone.0037839	http://dx.doi.org/10.1371/journal.pone.0037839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662236	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300126
J	Lu, CC; Yang, JS; Chiang, JH; Hour, MJ; Lin, KL; Lin, JJ; Huang, WW; Tsuzuki, M; Lee, TH; Chung, JG				Lu, Chi-Cheng; Yang, Jai-Sing; Chiang, Jo-Hua; Hour, Mann-Jen; Lin, Kuei-Li; Lin, Jen-Jyh; Huang, Wen-Wen; Tsuzuki, Minoru; Lee, Tsung-Han; Chung, Jing-Gung			Novel Quinazolinone MJ-29 Triggers Endoplasmic Reticulum Stress and Intrinsic Apoptosis in Murine Leukemia WEHI-3 Cells and Inhibits Leukemic Mice	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VIVO; TUBULIN POLYMERIZATION; ANTITUMOR-ACTIVITY; IMMUNE-RESPONSE; BINDING AGENTS; BALB/C MICE; DEATH; CANCER	The present study was to explore the biological responses of the newly compound, MJ-29 in murine myelomonocytic leukemia WEHI-3 cells in vitro and in vivo fates. We focused on the in vitro effects of MJ-29 on ER stress and mitochondria-dependent apoptotic death in WEHI-3 cells, and to hypothesize that MJ-29 might fully impair the orthotopic leukemic mice. Our results indicated that a concentration-dependent decrease of cell viability was shown in MJ-29-treated cells. DNA content was examined utilizing flow cytometry, whereas apoptotic populations were determined using annexin V/PI, DAPI staining and TUNEL assay. Increasing vital factors of mitochondrial dysfunction by MJ-29 were further investigated. Thus, MJ-29-provaked apoptosis of WEHI-3 cells is mediated through the intrinsic pathway. Importantly, intracellular Ca2+ release and ER stress-associated signaling also contributed to MJ-29-triggered cell apoptosis. We found that MJ-29 stimulated the protein levels of calpain 1, CHOP and p-eIF2 alpha pathways in WEHI-3 cells. In in vivo experiments, intraperitoneal administration of MJ-29 significantly improved the total survival rate, enhanced body weight and attenuated enlarged spleen and liver tissues in leukemic mice. The infiltration of immature myeloblastic cells into splenic red pulp was reduced in MJ-29-treated leukemic mice. Moreover, MJ-29 increased the differentiations of T and B cells but decreased that of macrophages and monocytes. Additionally, MJ-29-stimulated immune responses might be involved in anti-leukemic activity in vivo. Based on these observations, MJ-29 suppresses WEHI-3 cells in vitro and in vivo, and it is proposed that this potent and selective agent could be a new chemotherapeutic candidate for anti-leukemia in the future.	[Lu, Chi-Cheng; Chiang, Jo-Hua; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yang, Jai-Sing] China Med Univ, Dept Pharmacol, Taichung, Taiwan; [Hour, Mann-Jen] China Med Univ, Sch Pharm, Taichung, Taiwan; [Lin, Kuei-Li] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Jen-Jyh] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan; [Lin, Jen-Jyh] China Med Univ Hosp, Div Cardiol, Taichung, Taiwan; [Huang, Wen-Wen; Lee, Tsung-Han; Chung, Jing-Gung] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Tsuzuki, Minoru] Nihon Pharmaceut Univ, Dept Biochem, Saitama, Japan; [Tsuzuki, Minoru] China Med Univ, Tsuzuki Inst Tradit Med, Taichung, Taiwan; [Chung, Jing-Gung] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; Chi Mei Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Lu, CC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@dragon.nchu.edu.tw; jgchung@mail.cmu.edu.tw	huang, wen/GXW-0661-2022; Chiang, Jo-Hua/E-4411-2016; Yang, Jai Sing/M-1162-2015; Lu, Chi-Cheng/N-7770-2013; Huang, WW/GXH-0977-2022	Yang, Jai Sing/0000-0001-7302-8248; Lu, Chi-Cheng/0000-0003-3149-0914; Lee, Tsung-Han/0000-0002-3542-4335	National Science Council, Republic of China (Taiwan) [NSC 95-2320-B-039-049-MY2]; Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence [DOH101-TD-C-111-005]	National Science Council, Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence	The authors thank the grant-in-aid (NSC 95-2320-B-039-049-MY2) from the National Science Council, Republic of China ( Taiwan) and the grant support by the Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astashkin E I, 2004, Dokl Biol Sci, V399, P500, DOI 10.1007/s10630-005-0023-z; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Ceruti S, 2003, MOL PHARMACOL, V63, P1437, DOI 10.1124/mol.63.6.1437; Chang YH, 2009, BIOSCI BIOTECH BIOCH, V73, P2589, DOI 10.1271/bbb.90357; Chen JC, 2000, CYTOBIOS, V102, P95; Chiang JH, 2011, CHEM RES TOXICOL, V24, P20, DOI 10.1021/tx100248s; Choi AY, 2011, EUR J PHARMACOL, V668, P115, DOI 10.1016/j.ejphar.2011.06.047; Chung JG, 2007, PROTEOMICS, V7, P3305, DOI 10.1002/pmic.200700200; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Funk RK, 2008, BLOOD, V112, P1434, DOI 10.1182/blood-2008-01-132084; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; He Q, 2001, LEUKEMIA RES, V25, P455, DOI 10.1016/S0145-2126(00)00153-3; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Hour MJ, 2007, J CHIN CHEM SOC-TAIP, V54, P785, DOI 10.1002/jccs.200700113; Hour MJ, 2000, J MED CHEM, V43, P4479, DOI 10.1021/jm000151c; Itzykson R, 2009, LEUKEMIA, V23, P673, DOI 10.1038/leu.2008.362; Ji BC, 2009, J AGR FOOD CHEM, V57, P7596, DOI 10.1021/jf901308p; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kelloff GJ, 2000, J NUTR, V130, p467S, DOI 10.1093/jn/130.2.467S; LANDRIGAN PJ, 1995, NEW ENGL J MED, V333, P1286; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee SJ, 2007, BIOCHEM BIOPH RES CO, V357, P620, DOI 10.1016/j.bbrc.2007.03.191; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Lin JP, 2011, ENV TOXICOL; Lin SY, 2010, NUTR CANCER, V62, P593, DOI 10.1080/01635580903532341; Lin SS, 2000, NEUROCHEM RES, V25, P1503, DOI 10.1023/A:1007632326953; Liu T, 2002, LEUKEMIA, V16, P223, DOI 10.1038/sj.leu.2402360; Liu WL, 2010, BLOOD, V116, P4938, DOI 10.1182/blood-2009-10-246439; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Moretta L, 2007, SURG ONCOL, V16, pS3, DOI 10.1016/j.suronc.2007.10.043; Morris PG, 2008, CLIN CANCER RES, V14, P7167, DOI 10.1158/1078-0432.CCR-08-0169; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Quan ZW, 2010, CANCER LETT, V295, P252, DOI 10.1016/j.canlet.2010.03.008; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ripamonti M, 1996, INVEST NEW DRUG, V14, P139; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Sitaresmi MN, 2009, J PEDIATR ONCOL NURS, V26, P198, DOI 10.1177/1043454209340315; Stahnke K, 2003, LEUKEMIA, V17, P2130, DOI 10.1038/sj.leu.2403144; Tsou MF, 2009, LEUKEMIA RES, V33, P1505, DOI 10.1016/j.leukres.2009.01.030; Weisberg E, 2004, LEUKEMIA, V18, P1951, DOI 10.1038/sj.leu.2403519; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu PP, 2011, ONCOL REP, V25, P551, DOI 10.3892/or.2010.1080; Yang JS, 2010, J PHARMACOL EXP THER, V334, P477, DOI 10.1124/jpet.109.165415; Yang JS, 2006, ANTICANCER RES, V26, P219; Yang JS, 2004, ANTICANCER RES, V24, P1769; Yu FS, 2011, J DENT RES, V90, P168, DOI 10.1177/0022034510384619; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	58	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36831	10.1371/journal.pone.0036831	http://dx.doi.org/10.1371/journal.pone.0036831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662126	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300017
J	Starcevich, SJ; Howell, PJ; Jacobs, SE; Sankovich, PM				Starcevich, Steven J.; Howell, Philip J.; Jacobs, Steven E.; Sankovich, Paul M.			Seasonal Movement and Distribution of Fluvial Adult Bull Trout in Selected Watersheds in the Mid-Columbia River and Snake River Basins	PLOS ONE			English	Article							SALVELINUS-CONFLUENTUS; LIFE-HISTORY; MIGRATION PATTERNS; HABITAT USE; POPULATION; CONSERVATION; DRAINAGE; ECOLOGY; IDAHO; CHARR	From 1997 to 2004, we used radio telemetry to investigate movement and distribution patterns of 206 adult fluvial bull trout (mean, 449 mm FL) from watersheds representing a wide range of habitat conditions in northeastern Oregon and southwestern Washington, a region for which there was little previous information about this species. Migrations between spawning and wintering locations were longest for fish from the Imnaha River (median, 89 km) and three Grande Ronde River tributaries, the Wenaha (56 km) and Lostine (41 km) rivers and Lookingglass Creek (47 km). Shorter migrations were observed in the John Day (8 km), Walla Walla (20 km) and Umatilla river (22 km) systems, where relatively extensive human alterations of the riverscape have been reported. From November through May, fish displayed station-keeping behavior within a narrow range (basin medians, 0.5-6.2 km). Prespawning migrations began after snowmelt-driven peak discharge and coincided with declining flows. Most postspawning migrations began by late September. Migration rates of individuals ranged from 0.1 to 10.7 km/day. Adults migrated to spawning grounds in consecutive years and displayed strong fidelity to previous spawning areas and winter locations. In the Grande Ronde River basin, most fish displayed an unusual fluvial pattern: After exiting the spawning tributary and entering a main stem river, individuals moved upstream to wintering habitat, often a substantial distance (maximum, 49 km). Our work provides additional evidence of a strong migratory capacity in fluvial bull trout, but the short migrations we observed suggest adult fluvial migration may be restricted in basins with substantial anthropogenic habitat alteration. More research into bull trout ecology in large river habitats is needed to improve our understanding of how adults establish migration patterns, what factors influence adult spatial distribution in winter, and how managers can protect and enhance fluvial populations.	[Starcevich, Steven J.; Jacobs, Steven E.] Oregon Dept Fish & Wildlife, Native Fish Invest Project, Corvallis, OR USA; [Howell, Philip J.] US Forest Serv, USDA, La Grande, OR USA; [Sankovich, Paul M.] US Fish & Wildlife Serv, Columbia River Fisheries Program Off, La Grande, OR USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service	Starcevich, SJ (corresponding author), Oregon Dept Fish & Wildlife, Native Fish Invest Project, Corvallis, OR USA.	steve.starcevich@oregonstate.edu			Bonneville Power Administration [94B134342, 4101]; USDA Forest Service; Idaho Power Company	Bonneville Power Administration; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Idaho Power Company	Bonneville Power Administration Contract Numbers 94B134342, 4101 (http://www.bpa.gov/corporate/). USDA Forest Service (http://www.fs.fed.us/pnw/about/labs.shtml). No contract number is available. Idaho Power Company (http://www.idahopower.com/). No contract number is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr MA, 2004, ECOL FRESHW FISH, V13, P294, DOI 10.1111/j.1600-0633.2004.00071.x; Baxter C.V., 2002, THESIS OREGON STATE; BJORNN TED C, 1964, TRANS AMER FISH SOC, V93, P70, DOI 10.1577/1548-8659(1964)93[70:MOPAWT]2.0.CO;2; Brenkman SJ, 2005, N AM J FISH MANAGE, V25, P1073, DOI 10.1577/M04-132.1; Brown Richard S., 1999, North American Journal of Fisheries Management, V19, P867, DOI 10.1577/1548-8675(1999)019&lt;0867:ETCTRF&gt;2.0.CO;2; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Downs CC, 2006, N AM J FISH MANAGE, V26, P190, DOI 10.1577/M04-180.1; Dunham J, 2008, FISHERIES, V33, P537, DOI 10.1577/1548-8446-33.11.537; Dunham JB, 1999, ECOL APPL, V9, P642, DOI 10.2307/2641151; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; DuPont J, 2007, N AM J FISH MANAGE, V27, P1268, DOI 10.1577/M06-137.1; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fitch L, 1997, FRIENDS BULL TROUT C, P427; FRALEY JJ, 1989, NORTHWEST SCI, V63, P133; Gross M.R., 1987, AM FISHERIES SOC S, V1, P14; Herman S. J., 1997, FRIENDS B TROUT C P, P217; Hogen DM, 2006, ECOL FRESHW FISH, V15, P376, DOI 10.1111/j.1600-0633.2006.00148.x; Jakober MJ, 1998, T AM FISH SOC, V127, P223, DOI 10.1577/1548-8659(1998)127<0223:ROSIOF>2.0.CO;2; Johnston F. D., 2005, THESIS U CALGARY ALB; MCCART P, 1997, FRIENDS B TROUT C P, P191; MCLEOD CL, 1997, FRIENDS BULL TROUT C, P413; Mogen JT, 2005, T AM FISH SOC, V134, P841, DOI 10.1577/T04-143.1; Moore TL, 2006, MIGRATORY PATTERNS S; Nelson ML, 2002, ENVIRON BIOL FISH, V64, P321, DOI 10.1023/A:1016062708588; Northcote T. G., 1997, North American Journal of Fisheries Management, V17, P1029, DOI 10.1577/1548-8675(1997)017<1029:PISAMI>2.3.CO;2; Power G, 2002, ENVIRON BIOL FISH, V64, P17, DOI 10.1023/A:1016066519418; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Riehle M., 1997, FRIENDS B TROUT C P, P137; Rieman B.E., 1993, INT302 US FOR SERV I; Rieman BE, 2001, N AM J FISH MANAGE, V21, P756, DOI 10.1577/1548-8675(2001)021&lt;0756:EPSAGC&gt;2.0.CO;2; RIEMAN BE, 1995, T AM FISH SOC, V124, P285, DOI 10.1577/1548-8659(1995)124<0285:OOBTIN>2.3.CO;2; ROSS MJ, 1982, PROG FISH CULT, V44, P41, DOI 10.1577/1548-8659(1982)44[41:STFSIR]2.0.CO;2; Schill D, 1994, SEASONAL MOVEMENT SP; Schoby GP, 2011, T AM FISH SOC, V140, P636, DOI 10.1080/00028487.2011.585578; Sokal R.R., 2012, BIOMETRY; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Spruell P, 1999, ECOL FRESHW FISH, V8, P114, DOI 10.1111/j.1600-0633.1999.tb00063.x; Starcevich SJ, 2010, CONSERVING WILD TROU, P258; Swanberg TR, 1997, T AM FISH SOC, V126, P735, DOI 10.1577/1548-8659(1997)126<0735:MOAHUB>2.3.CO;2; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; USFWS [U.S. Fish and Wildlife Service], 2002, B TROUT SALV CONFL; Watry CB, 2008, ECOL FRESHW FISH, V17, P231, DOI 10.1111/j.1600-0633.2007.00274.x; White G.C., 1990, ANAL WILDLIFE RADIO; Whiteley AR, 2004, MOL ECOL, V13, P3675, DOI 10.1111/j.1365-294X.2004.02365.x; WINTER JD, 1996, FISHERIES TECHNIQUES; WISSMAR RC, 1994, NORTHWEST SCI, V68, P1	46	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37257	10.1371/journal.pone.0037257	http://dx.doi.org/10.1371/journal.pone.0037257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655037	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900012
J	Tong, SL; Wang, XY; Guo, YM				Tong, Shilu; Wang, Xiao Yu; Guo, Yuming			Assessing the Short-Term Effects of Heatwaves on Mortality and Morbidity in Brisbane, Australia: Comparison of Case-Crossover and Time Series Analyses	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; EUROPEAN CITIES; UNITED-STATES; HOSPITAL ADMISSIONS; AIR-POLLUTION; WAVE; IMPACT; TEMPERATURE; VULNERABILITY; POPULATION	Background: Heat-related impacts may have greater public health implications as climate change continues. It is important to appropriately characterize the relationship between heatwave and health outcomes. However, it is unclear whether a case-crossover design can be effectively used to assess the event- or episode-related health effects. This study examined the association between exposure to heatwaves and mortality and emergency hospital admissions (EHAs) from non-external causes in Brisbane, Australia, using both case-crossover and time series analyses approaches. Methods: Poisson generalised additive model (GAM) and time-stratified case-crossover analyses were used to assess the short-term impact of heatwaves on mortality and EHAs. Heatwaves exhibited a significant impact on mortality and EHAs after adjusting for air pollution, day of the week, and season. Results: For time-stratified case-crossover analysis, odds ratios of mortality and EHAs during heatwaves were 1.62 (95% confidence interval (CI): 1.36-1.94) and 1.22 (95% CI: 1.14-1.30) at lag 1, respectively. Time series GAM models gave similar results. Relative risks of mortality and EHAs ranged from 1.72 (95% CI: 1.40-2.11) to 1.81 (95% CI: 1.56-2.10) and from 1.14 (95% CI: 1.06-1.23) to 1.28 (95% CI: 1.21-1.36) at lag 1, respectively. The risk estimates gradually attenuated after the lag of one day for both case-crossover and time series analyses. Conclusions: The risk estimates from both case-crossover and time series models were consistent and comparable. This finding may have implications for future research on the assessment of event- or episode-related (e.g., heatwave) health effects.	[Tong, Shilu; Wang, Xiao Yu; Guo, Yuming] Queensland Univ Technol, Sch Publ Hlth & Social Work, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Tong, SL (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	s.tong@qut.edu.au	Guo, Yuming/I-8353-2018	Guo, Yuming/0000-0002-1766-6592	Australian Research Council [DP0559655]; National Health and Medical Research Council (NHMRC) [553043]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian Research Council (DP0559655). ST was supported by a National Health and Medical Research Council (NHMRC) research fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Conti S, 2005, ENVIRON RES, V98, P390, DOI 10.1016/j.envres.2004.10.009; Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253; Fouillet A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-114; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Ishigami A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-5; Johnson Helen, 2005, Health Stat Q, P6; Kaiser Reinhard, 2007, Am J Public Health, V97 Suppl 1, pS158, DOI 10.2105/AJPH.2006.100081; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Li SQ, 2012, J PHYSIOL SCI, V62, P29, DOI 10.1007/s12576-011-0183-6; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Pachauri RK, 2007, CLIM CHANG 2007 SYNT; QLD Queensland Government Population and Housing Fact sheet-Brisbane City Council, 2009, QLD QUEENSL GOV POP; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Tong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012155; Wang XY, 2012, OCCUP ENVIRON MED, V69, P163, DOI 10.1136/oem.2010.062141; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005	32	60	63	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37500	10.1371/journal.pone.0037500	http://dx.doi.org/10.1371/journal.pone.0037500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655052	Green Published, gold			2022-12-27	WOS:000305338900028
J	Yang, BH; Li, HP; He, XJ; Wang, GY; Xu, SY				Yang, Baohui; Li, Haopeng; He, Xijing; Wang, Guoyu; Xu, Siyue			Minimally Invasive Surgical Approaches and Traditional Total Hip Arthroplasty: A Meta-Analysis of Radiological and Complications Outcomes	PLOS ONE			English	Article							STANDARD-INCISION; OFFSET	Background: Minimally invasive total hip arthroplasty (MITHA) remains considerably controversial. Limited visibility and prosthesis malposition increase the risk of post-surgical complications compared to those of the traditional method. Methods: A meta-analysis was undertaken of all published databases up to May 2011. The studies were divided into four subgroups according to the surgical approach taken. The radiological outcomes and complications of minimally invasive surgery were compared to traditional total hip arthroplasty (TTHA) using risk ratio, mean difference, and standardized mean difference statistics. Results: In five studies involving the posterolateral approach, no significant differences were found between the MITHA groups and the TTHA groups in the acetabular cup abduction angle (p = 0.41), acetabular anteversion (p = 0.96), and femoral prosthesis position (p = 0.83). However, the femoral offset was significantly increased (WMD = 3.00; 95% CI, 0.40-5.60; p = 0.02). Additionally, there were no significant differences among the complications in both the groups (dislocations, nerve injury, infection, deep vein thrombosis, proximal femoral fracture) and revision rate (p > 0.05). In three studies involving the posterior approach, there were no significant differences in radiological outcomes or all other complications between MITHA or TTHA groups (p > 0.05). Three studies involved anterolateral approach, while 2 studies used the lateral approach. However, the information from imaging and complications was not adequate for statistical analysis. Conclusions: Posterior MITHA seems to be a safe surgical procedure, without the increased risk of post-operative complication rates and component malposition rates. The posterolateral approach THA may lead to increased femoral offset. The current data are not enough to reach a positive conclusion that lateral and anterolateral approaches will result in increased risks of adverse effects and complications at the prosthesis site.	[Yang, Baohui; Li, Haopeng; He, Xijing; Wang, Guoyu; Xu, Siyue] Xi An Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Hosp 2, Coll Med, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	Yang, BH (corresponding author), Xi An Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Hosp 2, Coll Med, Xian 710049, Shaanxi Provinc, Peoples R China.	LHP-3993@163.com	Li, Hao/GPS-9834-2022; He, Xijing/AAE-7424-2021	He, Xijing/0000-0002-0465-5376				Archibeck MJ, 2001, J BONE JOINT SURG AM, V83A, P1666, DOI 10.2106/00004623-200111000-00008; Bennett D, 2007, J ARTHROPLASTY, V22, P490, DOI 10.1016/j.arth.2006.02.173; Berger Richard A, 2004, Instr Course Lect, V53, P149; Berry DJ, 2003, J BONE JOINT SURG AM, V85A, P2235, DOI 10.2106/00004623-200311000-00029; Bertin KC, 2004, CLIN ORTHOP RELAT R, P248, DOI 10.1097/01.blo.0000150294.81825.8c; Cannestra VP, 2000, J BONE JOINT SURG AM, V82A, P1291, DOI 10.2106/00004623-200009000-00009; Cheng T, 2009, INT ORTHOP, V33, P1473, DOI 10.1007/s00264-009-0743-z; Chimento GF, 2005, J ARTHROPLASTY, V20, P139, DOI 10.1016/j.arth.2004.09.061; Dorr LD, 2007, J BONE JOINT SURG AM, V89A, P1153, DOI 10.2106/JBJS.F.00940; Dorr LD, 1998, CLIN ORTHOP RELAT R, P144; Goldstein WM, 2004, ORTHOP CLIN N AM, V35, P131, DOI 10.1016/S0030-5898(03)00108-1; Goosen JHM, 2011, CLIN ORTHOP RELAT R, V469, P200, DOI 10.1007/s11999-010-1331-7; Graw BP, 2010, CLIN ORTHOP RELAT R, V468, P2372, DOI 10.1007/s11999-010-1300-1; Hart Radek, 2005, Acta Orthop Belg, V71, P60; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Khan RJK, 2011, INT ORTHOP, V35, P299, DOI 10.1007/s00264-010-1170-x; Kim YH, 2006, J ARTHROPLASTY, V21, P1092, DOI 10.1016/j.arth.2006.01.015; Kleemann RU, 2003, J ORTHOP RES, V21, P767, DOI 10.1016/S0736-0266(03)00040-8; Mazoochian F, 2009, ARCH ORTHOP TRAUM SU, V129, P1633, DOI 10.1007/s00402-009-0870-4; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morrey BF, 1997, CLIN ORTHOP RELAT R, V344, P179; Nakamura S, 2004, INT ORTHOP, V28, P214, DOI 10.1007/s00264-004-0570-1; Ogonda L, 2005, J BONE JOINT SURG AM, V87A, P701, DOI 10.2106/JBJS.D.02645; Pagnano MW, 2006, J ARTHROPLASTY, V21, P80, DOI 10.1016/j.arth.2006.03.001; Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004; Roy L, 2010, INJURY, V41, P365, DOI 10.1016/j.injury.2009.10.002; Sculco TP, 2004, ORTHOP CLIN N AM, V35, P137, DOI 10.1016/S0030-5898(03)00116-0; Shitama T, 2009, INT ORTHOP, V33, P1543, DOI 10.1007/s00264-008-0708-7; Siguier T, 2004, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000136651.21191.9f; Smith TO, 2011, INT ORTHOP, V35, P173, DOI 10.1007/s00264-010-1075-8; Szendroi M, 2006, INT ORTHOP, V30, P167, DOI 10.1007/s00264-005-0049-8; Varela-Egocheaga JR, 2010, REV ESP CIR ORTOP TR, V54, P27; Wall SJ, 2008, J ARTHROPLASTY, V23, P55, DOI 10.1016/j.arth.2008.06.010; Wohlrab D, 2008, ORTHOPADE, V37, P1121, DOI 10.1007/s00132-008-1343-0; Woolson ST, 2004, J BONE JOINT SURG AM, V86A, P1353, DOI 10.2106/00004623-200407000-00001; Yang CF, 2009, CHINESE J BONE JOINT, V24, P385; Yang YH, 2008, CHINESE J BONE JOINT, V23, P110	37	15	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37947	10.1371/journal.pone.0037947	http://dx.doi.org/10.1371/journal.pone.0037947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655086	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900063
J	Blumenthal, A; Nagalingam, G; Huch, JH; Walker, L; Guillemin, GJ; Smythe, GA; Ehrt, S; Britton, WJ; Saunders, BM				Blumenthal, Antje; Nagalingam, Gayathri; Huch, Jennifer H.; Walker, Lara; Guillemin, Gilles J.; Smythe, George A.; Ehrt, Sabine; Britton, Warwick J.; Saunders, Bernadette M.			M-tuberculosis Induces Potent Activation of IDO-1, but This Is Not Essential for the Immunological Control of Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERFERON-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; PICOLINIC-ACID; ANTIMICROBIAL ACTIVITY; MACROPHAGE ACTIVATION; IMMUNE-RESPONSE; TRYPTOPHAN; INHIBITION; KYNURENINE	Indoleamine 2,3-dioxygenesae-1 (IDO-1) catalyses the initial, rate-limiting step in tryptophan metabolism, thereby regulating tryptophan availability and the formation of downstream metabolites, including picolinic and quinolinic acid. We found that Mycobacterium tuberculosis infection induced marked upregulation of IDO-1 expression in both human and murine macrophages in vitro and in the lungs of mice following aerosol challenge with M. tuberculosis. The absence of IDO-1 in dendritic cells enhanced the activation of mycobacteria-specific T cells in vitro. Interestingly, IDO-1-deficiency during M. tuberculosis infection in mice was not associated with altered mycobacteria-specific T cell responses in vivo. The bacterial burden of infected organs, pulmonary inflammatory responses, and survival were also comparable in M. tuberculosis-infected IDO-1 deficient and wild type animals. Tryptophan is metabolised into either picolinic acid or quinolinic acid, but only picolinic acid inhibited the growth of M. tuberculosis in vitro. By contrast macrophages infected with pathogenic mycobacteria, produced quinolinic, rather than picolinic acid, which did not reduce M. tuberculosis growth in vitro. Therefore, although M. tuberculosis induces robust expression of IDO-1 and activation of tryptophan metabolism, IDO-1-deficiency fails to impact on the immune control and the outcome of the infection in the mouse model of tuberculosis.	[Blumenthal, Antje; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Blumenthal, Antje; Britton, Warwick J.; Saunders, Bernadette M.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Nagalingam, Gayathri; Huch, Jennifer H.; Walker, Lara] Centenary Inst Sydney, Mycobacterial Res Program, Sydney, NSW, Australia; [Guillemin, Gilles J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Smythe, George A.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Ehrt, Sabine] Cornell Univ, Program Immunol & Microbial Pathogenesis, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Britton, Warwick J.; Saunders, Bernadette M.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	Cornell University; University of Queensland; University of Sydney; Centenary Institute; University of New South Wales Sydney; University of New South Wales Sydney; Cornell University; University of Sydney	Blumenthal, A (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	a.blumenthal@uq.edu.au; b.saunders@centenary.org.au	Guillemin, Gilles J/C-3878-2015; Blumenthal, Antje/A-3608-2011; Ehrt, Sabine/AAU-6449-2020	Guillemin, Gilles J/0000-0001-8105-4470; Blumenthal, Antje/0000-0003-3673-7015; Saunders, Bernadette/0000-0003-0540-4445; Britton, Warwick/0000-0001-6721-9646	Australian National Health and Medical Research Council; NSW state government; Australian Postgraduate Award; National Institutes of Health [HL68525]; I.T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068525] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NSW state government; Australian Postgraduate Award(Australian Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I.T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Australian National Health and Medical Research Council and the NSW state government through its infrastructure grant to the Centenary 1 Institute. GN is a recipient of an Australian Postgraduate Award. This work was supported in part by National Institutes of Health grant HL68525 (to SE) and the I.T. Hirschl Trust (to SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Cai S, 2006, J ANTIMICROB CHEMOTH, V57, P85, DOI 10.1093/jac/dki418; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cheng SC, 2010, J IMMUNOL, V185, P2450, DOI 10.4049/jimmunol.1000756; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Davies NWS, 2010, INT J TRYPTOPHAN RES, V3, P121; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Heller MC, 2010, VET IMMUNOL IMMUNOP, V138, P174, DOI 10.1016/j.vetimm.2010.07.013; JOHNSON GS, 1979, J BIOL CHEM, V254, P5483; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Li Q, 2011, IMMUNOL LETT, V138, P113, DOI 10.1016/j.imlet.2011.03.008; Li Q, 2011, CELL MOL IMMUNOL, V8, P172, DOI 10.1038/cmi.2010.80; MacKenzie CR, 1999, EUR J IMMUNOL, V29, P3254, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3254::AID-IMMU3254&gt;3.0.CO;2-0; Maneglier B, 2009, FUND CLIN PHARMACOL, V23, P573, DOI 10.1111/j.1472-8206.2009.00703.x; Medana IM, 2002, J INFECT DIS, V185, P650, DOI 10.1086/339009; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Narui K, 2009, BIOL PHARM BULL, V32, P41, DOI 10.1248/bpb.32.41; Ozeki Y, 2010, INT IMMUNOL, V22, P179, DOI 10.1093/intimm/dxp126; Pais TF, 2000, J IMMUNOL, V164, P389, DOI 10.4049/jimmunol.164.1.389; Pais TF, 2004, MICROBIOL-SGM, V150, P1507, DOI 10.1099/mic.0.26815-0; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2003, J RHEUMATOL, V30, P1935; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490; Suzuki Y, 2012, CLIN VACCINE IMMUNOL, V19, P436, DOI 10.1128/CVI.05402-11; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; VARESIO L, 1990, J IMMUNOL, V145, P4265; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09	54	58	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37314	10.1371/journal.pone.0037314	http://dx.doi.org/10.1371/journal.pone.0037314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649518	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335800036
J	El Helou, N; Tafflet, M; Berthelot, G; Tolaini, J; Marc, A; Guillaume, M; Hausswirth, C; Toussaint, JF				El Helou, Nour; Tafflet, Muriel; Berthelot, Geoffroy; Tolaini, Julien; Marc, Andy; Guillaume, Marion; Hausswirth, Christophe; Toussaint, Jean-Francois			Impact of Environmental Parameters on Marathon Running Performance	PLOS ONE			English	Article							ATHLETIC PERFORMANCE; EXERCISE PERFORMANCE; AIR-POLLUTION; ANTICIPATORY REDUCTION; AMBIENT-TEMPERATURE; HEAT; RUNNERS; COLD; DOMINANCE; TIME	Purpose: The objectives of this study were to describe the distribution of all runners' performances in the largest marathons worldwide and to determine which environmental parameters have the maximal impact. Methods: We analysed the results of six European (Paris, London, Berlin) and American (Boston, Chicago, New York) marathon races from 2001 to 2010 through 1,791,972 participants' performances (all finishers per year and race). Four environmental factors were gathered for each of the 60 races: temperature (degrees C), humidity (%), dew point (degrees C), and the atmospheric pressure at sea level (hPA); as well as the concentrations of four atmospheric pollutants: NO2 - SO2 - O-3 and PM10 (mu g.m(-3)). Results: All performances per year and race are normally distributed with distribution parameters (mean and standard deviation) that differ according to environmental factors. Air temperature and performance are significantly correlated through a quadratic model. The optimal temperatures for maximal mean speed of all runners vary depending on the performance level. When temperature increases above these optima, running speed decreases and withdrawal rates increase. Ozone also impacts performance but its effect might be linked to temperature. The other environmental parameters do not have any significant impact. Conclusions: The large amount of data analyzed and the model developed in this study highlight the major influence of air temperature above all other climatic parameter on human running capacity and adaptation to race conditions.	[El Helou, Nour; Tafflet, Muriel; Berthelot, Geoffroy; Tolaini, Julien; Marc, Andy; Guillaume, Marion; Toussaint, Jean-Francois] INSEP, IRMES, BioMed Res Inst Sports Epidemiol, Paris, France; [El Helou, Nour; Berthelot, Geoffroy; Marc, Andy; Toussaint, Jean-Francois] Univ Paris 05, Paris, France; [El Helou, Nour] Univ St Joseph, Fac Pharm, Dept Nutr, Beirut, Lebanon; [Tafflet, Muriel] Paris Cardiovasc Res Ctr PARCC, INSERM, U970, Paris, France; [Hausswirth, Christophe] INSEP, Res Dept, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, F-75181 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	El Helou, N (corresponding author), INSEP, IRMES, BioMed Res Inst Sports Epidemiol, Paris, France.	nour.elhelou@insep.fr	Helou, Nour El/AAH-6490-2021	Helou, Nour El/0000-0002-6012-0042				AirParif website, 2009, AIR POLL DAT PAR; Alvarez-Ramirez J, 2007, PHYSICA A, V380, P447, DOI 10.1016/j.physa.2007.03.008; Alvarez-Ramirez J, 2006, PHYSICA A, V365, P509, DOI 10.1016/j.physa.2005.09.066; Armstrong LE, 1996, MED SCI SPORT EXER, V28, pR1; Baker J, 2003, BRIT J SPORT MED, V37, P553, DOI 10.1136/bjsm.37.6.553; Beis LY, 2012, CLIN J SPORT MED, V22, P254, DOI 10.1097/JSM.0b013e31824a55d7; Berthelot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008800; BUONCRISTIANI JF, 1983, CHANCE, V6, P24; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Chimenti L, 2009, J SPORT SCI, V27, P925, DOI 10.1080/02640410902946493; Coyle EF, 2007, SPORTS MED, V37, P306, DOI 10.2165/00007256-200737040-00009; Dawson NJ, 1987, T MENZIES FDN, V14, P41; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Ely MR, 2007, MED SCI SPORT EXER, V39, P2029, DOI 10.1249/mss.0b013e318149f2c3; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Gonzalez-Alonso J, 2007, SPORTS MED, V37, P371, DOI 10.2165/00007256-200737040-00025; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Hamilton B, 2000, BRIT J SPORT MED, V34, P391, DOI 10.1136/bjsm.34.5.391; Hargreaves M, 2008, J SCI MED SPORT, V11, P66, DOI 10.1016/j.jsams.2007.07.002; Kenefick RW, 2007, SPORTS MED, V37, P312, DOI 10.2165/00007256-200737040-00010; Kirschbaum MUF, 2011, FOREST ECOL MANAG, V262, P1008, DOI 10.1016/j.foreco.2011.05.036; Korrick SA, 1998, ENVIRON HEALTH PERSP, V106, P93, DOI 10.2307/3433784; Laaidi M, 2006, INT J BIOMETEOROL, V51, P145, DOI 10.1007/s00484-006-0045-8; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Lippi G, 2008, INT J SPORTS MED, V29, P696, DOI 10.1055/s-2008-1038684; Lippi G, 2008, J PHYSIOL-LONDON, V586, P3017, DOI 10.1113/jphysiol.2008.155887; LondonAir website, 2009, AIR POLL DAT LOND; MacArthur D, 2005, HUM GENET, V116, P331, DOI 10.1007/s00439-005-1261-8; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; Marino FE, 2000, PFLUG ARCH EUR J PHY, V441, P359, DOI 10.1007/s004240000432; Marr LC, 2010, MED SCI SPORT EXER, V42, P585, DOI 10.1249/MSS.0b013e3181b84a85; Martin DE, 1999, CHANCE, V12, P20, DOI DOI 10.1080/09332480.1999.10542170; Maughan RJ, 2007, SPORTS MED, V37, P396, DOI 10.2165/00007256-200737040-00032; Montain SJ, 2007, SPORTS MED, V37, P320, DOI 10.2165/00007256-200737040-00012; Nimmo M, 2004, J SPORT SCI, V22, P898, DOI 10.1080/0264041400005883; Online worldwide athletic results database website, MAR RAC RES; Roberts WO, 2010, MED SCI SPORT EXER, V42, P226, DOI 10.1249/MSS.0b013e3181b1cdcf; Rundell KW, 2012, BR J SPORTS MED; Sawka MN, 2006, AM COLL SPORTS MED A; SHEPHARD RJ, 1984, CAN MED ASSOC J, V131, P105; Station Database of the Environmental Agency, 2009, AIR POLL BERL; Thibault V, 2010, J SPORT SCI MED, V9, P214; TRAPASSO LM, 1989, INT J BIOMETEOROL, V33, P233, DOI 10.1007/BF01051083; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Vihma T, 2010, INT J BIOMETEOROL, V54, P297, DOI 10.1007/s00484-009-0280-x; Walters TJ, 2000, J APPL PHYSIOL, V89, P799, DOI 10.1152/jappl.2000.89.2.799; Weller AS, 1997, AM J PHYSIOL-REG I, V272, pR226, DOI 10.1152/ajpregu.1997.272.1.R226; Zeng LQ, 2009, COMP BIOCHEM PHYS A, V153, P125, DOI 10.1016/j.cbpa.2009.01.013; ZHANG SP, 1992, INT J BIOMETEOROL, V36, P63; Zouhal H, 2009, INT J SPORTS MED, V30, P516, DOI 10.1055/s-0029-1202350; Zouhal H, 2011, BRIT J SPORT MED, V45, P1101, DOI 10.1136/bjsm.2010.074641	54	96	101	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37407	10.1371/journal.pone.0037407	http://dx.doi.org/10.1371/journal.pone.0037407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649525	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800043
J	Hotte, NSC; Salim, SY; Tso, RH; Albert, EJ; Bach, P; Walker, J; Dieleman, LA; Fedorak, RN; Madsen, KL				Hotte, Naomi S. C.; Salim, Saad Y.; Tso, Robert H.; Albert, Eric J.; Bach, Phil; Walker, John; Dieleman, Levinus A.; Fedorak, Richard N.; Madsen, Karen L.			Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA	PLOS ONE			English	Article							TLR9 POLYMORPHISMS; CROHNS-DISEASE; RECEPTOR 9; MUCOSA; PROBIOTICS; COLITIS; MURINE; GENE	Background: A critical role for the gut epithelium lies in its ability to discriminate between pathogens and commensals and respond appropriately. Dysfunctional interactions between microbes and epithelia are believed to have a role in inflammatory bowel disease (IBD). In this study, we analyzed microbiota and gene expression in IBD patients and examined responses of mucosal biopsies to bacterial DNA. Methods: Biopsies were taken from non-inflamed areas of the colon in healthy controls (HC) and Crohn's disease (CD) and ulcerative colitis (UC) patients in remission. Biopsies were snap-frozen or cultured with DNA from Lactobacillus plantarum (LP) or Salmonella dublin (SD). Gene expression was analyzed under basal conditions and in response to DNA. Gene networks were analyzed using Ingenuity Pathways software. Mucosal-associated microbiota was analyzed using terminal restriction fragment length polymorphism. Frequency of single nucleotide polymorphisms in NOD2 and TLR9 was assessed. Results: Patients with IBD had altered microbiota, enhanced expression of inflammatory genes, and increased correlations between specific gene expression and microbes. Principle component analysis showed CD and UC patients to cluster independently from healthy controls in both gene expression and microbial analysis. DNA from LP stimulated anti-inflammatory pathways in controls and UC patients, but induced an upregulation of IL17A in CD patients. There were no differences in SNP frequencies of TLR9 or NOD2 in the groups. Conclusions: Patients with Crohn's disease exhibit altered responses to bacterial DNA. These findings suggest that the gut response to bacterial DNA may depend not only on the specific type of bacterial DNA, but also on the host.	[Hotte, Naomi S. C.; Salim, Saad Y.; Tso, Robert H.; Albert, Eric J.; Bach, Phil; Walker, John; Dieleman, Levinus A.; Fedorak, Richard N.; Madsen, Karen L.] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta	Hotte, NSC (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Salim, Saad/C-6470-2013; Madsen, Karen L/H-5898-2011; Dieleman, Levinus/AAT-8198-2021	Salim, Saad/0000-0002-6036-3589; Fedorak, Richard/0000-0002-7382-0080; Dieleman, Levinus/0000-0001-7852-2122	Canadian Institutes for Health Research; Crohns and Colitis Foundation of Canada; Alberta Innovates; Alberta IBD Consortium	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Crohns and Colitis Foundation of Canada; Alberta Innovates; Alberta IBD Consortium	Canadian Institutes for Health Research, http://www.cihr-irsc.gc.ca; Crohns and Colitis Foundation of Canada, http://www.ccfc.ca; Alberta Innovates, http://www.albertainnovates.ca; Alberta IBD Consortium, http://albertaibdconsortium.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Campeau J, 2010, GASTROENTEROLOGY; Chen GY, 2011, GASTROENTEROLOGY; Chen KH, 2011, BRIT J SURG, V98, P1252, DOI 10.1002/bjs.7532; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hedin C, 2007, P NUTR SOC, V66, P307, DOI 10.1017/S0029665107005563; Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x; Jijon H, 2004, GASTROENTEROLOGY, V126, P1358, DOI 10.1053/j.gastro.2004.02.003; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Sam-Agudu NA, 2010, AM J TROP MED HYG, V82, P548, DOI 10.4269/ajtmh.2010.09-0467; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	24	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37932	10.1371/journal.pone.0037932	http://dx.doi.org/10.1371/journal.pone.0037932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649567	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800087
J	Jacobs, VL; Liu, YN; De Leo, JA				Jacobs, Valerie L.; Liu, Yingna; De Leo, Joyce A.			Propentofylline Targets TROY, a Novel Microglial Signaling Pathway	PLOS ONE			English	Article							FACTOR RECEPTOR SUPERFAMILY; FAMILY-MEMBER; BRAIN-TUMORS; STEM-CELLS; GLIOMA; GLIOBLASTOMA; EXPRESSION; TNFRSF19; INTEGRINS; MIGRATION	Glioblastoma multiforme (GBM) is the most common and aggressive primary brain cancer, with a median survival of less than 2 years after diagnosis with current available therapies. The tumor microenvironment serves a critical role in tumor invasion and progression, with microglia as a critical player. Our laboratory has previously demonstrated that propentofylline, an atypical methylxanthine with central nervous system glial modulating and anti-inflammatory actions, significantly decreases tumor growth in a GBM rodent model by preferentially targeting microglia. In the present study, we used the CNS-1 rat glioma model to elucidate the mechanisms of propentofylline. Here we demonstrate that propentofylline targets TROY, a novel signaling molecule up-regulated in infiltrating microglia, and not macrophages, in response to CNS-1 cells. We identify Pyk2, Rac1 and pJNK as the downstream signaling molecules of TROY through western blot analysis and siRNA transfection. We demonstrate that inhibition of TROY expression in microglia by siRNA transfection significantly inhibits microglial migration towards CNS-1 cells similar to 10 mu M propentofylline treatment. These results identify TROY as a novel molecule expressed in microglia, involved in their migration and targeted by propentofylline. Furthermore, these results describe a signaling molecule that is differentially expressed between microglia and macrophages in the tumor microenvironment.	[Jacobs, Valerie L.; Liu, Yingna; De Leo, Joyce A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Jacobs, Valerie L.; De Leo, Joyce A.] Neurosci Ctr Dartmouth, Lebanon, NH USA; [De Leo, Joyce A.] Univ Cambridge Emmanuel Coll, Boston, MA USA	Dartmouth College; Dartmouth College	Jacobs, VL (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA.	deleoj@emmanuel.edu			National Institutes of Health [NIH/NIDA 1RO1DA025211, NIH T32 A107363]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding support is through National Institutes of Health grants: NIH/NIDA 1RO1DA025211, NIH T32 A107363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 1998, PHARMACOL REV, V50, P197; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; DeAngelis LM, 2005, NEW ENGL J MED, V352, P1036, DOI 10.1056/NEJMe058010; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; FREDHOLM BB, 1986, ACTA PHARMACOL TOX, V58, P187; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gilbert MR, 2011, SEMIN ONCOL, V38, pS21, DOI 10.1053/j.seminoncol.2011.09.008; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Jacobs VL, 2011, NEURO ONCOL; KRUSE CA, 1994, J NEURO-ONCOL, V22, P191, DOI 10.1007/BF01052919; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; Morikawa Y, 2008, ANN NY ACAD SCI, V1126, pA1, DOI 10.1196/annals.1366.036; NAGATA K, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1034; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qiu WM, 2010, J BIOL CHEM, V285, P14438, DOI 10.1074/jbc.M109.052001; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Sweitzer Sarah, 2011, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-642-13443-2_8; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Tuettenberg J, 2009, J CANCER RES CLIN, V135, P1239, DOI 10.1007/s00432-009-0565-9; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Yeh WL, 2012, J CELL PHYSIOL, V227, P558, DOI 10.1002/jcp.22746	31	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37955	10.1371/journal.pone.0037955	http://dx.doi.org/10.1371/journal.pone.0037955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649568	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800088
J	Jorde, R; Schirmer, H; Wilsgaard, T; Joakimsen, RM; Mathiesen, EB; Njolstad, I; Lochen, ML; Figenschau, Y; Berg, JP; Svartberg, J; Grimnes, G				Jorde, Rolf; Schirmer, Henrik; Wilsgaard, Tom; Joakimsen, Ragnar Martin; Mathiesen, Ellisiv Bogeberg; Njolstad, Inger; Lochen, Maja-Lisa; Figenschau, Yngve; Berg, Jens Petter; Svartberg, Johan; Grimnes, Guri			Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromso Study	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; VITAMIN-D STATUS; PARATHYROID-HORMONE; GENETIC-VARIANTS; ASSOCIATION; METABOLISM; PREDICTOR; CALCIUM; LINKAGE	Objective: Low serum 25(OH)D levels are associated with cardiovascular risk factors, and also predict future myocardial infarction (MI), type 2 diabetes (T2DM), cancer and all-cause mortality. Recently several single nucleotide polymorphisms (SNPs) associated with serum 25-hydroxyvitamin D (25(OH)D) level have been identified. If these relations are causal one would expect a similar association between these SNPs and health. Methods: DNA was prepared from subjects who participated in the fourth survey of the Tromso Study in 1994-1995 and who were registered with the endpoints MI, T2DM, cancer or death as well as a randomly selected control group. The endpoint registers were complete up to 2007-2010. Genotyping was performed for 17 SNPs related to the serum 25(OH)D level. Results: A total of 9528 subjects were selected for genetic analyses which were successfully performed for at least one SNP in 9471 subjects. Among these, 2025 were registered with MI, 1092 with T2DM, 2924 with cancer and 3828 had died. The mean differences in serum 25(OH)D levels between SNP genotypes with the lowest and highest serum 25(OH)D levels varied from 0.1 to 7.8 nmol/L. A genotype score based on weighted risk alleles regarding low serum 25(OH)D levels was established. There was no consistent association between the genotype score or individuals SNPs and MI, T2DM, cancer, mortality or risk factors for disease. However, for rs6013897 genotypes (located at the 24-hydroxylase gene (CYP24A1)) there was a significant association with breast cancer (P<0.05). Conclusion: Our results do not support nor exclude a causal relationship between serum 25(OH)D levels and MI, T2DM, cancer or mortality, and our observation on breast cancer needs confirmation. Further genetic studies are warranted, particularly in populations with vitamin D deficiency.	[Jorde, Rolf; Joakimsen, Ragnar Martin; Svartberg, Johan; Grimnes, Guri] Univ Tromso, Tromso Endocrine Res Grp, Dept Clin Med, Tromso, Norway; [Jorde, Rolf; Joakimsen, Ragnar Martin; Svartberg, Johan; Grimnes, Guri] Univ Hosp N Norway, Div Internal Med, Tromso, Norway; [Wilsgaard, Tom; Njolstad, Inger; Lochen, Maja-Lisa] Univ Tromso, Dept Community Med, Tromso, Norway; [Mathiesen, Ellisiv Bogeberg] Univ Tromso, Brain & Circulat Res Grp, Dept Clin Med, Tromso, Norway; [Mathiesen, Ellisiv Bogeberg] Univ Hosp N Norway, Dept Neurol & Neurophysiol, Tromso, Norway; [Figenschau, Yngve] Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway; [Figenschau, Yngve] Univ Hosp N Norway, Dept Lab Med, Tromso, Norway; [Berg, Jens Petter] Univ Oslo, Dept Med Biochem, Inst Clin Med, Oslo, Norway; [Berg, Jens Petter] Oslo Univ Hosp, Oslo, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Oslo	Jorde, R (corresponding author), Univ Tromso, Tromso Endocrine Res Grp, Dept Clin Med, Tromso, Norway.	rolf.jorde@unn.no	Njolstad, Inger/X-3784-2019; Berg, Jens P/G-1455-2012	Berg, Jens P/0000-0003-0157-5888; Schirmer, Henrik/0000-0002-9348-3149; Joakimsen, Ragnar Martin/0000-0002-2125-8081; Lochen, Maja-Lisa/0000-0002-8532-6573	North Norway Regional Health Authority; Norwegian Diabetes Association; University of Tromso	North Norway Regional Health Authority; Norwegian Diabetes Association; University of Tromso	The present study was supported by grants from the North Norway Regional Health Authority (htpp/:www.helse-nord.no), the Norwegian Diabetes Association (htpp/:www.diabetes.no), and the University of Tromso (htpp/:www.uit.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Barnett CM, 2011, UROL CLIN N AM, V38, P333, DOI 10.1016/j.ucl.2011.04.007; Broderstad AR, 2011, SCAND J GASTROENTERO, V46, P350, DOI 10.3109/00365521.2010.525713; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Chen GA, 2011, CLIN CANCER RES, V17, P817, DOI 10.1158/1078-0432.CCR-10-1789; CONSTANS J, 1980, FEBS LETT, V111, P107, DOI 10.1016/0014-5793(80)80772-1; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dorjgochoo T, 2011, CANCER EPIDEM BIOMAR, V20, P2313, DOI 10.1158/1055-9965.EPI-11-0704; Engelman CD, 2010, J STEROID BIOCHEM, V122, P186, DOI 10.1016/j.jsbmb.2010.06.013; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Grimnes G, 2010, DIABETIC MED, V27, P1107, DOI 10.1111/j.1464-5491.2010.03092.x; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hutchinson MS, 2011, SCAND J CLIN LAB INV, V71, P399, DOI 10.3109/00365513.2011.575235; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jorde R, 2005, J HYPERTENS, V23, P1639, DOI 10.1097/01.hjh.0000179764.40701.36; Jorde R, 2010, EUR J CLIN NUTR, V64, P1457, DOI 10.1038/ejcn.2010.176; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Joseph J, 2011, EUR J EPIDEMIOL, V26, P117, DOI 10.1007/s10654-010-9540-7; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; LEWONTIN RC, 1964, GENETICS, V49, P49; Livshits G, 1999, ANN HUM GENET, V63, P429, DOI 10.1046/j.1469-1809.1999.6350429.x; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Mannsverk J, 2012, EUR J PREV CARDIOL, V19, P927, DOI 10.1177/1741826711421081; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Ramnath N, 2011, EXPERT REV RESP MED, V5, P305, DOI [10.1586/ERS.11.31, 10.1586/ers.11.31]; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Shen HQ, 2010, ARTERIOSCL THROM VAS, V30, P2648, DOI 10.1161/ATVBAHA.110.211805; THELLE DS, 1976, ACTA MED SCAND, V200, P107; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037; Zintzaras E, 2006, DIS MARKERS, V22, P317, DOI 10.1155/2006/921694	44	90	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37295	10.1371/journal.pone.0037295	http://dx.doi.org/10.1371/journal.pone.0037295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649517	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800035
J	Koide, T; Banno, M; Aleksic, B; Yamashita, S; Kikuchi, T; Kohmura, K; Adachi, Y; Kawano, N; Kushima, I; Nakamura, Y; Okada, T; Ikeda, M; Ohi, K; Yasuda, Y; Hashimoto, R; Inada, T; Ujike, H; Iidaka, T; Suzuki, M; Takeda, M; Iwata, N; Ozaki, N				Koide, Takayoshi; Banno, Masahiro; Aleksic, Branko; Yamashita, Saori; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Nakamura, Yukako; Okada, Takashi; Ikeda, Masashi; Ohi, Kazutaka; Yasuda, Yuka; Hashimoto, Ryota; Inada, Toshiya; Ujike, Hiroshi; Iidaka, Tetsuya; Suzuki, Michio; Takeda, Masatoshi; Iwata, Nakao; Ozaki, Norio			Common Variants in MAGI2 Gene Are Associated with Increased Risk for Cognitive Impairment in Schizophrenic Patients	PLOS ONE			English	Article							CARD SORTING TEST; BIPOLAR DISORDER; HERITABILITY; POPULATION; LINKAGE; LOCALIZATION; PLASTICITY; PROTEINS; ABILITY; GWAS	Schizophrenia is a complex psychiatric disorder characterized by positive symptoms, negative symptoms, and cognitive impairment. MAGI2, a relatively large gene (similar to 1.5 Mbps) that maps to chromosome 7q21, is involved in recruitment of neurotransmitter receptors such as AMPA- and NMDA-type glutamate receptors. A genetic association study designed to evaluate the association between MAGI2 and cognitive performance or schizophrenia has not been conducted. In this case-control study, we examined the relationship of single nucleotide polymorphism (SNP) variations in MAGI2 and risk for schizophrenia in a large Japanese sample and explored the potential relationships between variations in MAGI2 and aspects of human cognitive function related to glutamate activity. Based on the result of first schizophrenia genome-wide association study in a Japanese population (JGWAS), we selected four independent SNPs and performed an association study using a large independent Japanese sample set (cases 1624, controls 1621). Wisconsin Card Sorting Test (WCST) was used to evaluate executive function in 114 cases and 91 controls. We found suggestive evidence for genetic association of common SNPs within MAGI2 locus and schizophrenia in Japanese population. Furthermore in terms of association between MAGI2 and cognitive performance, we observed that genotype effect of rs2190665 on WCST score was significant (p = 0.034) and rs4729938 trended toward significance (p = 0.08). In conclusion, although we could not detect strong genetic evidence for association of common variants in MAGI2 and increased schizophrenia risk in a Japanese population, these SNPs may increase risk of cognitive impairment in schizophrenic patients.	[Koide, Takayoshi; Banno, Masahiro; Aleksic, Branko; Yamashita, Saori; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Nakamura, Yukako; Okada, Takashi; Iidaka, Tetsuya; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Ohi, Kazutaka; Yasuda, Yuka; Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Kanazawa Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Osaka Univ, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Hamamatsu Univ Grad Sch Med, Osaka, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Dept Psychiat, Tokyo, Japan; [Ujike, Hiroshi] Okayama Univ, Grad Sch Med & Dent, Dept Neuropsychiat, Okayama, Japan; [Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Koide, Takayoshi; Banno, Masahiro; Aleksic, Branko; Yamashita, Saori; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Nakamura, Yukako; Okada, Takashi; Ohi, Kazutaka; Yasuda, Yuka; Hashimoto, Ryota; Iidaka, Tetsuya; Iwata, Nakao; Ozaki, Norio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Nagoya University; Fujita Health University; Osaka University; Kanazawa University; Osaka University; Okayama University; University of Toyama; Japan Science & Technology Agency (JST)	Koide, T (corresponding author), Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	branko@med.nagoya-u.ac.jp	Banno, Masahiro/E-5341-2010; nakamura, yukako/M-8889-2014; Aleksic, Branko/G-1540-2011; Iidaka, Tetsuya/M-8847-2014; Hashimoto, Ryota/AAE-3200-2019; Ohi, Kazutaka/J-7851-2019; Ozaki, Norio/M-8908-2014; Hashimoto, Ryota/P-8572-2014; KUSHIMA, Itaru/M-8872-2014; Aleksic, Branko/L-7851-2019; OKADA, Takashi/M-8902-2014	Banno, Masahiro/0000-0002-2539-1031; nakamura, yukako/0000-0002-3306-7127; Aleksic, Branko/0000-0001-8982-4580; Iidaka, Tetsuya/0000-0002-6199-8711; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Ozaki, Norio/0000-0002-7360-4898; Hashimoto, Ryota/0000-0002-5941-4238; Aleksic, Branko/0000-0001-8982-4580; Ikeda, Masashi/0000-0001-6237-2449; Inada, Toshiya/0000-0002-8427-5639; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports and Culture of Japan; Comparative Cognitive Science Institutes; Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [22390225] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Comparative Cognitive Science Institutes; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/); The Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/); Grant-in-Aid for "Integrated research on neuropsychiatric disorder'' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://brainprogram.mext.go.jp/); Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan (https://www.hokatsu-nou.nips.ac.jp/); The Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes (http://www.meijo-u.ac.jp/sougou/gakujutsu/hitech.html); and the Core Research for Evolutional Science and Technology (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic B, 2010, SCHIZOPHR RES, V118, P113, DOI 10.1016/j.schres.2010.01.014; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burdick KE, 2010, AM J PSYCHIAT, V167, P436, DOI 10.1176/appi.ajp.2009.09050615; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Chou LN, 2010, BEHAV GENET, V40, P22, DOI 10.1007/s10519-009-9299-3; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; GOLDBERG TE, 1990, ARCH GEN PSYCHIAT, V47, P1066; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Heaton, 1981, WISCONSIN CARD SORTI; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hori H, 2006, SCHIZOPHR RES, V86, P138, DOI 10.1016/j.schres.2006.05.004; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Inagaki A, 2010, JPN J CLIN PSYCHOPHA, V13, P1349; Inagaki A, 2008, JPN J CLIN PSYCHOPHA, V11, P887; Kashima H, 1987, NEUROPSYCHOLOGICAL I; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kremen WS, 2007, AM J MED GENET B, V144B, P403, DOI 10.1002/ajmg.b.30527; Krystal JH, 2002, ARCH GEN PSYCHIAT, V59, P663, DOI 10.1001/archpsyc.59.7.663; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; Suzuki H, 2011, PROG NEURO-PSYCHOPH, V35, P161, DOI 10.1016/j.pnpbp.2010.10.021; Taylor J, 2007, TWIN RES HUM GENET, V10, P829, DOI 10.1375/twin.10.6.829; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yamada A, 2003, GENES CELLS, V8, P985, DOI 10.1046/j.1356-9597.2003.00690.x	40	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36836	10.1371/journal.pone.0036836	http://dx.doi.org/10.1371/journal.pone.0036836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649501	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800018
J	Sibole, SC; Erdemir, A				Sibole, Scott C.; Erdemir, Ahmet			Chondrocyte Deformations as a Function of Tibiofemoral Joint Loading Predicted by a Generalized High-Throughput Pipeline of Multi-Scale Simulations	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; HUMAN ARTICULAR-CARTILAGE; CELL-MATRIX INTERACTIONS; PERICELLULAR MATRIX; MECHANICAL-PROPERTIES; KNEE-JOINT; BEHAVIOR; STRESS; STRAIN; AGE	Cells of the musculoskeletal system are known to respond to mechanical loading and chondrocytes within the cartilage are not an exception. However, understanding how joint level loads relate to cell level deformations, e. g. in the cartilage, is not a straightforward task. In this study, a multi-scale analysis pipeline was implemented to post-process the results of a macro-scale finite element (FE) tibiofemoral joint model to provide joint mechanics based displacement boundary conditions to micro-scale cellular FE models of the cartilage, for the purpose of characterizing chondrocyte deformations in relation to tibiofemoral joint loading. It was possible to identify the load distribution within the knee among its tissue structures and ultimately within the cartilage among its extracellular matrix, pericellular environment and resident chondrocytes. Various cellular deformation metrics (aspect ratio change, volumetric strain, cellular effective strain and maximum shear strain) were calculated. To illustrate further utility of this multi-scale modeling pipeline, two micro-scale cartilage constructs were considered: an idealized single cell at the centroid of a 100 x 100 x 100 mm block commonly used in past research studies, and an anatomically based (11 cell model of the same volume) representation of the middle zone of tibiofemoral cartilage. In both cases, chondrocytes experienced amplified deformations compared to those at the macro-scale, predicted by simulating one body weight compressive loading on the tibiofemoral joint. In the 11 cell case, all cells experienced less deformation than the single cell case, and also exhibited a larger variance in deformation compared to other cells residing in the same block. The coupling method proved to be highly scalable due to micro-scale model independence that allowed for exploitation of distributed memory computing architecture. The method's generalized nature also allows for substitution of any macro-scale and/or micro-scale model providing application for other multi-scale continuum mechanics problems.	[Sibole, Scott C.] Cleveland Clin, Computat Biomodeling CoBi Core, Lerner Res Inst, Cleveland, OH 44106 USA; Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sibole, SC (corresponding author), Cleveland Clin, Computat Biomodeling CoBi Core, Lerner Res Inst, Cleveland, OH 44106 USA.	erdemira@ccf.org		Erdemir, Ahmet/0000-0002-4629-8055; Sibole, Scott/0000-0003-2260-8167	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health [R01EB009643]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009643] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the grant R01EB009643 provided by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (http://www.nibib.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusara Z, 2011, J BIOMECH, V44, P930, DOI 10.1016/j.jbiomech.2010.11.031; Alexopoulos LG, 2005, ACTA BIOMATER, V1, P317, DOI 10.1016/j.actbio.2005.02.001; Alexopoulos LG, 2003, J BIOMECH ENG-T ASME, V125, P323, DOI 10.1115/1.1579047; Barela AMF, 2008, J ELECTROMYOGR KINES, V18, P446, DOI 10.1016/j.jelekin.2006.10.008; Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492; BUTLER DL, 1990, J BIOMECH ENG-T ASME, V112, P38, DOI 10.1115/1.2891124; Cao L, 2009, CELL MOL BIOENG, V2, P306, DOI 10.1007/s12195-009-0081-7; Charlebois M, 2004, J BIOMECH ENG-T ASME, V126, P129, DOI 10.1115/1.1688771; Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164; Donahue TLH, 2002, J BIOMECH ENG-T ASME, V124, P273, DOI 10.1115/1.1470171; Donkelaar CC, 2011, BIOMECHANIC IN PRESS; Erdemir A, 2011, 23 C INT SOC BIOM BR; Erdemir A, OPEN KNEE 3 DIMENSIO; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Gardiner JC, 2003, J ORTHOP RES, V21, P1098, DOI 10.1016/S0736-0266(03)00113-X; Guilak F, 2005, ANN BIOMED ENG, V33, P1312, DOI 10.1007/s10439-005-4479-7; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Guillen T, 2011, J MECH BEHAV BIOMED, V4, P1452, DOI 10.1016/j.jmbbm.2011.05.015; Halloran JP, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005333; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Herzog W, 2006, BIOMECH MODEL MECHAN, V5, P64, DOI 10.1007/s10237-006-0029-y; Hofer JK, 2011, J ARTHROPLA IN PRESS; Hsieh CH, 2008, OSTEOARTHR CARTILAGE, V16, P480, DOI 10.1016/j.joca.2007.08.004; Hudelmaier M, 2001, ARTHRITIS RHEUM, V44, P2556, DOI 10.1002/1529-0131(200111)44:11<2556::AID-ART436>3.0.CO;2-U; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Karamanidis K, 2009, ANN BIOMED ENG, V37, P467, DOI 10.1007/s10439-008-9624-7; Kazemi M, 2011, J MECH BEHAV BIOMED, V4, P1351, DOI 10.1016/j.jmbbm.2011.05.004; Kim HA, 2000, J RHEUMATOL, V27, P455; Kolahi KS, 2010, WIRES SYST BIOL MED, V2, P625, DOI 10.1002/wsbm.79; Korhonen Rami K., 2010, Molecular & Cellular Biomechanics, V7, P125; Kouznetsova VG, 2004, COMPUT METHOD APPL M, V193, P5525, DOI 10.1016/j.cma.2003.12.073; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Maas S, 2010, FEBIO THEORY MANUAL; Maas S, 2009, COMP FEBIO ABAQUS NI; Mackerle Jaroslav, 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P149, DOI 10.1080/10255840600751523; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; MEACHIM G, 1962, ANN RHEUM DIS, V21, P45, DOI 10.1136/ard.21.1.45; MESSIER SP, 1994, MED SCI SPORT EXER, V26, P1446; Michalek AJ, 2007, J BIOMECH, V40, P1405, DOI 10.1016/j.jbiomech.2006.05.025; Peeters EAG, 2004, ANN BIOMED ENG, V32, P1443, DOI 10.1114/B:ABME.0000042231.59230.72; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x; RYU J, 1984, ARTHRITIS RHEUM, V27, P49, DOI 10.1002/art.1780270109; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; Tetsunaga T, 2011, OSTEOARTHR CARTILAGE, V19, P222, DOI 10.1016/j.joca.2010.11.004; TISSAKHT M, 1995, J BIOMECH, V28, P411, DOI 10.1016/0021-9290(94)00081-E; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Wilson W, 2005, MED ENG PHYS, V27, P810, DOI 10.1016/j.medengphy.2005.03.004; Worsley P, 2011, GAIT POSTURE, V33, P268, DOI 10.1016/j.gaitpost.2010.11.018; Yang NH, 2010, J ORTHOP RES, V28, P1539, DOI 10.1002/jor.21174; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P135, DOI 10.1115/1.2132373; Yutani Yasutaka, 1996, Osaka City Medical Journal, V42, P37	58	34	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37538	10.1371/journal.pone.0037538	http://dx.doi.org/10.1371/journal.pone.0037538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649535	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800054
J	Macanas-Pirard, P; Leisewitz, A; Broekhuizen, R; Cautivo, K; Barriga, FM; Leisewitz, F; Gidi, V; Riquelme, E; Montecinos, VP; Swett, P; Besa, P; Ramirez, P; Ocqueteau, M; Kalergis, AM; Holt, M; Rettig, M; DiPersio, JF; Nervi, B				Macanas-Pirard, Patricia; Leisewitz, Andrea; Broekhuizen, Richard; Cautivo, Kelly; Barriga, Francisco M.; Leisewitz, Francisco; Gidi, Victoria; Riquelme, Erick; Montecinos, Viviana P.; Swett, Pilar; Besa, Pelayo; Ramirez, Pablo; Ocqueteau, Mauricio; Kalergis, Alexis M.; Holt, Matthew; Rettig, Michael; DiPersio, John F.; Nervi, Bruno			Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MULTIDRUG-RESISTANCE PROTEIN-1; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ARA-C; DEOXYCYTIDINE KINASE; CYTOSINE-ARABINOSIDE; DRUG-RESISTANCE; CXCR4; MICROENVIRONMENT	Background: Despite a high response rate to chemotherapy, the majority of patients with acute myeloid leukemia (AML) are destined to relapse due to residual disease in the bone marrow (BM). The tumor microenvironment is increasingly being recognized as a critical factor in mediating cancer cell survival and drug resistance. In this study, we propose to identify mechanisms involved in the chemoprotection conferred by the BM stroma to leukemia cells. Methods: Using a leukemia mouse model and a human leukemia cell line, we studied the interaction of leukemia cells with the BM microenvironment. We evaluated in vivo and in vitro leukemia cell chemoprotection to different cytotoxic agents mediated by the BM stroma. Leukemia cell apoptosis was assessed by flow cytometry and western blotting. The activity of the equilibrative nucleoside transporter 1 (ENT1), responsible for cytarabine cell incorporation, was investigated by measuring transport and intracellular accumulation of H-3-adenosine. Results: Leukemia cell mobilization from the bone marrow into peripheral blood in vivo using a CXCR4 inhibitor induced chemo-sensitization of leukemia cells to cytarabine, which translated into a prolonged survival advantage in our mouse leukemia model. In vitro, the BM stromal cells secreted a soluble factor that mediated significant chemoprotection to leukemia cells from cytarabine induced apoptosis. Furthermore, the BM stromal cell supernatant induced a 50% reduction of the ENT1 activity in leukemia cells, reducing the incorporation of cytarabine. No protection was observed when radiation or other cytotoxic agents such as etoposide, cisplatin and 5-fluorouracil were used. Conclusion: The BM stroma secretes a soluble factor that significantly protects leukemia cells from cytarabine-induced apoptosis and blocks ENT1 activity. Strategies that modify the chemo-protective effects mediated by the BM microenvironment may enhance the benefit of conventional chemotherapy for patients with AML.	[Macanas-Pirard, Patricia; Leisewitz, Andrea; Broekhuizen, Richard; Leisewitz, Francisco; Gidi, Victoria; Montecinos, Viviana P.; Swett, Pilar; Besa, Pelayo; Ramirez, Pablo; Ocqueteau, Mauricio; Nervi, Bruno] Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Santiago, Chile; [Kalergis, Alexis M.] Pontificia Univ Catolica Chile, Dept Reumatol, Fac Med, Santiago, Chile; [Cautivo, Kelly; Barriga, Francisco M.; Riquelme, Erick; Kalergis, Alexis M.] Pontificia Univ Catolica Chile, Dept Genet Mol & Microbiol, Fac Ciencias Biol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Holt, Matthew; Rettig, Michael; DiPersio, John F.] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Washington University (WUSTL)	Macanas-Pirard, P (corresponding author), Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Alameda 340, Santiago, Chile.	bnervi@med.puc.cl	Macanas-Pirard, Patricia/HCI-9651-2022; Nervi, Bruno/L-7470-2014; RIQUELME, ERICK/AAA-6191-2022	Macanas-Pirard, Patricia/0000-0003-2631-8618; Nervi, Bruno/0000-0002-3016-7261; Cautivo, Kelly/0000-0003-4434-2814; Kalergis, Alexis/0000-0001-7622-5263; ramirez, pablo/0000-0003-0593-7161; Rettig, Michael/0000-0002-1091-0564	Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT) [11085015, 1110319, 11080206]; Millennium Institute on Immunology and Immunotherapy [P07/088-F]	Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy	This work was supported by grants from the Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT #11085015, #1110319 and #11080206) and by the Millennium Institute on Immunology and Immunotherapy (P07/088-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cashen Amanda F, 2007, Future Oncol, V3, P19, DOI 10.2217/14796694.3.1.19; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; Clarke Marilyn L, 2002, Cancer Treat Res, V112, P27; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Galmarini CM, 2003, INT J CANCER, V107, P149, DOI 10.1002/ijc.11339; Galmarini CM, 2003, LEUKEMIA LYMPHOMA, V44, P1105, DOI 10.1080/1042819031000077142; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Galmarini CM, 2002, LEUKEMIA RES, V26, P621, DOI 10.1016/S0145-2126(01)00184-9; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Jin GL, 2009, BIOCHEM BIOPH RES CO, V390, P1001, DOI 10.1016/j.bbrc.2009.10.094; Kanno SI, 2007, CLIN CHIM ACTA, V377, P144, DOI 10.1016/j.cca.2006.09.014; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Leisewitz AV, 2011, BIOCHEM BIOPH RES CO, V404, P370, DOI 10.1016/j.bbrc.2010.11.125; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Leslie EM, 2001, MOL PHARMACOL, V59, P1171, DOI 10.1124/mol.59.5.1171; Mackey JR, 1998, DRUG RESIST UPDATE, V1, P310, DOI 10.1016/S1368-7646(98)80047-2; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Molina-Arcas M, 2005, LEUKEMIA, V19, P64, DOI 10.1038/sj.leu.2403582; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Rettig MP, 2009, METHOD ENZYMOL, V460, P57, DOI 10.1016/S0076-6879(09)05203-3; Ryningen A, 2005, LEUKEMIA RES, V29, P185, DOI 10.1016/j.leukres.2004.06.008; SHEWACH DS, 1992, MOL PHARMACOL, V42, P518; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Taichman RS, 2002, CANCER RES, V62, P1832; Takagaki K, 2004, J BIOCHEM, V136, P733, DOI 10.1093/jb/mvh180; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; TATTERSALL MH, 1974, BRIT J HAEMATOL, V27, P39, DOI 10.1111/j.1365-2141.1974.tb06772.x; Veuger MJT, 2000, BLOOD, V96, P1517, DOI 10.1182/blood.V96.4.1517.h8001517_1517_1524; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	42	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37203	10.1371/journal.pone.0037203	http://dx.doi.org/10.1371/journal.pone.0037203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629369	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300026
J	Jonas, JB; Hayreh, SS; Tao, Y; Papastathopoulos, KI; Rensch, F				Jonas, Jost B.; Hayreh, Sohan Singh; Tao, Yong; Papastathopoulos, Konstantinos I.; Rensch, Florian			Optic Nerve Head Change in Non-Arteritic Anterior Ischemic Optic Neuropathy and Its Influence on Visual Outcome	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DISC MORPHOLOGY; BEIJING EYE; PARAPAPILLARY ATROPHY; COHERENCE TOMOGRAPHY; ADULT CHINESE; FIBER LAYER; PATHOGENESIS; RATIO; CUP	Purpose: To evaluate changes in cup/disc (C/D) diameter ratios and parapapillary atrophy in patients with non-arteritic anterior ischemic optic neuropathy (NA-AION), using morphometric methods. Methods: The clinical non-interventional study included 157 patients with unilateral or bilateral NA-AION. Optic disc photographs taken from both eyes at the end of follow-up were morphometrically examined. Results: Follow-up was 86.3 +/- 70.3 months. Horizontal and vertical disc diameters (P = 0.30; P = 0.61, respectively), horizontal and vertical C/D ratios (P = 0.47; P = 0.19, resp.), and size of alpha zone and beta zone of parapapillary atrophy (P = 0.27; P = 0.32, resp.) did not differ significantly between affected eyes and contralateral normal eyes in patients with unilateral NA-AION. Similarly, horizontal and vertical disc diameters, horizontal and vertical C/D ratios, and size of alpha zone and beta zone did not vary significantly (all P>0.05) between the unaffected eyes of patients with unilateral NA-AION and the eyes of patients with bilateral NA-AION. Optic disc diameters, C/D ratios, size of alpha zone or beta zone of parapapillary atrophy were not significantly associated with final visual outcome in the eyes affected with NA-AION (all P>0.20) nor with the difference in final visual acuity between affected eyes and unaffected eyes in patients with unilateral NA-AION (all P>0.25). Conclusions: NA-AION did not affect C/D ratios nor alpha zone and beta zone of parapapillary atrophy. Optic disc size was not related to the final visual acuity outcome in NA-AION.	[Jonas, Jost B.; Papastathopoulos, Konstantinos I.; Rensch, Florian] Univ Heidelberg, Dept Ophthalmol, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hayreh, Sohan Singh] Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA; [Hayreh, Sohan Singh] Univ Iowa, Coll Med, Dept Visual Sci, Iowa City, IA USA; [Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China	Ruprecht Karls University Heidelberg; University of Iowa; University of Iowa; Peking University	Jonas, JB (corresponding author), Univ Heidelberg, Dept Ophthalmol, Med Fac Mannheim, D-6800 Mannheim, Germany.	Jost.Jonas@augen.ma.uni-heidelberg.de	Hayreh, Sohan Singh/AFU-1623-2022	Hayreh, Sohan/0000-0002-0709-886X	U.S. National Institutes of Health [EY-1576]; Research to Prevent Blindness, Incorporated, New York, United States of America; NATIONAL EYE INSTITUTE [R01EY001576] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Incorporated, New York, United States of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Dr. S. S. Hayreh's grant EY-1576 from the U.S. National Institutes of Health, and in part by unrestricted grants from Research to Prevent Blindness, Incorporated, New York, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK RW, 1984, OPHTHALMOLOGY, V91, P1334; BECK RW, 1987, OPHTHALMOLOGY, V94, P1503; BURDE RM, 1993, AM J OPHTHALMOL, V116, P759, DOI 10.1016/S0002-9394(14)73478-6; Chan CKM, 2009, BRIT J OPHTHALMOL, V93, P731, DOI 10.1136/bjo.2008.143297; Contreras I, 2007, INVEST OPHTH VIS SCI, V48, P4087, DOI 10.1167/iovs.07-0171; Danesh-Meyer H, 2005, OPHTHALMOLOGY, V112, P1104, DOI 10.1016/j.ophtha.2004.12.041; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Danesh-Meyer HV, 2001, OPHTHALMOLOGY, V108, P593, DOI 10.1016/S0161-6420(00)00602-3; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; DORO S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1143; FEIT RH, 1984, AM J OPHTHALMOL, V98, P105, DOI 10.1016/0002-9394(84)90196-X; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P298, DOI 10.1016/j.ophtha.2007.05.027; Hayreh SS, 2007, GRAEF ARCH CLIN EXP, V245, P1107, DOI 10.1007/s00417-006-0494-0; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P2275, DOI 10.1016/j.ophtha.2008.08.007; HAYREH SS, 1972, BRIT J OPHTHALMOL, V56, P175, DOI 10.1136/bjo.56.3.175; HAYREH SS, 1972, BRIT J OPHTHALMOL, V56, P736, DOI 10.1136/bjo.56.10.736; Hayreh SS, 2001, OPHTHALMOLOGY, V108, P1586, DOI 10.1016/S0161-6420(01)00649-2; HAYREH SS, 1970, BRIT J OPHTHALMOL, V54, P461, DOI 10.1136/bjo.54.7.461; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P863, DOI 10.1136/bjo.58.10.863; Hayreh SS, 2011, ISCHEMIC OPTIC NEURO, P298; Hayreh SS, 1994, CURR OPIN OPHTHALMOL, V5II, P26; Hayreh SS, 1976, T AM ACAD OPHTHALMOL, V81; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; JONAS JB, 1993, INVEST OPHTH VIS SCI, V34, P2260; Jonas JB, 1999, AM J OPHTHALMOL, V127, P523, DOI 10.1016/S0002-9394(99)00030-6; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; JONAS JB, 1988, INT OPHTHALMOL, V12, P119, DOI 10.1007/BF00137137; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; QUIGLEY H, 1977, T AM ACAD OPHTHALMOL, V83, P755; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Saito H, 2008, OPHTHALMOLOGY, V115, P1585, DOI 10.1016/j.ophtha.2008.01.012; Saito H, 2006, OPHTHALMOLOGY, V113, P1340, DOI 10.1016/j.ophtha.2006.01.072; Suh MH, 2011, AM J OPHTHALMOL, V151, P277, DOI 10.1016/j.ajo.2010.08.033; Wang YX, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103788; Xu L, 2007, EUR J OPHTHALMOL, V17, P459, DOI 10.1177/112067210701700335; You QS, 2009, ACTA OPHTHALMOL, V87, P354, DOI 10.1111/j.1755-3768.2008.01426.x	40	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37499	10.1371/journal.pone.0037499	http://dx.doi.org/10.1371/journal.pone.0037499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629408	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100036
J	Buchanan, B; O'Brien, MJ; Kilby, JD; Huckell, BB; Collard, M				Buchanan, Briggs; O'Brien, Michael J.; Kilby, J. David; Huckell, Bruce B.; Collard, Mark			An Assessment of the Impact of Hafting on Paleoindian Point Variability	PLOS ONE			English	Article							MEASUREMENT ERROR; CLOVIS; SITE; DISCOVERY; ARTIFACTS; MAMMOTH; PLAINS; TESTS	It has long been argued that the form of North American Paleoindian points was affected by hafting. According to this hypothesis, hafting constrained point bases such that they are less variable than point blades. The results of several studies have been claimed to be consistent with this hypothesis. However, there are reasons to be skeptical of these results. None of the studies employed statistical tests, and all of them focused on points recovered from kill and camp sites, which makes it difficult to be certain that the differences in variability are the result of hafting rather than a consequence of resharpening. Here, we report a study in which we tested the predictions of the hafting hypothesis by statistically comparing the variability of different parts of Clovis points. We controlled for the potentially confounding effects of resharpening by analyzing largely unused points from caches as well as points from kill and camp sites. The results of our analyses were not consistent with the predictions of the hypothesis. We found that several blade characters and point thickness were no more variable than the base characters. Our results indicate that the hafting hypothesis does not hold for Clovis points and indicate that there is a need to test its applicability in relation to post-Clovis Paleoindian points.	[Buchanan, Briggs; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs; Collard, Mark] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; [Buchanan, Briggs; O'Brien, Michael J.; Collard, Mark] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Kilby, J. David] Eastern New Mexico Univ, Dept Anthropol & Appl Archaeol, Portales, NM USA; [Huckell, Bruce B.] Univ New Mexico, Maxwell Museum Anthropol, Albuquerque, NM 87131 USA; [Huckell, Bruce B.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	Simon Fraser University; Simon Fraser University; University of Missouri System; University of Missouri Columbia; University of New Mexico; University of New Mexico	Buchanan, B (corresponding author), Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada.	mcollard@sfu.ca		Kilby, David/0000-0003-2185-7065; Buchanan, Briggs/0000-0002-5684-9615; Collard, Mark/0000-0002-2725-4989	National Science Foundation; Social Sciences and Humanities Research Council; University of New Mexico; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund	National Science Foundation(National Science Foundation (NSF)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of New Mexico; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund	BB's work on this study was supported by a National Science Foundation Doctoral Dissertation Improvement Grant and postdoctoral fellowship grants from the National Science Foundation and the Social Sciences and Humanities Research Council. JDK's work on the study was supported by a National Science Foundation Doctoral Dissertation Improvement Grant and the University of New Mexico. MC's work on this study was supported by the Canada Research Chairs Program, the Social Sciences and Humanities Research Council, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund and Simon Fraser University was supported by a National Science Foundation Doctoral Dissertation Improvement Grant and the University of New Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, FENN CACHE CLO VIS W; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bement LC, 2003, CURRENT RES PLEISTOC, V20, P5; Bement LC, 2010, AM ANTIQUITY, V75, P907, DOI 10.7183/0002-7316.75.4.907; Benjamini Y, 2001, ANN STAT, V29, P1165; Bever MR., 2007, B TEXAS ARCHAEOLOGIC, V78, P65; Boldurian AnthonyT., 1999, CLOVIS REVISITED NEW; Buchanan B, 2002, PLAINS ANTHROPOL, V47, P121, DOI 10.1080/2052546.2002.11949236; Buchanan B, 2005, THESIS U NEW MEXICO; Buchanan B, 2012, PLOS ONE, V7, P1; Buchanan B, 2007, J ANTHROPOL ARCHAEOL, V26, P366, DOI 10.1016/j.jaa.2007.02.005; Buchanan B, 2011, J ARCHAEOL SCI, V38, P852, DOI 10.1016/j.jas.2010.11.007; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Buchanan B, 2009, AM ANTIQUITY, V74, P279, DOI 10.1017/S0002731600048605; Butler B.Robert., 1965, TEBIWA, V8, P38; Butler B.Robert., 1963, TEBIWA, V6, P22; Cheshier J, 2006, AM ANTIQUITY, V71, P353, DOI 10.2307/40035908; COTTER J. L., 1938, PROC ACAD NAT SCI PHILADELPHIA, V90, P113; COTTER JOHN LAMBERT, 1937, PROC ACAD NAT SCI PHILADELPHIA, V89, P1; Donnelly SM, 1999, AM J PHYS ANTHROPOL, V108, P507, DOI 10.1002/(SICI)1096-8644(199904)108:4<507::AID-AJPA8>3.0.CO;2-0; Eerkens JW, 2001, AM ANTIQUITY, V66, P493, DOI 10.2307/2694247; Ellis C., 2004, CANADIAN J ARCHAEOLO, V28, P205; Figgins JesseD., 1933, P COLORADO MUSEUM NA, V12; FLIGNER MA, 1976, J AM STAT ASSOC, V71, P210, DOI 10.2307/2285771; Frison G.C., 1986, COLBY MAMMOTH SITE T; FRISON GC, 1989, AM ANTIQUITY, V54, P766, DOI 10.2307/280681; Frison GeorgeC., 1991, RAW MAT EC PREHISTOR, P321; Gramly R. M., 1993, RICHEY CLOVIS CACHE; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haury EW, 1953, AM ANTIQUITY, V19, P1, DOI 10.2307/276409; HAURY EW, 1959, AM ANTIQUITY, V25, P2, DOI 10.2307/276674; Haynes C., 2007, MURRAY SPRINGS CLOVI; Haynes G., 2002, EARLY SETTLEMENT N A; Haynes G, 2007, SCIENCE, V317, DOI 10.1126/science.1141960; Haynes Jr CV, 1998, GEOARCHAEOLOGY, V13, P201; Hemmings, 1970, THESIS U ARIZONA TUC; Hester E.B., 1972, FORT BURGWIN RES CTR, V8; HOLLIDAY VT, 1994, QUATERNARY RES, V41, P234, DOI 10.1006/qres.1994.1025; HOWARD EDGAR B., 1935, PROC ACAD NAT SCI PHILADELPHIA, V87, P299; Huckell B.B., 1982, PLAINS ANTHROPOL, V27, P217; Huckell BB, 2006, FLAKED STONE A UNPUB; Hutchings WK, 1997, THESIS S FRASER U BU; Jones J.S., 1996, THESIS OREGON STATE; Jones S., 1994, CURR RES PLEISTOCENE, V11, P42; Judge W.J., 1973, PALEOINDIAN OCCUPATI; KEELEY LH, 1982, AM ANTIQUITY, V47, P798, DOI 10.2307/280285; Kilby J.D., 2008, THESIS U NEW MEXICO; LAHREN L, 1974, SCIENCE, V186, P147, DOI 10.1126/science.186.4159.147; Leonhardy F.C., 1966, DOMEBO PALEO INDIAN, V1, P14; Lyman RL, 1998, J ARCHAEOL SCI, V25, P887, DOI 10.1006/jasc.1997.0270; Mehringer Jr PJ, 1988, NATL GEOGR, V174, P500; Meltzer DJ, 2006, FOLSOM: NEW ARCHAEOLOGICAL INVESTIGATIONS OF A CLASSIC PALEOINDIAN BISON KILL, P1; Meltzer D.J., 1995, B TEXAS ARCHEOLOGICA, V66, P17; Morrow JE, 1999, AM ANTIQUITY, V64, P215, DOI 10.2307/2694275; Morrow JE., 2006, PALEOINDIAN ARCHAEOL, P123; Musil RR, 1988, CLOVIS ARCHAIC INTER, V21, P373; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; O'Brien MJ, 2001, J ARCHAEOL SCI, V28, P1115, DOI 10.1006/jasc.2001.0681; Owsley DW, 2001, PLAINS ANTHROPOL, V46, P115, DOI 10.1080/2052546.2001.11932062; Rohlf FJ, TPS SHAREWARE SERIES; Sellards EH, 1938, BULL GEOL SOC AM, V49, P999; Sokal R.R., 2012, BIOMETRY; Stanford DennisJ., 1988, CURR RES PLEISTOCENE, V5, P21; Strauss RE, 2003, J VERTEBR PALEONTOL, V23, P284, DOI 10.1671/0272-4634(2003)023[0284:EOTPAE]2.0.CO;2; Taylor DC, 1969, P MONT ACAD SCI, V29, P147; Tunnell C, 2000, TEXAS HIST COMMISSIO; WARNICA JM, 1966, AM ANTIQUITY, V31, P345, DOI 10.2307/2694737; Wilke P. J., 1991, J CALIFORNIA GREAT B, V13, P242; Woods JC, 1985, IDAHO ARCHAEOLOGIST, V8, P3; Wormington H.M., 1949, POPULAR SERIES, V4; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	71	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36364	10.1371/journal.pone.0036364	http://dx.doi.org/10.1371/journal.pone.0036364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959YF	22666320	gold, Green Published, Green Submitted			2022-12-27	WOS:000305353400007
J	Ferrandiz, N; Caraballo, JM; Garcia-Gutierrez, L; Devgan, V; Rodriguez-Paredes, M; Lafita, MC; Bretones, G; Quintanilla, A; Munoz-Alonso, MJ; Blanco, R; Reyes, JC; Agell, N; Delgado, MD; Dotto, GP; Leon, J				Ferrandiz, Nuria; Caraballo, Juan M.; Garcia-Gutierrez, Lucia; Devgan, Vikram; Rodriguez-Paredes, Manuel; Carmen Lafita, M.; Bretones, Gabriel; Quintanilla, Andrea; Jose Munoz-Alonso, M.; Blanco, Rosa; Reyes, Jose C.; Agell, Neus; Dolores Delgado, M.; Dotto, G. Paolo; Leon, Javier			p21 as a Transcriptional Co-Repressor of S-Phase and Mitotic Control Genes	PLOS ONE			English	Article							CELL-CYCLE INHIBITION; PROMOTER ELEMENTS; DNA-REPLICATION; P21(WAF1/CIP1); DIFFERENTIATION; P21(CIP1/WAF1); EXPRESSION; CDK; INDUCTION; CHROMATIN	It has been previously described that p21 functions not only as a CDK inhibitor but also as a transcriptional co-repressor in some systems. To investigate the roles of p21 in transcriptional control, we studied the gene expression changes in two human cell systems. Using a human leukemia cell line (K562) with inducible p21 expression and human primary keratinocytes with adenoviral-mediated p21 expression, we carried out microarray-based gene expression profiling. We found that p21 rapidly and strongly repressed the mRNA levels of a number of genes involved in cell cycle and mitosis. One of the most strongly down-regulated genes was CCNE2 (cyclin E2 gene). Mutational analysis in K562 cells showed that the N-terminal region of p21 is required for repression of gene expression of CCNE2 and other genes. Chromatin immunoprecipitation assays indicated that p21 was bound to human CCNE2 and other p21-repressed genes gene in the vicinity of the transcription start site. Moreover, p21 repressed human CCNE2 promoter-luciferase constructs in K562 cells. Bioinformatic analysis revealed that the CDE motif is present in most of the promoters of the p21-regulated genes. Altogether, the results suggest that p21 exerts a repressive effect on a relevant number of genes controlling S phase and mitosis. Thus, p21 activity as inhibitor of cell cycle progression would be mediated not only by the inhibition of CDKs but also by the transcriptional down-regulation of key genes.	[Ferrandiz, Nuria; Caraballo, Juan M.; Garcia-Gutierrez, Lucia; Carmen Lafita, M.; Bretones, Gabriel; Quintanilla, Andrea; Jose Munoz-Alonso, M.; Blanco, Rosa; Dolores Delgado, M.; Leon, Javier] Univ Cantabria, CSIC, SODERCAN, Dept Biol Mol,Inst Biomed & Biotecnol Cantabria I, E-39005 Santander, Spain; [Devgan, Vikram; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Rodriguez-Paredes, Manuel; Reyes, Jose C.] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, E-41080 Seville, Spain; [Jose Munoz-Alonso, M.] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Agell, Neus] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Harvard University; Massachusetts General Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Lausanne	Ferrandiz, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Fac Med, Hammersmith Hosp Campus, London, England.	leonj@unican.es	Ferrandiz-Diaz, Nuria/V-4071-2017; Leon, Javier/K-4615-2014; Rodríguez Paredes, Manuel/B-1480-2019; Agell, Neus/E-9640-2016; Gutierrez, Lucia Garcia/ABH-3682-2020; Rodríguez, Manuel/N-2708-2019; Bretones, Gabriel/AAB-4637-2021; Reyes, Jose C/K-3699-2014; Delgado, M. Dolores/K-9056-2014	Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; Rodríguez Paredes, Manuel/0000-0001-5471-4277; Agell, Neus/0000-0002-1205-6074; Gutierrez, Lucia Garcia/0000-0003-4396-4814; Bretones, Gabriel/0000-0002-1521-5544; Reyes, Jose C/0000-0002-8042-5142; Leon, Javier/0000-0001-5803-0112; Delgado, M. Dolores/0000-0003-4682-4040; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X	Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF08-01581, ISCIII-RETIC RD06/0020/0017]; MICINN [BFU2008-00238, CSD2006-00049]; Junta de Andalucia [P06-CVI-4844]; postdoctoral fellowship of the University of Cantabria;  [FIS 08/0829]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); postdoctoral fellowship of the University of Cantabria; 	This study was supported by grants SAF08-01581 and ISCIII-RETIC RD06/0020/0017 from the Spanish Ministerio de Ciencia e Innovacion (MICINN) to JL; FIS 08/0829 to MDD; BFU2008-00238 and CSD2006-00049 from MICINN, and P06-CVI-4844 from Junta de Andalucia to JCR. NF was the recipient of a postdoctoral fellowship of the University of Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Delgado MD, 2000, ONCOGENE, V19, P783, DOI 10.1038/sj.onc.1203384; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Efeyan A, 2007, ONCOGENE, V26, P1645, DOI 10.1038/sj.onc.1209972; Ferrandiz N, 2010, CANCER LETT, V292, P133, DOI 10.1016/j.canlet.2009.11.017; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Gartel AL, 2002, MOL CANCER THER, V1, P639; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARPER JW, 1993, CELL, V75, P805; Iglesias-Ara A, 2010, ONCOGENE, V29, P5579, DOI 10.1038/onc.2010.296; Janicke RU, 2007, CELL CYCLE, V6, P407; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Maclaren A, 2003, ONCOGENE, V22, P2383, DOI 10.1038/sj.onc.1206329; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Munoz-Alonso MJ, 2012, J CELL PHYSIOL, V227, P2069, DOI 10.1002/jcp.22935; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Munoz-Alonso MJ, 2003, MOL B INT U, P236; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Pippa R, 2012, ONCOGENE IN PRESS; Poole JC, 2004, CELL CYCLE, V3, P931; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; van Betteraey-Nikoleit M, 2003, EUR J BIOCHEM, V270, P3880, DOI 10.1046/j.1432-1033.2003.03769.x; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Zhu HM, 2002, CELL CYCLE, V1, P59, DOI 10.4161/cc.1.1.101	48	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37759	10.1371/journal.pone.0037759	http://dx.doi.org/10.1371/journal.pone.0037759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662213	Green Published, gold			2022-12-27	WOS:000305342300103
J	Hosseini-Tabatabaei, A; Jalili, RB; Li, YY; Kilani, RT; Rezakhanlou, AM; Ghahary, A				Hosseini-Tabatabaei, Azadeh; Jalili, Reza Baradar; Li, Yunyuan; Kilani, Ruhangiz T.; Rezakhanlou, Alireza Moeen; Ghahary, Aziz			Mechanism Underlying Defective Interferon Gamma-Induced IDO Expression in Non-obese Diabetic Mouse Fibroblasts	PLOS ONE			English	Article							INDOLEAMINE 2,3 DIOXYGENASE; TUMOR-INDUCED TOLERANCE; CLASS-I ANTIGEN; GENE-EXPRESSION; IFN-GAMMA; MHC CLASS; T-CELLS; 2,3-DIOXYGENASE EXPRESSION; TRYPTOPHAN CATABOLISM; PANCREATIC-ISLETS	Indoleamine 2,3-dioxygenase (IDO) can locally suppress T cell-mediated immune responses. It has been shown that defective self-tolerance in early prediabetic female non-obese diabetic (NOD) mice can be attributed to the impaired interferon-gamma (IFN-gamma)-induced IDO expression in dendritic cells of these animals. As IFN-gamma can induce IDO in both dendritic cells and fibroblasts, we asked the question of whether there exists a similar defect in IFN-gamma-induced IDO expression in NOD mice dermal fibroblasts. To this end, we examined the effect of IFN-gamma on expression of IDO and its enzymatic activity in NOD dermal fibroblasts. The results showed that fibroblasts from either prediabetic (8 wks of age) female or male, and diabetic female or male (12 and 24 wks of age respectively) NOD mice failed to express IDO in response to IFN-gamma treatment. To find underlying mechanisms, we scrutinized the IFN-gamma signaling pathway and investigated expression of other IFN-gamma-modulated factors including major histocompatibility complex class I (MHC-I) and type I collagen (COL-I). The findings revealed a defect of signal transducer and activator of transcription 1 (STAT1) phosphorylation in NOD cells relative to that of controls. Furthermore, we found an increase in MHC-I and suppression of COL-I expression in fibroblasts from both NOD and control mice following IFN-gamma treatment; indicating that the impaired response to IFN-gamma in NOD fibroblasts is specific to IDO gene. Finally, we showed that an IFN-gamma-independent IDO expression pathway i.e. lipopolysaccharide (LPS)-mediated-c-Jun kinase is operative in NOD mice fibroblast. In conclusion, the findings of this study for the first time indicate that IFN-gamma fails to induce IDO expression in NOD dermal fibroblasts; this may partially be due to defective STAT1 phosphorylation in IFN-gamma-induced-IDO signaling pathway.	[Hosseini-Tabatabaei, Azadeh; Jalili, Reza Baradar; Li, Yunyuan; Kilani, Ruhangiz T.; Rezakhanlou, Alireza Moeen; Ghahary, Aziz] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Hosseini-Tabatabaei, A (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	aghahary@interchange.ubc.ca			Canadian Institute of Health Research (CIHR); Vanier Canada Graduate Scholarship (Vanier CGS); CIHR/Skin Research Training Centre (CIHR/SRTC)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship (Vanier CGS); CIHR/Skin Research Training Centre (CIHR/SRTC)(Canadian Institutes of Health Research (CIHR))	The Canadian Institute of Health Research (CIHR) supported this study through a grant held by A. Ghahary. A. Hosseini-Tabatabaei holds the Vanier Canada Graduate Scholarship (Vanier CGS) and was also supported by a scholarship from CIHR/Skin Research Training Centre (CIHR/SRTC). The URLs for the CIHR and Vanier CGS websites are: http://www.cihr-irsc.gc.ca/and http://www.vanier.gc.ca/respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bauer TM, 2005, TRANSPL INT, V18, P95, DOI 10.1111/j.1432-2277.2004.00031.x; CHON SY, 1995, J INTERF CYTOK RES, V15, P517, DOI 10.1089/jir.1995.15.517; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Forouzandeh F, 2008, WOUND REPAIR REGEN, V16, P379, DOI 10.1111/j.1524-475X.2008.00377.x; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Ghosh AK, 2006, J CELL PHYSIOL, V207, P251, DOI 10.1002/jcp.20559; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Jalili RB, 2007, IRAN J ALLERGY ASTHM, V6, P167; Jalili RB, 2007, J CELL PHYSIOL, V213, P137, DOI 10.1002/jcp.21100; Jalili RB, 2010, DIABETES, V59, P2219, DOI 10.2337/db09-1560; Jalili RB, 2009, AM J PATHOL, V174, P196, DOI 10.2353/ajpath.2009.080539; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; Li YY, 2004, J INVEST DERMATOL, V122, P953, DOI 10.1111/j.0022-202X.2004.22409.x; Li YY, 2004, HUM IMMUNOL, V65, P114, DOI 10.1016/j.humimm.2003.11.004; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Puccetti P, 2007, EUR J IMMUNOL, V37, P876, DOI 10.1002/eji.200737184; Sarkhosh K, 2004, J CELL PHYSIOL, V201, P146, DOI 10.1002/jcp.20043; Sarkhosh K, 2003, WOUND REPAIR REGEN, V11, P337, DOI 10.1046/j.1524-475X.2003.11505.x; Sarkhosh K, 2003, J CELL BIOCHEM, V90, P206, DOI 10.1002/jcb.10593; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; Tan PH, 2009, EXPERT OPIN THER TAR, V13, P987, DOI 10.1517/14728220903018940; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454; Wang YX, 2010, BRAIN BEHAV IMMUN, V24, P201, DOI 10.1016/j.bbi.2009.06.152; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37747	10.1371/journal.pone.0037747	http://dx.doi.org/10.1371/journal.pone.0037747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662207	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300097
J	Long, QZ; Du, YF; Ding, XY; Li, X; Song, WB; Yang, Y; Zhang, P; Zhou, JP; Liu, XG				Long, Qing-Zhi; Du, Yue-Feng; Ding, Xiao-Ying; Li, Xiang; Song, Wen-Bin; Yang, Yong; Zhang, Peng; Zhou, Jian-Ping; Liu, Xiao-Gang			Replication and Fine Mapping for Association of the C2orf43, FOXP4, GPRC6A and RFX6 Genes with Prostate Cancer in the Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; SCAN; HEMOCHROMATOSIS; LOCI	Background: Prostate cancer represents the leading cause of male death across the world. A recent genome-wide association study (GWAS) identified five novel susceptibility loci for prostate cancer in the Japanese population. This study is to replicate and fine map the potential association of these five loci with prostate cancer in the Chinese Han population. Methods: In Phase I of the study, we tested the five single nucleotide polymorphisms (SNPs) which showed the strongest association evidence in the original GWAS in Japanese. The study sample consists of 1,169 Chinese Hans, comprising 483 patients and 686 healthy controls. Then in phase II, flanking SNPs of the successfully replicated SNPs in Phase I were genotyped and tested for association with prostate cancer to fine map those significant association signals. Results: We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60 x 10(-5)), rs12653946 (P = 1.33 x 10(-6)), rs1983891 (FOXP4, P = 6.22 x 10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42 x 10(-5)) with prostate cancer. The most significant odds ratio (OR) was recorded as 1.41 (95% confidence interval 1.18-1.68) for rs12653946. Rs9600079 did not show significant association (P = 8.07 x 10(-2)) with prostate cancer in this study. The Phase II study refined these association signals, and identified several SNPs showing more significant association with prostate cancer than the very SNPs tested in Phase I. Conclusions: Our results provide further support for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in Eastern Asian populations. This study also characterized the novel loci reported in the original GWAS with more details. Further work is still required to determine the functional variations and finally clarify the underlying biological mechanisms.	[Long, Qing-Zhi; Du, Yue-Feng; Li, Xiang; Song, Wen-Bin] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Ding, Xiao-Ying] Xi An Jiao Tong Univ, Dept Anesthesia, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Yang, Yong] Xi An Jiao Tong Univ, Affiliated Xian Ninth Hosp, Sch Med, Dept Urol, Xian 710049, Shaanxi, Peoples R China; [Zhang, Peng] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Zhou, Jian-Ping] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 3, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Liu, Xiao-Gang] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Long, QZ (corresponding author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Sch Med, Xian 710049, Shaanxi, Peoples R China.	qingzhilong@yahoo.cn			National Science Foundation of China [30900800, 30901500]; Science and Technology Program of Shaan-Xi Province; New Teacher Start Fund of Xi'an Jiaotong University; Fundamental Research Funds for the Central Universities - Innovation Program of Xi'an Jiaotong University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Shaan-Xi Province; New Teacher Start Fund of Xi'an Jiaotong University; Fundamental Research Funds for the Central Universities - Innovation Program of Xi'an Jiaotong University	This work was supported by the following: National Science Foundation of China (grant number: 30900800, 30901500; URL: http://www.nsfc.gov.cn); Science and Technology Program of Shaan-Xi Province; New Teacher Start Fund of Xi'an Jiaotong University; the Fundamental Research Funds for the Central Universities - Innovation Program of Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Christensen GB, 2010, PROSTATE, V70, P735, DOI 10.1002/pros.21106; Cropp CD, 2011, INT J CANC; Gillanders EM, 2004, JNCI-J NATL CANCER I, V96, P1240, DOI 10.1093/jnci/djh228; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Martinovici D, 2010, EUR J MED GENET, V53, P25, DOI 10.1016/j.ejmg.2009.10.004; Peng YM, 2008, J BONE MINER RES, V23, P247, DOI 10.1359/JBMR.071017; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Slager SL, 2006, PROSTATE, V66, P173, DOI 10.1002/pros.20332; Syrjakoski K, 2006, INT J CANCER, V118, P518, DOI 10.1002/ijc.21331; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Witte JS, 2003, PROSTATE, V57, P298, DOI 10.1002/pros.10304; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	17	31	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37866	10.1371/journal.pone.0037866	http://dx.doi.org/10.1371/journal.pone.0037866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662242	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300132
J	Takahashi, J; Waki, S; Matsumoto, R; Odake, J; Miyaji, T; Tottori, J; Iwanaga, T; Iwahashi, H				Takahashi, Junko; Waki, Shiori; Matsumoto, Rena; Odake, Junji; Miyaji, Takayuki; Tottori, Junichi; Iwanaga, Takehiro; Iwahashi, Hitoshi			Oligonucleotide Microarray Analysis of Dietary-Induced Hyperlipidemia Gene Expression Profiles in Miniature Pigs	PLOS ONE			English	Article							METABOLIC SYNDROME; INDUCED ATHEROSCLEROSIS; MESSENGER-RNA; ANIMAL-MODELS; GENOME; SWINE; TOXICOGENOMICS; REVEALS; PROGRAM; DISEASE	Background: Hyperlipidemia animal models have been established, but complete gene expression profiles of the transition from normal lipid levels have not been obtained. Miniature pigs are useful model animals for gene expression studies on dietary-induced hyperlipidemia because they have a similar anatomy and digestive physiology to humans, and blood samples can be obtained from them repeatedly. Methodology: Two typical dietary treatments were used for dietary-induced hyperlipidemia models, by using specific pathogen-free (SPF) Clawn miniature pigs. One was a high-fat and high-cholesterol diet (HFCD) and the other was a high-fat, high-cholesterol, and high-sucrose diet (HFCSD). Microarray analyses were conducted from whole blood samples during the dietary period and from white blood cells at the end of the dietary period to evaluate the transition of expression profiles of the two dietary models. Principal Findings: Variations in whole blood gene expression intensity within the HFCD or the HFCSD group were in the same range as the controls provide with normal diet at all periods. This indicates uniformity of dietary-induced hyperlipidemia for our dietary protocols. Gene ontology-(GO) based functional analyses revealed that characteristics of the common changes between HFCD and HFCSD were involved in inflammatory responses and reproduction. The correlation coefficient between whole blood and white blood cell expression profiles at 27 weeks with the HFCSD diet was significantly lower than that of the control and HFCD diet groups. This may be due to the effects of RNA originating from the tissues and/or organs. Conclusions: No statistically significant differences in fasting plasma lipids and glucose levels between the HFCD and HFCSD groups were observed. However, blood RNA analyses revealed different characteristics corresponding to the dietary protocols. In this study, whole blood RNA analyses proved to be a useful tool to evaluate transitions in dietary-induced hyperlipidemia gene expression profiles in miniature pigs.	[Takahashi, Junko] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Waki, Shiori; Matsumoto, Rena; Odake, Junji; Miyaji, Takayuki; Iwahashi, Hitoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Waki, Shiori; Iwahashi, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Tottori, Junichi; Iwanaga, Takehiro] Japan Farm Co Ltd, Kagoshima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Metrology Institute of Japan; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Takahashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	junko-takahashi@aist.go.jp	Iwahashi, Hitoshi/S-1360-2019; Takahashi, Junko/AAN-1019-2020; Takahashi, Junko/L-6921-2018	Takahashi, Junko/0000-0002-1941-0136	Regional Innovation Creation R&D Programs from the Ministry of Economy, Trade and Industry (METI), Japan	Regional Innovation Creation R&D Programs from the Ministry of Economy, Trade and Industry (METI), Japan	This work was partially supported by a Regional Innovation Creation R&D Programs from the Ministry of Economy, Trade and Industry (METI), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; deSmet BJGL, 1997, RADIOLOGY, V203, P484, DOI 10.1148/radiology.203.2.9114109; Hayashi Y, 2010, BIOL PHARM BULL, V33, P1033, DOI 10.1248/bpb.33.1033; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KOBARI Y, 1991, LAB ANIM, V25, P110, DOI 10.1258/002367791781082478; Kopreski MS, 1999, CLIN CANCER RES, V5, P1961; KROTKIEWSKI M, 1994, PRESSE MED, V23, P1393; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Lo KW, 1999, CLIN CHEM, V45, P1292; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Orbe J, 2001, CARDIOVASC RES, V49, P484, DOI 10.1016/S0008-6363(00)00260-1; Oron-Herman M, 2008, AM J HYPERTENS, V21, P1018, DOI 10.1038/ajh.2008.218; Pennie W, 2004, ENVIRON HEALTH PERSP, V112, P417, DOI 10.1289/ehp.6674; Poon LLM, 2000, CLIN CHEM, V46, P1832; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Roberts CK, 2002, ATHEROSCLEROSIS, V161, P133, DOI 10.1016/S0021-9150(01)00622-0; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Takahashi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019761; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Williams-Devane CR, 2009, TOXICOL SCI, V109, P358, DOI 10.1093/toxsci/kfp061; Yin W, 2004, J ENDOCRINOL, V180, P399, DOI 10.1677/joe.0.1800399; Zhang C, 2006, J LIPID RES, V47, P2055, DOI 10.1194/jlr.M600226-JLR200	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37581	10.1371/journal.pone.0037581	http://dx.doi.org/10.1371/journal.pone.0037581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662175	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300065
J	Vermeulen, JF; van de Ven, RAH; Ercan, C; van der Groep, P; van der Wall, E; Bult, P; Christgen, M; Lehmann, U; Daniel, J; van Diest, PJ; Derksen, PWB				Vermeulen, Jeroen F.; van de Ven, Robert A. H.; Ercan, Cigdem; van der Groep, Petra; van der Wall, Elsken; Bult, Peter; Christgen, Matthias; Lehmann, Ulrich; Daniel, Juliet; van Diest, Paul J.; Derksen, Patrick W. B.			Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; E-CADHERIN; TRANSCRIPTIONAL REPRESSOR; LOBULAR CARCINOMA; TUMOR MICROENVIRONMENT; ANOIKIS RESISTANCE; POOR-PROGNOSIS; PARTNER KAISO; DELTA-CATENIN; P120 CATENIN	Kaiso is a BTB/POZ transcription factor that is ubiquitously expressed in multiple cell types and functions as a transcriptional repressor and activator. Little is known about Kaiso expression and localization in breast cancer. Here, we have related pathological features and molecular subtypes to Kaiso expression in 477 cases of human invasive breast cancer. Nuclear Kaiso was predominantly found in invasive ductal carcinoma (IDC) (p = 0.007), while cytoplasmic Kaiso expression was linked to invasive lobular carcinoma (ILC) (p = 0.006). Although cytoplasmic Kaiso did not correlate to clinicopathological features, we found a significant correlation between nuclear Kaiso, high histological grade (p = 0.023), ER alpha negativity (p = 0.001), and the HER2-driven and basal/triple-negative breast cancers (p = 0.018). Interestingly, nuclear Kaiso was also abundant in BRCA1-associated breast cancer (p < 0.001) and invasive breast cancer overexpressing EGFR (p = 0.019). We observed a correlation between nuclear Kaiso and membrane-localized E-cadherin and p120-catenin (p120) (p < 0.01). In contrast, cytoplasmic p120 strongly correlated with loss of E-cadherin and low nuclear Kaiso (p = 0.005). We could confirm these findings in human ILC cells and cell lines derived from conditional mouse models of ILC. Moreover, we present functional data that substantiate a mechanism whereby E-cadherin controls p120-mediated relief of Kaiso-dependent gene repression. In conclusion, our data indicate that nuclear Kaiso is common in clinically aggressive ductal breast cancer, while cytoplasmic Kaiso and a p120-mediated relief of Kaiso-dependent transcriptional repression characterize ILC.	[Vermeulen, Jeroen F.; van de Ven, Robert A. H.; Ercan, Cigdem; van der Groep, Petra; van Diest, Paul J.; Derksen, Patrick W. B.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Groep, Petra; van der Wall, Elsken] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands; [Bult, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Christgen, Matthias] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany; [Daniel, Juliet] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Hannover Medical School; McMaster University	Vermeulen, JF (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.w.b.derksen@umcutrecht.nl	Derksen, Patrick/C-6643-2008; Bult, Peter/L-4236-2015	Derksen, Patrick/0000-0003-0732-7762; Bult, Peter/0000-0001-6427-9889	UMC Utrecht Cancer Center; Netherlands Organization for Scientific Research [NWO-VIDI 917.96.318]; Dutch Cancer Society [KWF-UU 2011-5230]; Pink Ribbon; AEGON Inc.	UMC Utrecht Cancer Center; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Pink Ribbon; AEGON Inc.	This work was supported by the UMC Utrecht Cancer Center, grants from The Netherlands Organization for Scientific Research (NWO-VIDI 917.96.318), the Dutch Cancer Society (KWF-UU 2011-5230), Pink Ribbon, and an unrestricted educational research grant from AEGON Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Costoya JA, 2001, CURR OPIN HEMATOL, V8, P212, DOI 10.1097/00062752-200107000-00006; Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f; Dai SD, 2011, CANCER SCI, V102, P95, DOI 10.1111/j.1349-7006.2010.01766.x; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Gonzalez-Angulo AM, 2006, CLIN BREAST CANCER, V7, P396, DOI 10.3816/CBC.2006.n.056; Iioka H, 2009, FEBS LETT, V583, P627, DOI 10.1016/j.febslet.2009.01.012; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Korkola JE, 2003, CANCER RES, V63, P7167; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Ogden SR, 2008, MOL BIOL CELL, V19, P4110, DOI 10.1091/mbc.E08-03-0283; Packeisen J, 2003, J CLIN PATHOL-MOL PA, V56, P198, DOI 10.1136/mp.56.4.198; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Qureshi HS, 2006, AM J CLIN PATHOL, V125, P377, DOI 10.1309/WMX7DRWTFVQP2LOT; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Ruzov A, 2009, DEVELOPMENT, V136, P729, DOI 10.1242/dev.025569; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Schonborn I, 1997, INT J ONCOL, V11, P1327; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; Singh R, 2009, EXP CELL RES, V315, P2899, DOI 10.1016/j.yexcr.2009.07.002; Siziopikou KP, 2007, BREAST, V16, P104, DOI 10.1016/j.breast.2006.09.003; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Takahashi K, 1997, ONCOGENE, V15, P71, DOI 10.1038/sj.onc.1201160; van de Wetering M, 2001, CANCER RES, V61, P278; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; van der Groep P, 2004, JNCI-J NATL CANCER I, V96, P712, DOI 10.1093/jnci/djh114; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Wagner SD, 2011, BRIT J HAEMATOL, V152, P3, DOI 10.1111/j.1365-2141.2010.08420.x; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	61	41	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37864	10.1371/journal.pone.0037864	http://dx.doi.org/10.1371/journal.pone.0037864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662240	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300130
J	Schillinger, C; Petrich, A; Lux, R; Riep, B; Kikhney, J; Friedmann, A; Wolinsky, LE; Gobel, UB; Daims, H; Moter, A				Schillinger, Claudia; Petrich, Annett; Lux, Renate; Riep, Birgit; Kikhney, Judith; Friedmann, Anton; Wolinsky, Lawrence E.; Goebel, Ulf B.; Daims, Holger; Moter, Annette			Co-Localized or Randomly Distributed? Pair Cross Correlation of In Vivo Grown Subgingival Biofilm Bacteria Quantified by Digital Image Analysis	PLOS ONE			English	Article							HUMAN PERIODONTAL POCKETS; DENTAL PLAQUE; ORAL BACTERIA; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; ACTINOMYCES-VISCOSUS; SPATIAL-DISTRIBUTION; MICROBIAL COMPLEXES; COAGGREGATION; HEALTH	The polymicrobial nature of periodontal diseases is reflected by the diversity of phylotypes detected in subgingival plaque and the finding that consortia of suspected pathogens rather than single species are associated with disease development. A number of these microorganisms have been demonstrated in vitro to interact and enhance biofilm integration, survival or even pathogenic features. To examine the in vivo relevance of these proposed interactions, we extended the spatial arrangement analysis tool of the software daime (digital image analysis in microbial ecology). This modification enabled the quantitative analysis of microbial co-localization in images of subgingival biofilm species, where the biomass was confined to fractions of the whole-image area, a situation common for medical samples. Selected representatives of the disease-associated red and orange complexes that were previously suggested to interact with each other in vitro (Tannerella forsythia with Fusobacterium nucleatum and Porphyromonas gingivalis with Prevotella intermedia) were chosen for analysis and labeled with specific fluorescent probes via fluorescence in situ hybridization. Pair cross-correlation analysis of in vivo grown biofilms revealed tight clustering of F. nucleatum/periodonticum and T. forsythia at short distances (up to 6 mu m) with a pronounced peak at 1.5 mu m. While these results confirmed previous in vitro observations for F. nucleatum and T. forsythia, random spatial distribution was detected between P. gingivalis and P. intermedia in the in vivo samples. In conclusion, we successfully employed spatial arrangement analysis on the single cell level in clinically relevant medical samples and demonstrated the utility of this approach for the in vivo validation of in vitro observations by analyzing statistically relevant numbers of different patients. More importantly, the culture-independent nature of this approach enables similar quantitative analyses for "as-yet-uncultured'' phylotypes which cannot be characterized in vitro.	[Schillinger, Claudia; Petrich, Annett; Kikhney, Judith; Goebel, Ulf B.; Moter, Annette] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany; [Lux, Renate] Univ Calif Los Angeles, UCLA Sch Dent, Los Angeles, CA USA; [Riep, Birgit] Charite, Abt Parodontol & Synopt Zahnmed, D-13353 Berlin, Germany; [Friedmann, Anton] Univ Witten, Fac Hlth, Sch Dent, Witten, Germany; [Wolinsky, Lawrence E.] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA; [Daims, Holger] Univ Vienna, Ctr Ecol, Dept Microbial Ecol, Vienna, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Vienna	Schillinger, C (corresponding author), Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany.	daims@microbial-ecology.net; annette.moter@charite.de	Daims, Holger/I-8410-2012	Daims, Holger/0000-0002-4195-0913; Valeeva, Aygul V./0000-0002-9968-9586; Kikhney, Judith/0000-0002-4849-7947; Petrich, Annett/0000-0002-2372-826X; Moter, Annette/0000-0003-1318-5780	National Institutes of Health [1R03DE018424-01A1]; Austrian Science Fund (FWF) [I44-B06]; European Science Foundation (ESF) [ERAS-CT-2003-980409]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Science Foundation (ESF)(European Science Foundation (ESF)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funded by National Institutes of Health grant 1R03DE018424-01A1 to RL and AM. In addition, this research was partly funded by Austrian Science Fund (FWF) grant I44-B06 and the European Science Foundation (ESF) under the EUROCORES Programme EuroDIVERSITY, COMIX project (contract no. ERAS-CT-2003-980409 of the European Commission, DG Research, FP6) to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2010, PERIODONTOL 2000, V53, P70, DOI 10.1111/j.1600-0757.2010.00357.x; Augspurger C, 2010, FEMS MICROBIOL ECOL, V72, P47, DOI 10.1111/j.1574-6941.2009.00830.x; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 2011, METHOD ENZYMOL, V496, P185, DOI 10.1016/B978-0-12-386489-5.00008-7; Dewhirst FE, 2010, J BACTERIOL; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Drescher J, 2010, EUR J ORAL SCI, V118, P466, DOI 10.1111/j.1600-0722.2010.00765.x; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Honma K, 2009, MICROBIOL-SGM, V155, P1912, DOI 10.1099/mic.0.027920-0; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; Kamaguchi A, 2003, MICROBIOL-SGM, V149, P1257, DOI 10.1099/mic.0.25997-0; Kara D, 2007, FEMS MICROBIOL LETT, V271, P90, DOI 10.1111/j.1574-6968.2007.00701.x; Kirschbaum M, 2010, ANAEROBE; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; KOLENBRANDER PE, 1988, ANNU REV MICROBIOL, V42, P627, DOI 10.1146/annurev.mi.42.100188.003211; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; KOLENBRANDER PE, 1985, INFECT IMMUN, V48, P741, DOI 10.1128/IAI.48.3.741-746.1985; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; LISTGARTEN MA, 1973, ARCH ORAL BIOL, V18, P651, DOI 10.1016/0003-9969(73)90105-2; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P1, DOI 10.1902/jop.1976.47.1.1; Listgarten MA, 1999, DENT PLAQUE REVISITE, P187; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nagaoka S, 2008, FEMS MICROBIOL LETT, V281, P183, DOI 10.1111/j.1574-6968.2008.01092.x; Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; Palmer Jr R. J., 2010, COMPEND CONTIN ED DE, V31, P108; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P138; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P124; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P110; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Palmer Robert J Jr, 2010, Compend Contin Educ Dent, V31, P104; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Reed MG, 1999, J MICROSC-OXFORD, V195, P96, DOI 10.1046/j.1365-2818.1999.00592.x; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Seymour RA, 2010, DENT UPDATE, V37, P210; Seymour Robin A, 2010, Dent Update, V37, P206; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; SOCRANSKY SS, 1988, J CLIN PERIODONTOL, V15, P440, DOI 10.1111/j.1600-051X.1988.tb01598.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Suzuki N, 2004, J CLIN MICROBIOL, V42, P2255, DOI 10.1128/JCM.42.5.2255-2257.2004; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Wade WG, 2010, J DENT, V38, pS21, DOI 10.1016/S0300-5712(10)70007-5; Wagner M, 2009, ANNU REV MICROBIOL, V63, P411, DOI 10.1146/annurev.micro.091208.073233; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Wimmer G, 2008, J CLIN PERIODONTOL, V35, P380, DOI 10.1111/j.1600-051X.2008.01284.x; Yamada M, 2005, FEMS MICROBIOL LETT, V250, P271, DOI 10.1016/j.femsle.2005.07.019; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	62	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37583	10.1371/journal.pone.0037583	http://dx.doi.org/10.1371/journal.pone.0037583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655057	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900033
J	Vahling-Armstrong, CM; Zhou, HS; Benyon, L; Morgan, JK; Duan, YP				Vahling-Armstrong, Cheryl M.; Zhou, Huasong; Benyon, Lesley; Morgan, J. Kent; Duan, Yongping			Two Plant Bacteria, S. meliloti and Ca. Liberibacter asiaticus, Share Functional znuABC Homologues That Encode for a High Affinity Zinc Uptake System	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; ESCHERICHIA-COLI; TRANSPORT PROTEIN; BINDING PROTEIN; SEQUENCE; GENE; VIRULENCE; ZUR; IDENTIFICATION; CONSTRUCTION	The Znu system, encoded for by znuABC, can be found in multiple genera of bacteria and has been shown to be responsible for the import of zinc under low zinc conditions. Although this high-affinity uptake system is known to be important for both growth and/or pathogenesis in bacteria, it has not been functionally characterized in a plant-associated bacterium. A single homologue of this system has been identified in the plant endosymbiont, Sinorhizobium meliloti, while two homologous systems were found in the destructive citrus pathogen, Candidatus Liberibacter asiaticus. To understand the role of these protein homologues, a complementation assay was devised allowing the individual genes that comprise the system to be assayed independently for their ability to reinstate a partially-inactivated Znu system. Results from the assays have demonstrated that although all of the genes from S. meliloti were able to restore activity, only one of the two Ca. Liberibacter asiaticus encoded gene clusters contained genes that were able to functionally complement the system. Additional analysis of the gene clusters reveals that distinct modes of regulation may also exist between the Ca. Liberibacter asiaticus and S. meliloti import systems despite the intracellular-plant niche common to both of these bacteria.	[Vahling-Armstrong, Cheryl M.; Zhou, Huasong; Benyon, Lesley; Morgan, J. Kent; Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Vahling-Armstrong, CM (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA.	yongping.duan@ars.usda.gov	Benyon, Lesley/GXV-7974-2022		US Department of Agriculture (USDA); Citrus Research and Development Foundation (CRDF) [162]; Florida Citrus Advanced Technology Program [162]	US Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Citrus Research and Development Foundation (CRDF); Florida Citrus Advanced Technology Program	US Department of Agriculture (USDA), and Citrus Research and Development Foundation (CRDF) grant #162. Funding for this work was provided by the Florida Citrus Advanced Technology Program award 162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Beard SJ, 2000, FEMS MICROBIOL LETT, V184, P231, DOI 10.1016/S0378-1097(00)00055-0; Bove JM, 2006, J PLANT PATHOL, V88, P7; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Choudhury R, 2001, CURR SCI INDIA, V81, P768; Dalet K, 1999, FEMS MICROBIOL LETT, V174, P111, DOI 10.1016/S0378-1097(99)00128-7; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; Garrido ME, 2003, FEMS MICROBIOL LETT, V221, P31, DOI 10.1016/S0378-1097(03)00131-9; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gottwald T.R., 2007, PLANT HLTH PROG, V8, P31, DOI [10.1094/PHP-2007-0906-01-RV, DOI 10.1094/PHP-2007-0906-01-RV]; Grass G, 2002, J BACTERIOL, V184, P864, DOI 10.1128/JB.184.3.864-866.2002; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; House BL, 2004, APPL ENVIRON MICROB, V70, P2806, DOI 10.1128/AEM.70.5.2806-2815.2004; Humann JL, 2008, APPL ENVIRON MICROB, V74, P6756, DOI 10.1128/AEM.01468-08; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lewis DA, 1999, INFECT IMMUN, V67, P5060, DOI 10.1128/IAI.67.10.5060-5068.1999; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Sabri M, 2009, INFECT IMMUN, V77, P1155, DOI 10.1128/IAI.01082-08; Schroeder BK, 2005, APPL ENVIRON MICROB, V71, P5858, DOI 10.1128/AEM.71.10.5858-5864.2005; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vahling CM, 2010, J BACTERIOL, V192, P834, DOI 10.1128/JB.01279-09; Yang XH, 2006, INFECT IMMUN, V74, P3874, DOI 10.1128/IAI.01957-05; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zekri M, 2009, MICRONUTRIENT DEFICI	43	30	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37340	10.1371/journal.pone.0037340	http://dx.doi.org/10.1371/journal.pone.0037340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655039	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900014
J	Xu, SL; Poidevin, M; Han, EJ; Bi, JZ; Jin, P				Xu, Shunliang; Poidevin, Mickael; Han, Enji; Bi, Jianzhong; Jin, Peng			Circadian Rhythm-Dependent Alterations of Gene Expression in Drosophila Brain Lacking Fragile X Mental Retardation Protein	PLOS ONE			English	Article							CGG REPEAT; FMR-1 GENE; INSTABILITY; RNA; INTERACTS; MUTATION; HOMOLOG; OUTPUT; LEVEL; DFMR1	Fragile X syndrome is caused by the loss of the FMR1 gene product, fragile X mental retardation protein (FMRP). The loss of FMRP leads to altered circadian rhythm behaviors in both mouse and Drosophila; however, the molecular mechanism behind this phenomenon remains elusive. Here we performed a series of gene expression analyses, including of both mRNAs and microRNAs (miRNAs), and identified a number of mRNAs and miRNAs (miRNA-1 and miRNA-281) with circadian rhythm-dependent altered expression in dfmr1 mutant flies. Identification of these RNAs lays the foundation for future investigations of the molecular pathway(s) underlying the altered circadian rhythms associated with loss of dFmr1.	[Xu, Shunliang; Bi, Jianzhong] Shandong Univ, Dept Neurol, Hosp 2, Jinan 250100, Shandong, Peoples R China; [Han, Enji] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Xu, Shunliang; Poidevin, Mickael; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Shandong University; Shandong University; Emory University	Xu, SL (corresponding author), Shandong Univ, Dept Neurol, Hosp 2, Jinan 250100, Shandong, Peoples R China.	sl_hsu@yahoo.com	Xu, Shunliang/AAO-7265-2021	Xu, Shunliang/0000-0001-6516-723X	NIH [R01 MH076090]; Shandong Provincial Natural Science Foundation, China [ZR2011LH021]; Independent Innovation Foundation of Shandong University, IIFSDU [2010JC016]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University, IIFSDU; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant R01 MH076090 to P.J. S. X. is supported by Shandong Provincial Natural Science Foundation, China (ZR2011LH021) and Independent Innovation Foundation of Shandong University, IIFSDU (2010JC016). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Francke F, 2006, J BIOL CHEM, V281, P32496, DOI 10.1074/jbc.M602889200; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gao FB, 2002, NEURON, V34, P859, DOI 10.1016/S0896-6273(02)00740-7; Hagerman R.J., 2002, FRAGILE X SYNDROME D; Inoue SB, 2002, CURR BIOL, V12, P1331, DOI 10.1016/S0960-9822(02)01036-9; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Sherman S. L., 2001, METABOLIC MOL BASES, V1, P1257; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; WOHRLE D, 1992, AM J HUM GENET, V51, P299; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Yang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000444; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37937	10.1371/journal.pone.0037937	http://dx.doi.org/10.1371/journal.pone.0037937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655085	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900062
J	Xu, ZK; Waeckerlin, R; Urbanowski, MD; van Marle, G; Hobman, TC				Xu, Zaikun; Waeckerlin, Regula; Urbanowski, Matt D.; van Marle, Guido; Hobman, Tom C.			West Nile Virus Infection Causes Endocytosis of a Specific Subset of Tight Junction Membrane Proteins	PLOS ONE			English	Article							CELLS; EXPRESSION; TRANSPORT; TRAFFICKING; INHIBITOR; MECHANISM; DYNAMIN; ENTRY; PCR	West Nile virus (WNV) is a blood-borne pathogen that causes systemic infections and serious neurological disease in human and animals. The most common route of infection is mosquito bites and therefore, the virus must cross a number of polarized cell layers to gain access to organ tissue and the central nervous system. Resistance to trans-cellular movement of macromolecules between epithelial and endothelial cells is mediated by tight junction complexes. While a number of recent studies have documented that WNV infection negatively impacts the barrier function of tight junctions, the intracellular mechanism by which this occurs is poorly understood. In the present study, we report that endocytosis of a subset of tight junction membrane proteins including claudin-1 and JAM-1 occurs in WNV infected epithelial and endothelial cells. This process, which ultimately results in lysosomal degradation of the proteins, is dependent on the GTPase dynamin and microtubule-based transport. Finally, infection of polarized cells with the related flavivirus, Dengue virus-2, did not result in significant loss of tight junction membrane proteins. These results suggest that neurotropic flaviviruses such as WNV modulate the host cell environment differently than hemorrhagic flaviviruses and thus may have implications for understanding the molecular basis for neuroinvasion.	[Xu, Zaikun; Urbanowski, Matt D.; Hobman, Tom C.] Univ Alberta, Li Ka Shing Inst Virol, Dept Cell Biol, Edmonton, AB, Canada; [Waeckerlin, Regula] Univ Calgary, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 1N4, Canada; [van Marle, Guido] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Hobman, Tom C.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta; University of Calgary; University of Calgary; University of Alberta	Xu, ZK (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Cell Biol, Edmonton, AB, Canada.	tom.hobman@ualberta.ca		van Marle, Guido/0000-0002-5148-6229	Alberta Innovates Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR); Tier 1 Canada Research Chair; CIHR; AIHS	Alberta Innovates Health Solutions (AIHS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS	ZX is the recipient of a Graduate Studentship from Alberta Innovates Health Solutions (AIHS) and MDU holds a Doctoral Scholarship from the Canadian Institutes of Health Research (CIHR). TCH holds a Scientist award from AIHS and a Tier 1 Canada Research Chair. This work is supported by a research grant from the CIHR to TCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Grone A, 2002, VIRAL IMMUNOL, V15, P493, DOI 10.1089/088282402760312368; HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08; Michikawa H, 2008, CELL TISSUE RES, V334, P255, DOI 10.1007/s00441-008-0689-2; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; SCHEEL J, 1990, J CELL SCI, V96, P711; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sips GJ, 2011, REV MED VIROL; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Wahl-Jensen VM, 2005, J VIROL, V79, P10442, DOI 10.1128/JVI.79.16.10442-10450.2005; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10; ZIMMERMAN GA, 1985, J CLIN INVEST, V76, P2235, DOI 10.1172/JCI112232	38	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37886	10.1371/journal.pone.0037886	http://dx.doi.org/10.1371/journal.pone.0037886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655077	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900054
J	Chauvaud, L; Patry, Y; Jolivet, A; Cam, E; Le Goff, C; Strand, O; Charrier, G; Thebault, J; Lazure, P; Gotthard, K; Clavier, J				Chauvaud, Laurent; Patry, Yann; Jolivet, Aurelie; Cam, Emmanuelle; Le Goff, Clement; Strand, Oivind; Charrier, Gregory; Thebault, Julien; Lazure, Pascal; Gotthard, Karl; Clavier, Jacques			Variation in Size and Growth of the Great Scallop Pecten maximus along a Latitudinal Gradient	PLOS ONE			English	Article							BODY-SIZE; COUNTERGRADIENT VARIATION; PHENOTYPIC PLASTICITY; GEOGRAPHIC-VARIATION; ANTARCTIC SCALLOP; INTRINSIC GROWTH; TEMPERATURE; LIFE; RATES; BAY	Understanding the relationship between growth and temperature will aid in the evaluation of thermal stress and threats to ectotherms in the context of anticipated climate changes. Most Pecten maximus scallops living at high latitudes in the northern hemisphere have a larger maximum body size than individuals further south, a common pattern among many ectotherms. We investigated differences in daily shell growth among scallop populations along the Northeast Atlantic coast from Spain to Norway. This study design allowed us to address precisely whether the asymptotic size observed along a latitudinal gradient, mainly defined by a temperature gradient, results from differences in annual or daily growth rates, or a difference in the length of the growing season. We found that low annual growth rates in northern populations are not due to low daily growth values, but to the smaller number of days available each year to achieve growth compared to the south. We documented a decrease in the annual number of growth days with age regardless of latitude. However, despite initially lower annual growth performances in terms of growing season length and growth rate, differences in asymptotic size as a function of latitude resulted from persistent annual growth performances in the north and sharp declines in the south. Our measurements of daily growth rates throughout life in a long-lived ectothermic species provide new insight into spatio-temporal variations in growth dynamics and growing season length that cannot be accounted for by classical growth models that only address asymptotic size and annual growth rate.	[Chauvaud, Laurent; Patry, Yann; Jolivet, Aurelie; Thebault, Julien; Clavier, Jacques] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin, CNRS,UMR 6539, Plouzane, France; [Cam, Emmanuelle] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Cam, Emmanuelle] Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Strand, Oivind] Inst Marine Res, N-5024 Bergen, Norway; [Charrier, Gregory] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden; [Le Goff, Clement; Lazure, Pascal] IFREMER, Ctr Brest, LOS, Plouzane, France; [Le Goff, Clement; Lazure, Pascal] IFREMER, Ctr Brest, Lab Phys Hydrodynam & Sedimentaire PHYSED, Plouzane, France; [Gotthard, Karl] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Institute of Marine Research - Norway; University of Gothenburg; Ifremer; Ifremer; Stockholm University	Chauvaud, L (corresponding author), Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin, CNRS,UMR 6539, Technopole Brest Iroise, Plouzane, France.	laurent.chauvaud@univ-brest.fr	lazure, pascal/L-4596-2015; Gotthard, Karl/F-1163-2011; Thébault, Julien/F-6198-2011	lazure, pascal/0000-0003-2794-8785; Gotthard, Karl/0000-0002-4560-6271; Thébault, Julien/0000-0002-3111-4428; le goff, clement/0000-0002-6565-8458; Jolivet, Aurelie/0000-0001-5415-3326; Cam, Emmanuelle/0000-0001-7324-6958	EU; ANR-Blanc (Agence Nationale de la Recherche : CHIVAS); Fondation Franco- Norvegienne (FNS); Stockholm University; GIS EUROPOLE MER; Research Axis 2 "Global change - Ocean - Marine ecosystems''	EU(European Commission); ANR-Blanc (Agence Nationale de la Recherche : CHIVAS)(French National Research Agency (ANR)); Fondation Franco- Norvegienne (FNS); Stockholm University; GIS EUROPOLE MER; Research Axis 2 "Global change - Ocean - Marine ecosystems''	This study was partly supported by the EU "Marie Curie'' program, the French program ANR-Blanc (Agence Nationale de la Recherche : CHIVAS project), the Fondation Franco- Norvegienne (FNS) and by the Strategic Research Program EkoKlim at Stockholm University (K. Gottard). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Laurent Chauvaud gratefully acknowledges the EU program "Training and mobility Researchers'' ("Large-Scale Facilities'' and "Marie Curie'' research training grants) for the award of a postdoctoral fellowship. C. Le Goff and A. Jolivet thank the GIS EUROPOLE MER and in particular the Research Axis 2 "Global change - Ocean - Marine ecosystems'' for their two postdoctoral fellowships. We would like to thank also the two referees (an anonymous and Vladimir Laptikhovsky) for their comments which helped improving the quality of our manuscript.	Angilletta MJ, 2006, AM NAT, V168, pE123, DOI 10.1086/507880; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Arendt JD, 1999, ECOLOGY, V80, P2793, DOI 10.1890/0012-9658(1999)080[2793:CSFRGI]2.0.CO;2; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Ayata SD, 2010, PROG OCEANOGR, V87, P18, DOI 10.1016/j.pocean.2010.09.022; BARNES DKA, 1995, J EXP MAR BIOL ECOL, V188, P181, DOI 10.1016/0022-0981(95)00003-A; BEAUMONT AR, 1993, J EXP MAR BIOL ECOL, V169, P77, DOI 10.1016/0022-0981(93)90044-O; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Blanckenhorn WU, 1998, EVOLUTION, V52, P1394, DOI [10.2307/2411309, 10.1111/j.1558-5646.1998.tb02021.x]; Boucher J, 1997, ANN I OCEANOGR PARIS, V73, P89; Brey T., 2001, POPULATION DYNAMICS; Brockington S, 2001, MAR BIOL, V139, P127; Buestel D., 1987, Haliotis, V16, P463; Campana Steven E., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P73; Chauvaud L, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000890; Chauvaud L, 1998, J EXP MAR BIOL ECOL, V227, P83, DOI 10.1016/S0022-0981(97)00263-3; Chauvaud L, 2011, ESTUAR COAST, V34, P211, DOI 10.1007/s12237-010-9267-4; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; Cox B.C., 2000, BIOGEOGRAPHY ECOLOGI; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Dinter WP., 2001, BIOGEOGRAPHY OSPAR M; Dittman DE, 1998, MAR BIOL, V132, P461, DOI 10.1007/s002270050412; FERGUSON GW, 1993, OECOLOGIA, V93, P88, DOI 10.1007/BF00321196; Forbes E, 1858, AK JOHNSTONS PHYS AT, P99; Goodwin DH, 2001, PALAIOS, V16, P387, DOI 10.2307/3515578; Gotthard K, 2001, EXPTL BIOL REV, P287; Guarini JM, 2011, J SEA RES, V65, P355, DOI 10.1016/j.seares.2011.02.001; Heilmayer O, 2005, POLAR BIOL, V28, P523, DOI 10.1007/s00300-005-0716-7; Heilmayer O, 2004, FUNCT ECOL, V18, P641, DOI 10.1111/j.0269-8463.2004.00905.x; Heilmayer O, 2003, J EXP MAR BIOL ECOL, V288, P239, DOI 10.1016/S0022-0981(03)00020-0; Hiscock K, 2004, AQUAT CONSERV, V14, P333, DOI 10.1002/aqc.628; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Imsland AK, 2002, FISH FISH, V3, P36, DOI 10.1046/j.1467-2979.2002.00070.x; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Irie T, 2005, AM NAT, V165, P238, DOI 10.1086/427157; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; Kennedy H, 2001, MAR BIOL, V139, P1115; Kobashi Takuro, 2003, Paleontological Research, V7, P343, DOI 10.2517/prpsj.7.343; Kozlowski J, 1987, EVOL ECOL, V1, P214, DOI 10.1007/BF02067552; Lankford TE, 2001, EVOLUTION, V55, P1873, DOI 10.1111/j.0014-3820.2001.tb00836.x; Laugen AT, 2003, J EVOLUTION BIOL, V16, P996, DOI 10.1046/j.1420-9101.2003.00560.x; LEVINTON JS, 1983, BIOL BULL, V165, P699, DOI 10.2307/1541472; Lorrain A, 2000, J MAR BIOL ASSOC UK, V80, P667, DOI 10.1017/S0025315400002496; Lorrain A, 2004, GEOCHIM COSMOCHIM AC, V68, P3509, DOI 10.1016/j.gca.2004.01.025; MACDONALD BA, 1988, BIOL BULL-US, V175, P361, DOI 10.2307/1541727; MASON J, 1957, J MAR BIOL ASSOC UK, V36, P473, DOI 10.1017/S0025315400025777; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mousseau TA, 2000, ADAPTATIVE GENETIC V; NIEWIAROWSKI PH, 1993, ECOLOGY, V74, P1992, DOI 10.2307/1940842; PALMER AR, 1994, REPRODUCTION AND DEVELOPMENT OF MARINE INVERTEBRATES, P177; Parsons KE, 1997, EVOLUTION, V51, P784, DOI 10.1111/j.1558-5646.1997.tb03661.x; Partridge L., 1996, Society for Experimental Biology Seminar Series, V59, P265; Pauly D., 1984, FISHBYTE, V2, P21; PERRIN N, 1992, AM NAT, V139, P1344, DOI 10.1086/285390; PERRIN N, 1995, OIKOS, V73, P137, DOI 10.2307/3545737; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Schultz ET, 1996, FUNCT ECOL, V10, P366, DOI 10.2307/2390285; Stearns S.C., 1992, pi; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Terribile LC, 2009, BIOL J LINN SOC, V98, P94, DOI 10.1111/j.1095-8312.2009.01262.x; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Weetman D, 2004, J PLANKTON RES, V26, P107, DOI 10.1093/plankt/fbh013; Wilding CS, 1998, J SHELLFISH RES, V17, P131	74	45	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37717	10.1371/journal.pone.0037717	http://dx.doi.org/10.1371/journal.pone.0037717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649553	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800073
J	Laing, CR; Zhang, YX; Gilmour, MW; Allen, V; Johnson, R; Thomas, JE; Gannon, VPJ				Laing, Chad R.; Zhang, Yongxiang; Gilmour, Matthew W.; Allen, Vanessa; Johnson, Roger; Thomas, James E.; Gannon, Victor P. J.			A Comparison of Shiga-Toxin 2 Bacteriophage from Classical Enterohemorrhagic Escherichia coli Serotypes and the German E. coli O104:H4 Outbreak Strain	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; GENOME SEQUENCE; PHYLOGENETIC ANALYSIS; PARALLEL EVOLUTION; VIRULENCE FACTORS; INSERTION SITE; O157-H7; O157H7; PHAGE; DIVERSITY	Escherichia coli O104:H4 was associated with a severe foodborne disease outbreak originating in Germany in May 2011. More than 4000 illnesses and 50 deaths were reported. The outbreak strain was a typical enteroaggregative E. coli (EAEC) that acquired an antibiotic resistance plasmid and a Shiga-toxin 2 (Stx2)-encoding bacteriophage. Based on whole-genome phylogenies, the O104:H4 strain was most closely related to other EAEC strains; however, Stx2-bacteriophage are mobile, and do not necessarily share an evolutionary history with their bacterial host. In this study, we analyzed Stx2-bacteriophage from the E. coli O104:H4 outbreak isolates and compared them to all available Stx2-bacteriophage sequences. We also compared Stx2 production by an E. coli O104:H4 outbreak-associated isolate (ON-2011) to that of E. coli O157:H7 strains EDL933 and Sakai. Among the E. coli Stx2-phage sequences studied, that from O111:H-strain JB1-95 was most closely related phylogenetically to the Stx2-phage from the O104:H4 outbreak isolates. The phylogeny of most other Stx2-phage was largely concordant with their bacterial host genomes. Finally, O104:H4 strain ON-2011 produced less Stx2 than E. coli O157:H7 strains EDL933 and Sakai in culture; however, when mitomycin C was added, ON-2011 produced significantly more toxin than the E. coli O157:H7 strains. The Stx2-phage from the E. coli O104:H4 outbreak strain and the Stx2-phage from O111:H-strain JB1-95 likely share a common ancestor. Incongruence between the phylogenies of the Stx2-phage and their host genomes suggest the recent Stx2-phage acquisition by E. coli O104:H4. The increase in Stx2-production by ON-2011 following mitomycin C treatment may or may not be related to the high rates of hemolytic uremic syndrome associated with the German outbreak strain. Further studies are required to determine whether the elevated Stx2-production levels are due to bacteriophage or E. coli O104:H4 host related factors.	[Laing, Chad R.; Zhang, Yongxiang; Gannon, Victor P. J.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada; [Gilmour, Matthew W.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Laing, Chad R.; Allen, Vanessa] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Johnson, Roger] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Thomas, James E.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; University of Lethbridge	Laing, CR (corresponding author), Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada.	vic.gannon@phac-aspc.gc.ca	Allen, Vanessa/AAE-2756-2022	Allen, Vanessa/0000-0001-9802-9730; Laing, Chad/0000-0003-1162-257X; Gilmour, Matthew/0000-0002-6005-3628	Public Health Agency of Canada; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures	Public Health Agency of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures	This work was supported by the Public Health Agency of Canada and grants from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) and Alberta Innovates Technology Futures (www.albertatechfutures.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2012, EMERG INFECT DIS, V18, P473, DOI 10.3201/eid1803.111281; Askar M, 2011, EUROSURVEILLANCE, V16, P2; Besser TE, 2007, APPL ENVIRON MICROB, V73, P671, DOI 10.1128/AEM.01035-06; Bielaszewska M, 2012, ANTIMICROB IN PRESS; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blaser MJ, 2011, NEW ENGL J MED, V365, P1835, DOI 10.1056/NEJMe1110896; Boerlin P, 1999, CELL MOL LIFE SCI, V56, P735, DOI 10.1007/s000180050020; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Sablet T, 2009, INFECT IMMUN, V77, P783, DOI 10.1128/IAI.01048-08; Denamur E, 2011, CLIN MICROBIOL INFEC, V17, P1124, DOI 10.1111/j.1469-0691.2011.03620.x; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garcia-Aljaro C, 2009, APPL ENVIRON MICROB, V75, P329, DOI 10.1128/AEM.01367-08; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Laing C, 2008, APPL ENVIRON MICROB, V74, P6606, DOI 10.1128/AEM.00985-08; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Mossoro C, 2002, J CLIN MICROBIOL, V40, P3086, DOI 10.1128/JCM.40.8.3086-3088.2002; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Robinson CM, 2006, P NATL ACAD SCI USA, V103, P9667, DOI 10.1073/pnas.0602359103; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sato T, 2003, GENE, V309, P35, DOI 10.1016/S0378-1119(03)00487-6; Sato T, 2003, J BACTERIOL, V185, P3966, DOI 10.1128/JB.185.13.3966-3971.2003; Scheutz F, 2011, EUROSURVEILLANCE, V16, P5; Serra-Moreno R, 2007, J BACTERIOL, V189, P6645, DOI 10.1128/JB.00466-07; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Shepard SM, 2012, J BACTERIOL, V194, P395, DOI 10.1128/JB.06225-11; Shimizu T, 2009, INFECT IMMUN, V77, P2813, DOI 10.1128/IAI.00060-09; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08; Vareille M, 2007, P NATL ACAD SCI USA, V104, P10199, DOI 10.1073/pnas.0702589104; Wieler LH, 1997, FEMS MICROBIOL LETT, V156, P49, DOI 10.1016/S0378-1097(97)00403-5; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Zhang YX, 2010, APPL ENVIRON MICROB, V76, P474, DOI 10.1128/AEM.01288-09; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Ziebell K, 2008, APPL ENVIRON MICROB, V74, P4314, DOI 10.1128/AEM.02821-07	56	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37362	10.1371/journal.pone.0037362	http://dx.doi.org/10.1371/journal.pone.0037362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649523	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800041
J	Lu, CM; Xie, G; Liu, MY; Zhu, H; Lei, BF				Lu, Chunmei; Xie, Gang; Liu, Mengyao; Zhu, Hui; Lei, Benfang			Direct Heme Transfer Reactions in the Group A Streptococcus Heme Acquisition Pathway	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; BINDING PROTEIN; IRON; IDENTIFICATION; HTSA; HEMOGLOBIN; SYSTEM; SHP; TRANSPORT; DOMAIN	The heme acquisition machinery in Group A Streptococcus (GAS) consists of the surface proteins Shr and Shp and ATP-binding cassette transporter HtsABC. Shp cannot directly acquire heme from methemoglobin (metHb) but directly transfers its heme to HtsA. It has not been previously determined whether Shr directly relays heme from metHb to Shp. Thus, the complete pathway for heme acquisition from metHb by the GAS heme acquisition machinery has remained unclear. In this study, the metHb-to-Shr and Shr-to-Shp heme transfer reactions were characterized by spectroscopy, kinetics and protein-protein interaction analyses. Heme is efficiently transferred from the beta and alpha subunits of metHb to Shr with rates that are 7 and 60 times greater than those of the passive heme release from metHb, indicating that Shr directly acquires heme from metHb. The rapid heme transfer from Shr to Shp involves an initial heme donor/acceptor complex and a spectrally and kinetically detectable transfer intermediate, implying that heme is directly channeled from Shr to Shp. The present results show that Shr speeds up heme transfer from metHb to Shp, whereas Shp speeds up heme transfer from Shr to HtsA. Furthermore, the findings demonstrate that Shr can interact with metHb and Shp but not HtsA. Taken together with our published results on the Shp/HtsA reaction, these findings establish a model of the heme acquisition pathway in GAS in which Shr directly extracts heme from metHb and Shp relays it from Shr to HtsA.	[Lu, Chunmei; Zhu, Hui] Harbin Med Univ, Dept Physiol, Harbin, Peoples R China; [Xie, Gang; Liu, Mengyao; Zhu, Hui; Lei, Benfang] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Harbin Medical University; Montana State University System; Montana State University Bozeman	Lu, CM (corresponding author), Harbin Med Univ, Dept Physiol, Harbin, Peoples R China.	dzhuhui@yahoo.com.cn; blei@montana.edu		Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI095704, P20 RR-020185, GM103500-09]; Montana State University Agricultural Experimental Station; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State of Education Ministry; Natural Science Foundation of Heilongjiang Province, China [LC2011C02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana State University Agricultural Experimental Station; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State of Education Ministry; Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants AI095704, P20 RR-020185, and GM103500-09, and the Montana State University Agricultural Experimental Station. The work done at Harbin Medical University was supported by a grant from the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State of Education Ministry and grant LC2011C02 from Natural Science Foundation of Heilongjiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fuhrhop JH, PORPHYRINS METALLOPO, P804; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; KLEBBA PE, 1993, J BIOENERG BIOMEMBR, V25, P603; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Sook BR, 2008, BIOCHEMISTRY-US, V47, P2678, DOI 10.1021/bi701604y; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	31	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37556	10.1371/journal.pone.0037556	http://dx.doi.org/10.1371/journal.pone.0037556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649539	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800058
J	Reilly, EC; Thompson, EA; Aspeslagh, S; Wands, JR; Elewaut, D; Brossay, L				Reilly, Emma C.; Thompson, Elizabeth A.; Aspeslagh, Sandrine; Wands, Jack R.; Elewaut, Dirk; Brossay, Laurent			Activated iNKT Cells Promote Memory CD8(+) T Cell Differentiation during Viral Infection	PLOS ONE			English	Article							INVARIANT NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; IMMUNE-RESPONSES; CUTTING EDGE; CYTOMEGALOVIRUS-INFECTION; PROTECTIVE IMMUNITY; INFLUENZA-VIRUS; KILLER; ANTIGEN; VACCINE	alpha-galactosylceramide (alpha-GalCer) is the prototypical lipid ligand for invariant NKT cells. Recent studies have proposed that alpha-GalCer is an effective adjuvant in vaccination against a range of immune challenges, however its mechanism of action has not been completely elucidated. A variety of delivery methods have been examined including pulsing dendritic cells with alpha-GalCer to optimize the potential of alpha-GalCer. These methods are currently being used in a variety of clinical trials in patients with advanced cancer but cannot be used in the context of vaccine development against pathogens due to their complexity. Using a simple delivery method, we evaluated alpha-GalCer adjuvant properties, using the mouse model for cytomegalovirus (MCMV). We measured several key parameters of the immune response to MCMV, including inflammation, effector, and central memory CD8(+) T cell responses. We found that alpha-GalCer injection at the time of the infection decreases viral titers, alters the kinetics of the inflammatory response, and promotes both increased frequencies and numbers of virus-specific memory CD8(+) T cells. Overall, our data suggest that iNKT cell activation by alpha-GalCer promotes the development of long-term protective immunity through increased fitness of central memory CD8(+) T cells, as a consequence of reduced inflammation.	[Reilly, Emma C.; Thompson, Elizabeth A.; Wands, Jack R.; Brossay, Laurent] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Reilly, Emma C.; Thompson, Elizabeth A.; Wands, Jack R.; Brossay, Laurent] Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; [Aspeslagh, Sandrine; Elewaut, Dirk] Univ Ghent, Fac Med & Hlth Sci, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium	Brown University; Brown University; Ghent University	Reilly, EC (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Laurent_Brossay@brown.edu	Thompson, Elizabeth A/M-4898-2017; Elewaut, Dirk/K-6831-2014	Thompson, Elizabeth A/0000-0001-8464-9904; Elewaut, Dirk/0000-0002-7468-974X; Brossay, Laurent/0000-0002-7497-8488	National Institutes of Health [AI46709, T32 5T32DK060415]; NCCR [1S10RR021051]; FWO; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046709, R21AI046709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCR(Swiss National Science Foundation (SNSF)); FWO(FWO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health research grant AI46709 and an NCCR equipment grant 1S10RR021051 to LB. NIH T32 5T32DK060415 Training Program in Gastroenterology to ER. SA was supported by a FWO Flanders pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x; Carnaud C, 1999, J IMMUNOL, V163, P4647; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Dhodapkar MV, 2011, CLIN IMMUNOL, V140, P160, DOI 10.1016/j.clim.2010.12.010; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Exley MA, 2001, J LEUKOCYTE BIOL, V69, P713; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HENSON D, 1972, AM J PATHOL, V68, P183; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; JORDAN MC, 1977, J GEN VIROL, V37, P419, DOI 10.1099/0022-1317-37-2-419; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kamijuku, 2008, MUCOSAL IMMUNOLOGY; Kim S, 2008, J CLIN INVEST, V118, P2301, DOI [10.1172/JC133071, 10.1172/JCI33071]; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Nolz JC, 2011, ADV EXP MED BIOL, V780, P69, DOI 10.1007/978-1-4419-5632-3_7; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Renneson J, 2011, AM J PATHOL, V179, P1872, DOI 10.1016/j.ajpath.2011.06.023; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schneiders FL, 2011, CLIN IMMUNOL, V140, P130, DOI 10.1016/j.clim.2010.11.010; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; van Dommelen SLH, 2003, J VIROL, V77, P1877, DOI 10.1128/JVI.77.3.1877-1884.2003; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wesley JD, 2005, J IMMUNOL, V174, P3864, DOI 10.4049/jimmunol.174.7.3864; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wiesel M, 2011, EUR J IMMUNOL; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Youn HJ, 2007, VACCINE, V25, P5189, DOI 10.1016/j.vaccine.2007.04.081; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	55	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37991	10.1371/journal.pone.0037991	http://dx.doi.org/10.1371/journal.pone.0037991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649570	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800090
J	Silva, LM; van Rossem, L; Jansen, PW; Hokken-Koelega, ACS; Moll, HA; Hofman, A; Mackenbach, JP; Jaddoe, VWV; Raat, H				Silva, Lindsay M.; van Rossem, Lenie; Jansen, Pauline W.; Hokken-Koelega, Anita C. S.; Moll, Henriette A.; Hofman, Albert; Mackenbach, Johan P.; Jaddoe, Vincent W. V.; Raat, Hein			Children of Low Socioeconomic Status Show Accelerated Linear Growth in Early Childhood; Results from the Generation R Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; MIDDLE-AGED MEN; BIRTH COHORT; FOLLOW-UP; MATERNAL SMOKING; GESTATIONAL-AGE; EARLY ADULTHOOD; BLOOD-PRESSURE; 1ST YEAR	Objective: People of low socioeconomic status are shorter than those of high socioeconomic status. The first two years of life being critical for height development, we hypothesized that a low socioeconomic status is associated with a slower linear growth in early childhood. We studied maternal educational level (high, mid-high, mid-low, and low) as a measure of socioeconomic status and its association with repeatedly measured height in children aged 0-2 years, and also examined to what extent known determinants of postnatal growth contribute to this association. Methods: This study was based on data from 2972 mothers with a Dutch ethnicity, and their children participating in The Generation R Study, a population-based cohort study in Rotterdam, the Netherlands (participation rate 61%). All children were born between April 2002 and January 2006. Height was measured at 2 months (mid-90% range 1.0-3.9), 6 months (mid-90% range 5.6-11.4), 14 months (mid-90% range 13.7-17.9) and 25 months of age (mid-90% range 23.6-29.6). Results: At 2 months, children in the lowest educational subgroup were shorter than those in the highest (difference: -0.87 cm; 95% CI: -1.16, -0.58). Between 1 and 18 months, they grew faster than their counterparts. By 14 months, children in the lowest educational subgroup were taller than those in the highest (difference at 14 months: 0.40 cm; 95% CI: 0.08,0.72). Adjustment for other determinants of postnatal growth did not explain the taller height. On the contrary, the differences became even larger (difference at 14 months: 0.61 cm; 95% CI: 0.26,0.95; and at 25 months: 1.00 cm; 95% CI: 0.57,1.43) Conclusions: Compared with children of high socioeconomic status, those of low socioeconomic status show an accelerated linear growth until the 18th month of life, leading to an overcompensation of their initial height deficit. The long-term consequences of these findings remain unclear and require further study.	[Silva, Lindsay M.; van Rossem, Lenie; Jansen, Pauline W.; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Generat Study Grp R, Erasmus MC, Rotterdam, Netherlands; [Silva, Lindsay M.; Hokken-Koelega, Anita C. S.; Moll, Henriette A.; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Dept Pediat, Erasmus MC, Rotterdam, Netherlands; [van Rossem, Lenie] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Jansen, Pauline W.] Univ Med Ctr Rotterdam, Dept Child & Adolescent Psychiat, Erasmus MC, Rotterdam, Netherlands; [Hofman, Albert] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Mackenbach, Johan P.; Raat, Hein] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Silva, LM (corresponding author), Univ Med Ctr Rotterdam, Generat Study Grp R, Erasmus MC, Rotterdam, Netherlands.	l.silva@erasmusmc.nl	van Rossem, Lenie/GXH-0118-2022	Jansen, Pauline/0000-0001-7747-5803	Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Netherlands Organization for Scientific Research (NWO) [017.002.107]	Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), and the Netherlands Organization for Scientific Research (NWO) (017.002.107 to LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, STAT NETHERLANDSALLO; [Anonymous], 2003, STAT NETHERLANDSSTAN; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Braveman P, 2001, PUBLIC HEALTH REP, V116, P449, DOI 10.1093/phr/116.5.449; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Spyrides MHC, 2008, J PEDIAT-BRAZIL, V84, P237, DOI [10.2223/JPED.1797, 10.1590/S0021-75572008000300009]; de Menezes RC, 2012, REV SAUDE PUBL, V45, P1079; Dewey KG, 2005, MATERN CHILD NUTR, V1, P11, DOI 10.1111/j.1740-8709.2004.00004.x; Dewey Kathryn G, 2003, J Hum Lact, V19, P9; Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010; DRACHLER M. L., 2002, CENT EUR J PUBL HEAL, V10, P135; du Prel X, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-312; Dubois L, 2003, PUBLIC HEALTH NUTR, V6, P773, DOI 10.1079/PHN2003497; Fewtrell MS, 2000, DIABETOLOGIA, V43, P714, DOI 10.1007/s001250051368; Finch BK, 2011, ECON HUM BIOL, V9, P272, DOI 10.1016/j.ehb.2011.02.005; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; Fredriks AM, ACTA PAEDIAT, V93, P817; FREDRIKS AM, 2001, NED TIJDSCHR GENEES, V145, P1308; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; HEINIG MJ, 1993, AM J CLIN NUTR, V58, P152, DOI 10.1093/ajcn/58.2.152; HERNGREEN WP, 1994, ANN HUM BIOL, V21, P449, DOI 10.1080/03014469400003472; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Kramer MS, 2004, J PEDIATR-US, V145, P600, DOI 10.1016/j.jpeds.2004.06.069; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Langenberg C, 2003, J EPIDEMIOL COMMUN H, V57, P816, DOI 10.1136/jech.57.10.816; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Lawson DW, 2008, INT J EPIDEMIOL, V37, P1408, DOI 10.1093/ije/dyn116; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; Li L, 2004, AM J CLIN NUTR, V80, P185; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Manor O, 2004, ANN EPIDEMIOL, V14, P453, DOI 10.1016/j.annepidem.2003.10.011; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; Mortensen LH, 2008, J EPIDEMIOL COMMUN H, V62, P325, DOI 10.1136/jech.2007.061473; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Rubin DB, 2004, MULTIPLE IMPUTATION; Seguin L, 2005, J EPIDEMIOL COMMUN H, V59, P42, DOI 10.1136/jech.2004.020438; Silventoinen K, 2006, AM J EPIDEMIOL, V163, P615, DOI 10.1093/aje/kwj081; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Spencer N, 2005, J EPIDEMIOL COMMUN H, V59, P842, DOI 10.1136/jech.2005.036301; TANNER JM, 1992, HORM RES, V38, P106, DOI 10.1159/000182580; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; Thrane N, 2005, EUR J EPIDEMIOL, V20, P467, DOI 10.1007/s10654-005-0719-2; van Rossem L, 2010, J PEDIATR-US, V157, P929, DOI 10.1016/j.jpeds.2010.06.008; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS72; Waterlow JC, 1994, EUR J CLIN NUTR S1, V48, pS73; WHINCUP PH, 1988, BMJ-BRIT MED J, V297, P980, DOI 10.1136/bmj.297.6654.980-c	61	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37356	10.1371/journal.pone.0037356	http://dx.doi.org/10.1371/journal.pone.0037356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649522	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800040
J	Yang, LL; Wei, Y; Yang, J; Sun, Y; Shi, WM; Li, M				Yang Lili; Wei Yi; Yang Ji; Sun Yue; Shi Weimin; Li Ming			Global Activation of CD8(+) Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo	PLOS ONE			English	Article							DISEASE-ACTIVITY; IFN-GAMMA; CD4(+); FOXP3; EFFECTOR	Melanocyte-specific CD8(+) cytotoxic T lymphocytes (CTLs) play a pivotal role in vitiligo-induced depigmentation. Yet, the mechanisms underlying the high frequency of generalized autoimmune disorders associated with generalized vitiligo (GV) are unknown. We hypothesized that an imbalance between activated CD8(+) CTLs and regulatory T cells (Tregs) exists in patients with GV. Assessment of the circulating CD8(+) CTLs and Tregs by flow cytometric analysis revealed an obvious expansion of CD8(+) CTLs and a concomitant decrease in Treg cells in GV patients. The percentages of skin infiltrating CD8(+) CTLs and Tregs were evaluated by immunohistochemistry and revealed dramatically increased numbers of both CD8(+) CTLs and Tregs in the perilesional skin of GV patients. However, peripheral Tregs were impaired in their ability to suppress the proliferation and cytolytic capacity of autologous CD8(+) T cells, suggesting that a functional failure of Tregs and the hyperactivation of CD8(+) CTLs may contribute to progressive GV. Our data indicate that reduced numbers and impaired function of natural Tregs fail to control the widespread activation of CD8(+) CTLs, which leads to the destruction of melanocytes and contributes to the elevated frequency of various associated autoimmune diseases. This knowledge furthers our understanding of the mechanisms of immune tolerance that are impaired in GV patients and may aid in the future development of effective immunotherapy for GV patients.	[Yang Lili; Wei Yi; Yang Ji; Li Ming] Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Sun Yue; Shi Weimin] Shanghai Jiao Tong Univ, Dept Dermatol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Yang, LL (corresponding author), Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	li.ming@zs-hospital.sh.cn		Yang, Lili/0000-0003-4560-0248	Innovation Fund; Fudan University	Innovation Fund; Fudan University	This work was supported by the Innovation Fund granted by Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Antiga E, 2010, J AUTOIMMUN, V35, P342, DOI 10.1016/j.jaut.2010.07.006; Ben Ahmed M, 2011, PIGMENT CELL MELANOM; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Breathnach CC, 2005, VET IMMUNOL IMMUNOP, V103, P207, DOI 10.1016/j.vetimm.2004.09.024; Chi LJ, 2008, J PERIPHER NERV SYST, V13, P54, DOI 10.1111/j.1529-8027.2008.00158.x; CUNLIFFE WJ, 1968, BRIT J DERMATOL, V80, P135, DOI 10.1111/j.1365-2133.1968.tb12282.x; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Giovanni F, 2011, J NEUROIMMUNOL, V240, P137, DOI 10.1016/j.jneuroim.2011.09.002; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Malyguine Anatoli, 2003, European Cytokine Network, V14, P36; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Palermo B, 2001, J INVEST DERMATOL, V117, P326, DOI 10.1046/j.1523-1747.2001.01408.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SCHALLREUTER KU, 1994, DERMATOLOGY, V188, P269, DOI 10.1159/000247164; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Westerhof W, 2007, PIGM CELL RES, V20, P345, DOI 10.1111/j.1600-0749.2007.00399.x; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	30	35	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37513	10.1371/journal.pone.0037513	http://dx.doi.org/10.1371/journal.pone.0037513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649532	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800051
J	Munro, KM; Perreau, VM; Turnley, AM				Munro, Kathryn M.; Perreau, Victoria M.; Turnley, Ann M.			Differential Gene Expression in the EphA4 Knockout Spinal Cord and Analysis of the Inflammatory Response Following Spinal Cord Injury	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ASTROCYTIC GLIOSIS; IMMUNE-RESPONSES; UP-REGULATION; REGENERATION; MICROGLIA; ARGINASE; CELLS; MICE; IDENTIFICATION	Mice lacking the axon guidance molecule EphA4 have been shown to exhibit extensive axonal regeneration and functional recovery following spinal cord injury. To assess mechanisms by which EphA4 may modify the response to neural injury a microarray was performed on spinal cord tissue from mice with spinal cord injury and sham injured controls. RNA was purified from spinal cords of adult EphA4 knockout and wild-type mice four days following lumbar spinal cord hemisection or laminectomy only and was hybridised to Affymetrix All-Exon Array 1.0 GeneChips (TM). While subsequent analyses indicated that several pathways were altered in EphA4 knockout mice, of particular interest was the attenuated expression of a number of inflammatory genes, including Arginase 1, expression of which was lower in injured EphA4 knockout compared to wild-type mice. Immunohistological analyses of different cellular components of the immune response were then performed in injured EphA4 knockout and wildtype spinal cords. While numbers of infiltrating CD3+ T cells were low in the hemisection model, a robust CD11b+ macrophage/microglial response was observed post-injury. There was no difference in the overall number or spread of macrophages/activated microglia in injured EphA4 knockout compared to wild-type spinal cords at 2, 4 or 14 days post-injury, however a lower proportion of Arginase-1 immunoreactive macrophages/activated microglia was observed in EphA4 knockout spinal cords at 4 days post-injury. Subtle alterations in the neuroinflammatory response in injured EphA4 knockout spinal cords may contribute to the regeneration and recovery observed in these mice following injury.	[Munro, Kathryn M.; Perreau, Victoria M.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Ctr Neurosci Res, Parkville, Vic 3052, Australia	University of Melbourne	Munro, KM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Ctr Neurosci Res, Parkville, Vic 3052, Australia.	vperreau@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X; Perreau, Victoria/0000-0002-0773-7246	Australian Postgraduate Award; National Health and Medical Research Council (NHMRC) Fellowship	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council (NHMRC) Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	K.M.M. was supported by an Australian Postgraduate Award and A. M. T. is supported by a National Health and Medical Research Council (NHMRC) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aasheim HC, 1997, BLOOD, V90, P3613, DOI 10.1182/blood.V90.9.3613; Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Alonso CL, 2008, LEUK RES; Canty AJ, 2006, P NATL ACAD SCI USA, V103, P15629, DOI 10.1073/pnas.0607350103; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Ghasemlou N, 2010, J NEUROSCI, V30, P13750, DOI 10.1523/JNEUROSCI.2998-10.2010; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2006, J COMP NEUROL, V497, P864, DOI 10.1002/cne.21029; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Gundra UM, 2011, INFECT IMMUN, V79, P2586, DOI 10.1128/IAI.00920-10; Hawthorne AL, 2011, NEUROTHERAPEUTICS; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Parmentier-Batteur S, 2011, J NEUROCHEM, V118, P1016, DOI 10.1111/j.1471-4159.2011.07375.x; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Prevost N, 2002, P NATL ACAD SCI USA, V99, P9219, DOI 10.1073/pnas.142053899; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sharfe N, 2008, MOL IMMUNOL, V45, P1208, DOI 10.1016/j.molimm.2007.09.019; Siegenthaler MM, 2007, J NEUROTRAUM, V24, P1631, DOI 10.1089/neu.2007.0302; Sobel RA, 2005, BRAIN PATHOL, V15, P35; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	48	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37635	10.1371/journal.pone.0037635	http://dx.doi.org/10.1371/journal.pone.0037635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629434	Green Published, gold			2022-12-27	WOS:000305345300064
J	Zaarour, RF; Chirivino, D; Del Maestro, L; Daviet, L; Atfi, A; Louvard, D; Arpin, M				Zaarour, Rania F.; Chirivino, Dafne; Del Maestro, Laurence; Daviet, Laurent; Atfi, Azeddine; Louvard, Daniel; Arpin, Monique			Ezrin Ubiquitylation by the E3 Ubiquitin Ligase, WWP1, and Consequent Regulation of Hepatocyte Growth Factor Receptor Activity	PLOS ONE			English	Article							DOMAIN BINDING-SITE; PLASMA-MEMBRANE; MET RECEPTOR; EPITHELIAL-CELLS; BREAST-CANCER; 1 TARGETS; PROTEIN; DEGRADATION; PHOSPHORYLATION; ACTIVATION	The membrane cytoskeleton linker ezrin participates in several functions downstream of the receptor Met in response to Hepatocyte Growth Factor (HGF) stimulation. Here we report a novel interaction of ezrin with a HECT E3 ubiquitin ligase, WWP1/Aip5/Tiul1, a potential oncogene that undergoes genomic amplification and overexpression in human breast and prostate cancers. We show that ezrin binds to the WW domains of WWP1 via the consensus motif PPVY477 present in ezrin's C-terminus. This association results in the ubiquitylation of ezrin, a process that requires an intact PPVY477 motif. Interestingly ezrin ubiquitylation does not target the protein for degradation by the proteasome. We find that ezrin ubiquitylation by WWP1 in epithelial cells leads to the upregulation of Met level in absence of HGF stimulation and increases the response of Met to HGF stimulation as measured by the ability of the cells to heal a wound. Interestingly this effect requires ubiquitylated ezrin since it can be rescued, after depletion of endogenous ezrin, by wild type ezrin but not by a mutant of ezrin that cannot be ubiquitylated. Taken together our data reveal a new role for ezrin in Met receptor stability and activity through its association with the E3 ubiquitin ligase WWP1. Given the role of Met in cell proliferation and tumorigenesis, our results may provide a mechanistic basis for understanding the role of ezrin in tumor progression.	[Zaarour, Rania F.; Chirivino, Dafne; Del Maestro, Laurence; Louvard, Daniel; Arpin, Monique] Ctr Natl Rech Sci, Unite Mixte Rech, Inst Curie, Paris, France; [Daviet, Laurent] Hybrigenics, Paris, France; [Atfi, Azeddine] Hop St Antoine, INSERM U, F-75571 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Zaarour, RF (corresponding author), Univ Sharjah, Coll Med, Sharjah Inst Med Res, Sharjah, U Arab Emirates.	marpin@curie.fr		Zaarour, Rania/0000-0001-9132-5940	Association pour la Recherche sur le Cancer ARC [3267, 4823]; Agence Nationale de la Recherche (ANR) [05BLAN033001]; GenHomme Network Grant [02490-6088]; Institut Curie; ANR [05BLAN033001]	Association pour la Recherche sur le Cancer ARC(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); GenHomme Network Grant; Institut Curie; ANR(French National Research Agency (ANR))	This work was supported by grants from Association pour la Recherche sur le Cancer ARC (3267, 4823), Agence Nationale de la Recherche (ANR 05BLAN033001) by a GenHomme Network Grant (02490-6088) to Hybrigenics and Institut Curie. Rania Zaarour was a recipient of fellowships from Institut Curie and ANR (05BLAN033001). Dafne Chirivino was a recipient of fellowship for PhD students from Institut Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Elliott BE, 2004, J CELL BIOCHEM, V92, P16, DOI 10.1002/jcb.20033; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Heiska L, 2005, J BIOL CHEM, V280, P10244, DOI 10.1074/jbc.M411353200; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37490	10.1371/journal.pone.0037490	http://dx.doi.org/10.1371/journal.pone.0037490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629406	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300045
J	Feng, B; Xu, JP; Wu, G; Zeng, NK; Li, YC; Tolgor, B; Kost, GW; Yang, ZL				Feng, Bang; Xu, Jianping; Wu, Gang; Zeng, Nian-Kai; Li, Yan-Chun; Tolgor, Bau; Kost, Gerhard W.; Yang, Zhu L.			DNA Sequence Analyses Reveal Abundant Diversity, Endemism and Evidence for Asian Origin of the Porcini Mushrooms	PLOS ONE			English	Article							BOLETUS-EDULIS; HISTORICAL BIOGEOGRAPHY; MAXIMUM-LIKELIHOOD; ECTOMYCORRHIZAL FUNGI; DIVERSIFICATION; EVOLUTION; PATTERNS; FORESTS; HOST; TOOL	The wild gourmet mushroom Boletus edulis and its close allies are of significant ecological and economic importance. They are found throughout the Northern Hemisphere, but despite their ubiquity there are still many unresolved issues with regard to the taxonomy, systematics and biogeography of this group of mushrooms. Most phylogenetic studies of Boletus so far have characterized samples from North America and Europe and little information is available on samples from other areas, including the ecologically and geographically diverse regions of China. Here we analyzed DNA sequence variation in three gene markers from samples of these mushrooms from across China and compared our findings with those from other representative regions. Our results revealed fifteen novel phylogenetic species (about one-third of the known species) and a newly identified lineage represented by Boletus sp. HKAS71346 from tropical Asia. The phylogenetic analyses support eastern Asia as the center of diversity for the porcini sensu stricto clade. Within this clade, B. edulis is the only known holarctic species. The majority of the other phylogenetic species are geographically restricted in their distributions. Furthermore, molecular dating and geological evidence suggest that this group of mushrooms originated during the Eocene in eastern Asia, followed by dispersal to and subsequent speciation in other parts of Asia, Europe, and the Americas from the middle Miocene through the early Pliocene. In contrast to the ancient dispersal of porcini in the strict sense in the Northern Hemisphere, the occurrence of B. reticulatus and B. edulis sensu lato in the Southern Hemisphere was probably due to recent human-mediated introductions.	[Feng, Bang; Wu, Gang; Zeng, Nian-Kai; Li, Yan-Chun; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Tolgor, Bau] Jilin Agr Univ, Inst Mycol, Changchun, Jilin, Peoples R China; [Kost, Gerhard W.] Univ Marburg, Marburg, Germany; [Feng, Bang; Wu, Gang; Zeng, Nian-Kai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; McMaster University; Jilin Agricultural University; Philipps University Marburg; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Feng, B (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	fungiamanita@gmail.com	Hosen, Md. Iqbal/I-6008-2013	Hosen, Md. Iqbal/0000-0003-2731-6841; Li, Yanchun/0000-0002-7109-9269; feng, bang/0000-0001-7237-2899	National Natural Science Foundation of China; Yunnan Provincial Government [U0836604]; National Basic Research Program of China [2009CB522300]; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]; CAS/SAFEA International Partnership Program for Creative Research Teams; Hundred Talents Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government; National Basic Research Program of China(National Basic Research Program of China); Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Joint Funds of the National Natural Science Foundation of China and Yunnan Provincial Government (No. U0836604), the National Basic Research Program of China (No. 2009CB522300), the Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences (No. 2009-LSF-GBOWS-01), the CAS/SAFEA International Partnership Program for Creative Research Teams, and the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora D, 2008, ECON BOT, V62, P356, DOI 10.1007/s12231-008-9050-7; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Beugelsdijk DCM, 2008, PERSOONIA, V20, P1, DOI 10.3767/003158508X283692; Binder M., 2002, Feddes Repertorium, V113, P30, DOI 10.1002/1522-239X(200205)113:1/2&lt;30::AID-FEDR30&gt;3.0.CO;2-D; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Dentinger BTM, 2010, MOL PHYLOGENET EVOL, V57, P1276, DOI 10.1016/j.ympev.2010.10.004; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ducousso M, 2004, MOL ECOL, V13, P231, DOI 10.1046/j.1365-294X.2003.02032.x; Garnica S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-213; Geml J, 2006, MOL ECOL, V15, P225, DOI 10.1111/j.1365-294X.2005.02799.x; Geml J, 2008, MOL PHYLOGENET EVOL, V48, P694, DOI 10.1016/j.ympev.2008.04.029; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes KW, 2009, NEW PHYTOL, V182, P795, DOI 10.1111/j.1469-8137.2009.02802.x; Jansen G, 2010, MOL PHYLOGENET EVOL, V56, P294, DOI 10.1016/j.ympev.2010.01.029; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Leonardi M, 2005, FEMS MICROBIOL LETT, V243, P411, DOI 10.1016/j.femsle.2005.01.003; Lian Bin, 2008, Electron. J. Biotechnol., V11, P102; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Mello A, 2006, J BIOTECHNOL, V121, P318, DOI 10.1016/j.jbiotec.2005.08.022; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; Nylander J, 2004, MRMODELTEST2 2 COMPU; Pound MJ, 2011, PALAEOGEOGR PALAEOCL, V300, P29, DOI 10.1016/j.palaeo.2010.11.029; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Shi GL, 2010, REV PALAEOBOT PALYNO, V162, P599, DOI 10.1016/j.revpalbo.2010.08.001; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Singer R, 1975, AGARICALES MODERN TA; Sitta N, 2008, ECON BOT, V62, P307, DOI 10.1007/s12231-008-9037-4; Skrede I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-230; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SY, 2004, MYCOLOGIA, V96, P180, DOI 10.2307/3762001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor TN, 2004, MYCOLOGIA, V96, P1403, DOI 10.2307/3762157; Tedersoo L, 2011, MOL ECOL, V20, P3071, DOI 10.1111/j.1365-294X.2011.05145.x; Vellinga EC, 2009, NEW PHYTOL, V181, P960, DOI 10.1111/j.1469-8137.2008.02728.x; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; WANG Y, 1995, NEW ZEAL J CROP HORT, V23, P227, DOI 10.1080/01140671.1995.9513892; WARING RH, 1979, SCIENCE, V204, P1380, DOI 10.1126/science.204.4400.1380; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yan Jun, 2010, Acta Edulis Fungi, V17, P26; Yu Y., 2014, RASP RECONSTRUCT ANC; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zang M., 2006, FLORA FUNGORUM SINIC, V22; Zhao Yong-Chang, 2006, Acta Botanica Yunnanica, V28, P575	66	78	87	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37567	10.1371/journal.pone.0037567	http://dx.doi.org/10.1371/journal.pone.0037567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629418	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500137
J	Scarpassa, VM; Alencar, RB				Scarpassa, Vera Margarete; Alencar, Ronildo Baiatone			Lutzomyia umbratilis, the Main Vector of Leishmania guyanensis, Represents a Novel Species Complex?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; PHLEBOTOMINE SANDFLIES; TRIATOMA-BRASILIENSIS; POPULATION-STRUCTURE; GENETIC-DIVERGENCE; DIPTERA; PSYCHODIDAE; PHYLOGEOGRAPHY; LONGIPALPIS; BRAZIL	Background: Lutzomyia umbratilis is an important Leishmania guyanensis vector in South America. Previous studies have suggested differences in the vector competence between L. umbratilis populations situated on opposite banks of the Amazonas and Negro Rivers in the central Amazonian Brazil region, likely indicating a species complex. However, few studies have been performed on these populations and the taxonomic status of L. umbratilis remains unclear. Methodology/Principal Findings: Phylogeographic structure was estimated for six L. umbratilis samples from the central Amazonian region in Brazil by analyzing mtDNA using 1181 bp of the COI gene to assess whether the populations on opposite banks of these rivers consist of incipient or distinct species. The genetic diversity was fairly high and the results revealed two distinct clades (=lineages) with 1% sequence divergence. Clade I consisted of four samples from the left bank of the Amazonas and Negro Rivers, whereas clade II comprised two samples from the right bank of Negro River. No haplotypes were shared between samples of two clades. Samples within clades exhibited low to moderate genetic differentiation (F-ST = 20.0390-0.1841), whereas samples between clades exhibited very high differentiation (F-ST = 0.7100-0.8497) and fixed differences. These lineages have diverged approximately 0.22 Mya in the middle Pleistocene. Demographic expansion was detected for the lineages I and II approximately 30,448 and 15,859 years ago, respectively, in the late Pleistocene. Conclusions/Significance: The two genetic lineages may represent an advanced speciation stage suggestive of incipient or distinct species within L. umbratilis. These findings suggest that the Amazonas and Negro Rivers may be acting as effective barriers, thus preventing gene flow between populations on opposite sides. Such findings have important implications for epidemiological studies, especially those related to vector competence and anthropophily, and for vector control strategies. In addition, L. umbratilis represents an interesting example in speciation studies.	[Scarpassa, Vera Margarete] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Alencar, Ronildo Baiatone] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Entomol, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Scarpassa, VM (corresponding author), Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	vera@inpa.gov.br	Scarpassa, Vera M./H-4125-2013	Scarpassa, Vera/0000-0003-1607-9246	National Council of Scientific and Technological Development [409058/2006-8, 575482/2008-7]; Foundation of Research Support of the State of Amazonas, Brazil; CNPq; FAPEAM	National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation of Research Support of the State of Amazonas, Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAM	This study was funded by National Council of Scientific and Technological Development grants, process numbers 409058/2006-8 to Toby Vicent Barrett and 575482/2008-7 to VMS, and by the Foundation of Research Support of the State of Amazonas to VMS, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are especially grateful for Sara A. Bickersmith (Wadsworth Center, Albany, NY, USA) who kindly and generously helped in the Bayesian inference statistical analyses and for Juliana de Souza Araujo (UFAM, Manaus) who kindly helped to prepare the figures. RBA was a doctoral student of the Graduate Program in Entomology at INPA, and received a fellowship from CNPq (from February 2008 to July 2010) and FAPEAM (from August 2010 to January 2012).	Aleixo A, 2004, EVOLUTION, V58, P1303, DOI 10.1111/j.0014-3820.2004.tb01709.x; ARIAS J R, 1977, Acta Amazonica, V7, P507; ARIAS J R, 1981, Memorias do Instituto Oswaldo Cruz, V76, P279, DOI 10.1590/S0074-02761981000300005; ARIAS J R, 1978, Acta Amazonica, V8, P387; Arrivillaga JC, 2002, INFECT GENET EVOL, V2, P83, DOI 10.1016/S1567-1348(02)00087-4; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise John C., 1994, pi; Azevedo ACR, 2002, J MED ENTOMOL, V39, P587, DOI 10.1603/0022-2585-39.4.587; Azevedo ACR, 2008, MEM I OSWALDO CRUZ, V103, P760, DOI 10.1590/S0074-02762008000800003; Balbino VQ, 2001, MEM I OSWALDO CRUZ, V96, P315, DOI 10.1590/S0074-02762001000300005; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa J, 1997, MEM I OSWALDO CRUZ, V92, P459, DOI 10.1590/S0074-02761997000400002; Coutinho-Abreu IV, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-16; Coyne J.A., 2004, SPECIATION; CRANDALL KA, 1993, GENETICS, V134, P959; Guerra Jorge Augusto de Oliveira, 2003, Rev. Soc. Bras. Med. Trop., V36, P587, DOI 10.1590/S0037-86822003000500008; DYE C, 1991, ANIM BEHAV, V42, P183, DOI 10.1016/S0003-3472(05)80549-4; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; Excoffier L., 2006, ARLEQUIN VERSION 3 1; FELICIANGELI MD, 1985, T ROY SOC TROP MED H, V79, P878, DOI 10.1016/0035-9203(85)90150-6; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Fu YX, 1997, GENETICS, V147, P915; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GENTILE B, 1981, T ROY SOC TROP MED H, V75, P612, DOI 10.1016/0035-9203(81)90223-6; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He LP, 2007, MOL PHYLOGENET EVOL, V43, P24, DOI 10.1016/j.ympev.2006.08.010; Herbert PDN, 2004, PLOS BIOL, V2, P312; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Justiniano S. C. B., 2004, Braz. J. Biol., V64, P227, DOI 10.1590/S1519-69842004000200007; Justiniano S. C. B., 2004, THESIS I NACL PESQUI; LAINSON R, 1981, T ROY SOC TROP MED H, V75, P530, DOI 10.1016/0035-9203(81)90192-9; LAINSON R, 1976, T ROY SOC TROP MED H, V70, P171, DOI 10.1016/0035-9203(76)90202-9; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P239, DOI 10.1016/0035-9203(79)90225-6; Le Pont F, 1980, CAHIERS ORSTOM EMP, V18, P359; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E., 1942, P1; Mazzoni CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-141; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; Monteiro FA, 2004, MOL PHYLOGENET EVOL, V32, P46, DOI 10.1016/j.ympev.2003.12.011; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; MORRISON AC, 1993, J MED ENTOMOL, V30, P427, DOI 10.1093/jmedent/30.2.427; Nei M., 1987, MOL EVOLUTIONARY GEN; Nery LCD, 2004, MEM I OSWALDO CRUZ, V99, P571, DOI 10.1590/S0074-02762004000600006; PAJOT FX, 1982, T ROY SOC TROP MED H, V76, P112, DOI 10.1016/0035-9203(82)90033-5; Pinheiro Francimeire Gomes, 2008, Acta Amaz., V38, P165, DOI 10.1590/S0044-59672008000100019; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL JR, 1986, P NATL ACAD SCI USA, V83, P9090, DOI 10.1073/pnas.83.23.9090; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rona LDP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-91; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J, 2001, LAB MANUAL; Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895; Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150; Scarpassa VM, 1999, AM J TROP MED HYG, V60, P1010, DOI 10.4269/ajtmh.1999.60.1010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1991, GENETICS, V129, P555; Gil LHS, 2009, MEM I OSWALDO CRUZ, V104, P955, DOI 10.1590/S0074-02762009000700002; Soto SIU, 2001, MOL PHYLOGENET EVOL, V18, P84, DOI 10.1006/mpev.2000.0863; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valenta DT, 1999, ANN TROP MED PARASIT, V93, P389, DOI 10.1080/00034989958384; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; WRIGHT S, 1978, P580; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x	72	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37341	10.1371/journal.pone.0037341	http://dx.doi.org/10.1371/journal.pone.0037341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22662146	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500103
J	Hou, WG; Ai, WB; Bai, XG; Dong, HL; Li, Z; Zhang, YQ; Xiong, LZ				Hou, Wu-Gang; Ai, Wen-Bo; Bai, Xiao-Guang; Dong, Hai-Long; Li, Zhen; Zhang, Yuan-Qiang; Xiong, Li-Ze			Genetic Variation in the EGFR Gene and the Risk of Glioma in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN CANCER; LUNG-CANCER; POLYMORPHISM; SUSCEPTIBILITY; LOCI	Previous studies have shown that regulation of the epidermal growth factor gene (EGFR) pathway plays a role in glioma progression. Certain genotypes of the EGFR gene may be related to increased glioblastoma risk, indicating that germ line EGFR polymorphisms may have implications in carcinogenesis. To examine whether and how variants in the EGFR gene contribute to glioma susceptibility, we evaluated nine tagging single-nucleotide polymorphisms (tSNPs) of the EGFR gene in a case-control study from Xi'an city of China (301 cases, 302 controls). EGFR SNP associations analyses were performed using SPSS 16.0 statistical packages, PLINK software, Haploview software package (version 4.2) and SHEsis software platform. We identified two susceptibility tSNPs in the EGFR gene that were potentially associated with an increased risk of glioma (rs730437, p = 0.016; OR: 1.32; 95% CI: 1.05-1.66 and rs1468727, p = 0.008; OR: 1.31; 95% CI: 1.04-1.65). However, after a strict Bonferroni correction analysis was applied, the significance level of the association between EGFR tSNPs and risk of glioma was attenuated. We observed a protective effect of haplotype "AATT'' of the EGFR gene, which was associated with a 29% reduction in the risk of developing glioma, while haplotype "CGTC'' increased the risk of developing glioma by 36%. Our results, combined with previous studies, suggested an association between the EGFR gene and glioma development.	[Hou, Wu-Gang; Bai, Xiao-Guang; Dong, Hai-Long; Xiong, Li-Ze] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China; [Ai, Wen-Bo] Fourth Mil Med Univ, Sch Prevent Med, Dept Hlth Serv, Xian 710032, Peoples R China; [Li, Zhen; Zhang, Yuan-Qiang] Fourth Mil Med Univ, Dept Histol & Embryol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Hou, WG (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	mzkxlz@126.com		Dong, Hailong/0000-0001-8984-9067	Natural Science Foundation of China [81000563]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (2010: No. 81000563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC C, 1964, Cesk Zdrav, V12, P613; Andersson U, 2010, ACTA ONCOL, V49, P767, DOI 10.3109/0284186X.2010.480980; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bender D, 2007, AM J HUMAN GENETICS, P81; Bethke L, 2008, HUM MOL GENET, V17, P800, DOI 10.1093/hmg/ddm351; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kharrat N, 2007, INT J BIOL MARKER, V22, P258, DOI 10.1177/172460080702200404; Koechl Silvano, 2005, V297, P13; Liu YH, 2010, CURR OPIN GENET DEV, V20, P239, DOI 10.1016/j.gde.2010.02.001; Ohgaki H, 2006, J NEUROPATH EXP NEUR, V65, P1111, DOI 10.1097/01.jnen.0000248544.28423.48; Perez CA, 2010, J UROLOGY, V183, P2062, DOI 10.1016/j.juro.2009.12.098; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Upadhyay R, 2008, ONCOL RES, V17, P167, DOI 10.3727/096504008785114147; Weiss WA, 2003, CANCER RES, V63, P1589; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Zhao Li, 2010, Chinese Journal of Pathology, V39, P476, DOI 10.3760/cma.j.issn.0529-5807.2010.07.010	26	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37531	10.1371/journal.pone.0037531	http://dx.doi.org/10.1371/journal.pone.0037531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662167	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300057
J	Liborio, AB; Santos, JPL; Minete, NFA; Diogenes, CD; Soares, AP; Queiroz, AL; Barreto, DMS				Liborio, Alexandre Braga; Lima Santos, Joao Paulo; Arraes Minete, Natalia Feitosa; Diogenes, Cecilia de Alencar; Soares, Ariane Pontes; Queiroz, Anaiara Lucena; Silva Barreto, Dulce Maria			Proteinuria Is Associated with Quality of Life and Depression in Adults with Primary Glomerulopathy and Preserved Renal Function	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NEPHROTIC SYNDROME; INFLAMMATION; ANXIETY; CKD	Background: There is no information about HRQoL, depression and associated factors in adult with nephrotic syndrome-associated glomerulopathy. Methodology/Principal Findings: Patients with primary glomerulopathy where compared with age and sex-matched hemodialysis patients and healthy subjects. Laboratory data, medical history, comorbid conditions were collected to evaluate factors associated with HRQoL (SF-36) and Depression (Hamilton Depression Rating Scale - HAMD). Glomerulopathy patients had low HRQoL in all eight SF-36 domains and two composite scores (physical and mental) in comparison with healthy subjects. HAMD score also was elevated and there was high depression prevalence. Overall, these data were comparable between glomerulopathy and hemodialysis patients. Using multiple regression analysis, factors associated with low HRQoL physical composite score were: last 24 h-urine protein excretion (-0.183, 95% CI -0.223 to -0.710 for each gram of proteinuria, p = 0.01) and cyclosporine use (-15.315, 95% CI -25.913 to 22.717, p = 0.03). Low HRQoL mental composite score was associated with last 24 h-urine protein excretion (-0.157, 95% CI -0.278 to -0.310 for each gram of proteinuria, p = 0.03) and HMAD score was independently associated with age (0.155, 95% CI 0.318 to 0.988 for each year, p = 0.04), female sex (4.788, 95% CI 1.005 to 8.620, 0 = 0.03), disease duration (0.074, 95% CI 0.021 to 0.128 for each month, p = 0.01) and last 24 h-urine protein excretion (0.050, 95% CI 0.018 to 0.085 for each gram of proteinuria, p = 0.02). Conclusions/Significance: Nephrotic-syndrome associated glomerulopathy patients have low HRQoL and high prevalence of depression symptoms, comparable with those of hemodialysis patients. Last 24 h-protein excretion rate is independently associated with physical and mental HRQoL domains in addition to depression.	[Liborio, Alexandre Braga] Univ Fortaleza, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil; [Lima Santos, Joao Paulo; Arraes Minete, Natalia Feitosa; Diogenes, Cecilia de Alencar; Soares, Ariane Pontes] Univ Fortaleza, UNIFOR, Med Course, Fortaleza, Ceara, Brazil; [Liborio, Alexandre Braga; Queiroz, Anaiara Lucena; Silva Barreto, Dulce Maria] Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Universidade Fortaleza	Liborio, AB (corresponding author), Univ Fortaleza, Postgrad Program Publ Hlth, Fortaleza, Ceara, Brazil.	alexandreliborio@yahoo.com.br		Lima Santos, Joao Paulo/0000-0003-0676-8515				Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; Almawi W, 2008, J ENDOCRINOL INVEST, V31, P1020, DOI 10.1007/BF03345642; [Anonymous], DIAGN STAT MENT DIS; Cameron JI, 2000, AM J KIDNEY DIS, V35, P629, DOI 10.1016/S0272-6386(00)70009-6; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P1332, DOI 10.2215/CJN.03951106; Dogra GK, 2002, NEPHROL DIAL TRANSPL, V17, P2220, DOI 10.1093/ndt/17.12.2220; Faller H, 2009, J CARD FAIL, V15, P286, DOI 10.1016/j.cardfail.2008.10.022; Farag YMK, 2011, CLIN NEPHROL, V75, P524, DOI 10.5414/CNP75524; Finkelstein FO, 2009, KIDNEY INT, V76, P946, DOI 10.1038/ki.2009.307; Fleck MPD, 2004, J NERV MENT DIS, V192, P103, DOI 10.1097/01.nmd.0000110281.35970.33; Gipson DS, 2011, KIDNEY INT, V79, P678, DOI 10.1038/ki.2010.485; GOKAL R, 1993, KIDNEY INT, V43, pS23; Kalender B, 2006, NEPHRON CLIN PRACT, V102, pC115, DOI 10.1159/000089669; Kennedy SH, 2001, J PSYCHIATR NEUROSCI, V26, pS23; Kimmel PL, 2006, CLIN J AM SOC NEPHRO, V1, P349, DOI 10.2215/CJN.00890306; Malafronte P, 2006, NEPHROL DIAL TRANSPL, V21, P3098, DOI 10.1093/ndt/gfl237; Mazairac AH, 2010, J REN NUTR; Miettola J, 2008, QUAL LIFE RES, V17, P1055, DOI 10.1007/s11136-008-9386-6; Omachi TA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.036; Painter PL, 2003, KIDNEY INT, V63, P2309, DOI 10.1046/j.1523-1755.2003.00038.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Ruth EM, 2004, J PEDIATR-US, V145, P778, DOI 10.1016/j.jpeds.2004.08.022; Saveanu RV, 2011, HEART FAIL CLIN, V7, P75, DOI 10.1016/j.hfc.2010.08.010; Simon GE, 2001, WESTERN J MED, V175, P292, DOI 10.1136/ewjm.175.5.292; Snow V, 2000, ANN INTERN MED, V132, P738, DOI 10.7326/0003-4819-132-9-200005020-00010; Taner E, 2007, INT J DERMATOL, V46, P1118, DOI 10.1111/j.1365-4632.2007.03247.x; Aguiar CCT, 2008, ARQ BRAS ENDOCRINOL, V52, P931, DOI 10.1590/S0004-27302008000600004; Unutzer J, 2007, NEW ENGL J MED, V357, P2269, DOI 10.1056/NEJMcp073754; Valderrabano F, 2001, AM J KIDNEY DIS, V38, P443, DOI 10.1053/ajkd.2001.26824; Zhu WL, 2011, J NEUROCHEM, V117, P1075, DOI 10.1111/j.1471-4159.2011.07285.x	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37763	10.1371/journal.pone.0037763	http://dx.doi.org/10.1371/journal.pone.0037763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662214	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300104
J	Lima, MHM; Caricilli, AM; de Abreu, LL; Araujo, EP; Pelegrinelli, FF; Thirone, ACP; Tsukumo, DM; Pessoa, AFM; dos Santos, MF; de Moraes, MA; Carvalheira, JBC; Velloso, LA; Saad, MJA				Lima, Maria H. M.; Caricilli, Andrea M.; de Abreu, Lelia L.; Araujo, Eliana P.; Pelegrinelli, Fabiana F.; Thirone, Ana C. P.; Tsukumo, Daniela M.; Pessoa, Ana Flavia M.; dos Santos, Marinilce F.; de Moraes, Maria A.; Carvalheira, Jose B. C.; Velloso, Licio A.; Saad, Mario J. A.			Topical Insulin Accelerates Wound Healing in Diabetes by Enhancing the AKT and ERK Pathways: A Double-Blind Placebo-Controlled Clinical Trial	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; HUMAN-SKIN FIBROBLASTS; NITRIC-OXIDE SYNTHASE; GROWTH FACTOR-BB; PROTEIN-KINASE; EPIDERMAL-KERATINOCYTES; ENDOTHELIAL-CELLS; ULCERS; ACTIVATION; GLUCOSE	Background: Wound healing is impaired in diabetes mellitus, but the mechanisms involved in this process are virtually unknown. Proteins belonging to the insulin signaling pathway respond to insulin in the skin of rats. Objective: The purpose of this study was to investigate the regulation of the insulin signaling pathway in wound healing and skin repair of normal and diabetic rats, and, in parallel, the effect of a topical insulin cream on wound healing and on the activation of this pathway. Research Design and Methods: We investigated insulin signaling by immunoblotting during wound healing of control and diabetic animals with or without topical insulin. Diabetic patients with ulcers were randomized to receive topical insulin or placebo in a prospective, double-blind and placebo-controlled, randomized clinical trial (NCT 01295177) of wound healing. Results and Conclusions: Expression of IR, IRS-1, IRS-2, SHC, ERK, and AKT are increased in the tissue of healing wounds compared to intact skin, suggesting that the insulin signaling pathway may have an important role in this process. These pathways were attenuated in the wounded skin of diabetic rats, in parallel with an increase in the time of complete wound healing. Upon topical application of insulin cream, the wound healing time of diabetic animals was normalized, followed by a reversal of defective insulin signal transduction. In addition, the treatment also increased expression of other proteins, such as eNOS (also in bone marrow), VEGF, and SDF-1 alpha in wounded skin. In diabetic patients, topical insulin cream markedly improved wound healing, representing an attractive and cost-free method for treating this devastating complication of diabetes.	[Lima, Maria H. M.; de Abreu, Lelia L.; Araujo, Eliana P.] Univ Estadual Campinas, Dept Nursing, FCM, Sao Paulo, Brazil; [Caricilli, Andrea M.; Pelegrinelli, Fabiana F.; Thirone, Ana C. P.; Tsukumo, Daniela M.; de Moraes, Maria A.; Carvalheira, Jose B. C.; Velloso, Licio A.; Saad, Mario J. A.] Univ Estadual Campinas, Dept Internal Med, FCM, Sao Paulo, Brazil; [Pessoa, Ana Flavia M.; dos Santos, Marinilce F.] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Lima, MHM (corresponding author), Univ Estadual Campinas, Dept Nursing, FCM, Sao Paulo, Brazil.	msaad@fcm.unicamp.br	Lima, Maria Helena Melo/C-5389-2018; Carvalheira, Jose B/H-8405-2012; Lima, Maria Helena Melo/R-3974-2019; Santos, Marinilce F/G-9548-2011; Pessoa, Ana Flávia Marçal/ABA-5236-2020; Araujo, EP/D-9231-2013; Saad, Mario/ABD-8262-2020; Lima, Maria Helena Melo/E-9595-2012; Velloso, Licio/AAJ-3778-2020; Carvalheira, Jose Barreto Campello/E-8562-2013	Lima, Maria Helena Melo/0000-0001-6521-8324; Lima, Maria Helena Melo/0000-0001-6521-8324; Santos, Marinilce F/0000-0002-3257-3327; Pessoa, Ana Flávia Marçal/0000-0003-3979-1607; Araujo, EP/0000-0002-7539-8477; Lima, Maria Helena Melo/0000-0001-6521-8324; Carvalheira, Jose Barreto Campello/0000-0002-0136-0943	Sao Paulo Research Foundation (FAPESP); National Institute of Science and Technology (INCT); National Council for Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Science and Technology (INCT); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP), National Institute of Science and Technology (INCT), and National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apikoglu-Rabus S, 2009, CLIN EXP DERMATOL; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; BELFIELD WO, 1970, VET MED SM ANIM CLIN, V65, P455; Benoliel AM, 1997, J CELL SCI, V110, P2089; BERTI L, 1994, J BIOL CHEM, V269, P3381; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; CHAIKEN RL, 1986, J CLIN ENDOCR METAB, V63, P1181, DOI 10.1210/jcem-63-5-1181; Cheng B, 2007, J DERMATOL SCI, V45, P193, DOI 10.1016/j.jdermsci.2006.11.014; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Embil JM, 2000, WOUND REPAIR REGEN, V8, P162, DOI 10.1046/j.1524-475x.2000.00162.x; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; FLIER JS, 1986, P NATL ACAD SCI USA, V83, P664, DOI 10.1073/pnas.83.3.664; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Galkowska H, 2006, WOUND REPAIR REGEN, V14, P558, DOI 10.1111/j.1743-6109.2006.00155.x; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gazel A, 2008, J CELL PHYSIOL, V215, P292, DOI 10.1002/jcp.21394; GERBER RM, 1979, NURS RES, V28, P16; Goren I, 2006, AM J PATHOL, V168, P765, DOI 10.2353/ajpath.2006.050293; Goren I, 2009, J INVEST DERMATOL, V129, P752, DOI 10.1038/jid.2008.230; Greenway S E, 1999, J Wound Care, V8, P526; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hanam S R, 1983, J Foot Surg, V22, P298; HAUGUELDEMOUZON S, 1995, BIOCHEM J, V305, P119, DOI 10.1042/bj3050119; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kido Y, 2001, J CLIN ENDOCR METAB, V86, P972, DOI 10.1210/jc.86.3.972; Kim MS, 2006, J INVEST DERMATOL, V126, P2697, DOI 10.1038/sj.jid.5700463; Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Madibally SV, 2003, J SURG RES, V109, P92, DOI 10.1016/S0022-4804(02)00036-7; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; MULLER HK, 1991, DIABETES, V40, P1440, DOI 10.2337/diabetes.40.11.1440; Nakai K, 2009, J DERMATOL SCI, V55, P170, DOI 10.1016/j.jdermsci.2009.06.002; Papanas N, 2007, Int J Low Extrem Wounds, V6, P37, DOI 10.1177/1534734606298416; Pelegrinelli FFF, 2001, J INVEST DERMATOL, V117, P971, DOI 10.1046/j.0022-202x.2001.01473.x; PORRASREYES BH, 1991, CONNECT TISSUE RES, V27, P63; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Rezvani O, 2009, OSTOMY WOUND MANAG, V55, P22; Riedl E, CELL PHYSL BIOCH, V28, P279; ROSS R, 1961, J BIOPHYS BIOCHEM CY, V11, P677, DOI 10.1083/jcb.11.3.677; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Verhofstad MHJ, 1998, INT J EXP PATHOL, V79, P321, DOI 10.1046/j.1365-2613.1998.t01-1-780407.x; WAGNER FW, 1987, ORTHOPEDICS, V10, P163; WERINGER EJ, 1982, ACTA ENDOCRINOL-COP, V99, P101, DOI 10.1530/acta.0.0990101; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wilson JM, 2008, ANN ROY COLL SURG, V90, P160, DOI 10.1308/003588408X261816; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102	55	134	140	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36974	10.1371/journal.pone.0036974	http://dx.doi.org/10.1371/journal.pone.0036974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662132	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300023
J	Rigothier, C; Auguste, P; Welsh, GI; Lepreux, S; Deminiere, C; Mathieson, PW; Saleem, MA; Ripoche, J; Combe, C				Rigothier, Claire; Auguste, Patrick; Welsh, Gavin I.; Lepreux, Sebastien; Deminiere, Colette; Mathieson, Peter W.; Saleem, Moin A.; Ripoche, Jean; Combe, Christian			IQGAP1 Interacts with Components of the Slit Diaphragm Complex in Podocytes and Is Involved in Podocyte Migration and Permeability In Vitro	PLOS ONE			English	Article							CONGENITAL NEPHROTIC SYNDROME; ACTIN CYTOSKELETON; GLOMERULAR PROTEIN; MAJOR SIALOPROTEIN; ADHERENS JUNCTION; BINDING PROTEIN; MICE LACKING; NEPHRIN; CELL; CDC42	IQGAP1 is a scaffold protein that interacts with proteins of the cytoskeleton and the intercellular adhesion complex. In podocytes, IQGAP1 is associated with nephrin in the glomerular slit diaphragm (SD) complex, but its role remains ill-defined. In this work, we investigated the interaction of IQGAP1 with the cytoskeleton and SD proteins in podocytes in culture, and its role in podocyte migration and permeability. Expression, localization, and interactions between IQGAP1 and SD or cytoskeletal proteins were determined in cultured human podocytes by Western blot (WB), immunocytolocalization (IC), immunoprecipitation (IP), and In situ Proximity Ligation assay (IsPL). Involvement of IQGAP1 in migration and permeability was also assessed. IQGAP1 expression in normal kidney biopsies was studied by immunohistochemistry. IQGAP1 expression by podocytes increased during their in vitro differentiation. IC, IP, and IsPL experiments showed colocalizations and/or interactions between IQGAP1 and SD proteins (nephrin, MAGI-1, CD2AP, NCK 1/2, podocin), podocalyxin, and cytoskeletal proteins (alpha-actinin-4). IQGAP1 silencing decreased podocyte migration and increased the permeability of a podocyte layer. Immunohistochemistry on normal human kidney confirmed IQGAP1 expression in podocytes and distal tubular epithelial cells and also showed an expression in glomerular parietal epithelial cells. In summary, our results suggest that IQGAP1, through its interaction with components of SD and cytoskeletal proteins, is involved in podocyte barrier properties.	[Rigothier, Claire; Ripoche, Jean; Combe, Christian] Univ Bordeaux Segalen, INSERM, U1026, Bordeaux, France; [Rigothier, Claire; Welsh, Gavin I.; Mathieson, Peter W.; Saleem, Moin A.] Univ Bristol, Southmead Hosp, Acad & Childrens Renal Unit, Bristol, Avon, England; [Rigothier, Claire; Combe, Christian] Ctr Hosp Univ, Serv Nephrol, Bordeaux, France; [Auguste, Patrick] Univ Bordeaux 1, F-33405 Talence, France; [Lepreux, Sebastien; Deminiere, Colette] Ctr Hosp Univ, Serv Anat Pathol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Southmead Hospital; University of Bristol; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Rigothier, C (corresponding author), Univ Bordeaux Segalen, INSERM, U1026, Bordeaux, France.	claire.rigothier@etud.u-bordeaux2.fr	Auguste, Patrick/J-9901-2014; Combe, Christian/N-3726-2015; HERAULT, EMILIE/M-3701-2014	Combe, Christian/0000-0002-0360-573X; Saleem, Moin/0000-0002-9808-4518; Welsh, Gavin Iain/0000-0002-2148-6658; Auguste, Patrick/0000-0003-1485-0295	ERA-EDTA (European Renal Association - European Dialysis and Transplant Association); Societe de Nephrologie; Centre Hospitalier Universitaire de Bordeaux; MRC [G0800200] Funding Source: UKRI; Medical Research Council [G0800200] Funding Source: researchfish	ERA-EDTA (European Renal Association - European Dialysis and Transplant Association); Societe de Nephrologie; Centre Hospitalier Universitaire de Bordeaux; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	C. Rigothier has been supported by a long-term fellowship from the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) and by grants from the Societe de Nephrologie and the Centre Hospitalier Universitaire de Bordeaux. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Coward RJM, 2005, J AM SOC NEPHROL, V16, P629, DOI 10.1681/ASN.2004030172; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Garcia AN, 2010, AM J RESP CRIT CARE, V181; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; KERJASCHKI D, 1986, J CLIN INVEST, V78, P1142, DOI 10.1172/JCI112694; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lai LW, 2008, J HISTOCHEM CYTOCHEM, V56, P659, DOI 10.1369/jhc.2008.950113; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Nakhaei-Nejad M, 2010, EUR J IMMUNOL, V40, P204, DOI 10.1002/eji.200839214; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tryggvason K, 2001, CURR OPIN NEPHROL HY, V10, P543, DOI 10.1097/00041552-200107000-00009; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	44	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37695	10.1371/journal.pone.0037695	http://dx.doi.org/10.1371/journal.pone.0037695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662192	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300082
J	Stautz, D; Wewer, UM; Kveiborg, M				Stautz, Dorte; Wewer, Ulla M.; Kveiborg, Marie			Functional Analysis of a Breast Cancer-Associated Mutation in the Intracellular Domain of the Metalloprotease ADAM12	PLOS ONE			English	Article							MELTRIN-ALPHA; TUMOR; DISINTEGRIN; EXPRESSION; TARGET	A recently identified breast cancer-associated mutation in the metalloprotease ADAM12 alters a potential dileucine trafficking signal, which could affect protein processing and cellular localization. ADAM12 belongs to the group of A Disintegrin And Metalloproteases (ADAMs), which are typically membrane-associated proteins involved in ectodomain shedding, cell-adhesion, and signaling. ADAM12 as well as several members of the ADAM family are over-expressed in various cancers, correlating with disease stage. Three breast cancer-associated somatic mutations were previously identified in ADAM12, and two of these, one in the metalloprotease domain and another in the disintegrin domain, were investigated and found to result in protein misfolding, retention in the secretory pathway, and failure of zymogen maturation. The third mutation, p.L792F in the ADAM12 cytoplasmic tail, was not investigated, but is potentially significant given its location within a di-leucine motif, which is recognized as a potential cellular trafficking signal. The present study was motivated both by the potential relevance of this documented mutation to cancer, as well as for determining the role of the di-leucine motif in ADAM12 trafficking. Expression of ADAM12 p. L792F in mammalian cells demonstrated quantitatively similar expression levels and zymogen maturation as wild-type (WT) ADAM12, as well as comparable cellular localizations. A cell surface biotinylation assay demonstrated that cell surface levels of ADAM12 WT and ADAM12 p. L792F were similar and that internalization of the mutant occurred at the same rate and extent as for ADAM12 WT. Moreover, functional analysis revealed no differences in cell proliferation or ectodomain shedding of epidermal growth factor (EGF), a known ADAM12 substrate between WT and mutant ADAM12. These data suggest that the ADAM12 p. L792F mutation is unlikely to be a driver (cancer causing)-mutation in breast cancer.	[Stautz, Dorte] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Stautz, D (corresponding author), Univ Copenhagen, Dept Biomed Sci, Ole Maaloes Vej, Copenhagen, Denmark.	marie.kveiborg@bric.ku.dk	Kveiborg, Marie/AAM-3019-2020	Kveiborg, Marie/0000-0002-1293-1019	Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; Arvid Nilssons Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilssons Foundation	Funding provided by The Lundbeck Foundation: http://www.lundbeckfonden.dk, The Danish Cancer Society: http://www.cancer.dk, The Novo Nordisk Foundation: http://www.novonordiskfonden.dk and Arvid Nilssons Foundation: http://www.arvidnilsson.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Frohlich C, 2011, MOL CANCER RES, V9, P1449, DOI 10.1158/1541-7786.MCR-11-0100; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Jacobsen J, 2009, CURR PHARM DESIGN, V15, P2300, DOI 10.2174/138161209788682389; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; Morrison P, 1996, BIOCHEMISTRY-US, V35, P14618, DOI 10.1021/bi961630+; Murphy G, 2010, INT J EXP PATHOL, V91, P303, DOI 10.1111/j.1365-2613.2010.00736.x; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tian BL, 2002, J CLIN PATHOL-MOL PA, V55, P394, DOI 10.1136/mp.55.6.394; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37628	10.1371/journal.pone.0037628	http://dx.doi.org/10.1371/journal.pone.0037628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662180	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300070
J	Zehender, G; Ebranati, E; Gabanelli, E; Shkjezi, R; Lai, A; Sorrentino, C; Lo Presti, A; Basho, M; Bruno, R; Tanzi, E; Bino, S; Ciccozzi, M; Galli, M				Zehender, Gianguglielmo; Ebranati, Erika; Gabanelli, Elena; Shkjezi, Renata; Lai, Alessia; Sorrentino, Chiara; Lo Presti, Alessandra; Basho, Mimoza; Bruno, Raffaele; Tanzi, Elisabetta; Bino, Silvia; Ciccozzi, Massimo; Galli, Massimo			Spatial and Temporal Dynamics of Hepatitis B Virus D Genotype in Europe and the Mediterranean Basin	PLOS ONE			English	Article							CHRONICALLY INFECTED PATIENTS; HEALTH-CARE SETTINGS; INJECTION-DRUG USERS; GLOBAL EPIDEMIOLOGY; HBSAG SUBTYPES; BLOOD-DONORS; EVOLUTIONARY DYNAMICS; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; UNSAFE INJECTIONS	Hepatitis B virus genotype D can be found in many parts of the world and is the most prevalent strain in south-eastern Europe, the Mediterranean Basin, the Middle East, and the Indian sub-continent. The epidemiological history of the D genotype and its subgenotypes is still obscure because of the scarcity of appropriate studies. We retrieved from public databases a total of 312 gene P sequences of HBV genotype D isolated in various countries throughout the world, and reconstructed the spatio-temporal evolutionary dynamics of the HBV-D epidemic using a Bayesian framework. The phylogeographical analysis showed that India had the highest posterior probability of being the location of the tree root, whereas central Asia was the most probable location of the common ancestor of subgenotypes D1-D3. HBV-D5 (identified in native Indian populations) diverged from the tree root earlier than D1-D3. The time of the most recent common ancestor (tMRCA) of the tree root was 128 years ago, which suggests that the common ancestor of the currently circulating subgenotypes existed in the second half of the XIX century. The mean tMRCA of subgenotypes D1-D3 was between the 1940s and the 1950-60s. On the basis of our phylogeographic reconstruction, it seems that HBV-D reached the Mediterranean area in the middle of the XX century by means of at least two routes: the first pathway (mainly due to the spread of subgenotype D1) crossing the Middle East and reaching north Africa and the eastern Mediterranean, and the second pathway (closely associated with D2) that crossed the former Soviet Union and reached eastern Europe and the Mediterranean through Albania. We hypothesise that the main route of dispersion of genotype D was the unsafe use of injections and drug addiction.	[Zehender, Gianguglielmo; Ebranati, Erika; Gabanelli, Elena; Shkjezi, Renata; Lai, Alessia; Sorrentino, Chiara; Galli, Massimo] Univ Milan, Infect Dis Sect, Dept Clin Sci Luigi Sacco, Milan, Italy; [Lo Presti, Alessandra; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediate Dis, Epidemiol Unit, I-00161 Rome, Italy; [Basho, Mimoza] Inst Publ Hlth, Dept Control & Prevent Infect Dis, Tirana, Albania; [Bruno, Raffaele] Univ Pavia, IRCCS San Matteo Hosp, Div Infect & Trop Dis, I-27100 Pavia, Italy; [Tanzi, Elisabetta] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy; [Bino, Silvia] Natl Inst Hlth, Control Infect Dis Dept, Tirana, Albania	University of Milan; Luigi Sacco Hospital; Istituto Superiore di Sanita (ISS); IRCCS Fondazione San Matteo; University of Pavia; University of Milan	Zehender, G (corresponding author), Univ Milan, Infect Dis Sect, Dept Clin Sci Luigi Sacco, Milan, Italy.	gianguglielmo.zehender@unimi.it	Lo Presti, Alessandra/K-1451-2016; Ciccozzi, Massimo/AAC-3271-2022; Bruno, Raffaele/L-3530-2018; Tanzi, Elisabetta/M-9066-2016; Bruno, Raffaele/AAB-9491-2022; CICCOZZI, MASSIMO/C-6484-2016; LAI, ALESSIA/AAR-1300-2021; GALLI, MASSIMO/L-7282-2017	Lo Presti, Alessandra/0000-0001-7611-5021; Ciccozzi, Massimo/0000-0003-3866-9239; Bruno, Raffaele/0000-0002-0235-9207; Tanzi, Elisabetta/0000-0002-4119-701X; Bruno, Raffaele/0000-0002-0235-9207; CICCOZZI, MASSIMO/0000-0003-3866-9239; LAI, ALESSIA/0000-0002-3174-5721; GALLI, MASSIMO/0000-0001-8887-6215				Ahmed CS, 2009, J GASTROEN HEPATOL, V24, P569, DOI 10.1111/j.1440-1746.2008.05642.x; Alavian SM, 2007, J GASTROINTEST LIVER, V16, P403; Amini-Bavil-Olyaee S, 2006, J MED VIROL, V78, P358, DOI 10.1002/jmv.20547; Asimina F, 2011, J MED VIROL, V83, P245, DOI 10.1002/jmv.21969; Baig Saeeda, 2009, BMC Res Notes, V2, P1, DOI 10.1186/1756-0500-2-1; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bozdayi G, 2005, J MED VIROL, V76, P476, DOI 10.1002/jmv.20386; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Ciccozzi M, 2011, INFECT GENET EVOL, V11, P863, DOI 10.1016/j.meegid.2011.02.006; Cox LE, 2011, J MED VIROL, V83, P1321, DOI 10.1002/jmv.22118; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Da Villa G, 2007, VACCINE, V25, P3133, DOI 10.1016/j.vaccine.2007.01.044; De Maddalena C, 2007, VIROLOGY, V365, P113, DOI 10.1016/j.virol.2007.03.015; Dentinger C, 2004, INFECT CONT HOSP EP, V25, P30, DOI 10.1086/502288; Deterding K, 2008, J MED VIROL, V80, P1707, DOI 10.1002/jmv.21294; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; European Centre for Disease Prevention and Control (ECDC), 2010, HEP B C EU NEIGHB PR; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77; Garmiri P, 2011, J MED VIROL, V83, P948, DOI 10.1002/jmv.21772; Ghosh S, 2010, J CLIN MICROBIOL, V48, P4063, DOI 10.1128/JCM.01174-10; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Hutin YJF, 1999, INT J EPIDEMIOL, V28, P782, DOI 10.1093/ije/28.4.782; Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kato H, 2002, J MED VIROL, V67, P477, DOI 10.1002/jmv.10126; Khan A, 2008, J MED VIROL, V80, P268, DOI 10.1002/jmv.21057; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Lazarevic I, 2007, ARCH VIROL, V152, P2017, DOI 10.1007/s00705-007-1031-0; Lazarevic I, 2010, J MED VIROL, V82, P1160, DOI 10.1002/jmv.21810; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lindh M, 1997, J INFECT DIS, V175, P1285, DOI 10.1086/516458; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Meldal BHM, 2009, J GEN VIROL, V90, P1622, DOI 10.1099/vir.0.009738-0; Mohebbi SR, 2012, J MED VIROL, V84, P414, DOI 10.1002/jmv.23200; MORTIMER PP, 1995, GENITOURIN MED, V71, P109; Murhekar MV, 2008, T ROY SOC TROP MED H, V102, P729, DOI 10.1016/j.trstmh.2008.04.044; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2008, CLIN MICROBIOL INFEC, V14, P575, DOI 10.1111/j.1469-0691.2008.01988.x; Oliphant John W., 1944, BULL NEW YORK ACAD MED, V20, P429; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Panessa C, 2009, J VIRAL HEPATITIS, V16, P64, DOI 10.1111/j.1365-2893.2008.01045.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourkarim MR, 2010, J MED VIROL, V82, P379, DOI 10.1002/jmv.21726; Rantala M, 2008, EUROSURVEILLANCE, V13, P21; Reuben A, 2002, HEPATOLOGY, V36, P770; Schaefer S, 2007, HEPATOL RES, V37, pS20, DOI 10.1111/j.1872-034X.2007.00099.x; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SEEFF LB, 1987, NEW ENGL J MED, V316, P965, DOI 10.1056/NEJM198704163161601; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swenson PD, 2001, J MED VIROL, V64, P305, DOI 10.1002/jmv.1051; Tallo T, 2004, J MED VIROL, V74, P221, DOI 10.1002/jmv.20169; Tallo T, 2008, J GEN VIROL, V89, P1829, DOI 10.1099/vir.0.83660-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Houdt R, 2010, J VIRAL HEPATITIS, V17, P108, DOI 10.1111/j.1365-2893.2009.01158.x; Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009; Zehender G, 2012, INFECT GENET EVOL, V12, P291, DOI [10.1016/j.meegid.2011.11.009, 10.101]; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1; Zuckerman J.N., 1999, CLIN LIVER DIS, V3, P179, DOI [10.1016/S1089-3261(05)70064-7, DOI 10.1016/S1089-3261(05)70064-7]	72	44	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37198	10.1371/journal.pone.0037198	http://dx.doi.org/10.1371/journal.pone.0037198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662136	gold, Green Published			2022-12-27	WOS:000305342300027
J	Liu, Q; Zhou, H; Cui, J; Cao, ZW; Xu, Y				Liu, Qi; Zhou, Han; Cui, Juan; Cao, Zhiwei; Xu, Ying			Reconsideration of In-Silico siRNA Design Based on Feature Selection: A Cross-Platform Data Integration Perspective	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; RANK AGGREGATION; MONTE-CARLO; INTERFERENCE; PREDICTION; EFFICIENT; MODEL	RNA interference via exogenous short interference RNAs (siRNA) is increasingly more widely employed as a tool in gene function studies, drug target discovery and disease treatment. Currently there is a strong need for rational siRNA design to achieve more reliable and specific gene silencing; and to keep up with the increasing needs for a wider range of applications. While progress has been made in the ability to design siRNAs with specific targets, we are clearly at an infancy stage towards achieving rational design of siRNAs with high efficacy. Among the many obstacles to overcome, lack of general understanding of what sequence features of siRNAs may affect their silencing efficacy and of large-scale homogeneous data needed to carry out such association analyses represents two challenges. To address these issues, we investigated a feature-selection based in-silico siRNA design from a novel cross-platform data integration perspective. An integration analysis of 4,482 siRNAs from ten meta-datasets was conducted for ranking siRNA features, according to their possible importance to the silencing efficacy of siRNAs across heterogeneous data sources. Our ranking analysis revealed for the first time the most relevant features based on cross-platform experiments, which compares favorably with the traditional in-silico siRNA feature screening based on the small samples of individual platform data. We believe that our feature ranking analysis can offer more creditable suggestions to help improving the design of siRNA with specific silencing targets. Data and scripts are available at http://csbl.bmb.uga.edu/publications/materials/qiliu/siRNA.html.	[Liu, Qi; Zhou, Han; Cao, Zhiwei] Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China; [Cui, Juan; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Cui, Juan; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Tongji University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Liu, Q (corresponding author), Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China.	zwcao@tongji.edu.cn; xyn@bmb.uga.edu			Project White Magnolia Funding, Shanghai [2010B127]; Shanghai Pujiang Talents Funding [11PJ1407400]; Tongji Excellent Young Scientist Funding [2000219052]; National Natural Science Foundation of China [30976611, 31100956, 61173117]; Young Teachers for the Doctoral Program of Ministry of Education, China [20110072120048]	Project White Magnolia Funding, Shanghai; Shanghai Pujiang Talents Funding; Tongji Excellent Young Scientist Funding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers for the Doctoral Program of Ministry of Education, China	1. Project White Magnolia Funding, Shanghai (Grant No. 2010B127) http://www.stcsm.gov.cn/structure/index.htm, 2. Shanghai Pujiang Talents Funding (Grant No. 11PJ1407400) http://www.stcsm.gov.cn/structure/index.htm, 3. Tongji Excellent Young Scientist Funding (Grant No. 2000219052) http://www.tongji.edu.cn/, 4. National Natural Science Foundation of China (Grant No. 30976611, Grant No. 31100956 and Grant No. 61173117)http://www.nsfc.gov.cn/Portal0/default152.htm, 5. Young Teachers for the Doctoral Program of Ministry of Education, China (Grant No. 20110072120048) http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chalk AM, 2004, BIOCHEM BIOPH RES CO, V319, P264, DOI 10.1016/j.bbrc.2004.04.181; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gomase VS, 2008, CURR DRUG METAB, V9, P241, DOI 10.2174/138920008783884777; Gong WM, 2008, BIOINFORMATICS, V24, P2405, DOI 10.1093/bioinformatics/btn442; Gong WM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-516; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; JI S., 2009, P 26 ANN INT C MACH, P457; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2003, J KOREAN MED SCI, V18, P309, DOI 10.3346/jkms.2003.18.3.309; Klingelhoefer JW, 2009, BIOINFORMATICS, V25, P1594, DOI 10.1093/bioinformatics/btp284; Lin SL, 2009, BIOMETRICS, V65, P9, DOI 10.1111/j.1541-0420.2008.01044.x; Liu J, SLEP SPARSE LEARNING; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-181; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Naito Y, 2006, NUCLEIC ACIDS RES, V34, pW448, DOI 10.1093/nar/gkl214; Peek AS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-182; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Ren YL, 2006, BIOINFORMATICS, V22, P1027, DOI 10.1093/bioinformatics/btl026; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shao Y, 2006, NUCLEIC ACIDS RES, V34, P5660, DOI 10.1093/nar/gkl715; Teramoto R, 2005, FEBS LETT, V579, P2878, DOI 10.1016/j.febslet.2005.04.045; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang LQ, 2004, BIOINFORMATICS, V20, P1818, DOI 10.1093/bioinformatics/bth164; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	39	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37879	10.1371/journal.pone.0037879	http://dx.doi.org/10.1371/journal.pone.0037879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655076	Green Published, gold			2022-12-27	WOS:000305338900053
J	Zhou, MT; Chen, BC; Sun, HW; Jin, YP; Yang, FJ; Zhang, X; Andersson, R; Zhang, QY				Zhou, Meng Tao; Chen, Bi Cheng; Sun, Hong Wei; Jin, Yue Peng; Yang, Fa Jing; Zhang, Xing; Andersson, Roland; Zhang, Qi Yu			Continuous Regional Arterial Infusion with Fluorouracil and Octreotide Attenuates Severe Acute Pancreatitis in a Canine Model	PLOS ONE			English	Article							ACUTE NECROTIZING PANCREATITIS; ACUTE LUNG INJURY; PROTEASE INHIBITOR; EARLY PHASE; RATS; 5-FLUOROURACIL; BAICALIN; ISCHEMIA; MECHANISMS; 5-FU	Aim: To investigate the therapeutic effects of fluorouracil (5-Fu) and octreotide (Oct) continuous regional arterial infusion (CRAI,) alone or in combination, was administered in a canine model of severe acute pancreatitis (SAP). Materials and Methods: The animals were divided into five groups; group A (Sham), group B (SAP), group C (SAP and 5-Fu), group D (SAP and Oct), and group E (SAP and 5-Fu + Oct). Levels of amylase, alpha-tumor necrosis factor (TNF-alpha), blood urea nitrogen (BUN), creatinine, thromboxane B2 and 6-keto-prostaglandin F1 alpha were measured both before and after the induction of SAP. Pathologic examination of the pancreas and kidneys was performed after termination of the study. Results: Pathologic changes noted in the pancreas in SAP significantly improved following CRAI with either single or combined administration of 5-Fu and Oct, where combination therapy demonstrated the lowest injury score. All treatment groups had significantly lower levels of serum TNF-alpha and amylase activity (P<0.05), though only groups D and E had a lower BUN level as compared to group B. The plasma thromboxane B-2 level increased in SAP, but the ratio of thromboxane B-2/6-keto-prostaglandin F-1 alpha decreased in the treatment groups, with the combination therapy (group E) demonstrating the lowest ratio as compared to the other 3 experimental groups (P<0.05). Conclusions: The findings in the present study demonstrate an attenuation of SAP in a canine model following CRAI administration with 5-Fu or Oct, alone or in combination.	[Zhou, Meng Tao; Chen, Bi Cheng; Zhang, Xing] Wenzhou Med Coll, Affiliated Hosp 1, Zhejiang Prov Top Key Discipline Surg, Wenzhou Key Lab Surg,Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Andersson, Roland] Lund Univ, Dept Surg, Lund, Sweden; [Andersson, Roland] Skane Univ Hosp, Lund, Sweden	Wenzhou Medical University; Lund University; Lund University; Skane University Hospital	Zhou, MT (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Zhejiang Prov Top Key Discipline Surg, Wenzhou Key Lab Surg,Dept Surg, Wenzhou, Zhejiang, Peoples R China.	zhangqiyu0577@hotmail.com		Zhou, Mengtao/0000-0002-2455-250X	grants of Zhejiang Provincial Top Key Discipline in Surgery; Natural Science Foundation of Zhejiang Province [Z2100853]; National Natural Science Foundation of China [81070732]	grants of Zhejiang Provincial Top Key Discipline in Surgery; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by grants of Zhejiang Provincial Top Key Discipline in Surgery, the Natural Science Foundation of Zhejiang Province (Grant No. Z2100853) and the National Natural Science Foundation of China (Grant No. 81070732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Andersson B, 2006, PANCREATOLOGY, V6, P536, DOI 10.1159/000096977; Bai Y, 2007, PANCREAS, V35, P232, DOI 10.1097/MPA.0b013e3180654d20; Barreto SG, 2010, HPB, V12, P403, DOI 10.1111/j.1477-2574.2010.00191.x; BIELECKI K, 1994, PANCREAS, V9, P518, DOI 10.1097/00006676-199407000-00016; CASTELLANOS J, 1975, J SURG RES, V18, P305, DOI 10.1016/0022-4804(75)90156-0; Chen BQZNLC, 2006, CHIN J CURR ADV GEN, V9, P215; Chen XL, 2009, WORLD J GASTROENTERO, V15, P2032, DOI 10.3748/wjg.15.2032; Coelho AMD, 2003, PANCREAS, V26, P230, DOI 10.1097/00006676-200304000-00004; Gu F, 1995, Zhonghua Wai Ke Za Zhi, V33, P339; Guler O, 2009, SURG TODAY, V39, P876, DOI 10.1007/s00595-009-3972-2; Gultekin FA, 2007, WORLD J GASTROENTERO, V13, P2932, DOI 10.3748/wjg.v13.i21.2932; Hayashi J, 1996, PANCREAS, V13, P184, DOI 10.1097/00006676-199608000-00010; Hukkanen RR, 2009, TOXICOL PATHOL, V37, P799, DOI 10.1177/0192623309343778; Imaizumi H, 2004, PANCREAS, V28, P369, DOI 10.1097/00006676-200405000-00003; Inoue K, 2003, PANCREAS, V26, P218, DOI 10.1097/00006676-200304000-00002; JOHNSON RM, 1973, AM J SURG, V125, P211, DOI 10.1016/0002-9610(73)90030-5; Kakugawa Y, 1990, Nihon Shokakibyo Gakkai Zasshi, V87, P1444; Kinami Y, 1976, Gastroenterol Jpn, V11, P123; Laptev VV, 1981, 5 FLUOROURACIL TREAT, P67; MANN SK, 1979, ARCH PATHOL LAB MED, V103, P79; Mikami Y, 2005, PANCREAS, V30, P248, DOI 10.1097/01.mpa.0000153328.54569.28; Mironov VI, 1985, CUMULATION 5 FLUOROU, P168; Omata F, 2010, J GASTROENTEROL, V45, P885, DOI 10.1007/s00535-010-0234-4; Paran H, 2000, DIGEST DIS SCI, V45, P2247, DOI 10.1023/A:1026679106463; SAARIO IA, 1983, AM J SURG, V145, P349, DOI 10.1016/0002-9610(83)90198-8; Satoh Hirohiko, 2004, J Med Invest, V51, P186, DOI 10.2152/jmi.51.186; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Takeda K, 2005, PANCREAS, V30, P40; Takeda K, 2001, J Hepatobiliary Pancreat Surg, V8, P216, DOI 10.1007/s005340170019; Tian H, 2009, INFLAMMATION, V32, P191, DOI 10.1007/s10753-009-9120-8; VANOOIJEN B, 1988, SCAND J GASTROENTERO, V23, P188, DOI 10.3109/00365528809103966; Woeste G, 2008, TRANSPLANTATION, V86, P961, DOI 10.1097/TP.0b013e318186b783; ZC ZS, 1991, CHINESE J PRACTICA Z, VZ1, P466; Zhang XP, 2007, J PANCREAS, V8, P400; Zhang XP, 2008, DIGEST DIS SCI, V53, P581, DOI 10.1007/s10620-007-9868-3; Zhang XP, 2007, WORLD J GASTROENTERO, V13, P5079, DOI 10.3748/wjg.v13.i38.5079; Zhang XP, 2008, WORLD J GASTROENTERO, V14, P6551, DOI 10.3748/wjg.14.6551; Zhao Yupei HY, 2001, CHINESE J EXPT SURG, V18, P54; Zhou MT, 2010, WORLD J GASTROENTERO, V16, P2094, DOI 10.3748/wjg.v16.i17.2094; Zhou MT, 2011, SCAND J GASTROENTERO, V46, P211, DOI 10.3109/00365521.2010.525715	42	11	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37347	10.1371/journal.pone.0037347	http://dx.doi.org/10.1371/journal.pone.0037347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655040	Green Published, gold			2022-12-27	WOS:000305338900015
J	Aguiar, ACC; Santos, RD; Figueiredo, FJB; Cortopassi, WA; Pimentel, AS; Franca, TCC; Meneghetti, MR; Krettli, AU				Campos Aguiar, Anna Caroline; Santos, Raquel de Meneses; Barbosa Figueiredo, Flavio Junior; Cortopassi, Wilian Augusto; Pimentel, Andre Silva; Costa Franca, Tanos Celmar; Meneghetti, Mario Roberto; Krettli, Antoniana Ursine			Antimalarial Activity and Mechanisms of Action of Two Novel 4-Aminoquinolines against Chloroquine-Resistant Parasites	PLOS ONE			English	Article							METAL-BASED CHEMOTHERAPY; ACTIVITY IN-VITRO; FALCIPARUM LACTATE-DEHYDROGENASE; PROTEIN DATA-BANK; PLASMODIUM-FALCIPARUM; TROPICAL DISEASES; DRUG DISCOVERY; HEMATIN POLYMERIZATION; COMPLEXES; MALARIA	Chloroquine (CQ) is a cost effective antimalarial drug with a relatively good safety profile (or therapeutic index). However, CQ is no longer used alone to treat patients with Plasmodium falciparum due to the emergence and spread of CQ-resistant strains, also reported for P. vivax. Despite CQ resistance, novel drug candidates based on the structure of CQ continue to be considered, as in the present work. One CQ analog was synthesized as monoquinoline (MAQ) and compared with a previously synthesized bisquinoline (BAQ), both tested against P. falciparum in vitro and against P. berghei in mice, then evaluated in vitro for their cytotoxicity and ability to inhibit hemozoin formation. Their interactions with residues present in the NADH binding site of P falciparum lactate dehydrogenase were evaluated using docking analysis software. Both compounds were active in the nanomolar range evaluated through the HRPII and hypoxanthine tests. MAQ and BAQ derivatives were not toxic, and both compounds significantly inhibited hemozoin formation, in a dose-dependent manner. MAQ had a higher selectivity index than BAQ and both compounds were weak PfLDH inhibitors, a result previously reported also for CQ. Taken together, the two CQ analogues represent promising molecules which seem to act in a crucial point for the parasite, inhibiting hemozoin formation.	[Campos Aguiar, Anna Caroline; Barbosa Figueiredo, Flavio Junior; Krettli, Antoniana Ursine] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Campos Aguiar, Anna Caroline; Krettli, Antoniana Ursine] Univ Fed Minas Gerais, Programa Pos Grad Med Mol, Fac Med, Belo Horizonte, MG, Brazil; [Santos, Raquel de Meneses; Meneghetti, Mario Roberto] Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil; [Cortopassi, Wilian Augusto; Costa Franca, Tanos Celmar] Inst Militar Engn, Lab Modelagem Mol Aplicada Defesa Quim & Biol LMD, Rio De Janeiro, Brazil; [Cortopassi, Wilian Augusto; Pimentel, Andre Silva] Pontificia Univ Catolica Rio de Janeiro, Dept Quim, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Alagoas; Instituto Militar de Engenharia (IME); Pontificia Universidade Catolica do Rio de Janeiro	Aguiar, ACC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	tanos@ime.eb.br; mario.meneghetti@pq.cnpq.br; akrettli@cpqrr.fiocruz.br	Aguiar, Anna Caroline/J-6970-2015; Pimentel, Andre/B-1278-2010; Cortopassi, Wilian/P-3136-2014; Meneghetti, Mario Roberto/B-9336-2016; França, Tanos Celmar Costa/I-9519-2012	Aguiar, Anna Caroline/0000-0003-0139-8279; Pimentel, Andre/0000-0002-1301-0561; Cortopassi, Wilian/0000-0001-8038-7847; Meneghetti, Mario Roberto/0000-0002-0722-8599; França, Tanos Celmar Costa/0000-0002-6048-8103	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT; FIOCRUZ-PAPES; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CNPq (Conselho Nacional de Pesquisa)	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-PAPES; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Conselho Nacional de Pesquisa)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Work supported from the Brazilian funding agencies MCT/CNPq/CT-Saude/MS/SCTIE/DECIT, FIOCRUZ-PAPES, FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) and by CNPq (Conselho Nacional de Pesquisa) fellowships to AUK, ACCA, FJBF and WAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade PA, 2006, J COORD CHEM, V59, P1621, DOI 10.1080/00958970500537838; Andrade-Neto VF, 2004, PHYTOTHER RES, V18, P634, DOI 10.1002/ptr.1510; Andrews S, 2010, J MED CHEM, V53, P916, DOI 10.1021/jm900972u; [Anonymous], 2010, SCIENCE, V328, P846, DOI 10.1126/science.328.5980.846; [Anonymous], WHO WORLD MAL REP 20; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blackie MAL, 2010, BIOORG MED CHEM LETT, V20, P1078, DOI 10.1016/j.bmcl.2009.12.030; Borenfreunda E, 1987, TOXICOL IN VITRO, V2, P1; Carey FA, 1990, ADV ORGANIC CHEM B, P597; CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113; Chellan P, 2010, J ORGANOMET CHEM, V695, P2225, DOI 10.1016/j.jorganchem.2010.06.010; Cortopassi WA, 2011, J BIOMOL STRUCT DYN, V29, P207, DOI 10.1080/07391102.2011.10507383; Cunico W, 2006, BIOORG MED CHEM LETT, V16, P649, DOI 10.1016/j.bmcl.2005.10.033; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; de Ridder S, 2008, J ETHNOPHARMACOL, V120, P302, DOI 10.1016/j.jep.2008.09.017; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dios AC, 2004, INORG CHEM, V43, P8078; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; Ekoue-Kovi K, 2009, BIOORGAN MED CHEM, V17, P270, DOI 10.1016/j.bmc.2008.11.009; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gabbiani C, 2009, J INORG BIOCHEM, V103, P310, DOI 10.1016/j.jinorgbio.2008.10.004; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Gasser G, 2011, J MED CHEM, V54, P3, DOI 10.1021/jm100020w; Girault S, 2001, J MED CHEM, V44, P1658, DOI 10.1021/jm001096a; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Krettli AU, 2009, CURR DRUG TARGETS, V10, P261, DOI 10.2174/138945009787581203; Krettli AU, 2009, EXPERT OPIN DRUG DIS, V4, P95, DOI 10.1517/17530050802678127; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leed A, 2002, BIOCHEMISTRY-US, V41, P10245, DOI 10.1021/bi020195i; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Menting JG, 1997, MOL BIOCHEM PARASIT, V88, P215, DOI 10.1016/S0166-6851(97)00095-9; Musonda CC, 2006, BIOORGAN MED CHEM, V14, P5605, DOI 10.1016/j.bmc.2006.04.035; Navarro M, 2004, J MED CHEM, V47, P5204, DOI 10.1021/jm049792o; Navarro M, 1997, J MED CHEM, V40, P1937, DOI 10.1021/jm9607358; Ncokazi KK, 2005, ANAL BIOCHEM, V338, P306, DOI 10.1016/j.ab.2004.11.022; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Portela C, 2003, FEBS LETT, V547, P217, DOI 10.1016/S0014-5793(03)00692-6; Read JA, 1999, J BIOL CHEM, V274, P10213, DOI 10.1074/jbc.274.15.10213; Rosenthal PJ, 2003, J EXP BIOL, V206, P3735, DOI 10.1242/jeb.00589; Ryckebusch A, 2005, BIOORG MED CHEM LETT, V15, P297, DOI 10.1016/j.bmcl.2004.10.080; SanchezDelgado RA, 1996, J MED CHEM, V39, P1095, DOI 10.1021/jm950729w; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Varotti FD, 2008, ANTIMICROB AGENTS CH, V52, P3868, DOI 10.1128/AAC.00510-08; Vippagunta SR, 1999, J MED CHEM, V42, P4630, DOI 10.1021/jm9902180; Wang C, 2010, BIOCHEM BIOPH RES CO, V402, P773, DOI 10.1016/j.bbrc.2010.10.108; Xu LL, 2005, EXP PARASITOL, V110, P80, DOI 10.1016/j.exppara.2005.02.004; Yearick K, 2008, J MED CHEM, V51, P1995, DOI 10.1021/jm800106u; Zhang HW, 2008, BIOMED PHARMACOTHER, V62, P65, DOI 10.1016/j.biopha.2007.04.007	57	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37259	10.1371/journal.pone.0037259	http://dx.doi.org/10.1371/journal.pone.0037259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649514	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800032
J	Chafekar, SM; Duennwald, ML				Chafekar, Sidhartha M.; Duennwald, Martin L.			Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin	PLOS ONE			English	Article							MUTANT HUNTINGTIN; MOUSE MODELS; DISEASE; PROTEIN; STRESS; MECHANISMS; INDUCTION; PROTEOSTASIS; AGGREGATION; NEURONS	The molecular mechanisms by which polyglutamine (polyQ)-expanded huntingtin (Htt) causes neurodegeneration in Huntington's disease (HD) remain unclear. The malfunction of cellular proteostasis has been suggested as central in HD pathogenesis and also as a target of therapeutic interventions for the treatment of HD. We present results that offer a previously unexplored perspective regarding impaired proteostasis in HD. We find that, under non-stress conditions, the proteostatic capacity of cells expressing full length polyQ-expanded Htt is adequate. Yet, under stress conditions, the presence of polyQ-expanded Htt impairs the heat shock response, a key component of cellular proteostasis. This impaired heat shock response results in a reduced capacity to withstand the damage caused by cellular stress. We demonstrate that in cells expressing polyQ-expanded Htt the levels of heat shock transcription factor 1 (HSF1) are reduced, and, as a consequence, these cells have an impaired a heat shock response. Also, we found reduced HSF1 and HSP70 levels in the striata of HD knock-in mice when compared to wild-type mice. Our results suggests that full length, non-aggregated polyQ-expanded Htt blocks the effective induction of the heat shock response under stress conditions and may thus trigger the accumulation of cellular damage during the course of HD pathogenesis.	[Chafekar, Sidhartha M.; Duennwald, Martin L.] Boston Biomed Res Inst, Regenerat Biol Program, Watertown, MA USA	Boston Biomedical Research Institute	Chafekar, SM (corresponding author), Boston Biomed Res Inst, Regenerat Biol Program, Watertown, MA USA.	duennwald@bbri.org			Heredity Disease Foundation	Heredity Disease Foundation	This work was supported by a research grant from the Heredity Disease Foundation (to MLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BEERE HM, 1993, CANCER RES, V53, P3034; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bush KT, 1997, J BIOL CHEM, V272, P9086; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; CARR VM, 1994, J COMP NEUROL, V348, P150, DOI 10.1002/cne.903480109; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Finkbeiner S., 2011, COLD SPRING HARB PER, V3; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; GUSELLA JF, 1995, SEMIN CELL BIOL, V6, P21, DOI 10.1016/1043-4682(95)90011-X; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perez-Navarro E, 2006, HISTOL HISTOPATHOL, V21, P1217, DOI 10.14670/HH-21.1217; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Sandqvist A, 2004, J CELL BIOL, V164, P15, DOI 10.1083/jcb.200311102; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tagawa K, 2007, J NEUROSCI, V27, P868, DOI 10.1523/JNEUROSCI.4522-06.2007; Tebbenkamp ATN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013675; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Van Raamsdonk JM, 2007, BRAIN RES BULL, V72, P124, DOI 10.1016/j.brainresbull.2006.10.018; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Wolfe KJ, 2011, SEMIN CELL DEV BIOL; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Zhang L, 2006, MOL PHARMACEUT, V3, P62, DOI 10.1021/mp050095h; Zhang YQ, 2007, J MOL MED-JMM, V85, P1421, DOI 10.1007/s00109-007-0251-9; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	43	52	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37929	10.1371/journal.pone.0037929	http://dx.doi.org/10.1371/journal.pone.0037929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649566	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800086
J	Tang, A; Sharma, A; Jen, R; Hirschfeld, AF; Chilvers, MA; Lavoie, PM; Turvey, SE				Tang, Anthony; Sharma, Ashish; Jen, Roger; Hirschfeld, Aaron F.; Chilvers, Mark A.; Lavoie, Pascal M.; Turvey, Stuart E.			Inflammasome-Mediated IL-1 beta Production in Humans with Cystic Fibrosis	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; PSEUDOMONAS-AERUGINOSA; LUNG-DISEASE; ANTIINFLAMMATORY TARGET; PULMONARY INFLAMMATION; AIRWAY INFLAMMATION; ACTIVATES CASPASE-1; NEGATIVE REGULATOR; EPITHELIAL-CELLS	Background: Inflammation and infection are major determinants of disease severity and consequently, the quality of life and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1 beta) is a key inflammatory mediator. Secretion of biologically active IL-1 beta involves inflammasome-mediated processing. Little is known about the contribution of IL-1 beta and the inflammasomes in CF inflammatory disease. This study examines inflammasome-mediated IL-1 beta production in CF bronchial epithelial cell lines and human patients with CF. Results: Bronchial epithelial cell lines were found to produce negligible amounts of basal or stimulated IL-1 beta compared to hematopoeitic cells and they did not significantly upregulate caspase-1 activity upon inflammasome stimulation. In contrast, peripheral blood mononuclear cells (PBMCs) from both CF and healthy control subjects produced large amounts of IL-1 beta and strongly upregulated caspase-1 activity upon inflammasome stimulation. PBMCs from CF patients and controls displayed similar levels of caspase-1 activation and IL-1 beta production when stimulated with inflammasome activators. This IL-1 beta production was dependent on NF-kappa B activity and could be enhanced by priming with LPS. Finally, chemical inhibition of CFTR activity in control PBMCs and THP-1 cells did not significantly alter IL-1 beta or IL-8 production in response to P. aeruginosa. Conclusion: Hematopoeitic cells appear to be the predominant source of inflammasome-induced pro-inflammatory IL-1 beta in CF. PBMCs derived from CF subjects display preserved inflammasome activation and IL-1 beta secretion in response to the major CF pathogen Pseudomonas aeruginosa. However, our data do not support the hypothesis that increased IL-1 beta production in CF subjects is due to an intrinsic increase in NF-kappa B activity through loss of CFTR function.	[Tang, Anthony; Turvey, Stuart E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Sharma, Ashish; Jen, Roger; Lavoie, Pascal M.; Turvey, Stuart E.] Univ British Columbia, Dept Expt Med, Vancouver, BC V5Z 1M9, Canada; [Hirschfeld, Aaron F.; Chilvers, Mark A.; Lavoie, Pascal M.; Turvey, Stuart E.] British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC V6H 3V4, Canada; [Hirschfeld, Aaron F.; Chilvers, Mark A.; Lavoie, Pascal M.; Turvey, Stuart E.] Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; Child & Family Research Institute	Tang, A (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	sturvey@cw.bc.ca	Turvey, Stuart/HGV-1191-2022	Turvey, Stuart/0000-0003-1599-1065	BC Lung Association; Cystic Fibrosis Canada; Michael Smith Foundation For Health Research; Canadian Institutes For Health Research; Child & Family Research Institute	BC Lung Association; Cystic Fibrosis Canada; Michael Smith Foundation For Health Research(Michael Smith Foundation for Health Research); Canadian Institutes For Health Research(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute	This work was supported by: BC Lung Association (www.bc.lung.ca); Cystic Fibrosis Canada (www.cysticfibrosis.ca); Michael Smith Foundation For Health Research (www.msfhr.org/); Canadian Institutes For Health Research (www.cihr-irsc.gc.ca); and Child & Family Research Institute (www.cfri.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Averna M, 2011, BBA-MOL CELL RES, V1813, P50, DOI 10.1016/j.bbamcr.2010.11.008; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Blohmke CJ, 2010, J IMMUNOL, V185, P7731, DOI 10.4049/jimmunol.1001513; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; CANTIN A, 1995, AM J RESP CRIT CARE, V151, P939; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/ajrccm.165.8.2104090; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Hirschfeld AF, 2007, CLIN IMMUNOL, V122, P271, DOI 10.1016/j.clim.2006.10.012; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Kotrange S, J LEUKOC BIOL, V89, P481; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; LeibundGut-Landmann S, 2011, J IMMUNOL, V186, P3130, DOI 10.4049/jimmunol.1003565; Levy H, 2009, PEDIATR PULM, V44, P580, DOI 10.1002/ppul.21026; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meyer M, 2009, AM J RESP CELL MOL B, P2008; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Osika E, 1999, EUR RESPIR J, V14, P339, DOI 10.1034/j.1399-3003.1999.14b17.x; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Rzemieniak SE, IMMUNOLOGY, V130, P288; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sorio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022212; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; van de Veerdonk FL, TRENDS IMMUNOL, V32, P110; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xu Y, PLOS ONE, V5; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026	63	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37689	10.1371/journal.pone.0037689	http://dx.doi.org/10.1371/journal.pone.0037689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649552	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800072
J	Verbeek, EC; Bakker, IMC; Bevova, MR; Bochdanovits, Z; Rizzu, P; Sondervan, D; Willemsen, G; de Geus, EJ; Smit, JH; Penninx, BW; Boomsma, DI; Hoogendijk, WJG; Heutink, P				Verbeek, Eva C.; Bakker, Ingrid M. C.; Bevova, Marianna R.; Bochdanovits, Zoltan; Rizzu, Patrizia; Sondervan, David; Willemsen, Gonneke; de Geus, Eco J.; Smit, Johannes H.; Penninx, Brenda W.; Boomsma, Dorret I.; Hoogendijk, Witte J. G.; Heutink, Peter			A Fine-Mapping Study of 7 Top Scoring Genes from a GWAS for Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PICCOLO; HYPOTHESIS; BEHAVIOR; NETWORK	Major depressive disorder (MDD) is a psychiatric disorder that is characterized -amongst others- by persistent depressed mood, loss of interest and pleasure and psychomotor retardation. Environmental circumstances have proven to influence the aetiology of the disease, but MDD also has an estimated 40% heritability, probably with a polygenic background. In 2009, a genome wide association study (GWAS) was performed on the Dutch GAIN-MDD cohort. A non-synonymous coding single nucleotide polymorphism (SNP) rs2522833 in the PCLO gene became only nominally significant after post-hoc analysis with an Australian cohort which used similar ascertainment. The absence of genome-wide significance may be caused by low SNP coverage of genes. To increase SNP coverage to 100% for common variants (m.a.f > 0.1, r(2)> 0.8), we selected seven genes from the GAIN-MDD GWAS: PCLO, GZMK, ANPEP, AFAP1L1, ST3GAL6, FGF14 and PTK2B. We genotyped 349 SNPs and obtained the lowest P-value for rs2715147 in PCLO at P=6.8E-7. We imputed, filling in missing genotypes, after which rs2715147 and rs2715148 showed the lowest P-value at P=1.2E-6. When we created a haplotype of these SNPs together with the non-synonymous coding SNP rs2522833, the P-value decreased to P=9.9E-7 but was not genome wide significant. Although our study did not identify a more strongly associated variant, the results for PCLO suggest that the causal variant is in high LD with rs2715147, rs2715148 and rs2522833.	[Verbeek, Eva C.; Bakker, Ingrid M. C.; Bevova, Marianna R.; Bochdanovits, Zoltan; Rizzu, Patrizia; Sondervan, David; Heutink, Peter] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Smit, Johannes H.; Penninx, Brenda W.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Willemsen, Gonneke; de Geus, Eco J.; Boomsma, Dorret I.] Vrije Univ Amsterdam Med Ctr, Dept Biol Psychol, Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Hoogendijk, Witte J. G.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); University of Groningen; Erasmus University Rotterdam; Erasmus MC	Verbeek, EC (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	e.verbeek@vumc.nl	de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Penninx, Brenda WJH/S-7627-2017	de Geus, Eco J.C./0000-0001-6022-2666; Penninx, Brenda WJH/0000-0001-7779-9672; Willemsen, Gonneke/0000-0003-3755-0236; Heutink, Peter/0000-0001-5218-1737	Netherlands Scientific Organization [904-61-090, 904-61-193, 480-04-004, 400-05-717, 912-100-20]; Centre for Medical Systems Biology (NWO Genomics); Neuroscience Campus Amsterdam (NCA); EMGO+ Institute; ZonMW [10-000-1002]; National Institute of Mental Health (NIMH) [RO1 MH059160]; NESDA; NTR; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; NIMH [MH081802]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081802, R01MH059160] Funding Source: NIH RePORTER	Netherlands Scientific Organization; Centre for Medical Systems Biology (NWO Genomics); Neuroscience Campus Amsterdam (NCA); EMGO+ Institute; ZonMW(Netherlands Organization for Health Research and Development); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NESDA; NTR; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding support for NESDA (Netherlands Study for Depression and Anxiety) and NTR (Netherlands Twin Registry) was provided by the Netherlands Scientific Organization (904-61-090, 904-61-193, 480-04-004, 400-05-717, 912-100-20) (http://www.nwo.nl/) Centre for Medical Systems Biology (NWO Genomics) (http://www.cmsb.nl/home/index.php), the Neuroscience Campus Amsterdam (NCA) (http://www.neurosciencecampus-amsterdam.nl/en/index.asp) and the EMGO+ Institute (http://www.emgo.nl/home/); ZonMW (Geestkracht program, 10-000-1002) (http://www.zonmw.nl/), National Institute of Mental Health (NIMH) (RO1 MH059160) and matching funds from participating institutes in NESDA and NTR. Genotyping was funded by the Genetic Association Information Network (GAIN)(http://www.genome.gov/19518664) of the Foundation for the US National Institutes of Health, and analysis was supported by grants from GAIN and the NIMH (MH081802) (http://www.nimh.nih.gov/index.shtml). Genotype data were obtained from dbGaP (http://www.ncbi.nlm.nih.gov/dbgap,accession number phs000020.v1.p1). The additional genotyping project was performed within the framework of the Center for Medical Systems Biology and TIPharma project T5-203 (http://www.tipharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Cen X, 2008, MOL PSYCHIATR, V13, P451, DOI 10.1038/sj.mp.4002132; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kondaurova EM, 2011, J NEUROSCI RES, V89, P267, DOI 10.1002/jnr.22545; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Lips ES, 2011, MOL PSYCHIATR, P1; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Pardo L, 2009, EUR J HUM GENET, V17, P802, DOI 10.1038/ejhg.2008.248; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reaux A, 1999, NEUROENDOCRINOLOGY, V69, P370, DOI 10.1159/000054439; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Sheehan TP, 2003, BIOL PSYCHIAT, V54, P540, DOI 10.1016/S0006-3223(02)01815-2; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; van Rossum G., 1991, EUROPEN C P; Velders FP, 2011, PSYCHONEUROENDOCRINO, V36, P1053, DOI 10.1016/j.psyneuen.2011.01.003; Wall L., 2000, PROGRAMMING PERL	39	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37384	10.1371/journal.pone.0037384	http://dx.doi.org/10.1371/journal.pone.0037384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649524	Green Published, gold			2022-12-27	WOS:000305335800042
J	Young, FB; Franciosi, S; Spreeuw, A; Deng, Y; Sanders, S; Tam, NCM; Huang, K; Singaraja, RR; Zhang, WN; Bissada, N; Kay, C; Hayden, MR				Young, Fiona B.; Franciosi, Sonia; Spreeuw, Amanda; Deng, Yu; Sanders, Shaun; Tam, Natalie C. M.; Huang, Kun; Singaraja, Roshni R.; Zhang, Weining; Bissada, Nagat; Kay, Chris; Hayden, Michael R.			Low Levels of Human HIP14 Are Sufficient to Rescue Neuropathological, Behavioural, and Enzymatic Defects Due to Loss of Murine HIP14 in Hip14-/- Mice	PLOS ONE			English	Article							YAC128 MOUSE MODEL; PROTEIN PALMITOYLATION; NEURONAL DEVELOPMENT; HUNTINGTONS-DISEASE; GENE; TRAFFICKING; EXPRESSION; TRANSMISSION; MUTATIONS; KNOCKOUT	Huntingtin Interacting Protein 14 (HIP14) is a palmitoyl acyl transferase (PAT) that was first identified due to altered interaction with mutant huntingtin, the protein responsible for Huntington Disease (HD). HIP14 palmitoylates a specific set of neuronal substrates critical at the synapse, and downregulation of HIP14 by siRNA in vitro results in increased cell death in neurons. We previously reported that mice lacking murine Hip14 (Hip14-/-) share features of HD. In the current study, we have generated human HIP14 BAC transgenic mice and crossed them to the Hip14-/- model in order to confirm that the defects seen in Hip14-/- mice are in fact due to loss of Hip14. In addition, we sought to determine whether human HIP14 can provide functional compensation for loss of murine Hip14. We demonstrate that despite a relative low level of expression, as assessed via Western blot, BAC-derived human HIP14 compensates for deficits in neuropathology, behavior, and PAT enzyme function seen in the Hip14-/- model. Our findings yield important insights into HIP14 function in vivo.	[Young, Fiona B.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia	Young, FB (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Young, Fiona/0000-0002-3534-6875; Singaraja, Roshni/0000-0002-3418-3867	Canadian Institutes of Health Research-Institute of Genetics Walter; Jessie Boyd and Charles Scriver MD/PhD studentship [IMD 78843]; Michael Smith Foundation for Health Research as a Junior Trainee [ST-JGS-00607(06-1)]	Canadian Institutes of Health Research-Institute of Genetics Walter(Canadian Institutes of Health Research (CIHR)); Jessie Boyd and Charles Scriver MD/PhD studentship; Michael Smith Foundation for Health Research as a Junior Trainee	FBY is supported by the Canadian Institutes of Health Research-Institute of Genetics Walter and Jessie Boyd and Charles Scriver MD/PhD studentship (funding reference number IMD 78843; http://www.cihr-irsc.gc.ca). She has also received funding from the Michael Smith Foundation for Health Research as a Junior Trainee (Award Number: ST-JGS-00607(06-1) BM; http://www.msfhr.org/). MRH is a Killam University Professor and holds a Canada Research Chair in Human Genetics and Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2005, J NEUROSCI, V25, P6263, DOI 10.1523/JNEUROSCI.4757-04.2005; Bradley SV, 2007, HUM MOL GENET, V16, P1279, DOI 10.1093/hmg/ddm076; Chen JY, 2002, J BIOL CHEM, V277, P42588, DOI 10.1074/jbc.M205117200; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Cheung C, 2004, CANCER RES, V64, P3849, DOI 10.1158/0008-5472.CAN-04-0322; Coutinho JM, 2005, J LIPID RES, V46, P1113, DOI 10.1194/jlr.M400506-JLR200; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gong S., 2005, CURRENT PROTOCOLS NE, P1; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Lako M, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400001824; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manson AL, 1997, EMBO J, V16, P4238, DOI 10.1093/emboj/16.14.4238; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Roshon M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-2; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sidera C, 2005, PROTEOMICS, V5, P1533, DOI 10.1002/pmic.200401185; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Van Raamsdonk JM, 2007, BRAIN RES BULL, V72, P124, DOI 10.1016/j.brainresbull.2006.10.018; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	45	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36315	10.1371/journal.pone.0036315	http://dx.doi.org/10.1371/journal.pone.0036315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649491	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800008
J	Deakin, NO; Ballestrem, C; Turner, CE				Deakin, Nicholas O.; Ballestrem, Christoph; Turner, Christopher E.			Paxillin and Hic-5 Interaction with Vinculin Is Differentially Regulated by Rac1 and RhoA	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; PROTEIN-PROTEIN INTERACTIONS; FOCAL-ADHESION MATURATION; EARLY MOLECULAR EVENTS; CELL-MATRIX ADHESIONS; INTEGRIN ADHESOME; MIGRATING CELLS; PLASMA-MEMBRANE; TALIN BINDING	Cell migration is of paramount importance to organism development and maintenance as well as multiple pathological processes, including cancer metastasis. The RhoGTPases Rac1 and RhoA are indispensable for cell migration as they regulate cell protrusion, cell-extracellular matrix (ECM) interactions and force transduction. However, the consequences of their activity at a molecular level within the cell remain undetermined. Using a combination of FRET, FRAP and biochemical analyses we show that the interactions between the focal adhesion proteins vinculin and paxillin, as well as the closely related family member Hic-5 are spatially and reciprocally regulated by the activity of Rac1 and RhoA. Vinculin in its active conformation interacts with either paxillin or Hic-5 in adhesions in response to Rac1 and RhoA activation respectively, while inactive vinculin interacts with paxillin in the membrane following Rac1 inhibition. Additionally, Rac1 specifically regulates the dynamics of paxillin as well as its binding partner and F-actin interacting protein actopaxin (a-parvin) in adhesions. Furthermore, FRET analysis of protein: protein interactions within cell adhesions formed in 3D matrices revealed that, in contrast to 2D systems vinculin interacts preferentially with Hic-5. This study provides new insight into the complexity of cell-ECM adhesions in both 2D and 3D matrices by providing the first description of RhoGTPase-coordinated protein: protein interactions in a cellular microenvironment. These data identify discrete roles for paxillin and Hic-5 in Rac1 and RhoA-dependent cell adhesion formation and maturation; processes essential for productive cell migration.	[Deakin, Nicholas O.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; [Ballestrem, Christoph] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Manchester	Deakin, NO (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA.	turnerce@upstate.edu		Ballestrem, Christoph/0000-0002-5375-7985	National Institutes of Health [R01 GM47607, HL070244]; Susan G. Komen for the Cure; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM47607 and HL070244 (C.E.T.) and Susan G. Komen for the Cure Postdoctoral Fellowship (N.O.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bastiaens PIH, 1996, P NATL ACAD SCI USA, V93, P8407, DOI 10.1073/pnas.93.16.8407; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Deakin NO, 2009, J CELL SCI, V122, P1654, DOI 10.1242/jcs.049130; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Kotani H, 1997, ONCOGENE, V14, P1705, DOI 10.1038/sj.onc.1200998; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lele TP, 2008, BIOCHEM BIOPH RES CO, V369, P929, DOI 10.1016/j.bbrc.2008.02.137; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mierke CT, 2010, J BIOL CHEM; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nishiya N, 2002, J BIOCHEM, V132, P279, DOI 10.1093/oxfordjournals.jbchem.a003222; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pignatelli J, 2012, JCB; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Sun YS, 2011, CHEMPHYSCHEM, V12, P462, DOI 10.1002/cphc.201000664; Thomas SM, 1999, J CELL SCI, V112, P181; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; WOOD CK, 1994, J CELL SCI, V107, P709; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2001, J CELL SCI, V114, P3583; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	88	46	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37990	10.1371/journal.pone.0037990	http://dx.doi.org/10.1371/journal.pone.0037990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629471	Green Published, gold			2022-12-27	WOS:000305345300085
J	Gagliano, M; Renton, M; Duvdevani, N; Timmins, M; Mancuso, S				Gagliano, Monica; Renton, Michael; Duvdevani, Nili; Timmins, Matthew; Mancuso, Stefano			Out of Sight but Not out of Mind: Alternative Means of Communication in Plants	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; KIN RECOGNITION; BIOLOGICAL COMMUNICATION; COMPETITION; DEFENSE; PHYTOCHROME; GERMINATION; DISPERSAL; INTERPLAY; CAPSICUM	Current knowledge suggests that the mechanisms by which plants communicate information take numerous forms. Previous studies have focussed their attention on communication via chemicals, contact and light; other methods of interaction between plants have remained speculative. In this study we tested the ability of young chilli plants to sense their neighbours and identify their relatives using alternative mechanism(s) to recognised plant communication pathways. We found that the presence of a neighbouring plant had a significant influence on seed germination even when all known sources of communication signals were blocked. Furthermore, despite the signalling restriction, seedlings allocated energy to their stem and root systems differently depending on the identity of the neighbour. These results provide clear experimental evidence for the existence of communication channels between plants beyond those that have been recognized and studied thus far.	[Gagliano, Monica; Duvdevani, Nili] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia; [Gagliano, Monica] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, Australia; [Gagliano, Monica; Renton, Michael] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Renton, Michael] CSIRO Ecosyst Sci, Floreat, Australia; [Timmins, Matthew] Univ Western Australia, Autralian Res Ctr ARC Ctr Excellence, Crawley, Australia; [Mancuso, Stefano] Univ Florence, Int Lab Plant Neurobiol, Dept Plant Soil & Environm Sci, Sesto, Italy	University of Western Australia; University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Florence	Gagliano, M (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia.	monica.gagliano@uwa.edu.au	Renton, Michael/A-9979-2011; Gagliano, Monica/A-3129-2012; Mancuso, Stefano/G-6515-2012	Renton, Michael/0000-0003-1316-0145; Gagliano, Monica/0000-0002-2414-6990; Mancuso, Stefano/0000-0003-1752-3986	UWA Postdoctoral Research Fellowship	UWA Postdoctoral Research Fellowship	This study was supported by a UWA Postdoctoral Research Fellowship to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aphalo PJ, 1999, J EXP BOT, V50, P1629, DOI 10.1093/jexbot/50.340.1629; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Ballare CL, 1997, FUNCT ECOL, V11, P441, DOI 10.1046/j.1365-2435.1997.00108.x; BALLARE CL, 1991, OECOLOGIA, V86, P561, DOI 10.1007/BF00318323; BALUSKA F, 2005, COMMUNICATION PLANTS; Baluska F, 2007, PLANT SIGNAL BEHAV, V2, P205, DOI 10.4161/psb.2.4.4550; Bates D, LME4 LINEAR MIXED EF; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carazo P, 2010, J EVOLUTION BIOL, V23, P661, DOI 10.1111/j.1420-9101.2010.01944.x; Collins B, 2000, ANN BOT-LONDON, V86, P739, DOI 10.1006/anbo.2000.1233; Dicke M, 2003, TRENDS PLANT SCI, V8, P403, DOI 10.1016/S1360-1385(03)00183-3; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Gagliano M, GREEN SYMPH IN PRESS; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; GEBER MA, 1989, ECOL MONOGR, V59, P267, DOI 10.2307/1942602; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Gregg RB, 1943, BIODYNAMICS, V3, P1; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2010, AM NAT, V176, P381, DOI 10.1086/655222; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kazan K, 2011, J EXP BOT, V62, P4087, DOI 10.1093/jxb/err142; Kelly JK, 1996, AM NAT, V147, P899, DOI 10.1086/285885; Murphy GP, 2007, J ECOL, V95, P261, DOI 10.1111/j.1365-2745.2007.01217.x; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Orrock JL, 2010, AM J BOT, V97, P694, DOI 10.3732/ajb.0900051; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Tielborger K, 2009, OIKOS, V118, P792, DOI 10.1111/j.1600-0706.2008.17175.x; Trewavas A, 2003, ANN BOT-LONDON, V92, P1, DOI 10.1093/aob/mcg101; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543	45	49	50	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37382	10.1371/journal.pone.0037382	http://dx.doi.org/10.1371/journal.pone.0037382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629387	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300036
J	Huang, WL; Lin, YH; Kuo, TBJ; Chang, LR; Chen, YZ; Yang, CCH				Huang, Wei-Lieh; Lin, Yu-Hsuan; Kuo, Terry B. J.; Chang, Li-Ren; Chen, Ying-Zai; Yang, Cheryl C. H.			Methadone-Mediated Autonomic Functioning of Male Patients with Heroin Dependence: The Influence of Borderline Personality Pattern	PLOS ONE			English	Article							OPIATE TREATMENT INDEX; POLYVAGAL THEORY; DISORDER; TEMPERAMENT; QUESTIONNAIRE; USERS; RISK; RELIABILITY; CHARACTER; OUTCOMES	Background: We hypothesize that the population with borderline personality shows different autonomic response to methadone compared to individuals with other personalities. This study applies heart rate variability (HRV) measurements and the Tridimensional Personality Questionnaire (TPQ) to examine this hypothesis. Methodology/Principal Findings: Forty-four male patients with heroin dependence were recruited from a methadone maintenance treatment program. Eight personality patterns were classified according to the TPQ norm used in Taiwan. The borderline pattern (BP, composed of high novelty seeking, high harm avoidance and low reward dependence) and the other personality patterns (OP) were separated into two groups. We compared the HRV profiles between the BP and OP groups. Correlation and regression analysis were performed to clarify relationship between HRV differences and the borderline index (BI, a new concept defined by us, which is calculated as novelty seeking + harm avoidance - reward dependence). The HRV targets investigated included low frequency (LF) power, high frequency (HF) power, total power (TP), normalized LF (LF%), and LF/HF. No baseline HRV parameters showed any inter-group difference. The BP group had a significantly lower Delta HF and a higher Delta LF/HF than the OP group. The personality dimension, reward dependence, showed a negative correlation with Delta LF/HF and Delta LF%. BI was negatively correlated with Delta HF and positively correlated with Delta LF/HF and Delta LF%. Conclusions/Significance: Borderline personality individuals show increased sympathetic activity and decreased parasympathetic activity compared to other personalities after taking methadone. The results support the hypothesis that there is an interaction between borderline personality and autonomic modulation.	[Huang, Wei-Lieh; Lin, Yu-Hsuan; Chang, Li-Ren; Chen, Ying-Zai] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Yunlin, Taiwan; [Huang, Wei-Lieh; Lin, Yu-Hsuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Huang, Wei-Lieh; Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Kuo, Terry B. J.] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University	Huang, WL (corresponding author), Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Yunlin, Taiwan.	cchyang@ym.edu.tw	Huang, Wei-Lieh/AAB-4851-2022	CHANG, LI-REN/0000-0003-0853-3904	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL.99N015]; National Science Council (Taiwan) [NSC 100-2627-B-010-002]; Ministry of Education, Aim for the Top University Plan [100AC-B3]	National Taiwan University Hospital, Yun-Lin Branch; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by a grant (NTUHYL.99N015) from National Taiwan University Hospital, Yun-Lin Branch, and a grant (NSC 100-2627-B-010-002) from the National Science Council (Taiwan), and a grant (100AC-B3) from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelekan M, 1996, DRUG ALCOHOL REV, V15, P261, DOI 10.1080/09595239600186001; Adelekan M, 1996, DRUG ALCOHOL REV, V15, P65, DOI 10.1080/09595239600185681; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anthony James C., 1995, P361; Austin MA, 2007, BRAIN COGNITION, V65, P69, DOI 10.1016/j.bandc.2006.05.007; Barnow S, 2007, PSYCHOPATHOLOGY, V40, P369, DOI 10.1159/000106467; Bejerot S, 1998, ACTA PSYCHIAT SCAND, V98, P243, DOI 10.1111/j.1600-0447.1998.tb10075.x; Bleil ME, 2008, PSYCHOSOM MED, V70, P328, DOI 10.1097/PSY.0b013e31816baefa; Camm AJ, 1996, EUR HEART J, V17, P354; Chang LR, 2012, PROG NEURO-PSYCHOPH, V37, P188, DOI 10.1016/j.pnpbp.2012.01.006; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Darke S, 2005, ADDICTION, V100, P1121, DOI 10.1111/j.1360-0443.2005.01123.x; Darke S, 2004, DRUG ALCOHOL DEPEN, V74, P77, DOI 10.1016/j.drugalcdep.2003.12.002; Darke S, 2007, ADDICTION, V102, P1140, DOI 10.1111/j.1360-0443.2007.01876.x; Deering DEA, 1996, DRUG ALCOHOL REV, V15, P57, DOI 10.1080/09595239600185671; Dijkstra BAG, 2007, EUR ADDICT RES, V13, P81, DOI 10.1159/000097937; Dishman RK, 2000, INT J PSYCHOPHYSIOL, V37, P121, DOI 10.1016/S0167-8760(00)00085-4; Jariani M, 2010, PSYCHIAT DANUB, V22, P544; JENKINS WO, 1950, PSYCHOL BULL, V47, P193, DOI 10.1037/h0060772; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lee TSH, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-6; Linehan M M, 1993, NIDA Res Monogr, V137, P201; Maggini C, 2000, COMPR PSYCHIAT, V41, P426, DOI 10.1053/comp.2000.16559; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Moldovanova I, 2008, HYPERTENSION, V51, P1203, DOI 10.1161/HYPERTENSIONAHA.107.107433; Moran P, 2007, J CLIN PSYCHIAT, V68, P69, DOI 10.4088/JCP.v68n0109; Ode S, 2010, EMOTION, V10, P536, DOI 10.1037/a0018698; Parker AG, 2006, PSYCHOL PSYCHOTHER-T, V79, P309, DOI 10.1348/147608305X70072; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Raby WN, 2006, DRUG ALCOHOL DEPEN, V81, P283, DOI 10.1016/j.drugalcdep.2005.07.008; Selby EA, 2009, REV GEN PSYCHOL, V13, P219, DOI 10.1037/a0015687; SHEK DTL, 1990, J CLIN PSYCHOL, V46, P35, DOI 10.1002/1097-4679(199001)46:1<35::AID-JCLP2270460106>3.0.CO;2-W; Stenbacka M, 2004, J PSYCHOACTIVE DRUGS, V36, P227, DOI 10.1080/02791072.2004.10399733; Svrakic DM, 2002, ACTA PSYCHIAT SCAND, V106, P189, DOI 10.1034/j.1600-0447.2002.02196.x; Weinberg A, 2009, BRAIN COGNITION, V71, P279, DOI 10.1016/j.bandc.2009.07.014; 1998, JAMA, V280, P1936, DOI DOI 10.1001/JAMA.280.22.1936	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37464	10.1371/journal.pone.0037464	http://dx.doi.org/10.1371/journal.pone.0037464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629400	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300043
J	Shao, J; Tian, LC; Lei, B; Wei, L; Yang, Y; Kijlstra, A; Yang, PZ				Shao, Ju; Tian, Lichun; Lei, Bo; Wei, Lin; Yang, Yan; Kijlstra, Aize; Yang, Peizeng			AAV2-Mediated Subretinal Gene Transfer of mIL-27p28 Attenuates Experimental Autoimmune Uveoretinitis in Mice	PLOS ONE			English	Article							VIRUS-INDUCED GENE-3; ADENOASSOCIATED VIRUS; CHRONIC UVEITIS; INTERLEUKIN-27; THERAPY; CELLS; IL-27; INFLAMMATION; INHIBITION; INFECTION	Background: Advances in gene transfer techniques have provided long-term, safe and stable transduction of retinal cells following subretinal injection with adeno-associated viral (AAV) vectors. In this study we investigated whether subretinal injection of AAV2-murine IL-27p28 vector was effective in inhibiting experimental autoimmune uveoretinitis (EAU) induced in B10RIII mice. Methodology/Principal Findings: An AAV2 vector encoding the murine IL-27p28 gene (rAAV2-CMV-mIL-27p28) was prepared and subretinally injected into B10RIII mice (4.35x10(8) vector genome (v. g.)). AAV2 vector mediating green fluorescent protein (rAAV2-CMV-GFP) served as a control (5x10(8) v.g.). The concentration of mIL-27p28 in homogenized eyes and serum was assayed by enzyme linked immunosorbent assay (ELISA) after subretinal injection. Human IRBP161-180 peptide and Complete Freund's Adjuvant were injected into mice receiving either the rAAV2-CMV-mIL-27p28 or rAAV2-CMV-GFP vector. EAU was evaluated clinically and pathologically. The level of IL-17 and IL-10 in homogenized eyes was measured on day 12 and day 21 following immunization. Delayed type hypersensitivity (DTH) and IRBP161-180-specific proliferation of lymphocytes from the spleen and lymph nodes were assayed to examine the influence of the subretinal delivery of rAAV2-CMV-mIL-27p28 on the systemic immune response. IL-27p28 was detectable by ELISA within the eyes from two weeks following subretinal injection of the rAAV2-CMV-mIL-27p28 vector and showed a sustained high expression from day 14 to 9 months with a highest expression at 5 months. Subretinal injection of the vector significantly attenuated the severity of EAU disease clinically and pathologically in association with a significantly decreased IL-17 expression and an increased IL-10 expression. The IL-27p28 vector did not affect the systemic immune response, as determined by DTH and IRBP161-180-specific lymphocyte proliferation. Conclusions/Significance: A high and stable expression of IL-27p28 was observed for at least 9 months following subretinal delivery of rAAV2-CMV-mIL-27p28. The amelioration of EAU disease severity was associated with a decreased IL-17 expression and an increased IL-10 expression.	[Shao, Ju; Tian, Lichun; Lei, Bo; Wei, Lin; Yang, Yan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing Eye Inst, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013	Lei, Bo/0000-0002-5497-0905	Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; National Natural Science Foundation Project [30973242]; National Natural Science Foundation of China [81070722]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Fund for PAR-EU Scholars Program	Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Key Project of Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation Project of CQ CSTC); National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Fund for PAR-EU Scholars Program	This work was supported by Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), http://www.ctin.ac.cn/View.aspx?id = 14380; Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), http://www.ctin.ac.cn/Class.aspx?clsId = 226; National Natural Science Foundation Project (30973242), http://159.226.244.22/portal/proj_search.asp; National Natural Science Foundation of China (81070722), http://159.226.244.22/portal/proj_search.asp; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000; Fund for PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barker SE, 2009, J GENE MED, V11, P486, DOI 10.1002/jgm.1327; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Broderick CA, 2005, MOL THER, V12, P369, DOI 10.1016/j.ymthe.2005.03.018; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Dick AD, 1997, BRIT J OPHTHALMOL, V81, P1107, DOI 10.1136/bjo.81.12.1107; Edelsten C, 2003, AM J OPHTHALMOL, V135, P676, DOI 10.1016/S0002-9394(02)02148-7; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jankowski M, 2010, ARCH IMMUNOL THER EX, V58, P417, DOI 10.1007/s00005-010-0098-6; Lai YKY, 2002, GENE THER, V9, P804, DOI 10.1038/sj.gt.3301695; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Lei B, 2009, MOL VIS, V15, P1374; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; NUSSENBLATT RB, 1983, LANCET, V2, P235; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Reeves SW, 2006, OPHTHALMOLOGY, V113, P302, DOI 10.1016/j.ophtha.2005.10.008; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Tian LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019542; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145	38	6	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37773	10.1371/journal.pone.0037773	http://dx.doi.org/10.1371/journal.pone.0037773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629453	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300076
J	Graves, JA; Wang, YD; Sims-Lucas, S; Cherok, E; Rothermund, K; Branca, MF; Elster, J; Beer-Stolz, D; Van Houten, B; Vockley, J; Prochownik, EV				Graves, J. Anthony; Wang, Yudong; Sims-Lucas, Sunder; Cherok, Edward; Rothermund, Kristi; Branca, Maria F.; Elster, Jennifer; Beer-Stolz, Donna; Van Houten, Bennett; Vockley, Jerry; Prochownik, Edward V.			Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc	PLOS ONE			English	Article							TARGETED HOMOLOGOUS RECOMBINATION; CHLOROMETHYL-X-ROSAMINE; CELL-CYCLE ENTRY; MAMMALIAN-CELLS; IN-VIVO; GLUTAMATE EXCITOTOXICITY; PERMEABILITY TRANSITION; GENOMIC INSTABILITY; METABOLIC NETWORKS; PROTEIN DRP1	Although the c-Myc (Myc) oncoprotein controls mitochondrial biogenesis and multiple enzymes involved in oxidative phosphorylation (OXPHOS), the coordination of these events and the mechanistic underpinnings of their regulation remain largely unexplored. We show here that re-expression of Myc in myc-/- fibroblasts is accompanied by a gradual accumulation of mitochondrial biomass and by increases in membrane polarization and mitochondrial fusion. A correction of OXPHOS deficiency is also seen, although structural abnormalities in electron transport chain complexes (ETC) are not entirely normalized. Conversely, the down-regulation of Myc leads to a gradual decrease in mitochondrial mass and a more rapid loss of fusion and membrane potential. Increases in the levels of proteins specifically involved in mitochondrial fission and fusion support the idea that Myc affects mitochondrial mass by influencing both of these processes, albeit favoring the latter. The ETC defects that persist following Myc restoration may represent metabolic adaptations, as mitochondrial function is re-directed away from producing ATP to providing a source of metabolic precursors demanded by the transformed cell.	[Graves, J. Anthony; Cherok, Edward; Rothermund, Kristi; Elster, Jennifer; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA 15213 USA; [Wang, Yudong; Vockley, Jerry] UPMC, Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA USA; [Sims-Lucas, Sunder] UPMC, Childrens Hosp Pittsburgh, Div Nephrol, Pittsburgh, PA USA; [Branca, Maria F.] UPMC, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Beer-Stolz, Donna] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Beer-Stolz, Donna] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA; [Van Houten, Bennett; Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Graves, JA (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA 15213 USA.	gravja@chp.edu	Van Houten, Bennett/K-2284-2019; Vockley, Jerry/B-5210-2016; Vockley, Jerry/AAF-8523-2020; Wang, Yudong/ABG-1086-2021	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Wang, Yudong/0000-0003-3224-4555; Sims-Lucas, Sunder/0000-0003-1908-4809	Harold Amos Medical Faculty Development Program; Robert Wood Johnson Foundation; Hyundai Hope on Wheels Scholarship; Public Health Service [R01 DYKE 8775]; University of Pittsburgh Cancer Institute; Commonwealth Universal Research Enhancement (C.U.R.E.) Program; Pennsylvania Settlement Fund; National Institutes of Health [CA140624, CA78259]; NATIONAL CANCER INSTITUTE [R01CA078259, R01CA140624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	Harold Amos Medical Faculty Development Program; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Hyundai Hope on Wheels Scholarship; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Pittsburgh Cancer Institute; Commonwealth Universal Research Enhancement (C.U.R.E.) Program; Pennsylvania Settlement Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: JAG was supported by the Harold Amos Medical Faculty Development Program sponsored by the Robert Wood Johnson Foundation and the Hyundai Hope on Wheels Scholarship, JV and YW were supported in part by Public Health Service grant R01 DYKE 8775, BVH was supported by The University of Pittsburgh Cancer Institute and Commonwealth Universal Research Enhancement (C.U.R.E.) Program, Pennsylvania Settlement Fund, and EVP was supported by National Institutes of Health grants CA140624 and CA78259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chung HJ, 2005, MOL CELLS, V20, P157; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Fukazawa T, 2010, ANTICANCER RES, V30, P4193; Gilmore K, 1999, CYTOMETRY, V36, P355, DOI 10.1002/(SICI)1097-0320(19990801)36:4<355::AID-CYTO11>3.0.CO;2-9; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Graves JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013717; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isenberg JS, 2000, TOXICOL SCI, V53, P340, DOI 10.1093/toxsci/53.2.340; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Prachar J, 2003, GEN PHYSIOL BIOPHYS, V22, P525; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; PROUTY SM, 1993, ONCOGENE, V8, P899; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SPIEGELMAN BM, 2007, FND S, V287, P60, DOI DOI 10.1002/9780470725207.CH5; SPIEGELMAN BM, 2007, FND S, V287, P63; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; WANG YD, 1995, BIOCHEMISTRY-US, V34, P7476, DOI 10.1021/bi00022a022; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang H, 1997, J BIOL CHEM, V272, P17416, DOI 10.1074/jbc.272.28.17416; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang SXL, 2009, AM J RESP CELL MOL, V40, P332, DOI 10.1165/rcmb.2008-0003OC; Zinchuk Vadim, 2011, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s52; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	73	84	84	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37699	10.1371/journal.pone.0037699	http://dx.doi.org/10.1371/journal.pone.0037699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629444	Green Accepted, Green Published, gold			2022-12-27	WOS:000305343100047
J	Jarosinski, KW				Jarosinski, Keith W.			Dual Infection and Superinfection Inhibition of Epithelial Skin Cells by Two Alphaherpesviruses Co-Occur in the Natural Host	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; VARICELLA-ZOSTER-VIRUS; U(L)13 PROTEIN-KINASE; HERPES-SIMPLEX-VIRUS; SCID-HU MOUSE; PSEUDORABIES VIRUS; HORIZONTAL TRANSMISSION; GENETIC-RECOMBINATION; BOVINE HERPESVIRUS-1; VACCINE STRAINS	Hosts can be infected with multiple herpesviruses, known as superinfection; however, superinfection of cells is rare due to the phenomenon known as superinfection inhibition. It is believed that dual infection of cells occurs in nature, based on studies examining genetic exchange between homologous alphaherpesviruses in the host, but to date, this has not been directly shown in a natural model. In this report, gallid herpesvirus 2 (GaHV-2), better known as Marek's disease virus (MDV), was used in its natural host, the chicken, to determine whether two homologous alphaherpesviruses can infect the same cells in vivo. MDV shares close similarities with the human alphaherpesvirus, varicella zoster virus (VZV), with respect to replication in the skin and exit from the host. Recombinant MDVs were generated that express either the enhanced GFP (eGFP) or monomeric RFP (mRFP) fused to the UL47 (VP13/14) herpesvirus tegument protein. These viruses exhibited no alteration in pathogenic potential and expressed abundant UL47-eGFP or -mRFP in feather follicle epithelial cells in vivo. Using laser scanning confocal microscopy, it was evident that these two similar, but distinguishable, viruses were able to replicate within the same cells of their natural host. Evidence of superinfection inhibition was also observed. These results have important implications for two reasons. First, these results show that during natural infection, both dual infection of cells and superinfection inhibition can co-occur at the cellular level. Secondly, vaccination against MDV with homologous alphaherpesvirus like attenuated GaHV-2, or non-oncogenic GaHV-3 or meleagrid herpesvirus (MeHV-1) has driven the virus to greater virulence and these results implicate the potential for genetic exchange between homologous avian alphaherpesviruses that could drive increased virulence. Because the live attenuated varicella vaccine is currently being administered to children, who in turn could be superinfected by wild-type VZV, this could potentiate recombination events of VZV as well.	[Jarosinski, Keith W.] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY USA	Cornell University	Jarosinski, KW (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	keith-jarosinski@uiowa.edu		Jarosinski, Keith/0000-0002-0391-9018	Public Health Service (PHS) [5RO1CA127238]; Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2010-65119-20493]; National Science Foundation (NSF) [NSF DBI-0618969]; TRIAD Foundation; NATIONAL CANCER INSTITUTE [R01CA127238] Funding Source: NIH RePORTER	Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture; National Science Foundation (NSF)(National Science Foundation (NSF)); TRIAD Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This report was supported by Public Health Service (PHS) grant 5RO1CA127238 and Agriculture and Food Research Initiative Competitive Grant no. 2010-65119-20493 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture. Dr. Jarosinski is grateful to the Plant Cell Imaging Center (PCIC) at the Boyce Thompson Institute for Plant Research for providing use of their Olympus SZX-12 Stereoscope that was purchased with an award from National Science Foundation (NSF) (NSF DBI-0618969). PCIC is supported by a grant from the TRIAD Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arvin AM, 2010, CURR TOP MICROBIOL, V342, P189, DOI 10.1007/82_2010_29; Baigent SJ, 2006, VET IMMUNOL IMMUNOP, V112, P78, DOI 10.1016/j.vetimm.2006.03.014; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Breuer J, 2010, J GEN VIROL, V91, P821, DOI 10.1099/vir.0.017814-0; Calnek BW, 2001, CURR TOP MICROBIOL, V255, P25; Card JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021141; Chbab N, 2010, VET RES, V41, DOI 10.1051/vetres/2010026; CHRISTEN L, 1990, VIROLOGY, V174, P35, DOI 10.1016/0042-6822(90)90051-R; CHRISTENSEN LS, 1993, ARCH VIROL, V132, P37, DOI 10.1007/BF01309842; COCKLEY KD, 1988, J VIROL, V62, P188, DOI 10.1128/JVI.62.1.188-195.1988; DANGLER CA, 1993, AM J VET RES, V54, P540; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; DOHNER DE, 1988, J MED VIROL, V24, P329, DOI 10.1002/jmv.1890240310; Dunn JR, 2010, AVIAN DIS, V54, P1038, DOI 10.1637/9348-033010-Reg.1; EIDSON CS, 1971, J NATL CANCER I, V47, P113; Gershon AA, 2001, ARCH VIR S, V17, P1; Gimeno IM, 2008, VACCINE, V26, pC31, DOI 10.1016/j.vaccine.2008.04.009; GLAZENBURG KL, 1994, VIRUS RES, V34, P115, DOI 10.1016/0168-1702(94)90094-9; GLAZENBURG KL, 1995, ARCH VIROL, V140, P671, DOI 10.1007/BF01309957; Han MG, 2001, VET MICROBIOL, V83, P321, DOI 10.1016/S0378-1135(01)00423-0; HENDERSON LM, 1990, AM J VET RES, V51, P1656; HENDERSON LM, 1991, AM J VET RES, V52, P820; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; HUTCHISON CA, 1971, J VIROL, V8, P121, DOI 10.1128/JVI.8.1.121-124.1971; Jarosinski KW, 2007, J VIROL, V81, P10575, DOI 10.1128/JVI.01065-07; Jarosinski KW, 2006, EXPERT REV VACCINES, V5, P761, DOI 10.1586/14760584.5.6.761; Jarosinski KW, 2012, J VIROL, V86, P2428, DOI 10.1128/JVI.06719-11; Jarosinski KW, 2010, J VIROL, V84, P7911, DOI 10.1128/JVI.00433-10; Jarosinski KW, 2005, J VIROL, V79, P11647, DOI 10.1128/JVI.79.18.11647-11659.2005; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; Katz J B, 1990, J Vet Diagn Invest, V2, P135; Kaufer BB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002333; KLIEM M, 1989, VIROLOGY, V171, P350, DOI 10.1016/0042-6822(89)90602-8; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; MCALLISTER WT, 1977, J VIROL, V24, P709, DOI 10.1128/JVI.24.2.709-711.1977; Meurens F, 2004, J VIROL, V78, P3872, DOI 10.1128/JVI.78.8.3872-3879.2004; Moffat JF, 1998, J VIROL, V72, P965, DOI 10.1128/JVI.72.2.965-974.1998; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; Muller T, 2011, ARCH VIROL, V156, P1691, DOI 10.1007/s00705-011-1080-2; NISHIYAMA Y, 1991, J VIROL, V65, P4520, DOI 10.1128/JVI.65.8.4520-4524.1991; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Parcells MS, 1999, J VIROL, V73, P1362, DOI 10.1128/JVI.73.2.1362-1373.1999; Schat K.A., 2008, LAB MANUAL IDENTIFIC, V5th ed., P195; Schmidt-Chanasit J, 2011, INFECT GENET EVOL, V11, P1, DOI 10.1016/j.meegid.2010.08.014; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Schynts F, 2003, J VIROL, V77, P12535, DOI 10.1128/JVI.77.23.12535-12542.2003; SHIRAKI K, 1991, J MED VIROL, V33, P128, DOI 10.1002/jmv.1890330212; SIMON KO, 1990, VIROLOGY, V177, P375, DOI 10.1016/0042-6822(90)90494-C; SUSSKIND MM, 1974, VIROLOGY, V62, P367, DOI 10.1016/0042-6822(74)90399-7; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; WITTER RL, 1971, AVIAN DIS, V15, P346, DOI 10.2307/1588707; Witter RL, 2001, CURR TOP MICROBIOL, V255, P57	56	20	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37428	10.1371/journal.pone.0037428	http://dx.doi.org/10.1371/journal.pone.0037428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629393	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100027
J	Edri-Brami, M; Rosental, B; Hayoun, D; Welt, M; Rosen, H; Wirguin, I; Nefussy, B; Drory, VE; Porgador, A; Lichtenstein, RG				Edri-Brami, Meital; Rosental, Benyamin; Hayoun, Dana; Welt, Michael; Rosen, Hila; Wirguin, Itzhak; Nefussy, Beatrice; Drory, Vivian E.; Porgador, Angel; Lichtenstein, Rachel G.			Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells	PLOS ONE			English	Article							SPINAL-CORD; ANTIINFLAMMATORY ACTIVITY; GLYCOSYLATION PATTERN; DISEASE PROGRESSION; EFFECTOR FUNCTIONS; IMMUNE-RESPONSES; MOTOR CORTEX; ALS PATIENTS; MOUSE MODEL; NK CELLS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by degeneration of upper and lower motor neurons. To date, glycosylation patterns of glycoproteins in fluids of ALS patients have not been described. Moreover, the aberrant glycosylation related to the pathogenesis of other neurodegenerative diseases encouraged us to explore the glycome of ALS patient sera. We found high levels of sialylated glycans and low levels of core fucosylated glycans in serum-derived N-glycans of patients with ALS, compared to healthy volunteer sera. Based on these results, we analyzed the IgG Fc N-297 -glycans, as IgG are major serum glycoproteins affected by sialylation or core fucosylation and are found in the motor cortex of ALS patients. The analyses revealed a distinct glycan, A2BG2, in IgG derived from ALS patient sera (ALS-IgG). This glycan increases the affinity of IgG to CD16 on effector cells, consequently enhancing Antibody-Dependent Cellular Cytotoxicity (ADCC). Therefore, we explore whether the Fc-N-297-glycans of IgG may be involved in ALS disease. Immunostaining of brain and spinal cord tissues revealed over-expression of CD16 and co-localization of intact ALS-IgG with CD16 and in brain with activated microglia of G93A-SOD1 mice. Intact ALS-IgG enhanced effector cell activation and ADCC reaction in comparison to sugar-depleted or control IgG. ALS-IgG were localized in the synapse between brain microglia and neurons of G93A-SOD1 mice, manifesting a promising in vivo ADCC reaction. Therefore, glycans of ALS-IgG may serve as a biomarker for the disease and may be involved in neuronal damage.	[Edri-Brami, Meital; Hayoun, Dana; Rosen, Hila; Lichtenstein, Rachel G.] Ben Gurion Univ Negev, Fac Engn, Avram & Stella Goren Goldstein Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Rosental, Benyamin; Welt, Michael; Porgador, Angel] Ben Gurion Univ Negev, Canc Res Ctr, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Rosental, Benyamin; Welt, Michael; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; [Wirguin, Itzhak] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurol, Beer Sheva, Israel; [Nefussy, Beatrice; Drory, Vivian E.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Nefussy, Beatrice; Drory, Vivian E.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Edri-Brami, M (corresponding author), Ben Gurion Univ Negev, Fac Engn, Avram & Stella Goren Goldstein Dept Biotechnol En, IL-84105 Beer Sheva, Israel.	ruha@bgu.ac.il	Rosental, Benyamin/X-5400-2019	Rosental, Benyamin/0000-0002-3974-3296; Porgador, Angel/0000-0003-1540-4449; Lichtenstein, Rachel/0000-0002-2225-1068	European Union [FP6 lifesciheal-7-037661]; IsrALS organization [IsrALS2083]	European Union(European Commission); IsrALS organization	This work was supported by the European Union's Sixth Research Framework Programme (FP6 lifesciheal-7-037661) and by the IsrALS organization (IsrALS2083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P601, DOI 10.1016/j.cbpa.2009.08.015; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Appel SH, 1996, CLIN NEUROSCI, V3, P368; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Avidan A, 2009, GLYCOCONJUGATE J, V26, P1181, DOI 10.1007/s10719-009-9238-9; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Brettschneider J, 2008, NEUROCHEM RES, V33, P2358, DOI 10.1007/s11064-008-9742-5; Brettschneider J, 2010, NEUROSCI LETT, V468, P23, DOI 10.1016/j.neulet.2009.10.053; Cohen M, 2010, J IMMUNOL, V185, P5869, DOI 10.4049/jimmunol.1001635; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; Couratier P, 1998, J NEUROL SCI, V154, P137, DOI 10.1016/S0022-510X(97)00219-0; Demestre M, 2005, J NEUROCHEM, V94, P268, DOI 10.1111/j.1471-4159.2005.03184.x; DONNENFELD H, 1984, J NEUROIMMUNOL, V6, P51, DOI 10.1016/0165-5728(84)90042-0; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAWASHIMA I, 1990, J BIOCHEM-TOKYO, V108, P109, DOI 10.1093/oxfordjournals.jbchem.a123148; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lev N, 2009, J MOL NEUROSCI, V38, P94, DOI 10.1007/s12031-008-9138-7; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Polymenidou M, 2008, NATURE, V454, P284, DOI 10.1038/454284a; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Routier FH, 1997, GLYCOCONJUGATE J, V14, P201, DOI 10.1023/A:1018589704981; RUDD PM, 1991, MOL IMMUNOL, V28, P1369, DOI 10.1016/0161-5890(91)90039-M; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; SCHOLL PR, 1992, J IMMUNOL, V149, P1751; Schuster M, 2005, CANCER RES, V65, P7934, DOI 10.1158/0008-5472.CAN-04-4212; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Sengun IS, 2003, J NEUROIMMUNOL, V142, P137, DOI 10.1016/S0165-5728(03)00263-7; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Silveyra MX, 2006, J NEUROCHEM, V96, P97, DOI 10.1111/j.1471-4159.2005.03514.x; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Tzur Y, 2008, J PROTEOME RES, V7, P1188, DOI 10.1021/pr070392+; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5	51	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e35772	10.1371/journal.pone.0035772	http://dx.doi.org/10.1371/journal.pone.0035772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666317	Green Published, Green Submitted, gold			2022-12-27	WOS:000305353400005
J	Eren, MI; Chao, A; Hwang, WH; Colwell, RK				Eren, Metin I.; Chao, Anne; Hwang, Wen-Han; Colwell, Robert K.			Estimating the Richness of a Population When the Maximum Number of Classes Is Fixed: A Nonparametric Solution to an Archaeological Problem	PLOS ONE			English	Article							DIVERSITY; CLASSIFICATION; BIODIVERSITY; CONSISTENCY; RAREFACTION; TYPOLOGY; MIDDLE	Background: Estimating assemblage species or class richness from samples remains a challenging, but essential, goal. Though a variety of statistical tools for estimating species or class richness have been developed, they are all singly-bounded: assuming only a lower bound of species or classes. Nevertheless there are numerous situations, particularly in the cultural realm, where the maximum number of classes is fixed. For this reason, a new method is needed to estimate richness when both upper and lower bounds are known. Methodology/Principal Findings: Here, we introduce a new method for estimating class richness: doubly-bounded confidence intervals (both lower and upper bounds are known). We specifically illustrate our new method using the Chao1 estimator, rarefaction, and extrapolation, although any estimator of asymptotic richness can be used in our method. Using a case study of Clovis stone tools from the North American Lower Great Lakes region, we demonstrate that singly-bounded richness estimators can yield confidence intervals with upper bound estimates larger than the possible maximum number of classes, while our new method provides estimates that make empirical sense. Conclusions/Significance: Application of the new method for constructing doubly-bound richness estimates of Clovis stone tools permitted conclusions to be drawn that were not otherwise possible with singly-bounded richness estimates, namely, that Lower Great Lakes Clovis Paleoindians utilized a settlement pattern that was probably more logistical in nature than residential. However, our new method is not limited to archaeological applications. It can be applied to any set of data for which there is a fixed maximum number of classes, whether that be site occupancy models, commercial products (e. g. athletic shoes), or census information (e. g. nationality, religion, age, race).	[Eren, Metin I.] Univ Kent, Dept Anthropol, Canterbury, Kent, England; [Chao, Anne] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Hwang, Wen-Han] Natl Chung Hsing Univ, Inst Stat, Taichung 40227, Taiwan; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	University of Kent; National Tsing Hua University; National Chung Hsing University; University of Connecticut	Eren, MI (corresponding author), Univ Kent, Dept Anthropol, Canterbury, Kent, England.	metin.i.eren@gmail.com	Colwell, Robert K/C-7276-2015					Baxter MJ, 2001, AM ANTIQUITY, V66, P715, DOI 10.2307/2694184; Bettinger R., 1991, HUNTER GATHERERS ARC; Bisson MS, 2000, J ARCHAEOL METHOD TH, V7, P1, DOI 10.1023/A:1009578011590; Bradley J. W., 2008, ARCHAEOLOGY E N AM, V36, P119; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; Chao A, 2006, AUST NZ J STAT, V48, P117, DOI 10.1111/j.1467-842X.2006.00430.x; Cochrane GWG, 2003, J ARCHAEOL SCI, V30, P837, DOI 10.1016/S0305-4403(02)00262-5; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Dunnell R.C., 1971, SYSTEMATICS PREHISTO; Eerkens JW, 2007, AM ANTIQUITY, V72, P585, DOI 10.2307/40035862; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellis C, 1988, MIDCONTINENTAL J ARC, V13, P111; Eren, 2011, THESIS SO METHODIST; Eren M. I., 2011, OPEN ANTHR J, V4, P40, DOI [10.2174/1874912701104010040, DOI 10.2174/1874912701104010040]; Eren MI, 2011, MIDCONT J ARCHAEOL, V36, P173, DOI 10.1179/mca.2011.009; FISH PR, 1978, AM ANTIQUITY, V43, P86, DOI 10.2307/279635; Gotelli N. J., 2012, ENCY BIODIVERSITY; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grayson DK, 1998, J ARCHAEOL SCI, V25, P927, DOI 10.1006/jasc.1997.0273; Grismer JL, 2010, ZOOTAXA, P47; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jackson L, 1998, CURRENT RES PLEISTOC, V15, P23; Kaufman D, 1998, AM ANTIQUITY, V63, P73, DOI 10.2307/2694777; KENT S, 1992, AM ANTIQUITY, V57, P635, DOI 10.2307/280827; KINTIGH KW, 1984, AM ANTIQUITY, V49, P44, DOI 10.2307/280511; Leonard R. D., 1989, QUANTIFYING DIVERSIT; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; OBRIAN MJ, 2000, APPL EVOLUTIONARY AR; OBrien M.J., 2003, CLADISTICS ARCHAEOLO; Plog Stephen, 1989, ARCHITECTURE SOCIAL, V1, P143; Reid J, 1982, ARCHAEOLOGICAL SERIE, V1, P193; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schiffer M. B, 1975, ARKANSAS ARCHAEOLOGI, V8, P265; Schlanger SH, 1990, PERSPECTIVES SW PREH, P103; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; Shott MichaelJ., 1997, MIDCONTINENTAL J ARC, V22, P197; Simek J, 1990, EMERGENCE MODERN HUM, P243; Surovell T., 2009, BEHAV ECOLOGY LITHIC; Thomas D, 1989, QUANTIFYING DIVERSIT, P85; Thomas David. H, 1988, ANTHR PAPERS AM MUSE, V66; Tomenchuk J, 1997, AM ANTIQUITY, V62, P508, DOI 10.2307/282168; van Roosmalen Marc G.M., 2002, Neotropical Primates, V10, P1; Whittaker JC, 1998, J ARCHAEOL METHOD TH, V5, P129, DOI 10.1007/BF02427967; Yellen J.E., 1977, STUDIES ARCHEOLOGY	55	35	35	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e34179	10.1371/journal.pone.0034179	http://dx.doi.org/10.1371/journal.pone.0034179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959WT	22666316	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305349600003
J	Ramakrishna, S; Suresh, B; Bae, SM; Ahn, WS; Lim, KH; Baek, KH				Ramakrishna, Suresh; Suresh, Bharathi; Bae, Su-Mi; Ahn, Woong-Shick; Lim, Key-Hwan; Baek, Kwang-Hyun			Hyaluronan Binding Motifs of USP17 and SDS3 Exhibit Anti-Tumor Activity	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; CELL-SURFACE CD44; MAMMARY-CARCINOMA CELLS; DEUBIQUITINATING ENZYMES; INTRACELLULAR HYALURONAN; RECEPTOR RHAMM; LINK PROTEIN; LOCALIZATION; ACID; IDENTIFICATION	Background: We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells. Furthermore, USP17 and SDS3 mutually interact with each other to block cell proliferation in HeLa cells but the mechanism for this inhibition in cell proliferation is not known. We wished to investigate whether the HABMs of USP17 were responsible for tumor suppression activity. Methodology/ Principal Findings: Similarly to USP17, we have identified that SDS3 also has three consecutive HABMs and shows direct binding with hyaluronan (HA) using cetylpyridinium chloride (CPC) assay. Additionally, HA oligosaccharides (618 sugar units) competitively block binding of endogenous HA polymer to HA binding proteins. Thus, administration of HA oligosaccharides antagonizes the interaction between HA and USP17 or SDS3. Interestingly, HABMs deleted USP17 showed lesser interaction with SDS3 but retain its deubiquitinating activity towards SDS3. The deletion of HABMs of USP17 could not alter its functional regulation on SDS3-associated HDAC activity. Furthermore, to explore whether HABMs in USP17 and SDS3 are responsible for the inhibition of cell proliferation, we investigated the effect of USP17 and SDS3-lacking HABMs on cell proliferation by soft agar, apoptosis, cell migration and cell proliferation assays. Conclusions: Our results have demonstrated that these HABMs in USP17 and its substrate SDS3 are mainly involved in the inhibition of anchorage-independent tumor growth.	[Ramakrishna, Suresh; Suresh, Bharathi; Lim, Key-Hwan; Baek, Kwang-Hyun] CHA Univ, CHA Gen Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea; [Bae, Su-Mi; Ahn, Woong-Shick] Catholic Univ, Korea Coll Med, Catholic Res Inst Med Sci, Seoul, South Korea	Pochon Cha University; Catholic University of Korea	Ramakrishna, S (corresponding author), CHA Univ, CHA Gen Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea.	baek@cha.ac.kr	Ramakrishna, Suresh/AAX-4096-2021	Baek, Kwang-Hyun/0000-0001-7662-7190	Korea Research Foundation Grant; Korean Government [KRF-2008-313-C00718]	Korea Research Foundation Grant(National Research Foundation of Korea); Korean Government(Korean Government)	The Korea Research Foundation Grant funded by the Korean Government (KRF-2008-313-C00718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599; Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Assmann V, 1998, J CELL SCI, V111, P1685; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; David G, 2006, ONCOGENE, V25, P7354, DOI 10.1038/sj.onc.1209734; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; EGGLI PS, 1995, J HISTOCHEM CYTOCHEM, V43, P689, DOI 10.1177/43.7.7608523; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Gao F, 2004, CHINESE MED J-PEKING, V117, P1072; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hofmann M, 1998, J CELL SCI, V111, P1673; Huang L, 2000, J BIOL CHEM, V275, P29829, DOI 10.1074/jbc.M002737200; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lesley J, 2000, J BIOL CHEM, V275, P26967; Liu NF, 2001, CANCER RES, V61, P1022; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Peterson RM, 2000, AM J PATHOL, V156, P2159, DOI 10.1016/S0002-9440(10)65086-9; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; RIPELLINO JA, 1988, J CELL BIOL, V106, P845, DOI 10.1083/jcb.106.3.845; RIPELLINO JA, 1989, J CELL BIOL, V108, P1899, DOI 10.1083/jcb.108.5.1899; Shin JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-292; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2008, CURR PHARM BIOTECHNO, V9, P249, DOI 10.2174/138920108785161569; Xu XM, 2003, CANCER RES, V63, P5685; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	43	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37772	10.1371/journal.pone.0037772	http://dx.doi.org/10.1371/journal.pone.0037772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662218	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300108
J	Sargsyan, O				Sargsyan, Ori			Analytical Framework for Identifying and Differentiating Recent Hitchhiking and Severe Bottleneck Effects from Multi-Locus DNA Sequence Data	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECENT COMMON ANCESTRY; HUMAN Y-CHROMOSOMES; MITOCHONDRIAL-DNA; SEGREGATING SITES; STATISTICAL PROPERTIES; NONCODING REGION; EVOLUTION; NUMBER; HUMANS	Hitchhiking and severe bottleneck effects have impact on the dynamics of genetic diversity of a population by inducing homogenization at a single locus and at the genome-wide scale, respectively. As a result, identification and differentiation of the signatures of such events from DNA sequence data at a single locus is challenging. This paper develops an analytical framework for identifying and differentiating recent homogenization events at multiple neutral loci in low recombination regions. The dynamics of genetic diversity at a locus after a recent homogenization event is modeled according to the infinite-sites mutation model and the Wright-Fisher model of reproduction with constant population size. In this setting, I derive analytical expressions for the distribution, mean, and variance of the number of polymorphic sites in a random sample of DNA sequences from a locus affected by a recent homogenization event. Based on this framework, three likelihood-ratio based tests are presented for identifying and differentiating recent homogenization events at multiple loci. Lastly, I apply the framework to two data sets. First, I consider human DNA sequences from four non-coding loci on different chromosomes for inferring evolutionary history of modern human populations. The results suggest, in particular, that recent homogenization events at the loci are identifiable when the effective human population size is 50000 or greater in contrast to 10000, and the estimates of the recent homogenization events are agree with the "Out of Africa" hypothesis. Second, I use HIV DNA sequences from HIV-1-infected patients to infer the times of HIV seroconversions. The estimates are contrasted with other estimates derived as the mid-time point between the last HIV-negative and first HIV-positive screening tests. The results show that significant discrepancies can exist between the estimates.	Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Sargsyan, O (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA.	sargsyan@lanl.gov			United States Department of Energy through the LANL/LDRD Program; National Institute of Health [5R01AI08752002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	United States Department of Energy through the LANL/LDRD Program; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Department of Energy through the LANL/LDRD Program and by the National Institute of Health [grant number 5R01AI08752002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIYOSHI K, 1992, LANCET, V340, P1257, DOI 10.1016/0140-6736(92)92953-D; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1996, SCIENCE, V274, P1554, DOI 10.1126/science.274.5292.1554; Buneman P., 1971, MATH ARCHAEOLOGICAL, P387; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Drake JW, 1998, GENETICS, V148, P1667; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; FU YX, 1993, GENETICS, V133, P693; Galtier N, 2000, GENETICS, V155, P981; GRIFFITHS RC, 1981, J APPL PROBAB, V18, P42, DOI 10.2307/3213165; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HOLMES EC, 1992, P NATL ACAD SCI USA, V89, P4835, DOI 10.1073/pnas.89.11.4835; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; HUDSON RR, 1985, GENETICS, V111, P147; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kingman J.F.C., 1982, EXCHANGEABILITY PROB, P97; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Nachman MW, 2000, GENETICS, V156, P297; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perlitz M, 1997, J MATH BIOL, V36, P1, DOI 10.1007/s002850050087; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Sherry ST, 1997, GENETICS, V147, P1977; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber J, 2001, BRIT MED BULL, V58, P61, DOI 10.1093/bmb/58.1.61; Wolfram Research Inc, 2007, MATH VERS 6 0; Yang ZH, 1996, GENETICS, V144, P1941; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	53	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37588	10.1371/journal.pone.0037588	http://dx.doi.org/10.1371/journal.pone.0037588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662176	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300066
J	Wang, L; Jia, Y; Tang, RJ; Xu, Z; Cao, YB; Jia, XM; Jiang, YY				Wang, Lin; Jia, Yu; Tang, Ren-Jie; Xu, Zheng; Cao, Yong-Bing; Jia, Xin-Ming; Jiang, Yuan-Ying			Proteomic Analysis of Rta2p-Dependent Raft-Association of Detergent-Resistant Membranes in Candida albicans	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; SPHINGOLIPID METABOLISM; ANTIFUNGAL AGENTS; ATPASE PMA1P; TRANSPORT; DOMAINS	In Candida albicans, lipid rafts (also called detergent-resistant membranes, DRMs) are involved in many cellular processes and contain many important proteins. In our previous study, we demonstrated that Rta2p was required for calcineurin-mediated azole resistance and sphingoid long-chain base release in C. albicans. Here, we found that Rta2p was co-localized with raft-constituted ergosterol on the plasma membrane of C. albicans. Furthermore, this membrane expression pattern was totally disturbed by inhibitors of either ergosterol or sphingolipid synthesis. Biochemical fractionation of DRMs together with immunoblot uncovered that Rta2p, along with well-known DRM-associated proteins (Pma1p and Gas1p homologue), was associated with DRMs and their associations were blocked by inhibitors of either ergosterol or sphingolipid synthesis. Finally, we used the proteomic analysis together with immunoblot and identified that Rta2p was required for the association of 10 proteins with DRMs. These 5 proteins (Pma1p, Gas1p homologue, Erg11p, Pmt2p and Ali1p) have been reported to be DRM-associated and also that Erg11p is a well-known target of azoles in C. albicans. In conclusion, our results showed that Rta2p was predominantly localized in lipid rafts and was required for the association of certain membrane proteins with lipid rafts in C. albicans.	[Wang, Lin; Jia, Yu; Tang, Ren-Jie; Xu, Zheng; Cao, Yong-Bing; Jiang, Yuan-Ying] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Wang, Lin; Jia, Xin-Ming] Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China	Naval Medical University; Tongji University	Jia, XM (corresponding author), Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China.	jiaxm@tongji.edu.cn; jiangyy@smmu.edu.cn	jiang, anyi/GPT-0379-2022		National Science Foundation of China [30900055, 30825041, 90913008]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (30900055, 30825041 and 90913008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnat M, 2002, BIOL CHEM, V383, P1475, DOI 10.1515/BC.2002.169; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o; Cabezon V, 2009, PROTEOMICS, V9, P4770, DOI 10.1002/pmic.200800988; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dupre S, 2003, TRAFFIC, V4, P83, DOI 10.1034/j.1600-0854.2003.40204.x; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Ferreira C, 2008, BBA-BIOMEMBRANES, V1778, P2648, DOI 10.1016/j.bbamem.2008.08.011; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2006, EUKARYOT CELL, V5, P945, DOI 10.1128/EC.00206-05; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hearn JD, 2003, J BIOL CHEM, V278, P3679, DOI 10.1074/jbc.M209170200; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; Insenser M, 2006, PROTEOMICS, V6, pS74, DOI 10.1002/pmic.200500465; Jia X, 2009, CELL MOL LIFE SCI, V66, P122, DOI 10.1007/s00018-008-8409-3; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Meroni V, 2006, CLIN MICROBIOL INFEC, V12, P679; Mishra N. N., 2007, Acta Microbiologica et Immunologica Hungarica, V54, P367, DOI 10.1556/AMicr.54.2007.4.4; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Pasrija R, 2005, BIOCHEM SOC T, V33, P1219, DOI 10.1042/BST20051219; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Prasad T, 2005, ANTIMICROB AGENTS CH, V49, P3442, DOI 10.1128/AAC.49.8.3442-3452.2005; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ruhnke M, 2006, CURR DRUG TARGETS, V7, P495, DOI 10.2174/138945006776359421; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Shukla S, 2007, BIOCHEMISTRY-US, V46, P12081, DOI 10.1021/bi700453e; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Sutterlin C, 1997, J CELL SCI, V110, P2703; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200	58	7	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37768	10.1371/journal.pone.0037768	http://dx.doi.org/10.1371/journal.pone.0037768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662216	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300106
J	Zakharova, L; Nural-Guvener, H; Gaballa, MA				Zakharova, Liudmila; Nural-Guvener, Hikmet; Gaballa, Mohamed A.			Cardiac Explant-Derived Cells Are Regulated by Notch-Modulated Mesenchymal Transition	PLOS ONE			English	Article							STEM-CELLS; EPICARDIAL CELLS; PROGENITOR CELLS; SIGNALING PATHWAY; IN-VITRO; TGF-BETA; HEART; DIFFERENTIATION; ACTIVATION; EXPRESSION	Background: Progenitor cell therapy is emerging as a novel treatment for heart failure. However the molecular mechanisms regulating the generation of cardiac progenitor cells is not fully understood. We hypothesized that cardiac progenitor cells are generated from cardiac explant via a process similar to epithelial to mesenchymal transition (EMT). Methods/Findings: Explant-derived cells were generated from partially digested atrial tissue. After 21 days in culture, c-Kit+ cells were isolated from cell outgrowth. The majority of explant-originated c-Kit+ cells expressed the epicardial marker Wt1. Cardiac cell outgrowth exhibits a temporal up-regulation of EMT-markers. Notch stimulation augmented, while Notch inhibition suppressed, mesenchymal transition in both c-Kit+ and c-Kit-cells. In c-Kit+ cells, Notch stimulation reduced, while Notch inhibition up-regulated pluripotency marker expressions such as Nanog and Sox2. Notch induction was associated with degradation of beta-catenin in c-Kit-cells. In contrast, Notch inhibition resulted in b-catenin accumulation, acquisition of epitheloid morphology, and up-regulation of Wnt target genes in c-Kit-cells. Conclusion: Our study suggests that Notch-mediated reversible EMT process is a mechanism that regulates explant-derived c-Kit+ and c-Kit-cells.	[Zakharova, Liudmila; Nural-Guvener, Hikmet; Gaballa, Mohamed A.] Banner Sun Hlth Res Inst, Cardiovasc Res Ctr, Sun City, AZ USA; [Gaballa, Mohamed A.] Univ Arizona, Tucson, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; University of Arizona	Zakharova, L (corresponding author), Banner Sun Hlth Res Inst, Cardiovasc Res Ctr, Sun City, AZ USA.	mohamed.gaballa@bannerhealth.com			National Institute of Aging; National Institutes of Health [NIH RO1 AG027263]; Banner Sun Health Research Institute, Sun City, Arizona; NATIONAL INSTITUTE ON AGING [R01AG027263] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banner Sun Health Research Institute, Sun City, Arizona; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Aging, National Institutes of Health (NIH RO1 AG027263) and funds from Banner Sun Health Research Institute, Sun City, Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bax NAM, 2011, BASIC RES CARDIOL, V106, P829, DOI 10.1007/s00395-011-0181-0; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Castaldo C, 2008, STEM CELLS, V26, P1723, DOI 10.1634/stemcells.2007-0732; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Compton LA, 2006, DEV DYNAM, V235, P82, DOI 10.1002/dvdy.20629; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Gittenberger-de Groot AC, 2010, J CELL MOL MED, V14, P1056, DOI 10.1111/j.1582-4934.2010.01077.x; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	36	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37800	10.1371/journal.pone.0037800	http://dx.doi.org/10.1371/journal.pone.0037800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662227	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300117
J	Albuquerque, P; Caridade, CMR; Rodrigues, AS; Marcal, ARS; Cruz, J; Cruz, L; Santos, CL; Mendes, MV; Tavares, F				Albuquerque, Pedro; Caridade, Cristina M. R.; Rodrigues, Arlete S.; Marcal, Andre R. S.; Cruz, Joana; Cruz, Leonor; Santos, Catarina L.; Mendes, Marta V.; Tavares, Fernando			Evolutionary and Experimental Assessment of Novel Markers for Detection of Xanthomonas euvesicatoria in Plant Samples	PLOS ONE			English	Article							CAMPESTRIS PV.-VESICATORIA; BACTERIAL SPOT DISEASE; PHYTOPATHOGENIC XANTHOMONAS; PATHOGENIC BACTERIA; BIOLOGICAL-CONTROL; DNA-SEQUENCES; TOMATO; PEPPER; IDENTIFICATION; STRAINS	Background: Bacterial spot-causing xanthomonads (BSX) are quarantine phytopathogenic bacteria responsible for heavy losses in tomato and pepper production. Despite the research on improved plant spraying methods and resistant cultivars, the use of healthy plant material is still considered as the most effective bacterial spot control measure. Therefore, rapid and efficient detection methods are crucial for an early detection of these phytopathogens. Methodology: In this work, we selected and validated novel DNA markers for reliable detection of the BSX Xanthomonas euvesicatoria (Xeu). Xeu-specific DNA regions were selected using two online applications, CUPID and Insignia. Furthermore, to facilitate the selection of putative DNA markers, a customized C program was designed to retrieve the regions outputted by both databases. The in silico validation was further extended in order to provide an insight on the origin of these Xeu-specific regions by assessing chromosomal location, GC content, codon usage and synteny analyses. Primer-pairs were designed for amplification of those regions and the PCR validation assays showed that most primers allowed for positive amplification with different Xeu strains. The obtained amplicons were labeled and used as probes in dot blot assays, which allowed testing the probes against a collection of 12 non-BSX Xanthomonas and 23 other phytopathogenic bacteria. These assays confirmed the specificity of the selected DNA markers. Finally, we designed and tested a duplex PCR assay and an inverted dot blot platform for culture-independent detection of Xeu in infected plants. Significance: This study details a selection strategy able to provide a large number of Xeu-specific DNA markers. As demonstrated, the selected markers can detect Xeu in infected plants both by PCR and by hybridization-based assays coupled with automatic data analysis. Furthermore, this work is a contribution to implement more efficient DNA-based methods of bacterial diagnostics.	[Albuquerque, Pedro; Santos, Catarina L.; Mendes, Marta V.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Albuquerque, Pedro; Tavares, Fernando] Univ Porto, Dept Biol, FCUP Fac Ciencias, P-4100 Oporto, Portugal; [Caridade, Cristina M. R.; Marcal, Andre R. S.] Univ Porto, Fac Ciencias, CICGE, P-4100 Oporto, Portugal; [Caridade, Cristina M. R.] ISEC, Coimbra, Portugal; [Rodrigues, Arlete S.; Marcal, Andre R. S.] Univ Porto, Fac Ciencias, CMUP, P-4100 Oporto, Portugal; [Cruz, Joana; Cruz, Leonor] INRB, Unidade Invest Proteccao Plantas, Lisbon, Portugal; [Tavares, Fernando] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Albuquerque, P (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	psilva@ibmc.up.pt	MARCAL, ANDRE R. S./F-6230-2013; Cruz, Leonor/AAH-1033-2021; Cruz, Joana/T-4472-2018; Tavares, Fernando/C-3375-2013; Cruz, Leonor/B-7847-2016; Mendes, Marta Vaz/A-8541-2008; Marcal, Andre/L-9850-2019; Albuquerque, Pedro/C-6180-2008; Caridade, Cristina Maria Ribeiro/AAI-5026-2021; Caridade, Cristina M.R./ABF-7942-2020	MARCAL, ANDRE R. S./0000-0002-8501-0974; Cruz, Joana/0000-0002-3390-0801; Tavares, Fernando/0000-0001-9913-1155; Cruz, Leonor/0000-0002-0053-5422; Mendes, Marta Vaz/0000-0002-6105-522X; Marcal, Andre/0000-0002-8501-0974; Albuquerque, Pedro/0000-0001-5916-557X; Caridade, Cristina Maria Ribeiro/0000-0003-3667-5328; Caridade, Cristina M.R./0000-0003-3667-5328; Rodrigues, Arlete/0000-0002-6966-1486; Lopes dos Santos, Catarina/0000-0002-4273-1077	FCT (Fundacao para a Ciencia e Tecnologia) [PTDC/AGR-PRO/111857/2009, POCTI/AGG/39216/2001, SFRH/BD/37249/2007, SFRH/BD/32150/2006, SFRH/BPD/62978/2009]; POPH(QREN); MCTES	FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); POPH(QREN); MCTES	This work was supported by the FCT (Fundacao para a Ciencia e Tecnologia) grants PTDC/AGR-PRO/111857/2009 and POCTI/AGG/39216/2001. Pedro Albuquerque, Cristina Caridade and Catarina L. Santos were supported by the FCT fellowships, SFRH/BD/37249/2007, SFRH/BD/32150/2006 and SFRH/BPD/62978/2009, respectively. Marta V. Mendes was supported by the "Ciencia 2007'' FCT program, sponsored by the POPH(QREN) program subsidized by the European Social Fund and by the MCTES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-You N, 2009, INT J SYST EVOL MICR, V59, P306, DOI 10.1099/ijs.0.65453-0; Albuquerque P, 2011, APPL ENVIRON MICROB, V77, P5619, DOI 10.1128/AEM.05189-11; Albuquerque P, 2009, SCI TOTAL ENVIRON, V407, P3641, DOI 10.1016/j.scitotenv.2008.10.054; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; CABI/EPPO, 1997, QUARANTINE PESTS EUR; Call DR, 2003, J MICROBIOL METH, V53, P235, DOI 10.1016/S0167-7012(03)00027-7; Canteros BI, 1995, PHYTOPATHOLOGY, V85, P1482, DOI 10.1094/Phyto-85-1482; Caridade CMR, 2010, IEEE ENG MED BIO, P6122, DOI 10.1109/IEMBS.2010.5627805; Cortez D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r65; Cuppels DA, 2006, PLANT DIS, V90, P451, DOI 10.1094/PD-90-0451; Drummond A., 2011, GENEIOUS V5 5; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; GARDE S, 1991, APPL ENVIRON MICROB, V57, P2435, DOI 10.1128/AEM.57.8.2435-2439.1991; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; GITAITIS R, 1992, PLANT DIS, V76, P651, DOI 10.1094/PD-76-0651; Hert AP, 2009, APPL ENVIRON MICROB, V75, P3323, DOI 10.1128/AEM.02399-08; Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; JONES JB, 1993, PHYTOPATHOLOGY, V83, P551, DOI 10.1094/Phyto-83-551; Kuflu KM, 1997, APPL ENVIRON MICROB, V63, P4462, DOI 10.1128/AEM.63.11.4462-4470.1997; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lanna R, 2010, PESQUI AGROPECU BRAS, V45, P1381, DOI 10.1590/S0100-204X2010001200007; LAZO GR, 1987, PHYTOPATHOLOGY, V77, P448, DOI 10.1094/Phyto-77-448; LAZO GR, 1987, INT J SYST BACTERIOL, V37, P214, DOI 10.1099/00207713-37-3-214; LEITE RP, 1994, APPL ENVIRON MICROB, V60, P1068, DOI 10.1128/AEM.60.4.1068-1077.1994; LEITE RP, 1995, PLANT DIS, V79, P917, DOI 10.1094/PD-79-0917; Lopez MM, 2009, CURR ISSUES MOL BIOL, V11, P13; Lopez MM, 2003, INT MICROBIOL, V6, P233, DOI 10.1007/s10123-003-0143-y; LOUWS FJ, 1995, PHYTOPATHOLOGY, V85, P528, DOI 10.1094/Phyto-85-528; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Louws FJ, 2001, PLANT DIS, V85, P481, DOI 10.1094/PDIS.2001.85.5.481; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Marcal ARS, 2009, IEEE ENG MED BIO, P6710, DOI 10.1109/IEMBS.2009.5333807; Mazumder R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-279; Moretti C, 2009, LETT APPL MICROBIOL, V49, P466, DOI 10.1111/j.1472-765X.2009.02690.x; Moss WP, 2007, BIOL CONTROL, V41, P199, DOI 10.1016/j.biocontrol.2007.01.008; Obradovic A, 2004, EUR J PLANT PATHOL, V110, P285, DOI 10.1023/B:EJPP.0000019797.27952.1d; Palacio-Bielsa A, 2009, J PLANT PATHOL, V91, P249; Park DS, 2009, MICROBIOL RES, V164, P36, DOI 10.1016/j.micres.2006.11.005; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Phillippy AM, 2009, NUCLEIC ACIDS RES, V37, pW229, DOI 10.1093/nar/gkp286; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Roberts PD, 2008, CROP PROT, V27, P1519, DOI 10.1016/j.cropro.2008.06.007; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Sahin F, 1998, PLANT DIS, V82, P794, DOI 10.1094/PDIS.1998.82.7.794; Sambrook J., 2001, MOL CLONING LAB MANU; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; STALL RE, 1994, INT J SYST BACTERIOL, V44, P47, DOI 10.1099/00207713-44-1-47; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Vallejos CE, 2010, THEOR APPL GENET, V121, P37, DOI 10.1007/s00122-010-1289-6; van Doorn J, 2001, APPL ENVIRON MICROB, V67, P598, DOI 10.1128/AEM.67.2.598-607.2001; VAUTERIN L, 1990, INT J SYST BACTERIOL, V40, P312, DOI 10.1099/00207713-40-3-312; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vincelli P, 2008, PLANT DIS, V92, P660, DOI 10.1094/PDIS-92-5-0660; WELLS JM, 1981, APPL ENVIRON MICROB, V42, P357, DOI 10.1128/AEM.42.2.357-363.1981; Wen AM, 2009, CROP PROT, V28, P859, DOI 10.1016/j.cropro.2009.04.013; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004	67	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37836	10.1371/journal.pone.0037836	http://dx.doi.org/10.1371/journal.pone.0037836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655073	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900050
J	Grafe, TU; Preininger, D; Sztatecsny, M; Kasah, R; Dehling, JM; Proksch, S; Hodl, W				Grafe, T. Ulmar; Preininger, Doris; Sztatecsny, Marc; Kasah, Rosli; Dehling, J. Maximilian; Proksch, Sebastian; Hoedl, Walter			Multimodal Communication in a Noisy Environment: A Case Study of the Bornean Rock Frog Staurois parvus	PLOS ONE			English	Article							ANIMAL COMMUNICATION; ANTHROPOGENIC NOISE; COURTSHIP DISPLAYS; AUDITORY MASKING; HIGHER PITCH; CALL; BEHAVIOR; ANURA; EVOLUTION; SIGNALS	High background noise is an impediment to signal detection and perception. We report the use of multiple solutions to improve signal perception in the acoustic and visual modality by the Bornean rock frog, Staurois parvus. We discovered that vocal communication was not impaired by continuous abiotic background noise characterised by fast-flowing water. Males modified amplitude, pitch, repetition rate and duration of notes within their advertisement call. The difference in sound pressure between advertisement calls and background noise at the call dominant frequency of 5578 Hz was 8 dB, a difference sufficient for receiver detection. In addition, males used several visual signals to communicate with conspecifics with foot flagging and foot flashing being the most common and conspicuous visual displays, followed by arm waving, upright posture, crouching, and an open-mouth display. We used acoustic playback experiments to test the efficacy-based alerting signal hypothesis of multimodal communication. In support of the alerting hypothesis, we found that acoustic signals and foot flagging are functionally linked with advertisement calling preceding foot flagging. We conclude that S. parvus has solved the problem of continuous broadband low-frequency noise by both modifying its advertisement call in multiple ways and by using numerous visual signals. This is the first example of a frog using multiple acoustic and visual solutions to communicate in an environment characterised by continuous noise.	[Grafe, T. Ulmar; Kasah, Rosli] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei; [Preininger, Doris; Sztatecsny, Marc; Hoedl, Walter] Univ Vienna, Dept Evolutionary Biol, Vienna, Austria; [Dehling, J. Maximilian; Proksch, Sebastian] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Theodor Boveri Inst, Biozentrum, Wurzburg, Germany	University Brunei Darussalam; University of Vienna; University of Wurzburg	Grafe, TU (corresponding author), Univ Brunei Darussalam, Dept Biol, Gadong, Brunei.	grafe@biozentrum.uni-wuerzburg.de		Kasah, Rosli/0000-0002-9634-3723; Preininger, Doris/0000-0001-6842-1133	Austrian Science Fund (FWF) [P22069-B17]; German Academic Exchange Programme (DAAD); Universiti Brunei Darussalam [RG 58]; Austrian Science Fund (FWF) [P 22069] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Academic Exchange Programme (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Universiti Brunei Darussalam; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants from the Austrian Science Fund (FWF): P22069-B17 (www.fwf.ac.at/en/index.asp), the German Academic Exchange Programme (DAAD) (www.daad.org/) and a research grant from the Universiti Brunei Darussalam (RG 58) (http://www.ubd.edu.bn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2004, HERPETOLOGICA, V60, P420, DOI 10.1655/02-51; Arch VS, 2008, BIOL LETTERS, V4, P19, DOI 10.1098/rsbl.2007.0494; Arifin U, 2011, ZOOTAXA, P39; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Boeckle M, 2009, HERPETOLOGICA, V65, P154, DOI 10.1655/07-071R1.1; Boersma P., 2010, PRAAT DOING PHONETIC; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BRENOWITZ EA, 1982, J COMP PHYSIOL, V147, P511, DOI 10.1007/BF00612017; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Brumm H, 2006, CURR BIOL, V16, pR1003, DOI 10.1016/j.cub.2006.10.043; Diaz M, 2011, BEHAV ECOL, V22, P332, DOI 10.1093/beheco/arq210; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Grafe TU, 1996, BEHAV ECOL SOCIOBIOL, V38, P149, DOI 10.1007/s002650050227; Grafe TU, 2003, ANIM BEHAV, V66, P127, DOI 10.1006/anbe.2003.2173; GREER BJ, 1980, HERPETOLOGICA, V36, P318; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Haddad CFB, 1999, HERPETOLOGICA, V55, P324; HARDING K A, 1982, Proceedings of the Biological Society of Washington, V95, P621; Hartmann MT, 2004, AMPHIBIA-REPTILIA, V25, P395, DOI 10.1163/1568538042788933; Hebets EA, 1999, ANIM BEHAV, V57, P865, DOI 10.1006/anbe.1998.1048; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hirschmann W, 2006, HERPETOLOGICA, V62, P18, DOI 10.1655/04-06.1; HODL W, 1977, OECOLOGIA, V28, P351, DOI 10.1007/BF00345990; Hodl W, 1997, FOOT FLAGGING DISPLA; Hoedl Walter, 2001, P121; Hulse SH, 2002, ADV STUD BEHAV, V31, P163, DOI 10.1016/S0065-3454(02)80008-0; Kaiser K, 2009, BEHAVIOUR, V146, P1053, DOI 10.1163/156853909X404457; Malkmus R., 2002, AMPHIBIANS REPTILES; Martin P., 1994, MEASURING BEHAV INTR, V3rd; Matsui M, 2007, ZOOL SCI, V24, P101, DOI 10.2108/zsj.24.101; Mclennan DA, 2003, BIOL J LINN SOC, V80, P555, DOI 10.1111/j.1095-8312.2003.00254.x; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NARINS PM, 1982, J COMP PHYSIOL, V147, P439, DOI 10.1007/BF00612008; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parris KM, 2009, ECOL SOC, V14; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; Penna M, 2011, ETHOLOGY, V117, P1147, DOI 10.1111/j.1439-0310.2011.01973.x; Preininger D, 2009, HERPETOLOGICA, V65, P166, DOI 10.1655/08-037R.1; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Schwartz JJ, 1998, ANIM BEHAV, V56, P55, DOI 10.1006/anbe.1998.0737; Schwartz JJ, 2002, BEHAV ECOL SOCIOBIOL, V53, P9, DOI 10.1007/s00265-002-0542-7; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Sukumaran Jeet, 2006, Herpetological Review, V37, P288; Taylor RC, 2011, J EXP BIOL, V214, P815, DOI 10.1242/jeb.043638; Velez A, 2011, ANIM BEHAV, V82, P1319, DOI 10.1016/j.anbehav.2011.09.015; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wilgers DJ, 2011, CURR ZOOL, V57, P175, DOI 10.1093/czoolo/57.2.175; Wollerman L, 2002, ANIM BEHAV, V63, P15, DOI 10.1006/anbe.2001.1885; ZELICK RD, 1983, J COMP PHYSIOL, V153, P403, DOI 10.1007/BF00612594	63	88	91	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37965	10.1371/journal.pone.0037965	http://dx.doi.org/10.1371/journal.pone.0037965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655089	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338900066
J	Klinger, C; Patel, Y; Postma, HWC				Klinger, Colin; Patel, Yogeshwari; Postma, Henk W. Ch.			Carbon Nanotube Solar Cells	PLOS ONE			English	Article							CHARGE-TRANSFER SENSITIZERS; COUNTER ELECTRODE; BLACK DYE; HIGH-EFFICIENCY; TIO2 FILMS; SINGLE; CONVERSION; TRANSPARENT; IMPROVEMENT	We present proof-of-concept all-carbon solar cells. They are made of a photoactive side of predominantly semiconducting nanotubes for photoconversion and a counter electrode made of a natural mixture of carbon nanotubes or graphite, connected by a liquid electrolyte through a redox reaction. The cells do not require rare source materials such as In or Pt, nor high-grade semiconductor processing equipment, do not rely on dye for photoconversion and therefore do not bleach, and are easy to fabricate using a spray-paint technique. We observe that cells with a lower concentration of carbon nanotubes on the active semiconducting electrode perform better than cells with a higher concentration of nanotubes. This effect is contrary to the expectation that a larger number of nanotubes would lead to more photoconversion and therefore more power generation. We attribute this to the presence of metallic nanotubes that provide a short for photo-excited electrons, bypassing the load. We demonstrate optimization strategies that improve cell efficiency by orders of magnitude. Once it is possible to make semiconducting-only carbon nanotube films, that may provide the greatest efficiency improvement.	[Klinger, Colin; Patel, Yogeshwari; Postma, Henk W. Ch.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	California State University System; California State University Northridge	Klinger, C (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	postma@csun.edu	Funde, Adinath M./D-8169-2012; Postma, Henk W.Ch./A-8770-2014	Postma, Henk/0000-0003-4349-9406				Aiga F, 2003, J MOL STRUCT, V658, P25, DOI 10.1016/S0022-2860(03)00408-3; Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Baxter JB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861510; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; Boschloo G, 2002, J PHOTOCH PHOTOBIO A, V148, P11, DOI 10.1016/S1010-6030(02)00072-2; Gao FF, 2008, CHEM COMMUN, P2635, DOI 10.1039/b802909a; Goldemberg J., 2004, WORLD ENERGY ASSESSM; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Han LY, 2006, CR CHIM, V9, P645, DOI 10.1016/j.crci.2005.02.046; Hu L, 2004, NANO LETT, V4, P2513, DOI 10.1021/nl048435y; Hwang S, 2007, ELECTRON LETT, V43, P1455, DOI 10.1049/el:20072867; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Kang M, 2010, ELECTRON LETT, V46, P1509, DOI 10.1049/el.2010.2606; Kohle O, 1996, INORG CHEM, V35, P4779, DOI 10.1021/ic9515665; Koo BK, 2006, J ELECTROCERAM, V17, P79, DOI 10.1007/s10832-006-9941-x; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Li C, 2007, J MATER CHEM, V17; Li C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2827189; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Mickelson ET, 1998, CHEM PHYS LETT, V296, P188, DOI 10.1016/S0009-2614(98)01026-4; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Nazeeruddin MK, 1997, CHEM COMMUN, P1705, DOI 10.1039/a703277c; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Postma HWC, 2000, PHYS REV B, V62, P10653, DOI 10.1103/PhysRevB.62.R10653; Ramasamy E, 2008, ELECTROCHEM COMMUN, V10, P1087, DOI 10.1016/j.elecom.2008.05.013; Rinzler AG, 1998, APPL PHYS A-MATER, V67, P29, DOI 10.1007/s003390050734; Saito Y, 2002, SYNTHETIC MET, V131, P185, DOI 10.1016/S0379-6779(02)00198-4; Shi D, 2008, J PHYS CHEM C, V112, P17046, DOI 10.1021/jp808018h; Tang YB, 2010, ACS NANO, V4, P3482, DOI 10.1021/nn100449w; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Trancik JE, 2008, NANO LETT, V8, P982, DOI 10.1021/nl071945i; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; VOGEL R, 1994, J PHYS CHEM-US, V98, P3183, DOI 10.1021/j100063a022; Wang ZS, 2005, LANGMUIR, V21, P4272, DOI 10.1021/la050134w; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Zhou YX, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187945	41	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37806	10.1371/journal.pone.0037806	http://dx.doi.org/10.1371/journal.pone.0037806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655070	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900046
J	Moore, FE; Reyon, D; Sander, JD; Martinez, SA; Blackburn, JS; Khayter, C; Ramirez, CL; Joung, JK; Langenau, DM				Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.			Improved Somatic Mutagenesis in Zebrafish Using Transcription Activator-Like Effector Nucleases (TALENs)	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; POOL ENGINEERING OPEN; MICROINJECTION; KNOCKOUT	Zinc Finger Nucleases (ZFNs) made by Context-Dependent Assembly (CoDA) and Transcription Activator-Like Effector Nucleases (TALENs) provide robust and user-friendly technologies for efficiently inactivating genes in zebrafish. These designer nucleases bind to and cleave DNA at particular target sites, inducing error-prone repair that can result in insertion or deletion mutations. Here, we assess the relative efficiencies of these technologies for inducing somatic DNA mutations in mosaic zebrafish. We find that TALENs exhibited a higher success rate for obtaining active nucleases capable of inducing mutations than compared with CoDA ZFNs. For example, all six TALENs tested induced DNA mutations at genomic target sites while only a subset of CoDA ZFNs exhibited detectable rates of mutagenesis. TALENs also exhibited higher mutation rates than CoDA ZFNs that had not been pre-screened using a bacterial two-hybrid assay, with DNA mutation rates ranging from 20%-76.8% compared to 1.1%-3.3%. Furthermore, the broader targeting range of TALENs enabled us to induce mutations at the methionine translation start site, sequences that were not targetable using the CoDA ZFN platform. TALENs exhibited similar toxicity to CoDA ZFNs, with >50% of injected animals surviving to 3 days of life. Taken together, our results suggest that TALEN technology provides a robust alternative to CoDA ZFNs for inducing targeted gene-inactivation in zebrafish, making it a preferred technology for creating targeted knockout mutants in zebrafish.	[Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Moore, Finola E.; Martinez, Sarah A.; Blackburn, Jessica S.; Langenau, David M.] Harvard Stem Cell Inst, Boston, MA USA; [Moore, Finola E.; Reyon, Deepak; Sander, Jeffry D.; Martinez, Sarah A.; Blackburn, Jessica S.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith; Langenau, David M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Reyon, Deepak; Sander, Jeffry D.; Khayter, Cyd; Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Moore, FE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA.	dlangenau@partners.org	Langenau, David/GXI-0197-2022; Reyon, Deepak/HCH-3183-2022	Langenau, David/0000-0001-6664-8318; Martinez Roth, Sarah/0000-0001-9528-7152; Blackburn, Jessica/0000-0001-9464-3784; Ramirez, Cherie/0000-0002-0397-6872	Alex's Lemonade Stand Foundation; American Cancer Society; Harvard Stem Cell Institute; NIH [K01 AR055619, RO1 CA154923, R21 CA156056, DP1 OD006862, R01 GM088040, T32 CA009216]; Jim and Ann Orr MGH Research Scholar Award; National Science Foundation [DBI-0923827]; NATIONAL CANCER INSTITUTE [T32CA009216, R21CA156056, R01CA154923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr MGH Research Scholar Award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	D.M.L. is supported by NIH grants K01 AR055619, RO1 CA154923, and R21 CA156056, the Alex's Lemonade Stand Foundation, the American Cancer Society, and the Harvard Stem Cell Institute. J.K.J. is supported by an NIH Director's Pioneer Award (DP1 OD006862), NIH R01 GM088040, and the Jim and Ann Orr MGH Research Scholar Award. J.D.S. is supported by NIH T32 CA009216. D. R. is supported by National Science Foundation award DBI-0923827. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Reyon D, 2012, NATURE BIOTECHNOLOGY; Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Westerfield M, 1993, ZEBRAFISH BOOK; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xu QL, 1999, METH MOL B, V127, P125, DOI 10.1385/1-59259-678-9:125; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779	32	125	164	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37877	10.1371/journal.pone.0037877	http://dx.doi.org/10.1371/journal.pone.0037877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655075	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900052
J	Vaca-Paniagua, F; Alvarez-Gomez, RM; Fragoso-Ontiveros, V; Vidal-Millan, S; Herrera, LA; Cantu, D; Bargallo-Rocha, E; Mohar, A; Lopez-Camarillo, C; Perez-Plasencia, C				Vaca-Paniagua, Felipe; Maria Alvarez-Gomez, Rosa; Fragoso-Ontiveros, Veronica; Vidal-Millan, Silvia; Alonso Herrera, Luis; Cantu, David; Bargallo-Rocha, Enrique; Mohar, Alejandro; Lopez-Camarillo, Cesar; Perez-Plasencia, Carlos			Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer	PLOS ONE			English	Article							GENOMIC REARRANGEMENTS; HEREDITARY BREAST; HIGH-RISK; GENES; VARIANTS; POPULATION; FAMILIES; CARRIERS; IDENTIFICATION; PREVALENCE	Hereditary breast cancer comprises 10% of all breast cancers. The most prevalent genes causing this pathology are BRCA1 and BRCA2 (breast cancer early onset 1 and 2), which also predispose to other cancers. Despite the outstanding relevance of genetic screening of BRCA deleterious variants in patients with a history of familial cancer, this practice is not common in Latin American public institutions. In this work we assessed mutations in the entire exonic and splice-site regions of BRCA in 39 patients with breast and ovarian cancer and with familial history of breast cancer or with clinical features suggestive for BRCA mutations by massive parallel pyrosequencing. First we evaluated the method with controls and found 41-485 reads per sequence in BRCA pathogenic mutations. Negative controls did not show deleterious variants, confirming the suitability of the approach. In patients diagnosed with cancer we found 4 novel deleterious mutations (c.2805_2808delAGAT and c.3124_3133delAGCAATATTA in BRCA1; c.2639_2640delTG and c.5114_5117delTAAA in BRCA2). The prevalence of BRCA mutations in these patients was 10.2%. Moreover, we discovered 16 variants with unknown clinical significance (11 in exons and 5 in introns); 4 were predicted as possibly pathogenic by in silico analyses, and 3 have not been described previously. This study illustrates how massive pyrosequencing technology can be applied to screen for BRCA mutations in the whole exonic and splice regions in patients with suspected BRCA-related cancers. This is the first effort to analyse the mutational status of BRCA genes on a Mexican-mestizo population by means of pyrosequencing.	[Vaca-Paniagua, Felipe; Fragoso-Ontiveros, Veronica; Perez-Plasencia, Carlos] Inst Nacl Cancerol, Lab Genom, Tlalpan, Mexico; [Vaca-Paniagua, Felipe; Maria Alvarez-Gomez, Rosa; Fragoso-Ontiveros, Veronica; Perez-Plasencia, Carlos] Inst Nacl Cancerol, Unidad Genom & Secuenciac Mas UGESEM, Tlalpan, Mexico; [Vidal-Millan, Silvia] Inst Nacl Cancerol, Clin Genet, Tlalpan, Mexico; [Alonso Herrera, Luis; Mohar, Alejandro] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Tlalpan, Mexico; [Cantu, David; Bargallo-Rocha, Enrique] Inst Nacl Cancerol, Dept Med Oncol, Tlalpan, Mexico; [Lopez-Camarillo, Cesar] UACM, Benito Juarez, Mexico; [Perez-Plasencia, Carlos] UNAM, Unidad Biomed, FES IZTACALA, Tlalnepantla, Mexico	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Vaca-Paniagua, F (corresponding author), Inst Nacl Cancerol, Lab Genom, Tlalpan, Mexico.	carlos.pplas@gmail.com	Lopez-Camarillo, Cesar/I-1946-2019; Perez-Plasencia, Carlos/P-2372-2019; Herrera, Luis/GOV-3311-2022; Cantu-de Leon, David/P-7930-2017	Lopez-Camarillo, Cesar/0000-0002-9417-2609; Perez-Plasencia, Carlos/0000-0002-8593-8211; Vaca Paniagua, Felipe/0000-0002-2200-9706; Cantu-de Leon, David/0000-0002-0229-7931	National Cancer Instite of Mexico;  [SALUD-2010-01-141907]	National Cancer Instite of Mexico; 	This work was supported by federal funds SALUD-2010-01-141907 (http://www.conacyt.mx/) and by National Cancer Instite of Mexico funds (www.incan.edu.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco A, 2012, BREAST CANCER RES TR, V132, P307, DOI 10.1007/s10549-011-1842-2; Borg A, 2010, HUM MUTAT, V31, pE1200, DOI 10.1002/humu.21202; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Clark AS, 2011, J MAMMARY GLAND BIOL, V16, P17, DOI 10.1007/s10911-011-9200-x; De Leeneer K, 2011, HUM MUTAT, V32, P335, DOI 10.1002/humu.21428; De Leeneer K, 2009, J MOL DIAGN, V11, P415, DOI 10.2353/jmoldx.2009.090032; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Diez Gilbert O, 1996, MED CLIN-BARCELONA, V107, P623; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; EASTON DF, 1995, AM J HUM GENET, V56, P265; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Evans DGR, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012104; Ewald IP, 2009, GENET MOL BIOL, V32, P437, DOI 10.1590/S1415-47572009005000049; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Gerhardus A, 2007, EUR J HUM GENET, V15, P619, DOI 10.1038/sj.ejhg.5201806; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Espeleta GAG, 2012, CLIN GENET, V82, P484, DOI 10.1111/j.1399-0004.2011.01774.x; Hofmann Wera, 2003, Hum Mutat, V22, P103, DOI 10.1002/humu.9154; Kwon JS, 2010, J CLIN ONCOL, V28, P675, DOI 10.1200/JCO.2008.21.4684; Lecarpentier J, 2011, BREAST CANCER RES TR, V130, P927, DOI 10.1007/s10549-011-1655-3; Liede A, 2002, AM J HUM GENET, V71, P595, DOI 10.1086/342506; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lynch HT, 2005, CANCER GENET CYTOGEN, V158, P119, DOI 10.1016/j.cancergencyto.2004.01.032; Manoukian S, 2011, BREAST CANCER RES TR, V130, P207, DOI 10.1007/s10549-011-1548-5; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Meindl A, 2011, DTSCH ARZTEBL INT, V108, P323, DOI 10.3238/arztebl.2011.0323; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Milne RL, 2010, BREAST CANCER RES TR, V119, P221, DOI 10.1007/s10549-009-0394-1; Moller P, 2007, EUR J CANCER, V43, P1713, DOI 10.1016/j.ejca.2007.04.023; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Musolino A, 2007, BREAST, V16, P280, DOI 10.1016/j.breast.2006.12.003; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nkondjock A, 2006, BREAST CANCER RES TR, V98, P285, DOI 10.1007/s10549-006-9161-8; Paradiso A, 2011, ANN ONCOL, V22, pi31, DOI 10.1093/annonc/mdq663; Petrucelli N, 2010, GENET MED, V12, P245, DOI 10.1097/GIM.0b013e3181d38f2f; Pruthi S, 2010, MAYO CLIN PROC, V85, P1111, DOI 10.4065/mcp.2010.0414; Ruiz-Flores P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9084; Salazar R, 2006, CANCER LETT, V233, P172, DOI 10.1016/j.canlet.2005.03.006; Saxena S, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-75; Simard J, 2007, J MED GENET, V44, P107, DOI 10.1136/jmg.2006.044388; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Tischkowitz M, 2008, EUR J HUM GENET, V16, P820, DOI 10.1038/ejhg.2008.13; Trainer AH, 2010, NAT REV CLIN ONCOL, V7, P708, DOI 10.1038/nrclinonc.2010.175; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vidal-Millan S, 2009, EUR J GYNAECOL ONCOL, V30, P527; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Wang G, 2011, GENET MED, V13, P1045, DOI 10.1097/GIM.0b013e31822a8113; Zhang LY, 2009, J MOL DIAGN, V11, P176, DOI 10.2353/jmoldx.2009.080137	53	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37432	10.1371/journal.pone.0037432	http://dx.doi.org/10.1371/journal.pone.0037432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655046	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900021
J	Barrett, BT; Panesar, GK; Scally, AJ; Pacey, IE				Barrett, Brendan T.; Panesar, Gurvinder K.; Scally, Andrew J.; Pacey, Ian E.			A Limited Role for Suppression in the Central Field of Individuals with Strabismic Amblyopia	PLOS ONE			English	Article							BINOCULAR VIEWING CONDITIONS; PERIPHERAL VISUAL-FIELD; INTEROCULAR SUPPRESSION; ANISOMETROPIC AMBLYOPIA; PRIMARY MICROSTRABISMUS; RETINAL CORRESPONDENCE; CLINICAL SUPPRESSION; COMITANT STRABISMUS; PERIMETRIC ARTIFACT; AUTOMATED PERIMETRY	Background: Although their eyes are pointing in different directions, people with long-standing strabismic amblyopia typically do not experience double-vision or indeed any visual symptoms arising from their condition. It is generally believed that the phenomenon of suppression plays a major role in dealing with the consequences of amblyopia and strabismus, by preventing images from the weaker/deviating eye from reaching conscious awareness. Suppression is thus a highly sophisticated coping mechanism. Although suppression has been studied for over 100 years the literature is equivocal in relation to the extent of the retina that is suppressed, though the method used to investigate suppression is crucial to the outcome. There is growing evidence that some measurement methods lead to artefactual claims that suppression exists when it does not. Methodology/Results: Here we present the results of an experiment conducted with a new method to examine the prevalence, depth and extent of suppression in ten individuals with strabismic amblyopia. Seven subjects (70%) showed no evidence whatsoever for suppression and in the three individuals who did (30%), the depth and extent of suppression was small. Conclusions: Suppression may play a much smaller role in dealing with the negative consequences of strabismic amblyopia than previously thought. Whereas recent claims of this nature have been made only in those with micro-strabismus our results show extremely limited evidence for suppression across the central visual field in strabismic amblyopes more generally. Instead of suppressing the image from the weaker/deviating eye, we suggest the visual system of individuals with strabismic amblyopia may act to maximise the possibilities for binocular co-operation. This is consistent with recent evidence from strabismic and amblyopic individuals that their binocular mechanisms are intact, and that, just as in visual normals, performance with two eyes is better than with the better eye alone in these individuals.	[Barrett, Brendan T.; Panesar, Gurvinder K.; Pacey, Ian E.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Scally, Andrew J.] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford	Barrett, BT (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	i.pacey@bradford.ac.uk		Barrett, Brendan/0000-0003-4159-4223; Scally, Andy/0000-0002-6189-2247				Agrawal R, 2006, ARCH OPHTHALMOL-CHIC, V124, P844, DOI 10.1001/archopht.124.6.844; Baker DH, 2007, INVEST OPHTH VIS SCI, V48, P5332, DOI 10.1167/iovs.07-0194; BIRCH EE, 1985, INVEST OPHTH VIS SCI, V26, P1624; BOLANOWSKI SJ, 1987, VISION RES, V27, P967, DOI 10.1016/0042-6989(87)90012-5; BRADLEY A, 1986, INVEST OPHTH VIS SCI, V27, P1404; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Buckley JG, 2010, INVEST OPHTH VIS SCI, V51, P2487, DOI 10.1167/iovs.09-3858; CAMPOS EC, 1983, DOC OPHTHALMOL, V55, P277, DOI 10.1007/BF00161285; CAMPOS EC, 1982, DOC OPHTHALMOL, V53, P249, DOI 10.1007/BF00140423; Ciuffreda KJ, 1990, AMBLYOPIA BASIC CLIN; Cleary M, 1998, BRIT J OPHTHALMOL, V82, P225, DOI 10.1136/bjo.82.3.225; Cooper J, 2000, Binocul Vis Strabismus Q, V15, P131; DEBELSUNCE S, 1991, INVEST OPHTH VIS SCI, V32, P2645; DENGLER B, 1993, GRAEF ARCH CLIN EXP, V231, P199, DOI 10.1007/BF00918841; Donahue SP, 1999, AM J OPHTHALMOL, V127, P312, DOI 10.1016/S0002-9394(98)90327-0; FLOM MC, 1985, AM J OPTOM PHYS OPT, V62, P153; Frandsen AD, 1960, ACTA OPHTHALMOL S, V62; Freeman AW, 1996, VISION RES, V36, P765, DOI 10.1016/0042-6989(95)00171-9; FREEMAN AW, 1994, VISION RES, V34, P2043, DOI 10.1016/0042-6989(94)90032-9; FUHR PS, 1990, ARCH OPHTHALMOL-CHIC, V108, P983, DOI 10.1001/archopht.1990.01070090085045; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; GRIFFIN JR, 1976, BINOCULAR ANOMALIES; Harrad R, 1996, EYE, V10, P270, DOI 10.1038/eye.1996.57; Harrad R, 1996, BRIT J OPHTHALMOL, V80, P373, DOI 10.1136/bjo.80.4.373; HARRAD RA, 1992, VISION RES, V32, P2135, DOI 10.1016/0042-6989(92)90075-T; Harwerth RS, 2003, INVEST OPHTH VIS SCI, V44, P4293, DOI 10.1167/iovs.03-0346; HESS RF, 1985, VISION RES, V25, P1577, DOI 10.1016/0042-6989(85)90128-2; Hess RF, 2010, J NEUROPHYSIOL, V104, P475, DOI 10.1152/jn.01060.2009; HOLOPIGIAN K, 1988, INVEST OPHTH VIS SCI, V29, P444; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; Joose M V, 2000, Strabismus, V8, P135, DOI 10.1076/0927-3972(200006)8:2;1-2;FT135; Joosse M V, 2000, Strabismus, V8, P233, DOI 10.1076/stra.8.4.233.686; Joosse MV, 1999, GRAEF ARCH CLIN EXP, V237, P535, DOI 10.1007/s004170050276; Joosse MV, 1997, VISION RES, V37, P2801, DOI 10.1016/S0042-6989(97)00067-9; Kilwinger S, 2002, VISION RES, V42, P2005, DOI 10.1016/S0042-6989(02)00095-0; KITAOJI H, 1987, INVEST OPHTH VIS SCI, V28, P1260; Leske DA, 2004, J AAPOS, V8, P28, DOI 10.1016/j.jaapos.2003.08.010; Li JR, 2011, INVEST OPHTH VIS SCI, V52, P4169, DOI 10.1167/iovs.11-7233; Maeda M, 1999, INVEST OPHTH VIS SCI, V28, P1260; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; MEHDORN E, 1989, DOC OPHTHALMOL, V71, P1, DOI 10.1007/BF00155128; Mullen KT, 1996, VISION RES, V36, P645, DOI 10.1016/0042-6989(95)00159-X; O'Connor AR, 2010, INVEST OPHTH VIS SCI, V51, P2019, DOI 10.1167/iovs.09-4434; Otto JMN, 2009, VISION RES, V49, P575, DOI 10.1016/j.visres.2009.01.007; PHILIPP W, 1989, GRAEF ARCH CLIN EXP, V227, P448, DOI 10.1007/BF02172897; PRATTJOHNSON JA, 1984, BRIT J OPHTHALMOL, V68, P174, DOI 10.1136/bjo.68.3.174; PRATTJOHNSON JA, 1983, ARCH OPHTHALMOL-CHIC, V101, P218; ROUSE MW, 1989, OPTOMETRY VISION SCI, V66, P355, DOI 10.1097/00006324-198906000-00004; Saladin J. J., 1998, BORISHS CLIN REFRACT, P724; Saladin JJ, 2005, OPTOMETRY VISION SCI, V82, P186, DOI 10.1097/01.OPX.0000156320.71949.9D; Selenow A., 1991, AMBLYOPIA BASIC CLIN; Sengpiel F, 1996, EYE, V10, P250, DOI 10.1038/eye.1996.54; Serrano-Pedraza I, 2011, INVEST OPHTH VIS SCI, V52, P2352, DOI 10.1167/iovs.10-6144; SIRETEANU R, 1989, INVEST OPHTH VIS SCI, V30, P2023; Sireteanu R, 1982, Hum Neurobiol, V1, P31; SIRETEANU R, 1981, VISION RES, V21, P1055, DOI 10.1016/0042-6989(81)90010-9; SIRETEANU R, 1981, VISION RES, V21, P1065, DOI 10.1016/0042-6989(81)90011-0; Tunnacliffe A. H., 1993, INTRO VISUAL OPTICS; von Graefe A., 1880, HDB GERAMMTEN AUGENH, V6; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; VONNOORDEN GK, 1985, INVEST OPHTH VIS SCI, V26, P1704; Watanabe Y, 2008, BRIT J OPHTHALMOL, V92, P47, DOI 10.1136/bjo.2007.117507; Wensveen JM, 2001, VISION RES, V41, P1593, DOI 10.1016/S0042-6989(00)00319-9; Wild JM, 2001, ACTA OPHTHALMOL SCAN, V79, P546, DOI 10.1034/j.1600-0420.2001.790602.x; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700	65	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36611	10.1371/journal.pone.0036611	http://dx.doi.org/10.1371/journal.pone.0036611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649494	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800011
J	Dantes, R; Metcalfe, J; Kim, E; Kato-Maeda, M; Hopewell, PC; Kawamura, M; Nahid, P; Cattamanchi, A				Dantes, Raymund; Metcalfe, John; Kim, Elizabeth; Kato-Maeda, Midori; Hopewell, Philip C.; Kawamura, Masae; Nahid, Payam; Cattamanchi, Adithya			Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENOMIC DELETIONS; GENE; PEROXIDASE; CATALASE; STRAINS	Background: Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of tuberculosis (TB) transmission. However, their role in the clinical presentation and outcomes of TB has not been evaluated. Methods: We included all cases of culture-confirmed, INH monoresistant tuberculosis reported to the San Francisco Department of Public Health Tuberculosis Control Section from October 1992 through October 2005. For cases with stored culture isolates, we used polymerase chain reaction (PCR) testing and gene sequencing to identify INH resistance-conferring mutations, and compared genotypic and phenotypic characteristics. Results: Among 101 consecutive cases of INH monoresistant TB in San Francisco 19 (19%) had isolates with a katG mutation other than S315T; 38 (38%) had isolates with the katG S315T mutation, 29 (29%) had isolates with a inhA-15;c-t promoter mutation, and 15 (15%) had isolates with other mutations. The katG S315T mutation was independently associated with high-level INH resistance (risk ratio [RR] 1.56, 95% confidence interval [CI] 1.07-2.27), and the inhA-15;c-t promoter mutation was inversely associated with high-level INH resistance ( RR 0.43, 95% CI 0.21-0.89). However, specific INH resistance-conferring mutations were not associated with the clinical severity or outcomes of INH monoresistant TB cases. Conclusion: These data suggest that INH resistance-conferring mutations do not impact the clinical presentation of TB.	[Dantes, Raymund; Metcalfe, John; Kim, Elizabeth; Kato-Maeda, Midori; Hopewell, Philip C.; Nahid, Payam; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Metcalfe, John; Kato-Maeda, Midori; Hopewell, Philip C.; Nahid, Payam; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Curry Int TB Ctr, San Francisco, CA USA; [Kawamura, Masae] Dept Publ Hlth, TB Control Sect, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Dantes, R (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	raydantes@gmail.com; acattamanchi@medsfgh.ucsf.edu		Nahid, Payam/0000-0003-2811-1311	National Institutes of Health [K23HL094141, K23HL092629, R01AI034238]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092629, K23HL094141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from the National Institutes of Health (K23HL094141 [AC], K23HL092629 [PN], and R01AI034238 [PH]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Cattamanchi A, 2006, INT J TUBERC LUNG D, V10, P297; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Metcalfe JZ, 2010, EMERG INFECT DIS, V16, P1403, DOI 10.3201/eid1609.100253; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; *WHO, 2009, WHO REP 2009 GLOB TU; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37956	10.1371/journal.pone.0037956	http://dx.doi.org/10.1371/journal.pone.0037956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649569	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800089
J	MacManes, MD; Lacey, EA				MacManes, Matthew D.; Lacey, Eileen A.			Is Promiscuity Associated with Enhanced Selection on MHC-DQ alpha in Mice (genus Peromyscus)?	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EFFECTIVE POPULATION-SIZE; DETECTING POSITIVE SELECTION; SEXUALLY-TRANSMITTED-DISEASE; II DRB DIVERSITY; MATE CHOICE; CONCURRENT PARTNERSHIPS; MICROSATELLITE MARKERS; MOLECULAR EVOLUTION; MONOGAMOUS RODENT	Reproductive behavior may play an important role in shaping selection on Major Histocompatibility Complex (MHC) genes. For example, the number of sexual partners that an individual has may affect exposure to sexually transmitted pathogens, with more partners leading to greater exposure and, hence, potentially greater selection for variation at MHC loci. To explore this hypothesis, we examined the strength of selection on exon 2 of the MHC-DQ alpha locus in two species of Peromyscus. While the California mouse (P. californicus) is characterized by lifetime social and genetic monogamy, the deer mouse (P. maniculatus) is socially and genetically promiscuous; consistent with these differences in mating behavior, the diversity of bacteria present within the reproductive tracts of females is significantly greater for P. maniculatus. To test the prediction that more reproductive partners and exposure to a greater range of sexually transmitted pathogens are associated with enhanced diversifying selection on genes responsible for immune function, we compared patterns and levels of diversity at the Class II MHC-DQ alpha locus in sympatric populations of P. maniculatus and P. californicus. Using likelihood based analyses, we show that selection is enhanced in the promiscuous P. maniculatus. This study is the first to compare the strength of selection in wild sympatric rodents with known differences in pathogen milieu.	[MacManes, Matthew D.; Lacey, Eileen A.] Univ Calif Berkeley, Museum Vertebrate Zool, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	MacManes, MD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	macmanes@gmail.com	MacManes, Matthew/B-8303-2011	MacManes, Matthew/0000-0002-2368-6960	NSF-DDIG [IOS0909798]; Museum of Vertebrate Zoology; Department of Integrative Biology; National Science Foundation; Texas Advanced Computing Center [TG-IBN100014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093227] Funding Source: NIH RePORTER	NSF-DDIG(National Science Foundation (NSF)); Museum of Vertebrate Zoology; Department of Integrative Biology; National Science Foundation(National Science Foundation (NSF)); Texas Advanced Computing Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a NSF-DDIG (IOS0909798), as well as by awards from the Museum of Vertebrate Zoology and Department of Integrative Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Computational resources were supported in part by the National Science Foundation through TeraGrid resources provided by The Texas Advanced Computing Center under grant number TG-IBN100014. The paper was greatly improved by suggestions from Sonal Singhal and several anonymous reviewers. Lastly, MDM would like to thank his wife Kate and his children, whose support has been unwavering.	Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anisimova M, 2003, GENETICS, V164, P1229; Bellinger MR, 2003, CONSERV BIOL, V17, P717, DOI 10.1046/j.1523-1739.2003.01581.x; Bester-Meredith JK, 2003, ETHOLOGY, V109, P797, DOI 10.1046/j.0179-1613.2003.00917.x; BIRDSALL DA, 1973, EVOLUTION, V27, P106, DOI 10.1111/j.1558-5646.1973.tb05922.x; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Bouzat JL, 2004, MOL ECOL, V13, P499, DOI 10.1046/j.1365-294X.2003.02068.x; Bredy TW, 2007, EUR J NEUROSCI, V25, P567, DOI 10.1111/j.1460-9568.2006.05266.x; Broquet T, 2009, EVOLUTION, V63, P674, DOI 10.1111/j.1558-5646.2008.00586.x; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chirhart SE, 2000, MOL ECOL, V9, P1669, DOI 10.1046/j.1365-294x.2000.01044-6.x; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Darwin C, 1859, ORIGIN SPECIES MEANS; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Eames KTD, 2004, MATH BIOSCI, V189, P115, DOI 10.1016/j.mbs.2004.02.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FOLTZ DW, 1981, AM NAT, V117, P665, DOI 10.1086/283751; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; FU YX, 1993, GENETICS, V133, P693; GUBERNICK DJ, 1993, BEHAV ECOL SOCIOBIOL, V32, P211; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; Hansen MM, 2007, MOL ECOL, V16, P1413, DOI 10.1111/j.1365-294X.2007.03255.x; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Harf R, 2005, MOL ECOL, V14, P85, DOI 10.1111/j.1365-294X.2004.02402.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HOLMES KK, 1994, P NATL ACAD SCI USA, V91, P2448, DOI 10.1073/pnas.91.7.2448; HURST GDD, 1995, ECOL ENTOMOL, V20, P230, DOI 10.1111/j.1365-2311.1995.tb00452.x; Johnson JA, 2004, MOL ECOL, V13, P2617, DOI 10.1111/j.1365-294X.2004.02264.x; Kalcounis-Rueppell Matina C, 2006, Front Zool, V3, P3, DOI 10.1186/1742-9994-3-3; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Kraut-Becher JR, 2003, SEX TRANSM DIS, V30, P221, DOI 10.1097/00007435-200303000-00009; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacManes MD, 2011, NATURWISSENSCHAFTEN, V98, P951, DOI 10.1007/s00114-011-0848-2; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Mullen LM, 2006, MOL ECOL NOTES, V6, P36, DOI 10.1111/j.1471-8286.2005.01128.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Oliver M, 2010, MOL ECOL, V19, P4099, DOI 10.1111/j.1365-294X.2010.04812.x; Oppelt C, 2010, MOL ECOL, V19, P4155, DOI 10.1111/j.1365-294X.2010.04766.x; Otto SP, 2000, TRENDS GENET, V16, P526, DOI 10.1016/S0168-9525(00)02141-7; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pfau RS, 1999, IMMUNOGENETICS, V49, P886, DOI 10.1007/s002510050569; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RIBBLE DO, 1992, ECOLOGY, V73, P859, DOI 10.2307/1940163; Ribble DO, 1996, ECOSCIENCE, V3, P423, DOI 10.1080/11956860.1996.11682359; RIBBLE DO, 1992, J ANIM ECOL, V61, P457, DOI 10.2307/5336; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schad J, 2011, HEREDITY, V107, P115, DOI 10.1038/hdy.2010.173; Schaschl H, 2006, HEREDITY, V97, P427, DOI 10.1038/sj.hdy.6800892; Schaschl H, 2005, IMMUNOGENETICS, V57, P108, DOI 10.1007/s00251-005-0784-4; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Shurtliff QR, 2005, J MAMMAL, V86, P531, DOI 10.1644/1545-1542(2005)86[531:PAOTCM]2.0.CO;2; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stiver JR, 2008, BIOL CONSERV, V141, P472, DOI 10.1016/j.biocon.2007.10.018; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; TAJIMA F, 1989, GENETICS, V123, P585; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; Vandegrift KJ, 2008, ECOLOGY, V89, P2251, DOI 10.1890/07-1935.1; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Whiteman NK, 2004, J PARASITOL, V90, P939, DOI 10.1645/GE-310R; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Wlasiuk G, 2010, EVOLUTION, V64, P2204, DOI 10.1111/j.1558-5646.2010.00989.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zelano B, 2002, AM NAT, V160, pS225, DOI 10.1086/342897; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	87	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37562	10.1371/journal.pone.0037562	http://dx.doi.org/10.1371/journal.pone.0037562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649541	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800060
J	Wang, RR; Zhang, XG; Zhang, JX; Fan, YY; Shen, Y; Hu, WW; Chen, Z				Wang, Rongrong; Zhang, Xiangnan; Zhang, Jianxiang; Fan, Yanying; Shen, Yao; Hu, Weiwei; Chen, Zhong			Oxygen-Glucose Deprivation Induced Glial Scar-Like Change in Astrocytes	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; CELL-CYCLE PROGRESSION; GROWTH-ASSOCIATED GENE; IN-VITRO MODEL; REACTIVE ASTROCYTES; AXONAL REGENERATION; RAT-BRAIN; EXPRESSION; NEUROCAN; STROKE	Background: It has been demonstrated that cerebral ischemia induces astrocyte reactivity, and subsequent glial scar formation inhibits axonal regeneration during the recovery phase. Investigating the mechanism of glial scar formation will facilitate the development of strategies to improve axonal regeneration. However, an in vitro model of ischemia-induced glial scar has not yet been systematically established. Methodology and Principal Findings: In the present study, we at the first time found that oxygen-glucose deprivation (OGD) in vitro can induce rat cortical astrocytes to present characteristics of glial scar. After OGD for 6 h, astrocytes showed a remarkable proliferation following 24 h reperfusion, evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and BrdU immunocytochemistry. Meanwhile, the expression of glial fibrillary acidic protein significantly increased, so did the expression of neurocan, which is a hallmark of the glial scar. In further experiments, neurons were co-cultured with astrocytes, which had been exposed to OGD, and then the immunostaining of class III beta-tubulin was carried out to assess the neurite growth. When the co-culture was performed at 48 h reperfusion of astrocytes, the neurite growth was obviously inhibited, and this inhibition could be reversed by chondroitinase ABC, which digests glycosaminoglycan chains on CSPGs, including neurocan. However, the processes of neurons were elongated, when the co-culture was performed immediately after OGD. Conclusions and Significance: Our results indicated that after conditioned OGD the astrocytes presented the characteristics of the glial scar, which are also comparable to the astrocytes in acute and chronic phases after cerebral ischemia in vivo. Therefore, the present system may be used as an in vitro model to explore the mechanisms underlying glial scar formation and the treatments to improve axonal regeneration after cerebral ischemia.	[Wang, Rongrong; Zhang, Xiangnan; Zhang, Jianxiang; Shen, Yao; Hu, Weiwei; Chen, Zhong] Zhejiang Univ, Coll Pharmaceut Sci,Dept Pharmacol, Sch Basic Med Sci,Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol,Minist Hlth China, Hangzhou, Zhejiang, Peoples R China; [Fan, Yanying] Shanxi Med Univ, Dept Pharmacol, Taiyuan, Shanxi, Peoples R China; [Shen, Yao] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China	Zhejiang University; Shanxi Medical University; Wenzhou Medical University	Chen, Z (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci,Dept Pharmacol, Sch Basic Med Sci,Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol,Minist Hlth China, Hangzhou, Zhejiang, Peoples R China.	huww@zju.edu.cn; chenzhong@zju.edu.cn	Zhang, xiangnan/C-9649-2010	Zhang, xiangnan/0000-0002-7603-7403	National Basic Research of China 973 Program [2011CB504403]; National Natural Science Foundation of China [81030061, 81173040, 81102429]	National Basic Research of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Basic Research of China 973 Program (2011CB504403, http://www.973.gov.cn), the National Natural Science Foundation of China (81030061, 81173040, 81102429; http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; Ciccarelli R, 2007, MOL PHARMACOL, V71, P1369, DOI 10.1124/mol.106.031617; Dai H, 2006, J NEUROCHEM, V96, P1390, DOI 10.1111/j.1471-4159.2005.03633.x; Deguchi K, 2005, BRAIN RES, V1037, P194, DOI 10.1016/j.brainres.2004.12.016; DOU CL, 1994, J NEUROSCI, V14, P7616; Gegg ME, 2005, BRAIN RES, V1036, P1, DOI 10.1016/j.brainres.2004.11.064; GRUMET M, 1994, J BIOL CHEM, V269, P12142; Huang XJ, 2008, GLIA, V56, P27, DOI 10.1002/glia.20588; Inatani M, 2000, INVEST OPHTH VIS SCI, V41, P2748; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kalman M, 2004, ADV MOL CEL, P787; Komitova M, 2002, J CEREBR BLOOD F MET, V22, P852, DOI 10.1097/00004647-200207000-00010; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Maeda N, 1996, DEVELOPMENT, V122, P647; Matsui F, 2005, J NEUROSCI RES, V81, P837, DOI 10.1002/jnr.20603; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Park LCH, 2001, MECH AGEING DEV, V123, P21, DOI 10.1016/S0047-6374(01)00336-0; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Wang Y, 1997, J NEUROSCI, V17, P4341; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Yamada H, 1997, J NEUROSCI, V17, P7784; Yang Q, 2011, J NEUROCHEM, V119, P644, DOI 10.1111/j.1471-4159.2011.07446.x; Yao XH, 2003, BRAIN RES, V967, P11, DOI 10.1016/S0006-8993(02)04120-3; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	44	49	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37574	10.1371/journal.pone.0037574	http://dx.doi.org/10.1371/journal.pone.0037574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629422	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300054
J	Zheng, WC; Reem, RE; Omarova, S; Huang, S; DiPatre, PL; Charvet, CD; Curcio, CA; Pikuleva, IA				Zheng, Wenchao; Reem, Rachel E.; Omarova, Saida; Huang, Suber; DiPatre, Pier Luigi; Charvet, Casey D.; Curcio, Christine A.; Pikuleva, Irina A.			Spatial Distribution of the Pathways of Cholesterol Homeostasis in Human Retina	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; OUTER SEGMENT MEMBRANES; AGE-RELATED MACULOPATHY; CENTRAL-NERVOUS-SYSTEM; SCAVENGER RECEPTOR BI; MACULAR DEGENERATION; IN-VIVO; VERTEBRATE RETINA; BRUCHS MEMBRANE; ACID SYNTHESIS	Background: The retina is a light-sensitive tissue lining the inner surface of the eye and one of the few human organs whose cholesterol maintenance is still poorly understood. Challenges in studies of the retina include its complex multicellular and multilayered structure; unique cell types and functions; and specific physico-chemical environment. Methodology/Principal Findings: We isolated specimens of the neural retina (NR) and underlying retinal pigment epithelium (RPE)/choroid from six deceased human donors and evaluated them for expression of genes and proteins representing the major pathways of cholesterol input, output and regulation. Eighty-four genes were studied by PCR array, 16 genes were assessed by quantitative real time PCR, and 13 proteins were characterized by immunohistochemistry. Cholesterol distribution among different retinal layers was analyzed as well by histochemical staining with filipin. Our major findings pertain to two adjacent retinal layers: the photoreceptor outer segments of NR and the RPE. We demonstrate that in the photoreceptor outer segments, cholesterol biosynthesis, catabolism and regulation via LXR and SREBP are weak or absent and cholesterol content is the lowest of all retinal layers. Cholesterol maintenance in the RPE is different, yet the gene expression also does not appear to be regulated by the SREBPs and varies significantly among different individuals. Conclusions/Significance: This comprehensive investigation provides important insights into the relationship and spatial distribution of different pathways of cholesterol input, output and regulation in the NR-RPE region. The data obtained are important for deciphering the putative link between cholesterol and age-related macular degeneration, a major cause of irreversible vision loss in the elderly.	[Zheng, Wenchao; Reem, Rachel E.; Omarova, Saida; Huang, Suber; Charvet, Casey D.; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Huang, Suber] Univ Hosp, Cleveland, OH USA; [DiPatre, Pier Luigi] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Curcio, Christine A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	Case Western Reserve University; University Hospitals of Cleveland; University of Texas System; University of Texas Medical Branch Galveston; University of Alabama System; University of Alabama Birmingham	Zheng, WC (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health [EY018383, AG024336, EY06109, T32 EY07157, P30 EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [P30EY011373, R01EY018383, R01EY006109, T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants EY018383 and AG024336 (IAP), EY06109 (CAC), T32 EY07157 (pre- and post-doctoral research training fellowships for CDC and RER, respectively), P30 EY11373 (to support the Visual Sciences Research Center Core Facilities), Jules and Doris Stein Professorship from the Research to Prevent Blindness Foundation (IAP), the Ohio Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; Bonilha VL, 1997, J CELL SCI, V110, P1717; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Bretillon L, 2007, CURR EYE RES, V32, P361, DOI 10.1080/02713680701231857; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Curcio CA, 2009, METHODS MOL BIOL, V580, P267, DOI 10.1007/978-1-60761-325-1_15; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; de la Llera-Moya M, 2001, J LIPID RES, V42, P1969; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Dotti MT, 2001, J INHERIT METAB DIS, V24, P696, DOI 10.1023/A:1012981019336; Duncan KG, 2009, BRIT J OPHTHALMOL, V93, P1116, DOI 10.1136/bjo.2008.144006; Duncan KG, 2002, BIOCHEM BIOPH RES CO, V292, P1017, DOI 10.1006/bbrc.2002.6756; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Elner Victor M, 2002, Trans Am Ophthalmol Soc, V100, P301; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FLIESLER SJ, 1993, FEBS LETT, V335, P234, DOI 10.1016/0014-5793(93)80736-E; Fliesler SJ, 1997, INT J BIOCHEM CELL B, V29, P877, DOI 10.1016/S1357-2725(97)00018-6; FLIESLER SJ, 1982, BIOCHIM BIOPHYS ACTA, V711, P138, DOI 10.1016/0005-2760(82)90020-0; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gordiyenko N, 2004, INVEST OPHTH VIS SCI, V45, P2822, DOI 10.1167/iovs.04-0074; GUARNERI P, 1994, J NEUROCHEM, V63, P86; Harris RBS, 1997, ANN NY ACAD SCI, V819, P155, DOI 10.1111/j.1749-6632.1997.tb51806.x; HAYES KC, 1989, INVEST OPHTH VIS SCI, V30, P225; Heo GY, 2011, J LIPID RES, V52, P1117, DOI 10.1194/jlr.M014217; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jaliffa CO, 2005, J NEUROCHEM, V94, P1666, DOI 10.1111/j.1471-4159.2005.03321.x; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Liao W-L, 2010, J PROTEOME RES; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; OMKUMAR RV, 1994, J BIOL CHEM, V269, P6810; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; RUSSELL DW, 2008, J LIPID RES, pS120; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Tserentsoodol N, 2006, MOL VIS, V12, P1319; Tserentsoodol N, 2006, MOL VIS, V12, P1306; Williams DL, 1999, CURR OPIN LIPIDOL, V10, P329, DOI 10.1097/00041433-199908000-00007; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	74	73	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37926	10.1371/journal.pone.0037926	http://dx.doi.org/10.1371/journal.pone.0037926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629470	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300084
J	Aggarwal, A; Monsivais, P; Drewnowski, A				Aggarwal, Anju; Monsivais, Pablo; Drewnowski, Adam			Nutrient Intakes Linked to Better Health Outcomes Are Associated with Higher Diet Costs in the US	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-ENERGY-DENSITY; VITAMIN-E CONSUMPTION; SOCIOECONOMIC POSITION; MONETARY COSTS; FATTY-ACIDS; WEIGHT-GAIN; RISK; CANCER; WOMEN	Purpose: Degrees of nutrient intake and food groups have been linked to differential chronic disease risk. However, intakes of specific nutrients may also be associated with differential diet costs and unobserved differences in socioeconomic status (SES). The present study examined degrees of nutrient intake, for every key nutrient in the diet, in relation to diet cost and SES. Methods: Socio-demographic data for a stratified random sample of adult respondents in the Seattle Obesity Study were obtained through telephone survey. Dietary intakes were assessed using food frequency questionnaire (FFQ) (n = 1,266). Following standard procedures, nutrient intakes were energy-adjusted using the residual method and converted into quintiles. Diet cost for each respondent was estimated using Seattle supermarket retail prices for 384 FFQ component foods. Results: Higher intakes of dietary fiber, vitamins A, C, D, E, and B12, beta carotene, folate, iron, calcium, potassium, and magnesium were associated with higher diet costs. The cost gradient was most pronounced for vitamin C, beta carotene, potassium, and magnesium. Higher intakes of saturated fats, trans fats and added sugars were associated with lower diet costs. Lower cost lower quality diets were more likely to be consumed by lower SES. Conclusion: Nutrients commonly associated with a lower risk of chronic disease were associated with higher diet costs. By contrast, nutrients associated with higher disease risk were associated with lower diet costs. The cost variable may help somewhat explain why lower income groups fail to comply with dietary guidelines and have highest rates of diet related chronic disease.	[Aggarwal, Anju; Monsivais, Pablo; Drewnowski, Adam] Univ Washington, Sch Publ Hlth, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA; [Aggarwal, Anju] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Monsivais, Pablo] Cambridge Inst Publ Hlth, United Kingdom Clin Res Collaborat Ctr Diet & Act, Cambridge, England	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge	Aggarwal, A (corresponding author), Univ Washington, Sch Publ Hlth, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA.	anjuagg@uw.edu	Drewnowski, Adam/HCI-4117-2022	Monsivais, Pablo/0000-0002-7088-6674	National Institutes of Health [NIDDK R01DK076608]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by National Institutes of Health Grant no. NIDDK R01DK076608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Bazzano LA, 2001, STROKE, V32, P1473, DOI 10.1161/01.STR.32.7.1473; Bray GA, 2004, AM J CLIN NUTR, V79, P537; BURKITT DP, 1972, LANCET, V1, P1408; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; Carlson A., 2008, DEV CNPP PRICES DATA; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P713; Cui X, 2010, INT J CANC; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Drewnowski A, 2004, AM J PUBLIC HEALTH, V94, P1555, DOI 10.2105/AJPH.94.9.1555; Drewnowski A, 2001, NUTR REV, V59, P370; Drewnowski A, 2010, AM J CLIN NUTR; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Fletcher RH, 2002, JAMA-J AM MED ASSOC, V287, P3127, DOI 10.1001/jama.287.23.3127; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Holcomb G, 2004, USDA COOKING YIELD D; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Jenkins DJA, 2000, BRIT J NUTR, V83, pS157; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1; KROMHOUT D, 1982, LANCET, V2, P518; Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Martinez ME, 1996, JNCI-J NATL CANCER I, V88, P1375, DOI 10.1093/jnci/88.19.1375; MCCARRON DA, 1990, MED HYPOTHESES, V31, P265, DOI 10.1016/0306-9877(90)90017-9; Monsivais P, 2007, J AM DIET ASSOC, V107, P2071, DOI 10.1016/j.jada.2007.09.009; Monsivais P, 2012, J EPIDEMIOL COMMUN H, V66, P530, DOI 10.1136/jech.2010.122333; Monsivais P, 2011, HEALTH AFFAIR, V30, P1471, DOI 10.1377/hlthaff.2010.1273; Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Murakami K, 2009, ENVIRON HEALTH INSIG, V3, P27; Neuhouser ML, 1999, CANCER EPIDEM BIOMAR, V8, P721; Ng K, 2009, BRIT J CANCER, V101, P916, DOI 10.1038/sj.bjc.6605262; Osganian SK, 2003, J AM COLL CARDIOL, V42, P246, DOI 10.1016/S0735-1097(03)00575-8; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Popkin BM, 1996, NEW ENGL J MED, V335, P716, DOI 10.1056/NEJM199609053351006; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Schroder H, 2006, INT J OBESITY, V30, P1574, DOI 10.1038/sj.ijo.0803308; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sources of Calcium among the US Population 2005-06, SOURC CALC US POP 20; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; Townsend MS, 2009, AM J CLIN NUTR, V89, P1220, DOI 10.3945/ajcn.2008.26916; TROWELL H, 1978, AM J CLIN NUTR, V31, pS53, DOI 10.1093/ajcn/31.10.S53; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; US Department of Agriculture, 2005, AD NUTR CAL NEEDS DI; US Department of Agriculture, 2010, TOT DIET COMB NUTR C; Waterlander WE, 2010, PUBLIC HEALTH NUTR, V13, P1599, DOI 10.1017/S1368980009992989; White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Yang H, 1999, Sheng Li Ke Xue Jin Zhan, V30, P123	66	82	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37533	10.1371/journal.pone.0037533	http://dx.doi.org/10.1371/journal.pone.0037533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662168	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300058
J	Jeelani, G; Sato, D; Husain, A; Escueta-de Cadiz, A; Sugimoto, M; Soga, T; Suematsu, M; Nozaki, T				Jeelani, Ghulam; Sato, Dan; Husain, Afzal; Escueta-de Cadiz, Aleyla; Sugimoto, Masahiro; Soga, Tomoyoshi; Suematsu, Makoto; Nozaki, Tomoyoshi			Metabolic Profiling of the Protozoan Parasite Entamoeba invadens Revealed Activation of Unpredicted Pathway during Encystation	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; L-CYSTEINE DEPRIVATION; ESCHERICHIA-COLI; GIARDIA-LAMBLIA; HISTOLYTICA; DIFFERENTIATION; IDENTIFICATION; POLYAMINE; CHITIN; GROWTH	Encystation, which is cellular differentiation from the motile, proliferative, labile trophozoite form to the dormant, resistant cyst form, is a crucial process found in parasitic and free-living protozoa such as Entamoeba, Giardia, Acanthamoeba, and Balamuthia. Since encystation is an essential process to deal with the adverse external environmental changes during the life cycle, and often integral to the transmission of the diseases, biochemical understanding of the process potentially provides useful measures against the infections caused by this group of protozoa. In this study, we investigated metabolic and transcriptomic changes that occur during encystation in Entamoeba invadens, the reptilian sibling of mammal-infecting E. histolytica, using capillary electrophoresis-tandem mass spectrometry-based metabolite profiling and DNA microarray-based expression profiling. As the encystation progressed, the levels of majority of metabolites involved in glycolysis and nucleotides drastically decreased, indicating energy generation is ceased. Furthermore, the flux of glycolysis was redirected toward chitin wall biosynthesis. We found remarkable temporal increases in biogenic amines such as isoamylamine, isobutylamine, and cadaverine, during the early period of encystation, when the trophozoites form large multicellular aggregates (precyst). We also found remarkable induction of c-aminobutyric acid (GABA) during encystation. This study has unveiled for the first time the dynamics of the transcriptional and metabolic regulatory networks during encystation, and should help in better understanding of the process in pathogenic eukaryotes, and further development of measures controlling infections they cause.	[Jeelani, Ghulam; Husain, Afzal; Escueta-de Cadiz, Aleyla; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Jeelani, Ghulam; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo, Japan; [Sato, Dan; Sugimoto, Masahiro; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Husain, Afzal; Escueta-de Cadiz, Aleyla] Gunma Univ, Grad Sch Med, Dept Parasitol, Maebashi, Gunma 371, Japan; [Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); Keio University; Keio University; Gunma University; University of Tsukuba	Jeelani, G (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018; Soga, Tomoyoshi/B-8105-2014; HUSAIN, AFZAL/GRO-1733-2022	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; Sugimoto, Masahiro/0000-0003-3316-2543; HUSAIN, AFZAL/0000-0002-6627-5520	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18GS0314, 18050006, 18073001, 20390119, 23390099]; MEXT [23117001]; Ministry of Health, Labour and Welfare of Japan [H20-Shinkosaiko-ippan-016, H23-Shinkosaiko-ippan-014]; Japan Health Sciences Foundation [KAA1551, KHA1101]; Global Center of Excellence Program for Human Metabolomic System Biology of MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Global Center of Excellence Program for Human Metabolomic System Biology of MEXT	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (18GS0314, 18050006, 18073001, 20390119, 23390099), a Grant-in-Aid for Innovative Scientific Research from MEXT (23117001), a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan (H20-Shinkosaiko-ippan-016, H23-Shinkosaiko-ippan-014), and a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (KAA1551, KHA1101) to TN. GJ and TN were supported in part by the Global Center of Excellence Program for Human Metabolomic System Biology of MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; ARROYOBEGOVICH A, 1982, J PARASITOL, V68, P253, DOI 10.2307/3281183; ATKINSON DE, 1969, ANNU REV MICROBIOL, V23, P47, DOI 10.1146/annurev.mi.23.100169.000403; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; BADETDENISOT MA, 1993, B SOC CHIM FR, V130, P249; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Barron-Gonzalez MP, 2008, EXP PARASITOL, V118, P600, DOI 10.1016/j.exppara.2007.11.002; BAUZA T, 1995, B OIV, V767, P42; BLANKENSHIP J, 1984, P SOC EXP BIOL MED, V177, P180, DOI 10.3181/00379727-177-41930; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Boudonck KJ, 2009, BIOANALYSIS, V1, P1645, DOI 10.4155/BIO.09.142; BRUCKNER DA, 1992, CLIN MICROBIOL REV, V5, P356, DOI 10.1128/CMR.5.4.356-369.1992; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; CHAGLA AH, 1974, J GEN MICROBIOL, V85, P139, DOI 10.1099/00221287-85-1-139; CHAPMAN A, 1985, FEBS LETT, V191, P287, DOI 10.1016/0014-5793(85)80026-0; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Chavez-Munguia B, 2005, J EUKARYOT MICROBIOL, V52, P153, DOI 10.1111/j.1550-7408.2005.04-3273.x; Chavez-Munguia B, 2007, PARASITOL RES, V100, P1169, DOI 10.1007/s00436-006-0447-x; EDWARDS MR, 1989, MOL BIOCHEM PARASIT, V37, P19, DOI 10.1016/0166-6851(89)90098-4; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Husain A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-275; Husain A, 2010, J BIOL CHEM, V285, P39160, DOI 10.1074/jbc.M110.167304; JAKOBY WB, 1959, J BIOL CHEM, V234, P2145; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kimball E, 2006, ANAL BIOCHEM, V358, P273, DOI 10.1016/j.ab.2006.07.038; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lonvaud-Funel A, 2001, FEMS MICROBIOL LETT, V199, P9, DOI 10.1016/S0378-1097(01)00157-4; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MCCONNACHIE EW, 1955, PARASITOLOGY, V45, P452, DOI 10.1017/S0031182000027803; MCLAUGHLIN J, 1985, J PROTOZOOL, V32, P221; MEEROVITCH E, 1961, J PARASITOL, V47, P791, DOI 10.2307/3275473; Morales-Vallarta M, 1997, Arch Med Res, V28 Spec No, P150; Muller M., 1991, P80; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Park MH, 1997, BIOL SIGNAL, V6, P115; Ramputh AL, 1996, PLANT PHYSIOL, V111, P1349, DOI 10.1104/pp.111.4.1349; REEVES RE, 1984, ADV PARASIT, V23, P105, DOI 10.1016/S0065-308X(08)60286-9; RHODES D, 1986, PLANT PHYSIOL, V82, P890, DOI 10.1104/pp.82.4.890; Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; Schnackenberg LK, 2006, PHARMACOGENOMICS, V7, P1077, DOI 10.2217/14622416.7.7.1077; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; SHUKLA O P, 1990, Biological Memoirs, V16, P6; Siddiqui R, 2010, EXP PARASITOL, V126, P22, DOI 10.1016/j.exppara.2009.09.013; Siddiqui R, 2009, PARASITOL RES, V104, P1439, DOI 10.1007/s00436-009-1346-8; SJOERDSMA A, 1984, CLIN PHARMACOL THER, V35, P287, DOI 10.1038/clpt.1984.33; SLOCUM RD, 1984, ARCH BIOCHEM BIOPHYS, V235, P283, DOI 10.1016/0003-9861(84)90201-7; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; SPINDLER KD, 1990, PARASITOL RES, V76, P283, DOI 10.1007/BF00928180; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STRUSZCZYK H, 1987, J APPL POLYM SCI, V33, P177, DOI 10.1002/app.1987.070330115; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; VAZQUEZDELARACISNEROS LG, 1984, J PARASITOL, V70, P629, DOI 10.2307/3281741; VERMA AK, 1974, BIOCHEM PHARMACOL, V23, P57, DOI 10.1016/0006-2952(74)90313-X; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; WALLACE W, 1984, PLANT PHYSIOL, V75, P170, DOI 10.1104/pp.75.1.170; WARD HD, 1985, INFECT IMMUN, V49, P629, DOI 10.1128/IAI.49.3.629-634.1985; Ximenez C, 2009, INFECT GENET EVOL, V9, P1023, DOI 10.1016/j.meegid.2009.06.008; Zhou JX, 1998, DIABETES, V47, P1836, DOI 10.2337/diabetes.47.12.1836; ZHU CM, 1989, MOL CELL BIOCHEM, V90, P145, DOI 10.1007/BF00221214; ZUO X, 1995, FEMS MICROBIOL LETT, V130, P253	74	48	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37740	10.1371/journal.pone.0037740	http://dx.doi.org/10.1371/journal.pone.0037740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662204	Green Published, gold			2022-12-27	WOS:000305342300094
J	Ma, Y; Han, SH				Ma, Yina; Han, Shihui			Is the Self Always Better than a Friend? Self-Face Recognition in Christians and Atheists	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; ADVANTAGE; AWARENESS; COGNITION; CULTURE; OTHERS	Early behavioral studies found that human adults responded faster to their own faces than faces of familiar others or strangers, a finding referred to as self-face advantage. Recent research suggests that the self-face advantage is mediated by implicit positive association with the self and is influenced by sociocultural experience. The current study investigated whether and how Christian belief and practice affect the processing of self-face in a Chinese population. Christian and Atheist participants were recruited for an implicit association test (IAT) in Experiment 1 and a face-owner identification task in Experiment 2. Experiment 1 found that atheists responded faster to self-face when it shared the same response key with positive compared to negative trait adjectives. This IAT effect, however, was significantly reduced in Christians. Experiment 2 found that atheists responded faster to self-face compared to a friend's face, but this self-face advantage was significantly reduced in Christians. Hierarchical regression analyses further showed that the IAT effect positively predicted self-face advantage in atheists but not in Christians. Our findings suggest that Christian belief and practice may weaken implicit positive association with the self and thus decrease the advantage of the self over a friend during face recognition in the believers.	[Ma, Yina; Han, Shihui] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	Peking University	Ma, Y (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	shan@pku.edu.cn	Ma, Yina/AAI-4307-2020; Ma, Yina/H-6203-2017	Ma, Yina/0000-0002-5457-0354	National Natural Science Foundation of China [91024032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Project 91024032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; [Anonymous], 2011, BLUE BOOK RELIG ANN; Burns C, 2003, BUDDHIST CHRISTIAN S, V23, P87; Ching Julia, 1984, BUDDHIST CHRISTIAN S, V4, P31, DOI DOI 10.2307/1389935; Chiu C-Y., 2006, SOCIAL PSYCHOL CULTU; Gallup GG, 1998, BEHAV PROCESS, V42, P239, DOI 10.1016/S0376-6357(97)00079-X; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Heine SJ, 2001, J PERS, V69, P881, DOI 10.1111/1467-6494.696168; Hoekema AA, 1975, CHRISTIAN LOOKS HIMS; Johnson MK, 2010, SOC PSYCHOL PERS SCI, V1, P119, DOI 10.1177/1948550609357246; Keenan J. P., 2003, FACE MIRROR SEARCH O; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Koole SL, 2010, PERS SOC PSYCHOL REV, V14, P95, DOI 10.1177/1088868309351109; Liew SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016901; Ma YN, 2010, J EXP PSYCHOL HUMAN, V36, P619, DOI 10.1037/a0015797; Ma YN, 2009, J EXP SOC PSYCHOL, V45, P1048, DOI 10.1016/j.jesp.2009.05.008; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Ng SH, 2010, ASIAN J SOC PSYCHOL, V13, P83, DOI 10.1111/j.1467-839X.2010.01303.x; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Sui J, 2007, PSYCHOL SCI, V18, P861, DOI 10.1111/j.1467-9280.2007.01992.x; Sui J, 2009, SOC NEUROSCI, V4, P402, DOI 10.1080/17470910802674825; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016	26	9	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37824	10.1371/journal.pone.0037824	http://dx.doi.org/10.1371/journal.pone.0037824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662231	Green Published, gold			2022-12-27	WOS:000305342300121
J	Maude, RJ; Socheat, D; Nguon, C; Saroth, P; Dara, P; Li, GQ; Song, JP; Yeung, S; Dondorp, AM; Day, NP; White, NJ; White, LJ				Maude, Richard J.; Socheat, Duong; Nguon, Chea; Saroth, Preap; Dara, Prak; Li, Guoqiao; Song, Jianping; Yeung, Shunmay; Dondorp, Arjen M.; Day, Nicholas P.; White, Nicholas J.; White, Lisa J.			Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance	PLOS ONE			English	Article							871G-GREATER-THAN-A; POPULATION; VARIANT; AREA	Background: Malaria elimination requires a variety of approaches individually optimized for different transmission settings. A recent field study in an area of low seasonal transmission in South West Cambodia demonstrated dramatic reductions in malaria parasite prevalence following both mass drug administration (MDA) and high treatment coverage of symptomatic patients with artemisinin-piperaquine plus primaquine. This study employed multiple combined strategies and it was unclear what contribution each made to the reductions in malaria. Method and Findings: A mathematical model fitted to the trial results was used to assess the effects of the various components of these interventions, design optimal elimination strategies, and explore their interactions with artemisinin resistance, which has recently been discovered in Western Cambodia. The modelling indicated that most of the initial reduction of P. falciparum malaria resulted from MDA with artemisinin-piperaquine. The subsequent continued decline and near elimination resulted mainly from high coverage with artemisinin-piperaquine treatment. Both these strategies were more effective with the addition of primaquine. MDA with artemisinin combination therapy (ACT) increased the proportion of artemisinin resistant infections, although much less than treatment of symptomatic cases with ACT, and this increase was slowed by adding primaquine. Artemisinin resistance reduced the effectiveness of interventions using ACT when the prevalence of resistance was very high. The main results were robust to assumptions about primaquine action, and immunity. Conclusions: The key messages of these modelling results for policy makers were: high coverage with ACT treatment can produce a long-term reduction in malaria whereas the impact of MDA is generally only short-term; primaquine enhances the effect of ACT in eliminating malaria and reduces the increase in proportion of artemisinin resistant infections; parasite prevalence is a better surveillance measure for elimination programmes than numbers of symptomatic cases; combinations of interventions are most effective and sustained efforts are crucial for successful elimination.	[Maude, Richard J.; Yeung, Shunmay; Dondorp, Arjen M.; Day, Nicholas P.; White, Nicholas J.; White, Lisa J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Maude, Richard J.; Dondorp, Arjen M.; Day, Nicholas P.; White, Nicholas J.; White, Lisa J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Maude, Richard J.] Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5ST, W Midlands, England; [Socheat, Duong; Nguon, Chea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Saroth, Preap] Kampot Prov Hlth Dept, Kampot, Cambodia; [Dara, Prak] Kampong Speu Prov Hlth Dept, Kampong Speu, Cambodia; [Li, Guoqiao; Song, Jianping] Guangzhou Univ Chinese Med, Res Ctr Qinghao Artemisia Annual L, Guangzhou, Guangdong, Peoples R China; [Yeung, Shunmay] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London WC1, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Heart of England NHS Foundation Trust; University of Birmingham; National Center Parasitology, Entomology & Malaria Control; Guangzhou University of Chinese Medicine; University of London; London School of Hygiene & Tropical Medicine	Maude, RJ (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	richardmaude@gmail.com	White, Lisa/AAC-9396-2020; White, Nick/AAC-6527-2019; Maude, Richard James/AAV-3567-2020; White, Nicholas J/I-4629-2012	White, Lisa/0000-0002-6523-185X; White, Nick/0000-0002-1897-1978; Maude, Richard James/0000-0002-5355-0562; Yeung, Shunmay/0000-0002-0997-0850	Wellcome Trust of Great Britain [077166/Z/05/Z]	Wellcome Trust of Great Britain(Wellcome Trust)	This study was funded by the Wellcome Trust of Great Britain (www.wellcome.ac.uk, grant number 077166/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006627; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Li G, 2010, J GUANGZHOU U TRADIT, V1, P90; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Maude RJ, 2010, INT HEALTH, V2, P239, DOI 10.1016/j.inhe.2010.09.005; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; National Center for Parasitology Entomology and Malaria Control Kingdom of Cambodia Ministry of Health Cambodia, 2011, STRAT PLAN EL MAL CA; National Center for Parasitology Entomology and Malaria Control Ministry of Health Cambodia, 2004, ANN PROGR REP NAT CT; National Institute of Statistics Ministry of Planning Cambodia, 2008, GEN POP CENS CAMB 20; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Pagnoni F, 1997, T ROY SOC TROP MED H, V91, P512, DOI 10.1016/S0035-9203(97)90006-7; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; Song J, 2006, J GUANGZHOU U TRADIT, V23, P89; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; WHO, 2010, GUID TREATM MAL, V2nd; *WHO MEK MAL PROGR, 2008, DEV STRAT EL PLASM F	24	67	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37166	10.1371/journal.pone.0037166	http://dx.doi.org/10.1371/journal.pone.0037166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662135	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300026
J	Morales-Espinosa, R; Soberon-Chavez, G; Delgado-Sapien, G; Sandner-Miranda, L; Mendez, JL; Gonzalez-Valencia, G; Cravioto, A				Morales-Espinosa, Rosario; Soberon-Chavez, Gloria; Delgado-Sapien, Gabriela; Sandner-Miranda, Luisa; Mendez, Jose L.; Gonzalez-Valencia, Gerardo; Cravioto, Alejandro			Genetic and Phenotypic Characterization of a Pseudomonas aeruginosa Population with High Frequency of Genomic Islands	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PATHOGENICITY ISLANDS; VIRULENCE GENES; ANTIBIOTIC-RESISTANCE; STRAIN PA14; DIVERSITY; CLONE; SEQUENCE; IDENTIFICATION; ENVIRONMENT	Various genomic islands, PAPI-1, PAPI-2, PAGI-1, PAGI-2, PAGI-3, and PAGI-4, and the element pKLC102 have been characterized in different P. aeruginosa strains from diverse habitats and geographical locations. Chromosomal DNA macroarray of 100 P. aeruginosa strains isolated from 85 unrelated patients hospitalized in an intensive care unit was created to assess the occurrence of these genomic islands (GEIs). The macroarray was then hybridized with labeled probes derived from each genomic island. In addition, PFGE patterns with SpeI, frequency of virulence genes, and antimicrobial resistance patterns of the strains were studied. Our results showed that almost all P. aeruginosa strains presented up to eight virulence genes. By SpeI macrorestriction fragment analysis we were able to identify 49 restriction patterns; 35 patterns correspond to single strains and the remaining 14 to strains subgroup (a-n). Most of the strains showed variation in number or composition of GEIs and a specific antimicrobial pattern indicating that each strain was an unrelated isolate. In terms of the number of genomic islands per strain, 7 GEIs were found in 34% of the strains, 6 in 18%, 5 in 12%, 4 in 14%, 3 in 10%, 2 in 7%, and 1 in 4%; only one isolate did not present any GEI. The genomic islands PAPI-1 and PAPI-2 and the element pKLC102 were the most frequently detected. The analysis of the location of each GEI in the chromosome of two strains show that the islands PAGI-3, PAPI-1, PAPI-2 and pKLC102 are present in the insertion site previously reported, but that PAGI-2 and PAGI-4 are inserted in another chromosome place in a site not characterized yet. In conclusion our data show that P. aeruginosa strains exhibited an epidemic population structure with horizontal transfer of DNA resulting in a high frequency of GEIs.	[Morales-Espinosa, Rosario; Delgado-Sapien, Gabriela; Sandner-Miranda, Luisa; Mendez, Jose L.] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Soberon-Chavez, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico; [Gonzalez-Valencia, Gerardo] Inst Mexicano Seguro Social, Ctr Med Nacl, Unit Med Invest Infect & Parasitol Dis, Mexico City, DF, Mexico; [Cravioto, Alejandro] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social; International Centre for Diarrhoeal Disease Research (ICDDR)	Morales-Espinosa, R (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	marosari@servidor.unam.mx		Delgado, Gabriela/0000-0003-4577-4440; Soberon-Chavez, Gloria/0000-0002-0282-3882; Morales-Espinosa, Rosario/0000-0003-2110-4397	CONACYT [100343]; DGAPA from Universidad Nacional Autonoma de Mexico [N206808]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA from Universidad Nacional Autonoma de Mexico	This research was funded by CONACYT grant number 100343 and DGAPA grant number N206808 from Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, TFPGA TOOLS POPULATI; [Anonymous], 2005, M100S15 CLSINCCLS; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; Arruda EAG, 1999, INFECT CONT HOSP EP, V20, P620, DOI 10.1086/501683; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Battle SE, 2009, FEMS MICROBIOL LETT, V290, P70, DOI 10.1111/j.1574-6968.2008.01406.x; Brewer C, 1996, CHEST, V109, P1019; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Choi JY, 2002, J BACTERIOL, V184, P952, DOI 10.1128/jb.184.4.952-961.2002; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; Finnan S, 2004, J CLIN MICROBIOL, V42, P5783, DOI 10.1128/JCM.42.12.5783-5792.2004; Gaballa A, 1998, MOL MICROBIOL, V30, P547, DOI 10.1046/j.1365-2958.1998.01085.x; GALLOWAY DR, 1991, MOL MICROBIOL, V5, P2315, DOI 10.1111/j.1365-2958.1991.tb02076.x; Gilligan Peter H., 1995, P509; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GRIFFITH SJ, 1989, J INFECT DIS, V160, P1030, DOI 10.1093/infdis/160.6.1030; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; KAPER JB, 1999, PATHOGENICITY ISLAND; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Liang XY, 2001, J BACTERIOL, V183, P843, DOI 10.1128/JB.183.3.843-853.2001; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Qiu XY, 2006, P NATL ACAD SCI USA, V103, P19830, DOI 10.1073/pnas.0606810104; REGELMANN WE, 1995, PEDIATR PULM, V19, P1, DOI 10.1002/ppul.1950190102; Romling U, 1997, J MOL BIOL, V271, P386, DOI 10.1006/jmbi.1997.1186; ROMLING U, 1995, MOL MICROBIOL, V17, P323, DOI 10.1111/j.1365-2958.1995.mmi_17020323.x; Rumbaugh KP, 1999, J SURG RES, V82, P95, DOI 10.1006/jsre.1998.5523; Schmidt KD, 1996, J BACTERIOL, V178, P85, DOI 10.1128/jb.178.1.85-93.1996; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Shen K, 2002, INFECT IMMUN, V74, P5272; Smith JM, 1993, P NATL ACAD SCI USA, V10, P3484; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tummler B, 2006, PSEUDOMONAS, V4, P5; WICK MJ, 1990, ANNU REV MICROBIOL, V44, P335, DOI 10.1146/annurev.mi.44.100190.002003; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wolska K, 2009, POL J MICROBIOL, V58, P255; Woods DE, 2004, TRENDS MICROBIOL, V12, P437, DOI 10.1016/j.tim.2004.08.003; Wuerdemann D, 2007, FEMS MICROBIOL LETT, V275, P244, DOI 10.1111/j.1574-6968.2007.00891.x	55	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37459	10.1371/journal.pone.0037459	http://dx.doi.org/10.1371/journal.pone.0037459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662157	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300047
J	Sato, N; Ochi, D; Minami, H; Yokawa, K				Sato, Noriyosi; Ochi, Daisuke; Minami, Hiroshi; Yokawa, Kotaro			Evaluation of the Effectiveness of Light Streamer Tori-Lines and Characteristics of Bait Attacks by Seabirds in the Western North Pacific	PLOS ONE			English	Article							LONGLINE FISHERY; MITIGATION MEASURES; CATCH RATES; BY-CATCH	To improve the effectiveness of tori-lines it is necessary to evaluate the ability of tori-lines to mitigate seabird bycatch and determine what kind of seabird species gather during line settings, attack the bait and are incidentally caught. We conducted two experiments in the western North Pacific and examined the effectiveness for seabird mitigation of light streamer tori-lines which have no long streamers but many light (short) streamers and are mainly used in the North Pacific area. Firstly, the effectiveness of two different types of tori-line (light streamer (1 m) and long streamer (up to 7 m) tori-line) and of two different colors (yellow and red) of light streamers for seabird bycatch avoidance was evaluated using 567 sets based on data from 20 offshore surface commercial longliners. No significant difference in the bycatch number between the different tori-line types and streamer colors was found. Secondly, we investigated the characteristics of the seabird bycatch in the North Pacific and the effectiveness of three different types of streamers (light, hybrid and modified light types) by detailed observations of seabird attacks using a chartered longline vessel. Although the appearance rate of albatrosses and shearwaters were 40.9% and 27.7%, Laysan albatross was the main seabird species that followed the vessel but shearwaters seldom followed the vessel and did not aggregate during line setting. In all attacks on bait observed during line settings, 81% and 7% were by albatrosses and shearwaters, respectively. In the number of primary attacks by Laysan albatrosses which attacked most aggressively of all seabirds, there were no significant differences among the tori-line types. No individuals of shearwater were caught. The results of both experiments indicated that light streamer tori-lines were as effective as tori-lines with long streamers for mitigating seabird bycatch in the North Pacific.	[Sato, Noriyosi; Ochi, Daisuke; Minami, Hiroshi; Yokawa, Kotaro] Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka, Japan; [Sato, Noriyosi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan	Japan Fisheries Research & Education Agency (FRA); Nagasaki University	Sato, N (corresponding author), Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka, Japan.	norico3000@gmail.com	Ochi, Daisuke/B-4329-2016	Ochi, Daisuke/0000-0002-6614-8193; Sato, Noriyosi/0000-0001-5023-5375				[Anonymous], 2010, R LANG ENV STAT COMP; Ashford J.R., 1995, CCAMLR Science, V2, P111; Barnes KN, 1997, BIOL CONSERV, V82, P227, DOI 10.1016/S0006-3207(97)00020-7; Bates D. M., 2007, LME4 LINEAR MIXED EF; Boggs CH, 2001, UASGCP REP, V2001, P79; Brooke M, 2004, ALBATROSSES PETRELS; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Hosono Takashi, 2008, Bulletin of Fisheries Research Agency, P1; IUCN, 2010, RED LIST THREAT SPEC; Japan WCPFC report, 2008, 4 REG SESS SCI COMM; Japan WCPFC report, 2009, 5 REG SESS SCI COMM; Klaer N, 1998, EMU, V98, P305, DOI 10.1071/MU98042; Lokkeborg S, 1998, ICES J MAR SCI, V55, P145, DOI 10.1006/jmsc.1997.9997; Melvin E.F., 2010, 3 M SEAB BYC WORK GR; Murray Talbot E., 1993, Bird Conservation International, V3, P181; Shealer David A., 2002, P137; Shiode D, 2001, CCSBTERS011160; Venables WN., 2002, MODERN APPL STAT S 4; WCPFC, 2007, 4 REG SESS SCI COMM; Yokota K, 2008, 4 REG SESS SCI COMM; Yokota K, 2007, 3 REG SESS SCI COMM; Yokota K, 2011, FISHERIES SCI, V77, P479, DOI 10.1007/s12562-011-0357-4	23	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37546	10.1371/journal.pone.0037546	http://dx.doi.org/10.1371/journal.pone.0037546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662169	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300059
J	Wang, JM; Wu, ZQ; Jin, Q				Wang, Jianmin; Wu, Zhiqiang; Jin, Qi			COPI Is Required for Enterovirus 71 Replication	PLOS ONE			English	Article							FUNCTIONAL GENOMIC SCREEN; MOUTH-DISEASE; BREFELDIN-A; SECRETORY PATHWAY; MOLECULAR EPIDEMIOLOGY; ENDOPLASMIC-RETICULUM; POLIOVIRUS INFECTION; WESTERN-AUSTRALIA; BINDING PROTEIN; RNA VIRUSES	Enterovirus 71 (EV71), a member of the Picornaviridae family, is found in Asian countries where it causes a wide range of human diseases. No effective therapy is available for the treatment of these infections. Picornaviruses undergo RNA replication in association with membranes of infected cells. COPI and COPII have been shown to be involved in the formation of picornavirus-induced vesicles. Replication of several picornaviruses, including poliovirus and Echovirus 11 (EV11), is dependent on COPI or COPII. Here, we report that COPI, but not COPII, is required for EV71 replication. Replication of EV71 was inhibited by brefeldin A and golgicide A, inhibitors of COPI activity. Furthermore, we found EV71 2C protein interacted with COPI subunits by co-immunoprecipitation and GST pull-down assay, indicating that COPI coatomer might be directed to the viral replication complex through viral 2C protein. Additionally, because the pathway is conserved among different species of enteroviruses, it may represent a novel target for antiviral therapies.	[Wang, Jianmin] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JM (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	wang, jian/GVS-0711-2022		National Basic Research Program [2011CB504902, 2005CB522905]; Ministry of Science and Technology of China	National Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The work was supported by the National Basic Research Program (Grant No. 2011CB504902 and No. 2005CB522905) (http://www.973.gov.cn/AreaAppl.aspx) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Barco A, 1998, J VIROL, V72, P3560, DOI 10.1128/JVI.72.5.3560-3570.1998; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1994, ARCH VIROL, P147; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2006, PLOS PATHOG, V2, P900, DOI 10.1371/journal.ppat.0020102; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Craig ME, 1999, J PAEDIATR CHILD H, V35, P107, DOI 10.1046/j.1440-1754.1999.t01-1-00348.x; Crotty S, 2004, J VIROL, V78, P3378, DOI 10.1128/JVI.78.7.3378-3386.2004; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; DeLisle RC, 1996, EUR J CELL BIOL, V71, P62; DOEDENS J, 1994, ARCH VIROL, P159; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; ECHEVERRI AC, 1995, VIROLOGY, V208, P540, DOI 10.1006/viro.1995.1185; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gazina EV, 2002, J VIROL, V76, P11113, DOI 10.1128/JVI.76.21.11113-11122.2002; IRURZUN A, 1992, VIROLOGY, V191, P166, DOI 10.1016/0042-6822(92)90178-R; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; O'Donnell VK, 2001, VIROLOGY, V287, P151, DOI 10.1006/viro.2001.1035; Orcl L, 1991, CELL, V64, P1183; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; van der Linden L, 2010, J VIROL, V84, P7535, DOI 10.1128/JVI.02684-09; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	58	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38035	10.1371/journal.pone.0038035	http://dx.doi.org/10.1371/journal.pone.0038035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662263	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300155
J	Pecsi, I; Hirmondo, R; Brown, AC; Lopata, A; Parish, T; Vertessy, BG; Toth, J				Pecsi, Ildiko; Hirmondo, Rita; Brown, Amanda C.; Lopata, Anna; Parish, Tanya; Vertessy, Beata G.; Toth, Judit			The dUTPase Enzyme Is Essential in Mycobacterium smegmatis	PLOS ONE			English	Article							BIFUNCTIONAL DCTP DEAMINASE; PHOSPHATE ESTER HYDROLYSIS; ACTIVE-SITE; CATALYTIC MECHANISM; ESCHERICHIA-COLI; METHANOCALDOCOCCUS-JANNASCHII; QUANTITATIVE-DETERMINATION; SACCHAROMYCES-CEREVISIAE; THYMIDYLATE METABOLISM; STRUCTURAL BASIS	Thymidine biosynthesis is essential in all cells. Inhibitors of the enzymes involved in this pathway (e. g. methotrexate) are thus frequently used as cytostatics. Due to its pivotal role in mycobacterial thymidylate synthesis dUTPase, which hydrolyzes dUTP into the dTTP precursor dUMP, has been suggested as a target for new antitubercular agents. All mycobacterial genomes encode dUTPase with a mycobacteria-specific surface loop absent in the human dUTPase. Using Mycobacterium smegmatis as a fast growing model for Mycobacterium tuberculosis, we demonstrate that dUTPase knock-out results in lethality that can be reverted by complementation with wild-type dUTPase. Interestingly, a mutant dUTPase gene lacking the genus-specific loop was unable to complement the knock-out phenotype. We also show that deletion of the mycobacteria-specific loop has no major effect on dUTPase enzymatic properties in vitro and thus a yet to be identified loop-specific function seems to be essential within the bacterial cell context. In addition, here we demonstrated that Mycobacterium tuberculosis dUTPase is fully functional in Mycobacterium smegmatis as it rescues the lethal knock-out phenotype. Our results indicate the potential of dUTPase as a target for antitubercular drugs and identify a genus-specific surface loop on the enzyme as a selective target.	[Pecsi, Ildiko; Hirmondo, Rita; Lopata, Anna; Vertessy, Beata G.; Toth, Judit] Hungarian Acad Sci, Inst Enzymol, RCNS, Budapest, Hungary; [Pecsi, Ildiko; Brown, Amanda C.; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of London; Queen Mary University London; Budapest University of Technology & Economics	Pecsi, I (corresponding author), Hungarian Acad Sci, Inst Enzymol, RCNS, Budapest, Hungary.	vertessy@enzim.hu; tothj@enzim.hu	Vertessy, Beata G/H-6202-2012	Vertessy, Beata G./0000-0002-1288-2982	US National Institutes of Health [1R01TW008130]; Howard Hughes Medical Institutes [55000342]; Hungarian Scientific Research Funds [PD72008, CK-78646, K68229, K72973, NI68466]; National Office for Research and Technology, Hungary [JAP_TSZ_071128_TB_INTER]; EU [SPINE2c LSHG-CT-2006-031220, TEACH-SG LSSG-CT-2007-037198]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; EMBO Short Term Fellowship; Postgraduate Research Fellowship of Gedeon Richter Plc. Hungary; Gedeon Richter Plc; FOGARTY INTERNATIONAL CENTER [R01TW008130] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Office for Research and Technology, Hungary(National Office for Research and Technology); EU(European Commission); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Postgraduate Research Fellowship of Gedeon Richter Plc. Hungary; Gedeon Richter Plc; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the US National Institutes of Health [grant number 1R01TW008130];, the Howard Hughes Medical Institutes [grant number 55000342]; the Hungarian Scientific Research Funds [grant numbers PD72008, CK-78646, K68229, K72973, NI68466]; the National Office for Research and Technology, Hungary [grant number JAP_TSZ_071128_TB_INTER] and the EU FP6 [grant numbers SPINE2c LSHG-CT-2006-031220, TEACH-SG LSSG-CT-2007-037198]. JT is the recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. IP is the recipient of an EMBO Short Term Fellowship and the Postgraduate Research Fellowship of Gedeon Richter Plc. Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that the first author received funding from a commercial source (Gedeon Richter Plc). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bjornberg O, 2003, J BIOL CHEM, V278, P20667, DOI 10.1074/jbc.M213010200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Chakroborty A, DRUG RESISTANT TUBER; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Furlow Bryant, 2010, Radiol Technol, V82, P33; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Goude R, 2008, J VIS EXP; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Helt SS, 2008, J MOL BIOL, V376, P554, DOI 10.1016/j.jmb.2007.11.099; Horvath A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq815; Huffman JL, 2003, J MOL BIOL, V331, P885, DOI 10.1016/S0022-2836(03)00789-7; Jagielski Tomasz, 2010, Wiad Lek, V63, P230; Jarmula A, 2010, MINI-REV MED CHEM, V10, P1211, DOI 10.2174/13895575110091211; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Johansson E, 2005, J BIOL CHEM, V280, P3051, DOI 10.1074/jbc.M409534200; Johansson E, 2003, J BIOL CHEM, V278, P27916, DOI 10.1074/jbc.M304361200; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Merenyi G, 2011, NUCLEOS NUCLEOT NUCL, V30, P369, DOI 10.1080/15257770.2011.582849; Mustafa AS, 2002, CLIN EXP IMMUNOL, V130, P37, DOI 10.1046/j.1365-2249.2002.01937.x; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Nyman PO, 2001, CURR PROTEIN PEPT SC, V2, P277, DOI 10.2174/1389203013381071; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06; Roberts G, 2003, FEMS MICROBIOL LETT, V221, P131, DOI 10.1016/S0378-1097(03)00177-0; Sampathkumar P, 2006, J MOL BIOL, V360, P1, DOI 10.1016/j.jmb.2006.04.061; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Silhavy T. J., 1984, EXPT GENE FUSIONS; Sinha KM, 2009, BIOCHEMISTRY-US, V48, P4019, DOI 10.1021/bi900103d; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Wilson PM, 2009, NUCLEIC ACIDS RES, V37, P78, DOI 10.1093/nar/gkn910; World Health Organization, 2010, GLOB TUB CONTR	61	41	42	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37461	10.1371/journal.pone.0037461	http://dx.doi.org/10.1371/journal.pone.0037461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655049	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305338900024
J	Wang, B; Zhang, SG; Wang, XF; Tan, M; Xi, YG				Wang, Bin; Zhang, Shu-Guang; Wang, Xiao-Feng; Tan, Ming; Xi, Yaguang			Testing for Differentially-Expressed MicroRNAs with Errors-in-Variables Nonparametric Regression	PLOS ONE			English	Article							MODEL; COEFFICIENT; AGREEMENT; VARIANCE; KAPPA; GENES	MicroRNA is a set of small RNA molecules mediating gene expression at post-transcriptional/translational levels. Most of well-established high throughput discovery platforms, such as microarray, real time quantitative PCR, and sequencing, have been adapted to study microRNA in various human diseases. The total number of microRNAs in humans is approximately 1,800, which challenges some analytical methodologies requiring a large number of entries. Unlike messenger RNA, the majority of microRNA (>60%) maintains relatively low abundance in the cells. When analyzed using microarray, the signals of these low-expressed microRNAs are influenced by other non-specific signals including the background noise. It is crucial to distinguish the true microRNA signals from measurement errors in microRNA array data analysis. In this study, we propose a novel measurement error model-based normalization method and differentially-expressed microRNA detection method for microRNA profiling data acquired from locked nucleic acids (LNA) microRNA array. Compared with some existing methods, the proposed method significantly improves the detection among low-expressed microRNAs when assessed by quantitative real-time PCR assay.	[Wang, Bin] Univ S Alabama, Dept Math & Stat, Mobile, AL 36688 USA; [Zhang, Shu-Guang] Univ Sci & Technol China, Dept Stat & Finance, Hefei 230026, Anhui, Peoples R China; [Wang, Xiao-Feng] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Tan, Ming; Xi, Yaguang] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA	University of South Alabama; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Cleveland Clinic Foundation; University of South Alabama	Wang, B (corresponding author), Univ S Alabama, Dept Math & Stat, Mobile, AL 36688 USA.	bwang@jaguar1.usouthal.edu; xi@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Xi, Yaguang/0000-0003-3681-9352; Wang, Bin/0000-0002-3689-6932	NATIONAL CANCER INSTITUTE [R21CA160280] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA160280] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruheim S, 2009, CLIN CANCER RES, V15, P7161, DOI 10.1158/1078-0432.CCR-08-2816; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Delaigle A, 2011, STAT SINICA, V21, P1023, DOI 10.5705/ss.2009.039; Delaigle A, 2009, J AM STAT ASSOC, V104, P348, DOI 10.1198/jasa.2009.0114; Dudoit S, 2002, STAT SINICA, V12, P111; Faraway JJ, 1995, J AM STAT ASSOC, V90, P1119; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mascellani N, 2008, MINERVA BIOTECNOL, V20, P23; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Qi R, 2011, HEPATOLOGY; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; ROCKE DM, 1995, TECHNOMETRICS, V37, P176, DOI 10.2307/1269619; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; SUN JY, 1994, ANN STAT, V22, P1328, DOI 10.1214/aos/1176325631; Wang B, 2011, BIOINFORMATICS, V27, P1506, DOI 10.1093/bioinformatics/btr180; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wang B, 2010, BIOINFORMATICS, V26, P228, DOI 10.1093/bioinformatics/btp655; Wang XF, 2012, J NONPARAMETR STAT, V24, P153, DOI 10.1080/10485252.2011.647024; Wang XF, 2011, J STAT SOFTW, V39, P1; Wang XF, 2010, COMPUT STAT DATA AN, V54, P25, DOI 10.1016/j.csda.2009.08.012; Wasserman L., 2006, ALL NONPARAMETRIC ST; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907	35	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37537	10.1371/journal.pone.0037537	http://dx.doi.org/10.1371/journal.pone.0037537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655055	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900031
J	Zeiger, AS; Loe, FC; Li, R; Raghunath, M; Van Vliet, KJ				Zeiger, Adam S.; Loe, Felicia C.; Li, Ran; Raghunath, Michael; Van Vliet, Krystyn J.			Macromolecular Crowding Directs Extracellular Matrix Organization and Mesenchymal Stem Cell Behavior	PLOS ONE			English	Article							MARROW STROMAL CELLS; IN-VITRO; INTERSTITIAL FLUID; EXCLUDED-VOLUME; CANCER; STABILITY; DEPOSITION; FILAMENTS; PROTEINS; LINEAGE	Microenvironments of biological cells are dominated in vivo by macromolecular crowding and resultant excluded volume effects. This feature is absent in dilute in vitro cell culture. Here, we induced macromolecular crowding in vitro by using synthetic macromolecular globules of nm-scale radius at physiological levels of fractional volume occupancy. We quantified the impact of induced crowding on the extracellular and intracellular protein organization of human mesenchymal stem cells (MSCs) via immunocytochemistry, atomic force microscopy (AFM), and AFM-enabled nanoindentation. Macromolecular crowding in extracellular culture media directly induced supramolecular assembly and alignment of extracellular matrix proteins deposited by cells, which in turn increased alignment of the intracellular actin cytoskeleton. The resulting cell-matrix reciprocity further affected adhesion, proliferation, and migration behavior of MSCs. Macromolecular crowding can thus aid the design of more physiologically relevant in vitro studies and devices for MSCs and other cells, by increasing the fidelity between materials synthesized by cells in vivo and in vitro.	[Zeiger, Adam S.; Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Zeiger, Adam S.; Loe, Felicia C.; Raghunath, Michael; Van Vliet, Krystyn J.] SMART, Biosyst & Micromech Interdisciplinary Res Grp Bio, Singapore, Singapore; [Loe, Felicia C.; Raghunath, Michael] Natl Univ Singapore, Fac Engn, Tissue Modulat Lab, Div Bioengn, Singapore 117548, Singapore; [Loe, Felicia C.] Natl Univ Singapore, Grad Programme Sci & Integrat Engn NGS, Singapore 117548, Singapore; [Li, Ran] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Raghunath, Michael] Yong Loo Ling Sch Med, Dept Biochem, Singapore, Singapore	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); National University of Singapore	Zeiger, AS (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	bierm@nus.edu.sg; krystyn@mit.edu	Raghunath, Michael/M-2727-2019; Raghunath, Michael/E-6483-2010	Raghunath, Michael/0000-0002-2138-6614	Singapore National Research Foundation through the Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; United States National Science Foundation [CBET-0644846]; US National Defense Science & Engineering Graduate Fellowship program; NIH [5T32EB006348-05]; NSF MRSEC REU [DMR-0819762]; NUS Faculty Research Committee; NUS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348] Funding Source: NIH RePORTER	Singapore National Research Foundation through the Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; United States National Science Foundation(National Science Foundation (NSF)); US National Defense Science & Engineering Graduate Fellowship program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF MRSEC REU(National Science Foundation (NSF)); NUS Faculty Research Committee; NUS(National University of Singapore); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research is supported by the Singapore National Research Foundation under the Singapore-MIT Alliance in Research & Technology (SMART) program, through the Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group (KJVV), as well as funding from the United States National Science Foundation CAREER Award, CBET-0644846 (KJVV), the US National Defense Science & Engineering Graduate Fellowship program and NIH Molecular, Cell, and Tissue Biomechanics Training Grant 5T32EB006348-05 (ASZ), and the NSF MRSEC REU program under DMR-0819762 (RL). FCL was a scholar of National University of Singapore (NUS) Graduate School for Integrative Sciences and Engineering, MR received funding from a NUS Faculty Research Committee Grant (Engineering in Medicine) and acknowledges the strong support of the NUS Tissue Engineering Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKLAND K, 1984, AM J PHYSIOL, V247, pH74, DOI 10.1152/ajpheart.1984.247.1.H74; BATEMAN JF, 1986, J BIOL CHEM, V261, P4198; BATES DO, 1993, CLIN SCI, V85, P737, DOI 10.1042/cs0850737; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; Beil M, 2005, J MICROSC-OXFORD, V220, P84, DOI 10.1111/j.1365-2818.2005.01505.x; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Chen C, 2011, ADV DRUG DELIVER REV, V63, P277, DOI 10.1016/j.addr.2011.03.003; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; FOLKOW B, 1971, ACTA PHYSIOL SCAND, V83, P532, DOI 10.1111/j.1748-1716.1971.tb05111.x; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Homouz D, 2009, BIOPHYS J, V96, P671, DOI 10.1016/j.bpj.2008.10.014; Hu Y, 2007, NANO LETT, V7, P3056, DOI 10.1021/nl071542i; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; Iborra FJ, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-15; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Jahne B., 2005, DIGITAL IMAGE PROCES; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Kulkarni AM, 2000, J CHEM PHYS, V113, P9863, DOI 10.1063/1.1321042; Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020; Lareu RR, 2007, BIOCHEM BIOPH RES CO, V363, P171, DOI 10.1016/j.bbrc.2007.08.156; Lareu RR, 2007, TISSUE ENG, V13, P385, DOI 10.1089/ten.2006.0224; LAURENT TC, 1995, BIOPHYS CHEM, V57, P7, DOI 10.1016/0301-4622(95)00048-3; Lode A, 2008, J TISSUE ENG REGEN M, V2, P400, DOI 10.1002/term.110; Loe F, 2011, UNPUB; MADDEN TL, 1993, BIOPHYS J, V65, P1147, DOI 10.1016/S0006-3495(93)81144-5; Maloney JM, 2010, BIOPHYS J, V99, P2479, DOI 10.1016/j.bpj.2010.08.052; McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169; PRICE PJ, 1982, IN VITRO CELL DEV B, V18, P576; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Rodriguez Luis G., 2004, V294, P23; Rodriguez-Almazan C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000497; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Thompson MT, 2006, BIOMACROMOLECULES, V7, P1990, DOI 10.1021/bm060146b; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; WADSWORTH GR, 1953, BRIT MED J, V2, P1138, DOI 10.1136/bmj.2.4846.1138; WILF J, 1985, THROMB RES, V37, P681, DOI 10.1016/0049-3848(85)90197-5; Yeoman D, ANIMAL CELL TECHNOLO; Yow SZ, 2009, BIOMATERIALS, V30, P1133, DOI 10.1016/j.biomaterials.2008.11.003; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	55	140	141	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37904	10.1371/journal.pone.0037904	http://dx.doi.org/10.1371/journal.pone.0037904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649562	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800082
J	Ritchie, AJ; Kuldanek, K; Moodie, Z; Wang, ZM; Fox, J; Nsubuga, RN; Legg, K; Birabwa, EF; Kaleebu, P; McMichael, AJ; Watera, C; Goonetilleke, N; Fidler, S				Ritchie, Adam J.; Kuldanek, Kristin; Moodie, Zoe; Wang, Z. Maggie; Fox, Julie; Nsubuga, Rebecca N.; Legg, Kenneth; Birabwa, Esther F.; Kaleebu, Pontiano; McMichael, Andrew J.; Watera, Christine; Goonetilleke, Nilu; Fidler, Sarah			Comparison of Sexual Behavior and HIV Risk between Two HIV-1 Serodiscordant Couple Cohorts: The CHAVI 002 Study	PLOS ONE			English	Article							HETEROSEXUAL ANAL INTERCOURSE; EXPOSED-UNINFECTED INDIVIDUALS; RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; HOMOSEXUAL-MEN; TRANSMISSION; INFECTION; METAANALYSIS; LYMPHOCYTES; PREVENTION	Background: The CHAVI002 study was designed to characterize immune responses, particularly HIV-specific T-cell responses, amongst 2 cohorts of HIV-exposed seronegative (HESN) individuals. The absence of a clear definition of HESNs has impaired comparison of research within and between such cohorts. This report describes two distinct HESN cohorts and attempts to quantify HIV exposure using a 'HIV risk index' (RI) model. Methods: HIV serodiscordant couples (UK; 24, Uganda; 72) and HIV unexposed seronegative (HUSN) controls (UK; 14, Uganda; 26 couples, 3 individuals) completed sexual behavior questionnaires every 3 months over a 9 month period. The two cohorts were heterogeneous, with most HESNs in the UK men who have sex with men (MSM), while all HESNs in Uganda were in heterosexual relationships. Concordance of responses between partners was determined. Each participant's sexual behavior score (SBS) was estimated based on the number and type of unprotected sex acts carried out in defined time periods. Independent HIV acquisition risk factors (partner plasma viral load, STIs, male circumcision, pregnancy) were integrated with the SBS, generating a RI for each HESN. Results: 96 HIV serodiscordant couples completed 929 SBQs. SBSs remained relatively stable amongst the UK cohort, whilst decreasing from Visit 1 to 2 in the Ugandan cohort. Compared to the Ugandan cohort, SBSs and RIs in the UK cohort were lower at visit 1, and generally higher at later visits. Differences between the cohorts, with lower rates of ART use in Uganda and higher risk per-act sex in the UK, had major impacts on the SBSs and RIs of each cohort. There was one HIV transmission event in the UK cohort. Conclusions: Employment of a risk quantification model facilitated quantification and comparison of HIV acquisition risk across two disparate HIV serodiscordant couple cohorts.	[Ritchie, Adam J.; McMichael, Andrew J.; Goonetilleke, Nilu] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Kuldanek, Kristin; Legg, Kenneth; Fidler, Sarah] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, HIV Clin Trials Ctr, London, England; [Moodie, Zoe; Wang, Z. Maggie] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Fox, Julie] Kings Coll London, Guy & St Thomas Hosp, Dept HIV, Fac Med, London WC2R 2LS, England; [Nsubuga, Rebecca N.; Birabwa, Esther F.; Kaleebu, Pontiano; Watera, Christine] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda	University of Oxford; Imperial College London; Fred Hutchinson Cancer Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Ritchie, AJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.	adam.ritchie@imm.ox.ac.uk		Fidler, Sarah/0000-0003-1676-7583; fox, Julie/0000-0002-0583-8019	Center for HIV/AIDS Vaccine Immunology (National Institute of Allergy and Infectious Diseases) [A1067854]	Center for HIV/AIDS Vaccine Immunology (National Institute of Allergy and Infectious Diseases)	This work was supported by the Center for HIV/AIDS Vaccine Immunology (National Institute of Allergy and Infectious Diseases grant A1067854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; BLASBAND D, 1985, ARCH SEX BEHAV, V14, P395, DOI 10.1007/BF01542001; Boily MC, 2009, SEX TRANSM INFECT, V85, P408, DOI 10.1136/sti.2009.037499; CLERICI M, 1992, J INFECT DIS, V165, P1012, DOI 10.1093/infdis/165.6.1012; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; del Romero J, 2002, AIDS, V16, P1296, DOI 10.1097/00002030-200206140-00017; Fox J, 2011, AIDS, V25, P1801, DOI 10.1097/QAD.0b013e32834a1cbb; Fox J, 2011, AIDS, V25, P1065, DOI 10.1097/QAD.0b013e328344fe4a; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Gerberry DJ, 2011, AIDS, V25, P1119, DOI 10.1097/QAD.0b013e328346be41; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Khan A, 2008, SEX TRANSM INFECT, V84, P150, DOI 10.1136/sti.2007.028050; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Lopalco L, 1997, J BIOL REG HOMEOS AG, V11, P27; Mackesy-Amiti ME, 2010, SEX TRANSM DIS, V37, P346, DOI [10.1097/OLQ.0b013e3181c71d617, 10.1097/OLQ.0b013e3181c71d61]; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McDaid LM, 2010, CURR OPIN HIV AIDS, V5, P311, DOI 10.1097/COH.0b013e32833a0b86; McGowan I, 2010, SEX TRANSM DIS, V37, P361, DOI 10.1097/OLQ.0b013e3181cd70c2; Mensch BS, 2008, INT FAM PLAN PERSPEC, V34, P169, DOI 10.1363/ifpp.34.169.08; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Perez CL, 2010, AIDS, V24, P969, DOI 10.1097/QAD.0b013e328337aff8; PINTO LA, 1995, J CLIN INVEST, V96, P867, DOI 10.1172/JCI118133; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Richens J, 2010, SEX TRANSM INFECT, V86, P310, DOI 10.1136/sti.2010.043422; Ritchie AJ, 2011, J VIROL, V85, P3507, DOI 10.1128/JVI.02444-10; Rosser BRS, 2010, J BEHAV MED, V33, P147, DOI 10.1007/s10865-009-9244-1; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Roye CF, 2010, J ASSOC NURSE AIDS C, V21, P291, DOI 10.1016/j.jana.2009.12.002; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; VOELLER B, 1991, ARCH SEX BEHAV, V20, P233, DOI 10.1007/BF01541846	37	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37727	10.1371/journal.pone.0037727	http://dx.doi.org/10.1371/journal.pone.0037727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629447	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300070
J	Tezuka, T; Matsuo, C; Iizuka, T; Oda, M; Marubashi, W				Tezuka, Takahiro; Matsuo, Chihiro; Iizuka, Takahiro; Oda, Masayuki; Marubashi, Wataru			Identification of Nicotiana tabacum Linkage Group Corresponding to the Q Chromosome Gene(s) Involved in Hybrid Lethality	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; DNA MARKERS; CELL-DEATH; SOLANACEAE; TOBACCO; SUAVEOLENS; EXPRESSION; EVOLUTION; REGIONS; CROSSES	Background: A linkage map consisting of 24 linkage groups has been constructed using simple sequence repeat (SSR) markers in Nicotiana tabacum. However, chromosomal assignments of all linkage groups have not yet been made. The Q chromosome in N. tabacum encodes a gene or genes triggering hybrid lethality, a phenomenon that causes death of hybrids derived from some crosses. Methodology/Principal Findings: We identified a linkage group corresponding to the Q chromosome using an interspecific cross between an N. tabacum monosomic line lacking the Q chromosome and N. africana. N. ingulba yielded inviable hybrids after crossing with N. tabacum. SSR markers on the identified linkage group were used to analyze hybrid lethality in this cross. The results implied that one or more genes on the Q chromosome are responsible for hybrid lethality in this cross. Furthermore, the gene(s) responsible for hybrid lethality in the cross N. tabacum6N. africana appear to be on the region of the Q chromosome to which SSR markers PT30342 and PT30365 map. Conclusions/Significance: Linkage group 11 corresponded to the Q chromosome. We propose a new method to correlate linkage groups with chromosomes in N. tabacum.	[Tezuka, Takahiro; Iizuka, Takahiro; Oda, Masayuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Matsuo, Chihiro] Osaka Prefecture Univ, Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Marubashi, Wataru] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Meiji University	Tezuka, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan.	tezuka@plant.osakafu-u.ac.jp	Tezuka, Takahiro/AAH-9589-2021	Tezuka, Takahiro/0000-0002-9203-1140	Japan Society for the Promotion of Science, Japan [20880024]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aid for Young Scientists (Start-up) No. 20880024 from the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bindler G, 2007, THEOR APPL GENET, V114, P341, DOI 10.1007/s00122-006-0437-5; Bindler G, 2011, THEOR APPL GENET, V123, P219, DOI 10.1007/s00122-011-1578-8; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; BURK LG, 1979, SCIENCE, V206, P585, DOI 10.1126/science.206.4418.585; CAMERON DR, 1959, TOBACCO SCI, V3, P164; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clausen RE, 1944, GENETICS, V29, P447; DANEHOWER DA, 1989, AGR BIOL CHEM TOKYO, V53, P2813, DOI 10.1080/00021369.1989.10869730; DEVERNA JW, 1987, THEOR APPL GENET, V73, P665, DOI 10.1007/BF00260773; Ichitani K, 2011, RICE, V4, P29, DOI 10.1007/s12284-011-9062-2; Iizuka T, 2012, EUPHYTICA IN PRESS, DOI [10.1007/s10681-011-0570-3, DOI 10.1007/S10681-011-0570-3]; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; KRAMER MG, 1988, J HERED, V79, P24, DOI 10.1093/oxfordjournals.jhered.a110439; KUBO T, 1982, TOBACCO SCI, V26, P126; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; McNAUGHTON I. H., 1960, NEW PHYTOL, V59, P27, DOI 10.1111/j.1469-8137.1960.tb06198.x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; Moon HS, 2008, GENOME, V51, P547, DOI 10.1139/G08-039; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Olmo HP, 1935, GENETICS, V20, P0286; Song L, 2009, THEOR APPL GENET, V119, P33, DOI 10.1007/s00122-009-1014-5; Tezuka T, 2006, THEOR APPL GENET, V112, P1172, DOI 10.1007/s00122-006-0219-0; Tezuka T, 2004, PLANT CELL PHYSIOL, V45, P1863, DOI 10.1093/pcp/pch204; Tezuka T, 2004, BREEDING SCI, V54, P59, DOI 10.1270/jsbbs.54.59; Tezuka T, 2007, PLANTA, V226, P753, DOI 10.1007/s00425-007-0522-2; Tezuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036204; Tezuka T, 2010, ANN BOT-LONDON, V106, P267, DOI 10.1093/aob/mcq114; Vontimitta V, 2010, J AGR FOOD CHEM, V58, P294, DOI 10.1021/jf903256h; Yamada T, 1999, BREEDING SCI, V49, P203, DOI 10.1270/jsbbs.49.203	34	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37822	10.1371/journal.pone.0037822	http://dx.doi.org/10.1371/journal.pone.0037822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629459	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300078
J	Liu, GH; Young, DL				Liu, Guohong; Young, Dallan			Conserved Orb6 Phosphorylation Sites Are Essential for Polarized Cell Growth in Schizosaccharomyces pombe	PLOS ONE			English	Article							NDR-PROTEIN-KINASE; FISSION YEAST; SIGNALING PATHWAY; MORPHOGENESIS; FAMILY; CYCLE; INTERACTS; MAINTENANCE; NETWORK; NAK1	The Ndr-related Orb6 kinase is a key regulator of polarized cell growth in fission yeast, however the mechanism of Orb6 activation is unclear. Activation of other Ndr kinases involves both autophosphorylation and phosphorylation by an upstream kinase. Previous reports suggest that the Nak1 kinase functions upstream from Orb6. Supporting this model, we show that HA-Orb6 overexpression partially restored cell polarity in nak1 ts cells. We also demonstrated by coimmunoprecipitation and in vitro binding assays that Nak1 and Orb6 physically interact, and that the Nak1 C-terminal region is required forNak1/Orb6 complex formation in vivo. However, results from in vitro kinase assays did not show phosphorylation of recombinant Orb6 by HA-Nak1, suggesting that Orb6 activation may not involve direct phosphorylation by Nak1. To investigate the role of Orb6 phosphorylation and activity, we substituted Ala at the ATP-binding and conserved phosphorylation sites. Overexpression of kinase-dead HA-Orb6(K122A) in wild-type cells resulted in a loss of cell polarity, suggesting that it has a dominant-negative effect, and it failed to rescue the polarity defect of nak1 or orb6 ts mutants. Recombinant GST-Orb6(S291A) did not autophosphorylate in vitro suggesting that Ser291 is the primary autophosphorylation site. HA-Orb6(S291A) overexpression only partially rescued the orb6 polarity defect and failed to rescue the nak1 defect, suggesting that autophosphorylation is important for Orb6 function. GST-Orb6(T456A) autophosphorylated in vitro, indicating that the conserved phosphorylation site at Thr456 is not essential for kinase activity. However, HA-Orb6(T456A) overexpression had similar effects as overexpressing kinase-dead HA-Orb6(K122A), suggesting that Thr456 is essential for Orb6 function in vivo. Also, we found that both phosphorylation site mutations impaired the ability of Myc-Nak1 to coimmunoprecipitate with HA-Orb6. Together, our results suggest a model whereby autophosphorylation of Ser291 and phosphorylation of Thr456 by an upstream kinase promote Nak1/Orb6 complex formation and Orb6 activation.	[Liu, Guohong] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; Univ Calgary, Dept Oncol, Calgary, AB, Canada	University of Calgary; University of Calgary	Liu, GH (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	young@ucalgary.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	lThis research was funded by a grant from the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Das M, 2009, CURR BIOL, V19, P1314, DOI 10.1016/j.cub.2009.06.057; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2011, CELL SIGNAL, V23, P1433, DOI 10.1016/j.cellsig.2011.04.007; Hou MC, 2003, J CELL SCI, V116, P125, DOI 10.1242/jcs.00206; Huang TY, 2005, J CELL SCI, V118, P199, DOI 10.1242/jcs.01608; Huang TY, 2003, J BIOL CHEM, V278, P991, DOI 10.1074/jbc.M208993200; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Leonhard K, 2005, J CELL SCI, V118, P1033, DOI 10.1242/jcs.01690; Loewith R, 2000, J CELL SCI, V113, P153; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; MILLWARD T, 1995, P NATL ACAD SCI USA, V92, P5022, DOI 10.1073/pnas.92.11.5022; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Ray S, 2010, J CELL BIOL, V190, P793, DOI 10.1083/jcb.201002055; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Tamaskovic R, 2003, J BIOL CHEM, V278, P6710, DOI 10.1074/jbc.M210590200; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wiley DJ, 2003, J BIOL CHEM, V278, P25256, DOI 10.1074/jbc.M209703200; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37221	10.1371/journal.pone.0037221	http://dx.doi.org/10.1371/journal.pone.0037221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629372	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100019
J	Petit, N; Pineyro, D; Lopez-Panades, E; Casacuberta, E; Navarro, A				Petit, Natalia; Pineyro, David; Lopez-Panades, Elisenda; Casacuberta, Elena; Navarro, Arcadi			HeT-A_pi1, a piRNA Target Sequence in the Drosophila Telomeric Retrotransposon HeT-A, Is Extremely Conserved across Copies and Species	PLOS ONE			English	Article							EVOLUTION; PIWI; ELEMENTS; MECHANISM; VIRILIS	The maintenance of the telomeres in Drosophila species depends on the transposition of the non-LTR retrotransposons HeT-A, TAHRE and TART. HeT-A and TART elements have been found in all studied species of Drosophila suggesting that their function has been maintained for more than 60 million years. Of the three elements, HeT-A is by far the main component of D. melanogaster telomeres and, unexpectedly for an element with an essential role in telomere elongation, the conservation of the nucleotide sequence of HeT-A is very low. In order to better understand the function of this telomeric retrotransposon, we studied the degree of conservation along HeT-A copies. We identified a small sequence within the 39 UTR of the element that is extremely conserved among copies of the element both, within D. melanogaster and related species from the melanogaster group. The sequence corresponds to a piRNA target in D. melanogaster that we named HeT-A_pi1. Comparison with piRNA target sequences from other Drosophila retrotransposons showed that HeT-A_pi1 is the piRNA target in the Drosophila genome with the highest degree of conservation among species from the melanogaster group. The high conservation of this piRNA target in contrast with the surrounding sequence, suggests an important function of the HeT-A_pi1 sequence in the co-evolution of the HeT-A retrotransposon and the Drosophila genome.	[Petit, Natalia; Navarro, Arcadi] Univ Pompeu Fabra, Dept Ciencies Expt & Salut DCEXS, Barcelona, Spain; [Petit, Natalia; Pineyro, David; Lopez-Panades, Elisenda; Casacuberta, Elena; Navarro, Arcadi] Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Navarro, Arcadi] Univ Pompeu Fabra, INB, Barcelona, Spain; [Navarro, Arcadi] ICREA, Catalonia, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; ICREA	Petit, N (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut DCEXS, Barcelona, Spain.	elena.casacuberta@ibe.upf-csic.es; arcadi.navarro@upf.edu	Navarro, Arcadi/F-1592-2011; Marty, Natalia Petit/AAI-7449-2021	Navarro, Arcadi/0000-0003-2162-8246; Marty, Natalia Petit/0000-0002-3810-1152; Casacuberta, Elena/0000-0002-8203-8357; Pineyro, David/0000-0001-5633-3339	Spanish Ministry of Science and Innovation [BFU2009-08318/BMC, BFU2009-13409-C02-02]; Spanish National Institute for Bioinformatics; Consejo Superior de Investigaciones Cientificas (CSIC) [JAE-doc09_01394]; FEDER; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute for Bioinformatics; Consejo Superior de Investigaciones Cientificas (CSIC); FEDER(European Commission); ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Science and Innovation BFU2009-08318/BMC to EC and BFU2009-13409-C02-02 to AN. Funding was also provided by the Spanish National Institute for Bioinformatics (www.inb.org). NP is supported by JAE-doc09_01394 from Consejo Superior de Investigaciones Cientificas (CSIC) and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; ASHBURNER M, 1994, DEVELOPMENT, V120, P2077; Blackburn, 2006, TELOMERES; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P14091, DOI 10.1073/pnas.1936193100; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P3363, DOI 10.1073/pnas.0230353100; Casacuberta E, 2002, GENETICS, V161, P1113; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Danilevskaya ON, 1998, GENETICS, V148, P233; Danilevskaya ON, 1998, P NATL ACAD SCI USA, V95, P3770, DOI 10.1073/pnas.95.7.3770; Danilevskaya ON, 1997, CELL, V88, P647, DOI 10.1016/S0092-8674(00)81907-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Lu J, 2010, GENOME RES, V20, P212, DOI 10.1101/gr.095406.109; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pardue ML, 2008, FLY, V2, P101, DOI 10.4161/fly.6393; Pardue ML, 1996, J MOL EVOL, V43, P572, DOI 10.1007/BF02202105; Pardue ML, 2005, CHROMOSOME RES, V13, P443, DOI 10.1007/s10577-005-0993-6; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Pineyro D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-573; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Siomi H, 2008, CURR OPIN GENET DEV, V18, P181, DOI 10.1016/j.gde.2008.01.002; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37405	10.1371/journal.pone.0037405	http://dx.doi.org/10.1371/journal.pone.0037405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629389	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100025
J	Deng, ZF; Yan, HJ; Hu, JJ; Zhang, SW; Peng, P; Liu, QZ; Guo, DY				Deng, Zhongfan; Yan, Huijuan; Hu, Jiajie; Zhang, Shengwei; Peng, Peng; Liu, Qingzhen; Guo, Deyin			Hepatitis C Virus Sensitizes Host Cells to TRAIL-Induced Apoptosis by Up-Regulating DR4 and DR5 via a MEK1-Dependent Pathway	PLOS ONE			English	Article							DEATH RECEPTOR-4; SP1 PHOSPHORYLATION; ACTIVATION; REPLICATION; INFECTION; LIGAND; IDENTIFICATION; INTERFERON; STABILITY; KINASE	Background: Hepatitis C virus (HCV) is the leading cause of liver fibrosis, cirrhosis and hepatocellular carcinoma. It is believed that continuous liver cell apoptosis contributes to HCV pathogenesis. Recent studies have shown that HCV infection can sensitize host cells to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis, but the mechanism by which HCV regulates the TRAIL pathway remains unclear. Methods and Results: Using a sub-genomic replicon and full length virus, JFH-1, we demonstrate that HCV can sensitize host cells to TRAIL-induced apoptosis by up-regulating two TRAIL receptors, death receptor 4 (DR4) and death receptor 5 (DR5). Furthermore, the HCV replicon enhanced transcription of DR5 via Sp1, and the HCV-mediated up-regulation of DR4 and DR5 required MEK1 activity. HCV infection also stimulated the activity of MEK1, and the inhibition of MEK1 activity or the knockdown of MEK1 increased the replication of HCV. Conclusions: Our studies demonstrate that HCV replication sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1 dependent pathway. These findings may help to further understand the pathogenesis of HCV infection and provide a therapeutic target.	[Deng, Zhongfan] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Deng, ZF (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	qzhliu@whu.edu.cn; dguo@whu.edu.cn	Guo, Deyin/A-9498-2011	Guo, Deyin/0000-0002-8297-0814	China "973" program [2009CB522506, 2010CB911800]; China Natural Science Foundation [30921001]	China "973" program(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by China "973" program (grant no. 2009CB522506 and 2010CB911800) and the China Natural Science Foundation (grant # 30921001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bild AH, 2002, ONCOGENE, V21, P6649, DOI 10.1038/sj.onc.1205819; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROTT BK, 1993, CELL GROWTH DIFFER, V4, P921; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Hailfinger S, 2007, INT J CANCER, V120, P1459, DOI 10.1002/ijc.22519; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Janssen HLA, 2003, J HEPATOL, V39, P414, DOI 10.1016/S0168-8278(03)00265-4; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kotelkin A, 2003, J VIROL, V77, P9156, DOI 10.1128/JVI.77.17.9156-9172.2003; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu XH, 2008, BIOCHEM BIOPH RES CO, V373, P643, DOI 10.1016/j.bbrc.2008.06.087; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2005, J GEN VIROL, V86, P1027, DOI 10.1099/vir.0.80724-0; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Murata T, 2005, VIROLOGY, V340, P105, DOI 10.1016/j.virol.2005.06.015; Ndjomou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007498; Saitou Y, 2005, HUM PATHOL, V36, P1066, DOI 10.1016/j.humpath.2005.07.019; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang SA, 2009, J MOL BIOL, V387, P1106, DOI 10.1016/j.jmb.2009.02.040; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; YAN MH, 1994, NATURE, V372, P798; Yano M, 2009, HEPATOLOGY, V50, P678, DOI 10.1002/hep.23026; Yano Y, 2003, INT J MOL MED, V11, P499; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	49	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37700	10.1371/journal.pone.0037700	http://dx.doi.org/10.1371/journal.pone.0037700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662193	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300083
J	Miro-Moran, A; Jardin, I; Ortega-Ferrusola, C; Salido, GM; Pena, FJ; Tapia, JA; Aparicio, IM				Miro-Moran, Alvaro; Jardin, Isaac; Ortega-Ferrusola, Cristina; Salido, Gines M.; Pena, Fernando J.; Tapia, Jose A.; Aparicio, Ines M.			Identification and Function of Exchange Proteins Activated Directly by Cyclic AMP (Epac) in Mammalian Spermatozoa	PLOS ONE			English	Article							INTACT BOAR SPERMATOZOA; ACROSOMAL EXOCYTOSIS; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; SPERM MOTILITY; CELL-ADHESION; CAMP; CAPACITATION; RAP1; BICARBONATE	The role of cAMP in spermatic functions was classically thought to be mediated exclusively through the activation of Protein Kinase A (PKA). However, it has recently been shown that cAMP also exerts its effects through a PKA-independent pathway activating a family of proteins known as Epac proteins. Therefore, many of the spermatic functions thought to be regulated by cAMP through the activation of PKA are again under study. We aimed to identify and to investigate the role of Epac proteins in spermatozoa using a specific permeable analog (8-Br-2'-O-Me-cAMP). Also, we aimed to study its relationship with E-cadherin, an adhesion protein involved in fertility. Our results demonstrate the presence and sub-cellular distribution of Epac 1 and Epac 2 in mammalian spermatozoa. Capacitation and the acrosome reaction induced a change in the localization of Epac proteins in sperm. Moreover, incubation with 8-Br-2'-O-Me-cAMP prompted an increase in Rap1 activation, in the scrambling of plasma membrane phospholipids (necessary for the capacitation process), the acrosome reaction, motility, and calcium mobilization, when spermatozoa were incubated in acrosome reaction conditions. Finally, the activation of Epac proteins induced a change in the distribution of E-cadherin. Therefore, the increase in the acrosome reaction, together with the increase in calcium (which is known to be essential for fertilization) and the Epac nteraction with E-cadherin, might indicate that Epac proteins have an important role in gamete recognition and fertilization.	[Miro-Moran, Alvaro; Jardin, Isaac; Salido, Gines M.; Tapia, Jose A.; Aparicio, Ines M.] Univ Extremadura, Cell Physiol Res Grp, Caceres, Spain; [Ortega-Ferrusola, Cristina; Pena, Fernando J.] Univ Extremadura, Vet Teaching Hosp, Lab Spermatol, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura	Miro-Moran, A (corresponding author), Univ Extremadura, Cell Physiol Res Grp, Caceres, Spain.	imad@unex.es	Salido, Gines M/A-4292-2009; Ortega-Ferrusola, Cristina/AGI-8478-2022; Aparicio, Ines Maria/L-5775-2014; Peña, Fernando J/D-8450-2012; Aparicio, Ines/AAH-2781-2021; Jardin, Isaac/E-8310-2016; Tapia, Jose A./C-5181-2008	Salido, Gines M/0000-0002-8687-2445; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Aparicio, Ines/0000-0003-0023-853X; Jardin, Isaac/0000-0003-4575-8264; Tapia, Jose A./0000-0002-3614-6867	University of Extremadura (Proyecto Accion VII); Junta de Extremadura-FEDER [GR10010]; Ministerio de Ciencia e Innovacion-FEDER [BFU2011-30261, AGL 2010-20758]; Ministerio Ciencia e Innovacion [BES-2008-002106]; Consejeria de Economia, Comercio e Innovacion (JUEX) [REI09013]	University of Extremadura (Proyecto Accion VII); Junta de Extremadura-FEDER(European Commission); Ministerio de Ciencia e Innovacion-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Comercio e Innovacion (JUEX)	This work was supported by University of Extremadura (Proyecto Accion VII), Junta de Extremadura-FEDER (GR10010) and by Ministerio de Ciencia e Innovacion-FEDER, grants BFU2011-30261 and AGL 2010-20758). Dr. Miro-Moran was supported by a predoctoral fellowship from the Ministerio Ciencia e Innovacion (BES-2008-002106). Dr. Aparicio was supported by Consejeria de Economia, Comercio e Innovacion (JUEX, REI09013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivatiadou E, 2007, MOL BIOL CELL, V18, P1530, DOI 10.1091/mbc.E06-10-0902; Aivatiadou E, 2009, MOL REPROD DEV, V76, P407, DOI 10.1002/mrd.20963; Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Angst BD, 2001, J CELL SCI, V114, P625; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragado MJ, 2010, J CELL BIOCHEM, V109, P65, DOI 10.1002/jcb.22393; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Bravo MM, 2005, MOL REPROD DEV, V71, P88, DOI 10.1002/mrd.20286; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Breitbart H, 2002, J REPROD IMMUNOL, V53, P151, DOI 10.1016/S0165-0378(01)00085-7; Carr D W, 2007, Soc Reprod Fertil Suppl, V63, P135; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; DZHURA I, 2010, J PHYSL; Espino J, 2010, FERTIL STERIL, V94, P1915, DOI 10.1016/j.fertnstert.2009.12.082; Fazeli A, 1997, BIOL REPROD, V56, P430, DOI 10.1095/biolreprod56.2.430; Flesch FM, 2001, J CELL SCI, V114, P3543; FRASER LR, 1992, J REPROD FERTIL, V96, P363, DOI 10.1530/jrf.0.0960363; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gadella BM, 2004, ANIM REPROD SCI, V82-3, P307, DOI 10.1016/j.anireprosci.2004.04.030; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gonzalez-Fernandez L, 2009, BIOL REPROD, V80, P1239, DOI 10.1095/biolreprod.108.073486; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harkema W, 1998, BIOL REPROD, V58, P421, DOI 10.1095/biolreprod58.2.421; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; HONG CY, 1985, BRIT J CLIN PHARMACO, V19, P45, DOI 10.1111/j.1365-2125.1985.tb02611.x; Kinukawa M, 2006, FEBS LETT, V580, P1515, DOI 10.1016/j.febslet.2006.01.078; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Luconi M, 2011, FRONT BIOSCI-LANDMRK, V16, P1315, DOI 10.2741/3791; Marin-Briggiler CI, 2008, MOL HUM REPROD, V14, P561, DOI 10.1093/molehr/gan053; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rufas O, 2000, MOL HUM REPROD, V6, P163, DOI 10.1093/molehr/6.2.163; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Wuttke M S, 2001, JOP, V2, P154; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Zarintash RJ, 1996, BIOL REPROD, V55, P19, DOI 10.1095/biolreprod55.1.19	47	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37713	10.1371/journal.pone.0037713	http://dx.doi.org/10.1371/journal.pone.0037713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662198	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300088
J	Qiu, P				Qiu, Peng			Inferring Phenotypic Properties from Single-Cell Characteristics	PLOS ONE			English	Article							FLOW-CYTOMETRY DATA; AUTOMATED IDENTIFICATION; CANCER; EXPRESSION; CLASSIFICATION; LEUKEMIA; MODEL; DREAM	Flow cytometry provides multi-dimensional data at the single-cell level. Such data contain information about the cellular heterogeneity of bulk samples, making it possible to correlate single-cell features with phenotypic properties of bulk tissues. Predicting phenotypes from single-cell measurements is a difficult challenge that has not been extensively studied. The 6th Dialogue for Reverse Engineering Assessments and Methods (DREAM6) invited the research community to develop solutions to a computational challenge: classifying acute myeloid leukemia (AML) positive patients and healthy donors using flow cytometry data. DREAM6 provided flow cytometry data for 359 normal and AML samples, and the class labels for half of the samples. Researchers were asked to predict the class labels of the remaining half. This paper describes one solution that was constructed by combining three algorithms: spanning-tree progression analysis of density-normalized events (SPADE), earth mover's distance, and a nearest-neighbor classifier called Relief. This solution was among the topper-forming methods that achieved 100% prediction accuracy.	Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Qiu, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	pqiu@mdanderson.org			TCGA Genome Data Analysis Center [U24 CA143883 02 S1]; Cancer Center Support Grant at the University of Texas M. D. Anderson Cancer Center [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, U24CA143883] Funding Source: NIH RePORTER	TCGA Genome Data Analysis Center; Cancer Center Support Grant at the University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is partially supported by: (1) TCGA Genome Data Analysis Center grant U24 CA143883 02 S1; (2) the Cancer Center Support Grant at the University of Texas M. D. Anderson Cancer Center P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Chan C, 2008, CYTOM PART A, V73A, P693, DOI 10.1002/cyto.a.20583; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Finak Greg, 2009, Advances in Bioinformatics, V2009, P247646, DOI 10.1155/2009/247646; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; HAHNE F, 2009, BMC BIOINFORMATICS, V10; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; MURPHY RF, 1985, CYTOMETRY, V6, P302, DOI 10.1002/cyto.990060405; Nowakowski GS, 2007, MAYO CLIN PROC, V82, P449, DOI 10.4065/82.4.449; O'Neill MC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-13; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pettie S., 1999, J ACM, V49, P49; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Qiu P, 2005, BIOINFORMATICS, V21, P3114, DOI 10.1093/bioinformatics/bti483; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun YJ, 2007, BIOINFORMATICS, V23, P30, DOI 10.1093/bioinformatics/btl543; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; Walther Guenther, 2009, Advances in Bioinformatics, V2009, P686759, DOI 10.1155/2009/686759; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	33	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37038	10.1371/journal.pone.0037038	http://dx.doi.org/10.1371/journal.pone.0037038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662133	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300024
J	Kazlauskas, E; Petrikaite, V; Michailoviene, V; Revuckiene, J; Matuliene, J; Grinius, L; Matulis, D				Kazlauskas, Egidijus; Petrikaite, Vilma; Michailoviene, Vilma; Revuckiene, Jurgita; Matuliene, Jurgita; Grinius, Leonas; Matulis, Daumantas			Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90	PLOS ONE			English	Article							SHOCK-PROTEIN 90; THERMAL SHIFT ASSAYS; 1-ANILINO-8-NAPHTHALENE SULFONATE; TITRATION CALORIMETRY; HIT IDENTIFICATION; RADICICOL BINDING; INHIBITORS; DOMAIN; ENERGETICS; CONSTANTS	The design of specific inhibitors against the Hsp90 chaperone and other enzyme relies on the detailed and correct understanding of both the thermodynamics of inhibitor binding and the structural features of the protein-inhibitor complex. Here we present a detailed thermodynamic study of binding of aryl-dihydroxyphenyl-thiadiazole inhibitor series to recombinant human Hsp90 alpha isozyme. The inhibitors are highly potent, with the intrinsic K-d approximately equal to 1 nM as determined by isothermal titration calorimetry (ITC) and thermal shift assay (TSA). Dissection of protonation contributions yielded the intrinsic thermodynamic parameters of binding, such as enthalpy, entropy, Gibbs free energy, and the heat capacity. The differences in binding thermodynamic parameters between the series of inhibitors revealed contributions of the functional groups, thus providing insight into molecular reasons for improved or diminished binding efficiency. The inhibitor binding to Hsp90 alpha primarily depended on a large favorable enthalpic contribution combined with the smaller favorable entropic contribution, thus suggesting that their binding was both enthalpically and entropically optimized. The enthalpy-entropy compensation phenomenon was highly evident when comparing the inhibitor binding enthalpies and entropies. This study illustrates how detailed thermodynamic analysis helps to understand energetic reasons for the binding efficiency and develop more potent inhibitors that could be applied for therapeutic use as Hsp90 inhibitors.	[Kazlauskas, Egidijus; Petrikaite, Vilma; Michailoviene, Vilma; Revuckiene, Jurgita; Matuliene, Jurgita; Grinius, Leonas; Matulis, Daumantas] Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania; [Petrikaite, Vilma] Lithuanian Univ Hlth Sci, Fac Pharm, Dept Drug Chem, Kaunas, Lithuania	Vilnius University; Lithuanian University of Health Sciences	Kazlauskas, E (corresponding author), Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania.	matulis@ibt.lt	Petrikaite, Vilma/D-3134-2017; Matulis, Daumantas/F-9367-2010; Petrikaite, Vilma/AAN-3351-2020	Matulis, Daumantas/0000-0002-6178-6276; Petrikaite, Vilma/0000-0002-4106-5535; Kazlauskas, Egidijus/0000-0001-8430-7349	Research Council of Lithuania [LIG-16/2010]; Lithuanian Science Council; European Union	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Lithuanian Science Council(Research Council of Lithuania (LMTLT)); European Union(European Commission)	This research was funded by a grant (No. LIG-16/2010) from the Research Council of Lithuania. Vilma Petrikaite thanks the Lithuanian Science Council for the fellowship obtained from the project "Postdoctoral Fellowship Implementation in Lithuania" funded by the European Union Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SR, 1969, BIOCHEMISTRY-US, V8, P371, DOI 10.1021/bi00829a051; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; Banz VM, 2009, BBA-MOL CELL RES, V1793, P1597, DOI 10.1016/j.bbamcr.2009.08.002; Barril X, 2006, BIOORG MED CHEM LETT, V16, P2543, DOI 10.1016/j.bmcl.2006.01.099; Biamonte MA, 2010, J MED CHEM, V53, P3, DOI 10.1021/jm9004708; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; Brough PA, 2009, J MED CHEM, V52, P4794, DOI 10.1021/jm900357y; Cheung KMJ, 2005, BIOORG MED CHEM LETT, V15, P3338, DOI 10.1016/j.bmcl.2005.05.046; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Cikotiene I, 2009, BIOORG MED CHEM LETT, V19, P1089, DOI 10.1016/j.bmcl.2009.01.003; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cimmperman P, 2011, RSC BIOMOL SCI, P247; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Freire Ernesto, 2004, Drug Discov Today Technol, V1, P295, DOI 10.1016/j.ddtec.2004.11.016; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Huang KH, 2009, J MED CHEM, V52, P4288, DOI 10.1021/jm900230j; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kung PP, 2010, J MED CHEM, V53, P499, DOI 10.1021/jm901209q; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nilapwar S, 2009, J MOL BIOL, V392, P923, DOI 10.1016/j.jmb.2009.07.041; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Petrikaite V, 2011, APPLICATION OF THERMODYNAMICS TO BIOLOGICAL AND MATERIALS SCIENCE, P77; Petrikaite V, 2011, MEDICINA-LITHUANIA, V47, P413, DOI 10.3390/medicina47080062; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Sgobba M, 2009, CHEMMEDCHEM, V4, P1399, DOI 10.1002/cmdc.200900256; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2011, BIOORGAN MED CHEM, V19, P2603, DOI 10.1016/j.bmc.2011.03.013; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Todd MJ, 2003, GENET ENG NEWS, V23, P28; Toleikis Z, 2011, ANAL BIOCHEM, V413, P171, DOI 10.1016/j.ab.2011.02.019; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; Vaughan CK, 2010, NAT STRUCT MOL BIOL, V17, P1400, DOI 10.1038/nsmb1210-1400; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zubriene A, 2010, BIOPHYS CHEM, V152, P153, DOI 10.1016/j.bpc.2010.09.003; Zubriene A, 2009, INT J MOL SCI, V10, P2662, DOI 10.3390/ijms10062662; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36899	10.1371/journal.pone.0036899	http://dx.doi.org/10.1371/journal.pone.0036899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655030	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900005
J	Yao, YZ; Ren, D; Rider, DA; Cai, WZ				Yao, Yunzhi; Ren, Dong; Rider, David A.; Cai, Wanzhi			Phylogeny of the Infraorder Pentatomomorpha Based on Fossil and Extant Morphology, with Description of a New Fossil Family from China	PLOS ONE			English	Article							HEMIPTERA HETEROPTERA; YIXIAN FORMATION; INSECTA; GENUS	Background: An extinct new family of Pentatomomorpha, Venicoridae Yao, Ren & Cai fam. nov., with 2 new genera and 2 new species (Venicoris solaris Yao, Ren & Rider gen. & sp. nov. and Clavaticoris zhengi Yao, Ren & Cai gen. & sp. nov.) are described from the Early Cretaceous Yixian Formation in Northeast China. Methodology/Principal Findings: A cladistic analysis based on a combination of fossil and extant morphological characters clarified the phylogenetic status of the new family and has allowed the reconstruction of intersuperfamily and interfamily relationships within the Infraorder Pentatomomorpha. The fossil record and diversity of Pentatomomorpha during the Mesozoic is discussed. Conclusions/Significance: Pentatomomorpha is a monophyletic group; Aradoidea and the Trichophora are sister groups; these fossils belong to new family, treated as the sister group of remainder of Trichophora; Pentatomoidea is a monophyletic group; Piesmatidae should be separated as a superfamily, Piesmatoidea. Origin time of Pentatomomorpha should be tracked back to the Middle or Early Triassic.	[Yao, Yunzhi; Ren, Dong; Cai, Wanzhi] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China; [Rider, David A.] N Dakota State Univ, Dept Entomol, Fargo, ND 58105 USA; [Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Yao, Yunzhi] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China	Capital Normal University; North Dakota State University Fargo; China Agricultural University; Chinese Academy of Sciences	Yao, YZ (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn; david.rider@ndsu.edu			National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [30800095, 31071964, 40872022]; Nature Science Foundation of Beijing [5082002]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [131021]; Beijing Municipal Education Commission of China [KM201210028016]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123114]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Beijing; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); Beijing Municipal Education Commission of China(Beijing Municipal Commission of Education); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences)	This research is partly supported by grants from the National Basic Research Program of China (973 Program) (No. 2012CB821900); National Natural Science Foundation of China (Nos. 30800095, 31071964, 40872022); Nature Science Foundation of Beijing (No. 5082002); Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (No. 131021); The General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China (No. KM201210028016); and the State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (No. 123114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Migdisova E. E., 1962, OSNOVY PALEONTOLOGII, P208; Carver M., 1991, P429; Cassis G, 2010, CLADISTICS, V26, P262, DOI 10.1111/j.1096-0031.2009.00283.x; Chen W., 2005, J STRATIGRAPHY, V29, P582; DRAKE CARL J., 1958, ANN ENT SOC AMER, V51, P567; Franzosa EA, 2007, TREEROT VERSION 3; Giebel CG, 1856, FAUNA VORWELT MIT ST, V2; Goloboff P., 1999, NONA NO NAME VERSION; Grazia J, 2008, CLADISTICS, V24, P932, DOI 10.1111/j.1096-0031.2008.00224.x; Handlirsch A., 1939, ANN NATURHISTORISCHE, V49, P1; Heiss Ernst, 2001, Carolinea, V59, P99; Henry T. J., 1988, CATALOG HETEROPTERA; Henry TJ, 1997, ANN ENTOMOL SOC AM, V90, P275, DOI 10.1093/aesa/90.3.275; Hong Y. C., 1983, MIDDLE JURASSIC FOSS; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; KORMILEV NA, 1986, J NAT HIST, V20, P279, DOI 10.1080/00222938600770231; Leston D., 1962, Proceedings of the Royal Entomological Society of London (A), V37, P135; Li HM, 2005, MOL PHYLOGENET EVOL, V37, P313, DOI 10.1016/j.ympev.2005.07.013; LI XZ, 1994, ZOOLOGICAL SOC CHINA, P1; Lin Q.-b., 1985, Acta Palaeontologica Sinica, V24, P300; Lin Q.-b., 1992, Acta Palaeontologica Sinica, V31, P313; Lin Q.B., 1986, EARLY MESOZOIC FOSSI, P54; Liu YS, 2007, CRETACEOUS RES, V28, P322, DOI 10.1016/j.cretres.2006.08.003; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Nixon K.C., 2002, WINCLADA VER 1 00 08; Pinto I. D., 1974, 28 C BRAS GEOL, V2, P289; Popov Y.A., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P166; Popov Y.A., 1986, INSECTS EARLY CRETAC, VVolume 28, P47; POPOV YA, 1977, SYST ENTOMOL, V2, P333, DOI 10.1111/j.1365-3113.1977.tb00382.x; Popov Yu.A., 1990, Trudy Paleontologicheskogo Instituta, V239, P20; Popov Yuri A., 1994, Genus (Wroclaw), V5, P307; Ren D., 1995, FAUNAE STRATIGRAPHY; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; SCHAEFER CW, 1993, EUR J ENTOMOL, V90, P105; Schuh R. T., 1995, CLASSIFICATION NATUR; Schuh R.T., 1979, SYST ZOOL, V28, P653, DOI DOI 10.2307/2412577; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; SCHUH RT, 1986, ANNU REV ENTOMOL, V31, P67, DOI 10.1146/annurev.en.31.010186.000435; SCOTESE C, 2009, PALEOMAP PROJECT; Shcherbakov DE, 2002, SUPERORDER CIMICIDEA, P143; STYS P, 1975, ACTA ENTOMOL BOHEMOS, V72, P65; Sweet Merrill H., 1996, P119; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; WOOTTON RJ, 1986, SYST ENTOMOL, V11, P389, DOI 10.1111/j.1365-3113.1986.tb00191.x; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Yao YZ, 2006, ANN ZOOL, V56, P753; Yao YZ, 2007, ZOOTAXA, P59, DOI 10.11646/zootaxa.1388.1.5; Yao Y, 2006, ZOOTAXA, P41; Yao YZ, 2006, ZOOTAXA, P1; Yao YZ, 2006, ZOOTAXA, P57; Yunzhi Y, 2008, ACTA GEOL SIN-ENGL, V82, P35; Zhang BL, 2006, ACTA GEOL SIN-ENGL, V80, P327; Zhang S.M., 1985, EC INSECT FAUNA CHIN; Zhou Zhonghe, 2006, P705	57	40	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37289	10.1371/journal.pone.0037289	http://dx.doi.org/10.1371/journal.pone.0037289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655038	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900013
J	Itan, E; Tannenbaum, E				Itan, Eran; Tannenbaum, Emmanuel			Effect of Chromosomal Instability on the Mutation-Selection Balance in Unicellular Populations	PLOS ONE			English	Article							GENETIC INSTABILITY; CANCER; DYNAMICS	This paper develops a mathematical model describing the evolutionary dynamics of a unicellular, asexually replicating population exhibiting chromosomal instability. Chromosomal instability is a form of genetic instability characterized by the gain or loss of entire chromosomes during cell division. We assume that the cellular genome is divided into several homologous groups of chromosomes, and that a single functional chromosome per homologous group is required for the cell to have the wild-type fitness. If the fitness is unaffected by the total number of chromosomes in the cell, our model is analytically solvable, and yields a mean fitness at mutation-selection balance that is identical to the mean fitness when there is no chromosomal instability. If this assumption is relaxed and the total number of chromosomes in the cell is not allowed to increase without bound, then chromosomal instability leads to a reduction in mean fitness. The results of this paper provide a useful baseline that can inform both future theoretial and experimental studies of chromosomal instability.	[Itan, Eran; Tannenbaum, Emmanuel] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel	Ben Gurion University	Itan, E (corresponding author), Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel.	emmanuel.tannenbaum@gmail.com						Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Brumer Y, 2006, J THEOR BIOL, V241, P216, DOI 10.1016/j.jtbi.2005.11.018; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Nowak MA, 2006, J THEOR BIOL, V241, P26, DOI 10.1016/j.jtbi.2005.11.012	7	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e26513	10.1371/journal.pone.0026513	http://dx.doi.org/10.1371/journal.pone.0026513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649487	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800003
J	Baba, K; Mazzoni, F; Owino, S; Contreras-Alcantara, S; Strettoi, E; Tosini, G				Baba, Kenkichi; Mazzoni, Francesca; Owino, Sharon; Contreras-Alcantara, Susana; Strettoi, Enrica; Tosini, Gianluca			Age-Related Changes in the Daily Rhythm of Photoreceptor Functioning and Circuitry in a Melatonin-Proficient Mouse Strain	PLOS ONE			English	Article							DEGENERATION; RETINA; EXPRESSION; RECEPTOR; CLOCK	Retinal melatonin is involved in the modulation of many important retinal functions. Our previous studies have shown that the viability of photoreceptors and ganglion cells is reduced during aging in mice that lack melatonin receptor type 1. This demonstrates that melatonin signaling is important for the survival of retinal neurons. In the present study, we investigate the effects of aging on photoreceptor physiology and retinal organization in CH3-f+/+ mice, a melatonin proficient mouse strain. Our data indicate that the amplitude of the a and b waves of the scotopic and photopic electroretinogram decreases with age. Moreover, the daily rhythm in the amplitude of the a- and b- waves is lost during the aging process. Similarly, the scotopic threshold response is significantly affected by aging, but only when it is measured during the night. Interestingly, the changes observed in the ERGs are not paralleled by relevant changes in retinal morphological features, and administration of exogenous melatonin does not affect the ERGs in C3H-f(+/+) at 12 months of age. This suggests that the responsiveness of the photoreceptors to exogenous melatonin is reduced during aging.	[Baba, Kenkichi; Owino, Sharon; Contreras-Alcantara, Susana; Tosini, Gianluca] CNR, Circadian Rhythms & Sleep Disorders Program, Inst Neurosci, Dept Anat & Neurobiol,Morehouse Sch Med, I-56100 Pisa, Italy; [Mazzoni, Francesca; Strettoi, Enrica] CNR, Italian Natl Res Council, Inst Neurosci, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Baba, K (corresponding author), CNR, Circadian Rhythms & Sleep Disorders Program, Inst Neurosci, Dept Anat & Neurobiol,Morehouse Sch Med, I-56100 Pisa, Italy.	gtosini@msm.edu	Mazzoni, Francesca/T-9044-2019	tosini, gianluca/0000-0003-3645-4533; Strettoi, Enrica/0000-0002-6101-599X; Mazzoni, Francesca/0000-0002-7826-2786	National Institutes of Health [NS43459, EY28821, EY022216, 5S21MD000101, 5U54NS060659, S21MD000101, G12-RR03034]; Georgia Research Alliance [EY12654]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY020821, R01EY012654, R01EY022216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043459, R01NS043459, U54NS060659] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants NS43459, EY28821, EY022216; 5S21MD000101, 5U54NS060659, S21MD000101, G12-RR03034, the Georgia Research Alliance (to G.T.), and EY12654 (to E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi N, 2010, MED SCI MONITOR, V16, pBR61; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Bubenik GA, 2011, J PHYSIOL PHARMACOL, V62, P13; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Fujieda H, 1999, NEUROSCIENCE, V93, P793, DOI 10.1016/S0306-4522(99)00111-6; Gagne Anne-Marie, 2009, J Circadian Rhythms, V7, P14, DOI 10.1186/1740-3391-7-14; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; Liang FQ, 2001, NEUROREPORT, V12, P1011, DOI 10.1097/00001756-200104170-00029; Liets LC, 2006, P NATL ACAD SCI USA, V103, P12156, DOI 10.1073/pnas.0605211103; Meyer P, 2002, BRIT J OPHTHALMOL, V86, P1053, DOI 10.1136/bjo.86.9.1053; Peters JL, 2005, J PINEAL RES, V38, P209, DOI 10.1111/j.1600-079X.2004.00195.x; PULIDO O, 1986, EXP GERONTOL, V21, P23, DOI 10.1016/0531-5565(86)90014-8; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Rosen R, 2009, MOL VIS, V15, P1673; Rufiange M, 2002, INVEST OPHTH VIS SCI, V43, P2491; Sanchez-Barcelo EJ, 2010, CURR MED CHEM, V17, P2070, DOI 10.2174/092986710791233689; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Sugawara T, 1998, INVEST OPHTH VIS SCI, V39, P2458; Terzibasi E, 2009, NEUROBIOL AGING, V30, P819, DOI 10.1016/j.neurobiolaging.2007.08.017; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2006, CHRONOBIOL INT, V23, P381, DOI 10.1080/07420520500482066; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228; Von Gall C, 2008, NEUROBIOL AGING, V29, P464, DOI 10.1016/j.neurobiolaging.2006.10.015; Wu YH, 2007, NEUROBIOL AGING, V28, P1239, DOI 10.1016/j.neurobiolaging.2006.06.002; Yi CX, 2005, ANN NY ACAD SCI, V1057, P384, DOI 10.1196/annals.1356.029	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37799	10.1371/journal.pone.0037799	http://dx.doi.org/10.1371/journal.pone.0037799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629458	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300077
J	Gerena, Y; Skolasky, RL; Velez, JM; Toro-Nieves, D; Mayo, R; Nath, A; Wojna, V				Gerena, Yamil; Skolasky, Richard L.; Velez, Joyce M.; Toro-Nieves, Dianedis; Mayo, Raul; Nath, Avindra; Wojna, Valerie			Soluble and Cell-Associated Insulin Receptor Dysfunction Correlates with Severity of HAND in HIV-Infected Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; BECK DEPRESSION INVENTORY; MULTICENTER AIDS COHORT; COGNITIVE IMPAIRMENT; NEUROCOGNITIVE DISORDERS; DIABETES-MELLITUS; HIV-1-INFECTED PATIENTS; NEUROLOGIC DISEASE; GLUCOSE-METABOLISM	Background: Blood sugar metabolism abnormalities have been identified in HIV-infected individuals and associated with HIV-associated neurocognitive disorders (HAND). These abnormalities may occur as a result of chronic HIV infection, long-term use of combined antiretroviral treatment (CART), aging, genetic predisposition, or a combination of these factors, and may increase morbidity and mortality in this population. Objective: To determine if changes in soluble and cell-associated insulin receptor (IR) levels, IR substrate-1 (IRS-1) levels, and IRS-1 tyrosine phosphorylation are associated with the presence and severity of HAND in a cohort of HIV-seropositive women. Methods and Results: This is a retrospective cross-sectional study using patient database information and stored samples from 34 HIV-seropositive women and 10 controls without history of diabetes from the Hispanic-Latino Longitudinal Cohort of Women. Soluble IR subunits [sIR, ectodomain (a) and full-length or intact (ab)] were assayed in plasma and CSF samples by ELISA. Membrane IR levels, IRS-1 levels, and IRS-1 tyrosine phosphorylation were analyzed in CSF white cell pellets (WCP) using flow cytometry. HIV-seropositive women had significantly increased levels of intact or full-length sIR in plasma (p<0.001) and CSF (p<0.005) relative to controls. Stratified by HAND, increased levels of full-length sIR in plasma were associated with the presence (p<0.001) and severity (p<0.005) of HAND. A significant decrease in IRS-1 tyrosine-phosphorylation in the WCP was also associated with the presence (p<0.02) and severity (p<0.02) of HAND. Conclusions: This study provides evidence that IR secretion is increased in HIV-seropositive women, and increased IR secretion is associated with cognitive impairment in these women. Thus, IR dysfunction may have a role in the progression of HAND and could represent a biomarker for the presence and severity of HAND.	[Gerena, Yamil; Velez, Joyce M.; Toro-Nieves, Dianedis; Mayo, Raul; Wojna, Valerie] Univ Puerto Rico, NeuroAIDS Specialized Neurosci Res Program, San Juan, PR 00936 USA; [Gerena, Yamil] Univ Puerto Rico, Sch Pharm, San Juan, PR 00936 USA; [Skolasky, Richard L.] Johns Hopkins Univ, Dept Orthopaed Surg, Baltimore, MD USA; [Mayo, Raul] Univ Puerto Rico, Dept Phys Med, San Juan, PR 00936 USA; [Mayo, Raul] Univ Puerto Rico, Dept Rehabil, San Juan, PR 00936 USA; [Nath, Avindra] Natl Inst Neurol Disorders & Stroke, Sect Infect Nervous Syst, NIH, Bethesda, MD USA; [Wojna, Valerie] Univ Puerto Rico, Internal Med Neurol Div, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Johns Hopkins University; University of Puerto Rico; University of Puerto Rico; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Puerto Rico	Gerena, Y (corresponding author), Univ Puerto Rico, NeuroAIDS Specialized Neurosci Res Program, San Juan, PR 00936 USA.	valerie.wojna1@upr.edu		Gerena, Yamil/0000-0002-5324-109X; Wojna, Valerie/0000-0002-4014-9921; Skolasky, Richard/0000-0002-2598-4427	National Institutes of Health (NIH) [1R21MH095524-01, 5S11NS046278-07, 5U54NS043011-11, 1U54RR026139-01A1, 5G12RR003051-25]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139, G12RR003051, P20RR011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080661, R21MH095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003130, S11NS046278, U54NS043011] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by the National Institutes of Health (NIH) grants: 1R21MH095524-01, 5S11NS046278-07, 5U54NS043011-11, 1U54RR026139-01A1, and 5G12RR003051-25. Its contents are solely the responsibility of authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; [Anonymous], 2006, AIDS READ; [Anonymous], 2006, AIDS READ; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bateman JM, 2006, CELL MOL LIFE SCI, V63, P1701, DOI 10.1007/s00018-006-6036-4; BERNAL G, 1995, REV LAT AM PSICOL, V27, P207; Bonilla J, 2004, J CLIN PSYCHOL, V60, P119, DOI 10.1002/jclp.10195; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Cohen RA, 2010, NEUROLOGY, V75, P2052, DOI 10.1212/WNL.0b013e318200d833; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Danoff A, 2005, JAIDS-J ACQ IMM DEF, V39, P55, DOI 10.1097/01.qai.0000147659.80642.5a; DAVIS TM, 1979, J CONSULT CLIN PSYCH, V47, P181, DOI 10.1037/0022-006X.47.1.181; Demsky YI, 1998, ASSESSMENT, V5, P25, DOI 10.1177/107319119800500105; Dube MP, 2000, CLIN INFECT DIS, V31, P1467, DOI 10.1086/317491; Ellis Ronald J, 2007, PLoS Clin Trials, V2, pe15, DOI 10.1371/journal.pctr.0020015; Genuth S, 2007, NEW ENGL J MED, V356, P1842; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard AA, 2005, CLIN INFECT DIS, V40, P1492, DOI 10.1086/429824; Huang Chiung-Chun, 2010, Chang Gung Med J, V33, P115; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Lee J, 2004, J PHARM PRACT, V17, P80; Letendre Scott L, 2010, Top HIV Med, V18, P45; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Liner Kevin J 2nd, 2010, Curr HIV/AIDS Rep, V7, P85, DOI 10.1007/s11904-010-0042-8; Lo YC, 2009, HIV MED, V10, P302, DOI 10.1111/j.1468-1293.2008.00687.x; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Maschke M, 2000, J NEUROL NEUROSUR PS, V69, P376, DOI 10.1136/jnnp.69.3.376; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McArthur JC, 1999, SEMIN NEUROL, V19, P129, DOI 10.1055/s-2008-1040831; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McArthur JC, 2010, AIDS, V24, P1367, DOI 10.1097/QAD.0b013e3283391d56; McGuire D, 2009, NEUROLOGY, V73, P1942, DOI 10.1212/WNL.0b013e3181c51a92; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; Obata T, 2007, DIABETES, V56, P2028, DOI 10.2337/db07-0394; Panza F, 2010, J ALZHEIMERS DIS, V21, P691, DOI 10.3233/JAD-2010-091669; Perry SW, 2005, NEUROTOX RES, V8, P161, DOI 10.1007/BF03033827; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Price RW, 2007, NEUROLOGY, V69, P1781, DOI 10.1212/01.wnl.0000278457.55877.eb; Price RW, 2010, J NEUROVIROL, V16, P68; Ragin AB, 2004, NEUROLOGY, V63, P2293, DOI 10.1212/01.WNL.0000147477.44791.BD; Ronnemaa E, 2008, NEUROLOGY, V71, P1065, DOI 10.1212/01.wnl.0000310646.32212.3a; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Schifitto G, 2009, NEUROLOGY, V73, P1975, DOI 10.1212/WNL.0b013e3181c51a48; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Schutzer SE, 2004, J NEUROIMMUNOL, V157, P120, DOI 10.1016/j.jneuroim.2004.08.024; Selnes OA, 2005, AIDS READ, V15, P294; Selnes Ola A, 2005, AIDS Read, V15, P289; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sesti G, 2006, BEST PRACT RES CL EN, V20, P665, DOI 10.1016/j.beem.2006.09.007; Shapshak P, 2010, AIDS, V24, P1; Sobieszczyk ME, 2008, JAIDS-J ACQ IMM DEF, V48, P272, DOI 10.1097/QAI.0b013e31817af461; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tebas P, 2008, JAIDS-J ACQ IMM DEF, V49, pS86, DOI 10.1097/QAI.0b013e31818651e6; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; Valcour VG, 2005, JAIDS-J ACQ IMM DEF, V38, P31, DOI 10.1097/00126334-200501010-00006; Valcour VG, 2006, JAIDS-J ACQ IMM DEF, V43, P405, DOI 10.1097/01.qai.0000243119.67529.f5; Wang TG, 2006, CLIN SCI, V110, P393, DOI 10.1042/CS20050278; Wojna V, 2007, AIDS PATIENT CARE ST, V21, P930, DOI 10.1089/apc.2006.0180; Wojna V., 2006, AIDS READ, V16, P629; Wojna Valerie, 2006, AIDS Read, V16, P615; Wojna V, 2006, J NEUROVIROL, V12, P356, DOI 10.1080/13550280600964576; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915	70	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37358	10.1371/journal.pone.0037358	http://dx.doi.org/10.1371/journal.pone.0037358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629383	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300034
J	Konopka, KH; Harbers, M; Houghton, A; Kortekaas, R; van Vliet, A; Timmerman, W; den Boer, JA; Struys, MMRF; van Wijhe, M				Konopka, Karl-Heinz; Harbers, Marten; Houghton, Andrea; Kortekaas, Rudie; van Vliet, Andre; Timmerman, Wia; den Boer, Johan A.; Struys, Michel M. R. F.; van Wijhe, Marten			Bilateral Sensory Abnormalities in Patients with Unilateral Neuropathic Pain; A Quantitative Sensory Testing (QST) Study	PLOS ONE			English	Article							HYPERALGESIA; MECHANISMS; INJURY; ACTIVATION; PROTOCOL; NEURONS; IMMUNE; SPREAD; MODEL	In patients who experience unilateral chronic pain, abnormal sensory perception at the non-painful side has been reported. Contralateral sensory changes in these patients have been given little attention, possibly because they are regarded as clinically irrelevant. Still, bilateral sensory changes in these patients could become clinically relevant if they challenge the correct identification of their sensory dysfunction in terms of hyperalgesia and allodynia. Therefore, we have used the standardized quantitative sensory testing (QST) protocol of the German Research Network on Neuropathic Pain (DFNS) to investigate somatosensory function at the painful side and the corresponding non-painful side in unilateral neuropathic pain patients using gender-and age-matched healthy volunteers as a reference cohort. Sensory abnormalities were observed across all QST parameters at the painful side, but also, to a lesser extent, at the contralateral, non-painful side. Similar relative distributions regarding sensory loss/gain for non-nociceptive and nociceptive stimuli were found for both sides. Once a sensory abnormality for a QST parameter at the affected side was observed, the prevalence of an abnormality for the same parameter at the non-affected side was as high as 57% (for Pressure Pain Threshold). Our results show that bilateral sensory dysfunction in patients with unilateral neuropathic pain is more rule than exception. Therefore, this phenomenon should be taken into account for appropriate diagnostic evaluation in clinical practice. This is particularly true for mechanical stimuli where the 95% Confidence Interval for the prevalence of sensory abnormalities at the non-painful side ranges between 33% and 50%.	[Konopka, Karl-Heinz; Struys, Michel M. R. F.; van Wijhe, Marten] Univ Groningen, Pain Management Unit, Dept Anesthesiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Harbers, Marten; den Boer, Johan A.] Univ Groningen, Dept Psychiat, Univ Med Ctr Groningen, Groningen, Netherlands; [Houghton, Andrea] Merck & Co Inc, West Point, NY USA; [Kortekaas, Rudie] Univ Groningen, Dept Neurosci, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [van Vliet, Andre; Timmerman, Wia] PRA Int, Zuidlaren, Netherlands	University of Groningen; University of Groningen; Merck & Company; University of Groningen	Konopka, KH (corresponding author), Univ Groningen, Pain Management Unit, Dept Anesthesiol, Univ Med Ctr Groningen, Groningen, Netherlands.	k.h.konopka@umcg.nl		Struys, Michel/0000-0003-0421-536X; van Wijhe, Marten/0000-0001-6873-4092	Dutch Top Institute Pharma [T5-108]	Dutch Top Institute Pharma	This study was performed within the framework of Dutch Top Institute Pharma project T5-108. Partners in this project include Merck. Co., Inc., PRA International and UMC Groningen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON R, 1994, NEUROSCI LETT, V165, P97, DOI 10.1016/0304-3940(94)90718-8; Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; Chacur M, 2001, PAIN, V94, P231, DOI 10.1016/S0304-3959(01)00354-2; Felix ER, 2009, J REHABIL RES DEV, V46, P69, DOI 10.1682/JRRD.2008.04.0058; Fernandez-de-las-Penas C, 2009, BRAIN, V132, P1472, DOI 10.1093/brain/awp050; Freynhagen R, 2008, PAIN, V135, P65, DOI 10.1016/j.pain.2007.05.004; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Gierthmuhlen J, 2011, PAIN; Haanpaa M, 2010, PAIN; Haanpaa ML, 2009, AM J MED, V122, pS13, DOI 10.1016/j.amjmed.2009.04.006; Hansson E, 2006, ACTA PHYSIOL, V187, P321, DOI 10.1111/j.1748-1716.2006.01568.x; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Hubbard RD, 2008, EXP NEUROL, V212, P482, DOI 10.1016/j.expneurol.2008.04.042; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; de la Llave-Rincon AI, 2009, EXP BRAIN RES, V198, P455, DOI 10.1007/s00221-009-1941-z; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Liu XG, 2000, PAIN, V84, P309, DOI 10.1016/S0304-3959(99)00211-0; Maier C, 2010, PAIN; Maleki J, 2000, PAIN, V88, P259, DOI 10.1016/S0304-3959(00)00332-8; Milligan ED, 2003, J NEUROSCI, V23, P1026; Moore DS, 2003, INTRO PRACTICE STAT, Vxxv; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; Ochoa JL, 2005, MUSCLE NERVE, V32, P459, DOI 10.1002/mus.20367; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Serra J, 2009, PAIN, V147, P46, DOI 10.1016/j.pain.2009.07.028; Shenker NG, 2008, RHEUMATOLOGY, V47, P1417, DOI 10.1093/rheumatology/ken251; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Veldman PHJM, 1996, PAIN, V64, P463, DOI 10.1016/0304-3959(95)00160-3; Walk D, 2009, CLIN J PAIN, V25, P632, DOI 10.1097/AJP.0b013e3181a68c64; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002	38	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37524	10.1371/journal.pone.0037524	http://dx.doi.org/10.1371/journal.pone.0037524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629414	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300049
J	Kravchenko, J; Akushevich, I; Abernethy, AP; Lyerly, HK				Kravchenko, Julia; Akushevich, Igor; Abernethy, Amy P.; Lyerly, H. Kim			Evaluating the Number of Stages in Development of Squamous Cell and Adenocarcinomas across Cancer Sites Using Human Population-Based Cancer Modeling	PLOS ONE			English	Article							STOCHASTIC CARCINOGENESIS MODEL; LUNG-CANCER; COLORECTAL-CANCER; MULTISTAGE CARCINOGENESIS; CERVICAL-CANCER; CARCINOMA; AGE; MORTALITY; RADIATION; TRENDS	Background: Adenocarcinomas (ACs) and squamous cell carcinomas (SCCs) differ by clinical and molecular characteristics. We evaluated the characteristics of carcinogenesis by modeling the age patterns of incidence rates of ACs and SCCs of various organs to test whether these characteristics differed between cancer subtypes. Methodology/Principal Findings: Histotype-specific incidence rates of 14 ACs and 12 SCCs from the SEER Registry (19732003) were analyzed by fitting several biologically motivated models to observed age patterns. A frailty model with the Weibull baseline was applied to each age pattern to provide the best fit for the majority of cancers. For each cancer, model parameters describing the underlying mechanisms of carcinogenesis including the number of stages occurring during an individual's life and leading to cancer (m-stages) were estimated. For sensitivity analysis, the age-period-cohort model was incorporated into the carcinogenesis model to test the stability of the estimates. For the majority of studied cancers, the numbers of m-stages were similar within each group (i.e., AC and SCC). When cancers of the same organs were compared (i.e., lung, esophagus, and cervix uteri), the number of m-stages were more strongly associated with the AC/SCC subtype than with the organ: 9.79+/-0.09, 9.93+/-0.19 and 8.80+/-0.10 for lung, esophagus, and cervical ACs, compared to 11.41+/-0.10, 12.86+/-0.34 and 12.01+/-0.51 for SCCs of the respective organs (p<0.05 between subtypes). Most SCCs had more than ten m-stages while ACs had fewer than ten m-stages. The sensitivity analyses of the model parameters demonstrated the stability of the obtained estimates. Conclusions/Significance: A model containing parameters capable of representing the number of stages of cancer development occurring during individual's life was applied to the large population data on incidence of ACs and SCCs. The model revealed that the number of m-stages differed by cancer subtype being more strongly associated with ACs/SCCs histotype than with organ/site.	[Kravchenko, Julia; Abernethy, Amy P.; Lyerly, H. Kim] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27706 USA; [Akushevich, Igor] Duke Univ, Med Ctr, Ctr Populat Hlth & Aging, Durham, NC USA; [Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA; [Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Div Gen Surg, Durham, NC 27710 USA; [Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Kravchenko, J (corresponding author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27706 USA.	julia.krauchanka@duke.edu	Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; Abernethy, Amy/0000-0001-6930-8722				Akushevich I, 2012, MATH BIOSCI, V236, P16, DOI 10.1016/j.mbs.2011.12.002; Akushevich IV, 2010, HEALTH PHYS, V99, P322, DOI 10.1097/HP.0b013e3181c61dc1; Areses K, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e21087; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; BOFFETTA P, 2002, TXB CANC EPIDEMIOLOG, P248; Bonafe M, 2001, CRIT REV ONCOL HEMAT, V39, P227, DOI 10.1016/S1040-8428(01)00168-8; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Calabrese P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-126; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; COOK GB, 1966, CANCER, V19, P959, DOI 10.1002/1097-0142(196607)19:7<959::AID-CNCR2820190709>3.0.CO;2-R; COY P, 1981, CHEST, V80, P453, DOI 10.1378/chest.80.4.453; de Rijke JM, 2000, CANCER, V89, P1121, DOI 10.1002/1097-0142(20000901)89:5<1121::AID-CNCR22>3.3.CO;2-7; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forman D, 2002, EUR J GASTROEN HEPAT, V14, P99, DOI 10.1097/00042737-200202000-00001; GAIL MH, 1984, CANCER, V54, P1802, DOI 10.1002/1097-0142(19841101)54:9<1802::AID-CNCR2820540908>3.0.CO;2-4; Green J, 2003, BRIT J CANCER, V89, P2078, DOI 10.1038/sj.bjc.6601296; Grotmol T, 2011, CANCER EPIDEM BIOMAR, V20, P1350, DOI 10.1158/1055-9965.EPI-10-1014; Hassan KA, 2009, CLIN CANCER RES, V15, P6386, DOI 10.1158/1078-0432.CCR-09-1105; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hazelton WD, 2005, CANCER EPIDEM BIOMAR, V14, P1171, DOI 10.1158/1055-9965.EPI-04-0756; Henson DE, 2009, ARCH PATHOL LAB MED, V133, P67, DOI 10.1043/1543-2165-133.1.67; Janssen-Heijnen MLG, 2001, LUNG CANCER, V31, P123, DOI 10.1016/S0169-5002(00)00197-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karayi MK, 2004, PROSTATE CANCER P D, V7, P6, DOI 10.1038/sj.pcan.4500697; Kawase A, 2012, JPN J CLIN ONCOL, V42, P189, DOI 10.1093/jjco/hyr188; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kondo M, 2002, HEPATO-GASTROENTEROL, V49, P1230; Kravchenko J, 2011, BREAST CANCER RES TR, V128, P483, DOI 10.1007/s10549-011-1347-z; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lindstrom AK, 2009, ANTICANCER RES, V29, P2577; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manton K, 2009, CANC MORTALITY MORBI; Manton KG, 2008, MATH POPUL STUD, V15, P137, DOI 10.1080/08898480802221665; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Miyaishi O, 2000, MECH AGEING DEV, V117, P47, DOI 10.1016/S0047-6374(00)00136-6; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1988, TOXICOL LETT, V43, P139, DOI 10.1016/0378-4274(88)90025-2; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; OKAMOTO T, 1989, JPN J CANCER RES, V80, P191; PETERSON P, 2007, J THORAC ONCOL S4, V2, pS851, DOI DOI 10.1097/01.JTO.0000284677.33344.62; PIANTANELLI L, 1988, ANN NY ACAD SCI, V521, P99, DOI 10.1111/j.1749-6632.1988.tb35268.x; Pierce DA, 1999, RADIAT RES, V152, P642, DOI 10.2307/3580260; Rieker RJ, 2008, PATHOL ONCOL RES, V14, P199, DOI 10.1007/s12253-008-9050-z; ROSENTHAL SA, 1990, CANCER TREAT REV, V17, P409, DOI 10.1016/0305-7372(90)90082-Q; SATO S, 1994, CANCER RES, V54, P5652; Schiffman M, 2006, CANC EPIDEMIOLOGY PR, P1044; Schollnberger H, 2006, CARCINOGENESIS, V27, P1432, DOI 10.1093/carcin/bgi345; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smith DWE, 1999, LONGEVITY PARADOXES, P61; Stanta G, 1997, CLIN GERIATR MED, V13, P55; Tan W. Y., 1991, STOCHASTIC MODELS CA; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Thune I, 1997, INT J CANCER, V70, P57; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Veremeyeva G. A., 2010, International Journal of Low Radiation, V7, P53, DOI 10.1504/IJLR.2010.032771; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yashin AI, 2009, MATH BIOSCI, V218, P88, DOI 10.1016/j.mbs.2008.12.007; Yoshida H, 2003, ONCOL REP, V10, P45	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37430	10.1371/journal.pone.0037430	http://dx.doi.org/10.1371/journal.pone.0037430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629394	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300040
J	Lee, S; Han, MJ; Lee, KS; Back, SC; Hwang, D; Kim, HY; Shin, JH; Suh, SP; Ryang, DW; Kim, HR; Shin, MG				Lee, Soong; Han, Moon-Jong; Lee, Ki-Sang; Back, Seung-Chul; Hwang, David; Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Kim, Hye-Ran; Shin, Myung-Geun			Frequent Occurrence of Mitochondrial DNA Mutations in Barrett's Metaplasia without the Presence of Dysplasia	PLOS ONE			English	Article							ESOPHAGEAL ADENOCARCINOMA; ATRIAL-FIBRILLATION; CANCER; PROGRESSION; TISSUE; MUSCLE	Background: Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma (EA). The numerous molecular events may play a role in the neoplastic transformation of Barrett's mucosa such as the change of DNA ploidy, p53 mutation and alteration of adhesion molecules. However, the molecular mechanism of the progression of BE to EA remains unclear and most studies of mitochondrial DNA (mtDNA) mutations in BE have performed on BE with the presence of dysplasia. Methods/Findings: Thus, the current study is to investigate new molecular events (Barrett's esophageal tissue-specific-mtDNA alterations/instabilities) in mitochondrial genome and causative factors for their alterations using the corresponding adjacent normal mucosal tissue (NT) and tissue (BT) from 34 patients having Barrett's metaplasia without the presence of dysplasia. Eighteen patients (53%) exhibited mtDNA mutations which were not found in adjacent NT. mtDNA copy number was about 3 times higher in BT than in adjacent NT. The activity of the mitochondrial respiratory chain enzyme complexes in tissues from Barrett's metaplasia without the presence of dysplasia was impaired. Reactive oxygen species (ROS) level in BT was significantly higher than those in corresponding samples. Conclusion/Significance: High ROS level in BT may contribute to the development of mtDNA mutations, which may play a crucial role in disease progression and tumorigenesis in BE.	[Lee, Soong; Han, Moon-Jong; Lee, Ki-Sang; Back, Seung-Chul; Hwang, David] Seonam Univ, Coll Med, Dept Internal Med, Namwon, South Korea; [Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea; [Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Dept Lab Med, Hwasun, South Korea; [Kim, Hye-Ran] Chonnam Natl Univ, Ctr Biomed Human Resources, Brain Korea Project 21, Kwangju, South Korea; [Kim, Hye-Ran; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea; [Kim, Hye-Ran; Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Environm Hlth Ctr Childhood Leukemia & Canc, Hwasun, South Korea	Seonam University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Lee, S (corresponding author), Seonam Univ, Coll Med, Dept Internal Med, Namwon, South Korea.	KimHR@chonnam.ac.kr; mgshin@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0024326]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0024326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann S, 2006, INT J CANCER, V119, P264, DOI 10.1002/ijc.21848; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Flejou JF, 2005, GUT, V54, pI6, DOI 10.1136/gut.2004.041525; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599; Lee JS, 2001, MUTAT RES-FUND MOL M, V480, P189, DOI 10.1016/S0027-5107(01)00199-3; Lee S, 2007, CLIN CHEM, V53, P1390, DOI 10.1373/clinchem.2007.088047; Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002; Nishikawa M, 2005, BRIT J CANCER, V93, P331, DOI 10.1038/sj.bjc.6602664; Park HW, 2007, J CLIN PATHOL, V60, P948, DOI 10.1136/jcp.2007.047134; Park SY, 2009, MITOCHONDRION, V9, P318, DOI 10.1016/j.mito.2009.04.006; PERA M, 1993, ANN THORAC SURG, V56, P1191, DOI 10.1016/0003-4975(95)90050-0; Sharma P, 2006, ENDOSCOPY, V38, P1206, DOI 10.1055/s-2006-944974; Shin MG, 2007, LEUKEMIA, V21, P369, DOI 10.1038/sj.leu.2404502; Shin MG, 2006, ELECTROPHORESIS, V27, P1331, DOI 10.1002/elps.200500551; Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724; Sommerer F, 2004, ONCOGENE, V23, P554, DOI 10.1038/sj.onc.1207189; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Tan BHL, 2009, EUR J CANCER, V45, P736, DOI 10.1016/j.ejca.2009.01.013; Tischoff Iris, 2008, Expert Rev Gastroenterol Hepatol, V2, P653, DOI 10.1586/17474124.2.5.653; Zagorowicz E, 2007, POSTGRAD MED J, V83, P529, DOI 10.1136/pgmj.2006.052910	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37571	10.1371/journal.pone.0037571	http://dx.doi.org/10.1371/journal.pone.0037571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629421	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300053
J	Santos, MD; Mohammadi, MH; Yang, SG; Liang, CW; Kao, JPY; Alger, BE; Thompson, SM; Tang, CM				Santos, Mariton D.; Mohammadi, Michael H.; Yang, Sunggu; Liang, Conrad W.; Kao, Joseph P. Y.; Alger, Bradley E.; Thompson, Scott M.; Tang, Cha-Min			Dendritic Hold and Read: A Gated Mechanism for Short Term Information Storage and Retrieval	PLOS ONE			English	Article							MEMORY	Two contrasting theories have been proposed to explain the mechanistic basis of short term memory. One theory posits that short term memory is represented by persistent neural activity supported by reverberating feedback networks. An alternate, more recent theory posits that short term memory can be supported by feedforward networks. While feedback driven memory can be implemented by well described mechanisms of synaptic plasticity, little is known of possible molecular and cellular mechanisms that can implement feedforward driven memory. Here we report such a mechanism in which the memory trace exists in the form of glutamate-bound but Mg2+-blocked NMDA receptors on the thin terminal dendrites of CA1 pyramidal neurons. Because glutamate dissociates from subsets of NMDA receptors very slowly, excitatory synaptic transmission can leave a silent residual trace that outlasts the electrical activity by hundreds of milliseconds. Read-out of the memory trace is possible if a critical level of these bound-but-blocked receptors accumulates on a dendritic branch that will allow these quasi-stable receptors to sustain a regenerative depolarization when triggered by an independent gating signal. This process is referred to here as dendritic hold and read (DHR). Because the read-out of the input is not dependent on repetition of the input and information flows in a single-pass manner, DHR can potentially support a feedforward memory architecture.	[Santos, Mariton D.; Mohammadi, Michael H.; Yang, Sunggu; Liang, Conrad W.; Tang, Cha-Min] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.; Alger, Bradley E.; Thompson, Scott M.; Tang, Cha-Min] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Tang, Cha-Min] Baltimore Vet Adm Med Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Santos, MD (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	ctang@som.umaryland.edu	Thompson, Scott M/K-8921-2015	Yang, Sunggu/0000-0002-7567-9949; Kao, Joseph/0000-0002-8875-2180	VA Merit Review; National Institutes of Health RO1; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065488] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by VA Merit Review (CMT) and National Institutes of Health RO1 (JPYK, SMT, BEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	antos MD, 2009, SOC NEUR ABST, V718, P11; BEKKERS JM, 1990, COLD SH Q B, V55, P131; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Liang CW, 2011, JOVE-J VIS EXP, DOI 10.3791/2003; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; Santos MD, 2007, SOC NEUR ABST, V251; Santos MD, 2008, SOC NEUR ABST, V44; TANG CM, 2006, CURRENT PROTOCOLS NE; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; White OL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.148102; Yang SG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046002; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	20	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37542	10.1371/journal.pone.0037542	http://dx.doi.org/10.1371/journal.pone.0037542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629416	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300051
J	Weisse, S; Heddergott, N; Heydt, M; Pflasterer, D; Maier, T; Haraszti, T; Grunze, M; Engstler, M; Rosenhahn, A				Weisse, Sebastian; Heddergott, Niko; Heydt, Matthias; Pflaesterer, Daniel; Maier, Timo; Haraszti, Tamas; Grunze, Michael; Engstler, Markus; Rosenhahn, Axel			A Quantitative 3D Motility Analysis of Trypanosoma brucei by Use of Digital In-line Holographic Microscopy	PLOS ONE			English	Article							AFRICAN TRYPANOSOMES; ACTIN CORTEX; FLAGELLUM; TRACKING; SURFACE; MODELS	We present a quantitative 3D analysis of the motility of the blood parasite Trypanosoma brucei. Digital in-line holographic microscopy has been used to track single cells with high temporal and spatial accuracy to obtain quantitative data on their behavior. Comparing bloodstream form and insect form trypanosomes as well as mutant and wildtype cells under varying external conditions we were able to derive a general two-state-run-and-tumble-model for trypanosome motility. Differences in the motility of distinct strains indicate that adaption of the trypanosomes to their natural environments involves a change in their mode of swimming.	[Weisse, Sebastian; Heydt, Matthias; Pflaesterer, Daniel; Maier, Timo; Haraszti, Tamas; Grunze, Michael; Rosenhahn, Axel] Univ Heidelberg, Heidelberg, Germany; [Weisse, Sebastian; Grunze, Michael; Rosenhahn, Axel] Karlsruhe Inst Technol, Inst Funct Interfaces, IFG, Karlsruhe, Germany; [Heddergott, Niko; Engstler, Markus] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Maier, Timo; Haraszti, Tamas] Max Planck Inst Intelligent Syst, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; University of Wurzburg; Max Planck Society	Weisse, S (corresponding author), Univ Heidelberg, Heidelberg, Germany.	axel.rosenhahn@urz.uni-heidelberg.de	Grunze, Michael H/H-1600-2013; Grunze, Michael/O-2912-2019; Rosenhahn, Axel/F-7319-2011; Pflästerer, Daniel/AAE-5052-2019	Rosenhahn, Axel/0000-0001-9393-7190; Haraszti, Tamas/0000-0002-7095-4358	"Optische Messtechniken fur die Charakterisierung von Transportprozessen an Grenzflachen" of the DFG [Graduiertenkolleg 1114]; Deutsche Forschungsgemeinschaft (DFG) [RO 2524/2-1]; Office of Naval Research [N00014-08-1-1116]; Helmholtz-programme Biointerfaces	"Optische Messtechniken fur die Charakterisierung von Transportprozessen an Grenzflachen" of the DFG; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Office of Naval Research(Office of Naval Research); Helmholtz-programme Biointerfaces	This work was funded by the Graduiertenkolleg 1114 "Optische Messtechniken fur die Charakterisierung von Transportprozessen an Grenzflachen" of the DFG. The authors acknowledge support by the Deutsche Forschungsgemeinschaft (DFG grant RO 2524/2-1), the Office of Naval Research (grant number N00014-08-1-1116), and the Helmholtz-programme Biointerfaces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Garcia-Sucerquia J, 2006, APPL OPTICS, V45, P836, DOI 10.1364/AO.45.000836; Haraszti T, 2009, CHEMPHYSCHEM, V10, P2777, DOI 10.1002/cphc.200900581; Haraszti Tamas, 2009, Biophysical Reviews and Letters, V4, P17, DOI 10.1142/S1793048009001009; Heydt M, 2007, J ADHESION, V83, P417, DOI 10.1080/00218460701377388; Heydt M, 2009, EUR PHYS J E, V30, P141, DOI 10.1140/epje/i2009-10459-9; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Kreuzer HJ, 2001, J PHYS-CONDENS MAT, V13, P10729, DOI 10.1088/0953-8984/13/47/313; Kreuzer HJ, 2003, DIGITAL IN LINE HOLO, P299; Leal Taixe L, 2009, IEEE WORKSH MOT VID; Leal Taixe L, 2010, LNCS, V6376, P283; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; Lewis NI, 2006, PHYCOLOGIA, V45, P61, DOI 10.2216/04-59.1; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Wirtz E, 1998, NUCLEIC ACIDS RES, V26, P4626, DOI 10.1093/nar/26.20.4626; Xu W, 2003, OPT LETT, V28, P164, DOI 10.1364/OL.28.000164	33	27	27	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37296	10.1371/journal.pone.0037296	http://dx.doi.org/10.1371/journal.pone.0037296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629379	Green Published, gold			2022-12-27	WOS:000305345300032
J	Arapitsas, P; Scholz, M; Vrhovsek, U; Di Blasi, S; Bartolini, AB; Masuero, D; Perenzoni, D; Rigo, A; Mattivi, F				Arapitsas, Panagiotis; Scholz, Matthias; Vrhovsek, Urska; Di Blasi, Stefano; Bartolini, Alessandra Biondi; Masuero, Domenico; Perenzoni, Daniele; Rigo, Adelio; Mattivi, Fulvio			A Metabolomic Approach to the Study of Wine Micro-Oxygenation	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FLIGHT MASS-SPECTROMETRY; SUPPORT VECTOR MACHINES; COLOR-RELATED PHENOLICS; OAK CHIP TREATMENTS; RED WINES; MALOLACTIC FERMENTATION; MULTIVARIATE-STATISTICS; VOLATILE COMPOSITION; VITIS-VINIFERA	Wine micro-oxygenation is a globally used treatment and its effects were studied here by analysing by untargeted LC-MS the wine metabolomic fingerprint. Eight different procedural variations, marked by the addition of oxygen (four levels) and iron (two levels) were applied to Sangiovese wine, before and after malolactic fermentation. Data analysis using supervised and unsupervised multivariate methods highlighted some known candidate biomarkers, together with a number of metabolites which had never previously been considered as possible biomarkers for wine micro-oxygenation. Various pigments and tannins were identified among the known candidate biomarkers. Additional new information was obtained suggesting a correlation between oxygen doses and metal contents and changes in the concentration of primary metabolites such as arginine, proline, tryptophan and raffinose, and secondary metabolites such as succinic acid and xanthine. Based on these findings, new hypotheses regarding the formation and reactivity of wine pigment during micro-oxygenation have been proposed. This experiment highlights the feasibility of using unbiased, untargeted metabolomic fingerprinting to improve our understanding of wine chemistry.	[Arapitsas, Panagiotis; Vrhovsek, Urska; Masuero, Domenico; Perenzoni, Daniele; Mattivi, Fulvio] Fdn Edmund Mach, Dept Food Qual & Nutr, Res & Innovat Ctr, San Michele All Adige, Italy; [Scholz, Matthias] Fdn Edmund Mach, Res & Innovat Ctr, Dept Computat Biol, San Michele All Adige, Italy; [Di Blasi, Stefano; Bartolini, Alessandra Biondi] Consorzio Tuscania, Florence, Italy; [Rigo, Adelio] Univ Padua, Dept Biol Chem, Padua, Italy	Fondazione Edmund Mach; Fondazione Edmund Mach; University of Padua	Arapitsas, P (corresponding author), Fdn Edmund Mach, Dept Food Qual & Nutr, Res & Innovat Ctr, San Michele All Adige, Italy.	fulvio.mattivi@fmach.it	Arapitsas, Panagiotis/N-5179-2019; Mattivi, Fulvio/B-7645-2011; Scholz, Matthias/B-3508-2018; Di Blasi, Stefano/AAT-2030-2021; Arapitsas, Panagiotis/B-7763-2011	Arapitsas, Panagiotis/0000-0002-9378-9287; Mattivi, Fulvio/0000-0003-4935-5876; Scholz, Matthias/0000-0003-1414-5924; Arapitsas, Panagiotis/0000-0002-9378-9287; Masuero, Domenico/0000-0003-0696-3206				Alcalde-Eon C, 2006, ANAL CHIM ACTA, V563, P238, DOI 10.1016/j.aca.2005.11.028; Atanasova V, 2002, ANAL CHIM ACTA, V458, P15, DOI 10.1016/S0003-2670(01)01617-8; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boccard J, 2010, CHEMOMETR INTELL LAB, V104, P20, DOI 10.1016/j.chemolab.2010.03.003; Bodan M, 2010, CROAT MED J, V51, P16; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boulton R. B., 1996, PRINCIPLES PRACTICES, DOI DOI 10.1007/978-1-4615-1781-8; Calabrese EJ, 2009, ARCH TOXICOL, V83, P203, DOI 10.1007/s00204-009-0412-4; Cano-Lopez M, 2008, J AGR FOOD CHEM, V56, P5932, DOI 10.1021/jf8006147; Cano-Lopez M, 2006, AM J ENOL VITICULT, V57, P325; Carpentieri A, 2007, ANAL BIOANAL CHEM, V389, P969, DOI 10.1007/s00216-007-1476-8; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Cejudo-Bastante MJ, 2011, LWT-FOOD SCI TECHNOL, V44, P866, DOI 10.1016/j.lwt.2010.10.015; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Cuadros-Inostroza A, 2010, ANAL CHEM, V82, P3573, DOI 10.1021/ac902678t; Danilewicz JC, 2003, AM J ENOL VITICULT, V54, P73; Danilewicz JC, 2010, AM J ENOL VITICULT, V61, P166; de Freitas V, 2011, ANAL BIOANAL CHEM, V401, P1463, DOI 10.1007/s00216-010-4479-9; Llaudy MD, 2006, J AGR FOOD CHEM, V54, P4246, DOI 10.1021/jf052842t; Dew TP, 2005, J AGR FOOD CHEM, V53, P6510, DOI 10.1021/jf050716j; Doco T, 2003, CARBOHYD POLYM, V53, P253, DOI 10.1016/S0144-8617(03)00072-9; Drinkine J, 2007, J AGR FOOD CHEM, V55, P6292, DOI 10.1021/jf070038w; Ducasse MA, 2010, CARBOHYD POLYM, V79, P747, DOI 10.1016/j.carbpol.2009.10.001; Ducasse MA, 2010, FOOD CHEM, V118, P369, DOI 10.1016/j.foodchem.2009.04.130; Durner D, 2010, AM J ENOL VITICULT, V61, P474, DOI 10.5344/ajev.2010.09122; Fulcrand H, 2008, PHYTOCHEMISTRY, V69, P3131, DOI 10.1016/j.phytochem.2008.03.016; Gomez-Plaza E, 2011, FOOD CHEM, V125, P1131, DOI 10.1016/j.foodchem.2010.10.034; Gougeon RD, 2009, P NATL ACAD SCI USA, V106, P9174, DOI 10.1073/pnas.0901100106; Guadalupe Z, 2007, J AGR FOOD CHEM, V55, P10720, DOI 10.1021/jf0716782; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Guasch-Jane MR, 2006, J ARCHAEOL SCI, V33, P1075, DOI 10.1016/j.jas.2005.11.012; Hong YS, 2011, J AGR FOOD CHEM, V59, P7237, DOI 10.1021/jf200664t; Cejudo-Bastante MJ, 2011, FOOD CHEM, V124, P738, DOI 10.1016/j.foodchem.2010.07.064; Cejudo-Bastante MJ, 2011, FOOD CHEM, V124, P727, DOI 10.1016/j.foodchem.2010.06.067; Kontoudakis N, 2011, J AGR FOOD CHEM, V59, P1974, DOI 10.1021/jf103038g; Liebermeister W, 2002, BIOINFORMATICS, V18, P51, DOI 10.1093/bioinformatics/18.1.51; Liger-Belair G, 2009, P NATL ACAD SCI USA, V106, P16545, DOI 10.1073/pnas.0906483106; Mahadevan S, 2008, ANAL CHEM, V80, P7562, DOI 10.1021/ac800954c; Martoglio AM, 2002, BIOINFORMATICS, V18, P1617, DOI 10.1093/bioinformatics/18.12.1617; Mattivi F, 1990, VITIS, P119; Mazerolles G, 2010, ANAL CHIM ACTA, V678, P195, DOI 10.1016/j.aca.2010.07.034; McSweeney CS, 2001, ANIM FEED SCI TECH, V91, P83, DOI 10.1016/S0377-8401(01)00232-2; Nassiri-Asl M, 2009, PHYTOTHER RES, V23, P1197, DOI 10.1002/ptr.2761; PASTEUR L, 1873, ETUDES VIN; Perez-Magarino S, 2007, FOOD CHEM, V101, P881, DOI 10.1016/j.foodchem.2006.02.037; Ribereau-Gayon P, 2005, HDB ENOLOGY, V1, p[99, 51]; Ribereau-Gayon P, 2000, HDB ENOLOGY, V2, p[99, 129]; Scholz M, 2004, BIOINFORMATICS, V20, P2447, DOI 10.1093/bioinformatics/bth270; Schwarz M, 2003, J AGR FOOD CHEM, V51, P3682, DOI 10.1021/jf0340963; SINGLETON VL, 1987, AM J ENOL VITICULT, V38, P69; Skogerson K, 2009, J AGR FOOD CHEM, V57, P6899, DOI 10.1021/jf9019322; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Son HS, 2009, ANAL CHEM, V81, P1137, DOI 10.1021/ac802305c; Son HS, 2009, J AGR FOOD CHEM, V57, P4801, DOI 10.1021/jf9005017; Son HS, 2009, J AGR FOOD CHEM, V57, P1481, DOI 10.1021/jf803388w; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Theodoridis G, 2012, METABOLOMICS, V8, P175, DOI 10.1007/s11306-011-0298-z; Vaclavik L, 2011, ANAL CHIM ACTA, V685, P45, DOI 10.1016/j.aca.2010.11.018; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; Vapnik V., 1998, STAT LEARNING THEORY; Villagra E, 2012, FOOD CHEM, V131, P692, DOI 10.1016/j.foodchem.2011.08.078; Waterhouse AL, 2006, AM J ENOL VITICULT, V57, P306; Yetukuri L, 2010, METABOLOMICS, V6, P18, DOI 10.1007/s11306-009-0179-x	64	70	72	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37783	10.1371/journal.pone.0037783	http://dx.doi.org/10.1371/journal.pone.0037783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662221	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300111
J	Flores, F; Hoogenboom, MO; Smith, LD; Cooper, TF; Abrego, D; Negri, AP				Flores, Florita; Hoogenboom, Mia O.; Smith, Luke D.; Cooper, Timothy F.; Abrego, David; Negri, Andrew P.			Chronic Exposure of Corals to Fine Sediments: Lethal and Sub-Lethal Impacts	PLOS ONE			English	Article							SHADE-ADAPTED COLONIES; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORALS; SUSPENDED SEDIMENTS; HERMATYPIC CORAL; REEF CORALS; LIGHT; TURBIDITY; RESPIRATION; EFFICIENCY	Understanding the sedimentation and turbidity thresholds for corals is critical in assessing the potential impacts of dredging projects in tropical marine systems. In this study, we exposed two species of coral sampled from offshore locations to six levels of total suspended solids (TSS) for 16 weeks in the laboratory, including a 4 week recovery period. Dose-response relationships were developed to quantify the lethal and sub-lethal thresholds of sedimentation and turbidity for the corals. The sediment treatments affected the horizontal foliaceous species (Montipora aequituberculata) more than the upright branching species (Acropora millepora). The lowest sediment treatments that caused full colony mortality were 30 mg l(-1) TSS (25 mg cm(-2) day(-1)) for M. aequituberculata and 100 mg l(-1) TSS (83 mg cm(-2) day(-1)) for A. millepora after 12 weeks. Coral mortality generally took longer than 4 weeks and was closely related to sediment accumulation on the surface of the corals. While measurements of damage to photosystem II in the symbionts and reductions in lipid content and growth indicated sub-lethal responses in surviving corals, the most reliable predictor of coral mortality in this experiment was long-term sediment accumulation on coral tissue.	[Flores, Florita; Abrego, David; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Smith, Luke D.] James Cook Univ, Australian Res Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cooper, Timothy F.; Abrego, David] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Nedlands, WA 6009, Australia	Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science; University of Western Australia	Flores, F (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Abrego, David/AAT-8120-2020; Flores, Florita/I-3033-2017; Hoogenboom, Mia O/D-3664-2012; Negri, Andrew P/G-9909-2017	Abrego, David/0000-0003-3311-2730; Flores, Florita/0000-0003-4637-1379; Hoogenboom, Mia O/0000-0003-3709-6344; Negri, Andrew P/0000-0003-1388-7395	Woodside Energy Ltd (as operator of the Browse LNG Development); Woodside Energy Ltd	Woodside Energy Ltd (as operator of the Browse LNG Development); Woodside Energy Ltd	This study was supported by funding from Woodside Energy Ltd (as operator of the Browse LNG Development) woodside.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Woodside Energy Ltd part funded this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 1999, LIMNOL OCEANOGR, V44, P1415, DOI 10.4319/lo.1999.44.6.1415; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; Bayer E, 2008, ICES J MAR SCI, V65, P1402, DOI 10.1093/icesjms/fsn141; BROWN BE, 1990, MAR ECOL PROG SER, V65, P273, DOI 10.3354/meps065273; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cooper KM, 2008, J EXP MAR BIOL ECOL, V366, P82, DOI 10.1016/j.jembe.2008.07.011; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; Cooper TF, 2009, ESTUAR COAST SHELF S, V83, P186, DOI 10.1016/j.ecss.2009.03.015; CRIPPS GC, 1992, MAR POLLUT BULL, V25, P266, DOI 10.1016/0025-326X(92)90681-U; DODGE RE, 1977, J MAR RES, V35, P715; DUBINSKY Z, 1984, PROC R SOC SER B-BIO, V222, P203, DOI 10.1098/rspb.1984.0059; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; ENTSCH B, 1983, LIMNOL OCEANOGR, V28, P465, DOI 10.4319/lo.1983.28.3.0465; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gilmour JP, 2002, MAR FRESHWATER RES, V53, P805, DOI 10.1071/MF01219; HARRIOTT VJ, 1993, ENVIRON MONIT ASSESS, V25, P131, DOI 10.1007/BF00549134; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Je CH, 2007, CHEMOSPHERE, V70, P187, DOI 10.1016/j.chemosphere.2007.06.033; JOHNSTONE RW, 1990, MAR ECOL PROG SER, V66, P273, DOI 10.3354/meps066273; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Larcombe P, 2001, SEDIMENTOLOGY, V48, P811, DOI 10.1046/j.1365-3091.2001.00396.x; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; McMahon K, 2011, MAR POLLUT BULL, V62, P270, DOI 10.1016/j.marpolbul.2010.11.001; MILLER RL, 1995, REMOTE SENS ENVIRON, V53, P177, DOI 10.1016/0034-4257(95)00081-B; Muscatine L., 1990, P75; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; PIANC, 2010, 1082010 PIANC UNEP; Pocock YP, 1972, INT J EARTH STUD, V61, P598; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; RICE SA, 1992, B MAR SCI, V51, P429; RIEGL B, 1995, MAR BIOL, V121, P517, DOI 10.1007/BF00349461; ROGERS CS, 1979, J EXP MAR BIOL ECOL, V41, P269, DOI 10.1016/0022-0981(79)90136-9; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Simpson CJ, 1988, ECOLOGY SCLERACTINIA; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Te F.T., 1997, P1899; TELESNICKI GJ, 1995, B MAR SCI, V57, P527; Thomas S, 2004, MAR GEOL, V207, P95, DOI 10.1016/j.margeo.2004.03.011; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Wesseling I, 1999, MAR ECOL PROG SER, V176, P11, DOI 10.3354/meps176011; WOLANSKI E, 1992, ESTUAR COAST SHELF S, V35, P473, DOI 10.1016/S0272-7714(05)80026-5; Wolanski E, 2008, ESTUAR COAST SHELF S, V77, P755, DOI 10.1016/j.ecss.2007.10.014; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	59	48	48	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37795	10.1371/journal.pone.0037795	http://dx.doi.org/10.1371/journal.pone.0037795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662225	gold, Green Accepted, Green Published			2022-12-27	WOS:000305342300115
J	Gilroy, JJ; Lockwood, JL				Gilroy, James J.; Lockwood, Julie L.			Mate-Finding as an Overlooked Critical Determinant of Dispersal Variation in Sexually-Reproducing Animals	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; BEHAVIORAL-RESPONSES; DEPENDENT DISPERSAL; MOVEMENT BEHAVIOR; MATING SYSTEMS; EVOLUTION; BIRDS; COMPETITION; EXTINCTION; LANDSCAPES	Dispersal is a critically important process in ecology, but robust predictive models of animal dispersal remain elusive. We identify a potentially ubiquitous component of variation in animal dispersal that has been largely overlooked until now: the influence of mate encounters on settlement probability. We use an individual-based model to simulate dispersal in sexually-reproducing organisms that follow a simple set of movement rules based on conspecific encounters, within an environment lacking spatial habitat heterogeneity. We show that dispersal distances vary dramatically with fluctuations in population density in such a model, even in the absence of variation in dispersive traits between individuals. In a simple random-walk model with promiscuous mating, dispersal distributions become increasingly 'fat-tailed' at low population densities due to the increasing scarcity of mates. Similar variation arises in models incorporating territoriality. In a model with polygynous mating, we show that patterns of sex-biased dispersal can even be reversed across a gradient of population density, despite underlying dispersal mechanisms remaining unchanged. We show that some widespread dispersal patterns found in nature (e.g. fat tailed distributions) can arise as a result of demographic variability in the absence of heterogeneity in dispersive traits across the population. This implies that models in which individual dispersal distances are considered to be fixed traits might be unrealistic, as dispersal distances vary widely under a single dispersal mechanism when settlement is influenced by mate encounters. Mechanistic models offer a promising means of advancing our understanding of dispersal in sexually-reproducing organisms.	[Gilroy, James J.; Lockwood, Julie L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Gilroy, JJ (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	james.gilroy1@googlemail.com		Gilroy, James/0000-0002-7597-5780; Lockwood, Julie/0000-0003-0177-449X	US Fish and Wildlife Service; Everglades National Park (Critical Ecosystems Science Initiative, National Park Service)	US Fish and Wildlife Service(US Fish & Wildlife Service); Everglades National Park (Critical Ecosystems Science Initiative, National Park Service)	Funding was provided to JLL by the US Fish and Wildlife Service and Everglades National Park (Critical Ecosystems Science Initiative, National Park Service). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Delgado MD, 2009, BEHAV ECOL SOCIOBIOL, V64, P35, DOI 10.1007/s00265-009-0815-5; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gros A, 2008, ECOL MODEL, V219, P226, DOI 10.1016/j.ecolmodel.2008.08.014; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; Holt RD, 2000, ECOL LETT, V3, P41, DOI 10.1046/j.1461-0248.2000.00116.x; HOWARD WALTER E., 1960, AMER MIDLAND NAT, V63, P152, DOI 10.2307/2422936; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Mabry KE, 2008, AM NAT, V172, P625, DOI 10.1086/591682; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Maxwell J.C., 1860, LONDON EDINBURGH DUB, V19, P19, DOI [10.1080/14786446008642818, DOI 10.1080/14786446008642818]; McCarthy MA, 1999, ECOL MODEL, V114, P305, DOI 10.1016/S0304-3800(98)00162-8; McCarthy MA, 1997, ECOLOGY, V78, P873; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Meier CM, 2011, OIKOS, V120, P1459, DOI 10.1111/j.1600-0706.2011.19487.x; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Morales JM, 2002, ECOLOGY, V83, P2240; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Paradis E, 2002, ECOL MODEL, V151, P279, DOI 10.1016/S0304-3800(01)00487-2; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Poethke HJ, 2011, J THEOR BIOL, V282, P93, DOI 10.1016/j.jtbi.2011.05.012; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; ROFF DA, 1975, OECOLOGIA, V19, P217, DOI 10.1007/BF00345307; Schmidt KA, 2010, OIKOS, V119, P304, DOI 10.1111/j.1600-0706.2009.17573.x; Schtickzelle N, 2003, J ANIM ECOL, V72, P533, DOI 10.1046/j.1365-2656.2003.00723.x; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005	48	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38091	10.1371/journal.pone.0038091	http://dx.doi.org/10.1371/journal.pone.0038091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662269	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300161
J	Rao, ZC; He, WY; Liu, L; Zheng, SC; Huang, LH; Feng, QL				Rao, Zhongchen; He, Wenyin; Liu, Lin; Zheng, Sichun; Huang, Lihua; Feng, Qili			Identification, Expression and Target Gene Analyses of MicroRNAs in Spodoptera litura	PLOS ONE			English	Article							NERVOUS-SYSTEM; SERINE PROTEASES; DROSOPHILA; CELL; PROTEIN; DIFFERENTIATION; MECHANISM; GENOMICS; MIRBASE; MIR-34A	MicroRNAs (miRNAs) are small RNAs widely present in animals and plants and involved in post-transcriptional regulation of gene transcripts. In this study we identified and validated 58 miRNAs from an EST dataset of Spodoptera litura based on the computational and experimental analysis of sequence conservation and secondary structure of miRNA by comparing the miRNA sequences in the miRbase. RT-PCR was conducted to examine the expression of these miRNAs and stem-loop RTPCR assay was performed to examine expression of 11 mature miRNAs (out of the 58 putative miRNA) that showed significant changes in different tissues and stages of the insect development. One hundred twenty eight possible target genes against the 11 miRNAs were predicted by using computational methods. Binding of one miRNA (sli-miR-928b) with the three possible target mRNAs was confirmed by Southern blotting, implying its possible function in regulation of the target genes.	[Rao, Zhongchen; He, Wenyin; Liu, Lin; Zheng, Sichun; Huang, Lihua; Feng, Qili] S China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University	Rao, ZC (corresponding author), S China Normal Univ, Guangdong Prov Key Lab Biotechnol Plant Dev, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	qlfeng@scnu.edu.cn			National Basic Research Program of China [2010CB126100]; Chinese National Natural Science Foundation [31071688]; National High-Tech R&D Program of China [2011AA10A204-3]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China)	This research was supported partially by the National Basic Research Program of China (2010CB126100), Chinese National Natural Science Foundation (31071688), and National High-Tech R&D Program of China (2011AA10A204-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-454; Bartel DP, 2007, CELL, V131, P11, DOI 10.1016/S0092-8674(04)00045-5; Begemann G, 1997, DEVELOPMENT, V124, P4321; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Cao CK, 2007, J CELL BIOL, V176, P843, DOI 10.1083/jcb.200611155; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Champagne MB, 2000, J MOL BIOL, V300, P759, DOI 10.1006/jmbi.2000.3802; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; del Alamo D, 2008, DEVELOPMENT, V135, P2895, DOI 10.1242/dev.022194; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; Giannakou ME, 2001, J EXP BIOL, V204, P3703; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Inbal A, 2004, DEV CELL, V7, P241, DOI 10.1016/j.devcel.2004.07.001; Ivanov AI, 2004, P NATL ACAD SCI USA, V101, P16216, DOI 10.1073/pnas.0407188101; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Koizumi K, 2007, P NATL ACAD SCI USA, V104, P5626, DOI 10.1073/pnas.0611687104; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu SP, 2010, BMC GENOMICS, V11; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Neubueser D, 2010, MOL BIOL CELL, V21, P2869, DOI 10.1091/mbc.E10-04-0328; Oakley BR, 2000, TRENDS CELL BIOL, V10, P537, DOI 10.1016/S0962-8924(00)01857-2; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Ozdowski EF, 2009, GENETICS, V183, P1027, DOI 10.1534/genetics.109.107367; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; Plasterk R, 2006, FEBS J, V273, P15; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Shah PK, 2008, GENE, V407, P199, DOI 10.1016/j.gene.2007.10.012; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Szafer-Glusman E, 2008, CURR BIOL, V18, P1426, DOI 10.1016/j.cub.2008.08.061; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Xue XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004034; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37730	10.1371/journal.pone.0037730	http://dx.doi.org/10.1371/journal.pone.0037730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662202	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300092
J	Robinson, KM; Ingvarsson, PK; Jansson, S; Albrectsen, BR				Robinson, Kathryn M.; Ingvarsson, Par K.; Jansson, Stefan; Albrectsen, Benedicte R.			Genetic Variation in Functional Traits Influences Arthropod Community Composition in Aspen (Populus tremula L.)	PLOS ONE			English	Article							HOST-PLANT; PHYSIOLOGICAL TRAITS; PHENOTYPIC VARIATION; STRUCTURAL TRAITS; HERBIVORE ATTACK; LEAF TRAITS; RESISTANCE; DEFENSE; DIVERSITY; PERFORMANCE	We conducted a study of natural variation in functional leaf traits and herbivory in 116 clones of European aspen, Populus tremula L., the Swedish Aspen (SwAsp) collection, originating from ten degrees of latitude across Sweden and grown in a common garden. In surveys of phytophagous arthropods over two years, we found the aspen canopy supports nearly 100 morphospecies. We identified significant broad-sense heritability of plant functional traits, basic plant defence chemistry, and arthropod community traits. The majority of arthropods were specialists, those coevolved with P. tremula to tolerate and even utilize leaf defence compounds. Arthropod abundance and richness were more closely related to plant growth rates than general chemical defences and relationships were identified between the arthropod community and stem growth, leaf and petiole morphology, anthocyanins, and condensed tannins. Heritable genetic variation in plant traits in young aspen was found to structure arthropod community; however no single trait drives the preferences of arthropod folivores among young aspen genotypes. The influence of natural variation in plant traits on the arthropod community indicates the importance of maintaining genetic variation in wild trees as keystone species for biodiversity. It further suggests that aspen can be a resource for the study of mechanisms of natural resistance to herbivores.	[Robinson, Kathryn M.; Jansson, Stefan; Albrectsen, Benedicte R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Ingvarsson, Par K.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University; Umea University	Robinson, KM (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	benedicte.albrectsen@plantphys.umu.se	Ingvarsson, Pär/G-2748-2010; Albrectsen, Benedicte/E-6963-2013; Jansson, Stefan/A-1119-2009; Robinson, Kathryn M/B-7807-2016	Jansson, Stefan/0000-0002-7906-6891; Robinson, Kathryn M/0000-0002-5249-604X; Ingvarsson, Par/0000-0001-9225-7521; Albrectsen, Benedicte Riber/0000-0002-9337-4540	Swedish Research Council; Kempe Foundation; 446 the Swedish Foundation for Strategic Research; Carl Tryggers Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; 446 the Swedish Foundation for Strategic Research; Carl Tryggers Foundation	The research was supported by the Swedish Research Council, the Kempe Foundation, 446 the Swedish Foundation for Strategic Research, and the Carl Tryggers Foundation. Funders provided salary for KMR and also funds to establish common gardens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Albrectsen BR, 2010, ECOGRAPHY, V33, P483, DOI 10.1111/j.1600-0587.2009.05982.x; Albrectsen BR, 2004, OIKOS, V105, P268, DOI 10.1111/j.0030-1299.2004.12892.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrew RL, 2007, OECOLOGIA, V153, P891, DOI 10.1007/s00442-007-0784-1; Antonovics J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P426; AUERBACH M, 1992, OECOLOGIA, V89, P1, DOI 10.1007/BF00319008; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; Barnes B. V., 1969, Silvae Genetica, V18, P130; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Campos RI, 2006, ECOGRAPHY, V29, P442, DOI 10.1111/j.2006.0906-7590.04520.x; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chang SX, 2003, FOREST ECOL MANAG, V181, P331, DOI 10.1016/S0378-1127(03)00004-5; Chen F, 2009, CRIT REV PLANT SCI, V28, P375, DOI 10.1080/07352680903241279; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coulianos C.-C, 1991, GALLER FALTHANDBOK G; Crawford KM, 2007, ECOLOGY, V88, P2114, DOI 10.1890/06-1441.1; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Delaplanque A, INSECTS ASS PEUPLIER; Donaldson JR, 2007, ECOLOGY, V88, P729, DOI 10.1890/06-0064; Donaldson JR, 2006, J CHEM ECOL, V32, P1415, DOI 10.1007/s10886-006-9059-2; Dungey HS, 2000, EVOLUTION, V54, P1938, DOI 10.1111/j.0014-3820.2000.tb01238.x; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Frewen BE, 2000, GENETICS, V154, P837; Fukui A, 2001, POPUL ECOL, V43, P31, DOI 10.1007/PL00012013; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hedenas H, 2007, BIOL CONSERV, V135, P380, DOI 10.1016/j.biocon.2006.10.008; HEMMING JDC, 1995, OECOLOGIA, V103, P79, DOI 10.1007/BF00328428; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Holeski LM, 2009, ECOLOGY, V90, P2969, DOI 10.1890/08-2378.1; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Kanaga MK, 2008, CAN J FOREST RES, V38, P1690, DOI 10.1139/X08-012; Kearsley MJC, 1998, ECOLOGY, V79, P178, DOI 10.1890/0012-9658(1998)079[0178:TDSOCA]2.0.CO;2; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Kleemann F, 2011, EUR J FOREST RES, V130, P707, DOI 10.1007/s10342-010-0460-6; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kuusinen M, 1996, LICHENOLOGIST, V28, P443, DOI 10.1006/lich.1996.0043; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Lopez-de-Heredia U, 2004, SILVAE GENET, V53, P227, DOI 10.1515/sg-2004-0041; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; Lynch Michael, 1998; Marques ESD, 2000, ENVIRON ENTOMOL, V29, P696, DOI 10.1603/0046-225X-29.4.696; Marron N, 2007, ENVIRON EXP BOT, V61, P103, DOI 10.1016/j.envexpbot.2007.04.002; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; Myking T, 2011, FORESTRY, V84, P61, DOI 10.1093/forestry/cpq044; Nakamura M, 2010, OIKOS, V119, P1445, DOI 10.1111/j.1600-0706.2010.18255.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Osier TL, 2000, ECOL ENTOMOL, V25, P197, DOI 10.1046/j.1365-2311.2000.00245.x; Ossipova S, 2001, PHYTOCHEM ANALYSIS, V12, P128, DOI 10.1002/pca.568; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Peacock L, 2001, J CHEM ECOL, V27, P1943, DOI 10.1023/A:1012278417424; Peeters PJ, 2002, BIOL J LINN SOC, V77, P43, DOI 10.1046/j.1095-8312.2002.00091.x; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; R Development Core Team, 2006, R LANG ENV STAT COMP; Rae AM, 2004, CAN J FOREST RES, V34, P1488, DOI 10.1139/X04-033; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; ROWELLRAHIER M, 1984, OECOLOGIA, V62, P26, DOI 10.1007/BF00377368; Rudgers JA, 2006, J ECOL, V94, P1249, DOI 10.1111/j.1365-2745.2006.01161.x; Santos JC, 2010, ACTA OECOL, V36, P617, DOI 10.1016/j.actao.2010.09.007; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; Smith EA, 2011, TREE PHYSIOL, V31, P68, DOI 10.1093/treephys/tpq100; St Clair SB, 2010, FOREST SCI, V56, P222; Stevens MT, 2008, FUNCT ECOL, V22, P40, DOI 10.1111/j.1365-2435.2007.01356.x; Stiling P, 2000, ECOLOGY, V81, P281, DOI 10.1890/0012-9658(2000)081[0281:DAIEOP]2.0.CO;2; Strong D., 1984, INSECTS PLANTS COMMU; Suominen O, 2003, FOREST ECOL MANAG, V175, P403, DOI 10.1016/S0378-1127(02)00142-1; Suvanto LI, 2005, MOL ECOL, V14, P2851, DOI 10.1111/j.1365-294X.2005.02634.x; Tovar-Sanchez E, 2006, OIKOS, V112, P370, DOI 10.1111/j.0030-1299.2006.14029.x; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Turesson G, 1922, HEREDITAS, V3, P211, DOI 10.1111/j.1601-5223.1922.tb02734.x; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Valkama E, 2005, TREES-STRUCT FUNCT, V19, P191, DOI 10.1007/s00468-004-0380-5; Waltz AM, 1997, ECOLOGY, V78, P2133, DOI 10.1890/0012-9658(1997)078[2133:PDAACO]2.0.CO;2; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu R, 1997, AM J BOT, V84, P143, DOI 10.2307/2446076; WU R, 1994, THEOR APPL GENET, V89, P1046, DOI 10.1007/BF00224537; Yarnes CT, 2005, ENTOMOL EXP APPL, V114, P87, DOI 10.1111/j.1570-7458.2005.00226.x	97	57	57	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37679	10.1371/journal.pone.0037679	http://dx.doi.org/10.1371/journal.pone.0037679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662190	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300080
J	Attar, CH; Muller, MM				Attar, Catherine Hindi; Mueller, Matthias M.			Selective Attention to Task-Irrelevant Emotional Distractors Is Unaffected by the Perceptual Load Associated with a Foreground Task	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; TIME-COURSE; VISUAL-CORTEX; HUMAN BRAIN; CUED SHIFTS; AUTOMATICITY; PICTURES; FACILITATION; MODULATION; ACTIVATION	A number of studies have shown that emotionally arousing stimuli are preferentially processed in the human brain. Whether or not this preference persists under increased perceptual load associated with a task at hand remains an open question. Here we manipulated two possible determinants of the attentional selection process, perceptual load associated with a foreground task and the emotional valence of concurrently presented task-irrelevant distractors. As a direct measure of sustained attentional resource allocation in early visual cortex we used steady-state visual evoked potentials (SSVEPs) elicited by distinct flicker frequencies of task and distractor stimuli. Subjects either performed a detection (low load) or discrimination (high load) task at a centrally presented symbol stream that flickered at 8.6 Hz while task-irrelevant neutral or unpleasant pictures from the International Affective Picture System (IAPS) flickered at a frequency of 12 Hz in the background of the stream. As reflected in target detection rates and SSVEP amplitudes to both task and distractor stimuli, unpleasant relative to neutral background pictures more strongly withdrew processing resources from the foreground task. Importantly, this finding was unaffected by the factor 'load' which turned out to be a weak modulator of attentional processing in human visual cortex.	[Attar, Catherine Hindi; Mueller, Matthias M.] Univ Leipzig, Inst Psychol, Leipzig, Germany; [Attar, Catherine Hindi] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Attar, CH (corresponding author), Univ Leipzig, Inst Psychol, Leipzig, Germany.	m.mueller@rz.uni-leipzig.de			German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) graduate program "function of attention in cognition''. DFG website: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Andersen SK, 2008, CURR BIOL, V18, P1006, DOI 10.1016/j.cub.2008.06.030; Attar CH, 2010, NEUROIMAGE, V53, P1326, DOI 10.1016/j.neuroimage.2010.06.074; Attar CH, 2010, J NEUROSCI, V30, P5204, DOI 10.1523/JNEUROSCI.5029-09.2010; BARGH J A, 1989, P3; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doallo S, 2006, NEUROREPORT, V17, P1797, DOI 10.1097/01.wnr.0000246325.51191.39; Donderi DC, 2006, PSYCHOL BULL, V132, P73, DOI 10.1037/0033-2909.132.1.73; Duncan J., 1996, ATTENTION PERFORM, P549; Eimer M, 2003, PSYCHOPHYSIOLOGY, V40, P924, DOI 10.1111/1469-8986.00110; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Glascher J, 2007, J NEUROSCI, V27, P4366, DOI 10.1523/JNEUROSCI.3310-06.2007; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Holmes A, 2006, NEUROSCI LETT, V394, P48, DOI 10.1016/j.neulet.2005.10.002; Holmes A, 2009, COGN AFFECT BEHAV NE, V9, P323, DOI 10.3758/CABN.9.3.323; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Keil A, 2005, CEREB CORTEX, V15, P1187, DOI 10.1093/cercor/bhi001; Keitel C, 2010, EXP BRAIN RES, V205, P489, DOI 10.1007/s00221-010-2384-2; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Larson CL, 2005, PSYCHOPHYSIOLOGY, V42, P604, DOI 10.1111/j.1469-8986.2005.00345.x; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lipp OV, 2005, EMOTION, V5, P365, DOI 10.1037/1528-3542.5.3.365; Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 2011, J NEUROSCI, V31, P15914, DOI 10.1523/JNEUROSCI.1997-11.2011; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Okon-Singer H, 2007, EMOTION, V7, P147, DOI 10.1037/1528-3542.7.1.147; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Peyk P, 2009, PSYCHOPHYSIOLOGY, V46, P200, DOI 10.1111/j.1469-8986.2008.00755.x; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Schupp HT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-16; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092; Wieser MJ, 2011, J COGNITIVE NEUROSCI, V23, P1973, DOI 10.1162/jocn.2010.21566	53	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37186	10.1371/journal.pone.0037186	http://dx.doi.org/10.1371/journal.pone.0037186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649513	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800031
J	Subramanian, L; Blumenfeld, H; Tohn, R; Ly, D; Aguilera, C; Maricic, I; Mansson, JE; Buschard, K; Kumar, V; Delovitch, TL				Subramanian, Lakshmimathy; Blumenfeld, Hartley; Tohn, Robert; Ly, Dalam; Aguilera, Carlos; Maricic, Igor; Mansson, Jan-Eric; Buschard, Karsten; Kumar, Vipin; Delovitch, Terry L.			NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice	PLOS ONE			English	Article							KILLER T-CELLS; DENDRITIC CELLS; INSULIN-SECRETION; CROSS-REGULATION; ACID ISOFORM; BETA-CELLS; GALACTOSYLCERAMIDE; PREVENTS; PROTECTION; INDUCTION	Sulfatide-reactive type II NKT cells have been shown to regulate autoimmunity and anti-tumor immunity. Although, two major isoforms of sulfatide, C16:0 and C24:0, are enriched in the pancreas, their relative role in autoimmune diabetes is not known. Here, we report that sulfatide/CD1d-tetramer(+) cells accumulate in the draining pancreatic lymph nodes, and that treatment of NOD mice with sulfatide or C24:0 was more efficient than C16: 0 in stimulating the NKT cell-mediated transfer of a delay in onset from T1D into NOD. Scid recipients. Using NOD. CD1d(-/-) mice, we show that this delay of T1D is CD1d-dependent. Interestingly, the latter delay or protection from T1D is associated with the enhanced secretion of IL-10 rather than IFN-g by C24:0-treated CD4(+) T cells and the deviation of the islet-reactive diabetogenic T cell response. Both C16:0 and C24:0 sulfatide isoforms are unable to activate and expand type I iNKT cells. Collectively, these data suggest that C24:0 stimulated type II NKT cells may regulate protection from T1D by activating DCs to secrete IL-10 and suppress the activation and expansion of type I iNKT cells and diabetogenic T cells. Our results raise the possibility that C24:0 may be used therapeutically to delay the onset and protect from T1D in humans.	[Subramanian, Lakshmimathy; Blumenfeld, Hartley; Tohn, Robert; Ly, Dalam; Delovitch, Terry L.] Western Univ, Robarts Res Inst, Lab Autoimmune Diabet, London, ON, Canada; [Subramanian, Lakshmimathy; Blumenfeld, Hartley; Tohn, Robert; Ly, Dalam; Delovitch, Terry L.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Ly, Dalam] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Aguilera, Carlos; Maricic, Igor; Kumar, Vipin] Torrey Pines Inst Mol Studies, Lab Autoimmun, San Diego, CA USA; [Mansson, Jan-Eric] Sahlgrens Univ Hosp, Dept Neurosci, Molndal, Sweden; [Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark	Western University (University of Western Ontario); Western University (University of Western Ontario); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Torrey Pines Institute for Molecular Studies, California; Sahlgrenska University Hospital; Rigshospitalet; University of Copenhagen	Subramanian, L (corresponding author), Western Univ, Robarts Res Inst, Lab Autoimmune Diabet, London, ON, Canada.	vkumar@tpims.org; del@robarts.ca	Subramanian, Lakshmimathy/T-4733-2019	Ly, Dalam/0000-0002-1177-0225; Buschard, Karsten/0000-0002-0126-7423	Juvenile Diabetes Research Foundation [24-2007-]; Canadian Institutes of Health Research [MOP 64386]; University of Western Ontario; Schulich Graduate Enhancement Scholarship; Department of Microbiology and Immunology; Ontario Graduate Scholarship; NATIONAL CANCER INSTITUTE [R01CA100660] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Western Ontario; Schulich Graduate Enhancement Scholarship; Department of Microbiology and Immunology; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Juvenile Diabetes Research Foundation International grant 24-2007- and Canadian Institutes of Health Research grant MOP 64386 to Dr. T.L. Delovitch. L. Subramanian was the recipient of Summer Research Training Program Studentship from the University of Western Ontario, H. Blumenfeld was the recipient of a Schulich Graduate Enhancement Scholarship and Department of Microbiology and Immunology Graduate Entrance Fellowship, and R. Tohn was the recipient of a Schulich Graduate Enhancement Scholarship, Department of Microbiology and Immunology Graduate Entrance Fellowship, and Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Arrenberg P, 2011, GASTROENTEROLOGY, V140, P646, DOI 10.1053/j.gastro.2010.10.003; Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; Arrenberg P, 2009, J CELL PHYSIOL, V218, P246, DOI 10.1002/jcp.21597; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blomqvist M, 2005, DIABETES-METAB RES, V21, P158, DOI 10.1002/dmrr.519; Blomqvist M, 2003, APMIS, V111, P867, DOI 10.1034/j.1600-0463.2003.1110905.x; Blomqvist M, 2003, J CELL BIOCHEM, V89, P301, DOI 10.1002/jcb.10513; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Blumenfeld HJ, 2011, CLIN EXP IMMUNOL, V166, P121, DOI 10.1111/j.1365-2249.2011.04454.x; Buschard K, 2005, DIABETOLOGIA, V48, P1957, DOI 10.1007/s00125-005-1926-9; Buschard K, 2005, DIABETIC MED, V22, P1190, DOI 10.1111/j.1464-5491.2005.01613.x; Buschard K, 2001, AUTOIMMUNITY, V34, P9, DOI 10.3109/08916930108994121; Buschard K, 1999, DIABETOLOGIA, V42, P1212, DOI 10.1007/s001250051294; Buschard K, 2006, DIABETES, V55, P2826, DOI 10.2337/db05-1355; Duarte N, 2004, J IMMUNOL, V173, P3112, DOI 10.4049/jimmunol.173.5.3112; Fredman P, 2000, GLYCOBIOLOGY, V10, P39, DOI 10.1093/glycob/10.1.39; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hava DL, 2005, CURR OPIN IMMUNOL, V17, P88, DOI 10.1016/j.coi.2004.12.003; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hussain S, 2005, IMMUNOL RES, V31, P177, DOI 10.1385/IR:31:3:177; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Kadri N, 2012, J IMMUNOL, V188, P3138, DOI 10.4049/jimmunol.1101390; Kojo S, 2005, J IMMUNOL, V175, P3648, DOI 10.4049/jimmunol.175.6.3648; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Ly D, 2010, CLIN EXP IMMUNOL, V160, P185, DOI 10.1111/j.1365-2249.2009.04074.x; Ly D, 2006, J IMMUNOL, V177, P3695, DOI 10.4049/jimmunol.177.6.3695; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Mi QS, 2004, DIABETES, V53, P1303, DOI 10.2337/diabetes.53.5.1303; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Osterbye T, 2001, GLYCOBIOLOGY, V11, P473, DOI 10.1093/glycob/11.6.473; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Roeske-Nielsen A, 2004, IMMUNOL LETT, V91, P205, DOI 10.1016/j.imlet.2003.12.010; ROSENGREN B, 1989, J NEUROCHEM, V52, P1035, DOI 10.1111/j.1471-4159.1989.tb01844.x; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Sundell I Birgitta, 2010, J Stem Cells, V5, P33, DOI jsc.2010.5.1.33; Tohn R, 2011, CLIN EXP IMMUNOL, V164, P26, DOI 10.1111/j.1365-2249.2011.04323.x; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wang J, 2008, J IMMUNOL, V181, P2438, DOI 10.4049/jimmunol.181.4.2438; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028; Yamaura A, 2008, BLOOD, V111, P4254, DOI 10.1182/blood-2007-04-085142; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2009, IMMUNOL REV, V230, P188, DOI 10.1111/j.1600-065X.2009.00802.x; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	50	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37771	10.1371/journal.pone.0037771	http://dx.doi.org/10.1371/journal.pone.0037771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649557	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800077
J	Adams, SM; Aksenova, MV; Aksenov, MY; Mactutus, CF; Booze, RM				Adams, Sheila M.; Aksenova, Marina V.; Aksenov, Michael Y.; Mactutus, Charles F.; Booze, Rosemarie M.			Soy Isoflavones Genistein and Daidzein Exert Anti-Apoptotic Actions via a Selective ER-mediated Mechanism in Neurons following HIV-1 Tat(1-86) Exposure	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SPATIAL MEMORY; DIETARY PHYTOESTROGENS; BETA IMMUNOREACTIVITY; POSTMENOPAUSAL WOMEN; TAT PROTEIN; RATS; INFECTION; ADULT; NEURODEGENERATION	Background: HIV-1 viral protein Tat partially mediates the neural dysfunction and neuronal cell death associated with HIV-1 induced neurodegeneration and neurocognitive disorders. Soy isoflavones provide protection against various neurotoxic insults to maintain neuronal function and thus help preserve neurocognitive capacity. Methodology/Principal Findings: We demonstrate in primary cortical cell cultures that 17 beta-estradiol or isoflavones (genistein or daidzein) attenuate Tat(1-86)-induced expression of apoptotic proteins and subsequent cell death. Exposure of cultured neurons to the estrogen receptor antagonist ICI 182,780 abolished the anti-apoptotic actions of isoflavones. Use of ER alpha or ER beta specific antagonists determined the involvement of both ER isoforms in genistein and daidzein inhibition of caspase activity; ER beta selectively mediated downregulation of mitochondrial pro-apoptotic protein Bax. The findings suggest soy isoflavones effectively diminished HIV-1 Tat-induced apoptotic signaling. Conclusions/Significance: Collectively, our results suggest that soy isoflavones represent an adjunctive therapeutic option with combination anti-retroviral therapy (cART) to preserve neuronal functioning and sustain neurocognitive abilities of HIV-1 infected persons.	[Adams, Sheila M.; Aksenova, Marina V.; Aksenov, Michael Y.; Mactutus, Charles F.; Booze, Rosemarie M.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Adams, SM (corresponding author), Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA.	Adamssm4@mailbox.sc.edu	Booze, Rosemarie/F-7543-2014	Booze, Rosemarie/0000-0003-3908-8313	National Institutes of Health [DA013137]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health grant DA013137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2010, SYNAPSE, V64, P829, DOI 10.1002/syn.20793; Aksenov MY, 2009, EXP NEUROL, V219, P586, DOI 10.1016/j.expneurol.2009.07.005; Aksenov MY, 2003, BRAIN RES, V987, P1, DOI 10.1016/S0006-8993(03)03194-9; Aksenova MV, 2009, EXP NEUROL, V215, P253, DOI 10.1016/j.expneurol.2008.10.006; Aksenova MV, 2006, NEUROSCI LETT, V395, P235, DOI 10.1016/j.neulet.2005.10.095; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bjornstrom L, 2005, MECH ESTROGEN RECEPT; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; Bryant DN, 2010, NEUROSCIENCE, V170, P1261, DOI 10.1016/j.neuroscience.2010.08.019; Bryant DN, 2006, ENDOCRINE, V29, P199, DOI 10.1385/ENDO:29:2:199; Busby MG, 2002, AM J CLIN NUTR, V75, P126, DOI 10.1093/ajcn/75.1.126; Campbell GR, 2011, AIDS RES HUM RETROV, V27, P647, DOI [10.1089/aid.2010.0192, 10.1089/AID.2010.0192]; Casanova M, 1999, TOXICOL SCI, V51, P236, DOI 10.1093/toxsci/51.2.236; Casini ML, 2006, FERTIL STERIL, V85, P972, DOI 10.1016/j.fertnstert.2005.09.048; Clifford David B, 2008, Top HIV Med, V16, P94; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Ferris MJ, 2010, J NEUROCHEM, V115, P885, DOI 10.1111/j.1471-4159.2010.06968.x; File SE, 2001, PSYCHOPHARMACOLOGY, V157, P430, DOI 10.1007/s002130100845; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Fitting S, 2006, PHARMACOL BIOCHEM BE, V84, P189, DOI 10.1016/j.pbb.2006.04.014; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hamilton-Reeves JM, 2010, FERTIL STERIL, V94, P997, DOI 10.1016/j.fertnstert.2009.04.038; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Jorgensen M, 2000, ENVIRON HEALTH PERSP, V108, P403, DOI 10.2307/3454380; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; King JE, 2010, AM J PATHOL, V176, P2819, DOI 10.2353/ajpath.2010.090642; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Lee YB, 2005, J NUTR BIOCHEM, V16, P641, DOI 10.1016/j.jnutbio.2005.06.010; Li WX, 2009, NEUROTOX RES, V16, P205, DOI 10.1007/s12640-009-9047-8; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Liner Kevin J 2nd, 2008, Curr HIV/AIDS Rep, V5, P64, DOI 10.1007/s11904-008-0011-7; Luine V, 2006, BRAIN RES, V1126, P183, DOI 10.1016/j.brainres.2006.07.016; Luine VN, 1998, HORM BEHAV, V34, P149, DOI 10.1006/hbeh.1998.1473; Lund TD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-20; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Messina M, 2006, NUTR CANCER, V55, P1, DOI 10.1207/s15327914nc5501_1; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Neese SL, 2010, NEUROTOXICOL TERATOL, V32, P200, DOI 10.1016/j.ntt.2009.11.003; Pan YL, 2000, MENOPAUSE, V7, P230, DOI 10.1097/00042192-200007040-00004; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Patisaul HB, 2010, FRONT NEUROENDOCRIN, V31, P400, DOI 10.1016/j.yfrne.2010.03.003; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Shughrue PJ, 2001, J COMP NEUROL, V436, P64; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silvers JM, 2007, NEUROTOXICOLOGY, V28, P1184, DOI 10.1016/j.neuro.2007.07.005; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zeng HY, 2004, FREE RADICAL BIO MED, V36, P180, DOI 10.1016/j.freeradbiomed.2003.10.018; Zhao LQ, 2009, ENDOCRINOLOGY, V150, P770, DOI 10.1210/en.2008-0715; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066; Zhao LX, 2002, EXP BIOL MED, V227, P509, DOI 10.1177/153537020222700716; Zhu J, 2009, J PHARMACOL EXP THER, V329, P1071, DOI 10.1124/jpet.108.150144	70	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37540	10.1371/journal.pone.0037540	http://dx.doi.org/10.1371/journal.pone.0037540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629415	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300050
J	Hu, ZH; Ma, XW; Qu, XC; Yang, WD; Liang, JM; Wang, J; Tian, J				Hu, Zhenhua; Ma, Xiaowei; Qu, Xiaochao; Yang, Weidong; Liang, Jimin; Wang, Jing; Tian, Jie			Three-dimensional Noninvasive Monitoring Iodine-131 Uptake in the Thyroid Using a Modified Cerenkov Luminescence Tomography Approach	PLOS ONE			English	Article							POSITRON-EMITTING RADIOTRACERS; BIOLUMINESCENCE TOMOGRAPHY; OPTICAL-PROPERTIES; RECONSTRUCTION; RADIATION; LIGHT; MODEL; MEDIA	Background: Cerenkov luminescence tomography (CLT) provides the three-dimensional (3D) radiopharmaceutical biodistribution in small living animals, which is vital to biomedical imaging. However, existing single-spectral and multispectral methods are not very efficient and effective at reconstructing the distribution of the radionuclide tracer. In this paper, we present a semi-quantitative Cerenkov radiation spectral characteristic-based source reconstruction method named the hybrid spectral CLT, to efficiently reconstruct the radionuclide tracer with both encouraging reconstruction results and less acquisition and image reconstruction time. Methodology/Principal Findings: We constructed the implantation mouse model implanted with a 400 mu Ci (NaI)-I-131 radioactive source and the physiological mouse model received an intravenous tail injection of 400 mu Ci radiopharmaceutical Iodine-131 (I-131) to validate the performance of the hybrid spectral CLT and compared the reconstruction results, acquisition, and image reconstruction time with that of single-spectral and multispectral CLT. Furthermore, we performed 3D noninvasive monitoring of I-131 uptake in the thyroid and quantified I-131 uptake in vivo using hybrid spectral CLT. Results showed that the reconstruction based on the hybrid spectral CLT was more accurate in localization and quantification than using single-spectral CLT, and was more efficient in the in vivo experiment compared with multispectral CLT. Additionally, 3D visualization of longitudinal observations suggested that the reconstructed energy of I-131 uptake in the thyroid increased with acquisition time and there was a robust correlation between the reconstructed energy versus the gamma ray counts of I-131 (r(2) = 0.8240). The ex vivo biodistribution experiment further confirmed the I-131 uptake in the thyroid for hybrid spectral CLT. Conclusions/Significance: Results indicated that hybrid spectral CLT could be potentially used for thyroid imaging to evaluate its function and monitor its treatment for thyroid cancer.	[Hu, Zhenhua; Qu, Xiaochao; Liang, Jimin; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Ma, Xiaowei; Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Hu, ZH (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	wangjin@fmmu.edu.cn; tian@ieee.org	Ma, Xiaowei/AAC-3232-2019; Liang, Jimin/B-5394-2014; Tian, Jie/H-1190-2011; Hu, Zhenhua/E-3375-2016; Wang, Jing/G-5261-2018; Life, MC/M-9554-2013; Hu, Zhenhua/V-1399-2019; Tian, Jie/M-5675-2013	Ma, Xiaowei/0000-0002-3062-4063; Liang, Jimin/0000-0003-1428-5804; Tian, Jie/0000-0003-0498-0432; 	National Basic Research and Development Program of China (973) [2011CB707702]; National Natural Science Foundation of China [81090272, 81101083, 81101084, 81101100, 81000632, 30900334, 30970847]; Shaanxi Provincial Natural Science Foundation Research Project [2009JQ8018]; Fundamental Research Funds for the Central Universities	National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Foundation Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Basic Research and Development Program of China (973) under Grant No. 2011CB707702; the National Natural Science Foundation of China under Grant Nos. 81090272, 81101083, 81101084, 81101100, 81000632, 30900334, 30970847; the Shaanxi Provincial Natural Science Foundation Research Project under Grant No. 2009JQ8018; and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis G, 2005, PHYS MED BIOL, V50, P4225, DOI 10.1088/0031-9155/50/17/021; Boschi F, 2011, EUR J NUCL MED MOL I, V38, P120, DOI 10.1007/s00259-010-1630-y; Boschi F, 2009, PHYS MED BIOL, V54, pL57, DOI 10.1088/0031-9155/54/23/L01; Cerenkov PA, 1934, DOKL AKAD NAUK SSSR, V2, P451; Chen XL, 2010, OPT EXPRESS, V18, P19876, DOI 10.1364/OE.18.019876; Dothager RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013300; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Frank I, 1937, CR ACAD SCI URSS, V14, P109; Gill P.E., 1981, PRACTICAL OPTIMIZATI; Gurfinkel M, 2004, J BIOMED OPT, V9, P1336, DOI 10.1117/1.1803549; Han RQ, 2009, OPT EXPRESS, V17, P14481, DOI 10.1364/OE.17.014481; He XW, 2010, OPT EXPRESS, V18, P24825, DOI 10.1364/OE.18.024825; Holland JP, 2011, MOL IMAGING, V10, P177, DOI 10.2310/7290.2010.00047; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; JELLEY JV, 1955, BRIT J APPL PHYS, V6, P227, DOI 10.1088/0508-3443/6/7/301; Li CQ, 2010, OPT LETT, V35, P1109, DOI 10.1364/OL.35.001109; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Liu JT, 2010, IEEE T BIO-MED ENG, V57, P2579, DOI 10.1109/TBME.2010.2056370; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; Qin CH, 2011, J BIOPHOTONICS, V4, P824, DOI 10.1002/jbio.201100049; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; SCHWEIGER M, 1995, MED PHYS, V22, P1779, DOI 10.1118/1.597634; Spinelli AE, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3653963; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Wang G, 2004, MED PHYS, V31, P2289, DOI 10.1118/1.1766420; Welch J., 1995, OPTICAL THERMAL RESP; Yan GR, 2008, J X-RAY SCI TECHNOL, V16, P225	29	28	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37623	10.1371/journal.pone.0037623	http://dx.doi.org/10.1371/journal.pone.0037623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629431	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300063
J	Xiao, FX; Hiremath, S; Knoll, G; Zimpelmann, J; Srivaratharajah, K; Jadhav, D; Fergusson, D; Kennedy, CRJ; Burns, KD				Xiao, Fengxia; Hiremath, Swapnil; Knoll, Greg; Zimpelmann, Joseph; Srivaratharajah, Kajenny; Jadhav, Deepak; Fergusson, Dean; Kennedy, Chris R. J.; Burns, Kevin D.			Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME-2; EXPRESSION; ACE2	Angiotensin-converting enzyme 2 (ACE2) is expressed in the kidney and may be a renoprotective enzyme, since it converts angiotensin (Ang) II to Ang-(1-7). ACE2 has been detected in urine from patients with chronic kidney disease. We measured urinary ACE2 activity and protein levels in renal transplant patients (age 54 yrs, 65% male, 38% diabetes, n = 100) and healthy controls (age 45 yrs, 26% male, n = 50), and determined factors associated with elevated urinary ACE2 in the patients. Urine from transplant subjects was also assayed for ACE mRNA and protein. No subjects were taking inhibitors of the renin-angiotensin system. Urinary ACE2 levels were significantly higher in transplant patients compared to controls (p = 0.003 for ACE2 activity, and p <= 0.001 for ACE2 protein by ELISA or western analysis). Transplant patients with diabetes mellitus had significantly increased urinary ACE2 activity and protein levels compared to non-diabetics (p<0.001), while ACE2 mRNA levels did not differ. Urinary ACE activity and protein were significantly increased in diabetic transplant subjects, while ACE mRNA levels did not differ from non-diabetic subjects. After adjusting for confounding variables, diabetes was significantly associated with urinary ACE2 activity (p = 0.003) and protein levels (p<0.001), while female gender was associated with urinary mRNA levels for both ACE2 and ACE. These data indicate that urinary ACE2 is increased in renal transplant recipients with diabetes, possibly due to increased shedding from tubular cells. Urinary ACE2 could be a marker of renal renin-angiotensin system activation in these patients.	[Xiao, Fengxia; Hiremath, Swapnil; Knoll, Greg; Zimpelmann, Joseph; Srivaratharajah, Kajenny; Jadhav, Deepak; Fergusson, Dean; Kennedy, Chris R. J.; Burns, Kevin D.] Univ Ottawa, Div Nephrol, Dept Med, Ottawa Hosp,Res Inst,Kidney Res Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Xiao, FX (corresponding author), Univ Ottawa, Div Nephrol, Dept Med, Ottawa Hosp,Res Inst,Kidney Res Ctr, Ottawa, ON, Canada.	kburns@ottawahospital.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416; Knoll, Greg/0000-0001-5442-9310; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research [MOP110929]; Kidney Foundation of Canada [KFOC100005]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada	The sources of funding that have supported the work include: Canadian Institutes of Health Research: grant number: MOP110929; http://www.cihr-irsc.gc.ca/; and The Kidney Foundation of Canada: grant number: KFOC100005; http://www.kidney.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casarini DE, 2001, INT J BIOCHEM CELL B, V33, P75, DOI 10.1016/S1357-2725(00)00072-8; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; HERMANN K, 1992, CLIN CHEM, V38, P1768; Iwata M, 2009, AM J PHYSIOL-CELL PH, V297, pC1318, DOI 10.1152/ajpcell.00036.2009; Ji H, 2008, EXP PHYSIOL, V93, P648, DOI 10.1113/expphysiol.2007.041392; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Koitka A, 2008, CLIN EXP PHARMACOL P, V35, P420, DOI 10.1111/j.1440-1681.2008.04889.x; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Leehey DJ, 2008, TRANSL RES, V151, P208, DOI 10.1016/j.trsl.2008.01.003; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Melenhorst WB, 2009, AM J PHYSIOL-RENAL, V297, pF781, DOI 10.1152/ajprenal.90610.2008; MEZZANO S, 2003, KIDNEY INT S, V86, P64; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, P82; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Warner FJ, 2005, J BIOL CHEM, V280, P39353, DOI 10.1074/jbc.M508914200; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76	28	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37649	10.1371/journal.pone.0037649	http://dx.doi.org/10.1371/journal.pone.0037649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629438	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300066
J	Yao, YF; Bruch, AA; Cheng, YM; Mosbrugger, V; Wang, YF; Li, CS				Yao, Yi-Feng; Bruch, Angela A.; Cheng, Ye-Ming; Mosbrugger, Volker; Wang, Yu-Fei; Li, Cheng-Sen			Monsoon versus Uplift in Southwestern China-Late Pliocene Climate in Yuanmou Basin, Yunnan	PLOS ONE			English	Article							EAST-ASIAN MONSOON; PALEOCLIMATE; SEA; PALEOVEGETATION; RECONSTRUCTION; EVOLUTION; RECORD; MA	Yuanmou Basin of Yunnan, SW China, is a famous locality with hominids, hominoids, mammals and plant fossils. Based on the published megaflora and palynoflora data from Yuanmou Basin, the climate of Late Pliocene is reconstructed using the Coexistence Approach. The results indicate a warm and humid subtropical climate with a mean annual temperature of ca. 16-17 degrees C and a mean annual precipitation of ca. 1500-1600 mm in the Late Pliocene rather than a dry, hot climate today, which may be due to the local tectonic change and gradual intensification of India monsoon. The comparison of Late Pliocene climate in Eryuan, Yangyi, Longling, and Yuanmou Basin of Yunnan Province suggests that the mean annual temperatures generally show a latitudinal gradient and fit well with their geographic position, while the mean annual precipitations seem to be related to the different geometries of the valleys under the same monsoon system.	[Yao, Yi-Feng; Wang, Yu-Fei; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Bruch, Angela A.] Senckenberg Res Inst, Heidelberg Acad Sci & Humanities, Res Ctr Role Culture Early Expans Humans, Frankfurt, Germany; [Cheng, Ye-Ming] Geol Museum China, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Senckenberg Gesellschaft fur Naturforschung (SGN)	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lics@ibcas.ac.cn			National Natural Science Foundation of China [30990241, 31170206, 40701191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by the National Natural Science Foundation of China (Nos. 30990241, 31170206, 40701191). This work is a contribution to the program "Neogene Climate Evolution in Eurasia-NECLIME". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; *BGMRYP, 1990, GEOL MEM 1; Bien M. N., 1940, Bulletin of the Geological Society of China, V20, P179; Chang ZG, 2010, J ASIAN EARTH SCI, V37, P166, DOI 10.1016/j.jseaes.2009.08.005; Chen ZY, 2001, CLIMATE YUNNAN; Cheng YM, 2007, ACTA PHYTOTAXON SIN, V45, P315, DOI 10.1360/aps050119; Cheng YM, 2006, IAWA J, V27, P145, DOI 10.1163/22941932-90000144; [程业明 Cheng Yeming], 2005, [古地理学报, Journal of palaeogeography], V7, P107; Ciochon RL, 2009, NATURE, V459, P910, DOI 10.1038/459910a; Hess S, 2005, MAR MICROPALEONTOL, V54, P63, DOI 10.1016/j.marmicro.2004.09.004; Hu C., 1973, ACTA GEOL SIN-ENGL, V1, P65; IDBMC, 1984, LAND CLIM DAT CHIN 5, p[4, 86]; Jiang NR, 1989, YUNNAN GEOLOGY S, V8, P96; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Kou XY, 2006, CLIMATIC CHANGE, V77, P431, DOI 10.1007/s10584-005-9039-5; Li CS, 2008, VEGETATION SUCCESSIO, V1; Li DY., 1989, YUNNAN GEOLOGY S, P35; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; [刘耕武 Liu Gengwu], 2002, [古生物学报, Acta Palaeontologica Sinica], V41, P1; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Mosbrugger V, 2005, P NATL ACAD SCI USA, V102, P14964, DOI 10.1073/pnas.0505267102; Pu Q., 1977, ACTA GEOL SIN-ENGL, V1, P89; Qian F, 1984, YUANMOU MAN, P3; Qian F, 1991, QUATERNARY GEOLOGY P; Song XL, 1989, YUNNAN GEOLOGY S, V8, P32; Song Z-C, 1999, FOSSIL SPORES POLLEN, V1; Tian J, 2004, QUATERNARY SCI REV, V23, P2007, DOI 10.1016/j.quascirev.2004.02.013; Urabe A, 2001, QUATERNARY SCI REV, V20, P1671, DOI 10.1016/S0277-3791(01)00023-3; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Wan SM, 2006, PALAEOGEOGR PALAEOCL, V241, P139, DOI 10.1016/j.palaeo.2006.06.013; Wehausen R, 2002, EARTH PLANET SC LETT, V201, P621, DOI 10.1016/S0012-821X(02)00746-X; Willis KJ, 1999, SCIENCE, V285, P568, DOI 10.1126/science.285.5427.568; Writing Group of Cenozoic Plants of China (WGCPC), 1978, CEN PLANTS CHIN FOSS, V3; Writing Group of Yunnan Vegetation (WGYV), 1987, VEG YUNN; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Yao YF, 2009, CLIMATIC CHANGE, V92, P169, DOI 10.1007/s10584-008-9457-2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang Zonghu, 1994, Marine Geology & Quaternary Geology (Beijing), V14, P1; Zhu RX, 2008, J HUM EVOL, V55, P1075, DOI 10.1016/j.jhevol.2008.08.005	39	25	28	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37760	10.1371/journal.pone.0037760	http://dx.doi.org/10.1371/journal.pone.0037760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629452	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300075
J	Fallah, M; Reynolds, JH				Fallah, Mazyar; Reynolds, John H.			Contrast Dependence of Smooth Pursuit Eye Movements following a Saccade to Superimposed Targets	PLOS ONE			English	Article							ATTENTIONAL MODULATION; AREA MT; NORMALIZATION MODEL; SPATIAL SUMMATION; SIMPLE CELLS; VISUAL AREA; SELECTION; INTEGRATION; INITIATION; LUMINANCE	Dorsal stream areas provide motion information used by the oculomotor system to generate pursuit eye movements. Neurons in these areas saturate at low levels of luminance contrast. We therefore hypothesized that during the early phase of pursuit, eye velocity would exhibit an oculomotor gain function that saturates at low luminance contrast. To test this, we recorded eye movements in two macaques trained to saccade to an aperture in which a pattern of dots moved left or right. Shortly after the end of the saccade, the eyes followed the direction of motion with an oculomotor gain that increased with contrast before saturating. The addition of a second pattern of dots, moving in the opposite direction and superimposed on the first, resulted in a rightward shift of the contrast-dependent oculomotor gain function. The magnitude of this shift increased with the contrast of the second pattern of dots. Motion was nulled when the two patterns were equal in contrast. Next, we varied contrast over time. Contrast differences that disappeared before saccade onset biased post-saccadic eye movements at short latency. Changes in contrast occurring during or after saccade termination did not influence eye movements for approximately 150 ms. Earlier studies found that eye movements can be explained by a vector average computation when both targets are equal in contrast. We suggest that this averaging computation may reflect a special case of divisive normalization, yielding saturating contrast response functions that shift to the right with opposed motion, averaging motions when targets are equated in contrast.	[Fallah, Mazyar] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Reynolds, John H.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	York University - Canada; Salk Institute	Fallah, M (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	mfallah@yorku.ca	Fallah, Mazyar/ABH-9906-2020	Fallah, Mazyar/0000-0001-5979-3955	National Institutes of Health [1R01EY13802-01]; Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant 1R01EY13802-01 and a grant from the Gatsby Charitable Foundation (http://www.gatsby.org.uk/) to JHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Baldauf D, 2008, J NEUROSCI, V28, P10081, DOI 10.1523/JNEUROSCI.3423-08.2008; Born RT, 2002, PROG BRAIN RES, V140, P225; Britten KH, 1999, J NEUROSCI, V19, P5074; Carandini M, 1997, J NEUROSCI, V17, P8621; Case GR, 2007, J NEUROPHYSIOL, V98, P2206, DOI 10.1152/jn.00021.2007; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; FERRERA VP, 1995, J NEUROSCI, V15, P7472; Gardner JL, 2002, NAT NEUROSCI, V5, P892, DOI 10.1038/nn897; Gegenfurtner KR, 1996, VISION RES, V36, P1281, DOI 10.1016/0042-6989(95)00198-0; GELLMAN RS, 1990, VISUAL NEUROSCI, V5, P107, DOI 10.1017/S0952523800000158; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; Groh JM, 1997, J NEUROSCI, V17, P4312; GROSSBERG S, 1973, STUD APPL MATH, V52, P213; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kawano K, 1999, CURR OPIN NEUROBIOL, V9, P467, DOI 10.1016/S0959-4388(99)80070-1; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P4175, DOI 10.1152/jn.1996.76.6.4175; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1997, J NEUROSCI, V17, P7490; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Liston D, 2003, J NEUROSCI, V23, P11305; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Miles FA, 1986, J NEUROPHYSIOL, V56, P1437; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Munoz DP, 2002, PROG BRAIN RES, V140, P89; Niu YQ, 2011, J NEUROPHYSIOL, V106, P741, DOI 10.1152/jn.01025.2010; Nothdurft HC, 2000, VISION RES, V40, P2421, DOI 10.1016/S0042-6989(00)00112-7; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710, DOI 10.1152/jn.1999.82.4.1710; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2003, VISION RES, V43, P59, DOI 10.1016/S0042-6989(02)00403-0; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPERLING G, 1968, J OPT SOC AM, V58, P1133, DOI 10.1364/JOSA.58.001133; STONE LS, 1992, VISION RES, V32, P1535, DOI 10.1016/0042-6989(92)90209-2; Takemura A, 2006, ANN NY ACAD SCI, V956, P456; Tchernikov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009338; Valdes-Sosa M, 2000, J EXP PSYCHOL HUMAN, V26, P488, DOI 10.1037/0096-1523.26.2.488; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Watamaniuk SNJ, 2011, VISION RES, V51, P1129, DOI 10.1016/j.visres.2011.03.003	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37888	10.1371/journal.pone.0037888	http://dx.doi.org/10.1371/journal.pone.0037888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629467	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100057
J	Franca, A; Freitas, AI; Henriques, AF; Cerca, N				Franca, Angela; Freitas, Ana I.; Henriques, Ana F.; Cerca, Nuno			Optimizing a qPCR Gene Expression Quantification Assay for S. epidermidis Biofilms: A Comparison between Commercial Kits and a Customized Protocol	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; STAPHYLOCOCCUS-EPIDERMIDIS; DYE CONCENTRATION; INFECTION; AMPLIFICATION; TRANSCRIPTION; ACCUMULATION; VALIDATION	Staphylococcus epidermidis biofilm-related infections are a current concern within the medical community due to their high incidence and prevalence, particularly in patients with indwelling medical devices. Biofilm gene expression analysis by quantitative real-time PCR (qPCR) has been increasingly used to understand the role of biofilm formation in the pathogenesis of S. epidermidis infections. However, depending on the RNA extraction procedure, and cDNA synthesis and qPCR master mixes used, gene expression quantification can be suboptimal. We recently showed that some RNA extraction kits are not suitable for S. epidermidis biofilms, due to sample composition, in particular the presence of the extracellular matrix. In this work, we describe a custom RNA extraction assay followed by the evaluation of gene expression using different commercial reverse transcriptase kits and qPCR master mixes. Our custom RNA extraction assay was able to produce good quality RNA with reproducible gene expression quantification, reducing the time and the costs associated. We also tested the effect of reducing cDNA and qPCR reaction volumes and, in most of the cases tested, no significant differences were found. Finally, we titered the SYBR Green I concentrations in standard PCR master mixes and compared the normalized expression of the genes icaA, bhp, aap, psm beta 1 and agrB using 4 distinct biofilm forming S. epidermidis strains to the results obtained with commercially available kits. The overall results demonstrated that despite some statistically, but not biologically significant differences observed, the customized qPCR protocol resulted in the same gene expression trend presented by the commercially available kits used.	[Franca, Angela; Freitas, Ana I.; Henriques, Ana F.; Cerca, Nuno] Univ Minho, CEB IBB, Ctr Engn Biol Inst Biotecnol & Bioengn, Braga, Portugal	Universidade do Minho	Franca, A (corresponding author), Univ Minho, CEB IBB, Ctr Engn Biol Inst Biotecnol & Bioengn, Campus Gualtar, Braga, Portugal.	nunocerca@ceb.uminho.pt	de Sousa França, Ângela Maria Oliveira/X-6192-2019; Freitas, Ana Isabel/L-4826-2019; Henriques, Ana Filipa/O-5835-2015; Freitas, Ana Isabel/D-1778-2011; Cerca, Nuno/B-4231-2010; França, Angela/O-5560-2015	de Sousa França, Ângela Maria Oliveira/0000-0001-7117-6837; Freitas, Ana Isabel/0000-0003-4276-356X; Henriques, Ana Filipa/0000-0003-4104-1901; Freitas, Ana Isabel/0000-0003-4276-356X; Cerca, Nuno/0000-0003-3365-3537; França, Angela/0000-0001-7117-6837	Fundacao para a Ciencia e a Tecnologia (The Foundation for Science and Technology: FCT); COMPETE (Programa Operacional Factores de Competitividade) [PTDC/BIA-MIC/113450/2009, FCOMP-01-0124-FEDER-014309]; FCT fellowship [SFRH/BD/62359/2009]	Fundacao para a Ciencia e a Tecnologia (The Foundation for Science and Technology: FCT); COMPETE (Programa Operacional Factores de Competitividade); FCT fellowship(Portuguese Foundation for Science and Technology)	This work was funded by Fundacao para a Ciencia e a Tecnologia (The Foundation for Science and Technology: FCT) and COMPETE (Programa Operacional Factores de Competitividade) grants PTDC/BIA-MIC/113450/2009 and FCOMP-01-0124-FEDER-014309. AF was funded by FCT fellowship SFRH/BD/62359/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217; Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007; Cerca N, 2008, J BACTERIOL, V190, P6530, DOI 10.1128/JB.00482-08; Cerca N, 2008, FEMS MICROBIOL LETT, V283, P36, DOI 10.1111/j.1574-6968.2008.01142.x; Cerca N, 2006, INFECT IMMUN, V74, P4849, DOI 10.1128/IAI.00230-06; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Franca A, 2012, CURR MICROBIOL, V65, P54, DOI 10.1007/s00284-012-0124-5; Franca Angela, 2011, BMC Res Notes, V4, P572, DOI 10.1186/1756-0500-4-572; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020918; Junttila Sini, 2009, BMC Res Notes, V2, P204, DOI 10.1186/1756-0500-2-204; Li M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nour A. M. A., 2010, Agriculture and Biology Journal of North America, V1, P448; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Rozen S, 2000, Methods Mol Biol, V132, P365; Rump Lydia V, 2010, BMC Res Notes, V3, P211, DOI 10.1186/1756-0500-3-211; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; Sheehan E, 2003, J ORTOPAEDIC RES; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Tavares Lucelia, 2011, BMC Res Notes, V4, P3, DOI 10.1186/1756-0500-1-140; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945; Zhu T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-287	41	35	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37480	10.1371/journal.pone.0037480	http://dx.doi.org/10.1371/journal.pone.0037480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629403	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100033
J	de Voux, A; Spaulding, AC; Beckwith, C; Avery, A; Williams, C; Messina, LC; Ball, S; Altice, FL				de Voux, Alex; Spaulding, Anne C.; Beckwith, Curt; Avery, Ann; Williams, Chyvette; Messina, Lauren C.; Ball, Sarah; Altice, Frederick L.			Early Identification of HIV: Empirical Support for Jail-Based Screening	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; INFECTED PRISONERS; CARE; ADHERENCE; RELEASE; TRANSMISSION; ACCEPTANCE; PREVENTION; FACILITIES	Background: Although routine HIV testing is recommended for jails, little empirical data exist describing newly diagnosed individuals in this setting. Methods: Client-level data (CLD) are available on a subset of individuals served in EnhanceLink, for the nine of the 10 sites who enrolled newly diagnosed persons in the client level evaluation. In addition to information about time of diagnosis, we analyzed data on initial CD4 count, use of antiretroviral therapy (ART), and linkage to care post discharge. Baseline data from newly diagnosed persons were compared to data from persons whose diagnoses predated jail admission. Results: CLD were available for 58 newly diagnosed and 708 previously diagnosed individuals enrolled between 9/08 and 3/11. Those newly diagnosed had a significantly younger median age (34 years) when compared to those previously diagnosed (41 years). In the 30 days prior to incarceration, 11% of those newly diagnosed reported injection drug use and 29% reported unprotected anal intercourse. Median CD4 count at diagnosis was 432 cells/mL (range: 22-1,453 cells/mL). A minority (21%, N = 12) of new diagnoses started antiretroviral treatment (ART) before release; 74% have evidence of linkage to community services. Conclusion: Preliminary results from a cross-sectional analysis of this cohort suggest testing in jails finds individuals early on in disease progression. Most HIV+ detainees did not start ART in jail; therefore screening may not increase pharmacy costs for jails. Detainees newly diagnosed with HIV in jails can be effectively linked to community resources. Jail-based HIV testing should be a cornerstone of "test and treat" strategies.	[de Voux, Alex; Spaulding, Anne C.; Messina, Lauren C.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Beckwith, Curt] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Avery, Ann] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Williams, Chyvette] Univ Illinois, Sch Publ Hlth, Chicago, IL USA; [Ball, Sarah] ABT Associates Inc, Cambridge, MA 02138 USA; [Altice, Frederick L.] Yale Univ, Sch Med, Dept Med, Infect Dis Sect, New Haven, CT 06510 USA; [Altice, Frederick L.] Yale Univ, Div Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA	Emory University; Rollins School Public Health; Brown University; Case Western Reserve University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; ABT Associates; Yale University; Yale University	de Voux, A (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	ASpauld@emory.edu			HRSA [H97HA08541, H97HA08543, H97HA085xx, H97HA08535, U90HA07632]; National Institutes on Drug Abuse for career development award [K24 DA017072]; National Institute on Drug Abuse grant [K23DA021095]; Lifespan/Tufts/Brown Center for AIDS Research grant [P30AI42853]; Emory Center for AIDS Research [P30AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, K23DA021095] Funding Source: NIH RePORTER	HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes on Drug Abuse for career development award; National Institute on Drug Abuse grant; Lifespan/Tufts/Brown Center for AIDS Research grant; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Authors are supported by the following HRSA grants: Dr. Altice: H97HA08541; Dr. Avery: H97HA08543; Dr. Williams: H97HA085xx; Dr. Beckwith: H97HA08535; and Dr. Spaulding: U90HA07632; Dr. Ball worked as a subcontractor under this grant. Frederick Altice was also supported by a National Institutes on Drug Abuse for career development award (K24 DA017072). Curt Beckwith was also supported by a National Institute on Drug Abuse grant (K23DA021095) and the Lifespan/Tufts/Brown Center for AIDS Research grant (P30AI42853). Alex de Voux, Lauren Messina and Anne Spaulding would like to acknowledge support from the Emory Center for AIDS Research (P30AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Beckwith C. G., 2010, Morbidity and Mortality Weekly Report, V59, P742; Beckwith CG, 2010, IDSA C VANC; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; CDC, 2006, MMWR WEEKLY, P421; CDC, 2011, 16 CDC; Centers for Disease Control and Prevention (CDC), 2009, HIV TEST IMPL GUID C, P1; Chandler RK, 2011, SEEK TEST TREAT RETA; Chen NE, 2013, AIDS BEHAV, V17, P2654, DOI 10.1007/s10461-011-0080-2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Draine J, 2011, AIDS CARE, V23, P366, DOI 10.1080/09540121.2010.507738; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goetz MB, 2011, JAIDS-J ACQ IMM DEF, V57, pE23, DOI 10.1097/QAI.0b013e31821a0600; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammett TM, NATL SURVEY INFECT D, P1; Huaman MA, 2011, INT J INFECT DIS, V15, pE764, DOI 10.1016/j.ijid.2011.06.007; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Kuo AM, 2005, AIDS PATIENT CARE ST, V19, P239, DOI 10.1089/apc.2005.19.239; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lyons MS, 2011, ANN EMERG MED S1, V58, p[S17, e11]; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Maruschak Laura M., 2006, MED PROBLEMS JAIL IN; Mostashari F, 1998, J ACQ IMMUN DEF SYND, V18, P341, DOI 10.1097/00042560-199808010-00005; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Pai NP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007115; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rich Josiah D, 2011, Curr HIV/AIDS Rep, V8, P288, DOI 10.1007/s11904-011-0095-3; Spaulding AC, 2011, AJPH, pe1; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Stephenson BL, 2006, INT J STD AIDS, V17, P103, DOI 10.1258/095646206775455775; Strick Lara B., 2011, Morbidity and Mortality Weekly Report, V60, P811; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027; White House Office of AIDS Policy, 2010, NAT HIV AIDS STRAT U	47	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37603	10.1371/journal.pone.0037603	http://dx.doi.org/10.1371/journal.pone.0037603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662177	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300067
J	Varga, Z; Diebold, J; Dommann-Scherrer, C; Frick, H; Kaup, D; Noske, A; Obermann, E; Ohlschlegel, C; Padberg, B; Rakozy, C; Oliver, SS; Schobinger-Clement, S; Schreiber-Facklam, H; Singer, G; Tapia, C; Wagner, U; Mastropasqua, MG; Viale, G; Lehr, HA				Varga, Zsuzsanna; Diebold, Joachim; Dommann-Scherrer, Corina; Frick, Harald; Kaup, Daniela; Noske, Aurelia; Obermann, Ellen; Ohlschlegel, Christian; Padberg, Barbara; Rakozy, Christiane; Oliver, Sara Sancho; Schobinger-Clement, Sylviane; Schreiber-Facklam, Heide; Singer, Gad; Tapia, Coya; Wagner, Urs; Mastropasqua, Mauro G.; Viale, Giuseppe; Lehr, Hans-Anton			How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; MIB-1 LABELING INDEXES; IMAGE-ANALYSIS; PROLIFERATIVE ACTIVITY; INTEROBSERVER VARIABILITY; HISTOLOGICAL GRADE; PROGNOSTIC-FACTORS; PRIMARY THERAPY; CANCER; EXPRESSION	Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessment of tumor proliferation. The Swiss Working Group of Gyneco- and Breast Pathologists has surveyed inter-and intraobserver consistency of Ki-67-based proliferative fraction in breast carcinomas. Methods: Five pathologists evaluated MIB-1-labeling index (LI) in ten breast carcinomas (G1, G2, G3) by counting and eyeballing. In the same way, 15 pathologists all over Switzerland then assessed MIB-1-LI on three G2 carcinomas, in self-selected or pre-defined areas of the tumors, comparing centrally immunostained slides with slides immunostained in the different laboratoires. To study intra-observer variability, the same tumors were re-examined 4 months later. Results: The Kappa values for the first series of ten carcinomas of various degrees of differentiation showed good to very good agreement for MIB-1-LI (Kappa 0.56-0.72). However, we found very high inter-observer variabilities (Kappa 0.04-0.14) in the read-outs of the G2 carcinomas. It was not possible to explain the inconsistencies exclusively by any of the following factors: (i) pathologists' divergent definitions of what counts as a positive nucleus (ii) the mode of assessment (counting vs. eyeballing), (iii) immunostaining technique, and (iv) the selection of the tumor area in which to count. Despite intensive confrontation of all participating pathologists with the problem, inter-observer agreement did not improve when the same slides were reexamined 4 months later (Kappa 0.01-0.04) and intra-observer agreement was likewise poor (Kappa 0.00-0.35). Conclusion: Assessment of mid-range Ki-67-LI suffers from high inter-and intra-observer variability. Oncologists should be aware of this caveat when using Ki-67-LI as a basis for treatment decisions in moderately differentiated breast carcinomas.	[Varga, Zsuzsanna; Noske, Aurelia] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Diebold, Joachim] Cantonal Hosp Luzern, Inst Pathol, Luzern, Switzerland; [Dommann-Scherrer, Corina] Cantonal Hosp Winterthur, Inst Pathol, Winterthur, Switzerland; [Frick, Harald; Padberg, Barbara] Cantonal Hosp Graubunden, Inst Pathol, Chur, Switzerland; [Kaup, Daniela] Liestal Hosp, Cantonal Inst Pathol, Liestal, Switzerland; [Obermann, Ellen] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Ohlschlegel, Christian] Cantonal Hosp St Gallen, Inst Pathol, St Gallen, Switzerland; [Rakozy, Christiane] Pathol Inst Biopsy Diagnost, Zurich, Switzerland; [Oliver, Sara Sancho; Schobinger-Clement, Sylviane] Promed SA, Pathol, Med Lab, Marly, Switzerland; [Schreiber-Facklam, Heide] Municipal Hosp Konstanz, Inst Pathol, Constance, Germany; [Singer, Gad] Cantonal Hosp Baden, Inst Pathol, Baden, Switzerland; [Tapia, Coya] Univ Bern, Inselspital, Inst Pathol, CH-3010 Bern, Switzerland; [Wagner, Urs] Unilabs Mittelland, Pathol, Bern, Switzerland; [Mastropasqua, Mauro G.; Viale, Giuseppe] European Inst Oncol, Div Anat Pathol, Milan, Italy; [Mastropasqua, Mauro G.; Viale, Giuseppe] Univ Milan, Milan, Italy; [Lehr, Hans-Anton] CHU Vaudois, Inst Pathol, CH-1011 Lausanne, Switzerland	University of Zurich; University Zurich Hospital; Lucerne Cantonal Hospital; Kantonsspital Graubunden; University of Basel; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; IRCCS European Institute of Oncology (IEO); University of Milan; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	Hans-Anton.Lehr@chuv.ch	MASTROPASQUA, Mauro/AAK-8813-2020; Obermann, Ellen/E-2656-2013; Viale, Giuseppe/AAE-8921-2019; Singer, Gad/W-4511-2017	MASTROPASQUA, Mauro/0000-0002-8306-0839; Singer, Gad/0000-0001-8090-7267				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abramovich CM, 1999, ARCH PATHOL LAB MED, V123, P793; Adams EJ, 1999, J CLIN PATHOL, V52, P75, DOI 10.1136/jcp.52.1.75; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Biesterfeld S, 1998, J PATHOL, V185, P25, DOI 10.1002/(SICI)1096-9896(199805)185:1<25::AID-PATH40>3.0.CO;2-R; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fandel TM, 2008, J PATHOL, V216, P193, DOI 10.1002/path.2395; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Grzybicki DM, 2001, CANCER-AM CANCER SOC, V92, P2720, DOI 10.1002/1097-0142(20011115)92:10<2720::AID-CNCR1626>3.0.CO;2-Z; Hamilton PW, 2009, J PATHOL, V218, P285, DOI 10.1002/path.2527; Hasegawa T, 2002, PATHOL INT, V52, P433, DOI 10.1046/j.1440-1827.2002.01378.x; Klintman M, 2010, MODERN PATHOL, V23, P251, DOI 10.1038/modpathol.2009.167; Lehr HA, 1999, HUM PATHOL, V30, P1314, DOI 10.1016/S0046-8177(99)90062-X; Lehr HA, 1996, APPL IMMUNOHISTOCHEM, V4, P117; MAKKINKNOMBRADO SV, 1995, ANAL CELL PATHOL, V8, P227; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Menter DG, 2001, ANAL QUANT CYTOL, V23, P218; Molenaar W M, 2000, Ann Diagn Pathol, V4, P228, DOI 10.1053/adpa.2000.8126; Offersen BV, 2003, HISTOPATHOLOGY, V43, P573, DOI 10.1111/j.1365-2559.2003.01745.x; Ozcan A, 2007, ANAL QUANT CYTOL, V29, P159; PINDER SE, 1995, BRIT J CANCER, V71, P146, DOI 10.1038/bjc.1995.30; Rezanko T, 2008, ANAL QUANT CYTOL, V30, P47; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; van Sandick JW, 2000, J PATHOL, V190, P177; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; WEIDNER N, 1994, HUM PATHOL, V25, P337, DOI 10.1016/0046-8177(94)90140-6; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Yamaguchi U, 2006, APPL IMMUNOHISTO M M, V14, P46, DOI 10.1097/01.pai.0000151023.88969.d7; Zhang R, 2010, CHINESE MED J-PEKING, V123, P1976, DOI 10.3760/cma.j.issn.0366-6999.2010.15.005	37	159	167	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37379	10.1371/journal.pone.0037379	http://dx.doi.org/10.1371/journal.pone.0037379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662150	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305342300039
J	Genton, C; Cristescu, R; Gatti, S; Levrero, F; Bigot, E; Caillaud, D; Pierre, JS; Menard, N				Genton, Celine; Cristescu, Romane; Gatti, Sylvain; Levrero, Florence; Bigot, Elodie; Caillaud, Damien; Pierre, Jean-Sebastien; Menard, Nelly			Recovery Potential of a Western Lowland Gorilla Population following a Major Ebola Outbreak: Results from a Ten Year Study	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; VULTURE GYPS-FULVUS; MBELI-BAI; ECOLOGY; CONGO; WILDLIFE; EXTINCTION; PATTERNS; FEVER; CONSERVATION	Investigating the recovery capacity of wildlife populations following demographic crashes is of great interest to ecologists and conservationists. Opportunities to study these aspects are rare due to the difficulty of monitoring populations both before and after a demographic crash. Ebola outbreaks in central Africa have killed up to 95% of the individuals in affected western lowland gorilla (Gorilla gorilla gorilla) populations. Assessing whether and how fast affected populations recover is essential for the conservation of this critically endangered taxon. The gorilla population visiting Lokoue forest clearing, Odzala-Kokoua National Park, Republic of the Congo, has been monitored before, two years after and six years after Ebola affected it in 2004. This allowed us to describe Ebola's short-term and long-term impacts on the structure of the population. The size of the population, which included around 380 gorillas before the Ebola outbreak, dropped to less than 40 individuals after the outbreak. It then remained stable for six years after the outbreak. However, the demographic structure of this small population has significantly changed. Although several solitary males have disappeared, the immigration of adult females, the formation of new breeding groups, and several birth events suggest that the population is showing potential to recover. During the outbreak, surviving adult and subadult females joined old solitary silverbacks. Those females were subsequently observed joining young silverbacks, forming new breeding groups where they later gave birth. Interestingly, some females were observed joining silverbacks that were unlikely to have sired their infant, but no infanticide was observed. The consequences of the Ebola outbreak on the population structure were different two years and six years after the outbreak. Therefore, our results could be used as demographic indicators to detect and date outbreaks that have happened in other, non-monitored gorilla populations.	[Genton, Celine; Gatti, Sylvain; Bigot, Elodie; Pierre, Jean-Sebastien; Menard, Nelly] Univ Rennes 1, CNRS, ECOBIO, Biol Stn Paimpont,UMR 6553, Paimpont, France; [Cristescu, Romane] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Levrero, Florence] Univ St Etienne, ENES CNPS, CNRS, UMR 8195, St Etienne, France; [Levrero, Florence] Ctr Natl Rech Sci, Ctr Neurosci Paris Sud, UMR 8195, Paris, France; [Caillaud, Damien] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; University of New South Wales Sydney; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; University of Texas System; University of Texas Austin	Genton, C (corresponding author), Univ Rennes 1, CNRS, ECOBIO, Biol Stn Paimpont,UMR 6553, Paimpont, France.	celine.genton@yahoo.fr	Caillaud, Damien/AAH-5850-2019; Levrero, Fabrizio/AAH-6833-2019; MENARD, Nelly/L-2214-2018	Caillaud, Damien/0000-0002-8347-6869; Levrero, Florence/0000-0002-6904-1375; MENARD, Nelly/0000-0003-4122-9330	ECOsystemes; Ministere de l'Ecologie et du Developpement Durable, France; La Bourbansais and La Palmyre zoological parks; NSF [DEB-0749097]; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation	ECOsystemes; Ministere de l'Ecologie et du Developpement Durable, France; La Bourbansais and La Palmyre zoological parks; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the ECOsystemes FORestiers program (http:// www.gip-ecofor.org/; Ministere de l'Ecologie et du Developpement Durable, France) and the Especes-Phares program (DG Environnement, UE, carried out by Reseau des Aires Protegees d'Afrique Centrale; http://www.rapac.org). The authors thank the Rent2Connect firm for their material support, and the La Bourbansais and La Palmyre zoological parks for their financial support. DC was supported by NSF Grant DEB-0749097 to L. A. Meyers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; [Anonymous], 2010, R LANG ENV STAT COMP; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Bermejo M, 2004, AM J PRIMATOL, V64, P223, DOI 10.1002/ajp.20073; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Bijleveld AI, 2010, OIKOS, V119, P277, DOI 10.1111/j.1600-0706.2009.17892.x; Breuer T, 2010, BEHAV ECOL SOCIOBIOL, V64, P515, DOI 10.1007/s00265-009-0867-6; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Caillaud D, 2008, AM J PHYS ANTHROPOL, V135, P379, DOI 10.1002/ajpa.20754; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Cipolletta C, 2004, AM J PRIMATOL, V64, P193, DOI 10.1002/ajp.20072; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; CREEL S, 1992, NATURE, V360, P633, DOI 10.1038/360633a0; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Devos C, 2008, ORYX, V42, P367, DOI 10.1017/S0030605308000161; DONAZAR JA, 1990, BIOL CONSERV, V53, P83, DOI 10.1016/0006-3207(90)90001-6; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Grenier MB, 2007, SCIENCE, V317, P779, DOI 10.1126/science.1144648; Hadley GL, 2006, J ANIM ECOL, V75, P1058, DOI 10.1111/j.1365-2656.2006.01118.x; Harcourt AH, 2001, ANIM BEHAV, V62, P905, DOI 10.1006/anbe.2001.1835; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023150; Herve M, 2011, DIVERSE BASIC STAT G; Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; Jennions MD, 2003, BEHAV ECOL, V14, P438, DOI 10.1093/beheco/14.3.438; JOHNSON KM, 1977, LANCET, V1, P569; Lachish S, 2009, J ANIM ECOL, V78, P427, DOI 10.1111/j.1365-2656.2008.01494.x; Lai LW, 2011, INT J ENVIRON HEAL R, V21, P133, DOI 10.1080/09603123.2010.515670; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Levrero F, 2006, AM J PRIMATOL, V68, P275, DOI 10.1002/ajp.20223; Loison A, 1996, J WILDLIFE MANAGE, V60, P517, DOI 10.2307/3802069; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; Magliocca F, 1999, AM J PRIMATOL, V48, P1, DOI 10.1002/(SICI)1098-2345(1999)48:1<1::AID-AJP1>3.0.CO;2-2; Mateo-Tomas P, 2011, IBIS, V153, P832, DOI 10.1111/j.1474-919X.2011.01154.x; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Mutze G, 2002, WILDLIFE RES, V29, P577, DOI 10.1071/WR00100; Nunn CL, 2006, INFECT DIS PRIMATES; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Pistorius PA, 2001, POLAR BIOL, V24, P343, DOI 10.1007/s003000000217; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Rudran R, 2003, INT J PRIMATOL, V24, P925, DOI 10.1023/A:1026241625910; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WCS, 2009, PROT MON GREAT AP OD; Wobeser G, 2002, CAN VET J, V43, P798; Yamagiwa J, 2009, PRIMATES, V50, P293, DOI 10.1007/s10329-009-0163-0	58	25	26	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37106	10.1371/journal.pone.0037106	http://dx.doi.org/10.1371/journal.pone.0037106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649511	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800029
J	Haak, KV; Cornelissen, FW; Morland, AB				Haak, Koen V.; Cornelissen, Frans W.; Morland, Antony B.			Population Receptive Field Dynamics in Human Visual Cortex	PLOS ONE			English	Article							RECURRENT NETWORK MODEL; MACAQUE V1 NEURONS; CONTEXTUAL MODULATION; MACULAR DEGENERATION; OCCIPITAL CORTEX; CEREBRAL-CORTEX; FUNCTIONAL MRI; FEEDBACK; SIGNALS; AREAS	Seminal work in the early nineties revealed that the visual receptive field of neurons in cat primary visual cortex can change in location and size when artificial scotomas are applied. Recent work now suggests that these single neuron receptive field dynamics also pertain to the neuronal population receptive field (pRF) that can be measured in humans with functional magnetic resonance imaging (fMRI). To examine this further, we estimated the pRF in twelve healthy participants while masking the central portion of the visual field. We found that the pRF changes in location and size for two differently sized artificial scotomas, and that these pRF dynamics are most likely due to a combination of the neuronal receptive field position and size scatter as well as modulatory feedback signals from extrastriate visual areas.	[Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Lab Expt Ophthalmol, Groningen, Netherlands; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Haak, Koen V.; Morland, Antony B.] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Morland, Antony B.] Hull York Med Sch, Ctr Neurosci, York, N Yorkshire, England	University of Groningen; University of Groningen; University of York - UK; University of Hull; University of York - UK	Haak, KV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Lab Expt Ophthalmol, Groningen, Netherlands.	a.morland@psychology.york.ac.uk	Haak, Koen/AAM-5500-2020; Haak, Koen V/G-6417-2018	Haak, Koen/0000-0001-9309-1906; Haak, Koen V/0000-0001-9309-1906; Morland, Antony/0000-0002-6754-5545	Medical Research Council [G0401339]; European Union [043157, 043261]; MRC [G0401339] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Medical Research Council (G0401339), European Union grant #043157 ( Syntex), European Union grant #043261 ( Percept), and a grant from Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Baseler HA, 2011, NAT NEUROSCI, V14, P649, DOI 10.1038/nn.2793; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cornelissen FW, 2006, J NEUROSCI, V26, P3634, DOI 10.1523/JNEUROSCI.4382-05.2006; Delboeuf JLR, 1892, B ACAD ROYALE SCI, V24, P545; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dilks DD, 2007, J NEUROSCI, V27, P9585, DOI 10.1523/JNEUROSCI.2650-07.2007; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Ichida JM, 2007, J NEUROPHYSIOL, V98, P2168, DOI 10.1152/jn.00298.2007; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; LEUBA G, 1989, EXP BRAIN RES, V77, P31; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Nurminen L, 2010, J VISION, V10, DOI 10.1167/10.13.9; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Schwabe L, 2010, NEUROIMAGE, V52, P777, DOI 10.1016/j.neuroimage.2010.01.032; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Vanni S, 2012, NEURAL NETWORKS, V25, P30, DOI 10.1016/j.neunet.2011.08.001; VICTOR JD, 1994, J NEUROPHYSIOL, V72, P2151, DOI 10.1152/jn.1994.72.5.2151; Wachtler T, 2001, VISION RES, V41, P1535, DOI 10.1016/S0042-6989(01)00017-7; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Zipser K, 1996, J NEUROSCI, V16, P7376	37	54	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37686	10.1371/journal.pone.0037686	http://dx.doi.org/10.1371/journal.pone.0037686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649551	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335800070
J	Jo, JW; Jee, BC; Suh, CS; Kim, SH				Jo, Jun Woo; Jee, Byung Chul; Suh, Chang Suk; Kim, Seok Hyun			The Beneficial Effects of Antifreeze Proteins in the Vitrification of Immature Mouse Oocytes	PLOS ONE			English	Article							GERMINAL-VESICLE OOCYTES; IN-VITRO MATURATION; EMBRYONIC-DEVELOPMENT; SPINDLE CHECKPOINT; GENE-EXPRESSION; MOTOR PROTEIN; CRYOPRESERVATION; EG5; OVEREXPRESSION; FERTILIZATION	Antifreeze proteins (AFPs) are a class of polypeptides that permit organismal survival in sub-freezing environments. The purpose of this study was to investigate the effect of AFP supplementation on immature mouse oocyte vitrification. Germinal vesicle-stage oocytes were vitrified using a two-step exposure to equilibrium and vitrification solution in the presence or absence of 500 ng/mL of AFP III. After warming, oocyte survival, in vitro maturation, fertilization, and embryonic development up to the blastocyst stage were assessed. Spindle and chromosome morphology, membrane integrity, and the expression levels of several genes were assessed in in vitro matured oocytes. The rate of blastocyst formation was significantly higher and the number of caspase-positive blastomeres was significantly lower in the AFP-treated group compared with the untreated group. The proportion of oocytes with intact spindles/chromosomes and stable membranes was also significantly higher in the AFP group. The AFP group showed increased Mad2, Hook-1, Zar1, Zp1, and Bcl2 expression and lower Eg5, Zp2, Caspase6, and Rbm3 expression compared with the untreated group. Supplementation of the vitrification medium with AFP has a protective effect on immature mouse oocytes, promoting their resistance to chilling injury. AFPs may preserve spindle forming ability and membrane integrity at GV stage. The fertilization and subsequent developmental competence of oocytes may be associated with the modulation of Zar1, Zp1/Zp2, Bcl2, Caspase6, and Rbm3.	[Jo, Jun Woo; Jee, Byung Chul; Suh, Chang Suk] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea; [Jo, Jun Woo; Jee, Byung Chul; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Seok Hyun] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul 110744, South Korea; [Jo, Jun Woo] Seoul Natl Univ, Inst Reprod Med & Populat, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Jo, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea.	suhcs@snu.ac.kr	Jee, Byung Chul/J-5676-2012; Suh, Chang-Suk/J-5513-2012					ARAV A, 1993, MOL REPROD DEV, V36, P488, DOI 10.1002/mrd.1080360413; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Blomberg LA, 2005, PHYSIOL GENOMICS, V20, P188, DOI 10.1152/physiolgenomics.00157.2004; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Castillo A, 2007, BIOCHEM BIOPH RES CO, V357, P694, DOI 10.1016/j.bbrc.2007.04.021; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Cobo A, 2010, FERTIL STERIL, V94, P1903, DOI 10.1016/j.fertnstert.2009.10.042; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Cooper A, 1998, HUM REPROD, V13, P971, DOI 10.1093/humrep/13.4.971; Exley GE, 1999, BIOL REPROD, V61, P231, DOI 10.1095/biolreprod61.1.231; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Habibi A, 2010, J ASSIST REPROD GEN, V27, P599, DOI 10.1007/s10815-010-9453-0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Hinsch E, 2003, THERIOGENOLOGY, V60, P1331, DOI 10.1016/S0093-691X(03)00169-9; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Huang JYJ, 2007, FERTIL STERIL, V88, P1093, DOI 10.1016/j.fertnstert.2006.12.066; Isachenko E, 2004, REPROD BIOMED ONLINE, V8, P553, DOI 10.1016/S1472-6483(10)61102-9; Isachenko EF, 1999, HUM REPROD, V14, P400, DOI 10.1093/humrep/14.2.400; Izawa M, 1998, FERTIL STERIL, V70, P549, DOI 10.1016/S0015-0282(98)00194-0; Jo JW, 2011, FERTIL STERIL; Madura JD, 2000, J MOL RECOGNIT, V13, P101, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<101::AID-JMR493>3.0.CO;2-9; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nagy ZP, 2009, SEMIN REPROD MED, V27, P450, DOI 10.1055/s-0029-1241054; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; PAYNE SR, 1994, CRYOBIOLOGY, V31, P180, DOI 10.1006/cryo.1994.1021; Rao GD, 2004, LANCET, V363, P1829, DOI 10.1016/S0140-6736(04)16320-4; RUBINSKY B, 1990, BIOCHEM BIOPH RES CO, V173, P1369, DOI 10.1016/S0006-291X(05)80939-8; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Smith GD, 2010, FERTIL STERIL, V94, P2088, DOI 10.1016/j.fertnstert.2009.12.065; Somfai T, 2006, THERIOGENOLOGY, V66, P415, DOI 10.1016/j.theriogenology.2005.11.023; Son WY, 1996, FERTIL STERIL, V66, P995, DOI 10.1016/S0015-0282(16)58696-8; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; TOTH TL, 1994, FERTIL STERIL, V61, P1077; TOTH TL, 1994, FERTIL STERIL, V61, P891; Ubaldi F, 2010, HUM REPROD, V25, P1199, DOI 10.1093/humrep/deq046; Wang JZ, 2009, REPRODUCTION, V137, P181, DOI 10.1530/REP-08-0339; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; WASSARMAN PM, 1988, SCI AM, V259, P78, DOI 10.1038/scientificamerican1288-78; Wrenzycki C, 1999, MOL REPROD DEV, V53, P8, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;8::AID-MRD2&gt;3.0.CO;2-K; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhou KW, 2009, CLIN INVEST MED, V32, pE103	46	40	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37043	10.1371/journal.pone.0037043	http://dx.doi.org/10.1371/journal.pone.0037043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649508	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800026
J	Josef, N; Amodio, P; Fiorito, G; Shashar, N				Josef, Noam; Amodio, Piero; Fiorito, Graziano; Shashar, Nadav			Camouflaging in a Complex Environment-Octopuses Use Specific Features of Their Surroundings for Background Matching	PLOS ONE			English	Article							DISRUPTIVE COLORATION; CUTTLEFISH CAMOUFLAGE; VISUAL-PERCEPTION; CONTRAST; SUBSTRATE; STATISTICS; MIMICRY; TEXTURE; CRYPSIS; OBJECTS	Living under intense predation pressure, octopuses evolved an effective and impressive camouflaging ability that exploits features of their surroundings to enable them to "blend in.'' To achieve such background matching, an animal may use general resemblance and reproduce characteristics of its entire surroundings, or it may imitate a specific object in its immediate environment. Using image analysis algorithms, we examined correlations between octopuses and their backgrounds. Field experiments show that when camouflaging, Octopus cyanea and O. vulgaris base their body patterns on selected features of nearby objects rather than attempting to match a large field of view. Such an approach enables the octopus to camouflage in partly occluded environments and to solve the problem of differences in appearance as a function of the viewing inclination of the observer.	[Josef, Noam; Shashar, Nadav] Ben Gurion Univ Negev, Dept Life Sci, Eilat Campus, IL-84105 Beer Sheva, Israel; [Amodio, Piero; Fiorito, Graziano] Stn Zool Anton Dohrn, Naples, Italy	Ben Gurion University; Stazione Zoologica Anton Dohrn di Napoli	Josef, N (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Eilat Campus, IL-84105 Beer Sheva, Israel.	bigblue79@bezeqint.net	Shashar, Nadav/Y-8552-2019; FIORITO, GRAZIANO/N-2270-2014; Amodio, Piero/ABH-6513-2020	FIORITO, GRAZIANO/0000-0003-2926-9479; Amodio, Piero/0000-0002-9408-2902	Ben-Gurion University	Ben-Gurion University	We thank the support of Ben-Gurion University's Marine Biology and Biotechnology program and the Inter University Institute for Marine Sciences in Eilat for logistical support. We are grateful to the cephalopod group in the Stazione Zoologica Anton Dohrn for their warm hospitality. Special thanks to the Israeli Nature and Parks Authority for monitoring the capture, maintenance, and release of the octopus. We are grateful for the contributions of B. Alon, A. Lerner, K. Levi, S. Maccusker, E. Yanowski, P. Amodio, C. Talbot, Y. Schnytzer and O. Polak, who provided constructive suggestions and discussions along the way, and Z. Livnat, who donated high resolution images for our study.	Barbosa A, 2004, BIOL BULL-US, V207, P154, DOI 10.1086/BBLv207n2p154; Barbosa A, 2011, P BIOL SCI; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Barbosa A, 2007, J EXP BIOL, V210, P1139, DOI 10.1242/jeb.02741; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Borrelli L, CATALOGUE BODY PATTE; BROWN PK, 1958, NATURE, V182, P1288, DOI 10.1038/1821288a0; Chiao CC, 2005, BIOL BULL-US, V208, P7, DOI 10.2307/3593095; Chiao CC, 2001, BIOL BULL, V201, P269, DOI 10.2307/1543359; Chiao CC, 2001, J EXP BIOL, V204, P2119; Chlao CC, 2007, VISION RES, V47, P2223, DOI 10.1016/j.visres.2007.05.001; COGGINS JM, 1985, PATTERN RECOGN LETT, V3, P195, DOI 10.1016/0167-8655(85)90053-4; Cott HB, ADAPTIVE COLORATION; Darwin C, 1859, ORIGIN SPECIES MEANS; Edmunds M, 1990, EVOLUTION CRYPTIC CO, P3; Edmunds M, DEFENCE ANIMALS SURV; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; FISHELSON L, 1983, PLANTS ANIMALS LAND; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Guilford T, 1992, PREDATOR PSYCHOL EVO, P375; Hailman JP, OPTICAL SIGNALS ANIM; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; Hanlon RT, CEPHALOPOD BEHAV; Hanlon RT, 1988, PHILOS T R SOC B, V320, P69; Hinton H.E., 1976, P390; Holmes William., 1940, PROC ZOOL SOC LONDON SER A, V110, P17; Kelman EJ, 2007, P R SOC B, V274, P1369, DOI 10.1098/rspb.2007.0240; Kenneth SN, 1964, ECOLOGY, V45, P16; Kovesi P. D., 2000, MATLAB OCTAVE FUNCTI; Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; Marshall NJ, 1996, NATURE, V382, P408, DOI 10.1038/382408b0; MATHER JA, 1991, B MAR SCI, V49, P256; Mathger LM, 2006, VISION RES, V46, P1746, DOI 10.1016/j.visres.2005.09.035; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita Sami, 2011, P17; MESSENGER JB, 1977, J EXP BIOL, V70, P49; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Packard A., 1977, Symposia of the Zoological Society of London, P191; Packard A, 1988, MOLLUSCA, V11, P30, DOI [10.1016/B978-0-12-751411-6.50010-2, DOI 10.1016/B978-0-12-751411-6.50010-2]; Shohet AJ, 2006, J EXP BIOL, V209, P4717, DOI 10.1242/jeb.02580; Stevens Martin, 2011, P1; Thayer AH, 1918, SCI MON, V7, P481; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Zylinski S, 2011, AM NAT, V177, P10	49	20	20	18	209	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37579	10.1371/journal.pone.0037579	http://dx.doi.org/10.1371/journal.pone.0037579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649542	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800061
J	Xu, YC; Yang, DB; Wang, DH				Xu, Yan-Chao; Yang, Deng-Bao; Wang, De-Hua			No Evidence for a Trade-Off between Reproductive Investment and Immunity in a Rodent	PLOS ONE			English	Article							SUSTAINED METABOLIC-RATE; LIFE-HISTORY TRAITS; ENERGY-INTAKE; ECOLOGICAL IMMUNOLOGY; FOOD-INTAKE; PHYSIOLOGICAL COSTS; MATERNAL TRANSFER; HUMORAL IMMUNITY; SERUM-LEPTIN; LITTER SIZE	Life history theory assumes there are trade-offs between competing functions such as reproduction and immunity. Although well studied in birds, studies of the trade-offs between reproduction and immunity in small mammals are scarce. Here we examined whether reduced immunity is a consequence of reproductive effort in lactating Brandt's voles (Lasiopodomys brandtii). Specifically, we tested the effects of lactation on immune function (Experiment I). The results showed that food intake and resting metabolic rate (RMR) were higher in lactating voles (6 <= litter size <= 8) than that in non-reproductive voles. Contrary to our expectation, lactating voles also had higher levels of serum total Immunoglobulin G (IgG) and anti-keyhole limpet hemocyanin (KLH) IgG and no change in phytohemagglutinin (PHA) response and anti-KLH Immunoglobulin M (IgM) compared with non-reproductive voles, suggesting improved rather than reduced immune function. To further test the effect of differences in reproductive investment on immunity, we compared the responses between natural large (n >= 8) and small litter size (n <= 6) (Experiment II) and manipulated large (11-13) and small litter size (2-3) (Experiment III). During peak lactation, acquired immunity (PHA response, anti-KLH IgG and anti-KLH IgM) was not significantly different between voles raising large or small litters in both experiments, despite the measured difference in reproductive investment (greater litter size, litter mass, RMR and food intake in the voles raising larger litters). Total IgG was higher in voles with natural large litter size than those with natural small litter size, but decreased in the enlarged litter size group compared with control and reduced group. Our results showed that immune function is not suppressed to compensate the high energy demands during lactation in Brandt's voles and contrasting the situation in birds, is unlikely to be an important aspect mediating the trade-off between reproduction and survival.	[Xu, Yan-Chao; Yang, Deng-Bao; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Xu, Yan-Chao; Yang, Deng-Bao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	wangdh@ioz.ac.cn			Ministry of Science and Technology [2007BC109103]; Chinese Academy of Sciences [KSCX2-EW-N-005]; National Natural Science Foundation of China [31071930]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Ministry of Science and Technology (2007BC109103), Chinese Academy of Sciences (KSCX2-EW-N-005) and National Natural Science Foundation of China (31071930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; Ardia DR, 2005, J ANIM ECOL, V74, P517, DOI 10.1111/j.1365-2656.2005.00950.x; Ardia DR, 2003, P ROY SOC B-BIOL SCI, V270, P1679, DOI 10.1098/rspb.2003.2424; Bleu J, 2012, P ROY SOC B-BIOL SCI, V279, P489, DOI 10.1098/rspb.2011.0966; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Brogan RS, 1999, ENDOCRINOLOGY, V140, P2621, DOI 10.1210/en.140.6.2621; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; Cox RM, 2010, FUNCT ECOL, V24, P1262, DOI 10.1111/j.1365-2435.2010.01756.x; Criscuolo F, 2006, PHYSIOL BIOCHEM ZOOL, V79, P514, DOI 10.1086/501065; de Bellocq JG, 2006, COMP BIOCHEM PHYS A, V145, P554, DOI 10.1016/j.cbpa.2006.08.045; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Demas GE, 2003, P ROY SOC B-BIOL SCI, V270, P905, DOI 10.1098/rspb.2003.2341; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Derting TL, 2003, PHYSIOL BIOCHEM ZOOL, V76, P744, DOI 10.1086/375662; Derting TL, 1998, PHYSIOL ZOOL, V71, P611, DOI 10.1086/515981; DIXON FJ, 1966, J IMMUNOL, V97, P350; Drazen DL, 2003, CAN J ZOOL, V81, P1406, DOI 10.1139/Z03-120; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Grattan DR, 2002, REPRODUCTION, V123, P497, DOI 10.1530/rep.0.1230497; Greives TJ, 2006, FUNCT ECOL, V20, P812, DOI 10.1111/j.1365-2435.2006.01167.x; HAMMOND KA, 1992, PHYSIOL ZOOL, V65, P952, DOI 10.1086/physzool.65.5.30158552; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; Hanssen SA, 2004, P ROY SOC B-BIOL SCI, V271, P925, DOI 10.1098/rspb.2004.2678; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; INNES DGL, 1981, CAN J ZOOL, V59, P785, DOI 10.1139/z81-113; Janeway C., 2004, IMMUNOBIOLOGY; Johnson MS, 2001, J EXP BIOL, V204, P1937; Johnson MS, 2001, J EXP BIOL, V204, P1925; Knobil E., 2006, KNOBIL NEILLS PHYSL; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Koivula M, 2003, ECOLOGY, V84, P398, DOI 10.1890/0012-9658(2003)084[0398:CORITW]2.0.CO;2; Lemke H, 2003, VACCINE, V21, P3428, DOI 10.1016/S0264-410X(03)00394-3; Li Qingfen, 1994, Acta Theriologica Sinica, V14, P217; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Martin II LB, 2006, OECOLOGIA, V147, P565, DOI 10.1007/s00442-005-0314-y; Martin LB, 2004, ECOLOGY, V85, P2323, DOI 10.1890/03-0365; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P815, DOI 10.1098/rspb.2005.3376; MATTINGLY DK, 1982, ECOLOGY, V63, P183, DOI 10.2307/1937043; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Naef L, 2007, ENDOCRINOLOGY, V148, P5977, DOI 10.1210/en.2007-0442; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; RICHNER H, 1995, P NATL ACAD SCI USA, V92, P1192, DOI 10.1073/pnas.92.4.1192; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Saino N, 2000, OECOLOGIA, V124, P358, DOI 10.1007/s004420000395; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Speakman JR, 2005, J COMP PHYSIOL B, V175, P375, DOI 10.1007/s00360-005-0013-3; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Stearns S.C., 1992, pi; Stocker CJ, 2007, AM J PHYSIOL-REG I, V292, pR1810, DOI 10.1152/ajpregu.00676.2006; THOMPSON SD, 1986, NATURE, V321, P690, DOI 10.1038/321690a0; TUOMI J, 1983, AM ZOOL, V23, P25; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P1271, DOI 10.1098/rspb.2001.1661; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wu SH, 2009, J EXP BIOL, V212, P3455, DOI 10.1242/jeb.030338; Yu-Lee LY, 2002, RECENT PROG HORM RES, V57, P435, DOI 10.1210/rp.57.1.435; Zhang XY, 2008, J COMP PHYSIOL B, V178, P637, DOI 10.1007/s00360-008-0255-y; Zhang XY, 2007, J EXP BIOL, V210, P512, DOI 10.1242/jeb.02659; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zysling DA, 2007, J COMP PHYSIOL B, V177, P339, DOI 10.1007/s00360-006-0133-4	77	102	112	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37182	10.1371/journal.pone.0037182	http://dx.doi.org/10.1371/journal.pone.0037182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649512	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800030
J	Chuang, YC; Su, WH; Lei, HY; Lin, YS; Liu, HS; Chang, CP; Yeh, TM				Chuang, Yung-Chun; Su, Wen-Hong; Lei, Huan-Yao; Lin, Yee-Shin; Liu, Hsiao-Sheng; Chang, Chih-Peng; Yeh, Trai-Ming			Macrophage Migration Inhibitory Factor Induces Autophagy via Reactive Oxygen Species Generation	PLOS ONE			English	Article							REGULATES AUTOPHAGY; OXIDATIVE STRESS; CANCER; INFLAMMATION; ACTIVATION; IMMUNITY; HMGB1; MIF; TUMORIGENESIS; MECHANISMS	Autophagy is an evolutionarily conserved catabolic process that maintains cellular homeostasis under stress conditions such as starvation and pathogen infection. Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that plays important roles in inflammation and tumorigenesis. Cytokines such as IL-1 beta and TNF-alpha that are induced by MIF have been shown to be involved in the induction of autophagy. However, the actual role of MIF in autophagy remains unclear. Here, we have demonstrated that incubation of human hepatoma cell line HuH-7 cells with recombinant MIF (rMIF) induced reactive oxygen species (ROS) production and autophagy formation, including LC3-II expression, LC3 punctae formation, autophagic flux, and mitochondria membrane potential loss. The autophagy induced by rMIF was inhibited in the presence of MIF inhibitor, ISO-1 as well as ROS scavenger N-acetyl-L-cysteine (NAC). In addition, serum starvation-induced MIF release and autophagy of HuH-7 cells were partly blocked in the presence of NAC. Moreover, diminished MIF expression by shRNA transfection or inhibition of MIF by ISO-1 decreased serum starvation-induced autophagy of HuH-7 cells. Taken together, these data suggest that cell autophagy was induced by MIF under stress conditions such as inflammation and starvation through ROS generation.	[Chuang, Yung-Chun] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chuang, Yung-Chun; Su, Wen-Hong; Lei, Huan-Yao; Lin, Yee-Shin; Liu, Hsiao-Sheng; Chang, Chih-Peng; Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Res Ctr Infect Dis & Signaling, Tainan 70101, Taiwan; [Lei, Huan-Yao; Lin, Yee-Shin; Liu, Hsiao-Sheng; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chuang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	today@mail.ncku.edu.tw	Chuang, Yung-Chun/J-9075-2014; Yeh, Trai-Ming/C-7193-2011	Yeh, Trai-Ming/0000-0003-3172-7432; Liu, Hsiao-Sheng/0000-0003-0576-7203; Chang, Chih-Peng/0000-0002-0061-3478	National Science Council grants in Taiwan [NSC99-2321-B-006-008, NSC99-2320-B-006-017-MY3]; Center of Infectious Disease and Signaling Research in National Cheng Kung University, Tainan, Taiwan; optic-image core lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital	National Science Council grants in Taiwan; Center of Infectious Disease and Signaling Research in National Cheng Kung University, Tainan, Taiwan; optic-image core lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital	This study was supported by National Science Council grants in Taiwan (NSC99-2321-B-006-008, NSC99-2320-B-006-017-MY3) and Center of Infectious Disease and Signaling Research in National Cheng Kung University, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support from the optic-image core lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital. This article is dedicated to Prof. H.Y. Lei who passed away during the preparation of the manuscript.	Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Bucala R, 2005, DRUG NEWS PERSPECT, V18, P417, DOI 10.1358/dnp.2005.18.7.939345; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; Eskelinen EL, 2008, INT REV CEL MOL BIO, V266, P207, DOI 10.1016/S1937-6448(07)66005-5; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Kafri T, 1999, J VIROL, V73, P576, DOI 10.1128/JVI.73.1.576-584.1999; Kang R, 2011, AUTOPHAGY, V7, P904, DOI 10.4161/auto.7.8.15704; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428	37	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37613	10.1371/journal.pone.0037613	http://dx.doi.org/10.1371/journal.pone.0037613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629429	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300060
J	Long, YH; Liu, HH; Yu, CH; Tian, X; Yang, YR; Wang, C; Pan, YJ				Long, Yanhua; Liu, Hui-Hui; Yu, Changhong; Tian, Xia; Yang, Yi-Ran; Wang, Cheng; Pan, Yajuan			Pre-Existing Diseases of Patients Increase Susceptibility to Hypoxemia during Gastrointestinal Endoscopy	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; VASCULAR FUNCTION; RISK-FACTORS; HYPOXIA; CONSISTENCY; OXYGEN; SEDATION; COMPLICATIONS; TACHYCARDIA; PROPOFOL	Hypoxemia is the most common adverse event that happened during gastrointestinal endoscopy. To estimate risk of hypoxemia prior to endoscopy, American Society of Anesthesiology (ASA) classification scores were used as a major predictive factor. But the accuracy of ASA scores for predicting hypoxemia incidence was doubted here, considering that the classification system ignores much information about general health status and fitness of patient that may contribute to hypoxemia. In this retrospective review of clinical data collected prospectively, the data on 4904 procedures were analyzed. The Pearson's chi-square test or the Fisher exact test was employed to analyze variance of categorical factors. Continuous variables were statistically evaluated using t-tests or Analysis of variance (ANOVA). As a result, only 245 (5.0%) of the enrolled 4904 patients were found to present hypoxemia during endoscopy. Multivariable logistic regressions revealed that independent risk factors for hypoxemia include high BMI (BMI 30 versus 20, Odd ratio: 1.52, 95% CI: 1.13-2.05; P = 0.0098), hypertension (Odd ratio: 2.28, 95% CI: 1.44-3.60; P = 0.0004), diabetes (Odd ratio: 2.37, 95% CI: 1.30-4.34; P = 0.005), gastrointestinal diseases (Odd ratio: 1.77, 95% CI: 1.21-2.60; P = 0.0033), heart diseases (Odd ratio: 1.97, 95% CI: 1.06-3.68; P = 0.0325) and the procedures that combined esophagogastroduodenoscopy (EGD) and colonoscopy (Odd ratio: 4.84, 95% CI: 1.61-15.51; P = 0.0292; EGD as reference). It is noteworthy that ASA classification scores were not included as an independent predictive factor, and susceptibility of youth to hypoxemia during endoscopy was as high as old subjects. In conclusion, some certain pre-existing diseases of patients were newly identified as independent risk factors for hypoxemia during GI endoscopy. High ASA scores are a confounding predictive factor of pre-existing diseases. We thus recommend that youth (<= 18 yrs), obese patients and those patients with hypertension, diabetes, heart diseases, or GI diseases should be monitored closely during sedation endoscopy.	[Long, Yanhua; Liu, Hui-Hui; Tian, Xia; Yang, Yi-Ran; Wang, Cheng; Pan, Yajuan] Wuhan Univ, Tong Ren Hosp, Hosp Wuhan 3, Dept Gastroenterol, Wuhan 430072, Hubei, Peoples R China; [Liu, Hui-Hui; Yang, Yi-Ran] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA	Wuhan University; Cleveland Clinic Foundation	Long, YH (corresponding author), Wuhan Univ, Tong Ren Hosp, Hosp Wuhan 3, Dept Gastroenterol, Wuhan 430072, Hubei, Peoples R China.	liuhhchris@gmail.com	LIU, HUI-HUI/F-8584-2012					Bernard Philip A, 2009, Int J Adolesc Med Health, V21, P213, DOI 10.1515/IJAMH.2009.21.2.213; BLOCK R, 1993, ENDOSCOPY, V25, P269, DOI 10.1055/s-2007-1010312; Christe C, 2000, J AM GERIATR SOC, V48, P1398, DOI 10.1111/j.1532-5415.2000.tb02628.x; DHARIWAL A, 1992, GASTROINTEST ENDOSC, V38, P684, DOI 10.1016/S0016-5107(92)70564-1; Eisen GM, 2000, GASTROINTEST ENDOSC, V51, pAB76, DOI 10.1016/S0016-5107(00)14079-9; Fisher L, 2006, GASTROINTEST ENDOSC, V63, P948, DOI 10.1016/j.gie.2005.09.020; Foster GE, 2007, EXP PHYSIOL, V92, P51, DOI 10.1113/expphysiol.2006.035204; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GRIFFIN SM, 1990, BRIT MED J, V300, P83, DOI 10.1136/bmj.300.6717.83; HARLING DW, 1995, ANAESTHESIA, V50, P659; HAYNES SR, 1995, ANAESTHESIA, V50, P195, DOI 10.1111/j.1365-2044.1995.tb04554.x; Holm C, 1998, SCAND J GASTROENTERO, V33, P769; IBER FL, 1993, GASTROINTEST ENDOSC, V39, P620, DOI 10.1016/S0016-5107(93)70211-4; Johnston SD, 2003, ENDOSCOPY, V35, P1039, DOI 10.1055/s-2003-44597; Lecube A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004692; LITTLE JP, 1995, ANAESTHESIA, V50, P658; Müller Suzana, 2004, Arq. Gastroenterol., V41, P162, DOI 10.1590/S0004-28032004000300005; Murthy Tvsp, 2009, Med J Armed Forces India, V65, P161, DOI 10.1016/S0377-1237(09)80133-0; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1016/S1542-3565(05)00742-1; Qadeer MA, 2011, DIGESTION, V84, P37, DOI 10.1159/000321621; Qadeer MA, 2009, DIGEST DIS SCI, V54, P1035, DOI 10.1007/s10620-008-0452-2; ROSTYKUS PS, 1980, GASTROENTEROLOGY, V78, P488; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; Steele Russell J, 2010, Stat Methodol, V7, P351; Thomas BJ, 2003, EUR J PHARMACOL, V477, P153, DOI 10.1016/j.ejphar.2003.08.015; Uday J, 1987, RESISTANCES REVOLUTI, P15; Vargo JJ, 2006, ALIMENT PHARM THER, V24, P955, DOI 10.1111/j.1365-2036.2006.03099.x; Vargo John, 2011, Gastroenterol Hepatol (N Y), V7, P189; Vargo JJ, 2010, CURR OPIN GASTROEN, V26, P421, DOI 10.1097/MOG.0b013e32833d1786; WOODS SDS, 1989, GASTROINTEST ENDOSC, V35, P523, DOI 10.1016/S0016-5107(89)72903-5	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37614	10.1371/journal.pone.0037614	http://dx.doi.org/10.1371/journal.pone.0037614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629430	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300061
J	Pincham, HL; Szucs, D				Pincham, Hannah L.; Szucs, Denes			Target Cueing Provides Support for Target- and Resource-Based Models of the Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; DIRECT PARAMETER SPECIFICATION; EVENT-RELATED POTENTIALS; TIME-COURSE; DEPLETION ACCOUNTS; TEMPORAL ATTENTION; WORKING-MEMORY; PERCEPTION; STIMULUS; MASKING	The attentional blink (AB) describes a time-based deficit in processing the second of two masked targets. The AB is attenuated if successive targets appear between the first and final target, or if a cueing target is positioned before the final target. Using various speeds of stimulus presentation, the current study employed successive targets and cueing targets to confirm and extend an understanding of target-target cueing in the AB. In Experiment 1, three targets were presented sequentially at rates of 30 msec/item or 90 msec/item. Successive targets presented at 90 msec improved performance compared with non-successive targets. However, accuracy was equivalently high for successive and non-successive targets presented at 30 msec/item, suggesting that-regardless of whether they occurred consecutively-those items fell within the temporally defined attentional window initiated by the first target. Using four different presentation speeds, Experiment 2 confirmed the time-based definition of the AB and the success of target-cueing at 30 msec/item. This experiment additionally revealed that cueing was most effective when resources were not devoted to the cue, thereby implicating capacity limitations in the AB. Across both experiments, a novel order-error measure suggested that errors tend to decrease with an increasing duration between the targets, but also revealed that certain stimulus conditions result in stable order accuracy. Overall, the results are best encapsulated by target-based and resource-sharing theories of the AB, which collectively value the contributions of capacity limitations and optimizing transient attention in time.	[Pincham, Hannah L.; Szucs, Denes] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Pincham, HL (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	hlp31@cam.ac.uk; ds377@cam.ac.uk		Szucs, Denes/0000-0002-9477-0801	Gates Cambridge Trust studentship; Medical Research Council [G0900643] Funding Source: researchfish; MRC [G0900643] Funding Source: UKRI	Gates Cambridge Trust studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a Gates Cambridge Trust studentship to HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2007, PSYCHOPHYSIOLOGY, V44, P383, DOI 10.1111/j.1469-8986.2007.00513.x; Bachmann T, 2005, PSYCHOL SCI, V16, P740, DOI 10.1111/j.1467-9280.2005.01604.x; BACHMANN T, 1988, VISION RES, V28, P1255, DOI 10.1016/0042-6989(88)90041-7; Bachmann T., 1999, COGNITIVE CONTRIBUTI, V129, P173; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Craston P, 2009, J COGNITIVE NEUROSCI, V21, P550, DOI 10.1162/jocn.2009.21036; Davenport JL, 2005, MEM COGNITION, V33, P241, DOI 10.3758/BF03195313; Dell'Acqua R, 2012, PSYCHON B REV, V19, P232, DOI 10.3758/s13423-011-0209-3; Dell'Acqua R, 2003, PSYCHOPHYSIOLOGY, V40, P629, DOI 10.1111/1469-8986.00064; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Harris IM, 2010, J EXP PSYCHOL HUMAN, V36, P1595, DOI 10.1037/a0019218; Hilkenmeier F, 2010, EUR J COGN PSYCHOL, V22, P1222, DOI 10.1080/09541440903418924; Hommel B, 2005, Q J EXP PSYCHOL-A, V58, P1415, DOI 10.1080/02724980443000647; Kawahara JI, 2006, PSYCHON B REV, V13, P886, DOI 10.3758/BF03194014; KLOTZ W, 1995, PSYCHOL RES-PSYCH FO, V58, P92, DOI 10.1007/BF00571098; Klotz W, 1999, J EXP PSYCHOL HUMAN, V25, P976, DOI 10.1037/0096-1523.25.4.976; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Livesey EJ, 2011, ATTEN PERCEPT PSYCHO, V73, P2104, DOI 10.3758/s13414-011-0177-8; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; NEUMANN O, 1994, ATTENTION PERFORM, V15, P123; Nieuwenhuis S, 2005, J EXP PSYCHOL GEN, V134, P291, DOI 10.1037/0096-3445.134.3.291; Nieuwenstein M, 2009, J VISION, V9, DOI 10.1167/9.9.18; Nieuwenstein MR, 2006, J EXP PSYCHOL HUMAN, V32, P973, DOI 10.1037/0096-1523.32.4.973; Nieuwenstein MR, 2006, PSYCHOL SCI, V17, P471, DOI 10.1111/j.1467-9280.2006.01730.x; Nieuwenstein MR, 2009, J EXP PSYCHOL HUMAN, V35, P159, DOI 10.1037/0096-1523.35.1.159; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2011, ATTEN PERCEPT PSYCHO, V73, P53, DOI 10.3758/s13414-010-0004-7; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Pincham HL, 2012, CEREB CORTEX, V22, P2346, DOI 10.1093/cercor/bhr314; Popple AV, 2007, VISION RES, V47, P2973, DOI 10.1016/j.visres.2007.06.022; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; Potter MC, 2005, PSYCHON B REV, V12, P460, DOI 10.3758/BF03193788; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Potter MC, 2005, COMPETITION ATTENTIO, P207; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Scharlau I, 2003, VISION RES, V43, P1351, DOI 10.1016/S0042-6989(03)00141-X; Spalek TM, 2012, J EXP PSYCHOL HUMAN, V38, P402, DOI 10.1037/a0025050; Spalek TM, 2006, PERCEPTION PSYCHOPHY, P68; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Visser TAW, 1999, PSYCHON B REV, V6, P432, DOI 10.3758/BF03210831; Visser TAW, 2011, J EXP PSYCHOL HUMAN, V37, P1527, DOI 10.1037/a0023508; Wyble B, 2011, J EXP PSYCHOL GEN, V140, P488, DOI 10.1037/a0023612; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P324, DOI 10.1037/a0013903	55	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37596	10.1371/journal.pone.0037596	http://dx.doi.org/10.1371/journal.pone.0037596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629426	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300057
J	Esteves, CL; Kelly, V; Begay, V; Man, TY; Morton, NM; Leutz, A; Seckl, JR; Chapman, KE				Esteves, Cristina L.; Kelly, Val; Begay, Valerie; Man, Tak Y.; Morton, Nicholas M.; Leutz, Achim; Seckl, Jonathan R.; Chapman, Karen E.			Regulation of Adipocyte 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD1) by CCAAT/Enhancer-Binding Protein (C/EBP) beta Isoforms, LIP and LAP	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTIONAL INHIBITORY PROTEIN; ADIPOSE-TISSUE; GENE-TRANSCRIPTION; METABOLIC SYNDROME; GLUCOSE-PRODUCTION; VISCERAL OBESITY; MICE; EXPRESSION; ALPHA	11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) catalyses intracellular regeneration of active glucocorticoids, notably in liver and adipose tissue. 11 beta-HSD1 is increased selectively in adipose tissue in human obesity, a change implicated in the pathogenesis of metabolic syndrome. With high fat (HF)-feeding, adipose tissue 11 beta-HSD1 is down-regulated in mice, plausibly to counteract metabolic disease. Transcription of 11 beta-HSD1 is directly regulated by members of the CCAAT/enhancer binding protein (C/EBP) family. Here we show that while total C/EBP beta in adipose tissue is unaltered by HF diet, the ratio of the C/EBP beta isoforms liver-enriched inhibitor protein (LIP) and liver-enriched activator protein (LAP) (C/EBP beta-LIP:LAP) is increased in subcutaneous adipose. This may cause changes in 11 beta-HSD1 expression since genetically modified C/EBP beta((+/L)) mice, with increased C/EBP beta-LIP:LAP ratio, have decreased subcutaneous adipose 11 beta-HSD1 mRNA levels, whereas C/EBP beta(Delta uORF) mice, with decreased C/EBP beta-LIP:LAP ratio, show increased subcutaneous adipose 11 beta-HSD1. C/EBP beta-LIP:LAP ratio is regulated by endoplasmic reticulum (ER) stress and mTOR signalling, both of which are altered in obesity. In 3T3-L1 adipocytes, 11 beta-HSD1 mRNA levels were down-regulated following induction of ER stress by tunicamycin but were up-regulated following inhibition of mTOR by rapamycin. These data point to a central role for C/EBP beta and its processing to LIP and LAP in transcriptional regulation of 11 beta-HSD1 in adipose tissue. Down-regulation of 11 beta-HSD1 by increased C/EBP beta-LIP:LAP in adipocytes may be part of a nutrient-sensing mechanism counteracting nutritional stress generated by HF diet.	[Esteves, Cristina L.; Kelly, Val; Man, Tak Y.; Seckl, Jonathan R.; Chapman, Karen E.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Morton, Nicholas M.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Mol Metab Grp, Edinburgh, Midlothian, Scotland; [Begay, Valerie; Leutz, Achim] Max Delbrueck Ctr Mol Med, Berlin, Germany	University of Edinburgh; University of Edinburgh; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Esteves, CL (corresponding author), Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland.	Karen.Chapman@ed.ac.uk	Seckl, Jonathan R/C-3555-2013; Esteves, Cristina/Y-5577-2019; Morton, NICHOLAS/ABF-3774-2020; Leutz, Achim/K-9643-2013	Leutz, Achim/0000-0001-8259-927X; Chapman, Karen/0000-0001-7777-6817	Wellcome Trust Programme Grant [WT083184]; Wellcome Trust Career Development Fellowship [079660/z/06/z]	Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust Career Development Fellowship(Wellcome Trust)	This work was supported by a Wellcome Trust Programme Grant (grant number WT083184 to JRS and KEC). NMM was funded by a Wellcome Trust Career Development Fellowship (grant 079660/z/06/z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai N, 2007, ENDOCRINOLOGY, V148, P5268, DOI 10.1210/en.2007-0349; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Cucinotta M, 2008, J BIOL CHEM, V283, P29760, DOI 10.1074/jbc.M803145200; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Gout J, 2006, BIOCHIMIE, V88, P1115, DOI 10.1016/j.biochi.2006.05.020; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Man TY, 2011, AM J PHYSIOL-ENDOC M, V300, pE1076, DOI 10.1152/ajpendo.00531.2010; Masaki T, 2006, BIOCHEM J, V397, P345, DOI 10.1042/BJ20051863; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Wake DJ, 2003, J CLIN ENDOCR METAB, V88, P3983, DOI 10.1210/jc.2003-030286; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Wethmar K, GENES DEV, V24, P15; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Yang Z, 2009, ENDOCRINE, V36, P404, DOI 10.1007/s12020-009-9245-4	44	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37953	10.1371/journal.pone.0037953	http://dx.doi.org/10.1371/journal.pone.0037953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662254	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305342300145
J	Lee, CH; Lee, MC; Lin, HH; Shu, CC; Wang, JY; Lee, LN; Chao, KM				Lee, Chih-Hsin; Lee, Ming-Chia; Lin, Hsien-Ho; Shu, Chin-Chung; Wang, Jann-Yuan; Lee, Li-Na; Chao, Kun-Mao			Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							IMPAIRMENT; PREDICTORS; DIAGNOSIS; BURDEN; COPD	Objective: Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide. It has been suggested as an important risk factor of chronic obstructive pulmonary disease (COPD), which is also a major cause of morbidity and mortality. This study investigated the impact of pulmonary TB and anti-TB treatment on the risk of developing COPD. Design, Setting, and Participants: This cohort study used the National Health Insurance Database of Taiwan, particularly the Longitudinal Health Insurance Database 2005 to obtain 3,176 pulmonary TB cases and 15,880 control subjects matched in age, sex, and timing of entering the database. Main Outcome Measures: Hazard ratios of potential risk factors of COPD, especially pulmonary TB and anti-TB treatment. Results: The mean age of pulmonary TB cases was 51.9 +/- 19.2. The interval between the initial study date and commencement of anti-TB treatment (delay in anti-TB treatment) was 75.8 +/- 65.4 days. Independent risk factors for developing COPD were age, male, low income, and history of pulmonary TB (hazard ratio 2.054 [1.768-2.387]), while diabetes mellitus was protective. The impact of TB persisted for six years after TB diagnosis and was significant in women and subjects aged >70 years. Among TB patients, delay in anti-TB treatment had a dose-response relationship with the risk of developing COPD. Conclusions: Some cases of COPD may be preventable by controlling the TB epidemic, early TB diagnosis, and prompt initiation of appropriate anti-TB treatment. Follow-up care and early intervention for COPD may be necessary for treated TB patients.	[Lee, Chih-Hsin; Chao, Kun-Mao] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lee, Chih-Hsin] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, New Taipei, Taiwan; [Lee, Chih-Hsin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ming-Chia] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Pharm, New Taipei, Taiwan; [Lin, Hsien-Ho] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Shu, Chin-Chung] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Shu, Chin-Chung; Wang, Jann-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CH (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	jywang@ntu.edu.tw	Lee, Ming-Chia/W-5350-2019; Lee, Ming-Chia/ABB-8800-2021; Lee, Chih-Hsin/D-2697-2014	Lee, Ming-Chia/0000-0002-6209-2313; SHU, CHIN-CHUNG/0000-0003-0311-5148; CHAO, KUN-MA0/0000-0003-2837-1279; WANG, JANN-YUAN/0000-0003-3406-366X; LIN, HSIEN-HO/0000-0002-7481-6016; LEE, LI-NA/0000-0002-7654-2450; Lee, Chih-Hsin/0000-0003-1492-3044	National Science Council, Taiwan [NSC 99-2314-B-002-088-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (grant NSC 99-2314-B-002-088-MY2; http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Blanc L, 2010, GLOBAL TUBERCULOSIS; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Garrigo M, 2007, J CLIN MICROBIOL, V45, P1766, DOI 10.1128/JCM.02162-06; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Grzybowski S, 1987, Tubercle, V68, P33; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Luh K-T, 2011, TAIWAN GUIDELINES TB; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pirkis JE, 1996, TUBERCLE LUNG DIS, V77, P401, DOI 10.1016/S0962-8479(96)90111-2; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Tan WC, 2003, RESPIROLOGY, V8, P192; Theakston F, 2008, WORLD HLTH STAT	29	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37978	10.1371/journal.pone.0037978	http://dx.doi.org/10.1371/journal.pone.0037978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662259	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300151
J	Liang, CY; Sun, LL; Yao, ZF; Liao, H; Tian, J				Liang, Cuiyue; Sun, Lili; Yao, Zhufang; Liao, Hong; Tian, Jiang			Comparative Analysis of PvPAP Gene Family and Their Functions in Response to Phosphorus Deficiency in Common Bean	PLOS ONE			English	Article							PURPLE ACID-PHOSPHATASE; ARABIDOPSIS-THALIANA; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; PHASEOLUS-VULGARIS; PHYTASE ACTIVITY; ACQUISITION; STARVATION; EFFICIENCY; IDENTIFICATION	Background: Purple acid phosphatases (PAPs) play a vital role in adaptive strategies of plants to phosphorus (P) deficiency. However, their functions in relation to P efficiency are fragmentary in common bean. Principal Findings: Five PvPAPs were isolated and sequenced in common bean. Phylogenetic analysis showed that PvPAPs could be classified into two groups, including a small group with low molecular mass, and a large group with high molecular mass. Among them, PvPAP3, PvPAP4 and PvPAP5 belong to the small group, while the other two belong to the large group. Transient expression of 35S:PvPAPs-GFP on onion epidermal cells verified the variations of subcellular localization among PvPAPs, suggesting functional diversities of PvPAPs in common bean. Quantitative PCR results showed that most PvPAPs were up-regulated by phosphate (Pi) starvation. Among them, the expression of the small group PvPAPs responded more to Pi starvation, especially in the roots of G19833, the P-efficient genotype. However, only overexpressing PvPAP1 and PvPAP3 could result in significantly increased utilization of extracellular dNTPs in the transgenic bean hairy roots. Furthermore, overexpressing PvPAP3 in Arabidopsis enhanced both plant growth and total P content when dNTPs were supplied as the sole external P source. Conclusions: The results suggest that PvPAPs in bean varied in protein structure, response to P deficiency and subcellular localization. Among them, both PvPAP1 and PvPAP3 might function as utilization of extracellular dNTPs.	[Liang, Cuiyue; Sun, Lili; Yao, Zhufang; Liao, Hong; Tian, Jiang] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China; [Liang, Cuiyue] Cornell Univ, Robert Holley Ctr Agr & Hlth, USDA, Agr Res Serv, Ithaca, NY USA; [Sun, Lili] Chinese Acad Trop Agr Sci, Inst Trop Crop Genet Resources, Danzhou, Peoples R China	South China Agricultural University; Cornell University; United States Department of Agriculture (USDA); Chinese Academy of Tropical Agricultural Sciences	Liang, CY (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China.	jtian@scau.edu.cn			National Natural Science Foundation of China [31101593, 30890131]; National Key Basic Research Special Funds of China [2011CB100301]; Ph.D. Programs Foundation of Ministry of Education of China [20094404120022]; project of science and technology new star in Zhujiang Guangzhou city	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Special Funds of China(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); project of science and technology new star in Zhujiang Guangzhou city	This study was in part supported by National Natural Science Foundation of China (No. 31101593 and 30890131), National Key Basic Research Special Funds of China (2011CB100301), Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20094404120022) and the project of science and technology new star in Zhujiang Guangzhou city. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat DL, 2010, SOIL BIOL BIOCHEM, V42, P2231, DOI 10.1016/j.soilbio.2010.08.023; BECK JL, 1986, BIOCHIM BIOPHYS ACTA, V869, P61, DOI 10.1016/0167-4838(86)90310-9; Bozzo GG, 2002, EUR J BIOCHEM, V269, P6278, DOI 10.1046/j.1432-1033.2002.03347.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buenemann EK, 2008, SOIL BIOL BIOCHEM, V40, P1908, DOI 10.1016/j.soilbio.2008.03.017; Cashikar AG, 1997, PLANT PHYSIOL, V114, P907, DOI 10.1104/pp.114.3.907; Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11&lt;1754::AID-ELPS1754&gt;3.0.CO;2-E; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Fan MS, 2003, FUNCT PLANT BIOL, V30, P493, DOI 10.1071/FP03046; George Timothy S., 2008, V7, P247; Graham MA, 2006, FUNCT PLANT BIOL, V33, P789, DOI 10.1071/FP06101; Hegeman CE, 2001, PLANT PHYSIOL, V126, P1598, DOI 10.1104/pp.126.4.1598; Hurley BA, 2010, PLANT PHYSIOL, V153, P1112, DOI 10.1104/pp.110.153270; Kaida R, 2008, PHYTOCHEMISTRY, V69, P2546, DOI 10.1016/j.phytochem.2008.07.008; Kuang RB, 2009, PLANT PHYSIOL, V151, P199, DOI 10.1104/pp.109.143180; Li CC, 2012, ANN BOT-LONDON, V109, P275, DOI 10.1093/aob/mcr246; Li DP, 2002, J BIOL CHEM, V277, P27772, DOI 10.1074/jbc.M204183200; Li WYF, 2008, NEW PHYTOL, V178, P80, DOI 10.1111/j.1469-8137.2007.02356.x; Liang CY, 2010, PLANT PHYSIOL, V152, P854, DOI 10.1104/pp.109.147918; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Ligaba A, 2004, FUNCT PLANT BIOL, V31, P1075, DOI 10.1071/FP04091; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Olczak M, 1997, BBA-PROTEIN STRUCT M, V1341, P14, DOI 10.1016/S0167-4838(97)00055-1; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Schenk G, 1999, ARCH BIOCHEM BIOPHYS, V370, P183, DOI 10.1006/abbi.1999.1407; Schenk G, 2000, GENE, V250, P117, DOI 10.1016/S0378-1119(00)00186-4; Shen H, 2002, ENVIRON EXP BOT, V48, P1, DOI 10.1016/S0098-8472(02)00009-6; Tian J, 2007, PLANTA, V227, P151, DOI 10.1007/s00425-007-0603-2; Tran HT, 2010, PLANT SCI, V179, P14, DOI 10.1016/j.plantsci.2010.04.005; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Veljanovski V, 2006, PLANT PHYSIOL, V142, P1282, DOI 10.1104/pp.106.087171; Wang XR, 2009, PLANT PHYSIOL, V151, P233, DOI 10.1104/pp.109.138891; Xiao K, 2006, PLANT SCI, V170, P191, DOI 10.1016/j.plantsci.2005.08.001; YAN XL, 1995, CROP SCI, V35, P1094, DOI 10.2135/cropsci1995.0011183X003500040029x; Yan XL, 2001, PLANT PHYSIOL, V125, P1901, DOI 10.1104/pp.125.4.1901; Yoneyama T, 2004, J BIOL CHEM, V279, P37477, DOI 10.1074/jbc.M405305200; Zhang SC, 2009, PLANT MOL BIOL, V69, P745, DOI 10.1007/s11103-009-9452-7; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zimmermann R, 2004, PLANT BIOLOGY, V6, P519, DOI 10.1055/s-2004-821091	44	23	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38106	10.1371/journal.pone.0038106	http://dx.doi.org/10.1371/journal.pone.0038106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662274	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300166
J	Verriere, V; Higgins, G; Al-Alawi, M; Costello, RW; McNally, P; Chiron, R; Harvey, BJ; Urbach, V				Verriere, Valia; Higgins, Gerard; Al-Alawi, Mazen; Costello, Richard W.; McNally, Paul; Chiron, Raphael; Harvey, Brian J.; Urbach, Valerie			Lipoxin A(4) Stimulates Calcium-Activated Chloride Currents and Increases Airway Surface Liquid Height in Normal and Cystic Fibrosis Airway Epithelia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN BRONCHIAL EPITHELIUM; ION-TRANSPORT; CA2+; CELLS; SECRETION; RESPONSES; VOLUME	Cystic Fibrosis (CF) is a genetic disease characterised by a deficit in epithelial Cl- secretion which in the lung leads to airway dehydration and a reduced Airway Surface Liquid (ASL) height. The endogenous lipoxin LXA(4) is a member of the newly identified eicosanoids playing a key role in ending the inflammatory process. Levels of LXA(4) are reported to be decreased in the airways of patients with CF. We have previously shown that in normal human bronchial epithelial cells, LXA(4) produced a rapid and transient increase in intracellular Ca2+. We have investigated, the effect of LXA(4) on Cl- secretion and the functional consequences on ASL generation in bronchial epithelial cells obtained from CF and non-CF patient biopsies and in bronchial epithelial cell lines. We found that LXA(4) stimulated a rapid intracellular Ca2+ increase in all of the different CF bronchial epithelial cells tested. In non-CF and CF bronchial epithelia, LXA(4) stimulated whole-cell Cl- currents which were inhibited by NPPB (calcium-activated Cl- channel inhibitor), BAPTA-AM (chelator of intracellular Ca2+) but not by CFTRinh-172 (CFTR inhibitor). We found, using confocal imaging, that LXA(4) increased the ASL height in non-CF and in CF airway bronchial epithelia. The LXA(4) effect on ASL height was sensitive to bumetanide, an inhibitor of transepithelial Cl- secretion. The LXA(4) stimulation of intracellular Ca2+, whole-cell Cl- currents, conductances and ASL height were inhibited by Boc-2, a specific antagonist of the ALX/FPR2 receptor. Our results provide, for the first time, evidence for a novel role of LXA(4) in the stimulation of intracellular Ca2+ signalling leading to Ca2+-activated Cl- secretion and enhanced ASL height in non-CF and CF bronchial epithelia.	[Verriere, Valia; Higgins, Gerard; Al-Alawi, Mazen; Harvey, Brian J.; Urbach, Valerie] Beaumont Hosp, Dept Mol Med, RCSI Educ & Res Ctr, Dublin 9, Ireland; [Chiron, Raphael] CRCM, Montpellier, France; [Al-Alawi, Mazen; Costello, Richard W.] Beaumont Hosp, Dept Resp Med, Dublin 9, Ireland; [Higgins, Gerard; McNally, Paul; Urbach, Valerie] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland	Royal College of Surgeons - Ireland; Universite de Montpellier; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Verriere, V (corresponding author), Beaumont Hosp, Dept Mol Med, RCSI Educ & Res Ctr, Dublin 9, Ireland.	valerie.urbach@ncrc.ie	Urbach, Valerie/C-3615-2012; McNally, Paul/I-3151-2013; McNally, Paul/AAL-4407-2021; Harvey, Brian J/A-5120-2010; Harvey, Brian/AAJ-4085-2020	Urbach, Valerie/0000-0001-7437-9365; McNally, Paul/0000-0001-7102-1712; McNally, Paul/0000-0001-7102-1712; Harvey, Brian J/0000-0002-7388-8034; Harvey, Brian/0000-0002-7388-8034; Costello, Richard/0000-0003-1179-6692; Higgins, Gerard/0000-0001-6739-8138; Al-Alawi, Mazen/0000-0002-0926-3208	French National Institute of Health (INSERM); Centre Hospitalier Universitaire (CHU) of Montpellier; French Cystic Fibrosis Association (Vaincre La Mucoviscidose); Career Enhancement and Mobility Programme Marie Curie Fellowship; Higher Education Authority of Ireland under the Programme for Research in Third Level Institutions (PRTLI); National Biophotonics and Imaging Platform, Ireland	French National Institute of Health (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre Hospitalier Universitaire (CHU) of Montpellier; French Cystic Fibrosis Association (Vaincre La Mucoviscidose); Career Enhancement and Mobility Programme Marie Curie Fellowship; Higher Education Authority of Ireland under the Programme for Research in Third Level Institutions (PRTLI); National Biophotonics and Imaging Platform, Ireland	This work was funded by the French National Institute of Health (INSERM), the Centre Hospitalier Universitaire (CHU) of Montpellier, the French Cystic Fibrosis Association (Vaincre La Mucoviscidose), a Career Enhancement and Mobility Programme Marie Curie Fellowship, the Higher Education Authority of Ireland under the Programme for Research in Third Level Institutions (PRTLI) Cycle 4 and the National Biophotonics and Imaging Platform, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Boat T.F., 1989, ACTA PAEDIATR SC   S, V363, P29; BOAT TF, 1989, ACTA PAEDIATR SCAND, P25; Bonnans C, 2006, AM J PATHOL, V168, P1064, DOI 10.2353/ajpath.2006.051056; Bonnans C, 2003, J BIOL CHEM, V278, P10879, DOI 10.1074/jbc.M210294200; Bonnans C, 2007, BIOMED PHARMACOTHER, V61, P261, DOI 10.1016/j.biopha.2007.02.016; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P581, DOI 10.1164/ajrccm.150.2.8049852; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Grumbach Y, 2009, AM J PHYSIOL-LUNG C, V296, pL101, DOI 10.1152/ajplung.00018.2008; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Ribeiro Carla Maria Pedrosa, 2006, Drugs R D, V7, P17, DOI 10.2165/00126839-200607010-00002; Scheckenbach KEL, 2011, AM J RESP CELL MOL, V44, P74, DOI 10.1165/rcmb.2009-0361OC; Serhan CN, 1999, CLIN CHEM LAB MED, V37, P299, DOI 10.1515/CCLM.1999.052; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	27	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37746	10.1371/journal.pone.0037746	http://dx.doi.org/10.1371/journal.pone.0037746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662206	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300096
J	Walker, J; Tabrizi, SN; Fairley, CK; Chen, MY; Bradshaw, CS; Twin, J; Taylor, N; Donovan, B; Kaldor, JM; McNamee, K; Urban, E; Walker, S; Currie, M; Birden, H; Bowden, F; Gunn, J; Pirotta, M; Gurrin, L; Harindra, V; Garland, SM; Hocking, JS				Walker, Jennifer; Tabrizi, Sepehr N.; Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona S.; Twin, Jimmy; Taylor, Nicole; Donovan, Basil; Kaldor, John M.; McNamee, Kathleen; Urban, Eve; Walker, Sandra; Currie, Marian; Birden, Hudson; Bowden, Francis; Gunn, Jane; Pirotta, Marie; Gurrin, Lyle; Harindra, Veerakathy; Garland, Suzanne M.; Hocking, Jane S.			Chlamydia trachomatis Incidence and Re-Infection among Young Women - Behavioural and Microbiological Characteristics	PLOS ONE			English	Article							INCLUSION-FORMING UNITS; ANTIMICROBIAL RESISTANCE; INFECTION; SEROVAR; DISEASE; LOAD	Background: This study aimed to estimate rates of chlamydia incidence and re-infection and to investigate the dynamics of chlamydia organism load in prevalent, incident and re-infections among young Australian women. Methods: 1,116 women aged 16 to 25 years were recruited from primary care clinics in Australia. Vaginal swabs were collected at 3 to 6 month intervals for chlamydia testing. Chlamydia organism load was measured by quantitative PCR. Results: There were 47 incident cases of chlamydia diagnosed and 1,056.34 person years of follow up with a rate of 4.4 per 100 person years (95% CI: 3.3, 5.9). Incident infection was associated with being aged 16 to 20 years [RR = 3.7 (95% CI: 1.9, 7.1)], being employed [RR = 2.4 (95% CI: 1.1, 4.9)] and having two or more new sex partners [RR = 5.5 (95% CI: 2.6, 11.7)]. Recent antibiotic use was associated with a reduced incidence [RR: 0.1 (95% CI: 0.0, 0.5)]. There were 14 re-infections with a rate of 22.3 per 100 person years (95% CI: 13.2, 37.6). The median time to re-infection was 4.6 months. Organism load was higher for prevalent than incident infections (p<0.01) and for prevalent than re-infections (p<0.01). Conclusions: Chlamydia is common among young women and a high proportion of women are re-infected within a short period of time, highlighting the need for effective partner treatment and repeat testing. The difference in organism load between prevalent and incident infections suggests prevalent infection may be more important for ongoing transmission of chlamydia.	[Walker, Jennifer] Univ Melbourne, CERSH Melbourne Med Sch, Melbourne, Vic 3010, Australia; [Walker, Jennifer; Garland, Suzanne M.; Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Tabrizi, Sepehr N.; Twin, Jimmy; Taylor, Nicole] Royal Womens Hosp, Dept Mol Microbiol, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona S.; Urban, Eve] Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona S.; Walker, Sandra] Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic 3010, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Donovan, Basil; Kaldor, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Donovan, Basil; Kaldor, John M.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNamee, Kathleen] Family Planning Victoria, Melbourne, Vic, Australia; [McNamee, Kathleen] Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Currie, Marian; Bowden, Francis] Australian Natl Univ, Canberra, ACT, Australia; [Birden, Hudson] Univ Sydney, Sydney Sch Publ Hlth, Sydney Inst Emerging Infect Dis & Biosecur, Lismore, NSW, Australia; [Birden, Hudson] Univ Ctr Rural Hlth, Lismore, NSW, Australia; [Gunn, Jane; Pirotta, Marie] Univ Melbourne, Dept Gen Practice, Primary Care Res Unit, Melbourne, Vic 3010, Australia; [Gurrin, Lyle] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Harindra, Veerakathy; Garland, Suzanne M.] St Marys Hosp, Portsmouth PO3 6AQ, Hants, England; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Monash University; University of New South Wales Sydney; Kirby Institute; Monash University; Australian National University; University of Sydney; University of Melbourne; University of Melbourne; University of Melbourne	Walker, J (corresponding author), Univ Melbourne, CERSH Melbourne Med Sch, Melbourne, Vic 3010, Australia.	walker@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Kaldor, John M/D-4545-2011; Donovan, Basil J/K-1246-2012; Birden, Hudson H/Q-7151-2016	Hocking, Jane/0000-0001-9329-8501; Donovan, Basil J/0000-0001-8851-4126; Birden, Hudson H/0000-0001-5134-7408; McIntosh, Jennifer/0000-0002-6655-0940; Gunn, Jane/0000-0001-8836-7525; Christopher, Fairley/0000-0001-9081-1664; Gurrin, Lyle/0000-0001-7052-1969; bradshaw, catriona/0000-0002-6643-5678	Department of Health and Ageing, Commonwealth of Australia, as part of a National Chlamydia Pilot program; National Health and Research Council in Australia [509144]	Department of Health and Ageing, Commonwealth of Australia, as part of a National Chlamydia Pilot program; National Health and Research Council in Australia	Funding was provided by the Department of Health and Ageing, Commonwealth of Australia, as part of a National Chlamydia Pilot program and by the National Health and Research Council (research grant number 509144) in Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken IJ, 2007, SEX TRANSM DIS, V34, P739, DOI 10.1097/01.olq.0000261326.65503.f6; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Carlin JB, 1999, STAT MED, V18, P2655, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.0.CO;2-#; Chen MY, 2009, SEX TRANSM INFECT, V85, P31, DOI 10.1136/sti.2008.030700; Cohen CR, 2005, J INFECT DIS, V192, P591, DOI 10.1086/432070; Cotter TW, 1996, RES IMMUNOL, V147, P587, DOI 10.1016/S0923-2494(97)85226-1; Eckert LO, 2000, J INFECT DIS, V182, P540, DOI 10.1086/315738; Geisler WM, 2004, J INFECT DIS, V190, P1723, DOI 10.1086/425077; Geisler WM, 2001, J INFECT DIS, V184, P1350, DOI 10.1086/323998; Ginige Samitha, 2006, Sex Health, V3, P221, DOI 10.1071/SH06013; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Guy R, 2012, SEX TRANSM DIS, V39, P136, DOI 10.1097/OLQ.0b013e31823ed4ec; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Handsfield HH, 2011, SEX TRANSM DIS, V38; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Hillis SD, 1997, AM J OBSTET GYNECOL, V176, P103, DOI 10.1016/S0002-9378(97)80020-8; Hocking Jane S, 2006, Sex Health, V3, P235, DOI 10.1071/SH06033; Horner P, 2006, SEX TRANSM INFECT, V82, P340, DOI 10.1136/sti.2005.019158; Horner PJ, 2012, SEX TRANSM INFECT, V88, P154, DOI 10.1136/sextrans-2011-050385; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Jones RB, 1995, PRINCIPLES PRACTICE, P1676; Jurstrand M, 2010, SEX TRANSM INFECT, V86, P56, DOI 10.1136/sti.2009.037572; LaMontagne DS, 2007, SEX TRANSM INF, V83; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Ness RB, 2008, SEX TRANSM DIS, V35, P129, DOI 10.1097/OLQ.0b013e3181557c25; Oh MK, 1996, J ADOLESCENT HEALTH, V18, P270, DOI 10.1016/1054-139X(95)00232-H; PAAVONEN J, 1985, AM J OBSTET GYNECOL, V151, P645, DOI 10.1016/0002-9378(85)90156-5; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pol BVD, 2010, P 12 INT S HUM CHLAM, P393; Rogers SM, SEX TRANSM INF, V84, P23; Schachter J, 2008, SEXUALLY TRANSMITTED; Schiller JH, 2003, SEMIN ONCOL, V30, P49, DOI [10.1053/sonc.2003.50032, 10.1097/00007435-200301000-00011]; Sex Health Society of Victoria, 2008, NAT MAN GUID SEX TRA; Stata Corporation, 2009, STAT STAT SOFTW REL; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Stevens MP, 2004, J CLIN MICROBIOL, V42, P2501, DOI 10.1128/JCM.42.6.2501-2507.2004; Su H, 2000, INFECT IMMUN, V68, P192, DOI 10.1128/IAI.68.1.192-196.2000; van den Broek IVF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-39; Veldhuijzen IK, 2005, SEX TRANSM DIS, V32, P599, DOI 10.1097/01.olq.0000179887.01141.c3; Walker J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-156; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; Wang SA, 2005, J INFECT DIS, V191, P917, DOI 10.1086/428290; Xu FJ, 2000, AM J EPIDEMIOL, V152, P1164, DOI 10.1093/aje/152.12.1164	46	84	85	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37778	10.1371/journal.pone.0037778	http://dx.doi.org/10.1371/journal.pone.0037778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662220	Green Published, gold			2022-12-27	WOS:000305342300110
J	Zandevakili, P; Hu, M; Qin, ZH				Zandevakili, Pooya; Hu, Ming; Qin, Zhaohui			GPUmotif: An Ultra-Fast and Energy-Efficient Motif Analysis Program Using Graphics Processing Units	PLOS ONE			English	Article							FACTOR-BINDING SITES; CHIP-SEQ DATA; CHROMATIN-IMMUNOPRECIPITATION; STATISTICAL PHYLOGENETICS; SEQUENCE ALIGNMENT; GENOME; ALGORITHM; ASSOCIATION	Computational detection of TF binding patterns has become an indispensable tool in functional genomics research. With the rapid advance of new sequencing technologies, large amounts of protein-DNA interaction data have been produced. Analyzing this data can provide substantial insight into the mechanisms of transcriptional regulation. However, the massive amount of sequence data presents daunting challenges. In our previous work, we have developed a novel algorithm called Hybrid Motif Sampler (HMS) that enables more scalable and accurate motif analysis. Despite much improvement, HMS is still time-consuming due to the requirement to calculate matching probabilities position-by-position. Using the NVIDIA CUDA toolkit, we developed a graphics processing unit (GPU)-accelerated motif analysis program named GPUmotif. We proposed a "fragmentation'' technique to hide data transfer time between memories. Performance comparison studies showed that commonly-used model-based motif scan and de novo motif finding procedures such as HMS can be dramatically accelerated when running GPUmotif on NVIDIA graphics cards. As a result, energy consumption can also be greatly reduced when running motif analysis using GPUmotif. The GPUmotif program is freely available at http://sourceforge.net/projects/gpumotif/	[Zandevakili, Pooya] Univ Michigan, Dept Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Hu, Ming] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Qin, Zhaohui] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Qin, Zhaohui] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Qin, Zhaohui] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; Harvard University; Emory University; Emory University; Emory University	Zandevakili, P (corresponding author), Microsoft Corp, Redmond, WA 98052 USA.	zhaohui.qin@emory.edu	Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui/0000-0002-1583-146X; Hu, Ming/0000-0002-6062-8794	National Institutes of Health [R01HG005119]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work is supported by National Institutes of Health grant R01HG005119. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdahl G M, 1967, P APR 18 20 1967 SPR, V30, P483, DOI [DOI 10.1145/1465482.1465560, 10.1145/1465482]; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Buckner J, 2010, BIOINFORMATICS, V26, P134, DOI 10.1093/bioinformatics/btp608; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Chikkagoudar Satish, 2011, BMC Res Notes, V4, P158, DOI 10.1186/1756-0500-4-158; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lei GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S14; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Shterev ID, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-329; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	26	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36865	10.1371/journal.pone.0036865	http://dx.doi.org/10.1371/journal.pone.0036865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662128	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300019
J	Zhang, BB; Lou, WY; Chen, WJ; Zong, MH				Zhang, Bo-Bo; Lou, Wen-Yong; Chen, Wen-Jing; Zong, Min-Hua			Efficient Asymmetric Reduction of 4-(Trimethylsilyl)-3-Butyn-2-One by Candida parapsilosis Cells in an Ionic Liquid-Containing System	PLOS ONE			English	Article							CCTCC M203011 CELLS; ALCOHOL-DEHYDROGENASE; KETONES; BIOCATALYSIS; SOLVENTS; ACID; BIOTRANSFORMATIONS; ENANTIOSELECTIVITY; CONVERSION; ADDITIVES	Hydrophilic ionic liquids (ILs) were employed as green solvents to construct an IL-containing co-solvent system for improving the asymmetric reduction of 4-(trimethylsilyl)-3-butyn-2-one by immobilized Candida parapsilosis cells. Among 14 hydrophilic ILs examined, 1-(2'-hydroxyl)ethyl-3-methylimidazolium nitrate (C2OHMIM center dot NO3) was considered as the most suitable IL for the bioreduction with the fastest initial reaction rate, the highest yield and the highest product e. e., which may be due to the good biocompatibility with the cells. For a better understanding of the bioreduction performed in the C2OHMIM center dot NO3-containing co-solvent system, the effects of several crucial variables were systematically investigated. The optimal C2OHMIM center dot NO3 content, substrate concentration, buffer pH, co-substrate concentration and temperature were 10% (v/v), 3.0 mmol/L, 5.0, 98.1 mmol/L and 30 degrees C, respectively. Under the optimal conditions, the initial reaction rate, the maximum yield and the product e.e. were 17.3 mu mol/h g(cell), 95.2% and >99.9%, respectively, which are much better than the corresponding results previously reported. Moreover, the immobilized cells remained more than 83% of their initial activity even after being used repeatedly for 10 batches in the C2OHMIM center dot NO3-containing system, exhibiting excellent operational stability.	[Zhang, Bo-Bo; Lou, Wen-Yong; Chen, Wen-Jing] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Bo-Bo] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Zong, Min-Hua] S China Univ Technol, Lab Appl Biocatalysis, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Jiangnan University; South China University of Technology	Zhang, BB (corresponding author), S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China.	wylou@scut.edu.cn; btmhzong@scut.edu.cn	Lou, Wen-Yong/AAL-8087-2020; Zhang, Bo-Bo/L-7234-2013	Lou, Wen-Yong/0000-0003-3474-3446; Zhang, Bo-Bo/0000-0003-1295-1703	National Program on Key Basic Research Project '973' [2010CB732201]; National Natural Science Foundation of China [21072065]; Fundamental Research Funds for the Central Universities - SCUT [2011ZG0018]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201504]; New Century Excellent Talents in University [NCET-10-0367]; Ph.D. Programs Foundation of the Ministry of Education of China [20090172110019]	National Program on Key Basic Research Project '973'(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities - SCUT(Fundamental Research Funds for the Central Universities); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This study was partially supported by the National Program on Key Basic Research Project '973' (Grant No. 2010CB732201), the National Natural Science Foundation of China (Grant No. 21072065), the Fundamental Research Funds for the Central Universities - SCUT (Grants No. 2011ZG0018), the Foundation for the Author of National Excellent Doctoral Dissertation of China (Grants No. 201504), the New Century Excellent Talents in University (Grant No. NCET-10-0367) and the Ph.D. Programs Foundation of the Ministry of Education of China (Grant No. 20090172110019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum S, 2012, ADV SYNTH CATAL, V354, P113, DOI 10.1002/adsc.201100391; Brautigam S, 2009, ENZYME MICROB TECH, V45, P310, DOI 10.1016/j.enzmictec.2009.06.015; Cornmell RJ, 2008, GREEN CHEM, V10, P836, DOI 10.1039/b807214k; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; de Gonzalo G, 2007, TETRAHEDRON-ASYMMETR, V18, P2541, DOI 10.1016/j.tetasy.2007.10.010; Dipeolu O, 2009, GREEN CHEM, V11, P397, DOI 10.1039/b812600c; Gorke J, 2010, BIOTECHNOL BIOPROC E, V15, P40, DOI 10.1007/s12257-009-3079-z; Itoh T, 2004, GREEN CHEM, V6, P437, DOI 10.1039/b405396f; Kohlmann C, 2011, J MOL CATAL B-ENZYM, V68, P147, DOI 10.1016/j.molcatb.2010.10.003; Kolasa T, 1996, TETRAHEDRON-ASYMMETR, V7, P729, DOI 10.1016/0957-4166(96)00068-7; Kratzer R, 2011, BIOTECHNOL BIOENG, V108, P797, DOI 10.1002/bit.23002; Kristensen JB, 2007, ENZYME MICROB TECH, V40, P888, DOI 10.1016/j.enzmictec.2006.07.014; Kulacki KJ, 2008, GREEN CHEM, V10, P104, DOI [10.1039/b709289j, 10.1039/B709289J]; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Liu ZQ, 2011, BIOTECHNOL PROGR, V27, P698, DOI 10.1002/btpr.603; Lou WY, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-90; Lou WY, 2009, J BIOTECHNOL, V143, P190, DOI 10.1016/j.jbiotec.2009.07.004; Lou WY, 2009, GREEN CHEM, V11, P1377, DOI 10.1039/b823502c; Luo F, 2011, J MOL CATAL B-ENZYM, V70, P101, DOI 10.1016/j.molcatb.2011.02.011; Matsuda T, 2009, TETRAHEDRON-ASYMMETR, V20, P513, DOI 10.1016/j.tetasy.2008.12.035; Moniruzzaman M, 2010, BIOCHEM ENG J, V48, P295, DOI 10.1016/j.bej.2009.10.002; Musa MM, 2008, ORG BIOMOL CHEM, V6, P887, DOI 10.1039/b717120j; Nakamura K, 2003, TETRAHEDRON-ASYMMETR, V14, P2659, DOI 10.1016/S0957-4166(03)00526-3; Ni Y, 2012, BIOTECHNOL IN PRESS, DOI [10.1016/j.biote-chadv.2011.10.007, DOI 10.1016/J.BIOTE-CHADV.2011.10.007]; NICANDER L, 1975, ACTA PHARMACOL TOX, V36, P40; Nie Y, 2004, ORG PROCESS RES DEV, V8, P246, DOI 10.1021/op0341519; Nie Y, 2007, APPL ENVIRON MICROB, V73, P3759, DOI 10.1128/AEM.02185-06; Patel RN, 2002, ENZYME MICROB TECH, V31, P804, DOI 10.1016/S0141-0229(02)00186-2; Ranke J, 2007, CHEM REV, V107, P2183, DOI 10.1021/cr050942s; Schroer K, 2009, BIOTECHNOL BIOENG, V104, P251, DOI 10.1002/bit.22390; Schubert T, 2001, EUR J ORG CHEM, V2001, P4181; Shibata J, 2000, ANTICANCER RES, V20, P3169; Stolte S, 2007, GREEN CHEM, V9, P1170, DOI 10.1039/b711119c; Tacke R, 2000, ORGANOMETALLICS, V19, P3486, DOI 10.1021/om000169l; Weaver KD, 2010, GREEN CHEM, V12, P507, DOI 10.1039/b918726j; Wood N, 2011, GREEN CHEM, V13, P1843, DOI 10.1039/c0gc00579g; Xie Y, 2010, BIORESOURCE TECHNOL, V101, P1054, DOI 10.1016/j.biortech.2009.09.003; Zhang BB, 2008, J MOL CATAL B-ENZYM, V54, P122, DOI 10.1016/j.molcatb.2007.12.018; Zhao H, 2010, J CHEM TECHNOL BIOT, V85, P891, DOI 10.1002/jctb.2375; Zheng LY, 2006, J MOL CATAL B-ENZYM, V38, P17, DOI 10.1016/j.molcatb.2005.10.003; ZHU XD, 1995, EUR J PHARMACOL, V276, P93, DOI 10.1016/0014-2999(95)00014-C	41	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37641	10.1371/journal.pone.0037641	http://dx.doi.org/10.1371/journal.pone.0037641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662183	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300073
J	Amalfi, S; Velez, LM; Heber, MF; Vighi, S; Ferreira, SR; Orozco, AV; Pignataro, O; Motta, AB				Amalfi, Sabrina; Martin Velez, Leandro; Florencia Heber, Maria; Vighi, Susana; Rocio Ferreira, Silvana; Vega Orozco, Adriana; Pignataro, Omar; Motta, Alicia Beatriz			Prenatal Hyperandrogenization Induces Metabolic and Endocrine Alterations Which Depend on the Levels of Testosterone Exposure	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; ACTIVATED-RECEPTOR-GAMMA; IMPAIRED GLUCOSE-TOLERANCE; LOW-BIRTH-WEIGHT; PRECOCIOUS PUBARCHE; NITRIC-OXIDE; ANDROGEN EXPOSURE; DIABETES-MELLITUS; CORPUS-LUTEUM; NEUROENDOCRINE CONSEQUENCES	Prenatal hyperandrogenism is able to induce polycystic ovary syndrome (PCOS) in rats. The aim of the present study was to establish if the levels of prenatal testosterone may determine the extent of metabolic and endocrine alterations during the adult life. Pregnant Sprague Dawley rats were prenatally injected with either 2 or 5 mg free testosterone (groups T2 and T5 respectively) from day 16 to day 19 day of gestation. Female offspring from T2 and T5 displayed different phenotype of PCOS during adult life. Offspring from T2 showed hyperandrogenism, ovarian cysts and ovulatory cycles whereas those from T5 displayed hyperandrogenism, ovarian cysts and anovulatory cycles. Both group showed increased circulating glucose levels after the intraperitoneal glucose tolerance test (IPGTT; an evaluation of insulin resistance). IPGTT was higher in T5 rats and directly correlated with body weight at prepubertal age. However, the decrease in the body weight at prepubertal age was compensated during adult life. Although both groups showed enhanced ovarian steroidogenesis, it appears that the molecular mechanisms involved were different. The higher dose of testosterone enhanced the expression of both the protein that regulates cholesterol availability (the steroidogenic acute regulatory protein (StAR)) and the protein expression of the transcriptional factor: peroxisome proliferator-activated receptor gamma (PPAR gamma). Prenatal hyperandrogenization induced an anti-oxidant response that prevented a possible pro-oxidant status. The higher dose of testosterone induced a pro-inflammatory state in ovarian tissue mediated by increased levels of prostaglandin E (PG) and the protein expression of cyclooxygenase 2 (COX2, the limiting enzyme of PGs synthesis). In summary, our data show that the levels of testosterone prenatally injected modulate the uterine environment and that this, in turn, would be responsible for the endocrine and metabolic abnormalities and the phenotype of PCOS during the adult life.	[Amalfi, Sabrina; Martin Velez, Leandro; Florencia Heber, Maria; Rocio Ferreira, Silvana; Motta, Alicia Beatriz] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Ctr Estudios Farmacol & Bot, Lab Fisiopatol Ovar, Buenos Aires, DF, Argentina; [Vighi, Susana] Hosp Clin Buenos Aires, Dept Patol, Buenos Aires, DF, Argentina; [Vega Orozco, Adriana] Inst Biol & Med Cuyo, Lab Invest Biomed, Buenos Aires, DF, Argentina; [Pignataro, Omar] Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Endocrinol Mol & Transducc Senales, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Amalfi, S (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Ctr Estudios Farmacol & Bot, Lab Fisiopatol Ovar, Buenos Aires, DF, Argentina.	aliciabmotta@yahoo.com.ar	Velez, Leandro Martin/V-8791-2019	Velez, Leandro Martin/0000-0001-8371-2633; Motta, Alicia/0000-0002-8478-728X; Heber, Maria Florencia/0000-0002-2392-3671	FONCyT-Argentina [BID 949/2006, BID 71/2010]	FONCyT-Argentina(FONCyT)	This work was supported by FONCyT-Argentina (BID 949/2006 and BID 71/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; Andreu C, 1998, MOL REPROD DEV, V51, P287, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;287::AID-MRD8&gt;3.0.CO;2-L; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; Blank SK, 2006, HUM REPROD UPDATE, V12, P351, DOI 10.1093/humupd/dml017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crawford MJ, 1995, DEV GENET, V17, P291, DOI 10.1002/dvg.1020170402; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Curti MLR, 2011, J OBES, V2011, DOI 10.1155/2011/497401; DelPunta K, 1996, ENDOCRINOLOGY, V137, P5337, DOI 10.1210/en.137.12.5337; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; Diamanti-Kandarakis E, 2008, CLIN ENDOCRINOL, V69, P634, DOI 10.1111/j.1365-2265.2008.03247.x; Diamanti-Kandarakis E, 2008, J STEROID BIOCHEM, V109, P242, DOI 10.1016/j.jsbmb.2008.03.014; Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1083, P54, DOI 10.1196/annals.1367.006; Diamanti-Kandarakis E, 2006, TRENDS MOL MED, V12, P324, DOI 10.1016/j.molmed.2006.05.006; Diamanti-Kandarakis E, 2009, EUR J ENDOCRINOL, V160, P847, DOI 10.1530/EJE-08-0510; Elia E, 2006, MOL HUM REPROD, V12, P475, DOI 10.1093/molehr/gal057; Faut M, 2011, FERTIL STERIL, V95, P333, DOI 10.1016/j.fertnstert.2010.07.1083; Foecking EM, 2008, HORM BEHAV, V53, P673, DOI 10.1016/j.yhbeh.2007.12.013; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Franks S, 2003, ENDOCRIN METAB CLIN, V32, P639, DOI 10.1016/S0889-8529(03)00044-6; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Froment P, 2003, BIOL REPROD, V69, P1665, DOI 10.1095/biolreprod.103.017244; Gonzalez E, 2000, BRAZ J MED BIOL RES, V33, P1335, DOI 10.1590/S0100-879X2000001100012; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Higashiyama H, 2007, HISTOCHEM CELL BIOL, V127, P485, DOI 10.1007/s00418-007-0279-5; Huang Z, 2008, BRIT J PHARMACOL, V155, P596, DOI 10.1038/bjp.2008.331; Husein MQ, 2003, REPROD DOMEST ANIM, V38, P228, DOI 10.1046/j.1439-0531.2003.00411.x; Ibabe A, 2002, HISTOCHEM CELL BIOL, V118, P231, DOI 10.1007/s00418-002-0434-y; Ibanez L, 1998, DIABETOLOGIA, V41, P1057, DOI 10.1007/s001250051030; Ibanez L, 1999, J CLIN ENDOCR METAB, V84, P2691, DOI 10.1210/jc.84.8.2691; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Ibanez L, 2004, J PEDIATR-US, V144, P23, DOI 10.1016/j.jpeds.2003.08.015; Ibanez L, 2001, J CLIN ENDOCR METAB, V86, P5788, DOI 10.1210/jc.86.12.5788; Ibanez L, 2001, CLIN ENDOCRINOL, V55, P667, DOI 10.1046/j.1365-2265.2001.01399.x; Ibanez L, 1999, CLIN ENDOCRINOL, V51, P395, DOI 10.1046/j.1365-2265.1999.00778.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Komar CM, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-41; LEE MT, 1991, ANAT REC, V231, P185, DOI 10.1002/ar.1092310206; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P789, DOI 10.1210/jc.2009-1849; Luchetti CG, 2004, J REPROD IMMUNOL, V64, P59, DOI 10.1016/j.jri.2004.04.002; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Elia EM, 2009, MOL HUM REPROD, V15, P421, DOI 10.1093/molehr/gap033; Medan MS, 2003, REPRODUCTION, V125, P751, DOI 10.1530/reprod/125.5.751; Mohan M, 2002, BIOL REPROD, V66, P692, DOI 10.1095/biolreprod66.3.692; Mondillo C, 2009, BIOL REPROD, V80, P144, DOI 10.1095/biolreprod.108.069484; Motta AB, 2001, REPRODUCTION, V121, P631, DOI 10.1530/rep.0.1210631; Motta AB, 2001, MOL HUM REPROD, V7, P43, DOI 10.1093/molehr/7.1.43; Motta AB, 1999, MOL HUM REPROD, V5, P1011, DOI 10.1093/molehr/5.11.1011; Mukherjee S, 2010, INDIAN J MED RES, V131, P743; Navarra P, 1996, PROSTAGLANDINS, V52, P187, DOI 10.1016/S0090-6980(96)00096-2; Neville KA, 2005, ARCH DIS CHILD, V90, P258, DOI 10.1136/adc.2004.053959; Nisenblat V, 2009, CURR OPIN ENDOCRINOL, V16, P224, DOI 10.1097/MED.0b013e32832afd4d; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Panidis D, 2011, HUM REPROD IN PRESS; Pustovrh MC, 2005, FREE RADICAL RES, V39, P1285, DOI 10.1080/10715760500188796; SADRKHANLOO R, 1987, ENDOCRINOLOGY, V120, P146, DOI 10.1210/endo-120-1-146; Sander VA, 2008, REPROD FERT DEVELOP, V20, P760, DOI 10.1071/RD08051; Sander VA, 2009, REPRODUCTION, V138, P571, DOI 10.1530/REP-08-0325; Stikkelbroeck NMML, 2003, OBSTET GYNECOL SURV, V58, P275; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Ward IL, 2003, HORM BEHAV, V43, P531, DOI 10.1016/S0018-506X(03)00061-8; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Wu XY, 2010, ENDOCR J, V57, P201, DOI 10.1507/endocrj.K09E-205	72	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37658	10.1371/journal.pone.0037658	http://dx.doi.org/10.1371/journal.pone.0037658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655062	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900038
J	Clifford, DM; Fisher, SA; Brunskill, SJ; Doree, C; Mathur, A; Clarke, MJ; Watt, SM; Martin-Rendon, E				Clifford, David M.; Fisher, Sheila A.; Brunskill, Susan J.; Doree, Carolyn; Mathur, Anthony; Clarke, Mike J.; Watt, Suzanne M.; Martin-Rendon, Enca			Long-Term Effects of Autologous Bone Marrow Stem Cell Treatment in Acute Myocardial Infarction: Factors That May Influence Outcomes	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; VENTRICULAR EJECTION FRACTION; MONONUCLEAR-CELLS; FOLLOW-UP; INTRACORONARY INJECTION; PROGENITOR CELLS; PILOT TRIAL; THERAPY; TRANSPLANTATION; INFUSION	Aims: To investigate whether there are important sources of heterogeneity between the findings of different clinical trials which administer autologous stem cell treatment for acute myocardial infarction (AMI) and to evaluate what factors may influence the long-term effects of this treatment. Methods and Results: MEDLINE (1950-January 2011), EMBASE (1974-January 2011), CENTRAL (The Cochrane Library 2011, Issue 1), CINAHL 1982-January 2011), and ongoing trials registers were searched for randomised trials of bone marrow stem cells as treatment for AMI. Hand-searching was used to screen recent, relevant conference proceedings (2005-2010/11). Meta-analyses were conducted using random-effects models and heterogeneity between subgroups was assessed using chi-squared tests. Planned analyses included length of follow-up, timing of cell infusion and dose, patient selection, small trial size effect, methodological quality, loss of follow-up and date of publication. Thirty-three trials with a total of 1,765 participants were included. There was no evidence of bias due to publication or time-lag, methodological quality of included studies, participant drop-out, duration of follow-up or date of the first disclosure of results. However, in long-term follow-ups the treatment seemed more effective when administered at doses greater than 10(8) cells and to patients with more severe heart dysfunction. Conclusions: Evaluation of heterogeneity between trials has not identified significant sources of bias in this study. However, clinical differences between trials are likely to exist which should be considered when undertaking future trials.	[Clifford, David M.; Watt, Suzanne M.; Martin-Rendon, Enca] John Radcliffe Hosp, Stem Cell Res Lab, NHS Blood & Transplant, Oxford OX3 9DU, England; [Clifford, David M.; Watt, Suzanne M.; Martin-Rendon, Enca] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Fisher, Sheila A.; Brunskill, Susan J.; Doree, Carolyn] John Radcliffe Hosp, Systemat Review Initiat, Clin Res Grp, NHSBT Oxford, Oxford OX3 9DU, England; [Mathur, Anthony] Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, Dept Clin Pharmacol, London EC1M 6BQ, England; [Clarke, Mike J.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Mathur, Anthony] Barts & London NIHR Biomed Res Unit, London, England	University of Oxford; University of Oxford; University of Oxford; University of London; Queen Mary University London; Queens University Belfast	Clifford, DM (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	enca.rendon@ndcsl.ox.ac.uk	Watt, Suzanne/AAV-4908-2021	Doree, Carolyn/0000-0001-6955-7497; MAthur, Anthony/0000-0001-7941-9653; Watt, Suzanne/0000-0001-7684-8022	Advanced Medical Science programme, University of Melbourne, Australia	Advanced Medical Science programme, University of Melbourne, Australia	This work was commissioned by the National Health Service Blood and Transplant (NHSBT), Research and Development (SJB, CD and SAF), and the National Institute of Health Research (NIHR), UK, under its Programme Grant Scheme (RP-PG-0310-1001, EMR and SMW). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. DMC was sponsored by the Advanced Medical Science programme, University of Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Arnesen H, 2007, LANCET, V369, P2142, DOI 10.1016/S0140-6736(07)60992-1; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Brunskill SJ, 2009, EUR J HEART FAIL, V11, P887, DOI 10.1093/eurjhf/hfp101; Cao F, 2009, EUR HEART J, V30, P1986, DOI 10.1093/eurheartj/ehp220; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; de Lezo JS, 2007, REV ESP CARDIOL, V60, P357, DOI 10.1016/S1885-5857(07)60168-6; Nogueira FBD, 2009, ARQ BRAS CARDIOL, V93, P374, DOI 10.1590/S0066-782X2009001000010; Fernandez-Pereira C, 2006, EUR HEART J      AUG; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Grajek S, 2010, EUR HEART J, V31, P691, DOI 10.1093/eurheartj/ehp536; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Hopewell S., 2007, COCHRANE DATABASE SY; Hopewell S, 2009, COCHRANE DATABASE SY; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Janssens SP, 2011, EUR HEART J, V32, P1697, DOI 10.1093/eurheartj/ehq513; [金波 Jin Bo], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P2267; Karpov RS, 2005, B EXP BIOL MED+, V140, P640, DOI 10.1007/s10517-006-0043-1; Kumar A, ACTA HAEMATOL, V125, P8; Li ZQ, 2007, INT J CARDIOL, V115, P52, DOI 10.1016/j.ijcard.2006.04.005; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Meluzin J, 2008, INT J CARDIOL, V128, P185, DOI 10.1016/j.ijcard.2007.04.098; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Penicka M, 2007, J AM COLL CARDIOL, V49, P2373, DOI 10.1016/j.jacc.2007.04.009; Piepoli MF, 2010, EUR J HEART FAIL, V12, P172, DOI 10.1093/eurjhf/hfp183; Quyyumi AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.025; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Roncalli J, 2011, EUR HEART J, V32, P1748, DOI 10.1093/eurheartj/ehq455; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; SIMOONS ML, 1989, J AM COLL CARDIOL, V14, P1609, DOI 10.1016/0735-1097(89)90003-X; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073; Traverse JH, 2010, TEX HEART I J, V37, P412; Traverse JH, 2009, AM HEART J, V158, P356, DOI 10.1016/j.ahj.2009.06.009; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yao K, 2009, EUR J HEART FAIL, V11, P691, DOI 10.1093/eurjhf/hfp062; Zhukova NS, 2009, KARDIOLOGIYA, V49, P19	50	54	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37373	10.1371/journal.pone.0037373	http://dx.doi.org/10.1371/journal.pone.0037373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655042	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900017
J	Hazlerigg, CRE; Lorenzen, K; Thorbek, P; Wheeler, JR; Tyler, CR				Hazlerigg, Charles R. E.; Lorenzen, Kai; Thorbek, Pernille; Wheeler, James R.; Tyler, Charles R.			Density-Dependent Processes in the Life History of Fishes: Evidence from Laboratory Populations of Zebrafish Danio rerio	PLOS ONE			English	Article							ECOLOGICAL RISK; MORTALITY; GROWTH; MONOPOLIZATION; CONSEQUENCES; RECRUITMENT; MECHANISMS; PREDATION; SURVIVAL; FOOD	Population regulation is fundamental to the long-term persistence of populations and their responses to harvesting, habitat modification, and exposure to toxic chemicals. In fish and other organisms with complex life histories, regulation may involve density dependence in different life-stages and vital rates. We studied density dependence in body growth and mortality through the life-cycle of laboratory populations of zebrafish Danio rerio. When feed input was held constant at population-level (leading to resource limitation), body growth was strongly density-dependent in the late juvenile and adult phases of the life-cycle. Density dependence in mortality was strong during the early juvenile phase but declined thereafter and virtually ceased prior to maturation. Provision of feed in proportion to individual requirements (easing resource limitation) removed density dependence in growth and substantially reduced density dependence in mortality, thus indicating that 'bottom-up' effects act on growth as well as mortality, but most strongly on growth. Both growth and mortality played an important role in population regulation, with density-dependent growth having the greater impact on population biomass while mortality had the greatest impact on numbers. We demonstrate a clear ontogenic pattern of change in density-dependent processes within populations of a very small (maximum length 5 mm) fish, maintained in constant homogeneous laboratory conditions. The patterns are consistent with those distilled from studies on wild fish populations, indicating the presence of broad ontogenic patterns in density-dependent processes that are invariant to maximum body size and hold in homogeneous laboratory, as well as complex natural environments.	[Hazlerigg, Charles R. E.; Lorenzen, Kai] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [Hazlerigg, Charles R. E.; Tyler, Charles R.] Univ Exeter, Ecotoxicol & Aquat Biol Res Grp, Exeter, Devon, England; [Hazlerigg, Charles R. E.; Lorenzen, Kai] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Thorbek, Pernille; Wheeler, James R.] Syngenta, Jealotts Hill Int Res Ctr, Environm Safety, Bracknell, Berks, England	Imperial College London; University of Exeter; State University System of Florida; University of Florida; Syngenta	Hazlerigg, CRE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England.	C.Hazlerigg07@imperial.ac.uk; klorenzen@ufl.edu	Lorenzen, Kai/A-3032-2015; Thorbek, Pernille/HGV-0078-2022	Lorenzen, Kai/0000-0002-9691-3693; Wheeler, James/0000-0002-9162-5035	University of Exeter; Syngenta, Ltd.; Biological and Biochemical Science Research Council	University of Exeter; Syngenta, Ltd.(Syngenta); Biological and Biochemical Science Research Council	The authors are grateful to the University of Exeter, Syngenta, Ltd. and the Biological and Biochemical Science Research Council for the funding of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Syngenta Ltd provided financial support for this work. Pernille Thorbek and James R. Wheeler are Syngenta employees (and were involved in the study design and preparation of the manuscript). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Beverton R.J.H., 1957, FISH INVEST LONDON S, V19; BUTLER JL, 1988, FISH B-NOAA, V86, P163; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Detrich HW, 2004, ZEBRAFISH; [EFSA PPR] European Food Safety Authority Plant Protection Products and Their Residues Panel, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Ferson S, 1996, WATER AIR SOIL POLL, V90, P71, DOI 10.1007/BF00619269; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Forbes VE, 2008, ENVIRON TOXICOL CHEM, V27, P1987, DOI 10.1897/08-029.1; Forbes VE, 2002, PHILOS T R SOC B, V357, P1299, DOI 10.1098/rstb.2002.1129; FORRESTER GE, 1995, OECOLOGIA, V103, P275, DOI 10.1007/BF00328615; GRANT JWA, 1992, ANIM BEHAV, V44, P101, DOI 10.1016/S0003-3472(05)80759-6; GULLAND JA, 1987, MAR ECOL PROG SER, V39, P197, DOI 10.3354/meps039197; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hilborn Ray, 1997, V28; Hixon M. A., 2002, CORAL REEF FISHES DY, P303; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hommen Udo, 2010, Integrated Environmental Assessment and Management, V6, P325, DOI 10.1002/ieam.69; ILES TC, 1991, NETH J SEA RES, V27, P217, DOI 10.1016/0077-7579(91)90026-W; Ish TL, 2003, THESIS U CALIFORNIA; Lawrence C, 2008, ENVIRON BIOL FISH, V81, P239, DOI 10.1007/s10641-007-9195-8; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Lorenzen K, 2005, PHILOS T R SOC B, V360, P171, DOI 10.1098/rstb.2004.1570; Lorenzen K, BIOL REV IN PRESS; Lorenzen K, 2008, B MAR SCI, V83, P181; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Munch SB, 2005, ECOL LETT, V8, P691, DOI 10.1111/j.1461-0248.2005.00766.x; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Paull GC, 2008, AQUAT TOXICOL, V87, P115, DOI 10.1016/j.aquatox.2008.01.008; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rothschild B.J., 1986, DYNAMICS MARINE FISH; Sandin SA, 2005, AM NAT, V165, P107, DOI 10.1086/426674; Schultz ET, 1997, OECOLOGIA, V109, P516, DOI 10.1007/s004420050112; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Tyler JA, 1997, EARLY LIFE HIST RECR, P391; VANDERVEER HW, 1986, MAR ECOL PROG SER, V29, P223, DOI 10.3354/meps029223; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Webster MS, 2000, MAR ECOL PROG SER, V196, P187, DOI 10.3354/meps196187; White JW, 2010, ECOLOGY, V91, P1949, DOI 10.1890/09-0298.1	44	46	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37550	10.1371/journal.pone.0037550	http://dx.doi.org/10.1371/journal.pone.0037550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655056	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900032
J	Morfin, M; Fromentin, JM; Jadaud, A; Bez, N				Morfin, Marie; Fromentin, Jean-Marc; Jadaud, Angelique; Bez, Nicolas			Spatio-Temporal Patterns of Key Exploited Marine Species in the Northwestern Mediterranean Sea	PLOS ONE			English	Article							HAKE MERLUCCIUS-MERLUCCIUS; COD GADUS-MORHUA; NEPHROPS-NORVEGICUS L; EUROPEAN HAKE; DEMERSAL ASSEMBLAGES; POPULATION-STRUCTURE; CONTINENTAL-SHELF; SPATIAL STRUCTURE; NORTH-SEA; FISH	This study analyzes the temporal variability/stability of the spatial distributions of key exploited species in the Gulf of Lions (Northwestern Mediterranean Sea). To do so, we analyzed data from the MEDITS bottom-trawl scientific surveys from 1994 to 2010 at 66 fixed stations and selected 12 key exploited species. We proposed a geostatistical approach to handle zero-inflated and non-stationary distributions and to test for the temporal stability of the spatial structures. Empirical Orthogonal Functions and other descriptors were then applied to investigate the temporal persistence and the characteristics of the spatial patterns. The spatial structure of the distribution (i.e. the pattern of spatial autocorrelation) of the 12 key species studied remained highly stable over the time period sampled. The spatial distributions of all species obtained through kriging also appeared to be stable over time, while each species displayed a specific spatial distribution. Furthermore, adults were generally more densely concentrated than juveniles and occupied areas included in the distribution of juveniles. Despite the strong persistence of spatial distributions, we also observed that the area occupied by each species was correlated to its abundance: the more abundant the species, the larger the occupation area. Such a result tends to support MacCall's basin theory, according to which density-dependence responses would drive the expansion of those 12 key species in the Gulf of Lions. Further analyses showed that these species never saturated their habitats, suggesting that they are below their carrying capacity; an assumption in agreement with the overexploitation of several of these species. Finally, the stability of their spatial distributions over time and their potential ability to diffuse outside their main habitats give support to Marine Protected Areas as a potential pertinent management tool.	[Morfin, Marie; Fromentin, Jean-Marc; Jadaud, Angelique] IFREMER, UMR EME 212, Sete, France; [Bez, Nicolas] IRD, UMR EME 212, Sete, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Morfin, M (corresponding author), IFREMER, UMR EME 212, Sete, France.	marie.morfin@ifremer.fr		Fromentin, Jean-Marc/0000-0002-1496-4332	Directorate-General for Maritime Affairs and Fisheries (DG-MARE) (European Commission); L'Institut Francais de Recherche pour l'Exploitation de la Mer (Ifremer); AMPED project through a grant from the French National Research Agency (ANR), Systerra Program [ANR-08-STRA-03]	Directorate-General for Maritime Affairs and Fisheries (DG-MARE) (European Commission); L'Institut Francais de Recherche pour l'Exploitation de la Mer (Ifremer); AMPED project through a grant from the French National Research Agency (ANR), Systerra Program(French National Research Agency (ANR))	MEDITS trawl survey is funded by the Directorate-General for Maritime Affairs and Fisheries (DG-MARE) (European Commission) and L'Institut Francais de Recherche pour l'Exploitation de la Mer (Ifremer). MM was supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR), Systerra Program, grant number ANR-08-STRA-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2005, FISH RES, V71, P295, DOI 10.1016/j.fishres.2004.08.036; Aldebert Y, 1997, VIE MILIEU, V47, P275; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Atkinson DB, 1997, CAN J FISH AQUAT SCI, V54, P132, DOI 10.1139/f96-158; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CADDY JF, 1995, OCEAN COAST MANAGE, V26, P1, DOI 10.1016/0964-5691(95)00015-T; Carlucci R, 2009, ESTUAR COAST SHELF S, V83, P529, DOI 10.1016/j.ecss.2009.04.034; Casini M, 2005, ICES J MAR SCI, V62, P671, DOI 10.1016/j.icesjms.2004.12.018; Chapman CJ, 1980, ECOLOGY JUVENILE ADU, V2, P143; Chiles J. P., 1999, GEOSTATISTICS MODELI; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Clark I, 1979, DOES GEOSTATISTICS W, P213; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; CRECCO V, 1990, CAN J FISH AQUAT SCI, V47, P385, DOI 10.1139/f90-040; Crowder LB, 2000, B MAR SCI, V66, P799; David M., 1977, GEOSTATISTICAL ORE R; FARINA AC, 1994, FISH RES, V19, P333, DOI 10.1016/0165-7836(94)90048-5; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; Fiorentino F, 2003, HYDROBIOLOGIA, V503, P223, DOI 10.1023/B:HYDR.0000008485.85468.ef; Freire J, 2000, MAR POLICY, V24, P375, DOI 10.1016/S0308-597X(00)00013-0; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gaertner JC, 1999, MAR BIOL, V135, P199, DOI 10.1007/s002270050617; Gaertner JC, 2000, J MAR BIOL ASSOC UK, V80, P777, DOI 10.1017/S0025315400002745; Gaertner JC, 2002, SCI MAR, V66, P221; Gaertner JC, 2007, MAR ECOL PROG SER, V341, P191, DOI 10.3354/meps341191; GFCM, 2008, 11 SESS SCI ADV COMM; GFCM, 2011, 13 SESS SCI ADV COMM; GFCM (General Fisheries Commission for the Mediterranean), 2010, 12 SESS SCI ADV COMM; GOOVAERTS P, 1994, MATH GEOL, V26, P389, DOI 10.1007/BF02089230; Isaaks EH, 1989, APPL GEOSTATISTICS; Journel A. G., 1978, MINING GEOSTATISTICS; Korres G, 2000, J CLIMATE, V13, P732, DOI 10.1175/1520-0442(2000)013<0732:TORTLF>2.0.CO;2; Lantuejoul C, 2002, GEOSTATISTICAL SIMULATION, P1; Legendre P., 2012, NUMERICAL ECOLOGY; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; LLORIS D, 1995, SCI MAR, V59, P399; Lombarte A, 2000, MAR ECOL PROG SER, V206, P239, DOI 10.3354/meps206239; Lorenz E.N., 1956, EMPIRICAL ORTHOGONAL; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Manchuk JG, 2009, MATH GEOSCI, V41, P799, DOI 10.1007/s11004-008-9195-z; MARSHALL CT, 1994, CAN J FISH AQUAT SCI, V51, P808, DOI 10.1139/f94-079; Martin CS, 2010, MAR ECOL PROG SER, V417, P211, DOI 10.3354/meps08802; Matern B., 1986, SPATIAL VARIATION, V2nd ed., DOI [10.1007/978-1-4615-7892-5, DOI 10.1007/978-1-4615-7892-5]; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Maynou F, 2006, FISH OCEANOGR, V15, P390, DOI 10.1111/j.1365-2419.2005.00398.x; Maynou F, 2003, FISH RES, V60, P65, DOI 10.1016/S0165-7836(02)00062-0; Maynou FX, 1998, ICES J MAR SCI, V55, P102, DOI 10.1006/jmsc.1997.0236; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Perdichizzi A, 2011, FISH RES, V109, P342, DOI 10.1016/j.fishres.2011.03.001; Petitgas P, 1997, ICES J MAR SCI, V54, P213, DOI 10.1006/jmsc.1996.0184; Petitgas P, 1998, ICES J MAR SCI, V55, P443, DOI 10.1006/jmsc.1997.0345; QUERO JC, 1997, POISSONS MER PECHES; R Core Team, 2021, R LANGUAGE ENV STAT; Recasens L, 1998, J FISH BIOL, V53, P387, DOI 10.1111/j.1095-8649.1998.tb00988.x; Rivoirard J., 2008, GEOSTATISTICS ESTIMA; Roberts CM, 1998, FISHERIES, V23, P16; Roberts CM, 2003, ECOL APPL, V13, pS199; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; SARDA F, 1991, CRUSTACEANA, V60, P186, DOI 10.1163/156854091X00399; Sumaila UR, 2007, MAR ECOL PROG SER, V345, P305, DOI 10.3354/meps07065; SWAIN DP, 1994, CAN J FISH AQUAT SCI, V51, P1046, DOI 10.1139/f94-104; TULLY O, 1995, FISH RES, V21, P329, DOI 10.1016/0165-7836(94)00303-E; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Woillez M, 2007, ICES J MAR SCI, V64, P537, DOI 10.1093/icesjms/fsm025	72	32	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37907	10.1371/journal.pone.0037907	http://dx.doi.org/10.1371/journal.pone.0037907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655079	Green Published, gold			2022-12-27	WOS:000305338900056
J	Ziska, LH; Gealy, DR; Tomecek, MB; Jackson, AK; Black, HL				Ziska, Lewis H.; Gealy, David R.; Tomecek, Martha B.; Jackson, Aaron K.; Black, Howard L.			Recent and Projected Increases in Atmospheric CO2 Concentration Can Enhance Gene Flow between Wild and Genetically Altered Rice (Oryza sativa)	PLOS ONE			English	Article							WEEDY RED RICE; CLEARFIELD(TM) RICE; NECTAR PRODUCTION; ENRICHMENT; PLANTS	Although recent and projected increases in atmospheric carbon dioxide can alter plant phenological development, these changes have not been quantified in terms of floral outcrossing rates or gene transfer. Could differential phenological development in response to rising CO2 between genetically modified crops and wild, weedy relatives increase the spread of novel genes, potentially altering evolutionary fitness? Here we show that increasing CO2 from an early 20th century concentration (300 mu mol mol(-1)) to current (400 mu mol mol(-1)) and projected, mid-21st century (600 mu mol mol(-1)) values, enhanced the flow of genes from wild, weedy rice to the genetically altered, herbicide resistant, cultivated population, with outcrossing increasing from 0.22% to 0.71% from 300 to 600 mu mol mol(-1). The increase in outcrossing and gene transfer was associated with differential increases in plant height, as well as greater tiller and panicle production in the wild, relative to the cultivated population. In addition, increasing CO2 also resulted in a greater synchronicity in flowering times between the two populations. The observed changes reported here resulted in a subsequent increase in rice dedomestication and a greater number of weedy, herbicide-resistant hybrid progeny. Overall, these data suggest that differential phenological responses to rising atmospheric CO2 could result in enhanced flow of novel genes and greater success of feral plant species in agroecosystems.	[Ziska, Lewis H.; Tomecek, Martha B.] ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD USA; [Gealy, David R.; Jackson, Aaron K.; Black, Howard L.] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ziska, LH (corresponding author), ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD USA.	l.ziska@ars.usda.gov		Jackson, Aaron/0000-0002-5540-9255				Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Andersson M. S., 2010, GENE FLOW CROPS THEI; ARIAS DM, 1994, THEOR APPL GENET, V89, P655, DOI 10.1007/BF00223700; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; Bryant R, 2011, GENETICA, V139, P1383, DOI 10.1007/s10709-012-9637-x; *CAST, 2007, 37 CAST; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; CURTIS PS, 1994, OECOLOGIA, V97, P100, DOI 10.1007/BF00317913; Dag A, 2000, J APICULT RES, V39, P88, DOI 10.1080/00218839.2000.11101027; Delouche J. C, 2007, 188 FAO; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; EIJLANDER R, 1994, SEX PLANT REPROD, V7, P29, DOI 10.1007/BF00241885; Ellstrand N.C., 2003, DANGEROUS LIASONS CU; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Estorninos LE, 2005, WEED SCI, V53, P676, DOI 10.1614/WS-03-141R2.1; Gealy DH, 2012, WEED SCI, V60, P451, DOI 10.1614/WS-D-11-00159.1; Gealy DR, 2006, WEED TECHNOL, V20, P839, DOI 10.1614/WT-05-066.1; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Johnson SL, 2000, GLOB CHANGE BIOL, V6, P767, DOI 10.1046/j.1365-2486.2000.00355.x; KIMBALL BA, 1993, VEGETATIO, V104, P65, DOI 10.1007/BF00048145; Lake JC, 1999, ANN BOT-LONDON, V84, P535, DOI 10.1006/anbo.1999.0949; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; MAYEUX HS, 1993, FUNCT ECOL, V7, P125, DOI 10.2307/2389875; McDonald A, 2009, AGR ECOSYST ENVIRON, V130, P131, DOI 10.1016/j.agee.2008.12.007; Murray BG, 2002, WEED SCI, V50, P321, DOI 10.1614/0043-1745(2002)050[0321:PMGFIW]2.0.CO;2; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; Shivrain VK, 2007, CROP PROT, V26, P349, DOI 10.1016/j.cropro.2005.09.019; Shivrain VK, 2009, WEED SCI, V57, P394, DOI 10.1614/WS-09-003.1; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Snow AA, 2002, NAT BIOTECHNOL, V20, P542, DOI 10.1038/nbt0602-542; Solomon S., 2007, PHYS SCI BASIS WORKI; Springer CJ, 2007, NEW PHYTOL, V176, P243, DOI 10.1111/j.1469-8137.2007.02196.x; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; TREHARNE K, 1989, CAS PAPER, V19, P67; Wayne P, 2002, ANN ALLERG ASTHMA IM, V80, P669; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Ziska LH, 2008, AGRON J, V100, P1259, DOI 10.2134/agronj2007.0324	39	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37522	10.1371/journal.pone.0037522	http://dx.doi.org/10.1371/journal.pone.0037522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649533	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800052
J	Ishiyama, K; Nakamura, K; Ikai, H; Kanno, T; Kohno, M; Sasaki, K; Niwano, Y				Ishiyama, Kirika; Nakamura, Keisuke; Ikai, Hiroyo; Kanno, Taro; Kohno, Masahiro; Sasaki, Keiichi; Niwano, Yoshimi			Bactericidal Action of Photogenerated Singlet Oxygen from Photosensitizers Used in Plaque Disclosing Agents	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; INACTIVATION; CANCER; INFECTIONS; GINGIVALIS; BIOFILMS; TUMOR	Background: Photodynamic therapy (PDT) has been suggested as an efficient clinical approach for the treatment of dental plaque in the field of dental care. In PDT, once the photosensitizer is irradiated with light of a specific wavelength, it transfers the excitation energy to molecular oxygen, which gives rise to singlet oxygen. Methodology/Principal Findings: Since plaque disclosing agents usually contain photosensitizers such as rose bengal, erythrosine, and phloxine, they could be used for PTD upon photoactivation. The aim of the present study is to compare the ability of these three photosensitizers to produce singlet oxygen in relation to their bactericidal activity. The generation rates of singlet oxygen determined by applying an electron spin resonance technique were in the order phloxine > erythrosine = rose bengal. On the other hand, rose bengal showed the highest bactericidal activity against Streptococcus mutans, a major causative pathogen of caries, followed by erythrosine and phloxine, both of which showed activity similar to each other. One of the reasons for the discrepancy between the singlet oxygen generating ability and bactericidal activity was the incorporation efficiency of the photosensitizers into the bacterial cells. The incorporation rate of rose bengal was the highest among the three photosensitizers examined in the present study, likely leading to the highest bactericidal activity. Meanwhile, the addition of L-histidine, a singlet oxygen quencher, cancelled the bactericidal activity of any of the three photoactivated photosensitizers, proving that singlet oxygen was responsible for the bactericidal action. Conclusions: It is strongly suggested that rose bengal is a suitable photosensitizer for the plaque disclosing agents as compared to the other two photosensitizers, phloxine and erythrosine, when used for PDT.	[Ishiyama, Kirika; Nakamura, Keisuke; Ikai, Hiroyo; Kanno, Taro; Sasaki, Keiichi; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Kohno, Masahiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Tokyo 152, Japan	Tohoku University; Tokyo Institute of Technology	Ishiyama, K (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan.	y.niwano@m.tohoku.ac.jp	Niwnao, Yoshimi/Z-3593-2019		Ministry of Education, Science, Sports and Culture, Japan [21791932]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 21791932, 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vera DMA, 2012, PHOTOCHEM PHOTOBIOL, V88, P499, DOI 10.1111/j.1751-1097.2012.01087.x; Bhatti M, 1998, PHOTOCHEM PHOTOBIOL, V68, P370, DOI 10.1111/j.1751-1097.1998.tb09694.x; Clo E, 2007, CHEMBIOCHEM, V8, P475, DOI 10.1002/cbic.200600454; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Garcia VG, 2011, J CLIN PERIODONTOL, V38, P1106, DOI 10.1111/j.1600-051X.2011.01785.x; Gonzales FP, 2012, FUNGAL BIOL-UK, V116, P1, DOI 10.1016/j.funbio.2011.10.001; Herrera David, 2011, Evid Based Dent, V12, P78, DOI 10.1038/sj.ebd.6400810; ilela S F, 2012, ARCH ORAL B IN PRESS, DOI [10.1016/j.archoralbio.2011.12.002, DOI 10.1016/J.ARCHORALBI0.2011.12.002]; IWAMOTO Y, 1985, CHEM PHARM BULL, V33, P5529; Juarranz A, 2008, CLIN TRANSL ONCOL, V10, P148, DOI 10.1007/s12094-008-0172-2; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Luo J, 2006, ANTIOXID REDOX SIGN, V8, P1307, DOI 10.1089/ars.2006.8.1307; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Martins J, 2004, PHOTOCHEM PHOTOBIOL, V80, P267, DOI 10.1562/2004-03-26-RA-124.1; Nagata JY, 2012, PHOTODIAGNO IN PRESS, DOI DOI 10.1016/J.PDPDT.2011.11.006; Nakamura K, 2011, J CLIN BIOCHEM NUTR, V49, P87, DOI 10.3164/jcbn.10-125; Niziolek-Kierecka M, 2010, PHOTOCHEM PHOTOBIOL, V86, P681, DOI 10.1111/j.1751-1097.2010.00712.x; Papastamou V, 2011, ARCH ORAL BIOL, V56, P264, DOI 10.1016/j.archoralbio.2010.10.007; Rolim JPML, 2012, J PHOTOCH PHOTOBIO B, V106, P40, DOI 10.1016/j.jphotobiol.2011.10.001; Simone CB, 2012, J THORAC DIS, V4, P63, DOI 10.3978/j.issn.2072-1439.2011.11.05; Soukos NS, 2006, J ENDODONT, V32, P979, DOI 10.1016/j.joen.2006.04.007; Soukos NS, 2011, PERIODONTOL 2000, V55, P143, DOI 10.1111/j.1600-0757.2010.00346.x; THOMAS JP, 1987, CANCER LETT, V35, P295, DOI 10.1016/0304-3835(87)90131-5; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Yamamoto J, 2006, CLIN CANCER RES, V12, P7132, DOI 10.1158/1078-0432.CCR-06-0786; ZANG LY, 1990, PHOTOCHEM PHOTOBIOL, V52, P677, DOI 10.1111/j.1751-1097.1990.tb08666.x	27	38	38	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37871	10.1371/journal.pone.0037871	http://dx.doi.org/10.1371/journal.pone.0037871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629466	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300081
J	Sprecher, BN; Gittings, ME; Ludwig, RA				Sprecher, Brittany N.; Gittings, Margo E.; Ludwig, Robert A.			Respiratory Membrane endo-Hydrogenase Activity in the Microaerophile Azorhizobium caulinodans Is Bidirectional	PLOS ONE			English	Article							SP STRAIN ORS571; PARACOCCUS-DENITRIFICANS; RHODOSPIRILLUM-RUBRUM; NITROGENASE ACTIVITY; ELECTRON-TRANSPORT; SESBANIA-ROSTRATA; N-2 FIXATION; COMPLEX-I; WILD-TYPE; RHIZOBIUM	Background: The microaerophilic bacterium Azorhizobium caulinodans, when fixing N-2 both in pure cultures held at 20 mu M dissolved O-2 tension and as endosymbiont of Sesbania rostrata legume nodules, employs a novel, respiratory-membrane endo-hydrogenase to oxidize and recycle endogenous H-2 produced by soluble Mo-dinitrogenase activity at the expense of O-2. Methods and Findings: From a bioinformatic analysis, this endo-hydrogenase is a core (6 subunit) version of (14 subunit) NADH:ubiquinone oxidoreductase (respiratory complex I). In pure A. caulinodans liquid cultures, when O-2 levels are lowered to <1 mu M dissolved O-2 tension (true microaerobic physiology), in vivo endo-hydrogenase activity reverses and continuously evolves H-2 at high rates. In essence, H-1 ions then supplement scarce O-2 as respiratory-membrane electron acceptor. Paradoxically, from thermodynamic considerations, such hydrogenic respiratory-membrane electron transfer need largely uncouple oxidative phosphorylation, required for growth of non-phototrophic aerobic bacteria, A. caulinodans included. Conclusions: A. caulinodans in vivo endo-hydrogenase catalytic activity is bidirectional. To our knowledge, this study is the first demonstration of hydrogenic respiratory-membrane electron transfer among aerobic (non-fermentative) bacteria. When compared with O-2 tolerant hydrogenases in other organisms, A. caulinodans in vivo endo-hydrogenase mediated H-2 production rates (50,000 pmol 10(9).cells(-1) min(-1)) are at least one-thousandfold higher. Conceivably, A. caulinodans respiratory-membrane hydrogenesis might initiate H-2 crossfeeding among spatially organized bacterial populations whose individual cells adopt distinct metabolic states in response to variant O-2 availability. Such organized, physiologically heterogeneous cell populations might benefit from augmented energy transduction and growth rates of the populations, considered as a whole.	[Sprecher, Brittany N.; Gittings, Margo E.; Ludwig, Robert A.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sprecher, BN (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	rludwig@ucsc.edu			California Institute for Quantitative Biosciences	California Institute for Quantitative Biosciences	This study was funded by the California Institute for Quantitative Biosciences (www.qb3.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GC, 1991, APPL ENVIRON MICROB, V57, P3220, DOI 10.1128/AEM.57.11.3220-3225.1991; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; BERGERSEN FJ, 1986, J GEN MICROBIOL, V132, P3325; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; BOOGERD FC, 1994, APPL ENVIRON MICROB, V60, P1859, DOI 10.1128/AEM.60.6.1859-1866.1994; BUCKMILLER LM, 1991, J BACTERIOL, V173, P2017, DOI 10.1128/jb.173.6.2017-2025.1991; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Ciccolella CO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012094; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DONALD RGK, 1985, J BACTERIOL, V162, P317, DOI 10.1128/JB.162.1.317-323.1985; DONALD RGK, 1986, J BACTERIOL, V165, P72, DOI 10.1128/jb.165.1.72-81.1986; DREYFUS BL, 1981, FEMS MICROBIOL LETT, V10, P313; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fox JD, 1996, J BACTERIOL, V178, P1515, DOI 10.1128/jb.178.6.1515-1524.1996; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Kaminski PA, 1996, J BACTERIOL, V178, P5989, DOI 10.1128/jb.178.20.5989-5994.1996; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Kotlyar AB, 2002, EUR J BIOCHEM, V269, P4020, DOI 10.1046/j.1432-1033.2002.03091.x; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOROCH AI, 1995, J BACTERIOL, V177, P7210, DOI 10.1128/jb.177.24.7210-7221.1995; Ludwig RA, 2004, RES MICROBIOL, V155, P61, DOI 10.1016/j.resmic.2003.11.001; LUDWIG RA, 1986, J BACTERIOL, V165, P304, DOI 10.1128/jb.165.1.304-307.1986; MEINHARDT SW, 1987, J BIOL CHEM, V262, P9147; Ng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004695; Pauling DC, 2001, MICROBIOL-SGM, V147, P2233, DOI 10.1099/00221287-147-8-2233; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCOTT A, 1966, J BIOL CHEM, V241, P1060; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; VINOGRADOV AD, 1993, J BIOENERG BIOMEMBR, V25, P367, DOI 10.1007/BF00762462; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; VREMAN HJ, 1988, CLIN CHEM, V34, P2562; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	36	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36744	10.1371/journal.pone.0036744	http://dx.doi.org/10.1371/journal.pone.0036744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22662125	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300033
J	Liou, YJ; Chen, CH; Cheng, CY; Chen, SY; Chen, TJ; Yu, YWY; Nian, FS; Tsai, SJ; Hong, CJ				Liou, Ying-Jay; Chen, Chien-Hsiun; Cheng, Chih-Ya; Chen, Shiow-Yi; Chen, Tai-Jui; Yu, Younger W-Y; Nian, Fang-Shin; Tsai, Shih-Jen; Hong, Chen-Jee			Convergent Evidence from Mouse and Human Studies Suggests the Involvement of Zinc Finger Protein 326 Gene in Antidepressant Treatment Response	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FORCED SWIMMING TEST; SEROTONIN REUPTAKE INHIBITORS; GENETICALLY SPECIFIC TYPES; QUANTITATIVE TRAIT LOCI; TAIL SUSPENSION TEST; REMISSION RATES; MICE; GENOME; DIFFERENTIATION	Objectives: The forced swim test (FST) is a commonly used model to predict antidepressant efficacy. Uncovering the genetic basis of the model may unravel the mechanism of antidepressant treatment. Methods: FVB/NJ (FVB) and C57BL/6J (B6) were first identified as the response and non-response strains to fluoxetine (a serotonin-specific reuptake inhibitor antidepressant) treatment in the mouse FST. Simple-interval (SIM) and composite-interval (CIM) mappings were applied to map the quantitative trait loci (QTLs) of the anti-immobility effect of fluoxetine in FST (FSTFLX) in 865 male B66FVB-F2 mice. The brain mRNA expressions of the gene with the maximum QTL-linkage signal for FSTFLX after the FST were compared between B6 and FVB mice and also compared between fluoxetine and saline treatment. The association of the variants in the human homologue of the mouse FSTFLX-QTL gene with major depressive disorder (MDD) and antidepressant response were investigated in 1080 human subjects (MDD/control = 582/498). Results: One linkage signal for FSTFLX-QTL was detected at an intronic SNP (rs6215396) of the mouse Zfp326 gene (maximal CIM-LOD = 9.36). The Zfp326 mRNA expression in the FVB thalamus was significantly down-regulated by fluoxetine in the FST, and the higher FVB-to-B6 Zfp326 mRNA expressions in the frontal cortex, striatum and hypothalamus diminished after fluoxetine treatment. Two coding-synonymous SNPs (rs2816881 and rs10922744) in the human homologue of Zfp326, ZNF326, were significantly associated with the 8-week antidepressant treatment response in the MDD patients (Bonferroni-corrected p = 0.004-0.028). Conclusions: The findings suggest the involvement of the Zfp326 and ZNF326 genes in antidepressant treatment response.	[Liou, Ying-Jay; Tsai, Shih-Jen; Hong, Chen-Jee] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Liou, Ying-Jay; Tsai, Shih-Jen; Hong, Chen-Jee] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan; [Nian, Fang-Shin; Hong, Chen-Jee] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Cheng, Chih-Ya] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chien-Hsiun] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Chen, Shiow-Yi] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Chen, Tai-Jui; Yu, Younger W-Y] Yus Psychiat Clin, Kaohsiung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; China Medical University Taiwan; National Taiwan Ocean University	Liou, YJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	cjhong@vghtpe.gov.tw	Tsai, Shih-Jen/AAK-7944-2020; Chen, Chien Hsiun/Q-3826-2018	Tsai, Shih-Jen/0000-0002-9987-022X; 	National Science Council, Taiwan [NSC 95-2314-B-075-108-MY2, 96-2314-B-075-065-MY2, 97-3112-B-075-005, 98-3112-B-075-005, 99-3112-B-075-005]; Taipei Veterans General Hospital, Taiwan [V98C1-055, V99A-045, V99C1-041 VGHUST98-P1-02, VGHUST99-P1-01]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC 95-2314-B-075-108-MY2, 96-2314-B-075-065-MY2, 97-3112-B-075-005, 98-3112-B-075-005 and 99-3112-B-075-005) and from Taipei Veterans General Hospital, Taiwan (V98C1-055, V99A-045, V99C1-041 VGHUST98-P1-02 and VGHUST99-P1-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett DK, 1997, GENET EPIDEMIOL, V14, P749, DOI 10.1002/(SICI)1098-2272(1997)14:6<749::AID-GEPI31>3.3.CO;2-I; Bauer Michael, 2002, World J Biol Psychiatry, V3, P5, DOI 10.3109/15622970209150599; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cheng ATA, 2001, BRIT J PSYCHIAT, V178, P567, DOI 10.1192/bjp.178.6.567; Crowley JJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2433, DOI 10.1038/sj.npp.1301065; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; Della Beffa Cristina, 2011, BMC Res Notes, V4, P443, DOI 10.1186/1756-0500-4-443; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Falconer D. S., 1996, INTRO QUANTITATIVE G; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Hong CJ, 2006, PHARMACOGENOMICS J, V6, P27, DOI 10.1038/sj.tpj.6500340; Kobayashi MS, 2004, J NEUROSCI RES, V76, P512, DOI 10.1002/jnr.20094; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leduc V, 2011, J NEUROSCI METH, V200, P14, DOI 10.1016/j.jneumeth.2011.05.026; Lee JY, 1998, DNA CELL BIOL, V17, P849, DOI 10.1089/dna.1998.17.849; Lee JY, 2000, DNA CELL BIOL, V19, P227, DOI 10.1089/104454900314492; Lerer B, 2002, INT J NEUROPSYCHOPH, V5, P255, DOI 10.1017/S1461145702002936; Liou YJ, 2009, PHARMACOGENET GENOM, V19, P735, DOI 10.1097/FPC.0b013e32832cbe61; Liu XQ, 2007, BIOL PSYCHIAT, V62, P81, DOI 10.1016/j.biopsych.2006.08.017; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Nembaware V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-265; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; OREILLY RL, 1994, BIOL PSYCHIAT, V36, P467, DOI 10.1016/0006-3223(94)90642-4; PARE CMB, 1971, J MED GENET, V8, P306, DOI 10.1136/jmg.8.3.306; PARE CMB, 1962, LANCET, V2, P1340; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Serretti A, 2008, PHARMACOGENOMICS J, V8, P90, DOI 10.1038/sj.tpj.6500477; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tecott LH, 2003, AM J PSYCHIAT, V160, P646, DOI 10.1176/appi.ajp.160.4.646; Tecott LH, 2001, ARCH GEN PSYCHIAT, V58, P995, DOI 10.1001/archpsyc.58.11.995; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; Thase ME, 2003, J CLIN PSYCHIAT, V64, P3; Tomida S, 2009, NAT GENET; Tsai SJ, 2008, PHARMACOGENOMICS J, V8, P384, DOI 10.1038/sj.tpj.6500486; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; Watters JW, 2003, TRENDS PHARMACOL SCI, V24, P55, DOI 10.1016/S0165-6147(02)00044-5; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yu YWY, 2002, MOL PSYCHIATR, V7, P1115, DOI 10.1038/sj.mp.4001141; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e32984	10.1371/journal.pone.0032984	http://dx.doi.org/10.1371/journal.pone.0032984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666313	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400002
J	van Bergeijk, P; Heimiller, J; Uyetake, L; Su, TT				van Bergeijk, Petra; Heimiller, Joseph; Uyetake, Lyle; Su, Tin Tin			Genome-Wide Expression Analysis Identifies a Modulator of Ionizing Radiation-Induced p53-Independent Apoptosis in Drosophila melanogaster	PLOS ONE			English	Article							N-TERMINAL KINASE; DNA-DAMAGE; GENE-EXPRESSION; CELL-DEATH; COMPENSATORY PROLIFERATION; SIGNALING PATHWAYS; P53 RESPONSE; HOMOLOG; FAMILY; REPAIR	Tumor suppressor p53 plays a key role in DNA damage responses in metazoa, yet more than half of human tumors show p53 deficiencies. Therefore, understanding how therapeutic genotoxins such as ionizing radiation (IR) can elicit DNA damage responses in a p53-independent manner is of clinical importance. Drosophila has been a good model to study the effects of IR because DNA damage responses as well as underlying genes are conserved in this model, and because streamlined gene families make loss-of-function analyses feasible. Indeed, Drosophila is the only genetically tractable model for IR-induced, p53-independent apoptosis and for tissue regeneration and homeostasis after radiation damage. While these phenomenon occur only in the larvae, all genome-wide gene expression analyses after irradiation to date have been in embryos. We report here the first analysis of IR-induced, genome-wide gene expression changes in wild type and p53 mutant Drosophila larvae. Key data from microarrays were confirmed by quantitative RT-PCR. The results solidify the central role of p53 in IR-induced transcriptome changes, but also show that nearly all changes are made of both p53-dependent and p53-independent components. p53 is found to be necessary not just for the induction of but also for the repression of transcript levels for many genes in response to IR. Furthermore, Functional analysis of one of the top-changing genes, EF1a-100E, implicates it in repression of IR-induced p53-independent apoptosis. These and other results support the emerging notion that there is not a single dominant mechanism but that both positive and negative inputs collaborate to induce p53-independent apoptosis in response to IR in Drosophila larvae.	[van Bergeijk, Petra; Heimiller, Joseph; Uyetake, Lyle; Su, Tin Tin] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	van Bergeijk, P (corresponding author), Univ Utrecht, Div Cell Biol, Dept Biol, Fac Sci, Utrecht, Netherlands.	tin.su@colorado.edu		Heimiller, Joseph/0000-0002-7770-3746	National Institutes of Health [RO1GM87276, T32GM007135]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM087276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (RO1GM87276) to TTS. JH was supported by a pre-doctoral training grant from the National Institutes of Health (T32GM007135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZK, 2009, ARCH OTOLARYNGOL, V135, P662, DOI 10.1001/archoto.2009.79; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gladstone M, 2012, DIS MODELS MECH; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; McNamee LM, 2009, GENETICS, V182, P423, DOI 10.1534/genetics.109.102327; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Peretz G, 2007, GENETICS, V177, P1691, DOI 10.1534/genetics.107.079517; Rashi-Elkeles S, 2011, MOL ONCOL, V5, P336, DOI 10.1016/j.molonc.2011.06.004; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sokolov M, 2006, RADIAT PROT DOSIM, V122, P195, DOI 10.1093/rpd/ncl423; Sokolov MV, 2011, MUTAT RES-FUND MOL M, V709-10, P40, DOI 10.1016/j.mrfmmm.2011.02.008; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vardhanabhuti S, 2006, OMICS, V10, P555, DOI 10.1089/omi.2006.10.555; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wakatsuki M, 2008, INT J RADIAT ONCOL, V70, P1189, DOI 10.1016/j.ijrobp.2007.08.033; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Wells BS, 2011, DEV BIOL IN PRESS; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018	46	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e36539	10.1371/journal.pone.0036539	http://dx.doi.org/10.1371/journal.pone.0036539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666323	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349600005
J	Dehghan, M; del Cerro, S; Zhang, XH; Cuneo, JM; Linetzky, B; Diaz, R; Merchant, AT				Dehghan, Mahshid; del Cerro, Silvia; Zhang, Xiaohe; Maini Cuneo, Jose; Linetzky, Bruno; Diaz, Rafael; Merchant, Anwar T.			Validation of a Semi-Quantitative Food Frequency Questionnaire for Argentinean Adults	PLOS ONE			English	Article							DIETARY ASSESSMENT; PROSPECTIVE URBAN; HIGH-INCOME; VALIDITY; REPRODUCIBILITY; CANCER; MIDDLE; PURE	Background: The Food Frequency Questionnaire (FFQ) is the most commonly used method for ranking individuals based on long term food intake in large epidemiological studies. The validation of an FFQ for specific populations is essential as food consumption is culture dependent. The aim of this study was to develop a Semi-quantitative Food Frequency Questionnaire (SFFQ) and evaluate its validity and reproducibility in estimating nutrient intake in urban and rural areas of Argentina. Methods/Principal Findings: Overall, 256 participants in the Argentinean arm of the ongoing Prospective Urban and Rural Epidemiological study (PURE) were enrolled for development and validation of the SFFQ. One hundred individuals participated in the SFFQ development. The other 156 individuals completed the SFFQs on two occasions, four 24-hour Dietary Recalls (24DRs) in urban, and three 24DRs in rural areas during a one-year period. Correlation coefficients (r) and de-attenuated correlation coefficients between 24DRs and SFFQ were calculated for macro and micro-nutrients. The level of agreement between the two methods was evaluated using classification into same and extreme quartiles and the Bland-Altman method. The reproducibility of the SFFQ was assessed by Pearson correlation coefficients and Intra-class Correlation Coefficients (ICC). The SFFQ consists of 96 food items. In both urban and rural settings de-attenuated correlations exceeded 0.4 for most of the nutrients. The classification into the same and adjacent quartiles was more than 70% for urban and 60% for rural settings. The Pearson correlation between two SFFQs varied from 0.30-0.56 and 0.32-0.60 in urban and rural settings, respectively. Conclusion: Our results showed that this SFFQ had moderate relative validity and reproducibility for macro and micronutrients in relation to the comparison method and can be used to rank individuals based on habitual nutrient intake.	[Dehghan, Mahshid; Zhang, Xiaohe] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [del Cerro, Silvia; Maini Cuneo, Jose; Linetzky, Bruno; Diaz, Rafael] Estudios Clin Latinoamer ECLA, Dept Clin Res, Rosario, Argentina; [Merchant, Anwar T.] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	McMaster University; Population Health Research Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dehghan, M (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	Mahshid.Dehghan@phri.ca						Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921; Bautista LE, 2005, PUBLIC HEALTH NUTR, V8, P181, DOI 10.1079/PHN2004672; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brunner E, 2001, BRIT J NUTR, V86, P405, DOI 10.1079/BJN2001414; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x; Dehghan M, 2011, J NUTR EDUC BEHAV; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Jackson MD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-28; Kim EHJ, 2011, NUTR CANCER, V63, P381, DOI 10.1080/01635581.2011.535963; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; McKeown NM, 2001, AM J CLIN NUTR, V74, P188; Merchant AT, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-37; Merchant AT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-2; Molag ML, 2007, AM J EPIDEMIOL, V166, P1468, DOI 10.1093/aje/kwm236; Navarro A, 2001, J EXP CLIN CANC RES, V20, P365; Nelson M, 1997, PHOTOGRAPHIC ATLAS F; Schroder H, 2001, CLIN NUTR, V20, P429, DOI 10.1054/clnu.2001.0460; Segovia-Siapco G, 2007, PUBLIC HEALTH NUTR, V10, P177, DOI 10.1017/S1368980007226047; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Willett WC, 1998, NUTR EPIDEMIOLOGY, P101, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.06; Xia W, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0019656; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	27	45	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37958	10.1371/journal.pone.0037958	http://dx.doi.org/10.1371/journal.pone.0037958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662256	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300147
J	Liu, J; Liu, HX; Sefah, K; Liu, B; Pu, Y; Van Simaeys, D; Tan, WH				Liu, Jun; Liu, Huixia; Sefah, Kwame; Liu, Bo; Pu, Ying; Van Simaeys, Dimitri; Tan, Weihong			Selection of Aptamers Specific for Adipose Tissue	PLOS ONE			English	Article							FATTY-ACID UPTAKE; 3T3-L1 ADIPOCYTES; BIOMARKER DISCOVERY; CARDIOVASCULAR-DISEASE; TRANSFERRIN RECEPTORS; MOLECULAR RECOGNITION; METABOLIC SYNDROME; CELL SELEX; INSULIN; DIFFERENTIATION	Background: Obesity has reached epidemic proportions, affecting more than one tenth of the world's population. As such, adipose tissue is being increasingly recognized as an important therapeutic target for obesity and related metabolic disorders. While many potential targets of adipose tissue have been established and drugs developed, very few of those drugs specifically target adipose tissue without affecting other tissue. This results from a limited knowledge of both cell-surface markers and physicochemical traits specific to adipocytes that might otherwise be exploited by circulating drugs. Methodology/Principal Findings: Here we report the use of cell-SELEX technology to select two aptamers that can specifically recognize mature adipocytes: adipo-1 and adipo-8. Adipo-8 shows high affinity for differentiated, mature 3T3-L1 adipocytes with a K-d value of 17.8 +/- 5.1 nM. The binding was sustained upon incubation at 37 degrees C and insulin stimulation, but was lost upon trypsin treatment. The binding ability was also verified on frozen tissue slides with low background fluorescence and isolated adipocytes. Conclusions/Significance: Aptamer adipo-8 selected from a random library appears to bind to mature differentiated adipocytes specifically. This aptamer holds great promise as a molecular recognition tool for adipocyte biomarker discovery or for targeted delivery of molecules to adipocytes.	[Liu, Jun; Liu, Huixia; Liu, Bo; Pu, Ying] Cent S Univ, Xiangya Hosp, Div Geriatr, Changsha, Hunan, Peoples R China; [Liu, Jun; Sefah, Kwame; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA; [Liu, Jun; Sefah, Kwame; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Shands Canc Ctr, UF Genet Inst, Gainesville, FL 32611 USA; [Liu, Jun; Sefah, Kwame; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Central South University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liu, J (corresponding author), Cent S Univ, Xiangya Hosp, Div Geriatr, Changsha, Hunan, Peoples R China.	lhx900@yahoo.com.cn; tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Tan, Weihong/0000-0002-8066-1524; Van Simaeys, Dimitri/0000-0003-3457-761X	National Key Scientific Program of China [2011CB911001, 2011CB911003]; Natural Science Foundation of Hunan Province, China [07JJ5108]; National Institutes of Health [GM066137, GM079359, CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359, R01GM066137] Funding Source: NIH RePORTER	National Key Scientific Program of China; Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Key Scientific Program of China (2011CB911001, 2011CB911003) and by the Natural Science Foundation of Hunan Province (07JJ5108), China. This work is also supported by grants awarded by the National Institutes of Health (GM066137, GM079359 and CA133086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-45; Berezovski MV, 2008, J AM CHEM SOC, V130, P9137, DOI 10.1021/ja801951p; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bergman RN, 2001, J INVEST MED, V49, P119, DOI 10.2310/6650.2001.34108; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Ching JK, 2010, AM J PHYSIOL-CELL PH, V299, pC1171, DOI 10.1152/ajpcell.00514.2009; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim YM, 2009, BIOMARK MED, V3, P193, DOI 10.2217/BMM.09.5; Klein J, 2006, TRENDS ENDOCRIN MET, V17, P26, DOI 10.1016/j.tem.2005.11.008; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kratchmarova I, 2002, MOL CELL PROTEOMICS, V1, P213, DOI 10.1074/mcp.M200006-MCP200; Le TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005189; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Li SH, 2009, J PATHOL, V218, P327, DOI 10.1002/path.2543; Liu J, 2011, ENDOCR J, V58, P199, DOI 10.1507/endocrj.K10E-318; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Ulrich H, 2009, CYTOM PART A, V75A, P727, DOI 10.1002/cyto.a.20766; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; ZHOU SL, 1992, J BIOL CHEM, V267, P14456	39	10	14	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37789	10.1371/journal.pone.0037789	http://dx.doi.org/10.1371/journal.pone.0037789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662223	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300113
J	Schulz, P; Neukermans, J; Van der Kelen, K; Muhlenbock, P; Van Breusegem, F; Noctor, G; Teige, M; Metzlaff, M; Hannah, MA				Schulz, Philipp; Neukermans, Jenny; Van der Kelen, Katrien; Muhlenbock, Per; Van Breusegem, Frank; Noctor, Graham; Teige, Markus; Metzlaff, Michael; Hannah, Matthew A.			Chemical PARP Inhibition Enhances Growth of Arabidopsis and Reduces Anthocyanin Accumulation and the Activation of Stress Protective Mechanisms	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; POLY(ADP-RIBOSE) POLYMERASE; OXIDATIVE STRESS; GENE-EXPRESSION; ADP-RIBOSYLATION; DROUGHT STRESS; REDOX STATE; CELL-DEATH; HIGH LIGHT; SECONDARY METABOLISM	Poly-ADP-ribose polymerase (PARP) post-translationally modifies proteins through the addition of ADP-ribose polymers, yet its role in modulating plant development and stress responses is only poorly understood. The experiments presented here address some of the gaps in our understanding of its role in stress tolerance and thereby provide new insights into tolerance mechanisms and growth. Using a combination of chemical and genetic approaches, this study characterized phenotypes associated with PARP inhibition at the physiological level. Molecular analyses including gene expression analysis, measurement of primary metabolites and redox metabolites were used to understand the underlying processes. The analysis revealed that PARP inhibition represses anthocyanin and ascorbate accumulation under stress conditions. The reduction in defense is correlated with enhanced biomass production. Even in unstressed conditions protective genes and molecules are repressed by PARP inhibition. The reduced anthocyanin production was shown to be based on the repression of transcription of key regulatory and biosynthesis genes. PARP is a key factor for understanding growth and stress responses of plants. PARP inhibition allows plants to reduce protection such as anthocyanin, ascorbate or Non-Photochemical-Quenching whilst maintaining high energy levels likely enabling the observed enhancement of biomass production under stress, opening interesting perspectives for increasing crop productivity.	[Schulz, Philipp; Metzlaff, Michael; Hannah, Matthew A.] Bayer CropSci NV, Ghent, Belgium; [Schulz, Philipp; Teige, Markus] Univ Vienna, Dept Biochem & Cell Biol, MFPL, Vienna, Austria; [Neukermans, Jenny; Noctor, Graham] Univ Paris 11, Inst Biol Plantes, Orsay, France; [Van der Kelen, Katrien; Muhlenbock, Per; Van Breusegem, Frank] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Van der Kelen, Katrien; Muhlenbock, Per; Van Breusegem, Frank] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Bayer AG; Bayer CropScience; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); UDICE-French Research Universities; Universite Paris Saclay; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Schulz, P (corresponding author), Bayer CropSci NV, Ghent, Belgium.	matthew.hannah@bayer.com	Van Breusegem, Frank/AAJ-2647-2020; Noctor, Graham/H-3157-2015; Teige, Markus/R-6443-2016; Van Breusegem, Frank/Y-2999-2019	Van Breusegem, Frank/0000-0002-3147-0860; Teige, Markus/0000-0001-7204-1379; Neukermans, Jenny/0000-0002-2618-7198; Van Der Kelen, Katrien/0000-0002-7686-8477; Hannah, Matthew/0000-0002-4889-490X	Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2009-235827]; EU [ITN-GA-2008-215174]; Multidisciplinary Research Partnership Ghent Bio-economy; Institute for the Promotion of Innovation by Science and technology in Flanders, Belgium (Research and Development project "Phoenix'')	Marie Curie Intra-European Fellowship for Career Development; EU(European Commission); Multidisciplinary Research Partnership Ghent Bio-economy; Institute for the Promotion of Innovation by Science and technology in Flanders, Belgium (Research and Development project "Phoenix'')	P.M. is the recipient of a Marie Curie Intra-European Fellowship for Career Development (PIEF-GA-2009-235827). The project was supported by the EU funded Marie-Curie ITN project on "Chloroplast signals'' (COSI) (ITN-GA-2008-215174), the Multidisciplinary Research Partnership Ghent Bio-economy and the Institute for the Promotion of Innovation by Science and technology in Flanders, Belgium (Research and Development project "Phoenix''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Amor Y, 1998, FEBS LETT, V440, P1, DOI 10.1016/S0014-5793(98)01408-2; Arena C, 2011, PLANT PHYSIOL BIOCH, V49, P435, DOI 10.1016/j.plaphy.2011.02.004; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Babiychuk E, 2001, PLANT J, V28, P245, DOI 10.1046/j.1365-313X.2001.01143.x; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Berglund T, 1996, FEBS LETT, V380, P188, DOI 10.1016/0014-5793(96)00027-0; Briggs AG, 2011, TRENDS PLANT SCI, V16, P372, DOI 10.1016/j.tplants.2011.03.008; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHEN YM, 1994, EUR J BIOCHEM, V224, P135, DOI 10.1111/j.1432-1033.1994.tb20004.x; Chung HJ, 1999, PLANT PHYSIOL, V121, P429, DOI 10.1104/pp.121.2.429; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Block M, 2005, PLANT J, V41, P95, DOI 10.1111/j.1365-313X.2004.02277.x; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; Divi UK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-151; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge LF, 2008, PLANTA, V228, P191, DOI 10.1007/s00425-008-0729-x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDERER G, 1991, BIOCHEM J, V277, P607, DOI 10.1042/bj2770607; Gould KS, 2002, PHYSIOL PLANTARUM, V116, P127, DOI 10.1034/j.1399-3054.2002.1160116.x; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hernandez I, 2010, PLANT SCI, V179, P297, DOI 10.1016/j.plantsci.2010.06.001; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Hughes NM, 2010, J EXP BOT, V61, P1699, DOI 10.1093/jxb/erq042; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; HWANG SY, 1991, PLANT PHYSIOL, V97, P593, DOI 10.1104/pp.97.2.593; Ishikawa T, 2010, PLANT CELL PHYSIOL, V51, P9, DOI 10.1093/pcp/pcp162; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kornas A, 2010, ACTA BIOCHIM POL, V57, P143; Lamb RS, 2012, CELL MOL LIFE SCI, V69, P175, DOI 10.1007/s00018-011-0793-4; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; LEPINIEC L, 1995, FEBS LETT, V364, P103, DOI 10.1016/0014-5793(95)00335-7; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; McCourt P, 2010, NEW PHYTOL, V185, P15, DOI 10.1111/j.1469-8137.2009.03045.x; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Munne-Bosch S, 2003, PLANT PHYSIOL, V131, P1816, DOI 10.1104/pp.102.019265; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagata T, 2003, J AGR FOOD CHEM, V51, P2992, DOI 10.1021/jf026179+; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Noctor G, 2007, METABOLOMICS, V3, P161, DOI 10.1007/s11306-007-0057-3; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pellny TK, 2009, MOL PLANT, V2, P442, DOI 10.1093/mp/ssp008; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; RANKIN PW, 1989, J BIOL CHEM, V264, P4312; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Smyth GK, 2004, STAT APP GEN MOL BIO, V3; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Storozhenko S, 2001, J EXP BOT, V52, P1375, DOI 10.1093/jexbot/52.359.1375; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Teotia S, 2009, PLANT PHYSIOL, V151, P180, DOI 10.1104/pp.109.142786; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tian RH, 2000, FEBS LETT, V474, P11, DOI 10.1016/S0014-5793(00)01561-1; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Toth R, 2010, TRENDS PLANT SCI, V15, P81, DOI 10.1016/j.tplants.2009.11.005; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Vanderauwera S, 2007, P NATL ACAD SCI USA, V104, P15150, DOI 10.1073/pnas.0706668104; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	94	40	43	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37287	10.1371/journal.pone.0037287	http://dx.doi.org/10.1371/journal.pone.0037287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662141	Green Published, gold			2022-12-27	WOS:000305342300031
J	Wiysonge, CS; Uthman, OA; Ndumbe, PM; Hussey, GD				Wiysonge, Charles S.; Uthman, Olalekan A.; Ndumbe, Peter M.; Hussey, Gregory D.			Individual and Contextual Factors Associated with Low Childhood Immunisation Coverage in Sub-Saharan Africa: A Multilevel Analysis	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; VACCINATION; CHILDREN; COSTS; DETERMINANTS; STRATEGIES; NIGERIA; MEASLES; HEALTH	Background: In 2010, more than six million children in sub-Saharan Africa did not receive the full series of three doses of the diphtheria-tetanus-pertussis vaccine by one year of age. An evidence-based approach to addressing this burden of unimmunised children requires accurate knowledge of the underlying factors. We therefore developed and tested a model of childhood immunisation that includes individual, community and country-level characteristics. Method and Findings: We conducted multilevel logistic regression analysis of Demographic and Health Survey data for 27,094 children aged 12-23 months, nested within 8,546 communities from 24 countries in sub-Saharan Africa. According to the intra-country and intra-community correlation coefficient implied by the estimated intercept component variance, 21% and 32% of the variance in unimmunised children were attributable to country- and community-level factors respectively. Children born to mothers (OR 1.35, 95%CI 1.18 to 1.53) and fathers (OR 1.13, 95%CI 1.12 to 1.40) with no formal education were more likely to be unimmunised than those born to parents with secondary or higher education. Children from the poorest households were 36% more likely to be unimmunised than counterparts from the richest households. Maternal access to media significantly reduced the odds of children being unimmunised (OR 0.94, 95%CI 0.94 to 0.99). Mothers with health seeking behaviours were less likely to have unimmunised children (OR 0.56, 95%CI 0.54 to 0.58). However, children from urban areas (OR 1.12, 95% CI 1.01 to 1.23), communities with high illiteracy rates (OR 1.13, 95% CI 1.05 to 1.23), and countries with high fertility rates (OR 4.43, 95% CI 1.04 to 18.92) were more likely to be unimmunised. Conclusion: We found that individual and contextual factors were associated with childhood immunisation, suggesting that public health programmes designed to improve coverage of childhood immunisation should address people, and the communities and societies in which they live.	[Wiysonge, Charles S.; Hussey, Gregory D.] Univ Cape Town, Vaccines Africa Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Wiysonge, Charles S.; Hussey, Gregory D.] Univ Cape Town, Div Med Microbiol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Uthman, Olalekan A.] African Publ Hlth Fdn, Abuja, Nigeria; [Uthman, Olalekan A.] Keele Univ, Keele, Staffs, England; [Ndumbe, Peter M.] Univ Buea, Fac Hlth Sci, Buea, Cameroon	University of Cape Town; University of Cape Town; Keele University	Wiysonge, CS (corresponding author), Univ Cape Town, Vaccines Africa Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	charles.wiysonge@uct.ac.za	Wiysonge, Charles Shey U/A-3843-2008; Uthman, Olalekan/N-5584-2019	Wiysonge, Charles Shey U/0000-0002-1273-4779; Uthman, Olalekan/0000-0002-8567-3081				Antai D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-181; Antai D, 2009, J BIOSOC SCI, V41, P57, DOI 10.1017/S0021932008002861; Babalola S, 2009, MATERN CHILD HLTH J, V13, P550, DOI 10.1007/s10995-008-0386-5; Bale C, 2011, PEDIATR INFECT DIS J, V30, P689, DOI 10.1097/INF.0b013e31821786a4; Batt K, 2004, B WORLD HEALTH ORGAN, V82, P689; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Clements CJ, 2008, VACCINE, V26, P1926, DOI 10.1016/j.vaccine.2008.02.032; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Measure DHS, 2011, DEMOGRAPHIC HLTH SUR; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Oladokun R E, 2009, Afr J Med Med Sci, V38, P9; Osgood D.W., 2003, JUVENILE DELINQUENCY, P12; Oyo-Ita A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008145.pub2; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Rasbash J, 2011, USERS GUIDE MLWIN VE; Ryman TK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-134; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Sanou A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S10; Sia D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-416; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sullivan MC, 2010, J COMMUN HEALTH, V35, P53, DOI 10.1007/s10900-009-9192-2; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; WARNER BD, 1993, CRIMINOLOGY, V31, P493, DOI 10.1111/j.1745-9125.1993.tb01139.x; Waters HR, 2004, B WORLD HEALTH ORGAN, V82, P668; Wiysonge CS, 2007, TROP DOCT, V37, P125, DOI 10.1177/004947550703700233; Wiysonge CS, 2009, LANCET, V373, P1174, DOI 10.1016/S0140-6736(09)60685-1; Wiysonge CS, 2002, LANCET, V359, P713, DOI 10.1016/S0140-6736(02)07798-X; Wiysonge CS, 2006, LANCET, V367, P394, DOI 10.1016/S0140-6736(06)68133-6; World Bank, WORLD BANK DAT; World Health Organization, 2010, WHO VACC PREV DIS MO	36	125	126	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37905	10.1371/journal.pone.0037905	http://dx.doi.org/10.1371/journal.pone.0037905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662247	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300138
J	Zell, E; Balcetis, E				Zell, Ethan; Balcetis, Emily			The Influence of Social Comparison on Visual Representation of One's Face	PLOS ONE			English	Article							BODY-IMAGE; SELF; RECOGNITION; VIEWPOINT; ATTRACTIVENESS; ENHANCEMENT; ADAPTATION; AWARENESS; IDENTITY; MIRROR	Can the effects of social comparison extend beyond explicit evaluation to visual self-representation-a perceptual stimulus that is objectively verifiable, unambiguous, and frequently updated? We morphed images of participants' faces with attractive and unattractive references. With access to a mirror, participants selected the morphed image they perceived as depicting their face. Participants who engaged in upward comparison with relevant attractive targets selected a less attractive morph compared to participants exposed to control images (Study 1). After downward comparison with relevant unattractive targets compared to control images, participants selected a more attractive morph (Study 2). Biased representations were not the products of cognitive accessibility of beauty constructs; comparisons did not influence representations of strangers' faces (Study 3). We discuss implications for vision, social comparison, and body image.	[Zell, Ethan] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA; [Balcetis, Emily] NYU, Dept Psychol, New York, NY 10003 USA	University of North Carolina; University of North Carolina Greensboro; New York University	Zell, E (corresponding author), Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.	e_zell@uncg.edu						Anton S D, 2000, Eat Behav, V1, P153, DOI 10.1016/S1471-0153(00)00015-5; Borod J. C., 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; BROWN JD, 1992, J PERS SOC PSYCHOL, V62, P717, DOI 10.1037/0022-3514.62.5.717; Buckingham JT, 2002, J PERS SOC PSYCHOL, V83, P1117, DOI 10.1037//0022-3514.83.5.1117; Burke P H, 1992, Br J Orthod, V19, P273; CARTER LF, 1949, PSYCHOL REV, V56, P200, DOI 10.1037/h0060745; CASH TF, 1983, PERS SOC PSYCHOL B, V9, P351, DOI 10.1177/0146167283093004; Clerkin EM, 2008, COGNITION EMOTION, V22, P1327, DOI 10.1080/02699930701766099; Crerand CE, 2006, PLAST RECONSTR SURG, V118, p167E, DOI 10.1097/01.prs.0000242500.28431.24; DARLEY JM, 1983, J PERS SOC PSYCHOL, V44, P20, DOI 10.1037/0022-3514.44.1.20; DUNNING D, 1992, J PERS SOC PSYCHOL, V63, P341, DOI 10.1037/0022-3514.63.3.341; Dunning D., 2001, BLACKWELL HDB SOCIAL, P348, DOI DOI 10.1002/9780470998519.ch16; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; ERDELYI MH, 1974, PSYCHOL REV, V81, P1, DOI 10.1037/h0035852; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gebauer JE, 2008, J EXP SOC PSYCHOL, V44, P1346, DOI 10.1016/j.jesp.2008.03.016; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Gramzow RH, 2006, PERS SOC PSYCHOL B, V32, P1114, DOI 10.1177/0146167206288600; Gurari I, 2006, BASIC APPL SOC PSYCH, V28, P273, DOI 10.1207/s15324834basp2803_6; HERR PM, 1986, J PERS SOC PSYCHOL, V51, P1106, DOI 10.1037/0022-3514.51.6.1106; Jaquet E, 2008, J EXP PSYCHOL HUMAN, V34, P101, DOI 10.1037/0096-1523.34.1.101; Kawakami K, 2012, J PERS SOC PSYCHOL, V102, P562, DOI 10.1037/a0025970; Khurana B, 2000, J EXP PSYCHOL HUMAN, V26, P246, DOI 10.1037/0096-1523.26.1.246; Krizan Z, 2007, PSYCHOL BULL, V133, P95, DOI 10.1037/0033-2909.133.1.95; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Laurence S, VIS COG IN PRESS; Laurence S, 2011, PERCEPTION, V40, P450, DOI 10.1068/p6774; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Maltby J, 2005, BRIT J HEALTH PSYCH, V10, P17, DOI 10.1348/135910704X15257; Mendes WB, 2001, EUR J SOC PSYCHOL, V31, P477, DOI 10.1002/ejsp.80; Moskowitz GB, 1999, J PERS SOC PSYCHOL, V76, P911, DOI 10.1037/0022-3514.76.6.911; Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004; Mussweiler T., 2005, SELF SOCIAL JUDGMENT, P109; Or CCF, 2010, VISION RES, V50, P1581, DOI 10.1016/j.visres.2010.05.016; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Pham-Kanter G, 2009, SOC SCI MED, V69, P335, DOI 10.1016/j.socscimed.2009.05.017; Polivy J, 2002, ANNU REV PSYCHOL, V53, P187, DOI 10.1146/annurev.psych.53.100901.135103; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Pyszczynski T, 1987, PSYCHOL BULL, P122; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ryu JJ, 2006, VISION RES, V46, P4059, DOI 10.1016/j.visres.2006.07.018; Scherer LD, 2009, J PERS SOC PSYCHOL, V97, P383, DOI 10.1037/a0015844; Senik C, 2009, J ECON BEHAV ORGAN, V72, P408, DOI 10.1016/j.jebo.2009.04.019; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Silvia PJ, 2001, PERS SOC PSYCHOL REV, V5, P230, DOI 10.1207/S15327957PSPR0503_4; Stone A, 2004, PSYCHON B REV, V11, P469, DOI 10.3758/BF03196597; Stone A, 2003, CORTEX, V39, P31, DOI 10.1016/S0010-9452(08)70072-8; Stone A, 2001, COGN AFFECT BEHAV NE, V1, P183, DOI 10.3758/CABN.1.2.183; Summerville A, 2008, J EXP SOC PSYCHOL, V44, P664, DOI 10.1016/j.jesp.2007.04.002; Sweeney PD, 2005, J OCCUP ORGAN PSYCH, V78, P113, DOI 10.1348/096317904X23808; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; van den Berg P, 2007, BODY IMAGE, V4, P29, DOI 10.1016/j.bodyim.2006.12.004; Van Overwalle F, 2012, J EXP SOC PSYCHOL, V48, P13, DOI 10.1016/j.jesp.2011.06.016; Verosky SC, 2010, NEUROIMAGE, V49, P1690, DOI 10.1016/j.neuroimage.2009.10.017; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360	60	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36742	10.1371/journal.pone.0036742	http://dx.doi.org/10.1371/journal.pone.0036742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662124	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300015
J	Zhu, HS; Vadigepalli, R; Rafferty, R; Gonye, GE; Weaver, DR; Schwaber, JS				Zhu, Haisun; Vadigepalli, Rajanikanth; Rafferty, Rachel; Gonye, Gregory E.; Weaver, David R.; Schwaber, James S.			Integrative Gene Regulatory Network Analysis Reveals Light-Induced Regional Gene Expression Phase Shift Programs in the Mouse Suprachiasmatic Nucleus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GABP; PHOTIC REGULATION; CREB PHOSPHORYLATION; CIRCADIAN VARIATION; PERIOD HOMOLOGS; IDENTIFICATION; ORGANIZATION; CLOCK; CELLS; MODEL	We use the multigenic pattern of gene expression across suprachiasmatic nuclei (SCN) regions and time to understand the dynamics within the SCN in response to a circadian phase-resetting light pulse. Global gene expression studies of the SCN indicate that circadian functions like phase resetting are complex multigenic processes. While the molecular dynamics of phase resetting are not well understood, it is clear they involve a "functional gene expression program'', e. g., the coordinated behavior of functionally related genes in space and time. In the present study we selected a set of 89 of these functionally related genes in order to further understand this multigenic program. By use of high-throughput qPCR we studied 52 small samples taken by anatomically precise laser capture from within the core and shell SCN regions, and taken at time points with and without phase resetting light exposure. The results show striking regional differences in light response to be present in the mouse SCN. By using network-based analyses, we are able to establish a highly specific multigenic correlation between genes expressed in response to light at night and genes normally activated during the day. The light pulse triggers a complex and highly coordinated network of gene regulation. The largest differences marking neuroanatomical location are in transmitter receptors, and the largest time-dependent differences occur in clock-related genes. Nighttime phase resetting appears to recruit transcriptional regulatory processes normally active in the day. This program, or mechanism, causes the pattern of core region gene expression to transiently shift to become more like that of the shell region.	[Zhu, Haisun; Vadigepalli, Rajanikanth; Rafferty, Rachel; Gonye, Gregory E.; Schwaber, James S.] Thomas Jefferson Univ, Daniel Baugh Inst, Philadelphia, PA 19107 USA; [Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA	Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Zhu, HS (corresponding author), Thomas Jefferson Univ, Daniel Baugh Inst, Philadelphia, PA 19107 USA.	james.schwaber@jefferson.edu		Weaver, David/0000-0001-7941-6719; Vadigepalli, Rajanikanth/0000-0002-8405-1037; schwaber, james/0000-0003-0598-7345	National Institutes of Health [R01GM076495, R01GM083108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083108, R01GM076495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM076495 and R01GM083108. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Antle MC, 2007, J BIOL RHYTHM, V22, P14, DOI 10.1177/0748730406296319; Araki R, 2006, BRAIN RES, V1098, P9, DOI 10.1016/j.brainres.2006.04.096; ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; Bannert N, 1999, P NATL ACAD SCI USA, V96, P1541, DOI 10.1073/pnas.96.4.1541; Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Clarke C, 2011, J BIOTECHNOL, V155, P350, DOI 10.1016/j.jbiotec.2011.07.011; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding JM, 1997, J NEUROSCI, V17, P667; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; EARNEST DJ, 1990, EXP NEUROL, V109, P353, DOI 10.1016/S0014-4886(05)80027-5; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; IBATA Y, 1989, NEUROSCI LETT, V97, P1, DOI 10.1016/0304-3940(89)90129-8; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Kang HS, 2008, J MOL BIOL, V377, P636, DOI 10.1016/j.jmb.2008.01.054; Karatsoreos IN, 2004, J NEUROSCI, V24, P68, DOI 10.1523/JNEUROSCI.1666-03.2004; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kornhauser JM, 1996, BEHAV GENET, V26, P221, DOI 10.1007/BF02359382; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Porterfield VM, 2009, NEUROSCI LETT, V463, P70, DOI 10.1016/j.neulet.2009.07.066; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1992, MOL BRAIN RES, V14, P124, DOI 10.1016/0169-328X(92)90019-8; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schroder S, 2012, J BIOL RHYTHM, V27, P79, DOI 10.1177/0748730411429659; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tanaka M, 1997, NEUROREPORT, V8, P2187, DOI 10.1097/00001756-199707070-00020; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; UHL GR, 1986, SCIENCE, V232, P390, DOI 10.1126/science.3961487; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Welsh DK, 2007, J BIOL RHYTHM, V22, P26, DOI 10.1177/0748730406297067; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	61	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37833	10.1371/journal.pone.0037833	http://dx.doi.org/10.1371/journal.pone.0037833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662235	Green Published, gold			2022-12-27	WOS:000305342300125
J	Kubo, M; Li, TS; Kurazumi, H; Takemoto, Y; Ohshima, M; Yamamoto, Y; Nishimoto, A; Mikamo, A; Fujimoto, M; Nakai, A; Hamano, K				Kubo, Masayuki; Li, Tao-Sheng; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ohshima, Mako; Yamamoto, Yumi; Nishimoto, Arata; Mikamo, Akihito; Fujimoto, Mitsuaki; Nakai, Akira; Hamano, Kimikazu			Heat Shock Factor 1 Contributes to Ischemia-Induced Angiogenesis by Regulating the Mobilization and Recruitment of Bone Marrow Stem/Progenitor Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; TRANSCRIPTION FACTOR-1; ISCHEMIA/REPERFUSION INJURY; THERAPEUTIC ANGIOGENESIS; PROTEOTOXIC STRESS; HINDLIMB ISCHEMIA; STEM-CELLS; NEOVASCULARIZATION; POTENCY; DISEASE	Bone marrow (BM)-derived stem/progenitor cells play an important role in ischemia-induced angiogenesis in cardiovascular diseases. Heat shock factor 1 (HSF1) is known to be induced in response to hypoxia and ischemia. We examined whether HSF1 contributes to ischemia-induced angiogenesis through the mobilization and recruitment of BM-derived stem/progenitor cells using HSF1-knockout (KO) mice. After the induction of ischemia, blood flow and microvessel density in the ischemic hindlimb were significantly lower in the HSF1-KO mice than in the wild-type (WT) mice. The mobilization of BM-derived Sca-1- and c-kit-positive cells in peripheral blood after ischemia was significantly lower in the HSF1-KO mice than in the WT mice. BM stem/progenitor cells from HSF1-KO mice showed a significant decrease in their recruitment to ischemic tissue and in migration, adhesion, and survival when compared with WT mice. Blood flow recovery in the ischemic hindlimb significantly decreased in WT mice receiving BM reconstitution with donor cells from HSF1-KO mice. Conversely, blood flow recovery in the ischemic hindlimb significantly increased in HSF1-KO mice receiving BM reconstitution with donor cells from WT mice. These findings suggest that HSF1 contributes to ischemia-induced angiogenesis by regulating the mobilization and recruitment of BM-derived stem/progenitor cells.	[Kubo, Masayuki; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ohshima, Mako; Yamamoto, Yumi; Nishimoto, Arata; Mikamo, Akihito; Hamano, Kimikazu] Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Li, Tao-Sheng] Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Fujimoto, Mitsuaki; Nakai, Akira] Yamaguchi Univ, Dept Biochem & Mol Biol, Grad Sch Med, Ube, Yamaguchi 755, Japan	Yamaguchi University; Nagasaki University; Yamaguchi University	Kubo, M (corresponding author), Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Ube, Yamaguchi 755, Japan.	litaoshe@nagasaki-u.ac.jp; kimikazu@yamaguchi-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Yamaguchi University Research Project on STRESS	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi University Research Project on STRESS	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the Yamaguchi University Research Project on STRESS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Ballard VLT, 2007, CIRC RES, V100, P1116, DOI 10.1161/01.RES.0000261964.19115.e3; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kubo M, 2008, AM J PHYSIOL-HEART C, V294, pH590, DOI 10.1152/ajpheart.00856.2007; Kubo M, 2007, AM J PHYSIOL-HEART C, V292, pH2582, DOI 10.1152/ajpheart.00786.2006; Kubo M, 2012, CIRC J, V76, P986, DOI 10.1253/circj.CJ-11-0605; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Li TS, 2010, J THORAC CARDIOV SUR, V139, P459, DOI 10.1016/j.jtcvs.2009.07.053; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakai A, 2009, BMB REP, V42, P631, DOI 10.5483/BMBRep.2009.42.10.631; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pfosser A, 2005, CARDIOVASC RES, V65, P728, DOI 10.1016/j.cardiores.2004.10.019; Qin S, 2008, CIRC J, V72, P2075, DOI 10.1253/circj.CJ-08-0392; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Tongers J, 2008, CARDIOVASC RES, V78, P294, DOI 10.1093/cvr/cvm107; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wu BJ, 2009, ARTERIOSCL THROM VAS, V29, P1537, DOI 10.1161/ATVBAHA.109.184713; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37934	10.1371/journal.pone.0037934	http://dx.doi.org/10.1371/journal.pone.0037934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655083	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900060
J	Merolla, F; Luise, C; Muller, MT; Pacelli, R; Fusco, A; Celetti, A				Merolla, Francesco; Luise, Chiara; Muller, Mark T.; Pacelli, Roberto; Fusco, Alfredo; Celetti, Angela			Loss of CCDC6, the First Identified RET Partner Gene, Affects pH2AX S139 Levels and Accelerates Mitotic Entry upon DNA Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; FACTOR RECEPTOR-BETA; DEPHOSPHORYLATES GAMMA-H2AX; PROTEIN PHOSPHATASE-4; ATM ACTIVATION; THYROID-CANCER; COMPLEX; H4(D10S170); CHECKPOINTS; LEUKEMIA	CCDC6 was originally identified in chimeric genes caused by chromosomal translocation involving the RET proto-oncogene in some thryoid tumors mostly upon ionizing radiation exposure. Recognised as a pro-apoptotic phosphoprotein that negatively regulates CREB1-dependent transcription, CCDC6 is an ATM substrate that is responsive to genotoxic stress. Here we report that following genotoxic stress, loss or inactivation of CCDC6 in cancers that carry the CCDC6 fusion, accelerates the dephosphorylation of pH2AX S139, resulting in defective G2 arrest and premature mitotic entry. Moreover, we show that CCDC6 depleted cells appear to repair DNA damaged in a shorter time compared to controls, based on reporter assays in cells. High-troughput proteomic screening predicted the interaction between the CCDC6 gene product and the catalytic subunit of Serin-Threonin Protein Phosphatase 4 (PP4c) recently identified as the evolutionarily conserved pH2AX S139 phosphatase that is activated upon DNA Damage. We describe the interaction between CCDC6 and PP4c and we report the modulation of PP4c enzymatic activity in CCDC6 depleted cells. We discuss the functional significance of CCDC6-PP4c interactions and hypothesize that CCDC6 may act in the DNA Damage Response by negatively modulating PP4c activity. Overall, our data suggest that in primary tumours the loss of CCDC6 function could influence genome stability and thereby contribute to carcinogenesis.	[Merolla, Francesco; Luise, Chiara; Fusco, Alfredo; Celetti, Angela] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Merolla, Francesco; Luise, Chiara; Fusco, Alfredo] Univ Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Muller, Mark T.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Pacelli, Roberto] Univ Federico II, Dipartimento Sci Biomorfolog & Funzionali, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; State University System of Florida; University of Central Florida; University of Naples Federico II	Merolla, F (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy.	celetti@unina.it	Pacelli, Roberto/AFS-0333-2022; Celetti, Angela/AAY-7172-2020	Pacelli, Roberto/0000-0002-2048-7675; Fusco, Alfredo/0000-0003-3332-5197	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell'Istruzione, dell' Universite della Ricerca (MIUR) [20072JHN5W_003]; "Accademia Nazionale dei Lincei", Italy; UICC	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell' Universite della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); "Accademia Nazionale dei Lincei", Italy; UICC	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) and from the Ministero dell'Istruzione, dell' Universite della Ricerca (MIUR) (PRIN 20072JHN5W_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Professor VE Avvedimento for helpful discussions and encouragments and to Mario Berardone for artwork. Francesco Merolla is recipient of a Post-Doctoral Fellowship from "Accademia Nazionale dei Lincei", Italy. Angela Celetti kindly acknowledges UICC for the ICRETT Award in 2010.	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Dainiak N, 1997, STEM CELLS, V15, P1; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Deininger MWN, 1998, CANCER RES, V58, P421; DiBiase SJ, 1999, INT J RADIAT ONCOL, V45, P743, DOI 10.1016/S0360-3016(99)00229-1; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Freeman AK, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-27; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gandhi M, 2010, MOL CELL ENDOCRINOL, V321, P36, DOI 10.1016/j.mce.2009.09.013; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; GRIECO M, 1994, ONCOGENE, V9, P2531; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Jossart GH, 1996, CYTOGENET CELL GENET, V75, P254, DOI 10.1159/000134495; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kulkarni S, 2000, CANCER RES, V60, P3592; Lazzaro F, 2009, DNA REPAIR, V8, P1055, DOI 10.1016/j.dnarep.2009.04.022; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nikiforov YE, 2007, ENDOCR PATHOL, V17, P307; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SPEIT G, 1995, MUTAGENESIS, V10, P555, DOI 10.1093/mutage/10.6.555; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tong Q, 1997, J BIOL CHEM, V272, P9043; Tsai IC, 2005, J CELL BIOCHEM, V94, P967, DOI 10.1002/jcb.20353; TUNG HYL, 1985, EUR J BIOCHEM, V148, P253, DOI 10.1111/j.1432-1033.1985.tb08833.x; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	58	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36177	10.1371/journal.pone.0036177	http://dx.doi.org/10.1371/journal.pone.0036177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655027	Green Published, gold			2022-12-27	WOS:000305338900001
J	Chen, LJ; Liu, KW; Xiao, XJ; Tsai, WC; Hsiao, YY; Huang, J; Liu, ZJ				Chen, Li-Jun; Liu, Ke-Wei; Xiao, Xin-Ju; Tsai, Wen-Chieh; Hsiao, Yu-Yun; Huang, Jie; Liu, Zhong-Jian			The Anther Steps onto the Stigma for Self-Fertilization in a Slipper Orchid	PLOS ONE			English	Article							REPRODUCTIVE ASSURANCE; POLLINATION; EVOLUTION; SYSTEMS; PLANTS	Background: Due to the spatial separation between male and female pollen grains from the anther of most flowering plants, including orchids, pollens are transported by wind or animals and deposited onto the receptive surface of the stigma of a different plant. However, self-pollination is common in pollinating animal-scarce habitats. In such habitats, self-pollinations require the assistance of a pollinating agent (e.g., wind, gravity, or floral assembly) to transport the pollen grains from the anther onto its own stigma. Methodology/Principal Findings: Based on observations on floral morphology and flowering phenology, tests of the breeding system, and a comparison of pollination mechanisms, a new self-pollination process was discovered in the hermaphroditic (i.e., possessing spatially separated male and female organs) flower of a slipper orchid, Paphiopedilum parishii. The anther changes from a solid to a liquid state and directly steps onto the stigma surface without the aid of any pollinating agent or floral assembly. Conclusions: The mode of self-pollination discussed here is a new addition to the broad range of genetic and morphological mechanisms that have evolved in flowering plants to ensure their reproductive success. The present self-contained pollination mechanism is a possible adaptation to the insect-scarce habitat of the orchid.	[Chen, Li-Jun; Liu, Ke-Wei; Xiao, Xin-Ju; Huang, Jie; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Chen, Li-Jun; Liu, Ke-Wei; Xiao, Xin-Ju; Huang, Jie; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Ke-Wei; Liu, Zhong-Jian] Tsinghua Univ, Ctr Biotechnol & BioMed, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Xiao, Xin-Ju] Beijing Forestry Univ, Continuing Educ Coll, Beijing, Peoples R China; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Liu, Zhong-Jian] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Beijing Forestry University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; South China Agricultural University	Chen, LJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	aju78@163.com; liuzj@sinicaorchid.org		Liu, Zhong-Jian/0000-0003-4390-3878	State Forestry Administration, People's Republic of China [2005-122]; Science and Technology Project of Shenzhen, China [SYF200646409, SY200704300157A]	State Forestry Administration, People's Republic of China; Science and Technology Project of Shenzhen, China	This work is supported by the State Forestry Administration, People's Republic of China (grant no. 2005-122), and the Science and Technology Project of Shenzhen, China (grant no. SYF200646409, SY200704300157A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WR, 1980, SCIENCE, V207, P892, DOI 10.1126/science.207.4433.892; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Catling P., 1990, ORCHID BIOL REV PERS, P121; Cribb P., 1998, GENUS PAPHIOPEDILUM; Darwin C, 1916, EFFECTS CROSS SELF F; Darwin CR., 1882, VARIOUS CONTRIVANCES, V2; DOLE JA, 1992, AM J BOT, V79, P650, DOI 10.2307/2444881; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Gale S, 2007, PLANT SYST EVOL, V268, P59, DOI 10.1007/s00606-007-0570-x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; Kalisz S, 2003, ECOLOGY, V84, P2928, DOI 10.1890/02-0519; Kalisz S, 1999, AM J BOT, V86, P1239, DOI 10.2307/2656771; Li QJ, 2001, NATURE, V410, P432, DOI 10.1038/35068635; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; Liu ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024864; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P2433; Liu ZJ, 2009, MIX BREEDING STRATEG; Liu ZJ, 2009, GENUS PAPHIOPEDILUM; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LORD EM, 1981, BOT REV, V47, P421, DOI 10.1007/BF02860538; Micheneau C, 2008, PLANT SYST EVOL, V272, P11, DOI 10.1007/s00606-007-0626-y; Peter CI, 2009, S AFR J BOT, V75, P791, DOI 10.1016/j.sajb.2009.07.007; PETER CI, 2009, THESIS U KWAZULUNATA; Richards A.J, 1997, PLANT BREEDING SYSTE; Schoen DJ, 1996, PHILOS T R SOC B, V351, P1281, DOI 10.1098/rstb.1996.0111; SCHOEN DJ, 1991, EVOLUTION, V45, P1651, DOI [10.1111/j.1558-5646.1991.tb02670.x, 10.2307/2409786]; Shi J, 2007, ACTA PHYTOTAXON SIN, V45, P551, DOI 10.1360/aps07025; Stebbins G. L., 1970, ANNU REV ECOL SYST, V1, P307, DOI DOI 10.1146/ANNUREV.ES.01.110170.001515; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Totland O, 2001, AM J BOT, V88, P1011, DOI 10.2307/2657082; van der Cingel N. A., 2001, ATLAS ORCHID POLLINA; van dersCingel N. A., 1995, ATLAS ORCHID POLLINA; Wang YQ, 2004, NATURE, V431, P39, DOI 10.1038/431039b; WYATT R, 1984, SYST BOT, V9, P432, DOI 10.2307/2418792; Xiao XJ, 2012, PLOS ONE, V7, P125, DOI 10.1371/journal.pone.0029718	39	8	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37478	10.1371/journal.pone.0037478	http://dx.doi.org/10.1371/journal.pone.0037478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649529	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800047
J	Ferreira, SR; Machado, GR; Ferreira, VC; Rodrigues, CFMA; de Moraes, TP; Divino, JC; Olandoski, M; McIntyre, C; Pecoits, R				Ferreira-Filho, Sebastiao R.; Machado, Gilberto R.; Ferreira, Valeria C.; Rodrigues, Carlos F. M. A.; de Moraes, Thyago Proenca; Divino-Filho, Jose C.; Olandoski, Marcia; McIntyre, Christopher; Pecoits-Filho, Roberto		BRAZPD Study Investigators	Back to Basics: Pitting Edema and the Optimization of Hypertension Treatment in Incident Peritoneal Dialysis Patients (BRAZPD)	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; CARDIOVASCULAR-DISEASE; VOLUME; FLUID; LONG; THERAPY	Systemic arterial hypertension is an important risk factor for cardiovascular disease that is frequently observed in populations with declining renal function. Initiation of renal replacement therapy at least partially decreases signs of fluid overload; however, high blood pressure levels persist in the majority of patients after dialysis initiation. Hypervolemia due to water retention predisposes peritoneal dialysis (PD) patients to hypertension and can clinically manifest in several forms, including peripheral edema. The approaches to detect edema, which include methods such as bioimpedance, inferior vena cava diameter and biomarkers, are not always available to physicians worldwide. For clinical examinations, the presence of pitting located in the lower extremities and/or over the sacrum to diagnose the presence of peripheral edema in their patients are frequently utulized. We evaluated the impact of edema on the control of blood pressure of incident PD patients during the first year of dialysis treatment. Patients were recruited from 114 Brazilian dialysis centers that were participating in the BRAZPD study for a total of 1089 incident patients. Peripheral edema was diagnosed by the presence of pitting after finger pressure was applied to the edematous area. Patients were divided into 2 groups: those with and without edema according to the monthly medical evaluation. Blood arterial pressure, body mass index, the number of antihypertensive drugs and comorbidities were analyzed. We observed an initial BP reduction in the first five months and a stabilization of blood pressure levels from five to twelve months. The edematous group exhibited higher blood pressure levels than the group without edema during the follow-up. The results strongly indicate that the presence of a simple and easily detectable clinical sign of peripheral edema is a very relevant tool that could be used to re-evaluate not only the patient's clinical hypertensive status but also the PD prescription and patient compliance.	[Ferreira-Filho, Sebastiao R.; Machado, Gilberto R.; Ferreira, Valeria C.; Rodrigues, Carlos F. M. A.] Nefroclin Uberlandia, Uberlandia, MG, Brazil; [Ferreira-Filho, Sebastiao R.; Machado, Gilberto R.] Univ Fed Uberlandia, Uberlandia, MG, Brazil; [de Moraes, Thyago Proenca; Olandoski, Marcia; Pecoits-Filho, Roberto] Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, Curitiba, Parana, Brazil; [Divino-Filho, Jose C.] Karolinska Inst, CLINTEC, Div Baxter Novum & Renal Med, Stockholm, Sweden; [McIntyre, Christopher] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England	Universidade Federal de Uberlandia; Pontificia Universidade Catolica do Parana; Karolinska Institutet; University of Nottingham	Ferreira, SR (corresponding author), Nefroclin Uberlandia, Uberlandia, MG, Brazil.	sebahferreira@gmail.com	Ferreira-Filho, S R/G-2354-2012; McIntyre, Christopher W/O-8927-2014; de Moraes, Thyago Proenca/M-9400-2014; Pecoits-Filho, Roberto/K-7986-2013; Divino-Filho, Jose/V-5425-2019	Ferreira-Filho, S R/0000-0003-4176-9572; de Moraes, Thyago Proenca/0000-0002-2983-3968; Pecoits-Filho, Roberto/0000-0002-0255-6710; 	Baxter Healthcare	Baxter Healthcare	Baxter Healthcare sponsored this study. During the data collection and analysis, JCDF was employed by Baxter. RPF received a consulting fee and speaker honorarium from Baxter Healthcare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ates K, 2001, KIDNEY INT, V60, P767, DOI 10.1046/j.1523-1755.2001.060002767.x; Barri YM, 2008, CURR HYPERTENS REP, V10, P39, DOI 10.1007/s11906-008-0009-y; Basile J, 2009, J CLIN HYPERTENSION, P11; Cocchi R, 1999, NEPHROL DIAL TRANSPL, V14, P1536, DOI 10.1093/ndt/14.6.1536; Fernandes N, 2008, KIDNEY INT, V73, pS145, DOI 10.1038/sj.ki.5002616; Fishbane S, 1996, AM J KIDNEY DIS, V28, P257, DOI 10.1016/S0272-6386(96)90309-1; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gunal AI, 2001, AM J KIDNEY DIS, V37, P588, DOI 10.1053/ajkd.2001.22085; Katzarski KS, 1999, NEPHROL DIAL TRANSPL, V14, P369, DOI 10.1093/ndt/14.2.369; Lameire N, 1993, Perit Dial Int, V13 Suppl 2, pS394; Lang SM, 1999, PERITON DIALYSIS INT, V19, P143; LEUNISSEN KML, 1993, KIDNEY INT, V43, pS50; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Lynn KL, 2002, KIDNEY INT, V62, P2281, DOI 10.1046/j.1523-1755.2002.00685.x; Mailloux LU, 1998, AM J KIDNEY DIS, V32, P705, DOI 10.1016/S0272-6386(98)70146-5; Menon MK, 2001, NEPHROL DIAL TRANSPL, V16, P2207, DOI 10.1093/ndt/16.11.2207; Rahman M, 1999, AM J KIDNEY DIS, V33, P498, DOI 10.1016/S0272-6386(99)70187-3; SALDANHA LF, 1993, AM J KIDNEY DIS, V21, P184, DOI 10.1016/S0272-6386(12)81091-2; SLINGENEYER A, 1983, NEPHRON, V33, P133, DOI 10.1159/000182927; Tang W, 2009, AM J NEPHROL, V30, P120, DOI 10.1159/000206697; TZAMALOUKAS AH, 1995, J AM SOC NEPHROL, V6, P198; Van Biesen W, 2008, PERITON DIALYSIS INT, V28, P596; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36758	10.1371/journal.pone.0036758	http://dx.doi.org/10.1371/journal.pone.0036758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649498	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800015
J	Calderone, NW				Calderone, Nicholas W.			Insect Pollinated Crops, Insect Pollinators and US Agriculture: Trend Analysis of Aggregate Data for the Period 1992-2009	PLOS ONE			English	Article							FACTOR SURVEILLANCE SYSTEM; ALFALFA LEAFCUTTING BEE; HONEY-BEES; APIS-MELLIFERA; ECONOMIC VALUE; UNITED-STATES; VEGETABLE CONSUMPTION; MEGACHILE-ROTUNDATA; FLOWERING PLANTS; NATIVE BEES	In the US, the cultivated area (hectares) and production (tonnes) of crops that require or benefit from insect pollination (directly dependent crops: apples, almonds, blueberries, cucurbits, etc.) increased from 1992, the first year in this study, through 1999 and continued near those levels through 2009; aggregate yield (tonnes/hectare) remained unchanged. The value of directly dependent crops attributed to all insect pollination (2009 USD) decreased from $14.29 billion in 1996, the first year for value data in this study, to $10.69 billion in 2001, but increased thereafter, reaching $15.12 billion by 2009. The values attributed to honey bees and non-Apis pollinators followed similar patterns, reaching $11.68 billion and $3.44 billion, respectively, by 2009. The cultivated area of crops grown from seeds resulting from insect pollination (indirectly dependent crops: legume hays, carrots, onions, etc.) was stable from 1992 through 1999, but has since declined. Production of those crops also declined, albeit not as rapidly as the decline in cultivated area; this asymmetry was due to increases in aggregate yield. The value of indirectly dependent crops attributed to insect pollination declined from $15.45 billion in 1996 to $12.00 billion in 2004, but has since trended upward. The value of indirectly dependent crops attributed to honey bees and non-Apis pollinators, exclusive of alfalfa leafcutter bees, has declined since 1996 to $5.39 billion and $1.15 billion, respectively in 2009. The value of alfalfa hay attributed to alfalfa leafcutter bees ranged between $4.99 and $7.04 billion. Trend analysis demonstrates that US producers have a continued and significant need for insect pollinators and that a diminution in managed or wild pollinator populations could seriously threaten the continued production of insect pollinated crops and crops grown from seeds resulting from insect pollination.	Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University	Calderone, NW (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	nwc4@cornell.edu			National Honey Board	National Honey Board	This project was funded in part by a grant from the National Honey Board to NWC. No additional external funding was received or used for this study. The author was obligated to publish the results of the study. The funders had no role in study design, data collection and analysis, decision where to publish or preparation of the manuscript.	Adams JW, 2006, SR0628 ERDCCERL; Adams JW, 2004, SR0424ADA432205 ERDC, VI; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; American Bee Journal, 1987, American Bee Journal, V127, P745; Batra S.W.T., 1978, MARYLAND AGR EXPT ST, V1, P307; Bauer D. M., 2010, Agricultural and Resource Economics Review, V39, P368; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blanck Heidi Michels, 2008, Prev Chronic Dis, V5, pA35; Bosch J, 1999, BEE WORLD, V80, P163, DOI 10.1080/0005772X.1999.11099452; Bosch J, 2000, ENVIRON ENTOMOL, V29, P8, DOI 10.1603/0046-225X-29.1.8; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Brooks N., 2009, J FOOD DISTRIBUTION, V40, P39; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Burgett M, 2004, AM BEE J, V144, P269; Burgett M, 2009, NATL HONEY REPORT, V29, P10; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Canestri J, 2001, CHALLENGES OF PSYCHOANALYSIS IN THE 21ST CENTURY, P1; Caron D, 2010, E BEEKEEPER POLLINAT; Caron D, 2010, BEE COLONY POLLINATI; Carvalheiro LG, 2010, J APPL ECOL, V47, P810, DOI 10.1111/j.1365-2664.2010.01829.x; Champetier A, 2010, BIOECONOMICS HONEY B; Chen Chi-Tung, 1996, Zhonghua Kunchong, V16, P167; Collins GS, 1982, P INT C PLANT VEG OI; Committee on the Status of Pollinators in North America, 2007, STAT POLL N AM; CORBET SA, 1993, ECOL ENTOMOL, V18, P17, DOI 10.1111/j.1365-2311.1993.tb01075.x; Daberkow S, 2009, J ECON ENTOMOL, V102, P868, DOI 10.1603/029.102.0304; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; DELFINADOBAKER M, 1984, AM BEE J, V124, P805; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dimou M, 2008, J APICULT RES, V47, P99, DOI 10.1080/00218839.2008.11101433; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi Lucas A., 2009, Communicative & Integrative Biology, V2, P37; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P652, DOI 10.1016/j.tree.2005.09.006; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Grimaldi David, 2005, pi; Gunstone FD, 2011, EUR J LIPID SCI TECH, V113, P3, DOI 10.1002/ejlt.201000104; Hendrickson MK, 2008, J AGR ENVIRON ETHIC, V21, P311, DOI 10.1007/s10806-008-9092-y; Ingram M., 1996, TROPINET, V7, P1; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kasina JM, 2009, J ECON ENTOMOL, V102, P467, DOI 10.1603/029.102.0201; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Kevan Peter G., 2003, Biodiversity (Ottawa), V4, P3; Kevan PG, 2001, CONSERV ECOL, V5; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kluser S., 2007, GLOBAL POLLINATOR DE; Kralova I, 2010, J DISPER SCI TECHNOL, V31, P409, DOI 10.1080/01932690903119674; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Kremen C, INSECTS PROVIDERS EC, P349; Kwon YJ, 2003, APPL ENTOMOL ZOOL, V38, P275, DOI 10.1303/aez.2003.275; Levin M. D., 1983, Bulletin of the Entomological Society of America, V29, P50; Li Ji-Lian, 2006, Acta Entomologica Sinica, V49, P342; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACKENZIE KE, 1994, APIDOLOGIE, V25, P375, DOI 10.1051/apido:19940404; Matsumoto S, 2009, SCI HORTIC-AMSTERDAM, V121, P73, DOI 10.1016/j.scienta.2009.01.003; Mattson JW, 2005, CHARACTERISTICS DECL; Mburu J, 2006, 12 ANN BIOECON C WEA; McGregor S.E., 1976, AGR HDB, V496; Metcalf CL., 1962, DESTRUCTIVE USEFUL I; Michener C. D., 2007, BEES WORLD; Muth M. K., 1995, Choices. The Magazine of Food, Farm, and Resources Issues, P19; NASS, 2011, HON HNY 1 2 11; NASS, 2011, VEG; NASS, 1999, STAT B USDA; NASS, 2004, 2002 CENS AGR AC 02; NASS, 2009, STAT B USDA; NASS, 2008, STAT B USDA; NASS, 2009, LAND VAL CASH RENTS; NASS, 1999, STAT B USDA; NASS, 2008, STAT B USDA A; NASS, 2010, HON HNY 1 2 10; NASS, 2001, AGR LAND VAL SP SY 3; NASS, 2009, FARMS LAND FARMS LIV; NASS, 2011, CROP PROD 2010 SUMM; NASS, 2008, LAND VAL CASH RENTS; NASS, 2008, STAT B USDA; NASS, 2007, LAND VAL CASH RENTS; NASS, 2010, TABLE003 XLS US TOT; NASS, 2005, LAND VAL CASH RENTS; NASS, 2003, AGR LAND VAL CASH RE; NASS, 2011, NONC FRUITS NUTS 201; NASS, 2011, CROP PROD; NASS, 1999, AGR LAND VAL SP SY 3; NASS, 2011, LAND VAL 2011 SUMM; NASS, 2004, STAT B USDA A; NASS, 2004, LAND VAL CASH RENTS; NASS, 2004, VEG FIN EST 1997 200; NASS, 2002, AGR LAND VAL SP SY 3; NASS, 2010, CITR FRUITS 2010 SUM; NASS, 2009, HON HNY 1 2 09; NASS, 1995, FARMS LAND FARMS FIN; NASS, 1997, AGR LAND VAL AGR CAS; NASS, 1999, STAT B USDA; NASS, 1998, STAT B USDA A; NASS, 1999, STAT B USDA; NASS, 2009, STAT B USDA; NASS, 2004, STAT B USDA A; NASS, 2011, CROP VAL 2010 SUMM; NASS, 2000, AGR LAND VAL SP SY 3; NASS, 2009, 2007 CENS AGR AC 07; NASS, 2006, LAND VAL CASH RENTS; NASS, 2010, LAND VAL CASH RENTS; NASS, 1995, STAT B USDA; NASS, 2004, STAT B USDA; NASS, 2011, VEG 2010 SUMM; NASS, 2006, FARMS LAND FARMS LIV; NASS, 1998, AGR LAND VAL; NASS, 1998, STAT B USDA A; NASS, 1999, STAT B USDA C; NASS, 2008, STAT B USDA; NASS, 2004, STAT B USDA; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nzaku K., 2010, Journal of Agribusiness, V28, P163; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Olschewski R, 2006, ECOL SOC, V11; Packer L, 2001, CONSERV ECOL, V5; Palumbo A. D., 1996, Colture Protette, V25, P61; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritts M. P., 1999, HortTechnology, V9, P13; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Raghavan V., 2000, DEV BIOL FLOWERING P; RICHARDS KW, 1993, REV SUISSE ZOOL, V100, P807, DOI 10.5962/bhl.part.79885; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; ROBINSON WS, 1989, AM BEE J, V129, P411; ROBINSON WS, 1989, AM BEE J, V129, P477; Sekita N., 1996, Bulletin of the Aomori Apple Experiment Station, P17; Serdula MK, 2004, AM J PUBLIC HEALTH, V94, P1014, DOI 10.2105/AJPH.94.6.1014; Serdula MK, 1996, EPIDEMIOLOGY, V7, P161, DOI 10.1097/00001648-199603000-00010; SHEPPARD WS, 1989, AM BEE J, V129, P664; SHEPPARD WS, 1989, AM BEE J, V129, P617; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Stephen WP, 1981, STATION B OREGON STA, V653, P10; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Stubbs CS, 1997, J KANSAS ENTOMOL SOC, V70, P81; Stubbs CS, 2001, J ECON ENTOMOL, V94, P609, DOI 10.1603/0022-0493-94.3.609; Stubbs CS, 1997, ACTA HORTIC, P189, DOI 10.17660/ActaHortic.1997.446.28; Sumner D, 2006, BEE CONOMICS LEAP PO; Tax, 1960, EVOLUTION DARWIN, P227; Thompson W, 2010, BIOMASS BIOENERG, V34, P883, DOI 10.1016/j.biombioe.2010.01.033; Tuell JK, 2010, J ECON ENTOMOL, V103, P668, DOI 10.1603/EC09314; U.S. Department of Labor BOLS, 2011, CONS PRIC IND; Underwood R., 2007, BEE CULTURE, V35, P13; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Ware G, 1973, BEES AGR THEIR PROBL; Winfree R, 2008, J APPL ECOL, V45, P793, DOI 10.1111/j.1365-2664.2007.01418.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zayed A, 2004, P ROY SOC B-BIOL SCI, V271, pS9, DOI 10.1098/rsbl.2003.0109; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102	164	341	353	8	306	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37235	10.1371/journal.pone.0037235	http://dx.doi.org/10.1371/journal.pone.0037235			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629374	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300028
J	Galuardi, B; Lutcavage, M				Galuardi, Benjamin; Lutcavage, Molly			Dispersal Routes and Habitat Utilization of Juvenile Atlantic Bluefin Tuna, Thunnus thynnus, Tracked with Mini PSAT and Archival Tags	PLOS ONE			English	Article							DEPENDENT ENERGY ALLOCATION; SEA-SURFACE-TEMPERATURE; VERTICAL MOVEMENTS; NORTHEASTERN PACIFIC; POPULATION-STRUCTURE; DIVING BEHAVIOR; NORTH-ATLANTIC; FISH; ORIENTALIS; EASTERN	Between 2005 and 2009, we deployed 58 miniature pop-up satellite archival tags (PSAT) and 132 implanted archival tags on juvenile Atlantic bluefin tuna (age 2-5) in the northwest Atlantic Ocean. Data returned from these efforts (n = 26 PSATs, 1 archival tag) revealed their dispersal routes, horizontal and vertical movements and habitat utilization. All of the tagged bluefin tuna remained in the northwest Atlantic for the duration observed, and in summer months exhibited core-use of coastal seas extending from Maryland to Cape Cod, MA, (USA) out to the shelf break. Their winter distributions were more spatially disaggregated, ranging south to the South Atlantic Bight, northern Bahamas and Gulf Stream. Vertical habitat patterns showed that juvenile bluefin tuna mainly occupied shallow depths (mean = 5-12 m, sd = 15-23.7 m) and relatively warm water masses in summer (mean = 17.9-20.9 degrees C, sd = 4.2-2.6 degrees C) and had deeper and more variable depth patterns in winter (mean = 41-58 m, sd = 48.9-62.2 m). Our tagging results reveal annual dispersal patterns, behavior and oceanographic associations of juvenile Atlantic bluefin tuna that were only surmised in earlier studies. Fishery independent profiling from electronic tagging also provide spatially and temporally explicit information for evaluating dispersals rates, population structure and fisheries catch patterns.	[Galuardi, Benjamin; Lutcavage, Molly] Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA	University of Massachusetts System; University of Massachusetts Amherst	Galuardi, B (corresponding author), Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA.	galuardi@eco.umass.edu			National Oceanic and Atmospheric Administration [NA04NMF4550391]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was funded by a National Oceanic and Atmospheric Administration Grant # NA04NMF4550391 to M. Lutcavage (www.noaa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrizabalaga H, 2008, FISH OCEANOGR, V17, P74, DOI 10.1111/j.1365-2419.2008.00464.x; AUER SJ, 1987, J GEOPHYS RES-OCEANS, V92, P11709, DOI 10.1029/JC092iC11p11709; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Brill R, 2002, FISH B-NOAA, V100, P155; Brill RW, 2001, AM FISH S S, V25, P179; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CAREY FG, 1983, COMP BIOCHEM PHYS A, V74, P333, DOI 10.1016/0300-9629(83)90612-6; CAREY FG, 1971, AM ZOOL, V11, P137; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Churnside JH, 1998, 287 NOAA ERLETL, P71; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Dickhut RM, 2009, ENVIRON SCI TECHNOL, V43, P8522, DOI 10.1021/es901810e; Domeier ML, 2005, FISH B-NOAA, V103, P292; EGGLESTON DB, 1990, FISH B-NOAA, V88, P389; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fudge DS, 1998, AM J PHYSIOL, V275; Fudge DS, 1996, GUELPH ICHTHYOLOGY R, V4; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; Gunn JS, 1994, P ICES MIN FISH MIGR, V2-4; Hoolihan JP, 2007, ICES J MAR SCI, V64, P1791, DOI 10.1093/icesjms/fsm148; ICCAT, 2009, ICCAT MAN; ICCAT, 2010, 2010 ATL BLUEF TUN S, P1; Itoh T, 2003, FISH B-NOAA, V101, P514; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P186, DOI 10.1139/F05-209; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kishino H, 1994, B JAPANESE SOC FISHE, V58; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Luo JG, 2006, FISH OCEANOGR, V15, P208, DOI 10.1111/j.1365-2419.2006.00360.x; LUTCAVAGE M, 1995, FISH B-NOAA, V93, P495; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; MEYER TL, 1979, FISH B-NOAA, V77, P243; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Nielsen A, 2009, STATE SPACE MODEL LI; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Porch Clay, 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V50, P591; Porch Clay E., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P1022; Restrepo VR, 2010, COL VOL SCI PAP ICCA, V160, P1; Roffer MA, 1987, INFLUENCE ENV APPARE; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Royer F, 2009, REV-METHODS TECHNOL, V9, P323, DOI 10.1007/978-1-4020-9640-2_20; Schaefer KM, 2002, FISH B-NOAA, V100, P765; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Schaefer KM, 2011, FISH RES, V112, P22, DOI 10.1016/j.fishres.2011.08.006; Sibert JR, 1999, CAN J FISH AQUAT SCI, V56, P925, DOI 10.1139/cjfas-56-6-925; STEVENS ED, 1984, AM J PHYSIOL, V246, pR487, DOI 10.1152/ajpregu.1984.246.4.R487; Sulikowski JA, 2010, MAR ECOL PROG SER, V418, P249, DOI 10.3354/meps08821; Tiews K, 1963, FAO FISH REP, V6, P422; Tiews K, 1963, INT COUNC EXPLOR SEA, V19, P183; Tolentino R, 2009, DEPL DAT REP CLOS LO; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Wilson PC, 1967, INVENTORY US EXPLORA; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wilson Steven G., 2010, Endangered Species Research, V10, P355; Yamashita Hideyuki, 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P809	69	68	68	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37829	10.1371/journal.pone.0037829	http://dx.doi.org/10.1371/journal.pone.0037829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629461	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300079
J	Karimi-Abdolrezaee, S; Schut, D; Wang, J; Fehlings, MG				Karimi-Abdolrezaee, Soheila; Schut, Desiree; Wang, Jian; Fehlings, Michael G.			Chondroitinase and Growth Factors Enhance Activation and Oligodendrocyte Differentiation of Endogenous Neural Precursor Cells after Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM/PROGENITOR CELLS; FUNCTIONAL RECOVERY; IN-VIVO; STEM-CELLS; ADULT-RAT; INHIBITORY MOLECULES; NG2-POSITIVE CELLS; GENE-EXPRESSION; CNS INJURY	The adult spinal cord harbours a population of multipotent neural precursor cells (NPCs) with the ability to replace oligodendrocytes. However, despite this capacity, proliferation and endogenous remyelination is severely limited after spinal cord injury (SCI). In the post-traumatic microenvironment following SCI, endogenous spinal NPCs mainly differentiate into astrocytes which could contribute to astrogliosis that exacerbate the outcomes of SCI. These findings emphasize a key role for the post-SCI niche in modulating the behaviour of spinal NPCs after SCI. We recently reported that chondroitin sulphate proteoglycans (CSPGs) in the glial scar restrict the outcomes of NPC transplantation in SCI by reducing the survival, migration and integration of engrafted NPCs within the injured spinal cord. These inhibitory effects were attenuated by administration of chondroitinase (ChABC) prior to NPC transplantation. Here, in a rat model of compressive SCI, we show that perturbing CSPGs by ChABC in combination with sustained infusion of growth factors (EGF, bFGF and PDGF-AA) optimize the activation and oligodendroglial differentiation of spinal NPCs after injury. Four days following SCI, we intrathecally delivered ChABC and/or GFs for seven days. We performed BrdU incorporation to label proliferating cells during the treatment period after SCI. This strategy increased the proliferation of spinal NPCs, reduced the generation of new astrocytes and promoted their differentiation along an oligodendroglial lineage, a prerequisite for remyelination. Furthermore, ChABC and GF treatments enhanced the response of non-neural cells by increasing the generation of new vascular endothelial cells and decreasing the number of proliferating macrophages/microglia after SCI. In conclusions, our data strongly suggest that optimization of the behaviour of endogenous spinal NPCs after SCI is critical not only to promote endogenous oligodendrocyte replacement, but also to reverse the otherwise detrimental effects of their activation into astrocytes which could negatively influence the repair process after SCI.	[Karimi-Abdolrezaee, Soheila] Univ Manitoba, Regenerat Med Program, Winnipeg, MB, Canada; [Karimi-Abdolrezaee, Soheila] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Schut, Desiree; Wang, Jian; Fehlings, Michael G.] Toronto Western Res Inst, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Neurosci Program, Toronto, ON, Canada	University of Manitoba; University of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Karimi-Abdolrezaee, S (corresponding author), Univ Manitoba, Regenerat Med Program, Winnipeg, MB, Canada.	karimis@cc.umanitoba.ca		Fehlings, Michael/0000-0002-5722-6364; Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663	Craig H. Neilsen (CHN) Foundation [56927]; Manitoba Health Research Council (MHRC); Krembil Chair in Neural Repair and Regeneration	Craig H. Neilsen (CHN) Foundation; Manitoba Health Research Council (MHRC); Krembil Chair in Neural Repair and Regeneration	This work was supported by grants from the Craig H. Neilsen (CHN) Foundation to SKA and MGF (#56927) and the Manitoba Health Research Council (MHRC) to SKA (http://www.mhrc.mb.ca), and the Krembil Chair in Neural Repair and Regeneration to MGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Butt AM, 1997, J NEUROSCI RES, V48, P588; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Fitch MT, 2007, EXP NEUROL; Frost EE, 2003, J NEUROBIOL, V54, P457, DOI 10.1002/neu.10158; FRYER HJL, 1992, J BIOL CHEM, V267, P9874; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; Lundquist A, 2003, BLOOD, V101, P4070, DOI 10.1182/blood-2002-07-1994; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nashmi R, 2001, MODULATOR; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sirko S, 2010, METHOD ENZYMOL, V479, P37, DOI 10.1016/S0076-6879(10)79003-0; Smith MB, 2002, AM J BOT, V89, P417, DOI 10.3732/ajb.89.3.417; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Weiss S, 1996, J NEUROSCI, V16, P7599; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	55	85	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37589	10.1371/journal.pone.0037589	http://dx.doi.org/10.1371/journal.pone.0037589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629425	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300056
J	Song, J; Lays, C; Vandenesch, F; Benito, Y; Bes, M; Chu, YL; Lina, G; Romby, P; Geissmann, T; Boisset, S				Song, Juan; Lays, Claire; Vandenesch, Francois; Benito, Yvonne; Bes, Michele; Chu, Yonglie; Lina, Gerard; Romby, Pascale; Geissmann, Thomas; Boisset, Sandrine			The Expression of Small Regulatory RNAs in Clinical Samples Reflects the Different Life Styles of Staphylococcus aureus in Colonization vs. Infection	PLOS ONE			English	Article							VIRULENCE FACTORS; GENE-EXPRESSION; NONCODING RNAS; AGR FUNCTION; IN-VITRO; RNAIII; BACTERIA; ROT; TRANSLATION; REVEALS	Small RNAs (sRNAs) are involved in the post-transcriptional regulation of metabolic pathways and in responses to stress and virulence. We analyzed the expression levels of five sRNAs of Staphylococcus aureus during human colonization or infection. Total RNA was isolated from nasal carriers, abscesses and cystic fibrosis patients (20 subjects per condition). The expression levels of the sRNAs were measured in the clinical samples and compared with those of the corresponding strains grown in vitro. Five sRNAs were encoded and expressed in all clinical strains in vitro. In vivo, the global expression of the five sRNAs was extremely variable in the abscessed patients, more homogeneous in the cystic fibrosis patients, and highly uniform in the nasal carrier samples. The expression levels of the sRNAs in vivo resembled those obtained at exponential phase or late exponential phase of growth in vitro, for three and one sRNA respectively; while for one sRNA, the expression was always higher in vivo as compared to in vitro growth. The in vitro conditions do not uniformly mimic the in vivo conditions for sRNA expression. Nasal colonization is associated with a unique expression pattern of sRNA that might reflect the commensalism of S. aureus in this niche.	[Song, Juan; Chu, Yonglie] Xi An Jiao Tong Univ, Dept Immunol & Pathogen Biol, Sch Med, Xian 710049, Shaanxi Provinc, Peoples R China; [Song, Juan; Lays, Claire; Vandenesch, Francois; Lina, Gerard; Geissmann, Thomas; Boisset, Sandrine] Univ Lyon 1, F-69365 Lyon, France; [Song, Juan; Lays, Claire; Vandenesch, Francois; Benito, Yvonne; Bes, Michele; Lina, Gerard; Geissmann, Thomas; Boisset, Sandrine] INSERM, U851, F-69008 Lyon, France; [Vandenesch, Francois; Benito, Yvonne; Bes, Michele; Lina, Gerard; Boisset, Sandrine] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bron, France; [Romby, Pascale] Univ Strasbourg, CNRS UPR 9002, IBMC, Strasbourg, France	Xi'an Jiaotong University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Song, J (corresponding author), Xi An Jiao Tong Univ, Dept Immunol & Pathogen Biol, Sch Med, Xian 710049, Shaanxi Provinc, Peoples R China.	sandrine.boisset@univ-lyon1.fr	Vandenesch, Francois/C-7209-2014; ROMBY, Pascale/AGP-3328-2022; Boisset, Sandrine SB/D-8144-2014; Geissmann, Thomas/L-9432-2014; Lina, Gerard J/L-9352-2014	Vandenesch, Francois/0000-0001-9412-7106; Boisset, Sandrine SB/0000-0001-8717-8749; Geissmann, Thomas/0000-0001-5734-5489; LAYS, Claire/0000-0002-8844-2748; Lina, Gerard/0000-0002-9236-7998	China Scholarship Council (CSC); 'Fondation pour la Recherche Medicale' (FRM); 'Institut National pour la Recherche Medicale' (INSERM); 'Centre National de la Recherche Scientifique' (CNRS); 'Agence Nationale pour la Recherche' [ANR09-BLAN-0024-01, ANR10-Pathogenomics-ARMSA]; European Community (CONCORD) [FP7-EC222718]	China Scholarship Council (CSC)(China Scholarship Council); 'Fondation pour la Recherche Medicale' (FRM)(Fondation pour la Recherche Medicale); 'Institut National pour la Recherche Medicale' (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); 'Centre National de la Recherche Scientifique' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); 'Agence Nationale pour la Recherche'(French National Research Agency (ANR)); European Community (CONCORD)	JS was supported by a generous grant from the China Scholarship Council (CSC) and from the 'Fondation pour la Recherche Medicale' (FRM). This work was supported by the 'Institut National pour la Recherche Medicale' (INSERM; FV & TG), the 'Centre National de la Recherche Scientifique' (CNRS; PR), the 'Agence Nationale pour la Recherche' (ANR09-BLAN-0024-01; ANR10-Pathogenomics-ARMSA; PR, FV & SB) and the European Community (CONCORD, FP7-EC222718; TG & GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Dumitrescu O, 2011, ANTIMICROB AGENTS CH, V55, P3261, DOI 10.1128/AAC.01401-10; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; French Society for Microbiology, 2011, REC COM ANT MIRCR; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1989, CELL, V59, P395, DOI 10.1016/0092-8674(89)90300-0; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Robert J, 2011, ANTIMICROB AGENTS CH, V55, P1734, DOI 10.1128/AAC.01221-10; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888	40	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37294	10.1371/journal.pone.0037294	http://dx.doi.org/10.1371/journal.pone.0037294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629378	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300031
J	Gerber, MM; Hampel, H; Schulz, NP; Fernandez, S; Wei, L; Zhou, XP; de la Chapelle, A; Toland, AE				Gerber, Madelyn M.; Hampel, Heather; Schulz, Nathan P.; Fernandez, Soledad; Wei, Lai; Zhou, Xiao-Ping; de la Chapelle, Albert; Toland, Amanda Ewart			Evaluation of Allele-Specific Somatic Changes of Genome-Wide Association Study Susceptibility Alleles in Human Colorectal Cancers	PLOS ONE			English	Article							LYNCH-SYNDROME; SNP RS6983267; RISK LOCUS; 8Q24; CARCINOMAS; IMBALANCE; SCAN; METAANALYSIS; METHYLATION; MUTATIONS	Background: Tumors frequently exhibit loss of tumor suppressor genes or allelic gains of activated oncogenes. A significant proportion of cancer susceptibility loci in the mouse show somatic losses or gains consistent with the presence of a tumor susceptibility or resistance allele. Thus, allele-specific somatic gains or losses at loci may demarcate the presence of resistance or susceptibility alleles. The goal of this study was to determine if previously mapped susceptibility loci for colorectal cancer show evidence of allele-specific somatic events in colon tumors. Methods: We performed quantitative genotyping of 16 single nucleotide polymorphisms (SNPs) showing statistically significant association with colorectal cancer in published genome-wide association studies (GWAS). We genotyped 194 paired normal and colorectal tumor DNA samples and 296 paired validation samples to investigate these SNPs for allele-specific somatic gains and losses. We combined analysis of our data with published data for seven of these SNPs. Results: No statistically significant evidence for allele-specific somatic selection was observed for the tested polymorphisms in the discovery set. The rs6983267 variant, which has shown preferential loss of the non-risk T allele and relative gain of the risk G allele in previous studies, favored relative gain of the G allele in the combined discovery and validation samples (corrected p-value = 0.03). When we combined our data with published allele-specific imbalance data for this SNP, the G allele of rs6983267 showed statistically significant evidence of relative retention (p-value = 2.06x10(-4)). Conclusions: Our results suggest that the majority of variants identified as colon cancer susceptibility alleles through GWAS do not exhibit somatic allele-specific imbalance in colon tumors. Our data confirm previously published results showing allele-specific imbalance for rs6983267. These results indicate that allele-specific imbalance of cancer susceptibility alleles may not be a common phenomenon in colon cancer.	[Gerber, Madelyn M.] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Hampel, Heather; Schulz, Nathan P.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hampel, Heather; de la Chapelle, Albert; Toland, Amanda Ewart] Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; [Hampel, Heather; de la Chapelle, Albert; Toland, Amanda Ewart] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Fernandez, Soledad; Wei, Lai] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Zhou, Xiao-Ping] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [de la Chapelle, Albert; Toland, Amanda Ewart] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gerber, MM (corresponding author), Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA.	Amanda.Toland@osumc.edu	Toland, Amanda Ewart/E-4202-2011; Hampel, Heather/AAV-4041-2020	Hampel, Heather/0000-0001-7558-9794	NIH/NCI [CA134461, CA67941]; Ohio State University Comprehensive Cancer Center Core grant [CA16058]; OSU College of Medicine Systems and Integrated Biology training grant; OSU College of Medicine Medical Student Research Scholarship; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA067941, R01CA134461, U01CA067941] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State University Comprehensive Cancer Center Core grant; OSU College of Medicine Systems and Integrated Biology training grant; OSU College of Medicine Medical Student Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the NIH/NCI (CA134461 to AET and CA67941 to AdlC) and the Ohio State University Comprehensive Cancer Center Core grant (CA16058). MMG was funded by an OSU College of Medicine Systems and Integrated Biology training grant. NPS was funded by an OSU College of Medicine Medical Student Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Dworkin AM, 2009, J INVEST DERMATOL, V129, P2868, DOI 10.1038/jid.2009.183; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kocarnik JD, 2010, CANCER EPIDEM BIOMAR, V19, P3131, DOI 10.1158/1055-9965.EPI-10-0878; LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086; Micale L, 2011, BLOOD CELL MOL DIS, V47, P259, DOI 10.1016/j.bcmd.2011.09.001; Nagase H, 2003, CANCER RES, V63, P4849; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Umetani N, 2004, ONCOGENE, V23, P8292, DOI 10.1038/sj.onc.1208022; VARMUS HE, 1984, ANNU REV GENET, V18, P553; Wang C, 2004, J PATHOL, V202, P215, DOI 10.1002/path.1507; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yearsley M, 2006, HUM PATHOL, V37, P831, DOI 10.1016/j.humpath.2006.02.009; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37672	10.1371/journal.pone.0037672	http://dx.doi.org/10.1371/journal.pone.0037672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629442	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100045
J	Schmitz, H; Bousack, H				Schmitz, Helmut; Bousack, Herbert			Modelling a Historic Oil-Tank Fire Allows an Estimation of the Sensitivity of the Infrared Receptors in Pyrophilous Melanophila Beetles	PLOS ONE			English	Article							STOCHASTIC RESONANCE; ACUMINATA COLEOPTERA; FOREST-FIRES; POOL FIRES; NOISE; BUPRESTIDAE; RADIATION; SENSILLA; TRANSDUCTION; CRAYFISH	Pyrophilous jewel beetles of the genus Melanophila approach forest fires and there is considerable evidence that these beetles can detect fires from great distances of more than 60 km. Because Melanophila beetles are equipped with infrared receptors and are also attracted by hot surfaces it can be concluded that these infrared receptors are used for fire detection. The sensitivity of the IR receptors is still unknown. The lowest threshold published so far is 0.6 W/m(2) which, however, cannot explain the detection of forest fires by IR radiation from distances larger than approximately 10 km. To investigate the possible sensitivity of the IR receptors we assumed that beetles use IR radiation for remote fire detection and we made use of a historic report about a big oil-tank fire in Coalinga, California, in 1924. IR emission of an oil-tank fire can be calculated by "pool fire" simulations which now are used for fire safety and risk analysis. Assuming that beetles were lured to the fire from the nearest forests 25 and 130 km away, our results show that detection from a distance of 25 km requires a threshold of the IR receptors of at least 3x10(-2) W/m(2). According to our investigations most beetles became aware of the fire from a distance of 130 km. In this case the threshold has to be 1.3 +/- 10(-4) W/m(2). Because such low IR intensities are buried in thermal noise we suggest that the infrared sensory system of Melanophila beetles utilizes stochastic resonance for the detection of weak IR radiation. Our simulations also suggest that the biological IR receptors might be even more sensitive than uncooled technical IR sensors. Thus a closer look into the mode of operation of the Melanophila IR receptors seems promising for the development of novel IR sensors.	[Schmitz, Helmut] Univ Bonn, Inst Zool, Bonn, Germany; [Bousack, Herbert] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany	University of Bonn; Helmholtz Association; Research Center Julich	Schmitz, H (corresponding author), Univ Bonn, Inst Zool, Bonn, Germany.	h.schmitz@uni-bonn.de	Bousack, Herbert/K-4578-2012		German Ministry of Education and Research (BMBF) [01RB0909A]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by the German Ministry of Education and Research (BMBF): www.bmbf.de Grant No.: 01RB0909A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adali T, 2010, ADAPTIVE SIGNAL PROC, pxv; Apel K. H., 1988, Beitrage fur die Forstwirtschaft, V22, P45; Apel K.-H., 1989, Entomologische Nachrichten und Berichte, V33, P278; Barr W. F., 1947, PAN PACIFIC ENT, V23, P162; Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; BEER FRANK M., 1940, PAN PACIFIC ENT, V16, P13; BEJAN A, 1991, J HEAT TRANS-T ASME, V113, P261, DOI 10.1115/1.2910540; Bennett M, 2004, FLUCT NOISE LETT, V4, pL1, DOI 10.1142/S0219477504001604; Beyler C., 2002, SFPE HDB FIRE PROTEC, V3rd; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; Bonsignore CP, 2007, EUR J ENTOMOL, V104, P425, DOI 10.14411/eje.2007.062; Bouchet O, FREE SPACE OPTICS PR; Bousack H, 2008, ACTUATOR, P786; Braxmeier H, MAP LAYERS RELIEF MA; BROECKMANN B, 1995, J LOSS PREVENT PROC, V8, P137, DOI 10.1016/0950-4230(95)00016-T; Budzier H, 2010, THERMAL INFRARED SEN, pxx; Center WRC, 2011, HIST CLIM INF; Center WRC, 2011, AV WIND SPEED; Champion GC, 1918, ENTOMOL MON MAG, V54, P199; CHEN RC, 1984, ACTA ENTOMOL SINICA, V27, P121; Clark B Earth Point, EARTH POINT TOOLS GO; Dean TJ, BOOK INSECT RECORDS; Derby CD, 2001, BIOL BULL, V200, P211, DOI 10.2307/1543318; Dettner K., 1999, LEHRBUCH ENTOMOLOGIE; Duke T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.158101; Evans HF, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P447; Evans WG, 2010, ANN ENTOMOL SOC AM, V103, P823, DOI 10.1603/AN10076; EVANS WG, 1964, NATURE, V202, P211, DOI 10.1038/202211a0; EVANS WG, 1966, ECOLOGY, V47, P1061, DOI 10.2307/1935658; EWELL DM, 1989, J APPL METEOROL, V28, P112, DOI 10.1175/1520-0450(1989)028<0112:ATITSS>2.0.CO;2; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gopfert MC, 2003, P NATL ACAD SCI USA, V100, P5514, DOI 10.1073/pnas.0737564100; Gopfert MC, 1999, J EXP BIOL, V202, P2727; GUELZIM A, 1993, J HEAT TRANS-T ASME, V115, P489, DOI 10.1115/1.2910708; Hammer DX, 2001, J INSECT PHYSIOL, V47, P1441, DOI 10.1016/S0022-1910(01)00134-2; Hammer DX, 2001, COMP BIOCHEM PHYS A, V128, P805, DOI 10.1016/S1095-6433(00)00322-6; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; HARDIN B, 1992, AGR RES, V40, P20; Heskestad G., 2002, SFPE HDB FIRE PROTEC; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; Humphrey JAC, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P129; Jafari MG, 2003, ADAPTRIVE NOISE CANC, P627; Johnson MT, 2005, PHYSICA D, V201, P306, DOI 10.1016/j.physd.2005.01.011; Keeys RJ, OPTICAL INFRARED DET; Klassen M, 1992, STRUCTURE RAD POOL F; Kruse P., 1962, ELEMENTS INFRARED TE; Kunzig R, 2000, DISCOVER, V21, P27; Larson DA, 1982, TIME DEPENDENT MODEL; Lindner JF, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051911; LINSLEY E. G., 1957, COLEOPT BULL, V11, P9; Linsley E. Gorton, 1943, JOUR ECON ENT, V36, P341, DOI 10.1093/jee/36.2.341; Linsley EG, 1933, PAN-PAC ENTOMOL, V9, P138; Lohle F, 1944, PHYS Z, V45, P7; Long B., 2004, GUIDE STORAGE TANKS; McCaffrey BJ, 1984, FIRE PLUME DYNAMICS; McGrattan KB, THERMAL RAD LARGE PO; Middleton W.E.K., 2019, VISION ATMOSPHERE; Munoz M, 2007, J HAZARD MATER, V144, P725, DOI 10.1016/j.jhazmat.2007.01.121; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; Nicholson GW, 1919, ENTOMOL MON MAG, V55, P156; Paine PM, 1913, OIL PRODUCTION METHO; Palm T., 1955, Entomologisk Tidskrift Stockholm, V76, P40; Parker SP, MCGRAW HILL DICT SCI; Raj PK, 2007, J HAZARD MATER, V140, P280, DOI 10.1016/j.jhazmat.2006.08.057; Raj PK, 2005, PROCESS SAF PROG, V24, P192, DOI 10.1002/prs.10082; Ricksecker LE, 1885, ENTOMOL AM, V1, P96; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Ryle G. B., 1923, Entomologist's Monthly Magazine, V59, P1; Salley MH, 2004, ESTIMATING RADIANT H; Salley MH, 2004, FIRE DYNAMICS TOOLS; Schmitz A, 2007, ARTHROPOD STRUCT DEV, V36, P291, DOI 10.1016/j.asd.2007.02.002; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; Schmitz H, 2000, J COMP PHYSIOL A, V186, P543, DOI 10.1007/s003590000109; Services GGW, CAL MEAN MONTH ANN P; SHARP W.E., 1918, ENTOMOL MON MAG, V54, P244; Shimozawa T, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P145; Siegel R, 2002, THERMAL RAD HEAT TRA; Sloop K. D., 1937, University of California Publications in Entomology, V7, P1; Takahashi N, 1999, FIRE SAFETY J, V33, P1, DOI 10.1016/S0379-7112(99)00009-0; Thomas PH, 1963, S INT COMBUSTION, V9, P844, DOI DOI 10.1016/S0082-0784(63)80091-0; Thurm U, 1982, GRUNDZUGE TRANSDUKTI, P681; Trefethen L. M., 1990, APPL MECH REV, V43, P153, DOI [10.1115/1.3119167, DOI 10.1115/1.3119167]; Trijonis J, TSCPDB6123; Van Dyke E.C., 1926, PAN-PAC ENTOMOL, V3, P41; VanDyke EC, 1928, PAN-PAC ENTOMOL, V4, P113; VanDyke EC, 1926, PAN PACIFIC ENTOMOLO, V3; Vondran T, 1995, TISSUE CELL, V27, P645, DOI 10.1016/S0040-8166(05)80020-5; Walther L, 1983, INFRAROTMESSTECHNIK; WAYNE FD, 1991, J LOSS PREVENT PROC, V4, P86; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilson CC, 1988, FOREST FIRE LAB RIVE; Womack J, WORK STRATEGIC POSIT; WorldClimate, 2011, CLIM DAT 36 N 120 W; Zhao XH, 2008, CHINESE PHYS LETT, V25, P1490, DOI 10.1088/0256-307X/25/4/088	97	24	26	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37627	10.1371/journal.pone.0037627	http://dx.doi.org/10.1371/journal.pone.0037627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629433	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100041
J	Henze, J; Muhlenberg, T; Simon, S; Grabellus, F; Rubin, B; Taeger, G; Schuler, M; Treckmann, J; Debiec-Rychter, M; Taguchi, T; Fletcher, JA; Bauer, S				Henze, Joern; Muehlenberg, Thomas; Simon, Susanne; Grabellus, Florian; Rubin, Brian; Taeger, Georg; Schuler, Martin; Treckmann, Juergen; Debiec-Rychter, Maria; Taguchi, Takahiro; Fletcher, Jonathan A.; Bauer, Sebastian			p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							GENE AMPLIFICATION; IMATINIB MESYLATE; IN-VIVO; C-KIT; APOPTOSIS; ACTIVATION; MUTATIONS; MDM2; HEAT-SHOCK-PROTEIN-90; INHIBITION	The KIT-inhibitor imatinib mesylate (IM) has greatly improved the treatment of metastatic gastrointestinal stromal tumors (GIST). IM exhibits strong antiproliferative effects but fails to induce sufficient levels of apoptosis resulting in low pathologic complete remission rates and a high rate of secondary progression in the metastatic setting. Upregulation of p53 by MDM2 inhibitors has been shown to induce apoptosis in p53 wildtype tumors. Analyzing a series of 62 mostly untreated, localized and metastatic GIST we detected a low rate (3%) of inactivating p53 mutations, thus providing a rationale for further exploration of p53-directed therapeutic strategies. To this end, we studied nutlin-3, an inhibitor of the p53 antagonist MDM2, and RITA, a putative p53 activator, in GIST cell lines. Nutlin-3 effectively induced p53 at therapeutically relevant levels, which resulted in moderate antiproliferative effects and cell cycle arrest in p53 wildtype GIST cell lines GIST430, GIST48 and GIST48B. P53 reactivation substantially improved the apoptotic response after effective KIT inhibition with sunitinib and 17-AAG in IM-resistant cell lines. The commonly used imatinib-sensitive cell lines GIST882 and GIST-T1 were shown to harbor defective p53 and therefore failed to respond to nutlin-3 treatment. RITA induced p53 in GIST48B, followed by antiproliferative effects and a strong induction of apoptosis. Surprisingly, GIST-T1 was also highly sensitive to RITA despite lacking functional p53. This suggested a more complex, p53-independent mechanism of action for the latter compound. No antagonistic effects from p53-activating drugs were seen with any drug combination. Our data provide first evidence that modulation of the MDM2/p53 pathway may be therapeutically useful to improve the apoptotic response of KIT-inhibitory drugs in the treatment of naive GIST, with p53 mutation status being a predictive factor of response.	[Henze, Joern; Muehlenberg, Thomas; Simon, Susanne; Schuler, Martin; Bauer, Sebastian] Univ Duisburg Essen, Sch Med, Dept Med Oncol, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Grabellus, Florian] Univ Duisburg Essen, Sch Med, Dept Pathol & Neuropathol, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Taeger, Georg] Univ Duisburg Essen, Sch Med, Dept Trauma & Orthoped Surg, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Treckmann, Juergen] Univ Duisburg Essen, Sch Med, Dept Visceral & Transplant Surg, Sarcoma Ctr,W German Canc Ctr, Essen, Germany; [Rubin, Brian] Cleveland Clin, Taussig Canc Ctr, Dept Mol Genet & Anat Pathol, Lerner Res Inst, Cleveland, OH 44106 USA; [Debiec-Rychter, Maria] Univ Leuven, Dept Human Genet, Louvain, Belgium; [Taguchi, Takahiro] Kochi Univ, Grad Sch Kuroshio Sci, Div Human Hlth & Med Sci, Nankoku, Kochi, Japan; [Fletcher, Jonathan A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Cleveland Clinic Foundation; KU Leuven; Kochi University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Henze, J (corresponding author), Univ Duisburg Essen, Sch Med, Dept Med Oncol, Sarcoma Ctr,W German Canc Ctr, Essen, Germany.	sebastian.bauer@uk-essen.de	Mühlenberg, Thomas/J-8423-2019; Bauer, Sebastian/HHR-9319-2022; Bauer, Sebastian/D-8120-2012	Mühlenberg, Thomas/0000-0002-2078-8857; Bauer, Sebastian/0000-0001-5949-8120	Max-Eder Fellowship from Deutsche Krebshilfe; Life Raft Group Research Initiative	Max-Eder Fellowship from Deutsche Krebshilfe; Life Raft Group Research Initiative	Grant support was received from Max-Eder Fellowship from the Deutsche Krebshilfe (SB) and Life Raft Group Research Initiative (SB, BR, JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Bauer S, 2005, INT J CANCER, V117, P316, DOI 10.1002/ijc.21164; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Choi Y, 2004, STEM CELLS, V22, P1070, DOI 10.1634/stemcells.22-6-1070; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 2001, J PATHOL, V193, P505, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E; Jackson SP, 2009, CANCER CELL, P171, DOI [10.1016/j.ccr.2009.01.019, DOI 10.1016/J.CCR.2009.01.019]; Karvinen J, 2002, J BIOMOL SCREEN, V7, P223, DOI 10.1177/108705710200700306; Kurosu T, 2010, APOPTOSIS, V15, P608, DOI 10.1007/s10495-010-0457-0; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Nakatani H, 2005, CANCER SCI, V96, P116, DOI 10.1111/j.1349-7006.2005.00018.x; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohayon T, 2005, BRIT J CANCER, V92, P1144, DOI 10.1038/sj.bjc.6602451; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Romeo S, 2009, CLIN CANCER RES, V15, P4191, DOI 10.1158/1078-0432.CCR-08-3297; Rubin BP, 2001, CANCER RES, V61, P8118; Schneider-Stock R, 2005, CLIN CANCER RES, V11, P638; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Tornillo L, 2005, LAB INVEST, V85, P921, DOI 10.1038/labinvest.3700284; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wardelmann E, 2006, CLIN CANCER RES, V12, P1743, DOI 10.1158/1078-0432.CCR-05-1211; Xia M, 2011, ONCOGENE, V30, P346, DOI 10.1038/onc.2010.413; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; Zhao CY, 2010, CELL CYCLE, V9, P1847, DOI 10.4161/cc.9.9.11545	38	42	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37776	10.1371/journal.pone.0037776	http://dx.doi.org/10.1371/journal.pone.0037776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662219	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300109
J	Moreno-Martinez, FJ; Montoro, PR				Javier Moreno-Martinez, Francisco; Montoro, Pedro R.			An Ecological Alternative to Snodgrass & Vanderwart: 360 High Quality Colour Images with Norms for Seven Psycholinguistic Variables	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SEMANTIC MEMORY; SURFACE DETAIL; NAME AGREEMENT; STANDARDIZED SET; 260 PICTURES; CATEGORY; KNOWLEDGE; ACQUISITION; AGE	This work presents a new set of 360 high quality colour images belonging to 23 semantic subcategories. Two hundred and thirty-six Spanish speakers named the items and also provided data from seven relevant psycholinguistic variables: age of acquisition, familiarity, manipulability, name agreement, typicality and visual complexity. Furthermore, we also present lexical frequency data derived from Internet search hits. Apart from the high number of variables evaluated, knowing that it affects the processing of stimuli, this new set presents important advantages over other similar image corpi: (a) this corpus presents a broad number of subcategories and images; for example, this will permit researchers to select stimuli of appropriate difficulty as required, (e.g., to deal with problems derived from ceiling effects); (b) the fact of using coloured stimuli provides a more realistic, ecologically-valid, representation of real life objects. In sum, this set of stimuli provides a useful tool for research on visual object-and word-processing, both in neurological patients and in healthy controls.	[Javier Moreno-Martinez, Francisco; Montoro, Pedro R.] Univ Nacl Educ Distancia, Dept Psicol Basica, E-28040 Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED)	Moreno-Martinez, FJ (corresponding author), Univ Nacl Educ Distancia, Dept Psicol Basica, E-28040 Madrid, Spain.	prmontoro@psi.uned.es	Montoro, Pedro R. R/B-2270-2014	Montoro, Pedro R. R/0000-0002-5665-8587				Adlam ALR, 2010, NEUROCASE, V16, P193, DOI 10.1080/13554790903405693; Adlington RL, 2009, J CLIN EXP NEUROPSYC, V31, P731, DOI 10.1080/13803390802488103; Adlington RL, 2009, NEUROPSYCHOLOGIA, V47, P2574, DOI 10.1016/j.neuropsychologia.2009.05.004; Allport D.A., 1985, CURRENT PERSPECTIVES, P32; Alvarez B, 2007, BEHAV RES METHODS, V39, P377, DOI 10.3758/BF03193006; Baayen R. H, 1995, CELEX LEXICAL DATABA; Barbarotto R, 2001, NEUROPSYCHOLOGIA, V39, P406, DOI 10.1016/S0028-3932(00)00128-7; Blair IV, 2002, BEHAV RES METH INS C, V34, P286, DOI 10.3758/BF03195456; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Bunn EM, 1998, NEUROPSYCHOLOGY, V12, P367, DOI 10.1037/0894-4105.12.3.367; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Crutch SJ, 2003, COGN NEUROPSYCHOL, V20, P355, DOI 10.1080/02643290244000220; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Dimitropoulou M, 2009, BEHAV RES METHODS, V41, P584, DOI 10.3758/BRM.41.2.584; Done DJ, 1997, COGNITIVE NEUROPSYCH, V14, P547; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; Filliter JH, 2005, BRAIN COGNITION, V57, P61, DOI 10.1016/j.bandc.2004.08.022; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; FUNNELL E, 1992, COGNITIVE NEUROPSYCH, V9, P135, DOI 10.1080/02643299208252056; GILHOOLY KJ, 1979, MEM COGNITION, V7, P214, DOI 10.3758/BF03197541; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Grossman M, 1998, NEUROPSYCHOLOGY, V12, P34, DOI 10.1037/0894-4105.12.1.34; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; Holmes SJ, 2006, J CLIN EXP NEUROPSYC, V28, P1010, DOI 10.1080/13803390591004392; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P480; Moreno-Martinez FJ, 2007, BRAIN COGNITION, V63, P167, DOI 10.1016/j.bandc.2006.11.003; Moreno-Martinez FJ, 2010, NEUROCASE, V16, P494, DOI 10.1080/13554791003730626; Moreno-Martinez FJ, 2011, AGING NEUROPSYCHOL C, V18, P293, DOI 10.1080/13825585.2010.540849; Moreno-Martinez FJ, 2010, APHASIOLOGY, V24, P1389, DOI 10.1080/02687030903515370; Kiran S, 2003, BRAIN LANG, V85, P441, DOI 10.1016/S0093-934X(03)00064-6; Kucera H., 1967, COMPUTATIONAL ANAL P; LAIACONA M, 1993, ARCH PSICOLOGIA NEUR, V54, P209; Laws KR, 2005, CORTEX, V41, P842, DOI 10.1016/S0010-9452(08)70303-4; Laws KR, 2005, CORTEX, V41, P452, DOI 10.1016/S0010-9452(08)70186-2; Magnie MN, 2003, J CLIN EXP NEUROPSYC, V25, P521, DOI 10.1076/jcen.25.4.521.13873; Mahon BZ, 2003, COGN NEUROPSYCHOL, V20, P433, DOI 10.1080/02643290342000014; McKenna P, 1998, CATEGORY SPECIFIC NA; McRae K, 2002, BRAIN DAM B, P211; Moreno FJ, 2005, REV PSICOPATOLOGIA P, V10, P205; Moreno-Martinez FJ, 2007, REV NEUROLOGIA, V44, P129, DOI 10.33588/rn.4403.2006284; Moreno-Martinez FJ, 2008, NEUROPSYCHOLOGY, V22, P485, DOI 10.1037/0894-4105.22.4.485; Moreno-Martinez FJ, 2007, PSICOLOGICA, V28, P1; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; P?rez M.-A., 2003, PSICOLOGICA, V24, P215; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; ROSCH E, 1976, J EXP PSYCHOL HUMAN, V2, P491, DOI 10.1037/0096-1523.2.4.491; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Samson D, 2003, COGN NEUROPSYCHOL, V20, P373, DOI 10.1080/02643290244000329; Sanfeliu MC, 1996, BEHAV RES METH INSTR, V28, P537, DOI 10.3758/BF03200541; Sebastian N., 2000, LEXESP LEXICO INFORM; Shelton JR, 1998, NEUROCASE, V4, P339, DOI 10.1093/neucas/4.4.339; Silveri MC, 2002, J CLIN EXP NEUROPSYC, V24, P755, DOI 10.1076/jcen.24.6.755.8407; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tanaka JW, 1999, PERCEPT PSYCHOPHYS, V61, P1140, DOI 10.3758/BF03207619; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Thomas MC, 2006, ELEMENTS INFORM THEO; Torralba A, 2009, VISUAL NEUROSCI, V26, P123, DOI 10.1017/S0952523808080930; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1329, DOI 10.1016/S0028-3932(97)00086-9; Tyler LK, 2003, COGN NEUROPSYCHOL, V20, P541, DOI 10.1080/02643290244000211; Viggiano MP, 2004, CORTEX, V40, P491, DOI 10.1016/S0010-9452(08)70142-4; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Whatmough C, 2003, BRAIN LANG, V84, P134, DOI 10.1016/S0093-934X(02)00524-2	69	107	108	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37527	10.1371/journal.pone.0037527	http://dx.doi.org/10.1371/journal.pone.0037527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662166	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300056
J	Maly, IV				Maly, Ivan V.			Efficiency of Organelle Capture by Microtubules as a Function of Centrosome Nucleation Capacity: General Theory and the Special Case of Polyspermia	PLOS ONE			English	Article							DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; TRANSITION FREQUENCIES; TUBULIN; PHOSPHORYLATION; ESTABLISHMENT; TRANSPORT; GROWTH; CYCLE; FERTILIZATION	Transport of organelles along microtubules is essential for the cell metabolism and morphogenesis. The presented analysis derives the probability that an organelle of a given size comes in contact with the microtubule aster. The question is asked how this measure of functionality of the microtubule aster is controlled by the centrosome. A quantitative model is developed to address this question. It is shown that for the given set of cellular parameters, such as size and total tubulin content, a centrosome nucleation capacity exists that maximizes the probability of the organelle capture. The developed general model is then applied to the capture of the female pronucleus by microtubules assembled on the sperm centrosome, following physiologically polyspermic fertilization. This application highlights an unintuitive reflection of nonlinearity of the nucleated polymerization of the cellular pool of tubulin. The prediction that the sperm centrosome should lower its nucleation capacity in the face of the competition from the other sperm is a stark illustration of the new optimality principle. Overall, the model calls attention to the capabilities of the centrosomal pathway of regulation of the transport-related functionality of the microtubule cytoskeleton. It establishes a quantitative and conceptual framework that can guide experiment design and interpretation.	Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maly, IV (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	ivanvmaly@gmail.com						Alieva I B, 1997, Membr Cell Biol, V11, P17; Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; [Anonymous], 1987, LINEAR AGGREGATION T; Borisy GG, 1999, FASEB J, V13, pS221, DOI 10.1096/fasebj.13.9002.S221; CARRE D, 1991, DEV BIOL, V147, P381, DOI 10.1016/0012-1606(91)90296-F; CARRE D, 1984, DEV BIOL, V105, P188, DOI 10.1016/0012-1606(84)90274-4; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; FREEMAN G, 1977, J EMBRYOL EXP MORPH, V42, P237; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gregoretti IV, 2006, J CELL SCI, V119, P4781, DOI 10.1242/jcs.03240; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HOULISTON E, 1993, DEVELOPMENT, V117, P75; Howell B, 1999, J CELL SCI, V112, P3713; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Jolly AL, 2011, BIOCHEM SOC T, V39, P1126, DOI 10.1042/BST0391126; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Komarova YA, 2002, J CELL SCI, V115, P3527; KURIYAMA R, 1981, J CELL BIOL, V91, P822, DOI 10.1083/jcb.91.3.822; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Lippincott-Schwartz Jennifer, 1993, Trends in Cell Biology, V3, P81, DOI 10.1016/0962-8924(93)90078-F; Maly IV, 2002, B MATH BIOL, V64, P213, DOI 10.1006/bulm.2001.0265; Maly IV, 2002, CELL BIOL INT, V26, P791, DOI 10.1016/S1065-6995(02)90946-7; Margolin G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041920; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1987, CELL BIOPHYS, V11, P35, DOI 10.1007/BF02797111; Mourao M, 2011, COMPUT BIOL CHEM, V35, P269, DOI 10.1016/j.compbiolchem.2011.06.002; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Oosawa F., 1975, THERMODYNAMICS POLYM; PFEFFER TA, 1976, J CELL BIOL, V69, P599, DOI 10.1083/jcb.69.3.599; Rodionov VI, 1998, CURR BIOL, V8, P165, DOI 10.1016/S0960-9822(98)70064-8; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; ROUVIERE C, 1994, CELL MOTIL CYTOSKEL, V29, P301, DOI 10.1002/cm.970290403; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SCHATTEN G, 1982, INT REV CYTOL, V79, P59, DOI 10.1016/S0074-7696(08)61673-3; Smurova K. M., 2007, CELL TISSUE BIOL, V1, P225; SNYDER JA, 1975, J CELL BIOL, V67, P744, DOI 10.1083/jcb.67.3.744; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Vorob'ev I A, 2000, Ontogenez, V31, P420; Vorobjev I, 2008, CELL TISSUE BIOL, V2, P272; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	54	0	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37675	10.1371/journal.pone.0037675	http://dx.doi.org/10.1371/journal.pone.0037675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662187	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300077
J	Nanguneri, S; Flottmann, B; Horstmann, H; Heilemann, M; Kuner, T				Nanguneri, Siddharth; Flottmann, Benjamin; Horstmann, Heinz; Heilemann, Mike; Kuner, Thomas			Three-Dimensional, Tomographic Super-Resolution Fluorescence Imaging of Serially Sectioned Thick Samples	PLOS ONE			English	Article							RAT CALYX; IN-VIVO; MICROSCOPY; RESOLUTION; PROTEINS; TRANSMISSION; ULTRASTRUCTURE; RECONSTRUCTION; LOCALIZATION; ARCHITECTURE	Three-dimensional fluorescence imaging of thick tissue samples with near-molecular resolution remains a fundamental challenge in the life sciences. To tackle this, we developed tomoSTORM, an approach combining single-molecule localization-based super-resolution microscopy with array tomography of structurally intact brain tissue. Consecutive sections organized in a ribbon were serially imaged with a lateral resolution of 28 nm and an axial resolution of 40 nm in tissue volumes of up to 50 mu mx50 mu mx2.5 mu m. Using targeted expression of membrane bound (m)GFP and immunohistochemistry at the calyx of Held, a model synapse for central glutamatergic neurotransmission, we delineated the course of the membrane and fine-structure of mitochondria. This method allows multiplexed super-resolution imaging in large tissue volumes with a resolution three orders of magnitude better than confocal microscopy.	[Nanguneri, Siddharth; Horstmann, Heinz; Kuner, Thomas] Univ Heidelberg, Inst Anat & Cell Biol, Heidelberg, Germany; [Flottmann, Benjamin; Heilemann, Mike] Univ Heidelberg, Bioquant Ctr, Heidelberg, Germany; [Heilemann, Mike] Univ Wurzburg, Wurzburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg	Nanguneri, S (corresponding author), Univ Heidelberg, Inst Anat & Cell Biol, Heidelberg, Germany.	m.heilemann@uni-wuerzburg.de; kuner@uni-heidelberg.de		Heilemann, Mike/0000-0002-9821-3578	German Ministry of Education and Research (BMBF; FORSYS initiative) [0315262]; CellNetworks Cluster of Excellence [EXC81]	German Ministry of Education and Research (BMBF; FORSYS initiative); CellNetworks Cluster of Excellence	M.H. is grateful for financial support by the German Ministry of Education and Research (BMBF; FORSYS initiative, grant nr. 0315262). T.K. is supported by the CellNetworks Cluster of Excellence (EXC81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bubeck D, 2008, J STRUCT BIOL, V162, P480, DOI 10.1016/j.jsb.2008.03.006; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Chao J, 2009, OPT EXPRESS, V17, P24377, DOI 10.1364/OE.17.024377; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2010, J BIOTECHNOL, V149, P243, DOI 10.1016/j.jbiotec.2010.03.012; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; MALECKI M, 1987, PROTOPLASMA, V139, P160, DOI 10.1007/BF01282287; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Micheva K.D., 2010, COLD SPRING HARB PRO, V2010; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Punge A, 2008, MICROSC RES TECHNIQ, V71, P644, DOI 10.1002/jemt.20602; Ram S, 2009, OPT EXPRESS, V17, P6881, DOI 10.1364/OE.17.006881; Satzler K, 2002, J NEUROSCI, V22, P10567; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Schwenger DB, 2010, EUR J NEUROSCI, V32, P974, DOI 10.1111/j.1460-9568.2010.07391.x; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x	35	56	57	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38098	10.1371/journal.pone.0038098	http://dx.doi.org/10.1371/journal.pone.0038098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662272	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300164
J	Parachnowitsch, AL; Caruso, CM; Campbell, SA; Kessler, A				Parachnowitsch, Amy L.; Caruso, Christina M.; Campbell, Stuart A.; Kessler, Andre			Lobelia siphilitica Plants That Escape Herbivory in Time Also Have Reduced Latex Production	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FLOWERING PHENOLOGY; NATURAL-SELECTION; FLORAL TRAITS; BRASSICA-RAPA; WILD RADISH; RAPHANUS-RAPHANISTRUM; DEFENSE; RESISTANCE; FITNESS	Flowering phenology is an important determinant of a plant's reproductive success. Both assortative mating and niche construction can result in the evolution of correlations between phenology and other reproductive, functional, and life history traits. Correlations between phenology and herbivore defence traits are particularly likely because the timing of flowering can allow a plant to escape herbivory. To test whether herbivore escape and defence are correlated, we estimated phenotypic and genetic correlations between flowering phenology and latex production in greenhouse-grown Lobelia siphilitica L. (Lobeliaceae). Lobelia siphilitica plants that flower later escape herbivory by a specialist pre-dispersal seed predator, and thus should invest fewer resources in defence. Consistent with this prediction, we found that later flowering was phenotypically and genetically correlated with reduced latex production. To test whether herbivore escape and latex production were costly, we also measured four fitness correlates. Flowering phenology was negatively genetically correlated with three out of four fitness estimates, suggesting that herbivore escape can be costly. In contrast, we did not find evidence for costs of latex production. Generally, our results suggest that herbivore escape and defence traits will not evolve independently in L. siphilitica.	[Parachnowitsch, Amy L.; Campbell, Stuart A.; Kessler, Andre] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Caruso, Christina M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Campbell, Stuart A.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; University of Guelph; Cornell University	Parachnowitsch, AL (corresponding author), Uppsala Univ, Dept Plant Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden.	amyparachnowitsch@gmail.com	Kessler, Andre/C-7810-2014; Campbell, Stuart/B-1494-2012; Parachnowitsch, Amy L/H-8398-2019	Parachnowitsch, Amy L/0000-0001-9668-6593; Caruso, Christina/0000-0001-7069-9572; Kessler, Andre/0000-0002-1797-7518	Cornell University; USA National Science Foundation [NSF-DEB 0717139]; Natural Science and Engineering Research Council (NSERC) of Canada; NSERC Doctoral Fellowship	Cornell University; USA National Science Foundation(National Science Foundation (NSF)); Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Doctoral Fellowship	This study was funded by Cornell University and the USA National Science Foundation (NSF-DEB 0717139), as well as a Discovery grant from the Natural Science and Engineering Research Council (NSERC) of Canada to CMC and an NSERC Doctoral Fellowship to SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2005, EVOL ECOL RES, V7, P651; Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Agrawal AA, 2008, ENTOMOL EXP APPL, V128, P126, DOI 10.1111/j.1570-7458.2008.00690.x; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; AGREN J, 1993, AM NAT, V141, P338, DOI 10.1086/285477; Aizen MA, 2003, ECOLOGY, V84, P2613, DOI 10.1890/02-0521; ANDERSON DM, 1973, P ENTOMOL SOC WASH, V75, P133; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; Beaudoin Yetter R, 1989, EXPRESSION MALE STER; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Bishop JG, 1998, ECOLOGY, V79, P534, DOI 10.1890/0012-9658(1998)079[0534:VIFPAI]2.0.CO;2; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Caruso CM, 2008, J EVOLUTION BIOL, V21, P1514, DOI 10.1111/j.1420-9101.2008.01610.x; Caruso CM, 2007, J EVOLUTION BIOL, V20, P1396, DOI 10.1111/j.1420-9101.2007.01361.x; Caruso CM, 2003, OECOLOGIA, V135, P524, DOI 10.1007/s00442-003-1199-2; CONNER J, 1993, EVOLUTION, V47, P704, DOI 10.1111/j.1558-5646.1993.tb02128.x; Conner JK, 2003, EVOLUTION, V57, P487, DOI 10.1111/j.0014-3820.2003.tb01540.x; Donohue K, 2003, INT J PLANT SCI, V164, pS79, DOI 10.1086/368397; Dudle DA, 2001, HEREDITY, V86, P265, DOI 10.1046/j.1365-2540.2001.00833.x; Dussourd DE, 2003, J CHEM ECOL, V29, P2023, DOI 10.1023/A:1025630301162; Ehrlen J, 2009, AM NAT, V173, P819, DOI 10.1086/598492; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; ENGLISHLOEB GM, 1992, OECOLOGIA, V89, P588, DOI 10.1007/BF00317168; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fornoni J, 2003, EVOL ECOL RES, V5, P1049; Franks SJ, 2008, J EVOLUTION BIOL, V21, P1321, DOI 10.1111/j.1420-9101.2008.01566.x; Franks SJ, 2008, AM NAT, V171, P678, DOI 10.1086/587078; Franks SJ, 2011, NEW PHYTOL, V190, P249, DOI 10.1111/j.1469-8137.2010.03603.x; Franks SJ, 2009, EVOL APPL, V2, P481, DOI 10.1111/j.1752-4571.2009.00073.x; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; JOHNSTON MO, 1992, EVOLUTION, V46, P688, DOI [10.2307/2409638, 10.1111/j.1558-5646.1992.tb02076.x]; Juenger T, 2005, EVOL ECOL, V19, P79, DOI 10.1007/s10682-004-8090-4; Kawagoe T, 2010, OECOLOGIA, V164, P713, DOI 10.1007/s00442-010-1709-y; Kesting JR, 2009, J NAT PROD, V72, P312, DOI 10.1021/np800743w; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kristensen TN, 2005, J EVOLUTION BIOL, V18, P763, DOI 10.1111/j.1420-9101.2005.00883.x; Lynch M., 1998, GENETICS ANAL QUANTI; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; McKey D, 1979, HERBIVORES THEIR INT, P55; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Oppel CB, 2009, J CHEM ECOL, V35, P625, DOI 10.1007/s10886-009-9643-3; Parachnowitsch AL, 2005, NATURAL SELECTION FL; Parachnowitsch AL, 2008, ECOLOGY, V89, P1802, DOI 10.1890/07-0555.1; Parachnowitsch AL, 2010, NEW PHYTOL, V188, P393, DOI 10.1111/j.1469-8137.2010.03410.x; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Rhoades D. F., 1979, HERBIVORES THEIR INT, P3; SCHMID B, 1995, CAN J BOT, V73, P1831, DOI 10.1139/b95-194; Sherrard ME, 2006, EVOLUTION, V60, P2478, DOI 10.1111/j.0014-3820.2006.tb01883.x; Sokal RR, 1995, BIOMETRY; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; Weis AE, 2005, J EVOLUTION BIOL, V18, P536, DOI 10.1111/j.1420-9101.2005.00891.x; Williams JL, 2001, AM J BOT, V88, P1577, DOI 10.2307/3558401	66	10	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37745	10.1371/journal.pone.0037745	http://dx.doi.org/10.1371/journal.pone.0037745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662205	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300095
J	Xu, Y; Li, Y; Pang, Y; Ling, M; Shen, L; Yang, XJ; Zhang, JP; Zhou, JW; Wang, XR; Liu, QZ				Xu, Yuan; Li, Yuan; Pang, Ying; Ling, Min; Shen, Lu; Yang, Xiaojun; Zhang, Jianping; Zhou, Jianwei; Wang, Xinru; Liu, Qizhan			EMT and Stem Cell-Like Properties Associated with HIF-2 alpha Are Involved in Arsenite-Induced Transformation of Human Bronchial Epithelial Cells	PLOS ONE			English	Article							LUNG-CANCER; MESENCHYMAL TRANSITION; MALIGNANT-TRANSFORMATION; TUMOR PROGRESSION; E-CADHERIN; KAPPA-B; EXPRESSION; HYPOXIA; GROWTH; OCT-4	Background: Arsenic is well-established as a human carcinogen, but the molecular mechanisms leading to arsenic-induced carcinogenesis are complex and elusive. It is not been determined if the epithelial-mesenchymal transition (EMT) and stem cell-like properties contribute in causing to carcinogen-induced malignant transformation and subsequent tumor formation. Methods: To investigate the molecular mechanisms underlying EMT and the emergence of cancer stem cell-like properties during neoplastic transformation of human bronchial epithelial (HBE) cells induced by chronic exposure to arsenite. HBE cells were continuously exposed to arsenite. Spheroid formation assays and analyses of side populations (SPs) were performed to confirm that arsenite induces the acquired EMT and cancer stem cell-like phenotype. Treated HBE cells were molecularly characterized by RT-PCR, Western blots, immunofluorescence, Southwestern assays, reporter assays, and chromatin immunoprecipitation. Results: With chronic exposure to arsenite, HBE cells undergo an EMT and then acquire a malignant cancer stem cell-like phenotype. Twist1 and Bmi1 are involved in arsenite-induced EMT. The process is directly regulated by HIF-2 alpha. The self-renewal genes, Oct4, Bmi1, and ALDH1, are necessary for arsenite-mediated maintenance of stem cells. Conclusions: EMT, regulated by HIF-2 alpha, and the development of a cancer stem cell-like phenotype are associated with arsenite-induced transformation of HBE cells.	[Xu, Yuan; Li, Yuan; Pang, Ying; Ling, Min; Shen, Lu; Liu, Qizhan] Nanjing Med Univ, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Xu, Yuan; Li, Yuan; Pang, Ying; Ling, Min; Shen, Lu; Zhou, Jianwei; Wang, Xinru; Liu, Qizhan] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiaojun; Zhang, Jianping] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Med Univ, Inst Toxicol, Nanjing, Jiangsu, Peoples R China.	drqzliu@hotmail.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Natural Science Foundations of China [30872146, 81072327]; Research Fund for the Doctoral Program of Higher Education of China [20103234110005]; Key Program of Educational Commission of Jiangsu Province of China [11KJA330002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Program of Educational Commission of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundations of China (30872146 and 81072327), Research Fund for the Doctoral Program of Higher Education of China (20103234110005), and Key Program of Educational Commission of Jiangsu Province of China (11KJA330002), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Borczuk Alain C, 2009, Proc Am Thorac Soc, V6, P152, DOI 10.1513/pats.200807-076LC; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cantor KP, 2007, TOXICOL APPL PHARM, V222, P252, DOI 10.1016/j.taap.2007.01.026; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P269; Jacquot C, 2002, ANTICANCER RES, V22, P2229; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li YA, 2010, ENVIRON HEALTH PERSP, V118, P936, DOI 10.1289/ehp.0901677; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patterson TJ, 2007, TOXICOL APPL PHARM, V221, P119, DOI 10.1016/j.taap.2007.02.003; Patterson TJ, 2005, TOXICOL APPL PHARM, V207, P69, DOI 10.1016/j.taap.2004.11.020; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; REDDEL RR, 1988, CANCER RES, V48, P1904; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shen SW, 2008, MOL CARCINOGEN, V47, P508, DOI 10.1002/mc.20406; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tokar EJ, 2011, ENV HLTH PERSPECT, V118, P108; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Waalkes MP, 2008, CANCER RES, V68, P8278, DOI 10.1158/0008-5472.CAN-08-2099; Wang Bo, 2010, Chin J Cancer, V29, P254; Wang Q, 2009, J CELL BIOCHEM, V106, P16, DOI 10.1002/jcb.21969; Wang ZS, 2011, TOXICOL SCI, V121, P110, DOI 10.1093/toxsci/kfr029; Wen GY, 2008, MOL MED, V14, P2, DOI 10.2119/2007-00090.Wen; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	47	38	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37765	10.1371/journal.pone.0037765	http://dx.doi.org/10.1371/journal.pone.0037765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662215	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300105
J	Zhu, LH; Ye, JR; Negi, S; Xu, XL; Wang, ZL; Ji, JY				Zhu, Li-hua; Ye, Jianren; Negi, Sapna; Xu, Xu-ling; Wang, Zhang-li; Ji, Jin-yi			Pathogenicity of Aseptic Bursaphelenchus xylophilus	PLOS ONE			English	Article							PINE WILT DISEASE; WOOD; APHELENCHOIDIDAE; TOXIN	Pine wilt is a disease of pine (Pinus spp.) caused by the pine wood nematode (PWN), Bursaphelenchus xylophilus. However, the pathogenic mechanism of pine wilt disease (PWD) remains unclear. Although the PWN was thought to be the only pathogenic agent associated with this disease, a potential role for bacterial symbionts in the disease process was recently proposed. Studies have indicated that aseptic PWNs do not cause PWD in aseptic pine trees, while PWNs associated with bacteria cause wilting symptoms. To investigate the pathogenicity of the PWN and its associated bacteria, 3-month-old microcuttings derived from certain clones of Pinus densiflora Siebold & Zucc. produced in vitro were inoculated under aseptic conditions with aseptic PWNs, non-aseptic PWNs and bacteria isolated from the nematodes. Six-month-old aseptic P. densiflora microcuttings and 7-month-old P. massoniana seedlings were also inoculated under aseptic conditions with aseptic PWNs and non-aseptic PWNs. The results showed that the aseptic microcuttings and seedlings inoculated with aseptic PWNs or non-aseptic PWNs wilted, while those inoculated with bacterial isolates did not wilt. Nematodes were recovered from wilted microcuttings and seedlings inoculated with aseptic PWNs and non-aseptic PWNs, and the asepsis of nematodes recovered from aseptic PWN-inoculated microcuttings and seedlings was reconfirmed by culturing them in NB liquid medium at 30 degrees C for more than 7 days. Taken together, the results indicate that the asepsis of PWN did not cause the loss of pathogenicity.	[Zhu, Li-hua; Ye, Jianren; Negi, Sapna; Xu, Xu-ling; Wang, Zhang-li; Ji, Jin-yi] Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Zhu, Li-hua; Ye, Jianren; Negi, Sapna; Xu, Xu-ling; Wang, Zhang-li; Ji, Jin-yi] Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Zhu, LH (corresponding author), Nanjing Forestry Univ, Inst Forest Protect, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	njfuhlyjr@yahoo.cn	Negi, Sapna/HGA-5265-2022		National Basic Research and Development Program of China [2009CB119205]; National Nature Science Foundation of China [31000303]; National Forestry Public Program of China [201204501]	National Basic Research and Development Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Forestry Public Program of China	Work in the Professor Jian-ren Ye Laboratory was supported by the National Basic Research and Development Program of China (No. 2009CB119205), National Nature Science Foundation of China (No. 31000303) and National Forestry Public Program of China (201204501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLLA RI, 1982, J NEMATOL, V14, P377; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Chi ShuYou, 2006, Scientia Silvae Sinicae, V42, P71; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; *FOR AG, 2004, ANN REP TRENDS FOR F; Fukuda K., 1992, Journal of the Japanese Forestry Society, V74, P289; GRESSHOFF PM, 1972, PLANTA, V107, P161, DOI 10.1007/BF00387721; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Higgins D. F., 1999, Sustainability of pine forests in relation to pine wilt and decline. Proceedings of International Symposium, Tokyo, Japan, 27-28 October, 1998, P23; Huang RE, 2007, THESIS NANJING FORES; Iwahori H., 1985, Japanese Journal of Nematology, V15, P64; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Kawazu K., 1999, Scientific Reports of the Faculty of Agriculture, Okayama University, P1; Kawazu K., 1998, Scientific Reports of the Faculty of Agriculture, Okayama University, P1; Kawazu K, 1996, BIOSCI BIOTECH BIOCH, V60, P1410, DOI 10.1271/bbb.60.1410; Kawazu Kazuyoshi, 1997, Japanese Journal of Nematology, V27, P76; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; MAMIYA Y, 1975, T JPN FOR SOC, V86, P285; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nobuchi T., 1984, Bulletin of the Kyoto University Forests, P224; OKU H, 1979, NATURWISSENSCHAFTEN, V66, P210, DOI 10.1007/BF00366031; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Sambrook J., 2001, MOL CLONING LAB MANU; Shin SC, 2006, P INT S CURR STAT RE, P31; Tamura H., 1983, Japanese Journal of Nematology, V13, P1; Tamura H., 1973, Japanese Journal of Nematology., V3, P30; Tan Jiajin, 2004, Scientia Silvae Sinicae, V40, P110; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; Tian Xueliang, 2010, Weishengwu Xuebao, V50, P909; Tzean S., 1985, P 6 ROC S ELECT MICR, P38; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang Bao-jun, 2002, Zhongguo Senlin Bingchong, V21, P27; Yang BJ, 2003, BURSAPHELENCHUS XYLO, P6; Yano S., 1913, SANRINKOUHOU, V4, P1; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhu LH, 2010, PLANT CELL TISS ORG, V102, P121, DOI 10.1007/s11240-010-9711-y; Zhu Lihua, 2011, Scientia Silvae Sinicae, V47, P92	43	30	38	8	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38095	10.1371/journal.pone.0038095	http://dx.doi.org/10.1371/journal.pone.0038095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662271	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300163
J	Esbjorn, BH; Somhovd, MJ; Turnstedt, C; Reinholdt-Dunne, ML				Esbjorn, Barbara Hoff; Somhovd, Mikael Julius; Turnstedt, Clara; Reinholdt-Dunne, Marie Louise			Assessing the Revised Child Anxiety and Depression Scale (RCADS) in a National Sample of Danish Youth Aged 8-16 Years	PLOS ONE			English	Article							DISORDERS SCARED-R; DEFINED ANXIETY; SYMPTOMS; QUESTIONNAIRE; DIFFICULTIES; ADOLESCENCE; RELIABILITY; VALIDITY; VERSION; SCREEN	Early identification of anxiety among youth is required to prevent them from going unrecognised and untreated by mental health professionals. A precise identification of the young person's primary difficulty is also required to guide treatment programs. Availability of a valid and easily administrable assessment tool is crucial for identifying youth suffering from anxiety disorders. The purpose of the present study was therefore to examine the psychometric properties of the Danish version of the Revised Children's Anxiety and Depression Scale (RCADS). A total of 667 youth from community schools (4(th) through 9(th) grade) across Denmark participated in the study. The psychometric properties of the RCADS-(DAN) resembled those reported in US and Europe. Within scale reliability was excellent with Chronbach's alpha of 96. All subscales also showed good to excellent internal reliability. The study provides convincing evidence that the RCADS-(DAN) is a valid assessment tool for screening anxiety in Danish youth.	[Esbjorn, Barbara Hoff; Somhovd, Mikael Julius; Turnstedt, Clara; Reinholdt-Dunne, Marie Louise] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	University of Copenhagen	Esbjorn, BH (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	barbara.hoff@psy.ku.dk		Reinholdt-Dunne, Marie Louise/0000-0002-2535-1064; Esbjorn, Barbara Hoff/0000-0002-4919-7209; Somhovd, Mikael Julius/0000-0001-9216-5264	Augustinus Foundation	Augustinus Foundation	This work was funded by Augustinus Foundation; partial funding of small presents for children, prints of questionnaires. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1983, MANUAL CHILD BEHAV C; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Angold A, 2009, J CHILD PSYCHOL PSYC, V50, P9, DOI 10.1111/j.1469-7610.2008.01981.x; Avenevoli S, 2011, HDB CHILD ADOLESCENT, P6; Chorpita BF, 2005, BEHAV RES THER, V43, P309, DOI 10.1016/j.brat.2004.02.004; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; de Ross RL, 2002, BEHAV CHANGE, V19, P90, DOI 10.1375/bech.19.2.90; Emslie GJ, 2008, NEW ENGL J MED, V359, P2835, DOI 10.1056/NEJMe0809401; Esbjorn BH, 2010, J ANXIETY DISORD, V24, P866, DOI 10.1016/j.janxdis.2010.06.009; Esbjorn BH, 2012, PENN STATE WOR UNPUB; Ferdinand RF, 2006, J ANXIETY DISORD, V20, P207, DOI 10.1016/j.janxdis.2004.12.003; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Joreskog K. G., 1989, LISREL 7 GUIDE PROGR; Kovacs M., 1992, CHILDRENS DEPRESSION; Muris P, 1999, ANXIETY STRESS COPIN, V12, P411, DOI 10.1080/10615809908249319; Muris P, 2004, J CHILD PSYCHOL PSYC, V45, P813, DOI 10.1111/j.1469-7610.2004.00274.x; Muris P, 2002, CLIN PSYCHOL PSYCHOT, V9, P430, DOI 10.1002/cpp.347; Muris P, 1999, PERS INDIV DIFFER, V26, P99; Muris P, 2001, BRIT J CLIN PSYCHOL, V40, P35, DOI 10.1348/014466501163463; Rapee RM, 2009, ANNU REV CLIN PSYCHO, V5, P311, DOI 10.1146/annurev.clinpsy.032408.153628; Reinholdt-Dunne ML, 2011, SCAND J PSYCHOL, V52, P433, DOI 10.1111/j.1467-9450.2011.00896.x; Reinholdt-Dunne ML., 2012, J EXP PSYCHOPATHOL, V3, P30, DOI [DOI 10.5127/JEP.019611, 10.5127/jep.019611]; Reynolds C.R., 1985, REVISED CHILDRENS MA; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spence SH, 1997, J ABNORM PSYCHOL, V106, P280, DOI 10.1037/0021-843X.106.2.280; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Thastum M, 2009, SCAND J PSYCHOL, V50, P47, DOI 10.1111/j.1467-9450.2008.00690.x; Van Oort FVA, 2009, J CHILD PSYCHOL PSYC, V50, P1209, DOI 10.1111/j.1469-7610.2009.02092.x; Weiss DC, 2011, REV CHILDRENS UNPUB	29	64	66	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37339	10.1371/journal.pone.0037339	http://dx.doi.org/10.1371/journal.pone.0037339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649520	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800038
J	Summa, KC; Vitaterna, MH; Turek, FW				Summa, Keith C.; Vitaterna, Martha Hotz; Turek, Fred W.			Environmental Perturbation of the Circadian Clock Disrupts Pregnancy in the Mouse	PLOS ONE			English	Article							VPAC(2) RECEPTOR; SHIFT WORK; OSCILLATORS; RHYTHMICITY; UTERUS; SLEEP	Background: The circadian clock has been linked to reproduction at many levels in mammals. Epidemiological studies of female shift workers have reported increased rates of reproductive abnormalities and adverse pregnancy outcomes, although whether the cause is circadian disruption or another factor associated with shift work is unknown. Here we test whether environmental disruption of circadian rhythms, using repeated shifts of the light: dark (LD) cycle, adversely affects reproductive success in mice. Methodology/Principal Findings: Young adult female C57BL/6J (B6) mice were paired with B6 males until copulation was verified by visual identification of vaginal plug formation. Females were then randomly assigned to one of three groups: control, phase-delay or phase-advance. Controls remained on a constant 12-hr light:12-hr dark cycle, whereas phase-delayed and phase-advanced mice were subjected to 6-hr delays or advances in the LD cycle every 5-6 days, respectively. The number of copulations resulting in term pregnancies was determined. Control females had a full-term pregnancy success rate of 90% (11/12), which fell to 50% (9/18; p<0.1) in the phase-delay group and 22% (4/18; p<0.01) in the phase-advance group. Conclusions/Significance: Repeated shifting of the LD cycle, which disrupts endogenous circadian timekeeping, dramatically reduces pregnancy success in mice. Advances of the LD cycle have a greater negative impact on pregnancy outcomes and, in non-pregnant female mice, require longer for circadian re-entrainment, suggesting that the magnitude or duration of circadian misalignment may be related to the severity of the adverse impact on pregnancy. These results explicitly link disruptions of circadian entrainment to adverse pregnancy outcomes in mammals, which may have important implications for the reproductive health of female shift workers, women with circadian rhythm sleep disorders and/or women with disturbed circadian rhythms for other reasons.	[Summa, Keith C.; Vitaterna, Martha Hotz; Turek, Fred W.] Northwestern Univ, Dept Neurobiol, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Summa, Keith C.; Turek, Fred W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Summa, KC (corresponding author), Northwestern Univ, Dept Neurobiol, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA.	fturek@northwestern.edu		Summa, Keith/0000-0001-9541-8458	March of Dimes Prematurity Research Initiative [21-FY08-506]; National Institutes of Health (NIH) at the Morehouse School of Medicine [U54 NS060659]; NIH [T32 HL007909]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659] Funding Source: NIH RePORTER	March of Dimes Prematurity Research Initiative(March of Dimes); National Institutes of Health (NIH) at the Morehouse School of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was funded by the March of Dimes Prematurity Research Initiative award 21-FY08-506 (F.W.T. & M.H.V.) (www.marchofdimes.com). In addition, support was provided by the National Institutes of Health (NIH) Cooperative Agreement U54 NS060659 to Peter MacLeish at the Morehouse School of Medicine (F.W.T.) and the NIH T32 HL007909 (K.C.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akiyama S, 2010, TOHOKU J EXP MED, V221, P287, DOI 10.1620/tjem.221.287; Aspholm R, 1999, J OCCUP ENVIRON MED, V41, P486, DOI 10.1097/00043764-199906000-00015; Bisanti L, 1996, J OCCUP ENVIRON MED, V38, P352, DOI 10.1097/00043764-199604000-00012; Cone JE, 1998, J OCCUP ENVIRON MED, V40, P210, DOI 10.1097/00043764-199803000-00002; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; CZEISLER CA, 1982, SCIENCE, V217, P460, DOI 10.1126/science.7089576; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; DAVIS FC, 1988, J COMP PHYSIOL A, V162, P601, DOI 10.1007/BF01342635; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Goodman R, 1999, ENCY REPROD, V4, P341; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Kennaway DJ, 2012, MOL CELL ENDOCRINOL, V349, P56, DOI 10.1016/j.mce.2011.08.013; Kennaway DJ, 2005, HUM REPROD UPDATE, V11, P91, DOI 10.1093/humupd/dmh054; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Labyak Susan, 2002, Health Care Women Int, V23, P703, DOI 10.1080/07399330290107449; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Okun ML, 2011, SLEEP, V34, P1493, DOI 10.5665/sleep.1384; Ratajczak CK, 2010, REPROD FERT DEVELOP, V22, P743, DOI 10.1071/RD09243; Roizen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000922; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Silver L.M., 1995, MOUSE GENETICS CONCE; SWANN JM, 1985, SCIENCE, V228, P898, DOI 10.1126/science.4001926; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	27	64	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37668	10.1371/journal.pone.0037668	http://dx.doi.org/10.1371/journal.pone.0037668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649550	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800069
J	Wang, SQ; Xiao, WM; Shan, SC; Jiang, CS; Chen, M; Zhang, Y; Lu, SQ; Chen, J; Zhang, CM; Chen, Q; Long, M				Wang, Shiqi; Xiao, Weiming; Shan, Sicong; Jiang, Chunsun; Chen, Ming; Zhang, Yan; Lu, Shouqin; Chen, Juan; Zhang, Chuanmao; Chen, Quan; Long, Mian			Multi-Patterned Dynamics of Mitochondrial Fission and Fusion in a Living Cell	PLOS ONE			English	Article							MAMMALIAN-CELLS; YEAST; MICROTUBULES; SEGREGATION; MORPHOLOGY; APOPTOSIS; TRANSPORT; MOVEMENT	Mitochondria are highly-dynamic organelles, but it is challenging to monitor quantitatively their dynamics in a living cell. Here we developed a novel approach to determine the global occurrence of mitochondrial fission and fusion events in living human epithelial cells (Hela) and mouse embryonic fibroblast cells (MEF). Distinct patterns of sequential events including fusion followed by fission (Fu-Fi), the so-called "kiss and run'' model previously described, fission followed by fusion (Fi-Fu), fusion followed by fusion (Fu-Fu), and fission followed by fission (Fi-Fi) were observed concurrently. The paired events appeared in high frequencies with short lifetimes and large sizes of individual mitochondria, as compared to those for unpaired events. The high frequencies of paired events were found to be biologically significant. The presence of membrane uncoupler CCCP enhanced the frequency of paired events (from both Fu-Fi and Fi-Fu patterns) with a reduced mitochondrial size. Knock-out of mitofusin protein Mfn1 increased the frequency of fission with increased lifetime of unpaired events whereas deletion of both Mfn1 and Mfn2 resulted in an instable dynamics. These results indicated that the paired events were dominant but unpaired events were not negligible, which provided a new insight into mitochondrial dynamics. In addition to kiss and run model of action, our data suggest that, from a global visualization over an entire cell, multiple patterns of action appeared in mitochondrial fusion and fission.	[Wang, Shiqi; Shan, Sicong; Zhang, Yan; Lu, Shouqin; Chen, Juan; Long, Mian] Chinese Acad Sci, Natl Micrograv Lab, Key Lab Micrograv, Beijing, Peoples R China; [Wang, Shiqi; Shan, Sicong; Zhang, Yan; Lu, Shouqin; Chen, Juan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China; [Xiao, Weiming; Jiang, Chunsun; Chen, Ming; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Xiao, Weiming; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China; [Xiao, Weiming; Zhang, Chuanmao] Peking Univ, Natl Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Wang, Shiqi] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University; Peking University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, SQ (corresponding author), Chinese Acad Sci, Natl Micrograv Lab, Key Lab Micrograv, Beijing, Peoples R China.	chenq@ioz.ac.cn; mlong@imech.ac.cn	Shan, Sicong/I-3412-2019	Shan, Sicong/0000-0002-4470-4662; Chen, Quan/0000-0001-7539-8728	Chinese Academy of Sciences [KJCX2-YW-L08]; National Natural Science; Foundation of China [30730032, 30730093]; National Key Basic Research Foundation of China [2006CB910303]; National High Technology Research and Development Program of China [2007AA02Z306]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science(National Natural Science Foundation of China (NSFC)); Foundation of China; National Key Basic Research Foundation of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by Chinese Academy of Sciences grant KJCX2-YW-L08, National Natural Science (http://english.cas.cn/), Foundation of China grants 30730032 and 30730093 (http://www.nsfc.gov.cn/Portal0/default106.htm), National Key Basic Research Foundation of China grant 2006CB910303 (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), and National High Technology Research and Development Program of China grant 2007AA02Z306 (http://www.most.gov.cn/eng/programmes1/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Knowles MK, 2002, P NATL ACAD SCI USA, V99, P14772, DOI 10.1073/pnas.232346999; Li DD, 2004, BIOPHYS J, V87, P1991, DOI 10.1529/biophysj.104.043281; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Rojo M, 2002, J CELL SCI, V115, P1663; SALMEEN I, 1985, BIOPHYS J, V48, P681, DOI 10.1016/S0006-3495(85)83825-X; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; TANG XW, 1994, CHINESE PHYS LETT, V11, P522, DOI 10.1088/0256-307X/11/8/016; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wang SQ, 2010, SCI CHINA PHYS MECH, V53, P680, DOI 10.1007/s11433-010-0163-5; Wang SQ, 2008, CELL MOL BIOENG, V1, P67, DOI 10.1007/s12195-008-0002-1; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	30	40	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e19879	10.1371/journal.pone.0019879	http://dx.doi.org/10.1371/journal.pone.0019879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649485	gold, Green Published			2022-12-27	WOS:000305335800001
J	Kiburu, IN; LaRonde-LeBlanc, N				Kiburu, Irene N.; LaRonde-LeBlanc, Nicole			Interaction of Rio1 Kinase with Toyocamycin Reveals a Conformational Switch That Controls Oligomeric State and Catalytic Activity	PLOS ONE			English	Article							CYTOPLASMIC MATURATION; CRYSTAL-STRUCTURE; FULGIDUS RIO2; RIBOSOMAL-RNA; FAMILY; INHIBITION; ASSEMBLIES; MECHANISM; SUBSTRATE; SOFTWARE	Rio1 kinase is an essential ribosome-processing factor required for proper maturation of 40 S ribosomal subunit. Although its structure is known, several questions regarding its functional remain to be addressed. We report that both Archaeoglobus fulgidus and human Rio1 bind more tightly to an adenosine analog, toyocamycin, than to ATP. Toyocamycin has antibiotic, antiviral and cytotoxic properties, and is known to inhibit ribosome biogenesis, specifically the maturation of 40 S. We determined the X-ray crystal structure of toyocamycin bound to Rio1 at 2.0 angstrom and demonstrated that toyocamycin binds in the ATP binding pocket of the protein. Despite this, measured steady state kinetics were inconsistent with strict competitive inhibition by toyocamycin. In analyzing this interaction, we discovered that Rio1 is capable of accessing multiple distinct oligomeric states and that toyocamycin may inhibit Rio1 by stabilizing a less catalytically active oligomer. We also present evidence of substrate inhibition by high concentrations of ATP for both archaeal and human Rio1. Oligomeric state studies show both proteins access a higher order oligomeric state in the presence of ATP. The study revealed that autophosphorylation by Rio1 reduces oligomer formation and promotes monomerization, resulting in the most active species. Taken together, these results suggest the activity of Rio1 may be modulated by regulating its oligomerization properties in a conserved mechanism, identifies the first ribosome processing target of toyocamycin and presents the first small molecule inhibitor of Rio1 kinase activity.	[Kiburu, Irene N.] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Kiburu, IN (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA.	nlaronde@umd.edu	LaRonde-LeBlanc, Nicole A/C-3399-2009	LaRonde-LeBlanc, Nicole A/0000-0002-2778-8358	National Institutes of Health National Cancer Institute (NIH/NCI) [K22CA123152]; National Center for Research Resources at the National Institutes of Health [RR-15301]; NATIONAL CANCER INSTITUTE [K22CA123152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health National Cancer Institute (NIH/NCI), award K22CA123152, and National Center for Research Resources at the National Institutes of Health, award RR-15301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Angermayr M, 2007, FEBS J, V274, P4654, DOI 10.1111/j.1742-4658.2007.05993.x; Beillard E, 2005, CELL CYCLE, V4, P434, DOI 10.4161/cc.4.3.1557; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Cohen BM, 1984, MOL PHARM, V27, P308; CONNELLCROWLEY L, 1993, MOL BIOL CELL, V4, P79, DOI 10.1091/mbc.4.1.79; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; HEINE U, 1969, CANCER RES, V29, P1875; Humbard MA, 2010, ARCHAEA, V2010, DOI 10.1155/2010/481725; Jaffe EK, 2012, METHODS MOL BIOL, V796, P217, DOI 10.1007/978-1-61779-334-9_12; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kokona B, 2008, BIOCHEMISTRY-US, V47, P10649, DOI 10.1021/bi801128d; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2005, FEBS J, V272, P2800, DOI 10.1111/j.1742-4658.2005.04702.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Long MC, 2006, BIOCHEM PHARMACOL, V71, P1671, DOI 10.1016/j.bcp.2006.03.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MANSOUR TE, 1972, J BIOL CHEM, V247, P6059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIOKA H, 1990, J ANTIBIOT, V43, P1586, DOI 10.7164/antibiotics.43.1586; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCZEWSKI K, 1990, BIOCHEMISTRY-US, V29, P6276, DOI 10.1021/bi00478a024; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; RIMAN J, 1969, CANCER RES, V29, P1707; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; SU JY, 1994, INT J BIOCHEM, V26, P519, DOI 10.1016/0020-711X(94)90009-4; TAVITIAN A, 1968, BIOCHIM BIOPHYS ACTA, V157, P33, DOI 10.1016/0005-2787(68)90261-X; UYEDA K, 1981, J BIOL CHEM, V256, P8394; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	54	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37371	10.1371/journal.pone.0037371	http://dx.doi.org/10.1371/journal.pone.0037371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629386	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300035
J	Stonkute, S; Braun, J; Pastukhov, A				Stonkute, Solveiga; Braun, Jochen; Pastukhov, Alexander			The Role of Attention in Ambiguous Reversals of Structure-From-Motion	PLOS ONE			English	Article							VISUAL-ATTENTION; PERCEPTUAL ORGANIZATION; MICROSACCADES; PERFORMANCE; SEGMENTATION; FLUCTUATIONS; ADAPTATION; FORM	Multiple dots moving independently back and forth on a flat screen induce a compelling illusion of a sphere rotating in depth (structure-from-motion). If all dots simultaneously reverse their direction of motion, two perceptual outcomes are possible: either the illusory rotation reverses as well (and the illusory depth of each dot is maintained), or the illusory rotation is maintained (but the illusory depth of each dot reverses). We investigated the role of attention in these ambiguous reversals. Greater availability of attention - as manipulated with a concurrent task or inferred from eye movement statistics - shifted the balance in favor of reversing illusory rotation (rather than depth). On the other hand, volitional control over illusory reversals was limited and did not depend on tracking individual dots during the direction reversal. Finally, display properties strongly influenced ambiguous reversals. Any asymmetries between 'front' and 'back' surfaces - created either on purpose by coloring or accidentally by random dot placement - also shifted the balance in favor of reversing illusory rotation (rather than depth). We conclude that the outcome of ambiguous reversals depends on attention, specifically on attention to the illusory sphere and its surface irregularities, but not on attentive tracking of individual surface dots.	[Stonkute, Solveiga; Braun, Jochen; Pastukhov, Alexander] Otto Von Guericke Univ, Inst Biol, Cognit Biol Lab, Magdeburg, Germany	Otto von Guericke University	Stonkute, S (corresponding author), Otto Von Guericke Univ, Inst Biol, Cognit Biol Lab, Magdeburg, Germany.	Pastukhov.Alexander@gmail.com	Stonkute, Solveiga/C-5572-2013; Braun, Jochen/F-1370-2013; Pastukhov, Alexander/F-1399-2013	Braun, Jochen/0000-0002-8886-078X; Pastukhov, Alexander/0000-0002-8738-8591	Bundesministerium fur Bildung und Forschung Bernstein Network; State of Saxony-Anhalt	Bundesministerium fur Bildung und Forschung Bernstein Network(Federal Ministry of Education & Research (BMBF)); State of Saxony-Anhalt	The authors were supported by the Bundesministerium fur Bildung und Forschung Bernstein Network (http://www.nncn.uni-freiburg.de) and the State of Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Bauer H-U, 2000, PREPARATIONAL INTELL, P163, DOI 10.1.1.30.5763; BENAV MB, 1992, PERCEPT PSYCHOPHYS, V52, P277, DOI 10.3758/BF03209145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Brouwer GJ, 2006, VISION RES, V46, P3393, DOI 10.1016/j.visres.2006.03.016; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Cohen MR, 2011, J NEUROSCI, V31, P15802, DOI 10.1523/JNEUROSCI.3063-11.2011; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fang F, 2004, CURR BIOL, V14, P247, DOI 10.1016/j.cub.2004.01.031; Helmholtz H., 1866, TREATISE PHYSL OPTIC, VVol. III; Hol K, 2003, J VISION, V3, P486, DOI 10.1167/3.7.3; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Jackson S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003982; Kang MS, 2010, ATTEN PERCEPT PSYCHO, V72, P179, DOI 10.3758/APP.72.1.179; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Kourtzi Z, 2008, TRENDS COGN SCI, V12, P230, DOI 10.1016/j.tics.2008.02.013; Lee DK, 1999, PERCEPT PSYCHOPHYS, V61, P1241, DOI 10.3758/BF03206177; Li HCO, 1999, VISION RES, V39, P881, DOI 10.1016/S0042-6989(98)00247-8; MACK A, 1992, COGNITIVE PSYCHOL, V24, P475, DOI 10.1016/0010-0285(92)90016-U; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Necker L. A., 1832, LONDON EDINBURGH PHI, V1, P329, DOI DOI 10.1080/14786443208647909; Orban GA, 2011, ANNU REV NEUROSCI, V34, P361, DOI 10.1146/annurev-neuro-061010-113819; Pastukhov A, 2012, J VISION, V12, DOI 10.1167/12.1.17; Pastukhov A, 2011, J VISION, V11, DOI 10.1167/11.10.12; Pastukhov A, 2010, VISION RES, V50, P1173, DOI 10.1016/j.visres.2010.04.007; Pastukhov A, 2009, VISION RES, V49, P1166, DOI 10.1016/j.visres.2008.04.011; Petersik JT, 2004, SPATIAL VISION, V17, P201, DOI 10.1163/1568568041866015; RAMACHANDRAN VS, 1983, NATURE, V304, P529, DOI 10.1038/304529a0; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; SCHWARTZ BJ, 1983, B PSYCHONOMIC SOC, V21, P456, DOI 10.3758/BF03330007; Sperling G., 1994, EARLY VISION, P133; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Treder MS, 2010, J VISION, V10, DOI 10.1167/10.4.5; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TREUE S, 1995, VISION RES, V35, P139, DOI 10.1016/0042-6989(94)E0069-W; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zivotofsky AZ, 2007, NEUROSCI LETT, V415, P195, DOI 10.1016/j.neulet.2007.01.016	52	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37734	10.1371/journal.pone.0037734	http://dx.doi.org/10.1371/journal.pone.0037734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629450	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300073
J	Bell, JL; Malyukova, A; Holien, JK; Koach, J; Parker, MW; Kavallaris, M; Marshall, GM; Cheung, BB				Bell, Jessica L.; Malyukova, Alena; Holien, Jessica K.; Koach, Jessica; Parker, Michael W.; Kavallaris, Maria; Marshall, Glenn M.; Cheung, Belamy B.			TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members	PLOS ONE			English	Article							B BOX PROTEIN; TRIPARTITE MOTIF; DOMAIN; SENSITIVITY; PML	The TRIM family of proteins is distinguished by its tripartite motif (TRIM). Typically, TRIM proteins contain a RING finger domain, one or two B-box domains, a coiled-coil domain and the more variable C-terminal domains. TRIM16 does not have a RING domain but does harbour two B-box domains. Here we showed that TRIM16 homodimerized through its coiled-coil domain and heterodimerized with other TRIM family members; TRIM24, Promyelocytic leukaemia (PML) protein and Midline-1 (MID1). Although, TRIM16 has no classic RING domain, three-dimensional modelling of TRIM16 suggested that its B-box domains adopts RING-like folds leading to the hypothesis that TRIM16 acts as an ubiquitin ligase. Consistent with this hypothesis, we demonstrated that TRIM16, devoid of a classical RING domain had auto-polyubiquitination activity and acted as an E3 ubiquitin ligase in vivo and in vitro assays. Thus via its unique structure, TRIM16 possesses both heterodimerization function with other TRIM proteins and also has E3 ubiquitin ligase activity.	[Bell, Jessica L.; Malyukova, Alena; Koach, Jessica; Kavallaris, Maria; Marshall, Glenn M.; Cheung, Belamy B.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Inst, Parkville, Vic 3052, Australia; [Marshall, Glenn M.] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Randwick, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; St. Vincent's Institute of Medical Research; University of Melbourne	Bell, JL (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia.	g.marshall@unsw.edu.au; bcheung@ccia.unsw.edu.au	Kavallaris, Maria/J-5240-2014; Holien, Jess/V-7005-2019; Parker, Michael W/F-9069-2013	Holien, Jess/0000-0002-8735-2871; Parker, Michael W/0000-0002-3101-1138; Cheung, Belamy/0000-0001-8784-860X; Bell, Jessica/0000-0002-8875-0943	Early Career Development Fellowship, Cancer Institute NSW; National Health & Medical Research Council (NHMRC); Biomedical PhD Scholarship; Victorian State Government Operational Infrastructure Support Program	Early Career Development Fellowship, Cancer Institute NSW; National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Biomedical PhD Scholarship; Victorian State Government Operational Infrastructure Support Program	This work was supported by an Early Career Development Fellowship, Cancer Institute NSW (B. C.); National Health & Medical Research Council (NHMRC) and a Biomedical PhD Scholarship (J.B.). M. W. P. is an Australian Research Council Federation Fellow and an NHMRC Honorary Fellow and thanks the Victorian State Government Operational Infrastructure Support Program for support. M. K. is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Cao TY, 1998, J CELL SCI, V111, P1319; Cao TY, 1997, J CELL SCI, V110, P1563; Cheung BB, 2006, J BIOL CHEM, V281, P18246, DOI 10.1074/jbc.M600879200; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Marshall GM, 2010, ONCOGENE, V29, P6172, DOI 10.1038/onc.2010.340; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Raif A, 2009, CANCER LETT, V277, P82, DOI 10.1016/j.canlet.2008.11.030; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	22	76	79	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37470	10.1371/journal.pone.0037470	http://dx.doi.org/10.1371/journal.pone.0037470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629402	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343100032
J	Gharib, SA; Khalyfa, A; Abdelkarim, A; Bhushan, B; Gozal, D				Gharib, Sina A.; Khalyfa, Abdelnaby; Abdelkarim, Amal; Bhushan, Bharat; Gozal, David			Integrative miRNA-mRNA Profiling of Adipose Tissue Unravels Transcriptional Circuits Induced by Sleep Fragmentation	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; ADIPOCYTE DIFFERENTIATION; SUBCUTANEOUS ADIPOSE; EXPRESSION PROFILES; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; GENE-EXPRESSION; HEART HEALTH; RISK-FACTORS; MICRORNAS	Obstructive sleep apnea (OSA) is a prevalent condition and strongly associated with metabolic disorders. Sleep fragmentation (SF) is a major consequence of OSA, but its contribution to OSA-related morbidities is not known. We hypothesized that SF causes specific perturbations in transcriptional networks of visceral fat cells, leading to systemic metabolic disturbances. We simultaneously profiled visceral adipose tissue mRNA and miRNA expression in mice exposed to 6 hours of SF during sleep, and developed a new computational framework based on gene set enrichment and network analyses to merge these data. This approach leverages known gene product interactions and biologic pathways to interrogate large-scale gene expression profiling data. We found that SF induced the activation of several distinct pathways, including those involved in insulin regulation and diabetes. Our integrative methodology identified putative controllers and regulators of the metabolic response during SF. We functionally validated our findings by demonstrating altered glucose and lipid homeostasis in sleep-fragmented mice. This is the first study to link sleep fragmentation with widespread disruptions in visceral adipose tissue transcriptome, and presents a generalizable approach to integrate mRNA-miRNA information for systematic mapping of regulatory networks.	[Gharib, Sina A.] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Gharib, Sina A.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Khalyfa, Abdelnaby; Abdelkarim, Amal; Bhushan, Bharat; Gozal, David] Univ Chicago, Dept Pediat, Div Biol Sci, Chicago, IL 60637 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	Gharib, SA (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA.	dgozal@uchicago.edu	Khalyfa, Abdelnaby/M-9498-2017; Bhushan, Bharat/G-3530-2016; Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020	Bhushan, Bharat/0000-0002-4182-9478; GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health [HL-065270, HL-086662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086662, R01HL065270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study is supported by National Institutes of Health grants HL-065270 and HL-086662 to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2007, OBES REV, V8, P119, DOI 10.1111/j.1467-789X.2006.00269.x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Gharib SA, 2011, J MOL MED B IN PRESS; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gozal D, 2001, Sleep Breath, V5, P35; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Heikkinen S., 2007, EVALUATION GLUCOSE H; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jun J, 2009, ILAR J, V50, P289, DOI 10.1093/ilar.50.3.289; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Khalyfa A, 2010, AM J RESP CRIT CARE, V181, P1114, DOI 10.1164/rccm.200909-1398OC; Khalyfa A, 2009, SLEEP MED, V10, P75, DOI 10.1016/j.sleep.2007.11.006; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Pohjanvirta R, 2008, TOXICOL APPL PHARM, V230, P41, DOI 10.1016/j.taap.2008.02.002; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Punjabi NM, 2009, AM J RESP CRIT CARE, V179, P235, DOI 10.1164/rccm.200809-1392OC; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Ramesh V., 2009, SLEEP SCI, V2, P64; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	63	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37669	10.1371/journal.pone.0037669	http://dx.doi.org/10.1371/journal.pone.0037669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629440	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100044
J	Krijt, J; Frydlova, J; Kukackova, L; Fujikura, Y; Prikryl, P; Vokurka, M; Necas, E				Krijt, Jan; Frydlova, Jana; Kukackova, Lenka; Fujikura, Yuzo; Prikryl, Petr; Vokurka, Martin; Necas, Emanuel			Effect of Iron Overload and Iron Deficiency on Liver Hemojuvelin Protein	PLOS ONE			English	Article							HEPCIDIN MESSENGER-RNA; HEREDITARY HEMOCHROMATOSIS; MATRIPTASE-2 TMPRSS6; MOUSE-LIVER; JUVENILE HEMOCHROMATOSIS; EXPRESSION; HOMEOSTASIS; GENE; REGULATOR; BMP6	Introduction: Hemojuvelin (Hjv) is a key component of the signaling cascade that regulates liver hepcidin (Hamp) expression. The purpose of this study was to determine Hjv protein levels in mice and rats subjected to iron overload and iron deficiency. Methods: C57BL/6 mice were injected with iron (200 mg/kg); iron deficiency was induced by feeding of an iron-deficient diet, or by repeated phlebotomies. Erythropoietin (EPO)-treated mice were administered recombinant EPO at 50 U/mouse. Wistar rats were injected with iron (1200 mg/kg), or fed an iron-deficient diet. Hjv protein was determined by immunoblotting, liver samples from Hjv-/- mice were used as negative controls. Mouse plasma Hjv content was determined by a commercial ELISA kit. Results: Liver crude membrane fraction from both mice and rats displayed a major Hjv-specific band at 35 kDa, and a weaker band of 20 kDa. In mice, the intensity of these bands was not changed following iron injection, repeated bleeding, low iron diet or EPO administration. No change in liver crude membrane Hjv protein was observed in iron-treated or iron-deficient rats. ELISA assay for mouse plasma Hjv did not show significant difference between Hjv+/+ and Hjv-/- mice. Liver Hamp mRNA, Bmp6 mRNA and Id1 mRNA displayed the expected response to iron overload and iron deficiency. EPO treatment decreased Id1 mRNA, suggesting possible participation of the bone morphogenetic protein pathway in EPO-mediated downregulation of Hamp mRNA. Discussion: Since no differences between Hjv protein levels were found following various experimental manipulations of body iron status, the results indicate that, in vivo, substantial changes in Hamp mRNA can occur without noticeable changes of membrane hemojuvelin content. Therefore, modulation of hemojuvelin protein content apparently does not represent the limiting step in the control of Hamp gene expression.	[Krijt, Jan; Frydlova, Jana; Kukackova, Lenka; Fujikura, Yuzo; Prikryl, Petr; Vokurka, Martin; Necas, Emanuel] Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic	Charles University Prague	Krijt, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic.	jkri@lf1.cuni.cz	FUJIKURA, YUZO/H-2652-2014; Frydlova, Jana/H-8878-2017; Prikryl, Petr/B-1359-2008; Necas, Emanuel/G-4455-2013; Krijt, Jan/B-2359-2009; Vokurka, Martin/F-7533-2017	Frydlova, Jana/0000-0001-9725-9526; Prikryl, Petr/0000-0001-6167-2853; Necas, Emanuel/0000-0002-6101-4639; Vokurka, Martin/0000-0001-5943-5939	Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021620806, LC06044]; Charles University [PRVOUK-P24/LF1/3, UNCE 204021]; Ministry of Health of the Czech Republic [NS10300-3/2009]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The work was supported by grants MSM 0021620806 and LC06044 from the Ministry of Education, Youth and Sports of the Czech Republic, PRVOUK-P24/LF1/3 and UNCE 204021 from Charles University, and NS10300-3/2009 from the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Chen J, 2011, BIOCH BIOPH IN PRESS; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Nicolas G, 2011, BRIT J HAEMATOL, V152, P498, DOI 10.1111/j.1365-2141.2010.08473.x; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Peng H, 2010, BRIT J HAEMATOL, V151, P106, DOI 10.1111/j.1365-2141.2010.08306.x; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, TRANSFUSION, V50, P1532, DOI 10.1111/j.1537-2995.2010.02601.x; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	41	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37391	10.1371/journal.pone.0037391	http://dx.doi.org/10.1371/journal.pone.0037391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629388	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500108
J	Tomita, Y; Ikeo, K; Tamakawa, H; Gojobori, T; Ikushima, S				Tomita, Yasuyuki; Ikeo, Kazuho; Tamakawa, Hideyuki; Gojobori, Takashi; Ikushima, Shigehito			Genome and Transcriptome Analysis of the Food-Yeast Candida utilis	PLOS ONE			English	Article							RIBOSOMAL-RNAS SACCHAROMYCETACEAE; MULTIPLE SEQUENCE ALIGNMENT; GENE ORDER BROWSER; L-LACTIC ACID; KLUYVEROMYCES-LACTIS; EFFICIENT PRODUCTION; GLUCOSE-TRANSPORT; BUDDING YEAST; PROTEIN; CEREVISIAE	The industrially important food-yeast Candida utilis is a Crabtree effect-negative yeast used to produce valuable chemicals and recombinant proteins. In the present study, we conducted whole genome sequencing and phylogenetic analysis of C. utilis, which showed that this yeast diverged long before the formation of the CUG and Saccharomyces/Kluyveromyces clades. In addition, we performed comparative genome and transcriptome analyses using next-generation sequencing, which resulted in the identification of genes important for characteristic phenotypes of C. utilis such as those involved in nitrate assimilation, in addition to the gene encoding the functional hexose transporter. We also found that an antisense transcript of the alcohol dehydrogenase gene, which in silico analysis did not predict to be a functional gene, was transcribed in the stationary-phase, suggesting a novel system of repression of ethanol production. These findings should facilitate the development of more sophisticated systems for the production of useful reagents using C. utilis.	[Tomita, Yasuyuki; Tamakawa, Hideyuki; Ikushima, Shigehito] KIRIN Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan; [Tomita, Yasuyuki; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Tomita, Yasuyuki; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 411, Japan	Kirin Holdings Co Ltd; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Tomita, Y (corresponding author), KIRIN Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan.	Shigehito_Ikushima@kirin.co.jp						Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Billard P, 1996, J BACTERIOL, V178, P5860, DOI 10.1128/jb.178.20.5860-5866.1996; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; BOZE H, 1992, CRIT REV BIOTECHNOL, V12, P65, DOI 10.3109/07388559209069188; BRUINENBERG PM, 1983, J GEN MICROBIOL, V129, P965; Buerth C, 2011, MICROBIOL-SGM, V157, P2493, DOI 10.1099/mic.0.049320-0; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CHOUDARY PV, 1982, BIOCHEM BIOPH RES CO, V108, P1293, DOI 10.1016/0006-291X(82)92140-4; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Harrison BR, 2009, BIOCHEM CELL BIOL, V87, P767, DOI 10.1139/O09-043; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; ICHII T, 1993, J FERMENT BIOENG, V75, P375, DOI 10.1016/0922-338X(93)90137-W; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P1818, DOI 10.1271/bbb.90186; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P879, DOI 10.1271/bbb.80799; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P152, DOI 10.1271/bbb.80568; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; KONDO K, 1995, J BACTERIOL, V177, P7171, DOI 10.1128/jb.177.24.7171-7177.1995; Kondo K, 1997, NAT BIOTECHNOL, V15, P453, DOI 10.1038/nbt0597-453; Kurtzman CP, 1998, YEAST TAXONOMIC STUD; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Milkowski C, 2001, J BACTERIOL, V183, P5223, DOI 10.1128/JB.183.18.5223-5229.2001; Miura Y, 1998, BIOTECHNOL BIOENG, V58, P306, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<306::AID-BIT29>3.0.CO;2-8; Miura Yutaka, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P129; Nishi T, 2005, GENE, V346, P115, DOI 10.1016/j.gene.2004.10.018; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamakawa H, 2012, J BIOSCI BIOENG, V113, P73, DOI 10.1016/j.jbiosc.2011.09.002; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; VANURK H, 1989, J GEN MICROBIOL, V135, P2399; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; YAMADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P518, DOI 10.1271/bbb.59.518; YAMADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P945, DOI 10.1271/bbb.59.945	59	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37226	10.1371/journal.pone.0037226	http://dx.doi.org/10.1371/journal.pone.0037226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629373	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500078
J	Choi, KS; Lee, C; Maatouk, DM; Harfe, BD				Choi, Kyung-Suk; Lee, Chanmi; Maatouk, Danielle M.; Harfe, Brian D.			Bmp2, Bmp4 and Bmp7 Are Co-Required in the Mouse AER for Normal Digit Patterning but Not Limb Outgrowth	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; VERTEBRATE LIMB; BONE-FORMATION; BUD; FGF8; INITIATION; P63; MORPHOGENESIS; MAINTENANCE	Outgrowth and patterning of the vertebrate limb requires a functional apical ectodermal ridge (AER). The AER is a thickening of ectodermal tissue located at the distal end of the limb bud. Loss of this structure, either through genetic or physical manipulations results in truncation of the limb. A number of genes, including Bmps, are expressed in the AER. Previously, it was shown that removal of the BMP receptor Bmpr1a specifically from the AER resulted in complete loss of hindlimbs suggesting that Bmp signaling in the AER is required for limb outgrowth. In this report, we genetically removed the three known AER-expressed Bmp ligands, Bmp2, Bmp4 and Bmp7 from the AER of the limb bud using floxed conditional alleles and the Msx2-cre allele. Surprisingly, only defects in digit patterning and not limb outgrowth were observed. In triple mutants, the anterior and posterior AER was present but loss of the central region of the AER was observed. These data suggest that Bmp ligands expressed in the AER are not required for limb outgrowth but instead play an essential role in maintaining the AER and patterning vertebrate digits.	[Choi, Kyung-Suk; Lee, Chanmi; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Choi, Kyung-Suk; Lee, Chanmi; Harfe, Brian D.] Univ Florida, Genet Inst, Gainesville, FL USA; [Maatouk, Danielle M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University	Choi, KS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	bharfe@mgm.ufl.edu			Korea Science and Engineering Foundation [KRF-2005-215-C00105]; March of Dimes	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); March of Dimes(March of Dimes)	K.-S.C. was partially supported by the Korea Science and Engineering Foundation (KRF-2005-215-C00105). Funding was provided by the March of Dimes (http://www.marchofdimes.com/) to B. D. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Cheifetz S, 1999, CRIT REV ORAL BIOL M, V10, P182, DOI 10.1177/10454411990100020501; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dealy CN, 1998, DEV BIOL, V202, P43, DOI 10.1006/dbio.1998.8988; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Loomis CA, 1998, DEVELOPMENT, V125, P1137; Lorda-Diez CI, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-69; Maatouk DM, 2009, DEV BIOL, V327, P516, DOI 10.1016/j.ydbio.2009.01.004; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Tsuji K, 2010, J ORTHOP RES, V28, P384, DOI 10.1002/jor.20996; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37826	10.1371/journal.pone.0037826	http://dx.doi.org/10.1371/journal.pone.0037826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662233	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300123
J	Coppin, E; Berteaux-Lecellier, V; Bidard, F; Brun, S; Ruprich-Robert, G; Espagne, E; Ait-Benkhali, J; Goarin, A; Nesseir, A; Planamente, S; Debuchy, R; Silar, P				Coppin, Evelyne; Berteaux-Lecellier, Veronique; Bidard, Frederique; Brun, Sylvain; Ruprich-Robert, Gwenael; Espagne, Eric; Ait-Benkhali, Jinane; Goarin, Anne; Nesseir, Audrey; Planamente, Sara; Debuchy, Robert; Silar, Philippe			Systematic Deletion of Homeobox Genes in Podospora anserina Uncovers Their Roles in Shaping the Fruiting Body	PLOS ONE			English	Article							MATING-TYPE; CLP1 PROTEIN; MORPHOLOGY; PHEROMONE; SEQUENCES; CYTOLOGY; NUCLEAR; CYCLE	Higher fungi, which comprise ascomycetes and basidiomycetes, play major roles in the biosphere. Their evolutionary success may be due to the extended dikaryotic stage of their life cycle, which is the basis for their scientific name: the Dikarya. Dikaryosis is maintained by similar structures, the clamp in basidiomycetes and the crozier in ascomycetes. Homeodomain transcription factors are required for clamp formation in all basidiomycetes studied. We identified all the homeobox genes in the filamentous ascomycete fungus Podospora anserina and constructed deletion mutants for each of these genes and for a number of gene combinations. Croziers developed normally in these mutants, including those with up to six deleted homeogenes. However, some mutants had defects in maturation of the fruiting body, an effect that could be rescued by providing wild-type maternal hyphae. Analysis of mutants deficient in multiple homeogenes revealed interactions between the genes, suggesting that they operate as a complex network. Similar to their role in animals and plants, homeodomain transcription factors in ascomycetes are involved in shaping multicellular structures.	[Coppin, Evelyne; Berteaux-Lecellier, Veronique; Bidard, Frederique; Brun, Sylvain; Ruprich-Robert, Gwenael; Espagne, Eric; Ait-Benkhali, Jinane; Goarin, Anne; Nesseir, Audrey; Planamente, Sara; Debuchy, Robert; Silar, Philippe] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Coppin, Evelyne; Berteaux-Lecellier, Veronique; Brun, Sylvain; Ruprich-Robert, Gwenael; Goarin, Anne; Debuchy, Robert; Silar, Philippe] CNRS, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Brun, Sylvain; Goarin, Anne; Silar, Philippe] Univ Paris Diderot, UFR Sci Vivant, Paris, France; [Ruprich-Robert, Gwenael] Univ Paris 05, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Coppin, E (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France.	evelyne.coppin@igmors.u-psud.fr; philippe.silar@igmors.u-psud.fr	Debuchy, Robert/J-3040-2012; Espagne, Eric/AAF-9794-2019; BERTEAUX-LECELLIER, Veronique/P-6456-2019; Ruprich-Robert, Gwenaël/AAF-9000-2020; Berteaux-Lecellier, Veronique/O-4767-2018; Espagne, Eric/GMX-2417-2022; Planamente, Sara/ABB-4551-2020	Debuchy, Robert/0000-0003-1206-0361; BERTEAUX-LECELLIER, Veronique/0000-0003-2152-6231; Berteaux-Lecellier, Veronique/0000-0003-2152-6231; Planamente, Sara/0000-0003-2778-1356; Ruprich-Robert, Gwenael/0000-0003-3679-428X; Espagne, Eric/0000-0002-5813-498X; silar, philippe/0000-0003-0104-987X; Brun, Sylvain/0000-0002-6714-4012	French National Research Agency [ANR-05-BLAN-0385]	French National Research Agency(French National Research Agency (ANR))	This study was funded by the French National Research Agency (http://www.agence-nationale-recherche.fr/) grant number ANR-05-BLAN-0385, project SexDevMycol, coordinator R. Debuchy and by a donor who wishes to remain anonymous. The salary of FB was funded by the French National Research Agency grant number ANR-05-BLAN-0385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaise S, 2001, MOL MICROBIOL, V39, P54, DOI 10.1046/j.1365-2958.2001.02163.x; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Bauer R, 2009, MYCOL RES, V113, P960, DOI 10.1016/j.mycres.2009.05.003; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Bidard Frederique, 2010, BMC Res Notes, V3, P171, DOI 10.1186/1756-0500-3-171; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; Buller AHR, 1958, RES FUNGI, V5, P1; BURGLIN TR, 2005, ENCY MOL CELL BIOL M, P179; Casselton L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P536; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 2000, GENETICS, V155, P657; Coppin E, 2005, EUKARYOT CELL, V4, P407, DOI 10.1128/EC.4.2.407-420.2005; COPPIN E, 1993, MOL GEN GENET, V241, P409, DOI 10.1007/BF00284694; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Ekena JL, 2008, EUKARYOT CELL, V7, P49, DOI 10.1128/EC.00377-07; El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Hansen PV, 2007, MYCOL RES, V111, P592, DOI 10.1016/j.mycres.2007.02.010; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Heimel K, 2010, PLANT CELL, V22, P2908, DOI 10.1105/tpc.110.076265; Inada K, 2001, GENETICS, V157, P133; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kirschner R, 2001, MYCOLOGIA, V93, P634, DOI 10.2307/3761818; KRAMER CL, 1960, MYCOLOGIA, V52, P295, DOI 10.2307/3756013; Lambou K, 2008, EUKARYOT CELL, V7, P1809, DOI 10.1128/EC.00149-08; Landvik S, 2003, MYCOL RES, V107, P1021, DOI 10.1017/S0953756203008219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lord M, 2008, P NATL ACAD SCI USA, V105, P8014, DOI 10.1073/pnas.0802874105; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Marcou D., 1961, ANN SCI NAT BOT BIOL, V12, P653; Martens P, 1932, B SOC MYCOL FR, V48, P259; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; OBERWINKLER F, 1990, MYCOLOGIA, V82, P671, DOI 10.2307/3760154; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Scherer M, 2006, PLANT CELL, V18, P2388, DOI 10.1105/tpc.106.043521; SHAFFER RL, 1975, MYCOLOGIA, V67, P1, DOI 10.2307/3758222; Silar P, 2005, MYCOL RES, V109, P137, DOI 10.1017/S0953756204002230; Silar P, 2011, FUNGAL BIOL-UK, V115, P793, DOI 10.1016/j.funbio.2011.06.005; SYROP M, 1976, CAN J BOT, V54, P293, DOI 10.1139/b76-027; THOMPSONCOFFE C, 1994, DEV BIOL, V165, P257, DOI 10.1006/dbio.1994.1251; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webster J., 2007, INTRO FUNGI, V3rd	51	22	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37488	10.1371/journal.pone.0037488	http://dx.doi.org/10.1371/journal.pone.0037488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662159	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300049
J	Farahat, WA; Wood, LB; Zervantonakis, IK; Schor, A; Ong, S; Neal, D; Kamm, RD; Asada, HH				Farahat, Waleed A.; Wood, Levi B.; Zervantonakis, Ioannis K.; Schor, Alisha; Ong, Sharon; Neal, Devin; Kamm, Roger D.; Asada, H. Harry			Ensemble Analysis of Angiogenic Growth in Three-Dimensional Microfluidic Cell Cultures	PLOS ONE			English	Article							ENDOTHELIAL-CELL; IN-VITRO; MATRIX; MIGRATION; PROLIFERATION; MORPHOGENESIS; PROTEOLYSIS; CHEMOTAXIS; PLATFORM; MODELS	We demonstrate ensemble three-dimensional cell cultures and quantitative analysis of angiogenic growth from uniform endothelial monolayers. Our approach combines two key elements: a micro-fluidic assay that enables parallelized angiogenic growth instances subject to common extracellular conditions, and an automated image acquisition and processing scheme enabling high-throughput, unbiased quantification of angiogenic growth. Because of the increased throughput of the assay in comparison to existing three-dimensional morphogenic assays, statistical properties of angiogenic growth can be reliably estimated. We used the assay to evaluate the combined effects of vascular endothelial growth factor (VEGF) and the signaling lipid sphingoshine-1-phosphate (S1P). Our results show the importance of S1P in amplifying the angiogenic response in the presence of VEGF gradients. Furthermore, the application of S1P with VEGF gradients resulted in angiogenic sprouts with higher aspect ratio than S1P with background levels of VEGF, despite reduced total migratory activity. This implies a synergistic effect between the growth factors in promoting angiogenic activity. Finally, the variance in the computed angiogenic metrics (as measured by ensemble standard deviation) was found to increase linearly with the ensemble mean. This finding is consistent with stochastic agent-based mathematical models of angiogenesis that represent angiogenic growth as a series of independent stochastic cell-level decisions.	[Farahat, Waleed A.; Wood, Levi B.; Zervantonakis, Ioannis K.; Schor, Alisha; Neal, Devin; Kamm, Roger D.; Asada, H. Harry] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Kamm, Roger D.; Asada, H. Harry] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Ong, Sharon; Kamm, Roger D.; Asada, H. Harry] Singapore MIT Alliance Res & Technol SMART, BioSym Interdisciplinary Res Grp, Singapore, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Farahat, WA (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	wfarahat@mit.edu	Zervantonakis, Ioannis/C-2890-2011; Kamm, Roger D/I-7630-2012; Zervantonakis, Ioannis/N-9717-2019; Zervantonakis, Ioannis/ADS-2519-2022	Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; /0000-0002-7232-304X; Ong, Lee Ling/0000-0002-4120-163X	National Science Foundation's Emerging Frontiers in Research and Innovation (NSF-EFRI) program [0735997]; Singapore-MIT Alliance for Research and Technology (SMART - BioSym IRG)	National Science Foundation's Emerging Frontiers in Research and Innovation (NSF-EFRI) program; Singapore-MIT Alliance for Research and Technology (SMART - BioSym IRG)(Singapore-MIT Alliance for Research & Technology Centre (SMART))	This work is funded by The National Science Foundation's Emerging Frontiers in Research and Innovation (NSF-EFRI) program (grant #0735997) (http://www.nsf.gov./div/index.jsp?div = EFRI) and The Singapore-MIT Alliance for Research and Technology (SMART - BioSym IRG) (http://smart.mit.edu/research/biosym/biosym.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Baronikova S, 2004, PLANTA MED, V70, P887, DOI 10.1055/s-2004-832611; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bishop C. M, 2006, PATTERN RECOGNITION; Bonetta L, 2005, NAT METHODS, V2, P785, DOI 10.1038/nmeth1005-785; Bonvin C, 2010, BIOTECHNOL BIOENG, V105, P982, DOI 10.1002/bit.22608; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j; Chung S, 2009, ADV MATER, V21, P4863, DOI 10.1002/adma.200901727; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cosgrove BD, 2008, CELL MOL BIOENG, V1, P33, DOI 10.1007/s12195-008-0007-9; Czirok A, 1998, PHYS REV LETT, V84; Das A, 2010, PHILOS T R SOC A, V368, P2937, DOI 10.1098/rsta.2010.0085; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Elcin Y, 2002, TECHNOL HEALTH CARE, V10, P306; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fisher KE, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-69; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Hegedus B, 2000, J NEUROSURG, V92, P428, DOI 10.3171/jns.2000.92.3.0428; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Johnson PC, 2010, ADV TISSUE ENG; Karagiannis ED, 2006, J THEOR BIOL, V238, P124, DOI 10.1016/j.jtbi.2005.05.020; Kothapalli C. R., 2011, LAB CHIP; KUNDU P.K., 2004, FLUID MECH-SOV RES; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Liu WW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002382; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Slungaard A, 2005, INT J BIOCHEM CELL B, V37, P1162, DOI 10.1016/j.biocel.2004.12.003; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Stroock AD, 2010, TISSUE ENG PT A, V16, P2143, DOI [10.1089/ten.tea.2009.0689, 10.1089/ten.TEA.2009.0689]; Sudo R, 2009, FASEB J; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Wissner-Gross ZD, 2011, INTEGRATIVE BIOL; Wood LB, 2008, STOCHASTIC CONTROL F, P390; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952; Zervantonakis SCIK, 2010, INT J MICRONANO SCAL, V1, P27	52	84	87	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37333	10.1371/journal.pone.0037333	http://dx.doi.org/10.1371/journal.pone.0037333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662145	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300035
J	Garza, DR; Thompson, CC; Loureiro, ECB; Dutilh, BE; Inada, DT; Sousa, EC; Cardoso, JF; Nunes, MRT; de Lima, CPS; Silvestre, RVD; Nunes, KNB; Santos, ECO; Edwards, RA; Vicente, ACP; Morais, LLCD				Garza, Daniel Rios; Thompson, Cristiane C.; Brito Loureiro, Edvaldo Carlos; Dutilh, Bas E.; Inada, Davi Toshio; Sousa Junior, Edivaldo Costa; Cardoso, Jedson Ferreira; Nunes, Marcio Roberto T.; Silva de Lima, Clayton Pereira; Duarte Silvestre, Rodrigo Vellasco; Barbosa Nunes, Keley Nascimento; Santos, Elisabeth C. O.; Edwards, Robert A.; Vicente, Ana Carolina P.; Canto de Sa Morais, Lena Lillian			Genome-Wide Study of the Defective Sucrose Fermenter Strain of Vibrio cholerae from the Latin American Cholera Epidemic	PLOS ONE			English	Article							VARIANTS; SEQUENCE	The 7th cholera pandemic reached Latin America in 1991, spreading from Peru to virtually all Latin American countries. During the late epidemic period, a strain that failed to ferment sucrose dominated cholera outbreaks in the Northern Brazilian Amazon region. In order to understand the genomic characteristics and the determinants of this altered sucrose fermenting phenotype, the genome of the strain IEC224 was sequenced. This paper reports a broad genomic study of this strain, showing its correlation with the major epidemic lineage. The potentially mobile genomic regions are shown to possess GC content deviation, and harbor the main V. cholera virulence genes. A novel bioinformatic approach was applied in order to identify the putative functions of hypothetical proteins, and was compared with the automatic annotation by RAST. The genome of a large bacteriophage was found to be integrated to the IEC224's alanine aminopeptidase gene. The presence of this phage is shown to be a common characteristic of the El Tor strains from the Latin American epidemic, as well as its putative ancestor from Angola. The defective sucrose fermenting phenotype is shown to be due to a single nucleotide insertion in the V. cholerae sucrose-specific transportation gene. This frame-shift mutation truncated a membrane protein, altering its structural pore-like conformation. Further, the identification of a common bacteriophage reinforces both the monophyletic and African-Origin hypotheses for the main causative agent of the 1991 Latin America cholera epidemics.	[Garza, Daniel Rios; Canto de Sa Morais, Lena Lillian] Evandro Chagas Inst, Lab Environm Microbiol, Ananindeua, Para, Brazil; [Thompson, Cristiane C.; Vicente, Ana Carolina P.] Inst Oswaldo Cruz, Lab Mol Genet Microorganisms, BR-20001 Rio De Janeiro, Brazil; [Brito Loureiro, Edvaldo Carlos] Evandro Chagas Inst, Bacteriol Sect, Ananindeua, Para, Brazil; [Dutilh, Bas E.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Dutilh, Bas E.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Inada, Davi Toshio; Sousa Junior, Edivaldo Costa; Cardoso, Jedson Ferreira; Nunes, Marcio Roberto T.; Silva de Lima, Clayton Pereira; Duarte Silvestre, Rodrigo Vellasco; Barbosa Nunes, Keley Nascimento] Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Instituto Evandro Chagas; Fundacao Oswaldo Cruz; Instituto Evandro Chagas; Radboud University Nijmegen; Radboud University Nijmegen; California State University System; San Diego State University; California State University System; San Diego State University; Instituto Evandro Chagas; United States Department of Energy (DOE); Argonne National Laboratory	Garza, DR (corresponding author), Evandro Chagas Inst, Lab Environm Microbiol, Ananindeua, Para, Brazil.	lenasa@iec.pa.gov.br	Thompson, Cristiane C/I-5783-2016; Edwards, Robert/Q-1691-2019; Garza, Daniel/AAN-8016-2021; Garza, Daniel Rios/A-1716-2016; Garza, Daniel/AAF-6237-2019; Dutilh, Bas E./B-9719-2011; Teixera Nunes, Marcio Roberto/B-2238-2016	Edwards, Robert/0000-0001-8383-8949; Garza, Daniel/0000-0003-3865-2146; Garza, Daniel Rios/0000-0001-5956-6832; Dutilh, Bas E./0000-0003-2329-7890; Teixera Nunes, Marcio Roberto/0000-0001-9739-5499	Evandro Chagas Institute, SVS, Brazilian Ministry of Health; Fundacao de Amparo a Pesquisa do Estado do Para-FAPESPA	Evandro Chagas Institute, SVS, Brazilian Ministry of Health; Fundacao de Amparo a Pesquisa do Estado do Para-FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Evandro Chagas Institute, SVS, Brazilian Ministry of Health (http://www.iec.pa.gov.br/); Fundacao de Amparo a Pesquisa do Estado do Para-FAPESPA (http://www.fapespa.pa.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1959, CHOLERA, P51; ANSARUZZAMAN M, 1995, J CLIN MICROBIOL, V33, P1339, DOI 10.1128/JCM.33.5.1339-1340.1995; Arakawa K, 2007, EVOL BIOINFORM, V3, P159; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; CAMERON DN, 1994, J CLIN MICROBIOL, V32, P1685, DOI 10.1128/JCM.32.7.1685-1690.1994; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASTILLO L, 1994, REV MED CHILE, V122, P986; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cho YJ, 2010, CURR OPIN MICROBIOL, V3, P1; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cuevas DA, ACSESS P; Drummond AJ AB, 2011, GENEIOUS V4 8; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KARAOLIS DKR, 1995, J BACTERIOL, V177, P3191, DOI 10.1128/jb.177.11.3191-3198.1995; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King AM, 2012, 9 REPORT INT COMMITT, P770; Lam C, 2010, EMERG INFECT DIS, V16, P1130, DOI 10.3201/eid1607.100131; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mutreja A, 2011, NATURE, V000, P1; Natale DA, 2000, GENETICA, V108, P9, DOI 10.1023/A:1004031323748; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; POPOVIC T, 1993, J CLIN MICROBIOL, V31, P2474, DOI 10.1128/JCM.31.9.2474-2482.1993; Ramos F, 1997, LATIN AM MICROBIOL, V39, P141; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Tauxe Robert, 1994, P321; Timms AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-214; VUGIA DJ, 1994, AM J TROP MED HYG, V50, P566, DOI 10.4269/ajtmh.1994.50.566; WACHSMUTH IK, 1993, J INFECT DIS, V167, P621, DOI 10.1093/infdis/167.3.621; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wei SW, 2008, INT J FOOD MICROBIOL, V122, P148, DOI 10.1016/j.ijfoodmicro.2007.11.061; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37283	10.1371/journal.pone.0037283	http://dx.doi.org/10.1371/journal.pone.0037283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662140	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300030
J	Jelsone-Swain, LM; Smith, DV; Baylis, GC				Jelsone-Swain, Laura M.; Smith, David V.; Baylis, Gordon C.			The Effect of Stimulus Duration and Motor Response in Hemispatial Neglect during a Visual Search Task	PLOS ONE			English	Article							SPATIAL NEGLECT; UNILATERAL NEGLECT; EXTINCTION; ATTENTION; AWARENESS; OBJECTS; INFORMATION; HEMISPHERE; DEFICITS; ANATOMY	Patients with hemispatial neglect exhibit a myriad of profound deficits. A hallmark of this syndrome is the patients' absence of awareness of items located in their contralesional space. Many studies, however, have demonstrated that neglect patients exhibit some level of processing of these neglected items. It has been suggested that unconscious processing of neglected information may manifest as a fast denial. This theory of fast denial proposes that neglected stimuli are detected in the same way as non-neglected stimuli, but without overt awareness. We evaluated the fast denial theory by conducting two separate visual search task experiments, each differing by the duration of stimulus presentation. Specifically, in Experiment 1 each stimulus remained in the participants' visual field until a response was made. In Experiment 2 each stimulus was presented for only a brief duration. We further evaluated the fast denial theory by comparing verbal to motor task responses in each experiment. Overall, our results from both experiments and tasks showed no evidence for the presence of implicit knowledge of neglected stimuli. Instead, patients with neglect responded the same when they neglected stimuli as when they correctly reported stimulus absence. These findings thus cast doubt on the concept of the fast denial theory and its consequent implications for non-conscious processing. Importantly, our study demonstrated that the only behavior affected was during conscious detection of ipsilesional stimuli. Specifically, patients were slower to detect stimuli in Experiment 1 compared to Experiment 2, suggesting a duration effect occurred during conscious processing of information. Additionally, reaction time and accuracy were similar when reporting verbally versus motorically. These results provide new insights into the perceptual deficits associated with neglect and further support other work that falsifies the fast denial account of non-conscious processing in hemispatial visual neglect.	[Jelsone-Swain, Laura M.; Smith, David V.; Baylis, Gordon C.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jelsone-Swain, LM (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	lauraswa@med.umich.edu	Smith, David V./A-5487-2011	Smith, David V./0000-0001-5754-9633; BAYLIS, Gordon/0000-0002-4223-9074; Jelsone-Swain, Laura/0000-0002-9179-8884	National Institutes of Health [NS042047]; University of South Carolina; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (GCB: NS042047) and by intramural funding from the University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Baylis GC, 2004, NEUROPSYCHOLOGIA, V42, P175, DOI 10.1016/j.neuropsychologia.2003.07.001; Baylis GC, 2001, VIS COGN, V8, P359, DOI 10.1080/13506280143000052; BAYLIS GC, 1993, J EXP PSYCHOL HUMAN, V19, P451, DOI 10.1037/0096-1523.19.3.451; Berti A, 1999, NEUROPSYCHOLOGIA, V37, P333, DOI 10.1016/S0028-3932(98)00077-3; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bisiach E, 1985, ATTENTION PERFORM, P239; Broeren J, 2007, ACTA NEUROL SCAND, V116, P157, DOI 10.1111/j.1600-0404.2007.00821.x; Cappelletti M, 2006, NEUROPSYCHOLOGIA, V44, P1999, DOI 10.1016/j.neuropsychologia.2006.03.014; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Cubelli R, 2011, CORTEX, V47, P899, DOI 10.1016/j.cortex.2011.01.006; Danckert J, 2006, NEUROPSYCHOLOGIA, V44, P987, DOI 10.1016/j.neuropsychologia.2005.09.004; DIPELLEGRINO G, 1995, NEUROPSYCHOLOGIA, V33, P353, DOI 10.1016/0028-3932(94)00106-Y; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Eskes GA, 2006, RESTOR NEUROL NEUROS, V24, P385; Gore CL, 2001, BEHAV NEUROL, V13, P29; Kanne SM, 2002, COGN NEUROPSYCHOL, V19, P245, DOI 10.1080/02643290143000178; Karnath H. O., 2011, NEUROPSYCHOLOGIA; Karnath HO, 2011, BRAIN, V134, P903, DOI 10.1093/brain/awq355; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Ladavas E, 1997, NEUROPSYCHOLOGIA, V35, P257, DOI 10.1016/S0028-3932(96)00066-8; Laeng B, 2002, NEUROPSYCHOLOGIA, V40, P1622, DOI 10.1016/S0028-3932(01)00230-5; Maravita A, 1997, NEUROREPORT, V8, P1671, DOI 10.1097/00001756-199705060-00022; MARSHALL JC, 1988, NATURE, V336, P766, DOI 10.1038/336766a0; Mattingley JB, 1998, NATURE, V392, P179, DOI 10.1038/32413; MIJOVICPRELEC D, 1994, NEUROPSYCHOLOGIA, V32, P151, DOI 10.1016/0028-3932(94)90002-7; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; POSNER MI, 1984, J NEUROSCI, V4, P1863; Rafal R, 2006, BRAIN RES, V1080, P2, DOI 10.1016/j.brainres.2005.01.108; Rastelli F, 2008, EXP BRAIN RES, V187, P439, DOI 10.1007/s00221-008-1316-x; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; Sackur J, 2008, CORTEX, V44, P673, DOI 10.1016/j.cortex.2007.02.003; Snow JC, 2011, CORTEX, P1; Suchan J, 2011, BRAIN, V134, P3059, DOI 10.1093/brain/awr120; VOLPE BT, 1979, NATURE, V282, P722, DOI 10.1038/282722a0; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Vuilleumier P, 2001, CORTEX, V37, P741, DOI 10.1016/S0010-9452(08)70629-4; Vuilleumier P, 2008, CURR BIOL, V18, P1525, DOI 10.1016/j.cub.2008.08.072	39	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37369	10.1371/journal.pone.0037369	http://dx.doi.org/10.1371/journal.pone.0037369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662149	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300038
J	Lundasen, T; Andersson, EM; Snaith, M; Lindmark, H; Lundberg, J; Ostlund-Lindqvist, AM; Angelin, B; Rudling, M				Lundasen, Thomas; Andersson, Eva-Marie; Snaith, Michael; Lindmark, Helena; Lundberg, Johanna; Ostlund-Lindqvist, Ann-Margret; Angelin, Bo; Rudling, Mats			Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LIVER-X-RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE ACTIVITY; INSULIN-RESISTANCE; ILEAL EXCLUSION; PPAR-ALPHA; CHOLESTYRAMINE; INDUCTION; EXPRESSION; ASSAY	Interruption of the enterohepatic circulation of bile acids increases cholesterol catabolism, thereby stimulating hepatic cholesterol synthesis from acetate. We hypothesized that such treatment should lower the hepatic acetate pool which may alter triglyceride and glucose metabolism. We explored this using mice deficient of the ileal sodium-dependent BA transporter (Slc10a2) and ob/ob mice treated with a specific inhibitor of Slc10a2. Plasma TG levels were reduced in Slc10a2-deficient mice, and when challenged with a sucrose-rich diet, they displayed a reduced response in hepatic TG production as observed from the mRNA levels of several key enzymes in fatty acid synthesis. This effect was paralleled by a diminished induction of mature sterol regulatory element-binding protein 1c (Srebp1c). Unexpectedly, the SR-diet induced intestinal fibroblast growth factor (FGF) 15 mRNA and normalized bile acid synthesis in Slc10a2-/- mice. Pharmacologic inhibition of Slc10a2 in diabetic ob/ob mice reduced serum glucose, insulin and TGs, as well as hepatic mRNA levels of Srebp1c and its target genes. These responses are contrary to those reported following treatment of mice with a bile acid binding resin. Moreover, when key metabolic signal transduction pathways in the liver were investigated, those of Mek1/2 - Erk1/2 and Akt were blunted after treatment of ob/ob mice with the Slc10a2 inhibitor. It is concluded that abrogation of Slc10a2 reduces hepatic Srebp1c activity and serum TGs, and in the diabetic ob/ob model it also reduces glucose and insulin levels. Hence, targeting of Slc10a2 may be a promising strategy to treat hypertriglyceridemia and diabetes.	[Lundasen, Thomas; Lundberg, Johanna; Angelin, Bo; Rudling, Mats] Karolinska Inst, Dept Endocrinol Metab & Diabet, Dept Med, Stockholm, Sweden; [Lundasen, Thomas; Lundberg, Johanna; Angelin, Bo; Rudling, Mats] Karolinska Univ Hosp Huddinge, Mol Nutr Unit, Ctr Biosci, Novum, Stockholm, Sweden; [Andersson, Eva-Marie; Lindmark, Helena; Ostlund-Lindqvist, Ann-Margret] AstraZeneca R&D, Biosci, Molndal, Sweden; [Lindmark, Helena] AstraZeneca R&D, Lead Generat, Molndal, Sweden; [Snaith, Michael] AstraZeneca R&D, Transgen & Comparat Genom, Molndal, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; AstraZeneca; AstraZeneca	Lundasen, T (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Florida Campus, Jupiter, FL USA.	mats.rudling@ki.se			Swedish Research Council; Swedish Foundation for Strategic Research; non-profit foundations of Gronberg; Female Old Servants; Swedish Diabetes; Swedish Heart-Lung Foundations; Stockholm City Council (ALF); Cardiovascular program, Karolinska Institute/Stockholm City Council; AstraZeneca; Albireo AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); non-profit foundations of Gronberg; Female Old Servants; Swedish Diabetes; Swedish Heart-Lung Foundations(Swedish Heart-Lung Foundation); Stockholm City Council (ALF); Cardiovascular program, Karolinska Institute/Stockholm City Council; AstraZeneca(AstraZeneca); Albireo AB	The work performed at Karolinska Institute was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research, and the non-profit foundations of Gronberg, Female Old Servants, Swedish Diabetes, and Swedish Heart-Lung Foundations, the Stockholm City Council (ALF), and the Cardiovascular program, Karolinska Institute/Stockholm City Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BA and MR have for other studies received research grants from AstraZeneca and Albireo AB; BA has served as a board member of and is a shareholder in AstraZeneca PLC; EMA, HL, SS and A-MO-L are employees at AstraZeneca. MS and SS were previously employed by AstraZeneca; TL and JL have nothing to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AKERLUND JE, 1994, GUT, V35, P1116, DOI 10.1136/gut.35.8.1116; ANGELIN B, 1990, J INTERN MED, V227, P201, DOI 10.1111/j.1365-2796.1990.tb00143.x; ANGELIN B, 1987, P NATL ACAD SCI USA, V84, P5434, DOI 10.1073/pnas.84.15.5434; ANGELIN B, 1978, J LIPID RES, V19, P1017; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; DOWLING R H, 1970, Journal of Clinical Investigation, V49, P232, DOI 10.1172/JCI106232; EINARSSON K, 1986, J LIPID RES, V27, P82; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Galman C, 2002, FASEB J, V16, P265, DOI 10.1096/fj.0341fje; Galman C, 2003, J LIPID RES, V44, P859, DOI 10.1194/jlr.D200043-JLR200; Galman C, 2002, ENDOCRINOLOGY, V143, P1809, DOI 10.1210/en.143.5.1809; Galman C, 2011, J INTERN MED; GRUNDY SM, 1971, J LAB CLIN MED, V78, P94; HASSAN AS, 1984, ATHEROSCLEROSIS, V51, P327, DOI 10.1016/0021-9150(84)90180-1; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Herrema H, 2010, HEPATOLOGY, V51, P806, DOI 10.1002/hep.23408; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; REIHNER E, 1990, J LIPID RES, V31, P2219; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; RUDLING M, 1992, J LIPID RES, V33, P493; RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983; RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Staels B, 2007, DRUGS, V67, P1383, DOI 10.2165/00003495-200767100-00001; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; WHITE MF, 1994, J BIOL CHEM, V269, P1; WITZTUM JL, 1976, J LAB CLIN MED, V88, P1008	44	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37787	10.1371/journal.pone.0037787	http://dx.doi.org/10.1371/journal.pone.0037787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662222	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300112
J	Tivnan, A; Orr, WS; Gubala, V; Nooney, R; Williams, DE; McDonagh, C; Prenter, S; Harvey, H; Domingo-Fernandez, R; Bray, IM; Piskareva, O; Ng, CY; Lode, HN; Davidoff, AM; Stallings, RL				Tivnan, Amanda; Orr, Wayne Shannon; Gubala, Vladimir; Nooney, Robert; Williams, David E.; McDonagh, Colette; Prenter, Suzanne; Harvey, Harry; Domingo-Fernandez, Raquel; Bray, Isabella M.; Piskareva, Olga; Ng, Catherine Y.; Lode, Holger N.; Davidoff, Andrew M.; Stallings, Raymond L.			Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD(2) Coated Nanoparticles	PLOS ONE			English	Article							IN-VIVO; CANCER-CELLS; DOWN-REGULATION; MYCN ONCOGENE; LUNG-CANCER; PHASE-I; N-MYC; EXPRESSION; THERAPY; SUPPRESSOR	Background: Neuroblastoma is one of the most challenging malignancies of childhood, being associated with the highest death rate in paediatric oncology, underlining the need for novel therapeutic approaches. Typically, patients with high risk disease undergo an initial remission in response to treatment, followed by disease recurrence that has become refractory to further treatment. Here, we demonstrate the first silica nanoparticle-based targeted delivery of a tumor suppressive, proapoptotic microRNA, miR-34a, to neuroblastoma tumors in a murine orthotopic xenograft model. These tumors express high levels of the cell surface antigen disialoganglioside GD2 (GD(2)), providing a target for tumor-specific delivery. Principal Findings: Nanoparticles encapsulating miR-34a and conjugated to a GD(2) antibody facilitated tumor-specific delivery following systemic administration into tumor bearing mice, resulted in significantly decreased tumor growth, increased apoptosis and a reduction in vascularisation. We further demonstrate a novel, multi-step molecular mechanism by which miR-34a leads to increased levels of the tissue inhibitor metallopeptidase 2 precursor (TIMP2) protein, accounting for the highly reduced vascularisation noted in miR-34a-treated tumors. Significance: These novel findings highlight the potential of anti-GD(2)-nanoparticle-mediated targeted delivery of miR-34a for both the treatment of GD(2)-expressing tumors, and as a basic discovery tool for elucidating biological effects of novel miRNAs on tumor growth.	[Tivnan, Amanda; Prenter, Suzanne; Harvey, Harry; Domingo-Fernandez, Raquel; Bray, Isabella M.; Piskareva, Olga; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Tivnan, Amanda; Prenter, Suzanne; Harvey, Harry; Domingo-Fernandez, Raquel; Bray, Isabella M.; Piskareva, Olga; Stallings, Raymond L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Orr, Wayne Shannon; Ng, Catherine Y.; Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Orr, Wayne Shannon; Davidoff, Andrew M.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Gubala, Vladimir; Nooney, Robert; Williams, David E.; McDonagh, Colette] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland; [Lode, Holger N.] Ernst Moritz Arndt Univ Greifswald, Dept Paediat & Paediat Haematol Oncol, Greifswald, Germany	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Dublin City University; Ernst Moritz Arndt Universitat Greifswald	Tivnan, A (corresponding author), Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland.	rstallings@rcsi.ie	Stallings, Raymond/A-7213-2008; Williams, David E/B-3222-2012	Williams, David E/0000-0003-4123-5626; Gubala, Vladimir/0000-0001-6301-3632; McDonagh, Colette/0000-0003-2786-8785; Lode, Holger/0000-0002-1201-208X; Harvey, Harry/0000-0001-9542-7530	Science Foundation Ireland [07/IN.1/B1776, 10/CE/B1821]; Children's Medical and Research Foundation; HRB PhD Scholars Programme in Diagnostics and Therapeutics for Human Disease [PHD/2007/11]; Assisi Foundation of Memphis; US Public Health Service [CA23099]; Cancer Center Support Grant from the National Cancer Institute [21766]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P01CA023099] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; HRB PhD Scholars Programme in Diagnostics and Therapeutics for Human Disease; Assisi Foundation of Memphis; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cancer Center Support Grant from the National Cancer Institute; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Science Foundation Ireland Principal Investigator Award (07/IN.1/B1776) (RLS), the Children's Medical and Research Foundation (RLS), the HRB PhD Scholars Programme in Diagnostics and Therapeutics for Human Disease (PHD/2007/11) (HH), the Assisi Foundation of Memphis (AMD), the US Public Health Service Childhood Solid Tumor Program Project Grant No. CA23099 (AMD), the Cancer Center Support Grant No. 21766 from the National Cancer Institute (AMD), and by the American Lebanese Syrian Associated Charities (ALSAC) (AMD). This material is based upon research supported by the Science Foundation Ireland, under Grant No. 10/CE/B1821 (RN). Human/mouse chimeric antibody ch14.18/CHO was made available by a European effort through SIOPN (President Assoc. Prof. R. Ladenstein) funded by charities throughout Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/nmat2992, 10.1038/NMAT2992]; Barbe C., 2004, ADV MATER, V16, P8; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136; Cheung NKV, 2000, CLIN CANCER RES, V6, P2653; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; Di Paolo D, 2011, MOL THER; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; FATTAL E, 1991, J MICROENCAPSUL, V8, P29, DOI 10.3109/02652049109021855; Finnie KS, 2009, J SOL-GEL SCI TECHN, V49, P12, DOI 10.1007/s10971-008-1847-4; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Foster-Waldl E, 2005, MOL IMMUNOL, V42, P319, DOI 10.1016/j.molimm.2004.07.011; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; Gubala V, 2011, ANAL ADV ARTICLE; Gubala V, 2010, TALANTA, V81, P1833, DOI 10.1016/j.talanta.2010.03.048; Haber M, 1999, ONCOGENE, V18, P2777, DOI 10.1038/sj.onc.1202859; HANDGRETINGER R, 1995, EUR J CANCER, V31A, P261, DOI 10.1016/0959-8049(94)00413-Y; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hobley G, 2008, SYNLETT, P1510, DOI 10.1055/s-2007-1077795; Hom C, 2009, J MATER CHEM, V19, P6308, DOI 10.1039/b904197d; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kim M, 2011, LANCET ONCOL, V12, P319, DOI 10.1016/S1470-2045(11)70067-5; Kim VN, 2005, MOL CELLS, V19, P1; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; MUELLER BM, 1990, J IMMUNOL, V144, P1382; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Murray JL, 1996, J IMMUNOTHER, V19, P206, DOI 10.1097/00002371-199605000-00005; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Nooney RI, 2009, ANAL BIOANAL CHEM, V393, P1143, DOI 10.1007/s00216-008-2418-9; Pagnan G, 2000, J NATL CANCER I, V92, P253, DOI 10.1093/jnci/92.3.253; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]; Park SJ, 2008, LANGMUIR, V24, P12134, DOI 10.1021/la8028885; Patil YB, 2010, BIOMATERIALS, V31, P358, DOI 10.1016/j.biomaterials.2009.09.048; Patterson DM, 2011, ANGIOGENESIS ADV ONL; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Ritter G, 1991, Semin Cancer Biol, V2, P401; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Seo DW, 2011, PEPTIDES, V32, P1840, DOI 10.1016/j.peptides.2011.08.010; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Trang P, 2011, MOL THER; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Wallace M, 1997, AN H ANALG, V85, P2; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiggins JF, CANC RES, V70, P5923; Williams RF, 2010, J PEDIATR SURG, V45, P1103, DOI 10.1016/j.jpedsurg.2010.02.073; WU ZL, 1986, CANCER RES, V46, P440; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yu AL, 1998, J CLIN ONCOL, V16, P2169, DOI 10.1200/JCO.1998.16.6.2169; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018; Zeytin HE, 2000, CANCER GENE THER, V7, P1426, DOI 10.1038/sj.cgt.7700240	74	176	187	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38129	10.1371/journal.pone.0038129	http://dx.doi.org/10.1371/journal.pone.0038129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662276	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305342300168
J	Veracx, A; Boutellis, A; Merhej, V; Diatta, G; Raoult, D				Veracx, Aurelie; Boutellis, Amina; Merhej, Vicky; Diatta, Georges; Raoult, Didier			Evidence for an African Cluster of Human Head and Body Lice with Variable Colors and Interbreeding of Lice between Continents	PLOS ONE			English	Article							PHTHIRAPTERA; PEDICULIDAE; EVOLUTION; LOUSE	Background: Human head lice and body lice have been classified based on phenotypic characteristics, including geographical source, ecotype (preferred egg laying site hair or clothes), shape and color. More recently, genotypic studies have been based on mitochondrial genes, nuclear genes and intergenic spacers. Mitochondrial genetic analysis reclassified lice into three genotypes (A, B and C). However, no previous study has attempted to correlate both genotypic and phenotypic data. Materials and Methods: Lice were collected in four African countries: Senegal, Burundi, Rwanda and Ethiopia and were photographed to compare their colors. The Multi-Spacer-Typing (MST) method was used to genotype lice belonging to the worldwide Clade A, allowing a comparison of phenotypic and genotypic data. Results: No congruence between louse color and genotype has been identified. Phylogenetic analysis of the spacer PM2, performed including lice from other sources, showed the existence of an African cluster of human lice. However, the analysis of other spacers suggested that lice from different areas are interbreeding. Conclusions: We identified two geotypes of Clade A head and body lice including one that is specifically African, that can be either black or grey and can live on the head or in clothing. We also hypothesized that lice from different areas are interbreeding.	[Veracx, Aurelie; Boutellis, Amina; Merhej, Vicky; Raoult, Didier] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 198,IFR48,Fac Med, Marseille, France; [Diatta, Georges] URMITE, Inst Rech Dev, Hann, UMR 198, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Veracx, A (corresponding author), Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 198,IFR48,Fac Med, Marseille, France.	Didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Merhej, Vicky/J-4733-2015	RAOULT, Didier/0000-0002-0633-5974; merhej, vicky/0000-0002-8688-6943				ALPATOV WW, 1955, B SOC NAT MOSCOW, V60, P79; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Bacot A., 1917, Parasitology Cambridge, V9, DOI 10.1017/S0031182000006065; Boutellis A, 2011, VECTOR BORN IN PRESS; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; BUSVINE JR, 1948, PARASITOLOGY, V39, P1, DOI 10.1017/S0031182000083505; BUSVINE JR, 1978, SYST ENTOMOL, V3, P1, DOI 10.1111/j.1365-3113.1978.tb00383.x; Buxton P. A, 1947, LOUSE ACCOUNT LICE W; De Geer C., 1778, MEMOIRES SERVIR HIST, P62; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler W., 1956, Dermatologische Wochenschrift Leipzig, V133, P657; EICHLER W, 1982, Angewandte Parasitologie, V23, P102; EWING H. E., 1926, PROC U S NATION MUS, V68, P1; Hans Zinsser, 1935, RATS LICE HIST; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Leo NP, 2005, PARASITOL RES, V98, P44, DOI 10.1007/s00436-005-0013-y; Leo NP, 2005, HEREDITY, V95, P34, DOI 10.1038/sj.hdy.6800663; Leo NP, 2002, INSECT MOL BIOL, V11, P651, DOI 10.1046/j.1365-2583.2002.00367.x; Leo NP, 2002, J MED ENTOMOL, V39, P662, DOI 10.1603/0022-2585-39.4.662; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Maunder J.W., 1983, Proceedings of the Royal Institution of Great Britain, V55, P1; Nuttall GH, 2012, PARASITOLOGY, V12, P136; Raoult D, 2008, J INFECT DIS, P197; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Shipley A.E., 1915, MINOR HORRORS WAR, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yong Z, 2003, C R BIOL, V326	27	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37804	10.1371/journal.pone.0037804	http://dx.doi.org/10.1371/journal.pone.0037804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662229	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300119
J	Ishima, T; Hashimoto, K				Ishima, Tamaki; Hashimoto, Kenji			Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 Receptors	PLOS ONE			English	Article							RAT-BRAIN; NEUROPSYCHIATRIC DISORDERS; THERAPEUTIC DRUGS; NMDA RECEPTORS; FLUVOXAMINE; ANTAGONIST; BINDING; AGONIST; CALCIUM; LIGAND	In addition to both the alpha 1 adrenergic receptor and N-methyl-D-aspartate (NMDA) receptor antagonists, ifenprodil binds to the sigma receptor subtypes 1 and 2. In this study, we examined the effects of ifenprodil on nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Ifenprodil significantly potentiated NGF-induced neurite outgrowth, in a concentration-dependent manner. In contrast, the alpha 1 adrenergic receptor antagonist, prazosin and the NMDA receptor NR2B antagonist, Ro 25-6981 did not alter NGF-induced neurite outgrowth. Potentiation of NGF-induced neurite outgrowth mediated by ifenprodil was significantly antagonized by co-administration of the selective sigma-1 receptor antagonist, NE-100, but not the sigma-2 receptor antagonist, SM-21. Similarly, ifenprodil enhanced NGF-induced neurite outgrowth was again significantly reduced by the inositol 1,4,5-triphosphate (IP3) receptor antagonists, xestospongin C and 2-aminoethoxydiphenyl borate (2-APB) treatment. Furthermore, BAPTA-AM, a chelator of intracellular Ca2+, blocked the effects of ifenprodil on NGF-induced neurite outgrowth, indicating the role of intracellular Ca2+ in the neurite outgrowth. These findings suggest that activation at sigma-1 receptors and subsequent interaction with IP3 receptors may mediate the pharmacological effects of ifenprodil on neurite outgrowth.	[Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	Chiba University	Ishima, T (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Grants-in-Aid for Scientific Research [23791308] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chambers R A, 1999, Semin Clin Neuropsychiatry, V4, P274; Cortese BM, 2005, CNS SPECTRUMS, V10, P820, DOI 10.1017/S1092852900010427; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Ghelardini C, 2000, PHARMACOL BIOCHEM BE, V67, P659, DOI 10.1016/S0091-3057(00)00405-6; HASHIMOTO K, 1994, EUR J PHARM-MOLEC PH, V266, P67, DOI 10.1016/0922-4106(94)90211-9; HASHIMOTO K, 1995, EUR J PHARMACOL, V273, P307, DOI 10.1016/0014-2999(94)00763-W; HASHIMOTO K, 1993, EUR J PHARMACOL, V236, P159, DOI 10.1016/0014-2999(93)90241-9; Hashimoto K, 2012, INT J GERIA IN PRESS; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; Hashimoto K, 2009, CNS NEUROL DISORD-DR, V8, P470, DOI 10.2174/187152709789824633; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Hayashi T, 2008, EXPERT OPIN THER TAR, V12, P45, DOI 10.1517/14728222.12.1.45; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hindmarch I, 2010, HUM PSYCHOPHARM CLIN, V25, P193, DOI 10.1002/hup.1106; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Itoh K, 2011, BRAIN RES, V1377, P32, DOI 10.1016/j.brainres.2010.12.075; Kishimoto A, 2012, BIOL PSYCHIAT, V71, pE7, DOI 10.1016/j.biopsych.2011.10.014; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Mutel V, 1998, J NEUROCHEM, V70, P2147; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875, DOI 10.2174/138161212799436476; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Okuyama S., 1996, CNS DRUG REV, V2, P226, DOI 10.1111/j.1527-3458.1996.tb00299.x; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Takeshita M, 2011, CHEM RES TOXICOL, V24, P1845, DOI 10.1021/tx200160g; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Yoshida T, 2012, CURR PSYCHI IN PRESS	37	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37989	10.1371/journal.pone.0037989	http://dx.doi.org/10.1371/journal.pone.0037989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655093	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900070
J	Jayasinghe, SS; Pathirana, KD				Jayasinghe, Sudheera S.; Pathirana, Kithsiri D.			Autonomic Function following Acute Organophosphorus Poisoning: A Cohort Study	PLOS ONE			English	Article							NEUROPATHY	Autonomic dysfunction after chronic low level exposure to organophosphorus (OP) pesticides has been consistently reported in the literature, but not following a single acute overdose. In order to study autonomic function after an acute OP overdose, sixty-six overdose patients were compared to 70 matched controls. Assessment of autonomic function was done by heart rate response to standing, deep breathing (HR-DB) and Valsalva manoeuvre; blood pressure (BP) response to standing and sustained hand grip; amplitude and latency of sympathetic skin response (SSR); pupil size and post-void urine volume. The patients were assessed one and six weeks after the exposure. The number of patients who showed abnormal autonomic function compared to standard cut-off values did not show statistically significantly difference from that of controls by Chi-Square test. When compared to the controls at one week the only significant differences consistent with autonomic dysfunction were change of diastolic BP 3 min after standing, HR-DB, SSR-Amplitude, SSR-Latency, post-void urine volume and size of the pupil. At 6 weeks significant recovery of autonomic function was observed and only HR-DB was decreased to a minor degree, -5 beats/min [95%CI 2-8]. This study provides good evidence for the lack of long term autonomic dysfunction following acute exposure to OP pesticides.	[Jayasinghe, Sudheera S.] Univ Ruhuna, Dept Pharmacol, Fac Med, Karapitiya, Galle, Sri Lanka; [Jayasinghe, Sudheera S.] Univ Peradeniya, S Asian Clin Toxicol Res Collaborat, Dept Med, Fac Med, Peradeniya, Sri Lanka; [Jayasinghe, Sudheera S.; Pathirana, Kithsiri D.] Univ Ruhuna, Clin Neurosci Ctr, Dept Med, Fac Med, Karapitiya, Galle, Sri Lanka	University Ruhuna; University of Peradeniya; University Ruhuna	Jayasinghe, SS (corresponding author), Univ Ruhuna, Dept Pharmacol, Fac Med, Karapitiya, Galle, Sri Lanka.	sudheerasj@yahoo.com			South Asian Clinical Toxicology Research Collaboration; Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant [GR071669MA]	South Asian Clinical Toxicology Research Collaboration; Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant	This study was supported by the South Asian Clinical Toxicology Research Collaboration, which is funded by the Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant GR071669MA. The study sponsor had no role in study design, data collection, data analysis, data interpretation, decision to publish, or preparation of the manuscript.	AMINOFF MJ, 2005, ELECTRODIAGNOSIS CLI; Annual Health Bulletin, 2003, ANN HLTH B HLTH MIN, P21; Eddleston M, 2008, QJM-INT J MED, V101, P467, DOI 10.1093/qjmed/hcn026; Engel LS, 1998, ARCH ENVIRON HEALTH, V53, P7, DOI 10.1080/00039899809605684; EWING DJ, 1981, DIABETOLOGIA, V21, P18, DOI 10.1007/BF03216217; EWING DJ, 1982, BRIT MED J, V285, P916, DOI 10.1136/bmj.285.6346.916; EWING DJ, 1981, LANCET, V1, P224; Guidelines EBM, 2004, DETERMINE VOLUME RES; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; Jayarathnam J, 1982, B WORLD HEALTH ORGAN, V60, P615; Kelly Christopher E, 2004, Rev Urol, V6 Suppl 1, pS32; RUIJTEN MWMM, 1994, ARCH ENVIRON HEALTH, V49, P188, DOI 10.1080/00039896.1994.9940381; SENANAYAKE N, 1987, NEW ENGL J MED, V316, P761, DOI 10.1056/NEJM198703263161301; SENANAYAKE N, 1982, NEW ENGL J MED, V306, P155, DOI 10.1056/NEJM198201213060306; Singh S, 2000, NEUROL INDIA, V48, P308; Steenland K, 2000, ENVIRON HEALTH PERSP, V108, P293, DOI 10.2307/3454346; Worek F, 1999, CLIN CHIM ACTA, V288, P73, DOI 10.1016/S0009-8981(99)00144-8	18	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37987	10.1371/journal.pone.0037987	http://dx.doi.org/10.1371/journal.pone.0037987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655091	gold, Green Published			2022-12-27	WOS:000305338900068
J	Rosjo, H; Stridsberg, M; Florholmen, G; Stenslokken, KO; Ottesen, AH; Sjaastad, I; Husberg, C; Dahl, MB; Oie, E; Louch, WE; Omland, T; Christensen, G				Rosjo, Helge; Stridsberg, Mats; Florholmen, Geir; Stenslokken, Kare-Olav; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Dahl, Mai Britt; Oie, Erik; Louch, William E.; Omland, Torbjorn; Christensen, Geir			Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties	PLOS ONE			English	Article							CHROMOGRANIN-A; PROGNOSTIC VALUE; SECRETONEURIN; NEUROPEPTIDE; PATHWAY; QUANTIFICATION; ASSOCIATION; EXPRESSION; CATESTATIN; PEPTIDE	Background: Several beneficial effects have been demonstrated for secretogranin II (SgII) in non-cardiac tissue. As cardiac production of chromogranin A and B, two related proteins, is increased in heart failure (HF), we hypothesized that SgII could play a role in cardiovascular pathophysiology. Methodology/Principal Findings: SgII production was characterized in a post-myocardial infarction heart failure (HF) mouse model, functional properties explored in experimental models, and circulating levels measured in mice and patients with stable HF of moderate severity. SgII mRNA levels were 10.5 fold upregulated in the left ventricle (LV) of animals with myocardial infarction and HF (p<0.001 vs. sham-operated animals). SgII protein levels were also increased in the LV, but not in other organs investigated. SgII was produced in several cell types in the myocardium and cardiomyocyte synthesis of SgII was potently induced by transforming growth factor-beta and norepinephrine stimulation in vitro. Processing of SgII to shorter peptides was enhanced in the failing myocardium due to increased levels of the proteases PC1/3 and PC2 and circulating SgII levels were increased in mice with HF. Examining a pathophysiological role of SgII in the initial phase of post-infarction HF, the SgII fragment secretoneurin reduced myocardial ischemia-reperfusion injury and cardiomyocyte apoptosis by 30% and rapidly increased cardiomyocyte Erk1/2 and Stat3 phosphorylation. SgII levels were also higher in patients with stable, chronic HF compared to age-and gender-matched control subjects: median 0.16 (Q1-3 0.14-0.18) vs. 0.12 (0.10-0.14) nmol/L, p<0.001. Conclusions: We demonstrate increased myocardial SgII production and processing in the LV in animals with myocardial infarction and HF, which could be beneficial as the SgII fragment secretoneurin protects from ischemia-reperfusion injury and cardiomyocyte apoptosis. Circulating SgII levels are also increased in patients with chronic, stable HF and may represent a new cardiac biomarker.	[Rosjo, Helge; Ottesen, Anett Hellebo; Dahl, Mai Britt; Omland, Torbjorn] Akershus Univ Hosp, Div Med, Lorenskog, Norway; [Rosjo, Helge; Florholmen, Geir; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Dahl, Mai Britt; Oie, Erik; Louch, William E.; Omland, Torbjorn; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Inst Clin Med, Oslo, Norway; [Rosjo, Helge; Florholmen, Geir; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Dahl, Mai Britt; Oie, Erik; Louch, William E.; Omland, Torbjorn; Christensen, Geir] Univ Oslo, KG Jebsen Cardiac Res Ctr, Inst Clin Med, Oslo, Norway; [Stridsberg, Mats] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Florholmen, Geir; Ottesen, Anett Hellebo; Sjaastad, Ivar; Husberg, Cathrine; Louch, William E.; Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Stenslokken, Kare-Olav] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Dahl, Mai Britt] Akershus Univ Hosp, Dept Clin Mol Biol, Lorenskog, Norway; [Oie, Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Uppsala University; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Rosjo, H (corresponding author), Akershus Univ Hosp, Div Med, Lorenskog, Norway.	helge.rosjo@medisin.uio.no		Stenslokken, Kare-Olav/0000-0003-2962-4143	South-Eastern Norway Regional Health Authority, Akershus University Hospital; University of Oslo; Norwegian National Health Association; Anders Jahre Foundation for Promotion of Science; K.G. Jebsen Foundation; South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority, Akershus University Hospital; University of Oslo; Norwegian National Health Association; Anders Jahre Foundation for Promotion of Science; K.G. Jebsen Foundation; South-Eastern Norway Regional Health Authority	This work was supported by the South-Eastern Norway Regional Health Authority, Akershus University Hospital, the University of Oslo, the Norwegian National Health Association, the Anders Jahre Foundation for Promotion of Science, and the K.G. Jebsen Foundation. H. R. is recipient of a research fellowship from the South-Eastern Norway Regional Health Authority to study granin proteins in cardiovascular disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 1996, BLOOD, V87, P674, DOI 10.1182/blood.V87.2.674.bloodjournal872674; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Berman Y, 2000, J NEUROCHEM, V75, P1763, DOI 10.1046/j.1471-4159.2000.0751763.x; Biswas N, 2010, CELL TISSUE RES, V342, P353, DOI 10.1007/s00441-010-1059-4; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Damas JK, 2000, CARDIOVASC RES, V45, P428, DOI 10.1016/S0008-6363(99)00262-X; DITTIE AS, 1995, BIOCHEM J, V310, P777, DOI 10.1042/bj3100777; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Estensen ME, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.008; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Heidrich FM, 2008, CIRC RES, V102, P1230, DOI 10.1161/CIRCRESAHA.107.166033; Heidrich Felix M, 2011, Congest Heart Fail, V17, P314, DOI 10.1111/j.1751-7133.2011.00249.x; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; HOFLEHNER J, 1995, FEBS LETT, V360, P294, DOI 10.1016/0014-5793(95)00127-U; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jin HK, 2004, CIRCULATION, V109, P2240, DOI 10.1161/01.CIR.0000127951.13380.B4; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitner B, 1996, J NEUROCHEM, V66, P1312; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Mahata SK, 2002, ANN NY ACAD SCI, V971, P27, DOI 10.1111/j.1749-6632.2002.tb04429.x; Omland T, 2003, AM J MED, V114, P25, DOI 10.1016/S0002-9343(02)01425-0; Peinado JR, 2006, ENDOCRINOLOGY, V147, P1408, DOI 10.1210/en.2005-0975; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; REINISCH N, 1993, FEBS LETT, V334, P41, DOI 10.1016/0014-5793(93)81676-Q; Rosjo H, 2010, CIRC-HEART FAIL, V3, P503, DOI 10.1161/CIRCHEARTFAILURE.109.867747; Rosjo H, 2010, EUR J HEART FAIL, V12, P549, DOI 10.1093/eurjhf/hfq055; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schneitler C, 1998, J NEUROIMMUNOL, V86, P87, DOI 10.1016/S0165-5728(98)00012-5; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Stridsberg M, 2005, REGUL PEPTIDES, V125, P193, DOI 10.1016/j.regpep.2004.08.027; Stridsberg M, 2008, REGUL PEPTIDES, V148, P95, DOI 10.1016/j.regpep.2008.03.007; Yoo SH, 2012, CELL CALCIUM, V51, P342, DOI 10.1016/j.ceca.2011.12.008	42	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37401	10.1371/journal.pone.0037401	http://dx.doi.org/10.1371/journal.pone.0037401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655045	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900020
J	Wang, H; Wu, ZH; Han, JY; Zheng, W; Yang, CW				Wang, Huan; Wu, Zhihai; Han, Jiayu; Zheng, Wei; Yang, Chunwu			Comparison of Ion Balance and Nitrogen Metabolism in Old and Young Leaves of Alkali-Stressed Rice Plants	PLOS ONE			English	Article							SALT-STRESS; OSMOTIC ADJUSTMENT; GENE-EXPRESSION; NA+ TRANSPORT; SALINITY; GROWTH; PHOTOSYNTHESIS; MECHANISMS	Background: Alkali stress is an important agricultural contaminant and has complex effects on plant metabolism. The aim of this study was to investigate whether the alkali stress has different effects on the growth, ion balance, and nitrogen metabolism in old and young leaves of rice plants, and to compare functions of both organs in alkali tolerance. Methodology/Principal Findings: The results showed that alkali stress only produced a small effect on the growth of young leaves, whereas strongly damaged old leaves. Rice protected young leaves from ion harm via the large accumulation of Na+ and Cl- in old leaves. The up-regulation of OsHKT1;1, OsAKT1, OsHAK1, OsHAK7, OsHAK10 and OsHAK16 may contribute to the larger accumulation of Na+ in old leaves under alkali stress. Alkali stress mightily reduced the NO3- contents in both organs. As old leaf cells have larger vacuole, under alkali stress these scarce NO3- was principally stored in old leaves. Accordingly, the expression of OsNRT1;1 and OsNRT1;2 in old leaves was up-regulated by alkali stress, revealing that the two genes might contribute to the accumulation of NO3- in old leaves. NO3- deficiency in young leaves under alkali stress might induce the reduction in OsNR1 expression and the subsequent lacking of NH4+, which might be main reason for the larger down-regulation of OsFd-GOGAT and OsGS2 in young leaves. Conclusions/Significance: Our results strongly indicated that, during adaptation of rice to alkali stress, young and old leaves have distinct mechanisms of ion balance and nitrogen metabolism regulation. We propose that the comparative studies of young and old tissues may be important for abiotic stress tolerance research.	[Wang, Huan; Han, Jiayu; Yang, Chunwu] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Jilin Province, Peoples R China; [Wu, Zhihai] Jilin Agr Univ, Dept Agron, Changchun, Jilin Province, Peoples R China; [Zheng, Wei] Chinese Acad Sci, NE Inst Geog & Agroecol, Changchun, Peoples R China	Northeast Normal University - China; Jilin Agricultural University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Wang, H (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Jilin Province, Peoples R China.	chunwuyang@gmail.com			State Key Basic Research and Development Plan of China [2011CB100205]; Programme for Introducing Talents to Universities [B07017]; National Natural Science Foundation of China Project [31072078, 30970232]; Fundamental Research Funds for the Central Universities [11QNJJ020, 10SSXT143]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Programme for Introducing Talents to Universities; National Natural Science Foundation of China Project(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the State Key Basic Research and Development Plan of China (2011CB100205), the Programme for Introducing Talents to Universities (No. B07017), the National Natural Science Foundation of China Project (Nos. 31072078 and 30970232), and the Fundamental Research Funds for the Central Universities (Nos. 11QNJJ020 and 10SSXT143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram MS, 2006, PAK J BOT, V38, P1661; Ashraf M, 1997, ACTA BOT NEERL, V46, P207; Gao CQ, 2008, PLANT MOL BIOL, V66, P245, DOI 10.1007/s11103-007-9266-4; Hajlaoui H, 2010, IND CROP PROD, V31, P122, DOI 10.1016/j.indcrop.2009.09.007; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kawanabe S., 1991, Nippon Sochi Gakkaishi = Journal of Japanese Society of Grassland Science, V37, P91; Kusano M, 2011, PLANT J, V66, P456, DOI 10.1111/j.1365-313X.2011.04506.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakamura T, 1996, PLANT CELL PHYSIOL, V37, P873, DOI 10.1093/oxfordjournals.pcp.a029026; Quinet M, 2010, J EXP BOT, V61, P2719, DOI 10.1093/jxb/erq118; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shi WM, 2010, PLANT SOIL, V326, P291, DOI 10.1007/s11104-009-0007-0; Ullrich WR, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P229; Vera-Estrella R, 2005, PLANT PHYSIOL, V139, P1507, DOI 10.1104/pp.105.067850; Wang H, 2011, PLANT SOIL ENVIRON, V57, P286, DOI 10.17221/36/2011-PSE; Wang YC, 2008, PLANT MOL BIOL REP, V26, P241, DOI 10.1007/s11105-008-0037-4; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Yang CW, 2008, PLANT GROWTH REGUL, V56, P179, DOI 10.1007/s10725-008-9299-y; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yasar F, 2006, PLANT SOIL ENVIRON, V52, P476, DOI 10.17221/3469-PSE; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhang Z, 2004, LAB MANUAL PLANT PHY, P160; Zheng H., 1999, FORM DYNAMIC TRAIT H, P137; Zhu G, 1993, LAB MANUAL PLANT PHY; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	32	29	36	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37817	10.1371/journal.pone.0037817	http://dx.doi.org/10.1371/journal.pone.0037817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655071	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900048
J	Ma, JZL; Lim, SN; Qin, JS; Yang, JP; Enomoto, N; Ruedl, C; Ronchese, F				Ma, Joel Zhi-long; Lim, So Nai; Qin, Jim Shixiang; Yang, Jianping; Enomoto, Noriyuki; Ruedl, Christiane; Ronchese, Franca			Murine CD4(+) T Cell Responses Are Inhibited by Cytotoxic T Cell-Mediated Killing of Dendritic Cells and Are Restored by Antigen Transfer	PLOS ONE			English	Article							LYMPHOCYTES IN-VIVO; CROSS-PRESENTATION; LYMPH-NODES; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DEPENDENT ELIMINATION; VIRAL-INFECTION; PERFORIN; ACTIVATION; CTL; EXPANSION	Cytotoxic T lymphocytes (CTL) provide protection against pathogens and tumors. In addition, experiments in mouse models have shown that CTL can also kill antigen-presenting dendritic cells (DC), reducing their ability to activate primary and secondary CD8(+) T cell responses. In contrast, the effects of CTL-mediated killing on CD4(+) T cell responses have not been fully investigated. Here we use adoptive transfer of TCR transgenic T cells and DC immunization to show that specific CTL significantly inhibited CD4(+) T cell proliferation induced by DC loaded with peptide or low concentrations of protein antigen. In contrast, CTL had little effect on CD4(+) T cell proliferation induced by DC loaded with high protein concentrations or expressing antigen endogenously, even if these DC were efficiently killed and failed to accumulate in the lymph node (LN). Residual CD4(+) T cell proliferation was due to the transfer of antigen from carrier DC to host APC, and predominantly involved skin DC populations. Importantly, the proliferating CD4(+) T cells also developed into IFN-gamma producing memory cells, a property normally requiring direct presentation by activated DC. Thus, CTL-mediated DC killing can inhibit CD4(+) T cell proliferation, with the extent of inhibition being determined by the form and amount of antigen used to load DC. In the presence of high antigen concentrations, antigen transfer to host DC enables the generation of CD4(+) T cell responses regardless of DC killing, and suggests mechanisms whereby CD4(+) T cell responses can be amplified.	[Ma, Joel Zhi-long; Lim, So Nai; Qin, Jim Shixiang; Yang, Jianping; Enomoto, Noriyuki; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand; [Ma, Joel Zhi-long; Lim, So Nai; Ronchese, Franca] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Ruedl, Christiane] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Malaghan Institute; Victoria University Wellington; Victoria University Wellington; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ma, JZL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	fronchese@malaghan.org.nz	Ronchese, Franca/M-9618-2019; Enomoto, Noriyuki/GLS-0691-2022; Ruedl, christiane/A-2219-2011	Ronchese, Franca/0000-0001-5835-8230; Enomoto, Noriyuki/0000-0003-3187-4264; Ruedl, christiane/0000-0002-5599-6541; Ma, Joel/0000-0002-0448-6744; Yang, Jianping/0000-0001-5336-6530	Marsden Fund; Health Research Council of New Zealand; Lottery Health	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Lottery Health	This work was funded by research grants from the Marsden Fund (http://www.royalsociety.org.nz/programmes/funds/marsden/) and Health Research Council of New Zealand (http://www.hrc.govt.nz/) to FR. JZM was funded by a Lottery Health (http://www.communitymatters. govt.nz/Funding-and-grants-Lottery- grants-Lottery-Health-Research) PhD Scholarship and the Marsden Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Andrew KA, 2008, J IMMUNOL, V181, P8356, DOI 10.4049/jimmunol.181.12.8356; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen M, 2012, BLOOD, V119, P127, DOI 10.1182/blood-2011-06-363994; Dickgreber N, 2009, J IMMUNOL, V182, P1260, DOI 10.4049/jimmunol.182.3.1260; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Enomoto N, 2012, J IMMUNOL, V188, P1734, DOI 10.4049/jimmunol.1102699; Feldmann J, 2002, BRIT J HAEMATOL, V117, P965, DOI 10.1046/j.1365-2141.2002.03534.x; Garrigan K, 1996, BLOOD, V88, P3508, DOI 10.1182/blood.V88.9.3508.bloodjournal8893508; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jusforgues-Saklani H, 2008, J IMMUNOL, V181, P3067, DOI 10.4049/jimmunol.181.5.3067; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kuipers H, 2009, J LEUKOCYTE BIOL, V85, P64, DOI 10.1189/jlb.0807519; Laffont S, 2008, BLOOD, V112, P661, DOI 10.1182/blood-2007-10-120089; Laffont S, 2006, BLOOD, V108, P2257, DOI 10.1182/blood-2005-10-4059; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Min L, 2010, J IMMUNOL, V184, P4625, DOI 10.4049/jimmunol.0903873; Mueller SN, 2006, J IMMUNOL, V176, P7379, DOI 10.4049/jimmunol.176.12.7379; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Petersen TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017657; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ritchie DS, 2000, J IMMUNOL METHODS, V246, P109, DOI 10.1016/S0022-1759(00)00300-8; Robinson MJ, 2010, IMMUNOL CELL BIOL, V88, P291, DOI 10.1038/icb.2009.96; Ronchese F, 2001, J EXP MED, V194, pF23, DOI 10.1084/jem.194.5.F23; Ruedl C, 2008, INT IMMUNOL, V20, P1211, DOI 10.1093/intimm/dxn079; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Yewdall AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011144	52	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37481	10.1371/journal.pone.0037481	http://dx.doi.org/10.1371/journal.pone.0037481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649530	Green Published, gold			2022-12-27	WOS:000305335800048
J	Berry, DJ; Vimaleswaran, KS; Whittaker, JC; Hingorani, AD; Hypponen, E				Berry, Diane J.; Vimaleswaran, Karani S.; Whittaker, John C.; Hingorani, Aroon D.; Hyppoenen, Elina			Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BRITISH BIRTH COHORT; AGE 45 YEARS; DETERMINANTS; POPULATION; RISK; IMPUTATION; DISEASE; ENZYME; ADULTS	Background: Mendelian randomization (MR) studies use genetic variants mimicking the influence of a modifiable exposure to assess and quantify a causal association with an outcome, with an aim to avoid problems with confounding and reverse causality affecting other types of observational studies. Aim: We evaluated genetic markers that index differences in 25-hydroxyvitamin D (25(OH) D) as instruments for MR studies on vitamin D. Methods and Findings: We used data from up-to 6,877 participants in the 1958 British birth cohort with information on genetic markers and 25(OH) D. As potential instruments, we selected 20 single nucleotide polymorphisms (SNP) which are located in the vitamin D metabolism pathway or affect skin pigmentation/tanning, including 4 SNPs from genome-wide association (GWA) meta-analyses on 25(OH) D. We analyzed SNP associations with 25(OH) D and evaluated the use of allele scores dividing genes to those affecting 25(OH) D synthesis (DHCR7, CYP2R1) and metabolism (GC, CYP24A1, CYP27B1). In addition to the GWA SNPs, only two SNPs (CYP27B1, OCA2) showed evidence for association with 25(OH) D, with the OCA2 association abolished after lifestyle adjustment. Per allele differences varied between -0.02 and -0.08 nmol/L (P <= 0.02 for all), with a 6.1 nmol/L and a 10.2 nmol/L difference in 25(OH) D between individuals with highest compared lowest number of risk alleles in synthesis and metabolism allele scores, respectively. Individual SNPs but not allele scores showed associations with lifestyle factors. An exception was geographical region which was associated with synthesis score. Illustrative power calculations (80% power, 5% alpha) suggest that approximately 80,000 participants are required to establish a causal effect of vitamin D on blood pressure using the synthesis allele score. Conclusions: Combining SNPs into allele scores provides a more powerful instrument for MR analysis than a single SNP in isolation. Population stratification and the potential for pleiotropic effects need to be considered in MR studies on vitamin D.	[Berry, Diane J.; Hyppoenen, Elina] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Berry, Diane J.; Vimaleswaran, Karani S.; Hyppoenen, Elina] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Whittaker, John C.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	Berry, DJ (corresponding author), UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England.	e.hypponen@ucl.ac.uk	Hypponen, Elina/B-2596-2014; Whittaker, John C/B-8609-2012	Hypponen, Elina/0000-0003-3670-9399; Whittaker, John C/0000-0002-3529-2379; Hingorani, Aroon/0000-0001-8365-0081; Karani, Vimal/0000-0002-8485-8930	British Heart Foundation; UK Medical Research Council [G0601653]; MRC [G0000934]; Wellcome Trust [068545/Z/02, 076113]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); MRC;  [U01 DK062418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; British Heart Foundation [PG/09/023/26806] Funding Source: researchfish; Medical Research Council [G0400546, G1001799, G0601653, G0000934, G0400546B] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish; MRC [G0601653, G1001799, G0400546] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the British Heart Foundation and the UK Medical Research Council [project grant G0601653, PrevMetSyn/SALVE with Academy of Finland]. EH is a Department of Health (UK) Public Health Career Scientist. The 25-hydroxyvitamin D assay in the 1958 British birth cohort was funded by the BUPA foundation. Genotype data from the 1958 British birth cohort DNA collection was funded by MRC grant G0000934 and Wellcome Trust grant 068545/Z/02. This research used resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study also makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. The work was undertaken at the Centre for Paediatric Epidemiology and Biostatistics which benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health. Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust benefits from R&D funding received from the NHS Executive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, AM REV RESPIR DIS, V136, P1285; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; BARRETT JC, 2009, NAT GENET; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; Cleves M., 1999, STAT TECH B, V48, P34; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Gibb I, 1999, CLIN CHEM, V45, P1833; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Institute of Medicine, 2011, DIETARY REFERENCE IN; Lanham-New S A, 2011, Br J Nutr, V105, P144, DOI 10.1017/S0007114510002576; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lee W, 2010, CURR OPIN INVEST DR, V11, P309; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nolte H, 1997, ANN ALLERG ASTHMA IM, V79, P27, DOI 10.1016/S1081-1206(10)63080-3; Palmer T.M., 2011, STAT METHODS MED RES; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 2007, INT J EPIDEMIOL, V36, P532, DOI 10.1093/ije/dyl310; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; StataCorp, 2009, STAT STAT SOFTW REL; Stern PH, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P565; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; [No title captured]	46	71	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37465	10.1371/journal.pone.0037465	http://dx.doi.org/10.1371/journal.pone.0037465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629401	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100031
J	Cote, J; Bovenzi, V; Savard, M; Dubuc, C; Fortier, A; Neugebauer, W; Tremblay, L; Muller-Esterl, W; Tsanaclis, AM; Lepage, M; Fortin, D; Gobeil, F				Cote, Jerome; Bovenzi, Veronica; Savard, Martin; Dubuc, Celena; Fortier, Audrey; Neugebauer, Witold; Tremblay, Luc; Mueller-Esterl, Werner; Tsanaclis, Ana-Maria; Lepage, Martin; Fortin, David; Gobeil, Fernand, Jr.			Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model	PLOS ONE			English	Article							BRAIN-BARRIER; PLASMA EXTRAVASATION; B-1 RECEPTORS; BRADYKININ; EXPRESSION; DELIVERY; CHEMOTHERAPY; SURVIVAL; CNS; TEMOZOLOMIDE	Treatment of malignant glioma with chemotherapy is limited mostly because of delivery impediment related to the blood-brain tumor barrier (BTB). B1 receptors (B1R), inducible prototypical G-protein coupled receptors (GPCR) can regulate permeability of vessels including possibly that of brain tumors. Here, we determine the extent of BTB permeability induced by the natural and synthetic peptide B1R agonists, LysdesArg(9)BK (LDBK) and SarLys[DPhe(8)]desArg(9)BK (NG29), in syngeneic F98 glioma-implanted Fischer rats. Ten days after tumor inoculation, we detected the presence of B1R on tumor cells and associated vasculature. NG29 infusion increased brain distribution volume and uptake profiles of paramagnetic probes (Magnevist and Gadomer) at tumoral sites (T-1-weighted imaging). These effects were blocked by B1R antagonist and nonselective cyclooxygenase inhibitors, but not by B2R antagonist and non-selective nitric oxide synthase inhibitors. Consistent with MRI data, systemic co-administration of NG29 improved brain tumor delivery of Carboplatin chemotherapy (ICP-Mass spectrometry). We also detected elevated B1R expression in clinical samples of high-grade glioma. Our results documented a novel GPCR-signaling mechanism for promoting transient BTB disruption, involving activation of B1R and ensuing production of COX metabolites. They also underlined the potential value of synthetic biostable B1R agonists as selective BTB modulators for local delivery of different sized-therapeutics at (peri) tumoral sites.	[Cote, Jerome; Bovenzi, Veronica; Savard, Martin; Dubuc, Celena; Fortier, Audrey; Neugebauer, Witold; Gobeil, Fernand, Jr.] Univ Hosp, Dept Pharmacol, Frankfurt, Germany; [Cote, Jerome; Tremblay, Luc; Lepage, Martin] Univ Hosp, Dept Nucl Med & Radiobiol, Frankfurt, Germany; [Mueller-Esterl, Werner] Univ Hosp, Inst Biochem 2, Frankfurt, Germany; [Tsanaclis, Ana-Maria] Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Dept Pathol, Sherbrooke, PQ J1K 2R1, Canada; [Fortin, David] Univ Sherbrooke, Dept Surg, Sherbrooke, PQ J1K 2R1, Canada; [Cote, Jerome; Bovenzi, Veronica; Savard, Martin; Dubuc, Celena; Lepage, Martin; Fortin, David; Gobeil, Fernand, Jr.] Univ Sherbrooke, Fac Med & Hlth Sci, Inst Pharmacol, Sherbrooke, PQ J1K 2R1, Canada	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Cote, J (corresponding author), Univ Hosp, Dept Pharmacol, Frankfurt, Germany.	fernand.gobeil@usherbrooke.ca		Lepage, Martin/0000-0002-5363-9487	Institut de Pharmacologie de Sherbrooke/Tranzyme Pharma Inc; Canadian Institute of Health Research [89832, MOP-81358]; Fonds de la recherche en sante du Quebec (FRSQ); FRSQ; Canada Foundation for Innovation; FRSQ-funded Centre de recherche clinique Etienne-Le Bel; Universite de Sherbrooke; Tranzyme Pharma Inc.	Institut de Pharmacologie de Sherbrooke/Tranzyme Pharma Inc; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); FRSQ-funded Centre de recherche clinique Etienne-Le Bel; Universite de Sherbrooke; Tranzyme Pharma Inc.	This work was funded by competitive grants from the Institut de Pharmacologie de Sherbrooke/Tranzyme Pharma Inc and the Canadian Institute of Health Research #MOP# 89832 (FG), #MOP-81358 (DF, ML, FG). Studentship/fellowship awards were obtained from the Fonds de la recherche en sante du Quebec (FRSQ) (JC, MS). FG is a recipient of a Junior 2 scholarship from the FRSQ and a researcher of the Canada Foundation for Innovation. ML and DF hold a Canada Research Chair in MRI and a Banque Nationale Chair in Brain Cancer, respectively. FG, ML and DF are members of the FRSQ-funded Centre de recherche clinique Etienne-Le Bel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DF, WN and FG from Universite de Sherbrooke hereby declare a duality of interest in view of their holding a patent made available to public in 2006 for the use of peptide kinin B1 receptor agonists in the treatment of brain cancer (Publication No. W0 2006/128293 A1). FG, DF and ML have received research funding from Tranzyme Pharma Inc. This company has no proprietary or financial interest in the outcome of the research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Afra D, 2002, LANCET, V359, P1011; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Belanger S, 2009, PEPTIDES, V30, P777, DOI 10.1016/j.peptides.2008.12.003; Bellavance MA, 2008, AAPS J, V10, P166, DOI 10.1208/s12248-008-9018-7; Black Keith L, 2004, Cancer Control, V11, P165; BLACK KL, 1992, J NEUROSURG, V77, P120, DOI 10.3171/jns.1992.77.1.0120; Borlongan CV, 2003, BRAIN RES BULL, V60, P297, DOI 10.1016/S0361-9230(03)00043-1; Bovenzi V, 2010, J CELL PHYSIOL, V222, P168, DOI 10.1002/jcp.21933; Cardoso RC, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-38; Chee J, 2008, BIOL CHEM, V389, P1225, DOI 10.1515/BC.2008.139; Chee J, 2007, BIOL CHEM, V388, P1235, DOI 10.1515/BC.2007.139; Cote J, 2010, NEUROPEPTIDES, V44, P177, DOI 10.1016/j.npep.2009.12.009; Cote J, 2009, PEPTIDES, V30, P788, DOI 10.1016/j.peptides.2008.12.018; CRUWYS SC, 1994, BRIT J PHARMACOL, V113, P940, DOI 10.1111/j.1476-5381.1994.tb17083.x; Dean R L, 1999, Neuro Oncol, V1, P268, DOI 10.1093/neuonc/1.4.268; Emerich DF, 2001, CLIN PHARMACOKINET, V40, P105, DOI 10.2165/00003088-200140020-00003; Emerich DF, 1999, BRIT J CANCER, V80, P964, DOI 10.1038/sj.bjc.6690450; Emerich DF, 2000, PHARMACEUT RES, V17, P1212, DOI 10.1023/A:1026462629438; Erdlenbruch B, 2003, BRIT J PHARMACOL, V140, P1201, DOI 10.1038/sj.bjp.0705554; Fortier A, 2006, MED SCI S2, V22, P24; Gilbert MR, 2010, NEURO-ONCOLOGY, V12, P1167, DOI 10.1093/neuonc/noq100; Gobeil F, 1999, HYPERTENSION, V33, P823, DOI 10.1161/01.HYP.33.3.823; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Hayashi I, 2002, LIFE SCI, V70, P937, DOI 10.1016/S0024-3205(01)01460-6; Hoffman S, 2006, NEURO-ONCOLOGY, V8, P27, DOI 10.1215/S1522851705000323; Jahnke K, 2009, NEURO-ONCOLOGY, V11, P142, DOI 10.1215/15228517-2008-077; Jean WC, 1997, NEUROSURGERY, V41, P726; Juillerat-Jeanneret L, 2008, DRUG DISCOV TODAY, V13, P1099, DOI 10.1016/j.drudis.2008.09.005; Ksendzovsky A, 2010, OPEN IMMUNOLOGY J, V3, P30; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Liu YH, 2001, NEUROL RES, V23, P379, DOI 10.1179/016164101101198596; Lu DY, 2010, J CELL BIOCHEM, V110, P141, DOI 10.1002/jcb.22520; Maeda H, 1996, IMMUNOPHARMACOLOGY, V33, P222, DOI 10.1016/0162-3109(96)00063-X; MAO Y, 1991, CAN MED ASSOC J, V145, P1583; Marceau F, 1998, PHARMACOL REV, V50, P357; Maroldi R, 2005, EUR RADIOL, V15, P617, DOI 10.1007/s00330-004-2617-5; Mathieu D, 2006, CAN J NEUROL SCI, V33, P127, DOI 10.1017/S0317167100004881; Mathieu D, 2007, CAN J NEUROL SCI, V34, P296, DOI 10.1017/S0317167100006715; Mathieu D, 2007, CURR CLIN PHARMACOL, V2, P197, DOI 10.2174/157488407781668767; McLean PG, 2000, CARDIOVASC RES, V48, P194, DOI 10.1016/S0008-6363(00)00184-X; Misra A, 2000, J NEURO-ONCOL, V48, P1, DOI 10.1023/A:1006435201961; Montana V, 2011, J NEUROSCI, V31, P4858, DOI 10.1523/JNEUROSCI.3825-10.2011; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Nakano S, 1997, NEUROL RES, V19, P501, DOI 10.1080/01616412.1997.11740848; Nakano S, 1996, CANCER RES, V56, P4027; Neugebauer W, 2002, CAN J PHYSIOL PHARM, V80, P287, DOI 10.1139/Y02-053; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Nieder C, 2009, CLIN ONCOL-UK, V21, P515, DOI 10.1016/j.clon.2009.05.003; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1942, DOI 10.1152/ajpheart.00948.2002; OHNISHI T, 1990, J NEUROSURG, V72, P245, DOI 10.3171/jns.1990.72.2.0245; Pardridge WM, 2002, DRUG DISCOV TODAY, V7, P5, DOI 10.1016/S1359-6446(01)02082-7; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Raidoo DM, 1999, IMMUNOPHARMACOLOGY, V43, P255, DOI 10.1016/S0162-3109(99)00097-1; Rainov Nikolai G, 2006, Neurosurg Focus, V20, pE9; Re RN, 2011, J AM SOC HYPERTENS, V5, P435, DOI 10.1016/j.jash.2011.07.001; Recinos VR, 2010, NEUROSURGERY, V66, P530, DOI 10.1227/01.NEU.0000365263.14725.39; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Ross BD, 1998, P NATL ACAD SCI USA, V95, P7012, DOI 10.1073/pnas.95.12.7012; Sarin H, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-33; Sarker MH, 2000, J PHYSIOL-LONDON, V528, P177, DOI 10.1111/j.1469-7793.2000.00177.x; Sasaki A, 1998, J NEUROPATH EXP NEUR, V57, P653, DOI 10.1097/00005072-199807000-00002; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Simard B, 2002, CAN J PHYSIOL PHARM, V80, P1203, DOI 10.1139/Y02-153; Tanaka S, 2003, J DRUG TARGET, V11, P45, DOI 10.1080/1061186031000086072; Uchida M, 2002, NEUROL RES, V24, P739, DOI 10.1179/016164102101200753; Vianna RMJ, 1998, BRIT J PHARMACOL, V123, P281, DOI 10.1038/sj.bjp.0701590; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; Walsh DA, 1997, KININ SYSTEM, P301; WILLIAMS TJ, 1979, BRIT J PHARMACOL, V65, P517, DOI 10.1111/j.1476-5381.1979.tb07860.x; WIRTH K, 1991, BRIT J PHARMACOL, V102, P774, DOI 10.1111/j.1476-5381.1991.tb12249.x; Yang WL, 2011, J NEURO-ONCOL, V101, P379, DOI 10.1007/s11060-010-0272-z; Yang WL, 2005, CLIN CANCER RES, V11, P341; Zuraw BL, 2006, IMMUNOL ALLERGY CLIN, V26, P691, DOI 10.1016/j.iac.2006.09.007	80	39	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37485	10.1371/journal.pone.0037485	http://dx.doi.org/10.1371/journal.pone.0037485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629405	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100035
J	Lee, LL; Lin, L; Bell, DS; Levine, S; Hanson, MR				Lee, Li Ling; Lin, Lin; Bell, David S.; Levine, Susan; Hanson, Maureen R.			Sensitivity of PCR Assays for Murine Gammaretroviruses and Mouse Contamination in Human Blood Samples	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; PROSTATE-CANCER; XMRV; RETROVIRUS; DNA; ENCEPHALOMYELITIS; SEQUENCES; TISSUE	Gammaretroviruses related to murine leukemia virus (MLV) have variously been reported to be present or absent in blood from chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients and healthy controls. Using subjects from New York State, we have investigated by PCR methods whether MLV-related sequences can be identified in nucleic acids isolated from whole blood or from peripheral blood mononuclear cells (PBMCs) or following PBMC culture. We have also passaged the prostate cancer cell line LNCaP following incubation with plasma from patients and controls and assayed nucleic acids for viral sequences. We have used 15 sets of primers that can effectively amplify conserved regions of murine endogenous and exogenous retrovirus sequences. We demonstrate that our PCR assays for MLV-related gag sequences and for mouse DNA contamination are extremely sensitive. While we have identified MLV-like gag sequences following PCR on human DNA preparations, we are unable to conclude that these sequences originated in the blood samples.	[Lee, Li Ling; Lin, Lin; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Bell, David S.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, LL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	mrh5@cornell.edu	Hanson, Maureen R/D-3879-2009	Hanson, Maureen R/0000-0001-8141-3058	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [1R21AI090553]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090553] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) grant 1R21AI090553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacich Dean J, 2011, BMC Res Notes, V4, P457, DOI 10.1186/1756-0500-4-457; BELL KM, 1991, REV INFECT DIS, V13, pS32; Capelli E, 2010, INT J IMMUNOPATH PH, V23, P981, DOI 10.1177/039463201002300402; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Elfaitouri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024602; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Hooper M, 2007, J CLIN PATHOL, V60, P466, DOI 10.1136/jcp.2006.042408; Jason Leonard A, 2009, Bull IACFS ME, V17, P88; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Johnson Hilary., 1996, OSLERS WEB INSIDE LA; Kearney MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030889; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Lee K, 2010, 1 INT WORKSH XMRV BE; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wyller VB, 2007, ACTA NEUROL SCAND, V115, P7, DOI 10.1111/j.1600-0404.2007.00840.x; Zhang YA, 2011, CANCER BIOL THER, V12, P617, DOI 10.4161/cbt.12.7.15955; Zheng HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029050	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37482	10.1371/journal.pone.0037482	http://dx.doi.org/10.1371/journal.pone.0037482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629404	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100034
J	Pollari, S; Leivonen, SK; Perala, M; Fey, V; Kakonen, SM; Kallioniemi, O				Pollari, Sirkku; Leivonen, Suvi-Katri; Perala, Merja; Fey, Vidal; Kakonen, Sanna-Maria; Kallioniemi, Olli			Identification of MicroRNAs Inhibiting TGF-beta-Induced IL-11 Production in Bone Metastatic Breast Cancer Cells	PLOS ONE			English	Article							TARGET PREDICTION; GENE-EXPRESSION; LET-7; SITES; INTERLEUKIN-11; PROLIFERATION; RECOGNITION; ACTIVATION; MICROARRAY; CARCINOMA	Development of bone metastases is dependent on the cancer cell-bone cell interactions in the bone microenvironment. Transforming growth factor beta (TGF-beta) is released from bone during osteoclastic bone resorption and induces production of osteolytic factors, such as interleukin 11 (IL-11), in breast cancer cells. IL-11 in turn increases osteolysis by stimulating osteoclast function, launching a vicious cycle of cancer growth and bone destruction. We aimed to identify and functionally characterize microRNAs (miRNAs) that mediate the bone metastatic process, focusing on miRNAs that regulate the TGF-beta induction of IL-11. First, we profiled the expression of 455 miRNAs in a highly bone metastatic MDA-MB-231(SA) variant as compared to the parental MDA-MB-231 breast cancer cell line and found 16 miRNAs (3.5%) having a >3-fold expression difference between the two cell types. We then applied a cell-based overexpression screen with Pre-miRNA constructs to functionally identify miRNAs regulating TGF-beta-induced IL-11 production. This analysis pinpointed miR-204, miR-211, and miR-379 as such key regulators. These miRNAs were shown to directly target IL11 by binding to its 3' UTR. MiR-379 also inhibited Smad2/3/4-mediated transcriptional activity. Gene expression analysis of miR-204 and miR-379-transfected cells indicated that these miRNAs downregulated the expression of several genes involved in TGF-beta signaling, including prostaglandin-endoperoxide synthase 2 (PTGS2). In addition, there was a significant correlation between the genes downregulated by miR-379 and a set of genes upregulated in basal subtype of breast cancer. Taken together, the functional evidence and clinical correlations imply novel mechanistic links between miRNAs and the key steps in the bone metastatic process in breast cancer, with potential clinical relevance.	[Pollari, Sirkku; Leivonen, Suvi-Katri; Perala, Merja; Fey, Vidal; Kallioniemi, Olli] Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland; [Pollari, Sirkku; Leivonen, Suvi-Katri; Perala, Merja; Fey, Vidal; Kallioniemi, Olli] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kakonen, Sanna-Maria] Univ Turku, Inst Biomed, Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Turku; University of Helsinki	Pollari, S (corresponding author), Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland.	sielpo@utu.fi	Kallioniemi, Olli P/H-5111-2011; Leivonen, Suvi-Katri/AAK-3096-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Fey, Vidal/0000-0003-1388-5904; Kakonen, Sanna-Maria/0000-0001-9393-6235; Leivonen, Suvi-Katri/0000-0003-3224-0757	Academy of Finland Centre of Excellence grant (Centre of Excellence in Translational Genome-Scale Biology) [20062011]; Academy of Finland post-doctoral grant; Verein zur Forderung der Krebsforschung (TIME project); Drug Discovery Graduate School; Sigrid Juselius Foundation; Finnish Cultural Foundation; Cancer Society of Southwestern Finland	Academy of Finland Centre of Excellence grant (Centre of Excellence in Translational Genome-Scale Biology); Academy of Finland post-doctoral grant; Verein zur Forderung der Krebsforschung (TIME project); Drug Discovery Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Cancer Society of Southwestern Finland	This work was supported by the Academy of Finland Centre of Excellence grant (Centre of Excellence in Translational Genome-Scale Biology 2006-2011) http://tgsb.vtt.fi/, Academy of Finland post-doctoral grant to SKL, Verein zur Forderung der Krebsforschung (TIME project), Drug Discovery Graduate School http://ddgs.utu.fi/, and by grants from the Finnish Cancer Organisations http://www.cancer.fi/, Sigrid Juselius Foundation http://www.sigridjuselius.fi/, Finnish Cultural Foundation http://www.skr.fi/, and Cancer Society of Southwestern Finland http://lssy.fi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Blagosklonny MV, 2009, PLOS ONE, V4, pe6896, DOI [10.1371/journal.pone.0006896, DOI 10.1371/JOURNAL.PONE.0006896]; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edlund S, 2004, J CELL SCI, V117, P1835, DOI 10.1242/jcs.01036; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Findlay VJ, 2008, CANCER RES, V68, P8499, DOI 10.1158/0008-5472.CAN-08-0907; Fisher JL, 2000, BREAST CANCER RES TR, V61, P1, DOI 10.1023/A:1006445129195; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Franchimont N, 2000, BONE, V26, P249, DOI 10.1016/S8756-3282(99)00275-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIRASOLE G, 1994, J CLIN INVEST, V93, P1516, DOI 10.1172/JCI117130; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanavadi S, 2006, ANN SURG ONCOL, V13, P802, DOI 10.1245/ASO.2006.05.028; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Morgan H, 2004, INT J CANCER, V109, P653, DOI 10.1002/ijc.20056; Morgan H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-1; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Pollari S, 2012, MOL CANCER RES, V10, P597, DOI 10.1158/1541-7786.MCR-11-0482; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sotiriou C, 2001, CANCER LETT, V169, P87, DOI 10.1016/S0304-3835(01)00524-9; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang L, 2011, ONCOGENE, DOI [10.1038/onc.2011.444:10.1038/onc.2011.444, DOI 10.1038/ONC.2011.444:10.1038/ONC.2011.444]; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Woodward JKL, 2007, BONE, V41, P912, DOI 10.1016/j.bone.2007.07.024; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	55	63	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37361	10.1371/journal.pone.0037361	http://dx.doi.org/10.1371/journal.pone.0037361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629385	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100024
J	Tian, H; Wang, J; Zhang, BF; Di, JH; Chen, FF; Li, HZ; Li, LT; Pei, DS; Zheng, JN				Tian, Hui; Wang, Jing; Zhang, BaoFu; Di, JieHui; Chen, FeiFei; Li, HuiZhong; Li, LianTao; Pei, DongSheng; Zheng, JunNian			MDA-7/IL-24 Induces Bcl-2 Denitrosylation and Ubiquitin-Degradation Involved in Cancer Cell Apoptosis	PLOS ONE			English	Article							DIFFERENTIATION-ASSOCIATED GENE-7; PROTEIN S-NITROSYLATION; NITRIC-OXIDE SYNTHASE; MELANOMA DIFFERENTIATION; PANCREATIC-CANCER; FAMILY; GROWTH; MDA-7; INACTIVATION; INHIBITION	MDA-7/IL-24 was involved in the specific cancer apoptosis through suppression of Bcl-2 expression, which is a key apoptosis regulatory protein of the mitochondrial death pathway. However, the underlying mechanisms of this regulation are unclear. We report here that tumor-selective replicating adenovirus ZD55-IL-24 leads to Bcl-2 S-denitrosylation and concomitant ubiquitination, which take part in the 26S proteasome degradation. IL-24-siRNA completely blocks Bcl-2 ubiquitination via reversion of Bcl-2 S-denitrosylation and protects it from proteasomal degradation which confirmed the significant role of MDA-7/IL-24 in regulating posttranslational modification of Bcl-2 in cancer cells. Nitric oxide (NO) is a key regulator of protein S-nitrosylation and denitrosylation. The NO donor, sodium nitroprusside (SNP), down-regulates Bcl-2 S-denitrosylation, attenuates Bcl-2 ubiquitination and subsequently counteracts MDA-7/IL-24 induced cancer cell apoptosis, whereas NO inhibitor 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxy-3-oxide (PTIO) shows the opposite effect. At the same time, these NO modulators fail to affect Bcl-2 phosphorylation, suggesting that NO regulates Bcl-2 stability in a phosphorylation-independent manner. In addition, Bcl-2 S-nitrosylation reduction induced by ZD55-IL-24 was attributed to both iNOS decrease and TrxR1 increase. iNOS-siRNA facilitates Bcl-2 S-denitrosylation and ubiquitin-degradation, whereas the TrxR1 inhibitor auranofin prevents Bcl-2 from denitrosylation and ubiquitination, thus restrains the caspase signal pathway activation and subsequent cancer cell apoptosis. Taken together, our studies reveal that MDA-7/IL-24 induces Bcl-2 S-denitrosylation via regulation of iNOS and TrxR1. Moreover, denitrosylation of Bcl-2 results in its ubiquitination and subsequent caspase protease family activation, as a consequence, apoptosis susceptibility. These findings provide a novel insight into MDA-7/IL-24 induced growth inhibition and carcinoma apoptosis.	[Tian, Hui; Wang, Jing; Zhang, BaoFu; Di, JieHui; Chen, FeiFei; Li, HuiZhong; Li, LianTao; Pei, DongSheng; Zheng, JunNian] Xuzhou Med Coll, Lab Biol Canc Therapy, Xuzhou, Peoples R China	Xuzhou Medical University	Tian, H (corresponding author), Xuzhou Med Coll, Lab Biol Canc Therapy, Xuzhou, Peoples R China.	jnzheng@xzmc.edu.cn		li, liantao/0000-0002-8788-2880	National Natural Science Foundation of China [81071854]; Science and Technology Department of Jiangsu Province [BK2010177, BK2010179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jiangsu Province	This project was supported by the National Natural Science Foundation of China (Nos. 81071854) and the Science and Technology Department of Jiangsu Province (BK2010177, BK2010179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Azad N, 2010, AM J RESP CELL MOL, V42, P578, DOI 10.1165/rcmb.2009-0094OC; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Ekmekcioglu S, 2003, MOL CANCER THER, V2, P9; Ekmekcioglu S, 2000, CLIN CANCER RES, V6, P4768; Ekmekcioglu S, 2008, CYTOKINE, V43, P34, DOI 10.1016/j.cyto.2008.04.010; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Fisher PB, 2005, CANCER RES, V65, P10128, DOI 10.1158/0008-5472.CAN-05-3127; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann J, 2001, J BIOL CHEM, V276, P41383, DOI 10.1074/jbc.M107566200; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kutuk O, 2008, CURR MOL MED, V8, P102; Lebedeva IV, 2006, CANCER RES, V66, P2403, DOI 10.1158/0008-5472.CAN-05-3510; Lebedeva IV, 2003, CANCER RES, V63, P8138; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Liu XY, 2006, CELL RES, V16, P25, DOI 10.1038/sj.cr.7310005; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Oxford SME, 2004, CURR MED CHEM, V11, P1031, DOI 10.2174/0929867043455486; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Su ZZ, 2001, P NATL ACAD SCI USA, V98, P10332, DOI 10.1073/pnas.171315198; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Yacoub A, 2003, CANCER BIOL THER, V2, P347, DOI 10.4161/cbt.2.4.422; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	38	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37200	10.1371/journal.pone.0037200	http://dx.doi.org/10.1371/journal.pone.0037200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629368	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100017
J	Mendlova, M; Desdevises, Y; Civanova, K; Pariselle, A; Simkova, A				Mendlova, Monika; Desdevises, Yves; Civanova, Kristina; Pariselle, Antoine; Simkova, Andrea			Monogeneans of West African Cichlid Fish: Evolution and Cophylogenetic Interactions	PLOS ONE			English	Article							CYTOCHROME-B GENE; ANCYROCEPHALIDAE GILL PARASITES; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; NUCLEOTIDE SUBSTITUTION; GYRODACTYLUS MONOGENEA; EXPLOSIVE SPECIATION; ENTEROGYRUS-PAPERNA; SYSTEMATIC REVISION; ADAPTIVE RADIATION	The goals of this paper were to investigate phylogenetic and evolutionary patterns of cichlid fish from West Africa and their Cichlidogyrus and Scutogyrus monogenean parasites, to uncover the presence of host-parasite cospeciation and to assess the level of morphological adaptation in parasites. This required the following steps, each one representing specific objectives of this paper: (1) to build phylogenetic trees for Cichlidogyrus and Scutogyrus species based on ribosomal DNA sequences, (2) to investigate phylogenetic relationships within West African cichlid fish based on the analysis of mitochondrial cytochrome b DNA sequences, (3) to investigate host-parasite cophylogenetic history to gain clues on parasite speciation process, and (4) to investigate the link between the morphology of the attachment apparatus and parasite phylogeny. Phylogenetic analyses supported the monophyletic origin of the Cichlidogyrus/Scutogyrus group, and suggested that Cichlidogyrus is polyphyletic and that Scutogyrus is monophyletic. The phylogeny of Cichlidae supported the separation of mouthbrooders and substrate-brooders and is consistent with the hypothesis that the mouthbrooding behavior of Oreochromis and Sarotherodon evolved from substrate-brooding behavior. The mapping of morphological characters of the haptor onto the parasite phylogenetic tree suggests that the attachment organ has evolved from a very simple form to a more complex one. The cophylogenetic analyses indicated a significant fit between trees using distance-based tests, but no significant cospeciation signal using tree-based tests, suggesting the presence of parasite duplications and host switches on related host species. This shed some light on the diversification process of Cichlidogyrus species parasitizing West African cichlids.	[Mendlova, Monika; Civanova, Kristina; Simkova, Andrea] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Desdevises, Yves] Univ Paris 06, UPMC, UMR 7232, Observ Oceanol,BIOM, Banyuls Sur Mer, France; [Desdevises, Yves] CNRS, UMR 7232, BIOM, Observ Oceanol, Banyuls Sur Mer, France; [Pariselle, Antoine] Univ Montpellier 2 CC065, Inst Sci Evolut, IRD CNRS UM2, Montpellier, France	Masaryk University Brno; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Mendlova, M (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	simkova@sci.muni.cz	Desdevises, Yves/AAH-2097-2019; Desdevises, Yves/H-5334-2019; Pariselle, Antoine/L-5776-2016; Simkova, Andrea/F-7636-2019; Desdevises, Yves/D-5528-2011; Civanova, Kristina/G-1182-2014	Desdevises, Yves/0000-0001-9774-0336; Pariselle, Antoine/0000-0002-1591-7423; Simkova, Andrea/0000-0002-5995-6766; Desdevises, Yves/0000-0001-9774-0336; Civanova, Kristina/0000-0001-5690-3637	Masaryk University, Brno, Czech Republic; Czech Science Foundation [P505/12/G112]	Masaryk University, Brno, Czech Republic(Czech Republic Government); Czech Science Foundation(Grant Agency of the Czech Republic)	The field studies in Africa and molecular analyses were funded by the research project of Masaryk University, Brno, Czech Republic. This study was supported by Czech Science Foundation No. P505/12/G112 (ECIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentz S, 2001, INT J PARASITOL, V31, P697, DOI 10.1016/S0020-7519(01)00179-5; Bilong Bilong Charles Felix, 1995, Journal of African Zoology, V109, P253; BILONG-BILONG C F, 1989, Revue de Zoologie Africaine, V103, P99; BilongBilong CF, 1996, SYST PARASITOL, V34, P37, DOI 10.1007/BF01531208; Boeger WA, 1997, INT J PARASITOL, V27, P1495, DOI 10.1016/S0020-7519(97)00140-9; BROOKS DR, 1979, SYST ZOOL, V28, P299, DOI 10.2307/2412584; Brooks DR, 1993, PARASCRIPT PARASITES; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Desdevises Y, 2002, EVOLUTION, V56, P2459, DOI 10.1111/j.0014-3820.2002.tb00171.x; Desdevises Y, 2000, INT J PARASITOL, V30, P741, DOI 10.1016/S0020-7519(00)00051-5; DOSSOU C, 1984, ANN SCI NAT ZOOL, V6, P101; DOSSOU C, 1982, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V44, P295; DOUELLOU L, 1993, SYST PARASITOL, V25, P159, DOI 10.1007/BF00007007; ERGENS R, 1981, FOLIA PARASIT, V28, P205; Ergens R., 1970, AGENTS FISH DIS; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; Huyse T, 2003, INT J PARASITOL, V33, P1679, DOI 10.1016/S0020-7519(03)00253-4; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Light JE, 2008, SYST BIOL, V57, P449, DOI 10.1080/10635150802169610; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; MALMBERG G., 1957, Skrifter utgivna av Sodra Sveriges Fiskeriforening, P19; Martin AP, 1998, MOL PHYLOGENET EVOL, V9, P192, DOI 10.1006/mpev.1997.0461; Mayer WE, 1998, HEREDITY, V80, P702, DOI 10.1046/j.1365-2540.1998.00347.x; Meier-Kolthoff JP, 2007, BIOINFORMATICS, V23, P898, DOI 10.1093/bioinformatics/btm027; Mendlova M, 2010, PARASITOL RES, V107, P1405, DOI 10.1007/s00436-010-2008-6; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Musilova Z, 2008, MOL PHYLOGENET EVOL, V46, P659, DOI 10.1016/j.ympev.2007.10.011; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; NOBLE ER, 1989, PARASITOLOGY BIOL AN; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Paperna I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA I, 1968, Bamidgeh, V20, P88; PAPERNA I, 1968, P HELM SOC WASH, V35, P200; Pariselle A, 1998, FOLIA PARASIT, V45, P275; PARISELLE A, 1994, SYST PARASITOL, V29, P229, DOI 10.1007/BF00009678; PARISELLE A, 1995, J HELMINTHOL SOC W, V62, P157; PARISELLE A, 1991, SYST PARASITOL, V20, P211, DOI 10.1007/BF00009785; Pariselle A, 2004, PARASITE, V11, P359, DOI 10.1051/parasite/2004114359; Pariselle A, 1997, SYST PARASITOL, V38, P221, DOI 10.1023/A:1005803202543; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; Pariselle A, 2003, FOLIA PARASIT, V50, P195, DOI 10.14411/fp.2003.035; PARISELLE A, 1995, SYST PARASITOL, V30, P187, DOI 10.1007/BF00010469; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Pariselle Antoine, 2003, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulin R, 2002, INT J PARASITOL, V32, P245, DOI 10.1016/S0020-7519(01)00329-0; ROHDE K, 1991, OIKOS, V60, P91, DOI 10.2307/3544997; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Simkova A, 2006, PARASITOLOGY, V133, P43, DOI 10.1017/S0031182006009942; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Simkova A, 2003, SYST PARASITOL, V54, P1, DOI 10.1023/A:1022133608662; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; STIASSNY MLJ, 1987, J NAT HIST, V21, P1311, DOI 10.1080/00222938700770811; Streelman JT, 1997, P ROY SOC B-BIOL SCI, V264, P1011, DOI 10.1098/rspb.1997.0140; Streelman JT, 1998, MOL BIOL EVOL, V15, P798, DOI 10.1093/oxfordjournals.molbev.a025985; Sturmbauer C, 1998, J FISH BIOL, V53, P18; SULTMANN H, 1995, MOL BIOL EVOL, V12, P1033; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Wu XY, 2007, MOL PHYLOGENET EVOL, V44, P530, DOI 10.1016/j.ympev.2007.03.025; Yang JQ, 2006, HYDROBIOLOGIA, V553, P255, DOI 10.1007/s10750-005-1301-3; Zardoya R, 1996, P ROY SOC B-BIOL SCI, V263, P1589, DOI 10.1098/rspb.1996.0233; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	85	67	69	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37268	10.1371/journal.pone.0037268	http://dx.doi.org/10.1371/journal.pone.0037268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22662139	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500087
J	Lorca-Oro, C; Pujols, J; Garcia-Bocanegra, I; Mentaberre, G; Granados, JE; Solanes, D; Fandos, P; Galindo, I; Domingo, M; Lavin, S; Lopez-Olvera, JR				Lorca-Oro, Cristina; Pujols, Joan; Garcia-Bocanegra, Ignacio; Mentaberre, Gregorio; Enrique Granados, Jose; Solanes, David; Fandos, Paulino; Galindo, Ivan; Domingo, Mariano; Lavin, Santiago; Ramon Lopez-Olvera, Jorge			Protection of Spanish Ibex (Capra pyrenaica) against Bluetongue Virus Serotypes 1 and 8 in a Subclinical Experimental Infection	PLOS ONE			English	Article							WILD RUMINANTS; MEDITERRANEAN BASIN; EPIDEMIOLOGY; DISEASE; EUROPE; IDENTIFICATION; SURVEILLANCE; ORBIVIRUS; EFFICACY	Many wild ruminants such as Spanish ibex (Capra pyrenaica) are susceptible to Bluetongue virus (BTV) infection, which causes disease mainly in domestic sheep and cattle. Outbreaks involving either BTV serotypes 1 (BTV-1) and 8 (BTV-8) are currently challenging Europe. Inclusion of wildlife vaccination among BTV control measures should be considered in certain species. In the present study, four out of fifteen seronegative Spanish ibexes were immunized with a single dose of inactivated vaccine against BTV-1, four against BTV-8 and seven ibexes were non vaccinated controls. Seven ibexes (four vaccinated and three controls) were inoculated with each BTV serotype. Antibody and IFN-gamma responses were evaluated until 28 days after inoculation (dpi). The vaccinated ibexes showed significant (P<0.05) neutralizing antibody levels after vaccination compared to non vaccinated ibexes. The non vaccinated ibexes remained seronegative until challenge and showed neutralizing antibodies from 7 dpi. BTV RNA was detected in the blood of non vaccinated ibexes from 2 to the end of the study (28 dpi) and in target tissue samples obtained at necropsy (8 and 28 dpi). BTV-1 was successfully isolated on cell culture from blood and target tissues of non vaccinated ibexes. Clinical signs were unapparent and no gross lesions were found at necropsy. Our results show for the first time that Spanish ibex is susceptible and asymptomatic to BTV infection and also that a single dose of vaccine prevents viraemia against BTV-1 and BTV-8 replication.	[Lorca-Oro, Cristina; Pujols, Joan; Solanes, David; Galindo, Ivan; Domingo, Mariano] UAB IRTA, CReSA, Barcelona, Spain; [Pujols, Joan] IRTA, Barcelona, Spain; [Garcia-Bocanegra, Ignacio] UCO, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Mentaberre, Gregorio; Lavin, Santiago; Ramon Lopez-Olvera, Jorge] UAB, Dept Med & Cirurgia Anim, Servei Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain; [Enrique Granados, Jose] Agencia Medio Ambiente & Agua, Granada, Spain; [Fandos, Paulino] Agencia Medio Ambiente & Agua, Seville, Spain; [Galindo, Ivan; Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; IRTA; Universidad de Cordoba; Autonomous University of Barcelona; Autonomous University of Barcelona	Lorca-Oro, C (corresponding author), UAB IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	cristina.lorca@cresa.uab.cat	Pujols, Joan/K-9693-2015; Lavín, Santiago/L-5975-2014; Mentaberre, Gregorio/AAB-5912-2020; Domingo, Mariano/A-1015-2009; Pujols, Joan/S-1141-2018; Torres, José Enrique Granados/AAS-5629-2020; Olvera, Jorge R López/H-8382-2015; Fandos, Paulino/M-7304-2015; Pujols, Joan/AAV-6427-2020; Mentaberre, Gregorio A/H-4629-2015; Lorca-Oró, Cristina/ABE-7268-2021; Bocanegra, Ignacio Garcia/G-1443-2016	Pujols, Joan/0000-0002-6940-1529; Lavín, Santiago/0000-0001-5655-588X; Mentaberre, Gregorio/0000-0001-9542-7514; Domingo, Mariano/0000-0002-9623-4826; Torres, José Enrique Granados/0000-0002-9787-9896; Olvera, Jorge R López/0000-0002-2999-3451; Fandos, Paulino/0000-0002-9607-8931; Pujols, Joan/0000-0002-6940-1529; Mentaberre, Gregorio A/0000-0001-9542-7514; Lorca-Oró, Cristina/0000-0001-5351-4169; Bocanegra, Ignacio Garcia/0000-0003-3388-2604	Instituto Nacional de Investigacion y Tecnologia Agroalimentaria (INIA) [FAU2008-00019-C03-01]	Instituto Nacional de Investigacion y Tecnologia Agroalimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA))	This work was supported by the project FAU2008-00019-C03-01, from the Instituto Nacional de Investigacion y Tecnologia Agroalimentaria (INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2007, DIVERS DISTRIB, V13, P587, DOI 10.1111/j.1472-4642.2007.00374.x; Aguero M, 2002, VET MICROBIOL, V86, P337, DOI 10.1016/S0378-1135(02)00011-1; Backx A, 2007, VET REC, V161, P591, DOI 10.1136/vr.161.17.591; BARRATTBOYES SM, 1992, J GEN VIROL, V73, P1953, DOI 10.1099/0022-1317-73-8-1953; Barzilai E., 1972, Refuah Veterinarith, V29, P45; Bender LC, 2003, J WILDLIFE DIS, V39, P772, DOI 10.7589/0090-3558-39.4.772; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Chaignat V, 2009, VET MICROBIOL, V138, P11, DOI 10.1016/j.vetmic.2009.02.003; Clavijo A, 2000, J VIROL METHODS, V87, P13, DOI 10.1016/S0166-0934(00)00150-6; ELLIS JA, 1993, AM J VET RES, V54, P1452; Enserink M, 2008, SCIENCE, V319, P710, DOI 10.1126/science.319.5864.710; Eschbaumer M, 2011, VET REC, V168, DOI 10.1136/vr.d1184; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fandos P., 1992, GLOBAL TRENDS WILDLI, P139; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Garcia-Bocanegra I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-88; Gerdes GH, 2004, VETER ITAL SER, V40, P39; Gonzalez-Candela M, 2006, J WILDLIFE DIS, V42, P325, DOI 10.7589/0090-3558-42.2.325; Granados J.E., 2001, Galemys, V13, P3; Hateley G, 2009, IN PRACTICE, V31, P202; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Howerth E. W., 2001, INFECT DIS WILD MAMM; Hund A, 2012, VET MICROBIOL, V154, P247, DOI 10.1016/j.vetmic.2011.07.019; KATZ JB, 1993, J CLIN MICROBIOL, V31, P3028, DOI 10.1128/JCM.31.11.3028-3030.1993; Leon-Vizcaino L, 1999, J WILDLIFE DIS, V35, P647, DOI 10.7589/0090-3558-35.4.647; Lorca-Oro C, 2012, VET MICROBIOL, V154, P240, DOI 10.1016/j.vetmic.2011.07.008; Lorca-Oro C, 2011, VET MICROBIOL, V149, P230, DOI 10.1016/j.vetmic.2010.10.023; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens P P C, 2004, Vet Ital, V40, P426; MURRAY J O, 1970, Journal of Wildlife Diseases, V6, P144; Perez JM, 2002, MAMMAL REV, V32, P26, DOI 10.1046/j.1365-2907.2002.00097.x; Perez JM, 2001, DISTRIBUCION GENETIC; Puentes E, 2008, EP 2008 BLUET SAT S; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Lopez-Olvera JR, 2010, VET MICROBIOL, V145, P148, DOI 10.1016/j.vetmic.2010.03.012; ROBINSON RM, 1967, J WILDLIFE MANAGE, V31, P165, DOI 10.2307/3798372; Rodriguez-Sanchez B, 2008, TRANSBOUND EMERG DIS, V55, P205, DOI 10.1111/j.1865-1682.2008.01029.x; Rodriguez-Sanchez B, 2008, VET MICROBIOL, V141, P164; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Sanchez-Cordon PJ, 2010, J COMP PATHOL, V143, P20, DOI 10.1016/j.jcpa.2009.12.017; Stallknecht DE, 2004, VETER ITAL SER, V40, P203; Tessaro SV, 2001, J WILDLIFE DIS, V37, P722, DOI 10.7589/0090-3558-37.4.722; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; VOSDING RA, 1968, CAN J COMPARAT MED, V32, P382; WHETTER LE, 1989, J GEN VIROL, V70, P1663, DOI 10.1099/0022-1317-70-7-1663; World Organization for Animal Health (OIE), 2009, BLUET EP HAEM DIS	52	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e36380	10.1371/journal.pone.0036380	http://dx.doi.org/10.1371/journal.pone.0036380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666321	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400008
J	Gao, YL; Reitz, SR; Wei, QB; Yu, WY; Lei, ZR				Gao, Yulin; Reitz, Stuart R.; Wei, Qingbo; Yu, Wenyan; Lei, Zhongren			Insecticide-Mediated Apparent Displacement between Two Invasive Species of Leafminer Fly	PLOS ONE			English	Article							LIRIOMYZA-SATIVAE DIPTERA; SPIREA APHID HOMOPTERA; BEMISIA-TABACI; APPLE APHID; COMPETITIVE DISPLACEMENT; PEST-MANAGEMENT; L-BRYONIAE; L-TRIFOLII; BIOTYPE-B; AGROMYZIDAE	Background: Closely related invasive species may often displace one another, but it is often difficult to determine mechanisms because of the historical nature of these events. The leafmining flies Liriomyza sativae and Liriomyza trifolii have become serious invasive agricultural pests throughout the world. Where both species have invaded the same region, one predominates over the other. Although L. sativae invaded Hainan Island of China first, it recently has been displaced by the newly invasive L. trifolii. We hypothesized that differential susceptibilities to insecticides could be causing this demographic shift. Methodology/Principal Findings: Avermectin and cyromazine are the most commonly used insecticides to manage leafminers, with laboratory bioassays demonstrating that L. trifolii is significantly less susceptible to these key insecticides than is L. sativae. In trials where similar numbers of larvae of both species infested plants, which subsequently were treated with the insecticides, the eclosing adults were predominately L. trifolii, yet similar numbers of adults of both species eclosed from control plants. The species composition was then surveyed in two regions where L. trifolii has just begun to invade and both species are still common. In field trials, both species occurred in similar proportions before insecticide treatments began. Following applications of avermectin and cyromazine, almost all eclosing adults were L. trifolii in those treatment plots. In control plots, similar numbers of adults of the two species eclosed, lending further credence to the hypothesis that differential insecticide susceptibilities could be driving the ongoing displacement of L. sativae by L. trifolii. Conclusions/Significance: Our results show that differential insecticide susceptibility can lead to rapid shifts in the demographics of pest complexes. Thus, successful pest management requires the identification of pest species to understand the outcome of insecticide applications. These results further demonstrate the importance of considering anthropogenic factors in the outcome of interspecific interactions.	[Gao, Yulin; Wei, Qingbo; Yu, Wenyan; Lei, Zhongren] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Reitz, Stuart R.] ARS, Ctr Med Agr & Vet Entomol, USDA, Tallahassee, FL USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Gao, YL (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zrlei@ippcaas.cn	Reitz, Stuart/AAC-4467-2019; Gao, Yu/HGE-1937-2022		National Key Basic Research Program (973 Projects) [2009CB119004]; China Agriculture Research System [CARS-25-B-07]	National Key Basic Research Program (973 Projects); China Agriculture Research System	This work was supported in part by the National Key Basic Research Program (973 Projects Grant 2009CB119004) and the China Agriculture Research System (CARS-25-B-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abe Y, 2001, APPL ENTOMOL ZOOL, V36, P277, DOI 10.1303/aez.2001.277; Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Bel Y, 2000, ARCH INSECT BIOCHEM, V45, P69, DOI 10.1002/1520-6327(200010)45:2&lt;69::AID-ARCH3&gt;3.0.CO;2-3; Brown MW, 1995, ENVIRON ENTOMOL, V24, P1581, DOI 10.1093/ee/24.6.1581; Chen XX, 2003, BIOCONTROL, V48, P515, DOI 10.1023/A:1025726813462; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Ferguson JS, 2004, J ECON ENTOMOL, V97, P112, DOI 10.1603/0022-0493-97.1.112; Gao YL, 2011, J ECON ENTOMOL, V104, P1771, DOI 10.1603/EC11206; HOGMIRE HW, 1992, J ENTOMOL SCI, V27, P113, DOI 10.18474/0749-8004-27.2.113; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; JOHNSON MW, 1983, J ECON ENTOMOL, V76, P1061, DOI 10.1093/jee/76.5.1061; LASOTA JA, 1991, ANNU REV ENTOMOL, V36, P91, DOI 10.1146/annurev.en.36.010191.000515; Lei ZR, 1997, ANN AGR SCI CHINA YO, P495; Lei ZR, 2005, BIOL MANAGEMENT INVA, P177; Lowery DT, 2006, J ECON ENTOMOL, V99, P1369, DOI 10.1603/0022-0493-99.4.1369; OATMAN E R, 1976, Journal of Economic Entomology, V69, P667, DOI 10.1093/jee/69.5.667; PALUMBO JC, 1994, J ECON ENTOMOL, V87, P1070, DOI 10.1093/jee/87.4.1070; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; Pascual S, 2004, B ENTOMOL RES, V94, P369, DOI 10.1079/BER2003307; Reitz SR, 1999, AGR ECOSYST ENVIRON, V73, P185, DOI 10.1016/S0167-8809(99)00016-X; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; SAS Institute, 2010, SAS STAT US GUID VER; Tokumaru S, 2005, JPN J APPL ENTOMOL Z, V49, P1, DOI 10.1303/jjaez.2005.1; TRUMBLE JT, 1985, AGR ECOSYST ENVIRON, V12, P181, DOI 10.1016/0167-8809(85)90109-4; TRUMBLE JT, 1983, ENVIRON ENTOMOL, V12, P810, DOI 10.1093/ee/12.3.810; Weintraub PG, 2001, CROP PROT, V20, P207, DOI 10.1016/S0261-2194(00)00128-9	27	32	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36622	10.1371/journal.pone.0036622	http://dx.doi.org/10.1371/journal.pone.0036622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662122	Green Published, gold			2022-12-27	WOS:000305342300013
J	Linehan, C; Gupta, S; Samali, A; O'Connor, L				Linehan, Chris; Gupta, Sanjeev; Samali, Afshin; O'Connor, Lynn			Bisphenol A-Mediated Suppression of LPL Gene Expression Inhibits Triglyceride Accumulation during Adipogenic Differentiation of Human Adult Stem Cells	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; C/EBP-ALPHA; INSULIN; TRANSCRIPTION; ADIPOCYTES; SECRETION; OBESITY; CLONING	The endocrine disrupting chemical, bisphenol A (BPA), has been shown to accelerate the rate of adipogenesis and increase the amount of triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. The objective of this study was to investigate if that observation is mirrored in human primary cells. Here we investigated the effect of BPA on adipogenesis in cultured human primary adult stem cells. Continuous exposure to BPA throughout the 14 days of differentiation dramatically reduced triglyceride accumulation and suppressed gene transcription of the lipogenic enzyme, lipoprotein lipase (LPL). Results presented in the present study show for the first time that BPA can reduce triglyceride accumulation during adipogenesis by attenuating the expression of LPL gene transcription. Also, by employing image cytometric analysis rather than conventional Oil red O staining techniques we show that BPA regulates triglyceride accumulation in a manner which does not appear to effect adipogenesis per se.	[Linehan, Chris; Samali, Afshin] Natl Univ Ireland Galway, Dept Biochem, Fac Life Sci, Galway, Ireland; [Gupta, Sanjeev] Natl Univ Ireland Galway, Dept Pathol, Sch Med, Inst Clin Sci, Galway, Ireland; [O'Connor, Lynn] Natl Univ Ireland Galway, Dept Pharmacol, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Linehan, C (corresponding author), Natl Univ Ireland Galway, Dept Biochem, Fac Life Sci, Galway, Ireland.	c.linehan1@gmail.com; Lynn.oconnor@nuigalway.ie	Gupta, Sanjeev/AAG-9749-2020; Samali, Afshin/A-9571-2008; gupta, sanjeev/B-2824-2008	Gupta, Sanjeev/0000-0002-4691-6853; Samali, Afshin/0000-0002-8610-8375; gupta, sanjeev/0000-0002-4691-6853	National University of Ireland Galway	National University of Ireland Galway	This work was supported by a Ph.D. fellowship from National University of Ireland Galway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; AUWERX J, 1992, CRIT REV CL LAB SCI, V29, P243, DOI 10.3109/10408369209114602; Brede C, 2003, FOOD ADDIT CONTAM, V20, P684, DOI [10.1080/0265203031000119061, 10.1080/02652030210134236]; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; De Ferranti Sarah D, 2007, Diab Vasc Dis Res, V4, P285, DOI 10.3132/dvdr.2007.055; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Gonzales AM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-22; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; GUPTA S, 2010, INT J CELL BIOL; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hung SC, 2004, GENE, V340, P141, DOI 10.1016/j.gene.2004.06.028; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Lane MD, 2005, BIRTH DEFECTS RES A, V73, P476, DOI 10.1002/bdra.20150; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lazar MA, 2002, GENE DEV, V16, P1, DOI 10.1101/gad.964002; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Masuno H, 2002, J LIPID RES, V43, P676; Masuno H, 2005, TOXICOL SCI, V84, P319, DOI 10.1093/toxsci/kfi088; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Newbold RR, 2007, REPROD TOXICOL, V23, P290, DOI 10.1016/j.reprotox.2006.12.010; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Olofsson LE, 2008, J CLIN ENDOCR METAB, V93, P4880, DOI 10.1210/jc.2008-0574; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Song W, 2011, LANGMUIR, V27, P6155, DOI 10.1021/la200487w; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wei E, 2005, BIOCHEM J, V388, P959, DOI 10.1042/BJ20041442; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36109	10.1371/journal.pone.0036109	http://dx.doi.org/10.1371/journal.pone.0036109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662114	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300008
J	Pilarski, R; Patel, DA; Weitzel, J; McVeigh, T; Dorairaj, JJ; Heneghan, HM; Miller, N; Weidhaas, JB; Kerin, MJ; McKenna, M; Wu, XF; Hildebrandt, M; Zelterman, D; Sand, S; Shulman, LP				Pilarski, Robert; Patel, Divya A.; Weitzel, Jeffrey; McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola; Weidhaas, Joanne B.; Kerin, Michael J.; McKenna, Megan; Wu, Xifeng; Hildebrandt, Michelle; Zelterman, Daniel; Sand, Sharon; Shulman, Lee P.			The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer	PLOS ONE			English	Article							FAMILY-HISTORY; BRCA2; MUTATIONS; CHEK2; SITE	Purpose: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), and with the risk of premenopausal triple negative breast cancer, we evaluated the association of the KRAS-variant with women with personal histories of both breast and ovarian cancer, referred to as double primary patients. Experimental Design: Germline DNA from double primary patients was tested for the KRAS-variant (n = 232). Confirmation of pathologic diagnoses, age of diagnoses, interval between ovarian cancer diagnosis and sample collection, additional cancer diagnoses, and family history were obtained when available. All patients were tested for deleterious BRCA mutations. Results: The KRAS-variant was significantly enriched in uninformative (BRCA negative) double primary patients, being found in 39% of patients accrued within two years of their ovarian cancer diagnosis. Furthermore, the KRAS-variant was found in 35% of uninformative double primary patients diagnosed with ovarian cancer post-menopausally, and was significantly associated with uninformative double primary patients with a positive family history. The KRAS-variant was also significantly enriched in uninformative patients who developed more then two primary cancers, being found in 48% of women with two breast primaries plus ovarian cancer or with triple primary cancers. Conclusions: These findings further validate the importance of the KRAS-variant in breast and ovarian cancer risk, and support the association of this variant as a genetic marker for HBOC families previously considered uninformative.	[Pilarski, Robert] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Pilarski, Robert] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Patel, Divya A.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Weitzel, Jeffrey; Sand, Sharon] City Hope Natl Med Ctr, Div Clin Canc Genet, Duarte, CA USA; [McVeigh, Terri; Dorairaj, Jemima J.; Heneghan, Helen M.; Miller, Nicola; Kerin, Michael J.] Natl Univ Ireland, Discipline Surg, Galway, Ireland; [Weidhaas, Joanne B.] Yale Univ, Dept Therapeut Radiol, New Haven, CT USA; [McKenna, Megan] Canc Ctr Santa Barbara, Santa Barbara, CA USA; [Wu, Xifeng; Hildebrandt, Michelle] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zelterman, Daniel] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Shulman, Lee P.] Northwestern Univ, Div Clin Genet, Feinberg Sch Med, Chicago, IL 60611 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Yale University; City of Hope; Ollscoil na Gaillimhe-University of Galway; Yale University; University of Texas System; UTMD Anderson Cancer Center; Yale University; Northwestern University; Feinberg School of Medicine	Pilarski, R (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	Robert.Pilarski@osumc.edu	McVeigh, Terri/AAX-8075-2021; Pilarski, Robert/X-3256-2019; Kerin, Michael J/D-6748-2013; Miller, Nicola/F-4009-2018; Pilarski, Robert/E-3871-2011	McVeigh, Terri/0000-0001-9201-9216; Miller, Nicola/0000-0002-5416-7047; Weidhaas, Joanne/0000-0002-5096-3281; Heneghan, Helen/0000-0002-2009-3406; Sand, Sharon/0000-0002-9390-5583; Zelterman, Daniel/0000-0003-0711-8688; Kerin, Michael/0000-0003-4164-5561	United States National Cancer Institute [1RC4CA153828]; National Breast Cancer Research Institute; Galway Biobank; NATIONAL CANCER INSTITUTE [RC4CA153828] Funding Source: NIH RePORTER	United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Research Institute; Galway Biobank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The collection of cases from City of Hope was supported in part by award #1RC4CA153828 from the United States National Cancer Institute (PI: Weitzel). Cases from The Ohio State University were obtained in part from the Stefanie Spielman Breast Cancer Tissue Bank. The authors thank the National Breast Cancer Research Institute that funds the Galway Biobank and researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and Dr. Weidhaas has the following conflicts: She has patented the KRAS-variant through Yale University. This patent covers the discovery of the KRAS-variant and testing the KRAS-variant that is discussed in this application. This marker has been licensed to a company that she has co-founded. Dr. Weidhaas is not employed by this company, but is a consultant. The company has developed the KRAS-variant as a test. The Irish cohort was supported partially from a commercial source, the Galway Biobank. These things do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The rest of the authors have no conflicts.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Armstrong K, 2000, CANCER EPIDEM BIOMAR, V9, P1251; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Cvelbar M, 2011, NEOPLASMA, V58, P198, DOI 10.4149/neo_2011_03_198; Evans DG, 2010, J MED GENET, V47, P561, DOI 10.1136/jmg.2009.075770; Fishman A, 2000, GYNECOL ONCOL, V79, P74, DOI 10.1006/gyno.2000.5895; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Metcalfe KA, 2009, BRIT J CANCER, V100, P421, DOI 10.1038/sj.bjc.6604830; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Paranjape T, 2011, LANCET ONCOLOGY; Pharoah P, 2011, CLIN CANC RES; Ratner E, 2011, ONCOGENE        1205; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Stadler ZK, 2010, J CLIN ONCOL, V28, P189, DOI 10.1200/JCO.2009.25.6875; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379	17	26	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37891	10.1371/journal.pone.0037891	http://dx.doi.org/10.1371/journal.pone.0037891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662244	Green Published, gold			2022-12-27	WOS:000305342300135
J	Chang, MW; Lo, JM; Juan, HF; Chang, HY; Chuang, CY				Chang, Ming-Wei; Lo, Jem-Mau; Juan, Hsueh-Fen; Chang, Hsin-Yi; Chuang, Chun-Yu			Combination of RGD Compound and Low-Dose Paclitaxel Induces Apoptosis in Human Glioblastoma Cells	PLOS ONE			English	Article							ASPARTIC ACID PEPTIDE; THERAPEUTIC TARGETS; ALPHA(V)BETA(3) INTEGRIN; ALPHA-V-BETA-3 INTEGRIN; CANCER; ACTIVATION; EXPRESSION; MULTIFORME; DEATH; CILENGITIDE	Background: Integrins are a family of transmembrane adhesion proteins that mediate cell adhesion and intracellular signaling. Integrin-alpha v beta 3 is expressed on the surface of human glioblastoma cells, and can be further induced by chemical stress. The Arg-Gly-Asp (RGD) motif-containing peptides are specifically bound to integrin-alpha v beta 3, and to inhibit neovasculature underlying competition to normal extracellular matrix proteins. This study employed two types of RGD peptides, cyclic RGD (c(RGDyK)) and bi-cyclic RGD (E[c(RGDyK)] 2) peptide, to human glioblastoma U87MG cells with combination of low dose Paclitaxel (PTX) pre-treatment to augment therapeutic activity for RGD peptide-induced apoptosis. Principal Findings: Human glioblastoma U87MG cells were treated with RGD peptides in the absence or presence of initial exposure to low-dose 10 nM PTX. Results showed that integrin-alpha v beta 3 expressing on the surface of U87MG cells was induced by 10 nM PTX pre-treatment for 12 hrs. Additionally, the U87MG cells pre-treated with PTX and followed by RGD peptides exhibited greater expression of caspases-3, -8 and -9 than those merely treated with single agent of PTX or RGD peptide. Furthermore, the caspase-3, -8 and -9 inhibitor presented significant protection against E[c(RGDyK)] 2 peptide induced U87MG programmed cell death. The increased expression of PTX-induced integrin-alpha v beta 3 was correlated with the enhanced apoptosis in U87MG cells. Conclusions: This study provides a novel concept of targeting integrin-alpha v beta 3 with RGD peptides in combination with low-dose PTX pre-treatment to improve efficiency in human glioblastoma treatment.	[Chang, Ming-Wei; Lo, Jem-Mau; Chuang, Chun-Yu] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Juan, Hsueh-Fen; Chang, Hsin-Yi] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	National Tsing Hua University; National Taiwan University; National Taiwan University	Chang, MW (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cychuang@mx.nthu.edu.tw		Chang, Hsin-Yi/0000-0002-2742-0676; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Tsing Hua University [95N2115E1]	National Tsing Hua University	This study was financially funded by National Tsing Hua University (95N2115E1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Andre N, 2000, CANCER RES, V60, P5349; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Buckner JC, 2006, J CLIN ONCOL, V24, P3871, DOI 10.1200/JCO.2005.04.6979; Chatterjee S, 2000, J NEURO-ONCOL, V46, P135, DOI 10.1023/A:1006444300504; Chen XY, 2004, J NUCL MED, V45, P1776; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Edlund M, 2001, CELL GROWTH DIFFER, V12, P99; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Haas MJ, 2009, SCIBX, V12, P1; HEIMANS JJ, 1994, ANN ONCOL, V5, P951, DOI 10.1093/oxfordjournals.annonc.a058736; Huang TC, 2007, FEBS LETT, V581, P3517, DOI 10.1016/j.febslet.2007.06.067; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; Kim R, 2005, ONCOL REP, V14, P595; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1296, DOI 10.1007/s00259-009-1112-2; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; Lu YJ, 2006, AAPS J, V8, pE466, DOI 10.1208/aapsj080355; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; Ng SSM, 2007, CANCER GENE THER, V14, P561, DOI 10.1038/sj.cgt.7701038; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Tseng S H, 1999, Neuro Oncol, V1, P101, DOI 10.1093/neuonc/1.2.101; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhou XM, 2001, J BIOL CHEM, V276, P44762, DOI 10.1074/jbc.M104029200	44	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37935	10.1371/journal.pone.0037935	http://dx.doi.org/10.1371/journal.pone.0037935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655084	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900061
J	Hu, WY; Zhao, G; Wang, CY; Zhang, JG; Fu, L				Hu, Wenyan; Zhao, Gang; Wang, Chunyou; Zhang, Jungang; Fu, Ling			Nonlinear Optical Microscopy for Histology of Fresh Normal and Cancerous Pancreatic Tissues	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; MULTIPHOTON MICROSCOPY; MOUSE MODEL; IN-VIVO; FLUORESCENCE; SPECTROSCOPY; FLAVOPROTEIN; CARCINOMA; NADH	Background: Pancreatic cancer is a lethal disease with a 5-year survival rate of only 1-5%. The acceleration of intraoperative histological examination would be beneficial for better management of pancreatic cancer, suggesting an improved survival. Nonlinear optical methods based on two-photon excited fluorescence (TPEF) and second harmonic generation (SHG) of intrinsic optical biomarkers show the ability to visualize the morphology of fresh tissues associated with histology, which is promising for real-time intraoperative evaluation of pancreatic cancer. Methodology/Principal Findings: In order to investigate whether the nonlinear optical imaging methods have the ability to characterize pancreatic histology at cellular resolution, we studied different types of pancreatic tissues by using label-free TPEF and SHG. Compared with other routine methods for the preparation of specimens, fresh tissues without processing were found to be most suitable for nonlinear optical imaging of pancreatic tissues. The detailed morphology of the normal rat pancreas was observed and related with the standard histological images. Comparatively speaking, the preliminary images of a small number of chemical-induced pancreatic cancer tissues showed visible neoplastic differences in the morphology of cells and extracellular matrix. The subcutaneous pancreatic tumor xenografts were further observed using the nonlinear optical microscopy, showing that most cells are leucocytes at 5 days after implantation, the tumor cells begin to proliferate at 10 days after implantation, and the extracellular collagen fibers become disordered as the xenografts grow. Conclusions/Significance: In this study, nonlinear optical imaging was used to characterize the morphological details of fresh pancreatic tissues for the first time. We demonstrate that it is possible to provide real-time histological evaluation of pancreatic cancer by the nonlinear optical methods, which present an opportunity for the characterization of the progress of spontaneous pancreatic cancer and further application in a non-invasive manner.	[Hu, Wenyan; Fu, Ling] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Hu, Wenyan; Fu, Ling] Huazhong Univ Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan 430074, Peoples R China; [Zhao, Gang; Wang, Chunyou; Zhang, Jungang] Huazhong Univ Sci & Technol, Pancreat Surg Ctr, Union Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Fu, L (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China.	lfu@mail.hust.edu.cn	Liu, Rebecca/F-3466-2014		National Major Scientific Research Program of China [2011CB910401]; National Natural Science Foundation of China [61178077]; Program for New Century Excellent Talents in University [NCET-08-0216]; Fundamental Research Funds for the Central Universities [HUST: 2011JC046]	National Major Scientific Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Major Scientific Research Program of China (No. 2011CB910401), National Natural Science Foundation of China (No. 61178077), Program for New Century Excellent Talents in University (No. NCET-08-0216), and the Fundamental Research Funds for the Central Universities (HUST: 2011JC046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chandra M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3314900; Chandra M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818029; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Cicchi R, 2010, OPT EXPRESS, V18, P3840, DOI 10.1364/OE.18.003840; Grosberg LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019925; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hu W, 2012, J BIOMED OPT, V17, DOI DOI 10.1117/1.JBO.17.2.0262007; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Islam MS, 2010, ISLETS LANGERHANS AD; Jiang XS, 2011, J INNOV OPT HEAL SCI, V4, P159, DOI 10.1142/S179354581100137X; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Kirkpatrick ND, 2007, CANCER EPIDEM BIOMAR, V16, P2048, DOI 10.1158/1055-9965.EPI-07-0009; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Neoptolemos JP, PANCREATIC CANC; Pandya AK, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815a3f1c; Ranchod M., 2010, INTRAOPERATIVE CONSU; Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237; Rivera JA, 1997, SURGERY, V122, P82, DOI 10.1016/S0039-6060(97)90268-3; Sauer BG, 2010, GASTROINTEST ENDOSC, V72, P84, DOI 10.1016/j.gie.2010.02.049; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Wilson RH, 2010, OPT EXPRESS, V18, P21612, DOI 10.1364/OE.18.021612; Wilson RH, 2009, OPT EXPRESS, V17, P17502, DOI 10.1364/OE.17.017502; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	31	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37962	10.1371/journal.pone.0037962	http://dx.doi.org/10.1371/journal.pone.0037962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655087	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900064
J	Ma, TZ; Su, ZJ; Chen, L; Liu, SY; Zhu, NX; Wen, LF; Yuan, Y; Lv, LL; Chen, XC; Huang, JM; Chen, HB				Ma, Tianzhong; Su, Zhongjing; Chen, Ling; Liu, Shuyan; Zhu, Ningxia; Wen, Lifeng; Yuan, Yan; Lv, Leili; Chen, Xiancai; Huang, Jianmin; Chen, Haibin			Human Papillomavirus Type 18 E6 and E7 Genes Integrate into Human Hepatoma Derived Cell Line Hep G2	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CERVICAL-CANCER; LIVER; TRANSFORMATION; INFECTION; APOPTOSIS; BIOLOGY; PROTEIN; HPV-18; HBV	Background and Objectives: Human papillomaviruses have been linked causally to some human cancers such as cervical carcinoma, but there is very little research addressing the effect of HPV infection on human liver cells. We chose the human hepatoma derived cell line Hep G2 to investigate whether HPV gene integration took place in liver cells as well. Methods: We applied PCR to detect the possible integration of HPV genes in Hep G2 cells. We also investigated the expression of the integrated E6 and E7 genes by using RT-PCR and Western blotting. Then, we silenced E6 and E7 expression and checked the cell proliferation and apoptosis in Hep G2 cells. Furthermore, we analyzed the potential genes involved in cell cycle and apoptosis regulatory pathways. Finally, we used in situ hybridization to detect HPV 16/18 in hepatocellular carcinoma samples. Results: Hep G2 cell line contains integrated HPV 18 DNA, leading to the expression of the E6 and E7 oncogenic proteins. Knockdown of the E7 and E6 genes expression reduced cell proliferation, caused the cell cycle arrest at the S phase, and increased apoptosis. The human cell cycle and apoptosis real-time PCR arrays analysis demonstrated E6 and E7-mediated regulation of some genes such as Cyclin H, UBA1, E2F4, p53, p107, FASLG, NOL3 and CASP14. HPV16/18 was found in only 9% (9/100) of patients with hepatocellular carcinoma. Conclusion: Our investigations showed that HPV 18 E6 and E7 genes can be integrated into the Hep G2, and we observed a low prevalence of HPV 16/18 in hepatocellular carcinoma samples. However, the precise risk of HPV as causative agent of hepatocellular carcinoma needs further study.	[Ma, Tianzhong; Su, Zhongjing; Liu, Shuyan; Zhu, Ningxia; Wen, Lifeng; Yuan, Yan; Lv, Leili; Chen, Xiancai; Chen, Haibin] Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China; [Chen, Ling] Shantou Univ, Dept Biochem & Mol Biol, Coll Med, Shantou, Guangdong, Peoples R China; [Huang, Jianmin] Harvard Univ, Sch Med, Boston, MA USA; [Huang, Jianmin] Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA	Shantou University; Shantou University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ma, TZ (corresponding author), Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China.	chenhb@stu.edu.cn			Natural Science Foundation of Guangdong Province, China [10151503102000034]; Research Foundation of Shantou University Medical College [LC0401]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Research Foundation of Shantou University Medical College	This study was supported by Natural Science Foundation of Guangdong Province, China (Grant No. 10151503102000034) and Research Foundation of Shantou University Medical College (Grant No. LC0401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BARBOSA MS, 1989, ONCOGENE, V4, P1529; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528; Fink SA, 2011, NAT REV GASTRO HEPAT, V8, P285, DOI 10.1038/nrgastro.2011.57; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Korzeniewski N, 2011, CANCER LETT, V305, P113, DOI 10.1016/j.canlet.2010.10.013; Lee DH, 1999, BIOCHEM BIOPH RES CO, V265, P62, DOI 10.1006/bbrc.1999.1636; Liu XS, 2007, PLANTA MED, V73, P1192, DOI 10.1055/s-2007-981597; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z; Qi ZL, 2010, BIOCHEM CELL BIOL, V88, P697, DOI 10.1139/O10-005; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SCINICARIELLO F, 1992, ANTICANCER RES, V12, P763; Su ZJ, 2012, GENE, V494, P161, DOI 10.1016/j.gene.2011.12.033	18	3	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37964	10.1371/journal.pone.0037964	http://dx.doi.org/10.1371/journal.pone.0037964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655088	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900065
J	Iizuka, T; Tamura, T; Sezutsu, H; Mase, K; Okada, E; Asaoka, K				Iizuka, Tetsuya; Tamura, Toshiki; Sezutsu, Hideki; Mase, Keisuke; Okada, Eiji; Asaoka, Kiyoshi			Genetic Analysis of the Electrophysiological Response to Salicin, a Bitter Substance, in a Polyphagous Strain of the Silkworm Bombyx mori	PLOS ONE			English	Article							GUSTATORY SENSITIVITY; TASTE RECEPTOR; DROSOPHILA; CATERPILLARS; LARVAE; CHEMORECEPTORS; PATHWAYS; SENSILLA; CELLS	Sawa-J is a polyphagous silkworm (Bombyx mori L.) strain that eats various plant leaves that normal silkworms do not. The feeding preference behavior of Sawa-J is controlled by one major recessive gene(s) on the polyphagous (pph) locus, and several minor genes; moreover, its deterrent cells possess low sensitivity to some bitter substances including salicin. To clarify whether taste sensitivity is controlled by the pph locus, we conducted a genetic analysis of the electrophysiological characteristics of the taste response using the polyphagous strain Sawa-J.lem, in which pph is linked to the visible larval marker lemon (lem) on the third chromosome, and the normal strain Daiankyo, in which the wild-type gene of pph (+(pph)) is marked with Zebra (Ze). Maxillary taste neurons of the two strains had similar dose-response relationships for sucrose, inositol, and strychnine nitrate, but the deterrent cell of Sawa-J.lem showed a remarkably low sensitivity to salicin. The F-1 generation of the two strains had characteristics similar to the Daiankyo strain, consistent with the idea that pph is recessive. In the BF1 progeny between F-1 females and Sawa-J.lem males where no crossing-over occurs, the lem and Ze phenotypes corresponded to different electrophysiological reactions to 25 mM salicin, indicating that the gene responsible for taste sensitivity to salicin is located on the same chromosome as the lem and Ze genes. The normal and weak reactions to 25 mM salicin were segregated in crossover-type larvae of the BF1 progeny produced by a reciprocal cross, and the recombination frequency agreed well with the theoretical ratio for the loci of lem, pph, and Ze on the standard linkage map. These results indicate that taste sensitivity to salicin is controlled by the gene(s) on the pph locus.	[Iizuka, Tetsuya; Tamura, Toshiki; Sezutsu, Hideki; Okada, Eiji] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan; [Mase, Keisuke] Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 156, Japan; [Asaoka, Kiyoshi] Natl Inst Agrobiol Sci, Insect Plant Interact Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Nihon University; National Institute of Agrobiological Sciences - Japan	Iizuka, T (corresponding author), Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan.	asaoka@affrc.go.jp		Sezutsu, Hideki/0000-0001-8886-1611	National Institute of Agrobiological Sciences (NIAS)	National Institute of Agrobiological Sciences (NIAS)	This work was funded by National Institute of Agrobiological Sciences (NIAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAOKA K, 1995, ENTOMOL EXP APPL, V77, P167, DOI 10.1007/BF02383030; Asaoka K, 2000, J COMP PHYSIOL A, V186, P1011, DOI 10.1007/s003590000154; Asaoka K, 2010, INT J WILD SILKMOTH, V14, P1; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dether VG, 1976, HUNGRY FLY; Glendinning JI, 1999, BEHAV NEUROSCI, V113, P840, DOI 10.1037/0735-7044.113.4.840; Glendinning JI, 2002, J NEUROSCI, V22, P7281; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Glendinning JI, 1998, J COMP PHYSIOL A, V183, P35, DOI 10.1007/s003590050232; HAMAMURA Y, 1962, NATURE, V194, P754, DOI 10.1038/194754a0; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Iizuka Tetsuya, 2007, Journal of Insect Biotechnology and Sericology, V76, P107; ISHIKAWA S, 1963, J CELL COMPAR PHYSL, V61, P99, DOI 10.1002/jcp.1030610111; ISHIKAWA S, 1966, J CELL PHYSIOL, V67, P1, DOI 10.1002/jcp.1040670102; Ishikawa S, 1966, B SERICUL EXPET STAT, V20, P291; ITO T, 1960, J INSECT PHYSIOL, V5, P95, DOI 10.1016/0022-1910(60)90035-4; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; KANDA T, 1988, Journal of Sericultural Science of Japan, V57, P489; KANDA T, 1992, B NATL I SERIC ENTOM, V5, P1; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Matsuo T, 2008, GENETICS, V178, P1061, DOI 10.1534/genetics.107.079046; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; MORI M, 1982, J INSECT PHYSIOL, V28, P969, DOI 10.1016/0022-1910(82)90114-7; OHNUMA A, 1996, REP SILK SCI RES I, V44, P1; Ohnuma Akio, 1997, Journal of Sericultural Science of Japan, V66, P431; Ouyang Q, 2009, COMP BIOCHEM PHYS A, V153, P309, DOI 10.1016/j.cbpa.2009.03.004; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; TAZIMA Y, 1989, SERICOLOGIA, V29, P437; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; TORII K, 1948, REP SILK SCI RES I, V2, P3; van Loon JJA, 1999, ENTOMOL EXP APPL, V91, P29, DOI 10.1046/j.1570-7458.1999.00463.x; VANDRONGELEN W, 1980, ENTOMOL EXP APPL, V28, P199, DOI 10.1007/BF00287129; Vermehren-Schmaedick A, 2011, J COMP PHYSIOL A, V197, P717, DOI 10.1007/s00359-011-0634-9; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Yamamoto T, 1983, J SERIC SCI JPN, V52, P330; YAZAWA M, 1991, Journal of Sericultural Science of Japan, V60, P363; YOKOYAMA T, 1975, REP SILK SCI RES I, V24, P27	40	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37549	10.1371/journal.pone.0037549	http://dx.doi.org/10.1371/journal.pone.0037549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649537	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800056
J	Mosqueira, M; Willmann, G; Zeiger, U; Khurana, TS				Mosqueira, Matias; Willmann, Gabriel; Zeiger, Ulrike; Khurana, Tejvir S.			Expression Profiling Reveals Novel Hypoxic Biomarkers in Peripheral Blood of Adult Mice Exposed to Chronic Hypoxia	PLOS ONE			English	Article							LEPTIN GENE-EXPRESSION; INDUCIBLE FACTOR-I; PULMONARY-HYPERTENSION; INTERMITTENT HYPOXIA; ERYTHROPOIETIN; SPECTRIN; RATS; CELLS; ALTITUDE; RECEPTOR	Hypoxia induces a myriad of changes including an increase in hematocrit due to erythropoietin (EPO) mediated erythropoiesis. While hypoxia is of importance physiologically and clinically, lacunae exist in our knowledge of the systemic and temporal changes in gene expression occurring in blood during the exposure and recovery from hypoxia. To identify these changes expression profiling was conducted on blood obtained from cohorts of C57Bl-10 wild type mice that were maintained at normoxia (NX), exposed for two weeks to normobaric chronic hypoxia (CH) or two weeks of CH followed by two weeks of normoxic recovery (REC). Using stringent bioinformatic cut-offs (0% FDR, 2 fold change cut-off), 230 genes were identified and separated into four distinct temporal categories. Class I) contained 1 transcript up-regulated in both CH and REC; Class II) contained 202 transcripts up-regulated in CH but down-regulated after REC; Class III) contained 9 transcripts down-regulated both in CH and REC; Class IV) contained 18 transcripts down-regulated after CH exposure but up-regulated after REC. Profiling was independently validated and extended by analyzing expression levels of selected genes as novel biomarkers from our profile (e.g. spectrin alpha-1, ubiquitin domain family-1 and pyrroline-5-carboxylate reductase-1) by performing qPCR at 7 different time points during CH and REC. Our identification and characterization of these genes define transcriptome level changes occurring during chronic hypoxia and normoxic recovery as well as novel blood biomarkers that may be useful in monitoring a variety of physiological and pathological conditions associated with hypoxia.	[Mosqueira, Matias; Willmann, Gabriel; Zeiger, Ulrike; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mosqueira, Matias; Willmann, Gabriel; Zeiger, Ulrike; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Mosqueira, Matias] Heidelberg Univ, Med Biophys Grp, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Willmann, Gabriel] Univ Cologne, Dept Vegetat Physiol, D-50931 Cologne, Germany	University of Pennsylvania; University of Pennsylvania; Ruprecht Karls University Heidelberg; University of Cologne	Mosqueira, M (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	tsk@mail.med.upenn.edu	Mosqueira, Matias/C-5899-2019	Mosqueira, Matias/0000-0001-7744-9138	Muscular Dystrophy of America; World Anti-Doping Agency	Muscular Dystrophy of America; World Anti-Doping Agency	The research was supported by grants from The Muscular Dystrophy of America (TSK) and the World Anti-Doping Agency (TSK and SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 1970, Int Rev Connect Tissue Res, V5, P1; Ahima RS, 2000, FRONT HORM RES, V26, P42; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Balbir A, 2007, AM J PHYSIOL-LUNG C, V292, pL704, DOI 10.1152/ajplung.00383.2006; Baze MM, 2010, PHYSL GENOMICS; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Chakrabarti A, 2006, BIOSCIENCE REP, V26, P369, DOI 10.1007/s10540-006-9024-x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dill RP, 2001, MECH AGEING DEV, V122, P533, DOI 10.1016/S0047-6374(01)00216-0; Ebert BL, 1999, BLOOD, V94, P1864; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fenner BJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1010, DOI 10.1016/j.bbapap.2009.02.013; Fisher JW, 2003, EXP BIOL MED, V228, P1; Forbes WH, 1936, AM J PHYSIOL, V116, P309, DOI 10.1152/ajplegacy.1936.116.2.309; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaber T, 2009, J RHEUMATOL, V36, P2655, DOI 10.3899/jrheum.090255; Gharib SA, 2010, SLEEP, V33, P1439, DOI 10.1093/sleep/33.11.1439; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gonzalez-Cinca N, 2004, HORM RES, V62, P191, DOI 10.1159/000080897; Grosfeld A, 2002, J BIOL CHEM, V277, P42953, DOI 10.1074/jbc.M206775200; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; HARIK SI, 1994, J APPL PHYSIOL, V77, P896, DOI 10.1152/jappl.1994.77.2.896; HILL NS, 1993, RESP PHYSIOL, V91, P261, DOI 10.1016/0034-5687(93)90104-I; Hoggard N, 1997, P NATL ACAD SCI USA, V94, P11073, DOI 10.1073/pnas.94.20.11073; Houwen B, 2002, CLIN LAB MED, V22, P1, DOI 10.1016/S0272-2712(03)00064-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JELKMANN W, 1986, RESP PHYSIOL, V63, P257, DOI 10.1016/0034-5687(86)90093-9; Juul SE, 2009, PEDIATR RES, V65, P485, DOI 10.1203/PDR.0b013e31819d90c8; KELLOGG RH, 1978, RESP PHYSIOL, V34, P1, DOI 10.1016/0034-5687(78)90046-4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koistinen PO, 2000, MED SCI SPORT EXER, V32, P800, DOI 10.1097/00005768-200004000-00012; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Kwapiszewska G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-109; Lai Y, 2009, ISLETS, V1, P19, DOI 10.4161/isl.1.1.8530; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Mwaikambo BR, 2009, J BIOL CHEM, V284, P26695, DOI 10.1074/jbc.M109.033480; OGAWA Y, 1995, J CLIN INVEST, V96, P1647, DOI 10.1172/JCI118204; OU LC, 1980, EXP HEMATOL, V8, P243; Ou LC, 2004, RESP PHYSIOL NEUROBI, V141, P59, DOI 10.1016/j.resp.2004.04.001; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Pfafflin A, 2006, CELL PHYSIOL BIOCHEM, V18, P199, DOI 10.1159/000097667; PISON CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE965, DOI 10.1152/ajpendo.1995.268.5.E965; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200; Savourey G, 2004, EUR J APPL PHYSIOL, V93, P47, DOI 10.1007/s00421-004-1159-5; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Serghides L, 2003, TRENDS PARASITOL, V19, P461, DOI 10.1016/j.pt.2003.08.006; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; Speicher D W, 1984, Prog Clin Biol Res, V165, P441; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Telen MJ, 2005, TRANSFUS MED REV, V19, P32, DOI 10.1016/j.tmrv.2004.09.006; Telen MJ, 2000, SEMIN HEMATOL, V37, P130, DOI 10.1016/S0037-1963(00)90038-6; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vishesh A, 2008, DIABETES OBES METAB, V10, P973, DOI 10.1111/j.1463-1326.2008.00852.x; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wenger RH, 2000, J EXP BIOL, V203, P1253; Windsor JS, 2007, POSTGRAD MED J, V83, P148, DOI 10.1136/pgmj.2006.049734; XIA Y, 1997, AM J PHYSIOL-REG I, V273, pR1734; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Yang YZ, 2006, INTERNAL MED, V45, P941, DOI 10.2169/internalmedicine.45.1733; YEH GC, 1980, BIOCHEM BIOPH RES CO, V94, P450, DOI 10.1016/0006-291X(80)91252-8; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	70	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37497	10.1371/journal.pone.0037497	http://dx.doi.org/10.1371/journal.pone.0037497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629407	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300046
J	Norris, SL; Holmer, HK; Burda, BU; Ogden, LA; Fu, RW				Norris, Susan L.; Holmer, Haley K.; Burda, Brittany U.; Ogden, Lauren A.; Fu, Rongwei			Conflict of Interest Policies for Organizations Producing a Large Number of Clinical Practice Guidelines	PLOS ONE			English	Article							PHARMACEUTICAL-INDUSTRY; CONCLUSIONS; AUTHORS; ASSOCIATION; QUALITY; TRIALS	Background: Conflict of interest (COI) of clinical practice guideline (CPG) sponsors and authors is an important potential source of bias in CPG development. The objectives of this study were to describe the COI policies for organizations currently producing a significant number of CPGs, and to determine if these policies meet 2011 Institute of Medicine (IOM) standards. Methodology/Principal Findings: We identified organizations with five or more guidelines listed in the National Guideline Clearinghouse between January 1, 2009 and November 5, 2010. We obtained the COI policy for each organization from publicly accessible sources, most often the organization's website, and compared those polices to IOM standards related to COI. 37 organizations fulfilled our inclusion criteria, of which 17 (46%) had a COI policy directly related to CPGs. These COI policies varied widely with respect to types of COI addressed, from whom disclosures were collected, monetary thresholds for disclosure, approaches to management, and updating requirements. Not one organization's policy adhered to all seven of the IOM standards that were examined, and nine organizations did not meet a single one of the standards. Conclusions/Significance: COI policies among organizations producing a large number of CPGs currently do not measure up to IOM standards related to COI disclosure and management. CPG developers need to make significant improvements in these policies and their implementation in order to optimize the quality and credibility of their guidelines.	[Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Burda, Brittany U.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Fu, Rongwei] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Oregon Health & Science University; Kaiser Permanente; Oregon Health & Science University	Norris, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	norriss@ohsu.edu		Holmer, Haley/0000-0003-4198-8708	Agency for Healthcare Research and Quality [1R01HS018500]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018500] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant number 1R01HS018500 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Breastfeeding Medicine, 2010, COD INT CO; Alpert JS, 2004, J AM COLL CARDIOL, V44, P1724, DOI 10.1016/j.jacc.2004.08.038; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American Association for the Study of Liver Diseases, 2009, POL DEV US PRACT GUI; American College of Obstetricians and Gynecologists, 2011, AM COLL OBST GYN CON; American Diabetes Association, AM DIAB ASS POL STAT; American Urological Association, 2011, PRINC POL PROC MAN C; [Anonymous], 2017, NATION; [Anonymous], 2008, US PREV SERV TASK FO; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Council of Medical Specialty Societies, 2010, COD INT CO; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; Edlund W., 2004, CLIN PRACTICE GUIDEL; European Association of Urology, EUR ASS UR DISCL POL; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; Institute for Clinical Systems Improvement, 2007, SCIENT DOC OV; International Committee of Medical Journal, 2010, UN DISCL FORM POT CO; International Committee of Medical Journal Editors, 2003, Rom J Gastroenterol, V12, P74; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lo B, 2009, CONFLICT INTEREST ME; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Michigan Quality Improvement Consortium, 2007, MICH QUAL IMPR CONS; National Collaborating Centre for Mental Health, 2009, COD PRACT DECL DEAL; National Collaborating Centre for Women's and Children's Health, COD PRACT DECL DEAL; National Institute for Health and Clinical Excellence, 2009, COD PRACT DECL DEAL; Norris S, 2011, PLOS ONE IN PRESS; Norris SL, 2011, J CLIN EPID IN PRESS; Program in Evidence-based Care, 2011, PROGR EV BAS CAR HDB; Registered Nurses' Association of Ontario, 2006, REG NURS ASS ONT GUI; Scottish Intercollegiate Guidelines Network, 2008, SIGN 50 GUID DEV HDB, P1; Society of Obstetricians and Gynaecologists of Canada, 2009, POL STAT CONFL INT; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; van der Sanden WJM, 2005, EUR J ORAL SCI, V113, P349, DOI 10.1111/j.1600-0722.2005.00232.x; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	43	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37413	10.1371/journal.pone.0037413	http://dx.doi.org/10.1371/journal.pone.0037413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629391	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300038
J	Pedrino, GR; Freiria-Oliveira, AH; Colombari, DSA; Rosa, DA; Cravo, SL				Pedrino, Gustavo Rodrigues; Freiria-Oliveira, Andre Henrique; Almeida Colombari, Debora Simoes; Rosa, Daniel Alves; Cravo, Sergio Luiz			A2 Noradrenergic Lesions Prevent Renal Sympathoinhibition Induced by Hypernatremia in Rats	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HYPERTONIC SALINE INFUSION; SYMPATHETIC-NERVE ACTIVITY; MEDULLARY CATECHOLAMINERGIC NEURONS; SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-VOLUME EXPANSION; CARDIOVASCULAR-RESPONSES; VENTROLATERAL MEDULLA; SOLITARY TRACT; HYPOTHALAMIC NEUROENDOCRINE	Renal vasodilation and sympathoinhibition are recognized responses induced by hypernatremia, but the central neural pathways underlying such responses are not yet entirely understood. Several findings suggest that A2 noradrenergic neurons, which are found in the nucleus of the solitary tract (NTS), play a role in the pathways that contribute to body fluid homeostasis and cardiovascular regulation. The purpose of this study was to determine the effects of selective lesions of A2 neurons on the renal vasodilation and sympathoinhibition induced by hypertonic saline (HS) infusion. Male Wistar rats (280-350 g) received an injection into the NTS of anti-dopamine-beta-hydroxylase-saporin (A2 lesion; 6.3 ng in 60 nl; n = 6) or free saporin (sham; 1.3 ng in 60 nl; n = 7). Two weeks later, the rats were anesthetized (urethane 1.2 g.kg(-1) b.wt., i.v.) and the blood pressure, renal blood flow (RBF), renal vascular conductance (RVC) and renal sympathetic nerve activity (RSNA) were recorded. In sham rats, the HS infusion (3 M NaCl, 1.8 ml.kg(-1) b.wt., i.v.) induced transient hypertension (peak at 10 min after HS; 9 +/- 2.7 mmHg) and increases in the RBF and RVC (141 +/- 7.9% and 140 +/- 7.9% of baseline at 60 min after HS, respectively). HS infusion also decreased the RSNA (-45 +/- 5.0% at 10 min after HS) throughout the experimental period. In the A2-lesioned rats, the HS infusion induced transient hypertension (6 +/- 1.4 mmHg at 10 min after HS), as well as increased RBF and RVC (133 +/- 5.2% and 134 +/- 6.9% of baseline at 60 min after HS, respectively). However, in these rats, the HS failed to reduce the RSNA (115 +/- 3.1% at 10 min after HS). The extent of the catecholaminergic lesions was confirmed by immunocytochemistry. These results suggest that A2 noradrenergic neurons are components of the neural pathways regulating the composition of the extracellular fluid compartment and are selectively involved in hypernatremia-induced sympathoinhibition.	[Pedrino, Gustavo Rodrigues; Rosa, Daniel Alves] Univ Fed Goias, Dept Physiol Sci, Goiania, Go, Brazil; [Freiria-Oliveira, Andre Henrique; Almeida Colombari, Debora Simoes] Sao Paulo State Univ, Sch Dent, Dept Physiol & Pathol, Sao Paulo, Brazil; [Cravo, Sergio Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Pedrino, GR (corresponding author), Univ Fed Goias, Dept Physiol Sci, Goiania, Go, Brazil.	pedrino@pq.cnpq.br	CRAVO, SERGIO L/K-4104-2012; Freiria-Oliveira, Andre/F-2756-2012; Pedrino, Gustavo R/I-5614-2015; Colombari, Débora/H-2916-2012; Colombari, Débora Simões A./AAG-1794-2021; Rosa, Daniel A/E-5429-2018	CRAVO, SERGIO L/0000-0002-3441-5576; Pedrino, Gustavo R/0000-0003-0488-5400; Colombari, Débora/0000-0003-4331-0271; Colombari, Débora Simões A./0000-0003-4331-0271; Rosa, Daniel A/0000-0002-7036-0840; Freiria-Oliveira, Andre Henrique/0000-0002-7511-5035	Coordenadoria de Aperfeicoamento em Pesquisa (CAPES) [BEX1380/07-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477832/2010-5]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG) [200910267000352]	Coordenadoria de Aperfeicoamento em Pesquisa (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by Coordenadoria de Aperfeicoamento em Pesquisa (CAPES; #BEX1380/07-9; www.capes.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; #477832/2010-5; www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG; #200910267000352; www.fapeg.go.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombari DSA, 2008, BRAIN RES BULL, V76, P572, DOI 10.1016/j.brainresbull.2008.04.001; ANTUNESRODRIGUES J, 1991, P NATL ACAD SCI USA, V88, P2956, DOI 10.1073/pnas.88.7.2956; ANTUNESRODRIGUES J, 1993, P NATL ACAD SCI USA, V90, P10240, DOI 10.1073/pnas.90.21.10240; Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; ARMSTRONG DM, 1982, J COMP NEUROL, V212, P173, DOI 10.1002/cne.902120207; Bealer SL, 1997, AM J PHYSIOL-REG I, V272, pR1283, DOI 10.1152/ajpregu.1997.272.4.R1283; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Buller KM, 1999, BRAIN RES, V834, P42, DOI 10.1016/S0006-8993(99)01539-5; CIRIELLO J, 1984, AM J PHYSIOL, V246, pR968, DOI 10.1152/ajpregu.1984.246.6.R968; Ciriello J, 1996, BRAIN RES, V726, P227, DOI 10.1016/S0006-8993(96)00474-X; Cravo SL, 2011, BRAZ J MED BIOL RES, V44, P877, DOI 10.1590/S0100-879X2011000900008; CUNNINGHAM ET, 1988, J COMP NEUROL, V274, P60, DOI 10.1002/cne.902740107; DAY TA, 1990, NEUROSCI LETT, V113, P156, DOI 10.1016/0304-3940(90)90296-L; DAY TA, 1992, BRAIN RES, V594, P244, DOI 10.1016/0006-8993(92)91131-W; Duale H, 2007, CARDIOVASC RES, V76, P184, DOI 10.1016/j.cardiores.2007.06.018; FERNANDEZGALAZ C, 1994, BRAIN RES, V636, P227, DOI 10.1016/0006-8993(94)91021-9; Geerling JC, 2007, J COMP NEUROL, V504, P379, DOI 10.1002/cne.21452; Godino A, 2005, NEUROSCIENCE, V133, P493, DOI 10.1016/j.neuroscience.2005.02.035; HOCHSTENBACH SL, 1995, BRAIN RES, V674, P46, DOI 10.1016/0006-8993(94)01434-J; HOCHSTENBACH SL, 1994, AM J PHYSIOL, V266, pR1916, DOI 10.1152/ajpregu.1994.266.6.R1916; Howe BM, 2004, EXP NEUROL, V187, P190, DOI 10.1016/j.expneurol.2004.01.020; KALIA M, 1982, J COMP NEUROL, V211, P248, DOI 10.1002/cne.902110304; Kasparov S, 2008, EXP PHYSIOL, V93, P725, DOI 10.1113/expphysiol.2007.041814; Madden CJ, 1999, AM J PHYSIOL-REG I, V277, pR1063, DOI 10.1152/ajpregu.1999.277.4.R1063; Madden CJ, 2003, AM J PHYSIOL-HEART C, V285, pH2734, DOI 10.1152/ajpheart.00155.2003; May CN, 2000, AM J PHYSIOL-REG I, V279, pR1827, DOI 10.1152/ajpregu.2000.279.5.R1827; Mozaffari MS, 1997, AM J MED SCI, V314, P370, DOI 10.1097/00000441-199712000-00003; Nishida Y, 1998, AM J PHYSIOL-REG I, V274, pR97, DOI 10.1152/ajpregu.1998.274.1.R97; Pedrino GR, 2005, AUTON NEUROSCI-BASIC, V117, P9, DOI 10.1016/j.autneu.2004.09.005; Pedrino GR, 2009, CLIN EXP PHARMACOL P, V36, pe83, DOI 10.1111/j.1440-1681.2009.05280.x; Pedrino GR, 2008, AUTON NEUROSCI-BASIC, V142, P55, DOI 10.1016/j.autneu.2008.06.006; Pedrino GR, 2006, EXP PHYSIOL, V91, P995, DOI 10.1113/expphysiol.2006.034611; RAUCH AL, 1990, AM J PHYSIOL, V258, pR531, DOI 10.1152/ajpregu.1990.258.2.R531; Rinaman L, 1997, NEUROSCIENCE, V79, P1165, DOI 10.1016/S0306-4522(97)00022-5; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; SAPHIER D, 1993, AM J PHYSIOL, V264, pR891, DOI 10.1152/ajpregu.1993.264.5.R891; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; Shi P, 2007, AM J PHYSIOL-REG I, V293, pR2279, DOI 10.1152/ajpregu.00160.2007; SMITH DW, 1995, AM J PHYSIOL-REG I, V268, pR1336, DOI 10.1152/ajpregu.1995.268.5.R1336; Spyer K M, 1981, Rev Physiol Biochem Pharmacol, V88, P24, DOI 10.1007/BFb0034536; Tanaka J, 2003, BRAIN RES BULL, V60, P233, DOI 10.1016/S0361-9230(03)00039-X; Tanaka J, 1997, NEUROREPORT, V8, P3147, DOI 10.1097/00001756-199709290-00028; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; TUCKER DC, 1987, J COMP NEUROL, V259, P591, DOI 10.1002/cne.902590408; Weiss ML, 1996, J AUTONOM NERV SYST, V57, P109, DOI 10.1016/0165-1838(95)00108-5	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37587	10.1371/journal.pone.0037587	http://dx.doi.org/10.1371/journal.pone.0037587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629424	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100039
J	Cserep, C; Szabadits, E; Szonyi, A; Watanabe, M; Freund, TF; Nyiri, G				Cserep, Csaba; Szabadits, Eszter; Szonyi, Andras; Watanabe, Masahiko; Freund, Tamas F.; Nyiri, Gabor			NMDA Receptors in GABAergic Synapses during Postnatal Development	PLOS ONE			English	Article							SYNAPTIC-SCAFFOLDING-MOLECULE; D-ASPARTATE RECEPTORS; HIPPOCAMPAL PYRAMIDAL CELLS; DEVELOPING CEREBRAL-CORTEX; SUBUNIT MESSENGER-RNAS; PDZ-DOMAIN PROTEIN; GLUTAMATERGIC SYNAPSES; SILENT SYNAPSES; GROWTH CONES; RAT HIPPOCAMPUS	GABA (gamma-aminobutyric-acid), the main inhibitory neurotransmitter in the adult brain, exerts depolarizing (excitatory) actions during development and this GABAergic depolarization cooperates with NMDARs (N-methyl-D-aspartate receptors) to drive spontaneous synchronous activity (SSA) that is fundamentally important for developing neuronal networks. Although GABAergic depolarization is known to assist in the activation of NMDARs during development, the subcellular localization of NMDARs relative to GABAergic synapses is still unknown. Here, we investigated the subcellular distribution of NMDARs in association with GABAergic synapses at the developmental stage when SSA is most prominent in mice. Using multiple immunofluorescent labeling and confocal laser-scanning microscopy in the developing mouse hippocampus, we found that NMDARs were associated with both glutamatergic and GABAergic synapses at postnatal day 6-7 and we observed a direct colocalization of GABA(A)- and NMDA-receptor labeling in GABAergic synapses. Electron microscopy of preembedding immunogold-immunoperoxidase reactions confirmed that GluN1, GluN2A and GluN2B NMDAR subunits were all expressed in glutamatergic and GABAergic synapses postsynaptically. Finally, quantitative post-embedding immunogold labeling revealed that the density of NMDARs was 3 times higher in glutamatergic than in GABAergic synapses. Since GABAergic synapses were larger, there was little difference in the total number of NMDA receptors in the two types of synapses. In addition, receptor density in synapses was substantially higher than extrasynaptically. These data can provide the neuroanatomical basis of a new interpretation of previous physiological data regarding the GABA(A)R-NMDAR cooperation during early development. We suggest that during SSA, synaptic GABA(A)R-mediated depolarization assists NMDAR activation right inside GABAergic synapses and this effective spatial cooperation of receptors and local change of membrane potential will reach developing glutamatergic synapses with a higher probability and efficiency even further away on the dendrites. This additional level of cooperation that operates within the depolarizing GABAergic synapse, may also allow its own modification triggered by Ca2+-influx through the NMDA receptors.	[Cserep, Csaba; Szabadits, Eszter; Szonyi, Andras; Freund, Tamas F.; Nyiri, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Lab Cerebral Cortex Res, Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hokkaido University	Cserep, C (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Lab Cerebral Cortex Res, Budapest, Hungary.	nyiri@koki.hu	WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Szonyi, Andras/0000-0002-6818-4550	National Institutes of Health [DA09158, MH54671, NS030549]; Nemzeti Kutatasi es Technologiai Hivatal-Orszagos Tudomanyos Kutatasi Alapprogramok [CNK77793]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nemzeti Kutatasi es Technologiai Hivatal-Orszagos Tudomanyos Kutatasi Alapprogramok; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institutes of Health (DA09158, MH54671, NS030549, www.nih.gov) and Nemzeti Kutatasi es Technologiai Hivatal-Orszagos Tudomanyos Kutatasi Alapprogramok (CNK77793, www.nih.gov.hu, www.otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, J NEUROSCI, V24, P7292, DOI 10.1523/JNEUROSCI.1261-04.2004; Aguado F, 2002, J NEUROSCI, V22, P9430; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Allene C, 2008, J NEUROSCI, V28, P12851, DOI 10.1523/JNEUROSCI.3733-08.2008; Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bergersen LH, 2009, NEUROSCIENCE, V158, P260, DOI 10.1016/j.neuroscience.2008.03.074; Bergersen LH, 2011, IMMUNOGOLD DETECTION; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Cherubini E, 2011, MOL NEUROBIOL, V43, P97, DOI 10.1007/s12035-010-8147-z; Crepel V, 2007, NEURON, V54, P105, DOI 10.1016/j.neuron.2007.03.007; Cserep C, 2011, CEREB CORTEX, V21, P2065, DOI 10.1093/cercor/bhq281; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dingledine R, 1999, PHARMACOL REV, V51, P7; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Elhardt M, 2010, NEUROSCI LETT, V468, P166, DOI 10.1016/j.neulet.2009.10.091; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gao XB, 2000, J PHYSIOL-LONDON, V523, P629, DOI 10.1111/j.1469-7793.2000.t01-1-00629.x; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Gundersen V, 2004, MOL CELL NEUROSCI, V26, P156, DOI 10.1016/j.mcn.2004.01.017; Harris LW, 2003, EUR J NEUROSCI, V18, P1706, DOI 10.1046/j.1460-9568.2003.02902.x; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Jay TM, 1999, J NEUROPHYSIOL, V81, P1741, DOI 10.1152/jn.1999.81.4.1741; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaindl AM, 2008, MOL CELL PROTEOMICS, V7, P2293, DOI 10.1074/mcp.M800030-MCP200; Kaminski RM, 2011, NEUROCHEM RES, V36, P146, DOI 10.1007/s11064-010-0284-2; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kittler JT, 2004, BIOCHEM PHARMACOL, V68, P1649, DOI 10.1016/j.bcp.2004.07.028; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MARTIN DL, 1991, J NEUROSCI, V11, P2725; McCabe AK, 2007, DEV NEUROBIOL, V67, P1574, DOI 10.1002/dneu.20533; Melone M, 2005, J COMP NEUROL, V492, P495, DOI 10.1002/cne.20743; Mohajerani Majid H., 2006, Critical Reviews in Neurobiology, V18, P13; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; OERTEL WH, 1981, J HISTOCHEM CYTOCHEM, V29, P977, DOI 10.1177/29.8.7024401; OERTEL WH, 1981, NEUROSCIENCE, V6, P2715, DOI 10.1016/0306-4522(81)90115-9; Pavlov I, 2004, EUR J NEUROSCI, V20, P3019, DOI 10.1111/j.1460-9568.2004.03806.x; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Soeda H, 2002, NEUROSCI LETT, V325, P5, DOI 10.1016/S0304-3940(02)00215-X; Soeda H, 1997, NEUROSCIENCE, V77, P1187, DOI 10.1016/S0306-4522(96)00465-4; Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x; Szabadits E, 2007, J NEUROSCI, V27, P8101, DOI 10.1523/JNEUROSCI.1912-07.2007; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Takai H, 2003, EXP MOL PATHOL, V75, P89, DOI 10.1016/S0014-4800(03)00030-3; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; Thomas CG, 2011, J NEUROSCI, V31, P4743, DOI 10.1523/JNEUROSCI.5953-10.2011; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; TROMMER BL, 1995, EXP NEUROL, V131, P83, DOI 10.1016/0014-4886(95)90010-1; Tyzio R, 1999, J NEUROSCI, V19, P10372; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Voigt T, 2005, J NEUROSCI, V25, P4605, DOI 10.1523/JNEUROSCI.3803-04.2005; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wenzel A, 1997, J NEUROCHEM, V68, P469; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yao WD, 2000, J NEUROSCI, V20, P2626; Yu GY, 2001, DEV BRAIN RES, V130, P217, DOI 10.1016/S0165-3806(01)00239-5; Yu W, 2008, J NEUROCHEM, V105, P2300, DOI 10.1111/j.1471-4159.2008.05311.x	91	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37753	10.1371/journal.pone.0037753	http://dx.doi.org/10.1371/journal.pone.0037753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662211	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305342300101
J	Rockx-Brouwer, D; Chong, A; Wehrly, TD; Child, R; Crane, DD; Celli, J; Bosio, CM				Rockx-Brouwer, Dedeke; Chong, Audrey; Wehrly, Tara D.; Child, Robert; Crane, Deborah D.; Celli, Jean; Bosio, Catharine M.			Low Dose Vaccination with Attenuated Francisella tularensis Strain SchuS4 Mutants Protects against Tularemia Independent of the Route of Vaccination	PLOS ONE			English	Article							AEROSOL CHALLENGE; INFECTION; LIVE; VIRULENCE; MICE; PULMONARY; S4; IDENTIFICATION; PROLIFERATION; IMMUNIZATION	Tularemia, caused by the Gram-negative bacterium Francisella tularensis, is a severe, sometimes fatal disease. Interest in tularemia has increased over the last decade due to its history as a biological weapon. In particular, development of novel vaccines directed at protecting against pneumonic tularemia has been an important goal. Previous work has demonstrated that, when delivered at very high inoculums, administration of live, highly attenuated strains of virulent F. tularensis can protect against tularemia. However, lower vaccinating inoculums did not offer similar immunity. One concern of using live vaccines is that the host may develop mild tularemia in response to infection and use of high inoculums may contribute to this issue. Thus, generation of a live vaccine that can efficiently protect against tularemia when delivered in low numbers, e.g. < 100 organisms, may address this concern. Herein we describe the ability of three defined, attenuated mutants of F. tularensis SchuS4, deleted for FTT0369c, FTT1676, or FTT0369c and FTT1676, respectively, to engender protective immunity against tularemia when delivered at concentrations of approximately 50 or fewer bacteria. Attenuated strains for use as vaccines were selected by their inability to efficiently replicate in macrophages in vitro and impaired replication and dissemination in vivo. Although all strains were defective for replication in vitro within macrophages, protective efficacy of each attenuated mutant was correlated with their ability to modestly replicate and disseminate in the host. Finally, we demonstrate the parenteral vaccination with these strains offered superior protection against pneumonic tularemia than intranasal vaccination. Together our data provides proof of principle that low dose attenuated vaccines may be a viable goal in development of novel vaccines directed against tularemia.	[Rockx-Brouwer, Dedeke; Chong, Audrey; Wehrly, Tara D.; Child, Robert; Celli, Jean] NIAID, Tularemia Pathogenesis Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA; [Crane, Deborah D.; Bosio, Catharine M.] NIAID, Immun Pulm Pathogens Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rockx-Brouwer, D (corresponding author), NIAID, Tularemia Pathogenesis Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.	jcelli@niaid.nih.gov; bosioc@niaid.nih.gov	Bosio, Catharine/D-7456-2015	Celli, Jean/0000-0002-6793-1788	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001013, ZIAAI000953] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anderson RV, 2010, VACCINE, V28, P6562, DOI 10.1016/j.vaccine.2010.07.072; BAKER JA, 1970, J AM VET MED ASSOC, V156, P1743; Bauler TJ, 2011, J IMMUNOL, V187, P1845, DOI 10.4049/jimmunol.1100377; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; EIGELSBACH H, 1961, P SOC EXP BIOL MED, V108, P732, DOI 10.3181/00379727-108-27049; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; HARRIS S, 1992, ANN NY ACAD SCI, V666, P21, DOI 10.1111/j.1749-6632.1992.tb38021.x; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; OLSUFJEV NG, 1982, J HYG EPID MICROB IM, V26, P291; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2008, INFECT IMMUN, V76, P3086, DOI 10.1128/IAI.00363-08; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Snyder MJ, 1957, T ASSOC AM PHYSICIAN, V70, P74; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; WENGER JD, 1989, ANN INTERN MED, V110, P888, DOI 10.7326/0003-4819-110-11-888; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	42	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37752	10.1371/journal.pone.0037752	http://dx.doi.org/10.1371/journal.pone.0037752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662210	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300100
J	Yang, CL; Liu, YY; Ma, YG; Xue, YX; Liu, DG; Ren, Y; Liu, XB; Li, Y; Li, Z				Yang, Cheng-Liang; Liu, Yong-Yu; Ma, Ye-Gang; Xue, Yi-Xue; Liu, De-Gui; Ren, Yi; Liu, Xiao-Bai; Li, Yao; Li, Zhen			Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CONSTITUTIVE ACTIVATION; STAT3; TRANSDUCER; EXPRESSION; INTERLEUKIN-6; INHIBITOR; SURVIVAL; SUPPRESSION; CARCINOMA	Curcumin, the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development. However, little is known about its anti-tumor mechanism in small cell lung cancer (SCLC). In this study, we found that curcumin can inhibit SCLC cell proliferation, cell cycle, migration, invasion and angiogenesis through suppression of the STAT3. SCLC cells were treated with curcumin (15 mu mol/L) and the results showed that curcumin was effective in inhibiting STAT3 phosphorylation to downregulate of an array of STAT3 downstream targets, which contributed to suppression of cell proliferation, loss of colony formation, depression of cell migration and invasion. Curcumin also suppressed the expression of proliferative proteins (Survivin, Bcl-X-L and Cyclin B1), and invasive proteins (VEGF, MMP-2, MMP-7 and ICAM-1). Knockdown of STAT3 expression by siRNA was able to induce anti-invasive effects in vitro. In contrast, activation of STAT3 upstream of interleukin 6 (IL-6) leads to the increased cell proliferation, cell survival, angiogenesis, invasion, migration and tumor growth. Our findings illustrate the biologic significance of IL-6/JAK/STAT3 signaling in SCLC progression and providenovel evidence that the pathway may be a new potential target for therapy of SCLC. It was concluded that curcumin is a potent agent in the inhibition of STAT3 with favorable pharmacological activity, and curcumin may have translational potential as an effective cancer therapeutic or preventive agent for SCLC.	[Yang, Cheng-Liang; Liu, Yong-Yu; Ma, Ye-Gang; Liu, De-Gui; Ren, Yi] Liaoning Canc Hosp & Inst, Dept Thorac Surg, Shenyang, Liaoning, Peoples R China; [Xue, Yi-Xue; Li, Yao] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning, Peoples R China; [Liu, Xiao-Bai] China Med Univ, Year Program 7, Shenyang, Liaoning, Peoples R China; [Li, Zhen] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Yang, CL (corresponding author), Liaoning Canc Hosp & Inst, Dept Thorac Surg, Shenyang, Liaoning, Peoples R China.	liuyongyu_china@126.com	Liu, Yongyu/AAL-5429-2021	Liu, Yongyu/0000-0002-4094-8555; Liu, Yong-Yu/0000-0002-7968-0162; Yang, Chengliang/0000-0002-5182-4494	Foundation of Provincial Key Laboratory of Esophageal Cancer, Liaoning Department of Science and Technology, People's Republic of China [[2011] 20]; Liaoning Department of Health, People's Republic of China [2010-079]; Liaoning Department of Human Resources and Social Security, People's Republic of China [2009-390]	Foundation of Provincial Key Laboratory of Esophageal Cancer, Liaoning Department of Science and Technology, People's Republic of China; Liaoning Department of Health, People's Republic of China; Liaoning Department of Human Resources and Social Security, People's Republic of China	This work was supported by Foundation of Provincial Key Laboratory of Esophageal Cancer, Liaoning Department of Science and Technology, People's Republic of China (No. [2011] 20), Liaoning Department of Health, People's Republic of China (No. 2010-079), Liaoning Department of Human Resources and Social Security, People's Republic of China (No. 2009-390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kim DK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-155; Klausen P, 2000, ONCOGENE, V19, P3675, DOI 10.1038/sj.onc.1203707; Koppikar P, 2008, CLIN CANCER RES, V14, P7682, DOI 10.1158/1078-0432.CCR-08-1328; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Magadula JJ, 2009, NAT PROD REP, V26, P1535, DOI 10.1039/b906089h; Manju V, 2005, CLIN CHIM ACTA, V358, P60, DOI 10.1016/j.cccn.2005.02.018; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Missale C, 1998, P NATL ACAD SCI USA, V95, P5366, DOI 10.1073/pnas.95.9.5366; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Shiraga M, 2002, CANCER RES, V62, P5967; Sinha R, 2003, J Postgrad Med, V49, P222; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Weinstein IB, 2000, CARCINOGENESIS, V21, P857, DOI 10.1093/carcin/21.5.857; Yang C, 2009, MOL CANCER THER, V8, P2597, DOI 10.1158/1535-7163.MCT-09-0504; Yang CL, 2012, DNA CELL BIOL, V31, P139, DOI 10.1089/dna.2011.1300	34	221	226	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37960	10.1371/journal.pone.0037960	http://dx.doi.org/10.1371/journal.pone.0037960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662257	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300148
J	Cuevas, JM; Delaunay, A; Visser, JC; Bellstedt, DU; Jacquot, E; Elena, SF				Cuevas, Jose M.; Delaunay, Agnes; Visser, Johan C.; Bellstedt, Dirk U.; Jacquot, Emmanuel; Elena, Santiago F.			Phylogeography and Molecular Evolution of Potato virus Y	PLOS ONE			English	Article							COAT PROTEIN; MOSAIC-VIRUS; GENETIC-STRUCTURE; AMINO-ACID; MUTATIONAL ANALYSIS; RECOMBINANT STRAIN; VENOUS NECROSIS; POTYVIRUS; IDENTIFICATION; RESISTANCE	Potato virus Y (PVY) is an important plant pathogen, whose host range includes economically important crops such as potato, tobacco, tomato, and pepper. PVY presents three main strains (PVYO, PVYN and PVYC) and several recombinant forms. PVY has a worldwide distribution, yet the mechanisms that promote and maintain its population structure and genetic diversity are still unclear. In this study, we used a pool of 77 complete PVY genomes from isolates collected worldwide. After removing the effect of recombination in our data set, we used Bayesian techniques to study the influence of geography and host species in both PVY population structure and dynamics. We have also performed selection and covariation analyses to identify evolutionarily relevant amino acid residues. Our results show that both geographic and host-driven adaptations explain PVY diversification. Furthermore, purifying selection is the main force driving PVY evolution, although some indications of positive selection accounted for the diversification of the different strains. Interestingly, the analysis of P3N-PIPO, a recently described gene in potyviruses, seems to show a variable length among the isolates analyzed, and this variability is explained, in part, by host-driven adaptation.	[Cuevas, Jose M.; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Delaunay, Agnes; Jacquot, Emmanuel] Univ Rennes 1, INRA, BiO3P Biol Organisms & Populat Appl Plant Protect, Le Rheu, France; [Visser, Johan C.; Bellstedt, Dirk U.] Univ Stellenbosch, Dept Biochem, Matieland, South Africa; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); INRAE; Universite de Rennes; Stellenbosch University; The Santa Fe Institute	Cuevas, JM (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	jmcuevas@uv.es	Cuevas, Jose M/C-6271-2016; Jacquot, Emmanuel/AAH-4367-2021; Elena, Santiago F./A-4191-2011	Cuevas, Jose M/0000-0003-2049-3554; Elena, Santiago F./0000-0001-8249-5593; Bellstedt, Dirk/0000-0002-6376-4855	Spanish Ministry of Science and Innovation grant [BFU2009-06993]; JAE program from CSIC	Spanish Ministry of Science and Innovation grant(Spanish Government); JAE program from CSIC	This research was supported by the Spanish Ministry of Science and Innovation grant BFU2009-06993 to SFE. JMC was supported by the JAE program from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ali MC, 2010, PLANT PATHOL, V59, P31, DOI 10.1111/j.1365-3059.2009.02174.x; Andersen K, 1998, VIROLOGY, V241, P304, DOI 10.1006/viro.1997.8967; Ayme V, 2006, MOL PLANT MICROBE IN, V19, P557, DOI 10.1094/MPMI-19-0557; Ayme V, 2007, J GEN VIROL, V88, P1594, DOI 10.1099/vir.0.82702-0; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Delatte H, 2007, J MOL EVOL, V65, P112, DOI 10.1007/s00239-007-0005-x; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dullemans AM, 2011, ARCH VIROL, V156, P473, DOI 10.1007/s00705-010-0853-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elena SF, 2011, MOL PLANT MICROBE IN, V24, P287, DOI 10.1094/MPMI-09-10-0214; Fanigliulo A, 2005, ARCH VIROL, V150, P709, DOI 10.1007/s00705-004-0449-x; Fares MA, 2004, BIOINFORMATICS, V20, P2867, DOI 10.1093/bioinformatics/bth303; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Feki S, 2005, EUR J PLANT PATHOL, V112, P221, DOI 10.1007/s10658-004-6807-4; Fellers JP, 2002, MOL PLANT PATHOL, V3, P145, DOI 10.1046/j.1364-3703.2002.00106.x; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Glais L, 2002, ARCH VIROL, V147, P363, DOI 10.1007/s705-002-8325-0; Hall JS, 1998, MOL PHYLOGENET EVOL, V10, P323, DOI 10.1006/mpev.1998.0535; Hu XX, 2009, ARCH VIROL, V154, P1303, DOI 10.1007/s00705-009-0448-z; Jimenez I, 2006, MOL PLANT MICROBE IN, V19, P350, DOI 10.1094/MPMI-19-0350; Jin YS, 2007, MOL PLANT MICROBE IN, V20, P1505, DOI 10.1094/MPMI-20-12-1505; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin L, 2011, VIRUS GENES, V43, P90, DOI 10.1007/s11262-011-0596-6; Lopez-Moya JJ, 1998, J GEN VIROL, V79, P161; Lorenzen J, 2008, ARCH VIROL, V153, P517, DOI 10.1007/s00705-007-0030-5; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mascia T, 2010, J PLANT PATHOL, V92, P131; Moury B, 2004, MOL PLANT MICROBE IN, V17, P322, DOI 10.1094/MPMI.2004.17.3.322; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Moury B, 2011, MOL BIOL EVOL, V28, P2707, DOI 10.1093/molbev/msr105; Moury B, 2010, MOL PLANT PATHOL, V11, P161, DOI [10.1111/j.1364-3703.2009.00573.x, 10.1111/j.1364-3703.2009.00573.X]; Ogawa T, 2008, VIRUS RES, V131, P199, DOI 10.1016/j.virusres.2007.09.010; Pagan I, 2006, PHYTOPATHOLOGY, V96, P274, DOI 10.1094/PHYTO-96-0274; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peng YH, 1998, J GEN VIROL, V79, P897, DOI 10.1099/0022-1317-79-4-897; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Roossinck MJ, 1999, J VIROL, V73, P6752, DOI 10.1128/JVI.73.8.6752-6758.1999; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Schubert J, 2007, J VIROL METHODS, V140, P66, DOI 10.1016/j.jviromet.2006.10.017; Shi Y, 2007, MOL PLANT PATHOL, V8, P785, DOI [10.1111/j.1364-3703.2007.00426.x, 10.1111/J.1364-3703.2007.00426.X]; Singh RP, 2008, ARCH VIROL, V153, P1, DOI 10.1007/s00705-007-1059-1; SLATKIN M, 1989, GENETICS, V123, P603; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Torres-Puente M, 2008, INFECT GENET EVOL, V8, P74, DOI 10.1016/j.meegid.2007.10.005; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; VERCHOT J, 1992, VIROLOGY, V190, P298, DOI 10.1016/0042-6822(92)91216-H; Visser JC, 2009, ARCH VIROL, V154, P1891, DOI 10.1007/s00705-009-0525-3; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Wen RH, 2010, VIROLOGY, V400, P1, DOI 10.1016/j.virol.2010.01.022; Wen RH, 2011, MOL PLANT PATHOL, P10; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	64	41	46	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37853	10.1371/journal.pone.0037853	http://dx.doi.org/10.1371/journal.pone.0037853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655074	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900051
J	Eberhardt, MK; Chang, WLW; Logsdon, NJ; Yue, YJ; Walter, MR; Barry, PA				Eberhardt, Meghan K.; Chang, W. L. William; Logsdon, Naomi J.; Yue, Yujuan; Walter, Mark R.; Barry, Peter A.			Host Immune Responses to a Viral Immune Modulating Protein: Immunogenicity of Viral Interleukin-10 in Rhesus Cytomegalovirus-Infected Rhesus Macaques	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; INTRAUTERINE TRANSMISSION; ANTIBODY-RESPONSES; GLYCOPROTEIN-B; VIRUS; IL-10; POPULATION; VACCINES; HOMOLOG	Background: Considerable evidence has accumulated that multiple viruses, bacteria, and protozoa manipulate interleukin-10 (IL-10)-mediated signaling through the IL-10 receptor (IL-10R) in ways that could enable establishment of a persistent microbial infection. This suggests that inhibition of pathogen targeting of IL-10/IL-10R signaling could prevent microbial persistence. Human cytomegalovirus (HCMV) and rhesus cytomegalovirus (RhCMV) express a viral interleukin-10 (cmvIL-10 and rhcmvIL-10, respectively) with comparable immune modulating properties in vitro to that of their host's cellular IL-10 (cIL-10). A prior study noted that rhcmvIL-10 alters innate and adaptive immunity to RhCMV in vivo, consistent with a central role for rhcmvIL-10 during acute virus-host interactions. Since cmvIL-10 and rhcmvIL-10 are extremely divergent from the cIL-10 of their respective hosts, vaccine-mediated neutralization of their function could inhibit establishment of viral persistence without inhibition of cIL-10. Methods and Findings: As a prelude to evaluating cmvIL-10-based vaccines in humans, the rhesus macaque model of HCMV was used to interrogate peripheral and mucosal immune responses to rhcmvIL-10 in RhCMV-infected animals. ELISA were used to detect rhcmvIL-10-binding antibodies in plasma and saliva, and an IL-12-based bioassay was used to quantify plasma antibodies that neutralized rhcmvIL-10 function. rhcmvIL-10 is highly immunogenic during RhCMV infection, stimulating high avidity rhcmvIL-10-binding antibodies in the plasma of all infected animals. Most infected animals also exhibited plasma antibodies that partially neutralized rhcmvIL-10 function but did not cross-neutralize the function of rhesus cIL-10. Notably, minimally detectable rhcmvIL-10-binding antibodies were detected in saliva. Conclusion: This study demonstrates that rhcmvIL-10, as a surrogate for cmvIL-10, is a viable vaccine candidate because (1) it is highly immunogenic during natural RhCMV infection, and (2) neutralizing antibodies to rhcmvIL-10 do not cross-react with rhesus cIL-10. Exceedingly low rhcmvIL-10 antibodies in saliva further suggest that the oral mucosa, which is critical in RhCMV natural history, is associated with suboptimal anti-rhcmvIL-10 antibody responses.	[Eberhardt, Meghan K.; Chang, W. L. William; Yue, Yujuan; Barry, Peter A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Logsdon, Naomi J.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Barry, Peter A.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Barry, Peter A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis; University of California System; University of California Davis	Eberhardt, MK (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	pabarry@ucdavis.edu	Chang, W. L. William/AAX-1773-2021		National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01 AI49342, RO1 AI047300, AI047300-S1]; National Center for Research Resources [P51 RR00169]; Office of Research Infrastructure Programs/OD [P51 OD011107]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300, R01AI049342] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants R01 AI49342 (to PAB) and RO1 AI047300 and AI047300-S1 (to MRW) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) of the National Institutes of Health (NIH). This project was also funded by the National Center for Research Resources (P51 RR00169) and is currently supported by the Office of Research Infrastructure Programs/OD (P51 OD011107) to the California National Primate Research Center (www.cnprc.ucdavis.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2010, J INFECT DIS, V202, P1800, DOI 10.1086/657412; Bahjat KS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000568; Barboza L, 2009, CELL IMMUNOL, V257, P61, DOI 10.1016/j.cellimm.2009.02.008; Biswas PS, 2007, J IMMUNOL, V179, P4520, DOI 10.4049/jimmunol.179.7.4520; BOPPANA SB, 1995, J INFECT DIS, V171, P1115, DOI 10.1093/infdis/171.5.1115; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Britt WJ, 1996, TRENDS MICROBIOL, V4, P34, DOI 10.1016/0966-842X(96)81503-4; BRITT WJ, 1984, VIROLOGY, V135, P369, DOI 10.1016/0042-6822(84)90193-4; Brodeur ND, 2010, VIRUS RES, V153, P265, DOI 10.1016/j.virusres.2010.08.012; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Chang KM, 2007, HEPATOL RES, V37, pS327, DOI 10.1111/j.1872-034X.2007.00220.x; Chang WLW, 2007, J IMMUNOL, V178, P7794, DOI 10.4049/jimmunol.178.12.7794; Chang WLW, 2010, P NATL ACAD SCI USA, V107, P22647, DOI 10.1073/pnas.1013794108; Chang WLW, 2009, VIROLOGY, V390, P330, DOI 10.1016/j.virol.2009.05.013; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Cui XH, 2008, VACCINE, V26, P5760, DOI 10.1016/j.vaccine.2008.07.092; Dar L, 2008, PEDIATR INFECT DIS J, V27, P841, DOI 10.1097/INF.0b013e3181723d55; ELEK SD, 1974, LANCET, V1, P1; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Estevez PT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-104; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Gandhoke Inderjeet, 2006, Indian Journal of Pediatrics, V73, P1095, DOI 10.1007/BF02763052; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; Gaytant MA, 2003, EUR J PEDIATR, V162, P248, DOI 10.1007/s00431-002-1115-3; HANSHAW JB, 1971, J INFECT DIS, V123, P555, DOI 10.1093/infdis/123.5.555; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jenkins C, 2008, J VIROL, V82, P3736, DOI 10.1128/JVI.02173-07; Jenkins C, 2004, J VIROL, V78, P1440, DOI 10.1128/JVI.78.3.1440-1447.2004; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Langhans B, 2010, CLIN SCI, V119, P97, DOI 10.1042/CS20090661; Li J, 2010, IMMUNOL CELL BIOL, V88, P834, DOI 10.1038/icb.2010.63; Lockridge KM, 1999, J VIROL, V73, P9576, DOI 10.1128/JVI.73.11.9576-9583.1999; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Logsdon NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028127; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Oxford KL, 2011, J VIROL, V85, P5105, DOI 10.1128/JVI.02631-10; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; PLOTKIN SA, 1994, SCIENCE, V265, P1383, DOI 10.1126/science.8073277; Raftery MJ, 2004, J IMMUNOL, V173, P3383, DOI 10.4049/jimmunol.173.5.3383; Raux M, 2000, AIDS RES HUM RETROV, V16, P583, DOI 10.1089/088922200309007; Revello MG, 2010, REV MED VIROL, V20, P136, DOI 10.1002/rmv.645; RIDDELL SR, 1992, SCIENCE, V257, P238; Rieper CD, 2011, J GEN VIROL, V92, P1508, DOI 10.1099/vir.0.028738-0; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Saccoccio FM, 2011, CLIN VACCINE IMMUNOL, V18, P1536, DOI 10.1128/CVI.05128-11; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; SOHN Y M, 1992, Journal of Korean Medical Science, V7, P47; Spencer JV, 2008, VIROLOGY, V374, P164, DOI 10.1016/j.virol.2007.11.031; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Stratton KR, 2000, VACCINES 21 CENTURY, DOI [10.17226/5501, DOI 10.17226/5501]; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; VOGEL P, 1994, LAB ANIM SCI, V44, P25; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wang JB, 1996, J INFECT DIS, V174, P387, DOI 10.1093/infdis/174.2.387; Wu XL, 2000, AIDS RES HUM RETROV, V16, P1423, DOI 10.1089/08892220050140973; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018; YOW MD, 1989, J INFECT DIS, V159, P163, DOI 10.1093/infdis/159.2.163; Yue YJ, 2003, J GEN VIROL, V84, P3371, DOI 10.1099/vir.0.19508-0	73	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37931	10.1371/journal.pone.0037931	http://dx.doi.org/10.1371/journal.pone.0037931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655082	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900059
J	Sack, BK; Merchant, S; Markusic, DM; Nathwani, AC; Davidoff, AM; Byrne, BJ; Herzog, RW				Sack, Brandon K.; Merchant, Sherin; Markusic, David M.; Nathwani, Amit C.; Davidoff, Andrew M.; Byrne, Barry J.; Herzog, Roland W.			Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; HEMOPHILIA-A MICE; IMMUNE TOLERANCE; FACTOR-IX; RITUXIMAB; INDUCTION; VECTOR; MANAGEMENT; INHIBITORS; MECHANISM	The major complication in the treatment of hemophilia A is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). The current method for eradicating inhibitors, termed immune tolerance induction (ITI), is costly and protracted. Clinical protocols that prevent rather than treat inhibitors are not yet established. Liver-directed gene therapy hopes to achieve long-term correction of the disease while also inducing immune tolerance. We sought to investigate the use of adeno-associated viral (serotype 8) gene transfer to induce tolerance to human B domain deleted FVIII in hemophilia A mice. We administered an AAV8 vector with either human B domain deleted FVIII or a codon-optimized transgene, both under a liver-specific promoter to two strains of hemophilia A mice. Protein therapy or gene therapy was given either alone or in conjunction with anti-CD20 antibody-mediated B cell depletion. Gene therapy with a low-expressing vector resulted in sustained near-therapeutic expression. However, supplementary protein therapy revealed that gene transfer had sensitized mice to hFVIII in a high-responder strain but not in mice of a low-responding strain. This heightened response was ameliorated when gene therapy was delivered with anti-murine CD20 treatment. Transient B cell depletion prevented inhibitor formation in protein therapy, but failed to achieve a sustained hypo-responsiveness. Importantly, use of a codon-optimized hFVIII transgene resulted in sustained therapeutic expression and tolerance without a need for B cell depletion. Therefore, anti-CD20 may be beneficial in preventing vector-induced immune priming to FVIII, but higher levels of liver-restricted expression are preferred for tolerance.	[Sack, Brandon K.; Merchant, Sherin; Markusic, David M.; Byrne, Barry J.; Herzog, Roland W.] Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32611 USA; [Byrne, Barry J.; Herzog, Roland W.] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL USA; [Nathwani, Amit C.] UCL Canc Inst, Dept Haematol, London, England; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of London; University College London; St Jude Children's Research Hospital	Sack, BK (corresponding author), Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32611 USA.	rherzog@ufl.edu		Byrne, Barry J./0000-0002-7302-1756; Markusic, David/0000-0002-3774-0825	NIH [R01 HL51390, P01 HD078810, R01 HL073838, P01 HL59412, P01 DK58327]; University of Florida College of Medicine; Howard Hughes Medical Institute's Science for Life Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073838, P01HL078810, P01HL059412, R01HL109442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida College of Medicine(University of Florida); Howard Hughes Medical Institute's Science for Life Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants R01 HL51390 and P01 HD078810 (to RWH), R01 HL073838 (to AMD), and P01 HL59412 and P01 DK58327 (to BJB). BKS was supported by a Dean's Fellowship from the University of Florida College of Medicine. SM was supported by the Howard Hughes Medical Institute's Science for Life Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem A, 2009, HAEMOPHILIA, V15, P210, DOI 10.1111/j.1365-2516.2008.01865.x; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Cao O, 2009, MOL THER, V17, P1733, DOI 10.1038/mt.2009.159; Collins PW, 2009, J THROMB HAEMOST, V7, P787, DOI 10.1111/j.1538-7836.2009.03332.x; Cooper M, 2009, HUM GENE THER, V20, P767, DOI 10.1089/hum.2008.161; Di Michele DM, 2011, J THROMB HAEMOST, V9, P216, DOI 10.1111/j.1538-7836.2011.04349.x; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Foster H, 2008, MOL THER, V16, P1825, DOI 10.1038/mt.2008.186; Gangadharan B, 2006, BLOOD, V107, P3859, DOI 10.1182/blood-2005-12-4961; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Ishiwata A, 2009, J GENE MED, V11, P1020, DOI 10.1002/jgm.1391; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; Li CW, 2011, P NATL ACAD SCI USA, V108, P14258, DOI 10.1073/pnas.1109522108; Lu H, 2008, HUM GENE THER, V19, P648, DOI 10.1089/hum.2007.0182; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Moghimi B, 2011, J THROMB HAEMOST, V9, P1524, DOI 10.1111/j.1538-7836.2011.04351.x; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Odeyemi IAO, 2009, CURR MED RES OPIN, V25, P239, DOI 10.1185/03007990802633863 ; Padegimas L, 2012, MOL THER, V20, P63, DOI 10.1038/mt.2011.196; Pescovitz MD, 2011, J ALLERGY CLIN IMMUN, V128, P1295, DOI 10.1016/j.jaci.2011.08.008; Qadura M, 2011, HAEMOPHILIA, V17, P288, DOI 10.1111/j.1365-2516.2010.02397.x; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; Sarkar R, 2003, J THROMB HAEMOST, V1, P220, DOI 10.1046/j.1538-7836.2003.00096.x; Singh AG, 2011, THROMB HAEMOSTASIS, V106, P172, DOI 10.1160/TH11-02-0097; Streif Werner, 2009, Hamostaseologie, V29, P151; Sun BD, 2010, MOL THER, V18, P353, DOI 10.1038/mt.2009.195; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Verweij CL, 2011, DISCOV MED, V12, P229; Wang LL, 2012, MOL GENET METAB, V105, P203, DOI 10.1016/j.ymgme.2011.10.020; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Xiang Y, 2012, J IMMUNOL IN PRESS; Zhang AH, 2011, BLOOD, V117, P2223, DOI 10.1182/blood-2010-06-293324	35	67	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37671	10.1371/journal.pone.0037671	http://dx.doi.org/10.1371/journal.pone.0037671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655063	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900039
J	Gao, Y; Li, YF; Guo, X; Wu, ZG; Zhang, W				Gao, Yan; Li, Yanfeng; Guo, Xing; Wu, Zhenguo; Zhang, Wei			Loss of STAT1 in Bone Marrow-Derived Cells Accelerates Skeletal Muscle Regeneration	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SATELLITE-CELL; MYOGENIC DIFFERENTIATION; TARGETED DISRUPTION; GROWTH-FACTOR; STEM-CELL; TNF-ALPHA; IN-VIVO; MICE; PROLIFERATION	Background: Skeletal muscle regeneration is a complex process which is not yet completely understood. Evidence suggested that the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway may have a role in myogenesis. In this study, we aim to explore the possible role of STAT1 in muscle regeneration. Methods: Wild-type and STAT1 knockout mice were used in this study. Tibialis anterior muscle injury was conducted by cardiotoxin (CTX) injection. Bone marrow transplantation and glucocorticoid treatment were performed to manipulate the immune system of the mice. Results: Muscle regeneration was accelerated in STAT1-/- mice after CTX injury. Bone marrow transplantation experiments showed that the regeneration process relied on the type of donor mice rather than on recipient mice. Levels of pro-inflammatory cytokines, TNF alpha and IL-1 beta, were significantly higher in STAT1-/- mice at 1 day and/ or 2 days post-injury, while levels of anti-inflammatory cytokine, IL-10, were lower in STAT1-/- mice at 2 days and 3 days post-injury. Levels of IGF-1 were significantly higher in the STAT1-/- mice at 1 day and 2 days post-injury. Furthermore, the muscle regeneration process was inhibited in glucocorticoid-treated mice. Conclusions: Loss of STAT1 in bone marrow-derived cells accelerates skeletal muscle regeneration.	[Gao, Yan; Li, Yanfeng; Guo, Xing; Wu, Zhenguo; Zhang, Wei] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Gao, Yan] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Wu, Zhenguo; Zhang, Wei] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Zhang, Wei] Ji Nan Univ, Coll Pharm, Ji Nan Univ Hong Kong Univ Sci & Technol Joint La, Guangzhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Capital Medical University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Hong Kong University of Science & Technology; Jinan University	Gao, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	zhangweisapce@gmail.com; bczgwu@ust.hk	li, yan/GTI-4638-2022	Wu, Zhenguo/0000-0003-3049-8324	Guangdong Natural Science Foundation [10451063201005367]; Shenzhen Science and Technology Project [JC200903180682A]; Beijing Natural Science Foundation [5102008]; Beijing Municipal Commission of Education [KM201010025003]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Project; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	The study was supported by the Research Grants of Guangdong Natural Science Foundation (10451063201005367), Shenzhen Science and Technology Project (JC200903180682A), Beijing Natural Science Foundation (5102008) and Scientific Research Common Program of Beijing Municipal Commission of Education (KM201010025003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Belcastro AN, 1996, J APPL PHYSIOL, V80, P1331, DOI 10.1152/jappl.1996.80.4.1331; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; GROUNDS MD, 1987, J PATHOL, V153, P71, DOI 10.1002/path.1711530110; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Ivashkiv L B, 2000, Rev Immunogenet, V2, P220; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Launay T, 2001, J HISTOCHEM CYTOCHEM, V49, P887, DOI 10.1177/002215540104900709; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007-0061; Nguyen HX, 2003, J PHYSIOL-LONDON, V547, P125, DOI 10.1113/jphysiol.2002.031450; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Ruzek MC, 1999, J IMMUNOL, V162, P3527; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wozniak AC, 2005, MUSCLE NERVE, V31, P283, DOI 10.1002/mus.20263; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Zador E, 2001, MUSCLE NERVE, V24, P1058, DOI 10.1002/mus.1110; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	41	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37656	10.1371/journal.pone.0037656	http://dx.doi.org/10.1371/journal.pone.0037656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649549	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800068
J	Vang, LL; Medvedev, AV; Adler, J				Vang, Lar L.; Medvedev, Alexei V.; Adler, Julius			Simple Ways to Measure Behavioral Responses of Drosophila to Stimuli and Use of These Methods to Characterize a Novel Mutant	PLOS ONE			English	Article							ADULT DROSOPHILA; CENTRAL COMPLEX; GENETIC-ANALYSIS; TRP CHANNELS; TASTE; GRAVITY; PERCEPTION; HYGROSENSATION; IDENTIFICATION; MELANOGASTER	The behavioral responses of adult Drosophila fruit flies to a variety of sensory stimuli - light, volatile and non-volatile chemicals, temperature, humidity, gravity, and sound - have been measured by others previously. Some of those assays are rather complex; a review of them is presented in the Discussion. Our objective here has been to find out how to measure the behavior of adult Drosophila fruit flies by methods that are inexpensive and easy to carry out. These new assays have now been used here to characterize a novel mutant that fails to be attracted or repelled by a variety of sensory stimuli even though it is motile.	[Vang, Lar L.; Medvedev, Alexei V.; Adler, Julius] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Vang, Lar L.; Medvedev, Alexei V.; Adler, Julius] Univ Wisconsin, Dept Genet, Madison, WI 53705 USA; [Medvedev, Alexei V.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Georgetown University	Vang, LL (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	adler@biochem.wisc.edu			Camille and Henry Dreyfus Foundation	Camille and Henry Dreyfus Foundation	Julius Adler is grateful to The Camille and Henry Dreyfus Foundation for supporting our research by undergraduates the past six years by means of the Senior Scientist Mentor Program. We thank Laura Vanderploeg for the art work.	Adler J, 2011, ANNU REV BIOCHEM, V80, P42, DOI 10.1146/annurev-biochem-121609-100316; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Anholt RRH, 2001, CHEM SENSES, V26, P215, DOI 10.1093/chemse/26.2.215; Armstrong JD, 2006, GENES BRAIN BEHAV, V5, P222, DOI 10.1111/j.1601-183X.2005.00154.x; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BORST A, 1982, J COMP PHYSIOL, V147, P479, DOI 10.1007/BF00612013; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Carpenter FW, 1905, AM NAT, V39, P157, DOI 10.1086/278502; Desroches CE, 2010, GENET RES, V92, P167, DOI 10.1017/S0016672310000194; Devaud JM, 2003, BEHAV PROCESS, V64, P177, DOI 10.1016/S0376-6357(03)00134-7; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; FALK R, 1975, NATURE, V254, P325, DOI 10.1038/254325a0; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hardie RC, 2012, WILEY INTERDISCIPLIN, V1, P162, DOI [10.1002/wmts.20, DOI 10.1002/WMTS.20]; HEISENBERG M, 1994, FORTS ZOOL, V39, P61; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; HEISENBERG M, 1972, J COMP PHYSIOL, V80, P119, DOI 10.1007/BF00696485; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; HIRSCH J, 1959, J COMP PHYSIOL PSYCH, V52, P304, DOI 10.1037/h0043498; Inagaki HK, 2010, NAT PROTOC, V5, P20, DOI 10.1038/nprot.2009.196; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; LEFFELAAR D, 1984, DEV GENET, V4, P211; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; McKemy DD, 2007, PFLUG ARCH EUR J PHY, V454, P777, DOI 10.1007/s00424-006-0199-6; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Pak WL, 2010, J NEUROGENET, V24, P55, DOI 10.3109/01677061003797302; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1995, J NEUROGENET, V10, P53; Strauss R, 1955, NERV SYST BEHAV P 4; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WOODARD C, 1989, GENETICS, V123, P315; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x	60	17	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37495	10.1371/journal.pone.0037495	http://dx.doi.org/10.1371/journal.pone.0037495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649531	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800049
J	Xu, CG; Fisher, R; Wullschleger, SD; Wilson, CJ; Cai, M; McDowell, NG				Xu, Chonggang; Fisher, Rosie; Wullschleger, Stan D.; Wilson, Cathy J.; Cai, Michael; McDowell, Nate G.			Toward a Mechanistic Modeling of Nitrogen Limitation on Vegetation Dynamics	PLOS ONE			English	Article							ELEVATED CO2; PHOTOSYNTHETIC ACCLIMATION; STOMATAL CONDUCTANCE; GROWTH TEMPERATURE; LIGHT GRADIENTS; SHADE TOLERANCE; LEAF NITROGEN; PLANT-GROWTH; CARBON GAIN; PINUS-TAEDA	Nitrogen is a dominant regulator of vegetation dynamics, net primary production, and terrestrial carbon cycles; however, most ecosystem models use a rather simplistic relationship between leaf nitrogen content and photosynthetic capacity. Such an approach does not consider how patterns of nitrogen allocation may change with differences in light intensity, growing-season temperature and CO2 concentration. To account for this known variability in nitrogen-photosynthesis relationships, we develop a mechanistic nitrogen allocation model based on a trade-off of nitrogen allocated between growth and storage, and an optimization of nitrogen allocated among light capture, electron transport, carboxylation, and respiration. The developed model is able to predict the acclimation of photosynthetic capacity to changes in CO2 concentration, temperature, and radiation when evaluated against published data of V-c,V-max (maximum carboxylation rate) and J(max) (maximum electron transport rate). A sensitivity analysis of the model for herbaceous plants, deciduous and evergreen trees implies that elevated CO2 concentrations lead to lower allocation of nitrogen to carboxylation but higher allocation to storage. Higher growing-season temperatures cause lower allocation of nitrogen to carboxylation, due to higher nitrogen requirements for light capture pigments and for storage. Lower levels of radiation have a much stronger effect on allocation of nitrogen to carboxylation for herbaceous plants than for trees, resulting from higher nitrogen requirements for light capture for herbaceous plants. As far as we know, this is the first model of complete nitrogen allocation that simultaneously considers nitrogen allocation to light capture, electron transport, carboxylation, respiration and storage, and the responses of each to altered environmental conditions. We expect this model could potentially improve our confidence in simulations of carbon-nitrogen interactions and the vegetation feedbacks to climate in Earth system models.	[Xu, Chonggang; Wilson, Cathy J.; McDowell, Nate G.] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Wullschleger, Stan D.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Fisher, Rosie] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Cai, Michael] Los Alamos Natl Lab, Div Intelligence & Space Res, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; National Center Atmospheric Research (NCAR) - USA; United States Department of Energy (DOE); Los Alamos National Laboratory	Xu, CG (corresponding author), Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA.	xuchongang@gmail.com	fisher, rosie/Y-4226-2019; Wullschleger, Stan D/B-8297-2012; Fisher, Rosie A/E-7746-2013	fisher, rosie/0000-0003-3260-9227; Wullschleger, Stan D/0000-0002-9869-0446; Xu, Chonggang/0000-0002-0937-5744	Department of Energy, Office of Science, Biological and Environmental Research (BER); Los Alamos National Laboratory (LANL); US Department of Energy [DE-AC05-00OR22725]; National Science Foundation	Department of Energy, Office of Science, Biological and Environmental Research (BER)(United States Department of Energy (DOE)); Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory); US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work is funded by Department of Energy, Office of Science, Biological and Environmental Research (BER) and Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development (LDRD) Program. This paper is published under the public release code of LA-UR-11-12108. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the US Department of Energy under contract DE-AC05-00OR22725. Rosie Fisher is funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 1997, ECOL MODEL, V101, P61, DOI 10.1016/S0304-3800(97)01953-4; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; BENDALL DS, 1958, BIOCHEM J, V70, P381, DOI 10.1042/bj0700381; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bonan GB, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001593; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Crous KY, 2008, TREE PHYSIOL, V28, P607, DOI 10.1093/treephys/28.4.607; Dewar RC, 2009, BIOSCIENCE, V59, P127, DOI 10.1525/bio.2009.59.2.6; EHLERINGER J, 1977, PLANT PHYSIOL, V59, P86, DOI 10.1104/pp.59.1.86; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fisher JB, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003621; FRIEND AD, 1991, PLANT CELL ENVIRON, V14, P895, DOI 10.1111/j.1365-3040.1991.tb00958.x; Haldimann P, 1998, PLANT CELL ENVIRON, V21, P200, DOI 10.1046/j.1365-3040.1998.00260.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hikosaka K, 2005, PLANT CELL PHYSIOL, V46, P1283, DOI 10.1093/pcp/pci137; HIKOSAKA K, 1995, PLANT CELL ENVIRON, V18, P605, DOI 10.1111/j.1365-3040.1995.tb00562.x; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281; HOLADAY AS, 1992, PLANT PHYSIOL, V98, P1105, DOI 10.1104/pp.98.3.1105; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kleijn D, 2005, NEW PHYTOL, V166, P565, DOI 10.1111/j.1469-8137.2005.01321.x; Kobayashi T., 1999, PLANT SPEC BIOL, V47, P155; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leegood R. C., 2004, PHOTOSYNTHESIS ENV, P191; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; MAKINO A, 1994, PLANT PHYSIOL, V105, P1231, DOI 10.1104/pp.105.4.1231; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; McCarthy HR, 2010, NEW PHYTOL, V185, P514, DOI 10.1111/j.1469-8137.2009.03078.x; McMurtrie RE, 2011, TREE PHYSIOL, V31, P1007, DOI 10.1093/treephys/tpr037; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; Niinemets U, 1998, TREE PHYSIOL, V18, P681; Niinemets U, 1998, TREE PHYSIOL, V18, P467; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Niinemets U, 1997, FUNCT ECOL, V11, P518, DOI 10.1046/j.1365-2435.1997.00109.x; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Nordin A, 1997, OECOLOGIA, V110, P487, DOI 10.1007/s004420050184; OAKS A, 1980, PLANTA, V148, P477, DOI [10.1007/BF00552663, 10.1007/BF02395318]; Perez R, 2002, SOL ENERGY, V73, P307, DOI 10.1016/S0038-092X(02)00122-6; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; REICH PB, 1995, OECOLOGIA, V104, P24, DOI 10.1007/BF00365558; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Ripullone F, 2003, TREE PHYSIOL, V23, P137, DOI 10.1093/treephys/23.2.137; Rogers A, 2002, PLANT CELL ENVIRON, V25, P851, DOI 10.1046/j.1365-3040.2002.00868.x; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; Seiwa K, 2007, ANN BOT-LONDON, V99, P537, DOI 10.1093/aob/mcl283; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; Tang JY, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011724; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Verkroost AWM, 2005, ANN BOT-LONDON, V96, P871, DOI 10.1093/aob/mci239; Warren CR, 2003, TREES-STRUCT FUNCT, V17, P359, DOI 10.1007/s00468-003-0246-2	59	43	44	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37914	10.1371/journal.pone.0037914	http://dx.doi.org/10.1371/journal.pone.0037914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649564	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800084
J	Zhao, YL; Wayne, NL				Zhao, Yali; Wayne, Nancy L.			Effects of Kisspeptin1 on Electrical Activity of an Extrahypothalamic Population of Gonadotropin-Releasing Hormone Neurons in Medaka (Oryzias latipes)	PLOS ONE			English	Article							MONKEY MACACA-MULATTA; TERMINAL NERVE-CELLS; ADULT MALE RATS; TESTICULAR DEGENERATION; REPRODUCTIVE-BEHAVIOR; TRANSGENIC MEDAKA; ACTIVATION; BRAIN; GPR54; RECEPTOR	Kisspeptin (product of the kiss1 gene) is the most potent known activator of the hypothalamo-pituitary-gonadal axis. Both kiss1 and the kisspeptin receptor are highly expressed in the hypothalamus of vertebrates, and low doses of kisspeptin have a robust and long-lasting stimulatory effect on the rate of action potential firing of hypophysiotropic gonadotropin releasing hormone-1 (GnRH1) neurons in mice. Fish have multiple populations of GnRH neurons distinguished by their location in the brain and the GnRH gene that they express. GnRH3 neurons located in the terminal nerve (TN) associated with the olfactory bulb are neuromodulatory and do not play a direct role in regulating pituitary-gonadal function. In medaka fish, the electrical activity of TN-GnRH3 neurons is modulated by visual cues from conspecifics, and is thought to act as a transmitter of information from the external environment to the central nervous system. TN-GnRH3 neurons also play a role in sexual motivation and arousal states, making them an important population of neurons to study for understanding coordination of complex behaviors. We investigated the role of kisspeptin in regulating electrical activity of TN-GnRH3 neurons in adult medaka. Using electrophysiology in an intact brain preparation, we show that a relatively brief treatment with 100 nM of kisspeptin had a long-lasting stimulatory effect on the electrical activity of an extrahypothalamic population of GnRH neurons. Dose-response analysis suggests a relatively narrow activational range of this neuropeptide. Further, blocking action potential firing with tetrodotoxin and blocking synaptic transmission with a low Ca2+/high Mg2+ solution inhibited the stimulatory action of kisspeptin on electrical activity, indicating that kisspeptin is acting indirectly through synaptic regulation to excite TN-GnRH3 neurons. Our findings provide a new perspective on kisspeptin's broader functions within the central nervous system, through its regulation of an extrahypothalamic population of GnRH neurons involved in multiple neuromodulatory functions.	[Zhao, Yali; Wayne, Nancy L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhao, YL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	nwayne@mednet.ucla.edu			National Institutes of Health [HD053767]; Department of Physiology and Office of the Vice Chancellor for Research, University of California Los Angeles; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Physiology and Office of the Vice Chancellor for Research, University of California Los Angeles; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health HD053767 (subcontract to NLW); and by funds from the Department of Physiology and Office of the Vice Chancellor for Research, University of California Los Angeles (NLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J REPROD DEVELOP, V57, P665, DOI 10.1262/jrd.11-055E; AMANO M, 1991, J COMP NEUROL, V314, P587, DOI 10.1002/cne.903140313; Arai AC, 2009, PEPTIDES, V30, P16, DOI 10.1016/j.peptides.2008.07.023; Behrens U, 2004, MICROSC RES TECHNIQ, V65, P25, DOI 10.1002/jemt.20108; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clasadonte J, 2008, ENDOCRINOLOGY, V149, P587, DOI 10.1210/en.2007-1260; Eisthen HL, 2000, J NEUROSCI, V20, P3947; Fu LY, 2010, J NEUROSCI, V30, P10205, DOI 10.1523/JNEUROSCI.2098-10.2010; George JT, 2011, J CLIN ENDOCR METAB, V96, pE1228, DOI 10.1210/jc.2011-0089; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Mitani Y, 2010, ENDOCRINOLOGY, V151, P1751, DOI 10.1210/en.2009-1174; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Nunemaker Craig S., 2003, Biological Procedures Online, V5, P53, DOI 10.1251/bpo46; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ogawa S, 2012, ENDOCRINOLOGY, V153, P2398, DOI 10.1210/en.2012-1062; OKA Y, 1995, J PHYSIOL-LONDON, V482, P1; OKA Y, 1993, J NEUROSCI, V13, P2161; Oka Y, 2009, J NEUROENDOCRINOL, V21, P334, DOI 10.1111/j.1365-2826.2009.01850.x; Okubo K, 2006, ENDOCRINOLOGY, V147, P1076, DOI 10.1210/en.2005-0468; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; Plant TM, 2006, ENDOCRINOLOGY, V147, P1007, DOI 10.1210/en.2005-1261; Ramakrishnan S, 2009, AM J PHYSIOL-REG I, V297, pR135, DOI 10.1152/ajpregu.00143.2009; Seminara SB, 2006, ENDOCRINOLOGY, V147, P2122, DOI 10.1210/en.2005-1550; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Thompson EL, 2009, BRIT J PHARMACOL, V156, P609, DOI 10.1111/j.1476-5381.2008.00061.x; Thompson EL, 2006, AM J PHYSIOL-ENDOC M, V291, pE1074, DOI 10.1152/ajpendo.00040.2006; Wayne NL, 2007, GEN COMP ENDOCR, V150, P41, DOI 10.1016/j.ygcen.2006.07.004; Wayne NL, 2005, BIOL REPROD, V73, P1228, DOI 10.1095/biolreprod.105.042721; Yamamoto N, 1997, NEUROENDOCRINOLOGY, V65, P403, DOI 10.1159/000127203	37	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37909	10.1371/journal.pone.0037909	http://dx.doi.org/10.1371/journal.pone.0037909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649563	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800083
J	Cao, ZL; Meng, JZ; Li, XX; Wu, RP; Huang, YX; He, YX				Cao, Zhiliang; Meng, Jiazi; Li, Xingxing; Wu, Ruiping; Huang, Yanxin; He, Yuxian			The Epitope and Neutralization Mechanism of AVFluIgG01, a Broad-Reactive Human Monoclonal Antibody against H5N1 Influenza Virus	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; A VIRUS; HEMAGGLUTININ MOLECULE; ANTIGENIC STRUCTURE; CONSERVED EPITOPE; FUSION-INHIBITION; RECEPTOR-BINDING; CELL EPITOPES; INFECTION; PREDICTION	The continued spread of highly pathogenic avian influenza (HPAI) H5N1 virus underscores the importance of effective antiviral approaches. AVFluIgG01 is a potent and broad-reactive H5N1-neutralizing human monoclonal antibody (mAb) showing great potential for use either for therapeutic purposes or as a basis of vaccine development, but its antigenic epitope and neutralization mechanism have not been finely characterized. In this study, we first demonstrated that AVFluIgG01 targets a novel conformation-dependent epitope in the globular head region of H5N1 hemagglutinin (HA). By selecting mimotopes from a random peptide library in combination with computational algorithms and site-directed mutagenesis, the epitope was mapped to three conserved discontinuous sites (I-III) that are located closely at the three-dimensional structure of HA. Further, we found that this HA1-specific human mAb can efficiently block both virus-receptor binding and post-attachment steps, while its Fab fragment exerts the post-attachment inhibition only. Consistently, AVFluIgG01 could inhibit HA-mediated cell-cell membrane fusion at a dose-dependent manner and block the acquisition of pH-induced protease sensitivity. These results suggest a neutralization mechanism of AVFluIgG01 by simultaneously blocking viral attachment to the receptors on host cells and interfering with HA conformational rearrangements associated with membrane fusion. The presented data provide critical information for developing novel antiviral therapeutics and vaccines against HPAI H5N1 virus.	[Cao, Zhiliang; Meng, Jiazi; Li, Xingxing; He, Yuxian] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China; [Cao, Zhiliang; Meng, Jiazi; Li, Xingxing; He, Yuxian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Ruiping] Wenzhou Med Coll, Wenzhou, Peoples R China; [Huang, Yanxin] No Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wenzhou Medical University	Cao, ZL (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China.	yhe@ipb.pumc.edu.cn			NSFC [81025009]; National 973 program of China [2010CB530100]; National Science and Technology Major Project [2012ZX10001-008]	NSFC(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); National Science and Technology Major Project	This work was supported by grants from the National Outstanding Youth Award of NSFC (81025009), and the National 973 program of China (2010CB530100), and the National Science and Technology Major Project (2012ZX10001-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Edwards MJ, 2001, J VIROL, V75, P10208, DOI 10.1128/JVI.75.21.10208-10218.2001; Edwards MJ, 2000, VIROLOGY, V278, P423, DOI 10.1006/viro.2000.0631; Edwards MJ, 2001, J GEN VIROL, V82, P1387, DOI 10.1099/0022-1317-82-6-1387; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Geeraedts F, 2011, ADV EXP MED BIOL, V780, P161, DOI 10.1007/978-1-4419-5632-3_13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gocnik M, 2007, J GEN VIROL, V88, P951, DOI 10.1099/vir.0.82563-0; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Huang YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-538; Irving MB, 2010, MOL IMMUNOL, V47, P1137, DOI 10.1016/j.molimm.2009.10.015; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Li OTW, 2009, EXPERT REV ANTI-INFE, V7, P687, DOI [10.1586/eri.09.48, 10.1586/ERI.09.48]; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Morris Glenn E, 2005, Methods Mol Biol, V295, P255; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Yen HL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000064; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	39	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38126	10.1371/journal.pone.0038126	http://dx.doi.org/10.1371/journal.pone.0038126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662275	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300167
J	Chaurasia, SS; Champakalakshmi, R; Li, A; Poh, R; Tan, XW; Lakshminarayanan, R; Lim, CT; Tan, DT; Mehta, JS				Chaurasia, Shyam S.; Champakalakshmi, Ravi; Li, Ang; Poh, Rebekah; Tan, Xiao Wei; Lakshminarayanan, Rajamani; Lim, Chwee T.; Tan, Donald T.; Mehta, Jodhbir S.			Effect of Fibrin Glue on the Biomechanical Properties of Human Descemet's Membrane	PLOS ONE			English	Article							AUTOMATED ENDOTHELIAL KERATOPLASTY; POSTERIOR LAMELLAR KERATOPLASTY; ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; NORMAL CORNEAS; TRANSPLANTATION; CELLS; DMEK; ELASTICITY; MODULUS	Background: Corneal transplantation has rapidly evolved from full-thickness penetrating keratoplasty (PK) to selective tissue corneal transplantation, where only the diseased portions of the patient's corneal tissue are replaced with healthy donor tissue. Descemet's membrane endothelial keratoplasty (DMEK) performed in patients with corneal endothelial dysfunction is one such example where only a single layer of endothelial cells with its basement membrane (10-15 mu m in thickness), Descemet's membrane (DM) is replaced. It is challenging to replace this membrane due to its intrinsic property to roll in an aqueous environment. The main objective of this study was to determine the effects of fibrin glue (FG) on the biomechanical properties of DM using atomic force microscopy (AFM) and relates these properties to membrane folding propensity. Methodology/Principal Findings: Fibrin glue was sprayed using the EasySpray applicator system, and the biomechanical properties of human DM were determined by AFM. We studied the changes in the "rolling up'' tendency of DM by examining the changes in the elasticity and flexural rigidity after the application of FG. Surface topography was assessed using scanning electron microscopy (SEM) and AFM imaging. Treatment with FG not only stabilized and stiffened DM but also led to a significant increase in hysteresis of the glue-treated membrane. In addition, flexural or bending rigidity values also increased in FG-treated membranes. Conclusions/Significance: Our results suggest that fibrin glue provides rigidity to the DM/endothelial cell complex that may aid in subsequent manipulation by maintaining tissue integrity.	[Chaurasia, Shyam S.; Champakalakshmi, Ravi; Poh, Rebekah; Tan, Xiao Wei; Lakshminarayanan, Rajamani; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Li, Ang; Lim, Chwee T.] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Li, Ang; Lim, Chwee T.] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Lim, Chwee T.] Mechanobiol Inst, Singapore, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Mehta, Jodhbir S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Chaurasia, SS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	jodmehta@gmail.com	Mehta, Jodhbir/O-6192-2015; Chaurasia, Shyam/AAB-4709-2019; Lim, chwee Teck/B-3307-2011; Rajamani, Lakshminarayanan/AAG-5541-2019	Chaurasia, Shyam/0000-0001-8725-676X; Lim, chwee Teck/0000-0003-4019-9782; Rajamani, Lakshminarayanan/0000-0001-8214-5315	National Medical Research Council (NMRC) [NIGSERI/2009-R711/61/2009]; National Research Foundation [NMRC/TCR/002-SERI/2008-TCR621/41/2008]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); National Research Foundation	This work was supported by National Medical Research Council (NMRC) New Investigator Grant [NIGSERI/2009-R711/61/2009] and National Research Foundation-Funded Translational & Clinical Research (TCR) Programme Grant [NMRC/TCR/002-SERI/2008-TCR621/41/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Albala DM, 2006, J AM COLL SURGEONS, V202, P685, DOI 10.1016/j.jamcollsurg.2005.11.027; Bahar I, 2009, BRIT J OPHTHALMOL, V93, P186, DOI 10.1136/bjo.2007.136630; Bourne WM, 2010, EYE CONTACT LENS, V36, P310, DOI 10.1097/ICL.0b013e3181ee1450; Busin M, 2010, OPHTHALMOLOGY, V117, P2273, DOI 10.1016/j.ophtha.2010.03.038; Champalakshmi R, 2011, OPTIMIZATION COMPARI; Chen ES, 2008, CORNEA, V27, P514, DOI 10.1097/ICO.0b013e3181611c50; Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/jbm.a.31186; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Fischbarg J, 2004, EXP EYE RES, V78, P537, DOI 10.1016/j.exer.2003.09.010; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Hall RC, 2009, CLIN EXP OPHTHALMOL, V37, P584, DOI 10.1111/j.1442-9071.2009.02105.x; Hjortdal JO, 1996, J BIOMECH, V29, P931, DOI 10.1016/0021-9290(95)00152-2; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; JOHNSON DH, 1982, ARCH OPHTHALMOL-CHIC, V100, P1942, DOI 10.1001/archopht.1982.01030040922011; Kaufman HE, 2003, OPHTHALMOLOGY, V110, P2168, DOI 10.1016/S0161-6420(03)00832-7; KENNEY MC, 1979, INVEST OPHTH VIS SCI, V18, P527; LAGOUTTE FM, 1989, BRIT J OPHTHALMOL, V73, P757, DOI 10.1136/bjo.73.9.757; Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012; Lie JT, 2008, J CATARACT REFR SURG, V34, P1578, DOI 10.1016/j.jcrs.2008.05.036; McCauley MB, 2009, J CATARACT REFR SURG, V35, P1659, DOI 10.1016/j.jcrs.2009.05.034; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Mehta JS, 2008, J CATARACT REFR SURG, V34, P889, DOI 10.1016/j.jcrs.2008.01.037; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 2002, CORNEA, V21, P415, DOI 10.1097/00003226-200205000-00016; Muftuoglu O, 2010, OPHTHALMOLOGY, V117, P878, DOI 10.1016/j.ophtha.2010.02.001; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P1402; NASH IS, 1982, EXP EYE RES, V35, P413, DOI 10.1016/0014-4835(82)90040-9; Ozcan AA, 2008, ANN OPHTHALMOL, V40, P107; Park HC, 2011, EXPERT REV OPHTHALMO, V6, P631, DOI 10.1586/EOP.11.64; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Ramos-Esteban JC, 2006, TECH OPHTHALMOL, V4, P30; Rasband WS, 2011, IMAGEJ; REID TW, 1994, PROG RETIN EYE RES, V13, P507, DOI 10.1016/1350-9462(94)90021-3; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Sidelmann JJ, 2000, SEMIN THROMB HEMOST, V26, P605, DOI 10.1055/s-2000-13216; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Terry MA, 2001, CORNEA, V20, P239, DOI 10.1097/00003226-200104000-00001; Timoshenko SP, 1959, THEORY PLATES SHELLS, P68; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P393; WARING GO, 1987, SURV OPHTHALMOL, V31, P262, DOI 10.1016/0039-6257(87)90025-7; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; Yeh DL, 2006, AM J OPHTHALMOL, V141, P960, DOI 10.1016/j.ajo.2005.12.001; Yeh Patrick C., 2004, International Ophthalmology Clinics, V44, P51, DOI 10.1097/00004397-200404410-00007	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37456	10.1371/journal.pone.0037456	http://dx.doi.org/10.1371/journal.pone.0037456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662156	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300046
J	Lindell, K; Fahlgren, A; Hjerde, E; Willassen, NP; Fallman, M; Milton, DL				Lindell, Kristoffer; Fahlgren, Anna; Hjerde, Erik; Willassen, Nils-Peder; Fallman, Maria; Milton, Debra L.			Lipopolysaccharide O-Antigen Prevents Phagocytosis of Vibrio anguillarum by Rainbow Trout (Oncorhynchus mykiss) Skin Epithelial Cells	PLOS ONE			English	Article							EPIDERMAL MALPIGHIAN CELLS; TELEOST FISH EPIDERMIS; ESCHERICHIA-COLI; CORE LIPOPOLYSACCHARIDE; VARYING TEMPERATURES; TISSUE LOCALIZATION; MITOTIC-ACTIVITY; VIRULENCE; BINDING; RESISTANCE	Colonization of host tissues is a first step taken by many pathogens during the initial stages of infection. Despite the impact of bacterial disease on wild and farmed fish, only a few direct studies have characterized bacterial factors required for colonization of fish tissues. In this study, using live-cell and confocal microscopy, rainbow trout skin epithelial cells, the main structural component of the skin epidermis, were demonstrated to phagocytize bacteria. Mutant analyses showed that the fish pathogen Vibrio anguillarum required the lipopolysaccharide O-antigen to evade phagocytosis and that O-antigen transport required the putative wzm-wzt-wbhA operon, which encodes two ABC polysaccharide transporter proteins and a methyltransferase. Pretreatment of the epithelial cells with mannose prevented phagocytosis of V. anguillarum suggesting that a mannose receptor is involved in the uptake process. In addition, the O-antigen transport mutants could not colonize the skin but they did colonize the intestines of rainbow trout. The O-antigen polysaccharides were also shown to aid resistance to the antimicrobial factors, lysozyme and polymyxin B. In summary, rainbow trout skin epithelial cells play a role in the fish innate immunity by clearing bacteria from the skin epidermis. In defense, V. anguillarum utilizes O-antigen polysaccharides to evade phagocytosis by the epithelial cells allowing it to colonize rapidly fish skin tissues.	[Lindell, Kristoffer; Fahlgren, Anna; Fallman, Maria; Milton, Debra L.] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden; [Milton, Debra L.] So Res Inst, Birmingham, AL 35255 USA; [Hjerde, Erik; Willassen, Nils-Peder] Univ Tromso, Dept Chem, Fac Sci & Technol, Tromso, Norway	Umea University; UiT The Arctic University of Tromso	Lindell, K (corresponding author), Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden.	miltond@southernresearch.org	Willassen, Nils Peder/AAE-1843-2019	Willassen, Nils Peder/0000-0002-4397-8020; Lindell, Kristoffer/0000-0001-5609-6097; Hjerde, Erik/0000-0002-6014-1249	Swedish Council for Environment, Agricultural Sciences and Spatial Planning [221-2O10-577]; Carl Tryggers Foundation, Sweden [CTS: 10-261]; Swedish Research Council; Natural Science Faculty of Umea University	Swedish Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Carl Tryggers Foundation, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Science Faculty of Umea University	This work was performed within the Umea Centre for Microbial Research and was supported by funding from the Swedish Council for Environment, Agricultural Sciences and Spatial Planning (221-2O10-577), from the Carl Tryggers Foundation, Sweden (CTS: 10-261), from the Swedish Research Council, and from the Natural Science Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis LA, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P570, DOI 10.1079/9781845935542.0570; AOKI T, 1985, B JPN SOC SCI FISH, V51, P1249; Asbakk K, 1998, J MAR BIOTECHNOL, V6, P30; Asbakk K, 2001, J FISH BIOL, V58, P953, DOI 10.1111/j.1095-8649.2001.tb00547.x; AUSTIN B, 1999, BACTERIAL FISH PATHO, P272; Bereiter-Hahn J., 1986, BIOL INTEGUMENT, P443; Boesen HT, 1999, INFECT IMMUN, V67, P294, DOI 10.1128/IAI.67.1.294-301.1999; BULLOCK AM, 1978, J ZOOL, V185, P197; BULLOCK AM, 1978, J ZOOL, V184, P423; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hansen GH, 1999, MICROB ECOL, V38, P1, DOI 10.1007/s002489900158; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Irie T, 2004, J VET MED SCI, V66, P205, DOI 10.1292/jvms.66.205; Kania PW, 2010, FISH SHELLFISH IMMUN, V29, P910, DOI 10.1016/j.fsi.2010.07.020; Kanno T., 1989, Journal of Aquatic Animal Health, V1, P2, DOI 10.1577/1548-8667(1989)001&lt;0002:MOTOVA&gt;2.3.CO;2; Karlsen C, 2012, VET MICROBIOL, V154, P353, DOI 10.1016/j.vetmic.2011.07.024; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Klena J, 2005, J BACTERIOL, V187, P1710, DOI 10.1128/JB.187.5.1710-1715.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; McGee K, 1996, J BACTERIOL, V178, P5188, DOI 10.1128/jb.178.17.5188-5198.1996; MEIGHEN EA, 1993, ADV MICROB PHYSIOL, V34, P1, DOI 10.1016/S0065-2911(08)60027-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; MUROGA K, 1987, FISH PATHOL, V22, P99, DOI 10.3147/jsfp.22.99; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Naka H, 2011, INFECT IMMUN, V79, P2889, DOI 10.1128/IAI.05138-11; Naka H, 2011, FISH PATHOL, V46, P1, DOI 10.3147/jsfp.46.1; NORQVIST A, 1993, INFECT IMMUN, V61, P2434, DOI 10.1128/IAI.61.6.2434-2444.1993; PHROMSUTHIRAK P, 1977, J FISH BIOL, V11, P193, DOI 10.1111/j.1095-8649.1977.tb04113.x; Plante CJ, 2000, AQUAT MICROB ECOL, V21, P211, DOI 10.3354/ame021211; PRESTON MA, 1987, INFECT IMMUN, V55, P1806, DOI 10.1128/IAI.55.8.1806-1812.1987; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rakers S, 2010, EXP DERMATOL, V19, P313, DOI 10.1111/j.1600-0625.2009.01059.x; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Russell S, 2008, FISH SHELLFISH IMMUN, V25, P91, DOI 10.1016/j.fsi.2008.02.018; Russell S, 2008, FISH SHELLFISH IMMUN, V24, P669, DOI 10.1016/j.fsi.2007.11.002; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Spanggaard B, 2000, J FISH DIS, V23, P423, DOI 10.1046/j.1365-2761.2000.00257.x; Stroeher UH, 1998, GENE, V223, P269, DOI 10.1016/S0378-1119(98)00407-7; Suzuki Y, 2003, COMP BIOCHEM PHYS B, V136, P723, DOI 10.1016/S1096-4959(03)00178-7; TRUST TJ, 1981, INFECT IMMUN, V34, P702, DOI 10.1128/IAI.34.3.702-707.1981; Tsutsui S, 2005, DEV COMP IMMUNOL, V29, P243, DOI 10.1016/j.dci.2004.06.005; Weber B, 2010, ENV MICROBIOL REP, V2, P133, DOI 10.1111/j.1758-2229.2009.00120.x; Welch TJ, 2005, INFECT IMMUN, V73, P5864, DOI 10.1128/IAI.73.9.5864-5872.2005; Zelensky AN, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-51; Zhang P, 2006, J IMMUNOL, V177, P4002, DOI 10.4049/jimmunol.177.6.4002	56	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37678	10.1371/journal.pone.0037678	http://dx.doi.org/10.1371/journal.pone.0037678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662189	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300079
J	Morris, DR; Moxon, JV; Biros, E; Krishna, SM; Golledge, J				Morris, Dylan R.; Moxon, Joseph V.; Biros, Erik; Krishna, Smriti M.; Golledge, Jonathan			Meta-Analysis of the Association between Transforming Growth Factor-Beta Polymorphisms and Complications of Coronary Heart Disease	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; GENE POLYMORPHISMS; GROWTH-FACTOR-BETA-1 GENE; TGF-BETA; SUSCEPTIBILITY	Objective: To investigate the association between common transforming growth factor beta (TGF-beta) single nucleotide polymorphisms (SNP) and significant complications of coronary heart disease (CHD). Method: We performed a meta-analysis of published case-control studies assessing the association of TGF-beta SNPs with a range of CHD complications. A random effects model was used to calculate odds ratios and confidence intervals. Analyses were conducted for additive, dominant and recessive modes of inheritance. Results: Six studies involving 5535 cases and 2970 controls examining the association of common SNPs in TGF-beta 1 with CHD were identified. Applying a dominant model of inheritance, three TGF-beta 1 SNPs were significantly associated with CHD complications: The T alleles of rs1800469 (OR = 1.125, 95% CI 1.016-1.247, p = 0.031) and rs1800470 (OR = 1.146, 95% CI 1.026-1.279, p = 0.021); and the C allele of rs1800471 (OR = 1.207, 95% CI 1.037-1.406, p = 0.021). Conclusion: This meta-analysis suggests that common genetic polymorphisms in TGF-beta 1 are associated with complications of CHD.	[Morris, Dylan R.; Moxon, Joseph V.; Biros, Erik; Krishna, Smriti M.; Golledge, Jonathan] James Cook Univ, Vasc Biol Unit, Sch Med & Dent, Townsville, Qld 4811, Australia	James Cook University	Morris, DR (corresponding author), James Cook Univ, Vasc Biol Unit, Sch Med & Dent, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	Moxon, Joseph/C-3585-2011; golledge, jonathan/I-2371-2013; KRISHNA, SMRITI/G-7791-2012	Moxon, Joseph/0000-0002-2131-2068; KRISHNA, SMRITI/0000-0002-0810-5144	National Heart Foundation of Australia; Practitioner Fellowship from the National Health and Medical Research Council, Australia; Senior Clinical Research Fellowship, from the Queensland Government; National and International Research Alliance Program (NIRAP) grant, from the Queensland Government	National Heart Foundation of Australia(National Heart Foundation of Australia); Practitioner Fellowship from the National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Clinical Research Fellowship, from the Queensland Government; National and International Research Alliance Program (NIRAP) grant, from the Queensland Government	DM and EB were supported by the National Heart Foundation of Australia (http://www.heartfoundation.org.au/Pages/default.aspx). JG holds a Practitioner Fellowship from the National Health and Medical Research Council, Australia (http://www.nhmrc.gov.au/), a Senior Clinical Research Fellowship, and National and International Research Alliance Program (NIRAP) grant, both from the Queensland Government (http://www.business.qld.gov.au/science/scientific-research/scientific-government-support.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DAT SINGL NUCL POL D; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Biggart S, 1998, CLIN CARDIOL, V21, P831, DOI 10.1002/clc.4960211109; Biros E, 2011, ATHEROSCLEROSIS; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Crobu F, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-13; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hindorff LA, 2009, DFD, V106, P9362; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holweg CTJ, 2001, J HEART LUNG TRANSPL, V20, P979, DOI 10.1016/S1053-2498(01)00296-0; Koch W, 2006, ARTERIOSCL THROM VAS, V26, P1114, DOI 10.1161/01.ATV.0000217747.66517.11; Libby P., 2008, BRAUNWALDS HEART DIS; Manginas A, 2008, CORONARY ARTERY DIS, V19, P575, DOI 10.1097/MCA.0b013e32831286e8; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Patel RS, 2011, HEART, V97, P1463, DOI 10.1136/hrt.2010.219675; Rao M, 2004, KIDNEY INT, V66, P419, DOI 10.1111/j.1523-1755.2004.00748.x; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Sie MPS, 2006, STROKE, V37, P2667, DOI 10.1161/01.STR.0000244779.30070.1a; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Syrris P, 1998, CLIN SCI, V95, P659, DOI 10.1042/cs0950659; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783	24	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37878	10.1371/journal.pone.0037878	http://dx.doi.org/10.1371/journal.pone.0037878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662243	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305342300134
J	Ruisanchez, E; Cselenyak, A; Papp, RS; Nemeth, T; Kaldi, K; Sandor, P; Benyo, Z				Ruisanchez, Eva; Cselenyak, Attila; Papp, Rege Sugarka; Nemeth, Tamas; Kaldi, Krisztina; Sandor, Peter; Benyo, Zoltan			Perivascular Expression and Potent Vasoconstrictor Effect of Dynorphin A in Cerebral Arteries	PLOS ONE			English	Article							RAT SPINAL-CORD; SENSITIVE K+ CHANNELS; SMOOTH-MUSCLE-CELLS; NEWBORN PIGS; BRAIN-INJURY; TRAUMATIC INJURY; OPIOID RECEPTORS; CEREBROVASCULAR RESPONSES; NEUROPEPTIDE-Y; NERVE-FIBERS	Background: Numerous literary data indicate that dynorphin A (DYN-A) has a significant impact on cerebral circulation, especially under pathophysiological conditions, but its potential direct influence on the tone of cerebral vessels is obscure. The aim of the present study was threefold: 1) to clarify if DYN-A is present in cerebral vessels, 2) to determine if it exerts any direct effect on cerebrovascular tone, and if so, 3) to analyze the role of kappa-opiate receptors in mediating the effect. Methodology/Principal Findings: Immunohistochemical analysis revealed the expression of DYN-A in perivascular nerves of rat pial arteries as well as in both rat and human intraparenchymal vessels of the cerebral cortex. In isolated rat basilar and middle cerebral arteries (BAs and MCAs) DYN-A (1-13) and DYN-A (1-17) but not DYN-A (1-8) or dynorphin B (DYN-B) induced strong vasoconstriction in micromolar concentrations. The maximal effects, compared to a reference contraction induced by 124 mM K+, were 115 +/- 6% and 104 +/- 10% in BAs and 113 +/- 3% and 125 +/- 9% in MCAs for 10 mM of DYN-A (1-13) and DYN-A (1-17), respectively. The vasoconstrictor effects of DYN-A (1-13) could be inhibited but not abolished by both the kappa-opiate receptor antagonist nor-Binaltorphimine dihydrochloride (NORBI) and blockade of G(i/o)-protein mediated signaling by pertussis toxin. Finally, des-Tyr(1) DYN-A (2-13), which reportedly fails to activate kappa-opiate receptors, induced vasoconstriction of 45 +/- 11% in BAs and 50 +/- 5% in MCAs at 10 mu M, which effects were resistant to NORBI. Conclusion/Significance: DYN-A is present in rat and human cerebral perivascular nerves and induces sustained contraction of rat cerebral arteries. This vasoconstrictor effect is only partly mediated by kappa-opiate receptors and heterotrimeric G(i/o)-proteins. To our knowledge our present findings are the first to indicate that DYN-A has a direct cerebral vasoconstrictor effect and that a dynorphin-induced vascular action may be, at least in part, independent of kappa-opiate receptors.	[Ruisanchez, Eva; Cselenyak, Attila; Nemeth, Tamas; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary; [Papp, Rege Sugarka] Hungarian Acad Sci, Budapest, Hungary; [Papp, Rege Sugarka] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University	Ruisanchez, E (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary.	ruisanchez.eva@med.semmelweis-univ.hu	Káldi, Krisztina/X-4080-2019	Kaldi, Krisztina/0000-0002-5724-0182; Benyo, Zoltan/0000-0001-6015-0359	Hungarian National Innovation Office [OMFB-00770/2009]; Hungarian Scientific Research Fund [OTKA K-68960, K-101775]; Health Science Council [ETT 427/2009, 477/2009]; Hungarian Science and Technology Foundation (TET-SIN-CELLTHER); National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EMBO/HHMI Startup Grant	Hungarian National Innovation Office; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Health Science Council; Hungarian Science and Technology Foundation (TET-SIN-CELLTHER); National Development Agency; EMBO/HHMI Startup Grant	This study was supported by grants from the Hungarian National Innovation Office (OMFB-00770/2009), Hungarian Scientific Research Fund (OTKA K-68960 and K-101775), Health Science Council (ETT 427/2009 and 477/2009), Hungarian Science and Technology Foundation (TET-SIN-CELLTHER), National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001) and by an EMBO/HHMI Startup Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTURA BT, 1984, BRIT J PHARMACOL, V82, P459, DOI 10.1111/j.1476-5381.1984.tb10781.x; ALTURA BT, 1983, P NATL ACAD SCI-BIOL, V80, P865, DOI 10.1073/pnas.80.3.865; ARENDT RM, 1995, J PHARMACOL EXP THER, V272, P1; ARMSTEAD WM, 1995, BRAIN RES, V689, P183, DOI 10.1016/0006-8993(95)00533-V; ARMSTEAD WM, 1990, J PHARMACOL EXP THER, V255, P1083; Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; Armstead WM, 1997, BRAIN RES, V747, P252, DOI 10.1016/S0006-8993(96)01284-X; ARMSTEAD WM, 1992, BRAIN RES, V571, P97, DOI 10.1016/0006-8993(92)90513-9; ARMSTEAD WM, 1992, J PHARMACOL EXP THER, V260, P1107; ARMSTEAD WM, 1992, AM J PHYSIOL, V262, pH862, DOI 10.1152/ajpheart.1992.262.3.H862; Benyo Z, 1996, CEREBROVAS BRAIN MET, V8, P326; Benyo Z, 2000, BRAIN RES, V877, P79, DOI 10.1016/S0006-8993(00)02611-1; Brugos B, 2004, PHARMAZIE, V59, P339; CAUDLE RM, 1988, BRAIN RES, V443, P329, DOI 10.1016/0006-8993(88)91628-9; CAUDLE RM, 1987, BRAIN RES, V435, P1, DOI 10.1016/0006-8993(87)91579-4; Deli M, 1992, NEUROCHEM INT, V21, pC3; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; Evans SJ, 2000, ENDOCRINOLOGY, V141, P2294, DOI 10.1210/en.141.7.2294; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1983, EUR J PHARMACOL, V91, P321, DOI 10.1016/0014-2999(83)90487-9; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1985, NEUROLOGY, V35, P1311, DOI 10.1212/WNL.35.9.1311; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; GRIDER JR, 1991, AM J PHYSIOL, V260, pG103, DOI 10.1152/ajpgi.1991.260.1.G103; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HARDEBO JE, 1994, J AUTONOM NERV SYST, V47, P171, DOI 10.1016/0165-1838(94)90178-3; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; Horvath B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014477; HU J, 1993, PHARMACOLOGY, V47, P351, DOI 10.1159/000139118; KAPADIA SE, 1984, BRAIN RES, V292, P33, DOI 10.1016/0006-8993(84)90887-4; KLEIN RL, 1990, J AUTONOM NERV SYST, V30, P37, DOI 10.1016/0165-1838(90)90162-C; KONG JY, 1990, PEPTIDES, V11, P565, DOI 10.1016/0196-9781(90)90060-I; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; MASSARDIER D, 1989, EUR J PHARMACOL, V170, P125, DOI 10.1016/0014-2999(89)90149-0; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; MIURA M, 1994, AM J PHYSIOL-ENDOC M, V267, pE702, DOI 10.1152/ajpendo.1994.267.5.E702; MOSKOWITZ MA, 1987, NEUROSCIENCE, V23, P731, DOI 10.1016/0306-4522(87)90090-X; MOSKOWITZ MA, 1986, CEPHALALGIA, V6, P81, DOI 10.1046/j.1468-2982.1986.0602081.x; MULLER S, 1995, PHARMACEUT RES, V12, P1165, DOI 10.1023/A:1016211910107; Muller S, 1996, NEUROCHEM RES, V21, P1213, DOI 10.1007/BF02532398; OUYANG A, 1988, AM J PHYSIOL, V254, pG224, DOI 10.1152/ajpgi.1988.254.2.G224; PICKEL VM, 1994, J NEUROSCI RES, V37, P735, DOI 10.1002/jnr.490370608; Quillan JM, 1997, PHARMACEUT RES, V14, P713, DOI 10.1023/A:1012185919153; Roy C S, 1890, J Physiol, V11, P85; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; SEVERI C, 1988, LIFE SCI, V42, P2373, DOI 10.1016/0024-3205(88)90191-9; SHANKAR V, 1995, AM J PHYSIOL-HEART C, V269, pH997, DOI 10.1152/ajpheart.1995.269.3.H997; Tada H, 2002, EUR J PHARMACOL, V454, P53, DOI 10.1016/S0014-2999(02)02474-3; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776, DOI 10.1152/ajpheart.1995.269.5.H1776; THURESONKLEIN A, 1989, BLOOD VESSELS, V26, P177; TONG JF, 1994, ACTA PHARM SINIC, V15, P488; UDDMAN R, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P230; Venteicher A, 1998, AM J PHYSIOL-HEART C, V275, pH2072, DOI 10.1152/ajpheart.1998.275.6.H2072; Willis Thomas, 1664, CEREBRI ANATOME CUI; YOUNG EA, 1987, PEPTIDES, V8, P701, DOI 10.1016/0196-9781(87)90046-5; ZHANG L, 1992, AM J PHYSIOL, V262, pG461, DOI 10.1152/ajpgi.1992.262.3.G461; ZHANG SW, 1995, J BIOL CHEM, V270, P22772, DOI 10.1074/jbc.270.39.22772	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37798	10.1371/journal.pone.0037798	http://dx.doi.org/10.1371/journal.pone.0037798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662226	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300116
J	Shapiro-Reznik, M; Jilg, A; Lerner, H; Earnest, DJ; Zisapel, N				Shapiro-Reznik, Mika; Jilg, Anje; Lerner, Hadas; Earnest, David J.; Zisapel, Nava			Diurnal Rhythms in Neurexins Transcripts and Inhibitory/Excitatory Synapse Scaffold Proteins in the Biological Clock	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; LONG-TERM POTENTIATION; CIRCADIAN-RHYTHMS; RECEPTOR; GABA; PLASTICITY; GLUTAMATE; CELLS; NEUROTRANSMITTER; DIFFERENTIATION	The neurexin genes (NRXN1/2/3) encode two families (alpha and beta) of highly polymorphic presynaptic proteins that are involved in excitatory/inhibitory synaptic balance. Recent studies indicate that neuronal activation and memory formation affect NRXN1/2/3 alpha expression and alternative splicing at splice sites 3 and 4 (SS#3/SS#4). Neurons in the biological clock residing in the suprachiasmatic nuclei of the hypothalamus (SCN) act as self-sustained oscillators, generating rhythms in gene expression and electrical activity, to entrain circadian bodily rhythms to the 24 hours day/night cycles. Cell autonomous oscillations in NRXN1/2/3 alpha expression and SS#3/SS#4 exons splicing and their links to rhythms in excitatory/inhibitory synaptic balance in the circadian clock were explored. NRXN1/2/3 alpha expression and SS#3/SS#4 splicing, levels of neurexin-2 alpha and the synaptic scaffolding proteins PSD-95 and gephyrin (representing excitatory and inhibitory synapses, respectively) were studied in mRNA and protein extracts obtained from SCN of C3H/J mice at different times of the 24 hours day/night cycle. Further studies explored the circadian oscillations in these components and causality relationships in immortalized rat SCN2.2 cells. Diurnal rhythms in mNRXN1 alpha and mNRXN2 alpha transcription, SS#3/SS#4 exon-inclusion and PSD-95 gephyrin and neurexin-2 alpha levels were found in the SCN in vivo. No such rhythms were found with mNRXN3 alpha. SCN2.2 cells also exhibited autonomous circadian rhythms in rNRXN1/2 expression SS#3/SS#4 exon inclusion and PSD-95, gephyrin and neurexin-2 alpha levels. rNRXN3 alpha and rNRXN1/2 beta were not expressed. Causal relationships were demonstrated, by use of specific siRNAs, between rNRXN2 alpha SS#3 exon included transcripts and gephyrin levels in the SCN2.2 cells. These results show for the first time dynamic, cell autonomous, diurnal rhythms in expression and splicing of NRXN1/2 and subsequent effects on the expression of neurexin-2 alpha and postsynaptic scaffolding proteins in SCN across the 24-h cycle. NRXNs gene transcripts may have a role in coupling the circadian clock to diurnal rhythms in excitatory/inhibitory synaptic balance.	[Shapiro-Reznik, Mika; Lerner, Hadas; Zisapel, Nava] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Jilg, Anje] Goethe Univ Frankfurt, Inst Cellular & Mol Anat, Frankfurt, Germany; [Earnest, David J.] Texas A&M Univ, Dept Neurosci & Expt Therapeut, Hlth Sci Ctr, College Stn, TX USA	Tel Aviv University; Goethe University Frankfurt; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Shapiro-Reznik, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	navazis@post.tau.ac.il	Zisapel, Nava/GRO-1677-2022	Earnest, David/0000-0003-4433-6481	AMN foundation; Chief Scientist Office of the Ministry of Health [3-3781]; Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel	AMN foundation; Chief Scientist Office of the Ministry of Health; Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel	This study was supported by a research grant from the AMN foundation and research grant no. 3-3781 from the Chief Scientist Office of the Ministry of Health, and the Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet D, 2008, GLIA, V56, P294, DOI 10.1002/glia.20613; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Earnest DJ, 1999, J NEUROBIOL, V39, P1, DOI 10.1002/(SICI)1097-4695(199904)39:1<1::AID-NEU1>3.0.CO;2-F; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Fukunaga K, 2002, J NEUROSCI RES, V70, P799, DOI 10.1002/jnr.10400; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; Girardet C, 2010, EUR J NEUROSCI, V31, P359, DOI 10.1111/j.1460-9568.2009.07071.x; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gompf HS, 2004, EUR J NEUROSCI, V19, P2791, DOI 10.1111/j.1460-9568.2004.03382.x; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GULDNER FH, 1979, NEUROSCI LETT, V14, P235, DOI 10.1016/0304-3940(79)96154-8; Hastings M H, 1999, J Neurosci, V19, pRC11; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kretschmannova K, 2005, ANN NY ACAD SCI, V1048, P103, DOI 10.1196/annals.1342.010; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meijer JH, 2010, EUR J NEUROSCI, V32, P2143, DOI 10.1111/j.1460-9568.2010.07522.x; MINORS DS, 1988, PSYCHONEUROENDOCRINO, V13, P443, DOI 10.1016/0306-4530(88)90030-3; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Moldavan MG, 2010, J NEUROPHYSIOL, V103, P2390, DOI 10.1152/jn.00695.2009; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; NISHIKAWA Y, 1995, BRAIN RES, V695, P158, DOI 10.1016/0006-8993(95)00717-5; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Petrillo Ezequiel, 2011, Commun Integr Biol, V4, P284, DOI 10.4161/cib.4.3.14777; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; River-Bermudez MA, 2004, BRAIN RES, V1002, P21, DOI 10.1016/j.brainres.2003.12.008; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	54	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37894	10.1371/journal.pone.0037894	http://dx.doi.org/10.1371/journal.pone.0037894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662246	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300137
J	Xie, CG; Wei, SM; Chen, JM; Xu, XF; Cai, JT; Chen, QY; Jia, LT				Xie, Chuan-Gao; Wei, Shu-Mei; Chen, Jia-Min; Xu, Xuan-Fu; Cai, Jian-Ting; Chen, Qin-Yu; Jia, Li-Tao			Down-Regulation of GEP100 Causes Increase in E-Cadherin Levels and Inhibits Pancreatic Cancer Cell Invasion	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; MESENCHYMAL TRANSITION; BREAST-CANCER; MONOCYTIC PHAGOCYTES; EXPRESSION; ARF6; SNAIL; SLUG; METASTASIS; ACTIVATION	Aims: Invasion and metastasis are major reasons for pancreatic cancer death and identifying signaling molecules that are specifically used in tumor invasion is of great significance. The purpose of this study was to elucidate the role of GEP100 in pancreatic cancer cell invasion and metastasis and the corresponding molecular mechanism. Methods: Stable cell lines with GEP100 knocked-down were established by transfecting GEP100 shRNA vector into PaTu8988 cells and selected by puromycin. qRT-PCR and Western blot were performed to detect gene expression. Matrigel-invasion assay was used to detect cancer cell invasion in vitro. Liver metastasis in vivo was determined by splenic injection of indicated cell lines followed by spleen resection. Immunofluorescence study was used to detect the intracellular localization of E-cadherin. Results: We found that the expression level of GEP100 protein was closely related to the invasive ability of a panel of 6 different human pancreatic cancer cell lines. Down-regulation of GEP100 in PaTu8988 cells significantly decreased invasive activity by Matrigel invasion assay, without affecting migration, invasion and viability. The inhibited invasive activity was rescued by over-expression of GEP100 cDNA. In vivo study showed that liver metastasis was significantly decreased in the PaTu8988 cells with GEP100 stably knocked-down. In addition, an epithelial-like morphological change, mimicking a mesenchymal to epithelial transition (MET) was induced by GEP100 down-regulation. The expression of E-cadherin protein was increased 2-3 folds accompanied by its redistribution to the cell-cell contacts, while no obvious changes were observed for E-cadherin mRNA. Unexpectedly, the mRNA of Slug was increased by GEP100 knock-down. Conclusion: These findings provided important evidence that GEP100 plays a significant role in pancreatic cancer invasion through regulating the expression of E-cadherin and the process of MET, indicating the possibility of it becoming a potential therapeutic target against pancreatic cancer.	[Xie, Chuan-Gao; Chen, Jia-Min; Cai, Jian-Ting; Chen, Qin-Yu; Jia, Li-Tao] Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 2, Hangzhou 310027, Zhejiang, Peoples R China; [Wei, Shu-Mei] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310027, Zhejiang, Peoples R China; [Xu, Xuan-Fu] Tongji Univ, Hosp 10, Shanghai 200092, Peoples R China	Zhejiang University; Zhejiang University; Tongji University	Xie, CG (corresponding author), Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 2, Hangzhou 310027, Zhejiang, Peoples R China.	autumn200327@yahoo.com.cn; jtcai@yahoo.cn	li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022		Zhejiang Provincial Natural Science Foundation of China [Y2080372]; National Natural Science Foundation of China [81101839]; Qianjiang Talent Programe from the Science and Technology Department of Zhejiang Province [2009R10057]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talent Programe from the Science and Technology Department of Zhejiang Province	Zhejiang Provincial Natural Science Foundation of China (No. Y2080372; URL: http://www.zjnsf.gov.cn/1/xm/lx.aspx) National Natural Science Foundation of China (No. 81101839; URL: http://159.226.244.22/portal/proj_search.asp) and Qianjiang Talent Programe from the Science and Technology Department of Zhejiang Province (No. 2009R10057; URL: http://www.zjsts.cn/index/index.jspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Dunphy JL, 2007, TRAFFIC, V8, P661, DOI 10.1111/j.1600-0854.2007.00561.x; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hiroi T, 2009, FRONT BIOSCI-LANDMRK, V14, P717, DOI 10.2741/3275; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jimenez RE, 2000, ANN SURG, V231, P644, DOI 10.1097/00000658-200005000-00004; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karayiannakis AJ, 1998, ANTICANCER RES, V18, P4177; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Shishido T, 1998, JPN J CANCER RES, V89, P963, DOI 10.1111/j.1349-7006.1998.tb00655.x; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2010, J BIOL CHEM, V285, P30698, DOI 10.1074/jbc.M110.107458; Someya A, 2006, J LEUKOCYTE BIOL, V80, P915, DOI 10.1189/jlb.0106059; Takao S, 2000, Hum Cell, V13, P15; Watanabe T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003020; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	39	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37854	10.1371/journal.pone.0037854	http://dx.doi.org/10.1371/journal.pone.0037854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662237	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300127
J	Ma, YG; Liu, WC; Dong, S; Du, C; Wang, XJ; Li, JS; Xie, XP; Wu, L; Ma, DC; Yu, ZB; Xie, MJ				Ma, Yu-Guang; Liu, Wen-Chao; Dong, Shuo; Du, Cheng; Wang, Xiao-Jun; Li, Jin-Sheng; Xie, Xiao-Ping; Wu, Li; Ma, Da-Chang; Yu, Zhi-Bin; Xie, Man-Jiang			Activation of BKCa Channels in Zoledronic Acid-Induced Apoptosis of MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							HUMAN GLIOMA-CELLS; POTASSIUM CHANNELS; SMOOTH-MUSCLE; OSTEOSARCOMA CELLS; ION CHANNELS; KCNMA1 GENE; PROLIFERATION; BISPHOSPHONATES; K+; EXPRESSION	Background: Zoledronic acid, one of the most potent nitrogen-containing biphosphonates, has been demonstrated to have direct anti-tumor and anti-metastatic properties in breast cancer in vitro and in vivo. In particular, tumor-cell apoptosis has been recognized to play an important role in the treatment of metastatic breast cancer with zoledronic acid. However, the precise mechanisms remain less clear. In the present study, we investigated the specific role of large conductance Ca2+-activated potassium (BKCa) channel in zoledronic acid-induced apoptosis of estrogen receptor (ER)-negative MDA-MB-231 breast cancer cells. Methodology/Principal Findings: The action of zoledronic acid on BKCa channel was investigated by whole-cell and cell-attached patch clamp techniques. Cell apoptosis was assessed with immunocytochemistry, analysis of fragmented DNA by agarose gel electrophoresis, and flow cytometry assays. Cell proliferation was investigated by MTT test and immunocytochemistry. In addition, such findings were further confirmed with human embryonic kidney 293 (HEK293) cells which were transfected with functional BKCa alpha-subunit (hSlo alpha). Our results clearly indicated that zoledronic acid directly increased the activities of BKCa channels, and then activation of BKCa channel by zoledronic acid contributed to induce apoptosis in MDA-MB-231 cells. The possible mechanisms were associated with the elevated level of intracellular Ca2+ and a concomitant depolarization of mitochondrial membrane potential (Delta psi m) in MDA-MB-231 cells. Conclusions: Activation of BKCa channel was here shown to be a novel molecular pathway involved in zoledronic acid-induced apoptosis of MDA-MB-231 cells in vitro.	[Ma, Yu-Guang; Liu, Wen-Chao; Du, Cheng] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian 710032, Peoples R China; [Ma, Yu-Guang; Wu, Li; Ma, Da-Chang] Lanzhou Univ, Dept Breast Dis, Hosp 1, Lanzhou 730000, Peoples R China; [Dong, Shuo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wang, Xiao-Jun; Li, Jin-Sheng; Xie, Xiao-Ping; Yu, Zhi-Bin; Xie, Man-Jiang] Fourth Mil Med Univ, Minist China, Dept Aerosp Physiol, Key Lab Aerosp Med, Xian 710032, Peoples R China	Air Force Military Medical University; Lanzhou University; Baylor College of Medicine; Air Force Military Medical University	Ma, YG (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian 710032, Peoples R China.	liuch@fmmu.edu.cn; manjiangxie@hotmail.com			National Science Foundation of China [81071894, 81000336, 31070768]; Key Project from Science and Technology Committee of Gansu Province [1104FKCA125]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project from Science and Technology Committee of Gansu Province	This work was supported by National Science Foundation of China (No. 81071894, 81000336, and 31070768) and Key Project from Science and Technology Committee of Gansu Province (1104FKCA125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Almubarak Hussain, 2011, J Carcinog, V10, P2, DOI 10.4103/1477-3163.75723; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Bosch-Barrera J, 2011, CLIN TRANSL ONCOL, V13, P148, DOI 10.1007/s12094-011-0634-9; Brevet M, 2008, HISTOL HISTOPATHOL, V23, P965, DOI 10.14670/HH-23.965; Burg ED, 2008, BRIT J PHARMACOL, V153, pS99, DOI 10.1038/sj.bjp.0707635; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Debska-Vielhaber G, 2009, J PHYSIOL PHARMACOL, V60, P27; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Green J, 2010, CANCER INVEST, V28, P944, DOI 10.3109/07357907.2010.512598; Green JR, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-90004-3; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li J, 2009, MOL CELL BIOCHEM, V331, P117, DOI 10.1007/s11010-009-0149-7; Ma YG, 2010, APOPTOSIS, V15, P426, DOI 10.1007/s10495-009-0423-x; Mitrofan LM, 2009, BONE, V45, P1153, DOI 10.1016/j.bone.2009.08.010; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Neville-Webbe HL, 2010, EUR J CANCER, V46, P1211, DOI 10.1016/j.ejca.2010.02.041; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Roger S, 2004, BBA-BIOMEMBRANES, V1667, P190, DOI 10.1016/j.bbamem.2004.10.002; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Senaratne SG, 2002, BREAST CANCER RES, V4, P18, DOI 10.1186/bcr412; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Tenta R, 2008, HORM METAB RES, V40, P737, DOI 10.1055/s-2008-1078753; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Xie MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1489, DOI 10.1152/ajpcell.00474.2009; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162	37	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37451	10.1371/journal.pone.0037451	http://dx.doi.org/10.1371/journal.pone.0037451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655048	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900023
J	Bottcher, C; Dennis, EG; Booker, GW; Polyak, SW; Boss, PK; Davies, C				Boettcher, Christine; Dennis, Eric G.; Booker, Grant W.; Polyak, Steven W.; Boss, Paul K.; Davies, Christopher			A Novel Tool for Studying Auxin-Metabolism: The Inhibition of Grapevine Indole-3-Acetic Acid-Amido Synthetases by a Reaction Intermediate Analogue	PLOS ONE			English	Article							VITIS-VINIFERA L.; EVOLUTIONARY HISTORY; CRYSTAL-STRUCTURES; GH3 FAMILY; ARABIDOPSIS; EXPRESSION; ADENYLATE; HYPOCOTYL; GENE; BIOSYNTHESIS	An important process for the regulation of auxin levels in plants is the inactivation of indole-3-acetic acid (IAA) by conjugation to amino acids. The conjugation reaction is catalysed by IAA-amido synthetases belonging to the family of GH3 proteins. Genetic approaches to study the biological significance of these enzymes have been hampered by large gene numbers and a high degree of functional redundancy. To overcome these difficulties a chemical approach based on the reaction mechanism of GH3 proteins was employed to design a small molecule inhibitor of IAA-amido synthetase activity. Adenosine-5'-[2-(1H-indol-3-yl)ethyl]phosphate (AIEP) mimics the adenylated intermediate of the IAA-conjugation reaction and was therefore proposed to compete with the binding of MgATP and IAA in the initial stages of catalysis. Two grapevine IAA-amido synthetases with different catalytic properties were chosen to test the inhibitory effects of AIEP in vitro. GH3-1 has previously been implicated in the grape berry ripening process and is restricted to two amino acid substrates, whereas GH3-6 conjugated IAA to 13 amino acids. AIEP is the most potent inhibitor of GH3 enzymes so far described and was shown to be competitive against MgATP and IAA binding to both enzymes with K-i-values 17-68-fold lower than the respective K-m-values. AIEP also exhibited in vivo activity in an ex planta test system using young grape berries. Exposure to 5-20 mu M of the inhibitor led to decreased levels of the common conjugate IAA-Asp and reduced the accumulation of the corresponding Asp-conjugate upon treatment with a synthetic auxin. AIEP therefore represents a novel chemical probe with which to study IAA-amido synthetase function.	[Boettcher, Christine; Dennis, Eric G.; Boss, Paul K.; Davies, Christopher] CSIRO Plant Ind, Glen Osmond, SA, Australia; [Booker, Grant W.; Polyak, Steven W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Bottcher, C (corresponding author), CSIRO Plant Ind, Glen Osmond, SA, Australia.	christine.bottcher@csiro.au	Boettcher, Christine/AAW-8080-2021; davies, christopher/F-3363-2010; Polyak, Steven W/A-7488-2019; Boss, Paul K/A-1292-2010; Bottcher, Christine/H-3323-2012; Polyak, Steven W./G-3185-2011	Boettcher, Christine/0000-0003-3317-5264; Polyak, Steven W/0000-0002-8458-5194; Boss, Paul K/0000-0003-0356-9342; Bottcher, Christine/0000-0003-3317-5264; Polyak, Steven W./0000-0002-8458-5194	Grape and Wine Research and Development Corporation [CSP 09/05]	Grape and Wine Research and Development Corporation	This work was supported by the Grape and Wine Research and Development Corporation (grant no. CSP 09/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTYMIUK PJ, 1994, NAT STRUCT BIOL, V1, P758, DOI 10.1038/nsb1194-758; Assmann SM, 2010, PLANT HORMONES BIOSY, P339; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bernier S, 2000, BIOORG MED CHEM LETT, V10, P2441, DOI 10.1016/S0960-894X(00)00478-9; Bottcher C, 2011, J EXP BOT, V62, P4267, DOI 10.1093/jxb/err134; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Chen Q, 2010, J BIOL CHEM, V285; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; da Costa TPS, 2012, J BIOL CHEM, V287, P17823, DOI 10.1074/jbc.M112.356576; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; Delker C, 2008, PLANTA, V227, P929, DOI 10.1007/s00425-008-0710-8; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Fan F, 2009, BIOCHEMISTRY-US, V48, P7150, DOI 10.1021/bi900457x; Forrest AK, 2000, BIOORG MED CHEM LETT, V10, P1871, DOI 10.1016/S0960-894X(00)00360-7; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gottlieb A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020361; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Khan S, 2007, PLANTA, V226, P21, DOI 10.1007/s00425-006-0462-2; Liu KD, 2005, PLANT MOL BIOL, V58, P447, DOI 10.1007/s11103-005-6505-4; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Okrent RA, 2011, PLANT MOL BIOL, V76, P489, DOI 10.1007/s11103-011-9776-y; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Ostin A, 1998, PLANT PHYSIOL, V118, P285, DOI 10.1104/pp.118.1.285; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang H, 2008, PLANT GROWTH REGUL, V56, P225, DOI 10.1007/s10725-008-9313-4; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhao Y, 2010, ANNU REV PLANT BIOL, V61, P1911	47	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37632	10.1371/journal.pone.0037632	http://dx.doi.org/10.1371/journal.pone.0037632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649546	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800065
J	Chatterjee, T; Pal, A; Dey, S; Chatterjee, BK; Chakrabarti, P				Chatterjee, Tanaya; Pal, Aritrika; Dey, Sucharita; Chatterjee, Barun K.; Chakrabarti, Pinak			Interaction of Virstatin with Human Serum Albumin: Spectroscopic Analysis and Molecular Modeling	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; LIGAND-BINDING; SECONDARY STRUCTURE; VIBRIO-CHOLERAE; BOVINE; THERMODYNAMICS; CONFORMATION; TRANSITION; VIRULENCE; PROTEINS	Virstatin is a small molecule that inhibits Vibrio cholerae virulence regulation, the causative agent for cholera. Here we report the interaction of virstatin with human serum albumin (HSA) using various biophysical methods. The drug binding was monitored using different isomeric forms of HSA (N form similar to pH 7.2, B form similar to pH 9.0 and F form similar to pH 3.5) by absorption and fluorescence spectroscopy. There is a considerable quenching of the intrinsic fluorescence of HSA on binding the drug. The distance (r) between donor (Trp214 in HSA) and acceptor (virstatin), obtained from Forster-type fluorescence resonance energy transfer (FRET), was found to be 3.05 nm. The ITC data revealed that the binding was an enthalpy-driven process and the binding constants K-a for N and B isomers were found to be 6.09X10(5) M-1 and 4.47X10(5) M (-1), respectively. The conformational changes of HSA due to the interaction with the drug were investigated from circular dichroism (CD) and Fourier Transform Infrared (FTIR) spectroscopy. For 1:1 molar ratio of the protein and the drug the far-UV CD spectra showed an increase in alpha-helicity for all the conformers of HSA, and the protein is stabilized against urea and thermal unfolding. Molecular docking studies revealed possible residues involved in the protein-drug interaction and indicated that virstatin binds to Site I (subdomain IIA), also known as the warfarin binding site.	[Chatterjee, Tanaya; Pal, Aritrika; Chakrabarti, Pinak] Bose Inst, Dept Biochem, Kolkata, India; [Dey, Sucharita; Chakrabarti, Pinak] Bose Inst, Bioinformat Ctr, Kolkata, India; [Chatterjee, Barun K.] Bose Inst, Dept Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Chatterjee, T (corresponding author), Bose Inst, Dept Biochem, Kolkata, India.	tanaya_chatterjee@yahoo.com; pinak@boseinst.ernet.in		Dey, Sucharita/0000-0003-0605-2576	Department of Science and Technology (India); Council of Scientific and Industrial Research (India); Department of Biotechnology (India)	Department of Science and Technology (India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (India)(Department of Biotechnology (DBT) India)	T. C. is supported by a Fast Track Young Scientist Project from the Department of Science and Technology (India); A.P. and S.D. are recipients of fellowships from the Council of Scientific and Industrial Research (India) and the Department of Biotechnology (India), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Bagatolli LA, 1996, J PHARM SCI, V85, P1131, DOI 10.1021/js960142k; Bian QQ, 2004, INT J BIOL MACROMOL, V34, P333, DOI 10.1016/j.ijbiomac.2004.09.005; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; Chatterjee T, 2011, BIOCHEMISTRY-US, V50, P2962, DOI 10.1021/bi101673x; Connelly Patrick R., 1994, Current Opinion in Biotechnology, V5, P381, DOI 10.1016/0958-1669(94)90046-9; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; ERA S, 1990, INT J PEPT PROT RES, V35, P1; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; Foster J.F, 1977, ALBUMIN STRUCTURE FU, VFunction and Uses; GEISOW MJ, 1977, BIOCHEM J, V163, P477, DOI 10.1042/bj1630477; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HIGGINS DE, 1992, J BACTERIOL, V174, P6974, DOI 10.1128/JB.174.21.6974-6980.1992; Hubbard S., 1992, NACCESS PROGRAM CALC; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; KHAN MY, 1986, BIOCHEM J, V236, P307, DOI 10.1042/bj2360307; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Lakowicz J.R., 2006, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEONARD WJ, 1963, J BIOL CHEM, V238, P1984; Li Y, 2006, BIOORGAN MED CHEM, V14, P1431, DOI 10.1016/j.bmc.2005.09.066; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Muzammil S, 2000, BBA-PROTEIN STRUCT M, V1476, P139, DOI 10.1016/S0167-4838(99)00226-5; Neault JF, 1998, BBA-PROTEIN STRUCT M, V1384, P153, DOI 10.1016/S0167-4838(98)00011-9; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T, ALL ALBUMIN BIOCH GE; Puri AW, 2009, ACS CHEM BIOL, V4, P603, DOI 10.1021/cb9001409; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; Shanmugam G, 2004, BIOPHYS CHEM, V111, P73, DOI 10.1016/j.bpc.2004.04.005; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P69, DOI 10.1016/j.jphotobiol.2007.11.003; SOGAMI M, 1982, INT J PEPT PROT RES, V19, P263; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Uversky VN, 1997, BIOCHEMISTRY-US, V36; Varshney A, 2011, PLOS ONE, V6; Waldor MK., 1996, ENTERIC INFECT IMMUN, P37, DOI [10.1007/978-1-4899-0313-6_3, DOI 10.1007/978-1-4899-0313-6_3]; Wi S, 1998, BIOSPECTROSCOPY, V4, P93, DOI 10.1002/(SICI)1520-6343(1998)4:2<93::AID-BSPY2>3.0.CO;2-T; WILTING J, 1980, BIOCHIM BIOPHYS ACTA, V626, P291, DOI 10.1016/0005-2795(80)90123-3; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; YAMASAKI M, 1990, INT J BIOL MACROMOL, V12, P263, DOI 10.1016/0141-8130(90)90007-W; Zsila F, 2011, BIOINFORMATICS, V27, P1806, DOI 10.1093/bioinformatics/btr284	53	106	107	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37468	10.1371/journal.pone.0037468	http://dx.doi.org/10.1371/journal.pone.0037468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649528	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800046
J	Han, BS; Rorke, EA; Adhikary, G; Chew, YC; Xu, W; Eckert, RL				Han, Bingshe; Rorke, Ellen A.; Adhikary, Gautam; Chew, Yap Ching; Xu, Wen; Eckert, Richard L.			Suppression of AP1 Transcription Factor Function in Keratinocyte Suppresses Differentiation	PLOS ONE			English	Article							HUMAN INVOLUCRIN PROMOTER; DOMINANT-NEGATIVE MUTANT; PROTEIN-KINASE-C; DISTAL REGULATORY REGION; GENE-EXPRESSION; JUN GENE; IN-VIVO; EPIDERMAL HYPERPROLIFERATION; CORNEAL EPITHELIUM; TRANSGENIC MICE	Our previous study shows that inhibiting activator protein one (AP1) transcription factor function in murine epidermis, using dominant-negative c-jun (TAM67), increases cell proliferation and delays differentiation. To understand the mechanism of action, we compare TAM67 impact in mouse epidermis and in cultured normal human keratinocytes. We show that TAM67 localizes in the nucleus where it forms TAM67 homodimers that competitively interact with AP1 transcription factor DNA binding sites to reduce endogenous jun and fos factor binding. Involucrin is a marker of keratinocyte differentiation that is expressed in the suprabasal epidermis and this expression requires AP1 factor interaction at the AP1-5 site in the promoter. TAM67 interacts competitively at this site to reduce involucrin expression. TAM67 also reduces endogenous c-jun, junB and junD mRNA and protein level. Studies with c-jun promoter suggest that this is due to reduced transcription of the c-jun gene. We propose that TAM67 suppresses keratinocyte differentiation by interfering with endogenous AP1 factor binding to regulator elements in differentiation-associated target genes, and by reducing endogenous c-jun factor expression.	[Han, Bingshe; Rorke, Ellen A.; Adhikary, Gautam; Chew, Yap Ching; Xu, Wen; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Han, BS (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	reckert@umaryland.edu		Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health (NIH) [R01 AR046494]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant R01 AR046494 awarded to Richard L. Eckert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P1219, DOI 10.1167/iovs.04-1285; Adhikary G, 2004, INVEST OPHTH VIS SCI, V45, P1080, DOI 10.1167/iovs.03-1180; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Balasubramanian S, 2007, J BIOL CHEM, V282, P6707, DOI 10.1074/jbc.M606003200; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; BERGER I, 1994, DNA CELL BIOL, V13, P249, DOI 10.1089/dna.1994.13.249; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; BROWN PH, 1994, ONCOGENE, V9, P791; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Diegmann J, 2005, EUR J CANCER, V41, P1794, DOI 10.1016/j.ejca.2005.05.005; Dong ZG, 1997, MOL CARCINOGEN, V19, P204, DOI 10.1002/(SICI)1098-2744(199707)19:3<204::AID-MC8>3.0.CO;2-D; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Feng ZW, 2002, MOL CELL BIOL, V22, P5357, DOI 10.1128/MCB.22.15.5357-5366.2002; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Grant S, 1996, CELL GROWTH DIFFER, V7, P603; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jin X, 2007, MOL CARCINOGEN, V46, P901, DOI 10.1002/mc.20319; KAHN CR, 1993, INVEST OPHTH VIS SCI, V34, P3429; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JJ, 1998, ONCOGENE, V16, P2711, DOI 10.1038/sj.onc.1201798; Liu YM, 2004, ONCOGENE, V23, P8238, DOI 10.1038/sj.onc.1207889; Madireddi MT, 2000, J CELL PHYSIOL, V185, P36, DOI 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V; Mizuno H, 2006, MOL CARCINOGEN, V45, P1, DOI 10.1002/mc.20160; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Ramos-Nino ME, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-81; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Rutberg SE, 2000, CANCER RES, V60, P6332; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; She QB, 2002, CANCER RES, V62, P1343; Shen Q, 2006, DEV BIOL, V295, P589, DOI 10.1016/j.ydbio.2006.03.042; Shi B, 2005, EXP DERMATOL, V14, P519, DOI 10.1111/j.0906-6705.2005.00317.x; Shimizu Y, 2008, BRIT J CANCER, V98, P915, DOI 10.1038/sj.bjc.6604267; STEIN B, 1992, PHOTOCHEM PHOTOBIOL, V55, P409, DOI 10.1111/j.1751-1097.1992.tb04255.x; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Thompson EJ, 2002, MOL CARCINOGEN, V35, P157, DOI 10.1002/mc.10090; Thompson EJ, 2002, CANCER RES, V62, P3044; Tichelaar JW, 2010, CANCER PREV RES, V3, P1148, DOI 10.1158/1940-6207.CAPR-10-0023; Wei P, 1998, MOL ENDOCRINOL, V12, P1322, DOI 10.1210/me.12.9.1322; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; YONEDA K, 1992, J BIOL CHEM, V267, P18060; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Young MR, 2002, MOL CARCINOGEN, V34, P72, DOI 10.1002/mc.10050; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963	66	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36941	10.1371/journal.pone.0036941	http://dx.doi.org/10.1371/journal.pone.0036941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649503	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800021
J	Lamb, T; Beamer, DA				Lamb, Trip; Beamer, David A.			Digits Lost or Gained? Evidence for Pedal Evolution in the Dwarf Salamander Complex (Eurycea, Plethodontidae)	PLOS ONE			English	Article							BODY-FORM; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR SYSTEMATICS; BAYESIAN-ESTIMATION; SQUAMATE REPTILES; LIMB EVOLUTION; MIXED MODELS; CONVERGENCE; GENUS; MINIATURIZATION	Change in digit number, particularly digit loss, has occurred repeatedly over the evolutionary history of tetrapods. Although digit loss has been documented among distantly related species of salamanders, it is relatively uncommon in this amphibian order. For example, reduction from five to four toes appears to have evolved just three times in the morphologically and ecologically diverse family Plethodontidae. Here we report a molecular phylogenetic analysis for one of these four-toed lineages - the Eurycea quadridigitata complex (dwarf salamanders) - emphasizing relationships to other species in the genus. A multilocus phylogeny reveals that dwarf salamanders are paraphyletic with respect to a complex of five-toed, paedomorphic Eurycea from the Edwards Plateau in Texas. We use this phylogeny to examine evolution of digit number within the dwarf-Edwards Plateau clade, testing contrasting hypotheses of digit loss (parallelism among dwarf salamanders) versus digit gain (re-evolution in the Edwards Plateau complex). Bayes factors analysis provides statistical support for a five-toed common ancestor at the dwarf-Edwards node, favoring, slightly, the parallelism hypothesis for digit loss. More importantly, our phylogenetic results pinpoint a rare event in the pedal evolution of plethodontid salamanders.	[Lamb, Trip; Beamer, David A.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Beamer, David A.] Nash Community Coll, Dept Math & Sci, Rocky Mount, NC USA	University of North Carolina; East Carolina University	Lamb, T (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	dbeamer@nashcc.edu			East Carolina University Research; South Carolina Department of Natural Resources	East Carolina University Research; South Carolina Department of Natural Resources	This project was supported by an East Carolina University Research/Creative Activity award and a grant from the South Carolina Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Ane C, 2007, MOL BIOL EVOL, V24, P412; Bickham JW, 1996, HERPETOLOGICA, V52, P89; Bonett RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005615; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; Camp CD, 2009, J ZOOL, V279, P86, DOI 10.1111/j.1469-7998.2009.00593.x; Chen W, 2009, MOL ECOL, V18, P2856, DOI 10.1111/j.1365-294X.2009.04258.x; Chippindale PT, 2000, HERPETOL MONOGR, V14, P1, DOI 10.2307/1467045; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Galis F, 2001, TRENDS ECOL EVOL, V16, P637, DOI 10.1016/S0169-5347(01)02289-3; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; HANKEN J, 1983, J MORPHOL, V177, P255, DOI 10.1002/jmor.1051770304; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Harrison JR, 2003, SOUTHEAST NAT, V2, P159, DOI 10.1656/1528-7092(2003)002[0159:ANSOEC]2.0.CO;2; Hillis DM, 2001, HERPETOLOGICA, V57, P266; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; Kohlsdorf T, 2010, EVOLUTION, V64, P2477, DOI 10.1111/j.1558-5646.2010.01042.x; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Masta SE, 2002, MOL PHYLOGENET EVOL, V24, P302, DOI 10.1016/S1055-7903(02)00216-6; Mittleman M.B., 1967, CAT AM AMPHIB REPTIL, V44, P1; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; ROTH G, 1990, BIOL J LINN SOC, V40, P165, DOI 10.1111/j.1095-8312.1990.tb01974.x; Roy S, 2002, J EXP ZOOL, V293, P186, DOI 10.1002/jez.10110; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Siler CD, 2011, EVOLUTION, V65, P2641, DOI 10.1111/j.1558-5646.2011.01315.x; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steiner CC, 2009, MOL BIOL EVOL, V26, P35, DOI 10.1093/molbev/msn218; Stopper GF, 2007, DEV DYNAM, V236, P321, DOI 10.1002/dvdy.21025; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vieites DR, 2011, MOL PHYLOGENET EVOL, V59, P623, DOI 10.1016/j.ympev.2011.03.012; Wagner GP, 1999, AM ZOOL, V39, P686; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wiens JJ, 2008, EVOL DEV, V10, P449, DOI 10.1111/j.1525-142X.2008.00256.x; Young RL, 2009, EVOL DEV, V11, P647, DOI 10.1111/j.1525-142X.2009.00372.x	57	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37544	10.1371/journal.pone.0037544	http://dx.doi.org/10.1371/journal.pone.0037544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649536	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800055
J	van Boxtel, JJA; Lu, HJ				van Boxtel, Jeroen J. A.; Lu, Hongjing			Signature Movements Lead to Efficient Search for Threatening Actions	PLOS ONE			English	Article							BIOLOGICAL-MOTION; VISUAL-SEARCH; PERCEPTION; EMOTION; ATTENTION; FACE; FAMILIARITY; STIMULUS; AMYGDALA; GENDER	The ability to find and evade fighting persons in a crowd is potentially life-saving. To investigate how the visual system processes threatening actions, we employed a visual search paradigm with threatening boxer targets among emotionally-neutral walker distractors, and vice versa. We found that a boxer popped out for both intact and scrambled actions, whereas walkers did not. A reverse correlation analysis revealed that observers' responses clustered around the time of the "punch'', a signature movement of boxing actions, but not around specific movements of the walker. These findings support the existence of a detector for signature movements in action perception. This detector helps in rapidly detecting aggressive behavior in a crowd, potentially through an expedited (sub) cortical threat-detection mechanism.	[van Boxtel, Jeroen J. A.; Lu, Hongjing] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Lu, Hongjing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	van Boxtel, JJA (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	j.j.a.vanboxtel@gmail.com; hongjing@ucla.edu	van Boxtel, Jeroen J.A./O-7624-2014	van Boxtel, Jeroen J.A./0000-0003-2643-0474	NSF (National Science Foundation) [BCS-0843880, EIA-0196217]	NSF (National Science Foundation)(National Science Foundation (NSF))	This work was supported by NSF (National Science Foundation) funding to H. Lu (NSF BCS-0843880). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Janice Lau and Michael Finch for their help in data collection. The motion capture data used in this project was obtained from http://mocap.cs. cmu.edu. The database was created with funding from NSF (National Science Foundation) EIA-0196217.	Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Chouchourelou A, 2006, SOC NEUROSCI-UK, V1, P63, DOI 10.1080/17470910600630599; Coelho CM, 2010, J VISION, V10, DOI 10.1167/10.1.7; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Gao T, 2010, PSYCHOL SCI, V21, P1845, DOI 10.1177/0956797610388814; Giese MA, 2002, VISION RES, V42, P1847, DOI 10.1016/S0042-6989(02)00093-7; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hirai M, 2006, NEUROSCI LETT, V403, P299, DOI 10.1016/j.neulet.2006.05.002; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; Ma YL, 2006, BEHAV RES METHODS, V38, P134, DOI 10.3758/BF03192758; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; Norman JF, 2004, PSYCHOL AGING, V19, P219, DOI 10.1037/0882-7974.19.1.219; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; POIZNER H, 1981, J EXP PSYCHOL HUMAN, V7, P430, DOI 10.1037/0096-1523.7.2.430; Purcell DG, 1996, PERCEPTION, V25, P1091, DOI 10.1068/p251091; Roether CL, 2009, J VISION, V9, DOI 10.1167/9.6.15; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Thirkettle M, 2009, J VISION, V9, DOI 10.1167/9.3.28; Thurman SM, 2008, J VISION, V8, DOI 10.1167/8.3.28; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Vangeneugden J, 2009, CEREB CORTEX, V19, P593, DOI 10.1093/cercor/bhn109; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wang L, 2010, PSYCHOL SCI, V21, P1083, DOI 10.1177/0956797610376072; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37085	10.1371/journal.pone.0037085	http://dx.doi.org/10.1371/journal.pone.0037085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649510	gold, Green Published			2022-12-27	WOS:000305335800028
J	Liang, J; Li, XH; Dai, L; Zeng, WY; Li, Q; Li, MR; Zhou, R; He, CH; Wang, YP; Zhu, J				Liang, Juan; Li, Xiaohong; Dai, Li; Zeng, Weiyue; Li, Qi; Li, Mingrong; Zhou, Rong; He, Chunhua; Wang, Yanping; Zhu, Jun			The Changes in Maternal Mortality in 1000 Counties in Mid-Western China by a Government-Initiated Intervention	PLOS ONE			English	Article							DEATHS	Background: Since 2000, the Chinese government has implemented an intervention program to reduce maternal mortality and eliminate neonatal tetanus in accordance with the Millennium Development Goals 5. To assess the effectiveness of this intervention program, we analyzed the level, trend and reasons defining the maternal mortality ratio (MMR) in the 1,000 priority counties before and after implementation of the intervention between 1999 and 2007. Methodology/Principal Findings: The data was obtained from the National Maternal and Child Health Routine Reporting System. The intervention included providing basic and emergency obstetric equipment and supplies to local medical hospitals, and also included providing professional training to local obstetric doctors, development of obstetric emergency centers and "green channel" express referral networks, reducing or waiving the cost of hospital delivery, and conducting community health education. Based on the initiation time of the intervention and the level of poverty, 1,000 counties, containing a total population of 300 million, were categorized into three groups. MMR significantly decreased by about 50%, with an average reduction rate of 9.24%, 16.06%, and 18.61% per year in the three county groups, respectively. The hospital delivery rate significantly increased. Obstetric hemorrhage was the leading cause of maternal deaths and significantly declined, with an average decrease in the MMR of 11.25%, 18.03%, and 24.90% per year, respectively. The magnitude of the MMR, the average reduction rate of the MMR, and the occurrence of the leading causes of death were closely associated with the percentage of poverty. Conclusions/Significance: The intervention program implemented by the Chinese government has significantly reduced the MMR in mid-western China, suggesting that well-targeted interventions could be an efficient strategy to reducing MMR in resource-poor areas. Reduction of the MMR not only depends on conducting proven interventions, but also relies on economic development in rural areas with a high burden of maternal death.	[Liang, Juan; Li, Qi; Li, Mingrong; Zhu, Jun] Sichuan Univ, W China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China; [Li, Xiaohong; Dai, Li; He, Chunhua; Wang, Yanping] Sichuan Univ, W China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu 610064, Sichuan, Peoples R China; [Zeng, Weiyue; Zhou, Rong] Sichuan Univ, W China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Liang, J (corresponding author), Sichuan Univ, W China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China.	yanpingwang0618@163.com; zzhj3121@163.com		Li, Xiaohong/0000-0003-0336-7302	Chinese Ministry of Health [QT2003-009, 05wsb-02]; UNICEF [YH601-11-1141]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0935]	Chinese Ministry of Health; UNICEF; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Chinese Ministry of Health (grants QT2003-009 and 05wsb-02), UNICEF (grant YH601-11-1141) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Cui FQ, 2007, CHIN J VACCINES IMMU, V13, P1; Department of Maternal and Child Health and Community Health Ministry of Health, 2008, AN 2007 NAT MAT CHIL; Department of Maternal and Child Health and Community Health Ministry of Health, 2002, EXP PROGR DECR MAT M; Department of Maternal and Child Health and Community Health Ministry of Health, 2008, EXP PROGR DECR MAT M; Feng ZC, 2006, MATERN CHILD HLTH J, V21, P2185; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huang A., 2010, CHIN, V11, P130; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Koblinsky M., 2003, REDUCING MATERNAL MO; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; Li XH, 2011, ACTA OBSTET GYN SCAN, V90, P586, DOI 10.1111/j.1600-0412.2011.01110.x; Liang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-243; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; Liang Juan, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P258; Lu Haixia, 2009, CHINESE HLTH EC, V28, P38; Luo R., 2007, MATERNAL CHILD HLTH, V22, P2313; National Bureau of Statistics of China, 2005, NAT ANN STAT B; PADMANATHAN I, 2003, INVESTING MATERNAL H; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shah QH, 2007, REPROD HEALTH MATTER, V15, P17, DOI 10.1016/S0968-8080(07)30339-X; The State Council Leading Group Office of Poverty Alleviation and Development, 2006, LIST STAT LEV POV ST; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; United Nations, 2001, 56 SESS NEW YORK 16; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 1992, INT CLASS DIS REL HL; Yadamsuren B, 2009, B WORLD HEALTH ORGAN, V88, P192; Yayla M, 2003, J PERINAT MED, V31, P386, DOI 10.1515/JPM.2003.059; Zhang K, 2002, MED AID POOR THEORIE; 梁娟, 2009, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V40, P341	36	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37458	10.1371/journal.pone.0037458	http://dx.doi.org/10.1371/journal.pone.0037458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629398	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100030
J	Tai, MC; Chen, YH; Cheng, JH; Liang, CM; Chen, JT; Chen, CL; Lu, DW				Tai, Ming-Cheng; Chen, Yi-Hao; Cheng, Jen-Hao; Liang, Chang-Min; Chen, Jiann-Torng; Chen, Ching-Long; Lu, Da-Wen			Early Ahmed Glaucoma Valve Implantation after Penetrating Keratoplasty Leads to Better Outcomes in an Asian Population with Preexisting Glaucoma	PLOS ONE			English	Article							MOLTENO IMPLANT; REFRACTORY GLAUCOMA; CLINICAL-EXPERIENCE; GRAFT-SURVIVAL; FOLLOW-UP; EYES; POLYPROPYLENE; SILICONE; SURGERY	Background: To evaluate the efficacy of Ahmed Glaucoma Valve (AGV) surgery and the optimal interval between penetrating keratoplasty (PKP) and AGV implantation in a population of Asian patients with preexisting glaucoma who underwent PKP. Methodology/Principal Findings: In total, 45 eyes of 45 patients were included in this retrospective chart review. The final intraocular pressures (IOPs), graft survival rate, and changes in visual acuity were assessed to evaluate the outcomes of AGV implantations in eyes in which AGV implantation occurred within 1 month of post-PKP IOP elevation (Group 1) and in eyes in which AGV implantation took place more than 1 month after the post-PKP IOP evaluation (Group 2). Factors that were associated with graft failure were analyzed, and the overall patterns of complications were reviewed. By their final follow-up visits, 58% of the patients had been successfully treated for glaucoma. After the operation, there were no statistically significant differences between the groups with respect to graft survival (p = 0.98), but significant differences for IOP control (p = 0.049) and the maintenance of visual acuity (VA) (p<0.05) were observed. One year after surgery, the success rates of IOP control in Group 1 and Group 2 were 80% and 46.7%, respectively, and these rates fell to 70% and 37.3%, respectively, by 2 years. Factors that were associated with a high risk of AGV failure were a diagnosis of preexisting angle-closure glaucoma, a history of previous PKP, and a preoperative IOP that was >21 mm Hg. The most common surgical complication, aside from graft failure, was hyphema. Conclusions/Significance: Early AGV implantation results in a higher probability of AGV survival and a better VA outcome without increasing the risk of corneal graft failure as a result of post-PKP glaucoma drainage tube implantation.	[Tai, Ming-Cheng; Chen, Yi-Hao; Cheng, Jen-Hao; Liang, Chang-Min; Chen, Jiann-Torng; Chen, Ching-Long; Lu, Da-Wen] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan; [Tai, Ming-Cheng; Chen, Yi-Hao; Liang, Chang-Min; Chen, Jiann-Torng; Chen, Ching-Long; Lu, Da-Wen] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Tai, MC (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	p310849@ms23.hinet.net			Tri-Service General Hospital [TSGHC100-008-006-6-S03, TSGH-C100-086]	Tri-Service General Hospital	This study is supported, in part, by grants from the Tri-Service General Hospital (TSGHC100-008-006-6-S03 and TSGH-C100-086). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aswad LA, 2006, AM J OPHTHALMOL, V141, P390, DOI 10.1016/j.ajo.2005.08.036; Al-Torbak A, 2003, CORNEA, V22, P194, DOI 10.1097/00003226-200304000-00002; Al-Torbak AA, 2004, CORNEA, V23, P554, DOI 10.1097/01.ico.0000122704.49054.95; Alvarenga LS, 2004, AM J OPHTHALMOL, V138, P200, DOI 10.1016/j.ajo.2004.02.058; Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1; Ayyala RS, 2000, SURV OPHTHALMOL, V45, P91, DOI 10.1016/S0039-6257(00)00141-7; Babizhayev MA, 2011, CURR MOL MED, V11, P528, DOI 10.2174/156652411800615126; Coleman AL, 1997, AM J OPHTHALMOL, V123, P54, DOI 10.1016/S0002-9394(14)70992-4; Das JC, 2005, EYE, V19, P183, DOI 10.1038/sj.eye.6701447; Doyle J W, 1994, Semin Ophthalmol, V9, P254, DOI 10.3109/08820539409060024; GOLDBERG DB, 1981, AM J OPHTHALMOL, V92, P372, DOI 10.1016/0002-9394(81)90527-4; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Kook MS, 2000, OPHTHALMIC SURG LAS, V31, P100; Kwon YH, 2001, OPHTHALMOLOGY, V108, P272, DOI 10.1016/S0161-6420(00)00496-6; Lai JSM, 2000, BRIT J OPHTHALMOL, V84, P718, DOI 10.1136/bjo.84.7.718; MCDONNELL PJ, 1988, OPHTHALMOLOGY, V95, P364; MUENZLER WS, 1981, OPHTHALMIC SURG LAS, V12, P210; Brasil MVOM, 2007, J GLAUCOMA, V16, P36, DOI 10.1097/01.ijg.0000243477.82779.31; RAPUANO CJ, 1995, CORNEA, V14, P26; Reinhard T, 1997, GRAEF ARCH CLIN EXP, V235, P553, DOI 10.1007/BF00947083; SHERWOOD MB, 1993, OPHTHALMIC SURG LAS, V24, P185; Sit M, 2001, CORNEA, V20, P129, DOI 10.1097/00003226-200103000-00002; Taglia DP, 2002, J GLAUCOMA, V11, P347, DOI 10.1097/00061198-200208000-00012; Tai MC, 2010, EYE, V24, P547, DOI 10.1038/eye.2009.181; Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X; Wilson MR, 2003, AM J OPHTHALMOL, V136, P464, DOI 10.1016/S0002-9394(03)00239-3; Yalvac IS, 2007, EYE, V21, P65, DOI 10.1038/sj.eye.6702125; Yamagami S, 1996, ACTA OPHTHALMOL SCAN, V74, P584	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37867	10.1371/journal.pone.0037867	http://dx.doi.org/10.1371/journal.pone.0037867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629464	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100055
J	Kim, BH; Ramanan, R; Cho, DH; Choi, GG; La, HJ; Ahn, CY; Oh, HM; Kim, HS				Kim, Byung-Hyuk; Ramanan, Rishiram; Cho, Dae-Hyun; Choi, Gang-Guk; La, Hyun-Joon; Ahn, Chi-Yong; Oh, Hee-Mock; Kim, Hee-Sik			Simple, Rapid and Cost-Effective Method for High Quality Nucleic Acids Extraction from Different Strains of Botryococcus braunii	PLOS ONE			English	Article							HYDROCARBONS; BIODIESEL; RNA	This study deals with an effective nucleic acids extraction method from various strains of Botryococcus braunii which possesses an extensive extracellular matrix. A method combining freeze/thaw and bead-beating with heterogeneous diameter of silica/zirconia beads was optimized to isolate DNA and RNA from microalgae, especially from B. braunii. Eukaryotic Microalgal Nucleic Acids Extraction (EMNE) method developed in this study showed at least 300 times higher DNA yield in all strains of B. braunii with high integrity and 50 times reduced working volume compared to commercially available DNA extraction kits. High quality RNA was also extracted using this method and more than two times the yield compared to existing methods. Real-time experiments confirmed the quality and quantity of the input DNA and RNA extracted using EMNE method. The method was also applied to other eukaryotic microalgae, such as diatoms, Chlamydomonas sp., Chlorella sp., and Scenedesmus sp. resulting in higher efficiencies. Cost-effectiveness analysis of DNA extraction by various methods revealed that EMNE method was superior to commercial kits and other reported methods by >15%. This method would immensely contribute to area of microalgal genomics.	[Kim, Byung-Hyuk; Ramanan, Rishiram; Cho, Dae-Hyun; Choi, Gang-Guk; La, Hyun-Joon; Ahn, Chi-Yong; Oh, Hee-Mock; Kim, Hee-Sik] KRIBB, Environm Biotechnol Res Ctr, Taejon, South Korea; [Oh, Hee-Mock; Kim, Hee-Sik] Univ Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, BH (corresponding author), KRIBB, Environm Biotechnol Res Ctr, Taejon, South Korea.	hkim@kribb.re.kr	Ahn, Chi-Yong/AAI-8370-2020; Ramanan, Rishiram/ABC-9528-2021; Ramanan, Rishiram/AAW-7916-2020; Ramanan, Rishiram/GOE-4622-2022	Ramanan, Rishiram/0000-0002-4641-9603; Dae-Hyun, Cho/0000-0001-8975-2468; Ahn, Chi-Yong/0000-0002-9626-2755; Oh, Hee-Mock/0000-0002-2151-3687	Korea Ministry of Education, Science and Technology as a "Global Frontier project"; KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program	Korea Ministry of Education, Science and Technology as a "Global Frontier project"; KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program	This research was supported by grants from the Korea Ministry of Education, Science and Technology as a "Global Frontier project" (www.biomass.re.kr) and grant from the KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program (www.kribb.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; BASHYAM MD, 1994, BIOTECHNIQUES, V17, P834; BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Kim BH, 2006, J PHYCOL, V42, P1137, DOI 10.1111/j.1529-8817.2006.00263.x; Kim H. S., 2011, PRIMER SETS DETECTIN; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Lee JY, 2010, BIORESOURCE TECHNOL, V101, pS75, DOI 10.1016/j.biortech.2009.03.058; Preiss M. R., 2010, J COMMERCIAL BIOTECH, V16, P293, DOI DOI 10.1057/jcb.2010.15; Qu CB, 2008, BIOTECHNOL LETT, V30, P1735, DOI 10.1007/s10529-008-9758-6; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; SANTOS AR, 1993, J MED MICROBIOL, V39, P298, DOI 10.1099/00222615-39-4-298; Slininger PJ, 2007, BIOCONTROL SCI TECHN, V17, P647, DOI 10.1080/09583150701408881; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; Yoo C, 2010, BIORESOURCE TECHNOL, V101, pS71, DOI 10.1016/j.biortech.2009.03.030; Zhang JinFa, 2000, Journal of Cotton Science, V4, P193; Zurzolo C, 2001, PLANT PHYSIOL, V127, P1339, DOI 10.1104/pp.010709	18	22	27	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37770	10.1371/journal.pone.0037770	http://dx.doi.org/10.1371/journal.pone.0037770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662217	gold, Green Published			2022-12-27	WOS:000305342300107
J	Lucet, JC; Laouenan, C; Chelius, G; Veziris, N; Lepelletier, D; Friggeri, A; Abiteboul, D; Bouvet, E; Mentre, F; Fleury, E				Lucet, Jean-Christophe; Laouenan, Cedric; Chelius, Guillaume; Veziris, Nicolas; Lepelletier, Didier; Friggeri, Adrien; Abiteboul, Dominique; Bouvet, Elisabeth; Mentre, France; Fleury, Eric			Electronic Sensors for Assessing Interactions between Healthcare Workers and Patients under Airborne Precautions	PLOS ONE			English	Article							HAND HYGIENE COMPLIANCE	Background: Direct observation has been widely used to assess interactions between healthcare workers (HCWs) and patients but is time-consuming and feasible only over short periods. We used a Radio Frequency Identification Device (RFID) system to automatically measure HCW-patient interactions. Methods: We equipped 50 patient rooms with fixed sensors and 111 HCW volunteers with mobile sensors in two clinical wards of two hospitals. For 3 months, we recorded all interactions between HCWs and 54 patients under airborne precautions for suspected (n = 40) or confirmed (n = 14) tuberculosis. Number and duration of HCW entries into patient rooms were collected daily. Concomitantly, we directly observed room entries and interviewed HCWs to evaluate their self-perception of the number and duration of contacts with tuberculosis patients. Results: After signal reconstruction, 5490 interactions were recorded between 82 HCWs and 54 tuberculosis patients during 404 days of airborne isolation. Median (interquartile range) interaction duration was 2.1 (0.8-4.4) min overall, 2.3 (0.8-5.0) in the mornings, 1.8 (0.8-3.7) in the afternoons, and 2.0 (0.7-4.3) at night (P < 10(-4)). Number of interactions/day/HCW was 3.0 (1.0-6.0) and total daily duration was 7.6 (2.4-22.5) min. Durations estimated from 28 direct observations and 26 interviews were not significantly different from those recorded by the network. Conclusions: The RFID was well accepted by HCWs. This original technique holds promise for accurately and continuously measuring interactions between HCWs and patients, as a less resource-consuming substitute for direct observation. The results could be used to model the transmission of significant pathogens. HCW perceptions of interactions with patients accurately reflected reality.	[Lucet, Jean-Christophe; Lepelletier, Didier] Hop Bichat Claude Bernard, AP HP, Infect Control Unit, F-75877 Paris 18, France; [Lucet, Jean-Christophe; Laouenan, Cedric; Bouvet, Elisabeth; Mentre, France] Univ Paris Diderot, Paris, France; [Laouenan, Cedric; Mentre, France] INSERM, U738, Paris, France; [Laouenan, Cedric; Mentre, France] Hop Bichat Claude Bernard, AP HP, Serv Biostat, F-75877 Paris 18, France; [Chelius, Guillaume; Friggeri, Adrien; Fleury, Eric] Univ Lyon 1, Lab Informat Parallelisme, UMR 5668, Ecole Normale Super,Inst Natl Rech Informat Appl, F-69365 Lyon, France; [Veziris, Nicolas] Univ Paris 06, Equipe Accueil 1541, Paris, France; [Veziris, Nicolas] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg, Paris, France; [Veziris, Nicolas] Hop La Pitie Salpetriere, AP HP, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France; [Abiteboul, Dominique] Hop Bichat Claude Bernard, AP HP, Dept Occupat Hlth, F-75877 Paris 18, France; [Bouvet, Elisabeth] Hop Bichat Claude Bernard, AP HP, Dept Infect Dis, F-75877 Paris 18, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Lucet, JC (corresponding author), Hop Bichat Claude Bernard, AP HP, Infect Control Unit, F-75877 Paris 18, France.	jean-christophe.lucet@bch.aphp.fr	Mentre, France/AFU-8218-2022; veziris, nicolas/O-9783-2017; Laouenan, Cedric/E-1157-2019	Mentre, France/0000-0002-7045-1275; veziris, nicolas/0000-0001-5660-6544; Laouenan, Cedric/0000-0002-3681-6314	French National Agency for Food, Environmental and Occupational Health Safety (ANSES/AFSSET) [EST 2007-50]	French National Agency for Food, Environmental and Occupational Health Safety (ANSES/AFSSET)	This work was supported by a public grant from the French National Agency for Food, Environmental and Occupational Health Safety (ANSES/AFSSET, EST 2007-50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Eckmanns T, 2006, J HOSP INFECT, V63, P406, DOI 10.1016/j.jhin.2006.03.015; Friggeri A, 2011, COMPUT COMMUN, V34, P609, DOI 10.1016/j.comcom.2010.06.005; Gundlapalli Adi, 2009, AMIA Annu Symp Proc, V2009, P213; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Manangan LP, 2000, CHEST, V117, P380, DOI 10.1378/chest.117.2.380; Marra AR, 2010, INFECT CONT HOSP EP, V31, P796, DOI 10.1086/653999; Muller MP, 2010, JAMA-J AM MED ASSOC, V304, P1116, DOI 10.1001/jama.2010.1301; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; World Health Organization, 2008, TUB AIR TRAV GUID PR, V3rd ed	12	24	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37893	10.1371/journal.pone.0037893	http://dx.doi.org/10.1371/journal.pone.0037893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662245	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300136
J	Morrison, SS; Williams, T; Cain, A; Froelich, B; Taylor, C; Baker-Austin, C; Verner-Jeffreys, D; Hartnell, R; Oliver, JD; Gibas, CJ				Morrison, Shatavia S.; Williams, Tiffany; Cain, Aurora; Froelich, Brett; Taylor, Casey; Baker-Austin, Craig; Verner-Jeffreys, David; Hartnell, Rachel; Oliver, James D.; Gibas, Cynthia J.			Pyrosequencing-Based Comparative Genome Analysis of Vibrio vulnificus Environmental Isolates	PLOS ONE			English	Article							IV SECRETION; GENE ONTOLOGY; SIALIC ACIDS; RNA GENES; IDENTIFICATION; VERSATILE; SYSTEM; PATHOGENESIS; EVOLUTION; DATABASE	Between 1996 and 2006, the US Centers for Disease Control reported that the only category of food-borne infections increasing in frequency were those caused by members of the genus Vibrio. The Gram-negative bacterium Vibrio vulnificus is a ubiquitous inhabitant of estuarine waters, and is the number one cause of seafood-related deaths in the US. Many V. vulnificus isolates have been studied, and it has been shown that two genetically distinct subtypes, distinguished by 16S rDNA and other gene polymorphisms, are associated predominantly with either environmental or clinical isolation. While local genetic differences between the subtypes have been probed, only the genomes of clinical isolates have so far been completely sequenced. In order to better understand V. vulnificus as an agent of disease and to identify the molecular components of its virulence mechanisms, we have completed whole genome shotgun sequencing of three diverse environmental genotypes using a pyrosequencing approach. V. vulnificus strain JY1305 was sequenced to a depth of 336, and strains E64MW and JY1701 were sequenced to lesser depth, covering approximately 99.9% of each genome. We have performed a comparative analysis of these sequences against the previously published sequences of three V. vulnificus clinical isolates. We find that the genome of V. vulnificus is dynamic, with 1.27% of genes in the C-genotype genomes not found in the E-genotype genomes. We identified key genes that differentiate between the genomes of the clinical and environmental genotypes. 167 genes were found to be specifically associated with environmental genotypes and 278 genes with clinical genotypes. Genes specific to the clinical strains include components of sialic acid catabolism, mannitol fermentation, and a component of a Type IV secretory pathway VirB4, as well as several other genes with potential significance for human virulence. Genes specific to environmental strains included several that may have implications for the balance between self-preservation under stress and nutritional competence.	[Morrison, Shatavia S.; Cain, Aurora; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Williams, Tiffany; Froelich, Brett; Taylor, Casey; Oliver, James D.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Baker-Austin, Craig; Verner-Jeffreys, David; Hartnell, Rachel] Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Centre for Environment Fisheries & Aquaculture Science	Morrison, SS (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu	Froelich, Brett/AAD-9486-2020; Froelich, Brett/W-9325-2019	Froelich, Brett/0000-0003-0402-2357; Morrison, Shatavia S/0000-0002-4658-5951; Gibas, Cynthia/0000-0002-1288-9543	United Kingdom's Department for Environment Food and Rural Affairs through Seedcorn project [AS0111]; United Kingdom's Department for Environment Food and Rural Affairs through Cefas project [DP254]; United States Department of Education Graduate Assistance in Areas of National Need award [P200A090351-10]; United States Department of Agriculture [2007-35201-1838, 2009-03571]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Office of Advanced Cyberinfrastructure (OAC) [1047896] Funding Source: National Science Foundation	United Kingdom's Department for Environment Food and Rural Affairs through Seedcorn project; United Kingdom's Department for Environment Food and Rural Affairs through Cefas project; United States Department of Education Graduate Assistance in Areas of National Need award; United States Department of Agriculture(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was partly funded by the United Kingdom's Department for Environment Food and Rural Affairs through Seedcorn project AS0111 and Cefas project DP254. No additional external funding was received for this study. SSM and AC were supported by United States Department of Education Graduate Assistance in Areas of National Need award #P200A090351-10. BF and TW were supported by United States Department of Agriculture awards #2007-35201-1838 and #2009-03571 to JDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P76, DOI 10.1111/j.1758-2229.2009.00092.x; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; Been M, 2011, MICROBIOLOGY, V157, P3; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; Cain AA, 2012, GENOSETS VISUAL ANAL; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Clegg S, 2002, J BACTERIOL, V184, P1209, DOI 10.1128/jb.184.4.1209-1213.2002; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Darling AE, PLOS ONE, V5; Drake SL, 2010, FOODBORNE PATHOG DIS, V7, P97, DOI 10.1089/fpd.2009.0362; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Froelich B., 2011, ADV STUD BIOL, V3, P151; Froelich BA, 2008, 108 GEN M AM SOC MIC; Grimes DJ, 2009, MICROB ECOL, V58, P447, DOI 10.1007/s00248-009-9578-9; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; Gutacker M, 2003, APPL ENVIRON MICROB, V69, P3203, DOI 10.1128/AEM.69.6.3203-3212.2003; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Hoffman JA, 2000, INFECT IMMUN, V68, P5062, DOI 10.1128/IAI.68.9.5062-5067.2000; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kim DE, 2005, PROTEIN EXPRES PURIF, V39, P107, DOI 10.1016/j.pep.2004.09.007; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li J, 2012, GENE, V494, P57, DOI 10.1016/j.gene.2011.11.051; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lubin JB, 2010, P VIBR 2010 C; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Merkel SM, 2001, INFECT IMMUN, V69, P6119, DOI 10.1128/IAI.69.10.6119-6122.2001; Murray JW, 2005, PNAS, V48, P17320; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Okura M, 2004, MICROBIOL IMMUNOL, V48, P787, DOI 10.1111/j.1348-0421.2004.tb03596.x; Oliver JD, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P253; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rambaut A., FIGTREE; Rosche TM, 2010, ENV MICROBIOL REP, V2, P128, DOI 10.1111/j.1758-2229.2009.00119.x; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Senoh M, 2005, MICROBIOL IMMUNOL, V49, P513, DOI 10.1111/j.1348-0421.2005.tb03756.x; Smith AJ, 1997, J PERIODONTAL RES, V32, P1, DOI 10.1111/j.1600-0765.1997.tb01376.x; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Starks AM, 2000, INFECT IMMUN, V68, P5785, DOI 10.1128/IAI.68.10.5785-5793.2000; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Suzuki H, 2011, GENOME BIOL EVOL, V3, P168, DOI 10.1093/gbe/evr006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Warner JM, 1998, APPL ENVIRON MICROB, V64, P3025; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Yatsunami R., 2004, ENZYMATIC SYNTHESES; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	79	53	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37553	10.1371/journal.pone.0037553	http://dx.doi.org/10.1371/journal.pone.0037553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662170	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305342300060
J	Suarez, J; Romero-Zerbo, Y; Marquez, L; Rivera, P; Iglesias, M; Bermudez-Silva, FJ; Andreu, M; de Fonseca, FR				Suarez, Juan; Romero-Zerbo, Yanina; Marquez, Lucia; Rivera, Patricia; Iglesias, Mar; Bermudez-Silva, Francisco J.; Andreu, Montserrat; Rodriguez de Fonseca, Fernando			Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; ENDOGENOUS CANNABINOID SYSTEM; AMIDE HYDROLASE FAAH; PPAR-ALPHA; NITRIC-OXIDE; MOLECULAR CHARACTERIZATION; DIFFERENTIAL EXPRESSION; COLON INFLAMMATION; FOOD-INTAKE	Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPAR alpha) system in inflammatory bowel diseases. However, the presence and function of NAE-PPAR alpha signaling system in the ulcerative colitis (UC) of humans remain unknown as well as its response to active anti-inflammatory therapies such as 5-aminosalicylic acid (5-ASA) and glucocorticoids. Expression of PPAR alpha receptor and PPAR alpha ligands-biosynthetic (NAPE-PLD) and -degrading (FAAH and NAAA) enzymes were analyzed in untreated active and 5-ASA/glucocorticoids/immunomodulators-treated quiescent UC patients compared to healthy human colonic tissue by RTPCR and immunohistochemical analyses. PPAR alpha, NAAA, NAPE-PLD and FAAH showed differential distributions in the colonic epithelium, lamina propria, smooth muscle and enteric plexus. Gene expression analysis indicated a decrease of PPAR alpha, PPAR gamma and NAAA, and an increase of FAAH and iNOS in the active colitis mucosa. Immunohistochemical expression in active colitis epithelium confirmed a PPAR alpha decrease, but showed a sharp NAAA increase and a NAPE-PLD decrease, which were partially restored to control levels after treatment. We also characterized the immune cells of the UC mucosa infiltrate. We detected a decreased number of NAAA-positive and an increased number of FAAH-positive immune cells in active UC, which were partially restored to control levels after treatment. NAE-PPAR alpha signaling system is impaired during active UC and 5-ASA/glucocorticoids treatment restored its normal expression. Since 5-ASA actions may work through PPAR alpha and glucocorticoids through NAE-producing/degrading enzymes, the use of PPAR alpha agonists or FAAH/NAAA blockers that increases endogenous PPAR alpha ligands may yield similar therapeutics advantages.	[Suarez, Juan; Romero-Zerbo, Yanina; Rivera, Patricia; Bermudez-Silva, Francisco J.; Rodriguez de Fonseca, Fernando] Hosp Carlos Haya, Lab Med Regenerativa, Mediterranean Inst Adv Biotechnol & Hlth Res Fdn, Malaga, Spain; [Marquez, Lucia; Andreu, Montserrat] Univ Autonoma Barcelona, Dept Gastroenterol, E-08193 Barcelona, Spain; [Suarez, Juan; Bermudez-Silva, Francisco J.; Rodriguez de Fonseca, Fernando] Minist Ciencia & Innnovac, Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, Dept Pathol, E-08193 Barcelona, Spain	Hospital Carlos Haya; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Autonomous University of Barcelona	Suarez, J (corresponding author), Hosp Carlos Haya, Lab Med Regenerativa, Mediterranean Inst Adv Biotechnol & Hlth Res Fdn, Malaga, Spain.	MAndreu@parcdesalutmar.cat; fernando.rodriguez@fundacionimabis.org	Marquez, Lucia/AAI-8215-2021; Andreu, Montserrat/D-9911-2015; Bermudez-Silva, Francisco-Javier/Q-6920-2016; Suarez, Juan/I-5188-2015	Andreu, Montserrat/0000-0003-4286-1098; Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; Suarez, Juan/0000-0001-5254-9802; Romero-Zerbo, Silvana-Yanina/0000-0002-6737-992X; MARQUEZ MOSQUERA, LUCIA/0000-0002-3182-9570; Rivera, Patricia/0000-0002-0478-6667	European Union [Health-F2-2008-223713, REPROBESITY]; Spanish Ministry of Science and Innovation [SAF2010-20521]; National Institute of Health "Carlos III" [PI07/1226, PI07/0880, PI 07/0953]; Red de Trastornos Adictivos-UE-ERDF [RD06/0001/0000]; El Centro de Investigacion Biomedica en Red de Fisiopatologia de Obesidad y Nutricion; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF [CTS-433, PI45403]; Consejeria de Salud de la Junta de Andalucia, Spain [PI0232/2008]; National Institute of Health "Carlos III", Madrid, Spain [CD08/00203, CD07/00283]	European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Health "Carlos III"; Red de Trastornos Adictivos-UE-ERDF; El Centro de Investigacion Biomedica en Red de Fisiopatologia de Obesidad y Nutricion; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF; Consejeria de Salud de la Junta de Andalucia, Spain(Junta de Andalucia); National Institute of Health "Carlos III", Madrid, Spain	This study was supported by grants to FRdF from the European Union's 7th Framework Programme (Health-F2-2008-223713, REPROBESITY); the following grants from the Spanish Ministry of Science and Innovation (SAF2010-20521); National Institute of Health "Carlos III" (PI07/1226, PI07/0880 and PI 07/0953), Red de Trastornos Adictivos-UE-ERDF (RD06/0001/0000) and El Centro de Investigacion Biomedica en Red de Fisiopatologia de Obesidad y Nutricion; grants from the Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF (CTS-433 and PI45403); and a grant from the Consejeria de Salud de la Junta de Andalucia (PI0232/2008), Spain. FJBS holds a Miguel Servet research contracts CD07/00283, and JS holds a Sara Borrell postdoctoral contract CD08/00203, both from the National Institute of Health "Carlos III", Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battista N, 2007, NEUROBIOL DIS, V27, P108, DOI 10.1016/j.nbd.2007.04.012; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brattsand R, 1996, ALIMENT PHARM THERAP, V10, P81, DOI 10.1046/j.1365-2036.1996.22164025.x; Brown WA, 2000, DIGEST DIS SCI, V45, P1578, DOI 10.1023/A:1005517112039; Celinski K, 2011, J PHYSIOL PHARMACOL, V62, P347; Clapper ML, 2008, INFLAMM BOWEL DIS, V14, P1341, DOI 10.1002/ibd.20489; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; Cuzzocrea S, 2008, MOL PHARMACOL, V73, P323, DOI 10.1124/mol.107.041475; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dworzanski T, 2010, J PHYSIOL PHARMACOL, V61, P683; Esposito E, 2010, PPAR RES, V2010, DOI 10.1155/2010/917312; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Huin C, 2000, J HISTOCHEM CYTOCHEM, V48, P603, DOI 10.1177/002215540004800504; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; Kho YH, 2001, PHARM WORLD SCI, V23, P17, DOI 10.1023/A:1011268302386; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; LennardJones JE, 1997, EUR J GASTROEN HEPAT, V9, P353, DOI 10.1097/00042737-199704000-00007; Linard C, 2008, J PHARMACOL EXP THER, V324, P911, DOI 10.1124/jpet.107.129122; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mazzon E, 2007, SHOCK, V28, P192, DOI 10.1097/shk.0b013e318033eb29; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Paukkeri EL, 2007, BRIT J PHARMACOL, V152, P1081, DOI 10.1038/sj.bjp.0707477; Reinacher-Schick A, 2003, CARCINOGENESIS, V24, P443, DOI 10.1093/carcin/24.3.443; Riccardi L, 2009, SHOCK, V31, P308, DOI 10.1097/SHK.0b013e31818339e7; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Saubermann LJ, 2002, INFLAMM BOWEL DIS, V8, P330, DOI 10.1097/00054725-200209000-00004; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sklyarov AY, 2011, J PHYSIOL PHARMACOL, V62, P65; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; TRAVIS SPL, 1994, PHARMACOL THERAPEUT, V63, P135, DOI 10.1016/0163-7258(94)90042-6; Tromm A, 1999, HEPATO-GASTROENTEROL, V46, P3124; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Tsuboi K, 2007, BBA-MOL CELL BIOL L, V1771, P623, DOI 10.1016/j.bbalip.2007.03.005; Ueda N, 2000, CHEM PHYS LIPIDS, V108, P107, DOI 10.1016/S0009-3084(00)00190-0; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201	63	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37729	10.1371/journal.pone.0037729	http://dx.doi.org/10.1371/journal.pone.0037729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662201	Green Published, gold			2022-12-27	WOS:000305342300091
J	Northrup, E; Zschemisch, NH; Eisenblatter, R; Glage, S; Wedekind, D; Cuppen, E; Dorsch, M; Hedrich, HJ				Northrup, Emily; Zschemisch, Nils-Holger; Eisenblaetter, Regina; Glage, Silke; Wedekind, Dirk; Cuppen, Edwin; Dorsch, Martina; Hedrich, Hans-Juergen			The ter Mutation in the Rat Dnd1 Gene Initiates Gonadal Teratomas and Infertility in Both Genders	PLOS ONE			English	Article							GERM-CELL TUMORS; TESTICULAR DYSGENESIS SYNDROME; GENOME-WIDE ASSOCIATION; RNA-BINDING PROTEIN; DEAD-END DND1; EMBRYONAL CARCINOMA; 129/SV-TER MICE; MESSENGER-RNA; STRAIN; SUSCEPTIBILITY	A spontaneous mutation leading to the formation of congenital ovarian and testicular tumors was detected in the WKY/Ztm rat strain. The histological evaluation revealed derivatives from all three germ layers, thereby identifying these tumors as teratomas. Teratocarcinogenesis was accompanied by infertility and the underlying mutation was termed ter. Linkage analysis of 58 (WKY-ter6SPRD-Cu3) F2 rats associated the ter mutation with RNO18 (LOD = 3.25). Sequencing of candidate genes detected a point mutation in exon 4 of the dead-end homolog 1 gene (Dnd1), which introduces a premature stop codon assumed to cause a truncation of the Dnd1 protein. Genotyping of the recessive ter mutation revealed a complete penetrance of teratocarcinogenesis and infertility in homozygous ter rats of both genders. Morphologically non-tumorous testes of homozygous ter males were reduced in both size and weight. This testicular malformation was linked to a lack of spermatogenesis using immunohistochemical and histological staining. Our WKY-Dnd1(ter)/Ztm rat is a novel animal model to investigate gonadal teratocarcinogenesis and the molecular mechanisms involved in germ cell development of both genders.	[Northrup, Emily; Zschemisch, Nils-Holger; Eisenblaetter, Regina; Glage, Silke; Wedekind, Dirk; Dorsch, Martina; Hedrich, Hans-Juergen] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Cuppen, Edwin] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Cuppen, Edwin] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands	Hannover Medical School; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Northrup, E (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany.	Northrup.Emily@mh-hannover.de	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542	German Cluster of Excellence REBIRTH (Regenerative Biology and Reconstructive Therapies) [EXC 62/1]	German Cluster of Excellence REBIRTH (Regenerative Biology and Reconstructive Therapies)	This study was supported in part by the German Cluster of Excellence REBIRTH (Regenerative Biology and Reconstructive Therapies; EXC 62/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; Bahrami A, 2007, ARCH PATHOL LAB MED, V131, P1267; Bhattacharya C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002315; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chieffi P, 2009, INT REV CEL MOL BIO, V278, P277, DOI 10.1016/S1937-6448(09)78006-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; COOK MS, 2011, DEVELOPMENT; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; Faulkner SW, 2000, GYNECOL ONCOL, V77, P283, DOI 10.1006/gyno.2000.5762; Giambartolomei C, 2009, CANCER EPIDEMIOL, V33, P31, DOI 10.1016/j.canep.2009.04.015; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Hotaling JM, 2009, NAT REV UROL, V6, P550, DOI 10.1038/nrurol.2009.179; ITOH T, 1985, EXP ANIM TOKYO, V34, P207, DOI 10.1538/expanim1978.34.2_207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Lam MYJ, 2007, HUM MOL GENET, V16, P2233, DOI 10.1093/hmg/ddm175; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Langer B, 2004, LAB ANIM-UK, V38, P425, DOI 10.1258/0023677041958873; Liu WY, 2010, FASEB J, V24, P2641, DOI 10.1096/fj.09-148403; Looijenga LHJ, 1999, REV REPROD, V4, P90, DOI 10.1530/ror.0.0040090; MIWA M, 1987, EXP ANIM TOKYO, V36, P205, DOI 10.1538/expanim1978.36.2_205; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; NINOMIYA H, 1983, EXP ANIM TOKYO, V32, P145, DOI 10.1538/expanim1978.32.3_145; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Northrup E, 2011, EXP CELL RES, V317, P1885, DOI 10.1016/j.yexcr.2011.04.013; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; RIVERS EN, 1986, AM J PATHOL, V124, P263; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; Sawaki M, 2000, TOXICOL PATHOL, V28, P832, DOI 10.1177/019262330002800611; SCHARDEIN JL, 1977, LAB ANIM SCI, V27, P114; Sheikine Y, 2012, AM J CANCER RES, V2, P153; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1959, J NATL CANCER I, V23, P1249; Turnbull C, 2011, INT J ANDROL, V34, pE86, DOI 10.1111/j.1365-2605.2011.01162.x; van de Geijn GJM, 2009, BIRTH DEFECTS RES C, V87, P96, DOI 10.1002/bdrc.20140; Vilar E, 2006, Clin Transl Oncol, V8, P846, DOI 10.1007/s12094-006-0147-0; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Xu SZ, 1996, GENETICS, V143, P1417; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zechel JL, 2011, INT J ANDROL, V34, pE278, DOI 10.1111/j.1365-2605.2011.01160.x; Zhu R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-37	52	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e38001	10.1371/journal.pone.0038001	http://dx.doi.org/10.1371/journal.pone.0038001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655094	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900071
J	Taylor, SS; Jenkins, DA; Arcese, P				Taylor, Sabrina S.; Jenkins, Deborah A.; Arcese, Peter			Loss of Mhc and Neutral Variation in Peary Caribou: Genetic Drift Is Not Mitigated by Balancing Selection or Exacerbated by Mhc Allele Distributions	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; QUEEN ELIZABETH ISLANDS; RANGIFER-TARANDUS; NATURAL-SELECTION; CONSERVATION GENETICS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; GENOTYPING ERRORS; LINKAGE MAP; DIVERSITY	Theory and empirical results suggest that the rate of loss of variation at Mhc and neutral microsatellite loci may differ because selection influences Mhc genes, and because a high proportion of rare alleles at Mhc loci may result in high rates of loss via drift. Most published studies compare Mhc and microsatellite variation in various contemporary populations to infer the effects of population size on genetic variation, even though different populations are likely to have different demographic histories that may also affect contemporary genetic variation. We directly compared loss of variation at Mhc and microsatellite loci in Peary caribou by comparing historical and contemporary samples. We observed that similar proportions of genetic variation were lost over time at each type of marker despite strong evidence for selection at Mhc genes. These results suggest that microsatellites can be used to estimate genome-wide levels of variation, but also that adaptive potential is likely to be lost following population bottlenecks. However, gene conversion and recombination at Mhc loci may act to increase variation following bottlenecks.	[Taylor, Sabrina S.] Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Arcese, Peter] Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC V5Z 1M9, Canada	Louisiana State University System; Louisiana State University; University of British Columbia	Taylor, SS (corresponding author), Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	staylor@lsu.edu		Taylor, Sabrina/0000-0002-0118-9883	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; NSERC post-doctoral fellowship; LSU AgCenter (start-up funding)	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC post-doctoral fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); LSU AgCenter (start-up funding)	PA received funding from a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant. SST received funding from an NSERC post-doctoral fellowship and the LSU AgCenter (start-up funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-47; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Allen JA, 1902, B AM MUS NAT HIST, V16, P409; Allen JA, 1908, B AM MUS NAT HIST, V24, P487; Allendorf F., 2007, CONSERVATION GENETIC; Allentoft ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016670; Belkhir K., 1999, GENETIX LOGICIEL WIN; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BISHOP MD, 1994, GENETICS, V136, P619; Bonnot N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014436; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; BRITON J, 1994, BIOL CONSERV, V69, P267, DOI 10.1016/0006-3207(94)90426-X; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Carmichael LE, 2008, CONSERV GENET, V9, P879, DOI 10.1007/s10592-007-9413-0; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; CRAWFORD AM, 1995, GENETICS, V140, P703; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Ellegren H, 1996, MOL ECOL, V5, P3, DOI 10.1111/j.1365-294X.1996.tb00286.x; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gravlund P, 1998, MOL PHYLOGENET EVOL, V10, P151, DOI 10.1006/mpev.1998.0525; Gunn A, 2006, ARCTIC, V59, P1; Hambuch TM, 2002, EVOLUTION, V56, P841; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hedrick PW, 1998, EVOLUTION, V52, P194, DOI 10.1111/j.1558-5646.1998.tb05152.x; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Jarvi SI, 2004, MOL ECOL, V13, P2157, DOI 10.1111/j.1365-294X.2004.02228.x; Jenkins D.A., 2011, RECENT TRENDS ABUNDA; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kennedy LJ, 2011, INT J IMMUNOGENET, V38, P109, DOI 10.1111/j.1744-313X.2010.00973.x; Lawler RR, 2003, MOL ECOL, V12, P2307, DOI 10.1046/j.1365-294X.2003.01909.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucas ZL, 2009, CAN J ZOOL, V87, P310, DOI 10.1139/Z09-019; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; MacPhee RDE, 2005, BMC EVOLUTIONARY BIO, V5; Madsen T, 2000, BIOL CONSERV, V94, P257, DOI 10.1016/S0006-3207(99)00127-5; Martinsohn JT, 1999, IMMUNOGENETICS, V50, P168, DOI 10.1007/s002510050593; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Mikko S, 1999, IMMUNOL REV, V167, P169, DOI 10.1111/j.1600-065X.1999.tb01390.x; MIKKO S, 1995, P NATL ACAD SCI USA, V92, P4259, DOI 10.1073/pnas.92.10.4259; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Miller FL, 2003, ARCTIC, V56, P381; MILLER FL, 1977, CAN J ZOOL, V55, P1029, DOI 10.1139/z77-131; Miller FL, 2007, ARCTIC, V60, P23; Miller Frank L., 2003, Rangifer, P267; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller HC, 2004, IMMUNOGENETICS, V56, P178, DOI 10.1007/s00251-004-0666-1; Miller HC, 2007, J HERED, V98, P666, DOI 10.1093/jhered/esm095; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Perez-Gonzalez J, 2009, MOL ECOL, V18, P1591, DOI 10.1111/j.1365-294X.2009.04150.x; Petersen SD, 2010, J MAMMAL, V91, P698, DOI 10.1644/09-MAMM-A-231.1; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Roed KH, 1998, MOL ECOL, V7, P1773, DOI 10.1046/j.1365-294x.1998.00514.x; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sawyer S, 1999, GENECONV COMPUTER PA; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; SIGURDARDOTTIR S, 1991, ANIM GENET, V22, P199, DOI 10.1111/j.1365-2052.1991.tb00670.x; STONE RT, 1995, MAMM GENOME, V6, P714, DOI 10.1007/BF00354294; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMAS DC, 1982, CAN J ZOOL, V60, P597, DOI 10.1139/z82-089; Van der Walt JM, 2001, MOL ECOL, V10, P1679, DOI 10.1046/j.0962-1083.2001.01321.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wilberg MJ, 2004, MOL ECOL NOTES, V4, P783, DOI 10.1111/j.1471-8286.2004.00797.x; Wilson GA, 1997, MOL ECOL, V6, P697, DOI 10.1046/j.1365-294X.1997.00237.x; Wilson PJ, 2003, CAN J ZOOL, V81, P670, DOI 10.1139/Z03-030; Zittlau KA, 2004, THESIS U ALBERTA CAN	79	22	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36748	10.1371/journal.pone.0036748	http://dx.doi.org/10.1371/journal.pone.0036748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655029	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900003
J	Lv, XJ; Jaafar, FM; Sun, XH; Belhouchet, M; Fu, SH; Zhang, S; Tong, SX; Lv, Z; Mertens, PPC; Liang, GD; Attoui, H				Lv, Xinjun; Jaafar, Fauziah Mohd; Sun, Xiaohong; Belhouchet, Mourad; Fu, Shihong; Zhang, Song; Tong, Su-xiang; Lv, Zhi; Mertens, Peter P. C.; Liang, Guodong; Attoui, Houssam			Isolates of Liao Ning Virus from Wild-Caught Mosquitoes in the Xinjiang Province of China in 2005	PLOS ONE			English	Article							SEQUENCE DETERMINATION; VECTOR COMPETENCE; BANNA VIRUS; COLTIVIRUSES; DISEASE; SEADORNAVIRUS; TRANSMISSION; STRATEGIES; CALIFORNIA; INFERENCE	Liao ning virus (LNV) is related to Banna virus, a known human-pathogen present in south-east Asia. Both viruses belong to the genus Seadornavirus, family Reoviridae. LNV causes lethal haemorrhage in experimentally infected mice. Twenty seven isolates of LNV were made from mosquitoes collected in different locations within the Xinjiang province of north-western China during 2005. These mosquitoes were caught in the accommodation of human patients with febrile manifestations, or in animal barns where sheep represent the main livestock species. The regions where LNV was isolated are affected by seasonal encephalitis, but are free of Japanese encephalitis (JE). Genome segment 10 (Seg-10) (encoding cell-attachment and serotype-determining protein VP10) and Seg-12 (encoding non-structural protein VP12) were sequenced for multiple LNV isolates. Phylogenetic analyses showed a less homogenous Seg-10 gene pool, as compared to segment 12. However, all of these isolates appear to belong to LNV type-1. These data suggest a relatively recent introduction of LNV into Xinjiang province, with substitution rates for LNV Seg-10 and Seg-12, respectively, of 2.29x10(-4) and 1.57x10(-4) substitutions/nt/year. These substitution rates are similar to those estimated for other dsRNA viruses. Our data indicate that the history of LNV is characterized by a lack of demographic fluctuations. However, a decline in the LNV population in the late 1980s - early 1990s, was indicated by data for both Seg-10 and Seg-12. Data also suggest a beginning of an expansion in the late 1990s as inferred from Seg-12 skyline plot.	[Lv, Xinjun; Sun, Xiaohong; Fu, Shihong; Lv, Zhi; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Jaafar, Fauziah Mohd; Belhouchet, Mourad; Mertens, Peter P. C.; Attoui, Houssam] Inst Anim Hlth, Dept Vector Borne Viral Dis, Woking, Surrey, England; [Zhang, Song; Tong, Su-xiang] Xinjiang Ctr Dis Control & Prevent, Xinjiang, Peoples R China	Chinese Center for Disease Control & Prevention; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Lv, XJ (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	houssam.attoui@iah.ac.uk		Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	Biotechnology and Biological Sciences Research Council (BBSRC); Department for Environment, Food and Rural Affairs (DEFRA) in the UK; Ministry of Science and Technology, China [2003BA712A08-01, 2008ZX10004-001]; State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]; Biotechnology and Biological Sciences Research Council [BB/J020699/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs (DEFRA) in the UK(Department for Environment, Food & Rural Affairs (DEFRA)); Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); State Key Laboratory for Infectious Disease Prevention and Control; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by funding from Biotechnology and Biological Sciences Research Council (BBSRC) and the Department for Environment, Food and Rural Affairs (DEFRA) in the UK. The study was also supported by the Ministry of Science and Technology, China (contracts: 2003BA712A08-01; 2008ZX10004-001) and by the Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (contract: 2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 1998, J GEN VIROL, V79, P2481, DOI 10.1099/0022-1317-79-10-2481; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Attoui H, 2006, J GEN VIROL, V87, P199, DOI 10.1099/vir.0.81294-0; Attoui H, 2005, EMERG INFECT DIS, V11, P1673, DOI 10.3201/eid1111.050868; Attoui H, 2002, ARCH VIROL, V147, P533, DOI 10.1007/s007050200005; Attoui H, 2010, VIRUS TAXONOMY, P497; Attoui H., 2005, VIRUS TAXONOMY, P504; Attoui H, 2007, J GEN VIROL, V88, P3078, DOI 10.1099/vir.0.83076-0; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Billoir F, 1999, J VIROL METHODS, V81, P39, DOI 10.1016/S0166-0934(99)00055-5; BROWN SE, 1993, VIROLOGY, V196, P363, DOI 10.1006/viro.1993.1490; Carpi G, 2010, J MOL EVOL, V70, P583, DOI 10.1007/s00239-010-9354-y; Chen BQ, 1996, CHINESE MED J-PEKING, V109, P13; Ciolpan O, 1998, Roum Arch Microbiol Immunol, V57, P77; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fischer JR, 1997, EMERG INFECT DIS, V3, P69, DOI 10.3201/eid0301.970110; FULHORST CF, 1994, SCIENCE, V263, P676, DOI 10.1126/science.8303276; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jaafar FM, 2005, STRUCTURE, V13, P17, DOI 10.1016/j.str.2004.10.017; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kramer LD, 1998, J MED ENTOMOL, V35, P1020, DOI 10.1093/jmedent/35.6.1020; Li Q. P. (et al.), 1992, Endemic Diseases Bulletin, V7, P77; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; MACDONALD W W, 1956, Med J Malaya, V10, P232; MACDONALD W W, 1956, Ann Trop Med Parasitol, V50, P385; MACDONALD W W, 1956, Ann Trop Med Parasitol, V50, P399; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; Monath T.P., 1996, FLAVIVIRUSES FIELDS; Nabeshima T, 2008, EMERG INFECT DIS, V14, P1276, DOI 10.3201/eid1408.080100; Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Romanowski M, 1989, P NEW JERS MOSQ EXT, P58; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; Song LiTing, 1995, Chinese Journal of Experimental and Clinical Virology, V9, P7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao SJ, 2005, CHINESE MED J-PEKING, V118, P581; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VARMA MGR, 1969, J MED ENTOMOL, V6, P432, DOI 10.1093/jmedent/6.4.432; Xu PuTing, 1990, Chinese Journal of Virology, V6, P27; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0	51	12	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37732	10.1371/journal.pone.0037732	http://dx.doi.org/10.1371/journal.pone.0037732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649554	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800074
J	Weiss, GJ; Liang, WS; Izatt, T; Arora, S; Cherni, I; Raju, RN; Hostetter, G; Kurdoglu, A; Christoforides, A; Sinari, S; Baker, AS; Metpally, R; Tembe, WD; Phillips, L; Von Hoff, DD; Craig, DW; Carpten, JD				Weiss, Glen J.; Liang, Winnie S.; Izatt, Tyler; Arora, Shilpi; Cherni, Irene; Raju, Robert N.; Hostetter, Galen; Kurdoglu, Ahmet; Christoforides, Alexis; Sinari, Shripad; Baker, Angela S.; Metpally, Raghu; Tembe, Waibhav D.; Phillips, Lori; Von Hoff, Daniel D.; Craig, David W.; Carpten, John D.			Paired Tumor and Normal Whole Genome Sequencing of Metastatic Olfactory Neuroblastoma	PLOS ONE			English	Article							CANCER GENOME; P53 GENE; MUTATIONS; EXPRESSION; CELLS; ESTHESIONEUROBLASTOMA; PROGNOSIS; SURVIVAL; COMPLEX; TOOLKIT	Background: Olfactory neuroblastoma (ONB) is a rare cancer of the sinonasal tract with little molecular characterization. We performed whole genome sequencing (WGS) on paired normal and tumor DNA from a patient with metastatic-ONB to identify the somatic alterations that might be drivers of tumorigenesis and/or metastatic progression. Methodology/Principal Findings: Genomic DNA was isolated from fresh frozen tissue from a metastatic lesion and whole blood, followed by WGS at >30X depth, alignment and mapping, and mutation analyses. Sanger sequencing was used to confirm selected mutations. Sixty-two somatic short nucleotide variants (SNVs) and five deletions were identified inside coding regions, each causing a non-synonymous DNA sequence change. We selected seven SNVs and validated them by Sanger sequencing. In the metastatic ONB samples collected several months prior to WGS, all seven mutations were present. However, in the original surgical resection specimen (prior to evidence of metastatic disease), mutations in KDR, MYC, SIN3B, and NLRC4 genes were not present, suggesting that these were acquired with disease progression and/or as a result of post-treatment effects. Conclusions/Significance: This work provides insight into the evolution of ONB cancer cells and provides a window into the more complex factors, including tumor clonality and multiple driver mutations.	[Weiss, Glen J.; Von Hoff, Daniel D.] Virginia G Piper Canc Ctr Clin Trials Scottsdale, Scottsdale, AZ 85258 USA; [Weiss, Glen J.; Arora, Shilpi; Cherni, Irene] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Liang, Winnie S.; Kurdoglu, Ahmet; Christoforides, Alexis; Sinari, Shripad; Phillips, Lori] Translat Genom Res Inst, Collaborat Sequencing Ctr, Phoenix, AZ USA; [Izatt, Tyler; Craig, David W.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Raju, Robert N.] Innovat Ctr, Kettering, OH USA; [Hostetter, Galen; Baker, Angela S.; Carpten, John D.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Metpally, Raghu; Tembe, Waibhav D.] Translat Genom Res Inst, Collaborat Bioinformat Ctr, Phoenix, AZ USA; [Von Hoff, Daniel D.] Translat Genom Res Inst, Clin Translat Res Div, Phoenix, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute	Weiss, GJ (corresponding author), Virginia G Piper Canc Ctr Clin Trials Scottsdale, Scottsdale, AZ 85258 USA.	gweiss@tgen.org	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955	National Foundation for Cancer Research; TGen Foundation; National Institutes of Health [1S10RR25056-01, 1S10RR023390-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025056, S10RR023390] Funding Source: NIH RePORTER	National Foundation for Cancer Research; TGen Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Foundation for Cancer Research www.nfcr.org TGen Foundation www.tgenfoundation.org National Institutes of Health grants #1S10RR25056-01 and #1S10RR023390-01 www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2009, CANCER RES, V69, P7175, DOI 10.1158/0008-5472.CAN-09-2068; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; CASTANEDA VL, 1991, AM J PEDIAT HEMATOL, V13, P62; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Faragalla H, 2009, ADV ANAT PATHOL, V16, P322, DOI 10.1097/PAP.0b013e3181b544cf; Feero WG, 2008, JAMA-J AM MED ASSOC, V299, P1351, DOI 10.1001/jama.299.11.1351; Guled M, 2008, MODERN PATHOL, V21, P770, DOI 10.1038/modpathol.2008.57; HIROSE T, 1995, CANCER, V76, P4, DOI 10.1002/1097-0142(19950701)76:1<4::AID-CNCR2820760103>3.0.CO;2-E; Kim JW, 2008, OTOLARYNG HEAD NECK, V139, P708, DOI 10.1016/j.otohns.2008.03.011; Koka VN, 1998, J LARYNGOL OTOL, V112, P628, DOI 10.1017/S0022215100141295; KOMURO H, 1993, CANCER RES, V53, P5284; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Koschny R, 2010, J NEURO-ONCOL, V97, P171, DOI 10.1007/s11060-009-0010-6; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lahousse SA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-41; Lee S, 2008, BRAIN RES, V1207, P19, DOI 10.1016/j.brainres.2008.02.016; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mao L, 2009, ONCOLOGY-BASEL, V77, P231, DOI 10.1159/000236047; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyagami Mitsusuke, 2002, Medical Electron Microscopy, V35, P160, DOI 10.1007/s007950200020; Nibu K, 2000, BIOCHEM BIOPH RES CO, V279, P172, DOI 10.1006/bbrc.2000.3899; Papadaki H, 1996, AM J SURG PATHOL, V20, P715, DOI 10.1097/00000478-199606000-00009; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Qiao JB, 2004, SURGERY, V136, P489, DOI 10.1016/j.surg.2004.05.030; Qiao JB, 2007, NEOPLASIA, V9, P184, DOI 10.1593/neo.06841; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Sohrabi S, 2011, J CLIN ONCOL, V29, pE358, DOI 10.1200/JCO.2010.30.9278; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Thompson LDR, 2009, HEAD NECK PATHOL, V3, P252, DOI 10.1007/s12105-009-0125-2; Voidonikolas G, 2009, WORLD J SURG, V33, P615, DOI 10.1007/s00268-008-9851-y; Weinreb I, 2009, HUM PATHOL, V40, P1330, DOI 10.1016/j.humpath.2009.02.001; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yamazaki Y, 2003, ORAL ONCOL, V39, P163, DOI 10.1016/S1368-8375(02)00064-7; Zanation AM, 2010, EUR ARCH OTO-RHINO-L, V267, P1667, DOI 10.1007/s00405-010-1360-6	38	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37029	10.1371/journal.pone.0037029	http://dx.doi.org/10.1371/journal.pone.0037029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649506	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800024
J	Arsenijevic, T; Gregoire, F; Delforge, V; Delporte, C; Perret, J				Arsenijevic, Tatjana; Gregoire, Francoise; Delforge, Valerie; Delporte, Christine; Perret, Jason			Murine 3T3-L1 Adipocyte Cell Differentiation Model: Validated Reference Genes for qPCR Gene Expression Analysis	PLOS ONE			English	Article							TRANSCRIPTION-PCR DATA; HOUSEKEEPING GENES; MESSENGER-RNA; NORMALIZATION; SELECTION; QUANTIFICATION; PUBLICATION	Background: Analysis of gene expression at the mRNA level, using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), mandatorily requires reference genes (RGs) as internal controls. However, increasing evidences have shown that RG expression may vary considerably under experimental conditions. We sought for an appropriate panel of RGs to be used in the 3T3-L1 cell line model during their terminal differentiation into adipocytes. To this end, the expression levels of a panel of seven widely used RG mRNAs were measured by qRT-PCR. The 7 RGs evaluated were beta-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyl-transferase I (HPRT), ATP synthase H+ transporting mitochondrial F1 complex beta subunit (ATP-5b), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), Non-POU-domain containing octamer binding protein (NoNo), and large ribosomal protein L13a (RPL). Methodology/Principal Findings: Using three Excel applications, GeNorm, NormFinder and BestKeeper, we observed that the number and the stability of potential RGs vary significantly during differentiation of 3T3-L1 cells into adipocytes. mRNA expression analyses using qRT-PCR revealed that during the entire differentiation program, only NoNo expression is relatively stable. Moreover, the RG sets that were acceptably stable were different depending on the phase of the overall differentiation process (i.e. mitotic clonal expansion versus the terminal differentiation phase). RPL, ACTB, and Ywhaz, are suitable for terminal differentiation, whereas ATP-5b and HPRT, are suitable during mitotic clonal expansion. Conclusion: Our results demonstrate that special attention must be given to the choice of suitable RGs during the various well defined phases of adipogenesis to ensure accurate data analysis and that the use of several RGs is absolutely required. Consequently, our data show for the first time, that during mitotic clonal expansion, the most suitable RGs are ATP-5b, NoNo and HPRT, while during terminal differentiation the most suitable RGs are, NoNo, RPL, ACTB and Ywhaz.	[Arsenijevic, Tatjana; Gregoire, Francoise; Delporte, Christine; Perret, Jason] Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium; [Delforge, Valerie] Nutrisub ASBL, Brussels, Belgium	Universite Libre de Bruxelles	Arsenijevic, T (corresponding author), Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium.	jperret@ulb.ac.be	Delporte, Christine/A-5733-2012	Delporte, Christine/0000-0003-0385-5824; Gregoire, Francoise/0000-0003-0452-8868	"Fonds National de la recherche scientifique" - FNRS; FRSM [3.4502.09]	"Fonds National de la recherche scientifique" - FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS)	TA is a recipient of a fellowship from "Fonds National de la recherche scientifique" - FNRS. This work was supported by FRSM grant no 3.4502.09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barroso I, 1999, EUR J ENDOCRINOL, V141, P169, DOI 10.1530/eje.0.1410169; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Gabrielsson BG, 2004, MOL CELL BIOCHEM, V258, P65, DOI 10.1023/B:MCBI.0000012837.11847.c8; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hendriks-Balk MC, 2007, BASIC RES CARDIOL, V102, P195, DOI 10.1007/s00395-007-0649-0; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Samaras K, 2010, OBES SURG, V20, P108, DOI 10.1007/s11695-009-9952-1; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Sugden K, 2010, J PSYCHOPHARMACOL, V24, P1253, DOI 10.1177/0269881108099690; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859	37	53	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37517	10.1371/journal.pone.0037517	http://dx.doi.org/10.1371/journal.pone.0037517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629413	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300048
J	Dematheis, F; Zimmerling, U; Flocco, C; Kurtz, B; Vidal, S; Kropf, S; Smalla, K				Dematheis, Flavia; Zimmerling, Ute; Flocco, Cecilia; Kurtz, Benedikt; Vidal, Stefan; Kropf, Siegfried; Smalla, Kornelia			Multitrophic Interaction in the Rhizosphere of Maize: Root Feeding of Western Corn Rootworm Larvae Alters the Microbial Community Composition	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; POPULATIONS COLEOPTERA; INDUCED RESISTANCE; PLANT-GROWTH; SOIL; INSECT; INFESTATION; BACTERIA; IMPACT; DIVERSITY	Background: Larvae of the Western Corn Rootworm (WCR) feeding on maize roots cause heavy economical losses in the US and in Europe. New or adapted pest management strategies urgently require a better understanding of the multitrophic interaction in the rhizosphere. This study aimed to investigate the effect of WCR root feeding on the microbial communities colonizing the maize rhizosphere. Methodology/Principal Findings: In a greenhouse experiment, maize lines KWS13, KWS14, KWS15 and MON88017 were grown in three different soil types in presence and in absence of WCR larvae. Bacterial and fungal community structures were analyzed by denaturing gradient gel electrophoresis (DGGE) of the 16S rRNA gene and ITS fragments, PCR amplified from the total rhizosphere community DNA. DGGE bands with increased intensity were excised from the gel, cloned and sequenced in order to identify specific bacteria responding to WCR larval feeding. DGGE fingerprints showed that the soil type and the maize line influenced the fungal and bacterial communities inhabiting the maize rhizosphere. WCR larval feeding affected the rhiyosphere microbial populations in a soil type and maize line dependent manner. DGGE band sequencing revealed an increased abundance of Acinetobacter calcoaceticus in the rhizosphere of several maize lines in all soil types upon WCR larval feeding. Conclusion/Significance: The effects of both rhizosphere and WCR larval feeding seemed to be stronger on bacterial communities than on fungi. Bacterial and fungal community shifts in response to larval feeding were most likely due to changes of root exudation patterns. The increased abundance of A. calcoaceticus suggested that phenolic compounds were released upon WCR wounding.	[Dematheis, Flavia; Zimmerling, Ute; Flocco, Cecilia; Smalla, Kornelia] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Kurtz, Benedikt; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Kropf, Siegfried] Univ Magdeburg, Dept Biometry & Med Informat, D-39106 Magdeburg, Germany	Julius Kuhn-Institut; University of Gottingen; Otto von Guericke University	Dematheis, F (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany.	kornelia.smalla@jki.bund.de	Vidal, Stefan/AAC-3130-2020; Smalla, Kornelia/H-4002-2011; Dematheis, Flavia/GRS-2490-2022	Vidal, Stefan/0000-0002-1673-4055; Flocco, Cecilia/0000-0001-9370-6130	Deutsche Forschungsgemeinschaft (DFG) [SM59/7-1, Vi117/17-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG SM59/7-1; Vi117/17-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baumgarte S, 2005, MOL ECOL, V14, P2539, DOI 10.1111/j.1365-294X.2005.02592.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Brimecombe MJ, 2001, BOOKS SOIL PLANT ENV, P95; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Broekgaarden C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-239; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clark PL, 2006, J ECON ENTOMOL, V99, P722, DOI 10.1603/0022-0493-99.3.722; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Davis CS, 2000, J ECON ENTOMOL, V93, P989, DOI 10.1603/0022-0493-93.3.989; Dawson LA, 2004, APPL SOIL ECOL, V25, P51, DOI 10.1016/S0929-1393(03)00099-4; Denton CS, 1999, SOIL BIOL BIOCHEM, V31, P155, DOI 10.1016/S0038-0717(98)00118-7; EFSA (European Food Safety Authority), 2009, EFSA J, V1193, P1, DOI DOI 10.2903/j.efsa.2009.1149; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; European Commission, 2006, OFF J EUR UNION L, V225, P30; European Commission, 2003, OFFICIAL J EUROPEAN, V275, P49; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Grayston SJ, 2001, EUR J SOIL BIOL, V37, P277, DOI 10.1016/S1164-5563(01)01098-6; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Kandeler E, 2002, PLANT SOIL, V238, P301, DOI 10.1023/A:1014479220689; Kavroulakis N, 2010, PLANT SOIL, V333, P233, DOI 10.1007/s11104-010-0338-x; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Kurtz B, 2010, THESIS U GOTTINGEN; Lanoue A, 2010, PLANT SIGNAL BEHAV, V5, P1037, DOI [10.4161/psb.5.8.12337, 10.1111/j.1469-8137.2009.03066.x]; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Levine Eli, 2002, American Entomologist, V48, P94; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Miethling-Graff R, 2010, EUR J SOIL BIOL, V46, P41, DOI 10.1016/j.ejsobi.2009.10.003; Nishida T, 2010, POPUL ECOL, V52, P507, DOI 10.1007/s10144-010-0208-7; Onstad DW, 2001, ENTOMOL EXP APPL, V100, P195, DOI 10.1023/A:1019289030248; Parimi S, 2006, CROP PROT, V25, P269, DOI 10.1016/j.cropro.2005.04.017; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Poerschmann J, 2008, J AGR FOOD CHEM, V56, P11906, DOI 10.1021/jf8023694; Prischmann DA, 2008, APPL SOIL ECOL, V40, P417, DOI 10.1016/j.apsoil.2008.06.012; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; SPIKE BP, 1991, J ECON ENTOMOL, V84, P1585, DOI 10.1093/jee/84.5.1585; Szalai M, 2011, J PEST SCI, V84, P133, DOI 10.1007/s10340-010-0336-z; Treonis AM, 2005, APPL SOIL ECOL, V28, P203, DOI 10.1016/j.apsoil.2004.08.004; Urias-Lopez M, 2000, ENVIRON ENTOMOL, V29, P861, DOI 10.1603/0046-225X-29.5.861; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Van Oosten VR, 2008, MOL PLANT MICROBE IN, V21, P919, DOI 10.1094/MPMI-21-7-0919; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; Wurst S, 2010, APPL SOIL ECOL, V45, P123, DOI 10.1016/j.apsoil.2010.04.005; Zhan Y, 2011, AM SOC MICROBIOL, DOI [10.1128/JB.00261-11, DOI 10.1128/JB.00261-11]	54	20	22	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37288	10.1371/journal.pone.0037288	http://dx.doi.org/10.1371/journal.pone.0037288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629377	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300030
J	Chai, LC; Kong, BH; Elemfareji, OI; Thong, KL				Chai, Lay Ching; Kong, Boon Hong; Elemfareji, Omar Ismail; Thong, Kwai Lin			Variable Carbon Catabolism among Salmonella enterica Serovar Typhi Isolates	PLOS ONE			English	Article							ESCHERICHIA-COLI; FATTY-ACIDS; TYPHIMURIUM; VIRULENCE; STRAINS; IDENTIFICATION; MACROPHAGES; METABOLISM; SEQUENCE; NITROGEN	Background: Salmonella enterica serovar Typhi (S. Typhi) is strictly a human intracellular pathogen. It causes acute systemic (typhoid fever) and chronic infections that result in long-term asymptomatic human carriage. S. Typhi displays diverse disease manifestations in human infection and exhibits high clonality. The principal factors underlying the unique lifestyle of S. Typhi in its human host during acute and chronic infections remain largely unknown and are therefore the main objective of this study. Methodology/Principal Findings: To obtain insight into the intracellular lifestyle of S. Typhi, a high-throughput phenotypic microarray was employed to characterise the catabolic capacity of 190 carbon sources in S. Typhi strains. The success of this study lies in the carefully selected library of S. Typhi strains, including strains from two geographically distinct areas oftyphoid endemicity, an asymptomatic human carrier, clinical stools and blood samples and sewage-contaminated rivers. An extremely low carbon catabolic capacity (27% of 190 carbon substrates) was observed among the strains. The carbon catabolic profiles appeared to suggest that S. Typhi strains survived well on carbon subtrates that are found abundantly in the human body but not in others. The strains could not utilise plant-associated carbon substrates. In addition, alpha-glycerolphosphate, glycerol, L-serine, pyruvate and lactate served as better carbon sources to monosaccharides in the S. Typhi strains tested. Conclusion: The carbon catabolic profiles suggest that S. Typhi could survive and persist well in the nutrient depleted metabolic niches in the human host but not in the environment outside of the host. These findings serve as caveats for future studies to understand how carbon catabolism relates to the pathogenesis and transmission of this pathogen.	[Chai, Lay Ching; Kong, Boon Hong; Elemfareji, Omar Ismail; Thong, Kwai Lin] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Chai, Lay Ching; Kong, Boon Hong; Elemfareji, Omar Ismail; Thong, Kwai Lin] Univ Malaya, Lab Biomed Sci & Mol Microbiol, Inst Grad Studies, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chai, LC (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	thongkl@um.edu.my	Chai, Lay Ching/A-7761-2011; Kong, Boon Hong/C-2568-2012; Thong, Kwai Lin/B-3946-2009; Kong, Boon Hong/AAU-3157-2021; Thong, Kwai-Lin/Q-2458-2019	Chai, Lay Ching/0000-0001-8280-3226; Kong, Boon Hong/0000-0003-3255-9960; Thong, Kwai-Lin/0000-0001-8557-5185	University of Malaya [UMC/HIR/MOHE/02 [A000002-50001]]	University of Malaya(Universiti Malaya)	The work was supported by grant from University of Malaya UMC/HIR/MOHE/02 [A000002-50001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo A, 2000, J NUTR BIOCHEM, V11, P81, DOI 10.1016/S0955-2863(99)00073-X; Baumler AJ, 1997, J BACTERIOL, V179, P317; BAUMLER AJ, 1995, J BACTERIOL, V177, P2087; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hammer-Jespersen K., 1983, METABOLISM NUCLEOTID, P203; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hughes LA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-4; Ismail A, 2011, MALAYSIAN J PUB HLTH, V11, P4; JENSEN KF, 1975, EUR J BIOCHEM, V51, P253, DOI 10.1111/j.1432-1033.1975.tb03925.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Lundberg BE, 1999, INFECT IMMUN, V67, P436, DOI 10.1128/IAI.67.1.436-438.1999; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; SIMMONDS RJ, 1981, J CHROMATOGR, V226, P369, DOI 10.1016/S0378-4347(00)86071-5; Skyberg JA, 2006, AVIAN DIS, V50, P77, DOI 10.1637/7417.1; Soto SM, 2006, J MED MICROBIOL, V55, P365, DOI 10.1099/jmm.0.46257-0; Sternfeld L, 1937, J AM CHEM SOC, V59, P2653, DOI 10.1021/ja01291a051; Sternfeld L, 1938, J BACTERIOL, V36, P53, DOI 10.1128/JB.36.1.53-56.1938; Thong KL, 1996, APPL ENVIRON MICROB, V62, P271, DOI 10.1128/AEM.62.1.271-274.1996; THONG KL, 1994, J CLIN MICROBIOL, V32, P1135, DOI 10.1128/JCM.32.5.1135-1141.1994; Utley M, 1998, FEMS MICROBIOL LETT, V163, P129, DOI 10.1016/S0378-1097(98)00162-1; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	44	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36201	10.1371/journal.pone.0036201	http://dx.doi.org/10.1371/journal.pone.0036201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662115	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300009
J	Chen, Z; Zeng, MJ; Song, BA; Hou, CR; Hu, DY; Li, XY; Wang, ZC; Fan, HT; Bi, L; Liu, JJ; Yu, DD; Jin, LH; Yang, S				Chen, Zhuo; Zeng, Mengjiao; Song, Baoan; Hou, Chengrui; Hu, Deyu; Li, Xiangyang; Wang, Zhenchao; Fan, Huitao; Bi, Liang; Liu, Jiaju; Yu, Dandan; Jin, Linhong; Yang, Song			Dufulin Activates HrBP1 to Produce Antiviral Responses in Tobacco	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; VISUALIZATION; ARABIDOPSIS; PROTEINS; ETHYLENE; STRESS; HARPIN; ANNOTATION; BLAST2GO	Background: Dufulin is a new antiviral agent that is highly effective against plant viruses and acts by activating systemic acquired resistance (SAR) in plants. In recent years, it has been used widely to prevent and control tobacco and rice viral diseases in China. However, its targets and mechanism of action are still poorly understood. Methodology/Principal Findings: Here, differential in-gel electrophoresis (DIGE) and classical two-dimensional electrophoresis (2-DE) techniques were combined with mass spectrometry (MS) to identify the target of Dufulin. More than 40 proteins were found to be differentially expressed (>= 1.5 fold or <= 1.5 fold) upon Dufulin treatment in Nicotiana tabacum K-326. Based on annotations in the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, these proteins were found to be related to disease resistance. Directed acyclic graph (DAG) analysis of the various pathways demonstrated harpin binding protein-1 (HrBP1) as the target of action of Dufulin. Additionally, western blotting, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR), and real time PCR analyses were also conducted to identify the specific mechanism of action of Dufulin. Our results show that activation of HrBP1 triggers the salicylic acid (SA) signaling pathway and thereby produces antiviral responses in the plant host. A protective assay based on lesion counting further confirmed the antiviral activity of Dufulin. Conclusion: This study identified HrBP1 as a target protein of Dufulin and that Dufulin can activate the SA signaling pathway to induce host plants to generate antiviral responses.	[Chen, Zhuo; Song, Baoan; Hu, Deyu; Li, Xiangyang; Wang, Zhenchao; Fan, Huitao; Bi, Liang; Liu, Jiaju; Yu, Dandan; Jin, Linhong; Yang, Song] Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China; [Zeng, Mengjiao] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou, Guangdong, Peoples R China; [Hou, Chengrui] Shanghai Appl Prot Technol Co Ltd, Shanghai, Peoples R China	Guizhou University; South China University of Technology	Chen, Z (corresponding author), Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China.	basong@gzu.edu.cn; fcc.syang@gzu.edu.cn	Chen, Zhuo/AFX-0411-2022; Yang, Song/H-2765-2013	Yang, Song/0000-0003-1301-3030	National Basic Research Program of China [2010CB126105]; National Basic Research Preliminary Program of China [2010CB134504]; National Natural Science Foundation of China [21132003, 20872021]	National Basic Research Program of China(National Basic Research Program of China); National Basic Research Preliminary Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the following funding sources: The National Basic Research Program of China (Nos. 2010CB126105) URL: http://www.973.gov.cn, the National Basic Research Preliminary Program of China (Grant No. 2010CB134504) URL: http://www.973.gov.cn and the National Natural Science Foundation of China (Nos. 21132003, 20872021) URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chen Z, 2008, BIOORGAN MED CHEM, V16, P3076, DOI 10.1016/j.bmc.2007.12.035; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GILLESPIE PG, 1991, P NATL ACAD SCI USA, V88, P2563, DOI 10.1073/pnas.88.6.2563; GOODING GV, 1967, PHYTOPATHOLOGY, V57, P1285; Gopalan S, 2008, BMC RES NOTES, V1, P1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hull Roger, 2002, MATTHEWS PLANT VIROL, p[56, 736]; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Li YM, 2008, PLANT BIOTECHNOL J, V6, P301, DOI 10.1111/j.1467-7652.2008.00322.x; Liu FQ, 2006, PHYTOPATHOLOGY, V96, P1052, DOI 10.1094/PHYTO-96-1052; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Midoh N, 1997, J PESTIC SCI, V22, P45; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; SCHNEPPENHEIM R, 1991, ELECTROPHORESIS, V12, P367, DOI 10.1002/elps.1150120508; Song B.A., 2009, ENV FRIENDLY ANTIPLA, P234; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853	34	42	53	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37944	10.1371/journal.pone.0037944	http://dx.doi.org/10.1371/journal.pone.0037944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662252	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300143
J	Jeong, J; Kim, WH; Yoo, J; Lee, C; Kim, S; Cho, JH; Jang, HK; Kim, DW; Lillehoj, HS; Min, W				Jeong, Jipseol; Kim, Woo H.; Yoo, Jeongmi; Lee, Changhwan; Kim, Suk; Cho, Jae-Hyeon; Jang, Hyung-Kwan; Kim, Dong W.; Lillehoj, Hyun S.; Min, Wongi			Identification and Comparative Expression Analysis of Interleukin 2/15 Receptor beta Chain in Chickens Infected with E. tenella	PLOS ONE			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; NATURAL-KILLER-CELLS; IL-2 RECEPTOR; T-CELLS; ALPHA-CHAIN; EIMERIA-ACERVULINA; GENOMIC ORGANIZATION; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; MICE LACKING	Background: Interleukin (IL) 2 and IL15 receptor beta chain (IL2/15R beta, CD122) play critical roles in signal transduction for the biological activities of IL2 and IL15. Increased knowledge of non-mammalian IL2/15R beta will enhance the understanding of IL2 and IL15 functions. Methology/Principal Findings: Chicken IL2/15R beta (chIL2/15R beta) cDNA was cloned using 5'/3'-RACE. The predicted protein sequence contained 576 amino acids and typical features of the type-I cytokine receptor family. COS-7 cells transfected with chIL2/15R beta produced proteins of approximately 75 and 62.5 kDa under normal and tunicamycin-treated conditions, respectively. The genomic structure of chIL2/15R beta was similar to its mammalian counterparts. chIL2/15R beta transcripts were detected in the lymphoblast cell line CU205 and in normal lymphoid organs and at moderate levels in bursa samples. Expression profiles of chIL2/15R beta and its related cytokines and receptors were examined in ConA-stimulated splenic lymphocytes and in ceca-tonsils of Eimeria tenella-infected chickens using quantitative real-time PCR. Expression levels of chIL2/15R beta, chIL2R alpha, and chIL15R alpha were generally elevated in ceca-tonsils and ConA-activated splenic lymphocytes. However, chIL2 and chIL15 expression levels were differentially regulated between the samples. chIL2 expression was upregulated in ConA-activated splenic lymphocytes, but not in ceca-tonsils. In constrast, chIL15 expression was upregulated in ceca-tonsils, but not in ConA-activated splenic lymphocytes. Conclusions/Significance: We identified an avian form of IL2/15R beta and compared its gene expression pattern with those of chIL2, chIL15, chIL2R alpha, and chIL15R alpha. Our observations suggest that chIL15 and its receptors, including chIL2/15R beta, play important roles in mucosal immunity to intestinal intracellular parasites such as Eimeria.	[Jeong, Jipseol; Kim, Woo H.; Yoo, Jeongmi; Lee, Changhwan; Kim, Suk; Cho, Jae-Hyeon; Min, Wongi] Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea; [Jeong, Jipseol; Kim, Woo H.; Yoo, Jeongmi; Lee, Changhwan; Kim, Suk; Cho, Jae-Hyeon; Min, Wongi] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju, South Korea; [Jang, Hyung-Kwan] Chonbuk Natl Univ, Coll Vet Med, Dept Infect Dis, Jeonju, South Korea; [Jang, Hyung-Kwan] Chonbuk Natl Univ, Coll Vet Med, Dept Avian Dis, Jeonju, South Korea; [Jang, Hyung-Kwan] Chonbuk Natl Univ, Korea Zoonosis Res Inst, Jeonju, South Korea; [Kim, Dong W.] Natl Inst Anim Sci, RDA, Cheonan, Chungnam, South Korea; [Lillehoj, Hyun S.] ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, USDA, Beltsville, MD USA	Gyeongsang National University; Gyeongsang National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; United States Department of Agriculture (USDA)	Jeong, J (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea.	wongimin@gnu.ac.kr		Min, Wongi/0000-0003-2437-7366	WCU program through the National Research Foundation of Korea [R33-10013]; Ministry of Education, Science and Technology; Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea [PJ907105032011, PJ007611052011]	WCU program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea	This research was supported by the WCU program (R33-10013) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, and by the Cooperative Research Program for Agriculture Science and Technology Development (PJ907105032011, PJ007611052011), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAO H, 1990, INT IMMUNOL, V2, P469, DOI 10.1093/intimm/2.5.469; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bodnar A, 2008, IMMUNOL LETT, V116, P117, DOI 10.1016/j.imlet.2007.12.014; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Codias EK, 2000, IMMUNOGENETICS, V51, P508, DOI 10.1007/s002510050653; COX GW, 1990, J IMMUNOL, V145, P1719; David D, 1998, BLOOD, V91, P165, DOI 10.1182/blood.V91.1.165.165_165_172; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gilmour KC, 2001, BLOOD, V98, P877, DOI 10.1182/blood.V98.3.877; Gobel TWF, 2001, INT IMMUNOL, V13, P757, DOI 10.1093/intimm/13.6.757; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; Hilton LS, 2002, J INTERF CYTOK RES, V22, P755, DOI 10.1089/107999002320271341; Hirose K, 1998, INFECT IMMUN, V66, P5677, DOI 10.1128/IAI.66.12.5677-5683.1998; HONDA M, 1990, J IMMUNOL, V145, P4131; InagakiOhara K, 1997, EUR J IMMUNOL, V27, P2885, DOI 10.1002/eji.1830271121; Jeong J, 2011, VET IMMUNOL IMMUNOP, V140, P159, DOI 10.1016/j.vetimm.2010.11.023; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; KONO T, 1990, P NATL ACAD SCI USA, V87, P1806, DOI 10.1073/pnas.87.5.1806; Kono T, 1993, Semin Immunol, V5, P299, DOI 10.1006/smim.1993.1036; Kurreeman FAS, 2009, ANN RHEUM DIS, V68, P1789, DOI 10.1136/ard.2008.106393; Li GX, 2001, VET IMMUNOL IMMUNOP, V82, P215, DOI 10.1016/S0165-2427(01)00359-2; Lillehoj HS, 2001, VET IMMUNOL IMMUNOP, V82, P229, DOI 10.1016/S0165-2427(01)00360-9; Liu HW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-364; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Ma DX, 2011, EXP PARASITOL, V127, P208, DOI 10.1016/j.exppara.2010.07.015; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Matsui K, 1999, FEMS IMMUNOL MED MIC, V24, P97; Matthews JO, 1997, POULTRY SCI, V76, P1014, DOI 10.1093/ps/76.7.1014; Min WG, 2001, VACCINE, V20, P267, DOI 10.1016/S0264-410X(01)00270-5; Min WG, 2002, BIOCHEM BIOPH RES CO, V299, P321, DOI 10.1016/S0006-291X(02)02636-0; Min WI, 2002, J INTERF CYTOK RES, V22, P1123, DOI 10.1089/10799900260442548; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; de Oca PM, 2010, J BIOL CHEM, V285, P22050, DOI 10.1074/jbc.M109.093088; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NIELSEN OH, 1995, AM J GASTROENTEROL, V90, P1301; Ohta N, 2002, J IMMUNOL, V169, P460, DOI 10.4049/jimmunol.169.1.460; PAGE TH, 1991, EUR J IMMUNOL, V21, P2133, DOI 10.1002/eji.1830210922; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; SCHAT KA, 1992, AVIAN DIS, V36, P432, DOI 10.2307/1591524; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SHARON M, 1988, J EXP MED, V167, P1265, DOI 10.1084/jem.167.3.1265; SHIBUYA H, 1990, NUCLEIC ACIDS RES, V18, P3697, DOI 10.1093/nar/18.13.3697; Sundick RS, 1997, J IMMUNOL, V159, P720; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; TANAKA T, 1991, J IMMUNOL, V147, P2222; Teng QY, 2006, FEBS LETT, V580, P4274, DOI 10.1016/j.febslet.2006.06.044; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; Usacheva A, 2002, J BIOL CHEM, V277, P48220, DOI 10.1074/jbc.M205757200; Vervelde L, 1996, PARASITE IMMUNOL, V18, P247, DOI 10.1046/j.1365-3024.1996.d01-94.x; Wang GF, 2001, BRAIN RES, V893, P244, DOI 10.1016/S0006-8993(00)03317-5; Wang TH, 2011, FISH SHELLFISH IMMUN, V31, P673, DOI 10.1016/j.fsi.2011.05.016; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106; Yoo J, 2011, KOREAN J PARASITOL, V49, P299, DOI 10.3347/kjp.2011.49.3.299; Yun CH, 2000, DEV COMP IMMUNOL, V24, P303, DOI 10.1016/S0145-305X(99)00080-4; Yun CH, 2000, INFECT IMMUN, V68, P1282, DOI 10.1128/IAI.68.3.1282-1288.2000	61	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37704	10.1371/journal.pone.0037704	http://dx.doi.org/10.1371/journal.pone.0037704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662196	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300086
J	Johansson, S; Irgens, H; Chudasama, KK; Molnes, J; Aerts, J; Roque, FS; Jonassen, I; Levy, S; Lima, K; Knappskog, PM; Bell, GI; Molven, A; Njolstad, PR				Johansson, Stefan; Irgens, Henrik; Chudasama, Kishan K.; Molnes, Janne; Aerts, Jan; Roque, Francisco S.; Jonassen, Inge; Levy, Shawn; Lima, Kari; Knappskog, Per M.; Bell, Graeme I.; Molven, Anders; Njolstad, Pal R.			Exome Sequencing and Genetic Testing for MODY	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; BETA-CELL; PHYSIOLOGICAL CHARACTERIZATION; SUSCEPTIBILITY LOCI; MOLECULAR-GENETICS; INSULIN-RESISTANCE; COMMON VARIANTS; ALPHA-GENE; MUTATIONS; ABCC8	Context: Genetic testing for monogenic diabetes is important for patient care. Given the extensive genetic and clinical heterogeneity of diabetes, exome sequencing might provide additional diagnostic potential when standard Sanger sequencing-based diagnostics is inconclusive. Objective: The aim of the study was to examine the performance of exome sequencing for a molecular diagnosis of MODY in patients who have undergone conventional diagnostic sequencing of candidate genes with negative results. Research Design and Methods: We performed exome enrichment followed by high-throughput sequencing in nine patients with suspected MODY. They were Sanger sequencing-negative for mutations in the HNF1A, HNF4A, GCK, HNF1B and INS genes. We excluded common, non-coding and synonymous gene variants, and performed in-depth analysis on filtered sequence variants in a pre-defined set of 111 genes implicated in glucose metabolism. Results: On average, we obtained 45 X median coverage of the entire targeted exome and found 199 rare coding variants per individual. We identified 0-4 rare non-synonymous and nonsense variants per individual in our a priori list of 111 candidate genes. Three of the variants were considered pathogenic (in ABCC8, HNF4A and PPARG, respectively), thus exome sequencing led to a genetic diagnosis in at least three of the nine patients. Approximately 91% of known heterozygous SNPs in the target exomes were detected, but we also found low coverage in some key diabetes genes using our current exome sequencing approach. Novel variants in the genes ARAP1, GLIS3, MADD, NOTCH2 and WFS1 need further investigation to reveal their possible role in diabetes. Conclusion: Our results demonstrate that exome sequencing can improve molecular diagnostics of MODY when used as a complement to Sanger sequencing. However, improvements will be needed, especially concerning coverage, before the full potential of exome sequencing can be realized.	[Johansson, Stefan; Irgens, Henrik; Chudasama, Kishan K.; Molnes, Janne; Knappskog, Per M.; Njolstad, Pal R.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Johansson, Stefan; Chudasama, Kishan K.; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Irgens, Henrik; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Aerts, Jan] Leuven Univ, Fac Engn ESAT SCD, Louvain, Belgium; [Aerts, Jan] Wellcome Trust Sanger Inst, Cambridge, England; [Roque, Francisco S.; Jonassen, Inge] Uni Res, Uni Comp, Computat Biol Unit, Bergen, Norway; [Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Lima, Kari] Akershus Univ Hosp, Div Med, Dept Endocrinol, Dept Med, Lorenskog, Norway; [Lima, Kari] Akershus Univ Hosp, Div Med, Dept Endocrinol, Dept Human Genet, Lorenskog, Norway; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Molven, Anders] Univ Bergen, Gade Inst, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; KU Leuven; Wellcome Trust Sanger Institute; University of Bergen; HudsonAlpha Institute for Biotechnology; University of Oslo; University of Oslo; University of Chicago; University of Chicago; University of Bergen; University of Bergen; Haukeland University Hospital	Johansson, S (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	pal.njolstad@uib.no	Johansson, Stefan/C-4394-2011; Irgens, Henrik/CAF-0204-2022; Jonassen, Inge/AAC-7035-2020; Aerts, Jan/AAQ-6949-2020	Johansson, Stefan/0000-0002-2298-7008; Aerts, Jan/0000-0002-6416-2717; Levy, Shawn/0000-0002-1369-5740; Jonassen, Inge/0000-0003-4110-0748	Research Council of Norway; University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; United States Public Health Service	Research Council of Norway(Research Council of Norway); University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	The study was supported in part by funds from the Research Council of Norway, the University of Bergen, Haukeland University Hospital, Helse Vest, Innovest, and the United States Public Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Bowman P, 2012, DIABETOLOGIA, V55, P123, DOI 10.1007/s00125-011-2319-x; Cheurfa N, 2010, DIABETOLOGIA, P1; Dimitri P, 2010, EUR J ENDOCRINOL; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edghill EL, 2010, J PANCREAS, V11, P14; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Grarup N, 2010, CURR DIABETES REP, V10, P485, DOI 10.1007/s11892-010-0154-y; Gurnell M, 2007, PPAR RES, V2007, DOI 10.1155/2007/83593; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Hattersley A, 2009, PEDIATR DIABETES, V10, P33, DOI 10.1111/j.1399-5448.2009.00571.x; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Porksen S, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-16; Riveline JP, 2012, DIABETES CARE, V35, P248, DOI 10.2337/dc11-1469; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sovik O, 1998, DIABETOLOGIA, V41, P607, DOI 10.1007/s001250050956; Steele AM, 2010, DIABETIC MED, V27, P157, DOI 10.1111/j.1464-5491.2009.02913.x; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	49	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38050	10.1371/journal.pone.0038050	http://dx.doi.org/10.1371/journal.pone.0038050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662265	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300157
J	Makino, CL; Wen, XH; Michaud, NA; Covington, HI; DiBenedetto, E; Hamm, HE; Lem, J; Caruso, G				Makino, Clint L.; Wen, Xiao-Hong; Michaud, Norman A.; Covington, Henry I.; DiBenedetto, Emmanuele; Hamm, Heidi E.; Lem, Janis; Caruso, Giovanni			Rhodopsin Expression Level Affects Rod Outer Segment Morphology and Photoresponse Kinetics	PLOS ONE			English	Article							PHOTORECEPTOR MEMBRANE; LATERAL DIFFUSION; TRANSGENIC MICE; DISK MEMBRANES; FINE STRUCTURE; KNOCKOUT MICE; MOUSE RETINA; PHOTOTRANSDUCTION; ORGANIZATION; TRANSPORT	Background: The retinal rod outer segment is a sensory cilium that is specialized for the conversion of light into an electrical signal. Within the cilium, up to several thousand membranous disks contain as many as a billion copies of rhodopsin for efficient photon capture. Disks are continually turned over, requiring the daily synthesis of a prodigious amount of rhodopsin. To promote axial diffusion in the aqueous cytoplasm, the disks have one or more incisures. Across vertebrates, the range of disk diameters spans an order of magnitude, and the number and length of the incisures vary considerably, but the mechanisms controlling disk architecture are not well understood. The finding that transgenic mice overexpressing rhodopsin have enlarged disks lacking an incisure prompted us to test whether lowered rhodopsin levels constrain disk assembly. Methodology/Principal Findings: The structure and function of rods from hemizygous rhodopsin knockout (R+/-) mice with decreased rhodopsin expression were analyzed by transmission electron microscopy and single cell recording. R+/- rods were structurally altered in three ways: disk shape changed from circular to elliptical, disk surface area decreased, and the single incisure lengthened to divide the disk into two sections. Photocurrent responses to flashes recovered more rapidly than normal. A spatially resolved model of phototransduction indicated that changes in the packing densities of rhodopsin and other transduction proteins were responsible. The decrease in aqueous outer segment volume and the lengthened incisure had only minor effects on photon response amplitude and kinetics. Conclusions/Significance: Rhodopsin availability limits disk assembly and outer segment girth in normal rods. The incisure may buffer the supply of structural proteins needed to form larger disks. Decreased rhodopsin level accelerated photoresponse kinetics by increasing the rates of molecular collisions on the membrane. Faster responses, together with fewer rhodopsins, combine to lower overall sensitivity of R+/- rods to light.	[Makino, Clint L.; Wen, Xiao-Hong; Michaud, Norman A.; Covington, Henry I.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [DiBenedetto, Emmanuele] Vanderbilt Univ, Dept Math, Nashville, TN USA; [Hamm, Heidi E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Lem, Janis] Tufts Univ, Sch Med, Dept Ophthalmol, Program Genet,Program Neurosci,Program Cell Mol &, Boston, MA 02111 USA; [Caruso, Giovanni] CNR, Construct Technol Inst, Rome, Italy	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Vanderbilt University; Vanderbilt University; Tufts University; Consiglio Nazionale delle Ricerche (CNR)	Makino, CL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA.	cmakino@meei.harvard.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069	National Eye Institute [EY006062, EY011358, EY014104, EY12008]; National Institute of General Medical Sciences [GM068953]; National Science Foundation [DMS 0652385, DMS 0970008]; Lions of Massachusetts; NATIONAL EYE INSTITUTE [P30EY014104, R29EY011358, R01EY011358, R01EY006062, R01EY012008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068953] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Lions of Massachusetts; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Eye Institute (EY006062, EY011358, EY014104, EY12008), National Institute of General Medical Sciences (GM068953), National Science Foundation (DMS 0652385, DMS 0970008), and Lions of Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Bailes HJ, 2006, J COMP NEUROL, V494, P381, DOI 10.1002/cne.20809; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Caruso G, 2006, BIOPHYS J, V91, P1192, DOI 10.1529/biophysj.106.083618; Caruso G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001031; COHEN AI, 1963, EXP EYE RES, V2, P88, DOI 10.1016/S0014-4835(63)80028-7; COHEN AI, 1960, AM J ANAT, V107, P23, DOI 10.1002/aja.1001070103; COHEN AI, 1965, ANAT REC, V152, P63, DOI 10.1002/ar.1091520108; COHEN AI, 1972, HDB SENSORY PHYSIOLO, V7, P63; CORLESS JM, 1987, EXP EYE RES, V45, P883, DOI 10.1016/S0014-4835(87)80104-5; CORLESS JM, 1987, J COMP NEUROL, V257, P9, DOI 10.1002/cne.902570103; DEROBERTIS E, 1956, J BIOPHYS BIOCHEM CY, V2, P319, DOI 10.1083/jcb.2.3.319; Eckmiller MS, 2000, VISUAL NEUROSCI, V17, P711, DOI 10.1017/S0952523800175054; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farrar GJ, 2012, GENE THER, V19, P137, DOI 10.1038/gt.2011.172; Fishelson L, 2004, ANAT REC PART A, V277A, P249, DOI 10.1002/ar.a.20005; Govardovskii VI, 2009, MOL VIS, V15, P1717; Gross A. K., 2011, ADLERS PHYSL EYE, P394; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; KATZ ML, 1991, INVEST OPHTH VIS SCI, V32, P1968; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; LOCKET NA, 1971, PROC R SOC SER B-BIO, V178, P161, DOI 10.1098/rspb.1971.0059; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; PEDLER CMH, 1967, VISION RES, V7, P829, DOI 10.1016/0042-6989(67)90003-X; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; ROOF D, 1991, J COMP NEUROL, V305, P289, DOI 10.1002/cne.903050210; ROOF DJ, 1982, J CELL BIOL, V95, P487, DOI 10.1083/jcb.95.2.487; SAXTON MJ, 1989, BIOCHIM BIOPHYS ACTA, V979, P27, DOI 10.1016/0005-2736(89)90519-1; SIDMAN RL, 1957, J BIOPHYS BIOCHEM CY, V3, P15, DOI 10.1083/jcb.3.1.15; SJOSTRAND FS, 1953, J CELL COMPAR PHYSL, V42, P45, DOI 10.1002/jcp.1030420104; STEINBERG RH, 1975, J ULTRA MOL STRUCT R, V51, P397, DOI 10.1016/S0022-5320(75)80102-X; STRYER L, 1987, CHEM SCRIPTA, V27B, P161; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; USUKURA J, 1981, BIOMED RES-TOKYO, V2, P177, DOI 10.2220/biomedres.2.177; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; WEN GY, 1982, ANAT EMBRYOL, V165, P315, DOI 10.1007/BF00305570; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016	50	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37832	10.1371/journal.pone.0037832	http://dx.doi.org/10.1371/journal.pone.0037832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662234	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300124
J	Neal, A; Boldrin, L; Morgan, JE				Neal, Alice; Boldrin, Luisa; Morgan, Jennifer Elizabeth			The Satellite Cell in Male and Female, Developing and Adult Mouse Muscle: Distinct Stem Cells for Growth and Regeneration	PLOS ONE			English	Article							MYONUCLEAR DOMAIN SIZE; SKELETAL-MUSCLE; FIBER GROWTH; SELF-RENEWAL; RAT; TESTOSTERONE; PROLIFERATION; HYPERTROPHY; NUMBER; AGE	Satellite cells are myogenic cells found between the basal lamina and the sarcolemma of the muscle fibre. Satellite cells are the source of new myofibres; as such, satellite cell transplantation holds promise as a treatment for muscular dystrophies. We have investigated age and sex differences between mouse satellite cells in vitro and assessed the importance of these factors as mediators of donor cell engraftment in an in vivo model of satellite cell transplantation. We found that satellite cell numbers are increased in growing compared to adult and in male compared to female adult mice. We saw no difference in the expression of the myogenic regulatory factors between male and female mice, but distinct profiles were observed according to developmental stage. We show that, in contrast to adult mice, the majority of satellite cells from two week old mice are proliferating to facilitate myofibre growth; however a small proportion of these cells are quiescent and not contributing to this growth programme. Despite observed changes in satellite cell populations, there is no difference in engraftment efficiency either between satellite cells derived from adult or pre-weaned donor mice, male or female donor cells, or between male and female host muscle environments. We suggest there exist two distinct satellite cell populations: one for muscle growth and maintenance and one for muscle regeneration.	[Neal, Alice; Boldrin, Luisa; Morgan, Jennifer Elizabeth] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Neal, Alice] UCL, Inst Neurol, MRC Ctr Neuromuscular Dis, London, England	University of London; University College London; University of London; University College London	Neal, A (corresponding author), UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	a.neal@ion.ucl.ac.uk; jennifer.morgan@ucl.ac.uk		Neal, Alice/0000-0002-4623-6102	Wellcome Trust University Award; Muscular Dystrophy Campaign; Medical Research Council; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Wellcome Trust University Award(Wellcome Trust); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Jennifer E. Morgan was funded by a Wellcome Trust University Award. Luisa Boldrin was funded by the Muscular Dystrophy Campaign. Alice Neal was funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravamudan B, 2006, J APPL PHYSIOL, V100, P1617, DOI 10.1152/japplphysiol.01277.2005; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; Boldrin L, 2009, STEM CELLS, V27, P2478, DOI 10.1002/stem.162; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; CHEEK DB, 1965, B JOHNS HOPKINS HOSP, V116, P378; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Ishido M, 2009, ACTA PHYSIOL, V195, P459, DOI 10.1111/j.1748-1716.2008.01905.x; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; JOUBERT Y, 1989, DEV BIOL, V131, P550, DOI 10.1016/S0012-1606(89)80025-9; JOUBERT Y, 1995, DEV BIOL, V169, P286, DOI 10.1006/dbio.1995.1144; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; MacLennan MB, 2011, NUTRIENTS, V3, P929, DOI 10.3390/nu3110929; Manzano R, 2011, J CELL BIOCHEM, V112, P2825, DOI 10.1002/jcb.23197; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Morgan JE, 2002, J CELL BIOL, V157, P693, DOI 10.1083/jcb.200108047; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; MULVANEY DR, 1988, P SOC EXP BIOL MED, V188, P40; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; NELSON JF, 1975, ACTA ENDOCRINOL-COP, V80, P744, DOI 10.1530/acta.0.0800744; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Rehfeldt C, 1997, BRIT POULTRY SCI, V38, P366, DOI 10.1080/00071669708418004; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; ROWE RWD, 1969, J ANAT, V104, P519; Roy RR, 1999, J APPL PHYSIOL, V87, P634, DOI 10.1152/jappl.1999.87.2.634; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; SCHULTZ E, 1976, AM J ANAT, V147, P49, DOI 10.1002/aja.1001470105; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Verheul AJ, 2004, J APPL PHYSIOL, V97, P1715, DOI 10.1152/japplphysiol.00625.2003; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	59	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37950	10.1371/journal.pone.0037950	http://dx.doi.org/10.1371/journal.pone.0037950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662253	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300144
J	Tambussi, CP; de Mendoza, R; Degrange, FJ; Picasso, MB				Tambussi, Claudia P.; de Mendoza, Ricardo; Degrange, Federico J.; Picasso, Mariana B.			Flexibility along the Neck of the Neogene Terror Bird Andalgalornis steulleti (Aves Phorusrhacidae)	PLOS ONE			English	Article							DINOSAURS; SYSTEM	Background: Andalgalornis steulleti from the upper Miocene-lower Pliocene (approximate to 6 million years ago) of Argentina is a medium-sized patagornithine phorusrhacid. It was a member of the predominantly South American radiation of 'terror birds' (Phorusrhacidae) that were apex predators throughout much of the Cenozoic. A previous biomechanical study suggests that the skull would be prepared to make sudden movements in the sagittal plane to subdue prey. Methodology/Principal Findings: We analyze the flexion patterns of the neck of Andalgalornis based on the neck vertebrae morphology and biometrics. The transitional cervical vertebrae 5th and 9th clearly separate regions 1-2 and 2-3 respectively. Bifurcate neural spines are developed in the cervical vertebrae 7th to 12th suggesting the presence of a very intricate ligamentary system and of a very well developed epaxial musculature. The presence of the lig. elasticum interespinale is inferred. High neural spines of R3 suggest that this region concentrates the major stresses during downstrokes. Conclusions/Significance: The musculoskeletal system of Andalgalornis seems to be prepared (1) to support a particularly big head during normal stance, and (2) to help the neck (and the head) rising after the maximum ventroflexion during a strike. The study herein is the first interpretation of the potential performance of the neck of Andalgalornis in its entirety and we considered this an important starting point to understand and reconstruct the flexion pattern of other phorusrhacids from which the neck is unknown.	[Tambussi, Claudia P.; de Mendoza, Ricardo; Picasso, Mariana B.] Museo La Plata, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Tambussi, Claudia P.; Degrange, Federico J.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Degrange, Federico J.] Ctr Invest Ciencias Tierra CICTERRA, Cordoba, Argentina	National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Tambussi, CP (corresponding author), Museo La Plata, Div Paleontol Vertebrados, Paseo del Bosque S-N, La Plata, Buenos Aires, Argentina.	tambussi.claudia@conicet.gov.ar	De Mendoza, Ricardo/GRX-2324-2022		CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas); Agencia Nacional de Promociones Cientificas y Tecnicas	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promociones Cientificas y Tecnicas	The study was funded in part by a grant from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) and Agencia Nacional de Promociones Cientificas y Tecnicas to CPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; Andrews C., 1896, IBIS, V7, P1; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Boas J., 1929, D KGL DANSKE VIDENSK, V9, P105; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Christian A., 2007, FOSS REC, V10, P37; De Mendoza RS, 2009, AMEGHINIANA, V46, p73R; De Mendoza RS, 2009, AMEGHINIANA, V46, p19R; Degrange FJ, 2011, J VERTEBR PALEONTOL, V31, P1080, DOI 10.1080/02724634.2011.595466; Degrange FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011856; Degrange FJ, 2012, THESIS U NACL LA PLA; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Guinard G, 2010, POLAR BIOL, V33, P807, DOI 10.1007/s00300-009-0759-2; Klingenberg CP, 2002, GENE, V287, P3, DOI 10.1016/S0378-1119(01)00867-8; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Patterson B., 1960, Publ Mus Cienc nat Mar del Plata, V1, P1; SINCLAIR WILLIAM J., 1932, REPT PRINCETON UNIV EXPED PATAGONIA 1896 1899, V7, P157; Tambussi Claudia, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P245; TAMBUSSI CP, 1997, AMEGHINIANA, V34, P541; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Dozo MT, 2010, PALAEOGEOGR PALAEOCL, V297, P100, DOI 10.1016/j.palaeo.2010.07.018; Tsuihiji T, 2004, J VERTEBR PALEONTOL, V24, P165, DOI 10.1671/A1129-12; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; VANDERLEEUW AHJ, 1992, NETH J ZOOL, V42, P23, DOI 10.1163/156854292X00026; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Vogel S., 2000, ANCAS PALANCAS MECAN; Wedel MJ, 1999, J VERTEBRATE PALEONT, V19, P83; Zusi RL., 1962, STRUCTURAL ADAPTATIO; Zweers G., 1994, P201	30	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37701	10.1371/journal.pone.0037701	http://dx.doi.org/10.1371/journal.pone.0037701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662194	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300084
J	Uebi, T; Itoh, Y; Hatano, O; Kumagai, A; Sanosaka, M; Sasaki, T; Sasagawa, S; Doi, J; Tatsumi, K; Mitamura, K; Morii, E; Aozasa, K; Kawamura, T; Okumura, M; Nakae, J; Takikawa, H; Fukusato, T; Koura, M; Nish, M; Hamsten, A; Silveira, A; Bertorello, AM; Kitagawa, K; Nagaoka, Y; Kawahara, H; Tomonaga, T; Naka, T; Ikegawa, S; Tsumaki, N; Matsuda, J; Takemori, H				Uebi, Tatsuya; Itoh, Yumi; Hatano, Osamu; Kumagai, Ayako; Sanosaka, Masato; Sasaki, Tsutomu; Sasagawa, Satoru; Doi, Junko; Tatsumi, Keita; Mitamura, Kuniko; Morii, Eiichi; Aozasa, Katsuyuki; Kawamura, Tomohiro; Okumura, Meinoshin; Nakae, Jun; Takikawa, Hajime; Fukusato, Toshio; Koura, Minako; Nish, Mayumi; Hamsten, Anders; Silveira, Angela; Bertorello, Alejandro M.; Kitagawa, Kazuo; Nagaoka, Yasuo; Kawahara, Hidehisa; Tomonaga, Takeshi; Naka, Tetsuji; Ikegawa, Shigeo; Tsumaki, Noriyuki; Matsuda, Junichiro; Takemori, Hiroshi			Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice	PLOS ONE			English	Article							SALT-INDUCIBLE KINASE; ACTIVATED PROTEIN-KINASE; CREB COACTIVATOR TORC2; RETINOID-X-RECEPTOR; BILE-ACID; NUCLEAR RECEPTOR; ENERGY-EXPENDITURE; GENE-EXPRESSION; 9-CIS-RETINOIC ACID; HEPATIC STEATOSIS	Salt-inducible kinase 3 (SIK3), an AMP-activated protein kinase-related kinase, is induced in the murine liver after the consumption of a diet rich in fat, sucrose, and cholesterol. To examine whether SIK3 can modulate glucose and lipid metabolism in the liver, we analyzed phenotypes of SIK3-deficent mice. Sik3(-/-) mice have a malnourished the phenotype (i.e., lipodystrophy, hypolipidemia, hypoglycemia, and hyper-insulin sensitivity) accompanied by cholestasis and cholelithiasis. The hypoglycemic and hyper-insulin-sensitive phenotypes may be due to reduced energy storage, which is represented by the low expression levels of mRNA for components of the fatty acid synthesis pathways in the liver. The biliary disorders in Sik3(-/-) mice are associated with the dysregulation of gene expression programs that respond to nutritional stresses and are probably regulated by nuclear receptors. Retinoic acid plays a role in cholesterol and bile acid homeostasis, wheras ALDH1a which produces retinoic acid, is expressed at low levels in Sik3(-/-) mice. Lipid metabolism disorders in Sik3(-/-) mice are ameliorated by the treatment with 9-cis-retinoic acid. In conclusion, SIK3 is a novel energy regulator that modulates cholesterol and bile acid metabolism by coupling with retinoid metabolism, and may alter the size of energy storage in mice.	[Uebi, Tatsuya; Itoh, Yumi; Kumagai, Ayako; Sanosaka, Masato; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab Dis, Osaka, Japan; [Hatano, Osamu; Nish, Mayumi] Nara Med Univ, Dept Anat, Nara, Japan; [Kumagai, Ayako; Nagaoka, Yasuo; Kawahara, Hidehisa] Kansai Univ, Dept Life Sci & Biotechnol, Suita, Osaka, Japan; [Sasaki, Tsutomu; Kitagawa, Kazuo] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Sasagawa, Satoru; Tsumaki, Noriyuki] Osaka Univ, Grad Sch Med, Dept Bone & Cartilage Biol, Osaka, Japan; [Doi, Junko] Senri Kinran Univ, Osaka, Japan; [Tatsumi, Keita] Osaka Univ, Grad Sch Med, Dept Lab Med, Osaka, Japan; [Mitamura, Kuniko; Ikegawa, Shigeo] Kinki Univ, Fac Pharmaceut Sci, Osaka 577, Japan; [Morii, Eiichi; Aozasa, Katsuyuki] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka, Japan; [Kawamura, Tomohiro; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Nakae, Jun] Keio Univ, Sch Med, Tokyo, Japan; [Takikawa, Hajime] Teikyo Univ, Sch Med, Dept Med, Tokyo 173, Japan; [Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan; [Hamsten, Anders; Silveira, Angela] Karolinska Inst, Karolinska Univ Hosp Solna, Cardiovasc Genet & Genom Atherosclerosis Res Unit, CMM, Stockholm, Sweden; [Bertorello, Alejandro M.] Karolinska Inst, Membrane Signaling Networks, Atherosclerosis Res Unit, CMM,Karolinska Univ Hosp Solna, Stockholm, Sweden; [Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka, Japan; [Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka, Japan; [Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan	National Institute of Health Sciences - Japan; Nara Medical University; Kansai University; Osaka University; Osaka University; Osaka University; Kindai University (Kinki University); Osaka University; Osaka University; Keio University; Teikyo University; Teikyo University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kyoto University	Uebi, T (corresponding author), Natl Inst Biomed Innovat, Lab Cell Signaling & Metab Dis, Osaka, Japan.	takemori@nibio.go.jp	邦子, 三田村/W-7184-2019	sasaki, tsutomu/0000-0001-8726-978X; Silveira, Angela/0000-0003-2063-4935; Tsumaki, Noriyuki/0000-0002-0520-3654; Naka, Tetsuji/0000-0002-1269-3997; Sasagawa, Satoru/0000-0001-5769-8700	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Natural Scientists and the Strategic Project; Sumitomo Foundation; Grants-in-Aid for Scientific Research [22591101] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Natural Scientists and the Strategic Project; Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Natural Scientists and the Strategic Project to Support the Formation of Research Bases at Private Universities; and a grant from the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Erickson JM, 2000, J THEOR BIOL, V206, P47, DOI 10.1006/jtbi.2000.2102; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hoeke MO, 2009, HEPATOLOGY, V49, P151, DOI 10.1002/hep.22661; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kok T, 2003, BIOCHEM J, V369, P539, DOI 10.1042/BJ20020981; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Lanjuin A, 2002, NEURON, V33, P369, DOI 10.1016/S0896-6273(02)00572-X; Lennerz JK, 2010, MOL CELL BIOL, V30, P5043, DOI 10.1128/MCB.01472-09; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Moschetta A, 2001, J HEPATOL, V34, P492, DOI 10.1016/S0168-8278(00)00046-5; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shikhman AR, 2001, J IMMUNOL, V167, P7001, DOI 10.4049/jimmunol.167.12.7001; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Weiss B, 2010, ISR MED ASSOC J, V12, P82; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Wu SF, 2011, ENDOCRINOLOGY, V152, P468, DOI 10.1210/en.2010-0803; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	61	47	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37803	10.1371/journal.pone.0037803	http://dx.doi.org/10.1371/journal.pone.0037803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662228	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300118
J	Wang, L; Guo, H; Yu, X; Wang, SY; Xu, CH; Fu, F; Jing, XR; Zhang, H; Dong, XZ				Wang, Lei; Guo, Heng; Yu, Xiao; Wang, Shouyan; Xu, Canhua; Fu, Feng; Jing, Xiaorong; Zhang, Hua; Dong, Xiuzhen			Responsive Electrical Stimulation Suppresses Epileptic Seizures in Rats	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; INDUCED FOCAL EPILEPSY; CORTICAL STIMULATION; BRAIN-STIMULATION; TEMPORAL-LOBE; IN-VITRO; MODEL; PARAMETERS; EEG	Background: A responsive electrical stimulation pattern based on our recently developed novel seizure prediction method was designed to suppress the penicillin-induced epileptic seizures. Methodology: Seizures were induced by Penicillin injection at rat cortex. A responsive electrical stimulation system was triggered prior to seizures predicted with phase synchronisation. Rats with induced seizures were stimulated by the electrical pulses at a responsive or 1 Hz periodic pattern of an open system. The effectiveness of stimulation on seizures suppression was assessed by measuring the average number and duration of seizures per hour. Results: The prediction algorithm reliably identified seizures in real time and triggered the responsive stimulation. This type of electrical stimulation dramatically suppressed seizure activity and the performance was better than the open stimulation system with fewer and shorter seizures. Conclusions: A responsive electrical stimulation system triggered by the phase synchronisation prediction is able to significantly suppress seizures. Significance: Responsive electrical stimulation could achieve superior treatment performance and reduce power consumption and side effects.	[Wang, Lei; Yu, Xiao; Xu, Canhua; Fu, Feng; Dong, Xiuzhen] Fourth Mil Med Univ, Fac Biomed Engn, Xian 710032, Peoples R China; [Wang, Lei] 323rd Hosp PLA, Xian, Peoples R China; [Guo, Heng; Jing, Xiaorong; Zhang, Hua] Fourth Mil Med Univ, Dept Neurosurg, Tangdu Hosp, Xian 710032, Peoples R China; [Wang, Shouyan] Univ Southampton, Inst Sound & Vibrat Res, Hearing & Balance Ctr, Southampton, Hants, England; [Wang, Shouyan] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; University of Southampton; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Wang, L (corresponding author), Fourth Mil Med Univ, Fac Biomed Engn, Xian 710032, Peoples R China.	zhanghuadoc@gmail.com; dongxiuzhen@fmmu.edu.cn			National Natural Science Foundation of China [30772221, 50937005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [30772221]; and the Key Program of National Natural Science Foundation of China [50937005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canan S, 2008, EPILEPSY RES, V82, P7, DOI 10.1016/j.eplepsyres.2008.06.005; Carrington CA, 2007, EPILEPSIA, V48, P1604, DOI 10.1111/j.1528-1167.2007.01077.x; Colpan ME, 2007, EPILEPSIA, V48, P1594, DOI 10.1111/j.1528-1167.2007.01073.x; Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Fountas KN, 2007, ACTA NEUROCHIR SUPPL, V97, P357; GAITO J, 1981, CAN J NEUROL SCI, V8, P249, DOI 10.1017/S0317167100043286; GAITO J, 1980, EPILEPSIA, V21, P73, DOI 10.1111/j.1528-1157.1980.tb04046.x; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; Goodman JH, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.0013-9580.2005.03804.x; Kinoshita M, 2005, CLIN NEUROPHYSIOL, V116, P1291, DOI 10.1016/j.clinph.2005.02.010; Kinoshita M, 2004, EPILEPSIA, V45, P787, DOI 10.1111/j.0013-9580.2004.60203.x; Kortelainen J, 2010, IEEE ENG MED BIO, P6674, DOI 10.1109/IEMBS.2010.5627154; Kossoff EH, 2004, EPILEPSIA, V45, P1560, DOI 10.1111/j.0013-9580.2004.26104.x; Lasemidis LD, 2003, IEEE T BIO-MED ENG, V50, P549, DOI 10.1109/TBME.2003.810705; Lesser RP, 1999, NEUROLOGY, V53, P2073, DOI 10.1212/WNL.53.9.2073; Lian J, 2003, J PHYSIOL-LONDON, V547, P427, DOI 10.1113/jphysiol.2002.033209; Liang SF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045001; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Lopez-Meraz ML, 2004, EPILEPSY RES, V59, P95, DOI 10.1016/j.eplepsyres.2004.02.005; Makiranta M, 2005, NEUROIMAGE, V27, P715, DOI 10.1016/j.neuroimage.2005.05.025; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; Mirski MA, 1997, EPILEPSY RES, V28, P89, DOI 10.1016/S0920-1211(97)00034-X; Morrell M, 2006, CURR OPIN NEUROL, V19, P164, DOI 10.1097/01.wco.0000218233.60217.84; Morrell MJ, 2002, SEMIN NEUROL, V22, P247, DOI 10.1055/s-2002-36645; Nadkarni S, 2005, NEUROLOGY, V64, pS2, DOI 10.1212/WNL.64.12_suppl_3.S2; Osorio I, 2001, J CLIN NEUROPHYSIOL, V18, P533, DOI 10.1097/00004691-200111000-00003; Raghunathan S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056005; Rajdev P, 2011, INT J NEURAL SYST, V21, P151, DOI 10.1142/S0129065711002730; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Schiller Y, 2007, J NEUROPHYSIOL, V97, P1887, DOI 10.1152/jn.00514.2006; Silfverhuth MJ, 2011, SEIZURE-EUR J EPILEP, V20, P513, DOI 10.1016/j.seizure.2011.03.006; Sun FT, 2008, NEUROTHERAPEUTICS, V5, P68, DOI 10.1016/j.nurt.2007.10.069; Sunderam S, 2010, EPILEPSY BEHAV, V17, P6, DOI 10.1016/j.yebeh.2009.10.017; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Velasco F, 2001, STEREOT FUNCT NEUROS, V77, P228, DOI 10.1159/000064611; Wang L, 2011, CLIN NEUROPHYSIOL, V122, P656, DOI 10.1016/j.clinph.2010.09.018; Yao QH, 2008, NEUROSCI LETT, V430, P187, DOI 10.1016/j.neulet.2007.10.024; YUEN TGH, 1981, NEUROSURGERY, V9, P292, DOI 10.1227/00006123-198109000-00013	38	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38141	10.1371/journal.pone.0038141	http://dx.doi.org/10.1371/journal.pone.0038141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662277	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300169
J	Hassan, F; Ren, DB; Zhang, WH; Gu, XX				Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Gu, Xin-Xing			Role of c-Jun N-Terminal Protein Kinase 1/2 (JNK1/2) in Macrophage-Mediated MMP-9 Production in Response to Moraxella catarrhalis Lipooligosaccharide (LOS)	PLOS ONE			English	Article							OTITIS-MEDIA; MATRIX-METALLOPROTEINASES; TYMPANIC MEMBRANE; EXPRESSION; LIPOPOLYSACCHARIDE; INHIBITION; ACTIVATION; MONOCYTES; APOPTOSIS; INJURY	Moraxella catarrhalis is a Gram negative bacterium and a leading causative agent of otitis media (OM) in children. Recent reports have provided strong evidence for the presence of high levels of matrix metalloproteinase (MMPs) in effusion fluids from children suffering with OM, however, the precise mechanisms by which MMPs are generated are currently unknown. We hypothesized that MMPs are secreted from macrophages in the presence of M. catarrhalis lipooligosaccharide (LOS). In this report, we demonstrate that in vitro stimulation of murine macrophage RAW 264.7 cells with LOS leads to secretion of MMP-9 as determined by ELISA and zymogram assays. We have also shown that inhibition of ERK1/2 and p38 kinase completely blocked LOS induced MMP-9 production. In contrast, inhibition of JNK1/2 by the specific inhibitor SP600125 actually increased the level of expression and production of MMP-9 at both mRNA and protein levels, respectively by almost five fold. This latter result was confirmed by knocking down JNK1/2 using siRNA. Similar results have been observed in murine bone marrow derived macrophages in vitro. In contrast to and in parallel with the LOS-induced increased levels of MMP-9 in the presence of SP600125, we found a corresponding dose-dependent inhibition of TIMP-1 (tissue inhibitor of matrix metalloproteinase-1) secretion. Results of subsequent in vitro studies provided evidence that when JNK1/2 was inhibited prior to stimulation with LOS, it significantly increased both the extent of macrophage cell migration and invasion compared to control cells or cells treated with LOS alone. The results of these studies contribute to an increased understanding of the underlying pathophysiology of OM with effusion in children.	[Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Gu, Xin-Xing] Natl Inst Deafness & Other Commun Disorders, Vaccine Res Sect, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Hassan, F (corresponding author), Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA.	guxx@mail.nih.gov	Ren, Dabin/H-6263-2013		Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America [NIH0010103632]	Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America	This research was supported by the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America (#NIH0010103632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli PJ, 2003, LARYNGOSCOPE, V113, P1347, DOI 10.1097/00005537-200308000-00015; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; EDEBRINK P, 1994, CARBOHYD RES, V257, P269, DOI 10.1016/0008-6215(94)80040-5; EDEBRINK P, 1995, CARBOHYD RES, V266, P237, DOI 10.1016/0008-6215(94)00276-L; FADEN H, 1992, INFECT IMMUN, V60, P3824, DOI 10.1128/IAI.60.9.3824-3829.1992; FOMSGAARD JS, 1991, INFECT IMMUN, V59, P3346, DOI 10.1128/IAI.59.9.3346-3349.1991; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Granstrom G, 2009, PERIODONTOL 2000, V49, P179, DOI 10.1111/j.1600-0757.2008.00281.x; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Jang CH, 2006, INT J PEDIATR OTORHI, V70, P1155, DOI 10.1016/j.ijporl.2005.11.013; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee KH, 2006, EXP MOL MED, V38, P408, DOI 10.1038/emm.2006.48; Leibovitz E, 2004, PEDIATR INFECT DIS J, V23, P1142, DOI 10.1097/01.inf.0000148233.57296.90; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Magnuson K, 1996, ANN OTO RHINOL LARYN, V105, P397, DOI 10.1177/000348949610500513; MAGNUSON K, 1994, EUR ARCH OTO-RHINO-L, V251, P393; Marderstein EL, 2003, SURGERY, V134, P280, DOI 10.1067/msy.2003.237; MASOUD H, 1994, CAN J CHEM, V72, P1466, DOI 10.1139/v94-182; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Moon SK, 2008, ACTA OTO-LARYNGOL, V128, P144, DOI 10.1080/00016480701477610; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; RUUSKANEN O, 1994, PEDIATR INFECT DIS J, V13, pS23, DOI 10.1097/00006454-199401001-00006; Schonermark M, 1996, ACTA OTO-LARYNGOL, V116, P451, DOI 10.3109/00016489609137872; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Wilmoth JG, 2003, OTOLARYNG HEAD NECK, V129, P647, DOI 10.1016/S0194-5998(03)01388-3; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37912	10.1371/journal.pone.0037912	http://dx.doi.org/10.1371/journal.pone.0037912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655080	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900057
J	Takiyama, K; Okada, M				Takiyama, Ken; Okada, Masato			Recovery in Stroke Rehabilitation through the Rotation of Preferred Directions Induced by Bimanual Movements: A Computational Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; ARM MOVEMENTS; CORTICAL REPRESENTATION; SUPPLEMENTARY MOTOR; MODEL; INFORMATION; POPULATIONS; NETWORKS; MONKEYS	Stroke patients recover more effectively when they are rehabilitated with bimanual movement rather than with unimanual movement; however, it remains unclear why bimanual movement is more effective for stroke recovery. Using a computational model of stroke recovery, this study suggests that bimanual movement facilitates the reorganization of a damaged motor cortex because this movement induces rotations in the preferred directions (PDs) of motor cortex neurons. Although the tuning curves of these neurons differ during unimanual and bimanual movement, changes in PD, but not changes in modulation depth, facilitate such reorganization. In addition, this reorganization was facilitated only when encoding PDs are rotated, but decoding PDs are not rotated. Bimanual movement facilitates reorganization because this movement changes neural activities through inter-hemispheric inhibition without changing cortical-spinal-muscle connections. Furthermore, stronger inter-hemispheric inhibition between motor cortices results in more effective reorganization. Thus, this study suggests that bimanual movement is effective for stroke rehabilitation because this movement rotates the encoding PDs of motor cortex neurons.	[Takiyama, Ken; Okada, Masato] Univ Tokyo, Dept Complex Sci & Engn, Grad Sch Frontier Sci, Chiba, Tokyo, Japan; [Okada, Masato] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	University of Tokyo; RIKEN	Takiyama, K (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Grad Sch Frontier Sci, Chiba, Tokyo, Japan.	okada@k.u-tokyo.ac.jp	Takiyama, Ken/M-4526-2015	Takiyama, Ken/0000-0003-2252-7826	Japan Society for the Promotion of Science Fellows [10J04910]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20240020]	Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (grant no. 10J04910) and a Grant-in-Aid for Scientific Research (A) (grant no. 20240020) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; Cunningham CL, 2002, ACTA PSYCHOL, V110, P321, DOI 10.1016/S0001-6918(02)00040-9; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goodall S, 1997, STROKE, V28, P101, DOI 10.1161/01.STR.28.1.101; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Grefkes C, 2011, BRAIN, P1; Guigon E, 2007, EUR J NEUROSCI, V26, P250, DOI 10.1111/j.1460-9568.2007.05634.x; Han CE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000133; Latimer CP, 2010, DISABIL REHABIL, V32, P1221, DOI 10.3109/09638280903483877; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; LUKASHIN AV, 1994, NEURAL COMPUT, V6, P19, DOI 10.1162/neco.1994.6.1.19; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; Mudie MH, 2000, DISABIL REHABIL, V22, P23, DOI 10.1080/096382800297097; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Reinkensmeyer DJ, 2003, NEURAL COMPUT, V15, P2619, DOI 10.1162/089976603322385090; Rokni U, 2003, J NEUROSCI, V23, P11577; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Rose Dorian K, 2004, Top Stroke Rehabil, V11, P20, DOI 10.1310/XAUM-LPBM-0RXD-RLDK; Rouille EM, 1994, EXP BRAIN RES, P227; SALINAS E, 1995, J NEUROSCI, V15, P6461; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Schweighofer N, 2009, PHYS THER, V89, P1327, DOI 10.2522/ptj.20080402; Steinberg O, 2002, EUR J NEUROSCI, V15, P1371, DOI 10.1046/j.1460-9568.2002.01968.x; Stevenson IH, 2011, J NEUROPHYSIOL; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Verstynen T, 2011, J NEUROSCI, V31, P10050, DOI 10.1523/JNEUROSCI.6525-10.2011	30	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37594	10.1371/journal.pone.0037594	http://dx.doi.org/10.1371/journal.pone.0037594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655060	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900036
J	Khoufache, K; Bazin, S; Girard, K; Guillemette, J; Roy, MC; Verreault, JP; Al-Abed, Y; Foster, W; Akoum, A				Khoufache, Khaled; Bazin, Sylvie; Girard, Karine; Guillemette, Julie; Roy, Marie-Christine; Verreault, Jean-Pierre; Al-Abed, Yousef; Foster, Warren; Akoum, Ali			Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo	PLOS ONE			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; PERITONEAL-FLUID MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; TAUTOMERASE ACTIVE-SITE; FACTOR MIF; SIGNALING PATHWAYS; MATRIX METALLOPROTEINASE-2; INTEGRIN ALPHA(V)BETA(3); STIMULATED SECRETION; MENSTRUAL-CYCLE	Endometriosis, a disease of reproductive age women, is a major cause of infertility, menstrual disorders and pelvic pain. Little is known about its etiopathology, but chronic pelvic inflammation is a common feature in affected women. Beside symptomatic treatment of endometriosis-associated pain, only two main suboptimal therapeutic approaches (hormonal and invasive surgery) are generally recommended to patients and no specific targeted treatment is available. Our studies led to the detection of a marked increase in the expression of macrophage migration inhibitory factor (MIF) in the eutopic endometrium, the peripheral blood and the peritoneal fluid of women with endometriosis, and in early, vascularized and active endometriotic lesions. Herein, we developed a treatment model of endometriosis, where human endometrial tissue was first allowed to implant into the peritoneal cavity of nude mice, to assess in vivo the effect of a specific antagonist of MIF (ISO-1) on the progression of endometriosis and evaluate its efficacy as a potential therapeutic tool. Administration of ISO-1 led to a significant decline of the number, size and in situ dissemination of endometriotic lesions. We further showed that ISO-1 may act by significantly inhibiting cell adhesion, tissue remodeling, angiogenesis and inflammation as well as by altering the balance of pro and anti-apoptotic factors. Actually, mice treatment with ISO-1 significantly reduced the expression of cell adhesion receptors alpha v and beta 3 integrins (P < 0.05), matrix metalloproteinases (MMP) 2 and 9 (P < 0.05), vascular endothelial cell growth factor (VEGF) (P < 0.01), interleukin 8 (IL8) (P < 0.05), cyclooxygenease (COX) 2 (P < 0.001) and the anti-apoptotic protein Bcl2 (P < 0.01), but significantly induced the expression of Bax (P < 0.05), a potent pro-apoptotic protein. These data provide evidence that specific inhibition of MIF alters endometriotic tissue growth and progression in vivo and may represent a promising potential therapeutic avenue.	[Khoufache, Khaled; Akoum, Ali] CHUQ, Ctr Rech, Hop St Francois Assise, Quebec City, PQ, Canada; [Bazin, Sylvie; Girard, Karine; Guillemette, Julie; Roy, Marie-Christine; Verreault, Jean-Pierre; Akoum, Ali] Univ Laval, Fac Med, Dept Obstet & Gynecol, Quebec City, PQ G1K 7P4, Canada; [Al-Abed, Yousef] Feinstein Inst Med Res, Manhasset, NY USA; [Foster, Warren] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada	Laval University; Laval University; Northwell Health; McMaster University	Khoufache, K (corresponding author), CHUQ, Ctr Rech, Hop St Francois Assise, Quebec City, PQ, Canada.	ali.akoum@crsfa.ulaval.ca			Canadian Institutes for Health Research [MOP-93716]; Wyeth-Ayerst CIHR/RD; HSFA research centre	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Wyeth-Ayerst CIHR/RD(Canadian Institutes of Health Research (CIHR)); HSFA research centre	Supported by grant MOP-93716 to AA from the Canadian Institutes for Health Research. AA is "Chercheur National'' of the FRSQ; KK was supported by a Wyeth-Ayerst CIHR/R&D Fellowship and holds a fellowship from HSFA research centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum A, 1996, FERTIL STERIL, V66, P17; Akoum A, 2002, FERTIL STERIL, V77, P989, DOI 10.1016/S0015-0282(02)03082-0; Akoum A, 2001, MOL HUM REPROD, V7, P859, DOI 10.1093/molehr/7.9.859; Akoum A, 2006, FERTIL STERIL, V85, P1379, DOI 10.1016/j.fertnstert.2005.10.073; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Anger DL, 2008, FRONT BIOSCI-LANDMRK, V13, P1578, DOI 10.2741/2782; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Barcza E, 2002, INT J GYNECOL OBSTET, V79, P229, DOI 10.1016/S0020-7292(02)00308-9; Bellehumeur C, 2005, HUM REPROD, V20, P1177, DOI 10.1093/humrep/deh749; BLOOM BR, 1970, ANN NY ACAD SCI, V169, P258, DOI 10.1111/j.1749-6632.1970.tb55994.x; Patrick KBA, 2008, J REPROD IMMUNOL, V77, P142, DOI 10.1016/j.jri.2007.07.004; Bondza Patrick Kibangou, 2009, Front Biosci (Elite Ed), V1, P415; Bondza PK, 2007, FERTIL STERIL; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BUDZYNSKI W, 1994, IMMUNOPHARM IMMUNOT, V16, P319, DOI 10.3109/08923979409007097; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Carli C, 2009, ENDOCRINOLOGY, V150, P3128, DOI 10.1210/en.2008-1088; Check JH, 2011, CLIN EXP OBSTET GYN, V38, P10; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Chuang PC, 2010, AM J PATHOL, V176, P850, DOI 10.2353/ajpath.2010.090551; Chung HW, 2002, FERTIL STERIL, V78, P787, DOI 10.1016/S0015-0282(02)03322-8; Colette S, 2011, EXPERT OPINION INVES; Dmowski WP, 1998, HUM REPROD UPDATE, V4, P696, DOI 10.1093/humupd/4.5.696; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gebel HM, 1998, FERTIL STERIL, V69, P1042, DOI 10.1016/S0015-0282(98)00073-9; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Harada T, 2007, FRONT BIOSCI-LANDMRK, V12, P3140, DOI 10.2741/2302; Hii LPP, 1998, HUM REPROD, V13, P1030, DOI 10.1093/humrep/13.4.1030; Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71; Hou XQ, 2009, ACTA VIROL, V53, P225, DOI 10.4149/av_2009_04_225; Kats R, 2002, FERTIL STERIL, V78, P69, DOI 10.1016/S0015-0282(02)03189-8; Kats R, 2002, J CLIN ENDOCR METAB, V87, P883, DOI 10.1210/jc.87.2.883; Khoufache K, 2009, J IMMUNOL, V182, P7795, DOI 10.4049/jimmunol.0803743; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Lin W, 2010, J OBSTET GYNAECOL RE, V36, P344, DOI 10.1111/j.1447-0756.2009.01123.x; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mahutte NG, 2004, FERTIL STERIL, V82, P97, DOI 10.1016/j.fertnstert.2003.11.044; McLaren J, 1997, HUM REPROD, V12, P146, DOI 10.1093/humrep/12.1.146; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Meyer-Siegler K, 2000, CYTOKINE, V12, P914, DOI 10.1006/cyto.2000.0682; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; Morand EF, 2005, FRONT BIOSCI-LANDMRK, V10, P12, DOI 10.2741/1501; Morin M, 2005, FERTIL STERIL, V83, P865, DOI 10.1016/j.fertnstert.2004.10.039; Murk W, 2008, J CLIN ENDOCR METAB, V93, P3532, DOI 10.1210/jc.2007-2051; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OLIVE DL, 1991, AM J OBSTET GYNECOL, V164, P953; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Osteen KG, 2004, GYNECOL OBSTET INVES, V57, P53; Osuga Y, 2011, AM J REPROD IMMUNOL, V65, P1, DOI 10.1111/j.1600-0897.2010.00887.x; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Rana N, 1996, FERTIL STERIL, V65, P925, DOI 10.1016/S0015-0282(16)58262-4; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Seeber B, 2008, FERTIL STERIL, V89, P1073, DOI 10.1016/j.fertnstert.2007.05.014; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; SIMPSON JL, 1980, AM J OBSTET GYNECOL, V137, P327, DOI 10.1016/0002-9378(80)90917-5; Stojanovic I, 2011, IMMUNOBIOLOGY; Taylor JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-135; Taylor RN, 2004, GYNECOL OBSTET INVES, V57, P54; Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417; Wenzl RJ, 1998, GYNECOL OBSTET INVES, V45, P253, DOI 10.1159/000009978; Yang YB, 2000, J CLIN ENDOCR METAB, V85, P4721, DOI 10.1210/jc.85.12.4721	70	31	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37264	10.1371/journal.pone.0037264	http://dx.doi.org/10.1371/journal.pone.0037264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649515	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800033
J	Liberato, MV; Nascimento, AS; Ayers, SD; Lin, JZ; Cvoro, A; Silveira, RL; Martinez, L; Souza, PCT; Saidemberg, D; Deng, T; Amato, AA; Togashi, M; Hsueh, WA; Phillips, K; Palma, MS; Neves, FAR; Skaf, MS; Webb, P; Polikarpov, I				Liberato, Marcelo Vizona; Nascimento, Alessandro S.; Ayers, Steven D.; Lin, Jean Z.; Cvoro, Aleksandra; Silveira, Rodrigo L.; Martinez, Leandro; Souza, Paulo C. T.; Saidemberg, Daniel; Deng, Tuo; Amato, Angela Angelica; Togashi, Marie; Hsueh, Willa A.; Phillips, Kevin; Palma, Mario Sergio; Neves, Francisco A. R.; Skaf, Munir S.; Webb, Paul; Polikarpov, Igor			Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) gamma Activators and Pan-PPAR Partial Agonists	PLOS ONE			English	Article							LIGAND-BINDING-DOMAIN; MOLECULAR-DYNAMICS; ALPHA; EXPRESSION; COMPLEX; GENES; SF-1	Thiazolidinediones (TZDs) act through peroxisome proliferator activated receptor (PPAR) gamma to increase insulin sensitivity in type 2 diabetes (T2DM), but deleterious effects of these ligands mean that selective modulators with improved clinical profiles are needed. We obtained a crystal structure of PPAR gamma ligand binding domain (LBD) and found that the ligand binding pocket (LBP) is occupied by bacterial medium chain fatty acids (MCFAs). We verified that MCFAs (C8-C10) bind the PPAR gamma LBD in vitro and showed that they are low-potency partial agonists that display assay-specific actions relative to TZDs; they act as very weak partial agonists in transfections with PPAR gamma LBD, stronger partial agonists with full length PPAR gamma and exhibit full blockade of PPAR gamma phosphorylation by cyclin-dependent kinase 5 (cdk5), linked to reversal of adipose tissue insulin resistance. MCFAs that bind PPAR gamma also antagonize TZD-dependent adipogenesis in vitro. X-ray structure B-factor analysis and molecular dynamics (MD) simulations suggest that MCFAs weakly stabilize C-terminal activation helix (H) 12 relative to TZDs and this effect is highly dependent on chain length. By contrast, MCFAs preferentially stabilize the H2-H3/beta-sheet region and the helix (H) 11-H12 loop relative to TZDs and we propose that MCFA assay-specific actions are linked to their unique binding mode and suggest that it may be possible to identify selective PPAR gamma modulators with useful clinical profiles among natural products.	[Liberato, Marcelo Vizona; Nascimento, Alessandro S.; Polikarpov, Igor] Univ Sao Paulo, Sao Carlos Phys Inst, Sao Paulo, Brazil; [Ayers, Steven D.; Lin, Jean Z.; Cvoro, Aleksandra; Deng, Tuo; Hsueh, Willa A.; Phillips, Kevin; Webb, Paul] Methodist Hosp, Houston, TX 77030 USA; [Saidemberg, Daniel; Palma, Mario Sergio] Sao Paulo State Univ, Inst Biosci, Sao Paulo, Brazil; [Amato, Angela Angelica; Togashi, Marie; Neves, Francisco A. R.] Univ Brasilia, Dept Pharmaceut Sci, Brasilia, DF, Brazil; [Silveira, Rodrigo L.; Martinez, Leandro; Souza, Paulo C. T.; Skaf, Munir S.] Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil	Universidade de Sao Paulo; The Methodist Hospital System; The Methodist Hospital - Houston; Universidade Estadual Paulista; Universidade de Brasilia; Universidade Estadual de Campinas	Liberato, MV (corresponding author), Univ Sao Paulo, Sao Carlos Phys Inst, Sao Paulo, Brazil.	pwebb@tmhs.org; ipolikarpov@if.sc.usp.br	Nascimento, Alessandro/Y-3394-2019; Nascimento, Alessandro S/G-9547-2012; Silveira, Rodrigo L/I-3961-2014; Skaf, Munir S/B-1614-2013; Palma, Mario Sergio/E-7800-2012; Deng, Tuo/M-3176-2015; Liberato, Marcelo V/J-3606-2014; Palma, Mario/N-3903-2019; Amato, Angélica/B-9247-2015; Fapesp, Biota/F-8655-2017; Telles de Souza, Paulo Cesar/E-5072-2013; Polikarpov, Igor/D-2575-2012; Martinez, Leandro/B-3792-2008	Nascimento, Alessandro/0000-0001-6656-5379; Nascimento, Alessandro S/0000-0001-6656-5379; Silveira, Rodrigo L/0000-0001-9515-3082; Skaf, Munir S/0000-0001-7485-1228; Palma, Mario Sergio/0000-0002-7363-8211; Liberato, Marcelo V/0000-0002-7609-7844; Amato, Angélica/0000-0002-8454-5504; Fapesp, Biota/0000-0002-9887-8449; Telles de Souza, Paulo Cesar/0000-0003-0660-1301; Martinez, Leandro/0000-0002-6857-1884; Polikarpov, Igor/0000-0001-9496-4174	National Institutes of Health [41482]; Sao Paulo Research Foundation [04/08070-9, 2006/06831-8, 06/00182-8]; National Council for Scientific and Technological Development	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institutes of Health grant 41482 (PW), Sao Paulo Research Foundation grants 04/08070-9 (ASN), 2006/06831-8 (LM) and 06/00182-8 (IP & MS) and National Council for Scientific and Technological Development (IP & MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrosio ALB, 2007, J BIOL CHEM, V282, P18625, DOI 10.1074/jbc.M702538200; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Fyffe SA, 2006, MOL CELL, V21, P1, DOI 10.1016/j.molcel.2005.12.001; Glass CK, 2000, GENE DEV, V14, P121; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Malapaka RRV, 2012, J BIOL CHEM, V287, P183, DOI 10.1074/jbc.M111.294785; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Martinez L, 2009, P NATL ACAD SCI USA, V106, P20717, DOI 10.1073/pnas.0911024106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rangwala Shamina M, 2002, Sci STKE, V2002, ppe9, DOI 10.1126/stke.2002.121.pe9; Sablin EP, 2009, MOL ENDOCRINOL, V23, P25, DOI 10.1210/me.2007-0508; Shi GQ, 2005, J MED CHEM, V48, P4457, DOI 10.1021/jm0502135; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waku T, 2009, FEBS LETT, V583, P320, DOI 10.1016/j.febslet.2008.12.017; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu HE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.148pe52; Yang JY, 2009, J NUTR BIOCHEM, V20, P537, DOI 10.1016/j.jnutbio.2008.05.013	44	127	129	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36297	10.1371/journal.pone.0036297	http://dx.doi.org/10.1371/journal.pone.0036297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649490	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800007
J	Wittschieber, D; Klauschen, F; Kimmritz, AC; von Winterfeld, M; Kamphues, C; Scholman, HJ; Erbersdobler, A; Pfeiffer, H; Denkert, C; Dietel, M; Weichert, W; Budczies, J; Stenzinger, A				Wittschieber, Daniel; Klauschen, Frederick; Kimmritz, Anna-Christin; von Winterfeld, Moritz; Kamphues, Carsten; Scholman, Hans-Joachim; Erbersdobler, Andreas; Pfeiffer, Heidi; Denkert, Carsten; Dietel, Manfred; Weichert, Wilko; Budczies, Jan; Stenzinger, Albrecht			Who Is at Risk for Diagnostic Discrepancies? Comparison of Pre- and Postmortal Diagnoses in 1800 Patients of 3 Medical Decades in East and West Berlin	PLOS ONE			English	Article							DEATH CERTIFICATES; CLINICAL DIAGNOSES; AUTOPSY DIAGNOSES; HOSPITAL DEATHS; QUALITY-CONTROL; NECROPSY; RATES; ERAS; CONSENT; ERRORS	Background: Autopsy rates in Western countries consistently decline to an average of <5%, although clinical autopsies represent a reasonable tool for quality control in hospitals, medically and economically. Comparing pre- and postmortal diagnoses, diagnostic discrepancies as uncovered by clinical autopsies supply crucial information on how to improve clinical treatment. The study aimed at analyzing current diagnostic discrepancy rates, investigating their influencing factors and identifying risk profiles of patients that could be affected by a diagnostic discrepancy. Methods and Findings: Of all adult autopsy cases of the Charite Institute of Pathology from the years 1988, 1993, 1998, 2003 and 2008, the pre- and postmortal diagnoses and all demographic data were analyzed retrospectively. Based on power analysis, 1,800 cases were randomly selected to perform discrepancy classification (class I-VI) according to modified Goldman criteria. The rate of discrepancies in major diagnoses (class I) was 10.7% (95% CI: 7.7%-14.7%) in 2008 representing a reduction by 15.1%. Subgroup analysis revealed several influencing factors to significantly correlate with the discrepancy rate. Cardiovascular diseases had the highest frequency among class-I-discrepancies. Comparing the 1988-data of East- and West-Berlin, no significant differences were found in diagnostic discrepancies despite an autopsy rate differing by nearly 50%. A risk profile analysis visualized by intuitive heatmaps revealed a significantly high discrepancy rate in patients treated in low or intermediate care units at community hospitals. In this collective, patients with genitourinary/renal or infectious diseases were at particularly high risk. Conclusions: This is the current largest and most comprehensive study on diagnostic discrepancies worldwide. Our well-powered analysis revealed a significant rate of class-I-discrepancies indicating that autopsies are still of value. The identified risk profiles may aid both pathologists and clinicians to identify patients at increased risk for a discrepant diagnosis and possibly suboptimal treatment intra vitam.	[Wittschieber, Daniel; Klauschen, Frederick; Kimmritz, Anna-Christin; von Winterfeld, Moritz; Scholman, Hans-Joachim; Denkert, Carsten; Dietel, Manfred; Budczies, Jan; Stenzinger, Albrecht] Charite, Inst Pathol, Berlin, Germany; [Wittschieber, Daniel; Pfeiffer, Heidi] Univ Hosp Munster, Inst Legal Med, Munster, Germany; [Weichert, Wilko; Stenzinger, Albrecht] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Erbersdobler, Andreas] Univ Hosp Rostock, Inst Pathol, Rostock, Germany; [Kamphues, Carsten] Charite, Dept Gen Visceral & Transplantat Surg, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Ruprecht Karls University Heidelberg; University of Rostock; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wittschieber, D (corresponding author), Charite, Inst Pathol, Berlin, Germany.	albrecht.stenzinger@med.uni-heidelberg.de	Klauschen, Frederick/C-5637-2015; Denkert, Carsten/AHE-2675-2022; Budczies, Jan/AAG-8122-2020; Kamphues, Carsten/AAG-1457-2021	Klauschen, Frederick/0000-0002-9131-2389; Kamphues, Carsten/0000-0002-5406-8540; Denkert, Carsten/0000-0002-2249-0982	Medical Faculty of the University of Heidelberg	Medical Faculty of the University of Heidelberg	This work was supported by a postdoctoral fellowship from the Medical Faculty of the University of Heidelberg to AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder's website is: http://www.medizinische-fakultaet-hd.uni-heidelberg.de/Postdoc Programme.105497.0.html?&L = en.	[Anonymous], 2000, LANCET, V355, P2007; BATTLE RM, 1987, JAMA-J AM MED ASSOC, V258, P339, DOI 10.1001/jama.258.3.339; Bauer TM, 1991, DEUT MED WOCHENSCHR, V116, P80180; Berufsverband Deutscher Pathologen eV, 2006, STAT UMFR 2004 PATH, V4, P4; BOERS M, 1988, EUR J CLIN INVEST, V18, P314, DOI 10.1111/j.1365-2362.1988.tb01265.x; Bonetti M, 2004, BIOSTATISTICS, V5, P465, DOI 10.1093/biostatistics/kxh002; Burton EC, 2004, AM J MED, V117, P255, DOI 10.1016/j.amjmed.2004.01.028; CAMERON HM, 1980, BRIT MED J, V281, P985, DOI 10.1136/bmj.281.6246.985; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; De Vlieger GYA, 2010, CRIT CARE, V14, DOI 10.1186/cc8925; Dietel M, 2008, Z EVIDENZ FORTBILD Q, V102, P189, DOI 10.1016/j.zefq.2008.02.044; Durr M, 2007, Praxis (Bern 1994), V96, P1677; EDWARDS JE, 1981, MAYO CLIN PROC, V56, P457; GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; GOUGH J, 1985, CAN MED ASSOC J, V133, P420; HARRIS MD, 1991, J CLIN PATHOL, V44, P862, DOI 10.1136/jcp.44.10.862; Hull MJ, 2007, HUM PATHOL, V38, P342, DOI 10.1016/j.humpath.2006.08.011; Jutte R, 2005, DTSCH ARZTEBL, V102, P3537; Kahl A, 2010, DTSCH ARZTEBL, V107, P2492; Kirch W, 1996, MEDICINE, V75, P29, DOI 10.1097/00005792-199601000-00004; Krukemeyer MG, 2007, PATHOLOGE, V28, P29429; Lemaire F, 2003, INTENS CARE MED, V29, P518, DOI 10.1007/s00134-002-1630-x; LOWRY F, 1995, CAN MED ASSOC J, V153, P811; Lugli A, 1999, LANCET, V354, P1391, DOI 10.1016/S0140-6736(05)76249-8; Moch H, 1999, Praxis (Bern 1994), V88, P861; MODELMOG D, 1992, CANCER CAUSE CONTROL, V3, P541, DOI 10.1007/BF00052751; O'Mara MS, 2004, CURR SURG, V61, P15115; ROBERTS WC, 1978, NEW ENGL J MED, V299, P332, DOI 10.1056/NEJM197808172990704; Rosenbaum GE, 2000, ARCH INTERN MED, V160, P374, DOI 10.1001/archinte.160.3.374; SCOTTOLINI AG, 1983, JAMA-J AM MED ASSOC, V250, P1192, DOI 10.1001/jama.250.9.1192; Shojania K G, 2002, Evid Rep Technol Assess (Summ), P1; Shojania KG, 2008, NEW ENGL J MED, V358, P873, DOI 10.1056/NEJMp0707996; Shojania KG, 2005, QUAL SAF HEALTH CARE, V14, P408, DOI 10.1136/qshc.2004.011973; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Sington JD, 2002, J CLIN PATHOL, V55, P499, DOI 10.1136/jcp.55.7.499; Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7; Souza VL, 1997, J GEN INTERN MED, V12, P315, DOI 10.1046/j.1525-1497.1997.012005315.x; STEVANOVIC G, 1986, HUM PATHOL, V17, P1225, DOI 10.1016/S0046-8177(86)80564-0; WAGNER BM, 1987, HUM PATHOL, V18, P875; Xiao JD, 2009, AM J MED SCI, V337, P41, DOI 10.1097/MAJ.0b013e318184ce2b; YOUNG NA, 1993, ARCH PATHOL LAB MED, V117, P531	41	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37460	10.1371/journal.pone.0037460	http://dx.doi.org/10.1371/journal.pone.0037460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629399	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300042
J	Santoro, N; Savoye, M; Kim, G; Marotto, K; Shaw, MM; Pierpont, B; Caprio, S				Santoro, Nicola; Savoye, Mary; Kim, Grace; Marotto, Katie; Shaw, Melissa M.; Pierpont, Bridget; Caprio, Sonia			Hepatic Fat Accumulation Is Modulated by the Interaction between the rs738409 Variant in the PNPLA3 Gene and the Dietary Omega6/Omega3 PUFA Intake	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; LIVER-DISEASE; I148M; QUANTIFICATION; RATIO; MR	Background: A single nucleotide polymorphism (SNP), the rs738409, in the patatin like phospholipase 3 gene (PNPLA3) has been recently associated with increased hepatic steatosis and ALT levels in adults and children. Given the potential role of PNPLA3 in fatty liver development, we aimed to explore whether the influence of PNPLA3 genotype on hepatic fat in obese youth might be modulated by dietary factors such as essential omega polyunsaturated fatty acids (PUFA) intake. Materials and Methods: We studied 127 children and adolescents (56 boys, 71 girls; 58 Caucasians; 30 African Americans and 39 Hispanics; mean age 14.7 +/- 3.3; mean BMI 30.7 +/- 7.2). The dietary composition was assessed by the Nutrition Data System for Research (NDS-R version 2011). The patients underwent a MRI study to assess the liver fat content (HFF%), ALT measurement and the genotyping of the rs738409 SNP by automatic sequencing. Results: As previously observed, HFF% and ALT levels varied according to the genotype in each ethnicity. ALT levels and HFF% were significantly influenced by the interaction between genotype and omega-6/omega-3 PUFA ratio (n-6/n-3), p = 0.003 and p = 0.002, respectively. HFF% and ALT levels were, in fact, related to the n-6/n-3 consumption only in subjects homozygote for the G allele of the rs738409 (r2 = 0.45, p = 0.001 and r2 = 0.40, p = 0.006, respectively). Conclusions: These findings suggest that the association of a high dietary n-6/n-3 PUFA with fatty liver and liver damage in obese youths may be driven by a predisposing genotype.	[Santoro, Nicola; Savoye, Mary; Kim, Grace; Marotto, Katie; Shaw, Melissa M.; Pierpont, Bridget; Caprio, Sonia] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University	Santoro, N (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	nicola.santoro@yale.edu; sonia.caprio@yale.edu	Santoro, Nicola/A-4897-2014	Santoro, Nicola/0000-0001-6437-4173	American Heart Association [11CRP5620013]; National Institutes of Health (NIH) [R01-HD-40787, R01-HD-28016, K24-HD-01464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028016, R01HD040787] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the American Heart Association (http://www.heart.org/HEARTORG/) (11CRP5620013 to NS) and the National Institutes of Health (NIH) (grants R01-HD-40787, R01-HD-28016, and K24-HD-01464) (http://www.nih.gov/) to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Cali AMG, 2009, HEPATOLOGY, V49, P1896, DOI 10.1002/hep.22858; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Cortez-Pinto H, 2006, CLIN NUTR, V25, P816, DOI 10.1016/j.clnu.2006.01.027; Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Kim H, 2008, MAGN RESON MED, V59, P521, DOI 10.1002/mrm.21561; Molendi-Coste O, 2011, GASTROENTER IN PRESS; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3012, DOI 10.3748/wjg.v17.i25.3012; Parker HM, 2012, J HEPATOL IN PRESS; Perttila J, 2012, AM J PHYSL IN PRESS; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Santoro N, 2012, HEPATOLOGY, V55, P781, DOI 10.1002/hep.24806; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Toshimitsu K, 2007, NUTRITION, V23, P46, DOI 10.1016/j.nut.2006.09.004; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Xu J, 2002, J NUTR, V132, P3333, DOI 10.1093/jn/132.11.3333; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	29	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37827	10.1371/journal.pone.0037827	http://dx.doi.org/10.1371/journal.pone.0037827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629460	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100053
J	Lewald, J; Tegenthoff, M; Peters, S; Hausmann, M				Lewald, Joerg; Tegenthoff, Martin; Peters, Soeren; Hausmann, Markus			Passive Auditory Stimulation Improves Vision in Hemianopia	PLOS ONE			English	Article							VISUAL-FIELD DEFECTS; PRIMATE SUPERIOR COLLICULUS; LATERAL GENICULATE-NUCLEUS; SPATIAL NEGLECT; PARIETAL CORTEX; LINE BISECTION; AUDIOVISUAL STIMULATION; MULTIMODAL INTEGRATION; SACCADIC LOCALIZATION; RESTORATION THERAPY	Techniques employed in rehabilitation of visual field disorders such as hemianopia are usually based on either visual or audio-visual stimulation and patients have to perform a training task. Here we present results from a completely different, novel approach that was based on passive unimodal auditory stimulation. Ten patients with either left or right-sided pure hemianopia (without neglect) received one hour of unilateral passive auditory stimulation on either their anopic or their intact side by application of repetitive trains of sound pulses emitted simultaneously via two loudspeakers. Immediately before and after passive auditory stimulation as well as after a period of recovery, patients completed a simple visual task requiring detection of light flashes presented along the horizontal plane in total darkness. The results showed that one-time passive auditory stimulation on the side of the blind, but not of the intact, hemifield of patients with hemianopia induced an improvement in visual detections by almost 100% within 30 min after passive auditory stimulation. This enhancement in performance was reversible and was reduced to baseline 1.5 h later. A non-significant trend of a shift of the visual field border toward the blind hemifield was obtained after passive auditory stimulation. These results are compatible with the view that passive auditory stimulation elicited some activation of the residual visual pathways, which are known to be multisensory and may also be sensitive to unimodal auditory stimuli as were used here.	[Lewald, Joerg] Ruhr Univ Bochum, Fac Psychol, Dept Cognit Psychol, Bochum, Germany; [Lewald, Joerg] Leibniz Res Ctr Working Environm & Human Factors, Res Grp Ageing & CNS Alterat, Dortmund, Germany; [Tegenthoff, Martin] Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Neurol, Bochum, Germany; [Peters, Soeren] Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Radiol, Bochum, Germany; [Hausmann, Markus] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Ruhr University Bochum; Ruhr University Bochum; Durham University	Lewald, J (corresponding author), Ruhr Univ Bochum, Fac Psychol, Dept Cognit Psychol, Univ Str 150, Bochum, Germany.	joerg.lewald@rub.de	Lewald, Jörg/D-3034-2009; Hausmann, Markus/F-4060-2014	Lewald, Jörg/0000-0001-9351-0170; Hausmann, Markus/0000-0002-2141-1154	Deutsche Forschungsgemeinschaft [FA 211/24-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (FA 211/24-1; http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; ASANUMA C, 1985, J COMP NEUROL, V241, P357, DOI 10.1002/cne.902410309; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bergsma DP, 2010, BRIT J OPHTHALMOL, V94, P88, DOI 10.1136/bjo.2008.154336; Bolognini N, 2005, BRAIN, V128, P2830, DOI 10.1093/brain/awh656; Borra E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00035; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; CHALUPA LM, 1975, SCIENCE, V190, P290, DOI 10.1126/science.1179212; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Damasio H, 1989, LESION ANAL NEUROPSY; Danckert J, 2005, NEUROSCI BIOBEHAV R, V29, P1035, DOI 10.1016/j.neubiorev.2005.02.001; Danckert J, 2000, CURR BIOL, V10, pR64, DOI 10.1016/S0960-9822(00)00284-0; Dinse H.R., 2005, ACM T APPL PERCEPT, V2, P71, DOI DOI 10.1145/1060581.1060583; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Falchier A, 2002, J NEUROSCI, V22, P5749; FENDRICH R, 1992, SCIENCE, V258, P1489, DOI 10.1126/science.1439839; Ferber S, 2001, BRAIN, V124, P527, DOI 10.1093/brain/124.3.527; FINDLAY JM, 1981, VISION RES, V21, P347, DOI 10.1016/0042-6989(81)90162-0; FISCHER B, 1986, EXP BRAIN RES, V64, P569, DOI 10.1007/BF00340494; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hausmann M, 2005, COGNITIVE BRAIN RES, V25, P537, DOI 10.1016/j.cogbrainres.2005.08.008; Hausmann M, 2003, NEUROPSYCHOLOGIA, V41, P1523, DOI 10.1016/S0028-3932(03)00076-9; Hausmann M, 2003, NEUROPSYCHOLOGY, V17, P602, DOI 10.1037/0894-4105.17.4.602; Holler M, 2007, THESIS RUHR U BOCHUM; Huxin KR, 2008, VISION RES, V48, P2154, DOI 10.1016/j.visres.2008.05.022; Huxlin KR, 2009, J NEUROSCI, V29, P3981, DOI 10.1523/JNEUROSCI.4882-08.2009; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; Jobke S, 2009, NEUROREHAB NEURAL RE, V23, P246, DOI 10.1177/1545968308324221; Johannsen L, 2004, J CLIN EXP NEUROPSYC, V26, P251, DOI 10.1076/jcen.26.2.251.28085; Kalisch T., 2009, FRONT NEUROSCI, V3, P96; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Kasten E, 1998, NAT MED, V4, P1083, DOI 10.1038/2079; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kentridge R. W., 1999, J CONSCIOUSNESS STUD, V6, P3; Leh SE, 2006, BRAIN, V129, P1822, DOI 10.1093/brain/awl111; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; Lewald J, 2004, J COGNITIVE NEUROSCI, V16, P828, DOI 10.1162/089892904970834; Lewald J, 1997, BEHAV BRAIN RES, V87, P35, DOI 10.1016/S0166-4328(96)02254-1; Lewald J, 2007, NEUROPSYCHOLOGIA, V45, P1215, DOI 10.1016/j.neuropsychologia.2006.10.006; Lewald J, 2009, EUR J NEUROSCI, V30, P1401, DOI 10.1111/j.1460-9568.2009.06905.x; Lewald J, 2009, BRAIN RES, V1287, P111, DOI 10.1016/j.brainres.2009.06.085; Lewald J, 2009, NEUROPSYCHOLOGIA, V47, P962, DOI 10.1016/j.neuropsychologia.2008.10.016; Marshall RS, 2010, CLIN REHABIL, V24, P1027, DOI 10.1177/0269215510362323; Meredith MA, 2009, HEARING RES, V258, P64, DOI 10.1016/j.heares.2009.03.005; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Passamonti C, 2009, NEUROPSYCHOLOGIA, V47, P546, DOI 10.1016/j.neuropsychologia.2008.10.008; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Poggel DA, 2006, BRAIN RES, V1097, P142, DOI 10.1016/j.brainres.2006.04.011; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; POPPEL E, 1987, EXP BRAIN RES, V68, P445; POTTHOFF RD, 1995, J NEUROSCI RES, V40, P787, DOI 10.1002/jnr.490400610; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Sabel BA, 2011, PROG BRAIN RES, V192, P199, DOI 10.1016/B978-0-444-53355-5.00013-0; Sahraie A, 2010, EXP BRAIN RES, V206, P25, DOI 10.1007/s00221-010-2395-z; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Schmielau F, 1998, INVEST OPHTH VIS SCI, V39, P2571; Schneider KA, 2009, J NEUROSCI, V29, P1784, DOI 10.1523/JNEUROSCI.4452-08.2009; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Siefer A., 2003, ZENTRALBLATT ARBEITS, V53, P346; Smith PS, 2009, ARCH PHYS MED REHAB, V90, P2108, DOI 10.1016/j.apmr.2009.07.017; Stein BE., 1993, MERGING SENSES; Stoerig P, 1996, TRENDS NEUROSCI, V19, P401, DOI 10.1016/S0166-2236(96)10051-5; Tegenthoff M, 1998, NEUROL REHABIL, V4, P5; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Werth R, 1999, RESTOR NEUROL NEUROS, V15, P229; Wust S, 2002, J COGNITIVE NEUROSCI, V14, P243, DOI 10.1162/089892902317236876; ZIHL J, 1984, NEUROPSYCHOLOGIA, V22, P1, DOI 10.1016/0028-3932(84)90002-2; ZIHL J, 1984, NEUROPSYCHOLOGIA, V22, P13, DOI 10.1016/0028-3932(84)90003-4; Zimmer U, 2004, EUR J NEUROSCI, V20, P3148, DOI 10.1111/j.1460-9568.2004.03766.x	84	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e31603	10.1371/journal.pone.0031603	http://dx.doi.org/10.1371/journal.pone.0031603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666311	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305349600001
J	Geloen, A; Helin, L; Geeraert, B; Malaud, E; Holvoet, P; Marguerie, G				Geloen, Alain; Helin, Lionel; Geeraert, Benjamine; Malaud, Eric; Holvoet, Paul; Marguerie, Gerard			CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SCAVENGER RECEPTOR CD36; LOW-DENSITY-LIPOPROTEIN; ADIPOCYTE MEMBRANE-PROTEIN; INSULIN SENSITIVITY; OXIDIZED LDL; CHOLESTEROL UPTAKE; MACROPHAGE; MICE; DEFICIENCY	CD36 is recognized as a lipid and fatty acid receptor and plays an important role in the metabolic syndrome and associated cardiac events. The pleiotropic activity and the multiple molecular associations of this scavenger receptor with membrane associated molecules in different cells and tissues have however questioned its potential as a therapeutic target. The present study shows that it is possible to identify low molecular weight chemicals that can block the CD36 binding and uptake functions. These inhibitors were able to reduce arterial lipid deposition, fatty acid intestinal transit, plasma concentration of triglycerides and glucose, to improve insulin sensitivity, glucose tolerance and to reduce the plasma concentration of HbAc1 in different and independent rodent models. Correlation between the anti-CD36 activity of these inhibitors and the known pathophysiological activity of this scavenger receptor in the development of atherosclerosis and diabetes were observed at pharmacological doses. Thus, CD36 might represent an attractive therapeutic target.	[Geloen, Alain] Lyon Univ, INSA Lyon, IMBL Villeurbanne, INSERM U1060,CarMeN Lab, Lyon, France; [Geeraert, Benjamine; Holvoet, Paul] Katholieke Univ Leuven, Atherosclerosis & Metab Unit, Dept Cardiovasc Sci, Louvain, Belgium; [Helin, Lionel; Malaud, Eric; Marguerie, Gerard] Arteria, Caissargues, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; KU Leuven	Geloen, A (corresponding author), Lyon Univ, INSA Lyon, IMBL Villeurbanne, INSERM U1060,CarMeN Lab, Lyon, France.	g.marguerie@arteria-lab.com	HOLVOET, PAUL/T-8434-2017	HOLVOET, PAUL/0000-0001-9201-0772; GELOEN, Alain/0000-0001-7921-1254	Arteria	Arteria	This research project was supported in whole by a grant from Arteria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Furuhashi M, 2003, DIABETES CARE, V26, P471, DOI 10.2337/diacare.26.2.471; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Haffner SM, 2002, AM J CARDIOL, V90, p55I, DOI 10.1016/S0002-9149(02)02634-6; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; Howard B V, 2000, Curr Atheroscler Rep, V2, P476, DOI 10.1007/s11883-000-0046-8; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Huang WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029092; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Masson CJ, 2009, PLOS ONE, V5; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Miao WM, 2001, BLOOD, V97, P1689, DOI 10.1182/blood.V97.6.1689; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Plutzky J, 2002, J DIABETES COMPLICAT, V16, P401, DOI 10.1016/S1056-8727(02)00202-7; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Sukhanov S, 2006, CIRC RES, V99, P191, DOI 10.1161/01.RES.0000232319.02303.8c; Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Verreth W, 2004, CIRCULATION, V110, P3259, DOI 10.1161/01.CIR.0000147614.85888.7A; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6	47	41	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37633	10.1371/journal.pone.0037633	http://dx.doi.org/10.1371/journal.pone.0037633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662181	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300071
J	Labrousse, VF; Nadjar, A; Joffre, C; Costes, L; Aubert, A; Gregoire, S; Bretillon, L; Laye, S				Labrousse, Virginie F.; Nadjar, Agnes; Joffre, Corinne; Costes, Laurence; Aubert, Agnes; Gregoire, Stephane; Bretillon, Lionel; Laye, Sophie			Short-Term Long Chain Omega3 Diet Protects from Neuroinflammatory Processes and Memory Impairment in Aged Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GAMMA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ARACHIDONIC-ACID; LEARNING-ABILITY; MICROGLIAL CELLS; FOS EXPRESSION; WORKING-MEMORY; GRANULE CELLS	Regular consumption of food enriched in omega3 polyunsaturated fatty acids (omega 3 PUFAs) has been shown to reduce risk of cognitive decline in elderly, and possibly development of Alzheimer's disease. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are the most likely active components of omega 3-rich PUFAs diets in the brain. We therefore hypothesized that exposing mice to a DHA and EPA enriched diet may reduce neuroinflammation and protect against memory impairment in aged mice. For this purpose, mice were exposed to a control diet throughout life and were further submitted to a diet enriched in EPA and DHA during 2 additional months. Cytokine expression together with a thorough analysis of astrocytes morphology assessed by a 3D reconstruction was measured in the hippocampus of young (3-month-old) and aged (22-month-old) mice. In addition, the effects of EPA and DHA on spatial memory and associated Fos activation in the hippocampus were assessed. We showed that a 2-month EPA/DHA treatment increased these long-chain omega 3 PUFAs in the brain, prevented cytokines expression and astrocytes morphology changes in the hippocampus and restored spatial memory deficits and Fos-associated activation in the hippocampus of aged mice. Collectively, these data indicated that diet-induced accumulation of EPA and DHA in the brain protects against neuroinflammation and cognitive impairment linked to aging, further reinforcing the idea that increased EPA and DHA intake may provide protection to the brain of aged subjects.	[Labrousse, Virginie F.; Nadjar, Agnes; Joffre, Corinne; Costes, Laurence; Aubert, Agnes; Laye, Sophie] INRA 1286, Bordeaux, France; [Labrousse, Virginie F.; Nadjar, Agnes; Joffre, Corinne; Costes, Laurence; Aubert, Agnes; Laye, Sophie] Univ Bordeaux, Bordeaux, France; [Gregoire, Stephane; Bretillon, Lionel] Univ Bourgogne, Eye & Nutr Res Grp, CGA, INRA, Dijon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Labrousse, VF (corresponding author), INRA 1286, Bordeaux, France.	sophie.laye@bordeaux.inra.fr	Laye, Sophie/AAX-2501-2020	Laye, Sophie/0000-0002-3843-1012; JOFFRE, Corinne/0000-0001-8327-3554; Bretillon, Lionel/0000-0002-6957-100X; NADJAR, Agnes/0000-0002-3969-6530; Labrousse, Francois/0000-0002-3185-4856	Region Aquitaine; Institut National de la Recherche Agronomique; Agence Nationale de Recherche (ANR); INRA	Region Aquitaine(Region Nouvelle-Aquitaine); Institut National de la Recherche Agronomique; Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); INRA	This work was supported by the Region Aquitaine, the Institut National de la Recherche Agronomique and the Agence Nationale de Recherche (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; V.F.L. receives a fellowship from the INRA and the Region Aquitaine. Quantitative PCR analyses were performed at the Bordeaux Genotyping and Sequencing facility. We thank F. Levet, P. Legros and C. Poujol of the Bordeaux Imaging Center at Bordeaux for their unceasing help. We thank P. Birac and C. Tridon for their help with the care of the mice. We thank Helen Bayer for editing the Ms.	Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Barham JB, 2000, J NUTR, V130, P1925, DOI 10.1093/jn/130.8.1925; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; BERNASCONIGUASTALLA S, 1994, HIPPOCAMPUS, V4, P53, DOI 10.1002/hipo.450040107; Boudrault C, 2009, J NUTR BIOCHEM, V20, P1, DOI 10.1016/j.jnutbio.2008.05.016; Bourre JM, 2005, J NUTR HEALTH AGING, V9, P31; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Campbell IL, 1997, MOL PSYCHIATR, V2, P125, DOI 10.1038/sj.mp.4000225; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Carrie I, 2002, NUTR NEUROSCI, V5, P43, DOI 10.1080/10284150290007074; Champeil-Potokar G, 2006, EUR J NEUROSCI, V24, P3084, DOI 10.1111/j.1460-9568.2006.05185.x; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Crawford MA, 2009, ANN NUTR METAB, V55, P202, DOI 10.1159/000229003; CRUSIO WE, 1987, BRAIN RES, V425, P182, DOI 10.1016/0006-8993(87)90498-7; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; DAS GD, 1976, BRAIN RES, V110, P199, DOI 10.1016/0006-8993(76)90397-8; Das UN, 2006, PROSTAG LEUKOTR ESS, V74, P165, DOI 10.1016/j.plefa.2006.01.002; De Smedt-Peyrusse V, 2008, J NEUROCHEM, V105, P296, DOI 10.1111/j.1471-4159.2007.05129.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gautron L, 2002, NEUROSCIENCE, V112, P717, DOI 10.1016/S0306-4522(02)00115-X; Gemma C, 2007, EUR J NEUROSCI, V26, P2795, DOI 10.1111/j.1460-9568.2007.05875.x; Gemma C, 2007, REV NEUROSCIENCE, V18, P137; GIBERTINI M, 1995, BRAIN BEHAV IMMUN, V9, P113, DOI 10.1006/brbi.1995.1012; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Joardar A, 2007, CELL MOL NEUROBIOL, V27, P973, DOI 10.1007/s10571-007-9204-7; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kavanagh T, 2004, PROSTAG LEUKOTR ESS, V70, P391, DOI 10.1016/j.plefa.2003.12.014; Kee N, 2007, NAT PROTOC, V2, P3033, DOI 10.1038/nprot.2007.415; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; LANDFIELD PW, 1977, J GERONTOL, V32, P3, DOI 10.1093/geronj/32.1.3; LAPING NJ, 1994, J NEUROSCI RES, V39, P710, DOI 10.1002/jnr.490390612; Laye S, 2010, PROSTAG LEUKOTR ESS, V82, P295, DOI 10.1016/j.plefa.2010.02.006; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; LINDSEY JD, 1979, J GERONTOL, V34, P661, DOI 10.1093/geronj/34.5.661; LIPP HP, 1984, SCIENCE, V225, P80, DOI 10.1126/science.6729469; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; Lu DY, 2010, NEUROPSYCHOPHARMACOL, V35, P2238, DOI 10.1038/npp.2010.98; Luchtman DW, 2012, BEHAV BRAIN RES, V226, P386, DOI 10.1016/j.bbr.2011.09.033; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Mesches MH, 2004, NEUROBIOL AGING, V25, P315, DOI 10.1016/S0197-4580(03)00116-7; Mingam R, 2008, EUR J NEUROSCI, V28, P1877, DOI 10.1111/j.1460-9568.2008.06470.x; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Minogue AM, 2007, J NEUROCHEM, V103, P914, DOI 10.1111/j.1471-4159.2007.04848.x; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P222, DOI 10.1016/j.intimp.2006.10.001; Moranis A, 2011, BRAIN BEHAV IMMUN; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Murray CA, 1998, J NEUROSCI, V18, P2974; NANRY KP, 1989, BEHAV BRAIN RES, V35, P45, DOI 10.1016/S0166-4328(89)80007-5; Petursdottir AL, 2008, J GERONTOL A-BIOL, V63, P1153, DOI 10.1093/gerona/63.11.1153; Porte Y, 2008, NEUROBIOL AGING, V29, P1533, DOI 10.1016/j.neurobiolaging.2007.03.023; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Schnebelen C, 2008, OPHTHALMIC IN PRESS; Schnebelen C, 2009, LIPIDS, V44, P465, DOI 10.1007/s11745-009-3289-3; Schuster G, 1997, NEUROBIOL LEARN MEM, V68, P86, DOI 10.1006/nlme.1997.3775; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shires KL, 2008, EUR J NEUROSCI, V28, P982, DOI 10.1111/j.1460-9568.2008.06402.x; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Spulber S, 2008, EUR J NEUROSCI, V27, P549, DOI 10.1111/j.1460-9568.2008.06050.x; Sykova E, 1998, EXP GERONTOL, V33, P837, DOI 10.1016/S0531-5565(98)00038-2; Tanabe Y, 2004, CLIN EXP PHARMACOL P, V31, P700, DOI 10.1111/j.1440-1681.2004.04068.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Touzani K, 2003, EUR J NEUROSCI, V17, P628, DOI 10.1046/j.1460-9568.2003.02464.x; Viau S, 2009, GRAEF ARCH CLIN EXP, V247, P1039, DOI 10.1007/s00417-009-1080-z; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Yurko-Mauro K, 2010, CURR ALZHEIMER RES, V7, P190, DOI 10.2174/156720510791050911; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	97	136	142	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36861	10.1371/journal.pone.0036861	http://dx.doi.org/10.1371/journal.pone.0036861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662127	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300018
J	Soares, CP; Midlej, V; de Oliveira, MEW; Benchimol, M; Costa, ML; Mermelstein, C				Soares, Carolina Pontes; Midlej, Victor; Weschollek de Oliveira, Maria Eduarda; Benchimol, Marlene; Costa, Manoel Luis; Mermelstein, Claudia			2D and 3D-Organized Cardiac Cells Shows Differences in Cellular Morphology, Adhesion Junctions, Presence of Myofibrils and Protein Expression	PLOS ONE			English	Article							SHAPE	Cardiac cells are organized in vivo in a complex tridimensional structural organization that is crucial for heart function. While in vitro studies can reveal details about cardiac cell biology, usually cells are grown on simplified two-dimensional (2D) environments. To address these differences, we established a cardiac cell culture composed of both 2D and three-dimensional (3D)-organized cells. Our results shows significant differences between the two culture contexts in relation to the overall morphology of the cells, contraction ability, proliferation rate, presence of intercellular adhesion structures, organization of myofibrils, mitochondria morphology, endoplasmic reticulum contents, cytoskeletal filaments and extracellular matrix distribution, and expression of markers of cardiac differentiation. Cardiac cells grown in 2D-context displayed a flattened and well spread shape, were mostly isolated and their cytoplasm was filled with a large network of microfilaments and microtubules. In contrast, 3D-cells were smaller in size, were always in close contact with each other with several cellular junctions, and displayed a less conspicuous cytoskeletal network. 3D-cells had more mitochondria and myofibrils and these cells contract spontaneously more often than 2D-cells. On the other hand, endoplasmic reticulum membranes were present in higher amounts in 2D-cells when compared to 3D-cells. The expression of desmin, cadherin and alpha-actinin was higher in 3D-aggregates compared to 2D-spread cells. These findings indicate that the tridimensional environment in which the cardiac cells are grown influence several aspects of cardiac differentiation, including cell adhesion, cell shape, myofibril assembly, mitochondria contents and protein expression. We suggest that the use of this cardiac culture model, with 2D and 3D-context cells, could be useful for studies on the effects of different drugs, or growth factors, giving valuable information on the biological response of cells grown in different spatial organizations.	[Soares, Carolina Pontes; Weschollek de Oliveira, Maria Eduarda; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Midlej, Victor; Benchimol, Marlene] Univ Santa Ursula, Lab Ultraestrutura Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Soares, CP (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	mermelstein, Claudia S/C-1464-2010; Costa, Manoel/B-5009-2010; Midlej, Victor/AFU-1569-2022	mermelstein, Claudia S/0000-0002-8897-8526; Costa, Manoel/0000-0002-9037-0085; do Valle Pereira Midlej, Victor/0000-0001-9294-6597	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RE, 2010, TISSUE ENG PT A, V16, P629, DOI 10.1089/ten.tea.2009.0458; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Byers H.R., 1984, Cell and Muscle Motility, V5, P83; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; CLAYCOMB WC, 1992, TRENDS CARDIOVAS MED, V2, P231, DOI 10.1016/1050-1738(92)90030-V; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; DECKER ML, 1991, J MOL CELL CARDIOL, V23, P817, DOI 10.1016/0022-2828(91)90215-8; Ehler E, 2000, Heart Fail Rev, V5, P259, DOI 10.1023/A:1009861504264; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; GONCHAROVA EJ, 1992, DEVELOPMENT, V114, P173; Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007; Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039; Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1; Motlagh D, 2003, BIOMATERIALS, V24, P2463, DOI 10.1016/S0142-9612(02)00644-0; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722; RENAUD JF, 1976, J MOL CELL CARDIOL, V8, P889, DOI 10.1016/0022-2828(76)90071-7; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Soares CP, 2010, CELLS TISSUES ORGANS, V192, P187, DOI 10.1159/000316005; SPERELAKIS N, 1978, ENVIRON HEALTH PERSP, V26, P243, DOI 10.2307/3428847; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194	26	95	96	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38147	10.1371/journal.pone.0038147	http://dx.doi.org/10.1371/journal.pone.0038147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662278	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300170
J	Sokolove, J; Bromberg, R; Deane, KD; Lahey, LJ; Derber, LA; Chandra, PE; Edison, JD; Gilliland, WR; Tibshirani, RJ; Norris, JM; Holers, VM; Robinson, WH				Sokolove, Jeremy; Bromberg, Reuven; Deane, Kevin D.; Lahey, Lauren J.; Derber, Lezlie A.; Chandra, Piyanka E.; Edison, Jess D.; Gilliland, William R.; Tibshirani, Robert J.; Norris, Jill M.; Holers, V. Michael; Robinson, William H.			Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; CHRONIC INFLAMMATORY DISEASE; TOLL-LIKE RECEPTORS; C-REACTIVE PROTEIN; DOUBLE-BLIND; UP-REGULATION; BLOOD-DONORS; UNDIFFERENTIATED ARTHRITIS; AUTOIMMUNE ARTHRITIS; IMMUNE-COMPLEXES	Rheumatoid arthritis (RA) is a prototypical autoimmune arthritis affecting nearly 1% of the world population and is a significant cause of worldwide disability. Though prior studies have demonstrated the appearance of RA-related autoantibodies years before the onset of clinical RA, the pattern of immunologic events preceding the development of RA remains unclear. To characterize the evolution of the autoantibody response in the preclinical phase of RA, we used a novel multiplex autoantigen array to evaluate development of the anti-citrullinated protein antibodies (ACPA) and to determine if epitope spread correlates with rise in serum cytokines and imminent onset of clinical RA. To do so, we utilized a cohort of 81 patients with clinical RA for whom stored serum was available from 1-12 years prior to disease onset. We evaluated the accumulation of ACPA subtypes over time and correlated this accumulation with elevations in serum cytokines. We then used logistic regression to identify a profile of biomarkers which predicts the imminent onset of clinical RA (defined as within 2 years of testing). We observed a time-dependent expansion of ACPA specificity with the number of ACPA subtypes. At the earliest timepoints, we found autoantibodies targeting several innate immune ligands including citrullinated histones, fibrinogen, and biglycan, thus providing insights into the earliest autoantigen targets and potential mechanisms underlying the onset and development of autoimmunity in RA. Additionally, expansion of the ACPA response strongly predicted elevations in many inflammatory cytokines including TNF-alpha, IL-6, IL-12p70, and IFN-gamma. Thus, we observe that the preclinical phase of RA is characterized by an accumulation of multiple autoantibody specificities reflecting the process of epitope spread. Epitope expansion is closely correlated with the appearance of preclinical inflammation, and we identify a biomarker profile including autoantibodies and cytokines which predicts the imminent onset of clinical arthritis.	[Sokolove, Jeremy; Bromberg, Reuven; Lahey, Lauren J.; Chandra, Piyanka E.; Robinson, William H.] Stanford Univ, Dept Med, Div Rheumatol, Sch Med, Stanford, CA 94305 USA; [Lahey, Lauren J.; Chandra, Piyanka E.; Tibshirani, Robert J.] Stanford Univ, Dept Stat, Sch Med, Stanford, CA 94305 USA; [Tibshirani, Robert J.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Sokolove, Jeremy; Bromberg, Reuven; Robinson, William H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Deane, Kevin D.; Derber, Lezlie A.; Holers, V. Michael] Univ Colorado, Div Rheumatol, Dept Med, Sch Med, Aurora, CO USA; [Edison, Jess D.; Gilliland, William R.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Norris, Jill M.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Sokolove, J (corresponding author), Stanford Univ, Dept Med, Div Rheumatol, Sch Med, Stanford, CA 94305 USA.	sokolove@stanford.edu; wrobins@stanford.edu		Robinson, William/0000-0003-4385-704X	United States National Institutes of Health; American College of Rheumatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050942] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology(General Electric); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by grants from the United States National Institutes of Health and the American College of Rheumatology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1993, J RHEUMATOL, V20, P1278; Aho K, 2000, J RHEUMATOL, V27, P1136; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Deane KD, 2010, ARTHRITIS RHEUM; DOEGLAS D, 1995, ANN RHEUM DIS, V54, P455, DOI 10.1136/ard.54.6.455; El-Gabalawy HS, 2009, J RHEUMATOL, V36, P1130, DOI 10.3899/jrheum.080855; FAARVANG KL, 1993, ANN RHEUM DIS, V52, P711, DOI 10.1136/ard.52.10.711; Firestein GS, 1997, NEW ENGL J MED, V337, P195, DOI 10.1056/NEJM199707173370310; HAAR D, 1993, SCAND J RHEUMATOL, V22, P113, DOI 10.3109/03009749309099254; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Hueber W, 2007, ANN RHEUM DIS, V66, P712, DOI 10.1136/ard.2006.054924; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Jorgensen KT, 2008, ANN RHEUM DIS, V67, P860, DOI 10.1136/ard.2007.073825; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kolfenbach JR, 2010, ARTHRITIS RHEUM-US, V62, P2633, DOI 10.1002/art.27570; KREMER JM, 1989, ARTHRITIS RHEUM, V32, P121, DOI 10.1002/anr.1780320202; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Majka DS, 2008, ANN RHEUM DIS, V67, P801, DOI 10.1136/ard.2007.076679; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Monach PA, 2009, P NATL ACAD SCI USA, V106, P15867, DOI 10.1073/pnas.0908032106; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; O'Dell JR, 2001, ARTHRITIS RHEUM-US, V44, P2235, DOI 10.1002/1529-0131(200110)44:10&lt;2235::AID-ART385&gt;3.0.CO;2-A; Pelayo R, 2007, NEW ENGL J MED, V356, P426, DOI 10.1056/NEJMc062467; Quinn MA, 2003, ARTHRITIS RHEUM, V48, P3039, DOI 10.1002/art.11269; Rantapaa-Dahlqvist S, 2007, ANN RHEUM DIS, V66, P121, DOI 10.1136/ard.2006.057331; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Sokolove J, 2010, ARTHRITIS RHEUM; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Stadt LA, 2011, ANN RHEUM DIS, V70, P128, DOI 10.1136/ard.2010.132662; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; 1997, JAMA, V277, P925	53	343	349	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35296	10.1371/journal.pone.0035296	http://dx.doi.org/10.1371/journal.pone.0035296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662108	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300003
J	Wu, YZ; Yu, T; Gilbertson, TA; Zhou, AH; Xu, H; Nguyen, KT				Wu, Yangzhe; Yu, Tian; Gilbertson, Timothy A.; Zhou, Anhong; Xu, Hao; Kytai Truong Nguyen			Biophysical Assessment of Single Cell Cytotoxicity: Diesel Exhaust Particle-Treated Human Aortic Endothelial Cells	PLOS ONE			English	Article							ADHESION MOLECULES; OXIDATIVE STRESS; PLASMA-MEMBRANE; IN-VIVO; BIOMECHANICS; ELASTICITY; EXPRESSION; REVEALS	Exposure to diesel exhaust particles (DEPs), a major source of traffic-related air pollution, has become a serious health concern due to its adverse influences on human health including cardiovascular and respiratory disorders. To elucidate the relationship between biophysical properties (cell topography, cytoskeleton organizations, and cell mechanics) and functions of endothelial cells exposed to DEPs, atomic force microscope (AFM) was applied to analyze the toxic effects of DEPs on a model cell line from human aortic endothelial cells (HAECs). Fluorescence microscopy and flow cytometry were also applied to further explore DEP-induced cytotoxicity in HAECs. Results revealed that DEPs could negatively impair cell viability and alter membrane nanostructures and cytoskeleton components in a dosage-and a time-dependent manner; and analyses suggested that DEPs-induced hyperpolarization in HAECs appeared in a time-dependent manner, implying DEP treatment would lead to vasodilation, which could be supported by down-regulation of cell biophysical properties (e.g., cell elasticity). These findings are consistent with the conclusion that DEP exposure triggers important biochemical and biophysical changes that would negatively impact the pathological development of cardiovascular diseases. For example, DEP intervention would be one cause of vasodilation, which will expand understanding of biophysical aspects associated with DEP cytotoxicity in HAECs.	[Wu, Yangzhe; Zhou, Anhong] Utah State Univ, Dept Biol Engn, Logan, UT 84322 USA; [Yu, Tian; Gilbertson, Timothy A.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Xu, Hao; Kytai Truong Nguyen] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Texas System; University of Texas Arlington	Wu, YZ (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	Anhong.Zhou@usu.edu	Yu, Tian/A-2854-2013; Wu, Yangzhe/C-4435-2012; Gilbertson, Timothy/G-7147-2011	Gilbertson, Timothy/0000-0003-2569-3096	Huntsman Environmental Research Center; Utah Water Research Laboratory, Logan, UT; National Institutes of Health [HL091232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091232] Funding Source: NIH RePORTER	Huntsman Environmental Research Center; Utah Water Research Laboratory, Logan, UT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is partially supported by Huntsman Environmental Research Center and Utah Water Research Laboratory, Logan, UT (to AZ). The authors also acknowledge the partial financial support from the National Institutes of Health grant HL091232 (to KTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist N, 2004, BIOPHYS J, V86, P1753, DOI 10.1016/S0006-3495(04)74243-5; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Brauer M., 2003, DIESEL EXHAUST PARTI, P1; Callies C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175104; Chtcheglova LA, 2007, BIOPHYS J, V93, pL11, DOI 10.1529/biophysj.107.109751; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Doornaert B, 2003, AM J PHYSIOL-LUNG C, V284, pL119, DOI 10.1152/ajplung.00039.2002; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Emerson GG, 2000, CIRC RES, V86, P94, DOI 10.1161/01.RES.86.1.94; Forchhammer L, 2012, TOXICOL LETT, V209, P121, DOI 10.1016/j.toxlet.2011.12.003; Hillebrand U, 2008, PFLUG ARCH EUR J PHY, V456, P51, DOI 10.1007/s00424-007-0411-3; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kidoaki S, 2007, J BIOMED MATER RES A, V81A, P728, DOI 10.1002/jbm.a.31112; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lee S, 2007, P NATL ACAD SCI USA, V104, P9609, DOI 10.1073/pnas.0702668104; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li TS, 2008, J MOL NEUROSCI, V35, P289, DOI 10.1007/s12031-008-9065-7; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Mann CL, 2001, ENDOCRINOLOGY, V142, P421, DOI 10.1210/en.142.1.421; Moller W, 2002, TOXICOL APPL PHARM, V182, P197, DOI 10.1006/taap.2002.9430; Montiel-Davalos A, 2007, INHAL TOXICOL, V19, P91, DOI 10.1080/08958370701495212; Nemmar A, 2007, AM J PHYSIOL-LUNG C, V292, pL664, DOI 10.1152/ajplung.00240.2006; Okayama Y, 2006, J TOXICOL ENV HEAL A, V69, P1699, DOI 10.1080/15287390600631078; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Reichlin T, 2005, J STRUCT BIOL, V152, P52, DOI 10.1016/j.jsb.2005.07.009; Ris C, 2007, INHAL TOXICOL, V19, P229, DOI 10.1080/08958370701497960; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Shah AM, 2004, HEART, V90, P486, DOI 10.1136/hrt.2003.029389; Shaw CA, 2010, AM J RESP CELL MOL B; Shaw CA, 2011, AM J RESP CELL MOL, V44, P840, DOI 10.1165/rcmb.2010-0011OC; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suzuki AK, 2008, TOXICOL LETT, V180, pS226, DOI 10.1016/j.toxlet.2008.06.110; Wildling L, 2009, PFLUG ARCH EUR J PHY, V458, P223, DOI 10.1007/s00424-008-0615-1; Wold LE, 2006, CARDIOVASC TOXICOL, V6, P69, DOI 10.1385/CT:6:1:69; Wu YZ, 2010, CANCER LETT, V293, P82, DOI 10.1016/j.canlet.2009.12.016; Wu YZ, 2009, CHEM COMMUN, P7021, DOI 10.1039/b914605a; Xu XH, 2009, TOXICOL LETT, V191, P57, DOI 10.1016/j.toxlet.2009.08.006	39	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36885	10.1371/journal.pone.0036885	http://dx.doi.org/10.1371/journal.pone.0036885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662129	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300020
J	Castoldi, A; Braga, TT; Correa-Costa, M; Aguiar, CF; Bassi, EJ; Correa-Silva, R; Elias, RM; Salvador, F; Moraes-Vieira, PM; Cenedeze, MA; Reis, MA; Hiyane, MI; Pacheco-Silva, A; Goncalves, GM; Camara, NOS				Castoldi, Angela; Braga, Tarcio Teodoro; Correa-Costa, Matheus; Aguiar, Cristhiane Favero; Bassi, Enio Jose; Correa-Silva, Reinaldo; Elias, Rosa Maria; Salvador, Fabia; Moraes-Vieira, Pedro Manoel; Cenedeze, Marcos Antonio; Reis, Marlene Antonia; Hiyane, Meire Ioshie; Pacheco-Silva, Alvaro; Goncalves, Giselle Martins; Saraiva Camara, Niels Olsen			TLR2, TLR4 and the MYD88 Signaling Pathway Are Crucial for Neutrophil Migration in Acute Kidney Injury Induced by Sepsis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; TOLL-LIKE RECEPTOR-2; NITRIC-OXIDE; ORGAN FAILURE; CELL-DEATH; LIPOPOLYSACCHARIDE; INHIBITION; EXPRESSION; APOPTOSIS; CYTOKINE	The aim of this study was to investigate the role of TLR2, TLR4 and MyD88 in sepsis-induced AKI. C57BL/6 TLR2(-/-), TLR4(-/-) and MyD88(-/-) male mice were subjected to sepsis by cecal ligation and puncture (CLP). Twenty four hours later, kidney tissue and blood samples were collected for analysis. The TLR2(-/-), TLR4(-/-) and MyD88(-/-) mice that were subjected to CLP had preserved renal morphology, and fewer areas of hypoxia and apoptosis compared with the wild-type C57BL/6 mice (WT). MyD88(-/-) mice were completely protected compared with the WT mice. We also observed reduced expression of proinflammatory cytokines in the kidneys of the knockout mice compared with those of the WT mice and subsequent inhibition of increased vascular permeability in the kidneys of the knockout mice. The WT mice had increased GR1(+low) cells migration compared with the knockout mice and decreased in GR1(+high) cells migration into the peritoneal cavity. The TLR2(-/-), TLR4(-/-), and MyD88(-/-) mice had lower neutrophil infiltration in the kidneys. Depletion of neutrophils in the WT mice led to protection of renal function and less inflammation in the kidneys of these mice. Innate immunity participates in polymicrobial sepsis-induced AKI, mainly through the MyD88 pathway, by leading to an increased migration of neutrophils to the kidney, increased production of proinflammatory cytokines, vascular permeability, hypoxia and apoptosis of tubular cells.	[Castoldi, Angela; Aguiar, Cristhiane Favero; Correa-Silva, Reinaldo; Elias, Rosa Maria; Salvador, Fabia; Cenedeze, Marcos Antonio; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil; [Castoldi, Angela; Braga, Tarcio Teodoro; Correa-Costa, Matheus; Bassi, Enio Jose; Moraes-Vieira, Pedro Manoel; Hiyane, Meire Ioshie; Goncalves, Giselle Martins; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Imunol, Lab Imunobiol Transplantes, Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Hosp Israelita Albert Einstein, IIEP, Sao Paulo, Brazil; [Reis, Marlene Antonia] Univ Fed Triangulo Mineiro, Uberaba, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade Federal do Triangulo Mineiro	Castoldi, A (corresponding author), Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil.	niels@icb.usp.br	Braga, Tarcio T/E-4827-2014; Braga, Tarcio/AAG-4475-2020; Bassi, Ênio José/P-9937-2019; Aguiar, Cristhiane/C-2678-2012; Complexos, INCT Fluidos/H-9172-2013; camara, niels olsen saraiva/AAX-3269-2020; Bassi, Ênio José/I-3616-2016; Moraes-Vieira, Pedro/C-8701-2014; Silva, Reinaldo/C-6285-2013; Castoldi, Angela/K-1889-2015; Camara, Niels OS/G-8336-2011; Correa-Costa, Matheus/B-2006-2014; Pacheco-Silva, Alvaro/K-3583-2013	Braga, Tarcio T/0000-0002-2989-1076; Bassi, Ênio José/0000-0002-7956-5746; camara, niels olsen saraiva/0000-0001-5436-1248; Bassi, Ênio José/0000-0002-7956-5746; Moraes-Vieira, Pedro/0000-0002-8263-786X; Camara, Niels OS/0000-0001-5436-1248; Castoldi, Angela/0000-0002-8434-7989	Brazilian Foundation - Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [07/07139-3]; International Associated Laboratory (CNPq- National Counsel of Technological and Scientific Development); National Institute of Science and Technology (INCT)	Brazilian Foundation - Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Associated Laboratory (CNPq- National Counsel of Technological and Scientific Development); National Institute of Science and Technology (INCT)	This work was supported by the Brazilian Foundation - Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP), Grants Number: 07/07139-3), International Associated Laboratory (CNPq- National Counsel of Technological and Scientific Development), and National Institute of Science and Technology (INCT) Complex Fluids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Filho J. C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P151; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Andonegui G, 2002, J IMMUNOL, V169, P2111, DOI 10.4049/jimmunol.169.4.2111; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bellomo R, 2008, NEPHRON EXP NEPHROL, V109, pE95, DOI 10.1159/000142933; Carattino MD, 1999, IMMUNOPHARMACOLOGY, V43, P241, DOI 10.1016/S0162-3109(99)00095-8; CAVERZASIO J, 1987, AM J PHYSIOL, V252, pF943, DOI 10.1152/ajprenal.1987.252.5.F943; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; GOLDIE AS, 1995, JAMA-J AM MED ASSOC, V274, P172, DOI 10.1001/jama.274.2.172; Gosemann JH, 2010, INJURY, V41, P1060, DOI 10.1016/j.injury.2010.05.021; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; KLINGEBIEL T, 1983, CLIN NEPHROL, V20, P1; Komura H, 2009, J IMMUNOL, V182, P581, DOI 10.4049/jimmunol.182.1.581; MercerJones MA, 1997, SHOCK, V8, P193, DOI 10.1097/00024382-199709000-00007; Messaris E, 2008, SURG INFECT, V9, P377, DOI 10.1089/sur.2006.018; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Miyazaki S, 2004, CLIN DIAGN LAB IMMUN, V11, P452, DOI 10.1128/CDLI.11.3.452-457.2004; Oberholzer C, 2001, FASEB J, V15, P879, DOI 10.1096/fj.00-058rev; Ortiz A, 2003, BIOCHEM PHARMACOL, V66, P1589, DOI 10.1016/S0006-2952(03)00515-X; SATO T, 1993, J LEUKOCYTE BIOL, V53, P144, DOI 10.1002/jlb.53.2.144; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schrier RW, 2002, J CLIN INVEST, V110, P743, DOI 10.1172/JCI200216568; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Traylor LA, 1997, ARCH BIOCHEM BIOPHYS, V338, P129, DOI 10.1006/abbi.1996.9840; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Yamano M, 1998, N-S ARCH PHARMACOL, V358, P253, DOI 10.1007/PL00005250; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Zhang CJ, 2000, BIOCHEM PHARMACOL, V59, P203, DOI 10.1016/S0006-2952(99)00324-X	39	105	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37584	10.1371/journal.pone.0037584	http://dx.doi.org/10.1371/journal.pone.0037584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655058	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900034
J	Krecek, RC; Mohammed, H; Michael, LM; Schantz, PM; Ntanjana, L; Morey, L; Werre, SR; Willingham, AL				Krecek, Rosina Claudia; Mohammed, Hamish; Michael, Lynne Margaret; Schantz, Peter Mullineaux; Ntanjana, Lulama; Morey, Liesl; Werre, Stephen Rakem; Willingham, Arve Lee, III			Risk Factors of Porcine Cysticercosis in the Eastern Cape Province, South Africa	PLOS ONE			English	Article							TAENIA-SOLIUM CYSTICERCOSIS; NORTH-WEST PROVINCE; RURAL-COMMUNITY; MORETELE 1; NEUROCYSTICERCOSIS; PREVALENCE; HEALTH; DISTRICT; EPILEPSY	There is a high prevalence of Taenia solium taeniosis/cysticercosis in humans and pigs in the Eastern Cape Province (ECP) of South Africa. The objective of this study was to identify risk factors of porcine cysticercosis in select districts of the ECP. Data were collected in 2003 by interviewing 217 pig producers from the area. Blood samples were collected from 261 of their pigs, which were tested using two enzyme-linked immunosorbent assays (ELISA) for the presence of antibodies to cysticercosis. Frequencies of both owner- and pig-level characteristics were determined. For pig-level analysis, all bivariable and multivariable associations were determined using the surveylogistic procedure of the SAS/STAT((R)) software to accommodate for the intraclass correlation that exists for clusters of pigs within one owner and for clusters of owners within a district. All tests for significance were performed at the alpha = 0.05 level, and adjusted odds ratios (aOR) and 95% confidence intervals (CI) were determined. Among the respondents, 48% of their households lacked a latrine, 98% slaughtered pigs at home, and 99% indicated that meat inspection services were not available. On bivariable analysis, there was a significant association between porcine infection and district (p = 0.003), breed (p = 0.041) and the absence of a latrine (p = 0.006). On multivariable analysis, the absence of a latrine was the only variable significantly associated with porcine infection (aOR = 1.89; 95% CI = 1.07, 3.35) (p = 0.028). The increased odds of porcine infection with households lacking a latrine contributes to our understanding of the transmission of this parasite in the ECP. Determining and addressing the risk factors for T. solium infection can potentially lower the very high prevalence in humans and pigs in this endemic area.	[Krecek, Rosina Claudia] RUSVM, Dept Res, Basseterre, St Kitts, St Kitts & Nevi; [Krecek, Rosina Claudia] Univ Johannesburg, Dept Zool, Auckland Pk, South Africa; [Mohammed, Hamish] Univ Trinidad & Tobago, Arima, Trinidad Tobago; [Michael, Lynne Margaret] Bayer Pty Ltd, Div Anim Hlth, Isando, South Africa; [Schantz, Peter Mullineaux] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Ntanjana, Lulama] Vet Serv Eastern Cape Prov, Dept Agr, Bhisho, Eastern Cape, South Africa; [Morey, Liesl] Agr Res Council, Biometry Unit, Pretoria, South Africa; [Werre, Stephen Rakem] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Lab Study Design & Stat Anal, Blacksburg, VA USA; [Willingham, Arve Lee, III] UNICEF UNDP World Bank WHO Special Programme Res, Stewardship Res Infect Dis Poverty STE, Geneva, Switzerland	University of Johannesburg; Bayer AG; Emory University; Rollins School Public Health; Agricultural Research Council of South Africa; Virginia Polytechnic Institute & State University; The World Bank; World Health Organization	Krecek, RC (corresponding author), RUSVM, Dept Res, Basseterre, St Kitts, St Kitts & Nevi.	tkrecek@rossvet.edu.kn	Krecek, Rosina/AAI-6962-2020	Mohammed, Hamish/0000-0002-2060-7286	United States Agency for International Development (South Africa); RUSVM	United States Agency for International Development (South Africa)(United States Agency for International Development (USAID)); RUSVM	Mr. D Stockdale and Dr. K Lucas of the United States Agency for International Development (USAID) Mission in South Africa, and RUSVM are thanked for support; Dr. L Mrwebi, Dr. R Hyde, Mr. M Lephallo and other staff of the Veterinary Services Eastern Cape Province; the Cysticercosis Working Group of Eastern and Southern Africa for technical inputs to field collections; Mr. TE Krecek of Krecek and Krecek CC, and Mr. B Weaver, Mr. B Ho-Thanh, Mr. M McMillan, Mr. D JohnKing, J Heller, J Moore and A Hefter of RUSVM for technical assistance; Dr. LJS Harrison, Dr. P Dorny and Dr. N Praet for inputs with the diagnostic test analysis; Ms. MF Smith of the Agricultural Research Council for statistical support; the emerging pig producers who cooperated so willingly throughout this study; and several anonymous reviewers for valuable comments that helped improve previous versions of this manuscript.r The source of funding for this work was the United States Agency for International Development (South Africa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MICR WIND PROF 2002; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; HARRISON LJS, 1989, PARASITE IMMUNOL, V11, P351, DOI 10.1111/j.1365-3024.1989.tb00673.x; International Livestock Research Institute (ILRI), 2000, LIV STRAT 2010 MAK L; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Krecek RC, 2011, VET PARASITOL, V183, P198, DOI 10.1016/j.vetpar.2011.09.033; Krecek R.C., 2004, SE ASIAN J TROPICAL, V35, P271; Krecek RC, 2005, J S AFR VET ASSOC, V76, P2; Krecek RC, 2004, J S AFR VET ASSOC, V75, P24; Letsoalo SS, 2000, J S AFR VET ASSOC, V71, P92; LJS Harrison, 1991, PARASITIC HELMINTHS; Mafojane NA, 2003, ACTA TROP, V87, P25, DOI 10.1016/S0001-706X(03)00052-4; Minnaar WN, 1999, J S AFR VET ASSOC, V70, P92; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; O'Neal SE, 2012, EMERG INFECT DIS MAR; Phiri IK, 2003, ACTA TROP, V87, P13, DOI 10.1016/S0001-706X(03)00051-2; Pondja A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000594; Sarti E, 1997, AM J TROP MED HYG, V56, P127, DOI 10.4269/ajtmh.1997.56.127; SAS Institute Inc, CAR; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Statistics South Africa, 2001, CENS 2007 COMM SURV; Vazquez-Flores S, 2001, SALUD PUBLICA MEXICO, V43, P574, DOI 10.1590/S0036-36342001000600009; Wells D, 2001, J S AFR VET ASSOC, V72, P37; Wohlgemut J, 2010, AM J TROP MED HYG, V82, P634, DOI 10.4269/ajtmh.2010.09-0404; World Health Organization, 2003, 56 WORLD HLTH ASS CO	27	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37718	10.1371/journal.pone.0037718	http://dx.doi.org/10.1371/journal.pone.0037718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655065	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900041
J	Li, Q; Yin, RX; Wei, XL; Yan, TT; Aung, LHH; Wu, DF; Wu, JZ; Lin, WX; Liu, CW; Pan, SL				Li, Qing; Yin, Rui-Xing; Wei, Xian-Liang; Yan, Ting-Ting; Aung, Lynn Htet Htet; Wu, Dong-Feng; Wu, Jin-Zhen; Lin, Wei-Xiong; Liu, Cheng-Wu; Pan, Shang-Ling			ATP-Binding Cassette Transporter G5 and G8 Polymorphisms and Several Environmental Factors with Serum Lipid Levels	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SINGLE NUCLEOTIDE POLYMORPHISMS; CHOLESTEROL CONCENTRATIONS; ABCG5/G8 POLYMORPHISMS; DIETARY-CHOLESTEROL; GENE POLYMORPHISMS; ABCG8 GENES; RISK; LOCI; ASSOCIATION	Background: The association of ATP-binding cassette (ABC) transporter single nucleotide polymorphisms (SNPs) and serum lipid profiles is inconsistent. The present study was undertaken to detect the association of ABCG5/G8 SNPs and several environmental factors with serum lipid levels. Methodology/Principal Findings: Genotyping of the ABCG5 (rs4131229 and rs6720173) and ABCG8 (rs3806471 and rs4148211) SNPs was performed in 719 unrelated subjects of Mulao nationality and 782 participants of Han nationality. There were no differences in the genotypic and allelic frequencies of four SNPs between the two ethnic groups besides the genotypic frequencies of rs4131229 SNP in Han. The levels of triglyceride (TG), apolipoprotein (Apo) A1, and ApoA1/ApoB ratio (rs4131229); low-density lipoprotein cholesterol (LDL-C) and ApoB (rs6720173); high-density lipoprotein cholesterol (HDL-C), ApoA1, ApoB, and ApoA1/ApoB ratio (rs3806471); and HDL-C, ApoA1, and ApoA1/ApoB ratio (rs4148211) in Han were different among their genotypes (P<0.05-0.001). The levels of LDL-C (rs6720173) and ApoA1 (rs3806471) in Mulao were also different among their genotypes (P<0.05 for each). The levels of TC, TG, HDL-C, ApoA1, and ApoA1/ApoB ratio (rs4131229); LDL-C and ApoB (rs6720173); HDL-C, ApoA1, and ApoA1/ApoB ratio (rs3806471); and TG, HDL-C, ApoA1, and ApoA1/ApoB ratio (rs4148211) in Han males; and ApoA1/ApoB ratio (rs4131229); LDL-C, ApoB, and ApoA1/ApoB ratio (rs3806471); HDL-C, ApoA1, and ApoA1/ApoB ratio (rs4148211) in Han females were different between the genotypes (P<0.05-0.001). The levels of LDL-C in Mulao females were also different between GG and GC/CC genotypes of rs6720173 (P<0.05). The correlation between serum lipid parameters and genotypes of four SNPs was observed in Han, especially in Han males. Serum lipid parameters were also correlated with several environmental factors. Conclusions: The associations of four ABCG5/G8 SNPs and serum lipid levels are different between the Mulao and Han populations, or between males and females, suggesting that there may be a racial/ethnic- and/or sex-specific association between ABCG5/G8 SNPs and some serum lipid parameters.	[Li, Qing; Yin, Rui-Xing; Yan, Ting-Ting; Aung, Lynn Htet Htet; Wu, Dong-Feng; Wu, Jin-Zhen] Guangxi Med Univ, Dept Cardiol, Inst Cardiovasc Dis, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Wei, Xian-Liang] Guangxi Med Univ, Dept Anat, Sch Premed Sci, Nanning, Guangxi, Peoples R China; [Lin, Wei-Xiong] Med Sci Res Ctr, Dept Mol Biol, Nanning, Guangxi, Peoples R China; [Liu, Cheng-Wu; Pan, Shang-Ling] Guangxi Med Univ, Dept Pathophysiol, Sch Premed Sci, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, Q (corresponding author), Guangxi Med Univ, Dept Cardiol, Inst Cardiovasc Dis, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	yinruixing@yahoo.com.cn	Aung, Lynn-Htet-Htet/AFN-6787-2022; Pan, Shang-Ling/G-9581-2016	Aung, Lynn-Htet-Htet/0000-0002-8853-0641; 	National Natural Science Foundation of China [30960130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No: 30960130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan R, 2010, ATHEROSCLEROSIS, V211, P203, DOI 10.1016/j.atherosclerosis.2010.01.030; Acalovschi M, 2006, EUR J INTERN MED, V17, P490, DOI 10.1016/j.ejim.2006.04.012; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Aung LHH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-230; AUSTIN MA, 1989, AM J EPIDEMIOL, V129, P249, DOI 10.1093/oxfordjournals.aje.a115130; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Berge KE, 2002, J LIPID RES, V43, P486; Bhattacharyya KA, 1974, J CLIN INVEST, V53, P1033; Caamano JM, 2008, CLIN CHEM LAB MED, V46, P1581, DOI 10.1515/CCLM.2008.311; Carey MC, 1997, GUT, V41, P721, DOI 10.1136/gut.41.5.721; Chan DC, 2004, ARTERIOSCL THROM VAS, V24, P2188, DOI 10.1161/01.ATV.0000143532.93729.d6; Chen ZC, 2008, J HUM GENET, V53, P757, DOI 10.1007/s10038-008-0310-2; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Garcia-Rios A, 2010, ATHEROSCLEROSIS, V210, P486, DOI 10.1016/j.atherosclerosis.2010.01.010; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gylling H, 2004, J LIPID RES, V45, P1660, DOI 10.1194/jlr.M300522-JLR200; Hazard SE, 2007, PFLUG ARCH EUR J PHY, V453, P745, DOI 10.1007/s00424-005-0040-7; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Herron KL, 2006, J NUTR, V136, P1161, DOI 10.1093/jn/136.5.1161; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hubacek J A, 2001, Hum Mutat, V18, P359, DOI 10.1002/humu.1206; Hubacek JA, 2004, PHYSIOL RES, V53, P395; IRVING S, 1992, CIRCULATION, V85, P1083; Jakulj L, 2010, J LIPID RES, V51, P3016, DOI 10.1194/jlr.M008128; Junyent M, 2010, NUTR METAB CARDIOVAS, V20, P558, DOI 10.1016/j.numecd.2009.05.005; Junyent M, 2009, J LIPID RES, V50, P565, DOI 10.1194/jlr.P800041-JLR200; Kajinami K, 2004, ATHEROSCLEROSIS, V175, P287, DOI 10.1016/j.atherosclerosis.2004.03.015; Kajinami K, 2004, J LIPID RES, V45, P653, DOI 10.1194/jlr.M300278-JLR200; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Klett EL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-5; Koeijvoets KCMC, 2009, ATHEROSCLEROSIS, V204, P453, DOI 10.1016/j.atherosclerosis.2008.09.018; KWITEROVICH PO, 1992, AM J CARDIOL, V69, P1015, DOI 10.1016/0002-9149(92)90856-T; Li Q, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-160; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; Miwa K, 2005, CLIN SCI, V109, P183, DOI 10.1042/CS20050030; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Plat J, 2005, J LIPID RES, V46, P68, DOI 10.1194/jlr.M400210-JLR200; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rudkowska I, 2008, NUTR REV, V66, P343, DOI 10.1111/j.1753-4887.2008.00042.x; Santosa S, 2007, J LIPID RES, V48, P2607, DOI 10.1194/jlr.M600452-JLR200; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; Srivastava A, 2010, DIS MARKERS, V28, P307, DOI [10.1155/2010/357304, 10.3233/DMA-2010-0710]; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Szilvasi A, 2010, GENET TEST MOL BIOMA, V14, P667, DOI 10.1089/gtmb.2010.0035; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Torres N, 2009, NUTR RES, V29, P728, DOI 10.1016/j.nutres.2009.09.013; Viturro E, 2006, GENET MED, V8, P594, DOI 10.1097/01.gim.0000237760.25195.e7; Weggemans RM, 2002, CLIN GENET, V62, P226, DOI 10.1034/j.1399-0004.2002.620307.x; Wei KK, 2011, J CLIN PHARM THER, V36, P725, DOI 10.1111/j.1365-2710.2010.01227.x; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xu Lin, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P96; Yan TT, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-248; Yin RX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017954; Yin RX, 2007, J LIPID RES, V48, P2673, DOI 10.1194/jlr.M700335-JLR200; Yin RX, 2009, PUBLIC HEALTH NUTR, V12, P553, DOI 10.1017/S1368980008002437; Yin RX, 2008, BLOOD PRESSURE, V17, P306, DOI 10.1080/08037050802589593; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2004, J LIPID RES, V45, P301, DOI 10.1194/jlr.M300377-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	65	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37972	10.1371/journal.pone.0037972	http://dx.doi.org/10.1371/journal.pone.0037972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655090	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900067
J	Zhu, YC; Tian, YH; Du, J; Hu, ZZ; Yang, L; Liu, JJ; Gu, L				Zhu, Yichao; Tian, Yinhui; Du, Jun; Hu, Zhenzhen; Yang, Ling; Liu, Jiaojing; Gu, Luo			Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; FRIZZLED-RELATED PROTEINS; CANONICAL WNT PATHWAY; TYROSINE KINASE ROR2; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; DISHEVELLED PHOSPHORYLATION; VERTEBRATE GASTRULATION; UP-REGULATION; BETA-CATENIN	Background: The Dishevelled (Dvl) and Dishevelled-associated activator of morphogenesis 1 (Daam1) pathway triggered by Wnt5a regulates cellular polarity during development and tissue homoeostasis. However, Wnt5a signaling in breast cancer progression remains poorly defined. Methodology/Principal Findings: We showed here that Wnt5a activated Dvl2, Daam1 and RhoA, and promoted migration of breast cancer cells, which was, however, abolished by Secreted Frizzled-related protein 2 (sFRP2) pretreatment. Dominant negative Dvl2 mutants or Dvl2 siRNA significantly decreased Wnt5a-induced Daam1/RhoA activation and cell migration. Ectopic expression of N-Daam1, a dominant negative mutant, or Daam1 siRNA remarkably inhibited Wnt5a-induced RhoA activation, stress fiber formation and cell migration. Ectopic expression of dominant negative RhoA (N19) or C3 exoenzyme transferase, a Rho inhibitor, decreased Wnt5a-induced stress fiber formation and cell migration. Conclusions/Significance: Taken together, we demonstrated for the first time that Wnt5a promotes breast cancer cell migration via Dvl2/Daam1/RhoA.	[Zhu, Yichao; Du, Jun; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Yichao; Du, Jun; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Tian, Yinhui; Hu, Zhenzhen; Liu, Jiaojing] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Yang, Ling] Suzhou Univ, Affiliated Hosp 3, Dept Cardiol, Changzhou, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, YC (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	lgu@njmu.edu.cn			Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; Jiangsu Planned Projects for Postdoctoral Research Funds [0902023C]; National Natural Science Foundation of China [30872926, 81172002, 81101999]	Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; Jiangsu Planned Projects for Postdoctoral Research Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30872926 and 81172002) and a research grant from Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University to Luo Gu, the National Natural Science Foundation of China (81101999), and the Jiangsu Planned Projects for Postdoctoral Research Funds (0902023C) to Yichao Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fernandez-Cobo M, 2007, ONCOL REP, V17, P903; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; HUGUET EL, 1994, CANCER RES, V54, P2615; Jonsson M, 2002, CANCER RES, V62, P409; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Liu XH, 2008, DIGEST LIVER DIS, V40, P560, DOI 10.1016/j.dld.2007.12.011; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moreno-Aspitia A, 2010, FUTURE ONCOL, V6, P655, DOI 10.2217/FON.10.41; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tada M, 2000, DEVELOPMENT, V127, P2227; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Tsuji T, 2010, MOL BIOL CELL, V21, P3590, DOI 10.1091/mbc.E10-02-0095; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644	64	77	83	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37823	10.1371/journal.pone.0037823	http://dx.doi.org/10.1371/journal.pone.0037823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655072	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900049
J	Bender, S; Rellum, T; Freitag, C; Resch, F; Rietschel, M; Treutlein, J; Jennen-Steinmetz, C; Brandeis, D; Banaschewski, T; Laucht, M				Bender, Stephan; Rellum, Thomas; Freitag, Christine; Resch, Franz; Rietschel, Marcella; Treutlein, Jens; Jennen-Steinmetz, Christine; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred			Dopamine Inactivation Efficacy Related to Functional DAT1 and COMT Variants Influences Motor Response Evaluation	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; CATECHOL-O-METHYLTRANSFERASE; TRANSPORTER GENE; WORKING-MEMORY; REWARD SENSITIVITY; CHILDREN; BRAIN; ATTENTION; POLYMORPHISM; ASSOCIATION	Background: Dopamine plays an important role in orienting, response anticipation and movement evaluation. Thus, we examined the influence of functional variants related to dopamine inactivation in the dopamine transporter (DAT1) and catechol-O-methyltransferase genes (COMT) on the time-course of motor processing in a contingent negative variation (CNV) task. Methods: 64-channel EEG recordings were obtained from 195 healthy adolescents of a community-based sample during a continuous performance task (A-X version). Early and late CNV as well as motor postimperative negative variation were assessed. Adolescents were genotyped for the COMT Val(158) Met and two DAT1 polymorphisms (variable number tandem repeats in the 3'-untranslated region and in intron 8). Results: The results revealed a significant interaction between COMT and DAT1, indicating that COMT exerted stronger effects on lateralized motor post-processing (centro-parietal motor postimperative negative variation) in homozygous carriers of a DAT1 haplotype increasing DAT1 expression. Source analysis showed that the time interval 500-1000 ms after the motor response was specifically affected in contrast to preceding movement anticipation and programming stages, which were not altered. Conclusions: Motor slow negative waves allow the genomic imaging of dopamine inactivation effects on cortical motor post-processing during response evaluation. This is the first report to point towards epistatic effects in the motor system during response evaluation, i.e. during the post-processing of an already executed movement rather than during movement programming.	[Bender, Stephan] Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany; [Bender, Stephan; Freitag, Christine] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Bender, Stephan; Resch, Franz] Univ Heidelberg Hosp, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelberg, Germany; [Rellum, Thomas; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Rietschel, Marcella; Treutlein, Jens] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Jennen-Steinmetz, Christine] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Biostat, D-6800 Mannheim, Germany; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Laucht, Manfred] Univ Potsdam, Dept Psychol, Potsdam, Germany	Technische Universitat Dresden; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Potsdam	Bender, S (corresponding author), Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany.	Stephan.Bender@uniklinik-dresden.de	Banaschewski, Tobias/ABE-5985-2020; Bender, Stephan/AAT-1266-2021	Banaschewski, Tobias/0000-0003-4595-1144; Freitag, Christine Margarete/0000-0001-9676-4782	Deutsche Forschungsgemeinschaft (DFG); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany [7601002]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany	This study was supported by multiple grants from the Deutsche Forschungsgemeinschaft (DFG), the Ministry of Science and Investigation, Baden-Wurttemberg, Germany, and a grant by the Medical Faculty of the Goethe University, Frankfurt, Germany (7601002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; Bender S, 2004, COGNITIVE BRAIN RES, V21, P49, DOI 10.1016/j.cogbrainres.2004.05.004; Bender S, 2004, CLIN NEUROPHYSIOL, V115, P1836, DOI 10.1016/j.clinph.2004.03.023; Bender S, 2002, CEPHALALGIA, V22, P132, DOI 10.1046/j.1468-2982.2002.00334.x; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039012; Bender S, 2010, CLIN NEUROPHYSIOL, V121, P2044, DOI 10.1016/j.clinph.2010.05.008; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Brandeis D, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00018; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Bruckmann S, BRAIN IN PRESS; Cattell R.B., 1960, CULTURE FAIR INTELLI; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; de Frias CM, 2010, J COGNITIVE NEUROSCI, V22, P1614, DOI 10.1162/jocn.2009.21318; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Franke B, 2008, AM J MED GENET B, V147B, P1576, DOI 10.1002/ajmg.b.30861; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GAILLARD AWK, 1977, PSYCHOPHYSIOLOGY, V14, P563, DOI 10.1111/j.1469-8986.1977.tb01200.x; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hahn T, 2011, HUM BRAIN MAPP, V32, P1557, DOI 10.1002/hbm.21127; Hallett M, 1994, Electromyogr Clin Neurophysiol, V34, P5; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; KAROUM F, 1994, BRIT J PHARMACOL, V113, P1391; Kiphardt E., 1974, KORPERKOORDINATIONST; Klein C, 1996, PSYCHOPHYSIOLOGY, V33, P426, DOI 10.1111/j.1469-8986.1996.tb01068.x; Klein C, 1998, PSYCHOPHYSIOLOGY, V35, P272, DOI 10.1017/S0048577298961212; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585; Linssen AM, 2011, PSYCHOPHARMACOLOGY B; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Marklund P, 2009, BRAIN, V132, P336, DOI 10.1093/brain/awn309; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prata DP, 2009, P NATL ACAD SCI USA, V106, P13600, DOI 10.1073/pnas.0903007106; Rockstroh B., 1989, SLOW CORTICAL POTENT; ROHRBAUGH JW, 1980, SCIENCE, V208, P1165, DOI 10.1126/science.7375925; SANO A, 1993, HUM GENET, V91, P405; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack S R, 1998, Adv Pharmacol, V42, P171; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; SOMMER W, 1994, PSYCHOPHYSIOLOGY, V31, P503, DOI 10.1111/j.1469-8986.1994.tb01054.x; Ulrich R, 1998, PSYCHOPHYSIOLOGY, V35, P721, DOI 10.1111/1469-8986.3560721; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Vandenbergh DJ, 2000, AM J MED GENET, V96, P678, DOI 10.1002/1096-8628(20001009)96:5<678::AID-AJMG15>3.0.CO;2-8; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Verleger R, 1999, CLIN NEUROPHYSIOL, V110, P1175, DOI 10.1016/S1388-2457(99)00023-1; Weiss R.H., 1987, GRUNDINTELLIGENZTEST; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	63	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37814	10.1371/journal.pone.0037814	http://dx.doi.org/10.1371/journal.pone.0037814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649558	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305335800078
J	Jiang, FK; Guo, M; Yang, F; Duncan, K; Jackson, D; Rafalski, A; Wang, SC; Li, BL				Jiang, Fukun; Guo, Mei; Yang, Fang; Duncan, Keith; Jackson, David; Rafalski, Antoni; Wang, Shoucai; Li, Bailin			Mutations in an AP2 Transcription Factor-Like Gene Affect Internode Length and Leaf Shape in Maize	PLOS ONE			English	Article							MERISTEM CELL FATE; GREEN-REVOLUTION; GIBBERELLIN BIOSYNTHESIS; SEX DETERMINATION; ARABIDOPSIS; ENCODES; PROTEIN; RICE; TRANSPORTER; EXPRESSION	Background: Plant height is an important agronomic trait that affects yield and tolerance to certain abiotic stresses. Understanding the genetic control of plant height is important for elucidating the regulation of maize development and has practical implications for trait improvement in plant breeding. Methodology/Principal Findings: In this study, two independent, semi-dwarf maize EMS mutants, referred to as dwarf & irregular leaf (dil1), were isolated and confirmed to be allelic. In comparison to wild type plants, the mutant plants have shorter internodes, shorter, wider and wrinkled leaves, as well as smaller leaf angles. Cytological analysis indicated that the leaf epidermal cells and internode parenchyma cells are irregular in shape and are arranged in a more random fashion, and the mutants have disrupted leaf epidermal patterning. In addition, parenchyma cells in the dil1 mutants are significantly smaller than those in wild-type plants. The dil1 mutation was mapped on the long arm of chromosome 6 and a candidate gene, annotated as an AP2 transcription factor-like, was identified through positional cloning. Point mutations near exonintron junctions were identified in both dil1 alleles, resulting in mis-spliced variants. Conclusion: An AP2 transcription factor-like gene involved in stalk and leaf development in maize has been identified. Mutations near exon-intron junctions of the AP2 gene give mis-spliced transcript variants, which result in shorter internodes and wrinkled leaves.	[Jiang, Fukun; Wang, Shoucai] China Agr Univ, Natl Maize Improvement Ctr China, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Jiang, Fukun; Duncan, Keith; Rafalski, Antoni; Li, Bailin] DuPont Agr Biotechnol, Wilmington, DE USA; [Guo, Mei] Pioneer HiBred Int Inc, Johnston, IA USA; [Yang, Fang; Jackson, David] Cold Spring Harbor Labs, Cold Spring Harbor, NY USA	China Agricultural University; DuPont; DuPont; Cold Spring Harbor Laboratory	Jiang, FK (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	Bailin.Li@cgr.dupont.com	Guo, Mei/AAE-5521-2019; li, bz/GVR-7133-2022	Guo, Mei/0000-0002-3274-9564; 	Chinese Scholarship Council; DuPont Agricultural Biotechnology	Chinese Scholarship Council(China Scholarship Council); DuPont Agricultural Biotechnology	This work was supported by the Chinese Scholarship Council and DuPont Agricultural Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Candela H, 2008, NAT REV GENET, V9, P192, DOI 10.1038/nrg2291; Cassani E, 2009, MOL BREEDING, V24, P375, DOI 10.1007/s11032-009-9298-3; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Jackson D, 2002, ARABIDOPSIS LAB MANU, P110; Johal GS, 2008, CROP SCI, V48, P2066, DOI 10.2135/cropsci2008.03.0150; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kirch T, 2003, PLANT CELL, V15, P694, DOI 10.1105/tpc.009480; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Mathur J, 2003, DEVELOPMENT, V130, P3137, DOI 10.1242/dev.00549; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Smith LG, 2001, J CELL BIOL, V152, P231, DOI 10.1083/jcb.152.1.231; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307; Xue GP, 2004, PLANT J, V37, P326, DOI 10.1046/j.1365-313X.2003.01963.x; Zhuang J, 2010, PLANT GROWTH REGUL, V62, P51, DOI 10.1007/s10725-010-9484-7	48	50	56	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37040	10.1371/journal.pone.0037040	http://dx.doi.org/10.1371/journal.pone.0037040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649507	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305335800025
J	MacLachlan, M; Amin, M; Mannan, H; El Tayeb, S; Bedri, N; Swartz, L; Munthali, A; Van Rooy, G; McVeigh, J				MacLachlan, Malcolm; Amin, Mutamad; Mannan, Hasheem; El Tayeb, Shahla; Bedri, Nafisa; Swartz, Leslie; Munthali, Alister; Van Rooy, Gert; McVeigh, Joanne			Inclusion and Human Rights in Health Policies: Comparative and Benchmarking Analysis of 51 Policies from Malawi, Sudan, South Africa and Namibia	PLOS ONE			English	Article							CARE; MANAGEMENT; FRAMEWORK; EQUITY; TB	While many health services strive to be equitable, accessible and inclusive, peoples' right to health often goes unrealized, particularly among vulnerable groups. The extent to which health policies explicitly seek to achieve such goals sets the policy context in which services are delivered and evaluated. An analytical framework was developed - EquiFrame - to evaluate 1) the extent to which 21 Core Concepts of human rights were addressed in policy documents, and 2) coverage of 12 Vulnerable Groups who might benefit from such policies. Using this framework, analysis of 51 policies across Malawi, Namibia, South Africa and Sudan, confirmed the relevance of all Core Concepts and Vulnerable Groups. Further, our analysis highlighted some very strong policies, serious shortcomings in others as well as country-specific patterns. If social inclusion and human rights do not underpin policy formation, it is unlikely they will be inculcated in service delivery. EquiFrame facilitates policy analysis and benchmarking, and provides a means for evaluating policy revision and development.	[MacLachlan, Malcolm; Mannan, Hasheem; McVeigh, Joanne] Trinity Coll Dublin, Sch Psychol, Ctr Global Hlth, Dublin, Ireland; [MacLachlan, Malcolm] Univ Stellenbosch, Ctr Rehabil Studies, ZA-7600 Stellenbosch, South Africa; [Amin, Mutamad] Ahfad Univ Women, Res Adm, Omdurman, Sudan; [El Tayeb, Shahla] Ahfad Univ Women, Sch Psychol, Omdurman, Sudan; [Bedri, Nafisa] Ahfad Univ Women, Sch Hlth Sci, Omdurman, Sudan; [Swartz, Leslie] Univ Stellenbosch, Sch Psychol, ZA-7600 Stellenbosch, South Africa; [Munthali, Alister] Univ Malawi, Ctr Social Res, Zomba, Malawi; [Van Rooy, Gert] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia	Trinity College Dublin; Stellenbosch University; Stellenbosch University; University of Malawi; University of Namibia	MacLachlan, M (corresponding author), Trinity Coll Dublin, Sch Psychol, Ctr Global Hlth, Dublin, Ireland.	malcolm.maclachlan@tcd.ie	Swartz, Leslie/A-5168-2008; Eltayeb, Shahla/AAG-6479-2019; Van Rooy, Gert/Q-6636-2019	Swartz, Leslie/0000-0003-1741-5897; Eltayeb, Shahla/0000-0002-3753-5821; Van Rooy, Gert/0000-0002-8013-8768; McVeigh, Joanne/0000-0002-3243-5995	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by the European Commission Framework Programme 7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2011, HLTH HUMAN RIGHTS IN, V13, P2; [Anonymous], 2006, WORK TOG HLTH; [Anonymous], 1978, INT C PRIM HLTH CAR; [Anonymous], UNHCR CONV PROT REL; Blas E, SOCIAL DETERMINANTS; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181; Buse K., 2005, MAKING HLTH POLICY U; Connell B.R, 1997, PRINCIPLES UNIVERSAL; Crichton J, 2008, HEALTH POLICY PLANN, V23, P339, DOI 10.1093/heapol/czn020; Dube AK, KHART AFR UN SOC AFF; Eichler M, 2006, CAN J PUBLIC HEALTH, V97, P63, DOI 10.1007/BF03405218; Ellis AA, 2007, SOC SCI MED, V64, P701, DOI 10.1016/j.socscimed.2006.10.011; Ensor T., 2004, OVERCOMING BARRIERS; Exworthy M, 2008, HEALTH POLICY PLANN, V23, P318, DOI 10.1093/heapol/czn022; Flaskerud JH, 1998, NURS RES, V47, P69, DOI 10.1097/00006199-199803000-00005; Gilson L, 2008, HEALTH POLICY PLANN, V23, P291, DOI 10.1093/heapol/czn025; Gostin Lawrence, 1994, Health Hum Rights, V1, P58, DOI 10.2307/4065262; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Kenny N, 2005, HEALTH CARE ANAL, V13, P247, DOI 10.1007/s10728-005-8123-3; La Rosa-Salas V, 2008, CUAD BIOET, V19, P355; London L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-14; MacLachlan M., 2011, OPEN MED, V5/1, P10; MacLachlan M, BAM GLOB HLTH MIN SU; MacLachlan M, 2012, TROP MED INT HEALTH, V17, P139, DOI 10.1111/j.1365-3156.2011.02876.x; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Mannan H, 2012, LANCET, V379, pE17, DOI 10.1016/S0140-6736(12)60106-8; Mannan H, 1 GLOB S HLTH SYST R; Mannan H, J DISABILIT IN PRESS; Mannan H., 2011, EQUIFRAME MANUAL TOO; Munthali A, 2010, WORKSH LIL 8 9 NOV 2; Nhongo TM, 2004, AG AFR C JOH 18 20 A; Office of the United Nations High Commissioner for Human Rights, 2008, RIGHT HLTH; Office of the United Nations High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD; Oliver A, 2002, LANCET, V360, P565, DOI 10.1016/S0140-6736(02)09713-1; Reichard A, 2004, MENT RETARD, V42, P459, DOI 10.1352/0047-6765(2004)42<459:ATHCFI>2.0.CO;2; Russell S, 2006, SOC SCI MED, V63, P1732, DOI 10.1016/j.socscimed.2006.04.017; Schatz E, 2007, WORLD DEV, V35, P1390, DOI 10.1016/j.worlddev.2007.04.004; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Stevens S, 2003, EQUITY HLTH HLTH CAR, P65; Stowe M. J., 2001, J DISABIL POLICY STU, V12, P206, DOI DOI 10.1177/104420730101200306; Stowe M.J., 2001, J DISABIL POLICY STU, V12, P133, DOI DOI 10.1177/104420730101200302; Tantivess S, 2008, HEALTH POLICY PLANN, V23, P328, DOI 10.1093/heapol/czn023; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Turnbull H. R, 2001, J DISABIL POLICY STU, V12, P177, DOI DOI 10.1177/104420730101200304; United Nations, UN CONV RIGHTS PERS; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024; Wiman R, M NEEDS PEOPLE DISAB; World Health Organization, HLTH HUM RIGHTS; World Health Organization, 2011, HIV AIDS TUB HIV	51	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e35864	10.1371/journal.pone.0035864	http://dx.doi.org/10.1371/journal.pone.0035864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649488	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305335800005
J	Rathore, SS; Agarwal, SK; Pande, S; Singh, SK; Mittal, T; Mittal, B				Rathore, Saurabh Singh; Agarwal, Surendra Kumar; Pande, Shantanu; Singh, Sushil Kumar; Mittal, Tulika; Mittal, Balraj			Therapeutic Dosing of Acenocoumarol: Proposal of a Population Specific Pharmacogenetic Dosing Algorithm and Its Validation in North Indians	PLOS ONE			English	Article							WARFARIN DOSE REQUIREMENTS; REDUCTASE COMPLEX SUBUNIT-1; GREATER-THAN-A; ANTITHROMBOTIC THERAPY; PATIENT CHARACTERISTICS; ANTICOAGULANT RESPONSE; V433M POLYMORPHISM; GENETIC-VARIANTS; CYP2C9; VKORC1	Objectives: To develop a population specific pharmacogenetic acenocoumarol dosing algorithm for north Indian patients and show its efficiency in dosage prediction. Methods: Multiple and linear stepwise regression analyses were used to include age, sex, height, weight, body surface area, smoking status, VKORC1 -1639 G>A, CYP4F2 1347 G>A, CYP2C9*2,* 3 and GGCX 12970 C>G polymorphisms as variables to generate dosing algorithms. The new dosing models were compared with already reported algorithms and also with the clinical data for various performance measures. Odds ratios for association of genotypes with drug sensitive and resistant groups were calculated. Results: The pharmacogenetic dosing algorithm generated by multiple regression analysis explains 41.4% (p-value <0.001) of dosage variation. Validation of the new algorithm showed its predictive ability to be better than the already established algorithms based on similar variables. Its validity in our population is reflected by increased sensitivity, specificity, accuracy and decreased rates of over-and under-estimation in comparison to clinical data. The VKORC1-1639 G>A polymorphism was found to be strongly associated with acenocoumarol sensitivity according to recessive model. Conclusions: We have proposed an efficient north India specific pharmacogenetic acenocoumarol dosing algorithm which might become a baseline for personalised medicine approach for treatment of patients in future.	[Rathore, Saurabh Singh; Mittal, Tulika; Mittal, Balraj] Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Singh, Sushil Kumar] Chhatrapati Shahuji Maharaj Med Univ, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; King George's Medical University	Rathore, SS (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	bml_pgi@yahoo.com			Department of Biotechnology (DBT), India	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This study was supported by research and fellowship grants from the Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2005, AM J MED, V118, P143, DOI 10.1016/j.amjmed.2004.11.015; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Aynacioglu AS, 1999, BRIT J CLIN PHARMACO, V48, P409; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Deng SM, 2010, PROG NEURO-PSYCHOPH, V34, P664, DOI 10.1016/j.pnpbp.2010.03.009; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Ezekowitz, 1999, J Cardiovasc Pharmacol Ther, V4, P3, DOI 10.1177/107424849900400102; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2003, J THROMB THROMBOLYS, V16, P73, DOI 10.1023/B:THRO.0000014598.24114.62; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; HIRSH J, 1992, AM HEART J, V123, P1115, DOI 10.1016/0002-8703(92)91070-H; Hirsh J, 2003, CIRCULATION, V107, P1692, DOI 10.1161/01.CIR.0000063575.17904.4E; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; La S, 2006, CLIN PHARMACOKINET, V45, P1189, DOI 10.2165/00003088-200645120-00004; LAUPACIS A, 1995, CHEST, V108, pS352, DOI 10.1378/chest.108.4_Supplement.352S; Lindh JD, 2005, CLIN PHARMACOL THER, V78, P540, DOI 10.1016/j.clpt.2005.08.006; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; Miao LY, 2007, EUR J CLIN PHARMACOL, V63, P1135, DOI 10.1007/s00228-007-0381-6; Ohno M, 2009, EUR J CLIN PHARMACOL, V65, P1097, DOI 10.1007/s00228-009-0685-9; Ozgon GO, 2008, EUR J CLIN PHARMACOL, V64, P889, DOI 10.1007/s00228-008-0507-5; Pavani A, 2011, PHARMACOGENOMICS J; Perez-Andreu V, 2010, J THROMB HAEMOST, V8, P1012, DOI 10.1111/j.1538-7836.2010.03800.x; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Rathore SS, 2010, BIOSCI TRENDS, V4, P333; RETTIE AE, 1994, PHARMACOGENETICS, V4, P39, DOI 10.1097/00008571-199402000-00005; Rieder MJ, 2007, J THROMB HAEMOST, V5, P2227, DOI 10.1111/j.1538-7836.2007.02744.x; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rosemary J, 2007, CURR CLIN PHARMACOL, V2, P93, DOI 10.2174/157488407779422302; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; STEIN PD, 1995, CHEST, V108, pS424, DOI 10.1378/chest.108.4_Supplement.424S; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, CLIN PHARMACOL THER, V85, P379, DOI 10.1038/clpt.2008.294; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wadelius M, 2005, PHARMACOGENOMICS J, V5, P262, DOI 10.1038/sj.tpj.6500313; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wen MS, 2008, CLIN PHARMACOL THER, V84, P83, DOI 10.1038/sj.clpt.6100453; Zhu Y, 2007, CLIN CHEM, V53, P1199, DOI 10.1373/clinchem.2006.078139	46	33	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37844	10.1371/journal.pone.0037844	http://dx.doi.org/10.1371/journal.pone.0037844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629463	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300080
J	Ma, J; Cui, W; He, SM; Duan, YH; Heng, LJ; Wang, L; Gao, GD				Ma, Jie; Cui, Wei; He, Shi-ming; Duan, Yong-hong; Heng, Li-jun; Wang, Liang; Gao, Guo-dong			Human U87 Astrocytoma Cell Invasion Induced by Interaction of beta ig-h3 with Integrin alpha 5 beta 1 Involves Calpain-2	PLOS ONE			English	Article							INDUCIBLE GENE-H3 BETA-IG-H3; GROWTH-FACTOR-BETA; ALPHA(5)BETA(1) INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; EXTRACELLULAR-MATRIX; IN-VITRO; TGF-BETA; ADHESION; GLIOMA; MIGRATION	It is known that beta ig-h3 is involved in the invasive process of many types of tumors, but its mechanism in glioma cells has not been fully clarified. Using immunofluorescent double-staining and confocal imaging analysis, and co-immunoprecipitation assays, we found that beta ig-h3 co-localized with integrin alpha 5 beta 1 in U87 cells. We sought to elucidate the function of this interaction by performing cell invasion assays and gelatin zymography experiments. We found that siRNA knockdowns of beta ig-h3 and calpain-2 impaired cell invasion and MMP secretion. Moreover, beta ig-h3, integrins and calpain-2 are known to be regulated by Ca2+, and they are also involved in tumor cell invasion. Therefore, we further investigated if calpain-2 was relevant to beta ig-h3-integrin alpha 5 beta 1 interaction to affect U87 cell invasion. Our data showed that beta ig-h3 co-localized with integrin alpha 5 beta 1 to enhance the invasion of U87 cells, and that calpain-2, is involved in this process, acting as a downstream molecule.	[Ma, Jie; He, Shi-ming; Heng, Li-jun; Wang, Liang; Gao, Guo-dong] Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China; [Cui, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China; [Duan, Yong-hong] Chinese Peoples Liberat Army, Hosp 451, Dept Orthopaed Surg, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ma, J (corresponding author), Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China.	neurogao@163.com	wang, liang/GXH-6755-2022	wang, liang/0000-0002-5247-6727	National Natural Science Foundation of China [31070940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (31070940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; Farber K, 2008, MOL CELL NEUROSCI, V39, P579, DOI 10.1016/j.mcn.2008.08.005; Fan DG, 2009, CELL BIOL INT, V33, P1263, DOI 10.1016/j.cellbi.2009.08.014; GAO JX, 1995, CELL IMMUNOL, V163, P178, DOI 10.1006/cimm.1995.1114; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo YS, 2011, CELL BIOL INT, V35, P811, DOI 10.1042/CBI20100916; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kim KW, 2009, NEUROCHEM RES, V34, P1479, DOI 10.1007/s11064-009-9935-6; Kim MO, 2003, NEUROSCI LETT, V336, P93, DOI 10.1016/S0304-3940(02)01260-0; Kita D, 2001, CANCER RES, V61, P7985; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Martin S, 2009, BBA-MOL CELL RES, V1793, P354, DOI 10.1016/j.bbamcr.2008.09.019; Meng XB, 2004, J PROTEOME RES, V3, P506, DOI 10.1021/pr0340983; PACHTER JA, 1995, ANAL BIOCHEM, V230, P101, DOI 10.1006/abio.1995.1443; Roumes H, 2010, EXP CELL RES, V316, P1587, DOI 10.1016/j.yexcr.2010.02.017; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Tang J, 2009, EXP BIOL MED, V234, P35, DOI 10.3181/0806-RM-187; Thapa N, 2005, BONE, V36, P232, DOI 10.1016/j.bone.2004.08.007; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Yun SJ, 2002, MOL BRAIN RES, V107, P57, DOI 10.1016/S0169-328X(02)00447-3; Zeng BX, 2007, J REPROD IMMUNOL, V73, P1, DOI 10.1016/j.jri.2006.05.007	38	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37297	10.1371/journal.pone.0037297	http://dx.doi.org/10.1371/journal.pone.0037297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629380	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100021
J	Sharples, RJ; Moss, SE; Patterson, TA; Hammond, PS				Sharples, Ruth J.; Moss, Simon E.; Patterson, Toby A.; Hammond, Philip S.			Spatial Variation in Foraging Behaviour of a Marine Top Predator (Phoca vitulina) Determined by a Large-Scale Satellite Tagging Program	PLOS ONE			English	Article							HARBOR SEALS; MORAY-FIRTH; GRAY SEALS; SEASONAL-VARIATION; GREY SEALS; MOVEMENTS; DIET; TELEMETRY; PATTERNS; SPACE	The harbour seal (Phoca vitulina) is a widespread marine predator in Northern Hemisphere waters. British populations have been subject to rapid declines in recent years. Food supply or inter-specific competition may be implicated but basic ecological data are lacking and there are few studies of harbour seal foraging distribution and habits. In this study, satellite tagging conducted at the major seal haul outs around the British Isles showed both that seal movements were highly variable among individuals and that foraging strategy appears to be specialized within particular regions. We investigated whether these apparent differences could be explained by individual level factors: by modelling measures of trip duration and distance travelled as a function of size, sex and body condition. However, these were not found to be good predictors of foraging trip duration or distance, which instead was best predicted by tagging region, time of year and inter-trip duration. Therefore, we propose that local habitat conditions and the constraints they impose are the major determinants of foraging movements. Specifically the distance to profitable feeding grounds from suitable haul-out locations may dictate foraging strategy and behaviour. Accounting for proximity to productive foraging resources is likely to be an important component of understanding population processes. Despite more extensive offshore movements than expected, there was also marked fidelity to the local haul-out region with limited connectivity between study regions. These empirical observations of regional exchange at short time scales demonstrates the value of large scale electronic tagging programs for robust characterization of at-sea foraging behaviour at a wide spatial scale.	[Sharples, Ruth J.; Moss, Simon E.; Hammond, Philip S.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Sharples, Ruth J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Patterson, Toby A.] CSIRO Wealth Oceans Res Flagship, Hobart, Tas, Australia	University of St Andrews; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sharples, RJ (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	rjsharples@gmail.com	Patterson, Toby/B-3836-2011	Patterson, Toby/0000-0002-7150-9205; Hammond, Philip/0000-0002-2381-8302	Department of Energy and Climate Change through its Strategic Environmental Assessment programme; Natural Environment Research Council [smru10001] Funding Source: researchfish	Department of Energy and Climate Change through its Strategic Environmental Assessment programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the United Kingdom Department of Trade and Industry, now the Department of Energy and Climate Change (http://www.decc.gov.uk/) through its Strategic Environmental Assessment programme (http://www.offshore-sea..uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SM, 2004, CAN J ZOOL, V82, P1230, DOI 10.1139/Z04-093; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; BAKER JR, 1990, VET REC, V126, P75; Baxter JM, 2001, AQUAT CONSERV, V11, P261, DOI 10.1002/aqc.465; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bolt HE, 2009, AQUAT CONSERV, V19, P671, DOI 10.1002/aqc.1030; Boyd IL, 1996, CAN J ZOOL, V74, P1696, DOI 10.1139/z96-187; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Bryant E, 2007, TR01 WILDTR TEL SYST; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cunningham L, 2009, AQUATIC CONSERVATION, V19; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Estes JA, 2009, PHILOS T R SOC B, V364, P1647, DOI 10.1098/rstb.2008.0231; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; FEDAK MA, 1983, J ZOOL, V200, P298, DOI 10.1111/j.1469-7998.1983.tb05794.x; Hall AJ, 1998, MAR ECOL PROG SER, V170, P269, DOI 10.3354/meps170269; Hall AJ, 2001, J ANIM ECOL, V70, P138; HARKONEN T, 1987, J ZOOL, V213, P535; Harris CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002710; Heath MR, 2005, ICES J MAR SCI, V62, P847, DOI 10.1016/j.icesjms.2005.01.023; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; PAYNE PM, 1989, MAR MAMMAL SCI, V5, P173, DOI 10.1111/j.1748-7692.1989.tb00331.x; PIERCE GJ, 1991, J ZOOL, V223, P641, DOI 10.1111/j.1469-7998.1991.tb04393.x; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Sharples RJ, 2009, MAR ECOL PROG SER, V390, P265, DOI 10.3354/meps08232; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; THOMPSON PM, 1991, J ANIM ECOL, V60, P283, DOI 10.2307/5460; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; THOMPSON PM, 1994, J ANIM ECOL, V63, P24, DOI 10.2307/5579; Tollit DJ, 1996, CAN J ZOOL, V74, P1110, DOI 10.1139/z96-123; VanParijs SM, 1997, ANIM BEHAV, V54, P35, DOI 10.1006/anbe.1996.0426; Venebles WilliamN., 2002, MODERN APPL STAT S; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Vincent C, NAMMCO SCI PUBLICATI, V8, P285; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	52	59	59	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37216	10.1371/journal.pone.0037216	http://dx.doi.org/10.1371/journal.pone.0037216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629370	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100018
J	Wen, Q; Jin, D; Zhou, CY; Zhou, MQ; Luo, W; Ma, L				Wen, Qian; Jin, Dan; Zhou, Chao-Ying; Zhou, Ming-Qian; Luo, Wei; Ma, Li			HGF-Transgenic MSCs Can Improve the Effects of Tissue Self-Repair in a Rabbit Model of Traumatic Osteonecrosis of the Femoral Head	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AVASCULAR NECROSIS; EXPRESSION; ENDOGLIN; PROTEIN; CELLS	Background: Osteonecrosis of the femoral head (ONFH) is generally characterized as an irreversible disease and tends to cause permanent disability. Therefore, understanding the pathogenesis and molecular mechanisms of ONFH and developing effective therapeutic methods is critical for slowing the progress of the disease. Methodology/Principal Findings: In this study, an experimental rabbit model of early stage traumatic ONFH was established, validated, and used for an evaluation of therapy. Computed tomography (CT) and magnetic resonance (MR) imaging confirmed that this model represents clinical Association Research Circulation Osseous (ARCO) phase I or II ONFH, which was also confirmed by the presence of significant tissue damage in osseous tissue and vasculature. Pathological examination detected obvious self-repair of bone tissue up to 2 weeks after trauma, as indicated by revascularization (marked by CD105) and expression of collagen type I (Col I), osteocalcin, and proliferating cell nuclear antigen. Transplantation of hepatocyte growth factor (HGF)-transgenic mesenchymal stem cells (MSCs) 1 week after trauma promoted recovery from ONFH, as evidenced by a reversed pattern of Col I expression compared with animals receiving no therapeutic treatment, as well as increased expression of vascular endothelial growth factor. Conclusions/Significance: These results indicate that the transplantation of HGF-transgenic MSCs is a promising method for the treatment for ONFH and suggest that appropriate interference therapy during the tissue self-repair stage contributes to the positive outcomes. This study also provides a model for the further study of the ONFH etiology and therapeutic interventions.	[Wen, Qian; Zhou, Chao-Ying; Zhou, Ming-Qian; Luo, Wei; Ma, Li] So Med Univ, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China; [Jin, Dan] So Med Univ, Dept Orthopaed & Traumatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Wen, Q (corresponding author), So Med Univ, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China.	maryhmz@126.com		Ma, Li/0000-0001-5847-2375; Zhou, Chao-ying/0000-0002-4188-9630	Cooperation Project in Industry, Education and Research of Guangdong province; Ministry of Education of People's Republic of China [2011B090400013]; Science and Technology Project of Guangzhou [2009Z1-E441]; State 863 Projects [2007AA02Z458]	Cooperation Project in Industry, Education and Research of Guangdong province; Ministry of Education of People's Republic of China(Ministry of Education, China); Science and Technology Project of Guangzhou; State 863 Projects(National High Technology Research and Development Program of China)	This work was supported by the Cooperation Project in Industry, Education and Research of Guangdong province and Ministry of Education of People's Republic of China (2011B090400013), Science and Technology Project of Guangzhou (2009Z1-E441) and State 863 Projects (2007AA02Z458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, ARCO NEWS; Arabmotlagh M, 2006, J ARTHROPLASTY, V21, P129, DOI 10.1016/j.arth.2005.04.014; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Barkalow Fern J., 1996, Microcirculation (Philadelphia), V3, P19, DOI 10.3109/10739689609146779; Dahners L E, 1989, J Orthop Trauma, V3, P309, DOI 10.1097/00005131-198912000-00009; Daltro Gildásio Cerqueira, 2008, Acta ortop. bras., V16, P23, DOI 10.1590/S1413-78522008000100004; Dong G, 2001, CANCER RES, V61, P5911; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; FREEMAN MAR, 1969, P ROY SOC MED, V62, P431, DOI 10.1177/003591576906200508; Gangji V, 2004, J BONE JOINT SURG AM, V86A, P1153, DOI 10.2106/00004623-200406000-00006; Gardeniers J, 1991, ARCO NEWS LETT, P153; Gardeniers JW, 1993, ARCO NEWS LETT, V5, P79; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P283; Huffman KM, 2007, RHEUMATOLOGY, V46, P523, DOI 10.1093/rheumatology/kel302; INOUE A, 1979, J BONE JOINT SURG BR, V61, P138, DOI 10.1302/0301-620X.61B2.438261; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Kusumi Tomomi, 2004, Nihon Rinsho, V62 Suppl 2, P136; Li CG, 2000, INT J CANCER, V89, P122, DOI 10.1002/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M; MALIZOS KN, 1993, J ORTHOP RES, V11, P350, DOI 10.1002/jor.1100110306; Minhajat R, 2006, PATHOL INT, V56, P717, DOI 10.1111/j.1440-1827.2006.02037.x; Mont MA, 2001, J BONE JOINT SURG AM, V83A, P1013, DOI 10.2106/00004623-200107000-00006; NADEL SN, 1992, AM J ROENTGENOL, V159, P1255, DOI 10.2214/ajr.159.6.1442396; Nakamura T, 1997, CLIN ORTHOP RELAT R, P68; Nishino M, 1997, ARCH ORTHOP TRAUM SU, V116, P259, DOI 10.1007/BF00390048; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Sengupta S, 2003, CIRCULATION, V107, P2955, DOI 10.1161/01.CIR.0000077501.19266.E5; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Van Belle E, 1998, CIRCULATION, V97, P381; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wen Q, 2008, GENE THER, V15, P1523, DOI 10.1038/gt.2008.110; Wen Q, 2012, J CELL MOL MED, V16, P1260, DOI 10.1111/j.1582-4934.2011.01407.x; Wojta J, 1999, LAB INVEST, V79, P427; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012	34	19	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37503	10.1371/journal.pone.0037503	http://dx.doi.org/10.1371/journal.pone.0037503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629409	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100037
J	Abraham, F; Sacerdoti, F; De Leon, R; Gentile, T; Canellada, A				Abraham, Florencia; Sacerdoti, Flavia; De Leon, Romina; Gentile, Teresa; Canellada, Andrea			Angiotensin II Activates the Calcineurin/NFAT Signaling Pathway and Induces Cyclooxygenase-2 Expression in Rat Endometrial Stromal Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; NUCLEAR-FACTOR; T-CELLS; TRANSCRIPTIONAL REGULATION; CYCLOSPORINE-A; TNF-ALPHA; COX-2; BLASTOCYST; INDUCTION; GENE	Cyclooxygenase (COX)-2, the inducible isoform of cyclooxygenase, plays a role in the process of uterine decidualization and blastocyst attachment. On the other hand, overexpression of COX-2 is involved in the proliferation of the endometrial tissue during endometriosis. Deregulation of the renin-angiotensin-system plays a role in the pathophysiology of endometriosis and pre-eclampsia. Angiotensin II increases intracellular Ca2+ concentration by targeting phospholypase C-gamma in endometrial stromal cells (ESC). A key element of the cellular response to Ca2+ signals is the activity of the Ca2+ - and calmodulin-dependent phosphatase calcineurin. Our first aim was to study whether angiotensin II stimulated Cox-2 gene expression in rat ESC and to analyze whether calcineurin activity was involved. In cells isolated from non-pregnant uteri, COX-2 expression -both mRNA and protein-was induced by co-stimulation with phorbol ester and calcium ionophore (PIo), as well as by angiotensin II. Pretreatment with the calcineurin inhibitor cyclosporin A inhibited this induction. We further analyzed the role of the calcineurin/NFAT signaling pathway in the induction of Cox-2 gene expression in non-pregnant rat ESC. Cyclosporin A abolished NFATc1 dephosphorylation and translocation to the nucleus. Cyclosporin A also inhibited the transcriptional activity driven by the Cox-2 promoter. Exogenous expression of the peptide VIVIT-specific inhibitor of calcineurin/NFAT binding-blocked the activation of Cox-2 promoter and the up-regulation of COX-2 protein in these cells. Finally we analyzed Cox-2 gene expression in ESC of early-pregnant rats. COX-2 expression -both mRNA and protein-was induced by stimulation with PIo as well as by angiotensin II. This induction appears to be calcineurin independent, since it was not abrogated by cyclosporin A. In conclusion, angiotensin II induced Cox-2 gene expression by activating the calcineurin/NFAT signaling pathway in endometrial stromal cells of non-pregnant but not of early-pregnant rats. These results might be related to differential roles that COX-2 plays in the endometrium.	[Abraham, Florencia; Sacerdoti, Flavia; De Leon, Romina; Gentile, Teresa; Canellada, Andrea] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral Prof Ricardo A Ma, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Abraham, F (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral Prof Ricardo A Ma, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina.	acanell@ffyb.uba.ar		Sacerdoti, Flavia/0000-0002-8480-756X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 20092011]; Universidad de Buenos Aires [UBACyT-B406, UBACyT-B118]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; www.conicet.gov.ar) (PIP 20092011) and Universidad de Buenos Aires (UBACyT-B406) and (UBACyT-B118; www.uba.ar). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braileanu GT, 2002, REPROD FERT DEVELOP, V14, P199, DOI 10.1071/RD02003; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Chen CC, 2000, J IMMUNOL, V165, P2719, DOI 10.4049/jimmunol.165.5.2719; Cong J, 2006, REPRODUCTION, V131, P139, DOI 10.1530/rep.1.00861; Cook IH, 2010, MOL HUM REPROD, V16, P158, DOI 10.1093/molehr/gap084; Corral RS, 2007, ONCOGENE, V26, P958, DOI 10.1038/sj.onc.1209856; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Derecka K, 2008, MOL CELL ENDOCRINOL, V287, P65, DOI 10.1016/j.mce.2008.02.015; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ebert AD, 2005, EUR J OBSTET GYN R B, V122, P144, DOI 10.1016/j.ejogrb.2005.04.017; Erol AYG, 2012, J MATERN-FETAL NEO M, V25, P826, DOI 10.3109/14767058.2011.595853; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Garavito RM, 1999, BBA-MOL CELL BIOL L, V1441, P278, DOI 10.1016/S1388-1981(99)00147-X; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; GRIENDLING KK, 1988, CLIN EXP PHARMACOL P, V15, P105, DOI 10.1111/j.1440-1681.1988.tb01051.x; Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x; Harris RC, 2003, ACTA PHYSIOL SCAND, V177, P423, DOI 10.1046/j.1365-201X.2003.01101.x; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hernandez J, 2002, AM J PHYSIOL-RENAL, V282, pF592, DOI 10.1152/ajprenal.00194.2001; Herse F, 2007, HYPERTENSION, V49, P604, DOI 10.1161/01.HYP.0000257797.49289.71; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Hsieh YY, 2005, MOL HUM REPROD, V11, P11, DOI 10.1093/molehr/gah131; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Inoue H, 1998, BIOCHEM BIOPH RES CO, V244, P143, DOI 10.1006/bbrc.1998.8222; Jaimes EA, 2005, KIDNEY INT, V68, P2143, DOI 10.1111/j.1523-1755.2005.00670.x; Kelly RW, 2001, REPRODUCTION, V121, P3, DOI 10.1530/rep.0.1210003; KENNEDY TG, 1993, PROSTAG OTH LIPID M, V46, P243, DOI 10.1016/0090-6980(93)90007-T; KENNEDY TG, 1980, BIOL REPROD, V23, P955, DOI 10.1095/biolreprod23.5.955; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu ZT, 2004, EXP CELL RES, V296, P317, DOI 10.1016/j.yexcr.2004.02.006; Maldonado-Perez D, 2009, BBA-MOL CELL RES, V1793, P1315, DOI 10.1016/j.bbamcr.2009.03.008; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Matsumoto Y, 2001, INT J MOL MED, V8, P31; McGiff JC, 2002, J PHYSIOL PHARMACOL, V53, P525; Nakamura H, 2004, AM J REPROD IMMUNOL, V51, P16, DOI 10.1046/j.8755-8920.2003.00116.x; Page M, 2002, J REPROD IMMUNOL, V54, P1, DOI 10.1016/S0165-0378(01)00122-X; Pham H, 2008, J CELL PHYSIOL, V214, P96, DOI 10.1002/jcp.21167; Sales KJ, 2010, AM J PATHOL, V176, P435, DOI 10.2353/ajpath.2010.090403; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; Schroer K, 2002, CIRCULATION, V105, P2760, DOI 10.1161/01.CIR.0000018127.10968.34; Shah DM, 2006, CURR HYPERTENS REP, V8, P144, DOI 10.1007/s11906-006-0011-1; Shah TJ, 2007, AM J OBSTET GYNECOL, V196, P48, DOI 10.1016/j.ajog.2006.08.038; SIROIS J, 1993, J BIOL CHEM, V268, P21931; Sobolewski Cyril, 2010, Int J Cell Biol, V2010, P215158, DOI 10.1155/2010/215158; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; SQUIRES PM, 1992, J REPROD FERTIL, V95, P791, DOI 10.1530/jrf.0.0950791; St-Louis I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-103; Sugimoto T, 2001, J AM SOC NEPHROL, V12, P1359, DOI 10.1681/ASN.V1271359; Tabata C, 2009, AM J REPROD IMMUNOL, V62, P44, DOI 10.1111/j.1600-0897.2009.00710.x; Wang J, 2007, DEV BIOL, V302, P143, DOI 10.1016/j.ydbio.2006.09.015; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xia Y, 2003, J SOC GYNECOL INVEST, V10, P82, DOI 10.1016/S1071-5576(02)00259-9; Xia Y, 2002, J BIOL CHEM, V277, P24601, DOI 10.1074/jbc.M201369200; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Young JL, 2008, GYNECOL ONCOL, V109, P140, DOI 10.1016/j.ygyno.2008.01.008	68	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37750	10.1371/journal.pone.0037750	http://dx.doi.org/10.1371/journal.pone.0037750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662209	Green Published, gold			2022-12-27	WOS:000305342300099
J	Essig, S; von der Weid, NX; Strippoli, MPF; Rebholz, CE; Michel, G; Rueegg, CS; Niggli, FK; Kuehni, CE				Essig, Stefan; von der Weid, Nicolas X.; Strippoli, Marie-Pierre F.; Rebholz, Cornelia E.; Michel, Gisela; Rueegg, Corina S.; Niggli, Felix K.; Kuehni, Claudia E.		Swiss Pediat Oncology Grp SPOG	Health-Related Quality of Life in Long-Term Survivors of Relapsed Childhood Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ADULT SURVIVORS; CANCER SURVIVOR; FOLLOW-UP; ADOLESCENT; TRANSLATION; US	Background: Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Approximately one-third of these children can be cured. Their risk for late effects is high because of intensified treatment, but their health-related quality of life (HRQOL) was largely unmeasured. Our aim was to compare HRQOL of ALL survivors with the general population, and of relapsed with non-relapsed ALL survivors. Methodology/Principal Findings: As part of the Swiss Childhood Cancer Survivor Study (SCCSS) we sent a questionnaire to all ALL survivors in Switzerland who had been diagnosed between 1976-2003 at age <16 years, survived >= 5 years, and were currently aged >= 16 years. HRQOL was assessed with the Short Form-36 (SF-36), which measures four aspects of physical health and four aspects of mental health. A score of 50 corresponded to the mean of a healthy reference population. We analyzed data from 457 ALL survivors (response: 79%). Sixty-one survivors had suffered a relapse. Compared to the general population, ALL survivors reported similar or higher HRQOL scores on all scales. Survivors with a relapse scored lower in general health perceptions (51.6) compared to those without (55.8; p = 0.005), but after adjusting for self-reported late effects, this difference disappeared. Conclusion/Significance: Compared to population norms, ALL survivors reported good HRQOL, even after a relapse. However, relapsed ALL survivors reported poorer general health than non-relapsed. Therefore, we encourage specialists to screen for poor general health in survivors after a relapse and, when appropriate, specifically seek and treat underlying late effects. This will help to improve patients' HRQOL.	[Essig, Stefan; Strippoli, Marie-Pierre F.; Rebholz, Cornelia E.; Michel, Gisela; Rueegg, Corina S.; Kuehni, Claudia E.] Univ Bern, Swiss Childhood Canc Registry, Inst Social & Prevent Med, Bern, Switzerland; [von der Weid, Nicolas X.] CHU Vaudois, Paediat Hematol Oncol Unit, CH-1011 Lausanne, Switzerland; [Niggli, Felix K.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University Children's Hospital Zurich	Essig, S (corresponding author), Univ Bern, Swiss Childhood Canc Registry, Inst Social & Prevent Med, Bern, Switzerland.	kuehni@ispm.unibe.ch	Strippoli, Marie-Pierre F/K-8164-2013; Rueegg, Corina Silvia/H-7128-2019; Michel, Gisela/G-1081-2018; Niggli, Felix/L-6547-2017	Strippoli, Marie-Pierre F/0000-0003-3053-484X; Rueegg, Corina Silvia/0000-0003-3720-4659; Michel, Gisela/0000-0002-9589-0928; Niggli, Felix/0000-0002-7553-3712; Essig, Stefan/0000-0003-3228-7010; Kuehni, Claudia E./0000-0001-8957-2002; Leibundgut, Kurt/0000-0003-2514-6041	Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008, KLS 02631-08-2010]; Wyeth Foundation; Bernese Cancer League; Cancer League Zurich; Swiss Bridge; Stiftung fur Krebsbekampfung; Cancer Research Switzerland [KFS-02606-06-2010]; Swiss National Science Foundation [PA001-117433/1, PZ00P3-121682/1, 323630-133897]; Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Swiss Conference of the Cantonal Ministers of Public Health	Swiss Cancer League; Wyeth Foundation(Wyeth); Bernese Cancer League; Cancer League Zurich; Swiss Bridge; Stiftung fur Krebsbekampfung; Cancer Research Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Swiss Conference of the Cantonal Ministers of Public Health	Swiss Cancer League (Grant No KLS-01605-10-2004, KLS-2215-02-2008 and KLS 02631-08-2010) http://www.krebsliga.ch/. Wyeth Foundation http://www.fondation-ch.org/. Bernese Cancer League http://www.bernischekrebsliga.ch/. Cancer League Zurich http://www.krebsliga-zh.ch/. Swiss Bridge http://www.swissbridge.ch/. Stiftung fur Krebsbekampfung http://www.krebsbekaempfung.ch/. Cancer Research Switzerland (Grant No KFS-02606-06-2010) http://www.krebsforschung.ch/. Swiss National Science Foundation (Grant No PA001-117433/1, PZ00P3-121682/1, 323630-133897) http://www.snf.ch/. Swiss Pediatric Oncology Group http://www.spog.ch/. Kinderkrebshilfe Schweiz http://www.kinderkrebshilfe.ch/. Stiftung fur krebskranke Kinder Regio Basiliensis http://www.krebskrankekinder.ch/. Swiss Conference of the Cantonal Ministers of Public Health http://www.gdk-cds.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Asner S, 2008, PEDIATR BLOOD CANCER, V51, P118, DOI 10.1002/pbc.21496; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Bellach B M, 1999, Gesundheitswesen, V61 Spec No, pS55; Bullinger M., 2000, BUNDESGESUNDHEITSBLA, V43, P190, DOI DOI 10.1007/S001030050034; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Filipp S-H, 1991, PRAXIS KLIN VERHALTE, V4, P274; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Gaynon PS, 1998, CANCER, V82, P1387, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1; Germann U, 2005, EIDGENOSSISCHE VOLKS; Goldsby RE, 2010, J CLIN ONCOL, V28, P324, DOI 10.1200/JCO.2009.22.5060; Harila MJ, 2010, PEDIATR BLOOD CANCER, V55, P331, DOI 10.1002/pbc.22531; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Kuehni CE, 2011, INT J EPIDE IN PRESS; Kuehni CE, 2011, CANCER IN PRESS; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Linabery AM, 2008, CANCER-AM CANCER SOC, V113, P2575, DOI 10.1002/cncr.23866; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Maunsell E, 2006, J CLIN ONCOL, V24, P2527, DOI 10.1200/JCO.2005.03.9297; Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129; Michel G, 2007, SWISS MED WKLY, V137, P502; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Moe PJ, 1997, PEDIATR HEMAT ONCOL, V14, P513, DOI 10.3109/08880019709030908; Morfeld M, 2005, SOZ PRAVENTIV MED, V50, P292, DOI 10.1007/s00038-005-4090-6; O'Leary TE, 2007, QUAL LIFE RES, V16, P1211, DOI 10.1007/s11136-007-9231-3; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Parry C, 2005, QUAL HEALTH RES, V15, P1055, DOI 10.1177/1049732305277860; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Reulen RC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-77; Reulen RC, 2007, INT J CANCER, V121, P633, DOI 10.1002/ijc.22658; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Sprangers MAG, 1999, ANN ONCOL, V10, P747, DOI 10.1023/A:1008305523548; Stam H, 2006, PSYCHO-ONCOLOGY, V15, P31, DOI 10.1002/pon.920; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Zebrack BJ, 2002, PSYCHO-ONCOLOGY, V11, P132, DOI 10.1002/pon.569; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	40	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38015	10.1371/journal.pone.0038015	http://dx.doi.org/10.1371/journal.pone.0038015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662262	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305342300154
J	Gandhi, S; Vaarmann, A; Yao, Z; Duchen, MR; Wood, NW; Abramov, AY				Gandhi, Sonia; Vaarmann, Annika; Yao, Zhi; Duchen, Michael R.; Wood, Nicholas W.; Abramov, Andrey Y.			Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; MONOAMINE-OXIDASE; CYCLOSPORINE-A; CALCIUM; NEURONS; VULNERABILITY; METABOLISM; MUTATIONS	Background: Parkinson's disease is a common neurodegenerative disease characterised by progressive loss of dopaminergic neurons, leading to dopamine depletion in the striatum. Mutations in the PINK1 gene cause an autosomal recessive form of Parkinson's disease. Loss of PINK1 function causes mitochondrial dysfunction, increased reactive oxygen species production and calcium dysregulation, which increases susceptibility to neuronal death in Parkinson's disease. The basis of neuronal vulnerability to dopamine in Parkinson's disease is not well understood. Methodology: We investigated the mechanism of dopamine induced cell death in transgenic PINK1 knockout mouse neurons. We show that dopamine results in mitochondrial depolarisation caused by mitochondrial permeability transition pore (mPTP) opening. Dopamine-induced mPTP opening is dependent on a complex of reactive oxygen species production and calcium signalling. Dopamine-induced mPTP opening, and dopamine-induced cell death, could be prevented by inhibition of reactive oxygen species production, by provision of respiratory chain substrates, and by alteration in calcium signalling. Conclusions: These data demonstrate the mechanism of dopamine toxicity in PINK1 deficient neurons, and suggest potential therapeutic strategies for neuroprotection in Parkinson's disease.	[Gandhi, Sonia; Vaarmann, Annika; Yao, Zhi; Wood, Nicholas W.; Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London, England	University of London; University College London; University of London; University College London	Gandhi, S (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London, England.	a.abramov@ucl.ac.uk	Abramov, Andrey/AAC-6712-2019; Wood, Nicholas W/C-2505-2009; YAO, Zhi/C-6096-2009; duchen, michael/A-2116-2009; Abramov, Andrey Y/H-9053-2012; Vaarmann, Annika/AAH-7289-2021; Yao, Zhi/B-9047-2013	Abramov, Andrey/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348; duchen, michael/0000-0003-2548-4294; Abramov, Andrey Y/0000-0002-7646-7235; Vaarmann, Annika/0000-0003-0296-8325; Yao, Zhi/0000-0001-6432-5734	The Wellcome Trust/MRC strategic award; Academy of Medical Sciences (AMS) [AMS-SGCL5-Gandhi] Funding Source: researchfish; Medical Research Council [MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [G-0612, F-0806, G-1101] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI	The Wellcome Trust/MRC strategic award; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AYA is a Parkinson's UK Senior Research Fellow. SG was a Wellcome Trust Clinical Research Fellow. NWW, AYA and MD are supported by The Wellcome Trust/MRC strategic award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Burchell VS, 2010, EXPERT OPIN THER TAR, V14, P369, DOI 10.1517/14728221003652489; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chu CT, 2010, BBA-MOL BASIS DIS, V1802, P20, DOI 10.1016/j.bbadis.2009.06.012; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Das UN, 2006, NUTRITION, V22, P965, DOI 10.1016/j.nut.2006.05.009; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Szabadkai G, 2007, CHAPERONES PARTS ORG, P64; Vaarmann A, 2010, CELL CALCIUM, V48, P176, DOI 10.1016/j.ceca.2010.08.008; Vaarmann A, 2010, J BIOL CHEM, V285, P25018, DOI 10.1074/jbc.M110.111450; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464	22	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37564	10.1371/journal.pone.0037564	http://dx.doi.org/10.1371/journal.pone.0037564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662171	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300061
J	Kostopoulou, F; Gkretsi, V; Malizos, KN; Iliopoulos, D; Oikonomou, P; Poultsides, L; Tsezou, A				Kostopoulou, Fotini; Gkretsi, Vasiliki; Malizos, Konstantinos N.; Iliopoulos, Dimitrios; Oikonomou, Pagona; Poultsides, Lazaros; Tsezou, Aspasia			Central Role of SREBP-2 in the Pathogenesis of Osteoarthritis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; LEUCINE ZIPPER PROTEIN; EXPRESSION; GENE; TRANSCRIPTION; CHOLESTEROL; IDENTIFICATION; (SREBP)-2; COMPLEX; OBESITY	Background: Recent studies have implied that osteoarthritis (OA) is a metabolic disease linked to deregulation of genes involved in lipid metabolism and cholesterol efflux. Sterol Regulatory Element Binding Proteins (SREBPs) are transcription factors regulating lipid metabolism with so far no association with OA. Our aim was to test the hypothesis that SREBP-2, a gene that plays a key role in cholesterol homeostasis, is crucially involved in OA pathogenesis and to identify possible mechanisms of action. Methodology/Principal Findings: We performed a genetic association analysis using a cohort of 1,410 Greek OA patients and healthy controls and found significant association between single nucleotide polymorphism (SNP) 1784G>C in SREBP-2 gene and OA development. Moreover, the above SNP was functionally active, as normal chondrocytes' transfection with SREBP-2-G/C plasmid resulted in interleukin-1 beta and metalloproteinase-13 (MMP-13) upregulation. We also evaluated SREBP-2, its target gene 3-hydroxy-3-methylglutaryl-coenzymeA reductase (HMGCR), phospho-phosphoinositide3-kinase (PI3K), phospho-Akt, integrin-alphaV (ITGAV) and transforming growth factor-beta (TGF-beta) mRNA and protein expression levels in osteoarthritic and normal chondrocytes and found that they were all significantly elevated in OA chondrocytes. To test whether TGF-beta alone can induce SREBP-2, we treated normal chondrocytes with TGF-beta and found significant upregulation of SREBP-2, HMGCR, phospho-PI3K and MMP-13. We also showed that TGF-beta activated aggrecan (ACAN) in chondrocytes only through Smad3, which interacts with SREBP-2. Finally, we examined the effect of an integrin inhibitor, cyclo-RGDFV peptide, on osteoarthritic chondrocytes, and found that it resulted in significant upregulation of ACAN and downregulation of SREBP-2, HMGCR, phospho-PI3K and MMP-13 expression levels. Conclusions/Significance: We demonstrated, for the first time, the association of SREBP-2 with OA pathogenesis and provided evidence on the molecular mechanism involved. We suggest that TGF-beta induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.	[Kostopoulou, Fotini; Tsezou, Aspasia] Univ Thessaly, Dept Cytogenet & Mol Genet, Sch Med, Larisa, Greece; [Kostopoulou, Fotini; Gkretsi, Vasiliki; Malizos, Konstantinos N.; Oikonomou, Pagona; Tsezou, Aspasia] Ctr Res & Technol Thessaly, Inst Biomed Res & Technol, Larisa, Greece; [Malizos, Konstantinos N.; Poultsides, Lazaros] Univ Thessaly, Dept Orthopaed, Sch Med, Larisa, Greece; [Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Tsezou, Aspasia] Univ Thessaly, Dept Biol, Sch Med, Larisa, Greece	University of Thessaly; University of Thessaly; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Thessaly	Kostopoulou, F (corresponding author), Univ Thessaly, Dept Cytogenet & Mol Genet, Sch Med, Larisa, Greece.	atsezou@med.uth.gr	Iliopoulos, Dimitrios/AAE-9106-2019; Gkretsi, Vasiliki/Q-2158-2019	Gkretsi, Vasiliki/0000-0002-3671-4078	Hellenic Society of Orthopaedic Surgery and Traumatology	Hellenic Society of Orthopaedic Surgery and Traumatology	The present study was financed by the Hellenic Society of Orthopaedic Surgery and Traumatology. No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aspden RM, 2001, LANCET, V357, P1118, DOI 10.1016/S0140-6736(00)04264-1; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; Davidson ENB, 2010, ARTHRITIS RES THER, V12, P1; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Gkretsi V, 2011, PROG LIPID RES, V50, P133, DOI 10.1016/j.plipres.2010.11.001; Grimsby S, 2004, FEBS LETT, V577, P93, DOI 10.1016/j.febslet.2004.09.069; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Gylling Helena, 2005, Curr Atheroscler Rep, V7, P466, DOI 10.1007/s11883-005-0064-7; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Laaksonen R, 2006, ATHEROSCLEROSIS, V185, P206, DOI 10.1016/j.atherosclerosis.2005.06.007; Liu XL, 2010, ATHEROSCLEROSIS, V208, P421, DOI 10.1016/j.atherosclerosis.2009.08.011; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Miserez AR, 2001, AIDS, V15, P2045, DOI 10.1097/00002030-200110190-00020; Muller PY, 2002, J MED GENET, V39, P271, DOI 10.1136/jmg.39.4.271; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Robinet P, 2003, ATHEROSCLEROSIS, V168, P381, DOI 10.1016/S0021-9150(03)00144-8; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakao K, 2009, J ORTHOP SCI, V14, P738, DOI 10.1007/s00776-009-1401-4; Schiphof D, 2008, ANN RHEUM DIS, V67, P1034, DOI 10.1136/ard.2007.079020; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Simopoulou T, 2007, CLIN EXP RHEUMATOL, V25, P605; Simopoulou T, 2010, J ORTHOP RES, V28, P110, DOI 10.1002/jor.20953; Sowers M, 2001, CURR OPIN RHEUMATOL, V13, P447, DOI 10.1097/00002281-200109000-00018; Tsezou A, 2010, J ORTHOP RES, V28, P1033, DOI 10.1002/jor.21084; VANSAASE JLCM, 1988, J RHEUMATOL, V15, P1152; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	38	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35753	10.1371/journal.pone.0035753	http://dx.doi.org/10.1371/journal.pone.0035753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662110	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300005
J	Lopez-Lopez, P; Sara, M; Di Vittorio, M				Lopez-Lopez, Pascual; Sara, Maurizio; Di Vittorio, Massimiliano			Living on the Edge: Assessing the Extinction Risk of Critically Endangered Bonelli's Eagle in Italy	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; HIERAAETUS-FASCIATUS; TOP PREDATORS; CONSERVATION; MANAGEMENT; DEMOGRAPHY; SURVIVAL; DENSITY; BIOLOGY; MODELS	Background: The population of Bonelli's eagle (Aquila fasciata) has declined drastically throughout its European range due to habitat degradation and unnatural elevated mortality. There are less than 1500 breeding pairs accounted for in Europe, and the species is currently catalogued as Critically Endangered in Italy, where the 22 territories of Sicily, represent nearly 95% of the entire Italian population. However, despite national and European conservation concerns, the species currently lacks a specific conservation plan, and no previous attempts to estimate the risk of extinction have been made. Methodology/Principal Findings: We incorporated the most updated demographic information available to assess the extinction risk of endangered Bonelli's eagle in Italy through a Population Viability Analysis. Using perturbation analyses (sensitivity and elasticity), and a combination of demographic data obtained from an assortment of independent methods, we evaluated which demographic parameters have more influence on the population's fate. We also simulated different scenarios to explore the effects of possible management actions. Our results showed that under the current conditions, Bonelli's eagle is expected to become extinct in Italy in less than 50 years. Stand-alone juvenile mortality was the most critical demographic parameter with the strongest influence on population persistence with respect to other demographic parameters. Measures aimed at either decreasing juvenile mortality, adult mortality or decreasing both juvenile and adult mortality resulted in equivalent net positive effects on population persistence (population growth rate lambda>1). In contrast, changes aimed at increasing breeding success had limited positive effects on demographic trends. Conclusions/Significance: Our PVA provides essential information to direct the decision-making process and exposes gaps in our previous knowledge. To ensure the long-term persistence of the species in Italy, measures are urgently needed to decrease both adult mortality due to poaching and juvenile mortality due to nest plundering, the top ranking mortality causes.	[Lopez-Lopez, Pascual] Univ Alicante, Vertebrates Zool Res Grp, E-03080 Alicante, Spain; [Sara, Maurizio; Di Vittorio, Massimiliano] Univ Palermo, Dept Environm Biol & Biodivers, Palermo, Italy	Universitat d'Alacant; University of Palermo	Lopez-Lopez, P (corresponding author), Univ Alicante, Vertebrates Zool Res Grp, E-03080 Alicante, Spain.	Pascual.Lopez@uv.es	Sarà, Maurizio/H-2662-2012; López-López, Pascual/C-1039-2011	Sarà, Maurizio/0000-0003-4274-422X; López-López, Pascual/0000-0001-5269-652X	"Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]	"Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness	PLL is supported by a "Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (reference JCI-2011-09588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Arrigoni degliOddi E., 1929, ORNITOLOGIA ITALIANA; Arroyo B, 1997, EUROPEAN UNION ACTIO; Barov B., 2011, REV IMPLEMENTATION S; Beissinger S. R., 2002, POPULATION VIABILITY; BirdLife International, 2011, IUCN RED LIST BIRDS; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Cadahia L, 2010, EUR J WILDLIFE RES, V56, P923, DOI 10.1007/s10344-010-0391-z; Calvario E., 1999, NEW RED LISTS BREEDI; Carrascal LM, 2009, ECOL RES, V24, P565, DOI 10.1007/s11284-008-0527-8; Carrete M, 2005, OIKOS, V108, P125, DOI 10.1111/j.0030-1299.2005.12942.x; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; Christie D ., 2001, RAPTORS BIRDS PREY W; Cortone P., 1987, Supplemento alle Ricerche di Biologia della Selvaggina, V12, P57; Di Vittorio M, 2007, THESIS U STUDI PALER; Di Vittorio M, 2012, BIRD STUDY, V59, P207, DOI 10.1080/00063657.2012.656577; DisVittorio M., 2000, ALULA, V7, P57; Doderlein P, 1869, AVIFAUNA MODENESE SI; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FERRER M, 1991, WILDLIFE SOC B, V19, P436; FERRER M, 1990, BIOL CONSERV, V51, P151, DOI 10.1016/0006-3207(90)90109-3; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Ferrer M, 2009, CONSERV BIOL, V23, P1017, DOI 10.1111/j.1523-1739.2009.01215.x; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fujiwara M, 2007, ECOLOGY, V88, P2345, DOI 10.1890/06-1405.1; Garcia-Ripolles C, 2011, J ORNITHOL, V152, P879, DOI 10.1007/s10336-011-0671-8; HARRIS R B, 1987, Conservation Biology, V1, P72, DOI 10.1111/j.1523-1739.1987.tb00011.x; Heppell S, 2000, ECOLOGY, V81, P605, DOI 10.1890/0012-9658(2000)081[0605:EAIPBM]2.0.CO;2; Hernandez-Matias A, 2011, P INT C MONTP FRANC, P23; Hernandez-Matias A, 2011, IBIS, V153, P846, DOI 10.1111/j.1474-919X.2011.01158.x; Hernandez-Matias A, 2011, J WILDLIFE MANAGE, V75, P856, DOI 10.1002/jwmg.102; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Lo Valvo M., 1992, FAUNA ITALIA, P616; Lopez-Lopez P, 2006, J ORNITHOL, V147, P97, DOI 10.1007/s10336-005-0019-3; Lopez-Lopez P, 2010, ITAL J ZOOL, V77, P289, DOI 10.1080/11250000902950637; Lopez-Lopez P, 2007, BIODIVERS CONSERV, V16, P3755, DOI 10.1007/s10531-007-9179-1; Lopez-Lopez P, 2007, BIRD STUDY, V54, P335, DOI 10.1080/00063650709461493; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; Lubben J, 2008, BIOL CONSERV, V141, P517, DOI 10.1016/j.biocon.2007.11.003; Massa B., 1983, LAVORI SOC ITALIANA, V8, P757; Massa B, 1985, NATURALISTA SICIL, P9; McDonald-Madden E, 2010, ECOL APPL, V20, P1476, DOI 10.1890/09-0647.1; McGowan CP, 2011, BIOL CONSERV, V144, P1400, DOI 10.1016/j.biocon.2011.01.005; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Miller PS., 2005, VORTEX STOCHASTIC SI; Moleon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022851; Morris W. F., 2002, QUANTITATIVE CONSERV; Naujokaitis-Lewis IR, 2009, CONSERV BIOL, V23, P225, DOI 10.1111/j.1523-1739.2008.01066.x; NORTON TW, 1995, BIOL CONSERV, V73, P91, DOI 10.1016/0006-3207(95)90027-6; Ontiveros D, 2005, BIOL CONSERV, V123, P19, DOI 10.1016/j.biocon.2004.10.004; Ontiveros D, 2004, ARDEOLA, V51, P461; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Pascual LL, 2011, ACTA OECOL, V37, P399, DOI 10.1016/j.actao.2011.05.004; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Ponchon C., 2011, CONSERVATION AIGLE B, P14; Primack RB, 2010, ESSENTIALS OF CONSERVATION BIOLOGY, FIFTH EDITION, P1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Real J, 1997, BIOL CONSERV, V79, P59, DOI 10.1016/S0006-3207(96)00100-0; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Scher O, 2011, P INT C MONTP INT C; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; Steenhof K., 2007, RAPTOR RES MANAGEMEN, P181; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Wintle BA, 2010, ECOL LETT, V13, P1325, DOI 10.1111/j.1461-0248.2010.01514.x	73	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37862	10.1371/journal.pone.0037862	http://dx.doi.org/10.1371/journal.pone.0037862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662239	Green Published, gold			2022-12-27	WOS:000305342300129
J	Tran, VG; Court, F; Duputie, A; Antoine, E; Aptel, N; Milligan, L; Carbonell, F; Lelay-Taha, MN; Piette, J; Weber, M; Montarras, D; Pinset, C; Dandolo, L; Forne, T; Cathala, G				Van Giang Tran; Court, Franck; Duputie, Anne; Antoine, Etienne; Aptel, Nathalie; Milligan, Laura; Carbonell, Francoise; Lelay-Taha, Marie-Noelle; Piette, Jacques; Weber, Michael; Montarras, Didier; Pinset, Christian; Dandolo, Luisa; Forne, Thierry; Cathala, Guy			H19 Antisense RNA Can Up-Regulate Igf2 Transcription by Activation of a Novel Promoter in Mouse Myoblasts	PLOS ONE			English	Article							LONG NONCODING RNA; TUMOR-SUPPRESSOR; IMPRINTED GENES; METHYLATED REGION; WILMS-TUMOR; IN-VIVO; EXPRESSION; LOCUS; CANCER; CELLS	It was recently shown that a long non-coding RNA (lncRNA), that we named the 91H RNA (i.e. antisense H19 transcript), is overexpressed in human breast tumours and contributes in trans to the expression of the Insulin-like Growth Factor 2 (IGF2) gene on the paternal chromosome. Our preliminary experiments suggested that an H19 antisense transcript having a similar function may also be conserved in the mouse. In the present work, we further characterise the mouse 91H RNA and, using a genetic complementation approach in H19 KO myoblast cells, we show that ectopic expression of the mouse 91H RNA can up-regulate Igf2 expression in trans despite almost complete unmethylation of the Imprinting-Control Region (ICR). We then demonstrate that this activation occurs at the transcriptional level by activation of a previously unknown Igf2 promoter which displays, in mouse tissues, a preferential mesodermic expression (Pm promoter). Finally, our experiments indicate that a large excess of the H19 transcript can counteract 91H-mediated Igf2 activation. Our work contributes, in conjunction with other recent findings, to open new horizons to our understanding of Igf2 gene regulation and functions of the 91H/H19 RNAs in normal and pathological conditions.	[Van Giang Tran; Court, Franck; Duputie, Anne; Antoine, Etienne; Aptel, Nathalie; Milligan, Laura; Carbonell, Francoise; Lelay-Taha, Marie-Noelle; Piette, Jacques; Weber, Michael; Forne, Thierry; Cathala, Guy] Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France; [Montarras, Didier] Inst Pasteur, Mol Genet Dev Unit, Dept Dev Biol, CNRS,URA 2578, Paris, France; [Pinset, Christian] CECS, ISTEM, Evry, France; [Dandolo, Luisa] Univ Paris 05, Inst Cochin, UMR 8104, Genet & Dev Dept,CNRS,INSERM,U567, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tran, VG (corresponding author), Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France.	forne@igmm.cnrs.fr; cathala@igmm.cnrs.fr	Forne, Thierry/D-3718-2013; Weber, Michael/P-1914-2016	Forne, Thierry/0000-0002-9179-1551; Weber, Michael/0000-0003-3484-5821; Milligan, Laura/0000-0001-6985-3034; Duputie, Anne/0000-0003-2213-7940; court, franck/0000-0003-0327-9708	Association pour la Recherche contre le Cancer [ARC] [SFI20101201555]; Agence Nationale de la Recherche [ANR-07-BLAN-0052-02, NT09_669034]; CEFIC-Long-range Research Initiative [LRI-EMSG49-CNRS-08]; Ligue Nationale contre le Cancer (comite de l'Herault); "Centre National de la Recherche Scientifique" (CNRS); fellowship from the Ligue Nationale contre le cancer (comite de l'Ardeche); governmental fellowship from the socialist republic of Vietnam	Association pour la Recherche contre le Cancer [ARC](Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); CEFIC-Long-range Research Initiative; Ligue Nationale contre le Cancer (comite de l'Herault); "Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); fellowship from the Ligue Nationale contre le cancer (comite de l'Ardeche); governmental fellowship from the socialist republic of Vietnam	This work was supported by grants from the Association pour la Recherche contre le Cancer [ARC contract n SFI20101201555 to T. F.]; the Agence Nationale de la Recherche [ANR-07-BLAN-0052-02 to T. F. and L. D., NT09_669034 to M. W.]; the CEFIC-Long-range Research Initiative [LRI-EMSG49-CNRS-08 to M. W.]; the Ligue Nationale contre le Cancer (comite de l'Herault) and the "Centre National de la Recherche Scientifique" (CNRS). F. C. was supported by a fellowship from the Ligue Nationale contre le cancer (comite de l'Ardeche). T. V. G. was supported by a governmental fellowship from the socialist republic of Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 1998, AM J PATHOL, V153, P1597, DOI 10.1016/S0002-9440(10)65748-3; Ariel I, 1997, J CLIN PATHOL-MOL PA, V50, P34, DOI 10.1136/mp.50.1.34; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; BIRAN H, 1994, TUMOR BIOL, V15, P123, DOI 10.1159/000217882; Braem C, 2008, J BIOL CHEM, V283, P18612, DOI 10.1074/jbc.M801883200; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Cooper MJ, 1996, J UROLOGY, V155, P2120, DOI 10.1016/S0022-5347(01)66120-2; Court F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r42; Court F, 2011, NUCLEIC ACIDS RES, V39, P5893, DOI 10.1093/nar/gkr209; Davies K, 2002, DEVELOPMENT, V129, P1657; Dejeux E, 2009, ENDOCR-RELAT CANCER, V16, P939, DOI 10.1677/ERC-08-0331; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Latos PA, 2009, RNA BIOL, V6, P100, DOI 10.4161/rna.6.2.7854; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; LustigYariv O, 1997, ONCOGENE, V15, P169, DOI 10.1038/sj.onc.1201175; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Milligan L, 2000, ONCOGENE, V19, P5810, DOI 10.1038/sj.onc.1203965; Milligan L, 2002, EMBO REP, V3, P774, DOI 10.1093/embo-reports/kvf142; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Onyango P, 2011, P NATL ACAD SCI USA, V108, P16759, DOI 10.1073/pnas.1110904108; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Schoenfelder S, 2007, EMBO REP, V8, P1068, DOI 10.1038/sj.embor.7401094; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Watanabe Y, 2010, GENOMICS, V96, P333, DOI 10.1016/j.ygeno.2010.08.007; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weber ML, 2003, ANAL BIOCHEM, V320, P252, DOI 10.1016/S0003-2697(03)00396-8; Wilkin F, 2000, EUR J BIOCHEM, V267, P4020, DOI 10.1046/j.1432-1327.2000.01438.x; Wilusz J, 2011, GENE DEV, V23, P1494; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105	58	34	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37923	10.1371/journal.pone.0037923	http://dx.doi.org/10.1371/journal.pone.0037923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662250	Green Published, gold			2022-12-27	WOS:000305342300141
J	Wang, X; Ke, ZJ; Chen, G; Xu, M; Bower, KA; Frank, JA; Zhang, Z; Shi, XL; Luo, J				Wang, Xin; Ke, Zunji; Chen, Gang; Xu, Mei; Bower, Kimberly A.; Frank, Jacqueline A.; Zhang, Zhuo; Shi, Xianglin; Luo, Jia			Cdc42-Dependent Activation of NADPH Oxidase Is Involved in Ethanol-Induced Neuronal Oxidative Stress	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; FREE-RADICAL DAMAGE; FETAL ALCOHOL; MOUSE; BRAIN; RAT; MITOCHONDRIA; ASTROCYTES; EXPRESSION; MECHANISM	It has been suggested that excessive reactive oxygen species (ROS) and oxidative stress play an important role in ethanol-induced damage to both the developing and mature central nervous system (CNS). The mechanisms underlying ethanol-induced neuronal ROS, however, remain unclear. In this study, we investigated the role of NADPH oxidase (NOX) in ethanol-induced ROS generation. We demonstrated that ethanol activated NOX and inhibition of NOX reduced ethanol-promoted ROS generation. Ethanol significantly increased the expression of p47(phox) and p67(phox), the essential subunits for NOX activation in cultured neuronal cells and the cerebral cortex of infant mice. Ethanol caused serine phosphorylation and membrane translocation of p47(phox) and p67(phox), which were prerequisites for NOX assembly and activation. Knocking down p47(phox) with the small interfering RNA was sufficient to attenuate ethanol-induced ROS production and ameliorate ethanol-mediated oxidative damage, which is indicated by a decrease in protein oxidation and lipid peroxidation. Ethanol activated cell division cycle 42 (Cdc42) and overexpression of a dominant negative (DN) Cdc42 abrogate ethanol-induced NOX activation and ROS generation. These results suggest that Cdc42-dependent NOX activation mediates ethanol-induced oxidative damages to neurons.	[Wang, Xin; Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40506 USA; [Ke, Zunji; Chen, Gang; Xu, Mei; Bower, Kimberly A.; Frank, Jacqueline A.; Luo, Jia] Univ Kentucky, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Wang, X (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40506 USA.	xshi5@uky.edu; jialuo888@uky.edu	Zhang, Zhuo/B-8601-2012; Ke, Zunji/E-4822-2010; Ke, Zun-Ji/N-5689-2014; Luo, Jia/E-4674-2012	Ke, Zunji/0000-0003-4038-2456; Ke, Zun-Ji/0000-0003-4038-2456; Luo, Jia/0000-0002-6968-3618	NIH [AA015407, AA019693]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA019693, R01AA015407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was supported by NIH grants AA015407 and AA019693. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; Antonio AM, 2008, BRAIN RES, V1204, P16, DOI 10.1016/j.brainres.2008.02.018; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chen SY, 2000, J PHARMACOL EXP THER, V294, P134; CHEN WJA, 1995, ALCOHOL, V12, P351, DOI 10.1016/0741-8329(95)00017-L; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Dong J, 2010, TOXICOL LETT, V193, P94, DOI 10.1016/j.toxlet.2009.12.012; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Hasegawa T, 2002, LIVER, V22, P321, DOI 10.1034/j.1600-0676.2002.01493.x; Heaton MB, 2006, J NEUROBIOL, V66, P95, DOI 10.1002/neu.20208; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Ke ZJ, 2011, J NEUROSCI RES, V89, P1676, DOI 10.1002/jnr.22689; Luo J, 2001, J NEUROCHEM, V76, P1354, DOI 10.1046/j.1471-4159.2001.00129.x; Luo J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00041; Miyano K, 2012, METHODS MOL BIOL, V827, P195, DOI 10.1007/978-1-61779-442-1_14; Naseer MI, 2011, SYNAPSE, V65, P562, DOI 10.1002/syn.20875; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Olney JW, 2002, NEUROBIOL DIS, V9, P205, DOI 10.1006/nbdi.2001.0475; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Polikandriotis JA, 2006, AM J RESP CELL MOL, V34, P314, DOI 10.1165/rcmb.2005-0320OC; Qian Y, 2005, J BIOL CHEM, V280, P3875, DOI 10.1074/jbc.M403788200; Qian Y, 2003, J BIOL CHEM, V278, P16189, DOI 10.1074/jbc.M207517200; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; Sigal N, 2003, J BIOL CHEM, V278, P4854, DOI 10.1074/jbc.M211011200; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Thomson A D, 2000, Alcohol Alcohol Suppl, V35, P2; Wang X, 2011, TOXICOL SCI, V123, P399, DOI 10.1093/toxsci/kfr180; Wentzel P, 2006, ALCOHOL CLIN EXP RES, V30, P1752, DOI 10.1111/j.1530-0277.2006.00208.x; Wentzel P, 2006, TOXICOL SCI, V92, P416, DOI 10.1093/toxsci/kfl024	38	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38075	10.1371/journal.pone.0038075	http://dx.doi.org/10.1371/journal.pone.0038075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662267	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300159
J	Zhu, FC; Liang, ZL; Meng, FY; Zeng, Y; Mao, QY; Chu, K; Song, XF; Yao, X; Li, JX; Ji, H; Zhang, YJ; Li, L; Pan, HX; Xu, K; Dai, WM; Zhang, WW; Deng, F; Wang, H; Wang, JZ				Zhu, Feng-Cai; Liang, Zheng-Lun; Meng, Fan-Yue; Zeng, Ying; Mao, Qun-Ying; Chu, Kai; Song, Xue-Fang; Yao, Xin; Li, Jing-Xin; Ji, Hong; Zhang, Yi-Ju; Li, Liang; Pan, Hong-Xing; Xu, Ke; Dai, Wei-Ming; Zhang, Wei-Wei; Deng, Fei; Wang, Hua; Wang, Jun-Zhi			Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants	PLOS ONE			English	Article							1998 ENTEROVIRUS-71 OUTBREAK; MOUTH-DISEASE; COXSACKIEVIRUS A16; 71 INFECTION; TAIWAN; FOOT; HAND; EPIDEMIOLOGY; CHINA; ANTIGENICITY	Background: Hand, foot, and mouth disease (HFMD) has been emerging as an important public problem over the past few decades, especially in Asian and Pacific regions. A national program on EV71 vaccine development against HFMD was initiated in China, in 2008, which called for a need for seroepidemiological study for the target population. Methodology/Principal Findings: This was a retrospective study conducted in Jiangsu Province, in October, 2010. We measured the neutralizing antibodies against EV71 and CoxA16 in a cohort of infants aged of 2, 7, 12, and 27-38 months and their mothers just before delivery. Series sera samples from 975 infants and 555 mothers were collected and analyzed. Questionnaires on the history of HFMD were completed in the survey. A total of 143 HFMD cases were collected, but only 11.2% were reported to the National Infectious Disease Information Management System. The level of maternal antibody titers decreased dramatically during the first 7 month and remained at a relatively low level thereafter. But it increased significantly from month 12 to months 27-38. The accumulate incidence density of HFMD demonstrated a significant increase after 14 months of age, resulting in a accumulate incidence density of 50.8/1000 person-years in survey period. Seropositivity of EV71 antibody in infants at the age of 2 months seems to demonstrate a protective effect against HFMD. Conclusions and Significance: High seropositive rate of EV71 and CoxA16 antibody was found in prenatal women in mainland China, and there is a need to enhance the HFMD case management and the current surveillance system. We suggest that infants aged between 6 to 14 months should have the first priority to receive EV71 vaccine.	[Zhu, Feng-Cai; Meng, Fan-Yue; Chu, Kai; Li, Jing-Xin; Ji, Hong; Zhang, Yi-Ju; Li, Liang; Pan, Hong-Xing; Xu, Ke; Dai, Wei-Ming; Deng, Fei; Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zeng, Ying; Song, Xue-Fang] Shenzhen Kangtai Biol Prod Co Ltd, Guangzhou, Guangdong, Peoples R China; [Liang, Zheng-Lun; Mao, Qun-Ying; Yao, Xin; Wang, Jun-Zhi] Natl Inst Food & Drug Control, Lab 2, Beijing, Peoples R China; [Zhang, Wei-Wei] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Southeast University - China	Zhu, FC (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	jszfc@vip.sina.com; lzlun@yahoo.com; wangjz@nicpbp.org.cn			Chinese governmental grants [2008BAI69B01, 2009ZX10004-806]	Chinese governmental grants	The study was funded by Chinese governmental grants (2008BAI69B01 and 2009ZX10004-806). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Jia Lei, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P635; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Teng Zheng, 2010, Chinese Journal of Virology, V26, P437; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wang SM, 2010, CLIN VACCINE IMMUNOL, V17, P1517, DOI 10.1128/CVI.00108-10; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	25	86	98	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37206	10.1371/journal.pone.0037206	http://dx.doi.org/10.1371/journal.pone.0037206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662137	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300028
J	Lutringer-Magnin, D; Girard, N; Cadranel, J; Leroux, C; Quoix, E; Cottin, V; Del Signore, C; Lebitasy, MP; Cordier, G; Vanhems, P; Mornex, JF				Lutringer-Magnin, Delphine; Girard, Nicolas; Cadranel, Jacques; Leroux, Caroline; Quoix, Elisabeth; Cottin, Vincent; Del Signore, Corinne; Lebitasy, Marie-Paule; Cordier, Genevieve; Vanhems, Philippe; Mornex, Jean-Francois			Professional Exposure to Goats Increases the Risk of Pneumonic-Type Lung Adenocarcinoma: Results of the IFCT-0504-Epidemio Study	PLOS ONE			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; HUMAN BRONCHIOLOALVEOLAR CARCINOMA; BRONCHOALVEOLAR CARCINOMA; NEVER SMOKERS; CANCER-RISK; VIRUS; RECEPTOR; TRANSFORMATION; SURVIVAL; PROTEIN	Pneumonic-type lung adenocarcinoma (P-ADC) represents a distinct subset of lung cancer with specific clinical, radiological, and pathological features. Given the weak association with tobacco-smoking and the striking similarities with jaagsiekte sheep retrovirus (JSRV)-induced ovine pulmonary adenocarcinoma, it has been suggested that a zoonotic viral agent infecting pulmonary cells may predispose to P-ADC in humans. Our objective was to explore whether exposure to domestic small ruminants may represent a risk factor for P-ADC. We performed a multicenter case-control study recruiting patients with P-ADC as cases and patients with non-P-ADC non-small cell lung cancer as controls. A dedicated 356-item questionnaire was built to evaluate exposure to livestock. A total of 44 cases and 132 controls were included. At multivariate analysis, P-ADC was significantly more associated with female gender (Odds-ratio (OR) = 3.23, 95% confidence interval (CI): 1.32-7.87, p = 0.010), never-smoker status (OR = 3.57, 95% CI: 1.27-10.00, p = 0.015), personal history of extra-thoracic cancer before P-ADC diagnosis (OR = 3.43, 95% CI: 1.10-10.72, p = 0.034), and professional exposure to goats (OR = 5.09, 95% CI: 1.05-24.69, p = 0.043), as compared to other subtypes of lung cancer. This case-control suggests a link between professional exposure to goats and P-ADC, and prompts for further epidemiological evaluation of potential environmental risk factors for P-ADC.	[Lutringer-Magnin, Delphine; Girard, Nicolas; Cottin, Vincent; Vanhems, Philippe; Mornex, Jean-Francois] Hosp Civils Lyon, Lyon, France; [Lutringer-Magnin, Delphine; Girard, Nicolas; Leroux, Caroline; Cottin, Vincent; Del Signore, Corinne; Cordier, Genevieve; Vanhems, Philippe; Mornex, Jean-Francois] Univ Lyon, Lyon, France; [Lutringer-Magnin, Delphine; Girard, Nicolas; Leroux, Caroline; Cottin, Vincent; Del Signore, Corinne; Cordier, Genevieve; Vanhems, Philippe; Mornex, Jean-Francois] Univ Lyon 1, F-69365 Lyon, France; [Lutringer-Magnin, Delphine; Del Signore, Corinne; Vanhems, Philippe] CNRS, UMR 5558, Lab Biometrie & Biol Evolut, Lyon, France; [Girard, Nicolas; Leroux, Caroline; Cottin, Vincent; Cordier, Genevieve; Mornex, Jean-Francois] INRA, UMR754, Lyon, France; [Cadranel, Jacques] Hop Tenon, Serv Pneumol, F-75970 Paris, France; [Quoix, Elisabeth] Hop Hautepierre, Serv Pneumol, Strasbourg, France; [Lebitasy, Marie-Paule] Intergrp Francais Cancerol Thorac, Paris, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lutringer-Magnin, D (corresponding author), Hosp Civils Lyon, Lyon, France.	mornex@univ-lyon1.fr	Girard, Nicolas/ABE-3618-2021	Girard, Nicolas/0000-0001-9909-2299; leroux, caroline/0000-0002-7923-3127	Institut National de la Recherche 304 Agronomique (EpiEmerge); Universite Lyon 1 (Bonus Qualite Recherche); Institut 305 National du Cancer	Institut National de la Recherche 304 Agronomique (EpiEmerge); Universite Lyon 1 (Bonus Qualite Recherche); Institut 305 National du Cancer	This study was supported by grants from Institut National de la Recherche 304 Agronomique (EpiEmerge), Universite Lyon 1 (Bonus Qualite Recherche) and Institut 305 National du Cancer (unite pilote de coordination pour la prise en charge des tumeurs 306 malignes rares intrathoraciques de l'adulte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira M, 1999, AM J ROENTGENOL, V173, P1623, DOI 10.2214/ajr.173.6.10584811; Bhatia R, 1998, EPIDEMIOLOGY, V9, P84, DOI 10.1097/00001648-199801000-00017; Boffetta P, 2005, INT J CANCER, V115, P263, DOI 10.1002/ijc.20854; Boffetta P, 2000, CANCER CAUSE CONTROL, V11, P627, DOI 10.1023/A:1008947531573; Cadranel J, 2009, J THORAC ONCOL, V4, P1126, DOI 10.1097/JTO.0b013e3181abeb5d; Caroline L, 2010, CURR HIV RES, V8, P94, DOI 10.2174/157016210790416415; Carretta A, 2001, EUR J CARDIO-THORAC, V20, P367, DOI 10.1016/S1010-7940(01)00733-3; De las Heras M, 2000, EUR RESPIR J, V16, P330, DOI 10.1034/j.1399-3003.2000.16b23.x; Dirks C, 2002, J VIROL, V76, P2141, DOI 10.1128/JVI.76.5.2141-2149.2002; Furak J, 2003, EUR J CARDIO-THORAC, V23, P818, DOI 10.1016/S1010-7940(03)00084-8; Garfield DH, 2006, J THORAC ONCOL, V1, P344, DOI 10.1097/01243894-200605000-00014; Griffiths DJ, 2010, J COMP PATHOL, V142, P260, DOI 10.1016/j.jcpa.2009.12.013; HARPOLE DH, 1988, ANN THORAC SURG, V46, P502, DOI 10.1016/S0003-4975(10)64685-1; Hopwood P, 2010, HUM PATHOL, V41, P1631, DOI 10.1016/j.humpath.2010.05.013; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; KOO LC, 1990, INT J EPIDEMIOL, V19, pS14, DOI 10.1093/ije/19.Supplement_1.S14; Lee HY, 2009, LUNG CANCER, V65, P170, DOI 10.1016/j.lungcan.2008.11.009; Leroux C, 2007, VET RES, V38, P211, DOI 10.1051/vetres:2006060; MARCO M, 1973, AM REV RESPIR DIS, V107, P621, DOI 10.1164/arrd.1973.107.4.621; Mornex JF, 2003, CURR TOP MICROBIOL, V275, P225; Morozov VA, 2004, VIROLOGY, V327, P162, DOI 10.1016/j.virol.2004.05.028; Nomori H, 2011, ANN THORAC CARDIOVAS, V17, P19, DOI 10.5761/atcs.oa.09.01529; Okubo K, 1999, J THORAC CARDIOV SUR, V118, P702, DOI 10.1016/S0022-5223(99)70016-4; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rai SK, 2000, J VIROL, V74, P4698, DOI 10.1128/JVI.74.10.4698-4704.2000; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Rocca S, 2008, HUM PATHOL, V39, P303, DOI 10.1016/j.humpath.2007.10.008; Tang NP, 2010, LUNG CANCER, V67, P17, DOI 10.1016/j.lungcan.2009.03.012; Travis WD, 2004, WHO CLASSIFICATION T, P10; Vida S, 2010, CANCER EPIDEM BIOMAR, V19, P1602, DOI 10.1158/1055-9965.EPI-10-0015; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Wislez M, 2003, CHEST, V123, P1868, DOI 10.1378/chest.123.6.1868; Wislez M, 2010, LUNG CANCER, V68, P185, DOI 10.1016/j.lungcan.2009.05.021; Yousem SA, 2001, HUM PATHOL, V32, P1039, DOI 10.1053/hupa.2001.28249	34	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37889	10.1371/journal.pone.0037889	http://dx.doi.org/10.1371/journal.pone.0037889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655078	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900055
J	Dinamarco, TM; Freitas, FZ; Almeida, RS; Brown, NA; dos Reis, TF; Ramalho, LNZ; Savoldi, M; Goldman, MHS; Bertolini, MC; Goldman, GH				Dinamarco, Taisa Magnani; Freitas, Fernanda Zanolli; Almeida, Ricardo S.; Brown, Neil Andrew; dos Reis, Thaila Fernanda; Zambelli Ramalho, Leandra Naira; Savoldi, Marcela; Goldman, Maria Helena S.; Bertolini, Maria Celia; Goldman, Gustavo Henrique			Functional Characterization of an Aspergillus fumigatus Calcium Transporter (PmcA) that Is Essential for Fungal Infection	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFORMATION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CALCINEURIN TARGET; CATION HOMEOSTASIS; CA2+; HOMOLOG; CRZ1; IDENTIFICATION	Aspergillus fumigatus is a primary and opportunistic pathogen, as well as a major allergen, of mammals. The Ca+2-calcineurin pathway affects virulence, morphogenesis and antifungal drug action in A. fumigatus. Here, we investigated three components of the A. fumigatus Ca+2-calcineurin pathway, pmcA,-B, and -C, which encode calcium transporters. We demonstrated that CrzA can directly control the mRNA accumulation of the pmcA-C genes by binding to their promoter regions. CrzA-binding experiments suggested that the 5'-CACAGCCAC-3' and 5'-CCCTGCCCC-3' sequences upstream of pmcA and pmcC genes, respectively, are possible calcineurin-dependent response elements (CDREs)-like consensus motifs. Null mutants were constructed for pmcA and -beta and a conditional mutant for pmcC demonstrating pmcC is an essential gene. The Delta pmcA and Delta pmcB mutants were more sensitive to calcium and resistant to manganese and cyclosporin was able to modulate the sensitivity or resistance of these mutants to these salts, supporting the interaction between calcineurin and the function of these transporters. The pmcA-C genes have decreased mRNA abundance into the alveoli in the Delta calA and Delta crzA mutant strains. However, only the A. fumigatus Delta pmcA was avirulent in the murine model of invasive pulmonary aspergillosis.	[Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil; [Dinamarco, Taisa Magnani; Brown, Neil Andrew; dos Reis, Thaila Fernanda; Savoldi, Marcela; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Zambelli Ramalho, Leandra Naira] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Almeida, Ricardo S.] Univ Londrina, Dept Microbiol, Londrina, Parana, Brazil; [Freitas, Fernanda Zanolli; Bertolini, Maria Celia] Univ Estadual Paulista, Inst Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Dinamarco, TM (corresponding author), Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil.	ggoldman@usp.br	Ramalho, Leandra Náira Zambelli/A-3983-2010; Almeida, Ricardo/AFO-8380-2022; dos Reis, Thaila F/N-6237-2014; Dinamarco, Taisa M/J-8923-2012; Zanolli Freitas, Fernanda/J-9425-2012; Zanolli Freitas, Fernanda/ABB-9297-2021; Dinamarco, Taisa/M-7174-2019; Goldman, Maria Helena S./D-1424-2012; Ramalho, Leandra/AAA-6432-2021; Goldman, Gustavo Henrique/F-1848-2013; Bertolini, Maria Celia/D-3654-2012	Ramalho, Leandra Náira Zambelli/0000-0002-3486-5294; Almeida, Ricardo/0000-0002-1427-936X; dos Reis, Thaila F/0000-0002-7776-977X; Dinamarco, Taisa M/0000-0001-6284-387X; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Dinamarco, Taisa/0000-0001-6284-387X; Goldman, Maria Helena S./0000-0002-6786-9320; Goldman, Gustavo Henrique/0000-0002-2986-350X; Bertolini, Maria Celia/0000-0001-5319-2710; Brown, Neil/0000-0002-3555-5765	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Cairns T, 2010, FEMS MICROBIOL LETT, V307, P1, DOI 10.1111/j.1574-6968.2010.01961.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; CORNELIUS G, 1987, J GEN MICROBIOL, V133, P2341; CRAMER CL, 1984, J BIOL CHEM, V259, P5152; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; DUNN T, 1994, J BIOL CHEM, V269, P7273; EILAM Y, 1985, J GEN MICROBIOL, V131, P623; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; Flipphi M, 2002, BIOCHEM J, V364, P25, DOI 10.1042/bj3640025; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Hirayama S, 2003, J BIOL CHEM, V20, P18078; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malavazi I, 2009, FUNGAL GENET BIOL, V46, P791, DOI 10.1016/j.fgb.2009.06.009; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; MILLER AJ, 1990, P NATL ACAD SCI USA, V87, P9348, DOI 10.1073/pnas.87.23.9348; Mota AO, 2008, MOL GENET GENOMICS, V280, P483, DOI 10.1007/s00438-008-0381-y; Olivero I, 2003, FEMS MICROBIOL LETT, V219, P137, DOI 10.1016/S0378-1097(03)00002-8; Onyewu Chiatogu, 2004, Infection and Immunity, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; Pinchai N, 2010, EUKARYOT CELL, V9, P472, DOI 10.1128/EC.00378-09; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Semighini CP, 2002, APPL ENVIRON MICROB, V68, P1351, DOI 10.1128/AEM.68.3.1351-1357.2002; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; STROOBANT P, 1979, P NATL ACAD SCI USA, V76, P3102, DOI 10.1073/pnas.76.7.3102; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005	51	44	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37591	10.1371/journal.pone.0037591	http://dx.doi.org/10.1371/journal.pone.0037591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649543	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800062
J	Ssengooba, W; Kiwanuka, N; Kateete, DP; Katamba, A; Joloba, ML				Ssengooba, Willy; Kiwanuka, Noah; Kateete, David P.; Katamba, Achilles; Joloba, Moses L.			Incremental Yield of Serial Sputum Cultures for Diagnosis of Tuberculosis among HIV Infected Smear Negative Pulmonary TB Suspects in Kampala, Uganda	PLOS ONE			English	Article							COST-EFFECTIVENESS	Background: Sputum culture is the gold standard for diagnosis of pulmonary tuberculosis (PTB). Although mostly used for research, culture is recommended by the World Health Organization for TB diagnosis among HIV infected smear negative PTB suspects. Even then, the number of sputum samples required remains unspecified. Here, we determined the Incremental Yield (IY) and number of samples required to diagnose an additional PTB case upon second and third serial sputum culture. Methods/Findings: This was a cross sectional study done between January and March 2011. Serial sputum samples were provided by participants within two days and cultured using Lowenstein Jensen (LJ) and Mycobacteria Growth Indicator Tube (MGIT) methods. A PTB case was defined as a positive culture on either one or both methods. The IY from the second and third serial cultures was determined and the reciprocal of the product of the fractions of IY provided the number of samples required for an additional PTB case. Of the 170 smear negative PTB suspects, 62 (36.5%) met the case definition. The IY of the second sample culture was 12.7%, 23.6% and 12.6% and for the third sample culture was 6.8%, 7.5% and 7.3% with LJ, MGIT and LJ or MGIT, respectively. The number of samples required for an additional PTB case and 95% CI upon the second sample culture were 29.9 (16.6, 156.5), 11.3 (7.6, 21.9) and 20.8 (12.5, 62.7); while for the third sample culture were 55.6 (26.4, 500.4), 35.7 (19.0, 313.8) and 36.1 (19.1, 330.9) by LJ, MGIT and LJ or MGIT respectively. Conclusions/Significance: Among HIV infected smear negative PTB suspects in Kampala, 93% of PTB cases are diagnosed upon the second serial sputum culture. The number of cultures needed to diagnose an additional PTB case, ranges from 11-30 and 35-56 by the second and third sputum samples, respectively.	[Ssengooba, Willy; Kateete, David P.; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda; [Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda.	akatamba@chs.mak.ac.ug; moses.joloba@case.edu	Ssengooba, Willy/ABE-2168-2020; Kateete, David Patrick/HCH-5603-2022	Ssengooba, Willy/0000-0002-1643-110X; Kateete, David Patrick/0000-0001-8075-3069; Joloba, Moses/0000-0002-0334-9983	Fogarty International Training grant under Clinical Operational and Health Services Research of the JCRC (Joint Research Clinical Center, Kampala, Uganda) [U2RTW006879]; FOGARTY INTERNATIONAL CENTER [U2RTW006879] Funding Source: NIH RePORTER	Fogarty International Training grant under Clinical Operational and Health Services Research of the JCRC (Joint Research Clinical Center, Kampala, Uganda); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a Fogarty International Training grant to WS under Clinical Operational and Health Services Research of the JCRC (Joint Research Clinical Center, Kampala, Uganda) (award #U2RTW006879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; CDC, 1985, PUBL HLTH MYC GUID L; CDC, 1979, LAB MAN AC FAST MICR; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Harries AD, 2000, INT J TUBERC LUNG D, V4, P36; Hirano K, 2004, J CLIN MICROBIOL, V42, P390, DOI 10.1128/JCM.42.1.390-392.2004; Ipuge YA, 1996, T R SOC TROP MED HYG, V90, P256; Katamba A, 2007, INT J TUBERC LUNG D, V11, P659; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Lee JJ, 2003, INT J TUBERC LUNG D, V7, P569; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Muchwa Christopher, 2012, BMC Res Notes, V5, P44, DOI 10.1186/1756-0500-5-44; Mueller DH, 2008, INT J TUBERC LUNG D, V12, P1196; Rieder HL, 2005, INT J TUBERC LUNG D, V9, P384; Siddiqi S H, 2006, MGIT PROC MAN BACTEC; Walker D, 2000, INT J TUBERC LUNG D, V4, P246; WHO, 2009, WHO ROL RESP TB HIV	22	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37650	10.1371/journal.pone.0037650	http://dx.doi.org/10.1371/journal.pone.0037650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629439	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300067
J	Wang, S; Huang, X; Sun, DN; Xin, XL; Pan, QM; Peng, SY; Liang, ZJ; Luo, C; Yang, YM; Jiang, HL; Huang, M; Chai, WG; Ding, J; Geng, MY				Wang, Shuai; Huang, Xun; Sun, Danni; Xin, Xianliang; Pan, Qiuming; Peng, Shuying; Liang, Zhongjie; Luo, Cheng; Yang, Yiming; Jiang, Hualiang; Huang, Min; Chai, Wengang; Ding, Jian; Geng, Meiyu			Extensive Crosstalk between O-GlcNAcylation and Phosphorylation Regulates Akt Signaling	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINE; PROTEIN-KINASE B; INSULIN-RESISTANCE; IN-VIVO; GLCNAC; IDENTIFICATION; ACTIVATION; DYNAMICS; GROWTH; SITE	O-linked N-acetylglucosamine glycosylations (O-GlcNAc) and O-linked phosphorylations (O-phosphate), as two important types of post-translational modifications, often occur on the same protein and bear a reciprocal relationship. In addition to the well documented phosphorylations that control Akt activity, Akt also undergoes O-GlcNAcylation, but the interplay between these two modifications and the biological significance remain unclear, largely due to the technique challenges. Here, we applied a two-step analytic approach composed of the O-GlcNAc immunoenrichment and subsequent O-phosphate immunodetection. Such an easy method enabled us to visualize endogenous glycosylated and phosphorylated Akt subpopulations in parallel and observed the inhibitory effect of Akt O-GlcNAcylations on its phosphorylation. Further studies utilizing mass spectrometry and mutagenesis approaches showed that O-GlcNAcylations at Thr 305 and Thr 312 inhibited Akt phosphorylation at Thr 308 via disrupting the interaction between Akt and PDK1. The impaired Akt activation in turn resulted in the compromised biological functions of Akt, as evidenced by suppressed cell proliferation and migration capabilities. Together, this study revealed an extensive crosstalk between O-GlcNAcylations and phosphorylations of Akt and demonstrated O-GlcNAcylation as a new regulatory modification for Akt signaling.	[Wang, Shuai; Huang, Xun; Sun, Danni; Xin, Xianliang; Pan, Qiuming; Huang, Min; Chai, Wengang; Ding, Jian; Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China; [Peng, Shuying; Yang, Yiming] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Mass Spectrometry, Shanghai 200031, Peoples R China; [Liang, Zhongjie; Luo, Cheng; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Discovery & Design, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Chai, Wengang] Imperial Coll London, Glycosci Lab, Fac Med, Harrow, Middx, England	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Imperial College London	Wang, S (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	jding@mail.shcnc.ac.cn; mygeng@mail.shcnc.ac.cn	Liang, Zhongjie/F-2108-2019; Huang, xun/AAM-3093-2020	Liang, Zhongjie/0000-0003-0763-5407; 	Natural Science Foundation of China for Distinguished Young Scholars [30725046]; Natural Science Foundation of China for Innovation Research Group [81021062]	Natural Science Foundation of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of China for Innovation Research Group(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the Natural Science Foundation of China for Distinguished Young Scholars (No. 30725046), and the Natural Science Foundation of China for Innovation Research Group (No. 81021062). Website: http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carr SM, 2011, EMBO J, V30, P317, DOI 10.1038/emboj.2010.311; Chalkley RJ, 2008, COMP ANAL C, V52, P353, DOI 10.1016/S0166-526X(08)00215-8; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Joost HG, 2000, METH MOL B, V155, P77; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; Kohler JJ, 2010, NAT CHEM BIOL, V6, P634, DOI 10.1038/nchembio.429; Lippa B, 2008, BIOORG MED CHEM LETT, V18, P3359, DOI 10.1016/j.bmcl.2008.04.034; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u	47	74	79	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37427	10.1371/journal.pone.0037427	http://dx.doi.org/10.1371/journal.pone.0037427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629392	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345300039
J	Franzen, M; Schweiger, O; Betzholtz, PE				Franzen, Markus; Schweiger, Oliver; Betzholtz, Per-Eric			Species-Area Relationships Are Controlled by Species Traits	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; HABITAT FRAGMENTATION; ISLAND BIOGEOGRAPHY; DISPERSAL ABILITY; LANDSCAPE CONTEXT; BODY-SIZE; PATTERNS; BUTTERFLIES; ABUNDANCE; MOTHS	The species-area relationship (SAR) is one of the most thoroughly investigated empirical relationships in ecology. Two theories have been proposed to explain SARs: classical island biogeography theory and niche theory. Classical island biogeography theory considers the processes of persistence, extinction, and colonization, whereas niche theory focuses on species requirements, such as habitat and resource use. Recent studies have called for the unification of these two theories to better explain the underlying mechanisms that generates SARs. In this context, species traits that can be related to each theory seem promising. Here we analyzed the SARs of butterfly and moth assemblages on islands differing in size and isolation. We tested whether species traits modify the SAR and the response to isolation. In addition to the expected overall effects on the area, traits related to each of the two theories increased the model fit, from 69% up to 90%. Steeper slopes have been shown to have a particularly higher sensitivity to area, which was indicated by species with restricted range (slope = 0.82), narrow dietary niche (slope = 0.59), low abundance (slope = 0.52), and low reproductive potential (slope = 0.51). We concluded that considering species traits by analyzing SARs yields considerable potential for unifying island biogeography theory and niche theory, and that the systematic and predictable effects observed when considering traits can help to guide conservation and management actions.	[Franzen, Markus; Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Franzen, Markus] Lund Univ, Dept Biol, Div Biodivers, Lund, Sweden; [Betzholtz, Per-Eric] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Lund University; Linnaeus University	Franzen, M (corresponding author), UFZ Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany.	markus.franzen@ufz.de	Schweiger, Oliver/B-4909-2008	Schweiger, Oliver/0000-0001-8779-2335	The Royal Physiographic Society in Lund; Krapperupsstiftelsen; FORMAS; European Commission Framework Programme (FP) 7 via the Integrated Project SCALES [226852]; European Commission Framework Programme (FP) 7 via the Collaborative Project STEP [244090]	The Royal Physiographic Society in Lund; Krapperupsstiftelsen; FORMAS(Swedish Research Council Formas); European Commission Framework Programme (FP) 7 via the Integrated Project SCALES; European Commission Framework Programme (FP) 7 via the Collaborative Project STEP	This study was supported by The Royal Physiographic Society in Lund, Krapperupsstiftelsen and FORMAS. The authors also acknowledge the support of the European Commission Framework Programme (FP) 7 via the Integrated Project SCALES [grant 226852] and the Collaborative Project STEP [grant 244090]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson H., 2002, TEMPERATUR NEDERBORD; Altermatt F, 2010, ECOL LETT, V13, P1475, DOI 10.1111/j.1461-0248.2010.01534.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BAZ A, 1995, J BIOGEOGR, V22, P129, DOI 10.2307/2846077; Beck J, 2006, J BIOGEOGR, V33, P694, DOI 10.1111/j.1365-2699.2005.01418.x; Beck J, 2007, GLOBAL ECOL BIOGEOGR, V16, P341, DOI 10.1111/j.1466-8238.2007.00289.x; Betzholtz PE, 2011, ECOL ENTOMOL, V36, P369, DOI 10.1111/j.1365-2311.2011.01281.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Brotons L, 2003, AM NAT, V162, P343, DOI 10.1086/376887; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Darlington P. J., 1943, ECOL MONOGR, V13, P37, DOI 10.2307/1943589; Davies N, 1998, GLOBAL ECOL BIOGEOGR, V7, P285; Dennis RLH, 2000, BIODIVERS CONSERV, V9, P343, DOI 10.1023/A:1008924329854; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Emmet A.M., 1991, P61; Franzen M, 2007, J INSECT CONSERV, V11, P367, DOI 10.1007/s10841-006-9053-6; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GASTON KJ, 1989, BIOL J LINN SOC, V37, P367, DOI 10.1111/j.1095-8312.1989.tb01912.x; Gelman A., 2007, DATA ANAL USING REGR; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Henriksen H.J., 1982, BUTTERFLIES SCANDINA; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holt Robert D., 1996, P313; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hubbell S.P., 2001, MG POP BIOL, V32; HULDEN L, 2000, ATLAS FINNISH MACROL; Hyden N, 2007, NATIONALNYCKELN SVER; INKINEN P, 1994, ANN ZOOL FENN, V31, P235; Itamies J, 1983, FACTORS CONTRIBUTING; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Karsholt O., 1998, REVIDERET KATALOG DA; Karsholt Ole, 2008, Entomologiske Meddelelser, V76, P3; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Lindeborg Mats, 2009, Entomologisk Tidskrift, V130, P11; Loder N, 1998, BIOL J LINN SOC, V63, P121, DOI 10.1111/j.1095-8312.1998.tb01642.x; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lomolino MV, 2009, Q REV BIOL, V84, P357, DOI 10.1086/648123; MAC ARTHUR ROBERT H., 1967; MACE GM, 1997, BIOL RARITY CAUSES C, P131; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Nieminen M, 1999, ECOGRAPHY, V22, P697, DOI 10.1111/j.1600-0587.1999.tb00519.x; NILSSON SG, 1988, J ANIM ECOL, V57, P685, DOI 10.2307/4933; Nordstrom F., 1943, Opuscula Entomologica, V8, P59; Ockinger E, 2012, LANDSCAPE ECOL, V27, P121, DOI 10.1007/s10980-011-9686-z; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Palm E, 1986, DANMARKS DYRELIV, V3; Parmesan Camille, 2001, Symposia of the Royal Entomological Society of London, V20, P387, DOI 10.1079/9780851994567.0387; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Powney GD, 2010, OIKOS, V119, P1690, DOI 10.1111/j.1600-0706.2010.18168.x; Poyry J, 2011, GLOBAL ECOL BIOGEOGR, V20, P289, DOI 10.1111/j.1466-8238.2010.00597.x; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RAZOWSKI, 1996, LEPIDOPTERA EUROPE D; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; SKOU P, 1991, NORDENS UGLER; Skou P., 1984, DANMARKS DYRELIV, V2; Solymos P, 2012, GLOBAL ECOL BIOGEOGR, V21, P109, DOI 10.1111/j.1466-8238.2011.00655.x; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Stadel Nielsen P, 2008, DATA REGISTERET MED; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Steffan-Dewenter I, 2000, ECOL LETT, V3, P449, DOI 10.1046/j.1461-0248.2000.00175.x; Svensson I., 1994, CATALOGUS LEPIDOPTER; SVENSSON I, 1993, LEPIDOPTERA CALENDER; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Ulrich W, 2003, ECOGRAPHY, V26, P365, DOI 10.1034/j.1600-0587.2003.03441.x; WILCOX BA, 1986, OECOLOGIA, V69, P188, DOI 10.1007/BF00377620	80	61	62	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37359	10.1371/journal.pone.0037359	http://dx.doi.org/10.1371/journal.pone.0037359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629384	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100023
J	Kuck, P; Mayer, C; Wagele, JW; Misof, B				Kueck, Patrick; Mayer, Christoph; Waegele, Johann-Wolfgang; Misof, Bernhard			Long Branch Effects Distort Maximum Likelihood Phylogenies in Simulations Despite Selection of the Correct Model	PLOS ONE			English	Article							SITE RATE VARIATION; EVOLUTIONARY TREES; DNA-SEQUENCES; SUBSTITUTION RATES; PARSIMONY; PERFORMANCE; ATTRACTION; HETEROGENEITY; ALGORITHMS; SUCCESS	The aim of our study was to test the robustness and efficiency of maximum likelihood with respect to different long branch effects on multiple-taxon trees. We simulated data of different alignment lengths under two different 11-taxon trees and a broad range of different branch length conditions. The data were analyzed with the true model parameters as well as with estimated and incorrect assumptions about among-site rate variation. If length differences between connected branches strongly increase, tree inference with the correct likelihood model assumptions can fail. We found that incorporating invariant sites together with Gamma distributed site rates in the tree reconstruction (Gamma+I) increases the robustness of maximum likelihood in comparison with models using only Gamma. The results show that for some topologies and branch lengths the reconstruction success of maximum likelihood under the correct model is still low for alignments with a length of 100,000 base positions. Altogether, the high confidence that is put in maximum likelihood trees is not always justified under certain tree shapes even if alignment lengths reach 100,000 base positions.	[Kueck, Patrick; Mayer, Christoph; Waegele, Johann-Wolfgang; Misof, Bernhard] Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Kuck, P (corresponding author), Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany.	patrick_kueck@web.de		Mayer, Christoph/0000-0001-5104-6621	Deutsche Forschungsgemeinschaft [MI649/6-2, SPP 1174 (WA530/33)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft (MI649/6-2 to BM and SPP 1174 (WA530/33) to WA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Bruno WJ, 1999, MOL BIOL EVOL, V16, P564, DOI 10.1093/oxfordjournals.molbev.a026137; Chang JT, 1996, MATH BIOSCI, V137, P51, DOI 10.1016/S0025-5564(96)00075-2; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fischer M, 2009, J THEOR BIOL, V256, P247, DOI 10.1016/j.jtbi.2008.09.031; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; FUKAMIKOBAYASHI K, 1991, J MOL EVOL, V32, P79, DOI 10.1007/BF02099932; Gaucher EA, 2005, MOL PHYLOGENET EVOL, V37, P928, DOI 10.1016/j.ympev.2005.03.027; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Kelchner SA, 2007, TRENDS ECOL EVOL, V22, P87, DOI 10.1016/j.tree.2006.10.004; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; Mayrose I, 2005, BIOINFORMATICS, V21, P151, DOI 10.1093/bioinformatics/bti1125; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Philippe H, 2000, MOL BIOL EVOL, V17, P830, DOI 10.1093/oxfordjournals.molbev.a026362; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; Regier JC, 2010, NATURE, V319, P473; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; Rogers JS, 1997, SYST BIOL, V46, P354, DOI 10.2307/2413629; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Siddall ME, 1998, CLADISTICS, V14, P209, DOI 10.1111/j.1096-0031.1998.tb00334.x; Sullivan J, 2001, SYST BIOL, V50, P723, DOI 10.1080/106351501753328848; Sullivan J, 1996, J MOL EVOL, V42, P308, DOI 10.1007/BF02198857; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Tourasse NJ, 1997, MOL BIOL EVOL, V14, P287, DOI 10.1093/oxfordjournals.molbev.a025764; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; YANG Z, 1995, SYST BIOL, V44, P384, DOI 10.2307/2413599; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 1997, MOL BIOL EVOL, V14, P105, DOI 10.1093/oxfordjournals.molbev.a025695	46	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36593	10.1371/journal.pone.0036593	http://dx.doi.org/10.1371/journal.pone.0036593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22662120	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100044
J	Kastberger, G; Weihmann, F; Hoetzl, T; Weiss, SE; Maurer, M; Kranner, I				Kastberger, Gerald; Weihmann, Frank; Hoetzl, Thomas; Weiss, Sara E.; Maurer, Michael; Kranner, Ilse			How to Join a Wave: Decision-Making Processes in Shimmering Behavior of Giant Honeybees (Apis dorsata)	PLOS ONE			English	Article							COLONY DEFENSE; MOTION	Shimmering is a collective defence behaviour in Giant honeybees (Apis dorsata) whereby individual bees flip their abdomen upwards, producing Mexican wave-like patterns on the nest surface. Bucket bridging has been used to explain the spread of information in a chain of members including three testable concepts: first, linearity assumes that individual "agent bees'' addresses the coincidence of the individual property of trigger direction with the collective property of wave direction. Second, continuity describes the transfer of information without being stopped, delayed or re-routed. The active-neighbours hypothesis assumes coincidence between the direction of the majority of shimmering-active neighbours and the trigger direction of the agents. Third, the graduality hypothesis refers to the interaction between an agent and her active neighbours, assuming a proportional relationship in the strength of abdomen flipping of the agent and her previously active neighbours. Shimmering waves provoked by dummy wasps were recorded with high-resolution video cameras. Individual bees were identified by 3D-image analysis, and their strength of abdominal flipping was assessed by pixel-based luminance changes in sequential frames. For each agent, the directedness of wave propagation was based on wave direction, trigger direction, and the direction of the majority of shimmering-active neighbours. The data supported the bucket bridging hypothesis, but only for a small proportion of agents: linearity was confirmed for 2.5%, continuity for 11.3% and graduality for 0.4% of surface bees (but in 2.6% of those agents with high wave-strength levels). The complimentary part of 90% of surface bees did not conform to bucket bridging. This fuzziness is discussed in terms of self-organisation and evolutionary adaptedness in Giant honeybee colonies to respond to rapidly changing threats such as predatory wasps scanning in front of the nest.	[Kastberger, Gerald; Weihmann, Frank; Hoetzl, Thomas; Weiss, Sara E.] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Maurer, Michael] Graz Univ Technol, Inst Comp Graph & Vis, A-8010 Graz, Austria; [Kranner, Ilse] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	University of Graz; Graz University of Technology; University of Innsbruck	Kastberger, G (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	gerald.kastberger@uni-graz.at	Kranner, Ilse/B-1039-2011	Kranner, Ilse/0000-0003-4959-9109	FWF (Soziale Wellen bei Riesenhonigbienen) [P 20515-B16]	FWF (Soziale Wellen bei Riesenhonigbienen)	The paper had been granted by the Austrian Science Fund (FWF Project P 20515-B16)(Soziale Wellen bei Riesenhonigbienen), http://www.fwf.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, BEHAV ECOLOGY; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Bradbury J.W., 1983, P109; BUCK J, 1976, SCI AM, V234, P74; Butani DK, 1950, INDIAN BEE J, V12, P115; BUTLER CG, 1962, WORLD HONEYBEE; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Camazine S., 2003, SELF ORG BIOL SYSTEM; Farkas I, 2002, NATURE, V419, P131, DOI 10.1038/419131a; Faugeras O, 1993, 3 DIMENSIONAL COMPUT; Freixenet J, 2002, LECT NOTES COMPUT SC, V2352, P408, DOI 10.1007/3-540-47977-5_27; Gibson R.M., 1986, P379; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Hepburn HR, 2007, APIDOLOGIE, V38, P219, DOI 10.1051/apido:2007010; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA, DOI DOI 10.1017/CBO9780511618536; Kastberger G, 1996, APIDOLOGIE, V27, P381, DOI 10.1051/apido:19960506; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 2010, COMMUNICATIVE INTEGR, V3, P1; Kastberger G, 2012, TRANSIENT MECH UNPUB; Kastberger G, 2011, TRANSMITTANCE UNPUB; KASTBERGER G, 1999, MAGIC TREES ASSAM DO; Kastberger G, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-3; Kastberger G, 2011, HONEYBEES OF ASIA, P397, DOI 10.1007/978-3-642-16422-4_18; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Klabunde RE, 2005, CARDIOVASCULAR PHYSL; KOENIGER N, 1975, Zeitschrift fuer Tierpsychologie, V37, P99; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; Lloyd J.E., 1979, P293; Morse RA, 1969, APIS DORSALA PHILLIP; OTTE D, 1977, BIOL BEHAV, V2, P143; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pasteels J.M., 1987, Experientia Supplementum (Basel), V54, P155; Phillips O.M., 1977, DYNAMICS UPPER OCEAN, V2nd ed.; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; Procaccini A, 2011, ANIM BEHAV, V82, P759, DOI 10.1016/j.anbehav.2011.07.006; Roepke W, 1930, BEOBACHTUNGEN INDISC; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sakagami S. F., 1960, Acta Hymenopterologica, V1, P171; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Schmelzer E, 2009, NATURWISSENSCHAFTEN, V96, P1431, DOI 10.1007/s00114-009-0605-y; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; TREHERNE JE, 1981, ANIM BEHAV, V29, P911, DOI 10.1016/S0003-3472(81)80028-0; Weihmann F, 2011, DGAAE ANN M S; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Woyke J, 2008, J INSECT BEHAV, V21, P481, DOI 10.1007/s10905-008-9144-1; Zureiki A, 2007, IEEE IMAGE PROC, P237	46	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36736	10.1371/journal.pone.0036736	http://dx.doi.org/10.1371/journal.pone.0036736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22662123	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335500027
J	Kerns, SL; Schultz, KM; Barry, KA; Thorne, TM; McGarry, TJ				Kerns, Sarah L.; Schultz, Kathryn M.; Barry, Kelly A.; Thorne, Tina M.; McGarry, Thomas J.			Geminin Is Required for Zygotic Gene Expression at the Xenopus Mid-Blastula Transition	PLOS ONE			English	Article							DROSOPHILA MIDBLASTULA TRANSITION; MAJOR DEVELOPMENTAL TRANSITION; CHK2 PROTEIN-KINASE; CELL-CYCLE; DNA-REPLICATION; PREVENTS REREPLICATION; CHECKPOINT CONTROL; EMBRYOS; PHOSPHORYLATION; TRANSCRIPTION	In many organisms early development is under control of the maternal genome and zygotic gene expression is delayed until the mid-blastula transition (MBT). As zygotic transcription initiates, cell cycle checkpoints become activated and the tempo of cell division slows. The mechanisms that activate zygotic transcription at the MBT are incompletely understood, but they are of interest because they may resemble mechanisms that cause stem cells to stop dividing and terminally differentiate. The unstable regulatory protein Geminin is thought to coordinate cell division with cell differentiation. Geminin is a bi-functional protein. It prevents a second round of DNA replication during S and G2 phase by binding and inhibiting the essential replication factor Cdt1. Geminin also binds and inhibits a number of transcription factors and chromatin remodeling proteins and is thought to keep dividing cells in an undifferentiated state. We previously found that the cells of Geminin-deficient Xenopus embryos arrest in G2 phase just after the MBT then disintegrate at the onset of gastrulation. Here we report that they also fail to express most zygotic genes. The gene expression defect is cell-autonomous and is reproduced by over-expressing Cdt1 or by incubating the embryos in hydroxyurea. Geminin deficient and hydroxyurea-treated blastomeres accumulate DNA damage in the form of double stranded breaks. Bypassing the Chk1 pathway overcomes the cell cycle arrest caused by Geminin depletion but does not restore zygotic gene expression. In fact, bypassing the Chk1 pathway by itself induces double stranded breaks and abolishes zygotic transcription. We did not find evidence that Geminin has a replication-independent effect on transcription. We conclude that Geminin is required to maintain genome integrity during the rapid cleavage divisions, and that DNA damage disrupts zygotic gene transcription at the MBT, probably through activation of DNA damage checkpoint pathways.	[Kerns, Sarah L.; Schultz, Kathryn M.; Barry, Kelly A.; Thorne, Tina M.; McGarry, Thomas J.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Kerns, Sarah L.; Barry, Kelly A.; McGarry, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [McGarry, Thomas J.] Northwestern Univ, Robert H Lurie Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kerns, SL (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA.	t-mcgarry@northwestern.edu			National Heart Lung and Blood Institute; American Heart Association; Schweppe Foundation; Illinois Division of the American Cancer Society	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Schweppe Foundation; Illinois Division of the American Cancer Society(American Cancer Society)	This work was supported by grants to TJM from the National Heart Lung and Blood Institute, the American Heart Association, the Schweppe Foundation, and the Illinois Division of the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; FOE VE, 1993, DEV DROSOPHILA MELAN; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Guo ZJ, 2000, MOL BIOL CELL, V11, P1535, DOI 10.1091/mbc.11.5.1535; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; KANE DA, 1993, DEVELOPMENT, V119, P447; Karamitros D, 2010, J IMMUNOL, V184, P2432, DOI 10.4049/jimmunol.0901983; Keren A, 2010, METHODS MOL BIOL, V661, P409, DOI 10.1007/978-1-60761-795-2_25; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Luo LF, 2004, CELL CYCLE, V3, P711; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nakajo N, 1999, DEV BIOL, V207, P432, DOI 10.1006/dbio.1998.9178; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017736; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Skirkanich J, 2011, DEV BIOL; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Spella M, 2011, STEM CELLS, V29, P1269, DOI 10.1002/stem.678; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILSON R, 1995, MECH DEVELOP, V49, P211, DOI 10.1016/0925-4773(94)00319-I; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wroble BN, 2005, DEV DYNAM, V233, P1359, DOI 10.1002/dvdy.20449; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	68	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38009	10.1371/journal.pone.0038009	http://dx.doi.org/10.1371/journal.pone.0038009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662261	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300153
J	Nghia, HDT; Tu, LTP; Wolbers, M; Hoang, NVM; Thanh, VN; Van, MP; Nga, TVT; Van, TL; Song, DT; Thi, PL; Thao, NTP; Van, CB; Tang, V; Tuan, HNA; Nguyen, D; Trung, TP; Lien, NTN; Kiem, HT; Tam, NTT; Campbell, J; Caws, M; Day, J; de Jong, MD; Chau, NVV; Van Doorn, HR; Tinh, HT; Farrar, J; Schultsz, C				Nghia Ho Dang Trung; Tu Le Thi Phuong; Wolbers, Marcel; Hoang Nguyen Van Minh; Vinh Nguyen Thanh; Minh Pham Van; Nga Tran Vu Thieu; Tan Le Van; Diep To Song; Phuong Le Thi; Thao Nguyen Thi Phuong; Cong Bui Van; Vu Tang; Tuan Hoang Ngoc Anh; Dong Nguyen; Tien Phan Trung; Lien Nguyen Thi Nam; Hao Tran Kiem; Tam Nguyen Thi Thanh; Campbell, James; Caws, Maxine; Day, Jeremy; de Jong, Menno D.; Chau Nguyen Van Vinh; Van Doorn, H. Rogier; Hien Tran Tinh; Farrar, Jeremy; Schultsz, Constance		VIZIONS CNS Infection Network	Aetiologies of Central Nervous System Infection in Viet Nam: A Prospective Provincial Hospital-Based Descriptive Surveillance Study	PLOS ONE			English	Article							ACQUIRED BACTERIAL-MENINGITIS; STREPTOCOCCUS-SUIS INFECTION; HERPES-SIMPLEX-VIRUS; TUBERCULOUS MENINGITIS; CEREBROSPINAL-FLUID; CRYPTOCOCCAL MENINGITIS; HAEMOPHILUS-INFLUENZAE; CLINICAL SPECIMENS; BCG VACCINATION; HIV-INFECTION	Background: Infectious diseases of the central nervous system (CNS) remain common and life-threatening, especially in developing countries. Knowledge of the aetiological agents responsible for these infections is essential to guide empiric therapy and develop a rational public health policy. To date most data has come from patients admitted to tertiary referral hospitals in Asia and there is limited aetiological data at the provincial hospital level where most patients are seen. Methods: We conducted a prospective Provincial Hospital-based descriptive surveillance study in adults and children at thirteen hospitals in central and southern Viet Nam between August 2007-April 2010. The pathogens of CNS infection were confirmed in CSF and blood samples by using classical microbiology, molecular diagnostics and serology. Results: We recruited 1241 patients with clinically suspected infection of the CNS. An aetiological agent was identified in 640/1241 (52%) of the patients. The most common pathogens were Streptococcus suis serotype 2 in patients older than 14 years of age (147/617, 24%) and Japanese encephalitis virus in patients less than 14 years old (142/624, 23%). Mycobacterium tuberculosis was confirmed in 34/617 (6%) adult patients and 11/624 (2%) paediatric patients. The acute case fatality rate (CFR) during hospital admission was 73/617 (12%) in adults and to 42/624 (7%) in children. Conclusions: Zoonotic bacterial and viral pathogens are the most common causes of CNS infection in adults and children in Viet Nam.	[Nghia Ho Dang Trung] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Nghia Ho Dang Trung; Tu Le Thi Phuong; Wolbers, Marcel; Hoang Nguyen Van Minh; Vinh Nguyen Thanh; Minh Pham Van; Nga Tran Vu Thieu; Tan Le Van; Campbell, James; Caws, Maxine; Day, Jeremy; de Jong, Menno D.; Van Doorn, H. Rogier; Hien Tran Tinh; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Ctr Trop Med, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nghia Ho Dang Trung; Diep To Song; Chau Nguyen Van Vinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Phuong Le Thi] Dong Thap Prov Hosp, Ho Chi Minh City, Dong Thap Provi, Vietnam; [Cong Bui Van] Kien Giang Prov Hosp, Ho Chi Minh City, Kien Giang Prov, Vietnam; [Tien Phan Trung; Lien Nguyen Thi Nam; Hao Tran Kiem] Hue Cent Hosp, Ho Chi Minh City, Thua Thien Hue, Vietnam; [Tam Nguyen Thi Thanh] Can Tho Cent Hosp, Can Tho City, Vietnam; [Wolbers, Marcel; Campbell, James; Caws, Maxine; Day, Jeremy; de Jong, Menno D.; Van Doorn, H. Rogier; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Nghia, HDT (corresponding author), Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam.	nghiahdt@oucru.org	Farrar, Jeremy J./HGA-7610-2022; van Doorn, H. Rogier/H-3080-2019	van Doorn, H. Rogier/0000-0002-9807-1821; Le Van, Tan/0000-0002-1791-3901; Kiem Hao, Tran/0000-0002-5218-3529; Caws, Maxine/0000-0002-9109-350X; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust Major Overseas Programme; MRC [G1100684] Funding Source: UKRI; Medical Research Council [G1100684] Funding Source: researchfish	Wellcome Trust Major Overseas Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust Major Overseas Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tawfiq JA, 2009, MED SCI MONITOR, V15, pPI10; Barnett, 2010, ANAL SEASONAL HLTH D; Beld M, 2004, J CLIN MICROBIOL, V42, P3059, DOI 10.1128/JCM.42.7.3059-3064.2004; Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Casas I, 1996, J MED VIROL, V50, P82, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;82::AID-JMV14&gt;3.0.CO;2-#; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Cho HK, 2010, J KOREAN MED SCI, V25, P895, DOI 10.3346/jkms.2010.25.6.895; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Ganiem AR, 2009, AIDS, V23, P2309, DOI 10.1097/QAD.0b013e3283320de8; Gjini AB, 2006, EPIDEMIOL INFECT, V134, P567, DOI 10.1017/S0950268805005595; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Ha D, 1994, TROP MED, P202; HENDARTO S K, 1992, Acta Paediatrica Japonica, V34, P350; HO DTN, 2011, PLOS ONE, V0006; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; Ihekwaba UK, 2008, CLIN INFECT DIS, V47, P783, DOI 10.1086/591129; Jackson ST, 2008, W INDIAN MED J, V57, P373; Jerome KR, 2002, J CLIN MICROBIOL, V40, P2609, DOI 10.1128/JCM.40.7.2609-2611.2002; KAY R, 1995, QJM-INT J MED, V88, P39; Koskiniemi M, 1996, J NEUROL NEUROSUR PS, V60, P174, DOI 10.1136/jnnp.60.2.174; Kumar P, 2005, NATL MED J INDIA, V18, P7; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lee BE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-68; Lo Re III V, 2003, AM J MED, V114, P217, DOI 10.1016/S0002-9343(02)01495-X; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Molyneux E, 2006, ANN TROP PAEDIATR, V26, P29, DOI 10.1179/146532806X90583; Muangchana C, 2009, SE ASIAN J TROP MED, V40, P553; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nguyen TY, 2010, AM J TROP MED HYG, V83, P816, DOI 10.4269/ajtmh.2010.10-0262; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Soares CN, 2011, J NEUROL SCI; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Srey VH, 2002, AM J TROP MED HYG, V66, P200, DOI 10.4269/ajtmh.2002.66.200; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Tang YW, 1997, J CLIN MICROBIOL, V35, P2869, DOI 10.1128/JCM.35.11.2869-2872.1997; Tansuphasawadikul S, 1999, J ACQ IMMUN DEF SYND, V21, P326, DOI 10.1097/00126334-199908010-00011; Thuy L, 2010, CLIN INFECT DIS, V51, pE65, DOI 10.1086/656685; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Tram TT, 1998, PEDIATR INFECT DIS J, V17, pS192, DOI 10.1097/00006454-199809001-00023; Tran VTN, 2011, DIAGN MICR INFEC DIS, V70, P461, DOI 10.1016/j.diagmicrobio.2010.12.015; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Varatharaj A, 2010, NEUROL INDIA, V58, P585, DOI 10.4103/0028-3886.68655; Vianello F, 2008, INFECTION, V36, P174, DOI 10.1007/s15010-007-6249-y; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Weinberg A, 2005, J INFECT DIS, V191, P234, DOI 10.1086/426402; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2003, WHO REC STAND SURV S; Yamamoto T, 2000, J NEUROVIROL, V6, P410, DOI 10.3109/13550280009018305; Yong YK, 2008, NEUROL ASIA, V13, P65; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	63	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37825	10.1371/journal.pone.0037825	http://dx.doi.org/10.1371/journal.pone.0037825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662232	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300122
J	Munoz, JP; Gonzalez, C; Parra, B; Corvalan, AH; Tornesello, ML; Eizuru, Y; Aguayo, F				Pablo Munoz, Juan; Gonzalez, Carolina; Parra, Barbara; Corvalan, Alejandro H.; Tornesello, Maria Lina; Eizuru, Yoshito; Aguayo, Francisco			Functional Interaction between Human Papillomavirus Type 16 E6 and E7 Oncoproteins and Cigarette Smoke Components in Lung Epithelial Cells	PLOS ONE			English	Article							CERVICAL-CANCER; ORAL CARCINOGENESIS; CARCINOMAS; INFECTION; HPV; MECHANISMS; NICOTINE; PROLIFERATION; INVOLVEMENT; PROTEINS	The smoking habit is the most important, but not a sufficient cause for lung cancer development. Several studies have reported the human papillomavirus type 16 (HPV16) presence and E6 and E7 transcripts expression in lung carcinoma cases from different geographical regions. The possible interaction between HPV infection and smoke carcinogens, however, remains unclear. In this study we address a potential cooperation between tobacco smoke and HPV16 E6 and E7 oncoproteins for alterations in proliferative and tumorigenic properties of lung epithelial cells. A549 (alveolar, tumoral) and BEAS-2B (bronchial, non-tumoral) cell lines were stably transfected with recombinant pLXSN vectors expressing HPV16 E6 and E7 oncoproteins and exposed to cigarette smoke condensate (CSC) at different concentrations. HPV16 E6 and E7 expression was associated with loss of p53 stability, telomerase (hTERT) and p16(INK4A) overexpression in BEAS-2B cells as demonstrated by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting (WB). In A549 cells we observed downregulation of p53 but not a significant increase of hTERT transcripts. In addition, the HPV16 E6/E7 transfected cell lines showed an increased proliferation rate and anchorage-independent growth in a HPV16 E6 and E7 expression-dependent manner. Moreover, both HPV16 E6/E7 and mock transfected cells showed an increased proliferation rate and anchorage-independent growth in the presence of 0.1 and 10 mu g/mL CSC. However, this increase was significantly greater in HPV16 E6/E7 transfected cells (p<0.001). Data were confirmed by FCSE proliferation assay. The results obtained in this study are suggestive of a functional interaction between tobacco smoke and HPV16 E6/E7 oncoproteins for malignant transformation and tumorigenesis of lung epithelial cells. More studies are warranted in order to dissect the molecular mechanisms involved in this cooperation.	[Pablo Munoz, Juan; Gonzalez, Carolina; Parra, Barbara; Aguayo, Francisco] Univ Chile, Fac Med, Virol Program, Inst Ciencias Biomed ICBM, Santiago 7, Chile; [Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Dept Hematol Oncol, Sch Med, Santiago, Chile; [Tornesello, Maria Lina] Natl Canc Inst Fond Pascale, Mol Biol & Viral Oncol & AIDS Reference Ctr, Naples, Italy; [Eizuru, Yoshito] Kagoshima Univ, Div Oncogen & Persistent Viruses, Ctr Chron Viral Dis, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Universidad de Chile; Pontificia Universidad Catolica de Chile; Kagoshima University	Munoz, JP (corresponding author), Univ Chile, Fac Med, Virol Program, Inst Ciencias Biomed ICBM, Santiago 7, Chile.	faguayo@med.uchile.cl	Tornesello, Maria Lina/A-1964-2008; Muñoz, Juan P/GSJ-1484-2022	Tornesello, Maria Lina/0000-0002-3523-3264; Corvalan, Alejandro/0000-0001-5492-3853	Fondecyt from the government of Chile [11080198]	Fondecyt from the government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondecyt Grant 11080198 to FA from the government of Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo F, 2007, BRIT J CANCER, V97, P85, DOI 10.1038/sj.bjc.6603848; Aguayo Francisco, 2010, Infect Agent Cancer, V5, P20, DOI 10.1186/1750-9378-5-20; Alam S, 2010, J VIROL, V84, P4630, DOI 10.1128/JVI.02431-09; Andl T, 1998, CANCER RES, V58, P5; ARMITAGE AK, 1975, BRIT MED J, V4, P313, DOI 10.1136/bmj.4.5992.313; Baroldi P, 2012, J CHILD ADOLESCENT P; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Buonomo T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-2; Castillo A, 2006, ONCOL REP, V15, P883; Center CoAcoKTRD, 1974, REF CIG PROGR; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Cheng YW, 2008, CLIN CANCER RES, V14, P7173, DOI 10.1158/1078-0432.CCR-08-0850; Cheng YW, 2004, LUNG CANCER-J IASLC, V46, P165, DOI 10.1016/j.lungcan.2004.03.023; Cheng YW, 2001, CANCER RES, V61, P2799; Ciotti M, 2009, RESPIRATION, V77, P427, DOI 10.1159/000176209; Coelho WS, 2012, INT J BIOCHEM CELL B, V44, P150, DOI 10.1016/j.biocel.2011.10.010; Dennis Phillip A, 2005, Cancer Epidemiol Biomarkers Prev, V14, P764, DOI 10.1158/1055-9965.EPI-04-0652; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Goto A, 2011, J MED VIROL, V83, P1383, DOI 10.1002/jmv.22150; Gunnell AS, 2006, CANCER EPIDEM BIOMAR, V15, P2141, DOI 10.1158/1055-9965.EPI-06-0399; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V88; Itakura M, 2000, INT J ONCOL, V16, P591; KIM MS, 1993, CANCER RES, V53, P4811; Klein F, 2009, LUNG CANCER, V65, P13, DOI 10.1016/j.lungcan.2008.10.003; Kometani T, 2009, CANCER LETT, V278, P27, DOI 10.1016/j.canlet.2008.12.017; Krikelis D, 2010, J CLIN VIROL, V49, P169, DOI 10.1016/j.jcv.2010.07.020; LI SL, 1992, CARCINOGENESIS, V13, P1981, DOI 10.1093/carcin/13.11.1981; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Motoyama Satoru, 2004, Kobe Journal of Medical Sciences, V50, P9; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; PARK NH, 1995, ONCOGENE, V10, P2145; Petersen I, 2008, PATHOLOGE S, V29, P118; Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e; Rohrer J, 2010, LARYNGOSCOPE, V120, P1609, DOI 10.1002/lary.20972; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Silva DCM, 2012, J PERIODONT IN PRESS, V47; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P885, DOI 10.1136/jcp.55.12.885; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; zur Hausen H, 2009, INDIAN J MED RES, V130, P209; zur Hausen H, 2009, ANGEW CHEM INT EDIT, V48, P5798, DOI 10.1002/anie.200901917	47	35	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38178	10.1371/journal.pone.0038178	http://dx.doi.org/10.1371/journal.pone.0038178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662279	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300171
J	Pendyala, G; Buescher, JL; Fox, HS				Pendyala, Gurudutt; Buescher, James L.; Fox, Howard S.			Methamphetamine and Inflammatory Cytokines Increase Neuronal Na+/K+-ATPase Isoform 3: Relevance for HIV Associated Neurocognitive Disorders	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; INFECTED MICROGLIA; BRAIN; AMPHETAMINE; ACTIVATION; EXPRESSION; PLASMA; NEURODEGENERATION; COMMUNICATION	Methamphetamine (METH) abuse in conjunction with human immunodeficiency virus (HIV) exacerbates neuropathogenesis and accelerates neurocognitive impairments in the central nervous system (CNS), collectively termed HIV Associated Neurocognitive Disorders (HAND). Since both HIV and METH have been implicated in altering the synaptic architecture, this study focused on investigating alterations in synaptic proteins. Employing a quantitative proteomics approach on synaptosomes isolated from the caudate nucleus from two groups of rhesus monkeys chronically infected with simian immunodeficiency virus (SIV) differing by one regimen, METH treatment, we identified the neuron specific Na+/K+-ATPase alpha 1 isoform 3 (ATP1A3) to be up regulated after METH treatment, and validated its up regulation by METH in vitro. Further studies on signaling mechanisms revealed that the activation of ATP1A3 involves the extracellular regulated kinase (ERK) pathway. Given its function in maintaining ionic gradients and emerging role as a signaling molecule, changes in ATP1A3 yields insights into the mechanisms associated with HAND and interactions with drugs of abuse.	[Pendyala, Gurudutt; Buescher, James L.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Pendyala, G (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	gpendyala@unmc.edu		Fox, Howard/0000-0003-2032-374X	National Institutes of Health [P30 MH062261, R01 DA032513, P01 DA026146]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146, R01DA032513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P30 MH062261, R01 DA032513 and P01 DA026146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Burdo TH, 2005, AIDS, V19, P1704, DOI 10.1097/01.aids.0000186823.76230.33; Burudi EME, 2002, J VIROL, V76, P12233, DOI 10.1128/JVI.76.23.12233-12241.2002; Cadet JL, 2007, NEUROTOX RES, V12, P181, DOI 10.1007/BF03033915; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Chang L, 2005, AM J PSYCHIAT, V162, P361, DOI 10.1176/appi.ajp.162.2.361; Cheng WS, 2010, J PSYCHOACTIVE DRUGS, V42, P11, DOI 10.1080/02791072.2010.10399781; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gelman BB, 2009, J NEUROIMMUNE PHARM; GJERDE H, 1993, J ANAL TOXICOL, V17, P65, DOI 10.1093/jat/17.2.65; Kalasinsky KS, 2001, FORENSIC SCI INT, V116, P163, DOI 10.1016/S0379-0738(00)00368-6; Klette KL, 2006, J ANAL TOXICOL, V30, P319, DOI 10.1093/jat/30.5.319; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Mahajan SD, 2006, MOL DIAGN THER, V10, P257, DOI 10.1007/BF03256465; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marquez C, 2009, AIDS CARE, V21, P575, DOI 10.1080/09540120802385579; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Muneer PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019258; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Orandle MS, 2002, J VIROL, V76, P5797, DOI 10.1128/JVI.76.11.5797-5802.2002; Pendyala G, 2011, AIDS RES HUM RETROV, V27, P179, DOI 10.1089/aid.2010.0090; Pendyala G, 2010, J PROTEOME RES, V9, P352, DOI 10.1021/pr900685u; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Runden E, 1998, J NEUROSCI, V18, P7296; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Schepers RJF, 2003, CLIN CHEM, V49, P121, DOI 10.1373/49.1.121; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shapshak P, 2011, AIDS, V25, P123, DOI 10.1097/QAD.0b013e328340fd42; SHARER LR, 1992, J NEUROPATH EXP NEUR, V51, P3, DOI 10.1097/00005072-199201000-00002; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Takayasu T, 1995, J Clin Forensic Med, V2, P25, DOI 10.1016/1353-1131(95)90036-5; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; WATRY D, 1995, AM J PATHOL, V146, P914; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	52	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37604	10.1371/journal.pone.0037604	http://dx.doi.org/10.1371/journal.pone.0037604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662178	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300068
J	Truong, HT; Ramos, AM; Yalcin, F; de Ruiter, M; van der Poel, HJA; Huvenaars, KHJ; Hogers, RCJ; van Enckevort, LJG; Janssen, A; van Orsouw, NJ; van Eijk, MJT				Truong, Hoa T.; Ramos, A. Marcos; Yalcin, Feyruz; de Ruiter, Marjo; van der Poel, Hein J. A.; Huvenaars, Koen H. J.; Hogers, Rene C. J.; van Enckevort, Leonora J. G.; Janssen, Antoine; van Orsouw, Nathalie J.; van Eijk, Michiel J. T.			Sequence-Based Genotyping for Marker Discovery and Co-Dominant Scoring in Germplasm and Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE MAP; ARABIDOPSIS-THALIANA; SNP DISCOVERY; AFLP; CONSTRUCTION; TECHNOLOGIES; TRAITS; BARLEY; L.	Conventional marker-based genotyping platforms are widely available, but not without their limitations. In this context, we developed Sequence-Based Genotyping (SBG), a technology for simultaneous marker discovery and co-dominant scoring, using next-generation sequencing. SBG offers users several advantages including a generic sample preparation method, a highly robust genome complexity reduction strategy to facilitate de novo marker discovery across entire genomes, and a uniform bioinformatics workflow strategy to achieve genotyping goals tailored to individual species, regardless of the availability of a reference sequence. The most distinguishing features of this technology are the ability to genotype any population structure, regardless whether parental data is included, and the ability to co-dominantly score SNP markers segregating in populations. To demonstrate the capabilities of SBG, we performed marker discovery and genotyping in Arabidopsis thaliana and lettuce, two plant species of diverse genetic complexity and backgrounds. Initially we obtained 1,409 SNPs for arabidopsis, and 5,583 SNPs for lettuce. Further filtering of the SNP dataset produced over 1,000 high quality SNP markers for each species. We obtained a genotyping rate of 201.2 genotypes/SNP and 58.3 genotypes/SNP for arabidopsis (n = 222 samples) and lettuce (n = 87 samples), respectively. Linkage mapping using these SNPs resulted in stable map configurations. We have therefore shown that the SBG approach presented provides users with the utmost flexibility in garnering high quality markers that can be directly used for genotyping and downstream applications. Until advances and costs will allow for routine whole-genome sequencing of populations, we expect that sequence-based genotyping technologies such as SBG will be essential for genotyping of model and non-model genomes alike.	[Truong, Hoa T.; Ramos, A. Marcos; Yalcin, Feyruz; de Ruiter, Marjo; van der Poel, Hein J. A.; Huvenaars, Koen H. J.; Hogers, Rene C. J.; van Enckevort, Leonora J. G.; Janssen, Antoine; van Orsouw, Nathalie J.; van Eijk, Michiel J. T.] Keygene NV, Wageningen, Netherlands	Keygene N.V.	Truong, HT (corresponding author), Keygene NV, Wageningen, Netherlands.	michiel.van-eijk@keygene.com		Ramos, Marcos/0000-0003-3450-0970				Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bao E, 2011, BIOINFORMATICS, V27, P2502, DOI 10.1093/bioinformatics/btr447; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Buntjer J, 2002, PLANT AN MICR GEN 10; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Edenberg HJ, 2009, LAB METHODS HIGH THR; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Hayes RJ, 2011, THEOR APPL GENET, V123, P509, DOI 10.1007/s00122-011-1603-y; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; NAM HG, 1989, PLANT CELL, V1, P699, DOI 10.1105/tpc.1.7.699; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Shinozuka H, 2010, PLANT MOL BIOL, V72, P343, DOI 10.1007/s11103-009-9574-y; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; van Poecke R, 2012, PLANT AN GEN 20 C SA; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 1999, THEOR APPL GENET, V99, P921, DOI 10.1007/s001220051399	37	97	105	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37565	10.1371/journal.pone.0037565	http://dx.doi.org/10.1371/journal.pone.0037565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662172	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300062
J	Wu, PH; Coultrap, S; Pinnix, C; Davies, KD; Tailor, R; Ang, KK; Browning, MD; Grosshans, DR				Wu, Peter H.; Coultrap, Steven; Pinnix, Chelsea; Davies, Kurtis D.; Tailor, Ramesh; Ang, Kian K.; Browning, Michael D.; Grosshans, David R.			Radiation Induces Acute Alterations in Neuronal Function	PLOS ONE			English	Article							NMDA RECEPTOR TRAFFICKING; CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; AMPA RECEPTOR; DENTATE GYRUS; ADULT-RAT; BRAIN; HIPPOCAMPAL	Every year, nearly 200,000 patients undergo radiation for brain tumors. For both patients and caregivers the most distressing adverse effect is impaired cognition. Efforts to protect against this debilitating effect have suffered from inadequate understanding of the cellular mechanisms of radiation damage. In the past it was accepted that radiation-induced normal tissue injury resulted from a progressive reduction in the survival of clonogenic cells. Moreover, because radiation-induced brain dysfunction is believed to evolve over months to years, most studies have focused on late changes in brain parenchyma. However, clinically, acute changes in cognition are also observed. Because neurons are fully differentiated post-mitotic cells, little information exists on the acute effects of radiation on synaptic function. The purpose of our study was to assess the potential acute effects of radiation on neuronal function utilizing ex vivo hippocampal brain slices. The cellular localization and functional status of excitatory and inhibitory neurotransmitter receptors was identified by immunoblotting. Electrophysiological recordings were obtained both for populations of neuronal cells and individual neurons. In the dentate gyrus region of isolated ex vivo slices, radiation led to early decreases in tyrosine phosphorylation and removal of excitatory N-methyl-D-aspartate receptors (NMDARs) from the cell surface while simultaneously increasing the surface expression of inhibitory gamma-aminobutyric acid receptors (GABA(A)Rs). These alterations in cellular localization corresponded with altered synaptic responses and inhibition of long-term potentiation. The non-competitive NMDAR antagonist memantine blocked these radiation-induced alterations in cellular distribution. These findings demonstrate acute effects of radiation on neuronal cells within isolated brain slices and open new avenues for study.	[Wu, Peter H.] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Coultrap, Steven; Davies, Kurtis D.; Browning, Michael D.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Pinnix, Chelsea; Tailor, Ramesh; Ang, Kian K.; Grosshans, David R.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; UTMD Anderson Cancer Center	Wu, PH (corresponding author), Univ Colorado Denver, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA.	dgrossha@mdanderson.org		Pinnix, Chelsea/0000-0003-3982-3664	DRG by the American Society for Radiation Oncology; American Cancer Society [IRG-08-061-01]	DRG by the American Society for Radiation Oncology; American Cancer Society(American Cancer Society)	This work was supported by awards provided to DRG by the American Society for Radiation Oncology and Grant # IRG-08-061-01 from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Coultrap SJ, 2005, MOL BRAIN RES, V135, P104, DOI 10.1016/j.molbrainres.2004.12.005; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; GROSSHANS DR, 2002, SCI STKE, pPL8; Hellier JL, 2007, J NEUROPHYSIOL, V98, P2818, DOI 10.1152/jn.00346.2007; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Meyers CA, 2006, J CLIN ONCOL, V24, P1305, DOI 10.1200/JCO.2005.04.6086; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Nakaya K, 2005, INT J RADIAT BIOL, V81, P545, DOI 10.1080/09553000500280492; PELLMAR TC, 1990, RADIAT RES, V122, P209, DOI 10.2307/3577608; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Shaw EG, 2006, J CLIN ONCOL, V24, P1415, DOI 10.1200/JCO.2005.03.3001; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun A, 2011, J CLIN ONCOL, V29, P279, DOI 10.1200/JCO.2010.29.6053; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Warrington JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030444; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7	40	62	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37677	10.1371/journal.pone.0037677	http://dx.doi.org/10.1371/journal.pone.0037677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662188	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300078
J	Zarringhalam, K; Zhang, L; Kiebish, MA; Yang, K; Han, XL; Gross, RW; Chuang, J				Zarringhalam, Kourosh; Zhang, Lu; Kiebish, Michael A.; Yang, Kui; Han, Xianlin; Gross, Richard W.; Chuang, Jeffrey			Statistical Analysis of the Processes Controlling Choline and Ethanolamine Glycerophospholipid Molecular Species Composition	PLOS ONE			English	Article							SHOTGUN LIPIDOMICS; MASS-SPECTROMETRY; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS; BIOSYNTHESIS; DECARBOXYLATION; BIOINFORMATICS; SPECIFICITY; METABOLISM; MEDIATORS	The regulation and maintenance of the cellular lipidome through biosynthetic, remodeling, and catabolic mechanisms are critical for biological homeostasis during development, health and disease. These complex mechanisms control the architectures of lipid molecular species, which have diverse yet highly regulated fatty acid chains at both the sn1 and sn2 positions. Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) serve as the predominant biophysical scaffolds in membranes, acting as reservoirs for potent lipid signals and regulating numerous enzymatic processes. Here we report the first rigorous computational dissection of the mechanisms influencing PC and PE molecular architectures from high-throughput shotgun lipidomic data. Using novel statistical approaches, we have analyzed multidimensional mass spectrometry-based shotgun lipidomic data from developmental mouse heart and mature mouse heart, lung, brain, and liver tissues. We show that in PC and PE, sn1 and sn2 positions are largely independent, though for low abundance species regulatory processes may interact with both the sn1 and sn2 chain simultaneously, leading to cooperative effects. Chains with similar biochemical properties appear to be remodeled similarly. We also see that sn2 positions are more regulated than sn1, and that PC exhibits stronger cooperative effects than PE. A key aspect of our work is a novel statistically rigorous approach to determine cooperativity based on a modified Fisher's exact test using Markov Chain Monte Carlo sampling. This computational approach provides a novel tool for developing mechanistic insight into lipidomic regulation.	[Zarringhalam, Kourosh; Zhang, Lu; Chuang, Jeffrey] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Kiebish, Michael A.; Yang, Kui; Gross, Richard W.] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Han, Xianlin] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL USA	Boston College; Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Zarringhalam, K (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	chuangj@bc.edu		Chuang, Jeffrey/0000-0002-3298-2358	Boston College Biology Department	Boston College Biology Department	This work was supported by startup funds from the Boston College Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; ARTHUR G, 1984, BIOCHIM BIOPHYS ACTA, V795, P221, DOI 10.1016/0005-2760(84)90069-9; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BORKENHAGEN L, 1961, J BIOL CHEM, V236, pPC28; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Forrester JS, 2004, MOL PHARMACOL, V65, P813, DOI 10.1124/mol.65.4.813; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Han X, 2011, MASS SPECTROMETRY RE; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Jung HR, 2011, BIOCH BIOPHYSICA ACT; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kazachkov M, 2008, LIPIDS, V43, P895, DOI 10.1007/s11745-008-3233-y; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Niemela PS, 2009, J CHROMATOGR B, V877, P2855, DOI 10.1016/j.jchromb.2009.01.025; Oresic M, 2011, BIOCH BIOPHYSICA ACT; Proschogo N, 2009, CURR OPIN LIPIDOL, V20, P522, DOI 10.1097/MOL.0b013e32833301cb; Pynn CJ, 2011, J LIPID RES, V52, P399, DOI 10.1194/jlr.d011916; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Seppanen-Laakso T, 2009, J MOL ENDOCRINOL, V42, P185, DOI 10.1677/JME-08-0150; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Torkhovskaya TI, 2007, B EXP BIOL MED+, V144, P408, DOI 10.1007/s10517-007-0342-1; Tsalouhidou S, 2006, J ANIM SCI, V84, P2818, DOI 10.2527/jas.2006-031; Vance DE, 2008, N COMP BIOC, P1; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; West LJ, 2008, J STAT SOFTW, V28, P1; Wheelock CE, 2009, METHODS MOL BIOL, V580, P339, DOI 10.1007/978-1-60761-325-1_19; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; ZELINSKI TA, 1980, J BIOL CHEM, V255, P1423; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	40	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37293	10.1371/journal.pone.0037293	http://dx.doi.org/10.1371/journal.pone.0037293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662143	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300033
J	Siboni, N; Abrego, D; Seneca, F; Motti, CA; Andreakis, N; Tebben, J; Blackall, LL; Harder, T				Siboni, Nachshon; Abrego, David; Seneca, Francois; Motti, Cherie A.; Andreakis, Nikos; Tebben, Jan; Blackall, Linda L.; Harder, Tilmann			Using Bacterial Extract along with Differential Gene Expression in Acropora millepora Larvae to Decouple the Processes of Attachment and Metamorphosis	PLOS ONE			English	Article							URCHIN HELIOCIDARIS-ERYTHROGRAMMA; SCLERACTINIAN CORAL; SEA-URCHIN; CYCLIC-AMP; SETTLEMENT; PROTEIN; INDUCTION; BIOFILMS; GENOME; STRESS	Biofilms of the bacterium Pseudoalteromonas induce metamorphosis of acroporid coral larvae. The bacterial metabolite tetrabromopyrrole (TBP), isolated from an extract of Pseudoalteromonas sp. associated with the crustose coralline alga (CCA) Neogoniolithon fosliei, induced coral larval metamorphosis (100%) with little or no attachment (0-2%). To better understand the molecular events and mechanisms underpinning the induction of Acropora millepora larval metamorphosis, including cell proliferation, apoptosis, differentiation, migration, adhesion and biomineralisation, two novel coral gene expression assays were implemented. These involved the use of reverse-transcriptase quantitative PCR (RT-qPCR) and employed 47 genes of interest (GOI), selected based on putative roles in the processes of settlement and metamorphosis. Substantial differences in transcriptomic responses of GOI were detected following incubation of A. millepora larvae with a threshold concentration and 10-fold elevated concentration of TBP-containing extracts of Pseudoalteromonas sp. The notable and relatively abrupt changes of the larval body structure during metamorphosis correlated, at the molecular level, with significant differences (p < 0.05) in gene expression profiles of 24 GOI, 12 hours post exposure. Fourteen of those GOI also presented differences in expression (p < 0.05) following exposure to the threshold concentration of bacterial TBP-containing extract. The specificity of the bacterial TBP-containing extract to induce the metamorphic stage in A. millepora larvae without attachment, using a robust, low cost, accurate, ecologically relevant and highly reproducible RT-qPCR assay, allowed partially decoupling of the transcriptomic processes of attachment and metamorphosis. The bacterial TBP-containing extract provided a unique opportunity to monitor the regulation of genes exclusively involved in the process of metamorphosis, contrasting previous gene expression studies that utilized cues, such as crustose coralline algae, biofilms or with GLW-amide neuropeptides that stimulate the entire onset of larval metamorphosis and attachment.	[Siboni, Nachshon; Abrego, David; Seneca, Francois; Motti, Cherie A.; Andreakis, Nikos; Blackall, Linda L.; Harder, Tilmann] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Tebben, Jan; Harder, Tilmann] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Tebben, Jan; Harder, Tilmann] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	Australian Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney	Siboni, N (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	N.Siboni@aims.gov.au	Seneca, Francois/F-9040-2010; Harder, Tilmann/B-6861-2008; Motti, Cherie/A-2588-2012; Abrego, David/AAT-8120-2020; Blackall, Linda Louise/AAC-4312-2020; Blackall, Linda L/H-1947-2013; Andreakis, Nikos/A-4010-2010; Tebben, Jan/ABD-2247-2020; Siboni, Nachshon/K-4202-2012	Seneca, Francois/0000-0002-8908-1227; Harder, Tilmann/0000-0003-3173-6806; Abrego, David/0000-0003-3311-2730; Blackall, Linda Louise/0000-0002-8848-7698; Blackall, Linda L/0000-0002-8848-7698; Andreakis, Nikos/0000-0001-7120-4279; Tebben, Jan/0000-0002-2780-2236; Siboni, Nachshon/0000-0001-6082-0949; Motti, Cherie/0000-0002-3292-2785	Australian Institute of Marine Science [2233]	Australian Institute of Marine Science	Funding was provided by the Australian Institute of Marine Science, Futures Project, Appropriation Fund 2233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER G, 1987, P NATL ACAD SCI USA, V84, P1867, DOI 10.1073/pnas.84.7.1867; Beltran-Ramirez V, 2010, THESIS J COOK U TOWN; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Tran C, 2011, MAR ECOL PROG SER, V433, P85, DOI 10.3354/meps09192; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chia CY, 2010, IUBMB LIFE, V62, P200, DOI 10.1002/iub.295; CLARE AS, 1995, J EXP BIOL, V198, P655; Davidson B, 2002, DEVELOPMENT, V129, P4739; Degnan SM, 2010, PHILOS T R SOC B, V365, P641, DOI 10.1098/rstb.2009.0248; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Haag ES, 1998, DEV GENES EVOL, V208, P188, DOI 10.1007/s004270050173; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hewes RS, 2000, GENETICS, V155, P1711; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; Huang YL, 2007, APPL ENVIRON MICROB, V73, P6284, DOI 10.1128/AEM.00578-07; Huang Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00228; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Jimbo M, 2010, FISHERIES SCI, V76, P355, DOI 10.1007/s12562-009-0204-z; Kenkel CD, 2011, P BIOL SCI, V26, P26; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Knack BA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-136; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li HL, 2007, THESIS HONG KONG U S; Li HL, 2008, J EXP ZOOL PART B, V310B, P417, DOI 10.1002/jez.b.21214; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; MORSE DE, 1990, B MAR SCI, V46, P465; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; PEARCE CM, 1990, BIOL BULL-US, V179, P304, DOI 10.2307/1542322; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; Qian PY, 2010, PROTEOMICS, V10, P3435, DOI 10.1002/pmic.201000199; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; RUMRILL SS, 1983, MAR BIOL, V72, P243, DOI 10.1007/BF00396829; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Williams EA, 2009, MOL ECOL, V18, P4434, DOI 10.1111/j.1365-294X.2009.04371.x; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v	64	27	27	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37774	10.1371/journal.pone.0037774	http://dx.doi.org/10.1371/journal.pone.0037774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655067	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900043
J	Kim, SM; Bhonsle, L; Besgen, P; Nickel, J; Backes, A; Held, K; Vollmer, S; Dornmair, K; Prinz, JC				Kim, Song-Min; Bhonsle, Latika; Besgen, Petra; Nickel, Jens; Backes, Anna; Held, Kathrin; Vollmer, Sigrid; Dornmair, Klaus; Prinz, Joerg C.			Analysis of the Paired TCR alpha- and beta-chains of Single Human T Cells	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; PSORIASIS-VULGARIS; CLONAL EXPANSIONS; SKIN-LESIONS; EXPRESSION; REARRANGEMENTS; REPERTOIRE; PERSIST; GENES	Analysis of the paired i.e. matching TCR alpha- and beta-chain rearrangements of single human T cells is required for a precise investigation of clonal diversity, tissue distribution and specificity of protective and pathologic T-cell mediated immune responses. Here we describe a multiplex RT-PCR based technology, which for the first time allows for an unbiased analysis of the complete sequences of both alpha- and beta-chains of TCR from single T cells. We validated our technology by the analysis of the pathologic T-cell infiltrates from tissue lesions of two T-cell mediated autoimmune diseases, psoriasis vulgaris (PV) and multiple sclerosis (MS). In both disorders we could detect various T cell clones as defined by multiple T cells with identical alpha- and beta-chain rearrangements distributed across the tissue lesions. In PV, single cell TCR analysis of lesional T cells identified clonal CD8(+) T cell expansions that predominated in the epidermis of psoriatic plaques. An MS brain lesion contained two dominant CD8(+) T-cell clones that extended over the white and grey matter and meninges. In both diseases several clonally expanded T cells carried dual TCRs composed of one V beta and two different V alpha-chain rearrangements. These results show that our technology is an efficient instrument to analyse alpha beta-T cell responses with single cell resolution in man. It should facilitate essential new insights into the mechanisms of protective and pathologic immunity in many human T-cell mediated conditions and allow for resurrecting functional TCRs from any alpha beta-T cell of choice that can be used for investigating their specificity.	[Kim, Song-Min; Besgen, Petra; Nickel, Jens; Vollmer, Sigrid; Prinz, Joerg C.] Univ Munich, Dept Dermatol, D-8000 Munich, Germany; [Bhonsle, Latika; Backes, Anna; Held, Kathrin; Dornmair, Klaus] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Bhonsle, Latika; Backes, Anna; Dornmair, Klaus] Max Planck Inst Neurobiol, Martinsried, Germany	University of Munich; University of Munich; Max Planck Society	Kim, SM (corresponding author), Univ Munich, Dept Dermatol, Frauenlobstr 9-11, D-8000 Munich, Germany.	joerg.prinz@med.uni-muenchen.de	Prinz, Jörg/AAP-9472-2021	Held, Kathrin/0000-0001-7057-6935	Deutsche Forschungsgemeinschaft [SFB-571-A1, SFB-571-A2]; Studienstiftung des Deutschen Volkes; Deutsche Multiple Sklerose Gesellschaft; German Academic Exchange Service	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; Deutsche Multiple Sklerose Gesellschaft; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the Deutsche Forschungsgemeinschaft through grants SFB-571-A1 and -A2 (to Dr. Dornmair and Dr. Prinz), the Studienstiftung des Deutschen Volkes (to Dr. Backes), the Deutsche Multiple Sklerose Gesellschaft (to Dr. Dornmair) and the German Academic Exchange Service (to Dr. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden Bernhard, 1995, Immunogenetics, V42, P455; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Besgen P, 2010, J IMMUNOL, V184, P5392, DOI 10.4049/jimmunol.0903520; CHANG JCC, 1994, P NATL ACAD SCI USA, V91, P9282, DOI 10.1073/pnas.91.20.9282; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Diluvio L, 2006, J IMMUNOL, V176, P7104, DOI 10.4049/jimmunol.176.11.7104; Dornmair K, 2009, SEMIN IMMUNOPATHOL, V31, P467, DOI 10.1007/s00281-009-0179-y; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; MENSSEN A, 1995, J IMMUNOL, V155, P4078; OKSENBERG JR, 1990, NATURE, V345, P344, DOI 10.1038/345344a0; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Prinz JC, 2003, J EUR ACAD DERMATOL, V17, P257, DOI 10.1046/j.1468-3083.2003.00720.x; PRINZ JC, 1994, EUR J IMMUNOL, V24, P593, DOI 10.1002/eji.1830240315; Seitz S, 2006, P NATL ACAD SCI USA, V103, P12057, DOI 10.1073/pnas.0604247103; Siewert K, 2011, NAT MED IN PRESS; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Vollmer S, 2001, J INVEST DERMATOL, V117, P1296, DOI 10.1046/j.0022-202x.2001.01494.x; Weisenseel P, 2002, J MED GENET, V39, P767, DOI 10.1136/jmg.39.10.767; WUCHERPFENNIG KW, 1992, J EXP MED, V175, P993, DOI 10.1084/jem.175.4.993	27	70	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37338	10.1371/journal.pone.0037338	http://dx.doi.org/10.1371/journal.pone.0037338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649519	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800037
J	Lever, M; George, PM; Elmslie, JL; Atkinson, W; Slow, S; Molyneux, SL; Troughton, RW; Richards, AM; Frampton, CM; Chambers, ST				Lever, Michael; George, Peter M.; Elmslie, Jane L.; Atkinson, Wendy; Slow, Sandy; Molyneux, Sarah L.; Troughton, Richard W.; Richards, A. Mark; Frampton, Christopher M.; Chambers, Stephen T.			Betaine and Secondary Events in an Acute Coronary Syndrome Cohort	PLOS ONE			English	Article							GLYCINE BETAINE; PLASMA HOMOCYSTEINE; CARDIOVASCULAR EVENTS; NATRIURETIC PEPTIDE; SUPPLEMENTATION; METABOLISM; CHOLINE; RISK; DERIVATIVES; OSMOLYTES	Betaine insufficiency is associated with unfavourable vascular risk profiles in metabolic syndrome patients. We investigated associations between betaine insufficiency and secondary events in acute coronary syndrome patients. Methods: Plasma (531) and urine (415) samples were collected four months after discharge following an acute coronary event. Death (34), secondary acute myocardial infarction (MI) (70) and hospital admission for heart failure (45) events were recorded over a median follow-up of 832 days. Principal Findings: The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0.0046, p = 0.013 compared with middle 60%) but not with subsequent acute MI. The lowest quintile of plasma betaine was associated with subsequent acute MI (p = 0.014), and the top quintile plasma betaine with heart failure (p = 0.043), especially in patients with diabetes (p<0.001). Top quintile plasma concentrations of dimethylglycine (betaine metabolite) and top quintile plasma homocysteine both associated with all three outcomes, acute MI (p = 0.004, <0.001), heart failure (p = 0.027, p<0.001) and survival (p<0.001, p<0.001). High homocysteine was associated with high or low betaine excretion in.60% of these subjects (p = 0.017). Median NT- proBNP concentrations were lowest in the middle quintile of plasma betaine concentration (p = 0.002). Conclusions: Betaine insufficiency indicates increased risk of secondary heart failure and acute MI. Its association with elevated homocysteine may partly explain the disappointing results of folate supplementation. In some patients, especially with diabetes, elevated plasma betaine also indicates increased risk.	[Lever, Michael; George, Peter M.; Elmslie, Jane L.; Atkinson, Wendy; Slow, Sandy; Molyneux, Sarah L.] Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand; [Lever, Michael; George, Peter M.; Slow, Sandy; Chambers, Stephen T.] Univ Otago Christchurch, Dept Pathol, Christchurch, New Zealand; [Troughton, Richard W.; Richards, A. Mark; Frampton, Christopher M.] Univ Otago Christchurch, Dept Med, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	Canterbury Health Laboratories; University of Otago; University of Otago	Lever, M (corresponding author), Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand.	michael.lever@otago.ac.nz	George, Peter M/A-1315-2013	George, Peter M/0000-0001-9100-3466; Molyneux, Sarah/0000-0001-6816-5619; Chambers, Stephen/0000-0002-0698-3285; Troughton, Richard/0000-0001-7484-4036	National Heart Foundation of New Zealand [1090]	National Heart Foundation of New Zealand	National Heart Foundation of New Zealand grant 1090; url: http://www.heartfoundation.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Armstrong LE, 2008, J STRENGTH COND RES, V22, P851, DOI 10.1519/JSC.0b013e31816a6efb; Atkinson W, 2009, NUTR METAB CARDIOVAS, V19, P767, DOI 10.1016/j.numecd.2009.01.004; Beck FX, 1998, PFLUG ARCH EUR J PHY, V436, P814, DOI 10.1007/s004240050710; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Ellis KL, 2011, J MOL CELL CARDIOL, V50, P695, DOI 10.1016/j.yjmcc.2011.01.010; Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-7; Holm PI, 2004, ARTERIOSCL THROM VAS, V24, P301, DOI 10.1161/01.ATV.0000114569.54976.31; Konstantinova SV, 2008, AM J CLIN NUTR, V88, P1663, DOI 10.3945/ajcn.2008.26531; Krupicka J, 2009, PHYSIOL RES, V58, P171, DOI 10.33549/physiolres.931461; Lee EC, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-27; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; Lever M, 2007, CLIN BIOCHEM, V40, P798, DOI 10.1016/j.clinbiochem.2007.03.009; Lever M, 2007, CLIN BIOCHEM, V40, P447, DOI 10.1016/j.clinbiochem.2006.10.029; Lever M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032460; Lever M, 2012, CLIN BIOCHEM, V45, P154, DOI 10.1016/j.clinbiochem.2011.10.021; Lever M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021666; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lever M, 2009, CARDIOVASC DRUG THER, V23, P395, DOI 10.1007/s10557-009-6188-1; Lever M, 2009, CLIN BIOCHEM, V42, P706, DOI 10.1016/j.clinbiochem.2009.02.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lv SW, 2009, EUR J NUTR, V48, P205, DOI 10.1007/s00394-009-0003-4; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Richards AM, 1999, HEART, V81, P114, DOI 10.1136/hrt.81.2.114; Rodriguez RMG, 2013, INT J CARDIOL, V167, P768, DOI 10.1016/j.ijcard.2012.03.047; Schwab U, 2006, J NUTR, V136, P34, DOI 10.1093/jn/136.1.34; Schwab U, 2011, EUR J CLIN NUTR, V65, P70, DOI 10.1038/ejcn.2010.230; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Shewan LG, 2010, INT J CARDIOL, V144, P1, DOI 10.1016/j.ijcard.2010.07.030; SIZELAND PCB, 1995, AM J PHYSIOL-RENAL, V268, pF227, DOI 10.1152/ajprenal.1995.268.2.F227; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Storer MK, 2006, J CHROMATOGR A, V1104, P263, DOI 10.1016/j.chroma.2005.11.123; Storer MK, 2006, ANAL CHIM ACTA, V558, P319, DOI 10.1016/j.aca.2005.10.060; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Wald DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016473; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wettstein M, 2000, AM J PHYSIOL-GASTR L, V278, pG227, DOI 10.1152/ajpgi.2000.278.2.G227	49	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37883	10.1371/journal.pone.0037883	http://dx.doi.org/10.1371/journal.pone.0037883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649561	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800081
J	Lin, Y; Son, H; Min, K; Lee, J; Choi, GJ; Kim, JC; Lee, YW				Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Jungkwan; Choi, Gyung Ja; Kim, Jin-Cheol; Lee, Yin-Won			A Putative Transcription Factor MYT2 Regulates Perithecium Size in the Ascomycete Gibberella zeae	PLOS ONE			English	Article							FUSARIUM-GRAMINEARUM; SEXUAL DEVELOPMENT; FUNCTIONAL ANALYSES; FEMALE FERTILITY; BINDING PROTEIN; C-MYB; GENE; FUNGUS; MORPHOGENESIS; PATHOGENESIS	The homothallic ascomycete fungus Gibberella zeae is a plant pathogen that is found worldwide, causing Fusarium head blight (FHB) in cereal crops and ear rot of maize. Ascospores formed in fruiting bodies (i.e., perithecia) are hypothesized to be the primary inocula for FHB disease. Perithecium development is a complex cellular differentiation process controlled by many developmentally regulated genes. In this study, we selected a previously reported putative transcription factor containing the Myb DNA-binding domain MYT2 for an in-depth study on sexual development. The deletion of MYT2 resulted in a larger perithecium, while its overexpression resulted in a smaller perithecium when compared to the wild-type strain. These data suggest that MYT2 regulates perithecium size differentiation. MYT2 overexpression affected pleiotropic phenotypes including vegetative growth, conidia production, virulence, and mycotoxin production. Nuclear localization of the MYT2 protein supports its role as a transcriptional regulator. Transcriptional analyses of trichothecene synthetic genes suggest that MYT2 additionally functions as a suppressor for trichothecene production. This is the first study characterizing a transcription factor required for perithecium size differentiation in G. zeae, and it provides a novel angle for understanding sexual development in filamentous fungi.	[Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Lee, Jungkwan] Dong A Univ, Dept Appl Biol, Pusan, South Korea; [Choi, Gyung Ja; Kim, Jin-Cheol] Korea Res Inst Chem Technol, Div Convergence Chem, Res Ctr Biobased Chem, Ecofriendly New Mat Res Grp, Taejon 305606, South Korea	Seoul National University (SNU); Seoul National University (SNU); Dong A University; Korea Research Institute of Chemical Technology (KRICT)	Lin, Y (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	lee2443@snu.ac.kr		Min, Kyunghun/0000-0002-2682-4660; Son, Hokyoung/0000-0001-5080-7951	National Research Foundation of Korea (NRF); Korean government (MEST) [2012-0000575]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2012-0000575). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BLACKWELL PUB PROF; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Desjardins AE, 2004, APPL ENVIRON MICROB, V70, P2437, DOI 10.1128/AEM.70.4.2437-2444.2004; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; Guldener U, 2006, FUNGAL GENET BIOL, V43, P316, DOI 10.1016/j.fgb.2006.01.005; Hallen HE, 2007, FUNGAL GENET BIOL, V44, P1146, DOI 10.1016/j.fgb.2007.04.007; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; HOHN TM, 1992, MOL PLANT MICROBE IN, V5, P249, DOI 10.1094/MPMI-5-249; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Kim JE, 2009, CURR GENET, V55, P449, DOI 10.1007/s00294-009-0258-6; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kwon SJ, 2009, VIRUS RES, V144, P96, DOI 10.1016/j.virusres.2009.04.004; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee J, 2010, BIOCHEM BIOPH RES CO, V401, P48, DOI 10.1016/j.bbrc.2010.09.005; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Lin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025586; Lipsick JS, 1996, ONCOGENE, V13, P223; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Min K, 2010, EUKARYOT CELL, V9, P1495, DOI 10.1128/EC.00083-10; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Nowrousian M, 2007, MOL MICROBIOL, V64, P923, DOI 10.1111/j.1365-2958.2007.05694.x; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; OHI R, 1994, EMBO J, V13, P471, DOI 10.1002/j.1460-2075.1994.tb06282.x; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Poggeler S., 2018, PHYSL GENETICS, V15, P325, DOI [10.1007/978-3-319-71740-1_1, DOI 10.1007/978-3-319-71740-1_1, DOI 10.1007/3-540-28135-5_16]; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Qi WH, 2006, MOL GENET GENOMICS, V276, P87, DOI 10.1007/s00438-006-0125-9; Raju NB, 2009, J BIOSCIENCES, V34, P139, DOI 10.1007/s12038-009-0015-5; Raju Namboori B., 2008, Fungal Biology Reviews, V22, P26, DOI 10.1016/j.fbr.2008.03.003; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Read ND, 1996, MYCOL RES, V100, P1281, DOI 10.1016/S0953-7562(96)80057-8; Rodriguez-Sanchez L, 2011, J CELL SCI, V124, P25, DOI 10.1242/jcs.070987; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Shen WC, 1998, GENETICS, V148, P1031; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Son H, 2012, FEMS MICROBIOL LETT, V329, P123, DOI 10.1111/j.1574-6968.2012.02511.x; Son H, 2011, FUNGAL BIOL-UK, V115, P1290, DOI 10.1016/j.funbio.2011.09.006; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Trail F, 2003, FUNGAL GENET BIOL, V38, P187, DOI 10.1016/S1087-1845(02)00529-7; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; Trail F, 2000, MYCOLOGIA, V92, P130, DOI 10.2307/3761457; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhao A, 1997, NUCLEIC ACIDS RES, V25, P904, DOI 10.1093/nar/25.4.904; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	72	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37859	10.1371/journal.pone.0037859	http://dx.doi.org/10.1371/journal.pone.0037859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649560	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335800080
J	Rattan, A; Levine, CS; Dweck, CS; Eberhardt, JL				Rattan, Aneeta; Levine, Cynthia S.; Dweck, Carol S.; Eberhardt, Jennifer L.			Race and the Fragility of the Legal Distinction between Juveniles and Adults	PLOS ONE			English	Article							CRIME POLICY; OFFENDERS; ATTITUDES; BLACK; ERA	Legal precedent establishes juvenile offenders as inherently less culpable than adult offenders and thus protects juveniles from the most severe of punishments. But how fragile might these protections be? In the present study, simply bringing to mind a Black (vs. White) juvenile offender led participants to view juveniles in general as significantly more similar to adults in their inherent culpability and to express more support for severe sentencing. Indeed, these differences in participants' perceptions of this foundational legal precedent distinguishing between juveniles and adults accounted for their greater support for severe punishment. These results highlight the fragility of protections for juveniles when race is in play. Furthermore, we suggest that this fragility may have broad implications for how juveniles are seen and treated in the criminal justice system.	[Rattan, Aneeta; Levine, Cynthia S.; Dweck, Carol S.; Eberhardt, Jennifer L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Rattan, A (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	arattan@stanford.edu; jleberhardt@stanford.edu	Rattan, Aneeta/L-7622-2015		Stanford University	Stanford University(Stanford University)	This research was supported in part by a Stanford University Dean's Award awarded to Jennifer L. Eberhardt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus DC, 1998, CORNELL LAW REV, V83, P1638; Bobo Lawrence, 2004, BOIS REV, V1.1, P151; Bobo LD, 2006, SOC RES, V73, P445; Bobo LawrenceD., 2010, DOING RACE 21 ESSAYS, P322; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Correll J, 2002, J PERS SOC PSYCHOL, V83, P1314, DOI 10.1037//0022-3514.83.6.1314; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Equal Justice Initiat, 2010, ILL RAC DISCR JUR SE; Freiburger, 2010, CRIMINAL JUSTICE POL, V21, P185, DOI [10.1177/0887403409354738, DOI 10.1177/0887403409354738]; Garland D., 2001, CULTURE CONTROL CRIM; Gilliam FD, 2000, AM J POLIT SCI, V44, P560, DOI 10.2307/2669264; Graham S, 2004, LAW HUMAN BEHAV, V28, P483, DOI 10.1023/B:LAHU.0000046430.65485.1f; GRASMICK HG, 1994, CRIMINOLOGY, V32, P23, DOI 10.1111/j.1745-9125.1994.tb01145.x; Hurwitz J, 2005, PUBLIC OPIN QUART, V69, P99, DOI 10.1093/poq/nfi004; McGonigle S, DALLAS MORNING NEWS; Mckee IR, 2008, SOC JUSTICE RES, V21, P138, DOI 10.1007/s11211-008-0066-z; Mitchell T, 2005, LAW HUMAN BEHAV, V29, P621, DOI 10.1007/s10979-005-8122-9; Peffley M, 2002, POLIT PSYCHOL, V23, P59, DOI 10.1111/0162-895X.00270; Sommers SR, 2008, SOC ISS POLICY REV, V2, P65, DOI 10.1111/j.1751-2409.2008.00011.x; Stevenson MC, 2009, J APPL SOC PSYCHOL, V39, P1660, DOI 10.1111/j.1559-1816.2009.00499.x; TURNER BM, 1986, J CRIM JUST, V14, P61, DOI 10.1016/0047-2352(86)90027-9; US Census Bureau, 2000, SPEC TAB REP AM BAR	24	48	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36680	10.1371/journal.pone.0036680	http://dx.doi.org/10.1371/journal.pone.0036680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649496	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800013
J	Aini, H; Ochi, H; Iwata, M; Okawa, A; Koga, D; Okazaki, M; Sano, A; Asou, Y				Aini, Hailati; Ochi, Hiroki; Iwata, Munetaka; Okawa, Atsushi; Koga, Daisuke; Okazaki, Mutsumi; Sano, Atsushi; Asou, Yoshinori			Procyanidin B3 Prevents Articular Cartilage Degeneration and Heterotopic Cartilage Formation in a Mouse Surgical Osteoarthritis Model	PLOS ONE			English	Article							PROANTHOCYANIDIN-RICH EXTRACT; NITRIC-OXIDE SYNTHASE; APOPTOTIC CHONDROCYTE DEATH; GRAPE SEED EXTRACT; IN-VIVO; HYALURONIC-ACID; METABOLIC ABNORMALITIES; SELECTIVE-INHIBITION; APPLE POLYPHENOLS; EXPRESSION	Osteoarthritis (OA) is a common disease in the elderly due to an imbalance in cartilage degradation and synthesis. Heterotopic ossification (HO) occurs when ectopic masses of endochondral bone form within the soft tissues around the joints and is triggered by inflammation of the soft tissues. Procyanidin B3 (B3) is a procyanidin dimer that is widely studied due to its high abundance in the human diet and antioxidant activity. Here, we evaluated the role of B3 isolated from grape seeds in the maintenance of chondrocytes in vitro and in vivo. We observed that B3 inhibited H2O2-induced apoptosis in primary chondrocytes, suppressed H2O2- or IL-1 beta-induced nitric oxide synthase (iNOS) production, and prevented IL-1 beta-induced suppression of chondrocyte differentiation marker gene expression in primary chondrocytes. Moreover, B3 treatment enhanced the early differentiation of ATDC5 cells. To examine whether B3 prevents cartilage destruction in vivo, OA was surgically induced in C57BL/6J mice followed by oral administration of B3 or vehicle control. Daily oral B3 administration protected articular cartilage from OA and prevented chondrocyte apoptosis in surgically-induced OA joints. Furthermore, B3 administration prevented heterotopic cartilage formation near the surgical region. iNOS protein expression was enhanced in the synovial tissues and the pseudocapsule around the surgical region in OA mice fed a control diet, but was reduced in mice that received B3. Together, these data indicated that in the OA model, B3 prevented OA progression and heterotopic cartilage formation, at least in a part through the suppression of iNOS. These results support the potential therapeutic benefits of B3 for treatment of human OA and heterotopic ossification.	[Aini, Hailati; Okazaki, Mutsumi] Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Ochi, Hiroki] Keio Univ, Dept Internal Med, Tokyo, Japan; [Iwata, Munetaka] Nippon Vet & Life Sci Univ, Sch Vet Med, Div Vet Surg, Tokyo, Japan; [Okawa, Atsushi; Koga, Daisuke; Asou, Yoshinori] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan; [Sano, Atsushi] Kikkoman Foods Inc, Div Res & Dev, Chiba, Japan	Tokyo Medical & Dental University (TMDU); Keio University; Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU); Kikkoman Corporation	Aini, H (corresponding author), Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Tokyo, Japan.	aso.orth@tmd.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Japanese Ministry of Education, Culture, Sports, Science and Technology [C21591935]; Kikkoman Corporation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kikkoman Corporation	This work was supported by Grants-in-Aid for Scientific Research (Grant Number C21591935) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and also by the Kikkoman Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akiyama H, 2000, BIOL PHARM BULL, V23, P1370, DOI 10.1248/bpb.23.1370; Akiyama H, 2005, FEBS LETT, V579, P4485, DOI 10.1016/j.febslet.2005.07.019; Andreutti D, 1999, J SUBMICR CYTOL PATH, V31, P173; Ariga T, 2004, BIOFACTORS, V21, P197, DOI 10.1002/biof.552210140; Asada S, 2001, INFLAMM RES, V50, P19, DOI 10.1007/s000110050719; Bartlett CS, 2006, BONE, V38, P322, DOI 10.1016/j.bone.2005.08.016; Beck KF, 1998, FEBS LETT, V435, P35, DOI 10.1016/S0014-5793(98)01035-7; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Carando S, 1999, J AGR FOOD CHEM, V47, P4161, DOI 10.1021/jf9810564; Carini M, 2000, LIFE SCI, V67, P1799, DOI 10.1016/S0024-3205(00)00771-2; Cheng AWM, 2011, OSTEOARTHR CARTILAGE, V19, P118, DOI 10.1016/j.joca.2010.10.019; Clancy RM, 1997, J CELL PHYSIOL, V172, P183, DOI 10.1002/(SICI)1097-4652(199708)172:2<183::AID-JCP5>3.0.CO;2-K; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Diaz-Gallego L, 2005, J ORTHOP RES, V23, P1370, DOI 10.1016/j.orthres.2005.05.003; Eisengart CA, 2000, CELL IMMUNOL, V204, P143, DOI 10.1006/cimm.2000.1686; FUKUDA K, 1995, INFLAMM RES, V44, P434, DOI 10.1007/BF01757700; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; HAKANSSON L, 1980, J CLIN INVEST, V66, P298, DOI 10.1172/JCI109857; Hamid N, 2010, J BONE JOINT SURG AM, V92A, P2032, DOI 10.2106/JBJS.I.01435; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hibasami H, 2004, INT J MOL MED, V13, P795; Hosalkar H, 2011, J BONE JOINT SURG AM, V93A, P1367, DOI 10.2106/JBJS.K.00448; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kim HA, 1999, ARTHRITIS RHEUM, V42, P1528, DOI 10.1002/1529-0131(199907)42:7<1528::AID-ANR28>3.0.CO;2-9; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim J, 2010, OSTEOARTHR CARTILAGE, V18, P424, DOI 10.1016/j.joca.2009.09.008; Koga T, 1999, J AGR FOOD CHEM, V47, P1892, DOI 10.1021/jf9810517; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; Kuhn K, 2003, J CELL PHYSIOL, V197, P379, DOI 10.1002/jcp.10372; Lotz M, 1999, RHEUM DIS CLIN N AM, V25, P269, DOI 10.1016/S0889-857X(05)70067-3; Maneiro E, 2005, ANN RHEUM DIS, V64, P388, DOI 10.1136/ard.2004.022152; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MANKIN HJ, 1973, FED PROC, V32, P1478; McInnes LB, 1996, J EXP MED, V184, P1519, DOI 10.1084/jem.184.4.1519; Nizamutdinova IT, 2009, FOOD CHEM TOXICOL, V47, P2806, DOI 10.1016/j.fct.2009.08.016; Oizumi Y, 2010, J ORG CHEM, V75, P4884, DOI 10.1021/jo1009382; Pelletier JP, 2000, ARTHRITIS RHEUM-US, V43, P1290, DOI 10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinde-Axtell Z, 2006, J AGR FOOD CHEM, V54, P9978, DOI 10.1021/jf060974w; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Sano A, 2003, BIOSCI BIOTECH BIOCH, V67, P1140, DOI 10.1271/bbb.67.1140; Scher Jose U, 2007, Curr Rheumatol Rep, V9, P9, DOI 10.1007/s11926-007-0016-z; Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741; Shah R, 2005, ARTHRITIS RHEUM-US, V52, P2799, DOI 10.1002/art.21239; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stevens AL, 2008, OSTEOARTHR CARTILAGE, V16, P489, DOI 10.1016/j.joca.2007.07.015; Takahashi T, 1999, J INVEST DERMATOL, V112, P310, DOI 10.1046/j.1523-1747.1999.00532.x; TASKIRAN D, 1994, BIOCHEM BIOPH RES CO, V200, P142, DOI 10.1006/bbrc.1994.1426; Yamaguchi F, 1999, J AGR FOOD CHEM, V47, P2544, DOI 10.1021/jf9806762; Yamakoshi J, 2004, PHYTOTHER RES, V18, P895, DOI 10.1002/ptr.1537; Yamakoshi J, 2003, PIGM CELL RES, V16, P629, DOI 10.1046/j.1600-0749.2003.00093.x; Yamakoshi J, 2002, J AGR FOOD CHEM, V50, P4983, DOI 10.1021/jf0201632; Yanagida A, 2000, J AGR FOOD CHEM, V48, P5666, DOI 10.1021/jf000363i; Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021; Zhao J, 1999, CARCINOGENESIS, V20, P1737, DOI 10.1093/carcin/20.9.1737	58	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37728	10.1371/journal.pone.0037728	http://dx.doi.org/10.1371/journal.pone.0037728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629448	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300071
J	Hatanaka, K; Lanahan, AA; Murakami, M; Simons, M				Hatanaka, Kunihiko; Lanahan, Anthony A.; Murakami, Masahiro; Simons, Michael			Fibroblast Growth Factor Signaling Potentiates VE-Cadherin Stability at Adherens Junctions by Regulating SHP2	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; TYROSINE PHOSPHORYLATION; BARRIER FUNCTION; DEPENDENT ENDOCYTOSIS; PARACELLULAR PATHWAY; CELLS; PERMEABILITY; P120-CATENIN; ASSOCIATION; ACTIVATION	Background: The fibroblast growth factor (FGF) system plays a critical role in the maintenance of vascular integrity via enhancing the stability of VE-cadherin at adherens junctions. However, the precise molecular mechanism is not well understood. In the present study, we aimed to investigate the detailed mechanism of FGF regulation of VE-cadherin function that leads to endothelial junction stabilization. Methods and Findings: In vitro studies demonstrated that the loss of FGF signaling disrupts the VE-cadherin-catenin complex at adherens junctions by increasing tyrosine phosphorylation levels of VE-cadherin. Among protein tyrosine phosphatases (PTPs) known to be involved in the maintenance of the VE-cadherin complex, suppression of FGF signaling reduces SHP2 expression levels and SHP2/VE-cadherin interaction due to accelerated SHP2 protein degradation. Increased endothelial permeability caused by FGF signaling inhibition was rescued by SHP2 overexpression, indicating the critical role of SHP2 in the maintenance of endothelial junction integrity. Conclusions: These results identify FGF-dependent maintenance of SHP2 as an important new mechanism controlling the extent of VE-cadherin tyrosine phosphorylation, thereby regulating its presence in adherens junctions and endothelial permeability.	[Hatanaka, Kunihiko; Lanahan, Anthony A.; Murakami, Masahiro; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University	Hatanaka, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	Masahiro.Murakami@Yale.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	NIH [HL053793]; AHA Scientist Development Grant [10SDG4170137]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107205, R01HL053793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH grant HL053793 (http://www.nhlbi.nih.gov/; MS) and AHA Scientist Development Grant 10SDG4170137 (http://www.americanheart.org/presenter.jhtml?identifier = 3059907; MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Esser S, 1998, J CELL SCI, V111, P1853; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Ha CH, 2008, J BIOL CHEM, V283, P7261, DOI 10.1074/jbc.M702881200; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Hudry-Clergeon H, 2005, FASEB J, V19, P512, DOI 10.1096/fj.04-2202com; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Murakami M, 2011, J CLIN INVEST; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Murakami M, 2009, J MOL MED, V87, P571, DOI 10.1007/s00109-009-0463-2; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pepper MS, 1998, EXP CELL RES, V241, P414, DOI 10.1006/excr.1998.4072; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Turowski P, 2008, J CELL SCI, V121, P29, DOI 10.1242/jcs.022681; UENO H, 1992, J BIOL CHEM, V267, P1470; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Vestweber D, 2010, CURR OPIN HEMATOL, V17, P230, DOI 10.1097/MOH.0b013e328338664b; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094	43	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37600	10.1371/journal.pone.0037600	http://dx.doi.org/10.1371/journal.pone.0037600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629427	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300058
J	Hebert, S; Canlon, B; Hasson, D; Hanson, LLM; Westerlund, H; Theorell, T				Hebert, Sylvie; Canlon, Barbara; Hasson, Dan; Hanson, Linda L. Magnusson; Westerlund, Hugo; Theorell, Tores			Tinnitus Severity Is Reduced with Reduction of Depressive Mood - a Prospective Population Study in Sweden	PLOS ONE			English	Article							HEARING-LOSS; D PERSONALITY; PREVALENCE; SYMPTOMS; ADULTS; HEALTH; NOISE	Tinnitus, the perception of sound without external source, is a highly prevalent public health problem with about 8% of the population having frequently occurring tinnitus, and about 1-2% experiencing significant distress from it. Population studies, as well as studies on self-selected samples, have reported poor psychological well-being in individuals with tinnitus. However, no study has examined the long-term co-variation between mood and tinnitus prevalence or tinnitus severity. In this study, the relationship between depression and tinnitus prevalence and severity over a 2-year period was examined in a representative sample of the general Swedish working population. Results show that a decrease in depression is associated with a decrease in tinnitus prevalence, and even more markedly with tinnitus severity. Hearing loss was a more potent predictor than depression for tinnitus prevalence, but was a weaker predictor than depression for tinnitus severity. In addition, there were sex differences for tinnitus prevalence, but not for tinnitus severity. This study shows a direct and long-term association between tinnitus severity and depression.	[Hebert, Sylvie] Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, BRAMS,Int Lab Brain Mus & Sound Res, Montreal, PQ H3C 3J7, Canada; [Hebert, Sylvie] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Hasson, Dan; Hanson, Linda L. Magnusson; Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Theorell, Tores] Karolinska Inst, Dept Publ Hlth, Stockholm, Sweden; [Canlon, Barbara; Hasson, Dan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Universite de Montreal; Universite de Montreal; Stockholm University; Karolinska Institutet; Karolinska Institutet	Hebert, S (corresponding author), Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, BRAMS,Int Lab Brain Mus & Sound Res, Montreal, PQ H3C 3J7, Canada.	sylvie.hebert@umontreal.ca	Hasson, Dan/T-9262-2019; Westerlund, Hugo/A-3049-2012; Hanson, Linda L Magnusson/D-2435-2017	Westerlund, Hugo/0000-0002-8806-5698; Hanson, Linda L Magnusson/0000-0002-2908-1903; Canlon, Barbara/0000-0002-4377-5266; Theorell, Tores/0000-0003-1956-7931	FAS Centre for Research on Hearing Problems in Working Life and Tysta Skolan; Swedish Medical Research Council; FAS Centre for Research on Hearing Problems in Working Life; Karolinska Institute; Tysta Skolan; Fondation Caroline-Durand; Swedish Council for Working Life and Social Research (FAS)	FAS Centre for Research on Hearing Problems in Working Life and Tysta Skolan; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); FAS Centre for Research on Hearing Problems in Working Life; Karolinska Institute(Karolinska Institutet); Tysta Skolan; Fondation Caroline-Durand; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Swedish Council for Working Life and Social Research (FAS). DH is supported by a grant from FAS Centre for Research on Hearing Problems in Working Life and Tysta Skolan. BC is supported from the Swedish Medical Research Council, FAS Centre for Research on Hearing Problems in Working Life, the Karolinska Institute, and Tysta Skolan. SH is supported by Fondation Caroline-Durand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Bartels H, 2010, OTOL NEUROTOL, V31, P11, DOI 10.1097/MAO.0b013e3181bc3dd1; Bartels H, 2010, PSYCHOSOMATICS, V51, P29, DOI 10.1176/appi.psy.51.1.29; Beck AT, 1996, BDI 2 BECK DEPRESSIO, Vvi, P38; Bulbul SF, 2009, INT J PEDIATR OTORHI, V73, P1124, DOI 10.1016/j.ijporl.2009.04.018; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Gopinath B, 2010, ANN EPIDEMIOL, V20, P129, DOI 10.1016/j.annepidem.2009.09.002; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hebert S, PSYCHOTHER IN PRESS; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Holgers KM, 2000, AUDIOLOGY, V39, P284; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2011, WORLD J BIOL PSYCHIA; Lipman R.S., 1986, ASSESSMENT DEPRESSIO, P232, DOI [DOI 10.1007/978-3-642-70486-4_22, 10.1007/978-3-642-70486-4_22]; Martinez Devesa P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub2; Ooms E, 2011, OTOLARYNG HEAD NECK, V145, P276, DOI 10.1177/0194599811403381; Palmer KT, 2002, OCCUP ENVIRON MED, V59, P634, DOI 10.1136/oem.59.9.634; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Saunders GH, 2009, NOISE HEALTH, V11, P14, DOI 10.4103/1463-1741.45308; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schlee W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027379; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003	28	52	57	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37733	10.1371/journal.pone.0037733	http://dx.doi.org/10.1371/journal.pone.0037733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629449	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300072
J	Ban, Y; Tozaki, T; Taniyama, M; Skrabanek, L; Nakano, Y; Ban, Y; Hirano, T				Ban, Yoshiyuki; Tozaki, Teruaki; Taniyama, Matsuo; Skrabanek, Luce; Nakano, Yasuko; Ban, Yoshio; Hirano, Tsutomu			Multiple SNPs in Intron 41 of Thyroglobulin Gene Are Associated with Autoimmune Thyroid Disease in the Japanese Population	PLOS ONE			English	Article							GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; SUSCEPTIBILITY LOCI; C/T POLYMORPHISM; UNITED-STATES; CD40 GENE; REGION; VARIANTS; EXON-33; COMMON	Background: The etiology of the autoimmune thyroid diseases (AITDs), Graves' disease (GD) and Hashimoto's thyroiditis (HT), is largely unknown. However, genetic susceptibility is believed to play a major role. Two whole genome scans from Japan and from the US identified a locus on chromosome 8q24 that showed evidence for linkage with AITD and HT. Recent studies have demonstrated an association between thyroglobulin (Tg) polymorphisms and AITD in Caucasians, suggesting that Tg is a susceptibility gene on 8q24. Objectives: The objective of the study was to refine Tg association with AITD, by analyzing a panel of 25 SNPs across an extended 260 kb region of the Tg. Methods: We studied 458 Japanese AITD patients (287 GD and 171 HT patients) and 221 matched Japanese control subjects in association studies. Case-control association studies were performed using 25 Tg single nucleotide polymorphisms (SNPs) chosen from a database of the Single Nucleotide Polymorphism Database (dbSNP). Haplotype analysis was undertaken using the computer program SNPAlyze version 7.0. Principal Findings and Conclusions: In total, 5 SNPs revealed association with GD (P<0.05), with the strongest SNP associations at rs2256366 (P = 0.002) and rs2687836 (P = 0.0077), both located in intron 41 of the Tg gene. Because of the strong LD between these two strongest associated variants, we performed the haplotype analysis, and identified a major protective haplotype for GD (P = 0.001). These results suggested that the Tg gene is involved in susceptibility for GD and AITD in the Japanese.	[Ban, Yoshiyuki; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan; [Tozaki, Teruaki; Nakano, Yasuko] Showa Univ, Sch Pharm, Dept Pharmacogen, Shinagawa Ku, Tokyo, Japan; [Taniyama, Matsuo] Showa Univ, Fujigaoka Hosp, Div Endocrinol & Metab, Yokohama, Kanagawa 227, Japan; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Ban, Yoshio] Ban Thyroid Clin, Meguro Ku, Tokyo, Japan	Showa University; Showa University; Showa University; Cornell University; Cornell University	Ban, Y (corresponding author), Showa Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan.	yshyban@yahoo.co.jp; yshyban@yahoo.co.jp	Tozaki, Teruaki/ABD-9286-2021	Tozaki, Teruaki/0000-0001-8797-6644	Showa University; Showa University School of Medicine Alumni Association; Yamaguchi Endocrine Research Association; Grants-in-Aid for Scientific Research [23590474] Funding Source: KAKEN	Showa University; Showa University School of Medicine Alumni Association; Yamaguchi Endocrine Research Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Showa University Grant-in-aid for Innovative Collaborative Research Projects (to Yoshiyuki Ban), a grant from the Showa University School of Medicine Alumni Association (to Yoshiyuki Ban), and a grant from the Yamaguchi Endocrine Research Association (to Yoshiyuki Ban). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ban Y, 2004, CLIN ENDOCRINOL, V61, P263, DOI 10.1111/j.1365-2265.2004.02096.x; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Ban YY, 2003, AUTOIMMUNITY, V36, P367, DOI 10.1080/08916930310001603037; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Collins JE, 2004, J CLIN ENDOCR METAB, V89, P6336, DOI 10.1210/jc.2004-1336; Collins JE, 2003, J CLIN ENDOCR METAB, V88, P5039, DOI 10.1210/jc.2003-030093; Davies T.F., 2000, WERNER INGBARS THYRO, P518; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hsiao JY, 2007, J CLIN ENDOCR METAB, V92, P3197, DOI 10.1210/jc.2007-0675; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Kim TY, 2003, THYROID, V13, P919, DOI 10.1089/105072503322511319; MANGKLABRUKS A, 1991, J CLIN ENDOCR METAB, V73, P236, DOI 10.1210/jcem-73-2-236; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Stefan M, 2011, J BIOL CHEM, V286, P31168, DOI 10.1074/jbc.M111.247510; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 1997, CLIN IMMUNOL IMMUNOP, V82, P3, DOI 10.1006/clin.1996.4243; Weetman Anthony P., 1996, P738; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yanagawa T, 1997, THYROID, V7, P843, DOI 10.1089/thy.1997.7.843; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41	31	37	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37501	10.1371/journal.pone.0037501	http://dx.doi.org/10.1371/journal.pone.0037501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662162	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300052
J	Cardone, L; Bardelli, A; Avvedimento, VE				Cardone, Luca; Bardelli, Alberto; Avvedimento, Vittorio Enrico			Activation of beta-Catenin by Oncogenic PIK3CA and EGFR Promotes Resistance to Glucose Deprivation by Inducing a Strong Antioxidant Response	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TUMOR-CELL GROWTH; OXIDATIVE STRESS; PROTEIN-KINASE; BREAST-CANCER; HIGH-FREQUENCY; LUNG-CANCER; METABOLISM; MUTATIONS; GENE	Glucose is an essential fuel for cell survival and its availability limits aberrant cellular proliferation. We have hypothesized that specific cancer mutations regulate metabolic response(s) to glucose deprivation (GD). By means of somatic knock-in cellular models, we have analyzed the response to glucose deprivation in cells carrying the frequent (delE746-A750)EGFR, (G13D)KRAS or (E545K)PIK3CA cancer alleles. We demonstrate that, in mammary epithelial cells, glucose has an essential antioxidant function and that these cells are very sensitive to GD. Conversely, isogenic cells carrying the (delE746-A750)EGFR or the (E545K)PIK3CA, but not the (G13D)KRAS allele, display high tolerance to GD by stimulating the expression of anti-oxidant genes (MnSOD and catalase). This adaptive transcriptional response is mediated by the activation of WNT/beta-catenin and FOXO4 signalling. Our data highlights a new functional synergism between oncogenic EGFR and PIK3CA with WNT/beta-catenin conferring high tolerance to oxidative stress generated by nutrient deprivation.	[Cardone, Luca; Avvedimento, Vittorio Enrico] Univ Naples Federico II, Sch Med, Dept Biol & Cellular & Mol Pathol, Naples, Italy; [Bardelli, Alberto] Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, Turin, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol IFOM, Milan, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; IFOM - FIRC Institute of Molecular Oncology	Cardone, L (corresponding author), Telethon Inst Genet & Med TIGEM, Naples, Italy.	lcardone@tigem.it; avvedim@unina.it	; BARDELLI, Alberto/J-9721-2018	Cardone, Luca/0000-0001-8184-2856; BARDELLI, Alberto/0000-0003-1647-5070	Associazione Italiana Ricerca sul Cancro (AIRC) [IG11364]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from the Associazione Italiana Ricerca sul Cancro (AIRC), IG11364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Blancher C, 2001, CANCER RES, V61, P7349; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Dansen TB, 2011, ANTIOXID REDOX SIGN, V14, P559, DOI 10.1089/ars.2010.3778; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Ennen M, 2011, FREE RADICAL BIO MED, V50, P1771, DOI 10.1016/j.freeradbiomed.2011.03.013; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Nelson KK, 2003, CLIN CANCER RES, V9, P424; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	47	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37526	10.1371/journal.pone.0037526	http://dx.doi.org/10.1371/journal.pone.0037526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662165	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300055
J	Hardy, C; Fara, E; Laffont, R; Dommergues, JL; Meister, C; Neige, P				Hardy, Clotilde; Fara, Emmanuel; Laffont, Remi; Dommergues, Jean-Louis; Meister, Christian; Neige, Pascal			Deep-Time Phylogenetic Clustering of Extinctions in an Evolutionarily Dynamic Clade (Early Jurassic Ammonites)	PLOS ONE			English	Article							TAXONOMIC SELECTIVITY; RISK; HISTORY; AUTOCORRELATION; DIVERSITY; PATTERNS; TETHYS; FUTURE; THREAT; SIGNAL	Conservation biologists and palaeontologists are increasingly investigating the phylogenetic distribution of extinctions and its evolutionary consequences. However, the dearth of palaeontological studies on that subject and the lack of methodological consensus hamper our understanding of that major evolutionary phenomenon. Here we address this issue by (i) reviewing the approaches used to quantify the phylogenetic selectivity of extinctions and extinction risks; (ii) investigating with a high-resolution dataset whether extinctions and survivals were phylogenetically clustered among early Pliensbachian (Early Jurassic) ammonites; (iii) exploring the phylogenetic and temporal maintenance of this signal. We found that ammonite extinctions were significantly clumped phylogenetically, a pattern that prevailed throughout the 6.6 Myr-long early Pliensbachian interval. Such a phylogenetic conservatism did not alter - or may even have promoted - the evolutionary success of this major cephalopod clade. However, the comparison of phylogenetic autocorrelation among studies remains problematic because the notion of phylogenetic conservatism is scale-dependent and the intensity of the signal is sensitive to temporal resolution. We recommend a combined use of Moran's I, Pearson's phi and Fritz and Purvis' D statistics because they highlight different facets of the phylogenetic pattern of extinctions and/or survivals.	[Hardy, Clotilde; Fara, Emmanuel; Laffont, Remi; Dommergues, Jean-Louis; Neige, Pascal] Univ Bourgogne, Lab Biogeosci, CNRS, UMR 6282, Dijon, France; [Meister, Christian] Museum Hist Nat Geneve, Dept Geol & Paleontol, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Geneva	Hardy, C (corresponding author), Univ Bourgogne, Lab Biogeosci, CNRS, UMR 6282, Dijon, France.	clotilde.hardy@u-bourgogne.fr	FARA, Emmanuel/B-8840-2013; Neige, Pascal/A-3346-2012; Neige, Pascal/ABC-8451-2021	FARA, Emmanuel/0000-0002-7991-4467; Neige, Pascal/0000-0002-6543-3611	Fondation pour la Recherche sur la Biodiversite (FRB)	Fondation pour la Recherche sur la Biodiversite (FRB)	This work is part of the project "PhyloDiv" kindly funded by the Fondation pour la Recherche sur la Biodiversite (FRB, http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2004, EVOL ECOL, V18, P273, DOI 10.1023/B:EVEC.0000035072.54176.5a; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1991, EXTINCTION BAD GENES; [Anonymous], [No title captured]; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bielby J, 2006, ANIM CONSERV, V9, P135, DOI 10.1111/j.1469-1795.2005.00013.x; Bilotta M, 2010, GEOBIOS-LYON, V43, P581, DOI 10.1016/j.geobios.2010.05.002; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Corey SJ, 2008, DIVERS DISTRIB, V14, P614, DOI 10.1111/j.1472-4642.2007.00448.x; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Davis Richard Arnold, 1996, Topics in Geobiology, V13, P463; Dera G, 2010, J GEOL SOC LONDON, V167, P21, DOI 10.1144/0016-76492009-068; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Dommergues J-L, 1997, B CTR RECHERCHE ELF, P347; Dommergues J-L, 2012, ACTA PALAEO IN PRESS, DOI 10.4202/app.2011.0148; Dommergues Jean-Louis, 2011, Revue de Paleobiologie, V30, P193; Dommergues Jean-Louis, 1999, Revue de Paleobiologie, V18, P273; Dommergues JL, 2009, PALAEOGEOGR PALAEOCL, V280, P64, DOI 10.1016/j.palaeo.2009.06.005; Dommergues JL, 2002, PALAEOGEOGR PALAEOCL, V184, P407, DOI 10.1016/S0031-0182(02)00276-6; Dommergues JL, 2001, PALAEOGEOGR PALAEOCL, V165, P195, DOI 10.1016/S0031-0182(00)00160-7; Doyle Peter, 1994, Palaeopelagos Special Publication, V1, P109; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; Escarguel G, 2011, CR BIOL, V334, P351, DOI 10.1016/j.crvi.2011.02.006; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Gittleman JL, 1998, BIODIVERSITY DYNAMICS, P51; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Green WA, 2011, PALEOBIOLOGY, V37, P72, DOI 10.1666/09078.1; Guilford J., 1936, PSYCHOMETRIC METHODS; Harnik PG, 2011, P NATL ACAD SCI USA, V108, P13594, DOI 10.1073/pnas.1100572108; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Hoffmann Rene, 2010, Revue de Paleobiologie, V29, P1; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Legendre P., 2012, NUMERICAL ECOLOGY; Lockwood JL, 2002, CONSERV BIOL, V16, P1137, DOI 10.1046/j.1523-1739.2002.01152.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Meister Christian, 2000, Revue de Paleobiologie, V19, P227; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Orme D., 2008, CAIC COMP ANAL USING; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Purvis A, 2005, CONSERV BIOL SER, V8, P295; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Ricotta C, 2004, DIVERS DISTRIB, V10, P143, DOI 10.1111/j.1366-9516.2004.00069.x; Rosales I, 2004, PALAEOGEOGR PALAEOCL, V203, P253, DOI 10.1016/S0031-0182(03)00686-2; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sjostrom A, 2006, J BIOGEOGR, V33, P271, DOI 10.1111/j.1365-2699.2005.01393.x; Upton GJG, 1985, SPATIAL DATA ANAL EX; VENTURI F., 2010, AMMONITI VIAGGIO GEO	56	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37977	10.1371/journal.pone.0037977	http://dx.doi.org/10.1371/journal.pone.0037977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662258	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300150
J	Hassan, F; Ren, DB; Zhang, WH; Merkel, TJ; Gu, XX				Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Merkel, Tod J.; Gu, Xin-Xing			Moraxella catarrhalis Activates Murine Macrophages through Multiple Toll Like Receptors and Has Reduced Clearance in Lungs from TLR4 Mutant Mice	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSES; MOUSE MODEL; SEROTYPE-A; RECOGNITION; EXPRESSION; LIPOPOLYSACCHARIDE; TOLL-LIKE-RECEPTOR-4; PATHOGEN; CHILDREN	Moraxella catarrhalis is a Gram negative bacterium and a leading causative agent of otitis media (OM) in children. Several recent reports have provided strong evidence for an association between toll like receptors and OM. It has been found that both Streptococcus pneumoniae and nontypeable Haemophilus influenzae activate host protective immune responses through toll like receptors (TLRs), however, the precise mechanism by which Moraxella catarrhalis initiates the host immune response is currently unknown. In this report, using murine macrophages generated from a series of knock-out mice, we have demonstrated that M. catarrhalis lipooligosaccharide (LOS) and either heat killed or live bacteria are recognized by one or more TLRs. LOS activates the host immune response through a membrane bound CD14-TLR4 complex, while both heat killed and live M. cat require recognition by multiple toll like receptors such as TLR2, TLR4 and TLR9 without the requirement of CD14. We have also shown that M. cat stimuli are capable of triggering the host innate immune response by both MyD88- and TRIF- dependent signaling pathways. We further showed that M. cat induced activation of mitogen activated protein kinase (MAPK) is essential in order to achieve optimal secretion of pro-inflammatory cytokine TNF-alpha. We finally showed that TLR4 mutant C3H/HeJ mice produce significantly lower levels of pro-inflammatory cytokines TNF-alpha and IL-6 in vivo, An increased bacterial loads at 12 and 24 hours (P<0.001) in their lungs upon challenge with live M. cat in an aerosol chamber compared to wild-type (WT) control mice. These data suggest that TLRs are crucial for an effective innate immune response induced by M. cat. The results of these studies contribute to an increased understanding of molecular mechanism and possible novel treatment strategies for diseases caused by M. cat by specifically targeting TLRs and their signaling pathways.	[Hassan, Ferdaus; Ren, Dabin; Zhang, Wenhong; Gu, Xin-Xing] Natl Inst Deafness & Other Commun Disorders, Vaccine Res Sect, Rockville, MD USA; [Merkel, Tod J.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); US Food & Drug Administration (FDA)	Hassan, F (corresponding author), Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA.	hassanmf@umkc.edu; guxx@mail.nih.gov	Ren, Dabin/H-6263-2013		Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America [NIH0010103632]	Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America	This research was supported by the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America (#NIH0010103632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; EDEBRINK P, 1994, CARBOHYD RES, V257, P269, DOI 10.1016/0008-6215(94)80040-5; FADEN H, 1992, INFECT IMMUN, V60, P3824, DOI 10.1128/IAI.60.9.3824-3829.1992; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Granath A, 2011, J INFECTION, V63, P174, DOI 10.1016/j.jinf.2011.06.006; Granath A, 2010, ACTA OTO-LARYNGOL, V130, P57, DOI 10.3109/00016480902963061; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hirano T, 2007, FEMS IMMUNOL MED MIC, V49, P75, DOI 10.1111/j.1574-695X.2006.00186.x; Hirano T, 2009, INT J PEDIATR OTORHI, V73, P1657, DOI 10.1016/j.ijporl.2009.08.015; Hu WG, 2001, INFECT IMMUN, V69, P1358, DOI 10.1128/IAI.69.3.1358-1363.2001; Hu WG, 1999, VACCINE, V18, P799, DOI 10.1016/S0264-410X(99)00335-7; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim MG, 2010, INT J PEDIATR OTORHI, V74, P1425, DOI 10.1016/j.ijporl.2010.09.026; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee YC, 2008, CLIN EXP OTORHINOLAR, V1, P189, DOI 10.3342/ceo.2008.1.4.189; Leibovitz E, 2004, PEDIATR INFECT DIS J, V23, P1142, DOI 10.1097/01.inf.0000148233.57296.90; Leichtle A, 2012, INNATE IMMUN-LONDON, V18, P3, DOI 10.1177/1753425910393539; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Slevogt H, 2007, CELL MICROBIOL, V9, P694, DOI 10.1111/j.1462-5822.2006.00821.x; Szczepanski M, 2006, EUR ARCH OTO-RHINO-L, V263, P603, DOI 10.1007/s00405-006-0030-1; VANEECHOUTTE M, 1990, J CLIN MICROBIOL, V28, P182, DOI 10.1128/JCM.28.2.182-187.1990; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37610	10.1371/journal.pone.0037610	http://dx.doi.org/10.1371/journal.pone.0037610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662179	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300069
J	Niizato, T; Gunji, YP				Niizato, Takayuki; Gunji, Yukio-Pegio			Fluctuation-Driven Flocking Movement in Three Dimensions and Scale-Free Correlation	PLOS ONE			English	Article							COLLECTIVE ANIMAL BEHAVIOR; FISH SCHOOLS; DENSITY; MODEL; SIMULATION; MECHANISM	Recent advances in the study of flocking behavior have permitted more sophisticated analyses than previously possible. The concepts of "topological distances'' and "scale-free correlations'' are important developments that have contributed to this improvement. These concepts require us to reconsider the notion of a neighborhood when applied to theoretical models. Previous work has assumed that individuals interact with neighbors within a certain radius (called the "metric distance''). However, other work has shown that, assuming topological interactions, starlings interact on average with the six or seven nearest neighbors within a flock. Accounting for this observation, we previously proposed a metric-topological interaction model in two dimensions. The goal of our model was to unite these two interaction components, the metric distance and the topological distance, into one rule. In our previous study, we demonstrated that the metrictopological interaction model could explain a real bird flocking phenomenon called scale-free correlation, which was first reported by Cavagna et al. In this study, we extended our model to three dimensions while also accounting for variations in speed. This three-dimensional metric-topological interaction model displayed scale-free correlation for velocity and orientation. Finally, we introduced an additional new feature of the model, namely, that a flock can store and release its fluctuations.	[Niizato, Takayuki; Gunji, Yukio-Pegio] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Gunji, Yukio-Pegio] Kobe Univ, Fac Sci, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Niizato, T (corresponding author), Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan.	t_niizato@yahoo.co.jp			 [21300093]		Funding provided by Grants-in-aid for Scientific Research (21300093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Bode NWF, 2010, J THEOR BIOL, V267, P292, DOI 10.1016/j.jtbi.2010.08.034; Bode W.F., 2010, J R SOC INTERFACE; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2010, PNAS; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Czirok A., 2006, COLLECTIVE BEHAV INT; Ginelli F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168103; Goldstone RL, 2009, TOP COGN SCI, V1, P412, DOI 10.1111/j.1756-8765.2009.01038.x; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Gregoire G, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011902; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022479; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Lukeman R, 2010, PNAS, V107, P12577; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Moussaid M, 2009, TOP COGN SCI, V1, P469, DOI 10.1111/j.1756-8765.2009.01028.x; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Niizato T, 2010, ARE FLOCKS IN PRESS; Niizato T, 2011, ECOL MODEL, V222, P3041, DOI 10.1016/j.ecolmodel.2011.06.008; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Strefler J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031927; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Szabo P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021908; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; VOS PG, 1988, PSYCHOL RES-PSYCH FO, V50, P148, DOI 10.1007/BF00310175; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	36	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35615	10.1371/journal.pone.0035615	http://dx.doi.org/10.1371/journal.pone.0035615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662109	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300004
J	Robinson, L; Spencer, MD; Thomson, LDG; Stanfield, AC; Owens, DGC; Hall, J; Johnstone, EC				Robinson, Louise; Spencer, Michael D.; Thomson, Lindsay D. G.; Stanfield, Andrew C.; Owens, David G. C.; Hall, Jeremy; Johnstone, Eve C.			Evaluation of a Screening Instrument for Autism Spectrum Disorders in Prisoners	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; FUNCTIONING AUTISM; ASPERGER-SYNDROME; COMMUNITY; PREVALENCE; EPIDEMIOLOGY; INTERVIEW; DEFICITS; ADULTS	There have been concerns that individuals with autism spectrum disorders (ASDs) are over-represented but not recognised in prison populations. A screening tool for ASDs in prisons has therefore been developed. Aims: We aimed to evaluate this tool in Scottish prisoners by comparing scores with standard measures of autistic traits (Autism Quotient (AQ)), neurodevelopmental history (Asperger Syndrome (and High-Functioning Autism) Diagnostic Interview (ASDI)), and social cognition (Ekman 60 Faces test). Methods: Prison officers across all 12 publicly-run closed prisons in Scotland assessed convicted prisoners using the screening tool. This sample included male and female prisoners and both adult and young offenders. Prisoners with high scores, along with an equal number of age and sex-matched controls, were invited to take part in interviews. Prisoners' relatives were contacted to complete a neurodevelopmental assessment. Results: 2458 prisoners were screened using the tool, and 4% scored above the cut-off. 126 prisoners were further assessed using standardised measures. 7 of those 126 assessed scored 32 or above (cut-off) on the AQ. 44 interviews were completed with prisoners' relatives, no prisoner reached the cut-off score on the ASDI. Scores on the screening tool correlated significantly with AQ and ASDI scores, and not with the Ekman 60 Faces Test or IQ. Sensitivity was 28.6% and specificity 75.6%; AUC was 59.6%. Conclusions: Although this screening tool measures autistic traits in this population, sensitivity for scores of 32 or above on the AQ is poor. We consider that this limits its usefulness and do not recommend that the tool is routinely used to screen for ASDs in prisons.	[Robinson, Louise; Thomson, Lindsay D. G.; Owens, David G. C.; Hall, Jeremy; Johnstone, Eve C.] Univ Edinburgh, Div Psychiat, Sch Mol & Clin Med, Edinburgh, Midlothian, Scotland; [Spencer, Michael D.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Stanfield, Andrew C.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Cambridge; University of Edinburgh	Robinson, L (corresponding author), Univ Edinburgh, Div Psychiat, Sch Mol & Clin Med, Edinburgh, Midlothian, Scotland.	Louise.Robinson@ed.ac.uk	Stanfield, Andrew/AFQ-1896-2022; Robinson, Louise/AAE-1570-2021	Robinson, Louise/0000-0001-6455-1360; Hall, Jeremy/0000-0002-0403-3278; Stanfield, Andrew/0000-0003-2459-1434; Spencer, Michael/0000-0002-1646-5254	Anthony Oliver bequest	Anthony Oliver bequest	This study was supported by the Anthony Oliver bequest, a financial donation to the Division of Psychiatry, University of Edinburgh in 1996. This is not a profit-making organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MW, 2011, EUR CHILD ADOLES PSY, V20, P599, DOI 10.1007/s00787-011-0220-2; Allen D, 2008, J AUTISM DEV DISORD, V38, P748, DOI 10.1007/s10803-007-0442-9; AMMONS RB, 1962, PSYCHOL REP, V11, P111, DOI 10.1177/003329416201100106; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Birmingham L, 2005, PSYCHIATR BULL, V29, P334, DOI 10.1192/pb.29.9.334; Brugha T, 2005, AM J PSYCHIAT, V162, P774, DOI 10.1176/appi.ajp.162.4.774; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; DAVIDSON M, 1995, BRIT J PSYCHIAT, V167, P545, DOI 10.1192/bjp.167.4.545; Ekman P., 1976, PICTURES FACIAL AFFE; Enterprise Ireland, 2009, ANN REPORT ACCOUNTS; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fraser A, 2007, BRIT MED J; Gillberg C, 2001, AUTISM, V5, P57, DOI 10.1177/1362361301005001006; GOLDBERG DP, 1970, BRIT J PREV SOC MED, V24, P18; Hare D.J., 1999, PRELIMINARY STUDY IN; Hassiotis A, 2011, BRIT J PSYCHIAT, V199, P156, DOI 10.1192/bjp.bp.110.088039; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MacAskill S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-865; Mouridsen SE, 2012, RES AUTISM SPECT DIS, V6, P79, DOI 10.1016/j.rasd.2011.09.003; Murphy D, 2011, J FORENSIC PSYCHI PS, V22, P518, DOI 10.1080/14789949.2011.596942; Myers F, 2004, FORENSIC OTHER SPECI; Philip RCM, 2010, PSYCHOL MED, V40, P1919, DOI 10.1017/S0033291709992364; Robinson L, 2012, INT J LAW PSYCHIAT, V35, P57, DOI 10.1016/j.ijlp.2011.11.009; SCHONELL FJ, 1960, DIAGNOSTIC ATTAINMEN; SCRAGG P, 1994, BRIT J PSYCHIAT, V165, P679, DOI 10.1192/bjp.165.5.679; Singleton N., 1998, PSYCHIAT MORBIDITY P; Siponmaa L, 2001, J AM ACAD PSYCHIATRY, V29, P420; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Wing L, 2008, SCREENING INSTRUMENT; Woodbury-Smith MR, 2006, J FORENSIC PSYCHI PS, V17, P108, DOI 10.1080/14789940600589464	32	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36078	10.1371/journal.pone.0036078	http://dx.doi.org/10.1371/journal.pone.0036078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UY	22662113	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305342300007
J	Shah, SB; Sahinidis, NV				Shah, Shweta B.; Sahinidis, Nikolaos V.			SAS-Pro: Simultaneous Residue Assignment and Structure Superposition for Protein Structure Alignment	PLOS ONE			English	Article							DATABASE; CLASSIFICATION; SEQUENCE; SEARCH; SIMILARITIES	Protein structure alignment is the problem of determining an assignment between the amino-acid residues of two given proteins in a way that maximizes a measure of similarity between the two superimposed protein structures. By identifying geometric similarities, structure alignment algorithms provide critical insights into protein functional similarities. Existing structure alignment tools adopt a two-stage approach to structure alignment by decoupling and iterating between the assignment evaluation and structure superposition problems. We introduce a novel approach, SAS-Pro, which addresses the assignment evaluation and structure superposition simultaneously by formulating the alignment problem as a single bilevel optimization problem. The new formulation does not require the sequentiality constraints, thus generalizing the scope of the alignment methodology to include non-sequential protein alignments. We employ derivative-free optimization methodologies for searching for the global optimum of the highly nonlinear and non-differentiable RMSD function encountered in the proposed model. Alignments obtained with SAS-Pro have better RMSD values and larger lengths than those obtained from other alignment tools. For non-sequential alignment problems, SAS-Pro leads to alignments with high degree of similarity with known reference alignments. The source code of SAS-Pro is available for download at http://eudoxus.cheme.cmu.edu/saspro/SAS-Pro.html.	[Shah, Shweta B.; Sahinidis, Nikolaos V.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Sahinidis, Nikolaos V.] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Shah, SB (corresponding author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.	sahinidis@cmu.edu	Sahinidis, Nikolaos V/L-7951-2016	Sahinidis, Nikolaos V/0000-0003-2087-9131				ALEXANDROV NN, 1992, J MOL BIOL, V225, P5, DOI 10.1016/0022-2836(92)91021-G; Alexandrov NN, 1996, ANAL TOPOLOGICAL NON; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreani R, 2008, IMA J NUMER ANAL, V28, P690, DOI 10.1093/imanum/drn012; Andreani R, 2008, MATH PROGRAM, V112, P93, DOI 10.1007/s10107-006-0091-3; Caprara A, 2004, J COMPUT BIOL, V11, P27, DOI 10.1089/106652704773416876; Carr RD, 2000, SAND20002171 SAND NA; Dell'Amico M, 2001, DISCRETE APPL MATH, V110, P25, DOI 10.1016/S0166-218X(00)00301-2; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Gerstein M, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P59; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 1996, NUCLEIC ACIDS RES, V24, P206, DOI 10.1093/nar/24.1.206; HUBER R, 1971, EUR J BIOCHEM, V19, P42, DOI 10.1111/j.1432-1033.1971.tb01285.x; Huyer W, 2008, ACM T MATH SOFTWARE, V35, DOI 10.1145/1377612.1377613; Kleywegt GJ, 1994, NEWSLETTER PROTEIN C, V31, P9; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Kolodny R, 2004, P NATL ACAD SCI USA, V101, P12201, DOI 10.1073/pnas.0404383101; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lackner P, 2000, PROTEIN ENG, V13, P745, DOI 10.1093/protein/13.11.745; Lancia G, 2004, MATH METHODS PROTEIN, V2666/2004, P1; Lancia G, 2001, P 5 ANN INT C COMP B, P193, DOI [10.1145/369133.369199, DOI 10.1145/369133.369199]; Mayr G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-50; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Rios L., 2009, THESIS U ILLINOIS UR; Rios LM, 2011, DERIVATIVE FREE OPTI; Rocha J, 2009, BIOINFORMATICS, V25, P1625, DOI 10.1093/bioinformatics/btp296; Salem Saeed, 2009, Journal of Bioinformatics and Computational Biology, V7, P571, DOI 10.1142/S0219720009004205; Salem S, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-12; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Singh AP, 2001, NATURE STRUCTURAL BI; SIPPL MJ, 1982, J MOL BIOL, V156, P359, DOI 10.1016/0022-2836(82)90334-5; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Wohlers I, 2010, BIOINFORMATICS, V26, P2273, DOI 10.1093/bioinformatics/btq420; Wu T D, 1998, Pac Symp Biocomput, P509; Xie W, 2007, J COMPUT BIOL, V14, P637, DOI 10.1089/cmb.2007.R007; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37493	10.1371/journal.pone.0037493	http://dx.doi.org/10.1371/journal.pone.0037493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662161	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300051
J	van Well, GTJ; Sanders, MS; Ouburg, S; van Furth, AM; Morre, SA				van Well, Gijs Th J.; Sanders, Marieke S.; Ouburg, Sander; van Furth, A. Marceline; Morre, Servaas A.			Polymorphisms in Toll-Like Receptors 2, 4, and 9 Are Highly Associated with Hearing Loss in Survivors of Bacterial Meningitis	PLOS ONE			English	Article							EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; INVASIVE MENINGOCOCCAL DISEASE; MANNOSE-BINDING LECTIN; STREPTOCOCCUS-PNEUMONIAE; INNATE IMMUNITY; FUNCTIONAL CONSEQUENCES; INFLAMMATORY RESPONSES; PATHOGEN RECOGNITION; SCHOOL-AGE; CHILDREN	Genetic variation in innate immune response genes contributes to inter-individual differences in disease manifestation and degree of complications upon infection. We recently described an association of single nucleotide polymorphisms (SNPs) in TLR9 with susceptibility to meningococcal meningitis (MM). In this study, we investigate the association of SNPs in multiple pathogen recognition and immune response genes with clinical features that determine severity and outcome (especially hearing loss) of childhood MM and pneumococcal meningitis (PM). Eleven SNPs in seven genes (TLR2, TLR4, TLR9, NOD1, NOD2, CASP1, and TRAIL) were genotyped in 393 survivors of childhood bacterial meningitis (BM) (327 MM patients and 66 PM patients). Genotype distributions of single SNPs and combination of SNPs were compared between thirteen clinical characteristics associated with severity of BM. After correction for multiple testing, TLR4+896 mutant alleles were highly associated with post-meningitis hearing loss, especially MM (p = 0.001, OR 4.0 for BM, p = 0.0004, OR 6.2 for MM). In a multigene analysis, combined carriership of the TLR2+2477 wild type (WT) with TLR4+896 mutant alleles increases the risk of hearing loss (p < 0.0001, OR 5.7 in BM and rho = 0.0001, OR 7.6 in MM). Carriage of one or both mutant alleles in TLR4+896 and TLR9-1237 increases the risk for hearing loss (p = 0.0006, OR 4.1 in BM). SNPs in immune response genes contribute to differences in clinical severity and outcome of BM. The TLR system seems to play an important role in the immune response to BM and subsequent neuronal damage as well as in cochlear inflammation. Genetic markers may be used for identification of high-risk patients by creating prediction rules for post-meningitis hearing loss and other sequelae, and provide more insight in the complex immune response in the CNS possibly resulting in new therapeutic interventions.	[van Well, Gijs Th J.; Sanders, Marieke S.; van Furth, A. Marceline] Vrije Univ Amsterdam, Dept Pediat Infect Dis Immunol & Rheumatol, Med Ctr, Amsterdam, Netherlands; [Sanders, Marieke S.; Ouburg, Sander; Morre, Servaas A.] Vrije Univ Amsterdam, Immunogenet Lab, Dept Med Microbiol, Med Ctr, Amsterdam, Netherlands; [van Well, Gijs Th J.] Maastricht Univ, Dept Pediat, Med Ctr, Maastricht, Netherlands; [Sanders, Marieke S.] St Antonius Hosp, Dept Surg, Nieuwegein, Netherlands; [Morre, Servaas A.] Univ Maastricht, Inst Publ Hlth Genom, Dept Genet & Cell Biol, Res Inst CAPHRI,Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Morre, Servaas A.] Univ Maastricht, GROW Sch Oncol & Dev Biol, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; St. Antonius Hospital Utrecht; Maastricht University; Maastricht University	van Well, GTJ (corresponding author), Vrije Univ Amsterdam, Dept Pediat Infect Dis Immunol & Rheumatol, Med Ctr, Amsterdam, Netherlands.	samorretravel@yahoo.co.uk	van Well, Gijs/L-3904-2013; Ouburg, Sander/H-5775-2019	Ouburg, Sander/0000-0002-2092-0002; Van Furth, Marceline/0000-0003-1666-8956				Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen A, 2003, PEDIATR INFECT DIS J, V22, P1018, DOI 10.1097/01.inf.0000095431.15606.68; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Blankenberg S, 2006, CIRC RES, V99, P102, DOI 10.1161/01.RES.0000232324.87983.4b; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Chavez-Bueno S, 2005, PEDIATR CLIN N AM, V52, P795, DOI 10.1016/j.pcl.2005.02.011; CHAVEZBUENO S, 2005, PEDIATR CLIN N AM, V52, pR7; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; de Jonge RCJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-232; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Faber J, 2007, PEDIATR INFECT DIS J, V26, P243, DOI 10.1097/01.inf.0000256751.76218.7c; Faber J, 2009, ACTA PAEDIATR, V98, P548, DOI 10.1111/j.1651-2227.2008.01163.x; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; HARRIS JP, 1995, OTOLARYNG HEAD NECK, V112, P639, DOI 10.1016/S0194-5998(95)70170-2; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Klein M, 2008, INFECTION, V36, P2, DOI 10.1007/s15010-007-7153-1; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2007, J INFECT DIS, V195, P1189, DOI 10.1086/512859; Koedel U, 2002, ANN NEUROL, V51, P319, DOI 10.1002/ana.10103; Koedel U, 2009, CURR TOP MICROBIOL, V336, P15, DOI 10.1007/978-3-642-00549-7_2; Koomen I, 2004, ACTA PAEDIATR, V93, P1378, DOI 10.1080/08035250410033349; Koomen I, 2003, PEDIATRICS, V112, P1049, DOI 10.1542/peds.112.5.1049; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lu WG, 2010, WORLD J GASTROENTERO, V16, P4348, DOI 10.3748/wjg.v16.i34.4348; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Sam-Agudu NA, 2010, AM J TROP MED HYG, V82, P548, DOI 10.4269/ajtmh.2010.09-0467; Sanders MS, 2011, GENES IMMUN, V12, P321, DOI 10.1038/gene.2011.20; Sanders MS, 2011, CLIN INFECT DIS, V52, P475, DOI 10.1093/cid/ciq155; Sanders MS, 2012, PEDIATRICS IN PRESS; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; Theiner G, 2008, MOL IMMUNOL, V45, P244, DOI 10.1016/j.molimm.2007.02.021; Weber A, 2004, J NEUROIMMUNOL, V149, P195, DOI 10.1016/j.jneuroim.2003.12.014; Winter AJ, 1997, INFECT IMMUN, V65, P4411, DOI 10.1128/IAI.65.11.4411-4418.1997; Yoshimura A, 1999, J IMMUNOL, V163, P1; Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155	49	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e35837	10.1371/journal.pone.0035837	http://dx.doi.org/10.1371/journal.pone.0035837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662111	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300006
J	Gonoi, W; Akai, H; Hagiwara, K; Akahane, M; Hayashi, N; Maeda, E; Yoshikawa, T; Kiryu, S; Tada, M; Uno, K; Ohtsu, H; Okura, N; Koike, K; Ohtomo, K				Gonoi, Wataru; Akai, Hiroyuki; Hagiwara, Kazuchika; Akahane, Masaaki; Hayashi, Naoto; Maeda, Eriko; Yoshikawa, Takeharu; Kiryu, Shigeru; Tada, Minoru; Uno, Kansei; Ohtsu, Hiroshi; Okura, Naoki; Koike, Kazuhiko; Ohtomo, Kuni			Meandering Main Pancreatic Duct as a Relevant Factor to the Onset of Idiopathic Recurrent Acute Pancreatitis	PLOS ONE			English	Article							MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; DIAGNOSTIC-CRITERIA; MR CHOLANGIOPANCREATOGRAPHY; PROGNOSTIC FACTORS; ODDI MANOMETRY; SPINK1 GENE; CFTR GENE; DIVISUM; SYSTEM; ASSOCIATION	Background: Meandering main pancreatic duct (MMPD), which comprises loop type and reverse-Z type main pancreatic duct (MPD), has long been discussed its relation to pancreatitis. However, no previous study has investigated its clinical significance. We aimed to determine the non-biased prevalence and the effect of MMPD on idiopathic pancreatitis using non-invasive magnetic resonance (MR) technique. Methods and Findings: A cross-sectional study performed in a tertiary referral center. The study enrolled 504 subjects from the community and 30 patients with idiopathic pancreatitis (7 acute, 13 chronic, and 10 recurrent acute). All subjects underwent MR scanning and medical examination. MMPD was diagnosed when the MPD in the head of pancreas formed two or more extrema in the horizontal direction on coronal images of MR cholangiopancreatography, making a loop or a reverse-Z shaped hairpin curves and not accompanied by other pancreatic ductal anomaly. Statistical comparison was made among groups on the rate of MMPD including loop and reverse-Z subtypes, MR findings, and clinical features. The rate of MMPD was significantly higher for all idiopathic pancreatitis/idiopathic recurrent acute pancreatitis (RAP) (20%/40%; P<0.001/0.0001; odds ratio (OR), 11.1/29.0) than in the community (2.2%) but was not higher for acute/chronic pancreatitis (14%/8%; P = 0.154/0.266). Multiple logistic regression analysis revealed MMPD to be a significant factor that induces pancreatitis/RAP (P<0.0001/0.0001; OR, 4.01/26.2). Loop/reverse-Z subtypes were found more frequently in idiopathic RAP subgroup (20%/20%; P = 0.009/0.007; OR, 20.2/24.2) than in the community (1.2%/1.0%). The other clinical and radiographic features were shown not associated with the onset of pancreatitis. Conclusions: MMPD is a common anatomical variant and might be a relevant factor to the onset of idiopathic RAP.	[Gonoi, Wataru; Akai, Hiroyuki; Hagiwara, Kazuchika; Akahane, Masaaki; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan; [Hayashi, Naoto; Maeda, Eriko; Yoshikawa, Takeharu; Uno, Kansei] Tokyo Univ Hosp, Dept Computat Diagnost Radiol & Prevent Med, Bunkyo Ku, Tokyo 113, Japan; [Kiryu, Shigeru] Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo, Japan; [Tada, Minoru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Ohtsu, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Clin Bioinformat, Bunkyo Ku, Tokyo, Japan; [Okura, Naoki] Kanto Rosai Hosp, Japan Labour Hlth & Welf Org, Dept Radiol, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Gonoi, W (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan.	watapi-tky@umin.net	Kiryu, Shigeru/B-6867-2019; Gonoi, Wataru/AAB-2160-2019; Akai, Hiroyuki/G-8962-2018; Ohtsu, Hiroshi/ABF-2536-2021	Kiryu, Shigeru/0000-0003-1440-9483; Gonoi, Wataru/0000-0002-5018-4683; Akai, Hiroyuki/0000-0002-6494-1091; Ohtsu, Hiroshi/0000-0003-3261-8828				Bang S, 2006, YONSEI MED J, V47, P243, DOI 10.3349/ymj.2006.47.2.243; BLAMEY SL, 1984, GUT, V25, P1340, DOI 10.1136/gut.25.12.1340; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Bret PM, 1996, RADIOLOGY, V199, P99, DOI 10.1148/radiology.199.1.8633179; Carnes ML, 2008, PANCREAS, V37, P151, DOI 10.1097/MPA.0b013e318164cbaf; COTTON PB, 1980, GUT, V21, P105, DOI 10.1136/gut.21.2.105; Coyle WJ, 2002, ENDOSCOPY, V34, P617, DOI 10.1055/s-2002-33245; Crisan LS, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.003; Delhaye M, 2008, WORLD J GASTROENTERO, V14, P1027, DOI 10.3748/wjg.14.1027; Dray X, 2007, PANCREAS, V35, P90, DOI 10.1097/MPA.0b013e318054771f; Garg PK, 2009, J CLIN GASTROENTEROL, V43, P848, DOI 10.1097/MCG.0b013e3181a4e772; Gonoi W, 2011, CLIN IMAG, V35, P442, DOI 10.1016/j.clinimag.2011.01.002; Gonoi W, 2011, GUT, V60, P1103, DOI 10.1136/gut.2010.230011; Ishii H, 1998, J Hepatobiliary Pancreat Surg, V5, P327, DOI 10.1007/s005340050054; Kamisawa T, 2007, SURG RADIOL ANAT, V29, P405, DOI 10.1007/s00276-007-0220-6; Kamisawa T, 2004, DIGESTION, V70, P146, DOI 10.1159/000081293; Kamisawa T, 1999, DIGESTION, V60, P161, DOI 10.1159/000007642; Kamisawa T, 2007, PANCREAS, V34, P96; Kaw M, 2002, GASTROINTEST ENDOSC, V55, P157, DOI 10.1067/mge.2002.118944; Koizumi M, 2006, J HEPATO-BILIARY-PAN, V13, P25, DOI 10.1007/s00534-005-1048-2; Kume K, 2005, PANCREATOLOGY, V5, P354, DOI 10.1159/000086535; Li ZS, 1998, WORLD J GASTROENTERO, V4, P178; Liao Z, 2009, ENDOSCOPY, V41, P439, DOI 10.1055/s-0029-1214505; Matos C, 2001, GASTROINTEST ENDOSC, V53, P728, DOI 10.1067/mge.2001.114784; Matsuno S, 1996, COMMITTEE INTRACTABL, P27; Milosavljevic T, 2010, DIGEST DIS, V28, P330, DOI 10.1159/000319409; Ogawa M, 2002, PANCREAS, V25, P325, DOI 10.1097/00006676-200211000-00001; Otsuki M, 2008, J GASTROENTEROL, V43, P403, DOI 10.1007/s00535-008-2205-6; Quest L, 2000, GUT, V47, P317, DOI 10.1136/gut.47.3.317; RANSON JHC, 1982, AM J GASTROENTEROL, V77, P633; RESHEF R, 1988, AM J GASTROENTEROL, V83, P86; Sajith KG, 2010, DIGEST DIS SCI, V55, P3610, DOI 10.1007/s10620-010-1175-8; Shanbhogue AKP, 2009, RADIOGRAPHICS, V29, P1003, DOI 10.1148/rg.294085748; Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Soto JA, 2005, RADIOLOGY, V235, P503, DOI 10.1148/radiol.2352040342; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; TANAKA T, 1992, AM J GASTROENTEROL, V87, P806; Vitellas KM, 2000, RADIOGRAPHICS, V20, P939, DOI 10.1148/radiographics.20.4.g00jl23939; Weiss FU, 2005, GUT, V54, P1456, DOI 10.1136/gut.2005.064808	39	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37652	10.1371/journal.pone.0037652	http://dx.doi.org/10.1371/journal.pone.0037652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655061	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900037
J	Liu, Q; Nie, JH; Huang, WJ; Meng, SF; Yuan, BZ; Gao, DY; Xu, XM; Wang, YC				Liu, Qiang; Nie, Jianhui; Huang, Weijin; Meng, Shufang; Yuan, Baozhu; Gao, Dongying; Xu, Xuemei; Wang, Youchun			Comparison of Two High-Throughput Assays for Quantification of Adenovirus Type 5 Neutralizing Antibodies in a Population of Donors in China	PLOS ONE			English	Article							ANTI-VECTOR IMMUNITY; PREEXISTING IMMUNITY; GENE-THERAPY; VACCINE; EPIDEMIOLOGY; INHIBITION; PREVALENCE; SEROTYPE-5; RESPONSES; AFRICA	Background: The presence of various levels of Adenovirus serotype 5 neutralizing antibodies (Ad5NAb) is thought to contribute to the inconsistent clinical results obtained from vaccination and gene therapy studies. Currently, two platforms based on high-throughput technology are available for Ad5NAb quantification, chemiluminescence- and fluorescence-based assays. The aim of this study was to compare the results of two assays in the seroepidemiology of Ad5NAb in a local population of donors. Methodology/Principal Findings: The fluorescence-based neutralizing antibody detection test (FRNT) using recombinant Ad5-EGFP virus and the chemiluminescence-based neutralizing antibody test (CLNT) using Ad5-Fluc were developed and standardized for detecting the presence of Ad5NAb in serum samples from the population of donors in Beijing and Anhui provinces, China. First, the overall percentage of people positive for Ad5NAb performed by CLNT was higher than that obtained by FRNT (85.4 vs 69.9%, p<0.001). There was an 84.5% concordance between the two assays for the 206 samples tested (144 positive in both assays and 30 negative in both assays). All 32 discordant sera were CLNT-positive/FRNT-negative and were confirmed positive by western blot. Secondly, for all 144 sera positive by both assays, the two assays showed high correlation (r = 0.94, p<0.001) and close agreement (mean difference: 0.395 log(10), 95% CI: -0.054 log(10) to 0.845 log(10)). Finally, it was found by both assays that there was no significant difference observed for titer or prevalence by gender (p = 0.503 vs 0.818, for two assays); however, age range (p = 0.049 vs 0.010) and geographic origin (p = 0.007 vs 0.011) were correlated with Ad5NAb prevalence in northern regions of China. Conclusion: The CLNT assay was relatively more simple and had higher sensitivity than the FRNT assay for determining Ad5NAb titers. It is strongly suggested that the CLNT assay be used for future epidemiological studies of Ad5NAb in other localities.	[Liu, Qiang; Nie, Jianhui; Huang, Weijin; Meng, Shufang; Yuan, Baozhu; Wang, Youchun] Natl Inst Food & Drug Control, Dept Cell Biol, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China; [Liu, Qiang; Xu, Xuemei] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Dept Biophys & Struct Biol,Sch Basic Med, Beijing 100730, Peoples R China; [Gao, Dongying] Beijing Blood Ctr, Beijing, Peoples R China	National Institute of Food & Drug Control - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Liu, Q (corresponding author), Natl Inst Food & Drug Control, Dept Cell Biol, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China.	xuemeixu@vip.sina.com; wychun3@yahoo.com	huang, weijin/AAY-5028-2020	huang, weijin/0000-0002-4246-8889	National Science and Technology Major Project [2009ZX10004-801]	National Science and Technology Major Project	This study was supported by grants from National Science and Technology Major Project (2009ZX10004-801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Bradley RR, 2011, J VIROL; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; Cohen Philip, 2006, IAVI Rep, V10, P1; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Dash R, 2011, DISCOV MED, V11, P46; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Gahery-Segard H, 1998, J VIROL, V72, P2388; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; Jenne L, 2001, TRENDS IMMUNOL, V22, P102, DOI 10.1016/S1471-4906(00)01813-5; Jones FR, 2011, VACCINE, V29, P7020, DOI 10.1016/j.vaccine.2011.07.073; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Osada T, 2009, CANCER GENE THER, V16, P673, DOI 10.1038/cgt.2009.17; Pichla-Gollon SL, 2009, J VIROL, V83, P5567, DOI 10.1128/JVI.00405-09; Pilankatta R, 2010, J MED VIROL, V82, P407, DOI 10.1002/jmv.21721; Pine SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018526; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Seregin SS, 2009, EXPERT OPIN BIOL TH, V9, P1521, DOI 10.1517/14712590903307388; Smith JG, 2010, CURR TOP MICROBIOL, V343, P195, DOI 10.1007/82_2010_16; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Sun CJ, 2011, VACCINE, V29, P3837, DOI 10.1016/j.vaccine.2011.03.042; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Vincent T, 2001, J VIROL, V75, P1516, DOI 10.1128/JVI.75.3.1516-1521.2001; Wang TB, 2010, WORLD J GASTROENTERO, V16, P5122, DOI 10.3748/wjg.v16.i40.5122; Yang TT, 1997, BIOTECHNIQUES, V23, P1110, DOI 10.2144/97236pf01; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328	32	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37532	10.1371/journal.pone.0037532	http://dx.doi.org/10.1371/journal.pone.0037532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655054	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900030
J	Rodriguez, AM; Pascutti, MF; Maeto, C; Falivene, J; Holgado, MP; Turk, G; Gherardi, MM				Maria Rodriguez, Ana; Fernanda Pascutti, Maria; Maeto, Cynthia; Falivene, Juliana; Pia Holgado, Maria; Turk, Gabriela; Magdalena Gherardi, Maria			IL-12 and GM-CSF in DNA/MVA Immunizations against HIV-1 CRF12_BF Nef Induced T-Cell Responses With an Enhanced Magnitude, Breadth and Quality	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COLONY-STIMULATING FACTOR; BOOST VACCINE REGIMEN; IMMUNE-RESPONSE; DNA VACCINE; PRIMARY INFECTION; RISK-FACTORS; TYPE-1; IMMUNOGENICITY; SUBTYPE	In Argentina, the HIV epidemic is characterized by the co-circulation of subtype B and BF recombinant viral variants. Nef is an HIV protein highly variable among subtypes, making it a good tool to study the impact of HIV variability in the vaccine design setting. We have previously reported a specific cellular response against NefBF with low cross-reactivity to NefB in mice. The aim of this work was to analyze whether the co-administration of IL-12 and GM-CSF, using DNA and MVA vaccine vectors, could improve the final cellular response induced. Mice received three DNA priming doses of a plasmid that express NefBF plus DNAs expressing IL-12 and/or GM-CSF. Afterwards, all the groups were boosted with a MVAnefBF dose. The highest increase in the magnitude of the NefBF response, compared to that induced in the control was found in the IL-12 group. Importantly, a response with higher breadth was detected in groups which received IL-12 or GM-CSF, evidenced as an increased frequency of recognition of homologous (BF) and heterologous (B) Nef peptides, as well as a higher number of other Nef peptide pools representing different viral subtypes. However, these improvements were lost when both DNA cytokines were simultaneously administered, as the response was focused against the immunodominant peptide with a detrimental response towards subdominant epitopes. The pattern of cytokines secreted and the specific-T-cell proliferative capacity were improved in IL-12 and IL-12+GM-CSF groups. Importantly IL-12 generated a significant higher T-cell avidity against a B heterologous peptide. This study indicates that the incorporation of DNA expressing IL-12 in DNA/MVA schemes produced the best results in terms of improvements of T-cell-response key properties such as breadth, cross-reactivity and quality (avidity and pattern of cytokines secreted). These relevant results contribute to the design of strategies aimed to induce T-cell responses against HIV antigens with higher quality.	[Maria Rodriguez, Ana; Fernanda Pascutti, Maria; Maeto, Cynthia; Falivene, Juliana; Pia Holgado, Maria; Turk, Gabriela; Magdalena Gherardi, Maria] Univ Buenos Aires, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina	University of Buenos Aires	Rodriguez, AM (corresponding author), Univ Buenos Aires, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	mgherardi@fmed.uba.ar		Pascutti, Maria Fernanda/0000-0003-3212-780X; Falivene, Juliana/0000-0003-3437-4863	Argentinean National Research Council (CONICET); ANPCYT [0459]; Spain Agency for International Cooperation for Development [A/031560/10]; Argentinean Agency for the Promotion of Science and Technology (ANPCyT)	Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCYT(ANPCyT); Spain Agency for International Cooperation for Development; Argentinean Agency for the Promotion of Science and Technology (ANPCyT)(ANPCyT)	AMR was supported by the Argentinean Agency for the Promotion of Science and Technology (ANPCyT) and the Argentinean National Research Council (CONICET). This study has been funded by ANPCYT grant 0459 and Spain Agency for International Cooperation for Development grant A/031560/10 to MMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Ahlers JD, 1997, J IMMUNOL, V158, P3947; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; [Anonymous], UNAIDS GLOB HIV AIDS; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Battig P, 2005, MICROBES INFECT, V7, P729, DOI 10.1016/j.micinf.2005.01.014; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brave Andreas, 2007, Infect Agent Cancer, V2, P14, DOI 10.1186/1750-9378-2-14; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Currier JR, 2002, J VIROL, V76, P4971, DOI 10.1128/JVI.76.10.4971-4986.2002; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; DALLO S, 1987, VIROLOGY, V159, P408, DOI 10.1016/0042-6822(87)90480-6; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; De Rose R, 2005, VACCINE, V23, P1949, DOI 10.1016/j.vaccine.2004.10.012; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Erfle V, 2005, MICROBES INFECT, V7, P1400, DOI 10.1016/j.micinf.2005.07.015; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; Gherardi MM, 2003, J VIROL, V77, P7048, DOI 10.1128/JVI.77.12.7048-7057.2003; Gherardi MM, 2000, J VIROL, V74, P6278, DOI 10.1128/JVI.74.14.6278-6286.2000; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez-Carrillo M, 2006, AIDS RES HUM RETROV, V22, P1186, DOI 10.1089/aid.2006.22.1186; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; Hinkula J, 1997, J VIROL, V71, P5528, DOI 10.1128/JVI.71.7.5528-5539.1997; Hoffmann Christian, 2007, HIV MED; Institute of Laboratory Animal Resources CoLSNRC, 1996, GUID CAR US LAB AN; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Majumder B, 2003, IMMUNOL LETT, V89, P207, DOI 10.1016/S0165-2478(03)00141-X; Rodriguez AM, 2010, MEDICINA-BUENOS AIRE, V70, P543; Markiewicz MA, 2009, J IMMUNOL, V182, P1351, DOI 10.4049/jimmunol.182.3.1351; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Ministerio de Salud PdlN, 2008, B VIH SIDA ARG; Monaco DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017185; Morrow MP, 2008, AIDS, V22, P333, DOI 10.1097/QAD.0b013e3282f42461; Okada E, 1997, J IMMUNOL, V159, P3638; Pando MA, 2008, J MED MICROBIOL, V57, P190, DOI 10.1099/jmm.0.47492-0; Ranasinghe C, 2011, VACCINE, V29, P3008, DOI 10.1016/j.vaccine.2011.01.106; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez AM, 2009, VIRUS RES, V146, P1, DOI 10.1016/j.virusres.2009.08.004; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Van der Ryst E, 1998, RES VIROLOGY, V149, P5, DOI 10.1016/S0923-2516(97)86896-3; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; Zimra R, 2002, CLIN APPL IMMUNOLOGY, V2, P32	63	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37801	10.1371/journal.pone.0037801	http://dx.doi.org/10.1371/journal.pone.0037801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655069	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900045
J	Yamamoto, DJ; Zahniser, NR				Yamamoto, Dorothy J.; Zahniser, Nancy R.			Differences in Rat Dorsal Striatal NMDA and AMPA Receptors following Acute and Repeated Cocaine-Induced Locomotor Activation	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; SELF-ADMINISTER COCAINE; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; INDIVIDUAL-DIFFERENCES; PSYCHOMOTOR STIMULANTS; DOPAMINE TRANSPORTER; IMPULSIVITY PREDICTS; DRUG-ADDICTION; PHOSPHORYLATION	Sprague-Dawley rats can be classified as low or high cocaine responders (LCRs or HCRs, respectively) based on their locomotor activity induced by an acute low dose of cocaine. Upon repeated cocaine exposure, LCRs display greater locomotor sensitization, reward, and reinforcement than HCRs. Altered glutamate receptor expression in the brain reward pathway has been linked to locomotor sensitization and addiction. To determine if such changes contribute to the differential development of locomotor sensitization, we examined protein levels of total, phosphorylated, and cell surface glutamate N-methyl D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors (Rs) following acute or repeated cocaine (10 mg/kg, i.p.) in LCRs, HCRs and saline controls. Three areas involved in the development and expression of locomotor sensitization were investigated: the ventral tegmental area (VTA), nucleus accumbens (NAc) and dorsal striatum (dSTR). Our results revealed differences only in the dSTR, where we found that after acute cocaine, GluN2B(Tyr-1472) phosphorylation was significantly greater in LCRs, compared to HCRs and controls. Additionally in dSTR, after repeated cocaine, we observed significant increases in total GluA1, phosphorylated GluA1(Ser-845), and cell surface GluA1 in all cocaine-treated animals vs. controls. The acute cocaine-induced increases in NMDARs in dSTR of LCRs may help to explain the more ready development of locomotor sensitization and susceptibility to addiction-like behaviors in rats that initially exhibit little or no cocaine-induced activation, whereas the AMPAR increases after repeated cocaine may relate to recruitment of more dorsal striatal circuits and maintenance of the marked cocaine-induced locomotor activation observed in all of the rats.	[Yamamoto, Dorothy J.; Zahniser, Nancy R.] Univ Colorado Anschutz Med Campus, Sch Med, Dept Pharmacol, Aurora, CO USA; [Zahniser, Nancy R.] Univ Colorado Anschutz Med Campus, Sch Med, Neurosci Program, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Yamamoto, DJ (corresponding author), Univ Colorado Anschutz Med Campus, Sch Med, Dept Pharmacol, Aurora, CO USA.	dorothy.yamamoto@ucdenver.edu			NIH [DA027277, DA015050, DA004216]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA027277, R37DA004216, K05DA015050, R01DA004216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by NIH grants DA027277 (DJY), DA015050 and DA004216 (NRZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2007, PHARMACOL BIOCHEM BE, V86, P37, DOI 10.1016/j.pbb.2006.12.005; Amen SL, 2011, NEUROPSYCHOPHARMACOL, V36, P871, DOI 10.1038/npp.2010.226; Anker JJ, 2009, PHARMACOL BIOCHEM BE, V93, P343, DOI 10.1016/j.pbb.2009.05.013; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Boudreau AC, 2009, J NEUROCHEM, V110, P363, DOI 10.1111/j.1471-4159.2009.06140.x; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Ferrario CR, 2011, SYNAPSE, V65, P54, DOI 10.1002/syn.20823; Ferrario CR, 2010, NEUROPSYCHOPHARMACOL, V35, P818, DOI 10.1038/npp.2009.190; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Gulley JM, 2003, NEUROPSYCHOPHARMACOL, V28, P2089, DOI 10.1038/sj.npp.1300279; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim M, 2009, BIOCHEM BIOPH RES CO, V379, P65, DOI 10.1016/j.bbrc.2008.12.003; Kim SM, 2009, NEUROSCIENCE, V163, P618, DOI 10.1016/j.neuroscience.2009.06.054; Klein DA, 2009, BEHAV PHARMACOL, V20, P67, DOI 10.1097/FBP.0b013e3283242fdd; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mandt B, 2008, PSYCHOPHARMACOLOGY, V201, P195, DOI 10.1007/s00213-008-1265-x; Mandt BH, 2010, NEUROPHARMACOLOGY, V58, P605, DOI 10.1016/j.neuropharm.2009.11.015; Nelson AM, 2009, J PHARMACOL EXP THER, V331, P985, DOI 10.1124/jpet.109.159897; Pascoli V, 2011, BIOL PSYCHIAT, V69, P218, DOI 10.1016/j.biopsych.2010.08.031; Philibin SD, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00060; Pierce RC, 1996, J NEUROSCI, V16, P1550; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sabeti J, 2003, J PHARMACOL EXP THER, V305, P180, DOI 10.1124/jpet.102.047258; Sabeti J, 2002, J PHARMACOL EXP THER, V302, P1201, DOI 10.1124/jpet.102.035816; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Schumann J, 2009, J NEUROSCI, V29, P6955, DOI 10.1523/JNEUROSCI.1329-09.2009; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Walker QD, 2009, PHARMACOL BIOCHEM BE, V91, P398, DOI 10.1016/j.pbb.2008.08.019; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006	46	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37673	10.1371/journal.pone.0037673	http://dx.doi.org/10.1371/journal.pone.0037673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655064	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900040
J	Amin, A; Nobauer, K; Patzl, M; Berger, E; Hess, M; Bilic, I				Amin, Aziza; Noebauer, Katharina; Patzl, Martina; Berger, Evelyn; Hess, Michael; Bilic, Ivana			Cysteine Peptidases, Secreted by Trichomonas gallinae, Are Involved in the Cytopathogenic Effects on a Permanent Chicken Liver Cell Culture	PLOS ONE			English	Article							TRITRICHOMONAS-FETUS; VAGINALIS; PROTEINASES; PROTEASES; FINCHES; PATHOGENICITY; PURIFICATION; PREVALENCE; MORTALITY; VIRULENCE	Trichomonas gallinae, the aetiological agent of avian trichomonosis, was shown to secrete soluble factors involved in cytopathogenic effect on a permanent chicken liver (LMH) cell culture. The present study focused on the characterization of these molecules. The addition of specific peptidase inhibitors to the cell-free filtrate partially inhibited the monolayer destruction, which implied the presence of peptidases in the filtrate and their involvement in the cytopathogenic effect. One-dimensional substrate (gelatin) SDS-PAGE confirmed the proteolytic character of the filtrate by demonstrating the proteolytic activity within the molecular weight range from 38 to 110 kDa. In addition, the proteolytic activity was specifically inhibited by addition of TLCK and E-64 cysteine peptidase inhibitors implying their cysteine peptidase nature. Furthermore, variations in the intensity and the number of proteolytic bands were observed between cell-free filtrates of low and high passages of the same T. gallinae clonal culture. Two-dimensional substrate gel electrophoresis of concentrated T. gallinae cell-free filtrate identified at least six proteolytic spots. The mass spectrometric analysis of spots from 2-D gels identified the presence of at least two different Clan CA, family C1, cathepsin L-like cysteine peptidases in the cell-free filtrate of T. gallinae. In parallel, a PCR approach using degenerated primers based on the conserved amino acid sequence region of cysteine peptidases from Trichomonas vaginalis identified the coding sequences for four different Clan CA, family C1, cathepsin L-like cysteine peptidases. Finally, this is the first report analyzing molecules secreted by T. gallinae and demonstrating the ubiquity of peptidases secreted by this protozoon.	[Amin, Aziza; Berger, Evelyn; Hess, Michael; Bilic, Ivana] Univ Vet Med, Clin Avian Reptile & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Noebauer, Katharina] Univ Vet Med, VetCore Facil Res, Vienna, Austria; [Patzl, Martina] Univ Vet Med, Dept Pathobiol, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Amin, A (corresponding author), Univ Vet Med, Clin Avian Reptile & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	ivana.bilic@vetmeduni.ac.at	Amin, Aziza/AAJ-7038-2020	Amin, Aziza/0000-0002-8490-1863; Hess, Michael/0000-0002-6991-0120; Bilic, Ivana/0000-0003-3296-5117	Egyptian Ministry of Higher Education, Egyptian Government, Egypt; Vetmeduni Vienna	Egyptian Ministry of Higher Education, Egyptian Government, Egypt; Vetmeduni Vienna	AA was supported by a scholarship from the Egyptian Ministry of Higher Education, Egyptian Government, Egypt. Additional funds for consumables were obtained from the Vetmeduni Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERETE JF, 1995, MICROB PATHOGENESIS, V19, P93, DOI 10.1006/mpat.1995.0049; Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; Amin A, 2012, VET PARASITOL, V186, P196, DOI 10.1016/j.vetpar.2011.11.037; Amin A, 2010, EXP PARASITOL, V124, P202, DOI 10.1016/j.exppara.2009.09.014; Anderson NL, 2009, VET PARASITOL, V161, P178, DOI 10.1016/j.vetpar.2009.01.023; Arroyo R, 1995, Arch Med Res, V26, P279; ARROYO R, 1989, INFECT IMMUN, V57, P2991, DOI 10.1128/IAI.57.10.2991-2997.1989; BAKER JR, 1986, VET REC, V118, P447, DOI 10.1136/vr.118.16.447; Bunbury N, 2007, J WILDLIFE DIS, V43, P399, DOI 10.7589/0090-3558-43.3.399; BURGESS DE, 1990, INFECT IMMUN, V58, P3627, DOI 10.1128/IAI.58.11.3627-3632.1990; COOMBS GH, 1983, PARASITOLOGY, V86, P1, DOI 10.1017/S0031182000057103; COOPER JE, 1988, J WILDLIFE DIS, V24, P80, DOI 10.7589/0090-3558-24.1.80; Cuervo P, 2008, J PROTEOMICS, V71, P109, DOI 10.1016/j.jprot.2008.01.010; De Jesus LB, 2009, J PROTEOME RES, V8, P1555, DOI 10.1021/pr8009066; Draper D, 1998, J INFECT DIS, V178, P815, DOI 10.1086/515366; Fiori PL, 1999, MICROBES INFECT, V1, P149, DOI 10.1016/S1286-4579(99)80006-9; Fiori PL, 1996, MICROB PATHOGENESIS, V20, P109, DOI 10.1006/mpat.1996.0010; Forzan MJ, 2010, CAN VET J, V51, P391; GARBER GE, 1989, J CLIN MICROBIOL, V27, P1548, DOI 10.1128/JCM.27.7.1548-1553.1989; GARBER GE, 1989, CAN J MICROBIOL, V35, P903, DOI 10.1139/m89-150; Garner MM, 1992, J ASS AVIAN VET, V6, P18; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Grabensteiner E, 2010, VET PARASITOL, V172, P53, DOI 10.1016/j.vetpar.2010.04.015; HARMON WM, 1987, J WILDLIFE DIS, V23, P492, DOI 10.7589/0090-3558-23.3.492; Hernandez-Gutierrez R, 2004, EXP PARASITOL, V107, P125, DOI 10.1016/j.exppara.2004.05.004; Hess M, 2008, VACCINE, V26, P4187, DOI 10.1016/j.vaccine.2008.05.071; HONIGBERG BM, 1961, J PARASITOL, V47, P545, DOI 10.2307/3275054; HONIGBERG BM, 1964, J PROTOZOOL, V11, P447, DOI 10.1111/j.1550-7408.1964.tb01779.x; Krone O, 2005, J WILDLIFE DIS, V41, P304, DOI 10.7589/0090-3558-41.2.304; KULDA J, 1967, Folia Parasitologica (Ceske Budejovice), V14, P295; Lehker MW, 1999, SEX TRANSM INFECT, V75, P231, DOI 10.1136/sti.75.4.231; LEMAHIEU P, 1977, VLAAMS DIERGEN TIJDS, V46, P442; LEVINE NORMAN D., 1940, POULTRY SCI, V19, P205, DOI 10.3382/ps.0190205; LOCKE LN, 1962, J PARASITOL, V48, P497, DOI 10.2307/3275231; LOCKWOOD BC, 1987, MOL BIOCHEM PARASIT, V24, P89, DOI 10.1016/0166-6851(87)90119-8; Lubick KJ, 2004, INFECT IMMUN, V72, P1284, DOI 10.1128/IAI.72.3.1284-1290.2004; Mendoza-Lopez MR, 2000, INFECT IMMUN, V68, P4907, DOI 10.1128/IAI.68.9.4907-4912.2000; Murphy J., 1992, Proceedings Annual Conference Association of Avian Veterinarians, V1992, P21; NARCISI EM, 1991, AVIAN DIS, V35, P55, DOI 10.2307/1591295; Neimanis AS, 2010, AVIAN DIS, V54, P136, DOI 10.1637/8952-060509-Case.1; NORTH MJ, 1990, MOL BIOCHEM PARASIT, V39, P183, DOI 10.1016/0166-6851(90)90057-S; Peters M, 2009, KLEINTIERPRAXIS, V54, P433; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; PINDAK FF, 1993, GENITOURIN MED, V69, P35; PROVENZANO D, 1995, INFECT IMMUN, V63, P3388, DOI 10.1128/IAI.63.9.3388-3395.1995; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Rosset I, 2002, PARASITOL RES, V88, P356, DOI 10.1007/s00436-001-0555-6; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh BN, 2004, INFECT IMMUN, V72, P4151, DOI 10.1128/IAI.72.7.4151-4158.2004; Sommer U, 2005, J BIOL CHEM, V280, P23853, DOI 10.1074/jbc.M501752200; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; STABLER RM, 1947, J PARASITOL, V33, P207, DOI 10.2307/3273551; STABLER RM, 1951, J PARASITOL, V37, P473, DOI 10.2307/3273255; Work TM, 1996, J WILDLIFE DIS, V32, P266, DOI 10.7589/0090-3558-32.2.266	56	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37417	10.1371/journal.pone.0037417	http://dx.doi.org/10.1371/journal.pone.0037417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649527	gold, Green Published			2022-12-27	WOS:000305335800045
J	Jerabek, H; Heermann, DW				Jerabek, Hansjoerg; Heermann, Dieter W.			Expression-Dependent Folding of Interphase Chromatin	PLOS ONE			English	Article							X-CHROMOSOME TERRITORIES; NUCLEAR ARCHITECTURE; TRANSCRIPTION SITES; DNA; ORGANIZATION; DYNAMICS; GENES; ORDER; CONFORMATION; MODEL	Multiple studies suggest that chromatin looping might play a crucial role in organizing eukaryotic genomes. To investigate the interplay between the conformation of interphase chromatin and its transcriptional activity, we include information from gene expression profiles into a polymer model for chromatin that incorporates genomic loops. By relating loop formation to transcriptional activity, we are able to generate chromosome conformations whose structural and topological properties are consistent with experimental data. The model particularly allows to reproduce the conformational variations that are known to occur between highly and lowly expressed chromatin regions. As previously observed in experiments, lowly expressed regions of the simulated polymers are much more compact. Due to the changes in loop formation, the distributions of chromatin loops are also expression-dependent and exhibit a steeper decay in highly active regions. As a results of entropic interaction between differently looped parts of the chromosome, we observe topological alterations leading to a preferential positioning of highly transcribed loci closer to the surface of the chromosome territory. Considering the diffusional behavior of the chromatin fibre, the simulations furthermore show that the higher the expression level of specific parts of the chromatin fibre is, the more dynamic they are. The results exhibit that variations of loop formation along the chromatin fibre, and the entropic changes that come along with it, do not only influence the structural parameters on the local scale, but also effect the global chromosome conformation and topology.	[Jerabek, Hansjoerg; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Philosophenweg 19, D-6900 Heidelberg, Germany; [Jerabek, Hansjoerg; Heermann, Dieter W.] Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Heermann, Dieter W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Heermann, Dieter W.] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Jackson Laboratory; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jerabek, H (corresponding author), Heidelberg Univ, Inst Theoret Phys, Philosophenweg 19, D-6900 Heidelberg, Germany.	jerabek@tphys.uni-heidelberg.de			Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences	HJ was funded by the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014428; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2004, BIOL CELL, V96, P555, DOI 10.1016/j.biolcel.2004.07.002; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; Dietzel S, 1999, EXP CELL RES, V252, P363, DOI 10.1006/excr.1999.4635; Doi M, 1997, INTRO POLYM PHYS; Dorier J, 2009, NUCLEIC ACIDS RES, V37, P6316, DOI 10.1093/nar/gkp702; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gavrilov A, 2009, METHODS MOL BIOL, V567, P171, DOI 10.1007/978-1-60327-414-2_12; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; GROSBERG AY, 1988, BIOFIZIKA+, V33, P247; Jackson Dean A., 2005, Briefings in Functional Genomics & Proteomics, V4, P143, DOI 10.1093/bfgp/4.2.143; Jones E., 2001, SCIPY OPEN SOURCE SC; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Marenduzzo D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09002; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; RUDNICK J, 1987, SCIENCE, V237, P384, DOI 10.1126/science.237.4813.384; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	49	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37525	10.1371/journal.pone.0037525	http://dx.doi.org/10.1371/journal.pone.0037525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649534	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800053
J	Miller, NLG; Lawson, C; Chen, XL; Lim, ST; Schlaepfer, DD				Miller, Nichol L. G.; Lawson, Christine; Chen, Xiao Lei; Lim, Ssang-Taek; Schlaepfer, David D.			Rgnef (p190RhoGEF) Knockout Inhibits RhoA Activity, Focal Adhesion Establishment, and Cell Motility Downstream of Integrins	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; MICE LACKING; T-CELLS; MIGRATION; KINASE; GTPASES; BINDING; PROTEIN; ACTIVATION; POLARITY	Background: Cell migration is a highly regulated process that involves the formation and turnover of cell-matrix contact sites termed focal adhesions. Rho-family GTPases are molecular switches that regulate actin and focal adhesion dynamics in cells. Guanine nucleotide exchange factors (GEFs) activate Rho-family GTPases. Rgnef (p190RhoGEF) is a ubiquitous 190 kDa GEF implicated in the control of colon carcinoma and fibroblast cell motility. Principal Findings: Rgnef exon 24 floxed mice (Rgnef(flox)) were created and crossed with cytomegalovirus (CMV)-driven Cre recombinase transgenic mice to inactivate Rgnef expression in all tissues during early development. Heterozygous Rgnef(WT/flox) (Cre+) crosses yielded normal Mendelian ratios at embryonic day 13.5, but Rgnef(flox/flox) (Cre+) mice numbers at 3 weeks of age were significantly less than expected. Rgnef(flox/flox) (Cre+) (Rgnef-/-) embryos and primary mouse embryo fibroblasts (MEFs) were isolated and verified to lack Rgnef protein expression. When compared to wildtype (WT) littermate MEFs, loss of Rgnef significantly inhibited haptotaxis migration, wound closure motility, focal adhesion number, and RhoA GTPase activation after fibronectin-integrin stimulation. In WT MEFs, Rgnef activation occurs within 60 minutes upon fibronectin plating of cells associated with RhoA activation. Rgnef-/- MEF phenotypes were rescued by epitope-tagged Rgnef re-expression. Conclusions: Rgnef-/- MEF phenotypes were due to Rgnef loss and support an essential role for Rgnef in RhoA regulation downstream of integrins in control of cell migration.	[Miller, Nichol L. G.; Lawson, Christine; Chen, Xiao Lei; Lim, Ssang-Taek; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Miller, NLG (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	dschlaepfer@ucsd.edu		Lim, Steve/0000-0003-0323-8607	NIH [GM087400, 1F32CA159558]; CIHR [200810MFE-193594-139144]; NATIONAL CANCER INSTITUTE [F32CA159558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087400] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM087400 to D.D.S. N.L.G.M. was partially supported by NIH 1F32CA159558. C.L. was supported by CIHR 200810MFE-193594-139144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hirsch E, 2002, MOL CELL BIOL, V22, P3140, DOI 10.1128/MCB.22.9.3140-3148.2002; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang DY, 2000, J CELL SCI, V113, P4221; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	56	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37830	10.1371/journal.pone.0037830	http://dx.doi.org/10.1371/journal.pone.0037830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649559	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800079
J	Suzuki, T; Arai, S; Takeuchi, M; Sakurai, C; Ebana, H; Higashi, T; Hashimoto, H; Hatsuzawa, K; Wada, I				Suzuki, Takahisa; Arai, Seisuke; Takeuchi, Mayumi; Sakurai, Chiye; Ebana, Hideaki; Higashi, Tsunehito; Hashimoto, Hitoshi; Hatsuzawa, Kiyotaka; Wada, Ikuo			Development of Cysteine-Free Fluorescent Proteins for the Oxidative Environment	PLOS ONE			English	Article							PHOTON-COUNTING HISTOGRAM; MONOMERIC RED; SECRETORY PATHWAY; GREEN; GENE; GFP; INNOVATIONS; EXPRESSION; MICROSCOPY; EVOLUTION	Molecular imaging employing fluorescent proteins has been widely used to highlight specific reactions or processes in various fields of the life sciences. Despite extensive improvements of the fluorescent tag, this technology is still limited in the study of molecular events in the extracellular milieu. This is partly due to the presence of cysteine in the fluorescent proteins. These proteins almost cotranslationally form disulfide bonded oligomers when expressed in the endoplasmic reticulum (ER). Although single molecule photobleaching analysis showed that these oligomers were not fluorescent, the fluorescent monomer form often showed aberrant behavior in folding and motion, particularly when fused to cysteine-containing cargo. Therefore we investigated whether it was possible to eliminate the cysteine without losing the brightness. By site-saturated mutagenesis, we found that the cysteine residues in fluorescent proteins could be replaced with specific alternatives while still retaining their brightness. cf(cysteine-free) SGFP2 showed significantly reduced restriction of free diffusion in the ER and marked improvement of maturation when fused to the prion protein. We further applied this approach to TagRFP family proteins and found a set of mutations that obtains the same level of brightness as the cysteine-containing proteins. The approach used in this study to generate new cysteine-free fluorescent tags should expand the application of molecular imaging to the extracellular milieu and facilitate its usage in medicine and biotechnology.	[Suzuki, Takahisa; Arai, Seisuke; Takeuchi, Mayumi; Sakurai, Chiye; Ebana, Hideaki; Higashi, Tsunehito; Hashimoto, Hitoshi; Hatsuzawa, Kiyotaka; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Japan	Fukushima Medical University	Suzuki, T (corresponding author), Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Japan.	iwada@fmu.ac.jp	Higashi, Tsunehito/G-1816-2012	Suzuki, Takahisa/0000-0001-6088-028X; Wada, Ikuo/0000-0001-5668-6994	Japan Society for the Promotion of Science [19370044, 22570189]; Ministry of Education, Culture, Sports, Science and Technology of Japan [19370044, 22570189, 08038570]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was in part supported by grants-in-aid (19370044, 22570189) from the Japan Society for the Promotion of Science and a grant-in-aid (08038570) by the Ministry of Education, Culture, Sports, Science and Technology of Japan to IW (19370044, 08038570) and KH (22570189). No additional external funding received for this study. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2008, CURR BIOL, V18, P987, DOI 10.1016/j.cub.2008.06.028; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chalfie M, 2005, GREEN FLUORESENT PRO; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Fang C, 2009, NATURE, V462, P200, DOI 10.1038/nature08527; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Hashiguchi T, 2008, PSSJ ARCH, V1, pe017; Hatsuzawa K, 2009, MOL BIOL CELL, V20, P4435, DOI 10.1091/mbc.E09-03-0241; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Holme A, 2003, EUR J NEUROSCI, V18, P571, DOI 10.1046/j.1460-9568.2003.02780.x; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huang B, 2004, CHEMPHYSCHEM, V5, P1523, DOI 10.1002/cphc.200400176; INOUYE S, 1994, FEBS LETT, V341, P277, DOI 10.1016/0014-5793(94)80472-9; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kremers GJ, 2011, J CELL SCI, V124, P157, DOI 10.1242/jcs.072744; Malchus N, 2010, J FLUORESC, V20, P19, DOI 10.1007/s10895-009-0517-4; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagaya H, 2008, J CELL BIOL, V180, P129, DOI 10.1083/jcb.200704078; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perroud TD, 2005, CHEMPHYSCHEM, V6, P905, DOI 10.1002/cphc.200400547; Perroud TD, 2003, CHEMPHYSCHEM, V4, P1121, DOI 10.1002/cphc.200300824; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Saxton MJ, 2001, BIOPHYS J, V81, P2226, DOI 10.1016/S0006-3495(01)75870-5; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Skakun Victor V, 2011, Front Biosci (Elite Ed), V3, P489, DOI 10.2741/e264; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Timpson P, 2011, J CELL SCI, V124, P2877, DOI 10.1242/jcs.085191; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wada I, 1997, EMBO J, V16, P5420, DOI 10.1093/emboj/16.17.5420; Worth DC, 2010, J CELL SCI, V123, P3629, DOI 10.1242/jcs.064485; Wu D, 2010, J CELL BIOCHEM, V111, P627, DOI 10.1002/jcb.22743; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	55	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37551	10.1371/journal.pone.0037551	http://dx.doi.org/10.1371/journal.pone.0037551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649538	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335800057
J	Kumar, B; Yadav, A; Lang, J; Teknos, TN; Kumar, P				Kumar, Bhavna; Yadav, Arti; Lang, James; Teknos, Theodoros N.; Kumar, Pawan			Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis	PLOS ONE			English	Article							SEVERITY STAGING SYSTEM; 5-YEAR SURVIVAL RATES; C-MET EXPRESSION; ENDOTHELIAL-CELLS; OROPHARYNGEAL CANCER; SUPPRESSIVE MIR-34A; SIGNALING PATHWAY; GENE-EXPRESSION; DOWN-REGULATION; SMALL RNAS	Background: MicroRNAs (miRs) are small non-coding RNAs that play an important role in cancer development where they can act as oncogenes or as tumor-suppressors. miR-34a is a tumor-suppressor that is frequently downregulated in a number of tumor types. However, little is known about the role of miR-34a in head and neck squamous cell carcinoma (HNSCC). Methods and Results: miR-34a expression in tumor samples, HNSCC cell lines and endothelial cells was examined by real time PCR. Lipofectamine-2000 was used to transfect miR-34a in HNSCC cell lines and human endothelial cells. Cell-proliferation, migration and clonogenic survival was examined by MTT, Xcelligence system, scratch assay and colony formation assay. miR-34a effect on tumor growth and tumor angiogenesis was examined by in vivo SCID mouse xenograft model. Our results demonstrate that miR-34a is significantly downregulated in HNSCC tumors and cell lines. Ectopic expression of miR-34a in HNSCC cell lines significantly inhibited tumor cell proliferation, colony formation and migration. miR-34a overexpression also markedly downregulated E2F3 and survivin levels. Rescue experiments using microRNA resistant E2F3 isoforms suggest that miR-34a-mediated inhibition of cell proliferation and colony formation is predominantly mediated by E2F3a isoform. In addition, tumor samples from HNSCC patients showed an inverse relationship between miR-34a and survivin as well as miR-34a and E2F3 levels. Overexpression of E2F3a completely rescued survivin expression in miR-34a expressing cells, thereby suggesting that miR-34a may be regulating survivin expression via E2F3a. Ectopic expression of miR-34a also significantly inhibited tumor growth and tumor angiogenesis in a SCID mouse xenograft model. Interestingly, miR-34a inhibited tumor angiogenesis by blocking VEGF production by tumor cells as well as directly inhibiting endothelial cell functions. Conclusions: Taken together, these findings suggest that dysregulation of miR-34a expression is common in HNSCC and modulation of miR34a activity might represent a novel therapeutic strategy for the treatment of HNSCC.	[Kumar, Bhavna; Lang, James; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Kumar, Bhavna; Yadav, Arti; Lang, James; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kumar, B (corresponding author), Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	pawan.kumar@osumc.edu	Kumar, Pawan/H-7777-2013		National Institutes of Health/National Cancer Institute [CA133250]; Joan's Fund Research Grant; NATIONAL CANCER INSTITUTE [K12CA133250] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joan's Fund Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health/National Cancer Institute grant CA133250 (PK) and Joan's Fund Research Grant (BK and PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Izu A, 2011, TOHOKU J EXP MED, V223, P187, DOI 10.1620/tjem.223.187; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Kumar P, 2005, LAB INVEST, V85, P756, DOI 10.1038/labinvest.3700272; Kumar P, 2008, LAB INVEST, V88, P740, DOI 10.1038/labinvest.2008.46; Kumar P, 2007, CANCER RES, V67, P1193, DOI 10.1158/0008-5472.CAN-06-2265; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liping S, 2010, ORAL SURG ORAL MED O, V110, P484; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mezquita P, 2005, ONCOGENE, V24, P889, DOI 10.1038/sj.onc.1208251; Nor JE, 2001, CANCER RES, V61, P2183; Preuss SF, 2008, BRIT J CANCER, V98, P627, DOI 10.1038/sj.bjc.6604192; Pugliano FA, 1999, OTOLARYNG HEAD NECK, V120, P38, DOI 10.1016/S0194-5998(99)70367-0; Pugliano FA, 1997, ARCH OTOLARYNGOL, V123, P1118; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reimer D, 2011, ONCOGENE; Reimer D, 2010, CANCER RES, V70, P4613, DOI 10.1158/0008-5472.CAN-09-3551; Richey LM, 2007, OTOLARYNG HEAD NECK, V136, P98, DOI 10.1016/j.otohns.2006.06.1267; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Walk Elyse L, 2011, Cancers (Basel), V3, P747, DOI 10.3390/cancers3010747; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yadav A, 2011, MOL CANCER THER, V10, P1241, DOI 10.1158/1535-7163.MCT-11-0004; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zygogianni A, 2011, ASIAN PAC J CANCER P, V12, P339	67	110	113	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37601	10.1371/journal.pone.0037601	http://dx.doi.org/10.1371/journal.pone.0037601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629428	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300059
J	Ovadia-Caro, S; Nir, Y; Soddu, A; Ramot, M; Hesselmann, G; Vanhaudenhuyse, A; Dinstein, I; Tshibanda, JFL; Boly, M; Harel, M; Laureys, S; Malach, R				Ovadia-Caro, Smadar; Nir, Yuval; Soddu, Andrea; Ramot, Michal; Hesselmann, Guido; Vanhaudenhuyse, Audrey; Dinstein, Ilan; Tshibanda, Jean-Flory L.; Boly, Melanie; Harel, Michal; Laureys, Steven; Malach, Rafael			Reduction in Inter-Hemispheric Connectivity in Disorders of Consciousness	PLOS ONE			English	Article							INTERHEMISPHERIC FUNCTIONAL CONNECTIVITY; RESTING-STATE; DEFAULT NETWORK; BRAIN ACTIVITY; BASE-LINE; VEGETATIVE STATE; MOTOR CORTEX; FLUCTUATIONS; SCALE; COMA	Clinical diagnosis of disorders of consciousness (DOC) caused by brain injury poses great challenges since patients are often behaviorally unresponsive. A promising new approach towards objective DOC diagnosis may be offered by the analysis of ultra-slow (<0.1 Hz) spontaneous brain activity fluctuations measured with functional magnetic resonance imaging (fMRI) during the resting-state. Previous work has shown reduced functional connectivity within the "default network", a subset of regions known to be deactivated during engaging tasks, which correlated with the degree of consciousness impairment. However, it remains unclear whether the breakdown of connectivity is restricted to the "default network", and to what degree changes in functional connectivity can be observed at the single subject level. Here, we analyzed resting-state interhemispheric connectivity in three homotopic regions of interest, which could reliably be identified based on distinct anatomical landmarks, and were part of the "Extrinsic" (externally oriented, task positive) network (pre- and postcentral gyrus, and intraparietal sulcus). Resting-state fMRI data were acquired for a group of 11 healthy subjects and 8 DOC patients. At the group level, our results indicate decreased inter-hemispheric functional connectivity in subjects with impaired awareness as compared to subjects with intact awareness. Individual connectivity scores significantly correlated with the degree of consciousness. Furthermore, a single-case statistic indicated a significant deviation from the healthy sample in 5/8 patients. Importantly, of the three patients whose connectivity indices were comparable to the healthy sample, one was diagnosed as locked-in. Taken together, our results further highlight the clinical potential of resting-state connectivity analysis and might guide the way towards a connectivity measure complementing existing DOC diagnosis.	[Ovadia-Caro, Smadar; Ramot, Michal; Hesselmann, Guido; Dinstein, Ilan; Harel, Michal; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Ovadia-Caro, Smadar] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Nir, Yuval] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Soddu, Andrea; Vanhaudenhuyse, Audrey; Tshibanda, Jean-Flory L.; Boly, Melanie; Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Soddu, Andrea; Vanhaudenhuyse, Audrey; Tshibanda, Jean-Flory L.; Boly, Melanie; Laureys, Steven] Univ Liege, Dept Neurol, Liege, Belgium; [Hesselmann, Guido] Charite Campus Mitte, Dept Psychiat, Berlin, Germany	Weizmann Institute of Science; Humboldt University of Berlin; University of Wisconsin System; University of Wisconsin Madison; University of Liege; University of Liege; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ovadia-Caro, S (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@gmail.com	Hesselmann, Guido/I-2880-2016; Soddu, Andrea/K-7087-2014; Laureys, Steven/AAN-2097-2021; Vanhaudenhuyse, Audrey/AAP-2455-2020; Dinstein, Ilan/AAW-4400-2020; Dinstein, Ilan/L-3325-2016; Laureys, Steven/A-3349-2011	Hesselmann, Guido/0000-0002-8873-7212; Soddu, Andrea/0000-0001-6833-745X; Laureys, Steven/0000-0002-3096-3807; Dinstein, Ilan/0000-0001-8106-5209; Dinstein, Ilan/0000-0001-8106-5209; Nir, Yuval/0000-0002-5433-6349; Ramot, Michal/0000-0001-9716-6469; Boly, Melanie/0000-0001-9584-0907	Israel Science Foundation [160/07]; ISF-Bikura; Helen Kimmel Award for Innovative Research; Belgian Funds for Scientific Research (FRS); European Commission (DECODER); McDonnell Foundation; Mind Science Foundation; University Hospital of Liege; University of Liege	Israel Science Foundation(Israel Science Foundation); ISF-Bikura; Helen Kimmel Award for Innovative Research; Belgian Funds for Scientific Research (FRS)(Fonds de la Recherche Scientifique - FNRS); European Commission (DECODER); McDonnell Foundation; Mind Science Foundation; University Hospital of Liege; University of Liege(University of Liege)	This study was supported by the Israel Science Foundation 160/07 and ISF-Bikura. Grants and the Helen Kimmel Award for Innovative Research to Rafael Malach. The study was supported by the Belgian Funds for Scientific Research (FRS) (http://www2.frs-fnrs.be/), European Commission (DECODER) (http://www.decoder.i1.psychologie.uni-wuerzburg.de/?Partners), McDonnell Foundation (http://www.jsmf.org/), Mind Science Foundation (http://www.mindscience.org/), University Hospital of Liege (http://www.chu.ulg.ac.be/jcms/r_127200/internet-accueil) and University of Liege (http://www.ulg.ac.be/cms/c_5000/home) for Steven Laureys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P211; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Balduzzi D, 2008, P NATL ACAD SCI USA, V105, P15641, DOI 10.1073/pnas.0808310105; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2008, HUM BRAIN MAPP, V29, P868, DOI 10.1002/hbm.20602; Bruno MA, 2011, PROG BRAIN RES, V193, P323, DOI 10.1016/B978-0-444-53839-0.00021-1; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gavrilescu M, 2010, PSYCHOL MED, V40, P1149, DOI 10.1017/S0033291709991632; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Goebel R., 1996, NEUROIMAGE, V3, P5604, DOI [10.1016/s1053-8119(96)80606-9, DOI 10.1016/S1053-8119(96)80606-9]; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Jelsone-Swain LM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00158; JENNETT B, 1975, LANCET, V1, P480; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Preminger S, 2011, NEUROIMAGE, V54, P1692, DOI 10.1016/j.neuroimage.2010.08.036; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Talairach J., 1988, COPLANAR STEREOTAXIC; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Uddin LQ, 2008, NEUROREPORT, V19, P703, DOI 10.1097/WNR.0b013e3282fb8203; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	70	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37238	10.1371/journal.pone.0037238	http://dx.doi.org/10.1371/journal.pone.0037238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629375	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300029
J	Roeber, F; Larsen, JWA; Anderson, N; Campbell, AJD; Anderson, GA; Gasser, RB; Jex, AR				Roeber, Florian; Larsen, John W. A.; Anderson, Norman; Campbell, Angus J. D.; Anderson, Garry A.; Gasser, Robin B.; Jex, Aaron R.			A Molecular Diagnostic Tool to Replace Larval Culture in Conventional Faecal Egg Count Reduction Testing in Sheep	PLOS ONE			English	Article							ANTHELMINTIC RESISTANCE; GASTROINTESTINAL NEMATODES; DRUG-RESISTANCE; INFECTIONS; RUMINANTS; EFFICACY; WORMS; BIAS	The accurate diagnosis of parasitic nematode infections in livestock (including sheep and goats) is central to their effective control and the detection of the anthelmintic resistance. Traditionally, the faecal egg count reduction test (FECRT), combined with the technique of larval culture (LC), has been used widely to assess drug-susceptibility/resistance in strongylid nematodes. However, this approach suffers from a lack of specificity, sensitivity and reliability, and is time-consuming and costly to conduct. Here, we critically assessed a specific PCR assay to support FECRT, in a well-controlled experiment on sheep with naturally acquired strongylid infections known to be resistant to benzimidazoles. We showed that the PCR results were in close agreement with those of total worm count (TWC), but not of LC. Importantly, albendazole resistance detected by PCR-coupled FECRT was unequivocally linked to Teladorsagia circumcincta and, to lesser extent, Trichostrongylus colubriformis, a result that was not achievable by LC. The key findings from this study demonstrate that our PCR-coupled FECRT approach has major merit for supporting anthelmintic resistance in nematode populations. The findings also show clearly that our PCR assay can be used as an alternative to LC, and is more time-efficient and less laborious, which has important practical implications for the effective management and control strongylid nematodes of sheep.	[Roeber, Florian; Campbell, Angus J. D.; Anderson, Garry A.; Gasser, Robin B.; Jex, Aaron R.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Larsen, John W. A.; Anderson, Norman; Campbell, Angus J. D.] Univ Melbourne, Mackinnon Project, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Roeber, F (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.	f.roeber@pgrad.unimelb.edu.au; robinbg@unimelb.edu.au	Gasser, Robin/ABH-6185-2020; Larsen, John/AAF-9958-2021; Larsen, John WA/H-5693-2013; Campbell, Angus J D/F-7671-2014; Jex, Aaron/AGZ-7897-2022	Gasser, Robin/0000-0002-4423-1690; Campbell, Angus J D/0000-0002-3907-5048; Jex, Aaron/0000-0002-1285-7947; LARSEN, JOHN/0000-0003-1436-1889	Australian Research Council (RBG)	Australian Research Council (RBG)(Australian Research Council)	This research was supported by the Australian Research Council (RBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON N, 1972, AUST J AGR RES, V23, P1113, DOI 10.1071/AR9721113; [Anonymous], 1948, J COUNCIL SCI IND RE; Beech RN, 2011, PARASITOLOGY, V138, P160, DOI 10.1017/S0031182010001198; Besier RB, 2003, AUST J EXP AGR, V43, P1383, DOI 10.1071/EA02229; BEVERIDGE I, 1983, VET PARASITOL, V13, P55, DOI 10.1016/0304-4017(83)90020-1; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Cabaret J, 2004, VET PARASITOL, V121, P105, DOI 10.1016/j.vetpar.2004.01.020; Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019; Conraths FJ, 2006, VET PARASITOL, V136, P91, DOI 10.1016/j.vetpar.2005.12.004; DIKMANS G., 1933, TRANS AMER MICROSC SOC, V52, P1, DOI 10.2307/3222221; Dobson RJ, 1996, INT J PARASITOL, V26, P993, DOI 10.1016/S0020-7519(96)80078-6; DOBSON RJ, 1992, INT J PARASITOL, V22, P1005, DOI 10.1016/0020-7519(92)90060-X; GASSER RB, 1993, NUCLEIC ACIDS RES, V21, P2525, DOI 10.1093/nar/21.10.2525; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485; Gibbons, 2010, KEYS NEMATODE PARASI, P83; Gordon HMEpidemiologyofhelminthosisinsheep, 1981, EPIDEMIOLOGY HELMINT, P551; GORDON HUGH McL, 1933, AUSTRALIAN VET JOUR, V9, P223, DOI 10.1111/j.1751-0813.1933.tb06301.x; Hosking BC, 2009, AUST VET J, V87, P455, DOI 10.1111/j.1751-0813.2009.00511.x; Hosking BC, 2010, PARASITOL RES, V106, P529, DOI 10.1007/s00436-009-1636-1; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Lichtenfels JR, 1997, VET PARASITOL, V72, P225, DOI 10.1016/S0304-4017(97)00099-X; Love SCJ, 2002, VET REC, V150, P87; MAFF, 1986, MAN VET PAR LAB TECH, P20; McMurtry LW, 2000, VET PARASITOL, V90, P73, DOI 10.1016/S0304-4017(00)00230-2; Nielsen MK, 2010, VET PARASITOL, V167, P55, DOI 10.1016/j.vetpar.2009.09.043; Roeber F, 2011, INFECT GENET EVOL, V11, P849, DOI 10.1016/j.meegid.2011.01.013; Sackett D, 2006, ASSESSING EC COST EN; Taylor MA, 2002, VET PARASITOL, V103, P183, DOI 10.1016/S0304-4017(01)00604-5; Thrusfield M, 2007, VET EPIDEMIOLOGY; van Wyk JA, 2004, VET PARASITOL, V119, P277, DOI 10.1016/j.vetpar.2003.11.012; Villanua D, 2006, PARASITOLOGY, V133, P251, DOI 10.1017/S003118200600031X; von Sarnson-Himmelstjerna G, 2006, VET PARASITOL, V136, P99, DOI 10.1016/j.vetpar.2005.12.005; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Zajac AM, 2006, VET CLIN N AM-FOOD A, V22, P529, DOI 10.1016/j.cvfa.2006.07.006	36	41	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37327	10.1371/journal.pone.0037327	http://dx.doi.org/10.1371/journal.pone.0037327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629381	Green Published, gold			2022-12-27	WOS:000305345300033
J	Abdullah, Z; Geiger, S; Nino-Castro, A; Bottcher, JP; Muraliv, E; Gaidt, M; Schildberg, FA; Riethausen, K; Flossdorf, J; Krebs, W; Chakraborty, T; Kurts, C; Schultze, JL; Knolle, PA; Klotz, L				Abdullah, Zeinab; Geiger, Sergej; Nino-Castro, Andrea; Boettcher, Jan P.; Muraliv, Eugenia; Gaidt, Moritz; Schildberg, Frank A.; Riethausen, Kati; Flossdorf, Juliane; Krebs, Wolfgang; Chakraborty, Trinad; Kurts, Christian; Schultze, Joachim L.; Knolle, Percy A.; Klotz, Luisa			Lack of PPAR gamma in Myeloid Cells Confers Resistance to Listeria monocytogenes Infection	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; TUMOR-NECROSIS-FACTOR; CD8-ALPHA(+) DENDRITIC CELLS; NATURAL-KILLER-CELLS; BACTERIAL-INFECTION; IMMUNE-RESPONSES; INFLAMMATORY RESPONSE; MICE DEFICIENT; T-CELLS; MACROPHAGES	The peroxisomal proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor that controls inflammation and immunity. Innate immune defense against bacterial infection appears to be compromised by PPAR gamma. The relevance of PPAR gamma in myeloid cells, that organize anti-bacterial immunity, for the outcome of immune responses against intracellular bacteria such as Listeria monocytogenes in vivo is unknown. We found that Listeria monocytogenes infection of macrophages rapidly led to increased expression of PPAR gamma. This prompted us to investigate whether PPAR gamma in myeloid cells influences innate immunity against Listeria monocytogenes infection by using transgenic mice with myeloid-cell specific ablation of PPAR gamma (LysMCrexPPAR gamma(flox/flox)). Loss of PPAR gamma in myeloid cells results in enhanced innate immune defense against Listeria monocytogenes infection both, in vitro and in vivo. This increased resistance against infection was characterized by augmented levels of bactericidal factors and inflammatory cytokines: ROS, NO, IFN gamma TNF IL-6 and IL-12. Moreover, myeloid cell-specific loss of PPAR gamma enhanced chemokine and adhesion molecule expression leading to improved recruitment of inflammatory Ly6C(hi) monocytes to sites of infection. Importantly, increased resistance against Listeria infection in the absence of PPAR gamma was not accompanied by enhanced immunopathology. Our results elucidate a yet unknown regulatory network in myeloid cells that is governed by PPAR gamma and restrains both listeriocidal activity and recruitment of inflammatory monocytes during Listeria infection, which may contribute to bacterial immune escape. Pharmacological interference with PPAR gamma activity in myeloid cells might represent a novel strategy to overcome intracellular bacterial infection.	[Abdullah, Zeinab; Geiger, Sergej; Boettcher, Jan P.; Muraliv, Eugenia; Gaidt, Moritz; Schildberg, Frank A.; Riethausen, Kati; Flossdorf, Juliane; Kurts, Christian; Knolle, Percy A.; Klotz, Luisa] Univ Bonn, Inst Mol Med, Bonn, Germany; [Abdullah, Zeinab; Geiger, Sergej; Boettcher, Jan P.; Muraliv, Eugenia; Gaidt, Moritz; Schildberg, Frank A.; Riethausen, Kati; Flossdorf, Juliane; Kurts, Christian; Knolle, Percy A.; Klotz, Luisa] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Nino-Castro, Andrea; Krebs, Wolfgang; Schultze, Joachim L.] Univ Bonn, LIMES Inst, Bonn, Germany; [Klotz, Luisa] Univ Munster, Clin Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany	University of Bonn; University of Bonn; Justus Liebig University Giessen; University of Bonn; University of Munster	Abdullah, Z (corresponding author), Univ Bonn, Inst Mol Med, Bonn, Germany.	pknolle@uni-bonn.de	Schultze, Joachim L/D-7794-2011; chakraborty, trinad/D-1812-2014; Schultze, Joachim L./ABA-8176-2020; Abdullah, Zeinab/HII-5346-2022	Schultze, Joachim L/0000-0003-2812-9853; Schultze, Joachim L./0000-0003-2812-9853; Gaidt, Moritz/0000-0002-8009-294X; Bottcher, Jan/0000-0002-8163-8107; Knolle, Percy A./0000-0003-2983-0414; Nino-Castro, Andrea/0000-0002-0895-3637	Deutsche Forschungsgemeinschaft [Sonderforschungsbereiche 670, 704]; BONFOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche 670 and 704) and an institutional grant by BONFOR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HAVELL EA, 1987, J IMMUNOL, V139, P4225; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Klotz L, 2005, J IMMUNOL, V175, P4948, DOI 10.4049/jimmunol.175.8.4948; Klotz L, 2007, J IMMUNOL, V178, P2122, DOI 10.4049/jimmunol.178.4.2122; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Malur A, 2009, J IMMUNOL, V182, P5816, DOI 10.4049/jimmunol.0803504; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Popov A, 2008, J IMMUNOL, V181, P4976, DOI 10.4049/jimmunol.181.7.4976; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Singh S, 2011, THORAX, V66, P383, DOI 10.1136/thx.2010.152777; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Stavrum R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026295; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; von Oppen N, 2009, HEPATOLOGY, V49, P1664, DOI 10.1002/hep.22795; Wu L, 2011, BLOOD; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	54	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37349	10.1371/journal.pone.0037349	http://dx.doi.org/10.1371/journal.pone.0037349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629382	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100022
J	Wani, KA; Catanese, M; Normantowicz, R; Herd, M; Maher, KN; Chase, DL				Wani, Khursheed A.; Catanese, Mary; Normantowicz, Robyn; Herd, Muriel; Maher, Kathryn N.; Chase, Daniel L.			D1 Dopamine Receptor Signaling Is Modulated by the R7 RGS Protein EAT-16 and the R7 Binding Protein RSBP-1 in Caenoerhabditis elegans Motor Neurons	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; COUPLED RECEPTOR; ACETYLCHOLINE-RELEASE; ADENYLYL-CYCLASE; RNA INTERFERENCE; MEMBRANE ANCHOR; GENE-EXPRESSION; DEP DOMAIN; COMPLEXES; REGULATORS	Dopamine signaling modulates voluntary movement and reward-driven behaviors by acting through G protein-coupled receptors in striatal neurons, and defects in dopamine signaling underlie Parkinson's disease and drug addiction. Despite the importance of understanding how dopamine modifies the activity of striatal neurons to control basal ganglia output, the molecular mechanisms that control dopamine signaling remain largely unclear. Dopamine signaling also controls locomotion behavior in Caenorhabditis elegans. To better understand how dopamine acts in the brain we performed a large-scale dsRNA interference screen in C. elegans for genes required for endogenous dopamine signaling and identified six genes (eat-16, rsbp-1, unc-43, flp-1, grk-1, and cat-1) required for dopamine-mediated behavior. We then used a combination of mutant analysis and cell-specific transgenic rescue experiments to investigate the functional interaction between the proteins encoded by two of these genes, eat-16 and rsbp-1, within single cell types and to examine their role in the modulation of dopamine receptor signaling. We found that EAT-16 and RSBP-1 act together to modulate dopamine signaling and that while they are coexpressed with both D1-like and D2-like dopamine receptors, they do not modulate D2 receptor signaling. Instead, EAT-16 and RSBP-1 act together to selectively inhibit D1 dopamine receptor signaling in cholinergic motor neurons to modulate locomotion behavior.	[Catanese, Mary; Normantowicz, Robyn; Herd, Muriel; Chase, Daniel L.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Wani, Khursheed A.; Maher, Kathryn N.; Chase, Daniel L.] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Wani, KA (corresponding author), Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA.	danchase@biochem.umass.edu	Wani, Khursheed/AAH-9203-2021	Catanese, Mary/0000-0002-0903-1853	Richard and Susan Smith Family Foundation; National Institutes of Health [MH077935-02]; NIH National Center for Research Services; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH077935] Funding Source: NIH RePORTER	Richard and Susan Smith Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Services; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Richard and Susan Smith Family Foundation (http://www.smithfamilyfoundation.net) and the National Institutes of Health (MH077935-02). Some strains were obtained from the Caenorhabditis Genetics Center, which is supported by the NIH National Center for Research Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PR, 1990, J BIOL CHEM, V265, P2098; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bouhamdan M, 2006, J NEUROSCI, V26, P2522, DOI 10.1523/JNEUROSCI.4083-05.2006; BRENNER S, 1974, GENETICS, V77, P71; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eastman C, 1999, J NEUROSCI, V19, P6225; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1109, DOI 10.1016/0306-4522(86)90127-2; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Gu ZL, 2006, MOL PHARMACOL, V69, P813, DOI 10.1124/mol.105.018853; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikarashi Y, 1997, BRAIN RES BULL, V43, P107, DOI 10.1016/S0361-9230(96)00351-6; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; KEBABIAN JW, 1972, P NATL ACAD SCI USA, V69, P2145, DOI 10.1073/pnas.69.8.2145; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; KIMURA K, 1995, J BIOL CHEM, V270, P14672, DOI 10.1074/jbc.270.24.14672; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; MADURO M, 1995, GENETICS, V141, P977; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nelson LS, 1998, MOL BRAIN RES, V58, P103, DOI 10.1016/S0169-328X(98)00106-5; Ng J, 2010, NEUROSCIENCE, V165, P535, DOI 10.1016/j.neuroscience.2009.10.017; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; OKKEMA PG, 1993, GENETICS, V135, P385; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Porter MY, 2010, MOL BIOL CELL, V21, P232, DOI 10.1091/mbc.E09-07-0642; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Shuey DJ, 1998, J NEUROCHEM, V70, P1964; Sidhu A, 2000, INT J DEV NEUROSCI, V18, P669, DOI 10.1016/S0736-5748(00)00033-2; So CH, 2009, MOL PHARMACOL, V75, P843, DOI 10.1124/mol.108.051805; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang HY, 1995, MOL PHARMACOL, V48, P988; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Witherow DS, 2003, J BIOL CHEM, V278, P21307, DOI 10.1074/jbc.M212884200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0; Zhuang XX, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0001.2000	72	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37831	10.1371/journal.pone.0037831	http://dx.doi.org/10.1371/journal.pone.0037831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629462	Green Published, gold			2022-12-27	WOS:000305343100054
J	Hamilton, JJ; Reed, JL				Hamilton, Joshua J.; Reed, Jennifer L.			Identification of Functional Differences in Metabolic Networks Using Comparative Genomics and Constraint-Based Models	PLOS ONE			English	Article							PROTEIN SYNTHASE-III; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; STAPHYLOCOCCUS-AUREUS; SCALE RECONSTRUCTION; KNOCKOUT STRATEGIES; ACID; BIOSYNTHESIS; FRAMEWORK	Genome-scale network reconstructions are useful tools for understanding cellular metabolism, and comparisons of such reconstructions can provide insight into metabolic differences between organisms. Recent efforts toward comparing genome-scale models have focused primarily on aligning metabolic networks at the reaction level and then looking at differences and similarities in reaction and gene content. However, these reaction comparison approaches are time-consuming and do not identify the effect network differences have on the functional states of the network. We have developed a bilevel mixed-integer programming approach, CONGA, to identify functional differences between metabolic networks by comparing network reconstructions aligned at the gene level. We first identify orthologous genes across two reconstructions and then use CONGA to identify conditions under which differences in gene content give rise to differences in metabolic capabilities. By seeking genes whose deletion in one or both models disproportionately changes flux through a selected reaction (e. g., growth or by-product secretion) in one model over another, we are able to identify structural metabolic network differences enabling unique metabolic capabilities. Using CONGA, we explore functional differences between two metabolic reconstructions of Escherichia coli and identify a set of reactions responsible for chemical production differences between the two models. We also use this approach to aid in the development of a genome-scale model of Synechococcus sp. PCC 7002. Finally, we propose potential antimicrobial targets in Mycobacterium tuberculosis and Staphylococcus aureus based on differences in their metabolic capabilities. Through these examples, we demonstrate that a gene-centric approach to comparing metabolic networks allows for a rapid comparison of metabolic models at a functional level. Using CONGA, we can identify differences in reaction and gene content which give rise to different functional predictions. Because CONGA provides a general framework, it can be applied to find functional differences across models and biological systems beyond those presented here.	[Hamilton, Joshua J.; Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Hamilton, JJ (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	reed@engr.wisc.edu	Reed, Jennifer L/E-5137-2011	Reed, Jennifer L/0000-0001-7854-6220; Hamilton, Joshua/0000-0001-9790-3609	Genomic Science Program (GSP); Office of Biological and Environmental Research (OBER); United States Department of Energy; Bird, Stewart, and Lightfoot Wisconsin Distinguished Graduate Fellowship; National Science Foundation Graduate Research Fellowship [DGE-0718123]	Genomic Science Program (GSP); Office of Biological and Environmental Research (OBER)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); Bird, Stewart, and Lightfoot Wisconsin Distinguished Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	The research was supported in part by the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), United States Department of Energy, and is a contribution of the PNNL Biofuels Scientific Focus Area. JJH also received support from the Bird, Stewart, and Lightfoot Wisconsin Distinguished Graduate Fellowship, and through a National Science Foundation Graduate Research Fellowship under grant no. DGE-0718123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blanchard JS, 1996, ANNU REV BIOCHEM, V65, P215, DOI 10.1146/annurev.bi.65.070196.001243; Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Ferris MC, 2008, LINEAR PROGRAMMING M; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Fu PC, 2009, J CHEM TECHNOL BIOT, V84, P473, DOI 10.1002/jctb.2065; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; He X, 2002, ANTIMICROB AGENTS CH, V46, P1310, DOI 10.1128/AAC.46.5.1310-1318.2002; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024162; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kumar VS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-28; Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7880, DOI 10.1128/AEM.71.12.7880-7887.2005; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Montagud A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-156; MURATA N, 1995, BIOCHEM J, V308, P1; Neres J, 2008, J MED CHEM, V51, P5349, DOI 10.1021/jm800567v; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nie Z, 2005, J MED CHEM, V48, P1596, DOI 10.1021/jm049141s; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sakamoto T, 1998, ARCH MICROBIOL, V169, P20; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Sun J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-174; Sun J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-15; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Vu T, PLOS COMPUT IN PRESS; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Williams H.P., 1999, MODEL BUILDING MATH, V4th; WRIGHT GD, 1992, ACCOUNTS CHEM RES, V25, P468, DOI 10.1021/ar00022a006; Yang L, 2011, METAB ENG, V13, P272, DOI 10.1016/j.ymben.2011.03.002; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	77	30	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34670	10.1371/journal.pone.0034670	http://dx.doi.org/10.1371/journal.pone.0034670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22666308	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000024
J	Janic, B; Jafari-Khouzani, K; Babajani-Feremi, A; Iskander, ASM; Varma, NRS; Ali, MM; Knight, RA; Arbab, AS				Janic, Branislava; Jafari-Khouzani, Kourosh; Babajani-Feremi, Abbas; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Ali, Meser M.; Knight, Robert A.; Arbab, Ali S.			MRI Tracking of FePro Labeled Fresh and Cryopreserved Long Term In Vitro Expanded Human Cord Blood AC133+Endothelial Progenitor Cells in Rat Glioma	PLOS ONE			English	Article							CIRCULATING ENDOTHELIAL-CELLS; STEM-CELL; HEMATOPOIETIC STEM; AC133+PROGENITOR CELLS; GROWTH-FACTOR; VIVO; ANGIOGENESIS; TRAFFICKING; DIFFERENTIATION; NEOVASCULARIZATION	Background: Endothelial progenitors cells (EPCs) are important for the development of cell therapies for various diseases. However, the major obstacles in developing such therapies are low quantities of EPCs that can be generated from the patient and the lack of adequate non-invasive imaging approach for in vivo monitoring of transplanted cells. The objective of this project was to determine the ability of cord blood (CB) AC133+ EPCs to differentiate, in vitro and in vivo, toward mature endothelial cells (ECs) after long term in vitro expansion and cryopreservation and to use magnetic resonance imaging (MRI) to assess the in vivo migratory potential of ex vivo expanded and cryopreserved CB AC133+ EPCs in an orthotopic glioma rat model. Materials, Methods and Results: The primary CB AC133+ EPC culture contained mainly EPCs and long term in vitro conditions facilitated the maintenance of these cells in a state of commitment toward endothelial lineage. At days 15-20 and 25-30 of the primary culture, the cells were labeled with FePro and cryopreserved for a few weeks. Cryopreserved cells were thawed and in vitro differentiated or IV administered to glioma bearing rats. Different groups of rats also received long-term cultured, magnetically labeled fresh EPCs and both groups of animals underwent MRI 7 days after IV administration of EPCs. Fluorescent microscopy showed that in vitro differentiation of EPCs was not affected by FePro labeling and cryopreservation. MRI analysis demonstrated that in vivo accumulation of previously cryopreserved transplanted cells resulted in significantly higher R2 and R2* values indicating a higher rate of migration and incorporation into tumor neovascularization of previously cryopreserved CB AC133+ EPCs to glioma sites, compared to non-cryopreserved cells. Conclusion: Magnetically labeled CB EPCs can be in vitro expanded and cryopreserved for future use as MRI probes for monitoring the migration and incorporation to the sites of neovascularization.	[Janic, Branislava; Jafari-Khouzani, Kourosh; Babajani-Feremi, Abbas; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Ali, Meser M.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Jafari-Khouzani, Kourosh] Harvard Univ, Sch Med, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Massachus, Boston, MA 02115 USA; [Knight, Robert A.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Harvard University; Harvard Medical School; Henry Ford Health System; Henry Ford Hospital	Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Arbab, Ali/AAS-1933-2020		AHA [09SDG2230011];  [R01 CA 122031];  [K25 CA 129173-01A2];  [R21 NS 055143-01]; NATIONAL CANCER INSTITUTE [R01CA122031, K25CA129173, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066143, R01NS055143] Funding Source: NIH RePORTER	AHA(American Heart Association); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: R01 CA 122031, K25 CA 129173-01A2, http://www.cancer.gov/; R21 NS 055143-01, http://www.ninds.nih.gov/; and AHA 09SDG2230011, http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar S, 2010, TRANSFUSION, V50, P2402, DOI 10.1111/j.1537-2995.2010.02743.x; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176; Bhattacharya V, 2000, BLOOD, V95, P581, DOI 10.1182/blood.V95.2.581; Bonanno G, 2007, TRANSFUSION, V47, P280, DOI 10.1111/j.1537-2995.2007.01104.x; Broxmeyer H.E., 2008, CORD BLOOD HEMATOPOI; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; Dong Chunming, 2007, J Interv Cardiol, V20, P93, DOI 10.1111/j.1540-8183.2007.00251.x; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Fibbe WE, 2001, ANN NY ACAD SCI, V938, P9; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Gammaitoni L, 2004, BLOOD, V103, P4440, DOI 10.1182/blood-2003-09-3079; Gehling UM, 2000, BLOOD, V95, P3106; Goldberg JL, 2007, J MOL CELL CARDIOL, V42, P912, DOI 10.1016/j.yjmcc.2007.02.005; Gross P, 2004, Rocz Akad Med Bialymst, V49, P174; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HLADOVEC J, 1978, KLIN WOCHENSCHR, V56, P1033, DOI 10.1007/BF01476669; HLADOVEC J, 1978, PHYSIOL BOHEMOSLOV, V27, P140; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Hur J, 2007, STEM CELLS, V25, P1769, DOI 10.1634/stemcells.2006-0385; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Katayama Y, 1997, BONE MARROW TRANSPL, V19, P283, DOI 10.1038/sj.bmt.1700644; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kuci S, 2008, CELL PROLIFERAT, V41, P12, DOI 10.1111/j.1365-2184.2007.00502.x; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Ma Gang, 2008, Zhonghua Zheng Xing Wai Ke Za Zhi, V24, P144; McGuckin CP, 2008, CELL PROLIFERAT, V41, P31, DOI 10.1111/j.1365-2184.2008.00490.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moise KJ, 2005, OBSTET GYNECOL, V106, P1393, DOI 10.1097/01.AOG.0000188388.84901.e4; Navarro-Sobrino M, 2010, MICROVASCUL IN PRESS; Rad AM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-28; Rafat N, 2010, J NEUROSURG, V112, P43, DOI 10.3171/2009.5.JNS081074; Richardson MR, 2010, J MOL CELL CARDIOL; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Scheubel RJ, 2003, J AM COLL CARDIOL, V42, P2073, DOI 10.1016/j.jacc.2003.07.025; SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3; Senegaglia AC, 2008, REV BRAS CIR CARDIOV, V23, P467, DOI 10.1590/S0102-76382008000400003; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; SOWEMIMOCOKER SO, 1989, AM J HEMATOL, V31, P263, DOI 10.1002/ajh.2830310409; Sputtek A, 2001, ANASTH INTENSIV NOTF, V36, pS162; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; TIMMERMANS F, 2008, J CELL MOL MED; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Varma NRS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030310; Watt SM, 2005, SEMIN FETAL NEONAT M, V10, P209, DOI 10.1016/j.siny.2005.02.001; Watt SM, 2010, J R SOC INTERFACE, V7, pS731, DOI [10.1098/rsif.2010.0377.focus, 10.1098/rsif.2010.0377.focas]; Werner C, 2008, BIOCHEM BIOPH RES CO, V377, P331, DOI 10.1016/j.bbrc.2008.09.081; Woods EJ, 2007, TRANSFUS MED HEMOTH, V34, P276, DOI 10.1159/000104183; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378; Yao CL, 2006, STEM CELLS DEV, V15, P70, DOI 10.1089/scd.2006.15.70; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Yokomuro H, 2010, ANN THORAC CARDIOVAS, V16, P105; Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004; Zeisberger SM, 2010, CELL TRANSPLANT	72	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37577	10.1371/journal.pone.0037577	http://dx.doi.org/10.1371/journal.pone.0037577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662174	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300064
J	Kautz, S; Ballhorn, DJ; Kroiss, J; Pauls, SU; Moreau, CS; Eilmus, S; Strohm, E; Heil, M				Kautz, Stefanie; Ballhorn, Daniel J.; Kroiss, Johannes; Pauls, Steffen U.; Moreau, Corrie S.; Eilmus, Sascha; Strohm, Erhard; Heil, Martin			Host Plant Use by Competing Acacia-Ants: Mutualists Monopolize While Parasites Share Hosts	PLOS ONE			English	Article							INTRASPECIFIC AGGRESSION; MICROSATELLITE LOCI; SOFTWARE; SPECIALIZATION; COEXISTENCE; PATTERNS; NECTAR	Protective ant-plant mutualisms that are exploited by non-defending parasitic ants represent prominent model systems for ecology and evolutionary biology. The mutualist Pseudomyrmex ferrugineus is an obligate plant-ant and fully depends on acacias for nesting space and food. The parasite Pseudomyrmex gracilis facultatively nests on acacias and uses host-derived food rewards but also external food sources. Integrative analyses of genetic microsatellite data, cuticular hydrocarbons and behavioral assays showed that an individual acacia might be inhabited by the workers of several P. gracilis queens, whereas one P. ferrugineus colony monopolizes one or more host trees. Despite these differences in social organization, neither of the species exhibited aggressive behavior among conspecific workers sharing a tree regardless of their relatedness. This lack of aggression corresponds to the high similarity of cuticular hydrocarbon profiles among ants living on the same tree. Host sharing by unrelated colonies, or the presence of several queens in a single colony are discussed as strategies by which parasite colonies could achieve the observed social organization. We argue that in ecological terms, the non-aggressive behavior of non-sibling P. gracilis workers - regardless of the route to achieve this social structure - enables this species to efficiently occupy and exploit a host plant. By contrast, single large and long-lived colonies of the mutualist P. ferrugineus monopolize individual host plants and defend them aggressively against invaders from other trees. Our findings highlight the necessity for using several methods in combination to fully understand how differing life history strategies affect social organization in ants.	[Kautz, Stefanie; Ballhorn, Daniel J.; Eilmus, Sascha; Heil, Martin] Univ Duisburg Essen, Dept Gen Bot, FB BioGeo, Essen, Germany; [Kautz, Stefanie; Moreau, Corrie S.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Ballhorn, Daniel J.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Kroiss, Johannes; Strohm, Erhard] Univ Regensburg, Dept Zool, Regensburg, Germany; [Kroiss, Johannes] Max Planck Inst Chem Ecol, Res Grp Insect Symbiosis, Jena, Germany; [Pauls, Steffen U.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Pauls, Steffen U.] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Heil, Martin] CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico	University of Duisburg Essen; Field Museum of Natural History (Chicago); Portland State University; University of Regensburg; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Kautz, S (corresponding author), Univ Duisburg Essen, Dept Gen Bot, FB BioGeo, Essen, Germany.	skautz@fieldmuseum.org	Pauls, Steffen U/C-2192-2011; Heil, Martin/AAC-2730-2022; Heil, Martin/I-1797-2012; Heil, Martin/T-3960-2019	Heil, Martin/0000-0001-8036-8697; Moreau, Corrie/0000-0003-1139-5792; Pauls, Steffen/0000-0002-6451-3425	Deutsche Forschungsgemeinschaft (DFG) [He 3169/4-2, Ba 3966/1-1]; Universitat Duisburg-Essen; DAAD; German Academy of Sciences Leopoldina [LPDS 2009-29, BMBF-LPD 9901/8-169]; Portland State University; 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Universitat Duisburg-Essen; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Academy of Sciences Leopoldina; Portland State University; 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG) (grant He 3169/4-2) and the Universitat Duisburg-Essen. The molecular work of this study was conducted in the Pritzker Laboratory of Molecular Systematics and Evolution at the Field Museum of Natural History in Chicago. Dr. Kautz gratefully acknowledges financial support from the DAAD and the German Academy of Sciences Leopoldina (grant LPDS 2009-29), Dr. Ballhorn from the DFG (grant Ba 3966/1-1) and start-up funds from Portland State University, Dr. Pauls from the German Academy of Sciences Leopoldina (grant BMBF-LPD 9901/8-169) and the research funding program 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Buckley R.C., 1982, Geobotany, V4, P111; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Clement Lars W, 2008, Behav Ecol Sociobiol, V62, P953; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; Dalecky A, 2007, EVOLUTION, V61, P579, DOI 10.1111/j.1558-5646.2007.00044.x; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Debout GDG, 2009, OIKOS, V118, P873, DOI 10.1111/j.1600-0706.2009.16317.x; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feldhaar H, 2005, INSECT SOC, V52, P222, DOI 10.1007/s00040-004-0797-2; Fiala B, 1996, DIPTEROCARP FOREST E, P102; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gonzalez-Teuber M, 2009, PLANT J, V58, P464, DOI 10.1111/j.1365-313X.2009.03790.x; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Heil M, 2005, SCIENCE, V308, P560, DOI 10.1126/science.1107536; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2010, CHEMOECOLOGY, V20, P63, DOI 10.1007/s00049-009-0036-4; Heil M, 2009, P NATL ACAD SCI USA, V106, P18091, DOI 10.1073/pnas.0904304106; Heinze Juergen, 2008, Myrmecological News, V11, P9; Holldobler B., 1990, pi; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Izzo TJ, 2009, INSECT SOC, V56, P341, DOI 10.1007/s00040-009-0029-x; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; JANZEN DH, 1973, J ANIM ECOL, V42, P727, DOI 10.2307/3134; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Janzen DH, 1974, SWOLLEN THORN ACACIA; Kautz S, 2009, MOL ECOL, V18, P5180, DOI 10.1111/j.1365-294X.2009.04395.x; Kautz S, 2009, MOL ECOL RESOUR, V9, P1016, DOI 10.1111/j.1755-0998.2009.02569.x; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Longino JT, 2006, ZOOTAXA, P1; Peng RK, 1998, AUST J ENTOMOL, V37, P249, DOI 10.1111/j.1440-6055.1998.tb01579.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; PROVOST E, 1991, BEHAV GENET, V21, P151, DOI 10.1007/BF01066333; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Schmid VS, 2009, MOL ECOL RESOUR, V9, P1150, DOI 10.1111/j.1755-0998.2009.02590.x; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; TALBOT CC, 1995, HUM MOL GENET, V4, P1193, DOI 10.1093/hmg/4.7.1193; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; Vander Meer Robert K., 1998, P79; VASCONCELOS HL, 1993, OECOLOGIA, V95, P439, DOI 10.1007/BF00321000; Vasquez GM, 2008, ANIM BEHAV, V75, P583, DOI 10.1016/j.anbehav.2007.06.019; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Ward Philip S., 1993, Journal of Hymenoptera Research, V2, P117; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]	51	11	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37691	10.1371/journal.pone.0037691	http://dx.doi.org/10.1371/journal.pone.0037691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662191	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300081
J	Qiu, J; Yang, R; Rao, YH; Du, YK; Kalembo, FW				Qiu, Jun; Yang, Rong; Rao, Yanhua; Du, Yukai; Kalembo, Fatch W.			Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HEALTH; WEIGHT; NURSES; CELLS; GAIN; GENE	Purpose: The purpose of this study was to explore the risk factors for breast cancer and establish the expression rate of IGF-2 in female patients. Methods: A case control study with 500 people in case group and 500 people in control group. A self-administered questionnaire was used to investigate risk factors for breast cancer. All cases were interviewed during a household survey. Immune-histochemical method was used to inspect the expression of IGF-2 in different tissues (benign breast lesions, breast cancer and tumor-adjacent tissue). Results: Multivariate adjusted odds ratios and 95% confidence intervals were calculated using unconditional logistic regression. High body mass index (OR = 1.012,95% CI = 1.008-1.016), working attributes (OR = 1.004, 95% CI = 1.002 = 1.006), long menstrual period (OR = 1.007, 95% CI = 1.005-1.009), high parity OR = 1.003, 95% CI = 1.001-1.005), frequent artificial abortion (OR = 1.004, 95% CI = 1.001-1.005), family history of cancer (OR = 1.003, 95% CI = 1.000-1.005), period of night shift (OR = 1.003, 95% CI = 1.001-1.006), live in high risk environment (OR = 1.005, 95% CI = 1.002-1.008), and family problems (OR = 1.010, 95% CI = 1.005-1.014) were associated with increased risk for breast cancer. In this study, good sleeping status, positive coping strategies, subjective support, and utility degree of social support were associated with reduced risk for breast cancer (OR = 0.998, 0.997, 0.985, 0.998 respectively; 95% CI = 0.996-1.000, 0.994-1.000, 0.980-0.989, 0.996-1.000, respectively). In benign breast lesions, breast cancer and tumor-adjacent tissue, IGF-2 was mainly expressed in the cytoplasm, but its expression rate was different (p < 0.05). Conclusions: The incidence of breast cancer is a common result of multiple factors. IGF-2 is involved in the development of breast cancer, and its expression varies in different tissues (benign breast lesions, breast cancer and tumor-adjacent tissue).	[Qiu, Jun; Du, Yukai; Kalembo, Fatch W.] Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Rong] Ctr Wuhan City Maternal & Child Hlth Care, Qiaokou, Peoples R China	Huazhong University of Science & Technology	Qiu, J (corresponding author), Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	duyukai100@yahoo.com.cn		Kalembo, Fatch W./0000-0003-3032-3495	Huazhong University of Science and Technology	Huazhong University of Science and Technology	Huazhong University of Science and Technology funded the research study (http://english.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer: Breast, 1980, HDB STAG CANC; De Myets P, 1994, DIABETOLOG, V37, pS135; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giani C, 2002, INT J BIOL MARKER, V17, P90, DOI 10.1177/172460080201700203; Grbesa I, 2006, CANCER LETT, V238, P224, DOI 10.1016/j.canlet.2005.07.003; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hankinson Susan E, 2003, Breast Dis, V17, P27; Harvie M, 2005, CANCER EPIDEM BIOMAR, V14, P656, DOI 10.1158/1055-9965.EPI-04-0001; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Kaaks R, 2001, Gynecol Obstet Fertil, V29, P185; Kang HJ, 2002, CANCER LETT, V178, P175, DOI 10.1016/S0304-3835(01)00861-8; Kotsopoulos J, 2005, CANCER CAUSE CONTROL, V16, P667, DOI 10.1007/s10552-005-1724-1; Kristensen VN, 2000, MUTAT RES-REV MUTAT, V462, P323, DOI 10.1016/S1383-5742(00)00018-1; LeRioth D, 2003, CANC LETT, V195, P127; Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2; Molloy CA, 2000, J BIOL CHEM, V275, P12565, DOI 10.1074/jbc.275.17.12565; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Muller S, 2000, EUR J CANCER, V36, P651, DOI 10.1016/S0959-8049(99)00328-7; Munagala R, 2011, INDIAN J PHARMACOL, V43, P236, DOI 10.4103/0253-7613.81497; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Richardson AE, 2011, GROWTH FACTORS, V29, P82, DOI 10.3109/08977194.2011.565003; ROSEN N, 1991, BREAST CANCER RES TR, V18, pS55, DOI 10.1007/BF02633529; Schernhammer ES, 2005, CANCER EPIDEM BIOMAR, V14, P699, DOI 10.1158/1055-9965.EPI-04-0561; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Shetty PJ, 2011, J CANCER RES CLIN, V137, P339, DOI 10.1007/s00432-010-0890-z; Soares MR, 2010, GROWTH HORM IGF RES, V20, P295, DOI 10.1016/j.ghir.2010.03.006; Turner-Cobb JM, 2000, PSYCHOSOM MED, V62, P337, DOI 10.1097/00006842-200005000-00007; Visual D, 2004, BREAST CANC RES TREA, V84, P225; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664	34	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36497	10.1371/journal.pone.0036497	http://dx.doi.org/10.1371/journal.pone.0036497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662119	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300012
J	Moreau, KL; King, JA				Moreau, Kate L.; King, Jonathan A.			Cataract-Causing Defect of a Mutant gamma-Crystallin Proceeds through an Aggregation Pathway Which Bypasses Recognition by the alpha-Crystallin Chaperone	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; B-CRYSTALLIN; IN-VITRO; DEAMIDATION DESTABILIZES; DIMER INTERFACE; A-CRYSTALLIN; STABILITY; SOLUBILITY	Background: The transparency of the eye lens depends upon maintenance of the native state of the gamma- and beta-crystallins, which is aided by the abundant chaperones alpha A-and alpha B-crystallin. Mature onset cataract, the leading cause of blindness worldwide, involves the polymerization of covalently damaged or partially unfolded crystallins into light-scattering aggregates. A number of single amino acid substitutions and truncations of gamma-crystallins result in congenital cataract in both humans and mice, though in many cases the coupling between the protein alterations and the accumulation of aggregates is poorly defined. Methodology/Principal Findings: We have studied the aggregation properties and chaperone interactions of human gamma D-crystallin carrying substitutions of two buried core mutants, I90F and V75D, which cause congenital cataract in mice. The in vitro aggregation pathway competing with productive refolding was not altered by either substitution. Furthermore, this aggregation pathway for both mutant proteins-originating from a partially folded intermediate-was efficiently suppressed by alpha B-crystallin. Thus the cataract pathology was unlikely to be associated with a direct folding defect. The native state of wild-type human gamma D-crystallin exhibited no tendency to aggregate under physiological conditions. However both I90F and V75D native-like proteins exhibited slow (days) aggregation to high molecular weight aggregates under physiological conditions. The perturbed conformation of I90F was recognized and bound by both alpha A and alpha B chaperones. In contrast, the aggregation derived from the perturbed state of V75D was not suppressed by either chaperone, and the aggregating species were not bound by the chaperone. Conclusions/Significance: The cataract phenotype of I90F in mice may be due to premature saturation of the finite alpha-crystallin pool. The V75D aggregation pathway and its escape from chaperone surveillance and aggregation suppression can account for the congenital cataract pathology of this mutant. Failure of chaperone recognition may be an important source of pathology for many other protein folding defects.	[Moreau, Kate L.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Moreau, KL (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	jaking@mit.edu			National Eye Institute [EY015834]; National Institutes of Health [GM17980]; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017980, R01GM017980] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a National Eye Institute grant EY015834 and a National Institutes of Health grant GM17980 to JAK. The funding websites are www.nih.gov and www.nei.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Banerjee PR, 2011, J MOL BIOL, V412, P647, DOI 10.1016/j.jmb.2011.07.058; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; CARTER JM, 1995, EXP EYE RES, V60, P181, DOI 10.1016/S0014-4835(95)80009-3; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Flaugh SL, 2006, FOLDING STABILITY AG; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; GOPALAKRISHNAN S, 1994, INVEST OPHTH VIS SCI, V35, P382; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Graw J, 2002, MAMM GENOME, V13, P452, DOI 10.1007/s00335-002-3021-6; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Heys KR, 2007, AGING CELL, V6, P807, DOI 10.1111/j.1474-9726.2007.00342.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Kim YH, 2002, BIOCHEMISTRY-US, V41, P14076, DOI 10.1021/bi026288h; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 2002, MOL VIS, V8, P359; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Mills-Henry I, 2007, STABILITY UNFOLDING; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Moran S. D., 2012, P NATL ACAD SCI US; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Rajaraman K, 2001, FEBS LETT, V497, P118, DOI 10.1016/S0014-5793(01)02451-6; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Sathish HA, 2004, J BIOL CHEM, V279, P16425, DOI 10.1074/jbc.M313402200; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Takata T, 2007, BIOCHEMISTRY-US, V46, P8861, DOI 10.1021/bi700487q; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wang YZ, 2010, ECS TRANSACTIONS, V33, P487, DOI 10.1149/1.3481638; Wang YT, 2010, INVEST OPHTH VIS SCI, V51, P672, DOI 10.1167/iovs.09-3987; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020564	68	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37256	10.1371/journal.pone.0037256	http://dx.doi.org/10.1371/journal.pone.0037256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655036	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900011
J	Remot, A; Roux, X; Dubuquoy, C; Fix, J; Bouet, S; Moudjou, M; Eleouet, JF; Riffault, S; Petit-Camurdan, A				Remot, Aude; Roux, Xavier; Dubuquoy, Catherine; Fix, Jenna; Bouet, Stephan; Moudjou, Mohammed; Eleouet, Jean-Francois; Riffault, Sabine; Petit-Camurdan, Agnes			Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; T-CELL RESPONSES; DNA IMMUNIZATION; YOUNG-CHILDREN; INFECTION; MICE; IMMUNOPATHOLOGY; EOSINOPHILS; TH2; DISEASE	Background: The human respiratory syncytial virus (hRSV) is the leading cause of severe bronchiolitis in infants worldwide. The most severe RSV diseases occur between 2 and 6 months-of-age, so pediatric vaccination will have to be started within the first weeks after birth, when the immune system is prone to Th2 responses that may turn deleterious upon exposure to the virus. So far, the high risk to prime for immunopathological responses in infants has hampered the development of vaccine. In the present study we investigated the safety and efficacy of ring-nanostructures formed by the recombinant nucleoprotein N of hRSV (N-SRS) as a mucosal vaccine candidate against RSV in BALB/c neonates, which are highly sensitive to immunopathological Th2 imprinting. Methodology and Principal Findings: A single intranasal administration of N-SRS with detoxified E.coli enterotoxin LT(R192G) to 5-7 day old neonates provided a significant reduction of the viral load after an RSV challenge at five weeks of age. However, neonatal vaccination also generated an enhanced lung infiltration by neutrophils and eosinophils following the RSV challenge. Analysis of antibody subclasses and cytokines produced after an RSV challenge or a boost administration of the vaccine suggested that neonatal vaccination induced a Th2 biased local immune memory. This Th2 bias and the eosinophilic reaction could be prevented by adding CpG to the vaccine formulation, which, however did not prevent pulmonary inflammation and neutrophil infiltration upon viral challenge. Conclusions/Significance: In conclusion, protective vaccination against RSV can be achieved in neonates but requires an appropriate combination of adjuvants to prevent harmful Th2 imprinting.	[Remot, Aude; Roux, Xavier; Dubuquoy, Catherine; Fix, Jenna; Moudjou, Mohammed; Eleouet, Jean-Francois; Riffault, Sabine; Petit-Camurdan, Agnes] French Natl Inst Agr Res, Mol Virol & Immunol UR892, Jouy En Josas, France; [Bouet, Stephan] French Natl Inst Agr Res, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Remot, A (corresponding author), French Natl Inst Agr Res, Mol Virol & Immunol UR892, Jouy En Josas, France.	sabine.riffault@jouy.inra.fr	Eléouët, Jean-François/AAD-1994-2019	ELeouet, Jean-Francois/0000-0002-7361-4885; Remot, Aude/0000-0001-9896-3216; Tripp, Ralph/0000-0002-2924-9956	National Institute for Agronomical Research (Institut National de la Recherche Agronomique, INRA)	National Institute for Agronomical Research (Institut National de la Recherche Agronomique, INRA)	During her thesis Aude Remot was the recipient of a grant for young investigators by the National Institute for Agronomical Research (Institut National de la Recherche Agronomique, INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios C, 1996, EUR J IMMUNOL, V26, P2666, DOI 10.1002/eji.1830261118; Barrios C, 1996, EUR J IMMUNOL, V26, P1489, DOI 10.1002/eji.1830260713; Boxus M, 2007, J VIROL, V81, P6879, DOI 10.1128/JVI.00502-07; Castilow EM, 2008, J IMMUNOL, V181, P6692, DOI 10.4049/jimmunol.181.10.6692; Castilow EM, 2008, FUTURE VIROL, V3, P445, DOI 10.2217/17460794.3.5.445; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; Cho JY, 2001, J ALLERGY CLIN IMMUN, V108, P697, DOI 10.1067/mai.2001.119918; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Cormier SA, 2010, EXPERT REV ANTI-INFE, V8, P1371, DOI [10.1586/eri.10.125, 10.1586/ERI.10.125]; Culley FJ, 2006, J VIROL, V80, P4521, DOI 10.1128/JVI.80.9.4521-4527.2006; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Dakhama A, 2005, J IMMUNOL, V175, P1876, DOI 10.4049/jimmunol.175.3.1876; Dakhama A, 2009, J ALLERGY CLIN IMMUN, V123, P138, DOI 10.1016/j.jaci.2008.10.012; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kovarik J, 1999, J IMMUNOL, V162, P1611; Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Martinez X, 1999, EUR J IMMUNOL, V29, P3390, DOI 10.1002/(SICI)1521-4141(199910)29:10<3390::AID-IMMU3390>3.0.CO;2-A; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Pala P, 2002, EUR RESPIR J, V20, P376, DOI 10.1183/09031936.02.00249902; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Plotnicky H, 2003, VACCINE, V21, P2651, DOI 10.1016/S0264-410X(03)00055-0; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Riffault S, 2010, VACCINE, V28, P3722, DOI 10.1016/j.vaccine.2010.03.008; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Rosenberg HF, 2009, ANTIVIR RES, V83, P1, DOI 10.1016/j.antiviral.2009.04.005; Roux X, 2011, EUR J IMMUNOL, V41, P2852, DOI 10.1002/eji.201041224; Roux X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001766; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Simmons CP, 2001, J IMMUNOL, V166, P1106, DOI 10.4049/jimmunol.166.2.1106; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Tasker L, 2008, CLIN EXP IMMUNOL, V153, P277, DOI 10.1111/j.1365-2249.2008.03591.x; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tregoning JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009381; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; VanCott JL, 2006, J VIROL, V80, P4949, DOI 10.1128/JVI.80.10.4949-4961.2006; Vaughan K, 2005, VACCINE, V23, P2928, DOI 10.1016/j.vaccine.2004.10.046; Venter M, 2003, J VIROL, V77, P7319, DOI 10.1128/JVI.77.13.7319-7329.2003; Wiley JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007142; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	55	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37722	10.1371/journal.pone.0037722	http://dx.doi.org/10.1371/journal.pone.0037722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655066	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900042
J	Apgar, J; Ross, M; Zuo, X; Dohle, S; Sturtevant, D; Shen, BZ; de la Vega, H; Lessard, P; Lazar, G; Raab, RM				Apgar, James; Ross, Mary; Zuo, Xiao; Dohle, Sarah; Sturtevant, Derek; Shen, Binzhang; de la Vega, Humberto; Lessard, Philip; Lazar, Gabor; Raab, R. Michael			A Predictive Model of Intein Insertion Site for Use in the Engineering of Molecular Switches	PLOS ONE			English	Article							PROTEIN SPLICING MECHANISM; YEAST VMA1 PROTOZYME; DNAE INTEIN; AMINO-ACIDS; ENDONUCLEASE; PURIFICATION; INBASE; IDENTIFICATION; MUTAGENESIS; MODULATION	Inteins are intervening protein domains with self-splicing ability that can be used as molecular switches to control activity of their host protein. Successfully engineering an intein into a host protein requires identifying an insertion site that permits intein insertion and splicing while allowing for proper folding of the mature protein post-splicing. By analyzing sequence and structure based properties of native intein insertion sites we have identified four features that showed significant correlation with the location of the intein insertion sites, and therefore may be useful in predicting insertion sites in other proteins that provide native-like intein function. Three of these properties, the distance to the active site and dimer interface site, the SVM score of the splice site cassette, and the sequence conservation of the site showed statistically significant correlation and strong predictive power, with area under the curve (AUC) values of 0.79, 0.76, and 0.73 respectively, while the distance to secondary structure/loop junction showed significance but with less predictive power (AUC of 0.54). In a case study of 20 insertion sites in the XynB xylanase, two features of native insertion sites showed correlation with the splice sites and demonstrated predictive value in selecting non-native splice sites. Structural modeling of intein insertions at two sites highlighted the role that the insertion site location could play on the ability of the intein to modulate activity of the host protein. These findings can be used to enrich the selection of insertion sites capable of supporting intein splicing and hosting an intein switch.	[Apgar, James; Ross, Mary; Zuo, Xiao; Dohle, Sarah; Sturtevant, Derek; Shen, Binzhang; de la Vega, Humberto; Lessard, Philip; Lazar, Gabor; Raab, R. Michael] Agrivida Inc, Medford, MD USA		Apgar, J (corresponding author), Agrivida Inc, Medford, MD USA.	michael.raab@agrivida.com		Apgar, James/0000-0002-4669-0188				Adam E, 2002, J MOL MICROB BIOTECH, V4, P479; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrondo M, 2008, STRUCTURE, V16, P513, DOI 10.1016/j.str.2008.01.012; Chen LX, 2001, GENE, V263, P39, DOI 10.1016/S0378-1119(00)00568-0; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; Evans TC, 1999, J BIOL CHEM, V274, P3923, DOI 10.1074/jbc.274.7.3923; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gangopadhyay JP, 2003, BBA-GEN SUBJECTS, V1619, P193, DOI 10.1016/S0304-4165(02)00495-6; Gray BN, 2011, PLANT BIOTECHNOL J, V9, P1100, DOI 10.1111/j.1467-7652.2011.00632.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Joachims T, 2002, METHODS THEORY ALGOR; Joachims T, 1999, LEARNING PRACTICAL A; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mills KV, 2005, PROTEIN PEPTIDE LETT, V12, P751, DOI 10.2174/0929866054864337; Mootz HD, 2002, J AM CHEM SOC, V124, P9044, DOI 10.1021/ja026769o; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Nogami S, 1997, GENETICS, V147, P73; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Pearl EJ, 2007, BBA-PROTEINS PROTEOM, V1774, P995, DOI 10.1016/j.bbapap.2007.05.015; Pearl EJ, 2007, FEBS LETT, V581, P3000, DOI 10.1016/j.febslet.2007.05.060; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Perler FB, 2000, NUCLEIC ACIDS RES, V28, P344, DOI 10.1093/nar/28.1.344; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 2005, NUCL ACID M, V16, P193; PERLER FB, 1992, P NATL ACAD SCI USA, V89, P5577, DOI 10.1073/pnas.89.12.5577; Perler FB, 1999, NUCLEIC ACIDS RES, V27, P346, DOI 10.1093/nar/27.1.346; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schwartz EC, 2003, CHEM COMMUN, P2087, DOI 10.1039/b304989m; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Skretas G, 2005, PROTEIN SCI, V14, P523, DOI 10.1110/ps.04996905; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Swithers KS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-303; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wood DW, 2000, BIOTECHNOL PROGR, V16, P1055, DOI 10.1021/bp0000858; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	54	10	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37355	10.1371/journal.pone.0037355	http://dx.doi.org/10.1371/journal.pone.0037355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649521	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335800039
J	Dauksa, A; Gulbinas, A; Barauskas, G; Pundzius, J; Oldenburg, J; El-Maarri, O				Dauksa, Albertas; Gulbinas, Antanas; Barauskas, Giedrius; Pundzius, Juozas; Oldenburg, Johannes; El-Maarri, Osman			Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; IP-RP-HPLC; PROMOTER METHYLATION; BREAST-CANCER; COLORECTAL-CANCER; BLADDER-CANCER; GASTRIC-CANCER; LEUKOCYTE DNA; CPG SITES; GENE	Pancreatic tumors are usually diagnosed at an advanced stage in the progression of the disease, thus reducing the survival chances of the patients. Non-invasive early detection would greatly enhance therapy and survival rates. Toward this aim, we investigated in a pilot study the power of methylation changes in whole blood as predictive markers for the detection of pancreatic tumors. We investigated methylation levels at selected CpG sites in the CpG rich regions at the promoter regions of p16, RARbeta, TNFRSF10C, APC, ACIN1, DAPK1, 3OST2, BCL2 and CD44 in the blood of 30 pancreatic tumor patients and in the blood of 49 matching controls. In addition, we studied LINE-1 and Alu repeats using degenerate amplification approach as a surrogate marker for genome-wide methylation. The site-specific methylation measurements at selected CpG sites were done by the SIRPH method. Our results show that in the patient's blood, tumor suppressor genes were slightly but significantly higher methylated at several CpG sites, while repeats were slightly less methylated compared to control blood. This was found to be significantly associated with higher risk for pancreatic ductal adenocarcinoma. Additionally, high methylation levels at TNFRSCF10C were associated with positive perineural spread of tumor cells, while higher methylation levels of TNFRSF10C and ACIN1 were significantly associated with shorter survival. This pilot study shows that methylation changes in blood could provide a promising method for early detection of pancreatic tumors. However, larger studies must be carried out to explore the clinical usefulness of a whole blood methylation based test for non-invasive early detection of pancreatic tumors.	[Dauksa, Albertas; Gulbinas, Antanas] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania; [Barauskas, Giedrius; Pundzius, Juozas] Lithuanian Univ Hlth Sci, Dept Surg, Kaunas, Lithuania; [Oldenburg, Johannes; El-Maarri, Osman] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; University of Bonn	Dauksa, A (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania.	gulbanta@yahoo.com; osman.elmaarri@ukb.uni-bonn.de	Barauskas, Giedrius/N-1701-2019; Oldenburg, Johannes/ABB-7817-2020	barauskas, giedrius/0000-0002-4321-7280; Gulbinas, Antanas/0000-0002-6683-1339; El-Maarri, Osman/0000-0002-6859-5819; Oldenburg, Johannes/0000-0002-1585-4100				Ahrendt SA, 1999, JNCI-J NATL CANCER I, V91, P332, DOI 10.1093/jnci/91.4.332; Belinsky SA, 2002, CANCER RES, V62, P2370; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Cheng Y, 2009, PROSTATE, V69, P327, DOI 10.1002/pros.20882; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Deng GR, 2004, CANCER RES, V64, P2692, DOI 10.1158/0008-5472.CAN-03-3000; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; El-Maarri O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e25; El-Maarri Osman, 2004, Methods Mol Biol, V287, P195; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fleisher AS, 2001, ONCOGENE, V20, P329, DOI 10.1038/sj.onc.1204104; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Fukushima N, 2003, BRIT J CANCER, V89, P338, DOI 10.1038/sj.bjc.6601039; Fukushima N, 2002, AM J PATHOL, V160, P1573, DOI 10.1016/S0002-9440(10)61104-2; Goessl C, 2001, ANN NY ACAD SCI, V945, P51; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Hoebeeck J, 2009, CANCER LETT, V273, P336, DOI 10.1016/j.canlet.2008.08.019; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jahr S, 2001, CANCER RES, V61, P1659; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kanai Y, 2008, PATHOL INT, V58, P544, DOI 10.1111/j.1440-1827.2008.02270.x; Kito H, 2001, PROSTATE, V49, P110, DOI 10.1002/pros.1124; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Mori T, 2005, J CLIN ONCOL, V23, P9351, DOI 10.1200/JCO.2005.02.9876; Muller HM, 2003, CANCER RES, V63, P7641; Muller HM, 2004, LANCET, V363, P1283, DOI 10.1016/S0140-6736(04)16002-9; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Pedersen KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018223; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Riall TS, 2006, SURGERY, V140, P764, DOI 10.1016/j.surg.2006.04.006; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Shivapurkar N, 2007, CANCER LETT, V247, P56, DOI 10.1016/j.canlet.2006.03.020; Shu YJ, 2006, J THORAC ONCOL, V1, P160, DOI 10.1097/01243894-200602000-00010; Sobin L, 2002, TNM CLASSIFICATION M, P81; Suzuki M, 2006, CANCER LETT, V242, P222, DOI 10.1016/j.canlet.2005.11.002; Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2001, J MAMMARY GLAND BIOL, V6, P193, DOI 10.1023/A:1011360724350; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1078; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	52	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37509	10.1371/journal.pone.0037509	http://dx.doi.org/10.1371/journal.pone.0037509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629410	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300047
J	Ussher, JR; Folmes, CDL; Keung, W; Fillmore, N; Jaswal, JS; Cadete, VJ; Beker, DL; Lam, VH; Zhang, LY; Lopaschuk, GD				Ussher, John R.; Folmes, Clifford D. L.; Keung, Wendy; Fillmore, Natasha; Jaswal, Jagdip S.; Cadete, Virgilio J.; Beker, Donna L.; Lam, Victoria H.; Zhang, Liyan; Lopaschuk, Gary D.			Inhibition of Serine Palmitoyl Transferase I Reduces Cardiac Ceramide Levels and Increases Glycolysis Rates following Diet-Induced Insulin Resistance	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACETYL-COA CARBOXYLASE; FATTY-ACID-METABOLISM; CONTRACTILE DYSFUNCTION; GLUCOSE-OXIDATION; CELL-DEATH; HEART; EFFICIENCY; OBESITY; MICE	Objective: Diet-induced obesity (DIO) leads to an accumulation of intra-myocardial lipid metabolites implicated in causing cardiac insulin resistance and contractile dysfunction. One such metabolite is ceramide, and our aim was to determine the effects of inhibiting de novo ceramide synthesis on cardiac function and insulin stimulated glucose utilization in mice subjected to DIO. Materials and Methods: C57BL/6 mice were fed a low fat diet or subjected to DIO for 12 weeks, and then treated for 4 weeks with either vehicle control or the serine palmitoyl transferase I (SPT I) inhibitor, myriocin. In vivo cardiac function was assessed via ultrasound echocardiography, while glucose metabolism was assessed in isolated working hearts. Results: DIO was not associated with an accumulation of intra-myocardial ceramide, but rather, an accumulation of intra-myocardial DAG (2.63 +/- 0.41 vs. 4.80 +/- 0.97 nmol/g dry weight). Nonetheless, treatment of DIO mice with myriocin decreased intra-myocardial ceramide levels (50.3 +/- 7.7 vs. 26.9 +/- 2.7 nmol/g dry weight) and prevented the DIO-associated increase in intra-myocardial DAG levels. Interestingly, although DIO impaired myocardial glycolysis rates (7789 +/- 1267 vs. 2671 +/- 326 nmol/min/g dry weight), hearts from myriocin treated DIO mice exhibited an increase in glycolysis rates. Conclusions: Our data reveal that although intra-myocardial ceramide does not accumulate following DIO, inhibition of de novo ceramide synthesis nonetheless reduces intra-myocardial ceramide levels and prevents the accumulation of intra-myocardial DAG. These effects improved the DIO-associated impairment of cardiac glycolysis rates, suggesting that SPT I inhibition increases cardiac glucose utilization.	[Ussher, John R.; Folmes, Clifford D. L.; Keung, Wendy; Fillmore, Natasha; Jaswal, Jagdip S.; Cadete, Virgilio J.; Beker, Donna L.; Lam, Victoria H.; Zhang, Liyan; Lopaschuk, Gary D.] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Edmonton, AB, Canada	University of Alberta	Ussher, JR (corresponding author), Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Edmonton, AB, Canada.	gary.lopaschuk@ualberta.ca	Zhang, Li/GWM-7501-2022	Folmes, Clifford/0000-0002-3683-9970; Fillmore, Natasha/0000-0002-6723-0869; Keung, Wendy/0000-0002-6827-6754	Heart and Stroke Foundation of Alberta	Heart and Stroke Foundation of Alberta	This study was supported by a grant from the Heart and Stroke Foundation of Alberta to GDL. JRU is a trainee of the AHFMR and Tomorrow's Research Cardiovascular Health Professionals (TORCH). CDLF is a trainee of the AHFMR, the Canadian Institutes of Health Research and TORCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, DIABETOLOGIA, V49, P2174, DOI 10.1007/s00125-006-0338-9; Atkinson LL, 2003, AM J PHYSIOL-ENDOC M, V284, pE923, DOI 10.1152/ajpendo.00360.2002; Baranowski M, 2010, J LIPID RES, V51, P74, DOI 10.1194/jlr.M900002-JLR200; Bose R, 2000, METHOD ENZYMOL, V322, P373; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; deVries JE, 1997, J LIPID RES, V38, P1384; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Farese RV, 2005, EXP BIOL MED, V230, P593; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Folmes CDL, 2006, CIRC RES, V99, P61, DOI 10.1161/01.RES.0000229656.05244.11; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Liu B, 1996, CIRC RES, V79, P940, DOI 10.1161/01.RES.79.5.940; Liu Q, 2002, J AM COLL CARDIOL, V39, P718, DOI 10.1016/S0735-1097(01)01803-4; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; OPIE LH, 1990, CARDIOVASC DRUG THER, V4, P777, DOI 10.1007/BF00051275; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tessier JP, 2003, CARDIOVASC RES, V60, P119, DOI 10.1016/S0008-6363(03)00320-1; Ussher JR, 2008, CARDIOVASC RES, V79, P259, DOI 10.1093/cvr/cvn130; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; Ussher JR, 2009, AM J PHYSIOL-ENDOC M, V297, pE349, DOI 10.1152/ajpendo.00009.2009; Ussher JR, 2009, BASIC RES CARDIOL, V104, P203, DOI 10.1007/s00395-009-0003-9; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	44	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37703	10.1371/journal.pone.0037703	http://dx.doi.org/10.1371/journal.pone.0037703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629445	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300069
J	Kumar, C; Singh, PK; Rai, RK				Kumar, Chandan; Singh, Prashant Kumar; Rai, Rajesh Kumar			Under-Five Mortality in High Focus States in India: A District Level Geospatial Analysis	PLOS ONE			English	Article							LOCAL SPATIAL AUTOCORRELATION; CHILD-MORTALITY; DEVELOPING-COUNTRIES; MATERNAL EDUCATION; SOCIOECONOMIC INEQUALITIES; NEONATAL-MORTALITY; INFANT-MORTALITY; URBAN HEALTH; SOUTH-AFRICA; SURVIVAL	Background: This paper examines if, when controlling for biophysical and geographical variables (including rainfall, productivity of agricultural lands, topography/temperature, and market access through road networks), socioeconomic and health care indicators help to explain variations in the under-five mortality rate across districts from nine high focus states in India. The literature on this subject is inconclusive because the survey data, upon which most studies of child mortality rely, rarely include variables that measure these factors. This paper introduces these variables into an analysis of 284 districts from nine high focus states in India. Methodology/Principal Findings: Information on the mortality indicator was accessed from the recently conducted Annual Health Survey of 2011 and other socioeconomic and geographic variables from Census 2011, District Level Household and Facility Survey (2007-08), Department of Economics and Statistics Divisions of the concerned states. Displaying high spatial dependence (spatial autocorrelation) in the mortality indicator (outcome variable) and its possible predictors used in the analysis, the paper uses the Spatial-Error Model in an effort to negate or reduce the spatial dependence in model parameters. The results evince that the coverage gap index (a mixed indicator of district wise coverage of reproductive and child health services), female literacy, urbanization, economic status, the number of newborn care provided in Primary Health Centers in the district transpired as significant correlates of under-five mortality in the nine high focus states in India. The study identifies three clusters with high under-five mortality rate including 30 districts, and advocates urgent attention. Conclusion: Even after controlling the possible biophysical and geographical variables, the study reveals that the health program initiatives have a major role to play in reducing under-five mortality rate in the high focus states in India.	[Kumar, Chandan] Indian Inst Technol, Dept Humanities & Social Sci, Roorkee, Uttarakhand, India; [Singh, Prashant Kumar] Int Inst Populat Sci, Bombay, Maharashtra, India; [Rai, Rajesh Kumar] Tata Inst Social Sci, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; International Institute for Population Sciences; Tata Institute of Social Sciences	Kumar, C (corresponding author), Indian Inst Technol, Dept Humanities & Social Sci, Roorkee, Uttarakhand, India.	c.kumar803@gmail.com	Kumar, Chandan/AAS-4525-2020	Kumar, Chandan/0000-0002-2351-2442; Rai, Rajesh Kumar/0000-0002-5249-9937; Singh, Prashant Kumar/0000-0003-1742-5534	Ministry of Human Resource Development, Government of India; Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India	Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CK is supported by a Doctoral Fellowship granted by Ministry of Human Resource Development, Government of India. PKS is supported by the Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 2009, NAVJ SHISH SUR KAR 2; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 1980, REGIONAL SCI DISSERT; Anselin L., 2006, PALGRAVE HDB ECONOME, P901; Anselin L., 2002, P CSISS WORKSH NEW T; Arokiasamy P, 2011, HEALTH POLICY PLANN, V26, P429, DOI 10.1093/heapol/czq075; Arokiasamy P, 2008, J BIOSOC SCI, V40, P183, DOI 10.1017/S0021932007002623; Balk D, 2005, FOOD POLICY, V30, P584, DOI 10.1016/j.foodpol.2005.10.007; Balk D., 2004, Population, Space and Place, V10, P175, DOI 10.1002/psp.328; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bhattacharjee A, 2005, CRIEFF DISCUSSION PA; Black RE, 2009, GLOBAL RES ACTIVITY; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; BOERMA JT, 1992, STUD FAMILY PLANN, V23, P243, DOI 10.2307/1966886; Booysen F, 2008, WORLD DEV, V36, P1113, DOI 10.1016/j.worlddev.2007.10.008; Boyle MH, 2006, SOC SCI MED, V63, P2242, DOI 10.1016/j.socscimed.2006.04.034; Cecatti JG, 2008, MATERN CHILD HLTH J, V12, P275, DOI 10.1007/s10995-007-0219-y; Chandan Kumar, 2011, Consilience: The Journal of Sustainable Development, P25; Chandramouli C, 2011, CENSUS INDIA 2011 ST; Chin B, 2011, HEALTH PLACE, V17, P929, DOI 10.1016/j.healthplace.2011.04.006; Claeson M, 2000, B WORLD HEALTH ORGAN, V78, P1192; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; CLELAND JG, 1984, POP STUD-J DEMOG, V38, P401, DOI 10.1080/00324728.1984.10410300; Cleland J, 2010, LANCET, V376, P933, DOI 10.1016/S0140-6736(10)61417-1; Curtis SL, 1998, EFFECT ARIDITY ZONE; DASGUPTA M, 1990, POP STUD-J DEMOG, V44, P489, DOI 10.1080/0032472031000144866; de Sherbinin A, 2011, POPUL SPACE PLACE, V17, P27, DOI 10.1002/psp.599; Demirel R, 2009, TURK KLIN TIP BILIM, V29, P25; Desai S, 2008, DEMOGRAPHY, V45, P245; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Fay M, 2005, WORLD DEV, V33, P1267, DOI 10.1016/j.worlddev.2005.03.001; Findley S, 2002, ANN M POP ASS AM ATL; Firestone R, 2011, SOC SCI MED, V72, P1420, DOI 10.1016/j.socscimed.2011.03.003; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Ghosh R, 2012, WORLD J PEDIATR, V8, P11, DOI 10.1007/s12519-012-0331-y; Ghosh R, 2010, J BIOSOC SCI, V42, P511, DOI 10.1017/S0021932010000040; Goovaerts Pierre, 2005, J Geogr Syst, V7, P137, DOI 10.1007/s10109-005-0154-7; Government of India Indiastat, 2012, INC POV 2006 07; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haque T., 2011, SOCIAL CHANGE, V41, P443, DOI [DOI 10.1177/004908571104100307, 10.1177/004908571104100307]; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Headey DD, 2009, POPUL DEV REV, V35, P221, DOI 10.1111/j.1728-4457.2009.00274.x; Hu Y, 2012, INT J ENVIRON HEAL R, V22, P184, DOI 10.1080/09603123.2011.613113; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF, V1; Jacquez GM, 2005, J GEOGR SYST, V7, P7, DOI DOI 10.1007/S10109-005-0147-6; Joe W, 2010, GLOB PUBLIC HEALTH, V5, P493, DOI 10.1080/17441690903213774; Kandala NB, 2006, QUAL QUANT, V40, P935, DOI 10.1007/s11135-005-3268-6; Kazembe LN, 2007, GEOSPATIAL HEALTH, V2, P41, DOI 10.4081/gh.2007.253; Kelejian HH, 1995, NEW DIRECTIONS SPATI; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kravdal O, 2004, POP STUD-J DEMOG, V58, P177, DOI 10.1080/0032472042000213721; Krishna A, 2006, WORLD DEV, V34, P271, DOI 10.1016/j.worlddev.2005.08.003; Lachaud JP, 2004, HEALTH PLACE, V10, P13, DOI 10.1016/S1353-8292(02)00070-9; Lalou R., 1997, POPULATION, V147-1689, P147; Lopez AD, 2000, B WORLD HEALTH ORGAN, V78, P1173; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; MACDOUGALL EB, 1992, CARTOGR GEOGR INFORM, V19, P237, DOI 10.1559/152304092783721268; Makepeace G, 2006, 2390 I STUD LAB; Malthus TR, 1798, ESSAY PRINCIPLE POPU, V1; Martin WJ, 2011, SCIENCE, V334, P180, DOI 10.1126/science.1213088; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Ministry of Health and Family Welfare, 2012, RUR HLTH STAT IND 20; Ministry of Health and Family Welfare, 2011, ANN REP 2010 11 GOV; Ministry of Health and Family Welfare, 2012, DISTR HLTH ACT PLAN; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morrison Joanna, 2005, BMC Pregnancy Childbirth, V5, P6, DOI 10.1186/1471-2393-5-6; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; National Research Council, 2001, WEATH CLIM EC INF DI; Nuwaha Fred, 2011, BMC Res Notes, V4, P484, DOI 10.1186/1756-0500-4-484; Ombok M, 2010, TROP MED INT HEALTH, V15, P423, DOI 10.1111/j.1365-3156.2010.02467.x; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ord JK, 2001, J REGIONAL SCI, V41, P411, DOI 10.1111/0022-4146.00224; Osotimehin B, 2011, SCIENCE, V333, P499, DOI 10.1126/science.1210732; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Pathak PK, 2011, SOC SCI MED, V73, P576, DOI 10.1016/j.socscimed.2011.06.024; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Paynter S, 2010, LANCET, V376, P1804, DOI 10.1016/S0140-6736(10)62141-1; Planning Commission, 2012, FAST SUST MOR INCL G; Planning Commission Government of India, 2012, POV EST 2004 05; Pouliou T, 2009, PREV MED, V48, P362, DOI 10.1016/j.ypmed.2009.01.017; Pradhan J, 2010, HEALTH POLICY, V98, P114, DOI 10.1016/j.healthpol.2010.05.010; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Reetika Khera, 2011, Economic and Political Weekly, V46, P36; Registrar General and Census Commissioner, 2012, ANN HLTH SURV 2010 1; Registrar General of India and Census Commissioner, 2011, CENS IND 2011 PROV P; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Russell Bernard H., 1995, RES METHODS ANTHR QU, Vsecond; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Sartorius BKD, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-61; Sartorius BKD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-645; Sastry N, 1997, SOC SCI MED, V44, P989, DOI 10.1016/S0277-9536(96)00224-9; Semba RD, 2011, AM J TROP MED HYG, V84, P443, DOI 10.4269/ajtmh.2011.10-0244; Sen B, 2003, WORLD DEV, V31, P513, DOI 10.1016/S0305-750X(02)00217-6; Shonkoff JP, 2012, PEDIATRICS, V129, pE460, DOI 10.1542/peds.2011-0366; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026856; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Sousa A, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-21; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Tottrup C, 2009, TROP MED INT HEALTH, V14, P653, DOI 10.1111/j.1365-3156.2009.02275.x; United Nations Children's Fund, 2009, STAT AS PAC CHILDR 2; United Nations Children's Fund, 2010, LEV TRENDS CHILD MOR; United Nations Children's Fund, 2012, CLIM CHANG CHILDR; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Voss PR, 2006, POPUL RES POLICY REV, V25, P369, DOI 10.1007/s11113-006-9007-4; Waddington C, 2008, INTEGRATED HLTH SERV; Waller L.A., 2004, APPL SPATIAL STAT PU; Warner R.M., 2012, APPL STAT BIVARIATE; Webb P, 1998, WORLD FOOD PROGRAMME; World Bank, 2008, ENVIRON DEV, P1, DOI 10.1596/978-0-8213-7236-4; World Health Organisation, 2007, REACH POOR CHALL CHI	123	53	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37515	10.1371/journal.pone.0037515	http://dx.doi.org/10.1371/journal.pone.0037515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22629412	Green Published, gold			2022-12-27	WOS:000305343500129
J	Meng, XM; Baylink, DJ; Sheng, M; Wang, HJ; Gridley, DS; Lau, KHW; Zhang, XB				Meng, Xianmei; Baylink, David J.; Sheng, Matilda; Wang, Hongjie; Gridley, Daila S.; Lau, K. -H. William; Zhang, Xiao-Bing			Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EX-VIVO EXPANSION; OVARIECTOMIZED RATS; LENTIVIRAL VECTORS; OSTEOPENIC RATS; STROMAL CELLS; FACTOR BFGF; MICE; STRENGTH; MASS	Fibroblast growth factor-2 (FGF2) has been demonstrated to be a promising osteogenic factor for treating osteoporosis. Our earlier study shows that transplantation of mouse Sca-1(+) hematopoietic stem/progenitor cells that are engineered to express a modified FGF2 leads to considerable endosteal/trabecular bone formation, but it also induces adverse effects like hypocalemia and osteomalacia. Here we report that the use of an erythroid specific promoter, beta-globin, leads to a 5-fold decrease in the ratio of serum FGF2 to the FGF2 expression in the marrow cavity when compared to the use of a ubiquitous promoter spleen focus-forming virus (SFFV). The confined FGF2 expression promotes considerable trabeculae bone formation in endosteum and does not yield anemia and osteomalacia. The avoidance of anemia in the mice that received Sca1(+) cells transduced with FGF2 driven by the beta-globin promoter is likely due to attenuation of high-level serum FGF2-mediated stem cell mobilization observed in the SFFV-FGF2 animals. The prevention of osteomalacia is associated with substantially reduced serum Fgf23/hypophosphatemia, and less pronounced secondary hyperparathyroidism. Our improved stem cell gene therapy strategy represents one step closer to FGF2-based clinical therapy for systemic skeletal augmentation.	[Meng, Xianmei; Baylink, David J.; Sheng, Matilda; Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA; [Wang, Hongjie] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Gridley, Daila S.] Loma Linda Univ, Dept Radiat Med, Loma Linda, CA 92350 USA; [Lau, K. -H. William] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA	Loma Linda University; University of Washington; University of Washington Seattle; Loma Linda University	Meng, XM (corresponding author), Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA.	xzhang@llu.edu	Gridley, Daila S/P-7711-2015	Lau, Kin-Hing/0000-0003-1109-5052	United States Army Medical Research Acquisition Activity (USAMRAA) [W81XWH-08-1-0697]; Loma Linda University GRASP Award; USAMRAA Concept Award [W81XWH-11-1-0607]; Radiation Research Laboratories in the Department of Radiation Medicine at Loma Linda University	United States Army Medical Research Acquisition Activity (USAMRAA); Loma Linda University GRASP Award; USAMRAA Concept Award; Radiation Research Laboratories in the Department of Radiation Medicine at Loma Linda University	This study was funded by United States Army Medical Research Acquisition Activity (USAMRAA) Grant W81XWH-08-1-0697 (DJB), Loma Linda University GRASP Award (XBZ), USAMRAA Concept Award W81XWH-11-1-0607 (XBZ), and Radiation Research Laboratories in the Department of Radiation Medicine at Loma Linda University (DSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Barde I, 2011, GENE THER, V18, P1087, DOI 10.1038/gt.2011.65; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Beyer I, 2011, MOL THER, V19, P479, DOI 10.1038/mt.2010.256; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; CHADA K, 1985, NATURE, V314, P377, DOI 10.1038/314377a0; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chen ST, 2007, J CELL BIOCHEM, V100, P1493, DOI 10.1002/jcb.21136; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; Menezes Filho Hamilton de, 2006, Arq Bras Endocrinol Metab, V50, P802, DOI 10.1590/S0004-27302006000400025; Hall SL, 2007, MOL THER, V15, P1881, DOI 10.1038/sj.mt.6300258; Hall SL, 2009, J GENE MED, V11, P877, DOI 10.1002/jgm.1369; Iwaniec UT, 2003, BONE, V33, P380, DOI 10.1016/S8756-3282(03)00118-2; Iwaniec UT, 2002, ENDOCRINOLOGY, V143, P2515, DOI 10.1210/en.143.7.2515; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Lane NE, 2003, OSTEOPOROSIS INT, V14, P374, DOI 10.1007/s00198-003-1374-7; Lane NE, 2003, J BONE MINER RES, V18, P2105, DOI 10.1359/jbmr.2003.18.12.2105; Lewiecki EM, 2010, MATURITAS, V66, P182, DOI 10.1016/j.maturitas.2010.02.008; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; MAZUE G, 1992, TOXICOL LETT, V64-5, P329, DOI 10.1016/0378-4274(92)90205-X; Meng X, 2011, MOL THER; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; NAGAI H, 1995, BONE, V16, P367, DOI 10.1016/8756-3282(94)00049-2; Nakamura K, 1997, J ORTHOPAED RES, V15, P307, DOI 10.1002/jor.1100150222; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Pestina TI, 2009, MOL THER, V17, P245, DOI 10.1038/mt.2008.259; Power RA, 2002, BONE, V31, P143, DOI 10.1016/S8756-3282(02)00799-8; Santilli G, 2011, MOL THER, V19, P122, DOI 10.1038/mt.2010.226; Sheng MHC, 2002, BONE, V30, P486, DOI 10.1016/S8756-3282(01)00693-7; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Silver J, 2010, PEDIATR NEPHROL, V25, P2241, DOI 10.1007/s00467-010-1565-3; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7; Wang HJ, 2005, J VIROL, V79, P10999, DOI 10.1128/JVI.79.17.10999-11013.2005; Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yao W, 2005, OSTEOPOROSIS INT, V16, P1939, DOI 10.1007/s00198-005-1969-2; Zhang XB, 2007, STEM CELLS, V25, P2074, DOI 10.1634/stemcells.2006-0742	49	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37569	10.1371/journal.pone.0037569	http://dx.doi.org/10.1371/journal.pone.0037569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629419	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500138
J	Liu, XY; Zhao, GX; Yan, Y; Bao, L; Chen, BD; Qi, RM				Liu, Xiyun; Zhao, Gexin; Yan, Yan; Bao, Li; Chen, Beidong; Qi, Ruomei			Ginkgolide B Reduces Atherogenesis and Vascular Inflammation in ApoE(-/-) Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; P-SELECTIN; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-E; DEFICIENT MICE; ATHEROSCLEROSIS; ACTIVATION; PLATELETS; ADHESION; KINASE	Aims: To investigate whether ginkgolide B (a platelet-activating factor inhibitor) affects vascular inflammation in atherosclerosis-prone apolipoprotein E-deficient (ApoE(-/-)) mice. Methods and Results: Human platelets were used to evaluate the effects of ginkgolide B on platelet aggregation and signal transduction. Ginkgolide B attenuated platelet aggregation and inhibited phosphatidylinositol 3 kinase (PI3K) activation and Akt phosphorylation in thrombin-and collagen-activated platelets. ApoE(-/-) mice were administered a high-cholesterol diet for 8 weeks. Plasma platelet factor 4 (PF4) and RANTES (regulated upon activation, normal T-cell expressed, and secreted protein) were then measured using an enzyme-linked immunosorbent assay. Scanning electron microscopy and immunohistochemistry were used to determine atherosclerotic lesions. Ginkgolide B decreased plasma PF4 and RANTES levels in ApoE(-/-) mice. Scanning electron microscopic examination showed that ginkgolide B reduced aortic plaque in ApoE(-/-) mice. Immunohistochemistry analysis demonstrated that ginkgolide B diminished P-selectin, PF4, RANTES, and CD40L expression in aortic plaque in ApoE(-/-) mice. Moreover, ginkgolide B suppressed macrophage and vascular cell adhesion protein 1 (VCAM-1) expression in aorta lesions in ApoE(-/-) mice. Similar effects were observed in aspirin-treated ApoE(-/-) mice. Conclusion: Ginkgolide B significantly reduced atherosclerotic lesions and P-selectin, PF4, RANTES, and CD40L expression in aortic plaque in ApoE(-/-) mice. The efficacy of ginkgolide B was similar to aspirin. These results provide direct evidence that ginkgolide B inhibits atherosclerosis, which may be associated with inhibition of the PI3K/Akt pathway in activated platelets.	[Liu, Xiyun] Minist Hlth, Beijing Inst Geriatr, Beijing Hosp, Beijing, Peoples R China; Minist Hlth, Key Lab Geriatr, Beijing, Peoples R China	Beijing Hospital	Liu, XY (corresponding author), Minist Hlth, Beijing Inst Geriatr, Beijing Hosp, Beijing, Peoples R China.	ruomeiqi@yahoo.com.cn	Zhao, Gexin/O-8269-2019; Stefanadis, Christodoulos/ABH-2232-2020	Zhao, Gexin/0000-0003-2278-3432; Stefanadis, Christodoulos/0000-0001-5974-6454	National Natural Science Foundation of China [81070231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (grant no. 81070231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Braquet P, 1986, Adv Prostaglandin Thromboxane Leukot Res, V16, P179; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Christodoulakos GE, 2007, ATHEROSCLEROSIS, V193, P142, DOI 10.1016/j.atherosclerosis.2006.05.045; Coppinger JA, 2007, CURR PHARM DESIGN, V13, P2640, DOI 10.2174/138161207781662885; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; Kasper B, 2004, BLOOD, V103, P1602, DOI 10.1182/blood-2003-08-2802; King SM, 2009, CIRCULATION, V120, P785, DOI 10.1161/CIRCULATIONAHA.108.845461; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; LAMANT V, 1987, BIOCHEM PHARMACOL, V36, P2749, DOI 10.1016/0006-2952(87)90259-0; Li R, 2009, J PHARMACOL SCI, V110, P362, DOI 10.1254/jphs.08275FP; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McClelland S, 2009, ATHEROSCLEROSIS, V202, P84, DOI 10.1016/j.atherosclerosis.2008.04.016; Nassar T, 2003, J BIOL CHEM, V278, P6187, DOI 10.1074/jbc.M208894200; Penna C, 2005, AM J PHYSIOL-HEART C, V288, pH2512, DOI 10.1152/ajpheart.00599.2004; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rex S, 2009, THROMB HAEMOSTASIS, V102, P97, DOI 10.1160/TH08-08-0513; Santilli F, 2007, INTERN EMERG MED, V2, P256, DOI 10.1007/s11739-007-0076-0; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Westmuckett AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020406; Zhang S, 2011, J CARDIOVASC PHARM, V57, P721, DOI 10.1097/FJC.0b013e31821a50a8; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201; ZUCKER MB, 1991, P SOC EXP BIOL MED, V198, P693	28	30	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36237	10.1371/journal.pone.0036237	http://dx.doi.org/10.1371/journal.pone.0036237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22662117	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338200018
J	Feyler, S; Scott, GB; Parrish, C; Jarmin, S; Evans, P; Short, M; McKinley, K; Selby, PJ; Cook, G				Feyler, Sylvia; Scott, Gina B.; Parrish, Christopher; Jarmin, Sarah; Evans, Paul; Short, Mike; McKinley, Katherine; Selby, Peter J.; Cook, Gordon			Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent	PLOS ONE			English	Article							IMMUNE SUPPRESSION; TGF-BETA; DENDRITIC CELLS; THERAPEUTIC REVERSAL; MOLECULAR-MECHANISMS; PERIPHERAL-BLOOD; INTERFERON-GAMMA; CANCER PATIENTS; FOXP3(+) TREGS; INDUCTION	Regulatory T-cells (T-Reg cells) are increased in patients with multiple myeloma (MM). We investigated whether MM cells could generate and/or expand T-Reg cells as a method of immuno-surveillance avoidance. In an in vitro model, CD4(+)CD25(-)FoxP3(-) T-cells co-cultured with malignant plasma cells (primary MM cells and cell lines) induced a significant generation of CD4(+)CD25(+)FoxP3(+) inducible T-Reg cells (tT(Reg) cells; p<0.0001), in a contact-dependent manner. tT(Reg) cells were polyclonal, demonstrated a suppressive phenotype and phenotypically, demonstrated increased FoxP3 (p = 0.0001), increased GITR (p<0.0001), increased PD1 (p = 0.003) and decreased CD62L (p = 0.007) expression compared with naturally occurring T-Reg cells. FACS-sorted tT(Reg) cells differentiated into FoxP(+)IL-17(+) and FoxP3(-)IL-17(+) CD4(+) cells upon TCR-mediated stimulation. Blocking experiments with anti-ICOS-L MoAb resulted in a significant inhibition of tT(Reg) cell generation whereas both IL-10 & TGF beta blockade did not. MM tumour cells can directly generate functional T-Reg cells in a contact-dependent manner, mediated by ICOS/ICOS-L. These features suggest that tumour generation of T-Reg cells may contribute to evasion of immune surveillance by the host.	[Feyler, Sylvia; Scott, Gina B.; Parrish, Christopher; Jarmin, Sarah; Cook, Gordon] Univ Leeds, Acad Dept Haematol & Oncol, Transplant Immunol Grp, Leeds, W Yorkshire, England; [Feyler, Sylvia] Calderdale & Huddersfield NHS Trust, Dept Haematol, Huddersfield, W Yorkshire, England; [Evans, Paul; Short, Mike] Leeds Teaching Hosp NHS Trust, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England; [McKinley, Katherine] Leeds Teaching Hosp Trust, Dept Clin Immunol, Leeds, W Yorkshire, England; [Cook, Gordon] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Dept Haematol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Saint James's University Hospital; University of Leeds	Feyler, S (corresponding author), Univ Leeds, Acad Dept Haematol & Oncol, Transplant Immunol Grp, Leeds, W Yorkshire, England.	Gordon.Cook@leedsth.nhs.uk			Tunstall Fellowship; British Society of Haematology; Leukaemia Lymphoma Research Fellowship; Leukemia Lymphoma Research; British Journal of Haematology Fellowship	Tunstall Fellowship; British Society of Haematology; Leukaemia Lymphoma Research Fellowship; Leukemia Lymphoma Research; British Journal of Haematology Fellowship	SF was supported by the Tunstall Fellowship, a British Society of Haematology research grant and Leukaemia Lymphoma Research Fellowship. GS is currently supported by Leukemia Lymphoma Research and SJ was supported by a British Journal of Haematology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; BERIOU G, 2009, BLOOD; Beyer M, 2006, BLOOD, V107, P3940, DOI 10.1182/blood-2005-09-3671; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Campbell JDM, 2001, J IMMUNOL, V167, P553, DOI 10.4049/jimmunol.167.1.553; Chatenoud L, 2006, J CLIN INVEST, V116, P2325, DOI 10.1172/JCI29748; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2003, TRANSPL INT, V16, P66, DOI 10.1111/j.1432-2277.2003.tb00266.x; Cook G, 1999, J LEUKOCYTE BIOL, V66, P981, DOI 10.1002/jlb.66.6.981; Coquerelle C, 2009, GUT, V58, P1363, DOI 10.1136/gut.2008.162842; Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020; de Jong YP, 2004, INT IMMUNOL, V16, P205, DOI 10.1093/intimm/dxh019; Feng T, 2011, GASTROENTEROLOGY, V140, P2031, DOI 10.1053/j.gastro.2011.03.009; Feyler S, 2009, BRIT J HAEMATOL, V144, P686, DOI 10.1111/j.1365-2141.2008.07530.x; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Fiore F, 2005, EUR J IMMUNOL, V35, P1155, DOI 10.1002/eji.200425093; Gabrilovich DI, 2007, CURR CANCER DRUG TAR, V7, P1, DOI 10.2174/156800907780006850; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; GJERDRUM LM, 2007, LEUKEMIA; Hadjur S, 2009, IMMUNOL LETT, V122, P37, DOI 10.1016/j.imlet.2008.11.001; HAMILTON MS, 1991, LEUKEMIA, V5, P768; Harrison SJ, 2005, BRIT J HAEMATOL, V130, P344, DOI 10.1111/j.1365-2141.2005.05534.x; Hauben E, 2005, MICROBES INFECT, V7, P1023, DOI 10.1016/j.micinf.2005.03.027; Herber DL, 2007, CANCER RES, V67, P5067, DOI 10.1158/0008-5472.CAN-07-0897; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Kitani A, 2008, MUCOSAL IMMUNOL, V1, pS43, DOI 10.1038/mi.2008.51; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Lizee G, 2006, CLIN CANCER RES, V12, P4794, DOI 10.1158/1078-0432.CCR-06-0944; Lutsiak MEC, 2008, J IMMUNOL, V180, P5871, DOI 10.4049/jimmunol.180.9.5871; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Mercer F, 2009, ADV EXP MED BIOL, V665, P47; Miller AM, 2006, J IMMUNOL, V177, P7398, DOI 10.4049/jimmunol.177.10.7398; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; Ohtsuki T, 1989, Hum Cell, V2, P297; Pan F, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001709; PELLATDECEUNYNK C, 1995, BLOOD, V86, P4001, DOI 10.1182/blood.V86.10.4001.bloodjournal86104001; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Prabhala RH, 2006, BLOOD, V107, P301, DOI 10.1182/blood-2005-08-3101; Riley JL, 2001, J IMMUNOL, V166, P4943, DOI 10.4049/jimmunol.166.8.4943; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VANRIET I, 1994, BRIT J HAEMATOL, V87, P258; Wang RF, 2006, SEMIN CANCER BIOL, V16, P73, DOI 10.1016/j.semcancer.2005.07.009; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321	56	56	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2012	7	5							e35981	10.1371/journal.pone.0035981	http://dx.doi.org/10.1371/journal.pone.0035981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WT	22666318	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349600004
J	Hrdinka, M; Otahal, P; Horejsi, V				Hrdinka, Matous; Otahal, Pavel; Horejsi, Vaclav			The Transmembrane Region Is Responsible for Targeting of Adaptor Protein LAX into "Heavy Rafts''	PLOS ONE			English	Article							T-CELL-ACTIVATION; LIPID RAFTS; SIGNAL-TRANSDUCTION; MEMBRANE RAFTS; PALMITOYLATION; RECEPTOR; LOCALIZATION; MICRODOMAINS; IDENTIFICATION; TRANSPORT	Background: The importance of membrane compartmentalization into specific membrane microdomains has been shown in many biological processes such as immunoreceptor signaling, membrane trafficking, pathogen infection, and tumor progression. Microdomains like lipid rafts, caveolae and tetraspanin enriched microdomains are relatively resistant to solubilization by some detergents. Large detergent-resistant membrane fragments (DRMs) resulting from such membrane solubilization can be conveniently isolated by density gradient ultracentrifugation or gel filtration. Recently, we described a novel type of raft-like membrane microdomains producing, upon detergent Brij98 solubilization, "heavy DRMs'' and containing a number of functionally relevant proteins. Transmembrane adaptor protein LAX is a typical "heavy raft'' protein. The present study was designed to identify the molecular determinants targeting LAX-derived constructs to heavy rafts. Methodology/Principal Findings: We prepared several constructs encoding chimeric proteins containing various informative segments of the LAX sequence and evaluated their effects on targeting to heavy rafts. Replacement of the polybasic membrane-proximal part of LAX by CD3e-derived membrane-proximal part had no effect on LAX solubilization. Similarly, the membrane-proximal part of LAX, when introduced into non-raft protein CD25 did not change CD25 detergent solubility. These results indicated that membrane-proximal part of LAX is not important for LAX targeting to heavy rafts. On the other hand, the replacement of transmembrane part of CD25 by the transmembrane part of LAX resulted in targeting into heavy rafts. We also show that LAX is not S-acylated, thus palmitoylation is not involved in LAX targeting to heavy rafts. Also, covalent dimerization was excluded as a cause of targeting into heavy rafts. Conclusions/Significance: We identified the transmembrane domain of LAX as a first motif targeting transmembrane protein constructs to detergent-resistant heavy rafts, a novel type of membrane microdomains containing a number of physiologically important proteins.	[Hrdinka, Matous; Otahal, Pavel; Horejsi, Vaclav] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hrdinka, M (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.	vaclav.horejsi@img.cas.cz	Hrdinka, Matous/B-9187-2011; Otahal, Pavel/G-3153-2014; Horejsi, Vaclav/G-3113-2014	Hrdinka, Matous/0000-0002-2981-2825; Horejsi, Vaclav/0000-0003-4925-0142; Otahal, Pavel/0000-0002-5513-4159	Academy of Sciences of the Czech Republic, GACR [AV0Z50520514, MEM/09/E011]; Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic) [1M0506]; Faculty of Science, Charles University, Prague, Czech Republic	Academy of Sciences of the Czech Republic, GACR; Center of Molecular and Cellular Immunology (Ministry of Education, Youth and Sports of the Czech Republic)(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government)	This work was supported by project no. AV0Z50520514, awarded by the Academy of Sciences of the Czech Republic, GACR (project MEM/09/E011), and by the Center of Molecular and Cellular Immunology (project 1M0506, Ministry of Education, Youth and Sports of the Czech Republic). MH was a Ph.D. student supported in part by the Faculty of Science, Charles University, Prague, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; GOLDSMITH MA, 1988, P NATL ACAD SCI USA, V85, P8613, DOI 10.1073/pnas.85.22.8613; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hrdinka M, 2011, J BIOL CHEM, V286, P19617, DOI 10.1074/jbc.M110.175117; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Ludford-Menting MJ, 2011, J LIPIDS, V2011, DOI 10.1155/2011/521863; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Otahal P, 2011, BBA-MOL CELL RES, V1813, P367, DOI 10.1016/j.bbamcr.2010.12.003; Otahal P, 2010, J IMMUNOL, V184, P3689, DOI 10.4049/jimmunol.0902075; PERSCHL A, 1995, J CELL SCI, V108, P1033; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36330	10.1371/journal.pone.0036330	http://dx.doi.org/10.1371/journal.pone.0036330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662118	Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300011
J	Lee, KH; Kim, SH; Kim, DY; Kim, S; Kim, KT				Lee, Kyung-Ha; Kim, Sung-Hoon; Kim, Do-Yeon; Kim, Seunghwan; Kim, Kyong-Tai			Internal Ribosomal Entry Site-Mediated Translation Is Important for Rhythmic PERIOD1 Expression	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; MESSENGER-RNA; HNRNP-Q; CIRCADIAN CLOCK; INITIATING TRANSLATION; MOUSE PERIOD; CKI-EPSILON; CELL-TYPE; PROTEIN; DEGRADATION	The mouse PERIOD1 (mPER1) plays an important role in the maintenance of circadian rhythm. Translation of mPer1 is directed by both a cap-dependent process and cap-independent translation mediated by an internal ribosomal entry site (IRES) in the 5' untranslated region (UTR). Here, we compared mPer1 IRES activity with other cellular IRESs. We also found critical region in mPer1 5'UTR for heterogeneous nuclear ribonucleoprotein Q (HNRNPQ) binding. Deletion of HNRNPQ binding region markedly decreased IRES activity and disrupted rhythmicity. A mathematical model also suggests that rhythmic IRES-dependent translation is a key process in mPER1 oscillation. The IRES-mediated translation of mPer1 will help define the post-transcriptional regulation of the core clock genes.	[Lee, Kyung-Ha; Kim, Do-Yeon; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Gyeongbuk, South Korea; [Kim, Sung-Hoon] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Kim, Seunghwan] Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, KH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Gyeongbuk, South Korea.	ktk@postech.ac.kr	Lee, Kyung-Ha/GRY-2640-2022	Lee, Kyung-Ha/0000-0003-0515-7392; KIM, Seunghwan/0000-0002-0563-3902; kim, sunghoon/0000-0002-1570-3230; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea (NRF) [20100030089, 20100002146, 20100019706, 20110031517]; Brain Korea 21 program; World Class University program [R31-10105]; Korean Ministry of Education, Science, and Technology (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); World Class University program; Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF) (nos. 20100030089, 20100002146, 20100019706, 20110031517), the Brain Korea 21 program, the World Class University program (R31-10105) funded by the Korean Ministry of Education, Science, and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; [Anonymous], 2005, J BIOL CHEM, DOI DOI 10.1074/jbc.M502716200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghalayini AJ, 2002, J BIOL CHEM, V277, P1469, DOI 10.1074/jbc.M011432200; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hamada J, 2004, FEBS LETT, V557, P204, DOI 10.1016/S0014-5793(03)01493-5; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hinsby AM, 2003, MOL CELL PROTEOMICS, V2, P29, DOI 10.1074/mcp.M200075-MCP200; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hresko RC, 2002, J BIOL CHEM, V277, P25233, DOI 10.1074/jbc.M202556200; INGRAHAM CA, 1992, ONCOGENE, V7, P95; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kim DY, 2011, NUCLEIC ACIDS RES, V39, P8901, DOI 10.1093/nar/gkr605; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kozak M, 2001, MOL CELL BIOL, V21, P1899, DOI 10.1128/MCB.21.6.1899-1907.2001; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Omri B, 1998, ONCOGENE, V16, P2351, DOI 10.1038/sj.onc.1201761; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Quaresma AJC, 2009, EXP CELL RES, V315, P968, DOI 10.1016/j.yexcr.2009.01.012; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schmutz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021325; Schneider R, 2001, MOL CELL BIOL, V21, P8238, DOI 10.1128/MCB.21.23.8238-8246.2001; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shima T, 2000, BRAIN RES, V870, P36, DOI 10.1016/S0006-8993(00)02399-4; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; ZHAO YH, 1991, ONCOGENE, V6, P1725	57	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37936	10.1371/journal.pone.0037936	http://dx.doi.org/10.1371/journal.pone.0037936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662251	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300142
J	Ley, B; Khatib, AM; Thriemer, K; von Seidlein, L; Deen, J; Mukhopadyay, A; Chang, NY; Hashim, R; Schmied, W; Busch, CJL; Reyburn, R; Wierzba, T; Clemens, JD; Wilfing, H; Enwere, G; Aguado, T; Jiddawi, MS; Sack, D; Ali, SM				Ley, Benedikt; Khatib, Ahmed M.; Thriemer, Kamala; von Seidlein, Lorenz; Deen, Jacqueline; Mukhopadyay, Asish; Chang, Na-Yoon; Hashim, Ramadhan; Schmied, Wolfgang; Busch, Clara J-L.; Reyburn, Rita; Wierzba, Thomas; Clemens, John D.; Wilfing, Harald; Enwere, Godwin; Aguado, Theresa; Jiddawi, Mohammad S.; Sack, David; Ali, Said M.			Evaluation of a Rapid Dipstick (Crystal VC) for the Diagnosis of Cholera in Zanzibar and a Comparison with Previous Studies	PLOS ONE			English	Article							FIELD-EVALUATION; OUTBREAK; TESTS; O139	Background: The gold standard for the diagnosis of cholera is stool culture, but this requires laboratory facilities and takes at least 24 hours. A rapid diagnostic test (RDT) that can be used by minimally trained staff at treatment centers could potentially improve the reporting and management of cholera outbreaks. Methods: We evaluated the Crystal VC (TM) RDT under field conditions in Zanzibar in 2009. Patients presenting to treatment centers with watery diarrhea provided a stool sample for rapid diagnostic testing. Results were compared to stool culture performed in a reference laboratory. We assessed the overall performance of the RDT and evaluated whether previous intake of antibiotics, intravenous fluids, location of testing, and skill level of the technician affected the RDT results. Results: We included stool samples from 624 patients. Compared to culture, the overall sensitivity of the RDT was 93.1% (95% CI: 88.7 to 96.2%), specificity was 49.2% (95% CI: 44.3 to 54.1%), the positive predictive value was 47.0% (95% CI: 42.1 to 52.0%) and the negative predictive value was 93.6% (95% CI: 89.6 to 96.5%). The overall false positivity rate was 50.8% (213/419); fieldworkers frequently misread very faint test lines as positive. Conclusion: The observed sensitivity of the Crystal VC RDT evaluated was similar compared to earlier versions, while specificity was poorer. The current version of the RDT could potentially be used as a screening tool in the field. Because of the high proportion of false positive results when field workers test stool specimens, positive results will need to be confirmed with stool culture.	[Ley, Benedikt; Thriemer, Kamala; Chang, Na-Yoon; Hashim, Ramadhan; Schmied, Wolfgang; Reyburn, Rita; Wierzba, Thomas; Clemens, John D.] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Ley, Benedikt; Wilfing, Harald] Univ Vienna, Bioctr, Vienna, Austria; [Khatib, Ahmed M.; Jiddawi, Mohammad S.; Ali, Said M.] Minist Hlth & Social Welf, Zanzibar, Tanzania; [von Seidlein, Lorenz; Deen, Jacqueline] Menzies Sch Hlth Res, Global Hlth Div, Casuarina, Australia; [Mukhopadyay, Asish] Natl Inst Cholera & Enter Dis, Kolkata, India; [Busch, Clara J-L.] Inst Mol Biotechnol, Vienna, Austria; [Enwere, Godwin; Aguado, Theresa] World Hlth Org, Geneva, Switzerland; [Sack, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Ali, Said M.] Publ Hlth Lab Pemba Ivo de Carneri, Chake Chake, Tanzania	International Vaccine Institute; University of Vienna; Charles Darwin University; Menzies School of Health Research; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ley, B (corresponding author), Int Vaccine Inst, Translat Res Div, Seoul, South Korea.	ley.benedikt@gmail.com	Wilfing, Harald/C-3918-2013; Schmied, Wolfgang/AAU-9961-2020	Wilfing, Harald/0000-0001-8591-2145; Schmied, Wolfgang/0000-0001-7625-0995; Ley, Benedikt/0000-0002-5734-0845; Thriemer, Kamala/0000-0001-7536-7497	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study has been funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; [Anonymous], 2011, CHOL; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; Bopp CA, 1999, LAB METHODS DIAGNOSI; Center for Disease Control, 2010, CHOL; Chaignat C-L, 2006, CHOLERA OUTBREAK RES; Global Task Force on Cholera Control, 2004, CHOL OUTBR ASS OUTBR, P26; Harris JR, 2009, TROP MED INT HEALTH, V14, P1117, DOI 10.1111/j.1365-3156.2009.02335.x; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Mukherjee P, 2010, JPN J INFECT DIS, V63, P234; National Bureau of Statistics, 2006, AN REP, VX, P2; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Riewpaiboon A, 2008, J HEALTH POPUL NUTR, V26, P442; The TDR Diagnostics Evaluation Expert Panel, 2010, NATURE REV MICROBIOL, P17, DOI [10.1038/nrmicro1523, DOI 10.1038/NRMICRO1523]; Wang XY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-17; World Health Organization, 2011, NUMB CHOL CAS	18	35	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36930	10.1371/journal.pone.0036930	http://dx.doi.org/10.1371/journal.pone.0036930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662131	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300022
J	Shoji, K; Oda, K; Kashiyama, T; Ikeda, Y; Nakagawa, S; Sone, K; Miyamoto, Y; Hiraike, H; Tanikawa, M; Miyasaka, A; Koso, T; Matsumoto, Y; Wada-Hiraike, O; Kawana, K; Kuramoto, H; McCormick, F; Aburatani, H; Yano, T; Kozuma, S; Taketani, Y				Shoji, Keiko; Oda, Katsutoshi; Kashiyama, Tomoko; Ikeda, Yuji; Nakagawa, Shunsuke; Sone, Kenbun; Miyamoto, Yuichiro; Hiraike, Haruko; Tanikawa, Michihiro; Miyasaka, Aki; Koso, Takahiro; Matsumoto, Yoko; Wada-Hiraike, Osamu; Kawana, Kei; Kuramoto, Hiroyuki; McCormick, Frank; Aburatani, Hiroyuki; Yano, Tetsu; Kozuma, Shiro; Taketani, Yuji			Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; HIGH-FREQUENCY; ANTITUMOR-ACTIVITY; CANCER-CELLS; MUTATIONS; PI3K; EVEROLIMUS; PIK3CA	The PI3K (phosphatidylinositol-3-kinase)/mTOR (mammalian target of rapamycin) pathway is frequently activated in endometrial cancer through various PI3K/AKT-activating genetic alterations. We examined the antitumor effect of NVP-BEZ235-a dual PI3K/mTOR inhibitor-and RAD001-an mTOR inhibitor-in 13 endometrial cancer cell lines, all of which possess one or more alterations in PTEN, PIK3CA, and K-Ras. We also combined these compounds with a MAPK pathway inhibitor (PD98059 or UO126) in cell lines with K-Ras alterations (mutations or amplification). PTEN mutant cell lines without K-Ras alterations (n = 9) were more sensitive to both RAD001 and NVP-BEZ235 than were cell lines with K-Ras alterations (n = 4). Dose-dependent growth suppression was more drastically induced by NVP-BEZ235 than by RAD001 in the sensitive cell lines. G1 arrest was induced by NVP-BEZ235 in a dose-dependent manner. We observed in vivo antitumor activity of both RAD001 and NVP-BEZ235 in nude mice. The presence of a MEK inhibitor, PD98059 or UO126, sensitized the K-Ras mutant cells to NVP-BEZ235. Robust growth suppression by NVP-BEZ235 suggests that a dual PI3K/mTOR inhibitor is a promising therapeutic for endometrial carcinomas. Our data suggest that mutational statuses of PTEN and K-Ras might be useful predictors of sensitivity to NVP-BEZ235 in certain endometrial carcinomas.	[Shoji, Keiko; Oda, Katsutoshi; Kashiyama, Tomoko; Ikeda, Yuji; Nakagawa, Shunsuke; Sone, Kenbun; Miyamoto, Yuichiro; Hiraike, Haruko; Tanikawa, Michihiro; Miyasaka, Aki; Koso, Takahiro; Matsumoto, Yoko; Wada-Hiraike, Osamu; Kawana, Kei; Yano, Tetsu; Kozuma, Shiro; Taketani, Yuji] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Kuramoto, Hiroyuki] Kitasato Univ, Grad Sch Med Sci, Dept Clin Cytol, Kanagawa, Japan; [McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo; Kitasato University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Tokyo	Shoji, K (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan.	katsutoshi-tky@umin.ac.jp		Wada-Hiraike, Osamu/0000-0002-3458-6711	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19599005, 23592437, 21791544, 20221009, 117100001060]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research (C), 19599005 and 23592437, a Grant-in-Aid for Young Scientists (B), grant number 21791544 (to KO), grant number: Scientific Research (S) 20221009 (to HA), and Next-Generation Cancer Research Project, grant number: 117100001060 to TY) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no rule in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bernstam F-M, 2009, J CLIN ONCOL, V27, P2278; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; ENOMOTO T, 1991, CANCER RES, V51, P5308; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Minaguchi T, 2001, CLIN CANCER RES, V7, P2636; Mordant P, 2010, MOL CANCER THER, V9, P358, DOI 10.1158/1535-7163.MCT-09-1014; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Murayama Hosokawa S, 2010, ONCOGENE, V29, P1897; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang JL, 2010, J CANCER RES CLIN, V136, P1303, DOI 10.1007/s00432-010-0781-3; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	46	65	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37431	10.1371/journal.pone.0037431	http://dx.doi.org/10.1371/journal.pone.0037431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662154	Green Published, gold			2022-12-27	WOS:000305342300044
J	Weber, H; Scholz, CJ; Domschke, K; Baumann, C; Klauke, B; Jacob, CP; Maier, W; Fritze, J; Bandelow, B; Zwanzger, PM; Lang, T; Fehm, L; Strohle, A; Hamm, A; Gerlach, AL; Alpers, GW; Kircher, T; Wittchen, HU; Arolt, V; Pauli, P; Deckert, J; Reif, A				Weber, Heike; Scholz, Claus Juergen; Domschke, Katharina; Baumann, Christian; Klauke, Benedikt; Jacob, Christian P.; Maier, Wolfgang; Fritze, Juergen; Bandelow, Borwin; Zwanzger, Peter Michael; Lang, Thomas; Fehm, Lydia; Stroehle, Andreas; Hamm, Alfons; Gerlach, Alexander L.; Alpers, Georg W.; Kircher, Tilo; Wittchen, Hans-Ulrich; Arolt, Volker; Pauli, Paul; Deckert, Juergen; Reif, Andreas			Gender Differences in Associations of Glutamate Decarboxylase 1 Gene (GAD1) Variants with Panic Disorder	PLOS ONE			English	Article							POPULATION-BASED ASSOCIATION; ANXIETY DISORDERS; GABA LEVELS; RESONANCE SPECTROSCOPY; ANTERIOR CINGULATE; MAJOR DEPRESSION; CANDIDATE GENES; DECARBOXYLASE 1; SCHIZOPHRENIA; ACID	Background: Panic disorder is common (5% prevalence) and females are twice as likely to be affected as males. The heritable component of panic disorder is estimated at 48%. Glutamic acid dehydrogenase GAD1, the key enzyme for the synthesis of the inhibitory and anxiolytic neurotransmitter GABA, is supposed to influence various mental disorders, including mood and anxiety disorders. In a recent association study in depression, which is highly comorbid with panic disorder, GAD1 risk allele associations were restricted to females. Methodology/Principal Findings: Nineteen single nucleotide polymorphisms (SNPs) tagging the common variation in GAD1 were genotyped in two independent gender and age matched case-control samples (discovery sample n = 478; replication sample n = 584). Thirteen SNPs passed quality control and were examined for gender-specific enrichment of risk alleles associated with panic disorder by using logistic regression including a genotypexgender interaction term. The latter was found to be nominally significant for four SNPs (rs1978340, rs3762555, rs3749034, rs2241165) in the discovery sample; of note, the respective minor/risk alleles were associated with panic disorder only in females. These findings were not confirmed in the replication sample; however, the genotypexgender interaction of rs3749034 remained significant in the combined sample. Furthermore, this polymorphism showed a nominally significant association with the Agoraphobic Cognitions Questionnaire sum score. Conclusions/Significance: The present study represents the first systematic evaluation of gender-specific enrichment of risk alleles of the common SNP variation in the panic disorder candidate gene GAD1. Our tentative results provide a possible explanation for the higher susceptibility of females to panic disorder.	[Weber, Heike; Domschke, Katharina; Baumann, Christian; Jacob, Christian P.; Arolt, Volker; Deckert, Juergen; Reif, Andreas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Scholz, Claus Juergen] Univ Wurzburg, Interdisciplinary Ctr Clin Res IZKF, Wurzburg, Germany; [Domschke, Katharina; Klauke, Benedikt; Zwanzger, Peter Michael] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Fritze, Juergen] Goethe Univ Frankfurt, Dept Psychiat, Frankfurt, Germany; [Bandelow, Borwin] Univ Gottingen, Dept Psychiat, Gottingen, Germany; [Lang, Thomas] Christoph Dornier Fdn Clin Psychol, Bremen, Germany; [Lang, Thomas] Univ Bremen, Zentrum Klin Psychol & Rehabil, D-28359 Bremen, Germany; [Fehm, Lydia] Univ Berlin, Inst Psychol, Berlin, Germany; [Stroehle, Andreas] Charite, Dept Psychiat, Berlin, Germany; [Hamm, Alfons] Ernst Moritz Arndt Univ Greifswald, Inst Psychol, Greifswald, Germany; [Gerlach, Alexander L.] Univ Cologne, Inst Clin Psychol & Psychotherapy, D-50931 Cologne, Germany; [Alpers, Georg W.; Pauli, Paul] Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [Alpers, Georg W.] Univ Mannheim, Sch Social Sci, Mannheim, Germany; [Kircher, Tilo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany	University of Wurzburg; University of Wurzburg; University of Munster; University of Bonn; Goethe University Frankfurt; University of Gottingen; University of Bremen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ernst Moritz Arndt Universitat Greifswald; University of Cologne; University of Wurzburg; University of Mannheim; Philipps University Marburg; Technische Universitat Dresden	Weber, H (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany.	Weber_H2@klinik.uni-wuerzburg.de	Kircher, Tilo/AAT-6480-2020; Scholz, Claus Jürgen/H-3202-2019; Bandelow, Borwin/E-7295-2011; Ströhle, Andreas/E-4286-2012; Wittchen, Hans-Ulrich/A-8507-2014; Domschke, Katharina/I-7921-2013; Wittchen, Hans-Ulrich/ABA-8901-2020; Gerlach, Alexander L./L-5045-2019; Gerlach, Alexander L. L/C-2990-2011	Kircher, Tilo/0000-0002-2514-2625; Scholz, Claus Jürgen/0000-0002-6406-7859; Bandelow, Borwin/0000-0003-2511-3768; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Gerlach, Alexander L./0000-0001-6794-5349; Gerlach, Alexander L. L/0000-0001-6794-5349; Pauli, Paul/0000-0003-0692-6720; Fehm, Lydia/0000-0002-0825-8466; Alpers, Georg W./0000-0001-9896-5158; Weber, Heike/0000-0002-9421-1292	Deutsche Forschungsgemeinschaft(DFG/German Reasearch Funding Organization) [SFB TRR 58 Z02, C01, C02, RE1632/1-5, KFO 125, RTG 1252]; Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research/BMBF); Bundesministerium fur Bildung und Forschung (Panic-Net)	Deutsche Forschungsgemeinschaft(DFG/German Reasearch Funding Organization)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research/BMBF)(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung (Panic-Net)(Federal Ministry of Education & Research (BMBF))	This study was supported by the Deutsche Forschungsgemeinschaft(DFG/German Reasearch Funding Organization; Grant SFB TRR 58 Z02 to AR, PP and JD, C01 to PZ and C02 to KD; RE1632/1-5 to AR, KFO 125 to AR, PP and CPJ; RTG 1252, to AR, PP and JD; for details see website http://www.dfg.de) and the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research/BMBF; Panic-Net, to ALG, TK, AS, HUW, VA, AH and JD; for details see web pages http://www.bmbf.de/ and http://www.paniknetz.de/netzwerk.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; [Anonymous], 2010, R LANG ENV STAT COMP; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Buttenschon HN, 2009, J NEURAL TRANSM, V116, P381, DOI 10.1007/s00702-008-0142-4; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Donner J, 2012, AM J MED GENET B, V159B, P316, DOI 10.1002/ajmg.b.32029; Du J, 2008, J NEURAL TRANSM, V115, P513, DOI 10.1007/s00702-007-0844-z; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fyer AJ, 2006, BIOL PSYCHIAT, V60, P388, DOI 10.1016/j.biopsych.2006.04.018; Geis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016775; Geller B, 2008, J CHILD ADOL PSYCHOP, V18, P25, DOI 10.1089/cap.2007.0056; Gloster AT, 2009, EUR ARCH PSY CLIN N, V259, P155, DOI 10.1007/s00406-009-0065-6; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Ham BJ, 2007, PROG NEURO-PSYCHOPH, V31, P403, DOI 10.1016/j.pnpbp.2006.10.011; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Ikeda M, 2007, SCHIZOPHR RES, V91, P22, DOI 10.1016/j.schres.2006.12.020; Jarius S, 2010, J NEUROIMMUNOL; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klauke B, 2010, DEPRESS ANXIETY, V27, P716, DOI 10.1002/da.20667; Koerner C, 2004, NEUROLOGY, V62, P1357, DOI 10.1212/01.WNL.0000120543.65812.33; Lappalainen J, 2004, AM J MED GENET B, V124B, P81, DOI 10.1002/ajmg.b.20055; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lundorf MD, 2005, AM J MED GENET B, V135B, P94, DOI 10.1002/ajmg.b.30137; MANNUZZA S, 1986, J PSYCHIAT RES, V20, P317, DOI 10.1016/0022-3956(86)90034-8; Marenco S, 2010, NEUROPSYCHOPHARMACOL, V35, P1708, DOI 10.1038/npp.2010.35; MCCARTHY MM, 1995, J COMP NEUROL, V360, P685, DOI 10.1002/cne.903600412; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X; Mosing MA, 2009, DEPRESS ANXIETY, V26, P1004, DOI 10.1002/da.20611; Noriega NC, 2010, BRAIN RES, V1307, P28, DOI 10.1016/j.brainres.2009.10.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabionet R, 2004, NEUROSCI LETT, V372, P209, DOI 10.1016/j.neulet.2004.09.037; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Utge S, 2010, AM J MED GENET B, V153B, P468, DOI 10.1002/ajmg.b.31002; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010; Zhao X, 2007, SCHIZOPHR RES, V93, P374, DOI 10.1016/j.schres.2007.02.023; Zwanzger P, 2005, J PSYCHIATR NEUROSCI, V30, P167	49	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37651	10.1371/journal.pone.0037651	http://dx.doi.org/10.1371/journal.pone.0037651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662185	Green Published, gold			2022-12-27	WOS:000305342300075
J	Kogan, GL; Usakin, LA; Ryazansky, SS; Gvozdev, VA				Kogan, Galina L.; Usakin, Lev A.; Ryazansky, Sergei S.; Gvozdev, Vladimir A.			Expansion and Evolution of the X-Linked Testis Specific Multigene Families in the melanogaster Species Subgroup	PLOS ONE			English	Article							PROTEIN-KINASE CK2; TRANSPOSABLE ELEMENTS; HELITRON TRANSPOSONS; REGULATORY SUBUNIT; DROSOPHILA; GENE; AMPLIFICATION; CHROMOSOMES; ABUNDANT; REPEATS	The testis specific X-linked genes whose evolution is traced here in the melanogaster species subgroup are thought to undergo fast rate of diversification. The CK2 beta tes and NAC beta tes gene families encode the diverged regulatory beta-subunits of protein kinase CK2 and the homologs of beta-subunit of nascent peptide associated complex, respectively. We annotated the CK2 beta tes-like genes related to CK2 beta tes family in the D. simulans and D. sechellia genomes. The ancestor CK2 beta tes-like genes preserved in D. simulans and D. sechellia are considered to be intermediates in the emergence of the D. melanogaster specific Stellate genes related to the CK2 beta tes family. The CK2 beta tes-like genes are more similar to the unique autosomal CK2 beta tes gene than to Stellates, taking into account their peculiarities of polymorphism. The formation of a variant the CK2 beta tes gene Stellate in D. melanogaster as a result of illegitimate recombination between a NAC beta tes promoter and a distinct polymorphic variant of CK2 beta tes-like ancestor copy was traced. We found a close nonrandom proximity between the dispersed defective copies of DINE-1 transposons, the members of Helitron family, and the CK2 beta tes and NAC beta tes genes, suggesting an involvement of DINE-1 elements in duplication and amplification of these genes.	[Kogan, Galina L.; Usakin, Lev A.; Ryazansky, Sergei S.; Gvozdev, Vladimir A.] Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Cell, Moscow, Russia	Russian Academy of Sciences	Kogan, GL (corresponding author), Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Cell, Moscow, Russia.	gvozdev@img.ras.ru	Ryazansky, Sergei/K-3692-2016; Gvozdev, Vladimir/AAH-1730-2021	Ryazansky, Sergei/0000-0002-3171-2997; Gvozdev, Vladimir/0000-0003-1694-1473; Kogan, Galina/0000-0003-0892-1771	Russian Academy of Sciences; Russian Foundation for Basic Research [11-04-00017-a]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Molecular and Cellular Biology Program of Russian Academy of Sciences and the Russian Foundation for Basic Research grant (No. 11-04-00017-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; [Anonymous], 2000, MOL EVOLUTION PHYLOG; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Chen ST, 2007, PLOS GENET, V3, P1131, DOI 10.1371/journal.pgen.0030107; Cocca E, 2011, MOL PHYLOGENET EVOL, V58, P439, DOI 10.1016/j.ympev.2010.12.020; Ding Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001255; Egorova KS, 2009, J MOL BIOL, V389, P895, DOI 10.1016/j.jmb.2009.04.064; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; HARDY RW, 1984, GENETICS, V107, P591; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Jagadeeshan S, 2005, MOL BIOL EVOL, V22, P1793, DOI 10.1093/molbev/msi175; Jagadeeshan S, 2007, MOL BIOL EVOL, V24, P929, DOI 10.1093/molbev/msm009; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalmykova AI, 1997, P NATL ACAD SCI USA, V94, P6297, DOI 10.1073/pnas.94.12.6297; Kalmykova AI, 2002, EUR J BIOCHEM, V269, P1418, DOI 10.1046/j.1432-1033.2002.02785.x; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kogan GL, 2000, MOL BIOL EVOL, V17, P697, DOI 10.1093/oxfordjournals.molbev.a026348; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LITCHFIELD DW, 1993, MOL CELL BIOCHEM, V128, P187, DOI 10.1007/BF01076770; Markesich DC, 2000, DEVELOPMENT, V127, P559; PALUMBO G, 1994, GENETICS, V138, P1181; Pritham EJ, 2007, P NATL ACAD SCI USA, V104, P1895, DOI 10.1073/pnas.0609601104; Sneath P. H. A., 1973, Numerical taxonomy. The principles and practice of numerical classification.; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tulin AV, 1997, GENETICS, V146, P253; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Usakin L A, 2009, Mol Biol (Mosk), V43, P400; Usakin LA, 2005, MOL BIOL EVOL, V22, P1555, DOI 10.1093/molbev/msi147; Yang HP, 2006, GENETICS, V173, P189, DOI 10.1534/genetics.105.051714; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhou QC, 2006, ZEBRAFISH, V3, P39, DOI 10.1089/zeb.2006.3.39	42	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37738	10.1371/journal.pone.0037738	http://dx.doi.org/10.1371/journal.pone.0037738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649555	gold, Green Published			2022-12-27	WOS:000305335800075
J	Tomillo, PS; Saba, VS; Blanco, GS; Stock, CA; Paladino, FV; Spotila, JR				Tomillo, Pilar Santidrian; Saba, Vincent S.; Blanco, Gabriela S.; Stock, Charles A.; Paladino, Frank V.; Spotila, James R.			Climate Driven Egg and Hatchling Mortality Threatens Survival of Eastern Pacific Leatherback Turtles	PLOS ONE			English	Article							MARINO-LAS-BAULAS; DERMOCHELYS-CORIACEA; EL-NINO; INCUBATION-TEMPERATURE; SAND TEMPERATURE; CARETTA-CARETTA; COSTA-RICA; SEX-RATIOS; FREQUENCY; AGE	Egg-burying reptiles need relatively stable temperature and humidity in the substrate surrounding their eggs for successful development and hatchling emergence. Here we show that egg and hatchling mortality of leatherback turtles (Dermochelys coriacea) in northwest Costa Rica were affected by climatic variability (precipitation and air temperature) driven by the El Nino Southern Oscillation (ENSO). Drier and warmer conditions associated with El Nino increased egg and hatchling mortality. The fourth assessment report of the Intergovernmental Panel on Climate Change (IPCC) projects a warming and drying in Central America and other regions of the World, under the SRES A2 development scenario. Using projections from an ensemble of global climate models contributed to the IPCC report, we project that egg and hatchling survival will rapidly decline in the region over the next 100 years by similar to 50-60%, due to warming and drying in northwestern Costa Rica, threatening the survival of leatherback turtles. Warming and drying trends may also threaten the survival of sea turtles in other areas affected by similar climate changes.	[Tomillo, Pilar Santidrian; Blanco, Gabriela S.; Spotila, James R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Tomillo, Pilar Santidrian] Leatherback Trust, Goldring Marine Biol Stn, Playa Grande, Costa Rica; [Saba, Vincent S.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; [Stock, Charles A.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Paladino, Frank V.] Indiana Purdue Univ, Dept Biol, Ft Wayne, IN USA	Drexel University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Purdue University System; Indiana University Purdue University Fort Wayne	Tomillo, PS (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	ms454@drexel.edu	Saba, Vincent/A-3799-2010; Stock, Charles A/H-1281-2012; Santidrián Tomillo, Pilar/N-5406-2014	Saba, Vincent/0000-0002-2974-4826; Stock, Charles A/0000-0001-9549-8013; Santidrián Tomillo, Pilar/0000-0002-6895-7218; Blanco, Gabriela S./0000-0001-6794-4207	Leatherback Trust; Betz Chair Endowment of Drexel University; Earthwatch Institute	Leatherback Trust; Betz Chair Endowment of Drexel University; Earthwatch Institute	Financial support was provided by The Leatherback Trust (www.leatherback.org), the Betz Chair Endowment of Drexel University and the Earthwatch Institute (www.earthwatch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman R.A., 2004, P15; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Binckley CA, 1998, COPEIA, P291; BUSTARD HR, 1967, NATURE, V214, P317, DOI 10.1038/214317a0; Casale Paolo, 2011, Endangered Species Research, V13, P123, DOI 10.3354/esr00319; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; DiNezio P. N., 2010, EOS T AM GEOPHYS UN, V91, P141, DOI DOI 10.1029/2010EO160001; Drake DL, 2002, J THERM BIOL, V27, P71, DOI 10.1016/S0306-4565(01)00017-1; GIBBS HL, 1987, ECOLOGY, V68, P1735, DOI 10.2307/1939865; Houghton JDR, 2007, J EXP MAR BIOL ECOL, V345, P71, DOI 10.1016/j.jembe.2007.02.001; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miller Jeffrey D., 1999, P124; Nakicenovic N, 2000, IPCC SPECIAL REPORTS; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Nordmoe ED, 2004, ANIM BEHAV, V68, P387, DOI 10.1016/j.anbehav.2003.07.015; Packard G.C., 1988, Biology of Reptilia, V16, P523; PACKARD GC, 1987, ECOLOGY, V68, P983, DOI 10.2307/1938369; Paladino F. V., 1991, GEOL S AM S, V238, P63; Reina RD, 2002, COPEIA, P653; Reina Richard D., 2009, Endangered Species Research, V7, P155, DOI 10.3354/esr00098; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Sarti Martinez L, 2000, IUCN 2010 2010 RED L; Martinez LS, 2007, CHELONIAN CONSERV BI, V6, P70, DOI 10.2744/1071-8443(2007)6[70:CABOTL]2.0.CO;2; Segura LN, 2010, HERPETOL CONSERV BIO, V5, P196; Sieg AE, 2010, PHYSL CONSTRAINTS EC; Sieg Annette E., 2011, Endangered Species Research, V15, P195, DOI 10.3354/esr00372; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Steyermark Anthony C., 1996, Chelonian Conservation and Biology, V2, P173; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Waylen PR, 1996, J CLIMATE, V9, P2606, DOI 10.1175/1520-0442(1996)009<2606:IVOMPI>2.0.CO;2; WEBB GJW, 1989, AM ZOOL, V29, P953; Webster PJ, 1997, NATURE, V390, P562, DOI 10.1038/37499; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K., 2011, MULTIVARIATE ENSO IN; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244; Zug GR, 2002, FISH B-NOAA, V100, P117	45	68	70	3	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37602	10.1371/journal.pone.0037602	http://dx.doi.org/10.1371/journal.pone.0037602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649544	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335800063
J	Yi, H; Cho, KH; Cho, YS; Kim, K; Nierman, WC; Kim, HS				Yi, Hyojeong; Cho, Kwang-Hwi; Cho, Yun Sung; Kim, Karan; Nierman, William C.; Kim, Heenam Stanley			Twelve Positions in a beta-Lactamase That Can Expand Its Substrate Spectrum with a Single Amino Acid Substitution	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; CEFTAZIDIME; EVOLUTION; MUTATIONS	The continuous evolution of beta-lactamases resulting in bacterial resistance to beta-lactam antibiotics is a major concern in public health, and yet the underlying molecular basis or the pattern of such evolution is largely unknown. We investigated the mechanics of the substrate fspectrum expansion of the class A beta-lactamase using PenA of Burkholderia thailandensis as a model. By analyzing 516 mutated enzymes that acquired the ceftazidime-hydrolyzing activity, we found twelve positions with single amino acid substitutions (altogether twenty-nine different substitutions), co-localized at the active-site pocket area. The ceftazidime MIC (minimum inhibitory concentration) levels and the relative frequency in the occurrence of substitutions did not correlate well with each other, and the latter appeared be largely influenced by the intrinsic mutational biases present in bacteria. Simulation studies suggested that all substitutions caused a congruent effect, expanding the space in a conserved structure called the omega loop, which in turn increased flexibility at the active site. A second phase of selection, in which the mutants were placed under increased antibiotic pressure, did not result in a second mutation in the coding region, but a mutation that increased gene expression arose in the promoter. This result suggests that the twelve amino acid positions and their specific substitutions in PenA may represent a comprehensive repertoire of the enzyme's adaptability to a new substrate. These mapped substitutions represent a comprehensive set of general mechanical paths to substrate spectrum expansion in class A beta-lactamases that all share a functional evolutionary mechanism using common conserved residues.	[Yi, Hyojeong; Kim, Karan; Kim, Heenam Stanley] Korea Univ, Coll Med, Dept Med, Seoul 136705, South Korea; [Cho, Kwang-Hwi; Cho, Yun Sung] Soongsil Univ, Sch Syst Biomed Sci & Res, Seoul, South Korea; [Cho, Kwang-Hwi; Cho, Yun Sung] Soongsil Univ, Ctr Integrat Basic Sci, Seoul, South Korea; [Nierman, William C.; Kim, Heenam Stanley] J Craig Venter Inst, Rockville, MD USA	Korea University; Korea University Medicine (KU Medicine); Soongsil University; Soongsil University; J. Craig Venter Institute	Yi, H (corresponding author), Korea Univ, Coll Med, Dept Med, Seoul 136705, South Korea.	hstanleykim@korea.ac.kr	Kim, Heenam Stanley/L-2279-2016	Kim, Heenam Stanley/0000-0003-4856-3518; Cho, Yun Sung/0000-0003-4490-8769	Basic Research Program from the Ministry of Education, Science & Technology in the Republic of Korea [20090088364]; Core Research Program from the Ministry of Education, Science & Technology in the Republic of Korea [20110016847]; 21C Frontier Microbial Genomics & Applications Center Program from the Ministry of Education, Science & Technology in the Republic of Korea [2009K000516]; Korea Foundation for International Cooperation of Science & Technology (KICOS) through Korean Ministry of Science & Technology (MOST) [K20903001812-11E0100-01700]	Basic Research Program from the Ministry of Education, Science & Technology in the Republic of Korea; Core Research Program from the Ministry of Education, Science & Technology in the Republic of Korea; 21C Frontier Microbial Genomics & Applications Center Program from the Ministry of Education, Science & Technology in the Republic of Korea; Korea Foundation for International Cooperation of Science & Technology (KICOS) through Korean Ministry of Science & Technology (MOST)	This work was supported by grants 20090088364 from the Basic Research Program, 20110016847 from the Core Research Program, and 2009K000516 from the 21C Frontier Microbial Genomics & Applications Center Program, all of which are from the Ministry of Education, Science & Technology in the Republic of Korea. Additional support was provided by the Korea Foundation for International Cooperation of Science & Technology (KICOS) through a grant provided by the Korean Ministry of Science & Technology (MOST) in K20903001812-11E0100-01700 to HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Bonacorsi S, 1999, ANTIMICROB AGENTS CH, V43, P213, DOI 10.1128/AAC.43.2.213; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Chen Y, 2005, J AM CHEM SOC, V127, P5423, DOI 10.1021/ja042850a; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Delmas J, 2006, ANTIMICROB AGENTS CH, V50, P731, DOI 10.1128/AAC.50.2.731-738.2006; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; Heritage J, 1999, J ANTIMICROB CHEMOTH, V44, P309, DOI 10.1093/jac/44.3.309; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Ho PL, 2002, J ANTIMICROB CHEMOTH, V50, P723, DOI 10.1093/jac/dkf208; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JOYCE LF, 1992, J CLIN MICROBIOL, V30, P2709, DOI 10.1128/JCM.30.10.2709-2713.1992; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim HS, 2008, J BACTERIOL, V190, P3700, DOI 10.1128/JB.00067-08; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Ma L, 2005, ANTIMICROB AGENTS CH, V49, P600, DOI 10.1128/AAC.49.2.600-605.2005; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P876, DOI 10.1128/AAC.00946-08; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Saika Takeshi, 2002, Journal of Infection and Chemotherapy, V8, P341, DOI 10.1007/s10156-002-0200-z; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Sam IC, 2009, J CLIN MICROBIOL, V47, P1556, DOI 10.1128/JCM.01657-08; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarovich DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030789; Simon R, 1983, ECTOR PLASMIDS VIVO; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Thongdee M, 2008, APPL ENV MICROBIOL; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; VAKULENKO SB, 1995, ANTIMICROB AGENTS CH, V39, P1878, DOI 10.1128/AAC.39.8.1878; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong WT, 2011, J BIOL CHEM, V286, P31771, DOI 10.1074/jbc.M110.198895; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	48	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37585	10.1371/journal.pone.0037585	http://dx.doi.org/10.1371/journal.pone.0037585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629423	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300055
J	Adhi, M; Aziz, S; Muhammad, K; Adhi, MI				Adhi, Mehreen; Aziz, Sumbul; Muhammad, Kashif; Adhi, Mohammad I.			Macular Thickness by Age and Gender in Healthy Eyes Using Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							FIBER LAYER THICKNESS; RETINAL THICKNESS; QUANTITATIVE ASSESSMENT; ULTRAHIGH-RESOLUTION; AXIAL LENGTH; HIGH-SPEED; REPRODUCIBILITY; REPEATABILITY; OCT	Purpose: To determine normal macular thickness and its variation by age and gender in healthy eyes using spectral-domain optical coherence tomography (SD-OCT). Methods: In this cross-sectional analysis, two hundred and twenty eyes of 220 healthy subjects underwent raster scanning using Topcon SD-OCT system, at the Department of Ophthalmology, Dow University of Health Sciences and Civil Hospital Karachi, Pakistan. Macular thickness from all 9 regions of the ETDRS map was documented for each subject. Variations in macular thickness measurements by age and gender were determined. Results: The 220 subjects had a mean age of 45.3 years (16-80 years). Using the ETDRS map, foveal thickness for all subjects was measured to be 229 +/- 20.46 mu m. Mean macular thickness for all subjects was 262.8 +/- 13.34 mu m. Male gender was associated with greater foveal (p<0.0001) and mean macular (p<0.0001) thickness compared to females. There was no association of mean macular thickness (r(2) = 0.01; p>0.05) and foveal thickness (r(2) = 0.00004; p>0.05) with age. Conclusion: We have provided normative data for macular thickness using Topcon SD-OCT system. Our results are comparable to some and vary from other reports using the similar OCT system. Our results suggest that male gender is associated with greater macular thickness, while macular thickness has no association with age in healthy eyes. This is the first normative data for macular thickness from Pakistan; benchmark for diagnosing and monitoring macular pathologies. The values obtained in this study may be useful for comparison with other populations, other SD-OCT systems and future imaging technologies.	[Adhi, Mehreen; Aziz, Sumbul; Muhammad, Kashif; Adhi, Mohammad I.] Dow Univ Hlth Sci & Civil Hosp, Dept Ophthalmol, Karachi, Pakistan; [Adhi, Mehreen] Tufts Med Ctr, New England Eye Ctr, Boston, MA USA	Dow University of Health Sciences; Tufts Medical Center	Adhi, M (corresponding author), Dow Univ Hlth Sci & Civil Hosp, Dept Ophthalmol, Karachi, Pakistan.	miadhi@hotmail.com	Adhi, Mohammad Idrees/Q-4117-2019; Adhi, Mehreen/AAS-9733-2021	Adhi, Mohammad Idrees/0000-0003-3971-8573; 				Alam S, 2006, OPHTHALMOLOGY, V113, P1425, DOI 10.1016/j.ophtha.2006.03.020; Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; [Anonymous], 1991, Ophthalmology, V98, P786; Asefzadeh B, 2007, OPTOMETRY VISION SCI, V84, P941; Asrani S, 1999, OPHTHALMOLOGY, V106, P269, DOI 10.1016/S0161-6420(99)90057-X; Bruce A, 2009, OPEN OPHTHALMOL J, V3, P10, DOI 10.2174/1874364100903010010; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Giani A, 2010, AM J OPHTHALMOL, V150, P815, DOI 10.1016/j.ajo.2010.06.025; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P1019, DOI 10.1001/archopht.1995.01100080071031; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang JJ, 2011, J GLAUCOMA, V20, P118, DOI 10.1097/IJG.0b013e3181d786f8; Kanadani FN, 2006, BRIT J OPHTHALMOL, V90, P1393, DOI 10.1136/bjo.2006.099069; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Koozekanani D, 2000, INVEST OPHTH VIS SCI, V41, P1486; Legarreta JE, 2008, OPHTHAL SURG LAS IM, V39, pS43, DOI 10.3928/15428877-20080715-02; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Muscat S, 2002, INVEST OPHTH VIS SCI, V43, P490; NUSSENBLATT RB, 1987, OPHTHALMOLOGY, V94, P1134; Oshitari T, 2007, CLIN OPHTHALMOL, V1, P133; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; Pierro L, 2010, AM J OPHTHALMOL, V150, P199, DOI 10.1016/j.ajo.2010.03.015; SHAHIDI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1115, DOI 10.1001/archopht.1991.01080080075032; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Sull AC, 2010, RETINA-J RET VIT DIS, V30, P235, DOI 10.1097/IAE.0b013e3181bd2c3b; Tewari Hem K., 2004, Indian Journal of Ophthalmology, V52, P199; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466	31	70	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37638	10.1371/journal.pone.0037638	http://dx.doi.org/10.1371/journal.pone.0037638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629435	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343100042
J	Amaral, CRL; Brito, PM				Amaral, Cesar R. L.; Brito, Paulo M.			A New Chanidae (Ostariophysii: Gonorynchiformes) from the Cretaceous of Brazil with Affinities to Laurasian Gonorynchiforms from Spain	PLOS ONE			English	Article							BIOGEOGRAPHY; TELEOSTEI; FOSSIL; BASIN	Based on specimens originally referred to as "Dastilbe minor", a nomem-nudum, we describe a new genus of Chanidae dagger Nanaichthys longipinnus nov. gen. and sp. which exhibits several diagnostic characters such as the absence of orbitosphenoid and basisphenoid, anteriorly displaced quadrate-mandibular articulation, laterally expanded supraneurals, an acute angle between the preopercular limbs, expansion at the angle between the preopercular limbs, and a curved maxillary articular process. Its occurrence and supposed relationship within the Chanidae reinforce the influence of the Mediterranean Tethys over the Gondwanan main rift system prior to the Aptian/Albian highstands.	[Amaral, Cesar R. L.; Brito, Paulo M.] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Sao Francisco Xavier, Maracana, Brazil	Universidade do Estado do Rio de Janeiro	Amaral, CRL (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Sao Francisco Xavier, Maracana, Brazil.	pbritopaleo@yahoo.com.br	Brito, Paulo/B-5784-2013; Amaral, Cesar/AAS-6841-2021	Brito, Paulo/0000-0002-4853-8630	Brazilian National Counsel of Technological and Scientific Development; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	Brazilian National Counsel of Technological and Scientific Development; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by the Brazilian National Counsel of Technological and Scientific Development and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2001, PALAEOGEOGR PALAEOCL, V165, P375, DOI 10.1016/S0031-0182(00)00172-3; Alvarado-Ortega J, 2010, PALAEONTOLOGY, V53, P297, DOI 10.1111/j.1475-4983.2010.00935.x; ARAMBOURG C, 1935, ANN PALEONTOL, V24, P139; Arratia G, 2010, COMPREHENSIVE REV GO, P71; Arratia Gloria, 1995, Bonner Zoologische Monographien, V36, P1; Brito I.M., 1979, BACIAS SEDIMENTARES; Brito PM, 2007, CYBIUM, V31, P139; Brito Paulo M., 2008, P279; Brito PM, 2008, GEOL SOC SPEC PUBL, V295, P145, DOI 10.1144/SP295.9; Davis MP, MESOZOIC FI IN PRESS; Forskal P., 1775, DESCRIPTIONES ANIMAL; Gasparini Z, 2006, SCIENCE, V311, P70, DOI 10.1126/science.1120803; Gasparini Z., 2005, NEUQUEN BASIN ARGENT, V252, P279; Gasparini Zulma, 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P125; Grande T, 1999, COPEIA, P453; Grande T, 1999, ZOOL J LINN SOC-LOND, V125, P197; Grande T, 2010, COMPREHENSIVE REV GO, P38; HALLAM A, 1983, PALAEOGEOGR PALAEOCL, V43, P181, DOI 10.1016/0031-0182(83)90010-X; Jordan D.S., 1910, ANALES CARGENIE MUSE, V7, P22; Jordan D. S., 1908, SMITHSONIAN MISCELLA, V52, P1; Poyato-Ariza FJ, 2010, SER TELEOST FISH BIO, P227, DOI 10.1201/b10194-8; KOUTSOUKOS EAM, 1992, PALAEOGEOGR PALAEOCL, V92, P295, DOI 10.1016/0031-0182(92)90089-N; MOODY JM, 1994, J VERTEBR PALEONTOL, V14, P1, DOI 10.1080/02724634.1994.10011534; Poyato F.J., 1990, Acta Salmanticensia Biblioteca de las Ciencias, P299; Poyato-Ariza Francisco Jose, 1994, Occasional Papers of the Museum of Natural History University of Kansas, V164, P1; Poyato-Ariza Francisco Jose, 1996, Palaeo Ichthyologica, V6, P5; Rosen D. E, 1970, Am. Mus. Novit., VNo. 2428, P1; Santos RS, 1972, PEIXES FORMACAO MARI; SANZ JL, 1988, GEOBIOS-LYON, V21, P611, DOI 10.1016/S0016-6995(88)80072-X; Schultze Hans-Peter, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P395; SMITH PL, 1983, CAN J EARTH SCI, V20, P86, DOI 10.1139/e83-008; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Traquair R. H., 1911, Mem Mus Belgique Bruxelles, V6; Wenz S, 1984, B MUS NAT HIST NAT C, V4, P275	34	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37247	10.1371/journal.pone.0037247	http://dx.doi.org/10.1371/journal.pone.0037247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629376	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100020
J	Olleros, ML; Vesin, D; Bisig, R; Santiago-Raber, ML; Schuepbach-Mallepell, S; Kollias, G; Gaide, O; Garcia, I				Olleros, Maria L.; Vesin, Dominique; Bisig, Ruth; Santiago-Raber, Marie-Laure; Schuepbach-Mallepell, Sonia; Kollias, George; Gaide, Olivier; Garcia, Irene			Membrane-Bound TNF Induces Protective Immune Responses to M. bovis BCG Infection: Regulation of memTNF and TNF Receptors Comparing Two memTNF Molecules	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CELL-MEDIATED-IMMUNITY; CALMETTE-GUERIN INFECTION; TRANSMEMBRANE TNF; IN-VIVO; MYCOBACTERIAL INFECTION; SECRETED TNF; LIVER-INJURY; FACTOR-ALPHA; MICE	Background: Several activities of the transmembrane form of TNF (memTNF) in immune responses to intracellular bacterial infection have been shown to be different from those exerted by soluble TNF. Evidence is based largely on studies in transgenic mice expressing memTNF, but precise cellular mechanisms are not well defined and the importance of TNF receptor regulation is unknown. In addition, memTNF activities are defined for a particular modification of the extracellular domain of TNF but a direct comparison of different mutant memTNF molecules has not been done in vivo. Methodology: To understand the activities of memTNF we compared two commonly used mouse strains lacking soluble TNF but possessing functional and normally regulated membrane-bound TNF knockin (memTNF KI) for their capacity to generate cell-mediated immune responses and resistance to M. bovis BCG infection, and to regulate TNF receptors. Principal Findings: M. bovis BCG infection resulted in similar bacterial loads in one strain of memTNF KI (memTNF(Delta 1-9,K11E)) and in wild-type mice, in contrast, the other strain of memTNF KI mice (memTNF(Delta 1-12)) showed higher sensitivity to infection with high mortality (75%), greater bacterial load and massive lung pathology. The pattern of cytokines/chemokines, inflammatory cells, pulmonary NF-kappa B phosphorylation, antigen-dependent IFN-gamma response, and splenic iNOS was impaired in M. bovis BCG-infected memTNF(Delta 1-12) KI mice. Macrophages expressing TNFR2 were reduced but soluble TNFRs were higher in memTNF(Delta 1-12) KI mice during the infection. In vitro, M. bovis BCG-induced NF-kappa B activation and cytokines were also decreased in memTNF(Delta 1-12) KI bone marrow-derived macrophages. Conclusion: Our data show that two memTNF molecules exerted very different activities upon M. bovis BCG infection resulting in protection or not to bacterial infection. These results suggest a regulatory mechanism of memTNF and TNF receptors being critical in the outcome of the infection and highlight the role of cell-bound and soluble TNFR2 in memTNF-mediated anti-microbial mechanisms.	[Olleros, Maria L.; Vesin, Dominique; Bisig, Ruth; Santiago-Raber, Marie-Laure; Garcia, Irene] Univ Geneva, CMU, Dept Pathol & Immunol, Geneva, Switzerland; [Schuepbach-Mallepell, Sonia; Gaide, Olivier] Univ Hosp Geneva, Dept Dermatol Venereol, Geneva, Switzerland; [Kollias, George] Inst Immunol, Biomed Sci Res Ctr Alexander Fleming, Vari Athens, Greece	University of Geneva; University of Geneva; Alexander Fleming Biomedical Sciences Research Center	Olleros, ML (corresponding author), Univ Geneva, CMU, Dept Pathol & Immunol, Geneva, Switzerland.	irene.garcia-gabay@unige.ch	Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150	Swiss National Foundation for Scientific Research [3200A0-118196]; Science and Technology Cooperation Program Switzerland-Russia	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Science and Technology Cooperation Program Switzerland-Russia	The work was supported by Grants 3200A0-118196 (to I.G.) from the Swiss National Foundation for Scientific Research and from the Science and Technology Cooperation Program Switzerland-Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Allenbach C, 2008, EUR J IMMUNOL, V38, P720, DOI 10.1002/eji.200737662; Allie N., 2008, IMMUNOLOGY; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Cowley SC, 2008, J INFECT DIS, V198, P284, DOI 10.1086/589620; Dambuza I, 2008, TUBERCULOSIS, V88, P221, DOI 10.1016/j.tube.2007.08.011; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; EISSNER G, 1995, BLOOD, V86, P4184, DOI 10.1182/blood.V86.11.4184.bloodjournal86114184; Fotio AL, 2010, INT J IMMUNOPATH PH, V23, P61, DOI 10.1177/039463201002300106; Fremond C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-136; Garcia I, 2000, LAB INVEST, V80, P1385, DOI 10.1038/labinvest.3780146; Garcia I, 2011, ADV EXP MED BIOL, V691, P187, DOI 10.1007/978-1-4419-6612-4_20; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Guler R, 2005, INFECT IMMUN, V73, P3668, DOI 10.1128/IAI.73.6.3668-3676.2005; Guler R, 2004, J HEPATOL, V41, P773, DOI 10.1016/j.jhep.2004.07.031; HANUS M, 1994, NEOPLASMA, V41, P25; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Liu J, 2005, AM J RESP CELL MOL, V33, P463, DOI 10.1165/rcmb.2005-0204OC; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Musicki K, 2006, INFECT IMMUN, V74, P3180, DOI 10.1128/IAI.02004-05; Olleros M. L., 2009, J INFECT DIS; Olleros ML, 2007, IMMUNOLOGY, V122, P350, DOI 10.1111/j.1365-2567.2007.02646.x; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Olleros ML, 2010, J HEPATOL; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2012	7	5							e31469	10.1371/journal.pone.0031469	http://dx.doi.org/10.1371/journal.pone.0031469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959YF	22666310	Green Published, gold, Green Submitted			2022-12-27	WOS:000305353400001
J	Barringer, LE; Tomback, DF; Wunder, MB; McKinney, ST				Barringer, Lauren E.; Tomback, Diana F.; Wunder, Michael B.; McKinney, Shawn T.			Whitebark Pine Stand Condition, Tree Abundance, and Cone Production as Predictors of Visitation by Clark's Nutcracker	PLOS ONE			English	Article							BLISTER RUST; BRITISH-COLUMBIA; SEED DISPERSAL; CANADA; ECOSYSTEM; BEETLE	Background: Accurately quantifying key interactions between species is important for developing effective recovery strategies for threatened and endangered species. Whitebark pine (Pinus albicaulis), a candidate species for listing under the Endangered Species Act, depends on Clark's nutcracker (Nucifraga columbiana) for seed dispersal. As whitebark pine succumbs to exotic disease and mountain pine beetles (Dendroctonus ponderosae), cone production declines, and nutcrackers visit stands less frequently, reducing the probability of seed dispersal. Methodology/Principal Findings: We quantified whitebark pine forest structure, health metrics, and the frequency of nutcracker occurrence in national parks within the Northern and Central Rocky Mountains in 2008 and 2009. Forest health characteristics varied between the two regions, with the northern region in overall poorer health. Using these data, we show that a previously published model consistently under-predicts the proportion of survey hours resulting in nutcracker observations at all cone density levels. We present a new statistical model of the relationship between whitebark pine cone production and the probability of Clark's nutcracker occurrence based on combining data from this study and the previous study. Conclusions/Significance: Our model clarified earlier findings and suggested a lower cone production threshold value for predicting likely visitation by nutcrackers: Although nutcrackers do visit whitebark pine stands with few cones, the probability of visitation increases with increased cone production. We use information theoretics to show that beta regression is a more appropriate statistical framework for modeling the relationship between cone density and proportion of survey time resulting in nutcracker observations. We illustrate how resource managers may apply this model in the process of prioritizing areas for whitebark pine restoration.	[Barringer, Lauren E.; Tomback, Diana F.; Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [McKinney, Shawn T.] Natl Pk Serv, Inventory & Monitoring Program, Sierra Nevada Network, El Portal, CA USA	University of Colorado System; University of Colorado Denver; United States Department of the Interior	Barringer, LE (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	Michael.Wunder@ucdenver.edu			Whitebark Pine Restoration Fund; USDA Forest Service; Forest Health Protection; Jerry O'Neal fellowship; National Park Service; Rocky Mountains Cooperative Ecosystem Studies Unit; Technical Assistance Grant; Global Forest Science [GF-18-2008-216]	Whitebark Pine Restoration Fund; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Forest Health Protection; Jerry O'Neal fellowship; National Park Service; Rocky Mountains Cooperative Ecosystem Studies Unit; Technical Assistance Grant; Global Forest Science	Funding for this project is gratefully acknowledged as follows: Whitebark Pine Restoration Fund, USDA Forest Service, Forest Health Protection, to DFT; Jerry O'Neal fellowship, National Park Service, Rocky Mountains Cooperative Ecosystem Studies Unit to LEB; Technical Assistance Grant, National Park Service, Rocky Mountains Cooperative Ecosystem Studies Unit to DFT; Global Forest Science grant (# GF-18-2008-216) to DFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell EM, 2000, CAN J FOREST RES, V30, P1051, DOI 10.1139/cjfr-30-7-1051; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; Kendall K.C., WHITEBARK PINE COMMU, P221; LANNER RM, 1982, CAN J FOREST RES, V12, P391, DOI 10.1139/x82-056; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Mahalovich MF, 2006, P RMRS P 43 FORT COL; McKinney ST, 2007, CAN J FOREST RES, V37, P1044, DOI 10.1139/X06-305; McKinney ST, 2010, OECOLOGIA, V162, P697, DOI 10.1007/s00442-009-1496-5; McKinney ST, 2009, ECOL APPL, V19, P597, DOI 10.1890/08-0151.1; McKinney ST, 2011, MOUNTAIN ECOSYSTEMS, P45; Schwandt JW, 2010, FOREST PATHOL, V40, P226, DOI 10.1111/j.1439-0329.2010.00656.x; Schwartz CC, 2010, ANN REPORT INTERAGEN, P63; Smith CM, 2008, CAN J FOREST RES, V38, P982, DOI 10.1139/X07-182; Tomback D., 2001, WHITEBARK PINE COMMU, P3; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback D.F., 2005, METHODS SURVEYING MO; Tomback D.F., 2001, WHITEBARK PINE COMMU, P243; Tomback DF, 2001, ECOLOGY, V82, P2587, DOI 10.1890/0012-9658(2001)082[2587:DSGIWP]2.0.CO;2; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; Tomback DF, 1998, BIRDS N AM; USFWS, 2011, FED REGISTER, V76, P42631; VANDERWALL SB, 1988, CONDOR, V90, P621, DOI 10.2307/1368351; Zeglen S, 2002, CAN J FOREST RES, V32, P1265, DOI 10.1139/X02-049	27	38	41	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37663	10.1371/journal.pone.0037663	http://dx.doi.org/10.1371/journal.pone.0037663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662186	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300076
J	Clark, SCA; Sharp, NP; Rowe, L; Agrawal, AF				Clark, Sean C. A.; Sharp, Nathaniel P.; Rowe, Locke; Agrawal, Aneil F.			Relative Effectiveness of Mating Success and Sperm Competition at Eliminating Deleterious Mutations in Drosophila melanogaster	PLOS ONE			English	Article							SEXUAL SELECTION; ADAPTATION; ENVIRONMENT; ALLELES; CAPTURE; LOAD	Condition-dependence theory predicts that sexual selection will facilitate adaptation by selecting against deleterious mutations that affect the expression of sexually selected traits indirectly via condition. Recent empirical studies have provided support for this prediction; however, their results do not elucidate the relative effects of pre- and postcopulatory sexual selection on deleterious mutations. We used the Drosophila melanogaster model system to discern the relative contributions of pre- and postcopulatory processes to selection against deleterious mutations. To assess second-male ejaculate competition success (P2; measured as the proportion of offspring attributable to the experimental male) and mating success, mutant and wild-type male D. melanogaster were given the opportunity to mate with females that were previously mated to a standard competitor male. This process was repeated for males subjected to a diet quality manipulation to test for effects of environmentally-manipulated condition on P2 and mating success. While none of the tested mutations affected P2, there was a clear effect of condition. Conversely, several of the mutations affected mating success, while condition showed no effect. Our results suggest that precopulatory selection may be more effective than postcopulatory selection at removing deleterious mutations. The opposite result obtained for our diet manipulation points to an interesting discrepancy between environmental and genetic manipulations of condition, which may be explained by the multidimensionality of condition. Establishing whether the various stages of sexual selection affect deleterious mutations differently, and to what extent, remains an important issue to resolve.	[Clark, Sean C. A.; Sharp, Nathaniel P.; Rowe, Locke; Agrawal, Aneil F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Clark, SCA (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	s.clark@utoronto.ca		Sharp, Nathaniel/0000-0001-6016-083X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) provided graduate fellowships to SCAC and NPS, and Discovery Grants to LR and AFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Amitin EG, 2007, J EVOLUTION BIOL, V20, P381, DOI 10.1111/j.1420-9101.2006.01184.x; Clark AG, 1998, GENETICS, V149, P1487; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Gromko MH, 1984, SPERM COMPETITION EV; Holland B, 2002, EVOLUTION, V56, P721, DOI 10.1554/0014-3820(2002)056[0721:SSFTPA]2.0.CO;2; Hollis B, 2009, EVOLUTION, V63, P324, DOI 10.1111/j.1558-5646.2008.00551.x; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Mallet MA, 2011, HEREDITY, V106, P994, DOI 10.1038/hdy.2010.148; Mallet MA, 2012, BIOL LETTERS, V8, P426, DOI 10.1098/rsbl.2011.0977; Mallet MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-156; McGraw LA, 2007, BIOL LETTERS, V3, P607, DOI 10.1098/rsbl.2007.0334; R Core Team, 2020, R LANG ENV STAT COMP; Radwan J, 2004, ECOL LETT, V7, P1149, DOI 10.1111/j.1461-0248.2004.00681.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rundle HD, 2006, EVOLUTION, V60, P2218, DOI 10.1111/j.0014-3820.2006.tb01859.x; Sharp NP, 2008, EVOLUTION, V62, P857, DOI 10.1111/j.1558-5646.2008.00333.x; Sharp NP, 2009, AM NAT, V174, P613, DOI 10.1086/605960; Simmons L. W., 2001, MG BEH ECOL; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wang AD, 2009, AM NAT, V174, P863, DOI 10.1086/645088; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7	24	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37351	10.1371/journal.pone.0037351	http://dx.doi.org/10.1371/journal.pone.0037351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662148	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300037
J	Moen, EL; Wen, SC; Anwar, T; Cross-Knorr, S; Brilliant, K; Birnbaum, F; Rahaman, S; Sedivy, JM; Moss, SF; Chatterjee, D				Moen, Erika L.; Wen, Sicheng; Anwar, Talha; Cross-Knorr, Sam; Brilliant, Kate; Birnbaum, Faith; Rahaman, Sherida; Sedivy, John M.; Moss, Steven F.; Chatterjee, Devasis			Regulation of RKIP Function by Helicobacter pylori in Gastric Cancer	PLOS ONE			English	Article							KINASE INHIBITOR PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; NF-KAPPA-B; INDUCED APOPTOSIS; GASTROINTESTINAL-TRACT; EXPRESSION; CELLS; ACTIVATION; PROSTATE	Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium that infects more than half of the world's population and is a major cause of gastric adenocarcinoma. The mechanisms that link H. pylori infection to gastric carcinogenesis are not well understood. In the present study, we report that the Raf-kinase inhibitor protein (RKIP) has a role in the induction of apoptosis by H. pylori in gastric epithelial cells. Western blot and luciferase transcription reporter assays demonstrate that the pathogenicity island of H. pylori rapidly phosphorylates RKIP, which then localizes to the nucleus where it activates its own transcription and induces apoptosis. Forced overexpression of RKIP enhances apoptosis in H. pylori-infected cells, whereas RKIP RNA inhibition suppresses the induction of apoptosis by H. pylori infection. While inducing the phosphorylation of RKIP, H. pylori simultaneously targets non-phosphorylated RKIP for proteasome-mediated degradation. The increase in RKIP transcription and phosphorylation is abrogated by mutating RKIP serine 153 to valine, demonstrating that regulation of RKIP activity by H. pylori is dependent upon RKIP's S153 residue. In addition, H. pylori infection increases the expression of Snail, a transcriptional repressor of RKIP. Our results suggest that H. pylori utilizes a tumor suppressor protein, RKIP, to promote apoptosis in gastric cancer cells.	[Moen, Erika L.; Wen, Sicheng; Anwar, Talha; Cross-Knorr, Sam; Brilliant, Kate; Birnbaum, Faith; Moss, Steven F.; Chatterjee, Devasis] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Moen, Erika L.; Cross-Knorr, Sam; Brilliant, Kate; Chatterjee, Devasis] Rhode Isl Hosp, Ctr Biomed Res Excellence COBRE, Providence, RI USA; [Rahaman, Sherida] Brown Univ, Dept Pathobiol, Grad Program, Providence, RI 02912 USA; [Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Brown University; Brown University	Moen, EL (corresponding author), Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.	dchatter@lifespan.org		Moen, Erika/0000-0002-9800-8742	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103421]; National Center for Research Resources (NCRR) [P20 RR 017695, R01 CA111533, R21 CA133601]; NATIONAL CANCER INSTITUTE [R21CA133601, R01CA111533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103421 (DC); the previous segment of this project was supported by the National Center for Research Resources (NCRR) under P20 RR 017695 (DC), R01 CA111533 (SFM) and R21 CA133601 (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Baritaki S, 2009, CANCER RES, V69, P8376, DOI 10.1158/0008-5472.CAN-09-1069; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; BRENES F, 1993, AM J GASTROENTEROL, V88, P1870; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chatterjee D, 2008, CLIN CANCER RES, V14, P2994, DOI 10.1158/1078-0432.CCR-07-4496; Chen G, 1997, BIOCHEM BIOPH RES CO, V239, P626, DOI 10.1006/bbrc.1997.7485; Chu SH, 2003, ANN NY ACAD SCI, V1010, P568, DOI 10.1196/annals.1299.106; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Garcia M, 2007, GLOBAL CANC FACTS FI, P1; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Ishihara S, 2001, HELICOBACTER, V6, P283, DOI 10.1046/j.1523-5378.2001.00043.x; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Matsumoto A, 2011, DIGEST DIS SCI, V56, P999, DOI 10.1007/s10620-010-1420-1; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Minohara Y, 2007, HELICOBACTER, V12, P583, DOI 10.1111/j.1523-5378.2007.00537.x; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Odenbreit S, 2006, HELICOBACTER, V11, P196, DOI 10.1111/j.1523-5378.2006.00400.x; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 2000, GASTROENTEROLOGY, V118, P48, DOI 10.1016/S0016-5085(00)70413-6; Pignatelli B, 2001, AM J GASTROENTEROL, V96, P1758, DOI 10.1111/j.1572-0241.2001.03869.x; Schuierer MM, 2006, ONCOL REP, V16, P451; Shibayama K, 2001, INFECT IMMUN, V69, P3181, DOI 10.1128/IAI.69.5.3181-3189.2001; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Sugimoto M, 2010, WORLD J GASTROENTERO, V16, P1188, DOI 10.3748/wjg.v16.i10.1188; Theroux S, 2007, BRAIN RES BULL, V71, P559, DOI 10.1016/j.brainresbull.2006.11.010; Wang TC, 1998, GASTROENTEROLOGY, V114, P675, DOI 10.1016/S0016-5085(98)70581-5; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Wen S, 2011, ONCOGENE; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	50	13	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37819	10.1371/journal.pone.0037819	http://dx.doi.org/10.1371/journal.pone.0037819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662230	gold, Green Published, Green Submitted			2022-12-27	WOS:000305342300120
J	Pilsner, JR; Hall, MN; Liu, XH; Ilievski, V; Slavkovich, V; Levy, D; Factor-Litvak, P; Yunus, M; Rahman, M; Graziano, JH; Gamble, MV				Pilsner, J. Richard; Hall, Megan N.; Liu, Xinhua; Ilievski, Vesna; Slavkovich, Vesna; Levy, Diane; Factor-Litvak, Pam; Yunus, Mahammad; Rahman, Mahfuzar; Graziano, Joseph H.; Gamble, Mary V.			Influence of Prenatal Arsenic Exposure and Newborn Sex on Global Methylation of Cord Blood DNA	PLOS ONE			English	Article							URINARY CREATININE; DRINKING-WATER; FOLATE-DEFICIENCY; LEUKOCYTE DNA; LUNG-CANCER; HYPOMETHYLATION; METABOLISM; HOMOCYSTEINE; EXPRESSION; MORTALITY	Background: An emerging body of evidence indicates that early-life arsenic (As) exposure may influence the trajectory of health outcomes later in life. However, the mechanisms underlying these observations are unknown. Objective: The objective of this study was to investigate the influence of prenatal As exposure on global methylation of cord blood DNA in a study of mother/newborn pairs in Matlab, Bangladesh. Design: Maternal and cord blood DNA were available from a convenience sample of 101 mother/newborn pairs. Measures of As exposure included maternal urinary As (uAs), maternal blood As (mbAs) and cord blood As (cbAs). Several measures of global DNA methylation were assessed, including the [3H]-methyl-incorporation assay and three Pyrosequencing assays: Alu, LINE-1 and LUMA. Results: In the total sample, increasing quartiles of maternal uAs were associated with an increase in covariate-adjusted means of newborn global DNA methylation as measured by the [3H]-methyl-incorporation assay (quartile 1 (Q1) and Q2 vs. Q4; p = 0.06 and 0.04, respectively). Sex-specific linear regression analyses, while not reaching significance level of 0.05, indicated that the associations between As exposures and Alu, LINE-1 and LUMA were positive among male newborns (N = 58) but negative among female newborns (N = 43); tests for sex differences were borderline significant for the association of cbAs and mbAs with Alu (p = 0.05 and 0.09, respectively) and for the association between maternal uAs and LINE-1 (p = 0.07). Sex-specific correlations between maternal urinary creatinine and newborn methyl-incorporation, Alu and LINE-1 were also evident (p < 0.05). Conclusions: These results suggest that prenatal As exposure is associated with global DNA methylation in cord blood DNA, possibly in a sex-specific manner. Arsenic-induced epigenetic modifications in utero may potentially influence disease outcomes later in life. Additional studies are needed to confirm these findings and to examine the persistence of DNA methylation marks over time.	[Pilsner, J. Richard] Univ Massachusetts, Div Environm Hlth Sci, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Hall, Megan N.; Factor-Litvak, Pam] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Liu, Xinhua; Levy, Diane] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA; [Ilievski, Vesna; Slavkovich, Vesna; Graziano, Joseph H.; Gamble, Mary V.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Yunus, Mahammad] ICDDR B, Dhaka, Bangladesh; [Rahman, Mahfuzar] Columbia Univ Arsen Project Bangladesh, Dhaka, Bangladesh	University of Massachusetts System; University of Massachusetts Amherst; Columbia University; Columbia University; Columbia University; International Centre for Diarrhoeal Disease Research (ICDDR)	Pilsner, JR (corresponding author), Univ Massachusetts, Div Environm Hlth Sci, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.	mvg7@columbia.edu		Yunus, Mohammed/0000-0003-1116-4978	National Institute of Environmental Health Sciences [P42 ES10349, P30 ES09089]; Mailman School of Public Health, Lamont-Dougherty Earth Observatory; Earth Institute at Columbia University; International Centre for Diarrheal Disease Research, Bangladesh; Mailman School of Public Health; The International Center for Diarrheal Disease, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES018890, P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mailman School of Public Health, Lamont-Dougherty Earth Observatory; Earth Institute at Columbia University; International Centre for Diarrheal Disease Research, Bangladesh; Mailman School of Public Health; The International Center for Diarrheal Disease, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences grants P42 ES10349 and P30 ES09089, the Mailman School of Public Health, Lamont-Dougherty Earth Observatory, the Earth Institute at Columbia University, and International Centre for Diarrheal Disease Research, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was a collaboration between the Mailman School of Public Health and The International Center for Diarrheal Disease, Bangladesh (ICDDR,B). We acknowledge with gratitude the support of these organizations for this research.	Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basu A, 2001, MUTAT RES-REV MUTAT, V488, P171, DOI 10.1016/S1383-5742(01)00056-4; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gamble MV, 2006, AM J CLIN NUTR, V84, P1093, DOI 10.1093/ajcn/84.5.1093; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, P1683, DOI 10.1289/ehp.8084; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; Gamble MV, 2005, AM J CLIN NUTR, V81, P1372; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hall MN, 2010, ENV HLTH PERSPECT; IARC W, SOM DRINK WAT DIS CO; Ireland Z, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-39; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Karimi M, 2006, EPIGENETICS-US, V1, P45; Kinniburgh D.G., 2003, ARSENIC GROUND WATER, P211, DOI [DOI 10.1007/0-306-47956-7_8, 10.1007/0, DOI 10.1007/0]; Majumdar S, 2010, ENVIRON TOXICOL, V25, P315, DOI 10.1002/tox.20497; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; NIXON DE, 1991, CLIN CHEM, V37, P1575; Nohara K, 2011, ARCH TOXICOL, V85, P653, DOI 10.1007/s00204-010-0611-z; Okoji RS, 2002, CARCINOGENESIS, V23, P777, DOI 10.1093/carcin/23.5.777; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pilsner JR, 2007, AM J CLIN NUTR, V86, P1179, DOI 10.1093/ajcn/86.4.1179; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P254, DOI 10.1289/ehp.11872; POOLE JR, 1975, J CLIN INVEST, V55, P1033, DOI 10.1172/JCI108004; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sciandrello G, 2004, CARCINOGENESIS, V25, P413, DOI 10.1093/carcin/bgh029; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P452; Vahter M, 2000, TOXICOL LETT, V112, P209, DOI 10.1016/S0378-4274(99)00271-4; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	63	105	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37147	10.1371/journal.pone.0037147	http://dx.doi.org/10.1371/journal.pone.0037147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662134	Green Published, gold			2022-12-27	WOS:000305342300025
J	Bai, GY; Gajer, P; Nandy, M; Ma, B; Yang, HQ; Sakamoto, J; Blanchard, MH; Ravel, J; Brotman, RM				Bai, Guoyun; Gajer, Pawel; Nandy, Melissa; Ma, Bing; Yang, Hongqiu; Sakamoto, Joyce; Blanchard, May H.; Ravel, Jacques; Brotman, Rebecca M.			Comparison of Storage Conditions for Human Vaginal Microbiome Studies	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; GRAM STAIN; IN-VITRO; URINE; ACID; COLONIZATION; COLLECTION; CONSISTENT; STABILITY; SEQUENCES	Background: The effect of storage conditions on the microbiome and metabolite composition of human biological samples has not been thoroughly investigated as a potential source of bias. We evaluated the effect of two common storage conditions used in clinical trials on the bacterial and metabolite composition of the vaginal microbiota using pyrosequencing of barcoded 16S rRNA gene sequencing and H-1-NMR analyses. Methodology/Principal Findings: Eight women were enrolled and four mid-vaginal swabs were collected by a physician from each woman. The samples were either processed immediately, stored at -80 degrees C for 4 weeks or at -20 degrees C for 1 week followed by transfer to -80 degrees C for another 4 weeks prior to analysis. Statistical methods, including Kolmogorovo-Smirnov and Wilcoxon tests, were performed to evaluate the differences in vaginal bacterial community composition and metabolites between samples stored under different conditions. The results showed that there were no significant differences between samples processed immediately after collection or stored for varying durations. H-1-NMR analysis of the small molecule metabolites in vaginal secretions indicated that high levels of lactic acid were associated with Lactobacillus-dominated communities. Relative abundance of lactic acid did not appear to correlate with relative abundance of individual Lactobacillus sp. in this limited sample, although lower levels of lactic acid were observed when L. gasseri was dominant, indicating differences in metabolic output of seemingly similar communities. Conclusions/Significance: These findings benefit large-scale, field-based microbiome and metabolomic studies of the vaginal microbiota.	[Bai, Guoyun; Gajer, Pawel; Nandy, Melissa; Ma, Bing; Yang, Hongqiu; Sakamoto, Joyce; Ravel, Jacques; Brotman, Rebecca M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Gajer, Pawel; Sakamoto, Joyce; Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Blanchard, May H.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Brotman, Rebecca M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bai, GY (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	rbrotman@som.umaryland.edu	Ma, Bing/C-8226-2014; Bai, Guoyun/H-1597-2012; Brotman, Rebecca M/H-5442-2011; Ravel, Jacques/D-2530-2009	Ma, Bing/0000-0002-3488-2393; Brotman, Rebecca M/0000-0001-8762-6214; Ravel, Jacques/0000-0002-0851-2233	National Institutes of Health, National Institute of Allergy and Infectious Diseases [K01-AI080974, U01-AI70921, U19AI084044]; NIH [UH2-AI083264]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044, UH2AI083264, K01AI080974, U01AI070921] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants K01-AI080974 (PI: Brotman), U01-AI70921 (PI: Ravel) and U19AI084044 (PI: Ravel) from the National Institutes of Health, National Institute of Allergy and Infectious Diseases and UH2-AI083264 from the NIH Common Fund (PI: Ravel and Forney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mushrif S, 2000, J MED MICROBIOL, V49, P1023, DOI 10.1099/0022-1317-49-11-1023; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bertram HC, 2007, ANAL CHEM, V79, P7110, DOI 10.1021/ac070928a; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chaudry AN, 2004, J CLIN MICROBIOL, V42, P5170, DOI 10.1128/JCM.42.11.5170-5175.2004; Claus RA, 2010, CURR MOL MED, V10, P227, DOI 10.2174/156652410790963358; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dolfing J, 2004, SCIENCE, V306, P813; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Keun HC, 2002, CHEM RES TOXICOL, V15, P1380, DOI 10.1021/tx0255774; Klammer S, 2005, ANN MICROBIOL, V55, P299; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MEIJERSEVERS GJ, 1987, SCAND J GASTROENTERO, V22, P672, DOI 10.3109/00365528709011141; Mirmonsef P, 2011, AM J REPROD IMMUNOL; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Peakman TC, 2008, INT J EPIDEMIOL, V37, P2, DOI 10.1093/ije/dyn019; Rao Suyog, 2005, Genome Inform, V16, P3; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Troyer Dean, 2008, V441, P193, DOI 10.1007/978-1-60327-047-2_13; Tzeneva VA, 2009, RES MICROBIOL, V160, P89, DOI 10.1016/j.resmic.2008.12.001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WICHMANN B, 1987, BYTE, V12, P127; WICHMANN BA, 1982, J R STAT SOC C-APPL, V31, P188; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	49	48	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e36934	10.1371/journal.pone.0036934	http://dx.doi.org/10.1371/journal.pone.0036934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655031	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900006
J	Gogliettino, M; Balestrieri, M; Cocca, E; Mucerino, S; Rossi, M; Petrillo, M; Mazzella, E; Palmieri, G				Gogliettino, Marta; Balestrieri, Marco; Cocca, Ennio; Mucerino, Sabrina; Rossi, Mose; Petrillo, Mauro; Mazzella, Emanuela; Palmieri, Gianna			Identification and Characterisation of a Novel Acylpeptide Hydrolase from Sulfolobus Solfataricus: Structural and Functional Insights	PLOS ONE			English	Article							OXIDIZED PROTEIN HYDROLASE; MULTIPLE SEQUENCE ALIGNMENT; ACYL-PEPTIDE-HYDROLASE; AEROPYRUM-PERNIX K1; ACYLAMINOACYL PEPTIDASE; PROLYL OLIGOPEPTIDASE; ENZYME; SITE; PURIFICATION; PHYLOGENIES	A novel acylpeptide hydrolase, named APEH-3(Ss), was isolated from the hypertermophilic archaeon Sulfolobus solfataricus. APEH is a member of the prolyl oligopeptidase family which catalyzes the removal of acetylated amino acid residues from the N terminus of oligopeptides. The purified enzyme shows a homotrimeric structure, unique among the associate partners of the APEH cluster and, in contrast to the archaeal APEHs which show both exo/endo peptidase activities, it appears to be a "true" aminopeptidase as exemplified by its mammalian counterparts, with which it shares a similar substrate specificity. Furthermore, a comparative study on the regulation of apeh gene expression, revealed a significant but divergent alteration in the expression pattern of apeh-3(Ss) and apeh(Ss) (the gene encoding the previously identified APEH(Ss) from S. solfataricus), which is induced in response to various stressful growth conditions. Hence, both APEH enzymes can be defined as stress-regulated proteins which play a complementary role in enabling the survival of S. solfataricus cells under different conditions. These results provide new structural and functional insights into S. solfataricus APEH, offering a possible explanation for the multiplicity of this enzyme in Archaea.	[Gogliettino, Marta; Balestrieri, Marco; Cocca, Ennio; Mucerino, Sabrina; Rossi, Mose; Mazzella, Emanuela; Palmieri, Gianna] Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy; [Petrillo, Mauro] CEINGE Biotecnol Avanzate, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); CEINGE Biotecnologie Avanzate	Gogliettino, M (corresponding author), Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy.	g.palmieri@ibp.cnr.it	Cocca, Ennio/AAY-3817-2020; Palmieri, Gianna/S-4872-2017; BALESTRIERI, MARCO/AAA-1869-2021; Palmieri, Gianna/AAW-6176-2020; Balestrieri, Marco/G-1847-2011; Petrillo, Mauro/AAL-6533-2021	Cocca, Ennio/0000-0003-2432-9663; BALESTRIERI, MARCO/0000-0003-4343-2148; Palmieri, Gianna/0000-0002-9007-4075; Petrillo, Mauro/0000-0002-6782-4704	Agenzia Spaziale Italiana [1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	FIRB-MERIT 1 GAE: P0000407 MoMa n. 1/014/06/0 of the Agenzia Spaziale Italiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Bergamo P, 2011, MOL NUTR FOOD RES, V55, pS248, DOI 10.1002/mnfr.201100295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; DIAZLAZCOZ Y, 1995, J MOL BIOL, V250, P123, DOI 10.1006/jmbi.1995.0363; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujino T, 2000, BBA-PROTEIN STRUCT M, V1478, P102, DOI 10.1016/S0167-4838(00)00004-2; Fujino T, 1998, BBA-BIOMEMBRANES, V1374, P47, DOI 10.1016/S0005-2736(98)00131-X; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; GADE W, 1978, J BIOL CHEM, V253, P5012; Gogliettino M, 2010, J BACTERIOL, V192, P3123, DOI 10.1128/JB.01414-09; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; Ishikawa K, 1998, J BIOL CHEM, V273, P17726, DOI 10.1074/jbc.273.28.17726; JONES WM, 1994, METHOD ENZYMOL, V244, P227; Kiss AL, 2008, J STRUCT BIOL, V162, P312, DOI 10.1016/j.jsb.2008.01.012; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; KOBAYASHI K, 1987, J BIOL CHEM, V262, P11435; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Palmieri G, 2010, MOL BIOSYST, V6, P2498, DOI 10.1039/c005293k; Palmieri G, 2009, J PROTEOME RES, V8, P327, DOI 10.1021/pr800587t; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Raphel V, 1999, BBA-PROTEIN STRUCT M, V1432, P371, DOI 10.1016/S0167-4838(99)00087-4; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; SCALONI A, 1992, J BIOL CHEM, V267, P3811; Senthilkumar R, 2002, J PROTEIN CHEM, V21, P323, DOI 10.1023/A:1019938217294; SHARMA KK, 1993, EUR J BIOCHEM, V216, P631, DOI 10.1111/j.1432-1033.1993.tb18183.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Szeltner Z, 2009, BBA-PROTEINS PROTEOM, V1794, P1204, DOI 10.1016/j.bbapap.2009.03.004; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang QY, 2006, J BIOL CHEM, V281, P18618, DOI 10.1074/jbc.M601015200; Yamin R, 2007, J NEUROCHEM, V100, P458, DOI 10.1111/j.1471-4159.2006.04251.x	47	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37921	10.1371/journal.pone.0037921	http://dx.doi.org/10.1371/journal.pone.0037921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655081	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900058
J	Sussillo, D; Abbott, LF				Sussillo, David; Abbott, L. F.			Transferring Learning from External to Internal Weights in Echo-State Networks with Sparse Connectivity	PLOS ONE			English	Article								Modifying weights within a recurrent network to improve performance on a task has proven to be difficult. Echo-state networks in which modification is restricted to the weights of connections onto network outputs provide an easier alternative, but at the expense of modifying the typically sparse architecture of the network by including feedback from the output back into the network. We derive methods for using the values of the output weights from a trained echo-state network to set recurrent weights within the network. The result of this "transfer of learning'' is a recurrent network that performs the task without requiring the output feedback present in the original network. We also discuss a hybrid version in which online learning is applied to both output and recurrent weights. Both approaches provide efficient ways of training recurrent networks to perform complex tasks. Through an analysis of the conditions required to make transfer of learning work, we define the concept of a "self-sensing'' network state, and we compare and contrast this with compressed sensing.	[Sussillo, David] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Abbott, L. F.] Columbia Univ, Dept Neurosci, New York, NY USA	Stanford University; Columbia University	Sussillo, D (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	sussillo@stanford.edu		Sussillo, David/0000-0003-1620-1264	Gatsby Foundation; Swartz Foundation; Kavli Institute for Brain Science at Columbia University; National Institutes of Health [MH093338]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093338] Funding Source: NIH RePORTER	Gatsby Foundation; Swartz Foundation; Kavli Institute for Brain Science at Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Gatsby Foundation, the Swartz Foundation, the Kavli Institute for Brain Science at Columbia University, and by National Institutes of Health grant MH093338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2011, DYNAMIC BRAIN EXPLOR, P65; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2011, IEEE T INFORM THEORY, V57, P7235, DOI 10.1109/TIT.2011.2161794; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Haykin S., 2001, ADAPTIVE FILTER THEO; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H, 2003, ADV NEURAL INFORM PR, V15; Jaeger H, 2010, 23 JAC U; Li J, 2011, 26 JAC U; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Martens J., 2011, P 28 INT C MACH LEAR, P1033; Mayer NM, 2004, LECT NOTES COMPUT SC, V3141, P40; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Reinhart R. F., 2011, EUR S ANNS D FACT, P59; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018	19	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37372	10.1371/journal.pone.0037372	http://dx.doi.org/10.1371/journal.pone.0037372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655041	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338900016
J	Xia, SS; Ma, YL; Zhang, W; Yang, YW; Wu, SW; Zhu, MZ; Deng, LF; Li, B; Liu, ZL; Qi, C				Xia, Sisi; Ma, Yanlin; Zhang, Wei; Yang, Yi; Wu, Shaowen; Zhu, Minzhe; Deng, Lingfu; Li, Bing; Liu, Zhonglai; Qi, Chao			Identification of Sare0718 As an Alanine-Activating Adenylation Domain in Marine Actinomycete Salinispora arenicola CNS-205	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; BIOSYNTHETIC GENE-CLUSTER; NATURAL-PRODUCTS; METABOLITES; POLYKETIDE; PREDICTION; DISCOVERY; RESOURCE; SEQUENCE; ASSAY	Background: Amino acid adenylation domains (A domains) are critical enzymes that dictate the identity of the amino acid building blocks to be incorporated during nonribosomal peptide (NRP) biosynthesis. NRPs represent a large group of valuable natural products that are widely applied in medicine, agriculture, and biochemical research. Salinispora arenicola CNS-205 is a representative strain of the first discovered obligate marine actinomycete genus, whose genome harbors a large number of cryptic secondary metabolite gene clusters. Methodology/Principal Findings: In order to investigate cryptic NRP-related metabolites in S. arenicola CNS-205, we cloned and identified the putative gene sare0718 annotated "amino acid adenylation domain''. Firstly, the general features and possible functions of sare0718 were predicted by bioinformatics analysis, which suggested that Sare0718 is a soluble protein with an AMP-binding domain contained in the sequence and its cognate substrate is L-Val. Then, a GST-tagged fusion protein was expressed and purified to further explore the exact adenylation activity of Sare0718 in vitro. By a newly mentioned nonradioactive malachite green colorimetric assay, we found that L-Ala but not L-Val is the actual activated amino acid substrate and the basic kinetic parameters of Sare0718 for it are K-m = 0.1164 +/- 0.0159 (mM), V-max = 3.1484 +/- 0.1278 (mu M/min), k(cat) = 12.5936 +/- 0.5112 (min(-1)). Conclusions/Significance: By revealing the biochemical role of sare0718 gene, we identified an alanine-activating adenylation domain in marine actinomycete Salinispora arenicola CNS-205, which would provide useful information for next isolation and function elucidation of the whole cryptic nonribosomal peptide synthetase (NRPS)-related gene cluster covering Sare0718. And meanwhile, this work also enriched the biochemical data of A domain substrate specificity in newly discovered marine actinomycete NRPS system, which bioinformatics prediction will largely depend on.	[Xia, Sisi; Ma, Yanlin; Zhang, Wei; Wu, Shaowen; Zhu, Minzhe; Deng, Lingfu; Li, Bing; Liu, Zhonglai; Qi, Chao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Yang, Yi] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China	Central China Normal University; Hebei Medical University	Xia, SS (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	hslzl2007@163.com; qichao@mail.ccnu.edu.cn		Xia, Sisi/0000-0003-3409-1302	National Science Foundation of China [20772040]; Central China Normal University (CCNU); MOE [CCNU11A02013]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central China Normal University (CCNU); MOE(Ministry of Higher Education & Scientific Research (MHESR))	This research was supported by the National Science Foundation of China (No. 20772040.) and financially supported by self-determined research funds of Central China Normal University (CCNU) from the colleges' basic research and operation of MOE (No. CCNU11A02013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; COSMINA P, 1993, MOL MICROBIOL, V8, P821, DOI 10.1111/j.1365-2958.1993.tb01629.x; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lam KS, 2006, CURR OPIN MICROBIOL, V9, P245, DOI 10.1016/j.mib.2006.03.004; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li J, 2008, CHEM BIOL, V15, P118, DOI 10.1016/j.chembiol.2007.12.014; Lombo F, 2006, CHEMBIOCHEM, V7, P366, DOI 10.1002/cbic.200500325; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; McQuade TJ, 2009, ANAL BIOCHEM, V386, P244, DOI 10.1016/j.ab.2008.12.014; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Mok MTS, 2005, J BIOL CHEM, V280, P39363, DOI 10.1074/jbc.M509209200; Mok MTS, 2005, ANAL BIOCHEM, V343, P341, DOI 10.1016/j.ab.2005.05.023; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Santi D V, 1974, Methods Enzymol, V29, P620; Schultz AW, 2008, J AM CHEM SOC, V130, P4507, DOI 10.1021/ja711188x; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, CURR OPIN CHEM BIOL, V5, P159, DOI 10.1016/S1367-5931(00)00185-X; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Wilkins MR, 1999, METH MOL B, V112, P531	42	5	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37487	10.1371/journal.pone.0037487	http://dx.doi.org/10.1371/journal.pone.0037487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655051	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338900027
J	Zhang, K; Wang, Z; Liu, XL; Yin, CC; Basit, ZS; Xia, B; Liu, WJ				Zhang, Ke; Wang, Zhao; Liu, Xiaoling; Yin, Changcheng; Basit, Zeshan; Xia, Bin; Liu, Wenjun			Dissection of Influenza A Virus M1 Protein: pH-Dependent Oligomerization of N-Terminal Domain and Dimerization of C-Terminal Domain	PLOS ONE			English	Article							RNA-BINDING-PROTEIN; MATRIX PROTEIN; MEMBRANE ASSOCIATION; M2 PROTEIN; PARTICLES; REPLICATION; MORPHOGENESIS; GLYCOPROTEINS; TRANSPORT; RIBONUCLEOPROTEINS	Background: The matrix 1 (M1) protein of Influenza A virus plays many critical roles throughout the virus life cycle. The oligomerization of M1 is essential for the formation of the viral matrix layer during the assembly and budding process. Methodology/Principal Findings: In the present study, we report that M1 can oligomerize in vitro, and that the oligomerization is pH-dependent. The N-terminal domain of M1 alone exists as multiple-order oligomers at pH 7.4, and the C-terminal domain alone forms an exclusively stable dimer. As a result, intact M1 can display different forms of oligomers and dimer is the smallest oligomerization state, at neutral pH. At pH 5.0, oligomers of the N-terminal domain completely dissociate into monomers, while the C-terminal domain remains in dimeric form. As a result, oligomers of intact M1 dissociate into a stable dimer at acidic pH. Conclusions/Significance: Oligomerization of M1 involves both the N- and C-terminal domains. The N-terminal domain determines the pH-dependent oligomerization characteristic, and C-terminal domain forms a stable dimer, which contributes to the dimerization of M1. The present study will help to unveil the mechanisms of influenza A virus assembly and uncoating process.	[Zhang, Ke; Liu, Xiaoling; Basit, Zeshan; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China; [Zhang, Ke; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Zhao; Yin, Changcheng] Peking Univ, Hlth Sci Ctr, Dept Biophys, Beijing 100871, Peoples R China; [Xia, Bin] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Zhang, K (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China.	binxia@pku.edu.cn; liuwj@im.ac.cn	wang, zhao/E-1996-2016; Liu, Xiaoling/HGD-3566-2022; wang, zhao/E-7013-2015	Yin, Chang-Cheng/0000-0001-7748-3205; Wang, Zhao/0000-0003-4897-9986	National Basic Research Program (973) of China [2011CB504705]; Chinese Academy of Sciences Innovation [KSCX2-YW-N-054, KSCX2-YW-R-158]; National Natural Science Foundation of China [30972185, 30901073]	National Basic Research Program (973) of China(National Basic Research Program of China); Chinese Academy of Sciences Innovation(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973) of China (2011CB504705), Chinese Academy of Sciences Innovation projects (KSCX2-YW-N-054, KSCX2-YW-R-158), and National Natural Science Foundation of China (30972185, 30901073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Avalos RT, 1997, J VIROL, V71, P2947, DOI 10.1128/JVI.71.4.2947-2958.1997; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; ELSTER C, 1994, J GEN VIROL, V75, P37, DOI 10.1099/0022-1317-75-1-37; ENAMI M, 1985, VIROLOGY, V142, P68, DOI 10.1016/0042-6822(85)90423-4; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11; FUJIYOSHI Y, 1994, EMBO J, V13, P318, DOI 10.1002/j.1460-2075.1994.tb06264.x; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; HEGGENESS MH, 1982, VIROLOGY, V118, P466, DOI 10.1016/0042-6822(82)90367-1; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Hui EKW, 2002, J GEN VIROL, V83, P3055, DOI 10.1099/0022-1317-83-12-3055; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Kraus I, 2005, FEBS LETT, V579, P2686, DOI 10.1016/j.febslet.2005.04.002; Ksenofontov AL, 2011, MOL BIOL+, V45, P634, DOI 10.1134/S0026893311030071; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Lamb RA, 2001, NAT MED, V7, P1286, DOI 10.1038/nm1201-1286; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; Laue TM, 2001, CURR PROTOC PROTEIN; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Pohl C, 2007, J GEN VIROL, V88, P1243, DOI 10.1099/vir.0.82578-0; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Ruigrok R, 2001, INT CONGR SER, V1219, P397, DOI 10.1016/S0531-5131(01)00637-9; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHULZE IT, 1972, VIROLOGY, V47, P181, DOI 10.1016/0042-6822(72)90251-6; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shishkov A, 2011, FEBS J IN PRESS; Shishkov AV, 2009, PROTEIN PEPTIDE LETT, V16, P1407, DOI 10.2174/092986609789353682; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; WAKEFIELD L, 1989, NUCLEIC ACIDS RES, V17, P8569, DOI 10.1093/nar/17.21.8569; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Wang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022625; Wu CY, 2011, J VIROL, V85, P6618, DOI 10.1128/JVI.02401-10; Zhao HX, 1998, J GEN VIROL, V79, P2435, DOI 10.1099/0022-1317-79-10-2435; ZHIRNOV OP, 1992, VIROLOGY, V186, P324, DOI 10.1016/0042-6822(92)90090-C	61	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37786	10.1371/journal.pone.0037786	http://dx.doi.org/10.1371/journal.pone.0037786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655068	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338900044
J	Wu, CS; Nohr, EA; Bech, BH; Vestergaard, M; Olsen, J				Wu, Chun S.; Nohr, Ellen A.; Bech, Bodil H.; Vestergaard, Mogens; Olsen, Jorn			Long-Term Health Outcomes in Children Born to Mothers with Diabetes: A Population-Based Cohort Study	PLOS ONE			English	Article							INTRAUTERINE EXPOSURE; BIRTH-WEIGHT; CONGENITAL-MALFORMATIONS; METABOLIC SYNDROME; INDIAN CHILDREN; BLOOD-PRESSURE; BREAST-CANCER; PREGNANCY; RISK; PREVALENCE	Background: To examine whether prenatal exposure to parental type 1 diabetes, type 2 diabetes, or gestational diabetes is associated with an increased risk of malignant neoplasm or diseases of the circulatory system in the offspring. Methods/Principal Findings: We conducted a population-based cohort study of 1,781,576 singletons born in Denmark from 1977 to 2008. Children were followed for up to 30 years from the day of birth until the onset of the outcomes under study, death, emigration, or December 31, 2009, whichever came first. We used Cox proportional hazards model to estimate hazard ratios (HR)with 95% confidence intervals (95% CI) for the outcomes under study while adjusting for potential confounders. An increased risk of malignant neoplasm was found in children prenatally exposed to maternal type 2 diabetes (HR = 2.2, 95%CI: 1.5-3.2). An increased risk of diseases of the circulatory system was found in children exposed to maternal type 1 diabetes (HR = 2.2, 95%CI: 1.6-3.0), type 2 diabetes (HR = 1.4, 95%CI: 1.1-1.7), and gestational diabetes (HR = 1.3, 95%CI: 1.1-1.6), but results were attenuated after excluding children with congenital malformations. An increased risk of diseases of the circulatory system was also found in children exposed to paternal type 2 diabetes (HR = 1.5, 95%CI: 1.1-2.2) and the elevated risk remained after excluding children with congenital malformations. Conclusions: This study suggests that susceptibility to malignant neoplasm is modified partly by fetal programming. Diseases of the circulatory system may be modified by genetic factors, other time-stable family factors, or fetal programming.	[Wu, Chun S.; Nohr, Ellen A.; Bech, Bodil H.; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles	Wu, CS (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	cw@soci.au.dk	Olsen, Jørn/F-8801-2015; Bech, Bodil Hammer/B-9646-2016; Vestergaard, Mogens/M-9333-2014	Olsen, Jørn/0000-0001-7462-5140; Bech, Bodil Hammer/0000-0002-0287-3687; Vestergaard, Mogens/0000-0001-8830-2174	Danish Cancer Society [DP04127]; Danish Medical Research Council (FSS)	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council (FSS)(Danish Medical Research Council)	The study was supported by the Danish Cancer Society (grant number DP04127) and the Danish Medical Research Council (FSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2001, EARLY HUM DEV, V61, P85, DOI 10.1016/S0378-3782(00)00125-0; Aberg A, 2001, ACTA PAEDIATR, V90, P746, DOI 10.1080/080352501750315645; Andersen TF, 1999, DAN MED BULL, V46, P263; Buchanan TA, 2004, DIABETES MELLITUS FU, P1237; Bunt JC, 2005, J CLIN ENDOCR METAB, V90, P3225, DOI 10.1210/jc.2005-0007; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Caughey RW, 2009, INT J CANCER, V124, P2658, DOI 10.1002/ijc.24225; Chen YW, 2010, PEDIATR NEPHROL, V25, P1319, DOI 10.1007/s00467-010-1506-1; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; DAMM P, 1989, AM J OBSTET GYNECOL, V161, P1163, DOI 10.1016/0002-9378(89)90656-X; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hawdon JM, 2011, BEST PRACT RES CL OB, V25, P91, DOI 10.1016/j.bpobgyn.2010.10.005; Jorgen Pedersen, 1977, PREGNANT DIABETIC HE; Knudsen LB, 1998, DAN MED BULL, V45, P320; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Mellemkjaer L, 2003, CANCER CAUSE CONTROL, V14, P61, DOI 10.1023/A:1022570305704; Moore TR, 2010, AM J OBSTET GYNECOL, V202, P643, DOI 10.1016/j.ajog.2010.02.059; Pedersen CB, 2006, DAN MED BULL, V53, P441; Reece EA, 2007, CLIN OBSTET GYNECOL, V50, P990, DOI 10.1097/GRF.0b013e31815a634b; Reece EA, 2012, CURR DIABETES REP, V12, P24, DOI 10.1007/s11892-011-0251-6; Ross JA, 2006, CANCER EPIDEM BIOMAR, V15, P1, DOI 10.1158/1055-9965.EPI-05-0923; Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363; SCHWARTZ R, 1990, NEW ENGL J MED, V323, P340, DOI 10.1056/NEJM199008023230512; Silverman BL, 1998, DIABETES CARE, V21, pB142; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; Tam WH, 2010, DIABETES CARE; Westbom L, 2002, BRIT J CANCER, V86, P1078, DOI [10.1038/sj.bjc.6600192, 10.1038/sj/bjc/6600192]; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wright CS, 2009, AM J HYPERTENS, V22, P215, DOI 10.1038/ajh.2008.326; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7	34	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36727	10.1371/journal.pone.0036727	http://dx.doi.org/10.1371/journal.pone.0036727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649497	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335800014
J	Goodman, CA; Kotecki, JA; Jacobs, BL; Hornberger, TA				Goodman, Craig A.; Kotecki, Jack A.; Jacobs, Brittany L.; Hornberger, Troy A.			Muscle Fiber Type-Dependent Differences in the Regulation of Protein Synthesis	PLOS ONE			English	Article							SKELETAL-MUSCLE; FOOD-DEPRIVATION; INDUCED GROWTH; MESSENGER-RNA; HYPERTROPHY; EXPRESSION; PGC-1-ALPHA; METABOLISM; ACTIVATION; ATROPHY	This study examined fiber type-dependent differences in the regulation of protein synthesis in individual muscle fibers found within the same whole muscle. Specifically, the in vivo SUrface SEnsing of Translation (SUnSET) methodology was used to measure protein synthesis in type 1, 2A, 2X and 2B fibers of the mouse plantaris muscle, in response to food deprivation (FD), and mechanical overload induced by synergist ablation (SA). The results show that 48 h of FD induced a greater decrease in protein synthesis in type 2X and 2B fibers compared to type 1 and 2A fibers. Type 2X and 2B fibers also had the largest FD-induced decrease in total S6 protein and Ser(240/244) S6 phosphorylation, respectively. Moreover, only type 2X and 2B fibers displayed a FD-induced decrease in cross-sectional area (CSA). Ten days of SA also induced fiber type-dependent responses, with type 2B fibers having the smallest SA-induced increases in protein synthesis, CSA and Ser(240/244) S6 phosphorylation, but the largest increase in total S6 protein. Embryonic myosin heavy chain (MHCEmb) positive fibers were also found in SA muscles and the protein synthesis rates, levels of S6 Ser(240/244) phosphorylation, and total S6 protein content, were 3.6-, 6.1- and 2.9-fold greater than that found in fibers from control muscles, respectively. Overall, these results reveal differential responses in the regulation of protein synthesis and fiber size between fiber types found within the same whole muscle. Moreover, these findings demonstrate that changes found at the whole muscle level do not necessarily reflect changes in individual fiber types.	[Goodman, Craig A.; Kotecki, Jack A.; Jacobs, Brittany L.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Goodman, CA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	Goodman, Craig/H-8085-2019	Goodman, Craig/0000-0002-5874-7743; Hornberger, Troy/0000-0002-2349-1899; Jacobs, Brittany/0000-0002-1078-2320	U.S. National Institutes of Health [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health grant AR057347 to TAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2010, J APPL PHYSIOL, V109, P692, DOI 10.1152/japplphysiol.00504.2010; ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; BAILLIE AGS, 1991, AM J PHYSIOL, V260, pE891, DOI 10.1152/ajpendo.1991.260.6.E891; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; FANG CH, 1995, J AM COLL SURGEONS, V180, P33; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; GOLDBERG AL, 1969, J PHYSIOL-LONDON, V200, P667, DOI 10.1113/jphysiol.1969.sp008715; GOLDBERG AL, 1968, J CELL BIOL, V36, P653, DOI 10.1083/jcb.36.3.653; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Habets PEMH, 1999, J HISTOCHEM CYTOCHEM, V47, P995, DOI 10.1177/002215549904700803; HARMON CS, 1984, BIOCHEM J, V223, P687, DOI 10.1042/bj2230687; Henneman E, 2010, HDB PHYSL NERVOUS 1, DOI 10.1002/cphy.cp010211; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; MCALLISTER RM, 1993, J RECONSTR MICROSURG, V9, P313, DOI 10.1055/s-2007-1006673; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; MILLWARD DJ, 1976, BIOCHEM J, V156, P185, DOI 10.1042/bj1560185; Mittendorfer B, 2005, J PHYSIOL-LONDON, V563, P203, DOI 10.1113/jphysiol.2004.077180; NAKANO K, 1979, BIOCHEM J, V184, P663, DOI 10.1042/bj1840663; Oded M, 2008, INT REV CEL MOL BIO, P1; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; PREEDY VR, 1988, BIOCHEM J, V254, P631, DOI 10.1042/bj2540631; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Stephenson GM, 2001, CLIN EXP PHARMACOL P, V28, P692, DOI 10.1046/j.1440-1681.2001.03505.x; Talmadge RJ, 2000, MUSCLE NERVE, V23, P661, DOI 10.1002/(SICI)1097-4598(200005)23:5<661::AID-MUS3>3.0.CO;2-J; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0	43	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37890	10.1371/journal.pone.0037890	http://dx.doi.org/10.1371/journal.pone.0037890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629468	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305345300082
J	Theron, G; Peter, J; Lenders, L; van Zyl-Smit, R; Meldau, R; Govender, U; Dheda, K				Theron, Grant; Peter, Jonny; Lenders, Laura; van Zyl-Smit, Richard; Meldau, Richard; Govender, Ureshnie; Dheda, Keertan			Correlation of Mycobacterium Tuberculosis Specific and Non-Specific Quantitative Th1 T-Cell Responses with Bacillary Load in a High Burden Setting	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS TREATMENT; ACTIVE TUBERCULOSIS; IMMUNE-RESPONSES; RECORDING-SYSTEM; INFECTION; DIAGNOSIS; SPOT.TB; METAANALYSIS	Background: Measures of bacillary load in patients with tuberculosis (TB) may be useful for predicting and monitoring response to treatment. The relationship between quantitative T-cell responses and mycobacterial load remains unclear. We hypothesised that, in a HIV-prevalent high burden setting, the magnitude of mycobacterial antigen-specific and nonspecific T-cell IFN-gamma responses would correlate with (a) bacterial load and (b) culture conversion in patients undergoing treatment. Methods: We compared baseline (n = 147), 2 (n = 35) and 6 month (n = 13) purified-protein-derivative (PPD) and RD1-specific (TSPOT.TB and QFT-GIT) blood RD1-specific (TSPOT.TB; QFT-GIT) responses with associates of sputum bacillary load in patients with culture-confirmed TB in Cape Town, South Africa. Results: IFN-gamma responses were not associated with liquid culture time-to-positivity, smear-grade, Xpert MTB/RIF-generated cycle threshold values or the presence of cavities on the chest radiograph in patients with culture-confirmed TB and irrespective of HIV-status. 2-month IGRA conversion rates (positive-to-negative) were negligible [<11% for TSPOT. TB (3/28) and QFT-GIT (1/29)] and lower compared to culture [60% (21/35); p<0.01]. Conclusions: In a high burden HIV-prevalent setting T-cell IFN-gamma responses to M. tuberculosis-specific and non-specific antigens do not correlate with bacillary load, including Xpert MTB/RIF-generated CT values, and are therefore poorly suited for monitoring treatment and prognostication.	[Theron, Grant; Peter, Jonny; Lenders, Laura; van Zyl-Smit, Richard; Meldau, Richard; Govender, Ureshnie; Dheda, Keertan] Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Theron, Grant; Peter, Jonny; Lenders, Laura; van Zyl-Smit, Richard; Meldau, Richard; Govender, Ureshnie; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Theron, G (corresponding author), Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415; Peter, Jonathan/0000-0002-2658-0723; van Zyl-Smit, Richard/0000-0002-4115-5362	EU-FP7 award (TBSusgent); EDCTP (TB-NEAT); South African National Research Foundation; Claude Leon Foundation; Discovery Foundation Fellowship; Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant [R24TW007988]; SATBAT; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI); FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	EU-FP7 award (TBSusgent); EDCTP (TB-NEAT); South African National Research Foundation(National Research Foundation - South Africa); Claude Leon Foundation; Discovery Foundation Fellowship; Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant; SATBAT; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by an EU-FP7 award (TBSusgent). GT and UG are supported by the EDCTP (TB-NEAT), the South African National Research Foundation (GT) and the Claude Leon Foundation (GT). RVZS and JP are supported by a Discovery Foundation Fellowship, the Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant R24TW007988, SATBAT (JP) and the EDCTP (TB-NEAT). KD is supported by the EDCTP (TB-NEAT, TESA), the SA DST and the SA NRF (SARChI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012502; Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Bark CM, 2012, J CLIN MICROBIOL, V50, P538, DOI 10.1128/JCM.06193-11; Basirudeen K, 2011, BMC INFECT DIS, P11; Bocchino M, 2010, RESP MED, V104, P1551, DOI 10.1016/j.rmed.2010.05.011; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; DANIEL TM, 1981, AM REV RESPIR DIS, V123, P556; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Dheda K, 2009, THORAX, V64, P847, DOI 10.1136/thx.2009.116376; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Diacon A., 2010, EUROPEAN J CLIN MICR, P1; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Ferrand RA, 2005, INT J TUBERC LUNG D, V9, P1034; Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lee SW, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-300; Ling D, 2011, LANCET INFECT DIS; Ling DI, 2011, EUROPEAN RESP J; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Netea MG, 2011, CLIN DEV IMMUNOLOGY; Oni T, 2010, EUR RESPIR J, V36, P594, DOI 10.1183/09031936.00171509; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Perrin FMR, 2010, INT J TUBERC LUNG D, V14, P1596; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Sauzullo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005187; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Theron G, 2011, AM J RESP CRIT CARE; Theron G, 2011, EUROPEAN RESP J; Theron G, 2011, CLIN INFECT DIS; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; World Health Organization, 2011, WHO PUBL; Wu-Hsieh BA, 2001, CLIN INFECT DIS, V33, P1336, DOI 10.1086/323044	46	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37436	10.1371/journal.pone.0037436	http://dx.doi.org/10.1371/journal.pone.0037436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629395	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300041
J	Huang, HB; Lai, CH; Chen, GW; Lin, YY; Jaakkola, JJK; Liou, SH; Wang, SL				Huang, Han-Bin; Lai, Ching-Huang; Chen, Guan-Wen; Lin, Yong-Yang; Jaakkola, Jouni J. K.; Liou, Saou-Hsing; Wang, Shu-Li			Traffic-Related Air Pollution and DNA Damage: A Longitudinal Study in Taiwanese Traffic Conductors	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; COMET ASSAY; 1-HYDROXYPYRENE GLUCURONIDE; PARTICULATE MATTER; OXIDATIVE DAMAGE; EXPOSURE; WORKERS; URINE; METABOLITES; VALIDATION	Background: There is accumulating epidemiologic evidence that exposure to traffic-related air pollutants, including particulate matter (PM) and polyaromatic hydro carbons (PAHs), plays a role in etiology and prognosis of a large scale of illnesses, although the role of specific causal agents and underlying mechanisms for different health outcomes remains unknown. Objective: Our general objective was to assess the relations between personal exposure to traffic exhausts, in particular ambient PM2.5 and PAHs, and the occurrence of DNA strand breaks by applying personal monitoring of PM and biomarkers of exposure (urinary 1-hydroxypyrene-glucuronide, 1-OHPG) and effect (urinary 8-hydroxydeoxyguanosine, 8-OHdG and DNA strand breaks). Methods: We recruited 91 traffic conductors and 53 indoor office workers between May 2009 and June 2011 in Taipei City, Taiwan. We used PM2.5 personal samplers to collect breathing-zone particulate PAHs samples. Spot urine and blood samples after work shift of 2 consecutive days were analyzed for 1-OHPG, 8-OHdG and DNA strand breaks, respectively. Statistical methods included linear regression and mixed models. Results: Urinary 8-OHdG levels and the occurrence of DNA strand breaks in traffic conductors significantly exceeded those in indoor office workers in mixed models. Particulate PAHs levels showed a positive association with urinary 1-OHPG in the regression model (beta = 0.056, p = 0.01). Urinary 1-OHPG levels were significantly associated with urinary 8-OHdG levels in the mixed model (beta = 0.101, p = 0.023). Our results provide evidence that exposure to fine particulates causes DNA damage. Further, particulate PAHs could be biologically active constituents of PM2.5 with reference to the induction of oxidative DNA damages.	[Huang, Han-Bin; Wang, Shu-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Huang, Han-Bin; Chen, Guan-Wen; Lin, Yong-Yang; Liou, Saou-Hsing; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli, Taiwan; [Lai, Ching-Huang] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Wang, Shu-Li] China Med Univ & Hosp, Coll Publ Hlth, Inst Environm Med, Taichung, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; National Defense Medical Center; University of Oulu; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, HB (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	slwang@nhri.org.tw	Chen, Guan Wen/S-8797-2019; Wang, Shu-Li/C-1367-2010; Jaakkola, Jouni J.K./G-4314-2012; Liou, Saou-Hsing/B-2667-2010; Lai, Ching-Huang/ABF-9274-2021	Jaakkola, Jouni/0000-0003-4168-4683	National Research Program for Genomic Medicine, Taiwan [DOH97-TD-G-111-032, DOH98-TD-G-111-021, DOH99-TD-G-111-018, NSC100-2325-B400-010]; Academy of Finland	National Research Program for Genomic Medicine, Taiwan(Ministry of Science and Technology, Taiwan); Academy of Finland(Academy of Finland)	This study was supported by the National Research Program for Genomic Medicine, Taiwan (grant no.: DOH97-TD-G-111-032, DOH98-TD-G-111-021, DOH99-TD-G-111-018 and NSC100-2325-B400-010). J.J. was supported by a grant from the Academy of Finland (SALVE Research Program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Bonvallot V, 2001, AM J RESP CELL MOL, V25, P515, DOI 10.1165/ajrcmb.25.4.4515; Chuang CY, 2003, CHEMOSPHERE, V52, P1163, DOI 10.1016/S0045-6535(03)00307-2; Collins A, 1997, ENVIRON MOL MUTAGEN, V30, P139, DOI 10.1002/(SICI)1098-2280(1997)30:2<139::AID-EM6>3.0.CO;2-I; Gonzalez-Flecha Beatriz, 2004, Molecular Aspects of Medicine, V25, P169, DOI 10.1016/j.mam.2004.02.017; Hininger I, 2004, MUTAT RES-GEN TOX EN, V558, P75, DOI 10.1016/j.mrgentox.2003.11.004; Hu CW, 2006, CLIN CHEM, V52, P1381, DOI 10.1373/clinchem.2005.063735; Hwang BF, 2011, ENVIRON HEALTH PERSP, V119, P1345, DOI 10.1289/ehp.1003056; KANG DH, 1995, OCCUP ENVIRON MED, V52, P593, DOI 10.1136/oem.52.9.593; Kim JY, 2004, ENVIRON HEALTH PERSP, V112, P666, DOI 10.1289/ehp.6827; Kure EH, 1996, CARCINOGENESIS, V17, P2201, DOI 10.1093/carcin/17.10.2201; Lai CH, 2004, ARCH ENVIRON HEALTH, V59, P61, DOI 10.3200/AEOH.59.2.61-69; Lai CH, 2005, OCCUP ENVIRON MED, V62, P216, DOI 10.1136/oem.2004.015107; Marczynski B, 2002, CARCINOGENESIS, V23, P273, DOI 10.1093/carcin/23.2.273; Marczynski B, 2009, ARCH TOXICOL, V83, P947, DOI 10.1007/s00204-009-0444-9; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Merlo F, 1998, CANCER EPIDEM BIOMAR, V7, P147; Moller P, 2006, BASIC CLIN PHARMACOL, V98, P336, DOI 10.1111/j.1742-7843.2006.pto_167.x; Nafstad P, 2003, THORAX, V58, P1071, DOI 10.1136/thorax.58.12.1071; On the Health Effects of Traffic-Related Air Pollution H. E. I, 2010, TRAFF REL AIR POLL C; Peng RD, 2009, ENVIRON HEALTH PERSP, V117, P957, DOI 10.1289/ehp.0800185; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Scandalios JG, 2002, GENOME BIOL, V3; Sorensen M, 2003, CANCER EPIDEM BIOMAR, V12, P191; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Strickland P, 1996, ENVIRON HEALTH PERSP, V104, P927, DOI 10.2307/3433012; STRICKLAND PT, 1994, CARCINOGENESIS, V15, P483, DOI 10.1093/carcin/15.3.483; Tovalin H, 2006, OCCUP ENVIRON MED, V63, P230, DOI 10.1136/oem.2005.019802; Tsai PJ, 2004, ENVIRON SCI TECHNOL, V38, P56, DOI 10.1021/es030588k; Tsai PJ, 2001, J OCCUP HEALTH, V43, P118, DOI 10.1539/joh.43.118; TUOMINEN J, 1988, ENVIRON SCI TECHNOL, V22, P1228, DOI 10.1021/es00175a017; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Wei YJ, 2009, ENVIRON SCI TECHNOL, V43, P4757, DOI 10.1021/es803337c; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167	37	37	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37412	10.1371/journal.pone.0037412	http://dx.doi.org/10.1371/journal.pone.0037412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629390	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343100026
J	Venhoff, N; Effelsberg, NM; Salzer, U; Warnatz, K; Peter, HH; Lebrecht, D; Schlesier, M; Voll, RE; Thiel, J				Venhoff, Nils; Effelsberg, Nora M.; Salzer, Ulrich; Warnatz, Klaus; Peter, Hans Hartmut; Lebrecht, Dirk; Schlesier, Michael; Voll, Reinhard E.; Thiel, Jens			Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY 1990 CRITERIA; CHURG-STRAUSS-SYNDROME; WEGENERS-GRANULOMATOSIS; STAPHYLOCOCCUS-AUREUS; LYMPHOCYTE DEPLETION; ARTHRITIS; CLASSIFICATION; DISEASE; IMMUNODEFICIENCY	Objective: To assess the impact of immunosuppressive therapy with cyclophosphamide (CYC) and rituximab (RTX) on serum immunoglobulin (Ig) concentrations and B lymphocyte counts in patients with ANCA-associated vasculitides (AAVs). Methods: Retrospective analysis of Ig concentrations and peripheral B cell counts in 55 AAV patients. Results: CYC treatment resulted in a decrease in Ig levels (median; interquartile range IQR) from IgG 12.8 g/L (8.15-15.45) to 9.17 g/L (8.04-9.90) (p = 0.002), IgM 1.05 g/L (0.70-1.41) to 0.83 g/L (0.60-1.17) (p = 0.046) and IgA 2.58 g/L (1.71-3.48) to 1.58 g/L (1-31-2.39) (p = 0.056) at a median follow-up time of 4 months. IgG remained significantly below the initial value at 14.5 months and 30 months analyses. Subsequent RTX treatment in patients that had previously received CYC resulted in a further decline in Ig levels from pre RTX IgG 9.84 g/L (8.71-11.60) to 7.11 g/L (5.75-8.77; p = 0.007), from pre RTX IgM 0.84 g/L (0.63-1.18) to 0.35 g/L (0.23-0.48; p<0.001) and from pre RTX IgA 2.03 g/L (1.37-2.50) to IgA 1.62 g/L (IQR 0.84-2.43; p = 0.365) 14 months after RTX. Treatment with RTX induced a complete depletion of B cells in all patients. After a median observation time of 20 months median B lymphocyte counts remained severely suppressed (4 B-cells/mu l, 1.25-9.5, p<0.001). Seven patients (21%) that had been treated with CYC followed by RTX were started on Ig replacement because of severe bronchopulmonary infections and serum IgG concentrations below 5 g/L. Conclusions: In patients with AAVs, treatment with CYC leads to a decline in immunoglobulin concentrations. A subsequent RTX therapy aggravates the decline in serum immunoglobulin concentrations and results in a profoundly delayed B cell repopulation. Surveying patients with AAVs post CYC and RTX treatment for serum immunoglobulin concentrations and persisting hypogammaglobulinemia is warranted.	[Venhoff, Nils; Effelsberg, Nora M.; Salzer, Ulrich; Warnatz, Klaus; Peter, Hans Hartmut; Lebrecht, Dirk; Schlesier, Michael; Voll, Reinhard E.; Thiel, Jens] Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Salzer, Ulrich; Warnatz, Klaus; Peter, Hans Hartmut; Schlesier, Michael; Voll, Reinhard E.; Thiel, Jens] Univ Hosp Freiburg, Ctr Chron Immunodeficiency CCI, Freiburg, Germany	University of Freiburg; University of Freiburg	Venhoff, N (corresponding author), Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany.	jens.thiel@uniklinik-freiburg.de	Warnatz, Klaus/AAD-3464-2022	Salzer, Ulrich/0000-0002-1769-1157				Abdulahad WH, 2011, ARTHRITIS RHEUM-US, V63, P1116, DOI 10.1002/art.30236; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; FAUCI AS, 1971, NEW ENGL J MED, V285, P1493, DOI 10.1056/NEJM197112302852701; Gottenberg JE, 2010, ARTHRITIS RHEUM-US, V62, P2625, DOI 10.1002/art.27555; Guerry MJCJ, 2012, RHEUMATOLOGY, V51, P634, DOI 10.1093/rheumatology/ker150; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Holle JU, 2012, ANN RHEUM DIS, V71, P327, DOI 10.1136/ard.2011.153601; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1065; Irie E, 2010, INT J HEMATOL, V91, P501, DOI 10.1007/s12185-010-0528-6; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Jones RB, 2009, ARTHRITIS RHEUM, V60, P2156, DOI 10.1002/art.24637; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kallenberg CGM, 2011, CLIN REV ALLERG IMMU, V41, P224, DOI 10.1007/s12016-011-8258-y; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Krumbholz M, 2005, J AUTOIMMUN, V25, P298, DOI 10.1016/j.jaut.2005.08.004; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Mansfield N, 2011, NEPHROL DIAL TRANSPL, V26, P3280, DOI 10.1093/ndt/gfr127; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Pepper RJ, 2008, RHEUMATOLOGY, V47, P1104, DOI 10.1093/rheumatology/ken175; Popa C, 2007, RHEUMATOLOGY, V46, P626, DOI 10.1093/rheumatology/kel393; Popa ER, 2002, ARTHRITIS RES, V4, P77, DOI 10.1186/ar392; Rees F, 2011, CLIN RHEUMATOL, V30, P1241, DOI 10.1007/s10067-011-1756-8; Roll P, 2006, ARTHRITIS RHEUM-US, V54, P2377, DOI 10.1002/art.22019; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; van Vollenhoven RF, 2010, J RHEUMATOL, V37, P558, DOI 10.3899/jrheum.090856; Walker AR, 2008, CANCER INVEST, V26, P431, DOI 10.1080/07357900701809068; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003	30	97	100	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37626	10.1371/journal.pone.0037626	http://dx.doi.org/10.1371/journal.pone.0037626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629432	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100040
J	Zhou, ZH; Xiong, HY; Jia, R; Yang, GY; Guo, TY; Meng, ZY; Huang, GY; Zhang, Y				Zhou, Zhenhua; Xiong, Hongyan; Jia, Ran; Yang, Guoyu; Guo, Tianyou; Meng, Zhaoyou; Huang, Guangyu; Zhang, Yao			The Risk Behaviors and Mental Health of Detained Adolescents: A Controlled, Prospective Longitudinal Study	PLOS ONE			English	Article							PSYCHOSOCIAL NEEDS; YOUNG OFFENDERS; JUVENILE; DELINQUENCY; DISORDERS; ATTENTION; ALCOHOL; JUSTICE; CRIME; YOUTH	Background: To assess the behavioral risk factors and mental health needs of adolescents in juvenile detention centers (JDC). Method: A total of 238 boys aged 12-17 years was surveyed who had been admitted to a detention center and compared them with boys from the community (n = 238) matched for sex and age. We assessed behavioral risk factors and mental health problems by using the Youth Risk Behavior Survey questionnaire (YRBS) and the Youth Self-Report questionnaire (YSR). Results: Young offenders had significantly higher YRBS scores than controls for drug use (odds ratio (OR) 5.16, 95% CI 2.27-7.84), sexual intercourse (OR, 2.51; 95% CI 1.55-2.90), irregular diet (4.78, 2.11-7.51), suicide attempts (1.96, 1.32-5.85), and physical fighting behavior (3.49, 1.60-7.07), but not for tobacco use, alcohol use, and high-risk cycling. Young offenders at the time of admission (6.61, 2.58-15.2), at 6 months (3.12, 1.81-10.1), and at 12 months (5.29, 1.98-13.3) reported statistically higher levels of total mental health problems than adolescents in a community sample. Conclusions: Young offenders have a high rate of mental and behavioral disorders. In the detention period, aggressive behavior, self-destructive/ identity, and externalizing of problems improved while withdrawn, anxious or depressed, and internalizing of problems worsened.	[Zhou, Zhenhua; Meng, Zhaoyou] Third Mil Med Univ, Southwest Hosp, Dept Neurol, Lab Brain & Cognit Sci, Chongqing, Peoples R China; [Xiong, Hongyan; Jia, Ran; Zhang, Yao] Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing, Peoples R China; [Yang, Guoyu] Third Mil Med Univ, Dept Psychol Med & Psychiat, Chongqing, Peoples R China; [Guo, Tianyou] Shenzhen Univ, Dept Psychol, Shenzhen, Peoples R China; [Huang, Guangyu] Third Mil Med Univ, Southwest Hospital, Inst Infect Dis, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Shenzhen University; Army Medical University	Zhou, ZH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurol, Lab Brain & Cognit Sci, Chongqing, Peoples R China.	sydzy2005@yahoo.com.cn	Zhou, Zhenhua/AID-6326-2022		United Nations Children's Fund; Natural Science Foundation of Chongqing (CSTC) [2009BB5319, 2010BB5190]	United Nations Children's Fund; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	The study was funded by the foreign-aid projects of the United Nations Children's Fund and the Natural Science Foundation of Chongqing (CSTC, 2009BB5319, 2010BB5190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Bailey S, 1996, J ADOLESCENCE, V19, P19, DOI 10.1006/jado.1996.0003; Bennett S, 2005, AGGRESS VIOLENT BEH, V10, P263, DOI 10.1016/j.avb.2004.07.001; Carswell K, 2004, J ADOLESCENCE, V27, P415, DOI 10.1016/j.adolescence.2004.04.003; DEMBO R, 1988, INT J ADDICT, V23, P351, DOI 10.3109/10826088809039203; Dolan M, 1999, J ADOLESCENCE, V22, P137, DOI 10.1006/jado.1998.0206; Douglas N, 2006, HLTH NEEDS ASSESSMEN; Elgar FJ, 2003, CAN J PSYCHIAT, V48, P633, DOI 10.1177/070674370304800911; Forrest CB, 2000, PEDIATRICS, V105, P286; Gao M, 2004, CHIN J SCH HLTH, V25, P143; Grunbaum Jo Anne, 2004, Morbidity and Mortality Weekly Report, V53, P1; Hagell Ann., 1994, PERSISTENT YOUNG OFF; Harrington RC, 2005, J CHILD PSYCHOL PSYC, V46, P859, DOI 10.1111/j.1469-7610.2004.00388.x; JAFFE PG, 1987, CAN J CRIMINOL, V29, P309; Jones Alice P, 2007, Crim Behav Ment Health, V17, P101, DOI 10.1002/cbm.641; Kessler C, 2002, LANCET, V359, P1956, DOI 10.1016/S0140-6736(02)08843-8; KOLBE LJ, 1993, PUBLIC HEALTH REP, V108, P2; Maniadaki Katerina, 2008, Crim Behav Ment Health, V18, P207, DOI 10.1002/cbm.698; Ramsay Michael C, 2002, KAMPHAUS ESSENTIALS; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Rossegger A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-81; Song YH, 2007, CHINESE J DIS CONTRO, V6, P556; STACY AW, 1994, HEALTH PSYCHOL, V13, P73, DOI 10.1037/0278-6133.13.1.73; Staton-Tindall M, 2007, WOMEN HEALTH ISS, V17, P183, DOI 10.1016/j.whi.2007.02.004; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; TimmonsMitchell J, 1997, BEHAV SCI LAW, V15, P195, DOI 10.1002/(SICI)1099-0798(199721)15:2<195::AID-BSL269>3.0.CO;2-8; Verhulst FC, 1997, MANUAL YSR; Vermeiren R, 2003, CLIN PSYCHOL REV, V23, P277, DOI 10.1016/S0272-7358(02)00227-1; Xing Y, 2006, J ADOLESCENT HEALTH, V39, P495, DOI 10.1016/j.jadohealth.2006.03.014; Zhang LN, 2008, CRIME LAW SOCIAL CH, V50, P149, DOI 10.1007/s10611-008-9137-1; Zhang LN, 2008, CRIME LAW SOCIAL CH, V50, P125, DOI 10.1007/s10611-008-9134-4	31	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37199	10.1371/journal.pone.0037199	http://dx.doi.org/10.1371/journal.pone.0037199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22629367	gold, Green Published			2022-12-27	WOS:000305343500071
J	Amselem, G; Theves, M; Bae, A; Bodenschatz, E; Beta, C				Amselem, Gabriel; Theves, Matthias; Bae, Albert; Bodenschatz, Eberhard; Beta, Carsten			A Stochastic Description of Dictyostelium Chemotaxis	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; CELL-MIGRATION; MOTION; DISCOIDEUM; GRADIENTS; MOVEMENT; MODEL; MOTILITY; SYSTEMS; REPAIR	Chemotaxis, the directed motion of a cell toward a chemical source, plays a key role in many essential biological processes. Here, we derive a statistical model that quantitatively describes the chemotactic motion of eukaryotic cells in a chemical gradient. Our model is based on observations of the chemotactic motion of the social ameba Dictyostelium discoideum, a model organism for eukaryotic chemotaxis. A large number of cell trajectories in stationary, linear chemoattractant gradients is measured, using microfluidic tools in combination with automated cell tracking. We describe the directional motion as the interplay between deterministic and stochastic contributions based on a Langevin equation. The functional form of this equation is directly extracted from experimental data by angle-resolved conditional averages. It contains quadratic deterministic damping and multiplicative noise. In the presence of an external gradient, the deterministic part shows a clear angular dependence that takes the form of a force pointing in gradient direction. With increasing gradient steepness, this force passes through a maximum that coincides with maxima in both speed and directionality of the cells. The stochastic part, on the other hand, does not depend on the orientation of the directional cue and remains independent of the gradient magnitude. Numerical simulations of our probabilistic model yield quantitative agreement with the experimental distribution functions. Thus our model captures well the dynamics of chemotactic cells and can serve to quantify differences and similarities of different chemotactic eukaryotes. Finally, on the basis of our model, we can characterize the heterogeneity within a population of chemotactic cells.	[Amselem, Gabriel; Theves, Matthias; Bae, Albert; Bodenschatz, Eberhard; Beta, Carsten] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Amselem, Gabriel] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Theves, Matthias; Beta, Carsten] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Bae, Albert; Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY USA; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, Gottingen, Germany	Max Planck Society; Harvard University; University of Potsdam; Cornell University; University of Gottingen	Amselem, G (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	beta@uni-potsdam.de		Amselem, Gabriel/0000-0003-4563-2899; Bodenschatz, Eberhard/0000-0002-2901-0144	Deutsche Forschungsgemeinschaft (DFG) [BE 3978/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	CB acknowledges financial support by the Deutsche Forschungsgemeinschaft (DFG BE 3978/3-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amselem G, 2010, THESIS U GOTTINGEN; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; Beta C, 2008, LAB CHIP, V8, P1087, DOI 10.1039/b801331d; Beta C, 2011, EUR J CELL BIOL, V90, P811, DOI 10.1016/j.ejcb.2011.05.006; Bodeker HU, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/28005; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Friedrich R, 2000, PHYS LETT A; Furth R, 1920, Z PHYS, V2, P244, DOI 10.1007/BF01328731; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gamba A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02019; Gruver JS, 2008, BIOPHYS J, V95, P4057, DOI 10.1529/biophysj.108.130179; Hu B, 2010, PHYS REV E, P81; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Kam Z, 1998, BIOIMAGING, V6, P166, DOI 10.1002/1361-6374(199812)6:4<166::AID-BIO2>3.0.CO;2-Y; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kloeden P.E., 1992, APPL MATH NEW YORK, V23, pxxxvi+632; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Przibram K, 1913, PFLUG ARCH GES PHYS, V153, P401, DOI 10.1007/BF01686480; Risken H., 1989, FOKKER PLANCK EQUATI, DOI 10.1007/978-3-642-61544-3; Romanczuk P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230601; Schenzle A, 1979, PHYS REV A, P20; SCHIENBEIN M, 1993, B MATH BIOL, V55, P585, DOI 10.1016/S0092-8240(05)80241-1; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Shenderov AD, 1997, BIOPHYS J, V72, P2382, DOI 10.1016/S0006-3495(97)78883-0; Siegert S, 1998, PHYS LETT A, V243, P275, DOI 10.1016/S0375-9601(98)00283-7; Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; STOKES CL, 1991, J CELL SCI, V99, P419; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Weber C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011132; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107	44	44	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37213	10.1371/journal.pone.0037213	http://dx.doi.org/10.1371/journal.pone.0037213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662138	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300029
J	Benz, V; Bloch, M; Wardat, S; Bohm, C; Maurer, L; Mahmoodzadeh, S; Wiedmer, P; Spranger, J; Foryst-Ludwig, A; Kintscher, U				Benz, Verena; Bloch, Mandy; Wardat, Sami; Boehm, Christian; Maurer, Lukas; Mahmoodzadeh, Shokoufeh; Wiedmer, Petra; Spranger, Joachim; Foryst-Ludwig, Anna; Kintscher, Ulrich			Sexual Dimorphic Regulation of Body Weight Dynamics and Adipose Tissue Lipolysis	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIPOPROTEIN-LIPASE; ENERGY-EXPENDITURE; FAT; LEPTIN; EXERCISE; NEURONS; WOMEN; GENE; MEN	Background: Successful reduction of body weight (BW) is often followed by recidivism to obesity. BW-changes including BW-loss and -regain is associated with marked alterations in energy expenditure (EE) and adipose tissue (AT) metabolism. Since these processes are sex-specifically controlled, we investigated sexual dimorphisms in metabolic processes during BW-dynamics (gain-loss-regain). Research Design: Obesity was induced in C57BL/6J male (m) and female (f) mice by 15 weeks high-fat diet (HFD) feeding. Subsequently BW was reduced (-20%) by caloric restriction (CR) followed by adaptive feeding, and a regain-phase. Measurement of EE, body composition, blood/organ sampling were performed after each feeding period. Lipolysis was analyzed ex-vivo in gonadal AT. Results: Male mice exhibited accelerated BW-gain compared to females (relative BW-gain m:140.5 +/- 3.2%; f:103.7 +/- 6.5%; p<0.001). In consonance, lean mass-specific EE was significantly higher in females compared to males during BW-gain. Under CR female mice reached their target-BW significantly faster than male mice (m:12.2 days; f:7.6 days; p<0.001) accompanied by a sustained sex-difference in EE. In addition, female mice predominantly downsized gonadal AT whereas the relation between gonadal and total body fat was not altered in males. Accordingly, only females exhibited an increased rate of forskolin-stimulated lipolysis in AT associated with significantly higher glycerol concentrations, lower RER-values, and increased AT expression of adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL). Analysis of AT lipolysis in estrogen receptor alpha (ER alpha)-deficient mice revealed a reduced lipolytic rate in the absence of ER alpha exclusively in females. Finally, re-feeding caused BW-regain faster in males than in females. Conclusion: The present study shows sex-specific dynamics during BW-gain-loss-regain. Female mice responded to CR with an increase in lipolytic activity, and augmented lipid-oxidation leading to more efficient weight loss. These processes likely involve ER alpha-dependent signaling in AT and sexual dimorphic regulation of genes involved in lipid metabolism.	[Benz, Verena; Bloch, Mandy; Wardat, Sami; Boehm, Christian; Foryst-Ludwig, Anna; Kintscher, Ulrich] Charite, Cardiovasc Res Ctr, Inst Pharmacol, D-13353 Berlin, Germany; [Maurer, Lukas; Spranger, Joachim] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Mahmoodzadeh, Shokoufeh] Charite, Cardiovasc Res Ctr, Inst Gender Med, D-13353 Berlin, Germany; [Wiedmer, Petra] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Benz, V (corresponding author), Charite, Cardiovasc Res Ctr, Inst Pharmacol, D-13353 Berlin, Germany.	ulrich.kintscher@charite.de	Biguzzi, Felipe A/E-4724-2015; Böhm, Christian/HDN-5925-2022	Wiedmer, Petra/0000-0001-7284-7823; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kintscher, Ulrich/0000-0001-7386-0990; Mahmoodzadeh, Shokoufeh/0000-0002-3094-7874; Benz, Verena/0000-0003-2710-3803	Deusche Forschungsgemeinschaft [DFG-KFO 218/1]	Deusche Forschungsgemeinschaft	This study was supported by the Deusche Forschungsgemeinschaft (DFG-KFO 218/1) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2001, DIABETES OBES METAB, V3, P338, DOI 10.1046/j.1463-1326.2001.00145.x; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Foryst-Ludwig A, 2011, AM J PHYSIOL-HEART C, V301, pH115, DOI 10.1152/ajpheart.01222.2010; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Geldszus R, 1996, EUR J ENDOCRINOL, V135, P659, DOI 10.1530/eje.0.1350659; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Homma H, 2000, J BIOL CHEM, V275, P11404, DOI 10.1074/jbc.275.15.11404; Horton TJ, 2009, J APPL PHYSIOL, V107, P200, DOI 10.1152/japplphysiol.90812.2008; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEIBEL RL, 1984, METABOLISM, V33, P164, DOI 10.1016/0026-0495(84)90130-6; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Maher AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012025; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Shi HF, 2007, AM J PHYSIOL-ENDOC M, V293, pE316, DOI 10.1152/ajpendo.00710.2006; Shi HF, 2009, OBESITY, V17, P1702, DOI 10.1038/oby.2009.106; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Toth MJ, 2000, ANN NY ACAD SCI, V904, P502; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	35	47	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37794	10.1371/journal.pone.0037794	http://dx.doi.org/10.1371/journal.pone.0037794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662224	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305342300114
J	Cai, YC; Lu, SN; Li, CY				Cai, Yong-Chun; Lu, Shena; Li, Chao-Yi			Interactions between Surround Suppression and Interocular Suppression in Human Vision	PLOS ONE			English	Article							CROSS-ORIENTATION SUPPRESSION; CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; 2 DISTINCT MECHANISMS; SPATIAL INTERACTIONS; PERCEIVED CONTRAST; INHIBITION; ATTENTION; FREQUENCIES; INTEGRATION	Several types of suppression phenomena have been observed in the visual system. For example, the ability to detect a target stimulus is often impaired when the target is embedded in a high-contrast surround. This contextual modulation, known as surround suppression, was formerly thought to occur only in the periphery. Another type of suppression phenomena is interocular suppression, in which the sensitivity to a monocular target is reduced by a superimposed mask in the opposite eye. Here, we explored how the two types of suppression operating across different spatial regions interact with one another when they simultaneously exert suppressive influences on a common target presented at the fovea. In our experiments, a circular target grating presented to the fovea of one eye was suppressed interocularly by a noise pattern of the same size in the other eye. The foveal stimuli were either shown alone or surrounded by a monocular annular grating. The orientation and eye-of-origin of the surround grating were varied. We found that the detection of the foveal target subjected to interocular suppression was severely impaired by the addition of the surround grating, indicating strong surround suppression in the fovea. In contrast, when the interocular suppression was released by superimposing a binocular fusion ring onto both the target and the dichoptic mask, the surround suppression effect was found to be dramatically decreased. In addition, the surround suppression was found to depend on the contrast of the dichoptic noise with the greatest surround suppression effect being obtained only when the noise contrast was at an intermediate level. These findings indicate that surround suppression and interocular suppression are not independent of each other, but there are strong interactions between them. Moreover, our results suggest that strong surround suppression may also occur at the fovea and not just the periphery.	[Cai, Yong-Chun; Lu, Shena] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Yong-Chun; Li, Chao-Yi] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Ctr Life Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Zhejiang University; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, YC (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yccai@zju.edu.cn			Natural Science Foundations of China [31100731, 60972108, 30900390, 90820301, 60835005]; Zhejiang Provincial Natural Science Foundation of China [Y2090524]; Zhejiang Province Education Department [Y201122208]	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Province Education Department	This research was supported by the Natural Science Foundations of China (31100731 and 60972108 to YC, 30900390 to SL, 90820301 and 60835005 to CL, website: http://www.nsfc.gov.cn), Zhejiang Provincial Natural Science Foundation of China (Y2090524 to SL, website: http://www.zjnsf.gov.cn), and Zhejiang Province Education Department (Y201122208 to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht D.C., 2003, VISUAL NEUROSCIENCES, P747; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Baker DH, 2007, NEUROSCIENCE, V146, P435, DOI 10.1016/j.neuroscience.2007.01.030; Baker DH, 2008, J VISION, V8, DOI 10.1167/8.4.26; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cai YC, 2008, J VISION, V8, DOI 10.1167/8.9.9; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEWEERT CMM, 1988, VISION RES, V28, P1031, DOI 10.1016/0042-6989(88)90080-6; Durand S, 2007, VISUAL NEUROSCI, V24, P679, DOI 10.1017/S0952523807070563; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; FUKUDA H, 1992, J EXP PSYCHOL HUMAN, V18, P362, DOI 10.1037/0096-1523.18.2.362; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; KOOI FL, 1993, DISPLAYS, V14, P11, DOI 10.1016/0141-9382(93)90004-O; LEGGE GE, 1979, J OPT SOC AM, V69, P838, DOI 10.1364/JOSA.69.000838; Li BW, 2005, J NEUROPHYSIOL, V94, P1645, DOI 10.1152/jn.00203.2005; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Meese TS, 2009, VISION RES, V49, P2927, DOI 10.1016/j.visres.2009.09.006; Meese TS, 2005, VISION RES, V45, P9, DOI 10.1016/j.visres.2004.08.004; Meese TS, 2004, J VISION, V4, P843, DOI 10.1167/4.10.2; Meier Lorenz, 2002, J Vis, V2, P293, DOI 10.1167/2.4.2; Murakami I, 1996, VISION RES, V36, P3629, DOI 10.1016/0042-6989(96)00094-6; Paffen CLE, 2006, VISION RES, V46, P599, DOI 10.1016/j.visres.2005.05.013; Paffen CLE, 2005, VISION RES, V45, P2642, DOI 10.1016/j.visres.2005.04.018; Paffen CLE, 2005, J VISION, V5, P571, DOI 10.1167/5.6.8; Paffen CLE, 2004, VISION RES, V44, P1635, DOI 10.1016/j.visres.2004.02.007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Petrov Y, 2006, J VISION, V6, P224, DOI 10.1167/6.3.4; Petrov Y, 2009, J VISION, V9, DOI 10.1167/9.1.21; Roberts MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3742, DOI 10.2741/2963; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Sengpiel F, 2005, J NEUROSCI, V25, P6394, DOI 10.1523/JNEUROSCI.0862-05.2005; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Takeuchi T, 2000, VISION RES, V40, P2697, DOI 10.1016/S0042-6989(00)00129-2; Walker GA, 1998, J NEUROPHYSIOL, V79, P227, DOI 10.1152/jn.1998.79.1.227; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Webb BS, 2005, J NEUROSCI, V25, P11666, DOI 10.1523/JNEUROSCI.3414-05.2005; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Zenger B, 2000, VISION RES, V40, P3717, DOI 10.1016/S0042-6989(00)00218-2	49	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38093	10.1371/journal.pone.0038093	http://dx.doi.org/10.1371/journal.pone.0038093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662270	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300162
J	Egeblad, L; Welin, M; Flodin, S; Graslund, S; Wang, LY; Balzarini, J; Eriksson, S; Nordlund, P				Egeblad, Louise; Welin, Martin; Flodin, Susanne; Graslund, Susanne; Wang, Liya; Balzarini, Jan; Eriksson, Staffan; Nordlund, Par			Pan-Pathway Based Interaction Profiling of FDA-Approved Nucleoside and Nucleobase Analogs with Enzymes of the Human Nucleotide Metabolism	PLOS ONE			English	Article							URIDINE PHOSPHORYLASE; GUANINE; BENZYLACYCLOURIDINE; PURIFICATION; SPECIFICITY; STABILITY; DEAMINASE; EVOLUTION; DISCOVERY; PROTEINS	To identify interactions a nucleoside analog library (NAL) consisting of 45 FDA-approved nucleoside analogs was screened against 23 enzymes of the human nucleotide metabolism using a thermal shift assay. The method was validated with deoxycytidine kinase; eight interactions known from the literature were detected and five additional interactions were revealed after the addition of ATP, the second substrate. The NAL screening gave relatively few significant hits, supporting a low rate of "off target effects." However, unexpected ligands were identified for two catabolic enzymes guanine deaminase (GDA) and uridine phosphorylase 1 (UPP1). An acyclic guanosine prodrug analog, valaciclovir, was shown to stabilize GDA to the same degree as the natural substrate, guanine, with a Delta T-agg around 7 degrees C. Aciclovir, penciclovir, ganciclovir, thioguanine and mercaptopurine were also identified as ligands for GDA. The crystal structure of GDA with valaciclovir bound in the active site was determined, revealing the binding of the long unbranched chain of valaciclovir in the active site of the enzyme. Several ligands were identified for UPP1: vidarabine, an antiviral nucleoside analog, as well as trifluridine, idoxuridine, floxuridine, zidovudine, telbivudine, fluorouracil and thioguanine caused concentration-dependent stabilization of UPP1. A kinetic study of UPP1 with vidarabine revealed that vidarabine was a mixed-type competitive inhibitor with the natural substrate uridine. The unexpected ligands identified for UPP1 and GDA imply further metabolic consequences for these nucleoside analogs, which could also serve as a starting point for future drug design.	[Egeblad, Louise; Wang, Liya; Eriksson, Staffan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Welin, Martin; Flodin, Susanne; Graslund, Susanne; Nordlund, Par] Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, Stockholm, Sweden; [Balzarini, Jan] Catholic Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium; [Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Nordlund, Par] Nanyang Technol Univ, Ctr Biomed Struct Biol, Sch Biol Sci, Singapore, Singapore	Swedish University of Agricultural Sciences; Karolinska Institutet; KU Leuven; Universite Catholique Louvain; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Egeblad, L (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	Staffan.Eriksson@slu.se	Gräslund, Susanne/ABB-6339-2020	Graslund, Susanne/0000-0003-0077-8333	Swedish Research Council; Swedish Cancer Society; KU Leuven [GOA 10/14]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); KU Leuven(KU Leuven); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Society and the KU Leuven (GOA 10/14). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beausejour CM, 2002, BIOCHEM BIOPH RES CO, V293, P1478, DOI 10.1016/S0006-291X(02)00413-8; BERGSTROM JD, 1979, ARCH BIOCHEM BIOPHYS, V194, P107, DOI 10.1016/0003-9861(79)90600-3; CALABRESI P, 1990, BLOOD, V76, P2210; Cao DL, 2002, CANCER RES, V62, P2313; De Clercq E, 2006, BRIT J PHARMACOL, V147, P1, DOI 10.1038/sj.bjp.0706446; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez JR, 2010, BIOORGAN MED CHEM, V18, P6748, DOI 10.1016/j.bmc.2010.07.054; Fernandez JR, 2009, J MOL EVOL, V68, P227, DOI 10.1007/s00239-009-9205-x; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; FRIEDMAN MA, 1978, CANCER CHEMOTH PHARM, V1, P77; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kubo K, 2006, J MED INVESTIG, V53, P264, DOI 10.2152/jmi.53.264; Matsunaga Hiroko, 2003, Journal of Medical Investigation, V50, P64; Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Peters Godefridus J., 2006, P1; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637; Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004; ROSSI CA, 1978, BIOCHIM BIOPHYS ACTA, V526, P235, DOI 10.1016/0005-2744(78)90308-X; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Usova EV, 1997, EUR J BIOCHEM, V248, P762, DOI 10.1111/j.1432-1033.1997.t01-2-00762.x; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vedadi M, 2010, J STRUCT BIOL, V172, P107, DOI 10.1016/j.jsb.2010.05.005; Welin M, 2010, BIOCHEM BIOPH RES CO, V396, P157, DOI 10.1016/j.bbrc.2010.04.054; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	41	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37724	10.1371/journal.pone.0037724	http://dx.doi.org/10.1371/journal.pone.0037724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662200	Green Published, gold			2022-12-27	WOS:000305342300090
J	Gidlof, O; Smith, JG; Melander, O; Lovkvist, H; Hedblad, B; Engstrom, G; Nilsson, P; Carlson, J; Berglund, G; Olsson, S; Jood, K; Jern, C; Norrving, B; Lindgren, A; Erlinge, D				Gidlof, Olof; Smith, J. Gustav; Melander, Olle; Lovkvist, Hakan; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Carlson, Joyce; Berglund, Goran; Olsson, Sandra; Jood, Katarina; Jern, Christina; Norrving, Bo; Lindgren, Arne; Erlinge, David			A Common Missense Variant in the ATP Receptor P2X7 Is Associated with Reduced Risk of Cardiovascular Events	PLOS ONE			English	Article							GAIN-OF-FUNCTION; HUMAN P2X(7) RECEPTOR; GENETIC ASSOCIATION; ISCHEMIC-STROKE; BLOOD-PRESSURE; POLYMORPHISM; DISEASE; LYMPHOCYTES; ATHEROSCLEROSIS; SUSCEPTIBILITY	Background and Purpose: Extracellular adenosine triphosphate (ATP) regulates inflammatory cells by activation of the P2X(7) receptor. We hypothesized that polymorphisms in P2RX7 influence the risk of ischemic heart disease (IHD), ischemic stroke (IS) and cardiovascular risk factors and tested this hypothesis using genetic association studies. Methods: Two loss-of-function SNPs in P2RX7 were genotyped in 1244 IHD cases and 2488 controls as well as 5969 individuals with cardiovascular risk factors. Eleven SNPs in a 250 kb region on chromosome 12 spanning P2RX7 as well as neighboring genes OASL, P2RX4 and CAMKK2 were genotyped in 4138 individuals with IS and 2528 controls. Association was examined using linear and logistic regression models with an additive genetic model. Results: The common loss-of-function variant rs3751143 was significantly associated with a decreased risk of IHD in smokers (P = 0.03) as well as decreased risk of IS (OR 0.89; 95% CI = 0.81-0.97; P = 0.012). In addition, an intronic SNP in CAMKK2, rs2686342, were associated with a decreased risk of IS (OR 0.89; 95% CI = 0.82-0.97; P = 0.011). In subgroup analyses, both SNPs were associated with decreased risk of IS in individuals with hypertension (P = 0.045 and 0.015, respectively). Conclusions: A common loss-of-function missense variant in the gene encoding the P2X7 receptor is associated with reduced risk of IS and with IHD in smokers. These findings might implicate a role of purinergic signaling in atherogenesis or atherothrombosis.	[Gidlof, Olof; Smith, J. Gustav; Lovkvist, Hakan; Norrving, Bo; Lindgren, Arne; Erlinge, David] Lund Univ, Dept Clin Sci, Lund, Sweden; [Carlson, Joyce] Lund Univ, Dept Lab Sci, Lund, Sweden; [Smith, J. Gustav; Melander, Olle; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Berglund, Goran] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Norrving, Bo; Lindgren, Arne] Skane Univ Hosp Lund, Dept Neurol, Lund, Sweden; [Olsson, Sandra; Jood, Katarina; Jern, Christina] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; University of Gothenburg	Gidlof, O (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	olof.gidlof@med.lu.se	Olsson, Sandra/L-5964-2013	Gidlof, Olof/0000-0002-7402-3139; Norrving, Bo/0000-0002-8024-5096; Melander, Olle/0000-0002-2581-484X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engstrom, Gunnar/0000-0002-8618-9152	Swedish Heart and Lung Foundation; Swedish Research Council; Vascular Wall Program; Swedish Stroke Association; Craaford Foundation; Lund University; Swedish state (ALF); Freemasons Lodge of Instruction EOS in Lund; Yngve Land foundation for Neurological Research; Gothenburg Foundation for Neurological Research	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vascular Wall Program; Swedish Stroke Association; Craaford Foundation; Lund University; Swedish state (ALF); Freemasons Lodge of Instruction EOS in Lund; Yngve Land foundation for Neurological Research; Gothenburg Foundation for Neurological Research	The study was supported by the Swedish Heart and Lung Foundation, the Swedish Research Council, the Vascular Wall Program, the Swedish Stroke Association, the Craaford Foundation, Lund University, the Swedish state (ALF), Freemasons Lodge of Instruction EOS in Lund, the Yngve Land foundation for Neurological Research and the Gothenburg Foundation for Neurological Research. DE holds the Lars Werko Distinguished Research Fellowship from the Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; BOTHIG S, 1989, INT J EPIDEMIOL, V18, pS29; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Dichgans M, 2005, STROKE, V36, P2027, DOI 10.1161/01.STR.0000177498.21594.9e; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hakim TS, 1997, J APPL PHYSIOL, V82, P852, DOI 10.1152/jappl.1997.82.3.852; Hallstrom B, 2007, ACTA NEUROL SCAND, V115, P49, DOI 10.1111/j.1600-0404.2006.00738.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kawamura H, 2005, J IMMUNOL, V174, P1971, DOI 10.4049/jimmunol.174.4.1971; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Oyanguren-Desez O, 2011, CELL CALCIUM, V50, P468, DOI 10.1016/j.ceca.2011.08.002; Palomino-Doza J, 2008, HYPERTENSION, V52, P980, DOI 10.1161/HYPERTENSIONAHA.108.113282; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Smith JG, 2009, CIRC-CARDIOVASC GENE, V2, P159, DOI 10.1161/CIRCGENETICS.108.835173; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	32	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37491	10.1371/journal.pone.0037491	http://dx.doi.org/10.1371/journal.pone.0037491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662160	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300050
J	Krasnoslobodtsev, AV; Peng, J; Asiago, JM; Hindupur, J; Rochet, JC; Lyubchenko, YL				Krasnoslobodtsev, Alexey V.; Peng, Jie; Asiago, Josephat M.; Hindupur, Jagadish; Rochet, Jean-Christophe; Lyubchenko, Yuri L.			Effect of Spermidine on Misfolding and Interactions of Alpha-Synuclein	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; IN-VITRO; TERMINAL REGION; AGGREGATION; PROTEIN; CONFORMATION; SPECTROSCOPY	Alpha-synuclein (alpha-Syn) is a 140 aa presynaptic protein which belongs to a group of natively unfolded proteins that are unstructured in aqueous solutions. The aggregation rate of alpha-Syn is accelerated in the presence of physiological levels of cellular polyamines. Here we applied single molecule AFM force spectroscopy to characterize the effect of spermidine on the very first stages of alpha-Syn aggregation - misfolding and assembly into dimers. Two alpha-Syn variants, the wild-type (WT) protein and A30P, were studied. The two protein molecules were covalently immobilized at the C-terminus, one at the AFM tip and the other on the substrate, and intermolecular interactions between the two molecules were measured by multiple approach-retraction cycles. At conditions close to physiological ones at which alpha-Syn misfolding is a rare event, the addition of spermidine leads to a dramatic increase in the propensity of the WT and mutant proteins to misfold. Importantly, misfolding is characterized by a set of conformations, and A30P changes the misfolding pattern as well as the strength of the intermolecular interactions. Together with the fact that spermidine facilitates late stages of alpha-Syn aggregation, our data demonstrate that spermidine promotes the very early stages of protein aggregation including alpha-Syn misfolding and dimerization. This finding suggests that increased levels of spermidine and potentially other polyamines can initiate the disease-related process of alpha-Syn.	[Krasnoslobodtsev, Alexey V.; Peng, Jie; Lyubchenko, Yuri L.] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68182 USA; [Peng, Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Asiago, Josephat M.; Hindupur, Jagadish; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	University of Nebraska System; University of Nebraska Medical Center; Shanghai Jiao Tong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Krasnoslobodtsev, AV (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68182 USA.	ylyubchenko@unmc.edu	Krasnoslobodtsev, Alexey/AAC-8536-2020	Peng, Jie/0000-0002-4748-3682; Rochet, Jean-Christophe/0000-0002-6484-1541	National Institutes of Health [1P01GM091743-01A1, 1 R01 GM096039-01A1]; U.S. Department of Energy [DE-FG02-08ER64579]; Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096039, P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by grants from National Institutes of Health Grants (1P01GM091743-01A1 and 1 R01 GM096039-01A1), U.S. Department of Energy Grant DE-FG02-08ER64579, and the Nebraska Research Initiative grant to YLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Grabenauer M, 2008, J PHYS CHEM B, V112, P11147, DOI 10.1021/jp801175w; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Kransnoslobodtsev AV, 2005, NANOMED-NANOTECHNOL, V1, P300, DOI 10.1016/j.nano.2005.10.005; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Losasso V, 2011, BIOCHEMISTRY-US, V50, P6994, DOI 10.1021/bi2007564; Lu Y, 2011, ACS CHEM NEUROSCI, V2, P667, DOI 10.1021/cn200074d; Lyubchenko YL, 2010, WIRES NANOMED NANOBI, V2, P526, DOI 10.1002/wnan.102; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yu JP, 2011, NANOMED-NANOTECHNOL, V7, P146, DOI 10.1016/j.nano.2010.08.001; Yu JP, 2009, J NEUROIMMUNE PHARM, V4, P10, DOI 10.1007/s11481-008-9115-5; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	47	40	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e38099	10.1371/journal.pone.0038099	http://dx.doi.org/10.1371/journal.pone.0038099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662273	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300165
J	Posnien, N; Hopfen, C; Hilbrant, M; Ramos-Womack, M; Murat, S; Schoenauer, A; Herbert, SL; Nunes, MDS; Arif, S; Breuker, CJ; Schlotterer, C; Mitteroecker, P; McGregor, AP				Posnien, Nico; Hopfen, Corinna; Hilbrant, Maarten; Ramos-Womack, Margarita; Murat, Sophie; Schoenauer, Anna; Herbert, Samantha L.; Nunes, Maria D. S.; Arif, Saad; Breuker, Casper J.; Schloetterer, Christian; Mitteroecker, Philipp; McGregor, Alistair P.			Evolution of Eye Morphology and Rhodopsin Expression in the Drosophila melanogaster Species Subgroup	PLOS ONE			English	Article							R8 PHOTORECEPTOR CELLS; COMPOUND EYES; OPSIN GENE; QUANTITATIVE GENETICS; MARGINAL OMMATIDIA; VISUAL-ACUITY; BODY PARTS; HEAD SHAPE; INSECTS; FLY	A striking diversity of compound eye size and shape has evolved among insects. The number of ommatidia and their size are major determinants of the visual sensitivity and acuity of the compound eye. Each ommatidium is composed of eight photoreceptor cells that facilitate the discrimination of different colours via the expression of various light sensitive Rhodopsin proteins. It follows that variation in eye size, shape, and opsin composition is likely to directly influence vision. We analyzed variation in these three traits in D. melanogaster, D. simulans and D. mauritiana. We show that D. mauritiana generally has larger eyes than its sibling species, which is due to a combination of larger ommatidia and more ommatidia. In addition, intra- and inter-specific differences in eye size among D. simulans and D. melanogaster strains are mainly caused by variation in ommatidia number. By applying a geometric morphometrics approach to assess whether the formation of larger eyes influences other parts of the head capsule, we found that an increase in eye size is associated with a reduction in the adjacent face cuticle. Our shape analysis also demonstrates that D. mauritiana eyes are specifically enlarged in the dorsal region. Intriguingly, this dorsal enlargement is associated with enhanced expression of rhodopsin 3 in D. mauritiana. In summary, our data suggests that the morphology and functional properties of the compound eyes vary considerably within and among these closely related Drosophila species and may be part of coordinated morphological changes affecting the head capsule.	[Posnien, Nico; Hilbrant, Maarten; Murat, Sophie; Nunes, Maria D. S.; Arif, Saad; Breuker, Casper J.; McGregor, Alistair P.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Posnien, Nico; Hopfen, Corinna; Murat, Sophie; Schoenauer, Anna; Nunes, Maria D. S.; Arif, Saad; Schloetterer, Christian; McGregor, Alistair P.] Vet Med Univ Wien, Inst Populat Genet, Vienna, Austria; [Ramos-Womack, Margarita] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Ramos-Womack, Margarita] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Herbert, Samantha L.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Mitteroecker, Philipp] Univ Vienna, Dept Theoret Biol, Vienna, Austria	Oxford Brookes University; University of Veterinary Medicine Vienna; Howard Hughes Medical Institute; Princeton University; Princeton University; Fundacao Champalimaud; University of Vienna	Posnien, N (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England.	philipp.mitteroecker@univie.ac.at; amcgregor@brookes.ac.uk	Breuker, Casper/N-6582-2013; Schlötterer, Christian/Q-5264-2019; Santos Nunes, Maria Daniela/A-4480-2013; Breuker, Casper/P-8270-2019; Schlötterer, Christian/G-6326-2010; Posnien, Nico/D-1639-2012; Mitteroecker, Philipp/A-1591-2012	Breuker, Casper/0000-0001-7909-1950; Schlötterer, Christian/0000-0003-4710-6526; Santos Nunes, Maria Daniela/0000-0003-2178-4628; Breuker, Casper/0000-0001-7909-1950; Schlötterer, Christian/0000-0003-4710-6526; Posnien, Nico/0000-0003-0700-5595; Mitteroecker, Philipp/0000-0002-5308-3837; McGregor, Alistair/0000-0002-2908-2420; , Samantha/0000-0002-1024-467X	ERC Starting Independent Investigator grant; Volkswagenstiftung fellowship	ERC Starting Independent Investigator grant; Volkswagenstiftung fellowship	This work was funded by an ERC Starting Independent Investigator grant to APM, and by a Volkswagenstiftung fellowship to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; BARLOW HB, 1952, J EXP BIOL, V29, P667; Bonduriansky R, 2003, EVOLUTION, V57, P2046, DOI 10.1111/j.0014-3820.2003.tb00384.x; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; Carleton KL, 2011, METHODS MOL BIOL, V772, P279, DOI 10.1007/978-1-61779-228-1_17; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; CAVICCHI S, 1989, J EVOLUTION BIOL, V2, P235, DOI 10.1046/j.1420-9101.1989.2040235.x; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P139, DOI 10.1002/ajpa.1330590204; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2001, SEMIN CELL DEV BIOL, V12, P509, DOI 10.1006/scdb.2001.0275; COWLEY DE, 1988, GENETICS, V119, P421; COWLEY DE, 1990, AM NAT, V135, P242, DOI 10.1086/285041; DEVRIES H, 1956, PROG BIOPHYS MOL BIO, V6, P208, DOI 10.1016/S0096-4174(18)30108-2; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Elzinga R. J., 2003, FUNDAMENTALS ENTOMOL; Emery Patrick, 2007, Methods Mol Biol, V362, P375; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Evans JM, 2008, J EXP BIOL, V211, P890, DOI 10.1242/jeb.014837; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Gonzalez-Bellido PT, 2011, P NATL ACAD SCI USA, V108, P4224, DOI 10.1073/pnas.1014438108; Good P, 2000, PERMUTATION TESTS PR; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Hammerle B, 2003, EVOL DEV, V5, P221, DOI 10.1046/j.1525-142X.2003.03030.x; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; Hofmann CM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000266; HORRIDGE GA, 1978, PHILOS T R SOC B, V285, P1, DOI 10.1098/rstb.1978.0093; HORRIDGE GA, 1978, PROC R SOC SER B-BIO, V200, P137, DOI 10.1098/rspb.1978.0011; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Huxley JS, 1924, NATURE, V114, P895, DOI 10.1038/114895a0; JANDER U, 1994, INT J INSECT MORPHOL, V23, P329, DOI 10.1016/0020-7322(94)90029-9; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; Kacmarczyk Thadeous, 2000, Drosophila Information Service, V83, P144; Kirschfeld K., 1976, P354; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1976, Z NATURFORSCH C, V31, P764, DOI 10.1515/znc-1976-11-1231; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Mallock A., 1894, Proceedings of the Royal Society London, Vlv, P85; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MONTELL C, 1987, J NEUROSCI, V7, P1558; MORATA G, 1979, DEV BIOL, V70, P355, DOI 10.1016/0012-1606(79)90033-2; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; Nilsson EE, 2000, J NEUROGENET, V13, P213, DOI 10.3109/01677060009084495; Norry FM, 2000, HEREDITY, V85, P177, DOI 10.1046/j.1365-2540.2000.00735.x; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; R Core Team, 2018, R LANG ENV STAT COMP; Rohlf F.J., 2006, TPSDIG2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rutowski RL, 2009, ARTHROPOD STRUCT DEV, V38, P91, DOI 10.1016/j.asd.2008.08.003; Schmitt A, 2005, J EXP BIOL, V208, P1247, DOI 10.1242/jeb.01527; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Snodgrass RE, 1935, PRINCIPLES INSECT MO; SNYDER AW, 1977, J COMP PHYSIOL, V116, P161, DOI 10.1007/BF00605401; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Stern DL, 1999, DEVELOPMENT, V126, P1091; Sukontason KL, 2008, PARASITOL RES, V103, P123, DOI 10.1007/s00436-008-0939-y; Tan SJ, 2005, CURR BIOL, V15, pR540, DOI 10.1016/j.cub.2005.07.019; Vasiliauskas D, 2011, NATURE; WADA S, 1974, Z MORPHOL TIERE, V77, P87, DOI 10.1007/BF00374212; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wernet MF, 2004, TRENDS CELL BIOL, V14, P576, DOI 10.1016/j.tcb.2004.09.007; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wolff Tanya, 1993, P1277; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	85	36	36	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37346	10.1371/journal.pone.0037346	http://dx.doi.org/10.1371/journal.pone.0037346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662147	Green Published, gold, Green Submitted			2022-12-27	WOS:000305342300036
J	Sau, A; Misra, AK				Sau, Abhijit; Misra, Anup Kumar			Synthesis of the Tetrasaccharide Motif and Its Structural Analog Corresponding to the Lipopolysaccharide of Escherichia coli O75	PLOS ONE			English	Article							PROMOTED REACTIONS; O-POLYSACCHARIDE; REPEATING UNIT; GLYCOSIDES; OLIGOSACCHARIDE; TRISACCHARIDE; RESISTANT; ANTIGEN	Background: Extraintestinal pathogenic E. coli are mostly responsible for a diverse spectrum of invasive human and animal infections leading to the urinary tract infections. Bacterial lipopolysaccharides are responsible for their pathogenicity and their interactions with host immune responses. In spite of several breakthroughs in the development of therapeutics to combat urinary tract infections and related diseases, the emergence of multidrug-resistant bacterial strains is a serious concern. Lipopolysaccharides are attractive targets for the development of long-term therapeutic agents to eradicate the infections. Since the natural sources cannot provide the required amount of oligosaccharides, development of chemical synthetic strategies for their synthesis is relevant to gain access to a reservoir of oligosaccharides and their close analogs. Methodology: Two tetrasaccharide derivatives were synthesized from a single disaccharide intermediate. beta-D-mannoside moiety was prepared from beta-D-glucoside moiety following oxidation-reduction methodology. A [2+2] stereoselective block glycosylation strategy has been adopted for the preparation of tetrasaccharide derivative. alpha-D-Glucosamine moiety was prepared from alpha-D-mannosidic moiety following triflate formation at C-2 and S-N(2) substitution. A one-pot iterative glycosylation exploiting the orthogonal property of thioglycoside was carried out during the synthesis of tetrasaccharide analog. Results: Synthesis of the tetrasaccharide motif (1) and its structural analog (2) corresponding to the lipopolysaccharide of Escherichia coli O75 was successfully achieved in excellent yield. Most of the reactions are clean and high yielding. Both compounds 1 and 2 were synthesized as their 4-methoxyphenyl glycoside, which can act as a temporary anomeric protecting group for further use of these tetrasaccharides in the preparation of glycoconjugates.	[Sau, Abhijit; Misra, Anup Kumar] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sau, A (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	akmisra69@gmail.com		Sau, Abhijit/0000-0002-9870-7420	Department of Science and Technology (DST), New Delhi [SR/S1/OC-83/2010]; Bose Institute, Kolkata; CSIR, New Delhi	Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India)); Bose Institute, Kolkata(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology (DST), New Delhi (Project No. SR/S1/OC-83/2010) and the Bose Institute, Kolkata. AS thanks CSIR, New Delhi, for providing a Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bergonzi MC, 1998, CARBOHYD RES, V311, P231, DOI 10.1016/S0008-6215(98)00211-0; BOCK K, 1974, J CHEM SOC PERK T 2, P293, DOI 10.1039/p29740000293; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]; Caracciolo A, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-3; Chang SL, 2006, PEDIATR CLIN N AM, V53, P379, DOI 10.1016/j.pcl.2006.02.011; CHARETTE AB, 1994, J CARBOHYD CHEM, V13, P421, DOI 10.1080/07328309408009203; Crich D, 2002, J ORG CHEM, V67, P4640, DOI 10.1021/jo0108818; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; EIS MJ, 1988, CARBOHYD RES, V176, P316, DOI 10.1016/0008-6215(88)80144-7; Eom JS, 2002, MICROB DRUG RESIST, V8, P227, DOI 10.1089/107662902760326959; ERBING C, 1978, CARBOHYD RES, V60, P400, DOI 10.1016/S0008-6215(78)80049-4; Gotze S, 2009, SYNLETT, P3346, DOI 10.1055/s-0029-1218356; Goluszko P, 1997, J CLIN INVEST, V99, P1662, DOI 10.1172/JCI119329; Hellerstein S, 2006, CURR OPIN PEDIATR, V18, P134, DOI 10.1097/01.mop.0000193271.09001.a3; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Karlowsky JA, 2006, ANTIMICROB AGENTS CH, V50, P2251, DOI 10.1128/AAC.00123-06; Kebira A. N., 2009, Journal of Applied Biosciences, V22, P1320; KONRADSSON P, 1990, TETRAHEDRON LETT, V31, P4313, DOI 10.1016/S0040-4039(00)97609-3; Madhusudan SK, 2005, CARBOHYD RES, V340, P1373, DOI 10.1016/j.carres.2005.03.007; MISRA AK, 1995, CARBOHYD RES, V278, P103; Misra AK, 1997, INDIAN J CHEM B, V36, P308; MOOTOO DR, 1989, TETRAHEDRON LETT, V30, P2363, DOI 10.1016/S0040-4039(01)80399-3; MOOTOO DR, 1988, J AM CHEM SOC, V110, P5583, DOI 10.1021/ja00224a060; Nimmich W, 1997, J CLIN MICROBIOL, V35, P1112, DOI 10.1128/JCM.35.5.1112-1117.1997; NOWICKI B, 1988, AM J PATHOL, V133, P1; Nowicki Bogdan J., 1996, P341; OGAWA T, 1981, CARBOHYD RES, V93, pC1, DOI 10.1016/S0008-6215(00)80764-8; Pandey S, 2009, SYNTHESIS-STUTTGART, P2584, DOI 10.1055/s-0029-1217401; PEARLMAN WM, 1967, TETRAHEDRON LETT, P1663; Pozsgay V, 2008, CURR TOP MED CHEM, V8, P126, DOI 10.2174/156802608783378864; RAY AK, 1990, CARBOHYD RES, V197, P93, DOI 10.1016/0008-6215(90)84132-E; Roy Rene, 2004, Drug Discov Today Technol, V1, P327, DOI 10.1016/j.ddtec.2004.10.005; Sau A, 2012, CARBOHYD RES, V352, P18, DOI 10.1016/j.carres.2012.01.026; Schmidt RR, 1982, ANGEW CHEM, V94, P790; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; VEENEMAN GH, 1990, TETRAHEDRON LETT, V31, P1331, DOI 10.1016/S0040-4039(00)88799-7; Warren John W., 1996, P3	37	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37291	10.1371/journal.pone.0037291	http://dx.doi.org/10.1371/journal.pone.0037291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662142	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300032
J	Verbeek, E; Oliver, MH; Waas, JR; McLeay, LM; Blache, D; Matthews, LR				Verbeek, Else; Oliver, Mark Hope; Waas, Joseph Rupert; McLeay, Lance Maxwell; Blache, Dominique; Matthews, Lindsay Ross			Reduced Cortisol and Metabolic Responses of Thin Ewes to an Acute Cold Challenge in Mid-Pregnancy: Implications for Animal Physiology and Welfare	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; BODY CONDITION SCORE; FEED RESTRICTION; PLASMA LEPTIN; FETAL-GROWTH; PERICONCEPTIONAL UNDERNUTRITION; CIRCULATING LEPTIN; NUTRITIONAL-STATUS; HORMONAL PROFILES; BLOOD METABOLITES	Background: Low food availability leading to reductions in Body Condition Score (BCS; 0 indicates emaciation and 5 obesity) in sheep often coincides with low temperatures associated with the onset of winter in New Zealand. The ability to adapt to reductions in environmental temperature may be impaired in animals with low BCS, in particular during pregnancy when metabolic demand is higher. Here we assess whether BCS affects a pregnant animal's ability to cope with cold challenges. Methods: Eighteen pregnant ewes with a BCS of 2.7 +/- 0.1 were fed to attain low (LBC: BCS2.3 +/- 0.1), medium (MBC: BCS3.2 +/- 0.2) or high BCS (HBC: BCS3.6 +/- 0.2). Shorn ewes were exposed to a 6-h acute cold challenge in a climate-controlled room (wet and windy conditions, 4.4 +/- 0.1 degrees C) in mid-pregnancy. Blood samples were collected during the BCS change phase, acute cold challenge and recovery phase. Results: During the BCS change phase, plasma glucose and leptin concentrations declined while free fatty acids (FFA) increased in LBC compared to MBC (P<0.01, P<0.01 and P<0.05, respectively) and HBC ewes (P<0.05, P<0.01 and P<0.01, respectively). During the cold challenge, plasma cortisol concentrations were lower in LBC than MBC (P<0.05) and HBC ewes (P<0.05), and FFA and insulin concentrations were lower in LBC than HBC ewes (P<0.05 and P<0.001, respectively). Leptin concentrations declined in MBC and HBC ewes while remaining unchanged in LBC ewes (P<0.01). Glucose concentrations and internal body temperature (T-core) increased in all treatments, although peak T-core tended to be higher in HBC ewes (P<0.1). During the recovery phase, T4 concentrations were lower in LBC ewes (P<0.05). Conclusion: Even though all ewes were able to increase T-core and mobilize glucose, low BCS animals had considerably reduced cortisol and metabolic responses to a cold challenge in mid-pregnancy, suggesting that their ability to adapt to cold challenges through some of the expected pathways was reduced.	[Verbeek, Else; Waas, Joseph Rupert; McLeay, Lance Maxwell] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Verbeek, Else; Matthews, Lindsay Ross] AgResearch Ltd, Anim Behav & Welf, Hamilton, New Zealand; [Oliver, Mark Hope] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Blache, Dominique] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Waikato; AgResearch - New Zealand; University of Auckland; University of Western Australia	Verbeek, E (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	else.verbeek@csiro.au	Blache, Dominique/H-4991-2014; Verbeek, Else/H-2814-2013	Blache, Dominique/0000-0003-3476-3068; Verbeek, Else/0000-0002-6769-8314; Verbeek, Else/0000-0002-1223-3480; Oliver, Mark/0000-0002-0359-2297	Beef+Lamb NZ [06AR/CS01]; Meat and Livestock Australia [06AR/CS01]; Foundation for Research, Science and Technology [C10X0312]	Beef+Lamb NZ; Meat and Livestock Australia(Meat and Livestock Australia); Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	The study received combined funding from Beef+Lamb NZ (http://www.beeflambnz.co.nz) and Meat and Livestock Australia (http://www.mla.com.au/Home; grant number: 06AR/CS01). Additional funding was received from the Foundation for Research, Science and Technology (grant number: C10X0312; http://www.frst.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana A, 2005, CAN J ANIM SCI, V85, P101, DOI 10.4141/A04-020; Asakuma S, 2003, COMP BIOCHEM PHYS A, V134, P329, DOI 10.1016/S1095-6433(02)00269-6; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Blache D, 2000, J ENDOCRINOL, V165, P625, DOI 10.1677/joe.0.1650625; Blache D, 2008, ANIM FEED SCI TECH, V147, P140, DOI 10.1016/j.anifeedsci.2007.09.014; Blum W F, 1994, Growth Regul, V4 Suppl 1, P11; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Caldeira RM, 2007, SMALL RUMINANT RES, V68, P233, DOI 10.1016/j.smallrumres.2005.08.027; Caldeira RM, 2007, SMALL RUMINANT RES, V68, P242, DOI 10.1016/j.smallrumres.2005.08.026; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Dallman MF, 2007, EXP NEUROL, V206, P179, DOI 10.1016/j.expneurol.2007.06.002; Daniel JA, 2002, J ANIM SCI, V80, P1083; Delavaud C, 2000, J ENDOCRINOL, V165, P519, DOI 10.1677/joe.0.1650519; DELFA R, 1989, ANIM PROD, V49, P327, DOI 10.1017/S0003356100032487; Ekpe ED, 2000, CAN J ANIM SCI, V80, P87, DOI 10.4141/A99-028; Faulconnier Y, 2001, BRIT J NUTR, V85, P299, DOI 10.1079/BJN2000275; Fernandez C, 1997, SMALL RUMINANT RES, V26, P277, DOI 10.1016/S0921-4488(97)00007-2; Fernandez C, 1998, SMALL RUMINANT RES, V27, P159, DOI 10.1016/S0921-4488(97)00034-5; Girotti M, 2006, NEUROSCIENCE, V138, P1067, DOI 10.1016/j.neuroscience.2005.12.002; Goldstein DS, 2007, STRESS, V10, P109, DOI 10.1080/10253890701288935; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; Jaquiery AL, 2006, J PHYSIOL-LONDON, V572, P109, DOI 10.1113/jphysiol.2006.105734; Jessop NS, 2000, FARM ANIMAL METABOLISM AND NUTRITION, P149, DOI 10.1079/9780851993782.0149; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Kenyon PR, 2003, NEW ZEAL VET J, V51, P200, DOI 10.1080/00480169.2003.36368; Korhonen T, 2005, COMP BIOCHEM PHYS A, V140, P217, DOI 10.1016/j.cbpb.2005.01.006; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Korte SM, 2009, VET J, V182, P378, DOI 10.1016/j.tvjl.2009.08.023; Li BT, 2000, CAN J ANIM SCI, V80, P97, DOI 10.4141/A99-041; Luther J, 2007, BIOL REPROD, V77, P343, DOI 10.1095/biolreprod.107.061440; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McMullen S, 2005, PLACENTA, V26, P25, DOI 10.1016/j.placenta.2004.04.010; Meza-Herrera CA, 2007, REPROD DOMEST ANIM, V42, P461, DOI 10.1111/j.1439-0531.2006.00807.x; Miller DR, 2009, J ANIM SCI, V87, P3167, DOI 10.2527/jas.2009-1825; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; NIWA, 2008, NAT CLIM SUMM; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; OLIVER MH, 1993, PEDIATR RES, V34, P62, DOI 10.1203/00006450-199307000-00015; Pijlman FTA, 2003, EUR NEUROPSYCHOPHARM, V13, P369, DOI 10.1016/S0924-977X(03)00040-3; Pijlman FTA, 2002, BEHAV BRAIN RES, V136, P365, DOI 10.1016/S0166-4328(02)00128-6; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rumball CWH, 2008, ENDOCRINOLOGY, V149, P1163, DOI 10.1210/en.2007-1306; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sano H, 1999, J ANIM SCI, V77, P2564; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SASAKI Y, 1980, J PHYSIOL-LONDON, V306, P323, DOI 10.1113/jphysiol.1980.sp013399; SLEE J, 1972, J PHYSIOL-LONDON, V227, P51, DOI 10.1113/jphysiol.1972.sp010019; Thomas L, 2001, J ENDOCRINOL, V169, P465, DOI 10.1677/joe.0.1690465; Tilbrook AJ, 2006, FRONT NEUROENDOCRIN, V27, P285, DOI 10.1016/j.yfrne.2006.06.002; Turner AI, 2011, SEX STEROIDS, P115; Vickers MH, 1999, GROWTH HORM IGF RES, V9, P236, DOI 10.1054/ghir.1999.0114; VOLLENWEIDER P, 1993, J CLIN INVEST, V92, P147, DOI 10.1172/JCI116542; Wallace JM, 2000, PLACENTA, V21, P100, DOI 10.1053/plac.1999.0440; Wallace JM, 1999, BIOL REPROD, V61, P101, DOI 10.1095/biolreprod61.1.101; WHEATON JE, 1993, ANIM REPROD SCI, V33, P127, DOI 10.1016/0378-4320(93)90111-4	60	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37315	10.1371/journal.pone.0037315	http://dx.doi.org/10.1371/journal.pone.0037315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662144	gold, Green Submitted, Green Published			2022-12-27	WOS:000305342300034
J	Yuan, SG; Le Roy, K; Venken, T; Lammens, W; Van den Ende, W; De Maeyer, M				Yuan, Shuguang; Le Roy, Katrien; Venken, Tom; Lammens, Willem; Van den Ende, Wim; De Maeyer, Marc			pKa Modulation of the Acid/Base Catalyst within GH32 and GH68: A Role in Substrate/Inhibitor Specificity?	PLOS ONE			English	Article							PROTEIN-LIGAND COMPLEXES; PH-DEPENDENT PROPERTIES; CELL-WALL INVERTASE; CRYSTAL-STRUCTURES; BETA-FRUCTOSIDASE; PK(A) VALUES; GLYCOSYL HYDROLASES; THERMOTOGA-MARITIMA; ASPERGILLUS-AWAMORI; CICHORIUM-INTYBUS	Glycoside hydrolases of families 32 (GH32) and 68 (GH68) belong to clan GH-J, containing hydrolytic enzymes (sucrose/fructans as donor substrates) and fructosyltransferases (sucrose/fructans as donor and acceptor substrates). In GH32 members, some of the sugar substrates can also function as inhibitors, this regulatory aspect further adding to the complexity in enzyme functionalities within this family. Although 3D structural information becomes increasingly available within this clan and huge progress has been made on structure-function relationships, it is not clear why some sugars bind as inhibitors without being catalyzed. Conserved aspartate and glutamate residues are well known to act as nucleophile and acid/bases within this clan. Based on the available 3D structures of enzymes and enzyme-ligand complexes as well as docking simulations, we calculated the pKa of the acid-base before and after substrate binding. The obtained results strongly suggest that most GH-J members show an acid-base catalyst that is not sufficiently protonated before ligand entrance, while the acid-base can be fully protonated when a substrate, but not an inhibitor, enters the catalytic pocket. This provides a new mechanistic insight aiming at understanding the complex substrate and inhibitor specificities observed within the GH-J clan. Moreover, besides the effect of substrate entrance on its own, we strongly suggest that a highly conserved arginine residue (in the RDP motif) rather than the previously proposed Tyr motif (not conserved) provides the proton to increase the pKa of the acid-base catalyst.	[Yuan, Shuguang; Le Roy, Katrien; Lammens, Willem; Van den Ende, Wim] Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Mol Plant Physiol, Heverlee, Belgium; [Yuan, Shuguang; Venken, Tom; De Maeyer, Marc] Katholieke Univ Leuven, Div Biochem Mol & Struct Biol, Dept Chem, Lab Biomol Modelling, Louvain, Belgium	KU Leuven; KU Leuven	Yuan, SG (corresponding author), Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Mol Plant Physiol, Heverlee, Belgium.	wim.vandenende@bio.kuleuven.be; marc.demaeyer@fys.kuleuven.be	Yuan, Shuguang/C-3615-2013; YUAN, SHUGUANG/S-9686-2019; Van Den Ende, Wim/I-6899-2013	YUAN, SHUGUANG/0000-0001-9858-4742; Van Den Ende, Wim/0000-0003-1137-3614; Venken, Tom/0000-0003-0773-1810	FWO Vlaanderen [G.0379.09, PDO-08-00246];  [DBOF/08/31];  [PDMK/09/104]	FWO Vlaanderen(FWO); ; 	SY was supported by DBOF/08/31. WVdE and MDM are supported by G.0379.09 (FWO Vlaanderen). KLR is supported by PDO-08-00246 (FWO Vlaanderen). WL was supported by PDMK/09/104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alexov E, 2003, PROTEINS, V50, P94, DOI 10.1002/prot.10265; Altenbach D, 2005, FEBS LETT, V579, P4647, DOI 10.1016/j.febslet.2005.07.034; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; [Anonymous], PYM MOL GRAPH SYST V; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bjarnadottir U, 2010, PROTEIN SCI, V19, P2485, DOI 10.1002/pro.530; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Coutinho PM, CARBOHYDRATE ACTIVE, P3; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies Matthew N., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-18; De Roover J, 1999, PHYSIOL PLANTARUM, V106, P28, DOI 10.1034/j.1399-3054.1999.106104.x; DELHAISE P, 1984, J MOL GRAPHICS, V2, P103, DOI 10.1016/0263-7855(84)80002-8; Esawy MA, 2008, BRAZ J CHEM ENG, V25, P237, DOI 10.1590/S0104-66322008000200003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fukamizo T, 2000, J BIOL CHEM, V275, P25633, DOI 10.1074/jbc.M002574200; Grigoriev IV, 1999, P NATL ACAD SCI USA, V96, P14318, DOI 10.1073/pnas.96.25.14318; Gunner MR, 2006, BBA-BIOENERGETICS, V1757, P942, DOI 10.1016/j.bbabio.2006.06.005; Hajjar E, 2009, J PHYS CHEM A, V113, P11783, DOI 10.1021/jp902930u; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOJ PB, 1995, PLANT J, V7, P367, DOI 10.1046/j.1365-313X.1995.7030367.x; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; Khandogin J, 2006, BIOCHEMISTRY-US, V45, P9363, DOI 10.1021/bi060706r; Kongsted J, 2007, BIOCHEMISTRY-US, V46, P13581, DOI 10.1021/bi7016365; KOSHLAND DE, 1954, J BIOL CHEM, V208, P139; Kukic P, 2010, PROTEINS, V78, P971, DOI 10.1002/prot.22621; Kulminskaya AA, 2003, BBA-PROTEINS PROTEOM, V1650, P22, DOI 10.1016/S1570-9639(03)00187-0; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Lawson SL, 1997, BIOCHEMISTRY-US, V36, P2257, DOI 10.1021/bi9620215; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liebl W, 1998, APPL MICROBIOL BIOT, V50, P55, DOI 10.1007/s002530051256; Mason AC, 2008, PROTEINS, V71, P81, DOI 10.1002/prot.21657; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Naumoff DG, 2001, PROTEINS, V42, P66, DOI 10.1002/1097-0134(20010101)42:1<66::AID-PROT70>3.0.CO;2-4; Nielsen JE, 2007, J MOL GRAPH MODEL, V25, P691, DOI 10.1016/j.jmgm.2006.05.007; Onufriev A, 2001, BIOCHEMISTRY-US, V40, P3413, DOI 10.1021/bi002740q; Polgar T, 2007, J CHEM INF MODEL, V47, P2366, DOI 10.1021/ci700223p; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; SCOTTI PA, 1995, FEBS LETT, V360, P307, DOI 10.1016/0014-5793(95)00099-U; Strube CP, 2011, J BIOL CHEM, V286, P17593, DOI 10.1074/jbc.M110.203166; Trujillo LE, 2001, ENZYME MICROB TECH, V28, P139, DOI 10.1016/S0141-0229(00)00290-8; Tynan-Connolly BM, 2007, PROTEIN SCI, V16, P239, DOI 10.1110/ps.062538707; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	55	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37453	10.1371/journal.pone.0037453	http://dx.doi.org/10.1371/journal.pone.0037453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662155	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300045
J	Franklin, MT; Ritland, CE; Myers, JH; Cory, JS				Franklin, Michelle T.; Ritland, Carol E.; Myers, Judith H.; Cory, Jenny S.			Multiple Mating and Family Structure of the Western Tent Caterpillar, Malacosoma californicum pluviale: Impact on Disease Resistance	PLOS ONE			English	Article							GENETIC DIVERSITY; HOST RACES; FITNESS; HETEROZYGOSITY; LEPIDOPTERA; INFECTION; OUTBREAKS; BEHAVIOR; POPULATIONS; POLYANDRY	Background: Levels of genetic diversity can strongly influence the dynamics and evolutionary changes of natural populations. Survival and disease resistance have been linked to levels of genetic diversity in eusocial insects, yet these relationships remain untested in gregarious insects where disease transmission can be high and selection for resistance is likely to be strong. Methodology/Principal Findings: Here we use 8 microsatellite loci to examine genetic variation in 12 families of western tent caterpillars, Malacosoma californicum pluviale from four different island populations to determine the relationship of genetic variability to survival and disease resistance. In addition these genetic markers were used to elucidate the population structure of western tent caterpillars. Multiple paternity was revealed by microsatellite markers, with the number of sires estimated to range from one to three per family (mean +/- SE = 1.92 +/- 0.23). Observed heterozygosity (H-O) of families was not associated to the resistance of families to a nucleopolyhedrovirus (NPV) (r = 0.161, F-1,F-12 = 0.271, P = 0.614), a major cause of mortality in high-density populations, but was positively associated with larval survival (r = 0.635, F-1,F-10 = 5.412, P = 0.048). Genetic differentiation among the families was high (F-ST = 0.269, P<0.0001), and families from the same island were as differentiated as were families from other islands. Conclusion/Significance: We have been able to describe and characterize 8 microsatellite loci, which demonstrate patterns of variation within and between families of western tent caterpillars. We have discovered an association between larval survival and family-level heterozygosity that may be relevant to the population dynamics of this cyclic forest lepidopteran, and this will be the topic of future work.	[Franklin, Michelle T.; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Ritland, Carol E.] Univ British Columbia, Dept Forest Sci, Genet Data Ctr, Vancouver, BC V6T 1W5, Canada; [Myers, Judith H.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; University of British Columbia	Franklin, MT (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jsc21@sfu.ca	Cory, Jenny S/M-9991-2013	Cory, Jenny S/0000-0002-4637-6439	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to JSC and JHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Cooke BJ, 2006, FOREST ECOL MANAG, V226, P110, DOI 10.1016/j.foreco.2006.01.034; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; Costa JT, 2003, P ROY SOC B-BIOL SCI, V270, P1697, DOI 10.1098/rspb.2003.2422; COSTA JT, 1993, BEHAV ECOL SOCIOBIOL, V32, P47, DOI 10.1007/BF00172222; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Ebert D, 2008, CURR OPIN MICROBIOL, V11, P290, DOI 10.1016/j.mib.2008.05.012; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Emelianov I, 2004, P ROY SOC B-BIOL SCI, V271, P97, DOI 10.1098/rspb.2003.2574; EMELIANOV I, 1995, HEREDITY, V75, P416, DOI 10.1038/hdy.1995.154; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fitzgerald T, 1995, TENT CATERPILLAR; Frid L, 2002, ECOL ENTOMOL, V27, P665, DOI 10.1046/j.1365-2311.2002.00460.x; Ganz HH, 2010, ECOLOGY, V91, P1263, DOI 10.1890/09-1243.1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hedrick PW, 2000, GENETICS POPULATIONS, P408; HOCHBERG ME, 1991, OIKOS, V61, P291, DOI 10.2307/3545236; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Joop G, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-19; King KC, 2011, EVOLUTION, V65, P1474, DOI 10.1111/j.1558-5646.2010.01215.x; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Myers JH, 1998, ECOLOGY, V79, P1111, DOI 10.1890/0012-9658(1998)079[1111:SIOOFL]2.0.CO;2; Myers JH, 2000, POPUL ECOL, V42, P231, DOI 10.1007/PL00012002; Nei M., 1987, MOL EVOLUTIONARY GEN; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Parker BJ, 2010, J ANIM ECOL, V79, P863, DOI 10.1111/j.1365-2656.2010.01690.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosengaus RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P546, DOI 10.1007/s002650100394; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SCHMIDHEMPEL P, 1994, PHILOS T R SOC B, V346, P313, DOI 10.1098/rstb.1994.0148; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Torres-Vila LM, 2004, BEHAV ECOL SOCIOBIOL, V55, P315, DOI 10.1007/s00265-003-0712-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WELLINGTON WG, 1962, J INSECT PATHOL, V4, P285; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wilson K., 2008, PHENOTYPIC PLASTICIT, V44, P137; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	52	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e37472	10.1371/journal.pone.0037472	http://dx.doi.org/10.1371/journal.pone.0037472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	22655050	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338900025
J	Sami, H; Maparu, AK; Kumar, A; Sivakumar, S				Sami, Haider; Maparu, Auhin K.; Kumar, Ashok; Sivakumar, Sri			Generic Delivery of Payload of Nanoparticles Intracellularly via Hybrid Polymer Capsules for Bioimaging Applications	PLOS ONE			English	Article							POLYELECTROLYTE; EMULSIONS; SPHERES; SIZE; MICROCONTAINERS; MICROCAPSULES; DEPENDENCE; PARTICLES; NANORODS; SILICA	Towards the goal of development of a generic nanomaterial delivery system and delivery of the 'as prepared' nanoparticles without 'further surface modification' in a generic way, we have fabricated a hybrid polymer capsule as a delivery vehicle in which nanoparticles are loaded within their cavity. To this end, a generic approach to prepare nanomaterials-loaded polyelectrolyte multilayered (PEM) capsules has been reported, where polystyrene sulfonate (PSS)/polyallylamine hydrochloride (PAH) polymer capsules were employed as nano/microreactors to synthesize variety of nanomaterials (metal nanoparticles; lanthanide doped inorganic nanoparticles; gadolinium based nanoparticles, cadmium based nanoparticles; different shapes of nanoparticles; co-loading of two types of nanoparticles) in their hollow cavity. These nanoparticles-loaded capsules were employed to demonstrate generic delivery of payload of nanoparticles intracellularly (HeLa cells), without the need of individual nanoparticle surface modification. Validation of intracellular internalization of nanoparticles-loaded capsules by HeLa cells was ascertained by confocal laser scanning microscopy. The green emission from Tb3+ was observed after internalization of LaF3:Tb3+(5%) nanoparticles-loaded capsules by HeLa cells, which suggests that nanoparticles in hybrid capsules retain their functionality within the cells. In vitro cytotoxicity studies of these nanoparticles-loaded capsules showed less/no cytotoxicity in comparison to blank capsules or untreated cells, thus offering a way of evading direct contact of nanoparticles with cells because of the presence of biocompatible polymeric shell of capsules. The proposed hybrid delivery system can be potentially developed to avoid a series of biological barriers and deliver multiple cargoes (both simultaneous and individual delivery) without the need of individual cargo design/modification.	[Sami, Haider; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Maparu, Auhin K.; Sivakumar, Sri] Indian Inst Technol, Unit Excellence Soft Nanofabricat, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Sami, H (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	ashokkum@iitk.ac.in; srisiva@iitk.ac.in	Kumar, Ashok/G-8515-2015; KUMAR, ASHOK/AAF-4055-2021; Sivakumar, Sri/F-2053-2013	KUMAR, ASHOK/0000-0002-9244-0622; Sivakumar, Sri/0000-0002-6472-2702; Kumar, Ashok/0000-0002-4910-9440	IIT Kanpur [IIT/CHE/20080352]; Department of Biotechnology [DBT/CHE/20100304]; Department of Science and Technology; India-UK Science Bridge [DST/BSBE/20090218]; DBT Junior Research Fellowship (DBT-JRF) programme	IIT Kanpur; Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); India-UK Science Bridge; DBT Junior Research Fellowship (DBT-JRF) programme	This work is funded by IIT Kanpur (IIT/CHE/20080352), Department of Biotechnology (DBT/CHE/20100304), Department of Science and Technology and India-UK Science Bridge (DST/BSBE/20090218). HS also acknowledges a senior research fellowship under the DBT Junior Research Fellowship (DBT-JRF) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alric C, 2008, J AM CHEM SOC, V130, P5908, DOI 10.1021/ja078176p; Angelatos AS, 2005, J PHYS CHEM B, V109, P3071, DOI 10.1021/jp045070x; Bedard MF, 2009, SOFT MATTER, V5, P148, DOI 10.1039/b812553h; Buchel G, 1998, ADV MATER, V10, P1036, DOI 10.1002/(SICI)1521-4095(199809)10:13<1036::AID-ADMA1036>3.0.CO;2-Z; Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Choi WS, 2005, J AM CHEM SOC, V127, P16136, DOI 10.1021/ja053981u; Cortez C, 2006, ADV MATER, V18, P1998, DOI 10.1002/adma.200600564; Cui JW, 2010, ADV FUNCT MATER, V20, P1625, DOI 10.1002/adfm.201000209; De Geest BG, 2009, SOFT MATTER, V5, P282, DOI 10.1039/b808262f; del Mercato LL, 2010, NANOSCALE, V2, P458, DOI 10.1039/b9nr00341j; Gorin DA, 2008, PHYS CHEM CHEM PHYS, V10, P6899, DOI 10.1039/b809696a; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Javier AM, 2008, ADV MATER, V20, P4281, DOI 10.1002/adma.200703190; Johnston APR, 2006, CURR OPIN COLLOID IN, V11, P203, DOI 10.1016/j.cocis.2006.05.001; Kievit FM, 2011, ADV MATER, V23, pH217, DOI 10.1002/adma.201102313; Koo HY, 2008, SMALL, V4, P742, DOI 10.1002/smll.200800021; Melancon MP, 2009, MRS BULL, V34, P415, DOI 10.1557/mrs2009.117; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pavlov AM, 2011, SOFT MATTER, V7, P4341, DOI 10.1039/c0sm01536a; Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585; Rivera Gil P, 2008, NANO TODAY, V3, P12; Rogach AL, 2000, CHEM MATER, V12, P2676, DOI 10.1021/cm000244i; Sau TK, 2004, LANGMUIR, V20, P6414, DOI 10.1021/la049463z; Shchukin DG, 2004, J PHYS CHEM B, V108, P19109, DOI 10.1021/jp048052o; Shchukin DG, 2003, LANGMUIR, V19, P4427, DOI 10.1021/la0268707; Sivakumar S, 2008, CHEM MATER, V20, P2063, DOI 10.1021/cm703237a; Sivakumar S, 2006, CHEM-EUR J, V12, P5878, DOI 10.1002/chem.200600224; Sivakumar S, 2009, ADV FUNCT MATER, V19, P2260, DOI 10.1002/adfm.200900399; Sivakumar S, 2009, ADV MATER, V21, P1820, DOI 10.1002/adma.200802475; Skirtach AG, 2004, LANGMUIR, V20, P6988, DOI 10.1021/la048873k; Skirtach AG, 2006, ANGEW CHEM INT EDIT, V45, P4612, DOI 10.1002/anie.200504599; Song Y, 2009, ANGEW CHEM INT EDIT, V48, P9143, DOI 10.1002/anie.200904666; Stadler B, 2011, ADV FUNCT MATER, V21, P14, DOI 10.1002/adfm.201001676; Thurn KT, 2007, NANOSCALE RES LETT, V2, P430, DOI 10.1007/s11671-007-9081-5; Wang YJ, 2008, NANO LETT, V8, P1741, DOI 10.1021/nl080877c; Wang YJ, 2006, CHEM MATER, V18, P4089, DOI 10.1021/cm060866p; Xu XL, 2002, J AM CHEM SOC, V124, P13864, DOI 10.1021/ja026901k; YUAN F, 1995, CANCER RES, V55, P3752; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001	41	18	20	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36195	10.1371/journal.pone.0036195	http://dx.doi.org/10.1371/journal.pone.0036195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649489	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335800006
J	Xia, TM; Xiao, D; Liu, D; Chai, WT; Gong, QQ; Wang, NN				Xia, Tongmei; Xiao, Dong; Liu, Dong; Chai, Wenting; Gong, Qingqiu; Wang, Ning Ning			Heterologous Expression of ATG8c from Soybean Confers Tolerance to Nitrogen Deficiency and Increases Yield in Arabidopsis	PLOS ONE			English	Article							NITRATE REDUCTASE-ACTIVITY; AUTOPHAGOSOME FORMATION; AMINO-ACIDS; CELL-DEATH; PROTEIN; VACUOLE; REMOBILIZATION; SENESCENCE; CYTOPLASM; PLANTS	Nitrogen is an essential element for plant growth and yield. Improving Nitrogen Use Efficiency (NUE) of crops could potentially reduce the application of chemical fertilizer and alleviate environmental damage. To identify new NUE genes is therefore an important task in molecular breeding. Macroautophagy (autophagy) is an intracellular process in which damaged or obsolete cytoplasmic components are encapsulated in double membraned vesicles termed autophagosomes, then delivered to the vacuole for degradation and nutrient recycling. One of the core components of autophagosome formation, ATG8, has been shown to directly mediate autophagosome expansion, and the transcript of which is highly inducible upon starvation. Therefore, we postulated that certain homologs of Saccharomyces cerevisiae ATG8 (ScATG8) from crop species could have potential for NUE crop breeding. A soybean (Glycine max, cv. Zhonghuang-13) ATG8, GmATG8c, was selected from the 11 family members based on transcript analysis upon nitrogen deprivation. GmATG8c could partially complement the yeast atg8 mutant. Constitutive expression of GmATG8c in soybean callus cells not only enhanced nitrogen starvation tolerance of the cells but accelerated the growth of the calli. Transgenic Arabidopsis over-expressing GmATG8c performed better under extended nitrogen and carbon starvation conditions. Meanwhile, under optimum growth conditions, the transgenic plants grew faster, bolted earlier, produced larger primary and axillary inflorescences, eventually produced more seeds than the wild-type. In average, the yield was improved by 12.9%. We conclude that GmATG8c may serve as an excellent candidate for breeding crops with enhanced NUE and better yield.	[Xia, Tongmei; Xiao, Dong; Liu, Dong; Chai, Wenting; Gong, Qingqiu; Wang, Ning Ning] Nankai Univ, Dept Plant Biol & Ecol, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Xia, TM (corresponding author), Nankai Univ, Dept Plant Biol & Ecol, Coll Life Sci, Tianjin 300071, Peoples R China.	gongq@nankai.edu.cn; wangnn@nankai.edu.cn	Gong, Qingqiu/AAU-9486-2021	Xiao, Dong/0000-0002-4968-9019	Major Technological Program on Cultivation of NewVarieties of Genetically Modified Organisms [2011ZX08004005-007, 2009ZX08009-133B, 2009ZX08009-126B, 2011ZX08010-002-004]; Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) [200800550017]; Tianjin Research Program of Applied Basic and Cutting-edge Technologies [11JCZDJC16400]	Major Technological Program on Cultivation of NewVarieties of Genetically Modified Organisms; Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Research Program of Applied Basic and Cutting-edge Technologies	This work was supported by the Major Technological Program on Cultivation of NewVarieties of Genetically Modified Organisms (No. 2011ZX08004005-007 and 2009ZX08009-133B) to NNW, (No. 2009ZX08009-126B and 2011ZX08010-002-004) to QG, Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) (No. 200800550017) to NNW, and Tianjin Research Program of Applied Basic and Cutting-edge Technologies (11JCZDJC16400) to QG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2012, PLANT CELL ENVIRON, V35, P38, DOI 10.1111/j.1365-3040.2011.02378.x; Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; Chang CY, 2007, MOL BIOL CELL, V18, P919, DOI 10.1091/mbc.E06-08-0683; Chung T, 2009, PLANT PHYSIOL, V149, P220, DOI 10.1104/pp.108.126714; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Fujiki Y, 2007, PLANT PHYSIOL, V143, P1132, DOI 10.1104/pp.106.093864; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; He Y, 2009, PLANT CELL TISS ORG, V98, P11, DOI 10.1007/s11240-009-9533-y; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; Honig A, 2012, PLANT CELL, V24, P288, DOI 10.1105/tpc.111.093112; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Izumi M, 2010, PLANT PHYSIOL, V154, P1196, DOI 10.1104/pp.110.158519; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kjeldahl J, 1883, Z ANAL CHEM, V22, P336; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Lai Z, 2011, PLANT J; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lenz HD, 2011, PLANT J; Liu D, 2010, J EXP BOT, V61, P1655, DOI 10.1093/jxb/erq033; Liu TB, 2010, AUTOPHAGY, V6, P74, DOI 10.4161/auto.6.1.10438; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Masclaux C, 2001, ANN APPL BIOL, V138, P69, DOI 10.1111/j.1744-7348.2001.tb00086.x; Masclaux-Daubresse C, 2008, PLANT BIOLOGY, V10, P23, DOI 10.1111/j.1438-8677.2008.00097.x; Masclaux-Daubresse C, 2011, J EXP BOT, V62, P2131, DOI 10.1093/jxb/erq405; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Matt P, 1998, PLANTA, V207, P27, DOI 10.1007/s004250050452; Mickelson S, 2003, J EXP BOT, V54, P801, DOI 10.1093/jxb/erg084; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pathak RR, 2008, CURRENT, P94; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; Sakhonwasee SA, 2009, AUTOPHAGY SUSTAINS A; SHIBLES RM, 1998, P 28 N CENTR EXT IND, P5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Slavikova S, 2005, J EXP BOT, V56, P2839, DOI 10.1093/jxb/eri276; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tewari K, 2004, J AGRON CROP SCI, V190, P46, DOI 10.1046/j.0931-2250.2003.00073.x; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wilkins MR, 1999, METH MOL B, V112, P531; Woods J, 2010, PHILOS T R SOC B, V365, P2991, DOI 10.1098/rstb.2010.0172; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yoshimoto K, 2010, FEBS LETT, V584, P1350, DOI 10.1016/j.febslet.2010.01.007; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zhang WH, 2007, FUNCT PLANT BIOL, V34, P314, DOI 10.1071/FP06271	73	67	74	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37217	10.1371/journal.pone.0037217	http://dx.doi.org/10.1371/journal.pone.0037217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629371	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300027
J	Chen, DB; Feng, L; Lin, XP; Zhang, W; Li, FR; Liang, XL; Li, XH				Chen, Ding-Bang; Feng, Li; Lin, Xiao-Pu; Zhang, Wei; Li, Fu-Rong; Liang, Xiu-Ling; Li, Xun-Hua			Penicillamine Increases Free Copper and Enhances Oxidative Stress in the Brain of Toxic Milk Mice	PLOS ONE			English	Article							WILSONS-DISEASE; NEUROLOGIC SYNDROME; ATPASE ATP7A; EXPRESSION; TRANSPORTER; TRANSITION; DIAGNOSIS; BARRIER; METALS; MOUSE	Wilson disease (WD) is characterized by the accumulation of copper arising from a mutation in the ATP7B gene. Penicillamine (PA) makes 10-50% of the patients with neurologic symptoms neurologically worse at the early stage of administration. The aim of this study was to determine how the copper metabolism changes and whether the change impairs the brain of toxic milk (tx) mice, an animal model of WD, during the PA administration. The free copper and protein-bound copper concentrations in the serum, cortex and basal ganglia of tx mice with PA administration for 3 days, 10 days and 14 days, respectively, were investigated. The expression of copper transporters, ATP7A and CTR1, was analyzed by real-time quantitative PCR, immunofluorescence and Western blot. Then SOD, MDA and GSH/GSSG were detected to determine whether the oxidative stress changed correspondingly. The results revealed the elevated free copper concentrations in the serum and brain, and declined protein-bound copper concentrations in the brain of tx mice during PA administration. Meanwhile, transiently increased expression of ATP7A and CTR1 was observed generally in the brain parenchyma by immunofluorescence, real-time quantitative PCR and Western blot. Additionally, ATP7A and CTR1 were observed to locate mainly at Golgi apparatus and cellular membrane respectively. Intense staining of ATP7A in the choroid plexus was found in tx mice on the 3rd and 10th day of PA treatment, but rare staining of ATP7A and CTR1 in the blood-brain barrier (BBB). Decreased GSH/GSSG and increased MDA concentrations were also viewed in the cortex and basal ganglia. Our results suggested the elevated free copper concentrations in the brain might lead to the enhanced oxidative stress during PA administration. The increased free copper in the brain might come from the copper mobilized from brain parenchyma cells but not from the serum according to the ATP7A and CTR1 expression analysis.	[Chen, Ding-Bang; Feng, Li; Liang, Xiu-Ling; Li, Xun-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Xiao-Pu] So Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei; Li, Fu-Rong] Sun Yat Sen Univ, Lab Anim Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University	Chen, DB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lxunh001@yahoo.com.cn			National Natural Science Foundation of China [30671154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Science Foundation of China(30671154,http://www.nsfc.gov.cn/Portal0/default106.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2006, BIOMETALS, V19, P555, DOI 10.1007/s10534-005-5918-5; Bohrer D, 2004, CLIN CHIM ACTA, V345, P113, DOI 10.1016/j.cccn.2004.03.001; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; Brewer GJ, 2009, TRANSL RES, V154, P70, DOI 10.1016/j.trsl.2009.05.002; Brewer GJ, 2006, ARCH NEUROL-CHICAGO, V63, P521, DOI 10.1001/archneur.63.4.521; BREWER GJ, 1987, ARCH NEUROL-CHICAGO, V44, P490, DOI 10.1001/archneur.1987.00520170020016; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-1007214; Cheng J, 2011, BIOL TRACE ELEM RES; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Lutsenko S, 2010, METALLOMICS, V2, P596, DOI 10.1039/c0mt00006j; Minghetti M, 2011, COMP BIOCHEM PHYS C, V154, P93, DOI 10.1016/j.cbpc.2011.03.010; Monnot AD, 2011, TOXICOL APPL PHARM; Niciu MJ, 2006, NEUROSCIENCE, V139, P947, DOI 10.1016/j.neuroscience.2006.01.044; Ozcelik D, 2003, BIOL TRACE ELEM RES, V96, P209, DOI 10.1385/BTER:96:1-3:209; Ozcelik D, 2009, BIOL TRACE ELEM RES, V127, P45, DOI 10.1007/s12011-008-8219-3; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Porzio S, 1997, ARCH NEUROL-CHICAGO, V54, P1166, DOI 10.1001/archneur.1997.00550210092019; RAUCH H, 1983, J HERED, V74, P141, DOI 10.1093/oxfordjournals.jhered.a109751; Reddy PVB, 2008, LAB INVEST, V88, P816, DOI 10.1038/labinvest.2008.49; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; SAKURAI H, 1992, BIOCHEM BIOPH RES CO, V185, P548, DOI 10.1016/0006-291X(92)91659-E; Sansinanea A S, 1998, Acta Physiol Pharmacol Ther Latinoam, V48, P25; Stuerenburg HJ, 2000, J NEURAL TRANSM, V107, P321, DOI 10.1007/s007020050026; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Tennant J, 2002, FEBS LETT, V527, P239, DOI 10.1016/S0014-5793(02)03253-2; Zhang SSZ, 2000, VET HUM TOXICOL, V42, P261	31	49	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37709	10.1371/journal.pone.0037709	http://dx.doi.org/10.1371/journal.pone.0037709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629446	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100048
J	Sunshine, JC; Sunshine, SB; Bhutto, I; Handa, JT; Green, JJ				Sunshine, Joel C.; Sunshine, Sarah B.; Bhutto, Imran; Handa, James T.; Green, Jordan J.			Poly(beta-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; THERAPY; NANOPARTICLES; EXPRESSION; POLYMERS; ESTERS)	A variety of genetic diseases in the retina, including retinitis pigmentosa and leber congenital amaurosis, might be excellent targets for gene delivery as treatment. A major challenge in non-viral gene delivery remains finding a safe and effective delivery system. Poly(beta-amino ester)s (PBAEs) have shown great potential as gene delivery reagents because they are easily synthesized and they transfect a wide variety of cell types with high efficacy in vitro. We synthesized a combinatorial library of PBAEs and evaluated them for transfection efficacy and toxicity in retinal pigment epithelial (ARPE-19) cells to identify lead polymer structures and transfection formulations. Our optimal polymer (B5-S5-E7 at 60 w/w polymer: DNA ratio) transfected ARPE-19 cells with 44 +/- 5% transfection efficacy, significantly higher than with optimized formulations of leading commercially available reagents Lipofectamine 2000 (26 +/- 7%) and X-tremeGENE HP DNA (22 +/- 6%); (p<0.001 for both). Ten formulations exceeded 30% transfection efficacy. This high non-viral efficacy was achieved with comparable cytotoxicity (23 +/- 6%) to controls; optimized formulations of Lipofectamine 2000 and X-tremeGENE HP DNA showed 15 +/- 3% and 32 +/- 9% toxicity respectively (p>0.05 for both). Our optimal polymer was also significantly better than a gold standard polymeric transfection reagent, branched 25 kDa polyethyleneimine (PEI), which achieved only 8 +/- 1% transfection efficacy with 25 +/- 6% cytotoxicity. Subretinal injections using lyophilized GFP-PBAE nanoparticles resulted in 1.1 +/- 1x10(3)-fold and 1.5 +/- 0.7x10(3)-fold increased GFP expression in the retinal pigment epithelium (RPE)/choroid and neural retina respectively, compared to injection of DNA alone (p = 0.003 for RPE/choroid, p<0.001 for neural retina). The successful transfection of the RPE in vivo suggests that these nanoparticles could be used to study a number of genetic diseases in the laboratory with the potential to treat debilitating eye diseases.	[Sunshine, Joel C.; Sunshine, Sarah B.; Bhutto, Imran; Handa, James T.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Sunshine, JC (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	green@jhu.edu	Green, Jordan/B-9001-2009	Green, Jordan/0000-0003-4176-3808; Sunshine, Joel/0000-0001-9987-6712	Maryland Technology Development Corporation Maryland Stem Cell Research Fund (TEDCO MSCRF) [2009-MSCRFE-0098-00]; Medical Scientist Training Program; HHMI-Foundation Fighting Blindness Medical Research Fellowship; Thome Foundation; Research to Prevent Blindness; Robert Bond Welch Professorship;  [EY019904];  [EY14005]; NATIONAL EYE INSTITUTE [R01EY014005, R01EY019904] Funding Source: NIH RePORTER	Maryland Technology Development Corporation Maryland Stem Cell Research Fund (TEDCO MSCRF); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI-Foundation Fighting Blindness Medical Research Fellowship; Thome Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Robert Bond Welch Professorship; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank the Maryland Technology Development Corporation Maryland Stem Cell Research Fund (TEDCO MSCRF, 2009-MSCRFE-0098-00), Medical Scientist Training Program (JCS), HHMI-Foundation Fighting Blindness Medical Research Fellowship (SBS), EY019904 (JTH), EY14005 (JTH), Thome Foundation grant (JTH), a Research to Prevent Blindness unrestricted grant (Wilmer), and the Robert Bond Welch Professorship for support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Hassan K, 2000, CURR EYE RES, V20, P361, DOI 10.1076/0271-3683(200005)20:5;1-1;FT361; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Bhise NS, 2011, SMALL; Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023; Bitner H, 2011, INVEST OPHTH VIS SCI, V52, P5332, DOI 10.1167/iovs.11-7174; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Check E, 2005, NATURE, V433, P561, DOI 10.1038/433561a; del Pozo-Rodriguez A, 2008, INT J PHARM, V360, P177, DOI 10.1016/j.ijpharm.2008.04.023; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Green JJ, 2007, ADV MATER, V19, P2836, DOI 10.1002/adma.200700371; Handa JT, 1998, EXP EYE RES, V66, P411, DOI 10.1006/exer.1997.0442; Jacobson SG, 2011, ARCH OPHTHALMOL; Koirala A, 2011, BIOMATERIALS, V32, P9483, DOI 10.1016/j.biomaterials.2011.08.062; Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388; Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645; Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006; Sunshine J, 2009, ADV MATER, V21, P4947, DOI 10.1002/adma.200901718; Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14; Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s; Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016; Urtti A, 2000, J DRUG TARGET, V7, P413, DOI 10.3109/10611860009102216; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255	23	75	80	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37543	10.1371/journal.pone.0037543	http://dx.doi.org/10.1371/journal.pone.0037543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629417	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100038
J	Urquidi, V; Kim, J; Chang, MR; Dai, YF; Rosser, CJ; Goodison, S				Urquidi, Virginia; Kim, Jeongsoon; Chang, Myron; Dai, Yunfeng; Rosser, Charles J.; Goodison, Steve			CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer	PLOS ONE			English	Article							ACTIVATOR INHIBITOR TYPE-1; IN-SITU HYBRIDIZATION; CLINICAL UTILITY; EXPRESSION; DIAGNOSIS; CELL; CYTOLOGY; MARKERS; CLASSIFICATION; UROKINASE	The early detection of bladder cancer (BCa) is pivotal for successful patient treatment and management. Through genomic and proteomic studies, we have identified a number of bladder cancer-associated biomarkers that have potential clinical utility. In a case-control study, we examined voided urines from 127 subjects: 64 tumor-bearing subjects and 63 controls. The urine concentrations of the following proteins were assessed by enzyme-linked immunosorbent assay (ELISA); C-C motif chemokine 18 (CCL18), Plasminogen Activator Inhibitor 1 (PAI-1) and CD44. Data were compared to a commercial ELISA-based BCa detection assay (BTA-Trak (c)) and voided urinary cytology. We used analysis of the area under the curve of receiver operating characteristic curves to compare the ability of CCL18, PAI-1, CD44, and BTA to detect BCa in voided urine samples. Urinary concentrations of CCL18, PAI-1, and BTA were significantly elevated in subjects with BCa. CCL18 was the most accurate biomarker (AUC; 0.919; 95% confidence interval [CI], 0.8704-0.9674). Multivariate regression analysis highlighted CCL18 (OR; 18.31; 95% CI, 4.95-67.70, p<0.0001) and BTA (OR; 6.43; 95% CI, 1.86-22.21, p = 0.0033) as independent predictors of BCa in voided urine samples. The combination of CCL18, PAI-1 and CD44 improved the area under the curve to0.938. Preliminary results indicate that CCL18 was a highly accurate biomarker for BCa detection in this cohort. Monitoring CCL18 in voided urine samples has the potential to improve non-invasive tests for BCa diagnosis. Furthermore using the combination of CCL18, PAI-1 and CD44 may make the model more robust to errors to detect BCa over the individual biomarkers or BTA.	[Chang, Myron; Dai, Yunfeng] Univ Florida, Dept Biostat, Gainesville, FL 32610 USA; [Rosser, Charles J.] Univ Texas MD Anderson Canc Ctr, Sect Urol Oncol, Orlando, FL USA; [Urquidi, Virginia; Rosser, Charles J.; Goodison, Steve] Nonagen Biosci Corp, Orlando, FL USA	State University System of Florida; University of Florida; University of Texas System; UTMD Anderson Cancer Center		Charles.rosser@orlandohealth.com			National Cancer Institute [RO1 CA116161]; Florida Department of Health James and Esther King Team Science Award [10KT-01]; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [R01CA116161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health James and Esther King Team Science Award; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by research grants from National Cancer Institute RO1 CA116161 (SG), Florida Department of Health James and Esther King Team Science Award 10KT-01 (CJR), Flight Attendant Medical Research Institute (CJR). The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Greene FL, 2002, ACS AJCCCANCERSTAGIN; Banos JLG, 2001, UROLOGY, V57, P685, DOI 10.1016/S0090-4295(00)01090-6; Becker M, 2010, CANCER-AM CANCER SOC, V116, P4502, DOI 10.1002/cncr.25326; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; CAJULIS RS, 1995, DIAGN CYTOPATHOL, V13, P214, DOI 10.1002/dc.2840130307; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Daniely M, 2007, CANCER CYTOPATHOL, V111, P517, DOI 10.1002/cncr.23119; Duffy MJ, 1996, CLIN CANCER RES, V2, P613; Eissa S, 2008, CLIN BIOCHEM, V41, P1335, DOI 10.1016/j.clinbiochem.2008.08.085; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Hudson MA, 1997, J NATL CANCER I, V89, P709, DOI 10.1093/jnci/89.10.709; Hwang EC, 2010, UROLOGY; Klatte T, 2010, J UROLOGY, V183, P2403, DOI 10.1016/j.juro.2010.01.064; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; Malinowsky K, 2010, CURR MED CHEM, V17, P4370, DOI 10.2174/092986710793361216; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Miyake H, 2002, J UROLOGY, V167, P1282, DOI 10.1016/S0022-5347(05)65282-2; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; PEDERSEN H, 1994, CANCER RES, V54, P120; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Pu FS, 1992, CHIN PHARM J, V44, P235; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; RIFE CC, 1979, UROL CLIN N AM, V6, P599; Rosser CJ, 2009, CANCER EPIDEM BIOMAR, V18, P444, DOI 10.1158/1055-9965.EPI-08-1002; Schmitt M, 2010, EXPERT REV MOL DIAGN, V10, P1051, DOI [10.1586/erm.10.71, 10.1586/ERM.10.71]; Span PN, 2008, BJU INT, V102, P177, DOI 10.1111/j.1464-410X.2008.07568.x; Wang Q, 2011, INT J BIOL MARKERS; Woodman AC, 2000, CLIN CANCER RES, V6, P2381; Yang N, 2011, CLIN CANCER RES, V17, P3349, DOI 10.1158/1078-0432.CCR-10-3121; Zohny SF, 2010, MED ONCOL, V27, P1246, DOI 10.1007/s12032-009-9366-x	33	66	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37797	10.1371/journal.pone.0037797	http://dx.doi.org/10.1371/journal.pone.0037797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629457	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100052
J	Huang, BT; Chang, PY; Su, CH; Chao, CCK; Sue, LC				Huang, Bo-Tsang; Chang, Pu-Yuan; Su, Ching-Hua; Chao, Chuck C-K; Sue Lin-Chao			Gas7-Deficient Mouse Reveals Roles in Motor Function and Muscle Fiber Composition during Aging	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; TERMINAL SCHWANN-CELLS; RAT SOLEUS MUSCLE; MULTIJOINT MOVEMENTS; GAS7; PROTEIN; GROWTH; ISOFORMS; MODEL; LEADS	Background: Growth arrest-specific gene 7 (Gas7) has previously been shown to be involved in neurite outgrowth in vitro; however, its actual role has yet to be determined. To investigate the physiological function of Gas7 in vivo, here we generated a Gas7-deficient mouse strain with a labile Gas7 mutant protein whose functions are similar to wild-type Gas7. Methodology/Principal Findings: Our data show that aged Gas7-deficient mice have motor activity defects due to decreases in the number of spinal motor neurons and in muscle strength, of which the latter may be caused by changes in muscle fiber composition as shown in the soleus. In cross sections of the soleus of Gas7-deficient mice, gross morphological features and levels of myosin heavy chain I (MHC I) and MHC II markers revealed significantly fewer fast fibers. In addition, we found that nerve terminal sprouting, which may be associated with slow and fast muscle fiber composition, was considerably reduced at neuromuscular junctions (NMJ) during aging. Conclusions/Significance: These findings indicate that Gas7 is involved in motor neuron function associated with muscle strength maintenance.	[Huang, Bo-Tsang; Sue Lin-Chao] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Huang, Bo-Tsang; Su, Ching-Hua] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Pu-Yuan; Chao, Chuck C-K] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Chang Gung University	Huang, BT (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Institute of Molecular Biology, Academia Sinica; National Science Council [NSC 92-2311-B-001-083, 93-2311-B-001-025, 94-2311-B-001-011]; Academia Sinica [2323]	Institute of Molecular Biology, Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by an intramural fund from the Institute of Molecular Biology, Academia Sinica, and by a grant from the National Science Council (NSC 92-2311-B-001-083, 93-2311-B-001-025, 94-2311-B-001-011), http://web1.nsc.gov.tw/mp.aspx?mp=7 and theme project of Academia Sinica (2323), http://www.sinica.edu.tw/main_e.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2009, J BIOL CHEM, V284, P32695, DOI 10.1074/jbc.M109.035998; Basco D, 2010, EUR J APPL PHYSIOL, V110, P1215, DOI 10.1007/s00421-010-1592-6; Bear MF, 1996, NEUROSCIENCE EXPLORI; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Boron WF, 2003, MEDICAL PHYSL; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Campana ALM, 2003, EUR J NEUROSCI, V17, P2135, DOI 10.1046/j.1460-9568.2003.02631.x; CASTON J, 1995, NEUROBIOL LEARN MEM, V64, P195, DOI 10.1006/nlme.1995.0002; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; Durieux AC, 2009, J PHYSIOL-LONDON, V587, P3703, DOI 10.1113/jphysiol.2009.171355; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Garwicz M, 2002, BRAIN RES REV, V40, P152, DOI 10.1016/S0165-0173(02)00198-4; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; GUTMANN E, 1972, Ceskoslovenska Fysiologie, V21, P9; Hayworth CR, 2006, J NEUROSCI, V26, P6873, DOI 10.1523/JNEUROSCI.1086-06.2006; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kang H, 2003, J NEUROCYTOL, V32, P975, DOI 10.1023/B:NEUR.0000020636.27222.2d; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; KUGELBERG E, 1976, J NEUROL SCI, V27, P269, DOI 10.1016/0022-510X(76)90001-0; Lain E, 2009, J BIOL CHEM, V284, P8921, DOI 10.1074/jbc.M809491200; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; LARSSON L, 1995, PROG NEUROBIOL, V45, P397, DOI 10.1016/0301-0082(95)98601-Z; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Lazakovitch EM, 1999, GENOMICS, V61, P298, DOI 10.1006/geno.1999.5964; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Mendler L, 2008, J HISTOCHEM CYTOCHEM, V56, P111, DOI 10.1369/jhc.7A7322.2007; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Prochazka A, 2002, PROG BRAIN RES, V137, P109; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; REISER PJ, 1985, J BIOL CHEM, V260, P9077; RondiReig L, 1997, NEUROSCIENCE, V77, P955, DOI 10.1016/S0306-4522(96)00518-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; SCHENAU GJV, 1995, HUM MOVEMENT SCI, V14, P511, DOI 10.1016/0167-9457(95)00026-1; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Song YN, 2006, NEUROSCIENCE, V140, P33, DOI 10.1016/j.neuroscience.2006.01.045; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stigger F, 2011, EXP NEUROL, V228, P183, DOI 10.1016/j.expneurol.2011.01.001; SUGIURA T, 1992, ACTA PHYSIOL SCAND, V144, P419, DOI 10.1111/j.1748-1716.1992.tb09315.x; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081; VANSOEST AJ, 1995, HUM MOVEMENT SCI, V14, P391, DOI 10.1016/0167-9457(95)00022-4; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094	64	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37702	10.1371/journal.pone.0037702	http://dx.doi.org/10.1371/journal.pone.0037702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	23166618	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300085
J	Huang, BL; Lv, CQ; Zhao, YL; Huang, R				Huang, Baoling; Lv, Chengqun; Zhao, Yili; Huang, Rong			A Novel Strain D5 Isolated from Acacia confusa	PLOS ONE			English	Article							NITROGEN-FIXATION; SP NOV.; SYM PLASMID; NODULATION; RHIZOBIA; NODULES; LEGUMES; MIMOSA; ROOTS	We isolated a novel strain D5 from nodules of Acacia confusa. Under strict sterile conditions the strain could successfully nodulate Acacia confusa, A. crassicarpa and A. mangium, with nitrogenase activity ranging from 18.90 to 19.86 nmol.g(-1).min(-1). In the phylogenetic tree based on a complete 16S rRNA gene sequence, the sequence of strain D5 shared 99% homology with that of four species of genus Pseudomonas. The 685 bp nodA fragment amplified from strain D5 shared 95% homology with the nodA sequence of 9 species of genus Bradyrhizobium, with a genetic distance of 0.01682. The 740 bp nifH gene fragment was amplified from strain D5. This strain D5 nifH gene and Bradyrhizobium spp. formed a branch, showing 98% homology and a genetic distance of 0. The homology between this branch and the Bradyrhizobium spp. DG in another branch was 99%, with a genetic distance of 0.007906. These results indicate that this strain D5 is a new type of nitrogen-fixing bacterium.	[Huang, Baoling; Lv, Chengqun; Zhao, Yili; Huang, Rong] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China	Guangxi University	Huang, BL (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China.	hnboln@126.com	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Department of Education, Guangxi Zhuang Autonomous Region [201012MS002]	Department of Education, Guangxi Zhuang Autonomous Region	This research was supported by the Scientific Research Project (201012MS002) of the Department of Education, Guangxi Zhuang Autonomous Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WenXin, 2004, Scientia Agricultura Sinica, V37, P81; Chen WM, 2001, INT J SYST EVOL MICR, V51, P1729, DOI 10.1099/00207713-51-5-1729; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; Desnoues N, 2003, MICROBIOL-SGM, V149, P2251, DOI 10.1099/mic.0.26270-0; [樊利勤 FAN Liqin], 2007, [生态科学, Ecologic Science], V26, P107; He S, 2008, ARCH MICROBIOL, V190, P1, DOI 10.1007/s00203-008-0354-x; HOOYKAAS PJJ, 1981, NATURE, V291, P351, DOI 10.1038/291351a0; Huang BL, 2007, SCI CHINA SER C, V50, P228, DOI 10.1007/s11427-007-0034-0; Huang BaoLing, 2006, Journal of Beijing Forestry University, V28, P102; Huang BaoLing, 2004, Journal of Nanjing Forestry University (Natural Sciences Edition), V28, P29; Lu Cheng-Qun, 2006, Journal of Tropical and Subtropical Botany, V14, P19; [吕成群 Lu Chengqun], 2003, [微生物学通报, Microbiology], V30, P1; [吕成群 LV ChengQun], 2008, [微生物学通报, Microbiology], V35, P215; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; [缪礼鸿 MIAO Lihong], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P428; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; PLAZINSKI J, 1985, J BACTERIOL, V162, P1261, DOI 10.1128/JB.162.3.1261-1269.1985; Shang JH, 2005, BIOTECHNOLOGY, V15, P72; Shang Jun-hong, 2005, Forest Research, V18, P177; TRINICK M. J., 1965, Australian Journal of Science, V27, P263; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; TRINICK MJ, 1968, EXP AGR, V4, P243, DOI 10.1017/S0014479700004257; Trujillo ME, 2005, APPL ENVIRON MICROB, V71, P1318, DOI 10.1128/AEM.71.3.1318-1327.2005; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Wang Fengqin, 2008, Weishengwu Xuebao, V48, P1; Wang Su-ying, 2006, Weishengwu Xuebao, V46, P132; Wang XD, 2006, BIOTECHNOLOGY, V16, P24; [韦原莲 WEI Yuanlian], 2006, [西北林学院学报, Journal of Northwest Forestry College], V21, P120; Xie ZH, 2006, MICROBIOL-SGM, V152, P3535, DOI 10.1099/mic.0.29171-0; Yan YL, 2008, J AGR SCI TECHNOLOGY, V10, P45; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yi YouJin, 2007, Acta Phytopathologica Sinica, V37, P301; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0	33	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49236	10.1371/journal.pone.0049236	http://dx.doi.org/10.1371/journal.pone.0049236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166618	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300034
J	Park, JI; Steen, EJ; Burd, H; Evans, SS; Redding-Johnson, AM; Batth, T; Benke, PI; D'haeseleer, P; Sun, N; Sale, KL; Keasling, JD; Lee, TS; Petzold, CJ; Mukhopadhyay, A; Singer, SW; Simmons, BA; Gladden, JM				Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.			A Thermophilic Ionic Liquid-Tolerant Cellulase Cocktail for the Production of Cellulosic Biofuels	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE ACTIVITIES; ESCHERICHIA-COLI; CLOSTRIDIUM-THERMOCELLUM; BACTERIAL CONSORTIA; SP-NOV.; BIOMASS; PRETREATMENT; ETHANOL; GROWTH; SWITCHGRASS	Generation of biofuels from sugars in lignocellulosic biomass is a promising alternative to liquid fossil fuels, but efficient and inexpensive bioprocessing configurations must be developed to make this technology commercially viable. One of the major barriers to commercialization is the recalcitrance of plant cell wall polysaccharides to enzymatic hydrolysis. Biomass pretreatment with ionic liquids (ILs) enables efficient saccharification of biomass, but residual ILs inhibit both saccharification and microbial fuel production, requiring extensive washing after IL pretreatment. Pretreatment itself can also produce biomass-derived inhibitory compounds that reduce microbial fuel production. Therefore, there are multiple points in the process from biomass to biofuel production that must be interrogated and optimized to maximize fuel production. Here, we report the development of an IL-tolerant cellulase cocktail by combining thermophilic bacterial glycoside hydrolases produced by a mixed consortia with recombinant glycoside hydrolases. This enzymatic cocktail saccharifies IL-pretreated biomass at higher temperatures and in the presence of much higher IL concentrations than commercial fungal cocktails. Sugars obtained from saccharification of IL-pretreated switchgrass using this cocktail can be converted into biodiesel (fatty acid ethyl-esters or FAEEs) by a metabolically engineered strain of E. coli. During these studies, we found that this biodiesel-producing E. coli strain was sensitive to ILs and inhibitors released by saccharification. This cocktail will enable the development of novel biomass to biofuel bioprocessing configurations that may overcome some of the barriers to production of inexpensive cellulosic biofuels.	[Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst JBEI, Biosci Div, Berkeley, CA 94720 USA; [Park, Joshua I.; Sale, Kenneth L.; Simmons, Blake A.; Gladden, John M.] Sandia Natl Labs, Bioengn & Biomass Sci & Convers Technol Dept, Livermore, CA USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Geochem, Berkeley, CA 94720 USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA 94720 USA; [Evans, Sophia S.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Park, JI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	JMGladden@lbl.gov; JMGladden@lbl.gov	Simmons, Blake/N-6022-2016; Mukhopadhyay, Aindrila/AAW-7257-2021; Keasling, Jay D/J-9162-2012; Sun, Ning/D-6709-2012; Sun, Ning/E-4815-2011; Singer, STeven W/I-1851-2014	Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Sun, Ning/0000-0002-9689-9430; D'haeseleer, Patrik/0000-0003-0007-8150; Petzold, Christopher/0000-0002-8270-5228; Batth, Tanveer Singh/0000-0001-5346-4544	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; US Department of Energy	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) and the Joint Genome Institute supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Bjornsdottir SH, 2006, EXTREMOPHILES, V10, P1, DOI 10.1007/s00792-005-0466-z; Brennan TCR, 2010, BIOENERG RES, V3, P123, DOI 10.1007/s12155-010-9091-5; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chhabra SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021470; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; DECKER J, 2009, RENEWABLE ENERGY WOR, P11; DOE US, 2010, US FEM CAT MAK FUELS; Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049; Ganske F, 2006, BIOTECHNOL LETT, V28, P465, DOI 10.1007/s10529-006-0006-7; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; KUNDU S, 1983, BIOTECHNOL BIOENG, V25, P1109, DOI 10.1002/bit.260250418; Laboratory ORN, 2011, US BILL TON UPD BIOM; Lee SM, 2005, KOREAN J CHEM ENG, V22, P687, DOI 10.1007/BF02705783; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Lyon PF, 2000, CAN J MICROBIOL, V46, P1029, DOI 10.1139/cjm-46-11-1029; Meyer AS, 2009, J CEREAL SCI, V50, P337, DOI 10.1016/j.jcs.2009.01.010; Nakayama S, 2011, APPL ENVIRON MICROB, V77, P6470, DOI 10.1128/AEM.00706-11; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Ouellet M, 2011, GREEN CHEM; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pimentel D, 2003, NAT RESOUR RES, V12, P127, DOI DOI 10.1023/A:1024214812527; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sluiter B., 2011, NRELTP51042618; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tadesse H., 2011, ENERGY ENV SCI; Touzel JP, 2000, INT J SYST EVOL MICR, V50, P315, DOI 10.1099/00207713-50-1-315; Turner MB, 2003, GREEN CHEM, V5, P443, DOI 10.1039/b302570e; Wald M.L., 2011, NY TIMES; Wang Y, 2011, BIOTECHNOL BIOENG, V108, P1042, DOI 10.1002/bit.23045; Watanabe K, 2007, INT J SYST EVOL MICR, V57, P1473, DOI 10.1099/ijs.0.64672-0; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	43	143	149	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37010	10.1371/journal.pone.0037010	http://dx.doi.org/10.1371/journal.pone.0037010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	23251512	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800023
J	Zhang, LD; Yu, SW; Zuo, KJ; Luo, LJ; Tang, KX				Zhang, Lida; Yu, Shunwu; Zuo, Kaijing; Luo, Lijun; Tang, Kexuan			Identification of Gene Modules Associated with Drought Response in Rice by Network-Based Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COEXPRESSION NETWORKS; EXPRESSION DATA; TOOL; TOLERANCE; DATABASE; TRAITS; FAMILY; DNA	Understanding the molecular mechanisms that underlie plant responses to drought stress is challenging due to the complex interplay of numerous different genes. Here, we used network-based gene clustering to uncover the relationships between drought-responsive genes from large microarray datasets. We identified 2,607 rice genes that showed significant changes in gene expression under drought stress; 1,392 genes were highly intercorrelated to form 15 gene modules. These drought-responsive gene modules are biologically plausible, with enrichments for genes in common functional categories, stress response changes, tissue-specific expression and transcription factor binding sites. We observed that a gene module (referred to as module 4) consisting of 134 genes was significantly associated with drought response in both drought-tolerant and drought-sensitive rice varieties. This module is enriched for genes involved in controlling the response of the plant to water and embryonic development, including a heat shock transcription factor as the key regulator in the expression of ABRE-containing genes. These results suggest that module 4 is highly conserved in the ABA-mediated drought response pathway in different rice varieties. Moreover, our study showed that many hub genes clustered in rice chromosomes had significant associations with QTLs for drought stress tolerance. The relationship between hub gene clusters and drought tolerance QTLs may provide a key to understand the genetic basis of drought tolerance in rice.	[Zhang, Lida; Zuo, Kaijing; Tang, Kexuan] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yu, Shunwu; Luo, Lijun] Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Academy of Agricultural Sciences	Zhang, LD (corresponding author), Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn	Tang, Kexuan/E-3555-2013; Vermund, Sten/AAD-3592-2020; Zhang, Lan/F-7687-2011	Tang, Kexuan/0000-0002-8748-9624; Vermund, Sten/0000-0001-7289-8698; 	Shanghai Science and Technology Commission [09DJ1400504]; Genetically Modified Organisms Breeding Major Projects of China; Shanghai Jiao Tong University; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R01AI078933] Funding Source: NIH RePORTER	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Genetically Modified Organisms Breeding Major Projects of China; Shanghai Jiao Tong University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Key Project of Shanghai Science and Technology Commission (Grant No. 09DJ1400504), Genetically Modified Organisms Breeding Major Projects of China, and Chen Xing Young Scholar Award Program of Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Faccioli P, 2005, PLANT MOL BIOL, V58, P739, DOI 10.1007/s11103-005-8159-7; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Harrak H, 1999, PLANT PHYSIOL, V121, P557, DOI 10.1104/pp.121.2.557; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r52; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Yue B, 2005, THEOR APPL GENET, V111, P1127, DOI 10.1007/s00122-005-0040-1; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	44	79	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e33748	10.1371/journal.pone.0033748	http://dx.doi.org/10.1371/journal.pone.0033748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662107	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300001
J	Shi, XD; Pan, Y; Wang, ML; Wang, DS; Li, WY; Jiang, T; Zhang, P; Chi, XM; Jiang, YF; Gao, YH; Zhong, J; Sun, B; Xu, DM; Jiang, J; Niu, JQ				Shi, Xiaodong; Pan, Yu; Wang, Moli; Wang, Dongsheng; Li, Wanyu; Jiang, Tao; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Zhong, Jin; Sun, Bing; Xu, Damo; Jiang, Jing; Niu, Junqi			IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; VIROLOGICAL RESPONSE; IFN-LAMBDA; INFECTION; THERAPY	Background: The interleukin-28B gene (IL28B) locus has been associated with host resistance to hepatitis C virus (HCV) infection and response to PEG-IFN/RBV treatment in western populations. This study was to determine whether this gene variant is also associated with spontaneous clearance of HCV infection, treatment response and IL-28B protein production in Chinese patients. Methods: We genotyped IL28B genetic variations (rs12980275, rs8103142, rs8099917 and rs12979860) by pyrosequencing DNA samples from cohorts consisting of 529 subjects with persistent HCV infection, 196 subjects who cleared the infection, 171 healthy individuals and 235 chronic HCV patients underwent IFN/RBV treatment. The expression of IL-28B were measured by ELISA and RT-PCR. Results: We found that the four IL28B variants were in complete linkage disequilibrium (r2 = 0.97-0.98). The rs12979860 CC genotype was strongly associated with spontaneously HCV clearance and successful IFN/RBV treatment compared to the CT/TT. IL-28B levels in persistent HCV patients were significantly lower than subjects who spontaneously resolved HCV and healthy controls and were also associated with high levels of ALT (alanine aminotransferase) and AST (aspartate aminotransferase). IL-28B levels were also significantly lower in individuals carrying T alleles than CC homozygous. Conclusions: Thus, the rs12979860-CC variant upstream of IL28B gene is associated with spontaneous clearance of HCV, susceptible to IFN/RBV treatment and increased IL-28B levels in this Chinese population.	[Shi, Xiaodong; Pan, Yu; Li, Wanyu; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Niu, Junqi] Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Jing] Jilin Univ, Dept Clin Epidemiol, Hosp 1, Changchun 130023, Peoples R China; [Zhong, Jin; Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Wang, Dongsheng; Jiang, Tao] Hosp HepatologyBiliary Jilin Prov, Changchun, Peoples R China; [Xu, Damo] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Wang, Moli] Jilin Univ, Hosp 4, Changchun 130023, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Glasgow; Jilin University	Shi, XD (corresponding author), Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China.	jiangjing19702000@yahoo.cn; junqiniu@yahoo.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Shanghai Pasteur Health Research Foundation [SPHRF2009001]; Eleventh 5-year National Key Programs on Infectious Disease [2008ZX10002-014]; National Natural Science Foundation of China [81001312/H1005, 81072347/H2609]; Jilin University [20101036]	Shanghai Pasteur Health Research Foundation; Eleventh 5-year National Key Programs on Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University(Jilin University)	This study was supported by grants from the Shanghai Pasteur Health Research Foundation (SPHRF2009001), the Eleventh 5-year National Key Programs on Infectious Disease (2008ZX10002-014), the National Natural Science Foundation of China under grants No 81001312/H1005 and 81072347/H2609 and the Graduate Innovation Fund of Jilin University (No. 20101036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bruno S, 2008, ANN HEPATOL, V7, P114, DOI 10.1016/S1665-2681(19)31865-4; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepburn MJ, 2004, AM J MED, V117, P163, DOI 10.1016/j.amjmed.2004.02.043; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Hwang SJ, 2001, J MED VIROL, V65, P505, DOI 10.1002/jmv.2064; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Rauch A, 2010, EUR J CLIN INVEST, V40, P950, DOI 10.1111/j.1365-2362.2010.02337.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013	40	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37054	10.1371/journal.pone.0037054	http://dx.doi.org/10.1371/journal.pone.0037054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649509	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305335800027
J	Shi, XW; Zhou, Z; Wang, LL; Yue, F; Wang, MQ; Yang, CY; Song, LS				Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng			The Immunomodulation of Acetylcholinesterase in Zhikong Scallop Chlamys farreri	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; MOLECULAR CHARACTERIZATION; MUSCLE REGENERATION; INNATE IMMUNITY; NERVOUS-SYSTEM; RAT-BRAIN; EXPRESSION; INHIBITION; HEMOCYTES; RECEPTOR	Background: Acetycholinesterase (AChE; EC 3.1.1.7) is an essential hydrolytic enzyme in the cholinergic nervous system, which plays an important role during immunomodulation in vertebrates. Though AChEs have been identified in most invertebrates, the knowledge about immunomodulation function of AChE is still quite meagre in invertebrates. Methodology: A scallop AChE gene was identified from Chlamys farreri (designed as CfAChE), and its open reading frame encoded a polypeptide of 522 amino acids. A signal peptide, an active site triad, the choline binding site and the peripheral anionic sites (PAS) were identified in CfAChE. The recombinant mature polypeptide of CfAChE (rCfAChE) was expressed in Pichia pastoris GS115, and its activity was 71.3 +/- 1.3 U mg(-1) to catalyze the hydrolysis of acetylthiocholine iodide. The mRNA transcripts of CfAChE were detected in haemocytes, hepatopancreas, adductor muscle, mantle, gill, kidney and gonad, with the highest expression level in hepatopancreas. The relative expression level of CfAChE mRNA in haemocytes was both up-regulated after LPS (0.5 mg mL(-1)) and human TNF-alpha (50 ng mL(-1)) stimulations, and it reached the highest level at 12 h (10.4-fold, P<0.05) and 1 h (3.2-fold, P<0.05), respectively. After Dichlorvos (DDVP) (50 mg L-1) stimulation, the CfAChE activity in the supernatant of haemolymph decreased significantly from 0.16 U mg(-1) at 0 h to 0.03 U mg(-1) at 3 h, while the expression level of lysozyme in the haemocytes was up-regulated and reached the highest level at 6 h, which was 3.0-fold (P<0.05) of that in the blank group. Conclusions:The results collectively indicated that CfAChE had the acetylcholine-hydrolyzing activity, which was in line with the potential roles of AChE in the neuroimmune system of vertebrates which may help to re-balance the immune system after immune response.	[Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Shi, Xiaowei; Zhou, Zhi; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, XW (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Chinese Ministry of Science and Technology [2010CB126404]; National Natural Science Foundation of China [30925028, 30730070, 31072192]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (973 program, no. 2010CB126404) from Chinese Ministry of Science and Technology, and grants (No. 30925028 and 30730070 to LS, and 31072192 to LW) from National Natural Science Foundation of China, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2004, EUR J HISTOCHEM, V48, P235; Anguiano GA, 2010, ENVIRON TOXICOL, V25, P327, DOI 10.1002/tox.20491; Arpagaus M, 1998, J PHYSIOLOGY-PARIS, V92, P363, DOI 10.1016/S0928-4257(99)80006-0; Askar KA, 2011, APPL BIOCH BIOTECHNO; Azevedo-Pereira HMVS, 2011, ECOTOX ENVIRON SAFE, V74, P1210, DOI 10.1016/j.ecoenv.2011.03.018; Baxter GD, 1999, INT J PARASITOL, V29, P1765, DOI 10.1016/S0020-7519(99)00136-8; BERGMANN F, 1950, BIOCHIM BIOPHYS ACTA, V6, P217, DOI 10.1016/0006-3002(50)90094-1; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boudinot E, 2009, RESP PHYSIOL NEUROBI, V165, P40, DOI 10.1016/j.resp.2008.10.003; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; BULBRING E, 1953, PROC R SOC SER B-BIO, V141, P445, DOI 10.1098/rspb.1953.0053; Cao A, 2007, INT IMMUNOPHARMACOL, V7, P1395, DOI 10.1016/j.intimp.2007.07.008; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P223; Cheng Thomas C., 1996, P299; Costa MM, 2009, FISH SHELLFISH IMMUN, V26, P515, DOI 10.1016/j.fsi.2009.02.001; CYMBOROWSKI B, 1970, COMP BIOCHEM PHYSIOL, V32, P367, DOI 10.1016/0010-406X(70)90950-3; Das UN, 2007, MED SCI MONITOR, V13, pRA214; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; DEWHURST SA, 1975, COMP BIOCHEM PHYS C, V50, P53; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELBERMANI AWI, 1978, J EMBRYOL EXP MORPH, V48, P177; HORNSTEIN EP, 1994, VISUAL NEUROSCI, V11, P989, DOI 10.1017/S0952523800003928; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Johnson JL, 2003, BIOCHEMISTRY-US, V42, P5438, DOI 10.1021/bi027065u; Jones AK, 2002, FASEB J, V16, P441, DOI 10.1096/fj.01-0683fje; Kang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019063; Karczmar AG, 2010, CHEM-BIOL INTERACT, V187, P34, DOI 10.1016/j.cbi.2010.03.009; Kawli T, 2010, DIS MODEL MECH, V3, P721, DOI 10.1242/dmm.003871; KEYHANI E, 1981, J CELL SCI, V52, P327; KUSSATHE.E, 1967, HISTOCHEMISTRY, V8, P237, DOI 10.1007/BF00306086; Leone P, 2010, CHEM-BIOL INTERACT, V187, P49, DOI 10.1016/j.cbi.2010.01.030; Lin G, 2005, J BIOCHEM MOL TOXIC, V19, P234, DOI 10.1002/jbt.20087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2010, BIOCHEM PHARMACOL, V80, P1427, DOI 10.1016/j.bcp.2010.07.020; MCKENNA OC, 1968, CIRC RES, V23, P645, DOI 10.1161/01.RES.23.5.645; Monnet-Tschudi F, 2000, TOXICOL APPL PHARM, V165, P175, DOI 10.1006/taap.2000.8934; Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013; ORON U, 1984, CELL MOL BIOL, V30, P411; Pegan K, 2010, CHEM-BIOL INTERACT, V187, P96, DOI 10.1016/j.cbi.2010.03.034; PITZURRA L, 1989, INFECT IMMUN, V57, P2452, DOI 10.1128/IAI.57.8.2452-2456.1989; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Rand James B, 2007, WormBook, P1; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; RYBICKA K, 1967, EXP PARASITOL, V20, P263, DOI 10.1016/0014-4894(67)90048-3; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; SCHWARTZ JH, 1975, J GEN PHYSIOL, V65, P255, DOI 10.1085/jgp.65.3.255; SERAVIN LN, 1965, DOKL AKAD NAUK SSSR+, V160, P486; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; Szegletes T, 1998, BIOCHEMISTRY-US, V37, P4206, DOI 10.1021/bi972158a; Talesa V, 1999, J NEUROCHEM, V72, P1250, DOI 10.1046/j.1471-4159.1999.0721250.x; THIEDEMANN KU, 1986, CELL TISSUE RES, V244, P153; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; Tyagi E, 2010, EUR J PHARMACOL, V640, P206, DOI 10.1016/j.ejphar.2010.04.041; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; von Wachtendonk D., 1979, Comparative Biochemistry and Physiology C Comparative Pharmacology, V63, P279, DOI 10.1016/0306-4492(79)90074-1; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; WATSON JE, 1976, PFLUG ARCH EUR J PHY, V363, P161, DOI 10.1007/BF01062285; WHITTAKER JR, 1980, J EMBRYOL EXP MORPH, V55, P343; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zaitseva O V, 2008, Morfologiia, V133, P55; Zhang HA, 2010, FISH SHELLFISH IMMUN, V29, P149, DOI 10.1016/j.fsi.2010.02.024; Zhao PC, 2010, J BIOCHEM MOL TOXIC, V24, P51, DOI 10.1002/jbt.20311; Zhou XX, 2011, PROTEIN EXPRES PURIF, V77, P62, DOI 10.1016/j.pep.2010.11.017	72	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30828	10.1371/journal.pone.0030828	http://dx.doi.org/10.1371/journal.pone.0030828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22649509	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600085
J	Zhang, L; Ding, XB; Lu, RR; Feng, LG; Li, XF; Xiao, Y; Ruan, YH; Vermund, SH; Shao, YM; Qian, HZ				Zhang, Lan; Ding, Xianbin; Lu, Rongrong; Feng, Liangui; Li, Xuefeng; Xiao, Yan; Ruan, Yuhua; Vermund, Sten H.; Shao, Yiming; Qian, Han-Zhu			Predictors of HIV and Syphilis among Men Who Have Sex with Men in a Chinese Metropolitan City: Comparison of Risks among Students and Non-Students	PLOS ONE			English	Article							HIDDEN POPULATIONS; DRUG-USERS; PREVALENCE; INFECTIONS; BEHAVIOR; PROVINCE; MUNICIPALITY; ATTITUDES; HIV/AIDS; WORKERS	Background: Men who have sex with men (MSM) are at a substantial risk of HIV, given rising HIV prevalence in urban China. Adolescent and adult students often take HIV-related risk as part of sexual exploration. We compared the risks of HIV and syphilis infections and risky sexual behaviors between student and non-student among urban MSM. Methods: Respondent driven sampling approach was used to recruit men who were self-identified as MSM in Chongqing Metropolitan City in southwestern China in 2009. Each participant completed a computer-assisted self-interview which collected demographic and behavioral data, and provided blood specimens for HIV and syphilis testing. Multivariable logistic regression analyses identified predictors for HIV and syphilis infections while comparing student and non-student MSM. Results: Among 503 MSM participants, 36.4% were students, of whom 84.2% were in college. The adjusted prevalence of HIV infection was 5.5% (95% confidence interval [CI]: 2.1%-10.2%) in students and 20.9% (95% CI: 13.7%-27.5%) in non-students; the adjusted prevalence of syphilis was 4.4% (95% CI: 0.7%-9.0%) in students and 7.9% (95% CI: 3.6%-12.9%) in non-students (P = 0.12). Two groups had similar risky sexual behaviors such as number of sexual partners and exchanging sex for money. Multivariate analysis showed that students had lower HIV prevalence than non-students (adjusted odds ratio [AOR]: 0.3; 95% CI: 0.1-0.8) adjusting for age, ethnicity and other variables. Conclusion: Student MSM have lower HIV and similar syphilis prevalence compared with non-student MSM. However, due to a shorter duration of sexual experience and high prevalence of at-risk sexual behaviors among student MSM, HIV risk might be quite high in students as in non-students.	[Zhang, Lan; Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Zhang, Lan; Li, Xuefeng; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ding, Xianbin; Lu, Rongrong; Feng, Liangui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Xiao, Yan] Joint United Nations Program HIV AIDS, China Off, Beijing, Peoples R China	Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, L (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	xiaoy1800@163.com; ruanyuhua92@gmail.com; han-zhu.qian@vanderbilt.edu	Tang, Kexuan/E-3555-2013; Vermund, Sten/AAD-3592-2020; Zhang, Lan/F-7687-2011	Tang, Kexuan/0000-0002-8748-9624; Vermund, Sten/0000-0001-7289-8698; 	United States National Institutes of Health [R01AI078933, D43TW001035, R01AI094562]; Ministry of Science and Technology of China [2012ZX10001-002]; Chinese State Key Laboratory for Infectious Disease Development Grant [2011SKLID102]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R01AI078933] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory for Infectious Disease Development Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	United States National Institutes of Health (R01AI078933, D43TW001035, and R01AI094562), the Ministry of Science and Technology of China (2012ZX10001-002), and a Chinese State Key Laboratory for Infectious Disease Development Grant (2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, pI1, DOI 10.1007/s11524-006-9108-8; Abdul-Quader AS, 2006, J URBAN HEALTH, V83, P459, DOI 10.1007/s11524-006-9052-7; Chongqing Municipal Goverment, 2007, ADV; Chow EP, 2011, AIDS BEHAV      0403; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; Dosekun O, 2010, CURR OPIN HIV AIDS, V5, P291, DOI 10.1097/COH.0b013e32833a88a3; Feng Lian-gui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P870; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2001, J DRUG ISSUES, V31, P543, DOI 10.1177/002204260103100209; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Jiang Y, 2010, INT J EPIDEMIOL, V39, pII72, DOI 10.1093/ije/dyq224; Kong TSK, 2009, CHINESE MALE HOMOSEX; Leiber E, 2009, AIDS EDUC PREV, V21, P415, DOI 10.1521/aeap.2009.21.5.415; Li Chun-mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P882; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Liu J, 2011, AIDS PATIENT CARE ST, V25, P423, DOI 10.1089/apc.2010.0333; Liu L, 2009, CURR HIV RES, V7, P390, DOI 10.2174/157016209788680642; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mahfoud Z, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000386733.02425.98; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Ouyang Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1001; Reisner SL, 2010, AIDS CARE, V22, P577, DOI 10.1080/09540120903311482; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Tao XR, 2010, SE ASIAN J TROP MED, V41, P358; Volz E, 2008, J OFF STAT, V24, P79; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; [许娟 Xu Juan], 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P975; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang HS, 2004, AIDS BEHAV, V8, P105, DOI 10.1023/B:AIBE.0000030242.46843.71; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhang LL, 2010, SUBST USE MISUSE, V45, P2503, DOI 10.3109/10826084.2010.487234; Zheng Jian-Dong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P337; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x	50	79	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37211	10.1371/journal.pone.0037211	http://dx.doi.org/10.1371/journal.pone.0037211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22662107	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500074
J	Zhang, L; Li, YG; Li, YH; Qi, L; Liu, XG; Yuan, CZ; Hus, NW; Ma, DX; Li, ZF; Yang, Q; Li, W; Li, JM				Zhang, Lei; Li, Yong-gang; Li, Yu-hua; Qi, Lei; Liu, Xin-guang; Yuan, Cun-zhong; Hus, Nai-wen; Ma, Dao-xin; Li, Zhen-feng; Yang, Qiang; Li, Wei; Li, Jian-min			Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR-BETA; MEMORY T-CELLS; DISEASE-ACTIVITY; PROINFLAMMATORY CYTOKINE; AUTOIMMUNE INFLAMMATION; INFLAMED JOINTS; CROHNS-DISEASE; INTERLEUKIN 22; DISTINCT	Background: T-helper (Th) 22 is involved in the pathogenesis of inflammatory diseases. The roles of Th22 cells in the pathophysiological of ankylosing spondylitis (AS) and rheumatoid arthritis (RA) remain unsettled. So we examined the frequencies of Th22 cells, Th17 cells and Th1 cells in peripheral blood (PB) from patients with AS and patients with RA compared with both healthy controls as well as patients with osteoarthritis. Design and Methods: We studied 32 AS patients, 20 RA patients, 10 OA patients and 20 healthy controls. The expression of IL-22, IL-17 and IFN-gamma were examined in AS, RA, OA patients and healthy controls by flow cytometry. Plasma IL-22 and IL-17 levels were examined by enzyme-linked immunosorbent assay. Results: Th22 cells, Th17 cells and interleukin-22 were significantly elevated in AS and RA patients compared with OA patients and healthy controls. Moreover, Th22 cells showed positive correlation with Th17 cells as well as interleukin-22 in AS and RA patients. However, positive correlation between IL-22 and Th17 cells was only found in AS patients not in RA patients. In addition, the percentages of both Th22 cells and Th17 cells correlated positively with disease activity only in RA patients not in AS patients. Conclusions:The frequencies of both Th22 cells and Th17 cells were elevated in PB from patients with AS and patients with RA. These findings suggest that Th22 cells and Th17 cells may be implicated in the pathogenesis of AS and RA, and Th22 cells and Th17 cells may be reasonable cellular targets for therapeutic intervention.	[Zhang, Lei; Li, Yong-gang; Qi, Lei; Li, Zhen-feng; Yang, Qiang; Li, Jian-min] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China; [Li, Yu-hua] Shandong Univ, Dept Emergency, Qilu Hosp, Jinan 250100, Peoples R China; [Liu, Xin-guang; Ma, Dao-xin] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Cun-zhong] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Peoples R China; [Hus, Nai-wen] Shandong Univ, Prov Hosp, Dept Rheumatol, Jinan 250100, Peoples R China; [Li, Wei] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, L (corresponding author), Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan 250100, Peoples R China.	daoxinma@hotmail.com; jianminli123456@163.com	Li, yu/HHZ-5236-2022	Zhang, Lurong/0000-0002-0829-4942; Liang, Guoqiang/0000-0002-2355-444X; Liu, Haiyan/0000-0002-4652-469X; Liu, Xin Guang/0000-0001-9033-9099; Yao, Fei/0000-0002-6936-4553; Li, Yonggang/0000-0001-8280-4827	National Natural Science Foundation [30600680, 81070407, 30973018]; Shandong Technological Development Project [2005BS03022, Q2008C07, BS2009SW014]; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU [yzc21300071613082, yzc10147]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070407 and 30973018), the Shandong Technological Development Project (2005BS03022, Q2008C07, and BS2009SW014), and Graduate Independent Innovation Foundation of Shandong University, GIIFSDU (yzc21300071613082, yzc10147). (http://www.nsfc.gov.cn/Portal0/default152.htm) (http://www.art.sdu.edu.cn/2011/0321/931.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Flytlie HA, 2010, CYTOKINE, V49, P24, DOI 10.1016/j.cyto.2009.10.005; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	187	202	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e31000	10.1371/journal.pone.0031000	http://dx.doi.org/10.1371/journal.pone.0031000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22485125	gold, Green Published, Green Submitted			2022-12-27	WOS:000304780500001
J	Song, YX; Zhou, X; Wang, ZN; Gao, P; Li, AL; Liang, JW; Zhu, JL; Xu, YY; Xu, HM				Song, Yong-Xi; Zhou, Xin; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian			The Association between Individual SNPs or Haplotypes of Matrix Metalloproteinase 1 and Gastric Cancer Susceptibility, Progression and Prognosis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MALDI-TOF MS; PROMOTER POLYMORPHISM; NO ASSOCIATION; RISK; MMP-1; MATRIX-METALLOPROTEINASE-1; GENES; EPIDEMIOLOGY; GENOTYPES	Background: The single nucleotide polymorphisms (SNPs) in matrix metalloproteinase 1(MMP-1) play important roles in some cancers. This study examined the associations between individual SNPs or haplotypes in MMP-1 and susceptibility, clinicopathological parameters and prognosis of gastric cancer in a large sample of the Han population in northern China. Methods: In this case-controlled study, there were 404 patients with gastric cancer and 404 healthy controls. Seven SNPs were genotyped using the MALDI-TOF MS system. Then, SPSS software, Haploview 4.2 software, Haplo. states software and THEsias software were used to estimate the association between individual SNPs or haplotypes of MMP-1 and gastric cancer susceptibility, progression and prognosis. Results: Among seven SNPs, there were no individual SNPs correlated to gastric cancer risk. Moreover, only the rs470206 genotype had a correlation with histologic grades, and the patients with GA/AA had well cell differentiation compared to the patients with genotype GG (OR = 0.573; 95% CI: 0.353-0.929; P = 0.023). Then, we constructed a four-marker haplotype block that contained 4 common haplotypes: TCCG, GCCG, TTCG and TTTA. However, all four common haplotypes had no correlation with gastric cancer risk and we did not find any relationship between these haplotypes and clinicopathological parameters in gastric cancer. Furthermore, neither individual SNPs nor haplotypes had an association with the survival of patients with gastric cancer. Conclusions: This study evaluated polymorphisms of the MMP-1 gene in gastric cancer with a MALDI-TOF MS method in a large northern Chinese case-controlled cohort. Our results indicated that these seven SNPs of MMP-1 might not be useful as significant markers to predict gastric cancer susceptibility, progression or prognosis, at least in the Han population in northern China.	[Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China; [Zhou, Xin] China Med Univ, Dept Gynecol & Obstet, ShengJing Hosp, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China.	josieon826@yahoo.com.cn	Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	Xu, Yingying/0000-0003-4924-9379; wang, zhen ning/0000-0003-0557-3097; Yu, Jiguo/0000-0001-7607-475X; Stal, Per/0000-0002-9340-5298	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), the Program of Scientific and Technological Department of Liaoning Province (No. 2010225032) and Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1324, DOI 10.1158/1055-9965.EPI-09-0046; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Camp NJ, 2012, CANCER EPIDEM BIOMAR, V21, P176, DOI 10.1158/1055-9965.EPI-11-0845; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang WL, 2010, ASS MATRIX METALLOPR; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Hettiaratchi A, 2007, BRIT J CANCER, V96, P783, DOI 10.1038/sj.bjc.6603630; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Jin X, 2005, WORLD J GASTROENTERO, V11, P2385, DOI 10.3748/wjg.v11.i16.2385; Justenhoven C, 2004, CANCER EPIDEM BIOMAR, V13, P2059; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030277; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Matsumura S, 2004, J CANCER RES CLIN, V130, P259, DOI 10.1007/s00432-004-0543-1; Nam SI, 2011, LARYNGOSCOPE, V121, P171, DOI 10.1002/lary.21334; Ostrovsky O, 2009, J LEUKOCYTE BIOL, V86, P445, DOI 10.1189/jlb.1208735; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Su L, 2006, CARCINOGENESIS, V27, P1024, DOI 10.1093/carcin/bgi283; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Xu EP, 2005, J BIOCHEM BIOPH METH, V63, P222, DOI 10.1016/j.jbbm.2005.03.007; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521; Yue ZY, 2010, J SURG ONCOL, V102, P68, DOI 10.1002/jso.21584; Zinzindohoue F, 2005, CLIN CANCER RES, V11, P594	39	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e38002	10.1371/journal.pone.0038002	http://dx.doi.org/10.1371/journal.pone.0038002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	23284946	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900072
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800088
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-27	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200043
